Unnamed: 0,reference,protein,mutation_pos,mutation_from,mutation_to,ligand_name,ligand_idtype,ligand_id,ligand_class,exp_type,exp_func,exp_wt_value,exp_wt_unit,exp_mu_effect_sign,exp_mu_effect_type,exp_mu_effect_value,exp_fold_change,exp_mu_effect_qual,exp_mu_effect_ligand_prop,exp_mu_ligand_ref,opt_receptor_expression,opt_basal_activity,opt_gain_of_activity,opt_ligand_emax,opt_agonist,Uniprot_ID,VESPAl
22,15626750,hrh1_human,37,I,V,Cetirizine,ChEMBL Compound ID,CHEMBL1000,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.9,,=,,7.7,-1.585,,,[3H]-mepyramine (radioligand),94.2,0.0,,0.0,,P35367,0.3538844153012918
78,15626750,hrh1_human,37,I,V,HP-HA,ChEMBL Compound ID,CHEMBL264491,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.1,,=,,5.9,-1.585,,,[3H]-mepyramine (radioligand),94.2,0.0,,0.0,,P35367,0.3538844153012918
106,15626750,hrh1_human,37,I,V,[3H]-mepyramine,ChEMBL Compound ID,CHEMBL511,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,1.2,nM,=,,1.7,-1.416,,,[3H]-mepyramine (radioligand),94.2,0.0,,0.0,,P35367,0.3538844153012918
164,15626750,hrh1_human,37,I,V,Histamine,ChEMBL Compound ID,CHEMBL90,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.3,,=,,3.9,-2.513,,,[3H]-mepyramine (radioligand),94.2,0.0,,0.0,,P35367,0.3538844153012918
210,15626750,hrh1_human,37,I,V,HP-HP,SMILES,C1(CCNCCC2=CNC(CCC(C3=CC=CC=C3)C4=CC=CC=C4)=N2)=CN=C(CCC(C5=CC=CC=C5)C6=CC=CC=C6)N1,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.8,,=,,6.9,1.259,,,[3H]-mepyramine (radioligand),94.2,0.0,,0.0,,P35367,0.3538844153012918
220,15626750,hrh1_human,37,I,V,VUF8401,SMILES,N=C(NCCCC1=CNC=N1)NCCSC(C2=CC=CC=C2)C3=CC=CC=C3,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.0,,=,,5.9,-1.259,,,[3H]-mepyramine (radioligand),94.2,0.0,,0.0,,P35367,0.3538844153012918
230,15626750,hrh1_human,37,I,V,VUF4669,SMILES,OC(C1=CC=CC=C1)(C2CCN(CCCOC3=CC=C(C(CC(C(O)=O)O4)=O)C4=C3)CC2)C5=CC=CC=C5,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.7,,=,,8.0,1.995,,,[3H]-mepyramine (radioligand),94.2,0.0,,0.0,,P35367,0.3538844153012918
24,15626750,hrh1_human,84,N,S,Cetirizine,ChEMBL Compound ID,CHEMBL1000,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.9,,=,,7.5,-2.513,,,[3H]-mepyramine (radioligand),53.7,0.0,,0.0,,P35367,0.4314995970779948
80,15626750,hrh1_human,84,N,S,HP-HA,ChEMBL Compound ID,CHEMBL264491,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.1,,=,,6.8,5.012,,,[3H]-mepyramine (radioligand),53.7,0.0,,0.0,,P35367,0.4314995970779948
95,15626750,hrh1_human,84,N,S,Histaprodifen,ChEMBL Compound ID,CHEMBL275507,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.2,,=,,6.2,1.0,,,[3H]-mepyramine (radioligand),53.7,0.0,,0.0,,P35367,0.4314995970779948
108,15626750,hrh1_human,84,N,S,[3H]-mepyramine,ChEMBL Compound ID,CHEMBL511,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,1.2,nM,=,,1.1,1.091,,,[3H]-mepyramine (radioligand),53.7,0.0,,0.0,,P35367,0.4314995970779948
166,15626750,hrh1_human,84,N,S,Histamine,ChEMBL Compound ID,CHEMBL90,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.3,,=,,4.2,-1.259,,,[3H]-mepyramine (radioligand),53.7,0.0,,0.0,,P35367,0.4314995970779948
212,15626750,hrh1_human,84,N,S,HP-HP,SMILES,C1(CCNCCC2=CNC(CCC(C3=CC=CC=C3)C4=CC=CC=C4)=N2)=CN=C(CCC(C5=CC=CC=C5)C6=CC=CC=C6)N1,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.8,,=,,7.3,3.162,,,[3H]-mepyramine (radioligand),53.7,0.0,,0.0,,P35367,0.4314995970779948
222,15626750,hrh1_human,84,N,S,VUF8401,SMILES,N=C(NCCCC1=CNC=N1)NCCSC(C2=CC=CC=C2)C3=CC=CC=C3,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.0,,=,,6.4,2.512,,,[3H]-mepyramine (radioligand),53.7,0.0,,0.0,,P35367,0.4314995970779948
232,15626750,hrh1_human,84,N,S,VUF4669,SMILES,OC(C1=CC=CC=C1)(C2CCN(CCCOC3=CC=C(C(CC(C(O)=O)O4)=O)C4=C3)CC2)C5=CC=CC=C5,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.7,,=,,8.9,15.849,,,[3H]-mepyramine (radioligand),53.7,0.0,,0.0,,P35367,0.4314995970779948
26,16408006,hrh1_human,111,S,A,Cetirizine,ChEMBL Compound ID,CHEMBL1000,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.3,,=,,7.3,1.0,,,[3H]-mepyramine (radioligand),58.3,0.0,,0.0,,P35367,0.4746920109601497
119,16408006,hrh1_human,111,S,A,[3H]-mepyramine,ChEMBL Compound ID,CHEMBL511,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,1.3,nM,=,,4.1,-3.155,,,[3H]-mepyramine (radioligand),58.3,0.0,,0.0,,P35367,0.4746920109601497
173,16408006,hrh1_human,111,S,A,Histamine,ChEMBL Compound ID,CHEMBL90,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.1,,=,,3.0,-12.658,,,[3H]-mepyramine (radioligand),58.3,0.0,,0.0,,P35367,0.4746920109601497
27,16408006,hrh1_human,111,S,C,Cetirizine,ChEMBL Compound ID,CHEMBL1000,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.3,,=,,7.5,1.585,,,[3H]-mepyramine (radioligand),55.0,0.0,,0.0,,P35367,0.5642469712028383
120,16408006,hrh1_human,111,S,C,[3H]-mepyramine,ChEMBL Compound ID,CHEMBL511,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,1.3,nM,=,,0.4,3.25,,,[3H]-mepyramine (radioligand),55.0,0.0,,0.0,,P35367,0.5642469712028383
174,16408006,hrh1_human,111,S,C,Histamine,ChEMBL Compound ID,CHEMBL90,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.1,,=,,4.4,1.995,,,[3H]-mepyramine (radioligand),55.0,0.0,,0.0,,P35367,0.5642469712028383
28,16408006,hrh1_human,111,S,T,Cetirizine,ChEMBL Compound ID,CHEMBL1000,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.3,,=,,7.5,1.585,,,[3H]-mepyramine (radioligand),63.6,0.0,,0.0,,P35367,0.4746920109601497
121,16408006,hrh1_human,111,S,T,[3H]-mepyramine,ChEMBL Compound ID,CHEMBL511,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,1.3,nM,=,,2.7,-2.079,,,[3H]-mepyramine (radioligand),63.6,0.0,,0.0,,P35367,0.4746920109601497
175,16408006,hrh1_human,111,S,T,Histamine,ChEMBL Compound ID,CHEMBL90,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.1,,=,,4.1,1.0,,,[3H]-mepyramine (radioligand),63.6,0.0,,0.0,,P35367,0.4746920109601497
29,8903934,hrh1_human,155,S,A,Cetirizine,ChEMBL Compound ID,CHEMBL1000,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.2,,=,,7.8,-2.513,,,[3H]-mepyramine (radioligand),0.0,0.0,,0.0,,P35367,0.4138434113825487
43,8903934,hrh1_human,155,S,A,Levocetirizine,ChEMBL Compound ID,CHEMBL1201191,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.5,,=,,8.2,-1.996,,,[3H]-mepyramine (radioligand),0.0,0.0,,0.0,,P35367,0.4138434113825487
60,8903934,hrh1_human,155,S,A,(S)-cetirizine,ChEMBL Compound ID,CHEMBL1334217,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.0,,=,,6.7,-1.996,,,[3H]-mepyramine (radioligand),0.0,0.0,,0.0,,P35367,0.4138434113825487
103,8903934,hrh1_human,155,S,A,Chlorpheniramine,ChEMBL Compound ID,CHEMBL505,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.6,,=,,8.4,-1.585,,,[3H]-mepyramine (radioligand),0.0,0.0,,0.0,,P35367,0.4138434113825487
123,8903934,hrh1_human,155,S,A,[3H]-mepyramine,ChEMBL Compound ID,CHEMBL511,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,3.7,nM,=,,2.6,1.423,,,[3H]-mepyramine (radioligand),0.0,0.0,,0.0,,P35367,0.4138434113825487
176,8903934,hrh1_human,155,S,A,Histamine,ChEMBL Compound ID,CHEMBL90,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.9,,=,,5.7,-1.585,,,[3H]-mepyramine (radioligand),0.0,0.0,,0.0,,P35367,0.4138434113825487
30,8903934,hrh1_human,194,T,A,Cetirizine,ChEMBL Compound ID,CHEMBL1000,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.2,,=,,8.5,1.995,,,[3H]-mepyramine (radioligand),0.0,0.0,,0.0,,P35367,0.4501957387623412
40,9593602,hrh1_human,194,T,A,[3H]-Olopatidine,ChEMBL Compound ID,CHEMBL1189432,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,2.5,nM,=,,3.7,-1.479,,,[3H]-Olopatidine,56.0,0.0,,0.0,,P35367,0.4501957387623412
45,8903934,hrh1_human,194,T,A,Levocetirizine,ChEMBL Compound ID,CHEMBL1201191,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.5,,=,,8.5,1.0,,,[3H]-mepyramine (radioligand),0.0,0.0,,0.0,,P35367,0.4501957387623412
46,11809864,hrh1_human,194,T,A,Levocetirizine,ChEMBL Compound ID,CHEMBL1201191,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.5,,=,,8.7,1.585,,,[3H]-mepyramine (radioligand),24.4,0.0,,0.0,,P35367,0.4501957387623412
47,8198587,hrh1_human,194,T,A,D-chlorpheniramine,ChEMBL Compound ID,CHEMBL1201353,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.79,nM,=,,0.56,1.411,,,[3H]-mepyramine (radioligand),126.0,0.0,,0.0,,P35367,0.4501957387623412
49,8198587,hrh1_human,194,T,A,2-methylhistamine,ChEMBL Compound ID,CHEMBL12620,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,42.0,ÂµM,=,,25.0,1.68,,,[3H]-mepyramine (radioligand),126.0,0.0,,0.0,,P35367,0.4501957387623412
62,8903934,hrh1_human,194,T,A,(S)-cetirizine,ChEMBL Compound ID,CHEMBL1334217,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.0,,=,,8.0,10.0,,,[3H]-mepyramine (radioligand),0.0,0.0,,0.0,,P35367,0.4501957387623412
63,11809864,hrh1_human,194,T,A,(S)-cetirizine,ChEMBL Compound ID,CHEMBL1334217,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.1,,=,,8.2,12.589,,,[3H]-mepyramine (radioligand),24.4,0.0,,0.0,,P35367,0.4501957387623412
65,14978232,hrh1_human,194,T,A,8R-Terguride,ChEMBL Compound ID,CHEMBL1480516,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.1,,=,,6.1,1.0,,,[3H]-mepyramine (radioligand),36.7,0.0,,0.0,,P35367,0.4501957387623412
67,11809864,hrh1_human,194,T,A,(S)-hydroxyzine,ChEMBL Compound ID,CHEMBL1513166,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.5,,=,,8.4,7.943,,,[3H]-mepyramine (radioligand),24.4,0.0,,0.0,,P35367,0.4501957387623412
69,14978232,hrh1_human,194,T,A,8R-Lisuride,ChEMBL Compound ID,CHEMBL1528238,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.9,,=,,8.0,1.259,,,[3H]-mepyramine (radioligand),36.7,0.0,,0.0,,P35367,0.4501957387623412
71,8198587,hrh1_human,194,T,A,L-chlorpheniramine,ChEMBL Compound ID,CHEMBL1554789,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,69.0,nM,=,,36.0,1.917,,,[3H]-mepyramine (radioligand),126.0,0.0,,0.0,,P35367,0.4501957387623412
74,8198587,hrh1_human,194,T,A,2-thiazolylethylamine,ChEMBL Compound ID,CHEMBL25414,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,24.0,ÂµM,=,,28.0,-1.167,,,[3H]-mepyramine (radioligand),126.0,0.0,,0.0,,P35367,0.4501957387623412
76,8198587,hrh1_human,194,T,A,2-(3-bromophenyl)histamine,ChEMBL Compound ID,CHEMBL26116,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.67,ÂµM,=,,0.44,1.523,,,[3H]-mepyramine (radioligand),126.0,0.0,,0.0,,P35367,0.4501957387623412
101,8198587,hrh1_human,194,T,A,2-pyridylethylamine,ChEMBL Compound ID,CHEMBL32813,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,38.0,ÂµM,=,,44.0,-1.157,,,[3H]-mepyramine (radioligand),126.0,0.0,,0.0,,P35367,0.4501957387623412
104,8903934,hrh1_human,194,T,A,Chlorpheniramine,ChEMBL Compound ID,CHEMBL505,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.6,,=,,9.0,2.512,,,[3H]-mepyramine (radioligand),0.0,0.0,,0.0,,P35367,0.4501957387623412
127,8093027,hrh1_human,194,T,A,[3H]-mepyramine,ChEMBL Compound ID,CHEMBL511,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,1.04,nM,=,,0.33,3.152,,,[3H]-mepyramine (radioligand),122.7,0.0,,0.0,,P35367,0.4501957387623412
128,8198587,hrh1_human,194,T,A,[3H]-mepyramine,ChEMBL Compound ID,CHEMBL511,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,0.58,nM,=,,0.22,2.636,,,[3H]-mepyramine (radioligand),126.0,0.0,,0.0,,P35367,0.4501957387623412
129,8903934,hrh1_human,194,T,A,[3H]-mepyramine,ChEMBL Compound ID,CHEMBL511,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,3.7,nM,=,,0.9,4.111,,,[3H]-mepyramine (radioligand),0.0,0.0,,0.0,,P35367,0.4501957387623412
130,11809864,hrh1_human,194,T,A,[3H]-mepyramine,ChEMBL Compound ID,CHEMBL511,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,4.2,nM,=,,0.9,4.667,,,[3H]-mepyramine (radioligand),24.4,0.0,,0.0,,P35367,0.4501957387623412
131,14978232,hrh1_human,194,T,A,[3H]-mepyramine,ChEMBL Compound ID,CHEMBL511,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,8.7,,=,,9.0,1.995,,,[3H]-mepyramine (radioligand),36.7,0.0,,0.0,,P35367,0.4501957387623412
179,8093027,hrh1_human,194,T,A,Histamine,ChEMBL Compound ID,CHEMBL90,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,16.9,ÂµM,=,,59.9,-3.546,,,[3H]-mepyramine (radioligand),122.7,0.0,,0.0,,P35367,0.4501957387623412
180,8198587,hrh1_human,194,T,A,Histamine,ChEMBL Compound ID,CHEMBL90,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,12.2,ÂµM,=,,28.0,-2.294,,,[3H]-mepyramine (radioligand),126.0,0.0,,0.0,,P35367,0.4501957387623412
181,8903934,hrh1_human,194,T,A,Histamine,ChEMBL Compound ID,CHEMBL90,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.9,,=,,5.2,-5.0,,,[3H]-mepyramine (radioligand),0.0,0.0,,0.0,,P35367,0.4501957387623412
182,11809864,hrh1_human,194,T,A,Histamine,ChEMBL Compound ID,CHEMBL90,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.9,,=,,5.2,-5.0,,,[3H]-mepyramine (radioligand),24.4,0.0,,0.0,,P35367,0.4501957387623412
183,14978232,hrh1_human,194,T,A,Histamine,ChEMBL Compound ID,CHEMBL90,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.2,,=,,3.7,-3.165,,,[3H]-mepyramine (radioligand),36.7,0.0,,0.0,,P35367,0.4501957387623412
209,11809864,hrh1_human,194,T,A,Loratadine,ChEMBL Compound ID,CHEMBL998,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.8,,=,,7.3,-3.165,,,[3H]-mepyramine (radioligand),24.4,0.0,,0.0,,P35367,0.4501957387623412
226,11809864,hrh1_human,194,T,A,(S)-ucb 29992,SMILES,O=C(COCCN1CCN(CC1)[C@@H](C2=CC=CC=C2)C3=CC=C(Cl)C=C3)OC,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.2,,=,,8.1,7.943,,,[3H]-mepyramine (radioligand),24.4,0.0,,0.0,,P35367,0.4501957387623412
228,11809864,hrh1_human,194,T,A,(R)-ucb 29992,SMILES,O=C(COCCN1CCN(CC1)[C@H](C2=CC=CC=C2)C3=CC=C(Cl)C=C3)OC,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.3,,=,,8.9,3.981,,,[3H]-mepyramine (radioligand),24.4,0.0,,0.0,,P35367,0.4501957387623412
237,11809864,hrh1_human,194,T,A,R-hydroxyzine,SMILES,OCCOCCN1CCN(CC1)[C@H](C2=CC=CC=C2)C3=CC=C(Cl)C=C3,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.0,,=,,9.3,1.995,,,[3H]-mepyramine (radioligand),24.4,0.0,,0.0,,P35367,0.4501957387623412
32,15626750,hrh1_human,433,I,V,Cetirizine,ChEMBL Compound ID,CHEMBL1000,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.9,,=,,8.0,1.259,,,[3H]-mepyramine (radioligand),81.8,0.0,,0.0,,P35367,0.203448959062641
85,15626750,hrh1_human,433,I,V,HP-HA,ChEMBL Compound ID,CHEMBL264491,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.1,,=,,6.2,1.259,,,[3H]-mepyramine (radioligand),81.8,0.0,,0.0,,P35367,0.203448959062641
149,12626648,hrh1_human,433,I,V,[3H]-mepyramine,ChEMBL Compound ID,CHEMBL511,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,4.49,nM,=,,53.7,-11.905,,,[3H]-mepyramine (radioligand),19.3,0.0,,0.0,,P35367,0.203448959062641
150,15626750,hrh1_human,433,I,V,[3H]-mepyramine,ChEMBL Compound ID,CHEMBL511,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,1.2,nM,=,,0.7,1.714,,,[3H]-mepyramine (radioligand),81.8,0.0,,0.0,,P35367,0.203448959062641
197,15626750,hrh1_human,433,I,V,Histamine,ChEMBL Compound ID,CHEMBL90,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.3,,=,,4.5,1.585,,,[3H]-mepyramine (radioligand),81.8,0.0,,0.0,,P35367,0.203448959062641
216,15626750,hrh1_human,433,I,V,HP-HP,SMILES,C1(CCNCCC2=CNC(CCC(C3=CC=CC=C3)C4=CC=CC=C4)=N2)=CN=C(CCC(C5=CC=CC=C5)C6=CC=CC=C6)N1,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.8,,=,,7.1,1.995,,,[3H]-mepyramine (radioligand),81.8,0.0,,0.0,,P35367,0.203448959062641
223,15626750,hrh1_human,433,I,V,VUF8401,SMILES,N=C(NCCCC1=CNC=N1)NCCSC(C2=CC=CC=C2)C3=CC=CC=C3,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.0,,=,,6.1,1.259,,,[3H]-mepyramine (radioligand),81.8,0.0,,0.0,,P35367,0.203448959062641
233,15626750,hrh1_human,433,I,V,VUF4669,SMILES,OC(C1=CC=CC=C1)(C2CCN(CCCOC3=CC=C(C(CC(C(O)=O)O4)=O)C4=C3)CC2)C5=CC=CC=C5,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.7,,=,,8.0,1.995,,,[3H]-mepyramine (radioligand),81.8,0.0,,0.0,,P35367,0.203448959062641
33,15626750,hrh1_human,449,L,V,Cetirizine,ChEMBL Compound ID,CHEMBL1000,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.9,,=,,7.9,1.0,,,[3H]-mepyramine (radioligand),80.2,0.0,,0.0,,P35367,0.2804092125394374
87,15626750,hrh1_human,449,L,V,HP-HA,ChEMBL Compound ID,CHEMBL264491,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.1,,=,,6.0,-1.259,,,[3H]-mepyramine (radioligand),80.2,0.0,,0.0,,P35367,0.2804092125394374
153,15626750,hrh1_human,449,L,V,[3H]-mepyramine,ChEMBL Compound ID,CHEMBL511,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,1.2,nM,=,,1.4,-1.167,,,[3H]-mepyramine (radioligand),80.2,0.0,,0.0,,P35367,0.2804092125394374
200,15626750,hrh1_human,449,L,V,Histamine,ChEMBL Compound ID,CHEMBL90,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.3,,=,,4.0,-1.996,,,[3H]-mepyramine (radioligand),80.2,0.0,,0.0,,P35367,0.2804092125394374
218,15626750,hrh1_human,449,L,V,HP-HP,SMILES,C1(CCNCCC2=CNC(CCC(C3=CC=CC=C3)C4=CC=CC=C4)=N2)=CN=C(CCC(C5=CC=CC=C5)C6=CC=CC=C6)N1,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.8,,=,,7.0,1.585,,,[3H]-mepyramine (radioligand),80.2,0.0,,0.0,,P35367,0.2804092125394374
224,15626750,hrh1_human,449,L,V,VUF8401,SMILES,N=C(NCCCC1=CNC=N1)NCCSC(C2=CC=CC=C2)C3=CC=CC=C3,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.0,,=,,6.0,1.0,,,[3H]-mepyramine (radioligand),80.2,0.0,,0.0,,P35367,0.2804092125394374
234,15626750,hrh1_human,449,L,V,VUF4669,SMILES,OC(C1=CC=CC=C1)(C2CCN(CCCOC3=CC=C(C(CC(C(O)=O)O4)=O)C4=C3)CC2)C5=CC=CC=C5,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.7,,=,,8.1,2.512,,,[3H]-mepyramine (radioligand),80.2,0.0,,0.0,,P35367,0.2804092125394374
34,15626750,hrh1_human,459,I,L,Cetirizine,ChEMBL Compound ID,CHEMBL1000,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.9,,=,,8.0,1.259,,,[3H]-mepyramine (radioligand),85.1,0.0,,0.0,,P35367,0.3241956059263486
89,15626750,hrh1_human,459,I,L,HP-HA,ChEMBL Compound ID,CHEMBL264491,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.1,,=,,6.0,-1.259,,,[3H]-mepyramine (radioligand),85.1,0.0,,0.0,,P35367,0.3241956059263486
156,15626750,hrh1_human,459,I,L,[3H]-mepyramine,ChEMBL Compound ID,CHEMBL511,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,1.2,nM,=,,1.0,1.2,,,[3H]-mepyramine (radioligand),85.1,0.0,,0.0,,P35367,0.3241956059263486
203,15626750,hrh1_human,459,I,L,Histamine,ChEMBL Compound ID,CHEMBL90,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.3,,=,,4.4,1.259,,,[3H]-mepyramine (radioligand),85.1,0.0,,0.0,,P35367,0.3241956059263486
219,15626750,hrh1_human,459,I,L,HP-HP,SMILES,C1(CCNCCC2=CNC(CCC(C3=CC=CC=C3)C4=CC=CC=C4)=N2)=CN=C(CCC(C5=CC=CC=C5)C6=CC=CC=C6)N1,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.8,,=,,7.0,1.585,,,[3H]-mepyramine (radioligand),85.1,0.0,,0.0,,P35367,0.3241956059263486
225,15626750,hrh1_human,459,I,L,VUF8401,SMILES,N=C(NCCCC1=CNC=N1)NCCSC(C2=CC=CC=C2)C3=CC=CC=C3,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.0,,=,,6.0,1.0,,,[3H]-mepyramine (radioligand),85.1,0.0,,0.0,,P35367,0.3241956059263486
235,15626750,hrh1_human,459,I,L,VUF4669,SMILES,OC(C1=CC=CC=C1)(C2CCN(CCCOC3=CC=C(C(CC(C(O)=O)O4)=O)C4=C3)CC2)C5=CC=CC=C5,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.7,,=,,7.8,1.259,,,[3H]-mepyramine (radioligand),85.1,0.0,,0.0,,P35367,0.3241956059263486
35,16408006,hrh1_human,460,N,C,Cetirizine,ChEMBL Compound ID,CHEMBL1000,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.3,,=,,7.1,-1.585,,,[3H]-mepyramine (radioligand),39.1,0.0,,0.0,,P35367,0.823394492090738
157,16408006,hrh1_human,460,N,C,[3H]-mepyramine,ChEMBL Compound ID,CHEMBL511,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,1.3,nM,=,,2.7,-2.079,,,[3H]-mepyramine (radioligand),39.1,0.0,,0.0,,P35367,0.823394492090738
204,16408006,hrh1_human,460,N,C,Histamine,ChEMBL Compound ID,CHEMBL90,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.1,,=,,4.7,3.981,,,[3H]-mepyramine (radioligand),39.1,0.0,,0.0,,P35367,0.823394492090738
37,16408006,hrh1_human,460,N,S,Cetirizine,ChEMBL Compound ID,CHEMBL1000,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.3,,=,,7.2,-1.259,,,[3H]-mepyramine (radioligand),48.3,0.0,,0.0,,P35367,0.6941396592737776
160,16408006,hrh1_human,460,N,S,[3H]-mepyramine,ChEMBL Compound ID,CHEMBL511,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,1.3,nM,=,,2.8,-2.155,,,[3H]-mepyramine (radioligand),48.3,0.0,,0.0,,P35367,0.6941396592737776
206,16408006,hrh1_human,460,N,S,Histamine,ChEMBL Compound ID,CHEMBL90,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.1,,=,,4.9,6.31,,,[3H]-mepyramine (radioligand),48.3,0.0,,0.0,,P35367,0.6941396592737776
39,9593602,hrh1_human,107,D,A,[3H]-Olopatidine,ChEMBL Compound ID,CHEMBL1189432,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,2.5,nM,=,,49.0,-19.608,,,[3H]-Olopatidine,64.7,0.0,,0.0,,P35367,0.607103171884797
42,9593602,hrh1_human,107,D,A,Olopatidine,ChEMBL Compound ID,CHEMBL1189432,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,1.8,,=,,25.0,1.58489319246111e+23,,,[3H]-Olopatidine,64.7,0.0,,0.0,,P35367,0.607103171884797
116,15033376,hrh1_human,107,D,A,[3H]-mepyramine,ChEMBL Compound ID,CHEMBL511,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,1.3,nM,>,,30.0,-23.256,Abolished effect,,[3H]-mepyramine (radioligand),0.0,0.0,,0.0,,P35367,0.607103171884797
163,9593602,hrh1_human,107,D,A,Doxepin,ChEMBL Compound ID,CHEMBL860,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,0.69,,=,,190.0,2.04173794466954e+189,,,[3H]-Olopatidine,64.7,0.0,,0.0,,P35367,0.607103171884797
44,11809864,hrh1_human,191,K,A,Levocetirizine,ChEMBL Compound ID,CHEMBL1201191,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.5,,=,,7.9,-3.984,,,[3H]-mepyramine (radioligand),55.2,0.0,,0.0,,P35367,0.4758157878357133
61,11809864,hrh1_human,191,K,A,(S)-cetirizine,ChEMBL Compound ID,CHEMBL1334217,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.1,,=,,6.3,-6.329,,,[3H]-mepyramine (radioligand),55.2,0.0,,0.0,,P35367,0.4758157878357133
73,11809864,hrh1_human,191,K,A,Terfenadine,ChEMBL Compound ID,CHEMBL17157,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.7,,=,,8.5,-1.585,,,[3H]-mepyramine (radioligand),55.2,0.0,,0.0,,P35367,0.4758157878357133
82,15033376,hrh1_human,191,K,A,HP-HA,ChEMBL Compound ID,CHEMBL264491,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.8,,=,,6.4,3.981,,,[3H]-mepyramine (radioligand),70.3,0.0,,0.0,,P35367,0.4758157878357133
91,15033376,hrh1_human,191,K,A,Methylhistaprodifen,ChEMBL Compound ID,CHEMBL275035,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.0,,=,,6.1,1.259,,,[3H]-mepyramine (radioligand),70.3,0.0,,0.0,,P35367,0.4758157878357133
97,15033376,hrh1_human,191,K,A,Histaprodifen,ChEMBL Compound ID,CHEMBL275507,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.6,,=,,5.9,1.995,,,[3H]-mepyramine (radioligand),70.3,0.0,,0.0,,P35367,0.4758157878357133
125,11809864,hrh1_human,191,K,A,[3H]-mepyramine,ChEMBL Compound ID,CHEMBL511,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,4.2,nM,=,,1.3,3.231,,,[3H]-mepyramine (radioligand),55.2,0.0,,0.0,,P35367,0.4758157878357133
126,15033376,hrh1_human,191,K,A,[3H]-mepyramine,ChEMBL Compound ID,CHEMBL511,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,1.3,nM,=,,0.6,2.167,,,[3H]-mepyramine (radioligand),70.3,0.0,,0.0,,P35367,0.4758157878357133
177,11809864,hrh1_human,191,K,A,Histamine,ChEMBL Compound ID,CHEMBL90,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.9,,=,,4.7,-15.873,,,[3H]-mepyramine (radioligand),55.2,0.0,,0.0,,P35367,0.4758157878357133
178,15033376,hrh1_human,191,K,A,Histamine,ChEMBL Compound ID,CHEMBL90,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.3,,=,,3.9,-2.513,,,[3H]-mepyramine (radioligand),70.3,0.0,,0.0,,P35367,0.4758157878357133
207,11809864,hrh1_human,191,K,A,Fexofenadine,ChEMBL Compound ID,CHEMBL914,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.0,,=,,7.4,-3.984,,,[3H]-mepyramine (radioligand),55.2,0.0,,0.0,,P35367,0.4758157878357133
208,11809864,hrh1_human,191,K,A,Loratadine,ChEMBL Compound ID,CHEMBL998,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.8,,=,,7.8,1.0,,,[3H]-mepyramine (radioligand),55.2,0.0,,0.0,,P35367,0.4758157878357133
227,11809864,hrh1_human,191,K,A,(R)-ucb 29992,SMILES,O=C(COCCN1CCN(CC1)[C@H](C2=CC=CC=C2)C3=CC=C(Cl)C=C3)OC,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.3,,=,,8.3,1.0,,,[3H]-mepyramine (radioligand),55.2,0.0,,0.0,,P35367,0.4758157878357133
229,15033376,hrh1_human,191,K,A,HP-HP,SMILES,O=C(COCCN1CCN(CC1)[C@H](C2=CC=CC=C2)C3=CC=C(Cl)C=C3)OC,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.2,,=,,6.6,2.512,,,[3H]-mepyramine (radioligand),70.3,0.0,,0.0,,P35367,0.4758157878357133
236,11809864,hrh1_human,191,K,A,R-hydroxyzine,SMILES,OCCOCCN1CCN(CC1)[C@H](C2=CC=CC=C2)C3=CC=C(Cl)C=C3,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.0,,=,,9.1,1.259,,,[3H]-mepyramine (radioligand),55.2,0.0,,0.0,,P35367,0.4758157878357133
58,25013351,hrh1_human,435,F,A,"[3H]-(2S,4R)-PAT",ChEMBL Compound ID,CHEMBL127307,Binding - unknown pharmacological activity,K(d),Binding - Radioligand competition/displacement,1.3,nM,=,,9.4,-7.246,,,[3H]-mepyramine (radioligand),0.0,0.0,,0.0,,P35367,0.5713576887711416
86,15033376,hrh1_human,435,F,A,HP-HA,ChEMBL Compound ID,CHEMBL264491,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.8,,=,,5.5,-1.996,,,[3H]-mepyramine (radioligand),85.1,0.0,,0.0,,P35367,0.5713576887711416
94,15033376,hrh1_human,435,F,A,Methylhistaprodifen,ChEMBL Compound ID,CHEMBL275035,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.0,,=,,5.5,-3.165,,,[3H]-mepyramine (radioligand),85.1,0.0,,0.0,,P35367,0.5713576887711416
100,15033376,hrh1_human,435,F,A,Histaprodifen,ChEMBL Compound ID,CHEMBL275507,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.6,,=,,5.3,-1.996,,,[3H]-mepyramine (radioligand),85.1,0.0,,0.0,,P35367,0.5713576887711416
151,15033376,hrh1_human,435,F,A,[3H]-mepyramine,ChEMBL Compound ID,CHEMBL511,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,1.3,nM,=,,5.7,-4.386,,,[3H]-mepyramine (radioligand),85.1,0.0,,0.0,,P35367,0.5713576887711416
152,25013351,hrh1_human,435,F,A,[3H]-mepyramine,ChEMBL Compound ID,CHEMBL511,Binding - unknown pharmacological activity,K(d),Binding - Radioligand competition/displacement,0.84,nM,=,,8.3,-9.901,,,[3H]-mepyramine (radioligand),0.0,0.0,,0.0,,P35367,0.5713576887711416
198,15033376,hrh1_human,435,F,A,Histamine,ChEMBL Compound ID,CHEMBL90,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.3,,=,,2.7,-40.0,,,[3H]-mepyramine (radioligand),85.1,0.0,,0.0,,P35367,0.5713576887711416
199,25013351,hrh1_human,435,F,A,Histamine,ChEMBL Compound ID,CHEMBL90,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,3.0,mM,>,,10.0,-3.333,,,[3H]-mepyramine (radioligand),0.0,0.0,,0.0,,P35367,0.5713576887711416
217,15033376,hrh1_human,435,F,A,HP-HP,SMILES,C1(CCNCCC2=CNC(CCC(C3=CC=CC=C3)C4=CC=CC=C4)=N2)=CN=C(CCC(C5=CC=CC=C5)C6=CC=CC=C6)N1,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.2,,=,,5.8,-2.513,,,[3H]-mepyramine (radioligand),85.1,0.0,,0.0,,P35367,0.5713576887711416
59,25013351,hrh1_human,458,Y,A,"[3H]-(2S,4R)-PAT",ChEMBL Compound ID,CHEMBL127307,Binding - unknown pharmacological activity,K(d),Binding - Radioligand competition/displacement,1.3,nM,=,,9.0,-6.944,,,[3H]-mepyramine (radioligand),0.0,0.0,,0.0,,P35367,0.5987156182552569
88,15626750,hrh1_human,458,Y,A,HP-HA,ChEMBL Compound ID,CHEMBL264491,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.1,,=,,6.8,5.012,,,[3H]-mepyramine (radioligand),67.8,0.0,,0.0,,P35367,0.5987156182552569
154,15626750,hrh1_human,458,Y,A,[3H]-mepyramine,ChEMBL Compound ID,CHEMBL511,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,1.2,nM,=,,3.0,-2.5,,,[3H]-mepyramine (radioligand),67.8,0.0,,0.0,,P35367,0.5987156182552569
155,25013351,hrh1_human,458,Y,A,[3H]-mepyramine,ChEMBL Compound ID,CHEMBL511,Binding - unknown pharmacological activity,K(d),Binding - Radioligand competition/displacement,0.84,nM,=,,9.1,-10.87,,,[3H]-mepyramine (radioligand),0.0,0.0,,0.0,,P35367,0.5987156182552569
201,15626750,hrh1_human,458,Y,A,Histamine,ChEMBL Compound ID,CHEMBL90,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.3,,=,,4.4,1.259,,,[3H]-mepyramine (radioligand),67.8,0.0,,0.0,,P35367,0.5987156182552569
202,25013351,hrh1_human,458,Y,A,Histamine,ChEMBL Compound ID,CHEMBL90,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,3.0,ÂµM,=,,51.0,-16.949,,,[3H]-mepyramine (radioligand),0.0,0.0,,0.0,,P35367,0.5987156182552569
64,14978232,hrh1_human,103,W,A,8R-Terguride,ChEMBL Compound ID,CHEMBL1480516,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.1,,=,,4.8,-20.0,,,[3H]-mepyramine (radioligand),23.9,0.0,,0.0,,P35367,0.601862994774495
68,14978232,hrh1_human,103,W,A,8R-Lisuride,ChEMBL Compound ID,CHEMBL1528238,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.9,,=,,6.4,-31.25,,,[3H]-mepyramine (radioligand),23.9,0.0,,0.0,,P35367,0.601862994774495
110,14978232,hrh1_human,103,W,A,[3H]-mepyramine,ChEMBL Compound ID,CHEMBL511,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,8.7,,=,,7.8,-7.937,,,[3H]-mepyramine (radioligand),23.9,0.0,,0.0,,P35367,0.601862994774495
111,14978232,hrh1_human,103,W,A,[3H]-mepyramine,ChEMBL Compound ID,CHEMBL511,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.7,,=,,7.8,-7.937,,,[3H]-mepyramine (radioligand),23.9,0.0,,0.0,,P35367,0.601862994774495
167,14978232,hrh1_human,103,W,A,Histamine,ChEMBL Compound ID,CHEMBL90,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.2,,<,,2.2,-100.0,,,[3H]-mepyramine (radioligand),23.9,0.0,,0.0,,P35367,0.601862994774495
109,15626750,hrh1_human,89,L,H,[3H]-mepyramine,ChEMBL Compound ID,CHEMBL511,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,1.2,nM,>,,30.0,-25.0,Abolished effect,,[3H]-mepyramine (radioligand),0.0,0.0,,0.0,,P35367,0.3501618959138118
114,8093027,hrh1_human,107,D,N,[3H]-mepyramine,ChEMBL Compound ID,CHEMBL511,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,1.04,nM,=,,131.0,-125.0,,,[3H]-mepyramine (radioligand),97.4,0.0,,0.0,,P35367,0.47387297567842
138,17959710,hrh1_human,420,I,A,[3H]-mepyramine,ChEMBL Compound ID,CHEMBL511,Binding - unknown pharmacological activity,pK(b),Binding - Radioligand saturation,8.0,,=,,8.2,1.585,,,[3H]-mepyramine (radioligand),25.0,0.0,,0.0,,P35367,0.4938911584405581
189,17959710,hrh1_human,420,I,A,Histamine,ChEMBL Compound ID,CHEMBL90,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.0,,=,,6.9,7.943,,,[3H]-mepyramine (radioligand),25.0,0.0,,0.0,,P35367,0.4938911584405581
140,17959710,hrh1_human,420,I,F,[3H]-mepyramine,ChEMBL Compound ID,CHEMBL511,Binding - unknown pharmacological activity,pK(b),Binding - Radioligand saturation,8.0,,=,,8.1,1.259,,,[3H]-mepyramine (radioligand),52.3,0.0,,0.0,,P35367,0.4491208958026405
191,17959710,hrh1_human,420,I,F,Histamine,ChEMBL Compound ID,CHEMBL90,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.0,,=,,5.9,-1.259,,,[3H]-mepyramine (radioligand),52.3,0.0,,0.0,,P35367,0.4491208958026405
141,17959710,hrh1_human,420,I,G,[3H]-mepyramine,ChEMBL Compound ID,CHEMBL511,Binding - unknown pharmacological activity,pK(b),Binding - Radioligand saturation,8.0,,=,,7.6,-2.513,,,[3H]-mepyramine (radioligand),40.9,0.0,,0.0,,P35367,0.6258344155253737
192,17959710,hrh1_human,420,I,G,Histamine,ChEMBL Compound ID,CHEMBL90,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.0,,=,,7.2,15.849,,,[3H]-mepyramine (radioligand),40.9,0.0,,0.0,,P35367,0.6258344155253737
144,17959710,hrh1_human,420,I,S,[3H]-mepyramine,ChEMBL Compound ID,CHEMBL511,Binding - unknown pharmacological activity,pK(b),Binding - Radioligand saturation,8.0,,=,,7.5,-3.165,,,[3H]-mepyramine (radioligand),22.7,0.0,,0.0,,P35367,0.5387385422977304
195,17959710,hrh1_human,420,I,S,Histamine,ChEMBL Compound ID,CHEMBL90,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.0,,=,,6.0,1.0,,,[3H]-mepyramine (radioligand),22.7,0.0,,0.0,,P35367,0.5387385422977304
147,15033376,hrh1_human,432,F,A,[3H]-mepyramine,ChEMBL Compound ID,CHEMBL511,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,1.3,nM,>,,30.0,-23.256,,,[3H]-mepyramine (radioligand),0.0,0.0,,0.0,,P35367,0.6385331126470288
158,16408006,hrh1_human,460,N,L,[3H]-mepyramine,ChEMBL Compound ID,CHEMBL511,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,1.3,nM,>,,30.0,-23.256,Abolished effect,,[3H]-mepyramine (radioligand),0.0,0.0,,0.0,,P35367,0.823394492090738
60,10.1016/j.bbrc.2014.08.048,cnr2_human,192,L,A,CP55940,PubChem CID,104895,Full agonist,K(i),Binding - Radioligand competition/displacement,2.6,nM,=,,2.3,1.13,,,H3CP55940,0.0,0.0,,0.0,,P34972,0.2961348108580627
61,10.1016/j.bbrc.2014.08.048,cnr2_human,192,L,A,SR144528,PubChem CID,3081355,Inverse agonist,K(i),Binding - Radioligand competition/displacement,1.0,nM,=,,4.8,-4.808,,,H3CP55940,0.0,0.0,,0.0,,P34972,0.2961348108580627
62,10.1016/j.bbrc.2014.08.048,cnr2_human,192,L,A,XIE95-26,SMILES,O=C(CC(NC(=O)CC1=CC=CC=C1)C2=CC=C(N(CC)CC)C=C2)CC3=CC=CC=C3,Inverse agonist,K(i),Binding - Radioligand competition/displacement,154.0,nM,=,,6.1,25.246,,,H3CP55940,0.0,0.0,,0.0,,P34972,0.2961348108580627
66,10.1016/j.bbrc.2014.08.048,cnr2_human,192,L,A,CP55940,PubChem CID,104895,Full agonist,EC50,Functional - cAMP accumulation,32.0,nM,=,,0.14,228.571,,,,0.0,0.0,,0.0,,P34972,0.2961348108580627
33,19133996,adrb3_human,265,T,M,[125I]Cyanopindolol,ChEMBL Compound ID,CHEMBL210309,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,306.0,pM,=,,295.0,1.037,,,,88.4,0.0,,0.0,,P13945,0.3266476553570441
341,9733718,acm5_human,130,F,C,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL1201268,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,0.2,nM,=,,0.2,1.0,,,[3H]N-methyl scopolamine (radioligand),82.4,0.0,,0.0,,P08912,0.4793510683922495
343,9733718,acm5_human,130,F,M,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL1201268,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,0.2,nM,=,,0.27,-1.35,,,[3H]N-methyl scopolamine (radioligand),101.4,0.0,,0.0,,P08912,0.3912499971791229
345,9733718,acm5_human,134,R,E,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL1201268,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,0.2,nM,=,,0.15,1.333,,,[3H]N-methyl scopolamine (radioligand),58.1,0.0,,0.0,,P08912,0.4102889910821646
347,9733718,acm5_human,138,Y,T,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL1201268,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,0.2,nM,=,,0.18,1.111,,,[3H]N-methyl scopolamine (radioligand),44.6,0.0,,0.0,,P08912,0.6227460828124505
348,9733718,acm5_human,142,R,H,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL1201268,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,0.2,nM,=,,0.17,1.176,,,[3H]N-methyl scopolamine (radioligand),101.4,0.0,,0.0,,P08912,0.4962034762226325
349,9733718,acm5_human,142,R,N,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL1201268,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,0.2,nM,=,,0.24,-1.2,,,[3H]N-methyl scopolamine (radioligand),125.7,0.0,,0.0,,P08912,0.4962034762226325
350,8621674,acm5_human,216,I,F,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL1201268,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,520.0,pM,=,,221.0,2.353,,,[3H]N-methyl scopolamine (radioligand),64.3,0.0,,0.0,,P08912,0.5445856759700309
351,8621674,acm5_human,216,I,G,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL1201268,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,520.0,pM,=,,388.0,1.34,,,[3H]N-methyl scopolamine (radioligand),132.1,0.0,,0.0,,P08912,0.7105116650326966
352,8621674,acm5_human,217,Y,S,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL1201268,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,520.0,pM,=,,423.0,1.229,,,[3H]N-methyl scopolamine (radioligand),110.7,0.0,,0.0,,P08912,0.5828579493458431
353,8621674,acm5_human,220,T,A,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL1201268,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,520.0,pM,=,,540.0,-1.038,,,[3H]N-methyl scopolamine (radioligand),198.2,0.0,,0.0,,P08912,0.5107785408953925
357,8621674,acm5_human,220,T,V,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL1201268,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,520.0,pM,=,,530.0,-1.019,,,[3H]N-methyl scopolamine (radioligand),144.6,0.0,,0.0,,P08912,0.5107785408953925
358,8621674,acm5_human,223,R,E,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL1201268,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,520.0,pM,=,,497.0,1.046,,,[3H]N-methyl scopolamine (radioligand),183.9,0.0,,0.0,,P08912,0.5371916064349077
359,8621674,acm5_human,223,R,L,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL1201268,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,520.0,pM,=,,1200.0,-2.309,,,[3H]N-methyl scopolamine (radioligand),252.7,0.0,,0.0,,P08912,0.6245391555705178
360,9521726,acm5_human,439,K,A,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL1201268,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,71.0,pM,=,,149.0,-2.096,,,[3H]N-methyl scopolamine (radioligand),107.1,0.0,,0.0,,P08912,0.6027492027814483
361,9521726,acm5_human,439,K,E,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL1201268,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,71.0,pM,=,,98.0,-1.381,,,[3H]N-methyl scopolamine (radioligand),60.7,0.0,,0.0,,P08912,0.5142729760741505
362,9521726,acm5_human,439,K,G,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL1201268,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,71.0,pM,=,,184.0,-2.591,,,[3H]N-methyl scopolamine (radioligand),96.4,0.0,,0.0,,P08912,0.6449168819009892
364,9521726,acm5_human,439,K,Q,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL1201268,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,71.0,pM,=,,179.0,-2.519,,,[3H]N-methyl scopolamine (radioligand),92.9,0.0,,0.0,,P08912,0.5142729760741505
365,9521726,acm5_human,440,A,E,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL1201268,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,71.0,pM,=,,318.0,-4.484,,,[3H]N-methyl scopolamine (radioligand),100.0,0.0,,0.0,,P08912,0.605357575522899
367,9521726,acm5_human,440,A,Q,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL1201268,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,71.0,pM,=,,263.0,-3.704,,,[3H]N-methyl scopolamine (radioligand),207.1,0.0,,0.0,,P08912,0.605357575522899
370,7852396,acm5_human,441,A,I,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL1201268,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,141.0,pM,=,,339.0,-2.404,,,[3H]N-methyl scopolamine (radioligand),300.0,0.0,,0.0,,P08912,0.5920807939424774
407,7852396,acm5_human,441,A,I,Carbachol,ChEMBL Compound ID,CHEMBL965,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,3.1,ÂµM,=,,6.3,-2.033,,,[3H]N-methyl scopolamine (radioligand),300.0,0.0,,0.0,,P08912,0.5920807939424774
371,7852396,acm5_human,441,A,P,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL1201268,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,141.0,pM,=,,201.0,-1.427,,,[3H]N-methyl scopolamine (radioligand),155.6,0.0,,0.0,,P08912,0.5920807939424774
408,7852396,acm5_human,441,A,P,Carbachol,ChEMBL Compound ID,CHEMBL965,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,3.1,ÂµM,=,,11.0,-3.546,,,[3H]N-methyl scopolamine (radioligand),155.6,0.0,,0.0,,P08912,0.5920807939424774
372,7852396,acm5_human,441,A,R,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL1201268,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,141.0,pM,=,,217.0,-1.538,,,[3H]N-methyl scopolamine (radioligand),194.4,0.0,,0.0,,P08912,0.5920807939424774
409,7852396,acm5_human,441,A,R,Carbachol,ChEMBL Compound ID,CHEMBL965,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,3.1,ÂµM,=,,5.7,-1.838,,,[3H]N-methyl scopolamine (radioligand),194.4,0.0,,0.0,,P08912,0.5920807939424774
373,7852396,acm5_human,441,A,T,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL1201268,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,141.0,pM,=,,208.0,-1.475,,,[3H]N-methyl scopolamine (radioligand),200.0,0.0,,0.0,,P08912,0.548030942362259
410,7852396,acm5_human,441,A,T,Carbachol,ChEMBL Compound ID,CHEMBL965,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,3.1,ÂµM,=,,8.7,-2.809,,,[3H]N-methyl scopolamine (radioligand),200.0,0.0,,0.0,,P08912,0.548030942362259
374,7852396,acm5_human,441,A,Y,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL1201268,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,141.0,pM,=,,315.0,-2.232,,,[3H]N-methyl scopolamine (radioligand),333.3,0.0,,0.0,,P08912,0.6346852537499974
411,7852396,acm5_human,441,A,Y,Carbachol,ChEMBL Compound ID,CHEMBL965,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,3.1,ÂµM,=,,5.9,-1.905,,,[3H]N-methyl scopolamine (radioligand),333.3,0.0,,0.0,,P08912,0.6346852537499974
375,9705286,acm5_human,447,I,S,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL1201268,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,9.9,,=,,9.6,-1.996,,,[3H]N-methyl scopolamine (radioligand),87.5,0.0,,0.0,,P08912,0.538288585656012
377,9705286,acm5_human,459,N,H,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL1201268,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,9.9,,=,,8.5,-25.0,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P08912,0.5249292049335359
394,9705286,acm5_human,459,N,H,Atropine,ChEMBL Compound ID,CHEMBL517712,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,1.0,nM,=,,200.0,-200.0,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P08912,0.5249292049335359
378,9254607,acm5_human,465,S,A,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL1201268,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,0.48,nM,=,,0.31,1.548,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P08912,0.391468314103557
401,9254607,acm5_human,465,S,A,Atropine,ChEMBL Compound ID,CHEMBL517712,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,1.8,nM,=,,0.97,1.856,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P08912,0.391468314103557
379,9254607,acm5_human,465,S,F,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL1201268,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,0.48,nM,=,,0.44,1.091,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P08912,0.5246785577893457
402,9254607,acm5_human,465,S,F,Atropine,ChEMBL Compound ID,CHEMBL517712,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,1.8,nM,=,,1.1,1.636,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P08912,0.5246785577893457
380,9254607,acm5_human,465,S,G,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL1201268,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,0.48,nM,=,,1.0,-2.083,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P08912,0.435070291710631
403,9254607,acm5_human,465,S,G,Atropine,ChEMBL Compound ID,CHEMBL517712,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,1.8,nM,=,,2.5,-1.389,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P08912,0.435070291710631
381,9254607,acm5_human,465,S,R,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL1201268,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,0.48,nM,=,,1.5,-3.125,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P08912,0.4797083834389354
404,9254607,acm5_human,465,S,R,Atropine,ChEMBL Compound ID,CHEMBL517712,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,1.8,nM,=,,1.6,1.125,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P08912,0.4797083834389354
382,9254607,acm5_human,465,S,V,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL1201268,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,0.48,nM,=,,0.31,1.548,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P08912,0.5246785577893457
405,9254607,acm5_human,465,S,V,Atropine,ChEMBL Compound ID,CHEMBL517712,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,1.8,nM,=,,0.73,2.466,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P08912,0.5246785577893457
383,9705286,acm5_human,451,F,A,Atropine,ChEMBL Compound ID,CHEMBL517712,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,4.0,nM,=,,60.0,-14.925,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P08912,0.8219676610033207
384,9705286,acm5_human,451,F,C,Atropine,ChEMBL Compound ID,CHEMBL517712,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,4.0,nM,=,,60.0,-14.925,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P08912,0.8219676610033207
385,9705286,acm5_human,451,F,G,Atropine,ChEMBL Compound ID,CHEMBL517712,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,4.0,nM,>,,1000.0,-250.0,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P08912,0.846799483370637
387,9705286,acm5_human,451,F,V,Atropine,ChEMBL Compound ID,CHEMBL517712,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,4.0,nM,=,,10.0,-2.5,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P08912,0.7940846265244316
388,9705286,acm5_human,451,F,W,Atropine,ChEMBL Compound ID,CHEMBL517712,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,4.0,nM,=,,1.0,4.0,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P08912,0.7290159560388415
390,9705286,acm5_human,459,N,C,Atropine,ChEMBL Compound ID,CHEMBL517712,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,1.0,nM,=,,1000.0,-1000.0,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P08912,0.6940790018889036
391,9705286,acm5_human,459,N,D,Atropine,ChEMBL Compound ID,CHEMBL517712,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,1.0,nM,>,,1000.0,-1000.0,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P08912,0.5249292049335359
392,9705286,acm5_human,459,N,F,Atropine,ChEMBL Compound ID,CHEMBL517712,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,1.0,nM,=,,200.0,-200.0,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P08912,0.6940790018889036
393,9705286,acm5_human,459,N,G,Atropine,ChEMBL Compound ID,CHEMBL517712,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,1.0,nM,=,,300.0,-333.333,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P08912,0.5694827330810173
397,9705286,acm5_human,459,N,S,Atropine,ChEMBL Compound ID,CHEMBL517712,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,1.0,nM,=,,100.0,-100.0,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P08912,0.5249292049335359
398,9705286,acm5_human,459,N,T,Atropine,ChEMBL Compound ID,CHEMBL517712,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,1.0,nM,=,,200.0,-200.0,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P08912,0.5694827330810173
399,9705286,acm5_human,459,N,V,Atropine,ChEMBL Compound ID,CHEMBL517712,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,1.0,nM,=,,200.0,-200.0,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P08912,0.6940790018889036
400,9705286,acm5_human,459,N,Y,Atropine,ChEMBL Compound ID,CHEMBL517712,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,1.0,nM,>,,1000.0,-1000.0,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P08912,0.654635314927328
30,7643110,drd1_human,347,C,G,Bulbocapnine,ChEMBL Compound ID,CHEMBL157912,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,155.0,nM,=,,140.0,1.107,,,[3H]SCH23390,0.0,0.0,,0.0,,P21728,0.45681090502644
38,7643110,drd1_human,347,C,G,Spiperone,ChEMBL Compound ID,CHEMBL267930,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,110.0,nM,=,,120.0,-1.091,,,[3H]SCH23390,0.0,0.0,,0.0,,P21728,0.45681090502644
48,7643110,drd1_human,347,C,G,Clozapine,ChEMBL Compound ID,CHEMBL42,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,42.0,nM,=,,44.0,-1.047,,,[3H]SCH23390,0.0,0.0,,0.0,,P21728,0.45681090502644
54,7643110,drd1_human,347,C,G,cis-flupentixol,ChEMBL Compound ID,CHEMBL54661,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,3.0,nM,=,,2.0,1.5,,,[3H]SCH23390,0.0,0.0,,0.0,,P21728,0.45681090502644
83,7643110,drd1_human,347,C,G,[3H]SCH23390,ChEMBL Compound ID,CHEMBL62,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,1.6,nM,=,,1.5,1.067,,,,21.1,0.0,,0.0,,P21728,0.45681090502644
100,7643110,drd1_human,347,C,G,SCH-23390,ChEMBL Compound ID,CHEMBL62,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,1.9,nM,=,,2.3,-1.211,,,[3H]SCH23390,0.0,0.0,,0.0,,P21728,0.45681090502644
112,7643110,drd1_human,347,C,G,Chlorpromazine,ChEMBL Compound ID,CHEMBL71,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,40.0,nM,=,,41.0,-1.025,,,[3H]SCH23390,0.0,0.0,,0.0,,P21728,0.45681090502644
114,7643110,drd1_human,347,C,G,(+)-Butaclamol,ChEMBL Compound ID,CHEMBL8514,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.7,nM,=,,0.5,1.4,,,[3H]SCH23390,0.0,0.0,,0.0,,P21728,0.45681090502644
120,7643110,drd1_human,347,C,G,(S)-Eticlopride,ChEMBL Compound ID,CHEMBL8946,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,10000.0,nM,>,,10000.0,1.0,,,[3H]SCH23390,0.0,0.0,,0.0,,P21728,0.45681090502644
31,7643110,drd1_human,351,C,G,Bulbocapnine,ChEMBL Compound ID,CHEMBL157913,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,155.0,nM,=,,116.0,1.336,,,[3H]SCH23390,0.0,0.0,,0.0,,P21728,0.4056820106080501
39,7643110,drd1_human,351,C,G,Spiperone,ChEMBL Compound ID,CHEMBL267930,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,110.0,nM,=,,174.0,-1.582,,,[3H]SCH23390,0.0,0.0,,0.0,,P21728,0.4056820106080501
49,7643110,drd1_human,351,C,G,Clozapine,ChEMBL Compound ID,CHEMBL42,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,42.0,nM,=,,48.0,-1.143,,,[3H]SCH23390,0.0,0.0,,0.0,,P21728,0.4056820106080501
55,7643110,drd1_human,351,C,G,cis-flupentixol,ChEMBL Compound ID,CHEMBL54661,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,3.0,nM,=,,2.1,1.429,,,[3H]SCH23390,0.0,0.0,,0.0,,P21728,0.4056820106080501
85,7643110,drd1_human,351,C,G,[3H]SCH23390,ChEMBL Compound ID,CHEMBL62,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,1.6,nM,=,,1.6,1.0,,,,63.2,0.0,,0.0,,P21728,0.4056820106080501
102,7643110,drd1_human,351,C,G,SCH-23390,ChEMBL Compound ID,CHEMBL62,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,1.9,nM,=,,1.1,1.727,,,[3H]SCH23390,0.0,0.0,,0.0,,P21728,0.4056820106080501
113,7643110,drd1_human,351,C,G,Chlorpromazine,ChEMBL Compound ID,CHEMBL71,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,40.0,nM,=,,29.0,1.379,,,[3H]SCH23390,0.0,0.0,,0.0,,P21728,0.4056820106080501
115,7643110,drd1_human,351,C,G,(+)-Butaclamol,ChEMBL Compound ID,CHEMBL8514,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.7,nM,=,,0.6,1.167,,,[3H]SCH23390,0.0,0.0,,0.0,,P21728,0.4056820106080501
121,7643110,drd1_human,351,C,G,(S)-Eticlopride,ChEMBL Compound ID,CHEMBL8946,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,10000.0,nM,>,,10000.0,1.0,,,[3H]SCH23390,0.0,0.0,,0.0,,P21728,0.4056820106080501
32,1355478,drd1_human,199,S,A,SKF-38393,ChEMBL Compound ID,CHEMBL24077,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,173.6,nM,=,,2187.0,-12.658,,,[3H]SCH23390,0.0,0.0,,0.0,,P21728,0.4241096688651875
42,1355478,drd1_human,199,S,A,SKF-82958,ChEMBL Compound ID,CHEMBL317741,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,83.1,nM,=,,375.5,-4.525,,,[3H]SCH23390,0.0,0.0,,0.0,,P21728,0.4241096688651875
52,1355478,drd1_human,199,S,A,cis-flupentixol,ChEMBL Compound ID,CHEMBL54661,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,2.06,nM,=,,18.8,-9.091,,,[3H]SCH23390,0.0,0.0,,0.0,,P21728,0.4241096688651875
63,1355478,drd1_human,199,S,A,Dopamine,ChEMBL Compound ID,CHEMBL59,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,1298.0,nM,=,,12800.0,-9.901,,,[3H]SCH23390,0.0,0.0,,0.0,,P21728,0.4241096688651875
78,1355478,drd1_human,199,S,A,[3H]SCH23390,ChEMBL Compound ID,CHEMBL62,Binding - unknown pharmacological activity,K(m),Binding - Radioligand saturation,0.6,nM,=,,16.6,-27.778,,,,427.3,0.0,,0.0,,P21728,0.4241096688651875
95,1355478,drd1_human,199,S,A,SCH-23390,ChEMBL Compound ID,CHEMBL62,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.95,nM,=,,68.0,-71.429,,,[3H]SCH23390,0.0,0.0,,0.0,,P21728,0.4241096688651875
107,1355478,drd1_human,199,S,A,SCH-23388,ChEMBL Compound ID,CHEMBL63321,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,300.0,nM,=,,1648.0,-5.495,,,[3H]SCH23390,0.0,0.0,,0.0,,P21728,0.4241096688651875
33,1355478,drd1_human,202,S,A,SKF-38393,ChEMBL Compound ID,CHEMBL24077,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,173.6,nM,=,,332.0,-1.912,,,[3H]SCH23390,0.0,0.0,,0.0,,P21728,0.4338723468559922
43,1355478,drd1_human,202,S,A,SKF-82958,ChEMBL Compound ID,CHEMBL317741,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,83.1,nM,=,,100.8,-1.214,,,[3H]SCH23390,0.0,0.0,,0.0,,P21728,0.4338723468559922
53,1355478,drd1_human,202,S,A,cis-flupentixol,ChEMBL Compound ID,CHEMBL54661,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,2.06,nM,=,,2.76,-1.34,,,[3H]SCH23390,0.0,0.0,,0.0,,P21728,0.4338723468559922
64,1355478,drd1_human,202,S,A,Dopamine,ChEMBL Compound ID,CHEMBL59,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,1298.0,nM,=,,62250.0,-47.619,,,[3H]SCH23390,0.0,0.0,,0.0,,P21728,0.4338723468559922
79,1355478,drd1_human,202,S,A,[3H]SCH23390,ChEMBL Compound ID,CHEMBL62,Binding - unknown pharmacological activity,K(m),Binding - Radioligand saturation,0.6,nM,=,,0.71,-1.183,,,,590.9,0.0,,0.0,,P21728,0.4338723468559922
96,1355478,drd1_human,202,S,A,SCH-23390,ChEMBL Compound ID,CHEMBL62,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.95,nM,=,,0.69,1.377,,,[3H]SCH23390,0.0,0.0,,0.0,,P21728,0.4338723468559922
108,1355478,drd1_human,202,S,A,SCH-23388,ChEMBL Compound ID,CHEMBL63321,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,300.0,nM,=,,174.5,1.719,,,[3H]SCH23390,0.0,0.0,,0.0,,P21728,0.4338723468559922
34,8913366,drd1_human,205,I,A,SKF-38393,ChEMBL Compound ID,CHEMBL24077,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,530.0,nM,=,,900.0,-1.698,,,[3H]SCH23390,0.0,0.0,,0.0,,P21728,0.3914500915165799
44,8913366,drd1_human,205,I,A,SKF-82958,ChEMBL Compound ID,CHEMBL317741,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,23.0,nM,=,,13.0,1.769,,,[3H]SCH23390,0.0,0.0,,0.0,,P21728,0.3914500915165799
56,8913366,drd1_human,205,I,A,cis-Z-flupentixol,ChEMBL Compound ID,CHEMBL54661,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.45,nM,=,,0.79,-1.754,,,[3H]SCH23390,0.0,0.0,,0.0,,P21728,0.3914500915165799
65,8913366,drd1_human,205,I,A,Dopamine,ChEMBL Compound ID,CHEMBL59,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,1.9,ÂµM,=,,2.5,-1.316,,,[3H]SCH23390,0.0,0.0,,0.0,,P21728,0.3914500915165799
87,8913366,drd1_human,205,I,A,R(+)[3H]SCH23390,ChEMBL Compound ID,CHEMBL62,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,0.71,nM,=,,0.37,1.919,,,,0.0,0.0,,0.0,,P21728,0.3914500915165799
35,8913366,drd1_human,205,I,Y,SKF-38393,ChEMBL Compound ID,CHEMBL24077,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,530.0,nM,=,,13000.0,-24.39,,,[3H]SCH23390,0.0,0.0,,0.0,,P21728,0.3914500915165799
45,8913366,drd1_human,205,I,Y,SKF-82958,ChEMBL Compound ID,CHEMBL317741,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,23.0,nM,=,,500.0,-21.739,,,[3H]SCH23390,0.0,0.0,,0.0,,P21728,0.3914500915165799
57,8913366,drd1_human,205,I,Y,cis-Z-flupentixol,ChEMBL Compound ID,CHEMBL54661,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.45,nM,=,,0.31,1.452,,,[3H]SCH23390,0.0,0.0,,0.0,,P21728,0.3914500915165799
66,8913366,drd1_human,205,I,Y,Dopamine,ChEMBL Compound ID,CHEMBL59,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,1.9,ÂµM,=,,94.0,-50.0,,,[3H]SCH23390,0.0,0.0,,0.0,,P21728,0.3914500915165799
88,8913366,drd1_human,205,I,Y,R(+)[3H]SCH23390,ChEMBL Compound ID,CHEMBL62,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,0.71,nM,=,,5.2,-7.299,,,,0.0,0.0,,0.0,,P21728,0.3914500915165799
36,8913366,drd1_human,286,L,A,SKF-38393,ChEMBL Compound ID,CHEMBL24077,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,530.0,nM,=,,680.0,-1.284,,,[3H]SCH23390,0.0,0.0,,0.0,,P21728,0.5356754342673471
46,8913366,drd1_human,286,L,A,SKF-82958,ChEMBL Compound ID,CHEMBL317741,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,23.0,nM,=,,46.0,-2.0,,,[3H]SCH23390,0.0,0.0,,0.0,,P21728,0.5356754342673471
58,8913366,drd1_human,286,L,A,cis-Z-flupentixol,ChEMBL Compound ID,CHEMBL54661,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.45,nM,=,,0.7,-1.555,,,[3H]SCH23390,0.0,0.0,,0.0,,P21728,0.5356754342673471
70,8913366,drd1_human,286,L,A,Dopamine,ChEMBL Compound ID,CHEMBL59,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,1.9,ÂµM,=,,1.2,1.583,,,[3H]SCH23390,0.0,0.0,,0.0,,P21728,0.5356754342673471
89,8913366,drd1_human,286,L,A,R(+)[3H]SCH23390,ChEMBL Compound ID,CHEMBL62,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,0.71,nM,=,,1.1,-1.55,,,,0.0,0.0,,0.0,,P21728,0.5356754342673471
40,8910419,drd1_human,264,F,I,[125I]CH23982,ChEMBL Compound ID,CHEMBL290118,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,0.6,nM,~,,0.6,1.0,,,,100.0,0.0,,0.0,,P21728,0.2474964958923293
67,8910419,drd1_human,264,F,I,Dopamine,ChEMBL Compound ID,CHEMBL59,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,5610.0,nM,=,,2950.0,1.902,,,[125I]CH23982,0.0,0.0,,0.0,,P21728,0.2474964958923293
116,8910419,drd1_human,264,F,I,Butaclamol,ChEMBL Compound ID,CHEMBL8514,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,9.3,nM,=,,8.0,1.163,,,[125I]CH23982,0.0,0.0,,0.0,,P21728,0.2474964958923293
41,8910419,drd1_human,266,R,K,[125I]CH23982,ChEMBL Compound ID,CHEMBL290118,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,0.6,nM,~,,0.6,1.0,,,,100.0,0.0,,0.0,,P21728,0.3725127424476709
68,8910419,drd1_human,266,R,K,Dopamine,ChEMBL Compound ID,CHEMBL59,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,5610.0,nM,=,,4130.0,1.358,,,[125I]CH23982,0.0,0.0,,0.0,,P21728,0.3725127424476709
117,8910419,drd1_human,266,R,K,Butaclamol,ChEMBL Compound ID,CHEMBL8514,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,9.3,nM,=,,7.3,1.274,,,[125I]CH23982,0.0,0.0,,0.0,,P21728,0.3725127424476709
50,9137920,drd1_human,347,C,A,Haloperidol,ChEMBL Compound ID,CHEMBL54,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,177.4,nM,=,,159.89,1.11,,,[3H]SCH23390,0.0,0.0,,0.0,,P21728,0.3288677590751893
84,9137920,drd1_human,347,C,A,[3H]SCH23390,ChEMBL Compound ID,CHEMBL62,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,284.2,pM,=,,369.6,-1.3,,,,0.0,0.0,,0.0,,P21728,0.3288677590751893
101,9137920,drd1_human,347,C,A,SCH-23390,ChEMBL Compound ID,CHEMBL62,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,3.93,nM,=,,3.13,1.256,,,[3H]SCH23390,0.0,0.0,,0.0,,P21728,0.3288677590751893
118,9137920,drd1_human,347,C,A,Butaclamol,ChEMBL Compound ID,CHEMBL8514,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,31.75,nM,=,,26.34,1.205,,,[3H]SCH23390,0.0,0.0,,0.0,,P21728,0.3288677590751893
51,9137920,drd1_human,351,C,A,Haloperidol,ChEMBL Compound ID,CHEMBL54,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,177.4,nM,=,,223.75,-1.261,,,[3H]SCH23390,0.0,0.0,,0.0,,P21728,0.2845513145331651
86,9137920,drd1_human,351,C,A,[3H]SCH23390,ChEMBL Compound ID,CHEMBL62,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,284.2,pM,=,,363.0,-1.277,,,,0.0,0.0,,0.0,,P21728,0.2845513145331651
103,9137920,drd1_human,351,C,A,SCH-23390,ChEMBL Compound ID,CHEMBL62,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,3.93,nM,=,,5.91,-1.504,,,[3H]SCH23390,0.0,0.0,,0.0,,P21728,0.2845513145331651
119,9137920,drd1_human,351,C,A,Butaclamol,ChEMBL Compound ID,CHEMBL8514,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,31.75,nM,=,,42.52,-1.339,,,[3H]SCH23390,0.0,0.0,,0.0,,P21728,0.2845513145331651
60,8466481,drd1_human,70,D,V,Dopamine,ChEMBL Compound ID,CHEMBL59,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,2340.0,nM,=,,21500.0,-9.174,,,[3H]SCH23402,0.0,0.0,,0.0,,P21728,0.8675862245732796
61,8466481,drd1_human,70,D,V,Dopamine,ChEMBL Compound ID,CHEMBL59,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,3100.0,nM,=,,14600.0,-4.717,,,[3H]SCH23403,0.0,0.0,,0.0,,P21728,0.8675862245732796
74,8466481,drd1_human,70,D,V,[3H]SCH23390,ChEMBL Compound ID,CHEMBL62,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,362.0,pM,=,,1056.0,-2.915,,,,0.0,0.0,,0.0,,P21728,0.8675862245732796
75,8466481,drd1_human,70,D,V,[3H]SCH23390,ChEMBL Compound ID,CHEMBL62,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,703.0,pM,=,,788.0,-1.121,,,,0.0,0.0,,0.0,,P21728,0.8675862245732796
92,8466481,drd1_human,70,D,V,SCH-23390,ChEMBL Compound ID,CHEMBL62,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.35,nM,=,,1.67,-4.762,,,[3H]SCH23390,0.0,0.0,,0.0,,P21728,0.8675862245732796
93,8466481,drd1_human,70,D,V,SCH-23390,ChEMBL Compound ID,CHEMBL62,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.78,nM,=,,0.86,-1.103,,,[3H]SCH23391,0.0,0.0,,0.0,,P21728,0.8675862245732796
104,8466481,drd1_human,70,D,V,SCH-23388,ChEMBL Compound ID,CHEMBL63321,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,41.0,nM,=,,46.0,-1.122,,,[3H]SCH23396,0.0,0.0,,0.0,,P21728,0.8675862245732796
105,8466481,drd1_human,70,D,V,SCH-23388,ChEMBL Compound ID,CHEMBL63321,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,76.0,nM,=,,60.0,1.267,,,[3H]SCH23397,0.0,0.0,,0.0,,P21728,0.8675862245732796
62,8466481,drd1_human,81,K,E,Dopamine,ChEMBL Compound ID,CHEMBL59,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,2340.0,nM,=,,4200.0,-1.795,,,[3H]SCH23404,0.0,0.0,,0.0,,P21728,0.3575433520960611
76,8466481,drd1_human,81,K,E,[3H]SCH23390,ChEMBL Compound ID,CHEMBL62,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,362.0,pM,=,,556.0,-1.536,,,,0.0,0.0,,0.0,,P21728,0.3575433520960611
94,8466481,drd1_human,81,K,E,SCH-23390,ChEMBL Compound ID,CHEMBL62,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.35,nM,=,,0.65,-1.859,,,[3H]SCH23392,0.0,0.0,,0.0,,P21728,0.3575433520960611
106,8466481,drd1_human,81,K,E,SCH-23388,ChEMBL Compound ID,CHEMBL63321,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,41.0,nM,=,,55.0,-1.342,,,[3H]SCH23398,0.0,0.0,,0.0,,P21728,0.3575433520960611
69,8466481,drd1_human,283,C,V,Dopamine,ChEMBL Compound ID,CHEMBL59,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,2340.0,nM,=,,5400.0,-2.309,,,[3H]SCH23405,0.0,0.0,,0.0,,P21728,0.3252948664708581
80,8466481,drd1_human,283,C,V,[3H]SCH23390,ChEMBL Compound ID,CHEMBL62,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,362.0,pM,=,,654.0,-1.805,,,,0.0,0.0,,0.0,,P21728,0.3252948664708581
97,8466481,drd1_human,283,C,V,SCH-23390,ChEMBL Compound ID,CHEMBL62,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.35,nM,=,,0.6,-1.715,,,[3H]SCH23393,0.0,0.0,,0.0,,P21728,0.3252948664708581
109,8466481,drd1_human,283,C,V,SCH-23388,ChEMBL Compound ID,CHEMBL63321,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,41.0,nM,=,,165.0,-4.032,,,[3H]SCH23399,0.0,0.0,,0.0,,P21728,0.3252948664708581
44,20051519,acm2_human,80,Y,A,AC-42,ChEMBL Compound ID,CHEMBL1242950,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.6,,=,,6.0,2.512,,,[3H]QNB (radioligand),0.0,0.0,,0.0,,P08172,0.5085159405160643
53,20051519,acm2_human,80,Y,A,[3H]QNB,ChEMBL Compound ID,CHEMBL12980,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,10.0,,=,,9.6,-2.513,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P08172,0.5085159405160643
138,20051519,acm2_human,80,Y,A,McN-A343,ChEMBL Compound ID,CHEMBL40554,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.3,,=,,4.4,1.259,,,[3H]QNB (radioligand),0.0,0.0,,0.0,,P08172,0.5085159405160643
163,20051519,acm2_human,80,Y,A,Pilocarpine,ChEMBL Compound ID,CHEMBL550,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.0,,=,,4.8,-1.585,,,[3H]QNB (radioligand),0.0,0.0,,0.0,,P08172,0.5085159405160643
176,20051519,acm2_human,80,Y,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.1,,=,,4.9,-1.585,,,[3H]QNB (radioligand),0.0,0.0,,0.0,,P08172,0.5085159405160643
192,20051519,acm2_human,80,Y,A,Arecoline,ChEMBL Compound ID,CHEMBL7303,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.0,,=,,4.7,-1.996,,,[3H]QNB (radioligand),0.0,0.0,,0.0,,P08172,0.5085159405160643
206,20051519,acm2_human,80,Y,A,NDMC,ChEMBL Compound ID,CHEMBL845,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.2,,=,,5.9,-1.996,,,[3H]QNB (radioligand),0.0,0.0,,0.0,,P08172,0.5085159405160643
228,20051519,acm2_human,80,Y,A,Carbachol,ChEMBL Compound ID,CHEMBL965,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.9,,=,,4.2,-5.0,,,[3H]QNB (radioligand),0.0,0.0,,0.0,,P08172,0.5085159405160643
249,20051519,acm2_human,80,Y,A,77-LH-28-1,SMILES,O=C1N(CCCN2CCC(CCCC)CC2)C3=C(C=CC=C3)CC1,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.7,,=,,7.1,25.119,,,[3H]QNB (radioligand),0.0,0.0,,0.0,,P08172,0.5085159405160643
45,20051519,acm2_human,99,W,A,AC-42,ChEMBL Compound ID,CHEMBL1242950,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.6,,=,,7.4,63.096,,,[3H]QNB (radioligand),0.0,0.0,,0.0,,P08172,0.600748173715407
54,10513578,acm2_human,99,W,A,[3H]QNB,ChEMBL Compound ID,CHEMBL12980,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,180.0,pM,=,,410.0,-2.278,,,[3H]QNB (radioligand),0.0,0.0,,0.0,,P08172,0.600748173715407
55,20051519,acm2_human,99,W,A,[3H]QNB,ChEMBL Compound ID,CHEMBL12980,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,10.0,,=,,9.6,-2.513,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P08172,0.600748173715407
112,10513578,acm2_human,99,W,A,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,260.0,pM,=,,270.0,-1.038,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P08172,0.600748173715407
140,20051519,acm2_human,99,W,A,McN-A343,ChEMBL Compound ID,CHEMBL40554,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.3,,=,,4.7,2.512,,,[3H]QNB (radioligand),0.0,0.0,,0.0,,P08172,0.600748173715407
164,20051519,acm2_human,99,W,A,Pilocarpine,ChEMBL Compound ID,CHEMBL550,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.0,,=,,4.6,-2.513,,,[3H]QNB (radioligand),0.0,0.0,,0.0,,P08172,0.600748173715407
178,20051519,acm2_human,99,W,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.1,,=,,4.5,-3.984,,,[3H]QNB (radioligand),0.0,0.0,,0.0,,P08172,0.600748173715407
193,20051519,acm2_human,99,W,A,Arecoline,ChEMBL Compound ID,CHEMBL7303,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.0,,=,,5.2,1.585,,,[3H]QNB (radioligand),0.0,0.0,,0.0,,P08172,0.600748173715407
207,20051519,acm2_human,99,W,A,NDMC,ChEMBL Compound ID,CHEMBL845,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand saturation,6.2,,=,,6.3,1.259,,,[3H]QNB (radioligand),0.0,0.0,,0.0,,P08172,0.600748173715407
229,20051519,acm2_human,99,W,A,Carbachol,ChEMBL Compound ID,CHEMBL965,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.9,,=,,4.3,-3.984,,,[3H]QNB (radioligand),0.0,0.0,,0.0,,P08172,0.600748173715407
250,20051519,acm2_human,99,W,A,77-LH-28-1,SMILES,O=C1N(CCCN2CCC(CCCC)CC2)C3=C(C=CC=C3)CC1,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.7,,=,,8.8,1258.925,,,[3H]QNB (radioligand),0.0,0.0,,0.0,,P08172,0.600748173715407
46,20051519,acm2_human,100,L,A,AC-42,ChEMBL Compound ID,CHEMBL1242950,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.6,,=,,5.7,1.259,,,[3H]QNB (radioligand),0.0,0.0,,0.0,,P08172,0.5326233659215622
56,20051519,acm2_human,100,L,A,[3H]QNB,ChEMBL Compound ID,CHEMBL12980,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,10.0,,=,,8.7,-20.0,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P08172,0.5326233659215622
142,20051519,acm2_human,100,L,A,McN-A343,ChEMBL Compound ID,CHEMBL40554,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.3,,=,,4.3,1.0,,,[3H]QNB (radioligand),0.0,0.0,,0.0,,P08172,0.5326233659215622
165,20051519,acm2_human,100,L,A,Pilocarpine,ChEMBL Compound ID,CHEMBL550,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.0,,=,,4.0,-10.0,,,[3H]QNB (radioligand),0.0,0.0,,0.0,,P08172,0.5326233659215622
179,20051519,acm2_human,100,L,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.1,,=,,3.3,-62.5,,,[3H]QNB (radioligand),0.0,0.0,,0.0,,P08172,0.5326233659215622
194,20051519,acm2_human,100,L,A,Arecoline,ChEMBL Compound ID,CHEMBL7303,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.0,,=,,3.6,-25.0,,,[3H]QNB (radioligand),0.0,0.0,,0.0,,P08172,0.5326233659215622
208,20051519,acm2_human,100,L,A,NDMC,ChEMBL Compound ID,CHEMBL845,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.2,,=,,5.0,-15.873,,,[3H]QNB (radioligand),0.0,0.0,,0.0,,P08172,0.5326233659215622
230,20051519,acm2_human,100,L,A,Carbachol,ChEMBL Compound ID,CHEMBL965,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.9,,=,,3.3,-40.0,,,[3H]QNB (radioligand),0.0,0.0,,0.0,,P08172,0.5326233659215622
251,20051519,acm2_human,100,L,A,77-LH-28-1,SMILES,O=C1N(CCCN2CCC(CCCC)CC2)C3=C(C=CC=C3)CC1,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.7,,=,,5.6,-1.259,,,[3H]QNB (radioligand),0.0,0.0,,0.0,,P08172,0.5326233659215622
47,20051519,acm2_human,104,Y,A,AC-42,ChEMBL Compound ID,CHEMBL1242950,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.6,,=,,5.2,-2.513,,,[3H]QNB (radioligand),0.0,0.0,,0.0,,P08172,0.5574435920229411
58,20051519,acm2_human,104,Y,A,[3H]QNB,ChEMBL Compound ID,CHEMBL12980,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,10.0,,=,,8.4,-40.0,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P08172,0.5574435920229411
149,20051519,acm2_human,104,Y,A,McN-A343,ChEMBL Compound ID,CHEMBL40554,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.3,,=,,4.3,1.0,,,[3H]QNB (radioligand),0.0,0.0,,0.0,,P08172,0.5574435920229411
169,20051519,acm2_human,104,Y,A,Pilocarpine,ChEMBL Compound ID,CHEMBL550,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.0,,=,,3.0,-100.0,,,[3H]QNB (radioligand),0.0,0.0,,0.0,,P08172,0.5574435920229411
186,20051519,acm2_human,104,Y,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.1,,=,,2.5,-333.333,,,[3H]QNB (radioligand),0.0,0.0,,0.0,,P08172,0.5574435920229411
197,20051519,acm2_human,104,Y,A,Arecoline,ChEMBL Compound ID,CHEMBL7303,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.0,,=,,3.0,-100.0,,,[3H]QNB (radioligand),0.0,0.0,,0.0,,P08172,0.5574435920229411
209,20051519,acm2_human,104,Y,A,NDMC,ChEMBL Compound ID,CHEMBL845,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.2,,=,,5.8,-2.513,,,[3H]QNB (radioligand),0.0,0.0,,0.0,,P08172,0.5574435920229411
235,20051519,acm2_human,104,Y,A,Carbachol,ChEMBL Compound ID,CHEMBL965,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.9,,=,,2.5,-250.0,,,[3H]QNB (radioligand),0.0,0.0,,0.0,,P08172,0.5574435920229411
252,20051519,acm2_human,104,Y,A,77-LH-28-1,SMILES,O=C1N(CCCN2CCC(CCCC)CC2)C3=C(C=CC=C3)CC1,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.7,,=,,5.2,-3.165,,,[3H]QNB (radioligand),0.0,0.0,,0.0,,P08172,0.5574435920229411
48,20051519,acm2_human,107,S,A,AC-42,ChEMBL Compound ID,CHEMBL1242950,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.6,,=,,5.6,1.0,,,[3H]QNB (radioligand),0.0,0.0,,0.0,,P08172,0.4679599739295645
59,20051519,acm2_human,107,S,A,[3H]QNB,ChEMBL Compound ID,CHEMBL12980,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,10.0,,=,,9.7,-1.996,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P08172,0.4679599739295645
150,20051519,acm2_human,107,S,A,McN-A343,ChEMBL Compound ID,CHEMBL40554,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.3,,=,,4.4,1.259,,,[3H]QNB (radioligand),0.0,0.0,,0.0,,P08172,0.4679599739295645
170,20051519,acm2_human,107,S,A,Pilocarpine,ChEMBL Compound ID,CHEMBL550,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.0,,=,,4.8,-1.585,,,[3H]QNB (radioligand),0.0,0.0,,0.0,,P08172,0.4679599739295645
187,20051519,acm2_human,107,S,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.1,,=,,3.8,-20.0,,,[3H]QNB (radioligand),0.0,0.0,,0.0,,P08172,0.4679599739295645
198,20051519,acm2_human,107,S,A,Arecoline,ChEMBL Compound ID,CHEMBL7303,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.0,,=,,4.3,-5.0,,,[3H]QNB (radioligand),0.0,0.0,,0.0,,P08172,0.4679599739295645
210,20051519,acm2_human,107,S,A,NDMC,ChEMBL Compound ID,CHEMBL845,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.2,,=,,5.7,-3.165,,,[3H]QNB (radioligand),0.0,0.0,,0.0,,P08172,0.4679599739295645
236,20051519,acm2_human,107,S,A,Carbachol,ChEMBL Compound ID,CHEMBL965,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.9,,=,,3.6,-20.0,,,[3H]QNB (radioligand),0.0,0.0,,0.0,,P08172,0.4679599739295645
253,20051519,acm2_human,107,S,A,77-LH-28-1,SMILES,O=C1N(CCCN2CCC(CCCC)CC2)C3=C(C=CC=C3)CC1,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.7,,=,,5.7,1.0,,,[3H]QNB (radioligand),0.0,0.0,,0.0,,P08172,0.4679599739295645
49,20051519,acm2_human,177,Y,A,AC-42,ChEMBL Compound ID,CHEMBL1242950,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.6,,=,,5.5,-1.259,,,[3H]QNB (radioligand),0.0,0.0,,0.0,,P08172,0.3951646768739192
61,20051519,acm2_human,177,Y,A,[3H]QNB,ChEMBL Compound ID,CHEMBL12980,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,10.0,,=,,10.0,1.0,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P08172,0.3951646768739192
103,18723515,acm2_human,177,Y,A,Gallamine,ChEMBL Compound ID,CHEMBL360055,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.17,,=,,4.9,-18.519,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P08172,0.3951646768739192
151,20051519,acm2_human,177,Y,A,McN-A343,ChEMBL Compound ID,CHEMBL40554,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.3,,=,,4.4,1.259,,,[3H]QNB (radioligand),0.0,0.0,,0.0,,P08172,0.3951646768739192
171,20051519,acm2_human,177,Y,A,Pilocarpine,ChEMBL Compound ID,CHEMBL550,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.0,,=,,4.8,-1.585,,,[3H]QNB (radioligand),0.0,0.0,,0.0,,P08172,0.3951646768739192
188,20051519,acm2_human,177,Y,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.1,,=,,5.0,-1.259,,,[3H]QNB (radioligand),0.0,0.0,,0.0,,P08172,0.3951646768739192
199,20051519,acm2_human,177,Y,A,Arecoline,ChEMBL Compound ID,CHEMBL7303,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.0,,=,,4.8,-1.585,,,[3H]QNB (radioligand),0.0,0.0,,0.0,,P08172,0.3951646768739192
211,20051519,acm2_human,177,Y,A,NDMC,ChEMBL Compound ID,CHEMBL845,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.2,,=,,6.2,1.0,,,[3H]QNB (radioligand),0.0,0.0,,0.0,,P08172,0.3951646768739192
237,20051519,acm2_human,177,Y,A,Carbachol,ChEMBL Compound ID,CHEMBL965,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.9,,=,,4.4,-3.165,,,[3H]QNB (radioligand),0.0,0.0,,0.0,,P08172,0.3951646768739192
254,20051519,acm2_human,177,Y,A,77-LH-28-1,SMILES,O=C1N(CCCN2CCC(CCCC)CC2)C3=C(C=CC=C3)CC1,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.7,,=,,6.2,3.162,,,[3H]QNB (radioligand),0.0,0.0,,0.0,,P08172,0.3951646768739192
50,20051519,acm2_human,403,Y,A,AC-42,ChEMBL Compound ID,CHEMBL1242950,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.6,,=,,5.5,-1.259,,,[3H]QNB (radioligand),0.0,0.0,,0.0,,P08172,0.5929994420960953
65,20051519,acm2_human,403,Y,A,[3H]QNB,ChEMBL Compound ID,CHEMBL12980,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,10.0,,=,,9.5,-3.165,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P08172,0.5929994420960953
152,20051519,acm2_human,403,Y,A,McN-A343,ChEMBL Compound ID,CHEMBL40554,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.3,,=,,4.5,1.585,,,[3H]QNB (radioligand),0.0,0.0,,0.0,,P08172,0.5929994420960953
172,20051519,acm2_human,403,Y,A,Pilocarpine,ChEMBL Compound ID,CHEMBL550,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.0,,=,,3.4,-40.0,,,[3H]QNB (radioligand),0.0,0.0,,0.0,,P08172,0.5929994420960953
189,20051519,acm2_human,403,Y,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.1,,=,,3.1,-100.0,,,[3H]QNB (radioligand),0.0,0.0,,0.0,,P08172,0.5929994420960953
200,20051519,acm2_human,403,Y,A,Arecoline,ChEMBL Compound ID,CHEMBL7303,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.0,,=,,3.7,-20.0,,,[3H]QNB (radioligand),0.0,0.0,,0.0,,P08172,0.5929994420960953
212,20051519,acm2_human,403,Y,A,NDMC,ChEMBL Compound ID,CHEMBL845,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.2,,=,,5.9,-1.996,,,[3H]QNB (radioligand),0.0,0.0,,0.0,,P08172,0.5929994420960953
243,20051519,acm2_human,403,Y,A,Carbachol,ChEMBL Compound ID,CHEMBL965,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.9,,=,,3.0,-76.923,,,[3H]QNB (radioligand),0.0,0.0,,0.0,,P08172,0.5929994420960953
255,20051519,acm2_human,403,Y,A,77-LH-28-1,SMILES,O=C1N(CCCN2CCC(CCCC)CC2)C3=C(C=CC=C3)CC1,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.7,,=,,6.3,3.981,,,[3H]QNB (radioligand),0.0,0.0,,0.0,,P08172,0.5929994420960953
52,20051519,acm2_human,423,T,A,AC-42,ChEMBL Compound ID,CHEMBL1242950,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.6,,=,,5.2,-2.513,,,[3H]QNB (radioligand),0.0,0.0,,0.0,,P08172,0.3215404089847626
68,20051519,acm2_human,423,T,A,[3H]QNB,ChEMBL Compound ID,CHEMBL12980,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,10.0,,=,,9.6,-2.513,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P08172,0.3215404089847626
154,20051519,acm2_human,423,T,A,McN-A343,ChEMBL Compound ID,CHEMBL40554,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.3,,=,,4.6,1.995,,,[3H]QNB (radioligand),0.0,0.0,,0.0,,P08172,0.3215404089847626
174,20051519,acm2_human,423,T,A,Pilocarpine,ChEMBL Compound ID,CHEMBL550,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.0,,=,,5.1,1.259,,,[3H]QNB (radioligand),0.0,0.0,,0.0,,P08172,0.3215404089847626
191,20051519,acm2_human,423,T,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.1,,=,,5.5,2.512,,,[3H]QNB (radioligand),0.0,0.0,,0.0,,P08172,0.3215404089847626
202,20051519,acm2_human,423,T,A,Arecoline,ChEMBL Compound ID,CHEMBL7303,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.0,,=,,5.2,1.585,,,[3H]QNB (radioligand),0.0,0.0,,0.0,,P08172,0.3215404089847626
214,20051519,acm2_human,423,T,A,NDMC,ChEMBL Compound ID,CHEMBL845,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.2,,=,,6.0,-1.585,,,[3H]QNB (radioligand),0.0,0.0,,0.0,,P08172,0.3215404089847626
245,20051519,acm2_human,423,T,A,Carbachol,ChEMBL Compound ID,CHEMBL965,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.9,,=,,4.9,1.0,,,[3H]QNB (radioligand),0.0,0.0,,0.0,,P08172,0.3215404089847626
257,20051519,acm2_human,423,T,A,77-LH-28-1,SMILES,O=C1N(CCCN2CCC(CCCC)CC2)C3=C(C=CC=C3)CC1,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.7,,=,,6.0,1.995,,,[3H]QNB (radioligand),0.0,0.0,,0.0,,P08172,0.3215404089847626
60,10513578,acm2_human,155,W,A,[3H]QNB,ChEMBL Compound ID,CHEMBL12980,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,180.0,pM,=,,3000.0,-16.667,,,[3H]QNB (radioligand),0.0,0.0,,0.0,,P08172,0.6171851612371004
62,10513578,acm2_human,179,Q,A,[3H]QNB,ChEMBL Compound ID,CHEMBL12980,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,180.0,pM,=,,190.0,-1.056,,,[3H]QNB (radioligand),0.0,0.0,,0.0,,P08172,0.3743565827345173
118,10513578,acm2_human,179,Q,A,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,260.0,pM,=,,180.0,1.444,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P08172,0.3743565827345173
63,10513578,acm2_human,187,T,A,[3H]QNB,ChEMBL Compound ID,CHEMBL12980,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,180.0,pM,=,,170.0,1.059,,,[3H]QNB (radioligand),0.0,0.0,,0.0,,P08172,0.4660985757971594
119,10513578,acm2_human,187,T,A,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,260.0,pM,=,,730.0,-2.809,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P08172,0.4660985757971594
64,10513578,acm2_human,190,T,A,[3H]QNB,ChEMBL Compound ID,CHEMBL12980,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,180.0,pM,=,,800.0,-4.444,,,[3H]QNB (radioligand),0.0,0.0,,0.0,,P08172,0.463506540377709
120,10513578,acm2_human,190,T,A,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,260.0,pM,=,,900.0,-3.46,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P08172,0.463506540377709
71,10188794,acm2_human,103,D,N,Arylacetylene oxime-4,ChEMBL Compound ID,CHEMBL155763,Binding - unknown pharmacological activity,Kapp,Binding - Radioligand competition/displacement,31.0,ÂµM,=,,50.8,-1.639,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P08172,0.4723798591137212
73,10188794,acm2_human,103,D,N,Aryl-ene-yne oxime-12,ChEMBL Compound ID,CHEMBL155960,Binding - unknown pharmacological activity,Kapp,Binding - Radioligand competition/displacement,0.1,ÂµM,=,,6.5,-66.667,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P08172,0.4723798591137212
75,10188794,acm2_human,103,D,N,Aryl-ene-yne oxime-5,ChEMBL Compound ID,CHEMBL160509,Binding - unknown pharmacological activity,Kapp,Binding - Radioligand competition/displacement,21.2,ÂµM,=,,71.0,-3.344,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P08172,0.4723798591137212
77,10188794,acm2_human,103,D,N,Aryl-ene-yne oxime-10,ChEMBL Compound ID,CHEMBL160582,Binding - unknown pharmacological activity,Kapp,Binding - Radioligand competition/displacement,0.4,ÂµM,=,,17.2,-43.478,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P08172,0.4723798591137212
90,10188794,acm2_human,103,D,N,Aryl-ene-yne oxime-11,ChEMBL Compound ID,CHEMBL345415,Binding - unknown pharmacological activity,Kapp,Binding - Radioligand competition/displacement,9.2,ÂµM,=,,14.4,-1.565,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P08172,0.4723798591137212
115,10188794,acm2_human,103,D,N,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,118.0,pM,=,,0.0,30.0,Decreased effect,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P08172,0.4723798591137212
135,20643905,acm2_human,103,D,N,N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.11,,=,,7.93,-15.152,,,N-methyl scopolamine,0.0,0.0,,0.0,,P08172,0.4723798591137212
136,23826889,acm2_human,103,D,N,N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.14,,=,,7.86,-19.231,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P08172,0.4723798591137212
146,10188794,acm2_human,103,D,N,McN-A343,ChEMBL Compound ID,CHEMBL40554,Binding - unknown pharmacological activity,Kapp,Binding - Radioligand competition/displacement,16.1,ÂµM,=,,27.4,-1.701,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P08172,0.4723798591137212
147,20643905,acm2_human,103,D,N,McN-A343,ChEMBL Compound ID,CHEMBL40554,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.59,,=,,4.2,-2.457,,,N-methyl scopolamine,0.0,0.0,,0.0,,P08172,0.4723798591137212
148,23826889,acm2_human,103,D,N,McN-A343,ChEMBL Compound ID,CHEMBL40554,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.57,,=,,4.12,-2.817,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P08172,0.4723798591137212
156,10188794,acm2_human,103,D,N,Aryl-ene-yne oxime-7,ChEMBL Compound ID,CHEMBL434072,Binding - unknown pharmacological activity,Kapp,Binding - Radioligand competition/displacement,0.8,ÂµM,=,,21.2,-26.316,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P08172,0.4723798591137212
160,10188794,acm2_human,103,D,N,Oxotremorine-M,ChEMBL Compound ID,CHEMBL44674,Binding - unknown pharmacological activity,Kapp,Binding - Radioligand competition/displacement,0.2,ÂµM,=,,19.5,-100.0,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P08172,0.4723798591137212
168,10188794,acm2_human,103,D,N,Pilocarpine,ChEMBL Compound ID,CHEMBL550,Binding - unknown pharmacological activity,Kapp,Binding - Radioligand competition/displacement,2.1,ÂµM,=,,162.0,-76.923,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P08172,0.4723798591137212
183,20643905,acm2_human,103,D,N,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,Single-point,Binding - Radioligand competition/displacement,7.79,%,=,,79.0,10.141,,,N-methyl scopolamine,0.0,0.0,,0.0,,P08172,0.4723798591137212
184,20643905,acm2_human,103,D,N,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.68,,=,,3.01,-500.0,,,N-methyl scopolamine,0.0,0.0,,0.0,,P08172,0.4723798591137212
185,23826889,acm2_human,103,D,N,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.64,,=,,2.93,-500.0,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P08172,0.4723798591137212
196,10188794,acm2_human,103,D,N,Arecoline,ChEMBL Compound ID,CHEMBL7303,Binding - unknown pharmacological activity,Kapp,Binding - Radioligand competition/displacement,3.3,ÂµM,=,,605.7,-200.0,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P08172,0.4723798591137212
205,10188794,acm2_human,103,D,N,Arylacetylene oxime-3,ChEMBL Compound ID,CHEMBL81878,Binding - unknown pharmacological activity,Kapp,Binding - Radioligand competition/displacement,23.4,ÂµM,=,,45.6,-1.949,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P08172,0.4723798591137212
216,10188794,acm2_human,103,D,N,Aryl-ene-yne oxime-9,ChEMBL Compound ID,CHEMBL84726,Binding - unknown pharmacological activity,Kapp,Binding - Radioligand competition/displacement,0.1,ÂµM,=,,10.8,-111.111,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P08172,0.4723798591137212
218,10188794,acm2_human,103,D,N,Arylacetylene oxime-1,ChEMBL Compound ID,CHEMBL84893,Binding - unknown pharmacological activity,Kapp,Binding - Radioligand competition/displacement,14.4,ÂµM,=,,37.2,-2.584,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P08172,0.4723798591137212
220,10188794,acm2_human,103,D,N,Arylacetylene oxime-2,ChEMBL Compound ID,CHEMBL84919,Binding - unknown pharmacological activity,Kapp,Binding - Radioligand competition/displacement,37.5,ÂµM,=,,25.3,1.482,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P08172,0.4723798591137212
222,10188794,acm2_human,103,D,N,Aryl-ene-yne oxime-8,ChEMBL Compound ID,CHEMBL86903,Binding - unknown pharmacological activity,Kapp,Binding - Radioligand competition/displacement,0.7,ÂµM,=,,42.0,-58.824,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P08172,0.4723798591137212
224,10188794,acm2_human,103,D,N,Aryl-ene-yne oxime-6,ChEMBL Compound ID,CHEMBL87622,Binding - unknown pharmacological activity,Kapp,Binding - Radioligand competition/displacement,4.0,ÂµM,=,,50.8,-12.658,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P08172,0.4723798591137212
234,10188794,acm2_human,103,D,N,Carbachol,ChEMBL Compound ID,CHEMBL965,Binding - unknown pharmacological activity,Kapp,Binding - Radioligand competition/displacement,2.8,ÂµM,>,,950.0,-333.333,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P08172,0.4723798591137212
262,20643905,acm2_human,103,D,N,BR-384,PubChem CID,3078975,Binding - unknown pharmacological activity,Single-point,Binding - Radioligand competition/displacement,1.29,%,=,,3.0,2.326,,,N-methyl scopolamine,0.0,0.0,,0.0,,P08172,0.4723798591137212
78,10940778,acm2_human,401,A,T,AF-DX 116,ChEMBL Compound ID,CHEMBL17045,Binding - unknown pharmacological activity,pIC50,Binding - Radioligand competition/displacement,7.3,,=,,7.3,1.0,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P08172,0.4732977289555453
203,10940778,acm2_human,401,A,T,4-DAMP,ChEMBL Compound ID,CHEMBL76897,Binding - unknown pharmacological activity,pIC50,Binding - Radioligand competition/displacement,8.5,,=,,8.6,1.259,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P08172,0.4732977289555453
248,10940778,acm2_human,401,A,T,Pirenzepine,ChEMBL Compound ID,CHEMBL9967,Binding - unknown pharmacological activity,pIC50,Binding - Radioligand competition/displacement,6.6,,=,,7.3,5.012,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P08172,0.4732977289555453
265,10940778,acm2_human,401,A,T,UH-AH 37,SMILES,O=C1C2=CC=CC=C2N(C(CC3CCN(C)CC3)=O)C4=C(Cl)C=CC=C4N1,Binding - unknown pharmacological activity,pIC50,Binding - Radioligand competition/displacement,7.5,,=,,8.0,3.162,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P08172,0.4732977289555453
81,15937215,acm2_human,172,E,P,W84,ChEMBL Compound ID,CHEMBL28407,Binding - unknown pharmacological activity,pKapp,Binding - Radioligand competition/displacement,7.7,,=,,7.3,-2.513,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P08172,0.2832324289199521
100,15937215,acm2_human,172,E,P,Gallamine,ChEMBL Compound ID,CHEMBL360055,Binding - unknown pharmacological activity,pKapp,Binding - Radioligand competition/displacement,7.0,,=,,6.6,-2.513,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P08172,0.2832324289199521
82,15937215,acm2_human,175,E,Q,W84,ChEMBL Compound ID,CHEMBL28407,Binding - unknown pharmacological activity,pKapp,Binding - Radioligand competition/displacement,7.7,,=,,7.4,-1.996,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P08172,0.2149876778833197
101,15937215,acm2_human,175,E,Q,Gallamine,ChEMBL Compound ID,CHEMBL360055,Binding - unknown pharmacological activity,pKapp,Binding - Radioligand competition/displacement,7.0,,=,,6.7,-1.996,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P08172,0.2149876778833197
85,15937215,acm2_human,419,N,V,W84,ChEMBL Compound ID,CHEMBL28407,Binding - unknown pharmacological activity,pKapp,Binding - Radioligand competition/displacement,7.7,,=,,8.1,2.512,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P08172,0.350735595567276
107,15937215,acm2_human,419,N,V,Gallamine,ChEMBL Compound ID,CHEMBL360055,Binding - unknown pharmacological activity,pKapp,Binding - Radioligand competition/displacement,7.0,,=,,7.2,1.585,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P08172,0.350735595567276
272,10940778,acm2_human,419,N,V,UH-AH 37,SMILES,O=C1C2=CC=CC=C2N(C(CC3CCN(C)CC3)=O)C4=C(Cl)C=CC=C4N1,Binding - unknown pharmacological activity,pIC50,Binding - Radioligand competition/displacement,7.5,,=,,7.6,1.259,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P08172,0.350735595567276
91,8190113,acm2_human,22,E,Q,Gallamine,ChEMBL Compound ID,CHEMBL360055,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,12.1,ÂµM,=,,10.7,1.131,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P08172,0.2275171497303142
92,8190113,acm2_human,22,E,Q,Gallamine,ChEMBL Compound ID,CHEMBL360055,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,6.8,ÂµM,=,,6.7,1.015,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P08172,0.2275171497303142
109,8190113,acm2_human,22,E,Q,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,132.0,pM,=,,114.0,1.158,,,,47.2,0.0,,0.0,,P08172,0.2275171497303142
93,8190113,acm2_human,69,D,N,Gallamine,ChEMBL Compound ID,CHEMBL360055,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,12.1,ÂµM,=,,30.4,-2.513,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P08172,0.7585062240199908
94,8190113,acm2_human,69,D,N,Gallamine,ChEMBL Compound ID,CHEMBL360055,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,6.8,ÂµM,=,,21.2,-3.115,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P08172,0.7585062240199908
110,8190113,acm2_human,69,D,N,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,132.0,pM,=,,58.0,2.276,,,,13.2,0.0,,0.0,,P08172,0.7585062240199908
130,23826889,acm2_human,69,D,N,N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.14,,=,,9.35,1.622,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P08172,0.7585062240199908
137,23826889,acm2_human,69,D,N,McN-A343,ChEMBL Compound ID,CHEMBL40554,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.57,,=,,5.15,3.802,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P08172,0.7585062240199908
175,23826889,acm2_human,69,D,N,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.64,,=,,5.75,1.288,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P08172,0.7585062240199908
95,8190113,acm2_human,97,D,N,Gallamine,ChEMBL Compound ID,CHEMBL360055,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,12.1,ÂµM,=,,11.3,1.071,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P08172,0.373625189744563
96,8190113,acm2_human,97,D,N,Gallamine,ChEMBL Compound ID,CHEMBL360055,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,6.8,ÂµM,=,,4.7,1.447,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P08172,0.373625189744563
111,8190113,acm2_human,97,D,N,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,132.0,pM,=,,197.0,-1.493,,,,104.4,0.0,,0.0,,P08172,0.373625189744563
131,20643905,acm2_human,97,D,N,N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.11,,=,,8.86,-1.779,,,N-methyl scopolamine,0.0,0.0,,0.0,,P08172,0.373625189744563
139,20643905,acm2_human,97,D,N,McN-A343,ChEMBL Compound ID,CHEMBL40554,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.59,,=,,4.63,1.096,,,N-methyl scopolamine,0.0,0.0,,0.0,,P08172,0.373625189744563
177,20643905,acm2_human,97,D,N,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.68,,=,,3.65,-111.111,,,N-methyl scopolamine,0.0,0.0,,0.0,,P08172,0.373625189744563
259,20643905,acm2_human,97,D,N,BR-384,PubChem CID,3078975,Binding - unknown pharmacological activity,Single-point,Binding - Radioligand competition/displacement,1.29,%,=,,3.0,2.326,,,N-methyl scopolamine,0.0,0.0,,0.0,,P08172,0.373625189744563
97,8190113,acm2_human,120,D,N,Gallamine,ChEMBL Compound ID,CHEMBL360055,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,12.1,ÂµM,=,,9.7,1.247,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P08172,0.7217321529926201
98,8190113,acm2_human,120,D,N,Gallamine,ChEMBL Compound ID,CHEMBL360055,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,6.8,ÂµM,=,,6.2,1.097,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P08172,0.7217321529926201
117,8190113,acm2_human,120,D,N,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,132.0,pM,=,,92.0,1.435,,,,10.1,0.0,,0.0,,P08172,0.7217321529926201
104,8190113,acm2_human,382,E,Q,Gallamine,ChEMBL Compound ID,CHEMBL360055,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,12.1,ÂµM,=,,11.9,1.017,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P08172,0.5027419032036332
105,8190113,acm2_human,382,E,Q,Gallamine,ChEMBL Compound ID,CHEMBL360055,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,6.8,ÂµM,=,,6.2,1.097,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P08172,0.5027419032036332
122,8190113,acm2_human,382,E,Q,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,132.0,pM,=,,137.0,-1.037,,,,62.9,0.0,,0.0,,P08172,0.5027419032036332
121,8157684,acm2_human,210,S,Y,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,115.0,pM,=,,81.0,1.42,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P08172,0.5930355278147492
238,8157684,acm2_human,210,S,Y,Carbachol,ChEMBL Compound ID,CHEMBL965,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,5.6,ÂµM,=,,2.9,1.931,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P08172,0.5930355278147492
123,9063897,acm2_human,385,V,A,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,232.0,pM,=,,428.0,-1.845,,,[3H]N-methyl scopolamine (radioligand),127.5,0.0,,0.0,,P08172,0.4978092650887212
239,9063897,acm2_human,385,V,A,Carbachol,ChEMBL Compound ID,CHEMBL965,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,10.6,ÂµM,=,,18.7,-1.764,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P08172,0.4978092650887212
124,9063897,acm2_human,386,T,A,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,232.0,pM,=,,425.0,-1.832,,,[3H]N-methyl scopolamine (radioligand),106.4,0.0,,0.0,,P08172,0.5012947635659639
240,9063897,acm2_human,386,T,A,Carbachol,ChEMBL Compound ID,CHEMBL965,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,10.6,ÂµM,=,,5.7,1.86,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P08172,0.5012947635659639
125,9063897,acm2_human,389,I,L,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,232.0,pM,=,,535.0,-2.304,,,[3H]N-methyl scopolamine (radioligand),125.3,0.0,,0.0,,P08172,0.3781573964538272
241,9063897,acm2_human,389,I,L,Carbachol,ChEMBL Compound ID,CHEMBL965,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,10.6,ÂµM,=,,66.1,-6.25,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P08172,0.3781573964538272
126,9063897,acm2_human,390,L,S,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,232.0,pM,=,,704.0,-3.03,,,[3H]N-methyl scopolamine (radioligand),122.1,0.0,,0.0,,P08172,0.5296677236006917
242,9063897,acm2_human,390,L,S,Carbachol,ChEMBL Compound ID,CHEMBL965,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,10.6,ÂµM,=,,10.9,-1.029,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P08172,0.5296677236006917
127,10570052,acm2_human,419,N,D,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,pKapp,Binding - Radioligand kinetics (association/dissociation),6.8,,=,,7.4,3.981,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P08172,0.208180216550665
182,20643905,acm2_human,103,D,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,Single-point,Binding - Radioligand competition/displacement,7.79,%,=,,70.0,8.986,,,N-methyl scopolamine,0.0,0.0,,0.0,,P08172,0.60566701997034
261,20643905,acm2_human,103,D,A,BR-384,PubChem CID,3078975,Binding - unknown pharmacological activity,Single-point,Binding - Radioligand competition/displacement,1.29,%,=,,15.0,11.628,,,N-methyl scopolamine,0.0,0.0,,0.0,,P08172,0.60566701997034
246,9143344,acm2_human,457,C,A,Carbachol,ChEMBL Compound ID,CHEMBL965,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.73,,=,,6.88,1.413,,,[3H]QNB (radioligand),102.6,0.0,,0.0,,P08172,0.3793102304604312
247,9143344,acm2_human,457,C,A,Carbachol,ChEMBL Compound ID,CHEMBL965,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.0,,=,,4.21,1.622,,,[3H]QNB (radioligand),102.6,0.0,,0.0,,P08172,0.3793102304604312
258,20643905,acm2_human,76,S,A,BR-384,PubChem CID,3078975,Binding - unknown pharmacological activity,Single-point,Binding - Radioligand competition/displacement,1.29,%,=,,1.29,1.0,,,N-methyl scopolamine,0.0,0.0,,0.0,,P08172,0.4326070862652534
266,10940778,acm2_human,405,V,I,UH-AH 37,SMILES,O=C1C2=CC=CC=C2N(C(CC3CCN(C)CC3)=O)C4=C(Cl)C=CC=C4N1,Binding - unknown pharmacological activity,pIC50,Binding - Radioligand competition/displacement,7.5,,=,,7.4,-1.259,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P08172,0.2259852969911628
267,10940778,acm2_human,409,I,V,UH-AH 37,SMILES,O=C1C2=CC=CC=C2N(C(CC3CCN(C)CC3)=O)C4=C(Cl)C=CC=C4N1,Binding - unknown pharmacological activity,pIC50,Binding - Radioligand competition/displacement,7.5,,=,,7.7,1.585,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P08172,0.2084173939896346
268,10940778,acm2_human,410,N,S,UH-AH 37,SMILES,O=C1C2=CC=CC=C2N(C(CC3CCN(C)CC3)=O)C4=C(Cl)C=CC=C4N1,Binding - unknown pharmacological activity,pIC50,Binding - Radioligand competition/displacement,7.5,,=,,7.7,1.585,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P08172,0.3864865204255919
271,10940778,acm2_human,417,I,V,UH-AH 37,SMILES,O=C1C2=CC=CC=C2N(C(CC3CCN(C)CC3)=O)C4=C(Cl)C=CC=C4N1,Binding - unknown pharmacological activity,pIC50,Binding - Radioligand competition/displacement,7.5,,=,,7.6,1.259,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P08172,0.2530064813522635
0,20233217,cxcr2_human,249,A,L,IP8_HUMAN,UniProt Entry Code (peptide),P10145,Full agonist,K(d),Binding - Radioligand saturation,0.134,nM,=,,0.321,-2.398,,,,0.0,0.0,,0.0,,P25025,0.5892912207527347
12,20233217,cxcr2_human,249,A,L,IP8_HUMAN,UniProt Entry Code (peptide),P10145,Full agonist,pEC50,Functional - Other,8.47,,=,,8.05,-2.632,,,,0.0,0.0,,0.0,,P25025,0.5892912207527347
22,20233217,cxcr2_human,249,A,L,[3H]SB-265610,SMILES,N#CC1=C(N=NN2)C2=C(NC(NC3=C(Br)C=CC=C3)=O)C=C1,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,2.1,nM,=,,3.54,-1.686,,,,0.0,0.0,,0.0,,P25025,0.5892912207527347
32,20233217,cxcr2_human,249,A,L,SB-265610,SMILES,N#CC1=C(N=NN2)C2=C(NC(NC3=C(Br)C=CC=C3)=O)C=C1,Antagonist (neutral/silent),pIC50,Binding - Other,8.31,,=,,8.44,1.349,,,,0.0,0.0,,0.0,,P25025,0.5892912207527347
42,20233217,cxcr2_human,249,A,L,[3H]Pteridone-1,SMILES,O=C1C=NC2=C(N=C(SCC3=CC=CC(F)=C3F)N=C2N[C@H](C)CO)N1,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,2.37,nM,=,,33.64,-14.286,,,,0.0,0.0,,0.0,,P25025,0.5892912207527347
52,20233217,cxcr2_human,249,A,L,Pteridone-1,SMILES,O=C1C=NC2=C(N=C(SCC3=CC=CC(F)=C3F)N=C2N[C@H](C)CO)N1,Antagonist (neutral/silent),pIC50,Binding - Other,7.63,,=,,6.54,-12.346,,,,0.0,0.0,,0.0,,P25025,0.5892912207527347
62,20233217,cxcr2_human,249,A,L,[3H]Sch527123,SMILES,OC1=C(NC2=C(N[C@@H](C3=CC=C(C)O3)CC)C(C2=O)=O)C=CC=C1C(N(C)C)=O,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,0.059,nM,=,,16.52,-250.0,,,,0.0,0.0,,0.0,,P25025,0.5892912207527347
1,20233217,cxcr2_human,320,K,A,IP8_HUMAN,UniProt Entry Code (peptide),P10145,Full agonist,K(d),Binding - Radioligand saturation,0.134,nM,=,,0.358,-2.674,,,,0.0,0.0,,0.0,,P25025,0.5417983657956145
10,20233217,cxcr2_human,320,K,A,IP8_HUMAN,UniProt Entry Code (peptide),P10145,Full agonist,pEC50,Functional - Other,8.47,,=,,8.21,-1.818,,,,0.0,0.0,,0.0,,P25025,0.5417983657956145
20,20233217,cxcr2_human,320,K,A,[3H]SB-265610,SMILES,N#CC1=C(N=NN2)C2=C(NC(NC3=C(Br)C=CC=C3)=O)C=C1,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,2.1,nM,=,,9.34,-4.444,,,,0.0,0.0,,0.0,,P25025,0.5417983657956145
30,20233217,cxcr2_human,320,K,A,SB-265610,SMILES,N#CC1=C(N=NN2)C2=C(NC(NC3=C(Br)C=CC=C3)=O)C=C1,Antagonist (neutral/silent),pIC50,Binding - Other,8.31,,=,,7.3,-10.204,,,,0.0,0.0,,0.0,,P25025,0.5417983657956145
40,20233217,cxcr2_human,320,K,A,[3H]Pteridone-1,SMILES,O=C1C=NC2=C(N=C(SCC3=CC=CC(F)=C3F)N=C2N[C@H](C)CO)N1,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,2.37,nM,=,,38.77,-16.393,,,,0.0,0.0,,0.0,,P25025,0.5417983657956145
50,20233217,cxcr2_human,320,K,A,Pteridone-1,SMILES,O=C1C=NC2=C(N=C(SCC3=CC=CC(F)=C3F)N=C2N[C@H](C)CO)N1,Antagonist (neutral/silent),pIC50,Binding - Other,7.63,,=,,6.54,-12.346,,,,0.0,0.0,,0.0,,P25025,0.5417983657956145
60,20233217,cxcr2_human,320,K,A,[3H]Sch527123,SMILES,OC1=C(NC2=C(N[C@@H](C3=CC=C(C)O3)CC)C(C2=O)=O)C=CC=C1C(N(C)C)=O,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,0.059,nM,=,,1.82,-31.25,,,,0.0,0.0,,0.0,,P25025,0.5417983657956145
2,20233217,cxcr2_human,314,Y,A,IP8_HUMAN,UniProt Entry Code (peptide),P10145,Full agonist,K(d),Binding - Radioligand saturation,0.134,nM,=,,0.289,-2.155,,,,0.0,0.0,,0.0,,P25025,0.816381194110447
11,20233217,cxcr2_human,314,Y,A,IP8_HUMAN,UniProt Entry Code (peptide),P10145,Full agonist,pEC50,Functional - Other,8.47,,=,,8.23,-1.739,,,,0.0,0.0,,0.0,,P25025,0.816381194110447
21,20233217,cxcr2_human,314,Y,A,[3H]SB-265610,SMILES,N#CC1=C(N=NN2)C2=C(NC(NC3=C(Br)C=CC=C3)=O)C=C1,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,2.1,nM,=,,18.33,-8.696,,,,0.0,0.0,,0.0,,P25025,0.816381194110447
61,20233217,cxcr2_human,314,Y,A,[3H]Sch527123,SMILES,OC1=C(NC2=C(N[C@@H](C3=CC=C(C)O3)CC)C(C2=O)=O)C=CC=C1C(N(C)C)=O,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,0.059,nM,=,,0.415,-7.042,,,,0.0,0.0,,0.0,,P25025,0.816381194110447
3,20233217,cxcr2_human,300,E,Q,IP8_HUMAN,UniProt Entry Code (peptide),P10145,Full agonist,K(d),Binding - Radioligand saturation,0.134,nM,=,,0.238,-1.776,,,,0.0,0.0,,0.0,,P25025,0.3632317199933066
13,20233217,cxcr2_human,300,E,Q,IP8_HUMAN,UniProt Entry Code (peptide),P10145,Full agonist,pEC50,Functional - Other,8.47,,=,,8.14,-2.137,,,,0.0,0.0,,0.0,,P25025,0.3632317199933066
23,20233217,cxcr2_human,300,E,Q,[3H]SB-265610,SMILES,N#CC1=C(N=NN2)C2=C(NC(NC3=C(Br)C=CC=C3)=O)C=C1,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,2.1,nM,=,,2.88,-1.372,,,,0.0,0.0,,0.0,,P25025,0.3632317199933066
33,20233217,cxcr2_human,300,E,Q,SB-265610,SMILES,N#CC1=C(N=NN2)C2=C(NC(NC3=C(Br)C=CC=C3)=O)C=C1,Antagonist (neutral/silent),pIC50,Binding - Other,8.31,,=,,8.32,1.023,,,,0.0,0.0,,0.0,,P25025,0.3632317199933066
43,20233217,cxcr2_human,300,E,Q,[3H]Pteridone-1,SMILES,O=C1C=NC2=C(N=C(SCC3=CC=CC(F)=C3F)N=C2N[C@H](C)CO)N1,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,2.37,nM,=,,3.43,-1.447,,,,0.0,0.0,,0.0,,P25025,0.3632317199933066
53,20233217,cxcr2_human,300,E,Q,Pteridone-1,SMILES,O=C1C=NC2=C(N=C(SCC3=CC=CC(F)=C3F)N=C2N[C@H](C)CO)N1,Antagonist (neutral/silent),pIC50,Binding - Other,7.63,,=,,7.64,1.023,,,,0.0,0.0,,0.0,,P25025,0.3632317199933066
63,20233217,cxcr2_human,300,E,Q,[3H]Sch527123,SMILES,OC1=C(NC2=C(N[C@@H](C3=CC=C(C)O3)CC)C(C2=O)=O)C=CC=C1C(N(C)C)=O,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,0.059,nM,=,,0.032,1.844,,,,0.0,0.0,,0.0,,P25025,0.3632317199933066
83,21948388,cxcr2_human,300,E,Q,IP8_HUMAN,UniProt Entry Code (peptide),P10145,Full agonist,pK(d),Binding - Radioligand kinetics (association/dissociation),9.4,,=,,9.0,-2.513,,,125I-CXCL8,0.0,0.0,,0.0,,P25025,0.3632317199933066
97,21948388,cxcr2_human,300,E,Q,SB-265617,SMILES,N#CC1=C(N=NN2)C2=C(NC(NC3=C(Br)C=CC=C3)=O)C=C1,Antagonist (neutral/silent),pK(i),Binding - Radioligand competition/displacement,7.68,,=,,7.26,-2.632,,,125I-CXCL8,0.0,0.0,,0.0,,P25025,0.3632317199933066
111,21948388,cxcr2_human,300,E,Q,imidazolylpyrimidine 1,SMILES,CCCCCCCCSC1=CC(N[C@@H](CCCN2CCCOCC)C2=O)=NC(N3C=NC=C3)=N1,Antagonist (neutral/silent),pK(i),Binding - Radioligand competition/displacement,7.18,,=,,6.69,-3.086,,,radioligand: [125I]-CXCL28,0.0,0.0,,0.0,,P25025,0.3632317199933066
4,20233217,cxcr2_human,321,F,A,IP8_HUMAN,UniProt Entry Code (peptide),P10145,Full agonist,K(d),Binding - Radioligand saturation,0.134,nM,=,,0.211,-1.575,,,,0.0,0.0,,0.0,,P25025,0.7726651813447616
14,20233217,cxcr2_human,321,F,A,IP8_HUMAN,UniProt Entry Code (peptide),P10145,Full agonist,pEC50,Functional - Other,8.47,,=,,8.91,2.754,,,,0.0,0.0,,0.0,,P25025,0.7726651813447616
24,20233217,cxcr2_human,321,F,A,[3H]SB-265610,SMILES,N#CC1=C(N=NN2)C2=C(NC(NC3=C(Br)C=CC=C3)=O)C=C1,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,2.1,nM,=,,3.96,-1.887,,,,0.0,0.0,,0.0,,P25025,0.7726651813447616
34,20233217,cxcr2_human,321,F,A,SB-265610,SMILES,N#CC1=C(N=NN2)C2=C(NC(NC3=C(Br)C=CC=C3)=O)C=C1,Antagonist (neutral/silent),pIC50,Binding - Other,8.31,,=,,7.87,-2.755,,,,0.0,0.0,,0.0,,P25025,0.7726651813447616
44,20233217,cxcr2_human,321,F,A,[3H]Pteridone-1,SMILES,O=C1C=NC2=C(N=C(SCC3=CC=CC(F)=C3F)N=C2N[C@H](C)CO)N1,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,2.37,nM,=,,5.41,-2.283,,,,0.0,0.0,,0.0,,P25025,0.7726651813447616
54,20233217,cxcr2_human,321,F,A,Pteridone-1,SMILES,O=C1C=NC2=C(N=C(SCC3=CC=CC(F)=C3F)N=C2N[C@H](C)CO)N1,Antagonist (neutral/silent),pIC50,Binding - Other,7.63,,=,,6.29,-21.739,,,,0.0,0.0,,0.0,,P25025,0.7726651813447616
64,20233217,cxcr2_human,321,F,A,[3H]Sch527123,SMILES,OC1=C(NC2=C(N[C@@H](C3=CC=C(C)O3)CC)C(C2=O)=O)C=CC=C1C(N(C)C)=O,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,0.059,nM,=,,0.109,-1.848,,,,0.0,0.0,,0.0,,P25025,0.7726651813447616
5,20233217,cxcr2_human,84,D,N,IP8_HUMAN,UniProt Entry Code (peptide),P10145,Full agonist,K(d),Binding - Radioligand saturation,0.134,nM,=,,0.211,-1.575,,,,0.0,0.0,,0.0,,P25025,0.4797711749162988
15,20233217,cxcr2_human,84,D,N,IP8_HUMAN,UniProt Entry Code (peptide),P10145,Full agonist,pEC50,Functional - Other,8.47,,=,,8.49,1.047,,,,0.0,0.0,,0.0,,P25025,0.4797711749162988
35,20233217,cxcr2_human,84,D,N,SB-265610,SMILES,N#CC1=C(N=NN2)C2=C(NC(NC3=C(Br)C=CC=C3)=O)C=C1,Antagonist (neutral/silent),pIC50,Binding - Other,8.31,,=,,6.79,-33.333,,,,0.0,0.0,,0.0,,P25025,0.4797711749162988
45,20233217,cxcr2_human,84,D,N,[3H]Pteridone-1,SMILES,O=C1C=NC2=C(N=C(SCC3=CC=CC(F)=C3F)N=C2N[C@H](C)CO)N1,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,2.37,nM,=,,10.79,-4.545,,,,0.0,0.0,,0.0,,P25025,0.4797711749162988
55,20233217,cxcr2_human,84,D,N,Pteridone-1,SMILES,O=C1C=NC2=C(N=C(SCC3=CC=CC(F)=C3F)N=C2N[C@H](C)CO)N1,Antagonist (neutral/silent),pIC50,Binding - Other,7.63,,=,,6.63,-10.0,,,,0.0,0.0,,0.0,,P25025,0.4797711749162988
65,20233217,cxcr2_human,84,D,N,[3H]Sch527123,SMILES,OC1=C(NC2=C(N[C@@H](C3=CC=C(C)O3)CC)C(C2=O)=O)C=CC=C1C(N(C)C)=O,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,0.059,nM,=,,4.1,-71.429,,,,0.0,0.0,,0.0,,P25025,0.4797711749162988
6,20233217,cxcr2_human,83,T,A,IP8_HUMAN,UniProt Entry Code (peptide),P10145,Full agonist,K(d),Binding - Radioligand saturation,0.134,nM,=,,0.232,-1.73,,,,0.0,0.0,,0.0,,P25025,0.4966720897549998
16,20233217,cxcr2_human,83,T,A,IP8_HUMAN,UniProt Entry Code (peptide),P10145,Full agonist,pEC50,Functional - Other,8.47,,=,,8.39,-1.202,,,,0.0,0.0,,0.0,,P25025,0.4966720897549998
26,20233217,cxcr2_human,83,T,A,[3H]SB-265610,SMILES,N#CC1=C(N=NN2)C2=C(NC(NC3=C(Br)C=CC=C3)=O)C=C1,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,2.1,nM,=,,11.65,-5.556,,,,0.0,0.0,,0.0,,P25025,0.4966720897549998
36,20233217,cxcr2_human,83,T,A,SB-265610,SMILES,N#CC1=C(N=NN2)C2=C(NC(NC3=C(Br)C=CC=C3)=O)C=C1,Antagonist (neutral/silent),pIC50,Binding - Other,8.31,,=,,7.39,-8.333,,,,0.0,0.0,,0.0,,P25025,0.4966720897549998
46,20233217,cxcr2_human,83,T,A,[3H]Pteridone-1,SMILES,O=C1C=NC2=C(N=C(SCC3=CC=CC(F)=C3F)N=C2N[C@H](C)CO)N1,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,2.37,nM,=,,3.54,-1.495,,,,0.0,0.0,,0.0,,P25025,0.4966720897549998
56,20233217,cxcr2_human,83,T,A,Pteridone-1,SMILES,O=C1C=NC2=C(N=C(SCC3=CC=CC(F)=C3F)N=C2N[C@H](C)CO)N1,Antagonist (neutral/silent),pIC50,Binding - Other,7.63,,=,,7.22,-2.571,,,,0.0,0.0,,0.0,,P25025,0.4966720897549998
66,20233217,cxcr2_human,83,T,A,[3H]Sch527123,SMILES,OC1=C(NC2=C(N[C@@H](C3=CC=C(C)O3)CC)C(C2=O)=O)C=CC=C1C(N(C)C)=O,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,0.059,nM,=,,0.694,-11.765,,,,0.0,0.0,,0.0,,P25025,0.4966720897549998
7,20233217,cxcr2_human,147,A,L,IP8_HUMAN,UniProt Entry Code (peptide),P10145,Full agonist,K(d),Binding - Radioligand saturation,0.134,nM,=,,0.193,-1.441,,,,0.0,0.0,,0.0,,P25025,0.5584069756247791
27,20233217,cxcr2_human,147,A,L,[3H]SB-265610,SMILES,N#CC1=C(N=NN2)C2=C(NC(NC3=C(Br)C=CC=C3)=O)C=C1,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,2.1,nM,=,,3.24,-1.543,,,,0.0,0.0,,0.0,,P25025,0.5584069756247791
47,20233217,cxcr2_human,147,A,L,[3H]Pteridone-1,SMILES,O=C1C=NC2=C(N=C(SCC3=CC=CC(F)=C3F)N=C2N[C@H](C)CO)N1,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,2.37,nM,=,,1.85,1.281,,,,0.0,0.0,,0.0,,P25025,0.5584069756247791
67,20233217,cxcr2_human,147,A,L,[3H]Sch527123,SMILES,OC1=C(NC2=C(N[C@@H](C3=CC=C(C)O3)CC)C(C2=O)=O)C=CC=C1C(N(C)C)=O,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,0.059,nM,=,,0.194,-3.289,,,,0.0,0.0,,0.0,,P25025,0.5584069756247791
8,20233217,cxcr2_human,83,T,L,IP8_HUMAN,UniProt Entry Code (peptide),P10145,Full agonist,K(d),Binding - Radioligand saturation,0.134,nM,=,,0.27,-2.016,,,,0.0,0.0,,0.0,,P25025,0.5415276340245896
18,20233217,cxcr2_human,83,T,L,IP8_HUMAN,UniProt Entry Code (peptide),P10145,Full agonist,pEC50,Functional - Other,8.47,,=,,8.14,-2.137,,,,0.0,0.0,,0.0,,P25025,0.5415276340245896
28,20233217,cxcr2_human,83,T,L,[3H]SB-265610,SMILES,N#CC1=C(N=NN2)C2=C(NC(NC3=C(Br)C=CC=C3)=O)C=C1,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,2.1,nM,=,,1.89,1.111,,,,0.0,0.0,,0.0,,P25025,0.5415276340245896
38,20233217,cxcr2_human,83,T,L,SB-265610,SMILES,N#CC1=C(N=NN2)C2=C(NC(NC3=C(Br)C=CC=C3)=O)C=C1,Antagonist (neutral/silent),pIC50,Binding - Other,8.31,,=,,8.31,1.0,,,,0.0,0.0,,0.0,,P25025,0.5415276340245896
48,20233217,cxcr2_human,83,T,L,[3H]Pteridone-1,SMILES,O=C1C=NC2=C(N=C(SCC3=CC=CC(F)=C3F)N=C2N[C@H](C)CO)N1,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,2.37,nM,=,,0.93,2.548,,,,0.0,0.0,,0.0,,P25025,0.5415276340245896
58,20233217,cxcr2_human,83,T,L,Pteridone-1,SMILES,O=C1C=NC2=C(N=C(SCC3=CC=CC(F)=C3F)N=C2N[C@H](C)CO)N1,Antagonist (neutral/silent),pIC50,Binding - Other,7.63,,=,,7.88,1.778,,,,0.0,0.0,,0.0,,P25025,0.5415276340245896
68,20233217,cxcr2_human,83,T,L,[3H]Sch527123,SMILES,OC1=C(NC2=C(N[C@@H](C3=CC=C(C)O3)CC)C(C2=O)=O)C=CC=C1C(N(C)C)=O,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,0.059,nM,=,,2.47,-41.667,,,,0.0,0.0,,0.0,,P25025,0.5415276340245896
9,20233217,cxcr2_human,143,D,R,IP8_HUMAN,UniProt Entry Code (peptide),P10145,Full agonist,K(d),Binding - Radioligand saturation,0.134,nM,=,,0.149,-1.112,,,,0.0,0.0,,0.0,,P25025,0.7824317179366463
19,20233217,cxcr2_human,143,D,R,IP8_HUMAN,UniProt Entry Code (peptide),P10145,Full agonist,pEC50,Functional - Other,8.47,,=,,8.13,-2.188,,,,0.0,0.0,,0.0,,P25025,0.7824317179366463
29,20233217,cxcr2_human,143,D,R,[3H]SB-265610,SMILES,N#CC1=C(N=NN2)C2=C(NC(NC3=C(Br)C=CC=C3)=O)C=C1,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,2.1,nM,=,,25.38,-12.048,,,,0.0,0.0,,0.0,,P25025,0.7824317179366463
39,20233217,cxcr2_human,143,D,R,SB-265610,SMILES,N#CC1=C(N=NN2)C2=C(NC(NC3=C(Br)C=CC=C3)=O)C=C1,Antagonist (neutral/silent),pIC50,Binding - Other,8.31,,=,,7.16,-14.085,,,,0.0,0.0,,0.0,,P25025,0.7824317179366463
49,20233217,cxcr2_human,143,D,R,[3H]Pteridone-1,SMILES,O=C1C=NC2=C(N=C(SCC3=CC=CC(F)=C3F)N=C2N[C@H](C)CO)N1,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,2.37,nM,=,,2.56,-1.08,,,,0.0,0.0,,0.0,,P25025,0.7824317179366463
59,20233217,cxcr2_human,143,D,R,Pteridone-1,SMILES,O=C1C=NC2=C(N=C(SCC3=CC=CC(F)=C3F)N=C2N[C@H](C)CO)N1,Antagonist (neutral/silent),pIC50,Binding - Other,7.63,,=,,7.39,-1.739,,,,0.0,0.0,,0.0,,P25025,0.7824317179366463
69,20233217,cxcr2_human,143,D,R,[3H]Sch527123,SMILES,OC1=C(NC2=C(N[C@@H](C3=CC=C(C)O3)CC)C(C2=O)=O)C=CC=C1C(N(C)C)=O,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,0.059,nM,=,,0.804,-13.699,,,,0.0,0.0,,0.0,,P25025,0.7824317179366463
70,21948388,cxcr2_human,217,S,T,IP8_HUMAN,UniProt Entry Code (peptide),P10145,Full agonist,pK(d),Binding - Radioligand kinetics (association/dissociation),9.4,,=,,9.2,-1.585,,,125I-CXCL8,0.0,0.0,,0.0,,P25025,0.2011683744892581
84,21948388,cxcr2_human,217,S,T,SB-265610,SMILES,N#CC1=C(N=NN2)C2=C(NC(NC3=C(Br)C=CC=C3)=O)C=C1,Antagonist (neutral/silent),pK(i),Binding - Radioligand competition/displacement,7.68,,=,,7.92,1.738,,,125I-CXCL8,0.0,0.0,,0.0,,P25025,0.2011683744892581
98,21948388,cxcr2_human,217,S,T,imidazolylpyrimidine 1,SMILES,CCCCCCCCSC1=CC(N[C@@H](CCCN2CCCOCC)C2=O)=NC(N3C=NC=C3)=N1,Antagonist (neutral/silent),pK(i),Binding - Radioligand competition/displacement,7.18,,=,,5.77,-25.641,,,radioligand: [125I]-CXCL9,0.0,0.0,,0.0,,P25025,0.2011683744892581
71,21948388,cxcr2_human,268,N,H,IP8_HUMAN,UniProt Entry Code (peptide),P10145,Full agonist,pK(d),Binding - Radioligand kinetics (association/dissociation),9.4,,=,,9.18,-1.658,,,125I-CXCL8,0.0,0.0,,0.0,,P25025,0.4895980332102407
85,21948388,cxcr2_human,268,N,H,SB-265610,SMILES,N#CC1=C(N=NN2)C2=C(NC(NC3=C(Br)C=CC=C3)=O)C=C1,Antagonist (neutral/silent),pK(i),Binding - Radioligand competition/displacement,7.68,,=,,7.14,-3.472,,,125I-CXCL8,0.0,0.0,,0.0,,P25025,0.4895980332102407
99,21948388,cxcr2_human,268,N,H,imidazolylpyrimidine 1,SMILES,CCCCCCCCSC1=CC(N[C@@H](CCCN2CCCOCC)C2=O)=NC(N3C=NC=C3)=N1,Antagonist (neutral/silent),pK(i),Binding - Radioligand competition/displacement,7.18,,<,,5.0,-142.857,,,radioligand: [125I]-CXCL10,0.0,0.0,,0.0,,P25025,0.4895980332102407
72,21948388,cxcr2_human,280,Q,R,IP8_HUMAN,UniProt Entry Code (peptide),P10145,Full agonist,pK(d),Binding - Radioligand kinetics (association/dissociation),9.4,,=,,9.13,-1.862,,,125I-CXCL8,0.0,0.0,,0.0,,P25025,0.1980782296708725
86,21948388,cxcr2_human,280,Q,R,SB-265610,SMILES,N#CC1=C(N=NN2)C2=C(NC(NC3=C(Br)C=CC=C3)=O)C=C1,Antagonist (neutral/silent),pK(i),Binding - Radioligand competition/displacement,7.68,,=,,7.29,-2.457,,,125I-CXCL8,0.0,0.0,,0.0,,P25025,0.1980782296708725
100,21948388,cxcr2_human,280,Q,R,imidazolylpyrimidine 1,SMILES,CCCCCCCCSC1=CC(N[C@@H](CCCN2CCCOCC)C2=O)=NC(N3C=NC=C3)=N1,Antagonist (neutral/silent),pK(i),Binding - Radioligand competition/displacement,7.18,,=,,7.1,-1.202,,,radioligand: [125I]-CXCL13,0.0,0.0,,0.0,,P25025,0.1980782296708725
75,21948388,cxcr2_human,287,E,Q,IP8_HUMAN,UniProt Entry Code (peptide),P10145,Full agonist,pK(d),Binding - Radioligand kinetics (association/dissociation),9.4,,=,,9.11,-1.949,,,125I-CXCL8,0.0,0.0,,0.0,,P25025,0.170848600344233
89,21948388,cxcr2_human,287,E,Q,SB-265610,SMILES,N#CC1=C(N=NN2)C2=C(NC(NC3=C(Br)C=CC=C3)=O)C=C1,Antagonist (neutral/silent),pK(i),Binding - Radioligand competition/displacement,7.68,,=,,7.39,-1.949,,,125I-CXCL8,0.0,0.0,,0.0,,P25025,0.170848600344233
103,21948388,cxcr2_human,287,E,Q,imidazolylpyrimidine 1,SMILES,CCCCCCCCSC1=CC(N[C@@H](CCCN2CCCOCC)C2=O)=NC(N3C=NC=C3)=N1,Antagonist (neutral/silent),pK(i),Binding - Radioligand competition/displacement,7.18,,=,,6.99,-1.548,,,radioligand: [125I]-CXCL16,0.0,0.0,,0.0,,P25025,0.170848600344233
76,21948388,cxcr2_human,294,R,Q,IP8_HUMAN,UniProt Entry Code (peptide),P10145,Full agonist,pK(d),Binding - Radioligand kinetics (association/dissociation),9.4,,=,,9.15,-1.779,,,125I-CXCL8,0.0,0.0,,0.0,,P25025,0.1918904012855222
90,21948388,cxcr2_human,294,R,Q,SB-265610,SMILES,N#CC1=C(N=NN2)C2=C(NC(NC3=C(Br)C=CC=C3)=O)C=C1,Antagonist (neutral/silent),pK(i),Binding - Radioligand competition/displacement,7.68,,=,,7.24,-2.755,,,125I-CXCL8,0.0,0.0,,0.0,,P25025,0.1918904012855222
104,21948388,cxcr2_human,294,R,Q,imidazolylpyrimidine 1,SMILES,CCCCCCCCSC1=CC(N[C@@H](CCCN2CCCOCC)C2=O)=NC(N3C=NC=C3)=N1,Antagonist (neutral/silent),pK(i),Binding - Radioligand competition/displacement,7.18,,=,,7.04,-1.381,,,radioligand: [125I]-CXCL17,0.0,0.0,,0.0,,P25025,0.1918904012855222
77,21948388,cxcr2_human,107,S,A,IP8_HUMAN,UniProt Entry Code (peptide),P10145,Full agonist,pK(d),Binding - Radioligand kinetics (association/dissociation),9.4,,=,,9.09,-2.041,,,125I-CXCL8,0.0,0.0,,0.0,,P25025,0.3085439488815068
91,21948388,cxcr2_human,107,S,A,SB-265611,SMILES,N#CC1=C(N=NN2)C2=C(NC(NC3=C(Br)C=CC=C3)=O)C=C1,Antagonist (neutral/silent),pK(i),Binding - Radioligand competition/displacement,7.68,,=,,7.1,-3.802,,,125I-CXCL8,0.0,0.0,,0.0,,P25025,0.3085439488815068
105,21948388,cxcr2_human,107,S,A,imidazolylpyrimidine 1,SMILES,CCCCCCCCSC1=CC(N[C@@H](CCCN2CCCOCC)C2=O)=NC(N3C=NC=C3)=N1,Antagonist (neutral/silent),pK(i),Binding - Radioligand competition/displacement,7.18,,=,,6.73,-2.817,,,radioligand: [125I]-CXCL22,0.0,0.0,,0.0,,P25025,0.3085439488815068
78,21948388,cxcr2_human,130,F,A,IP8_HUMAN,UniProt Entry Code (peptide),P10145,Full agonist,pK(d),Binding - Radioligand kinetics (association/dissociation),9.4,,=,,9.65,1.778,,,125I-CXCL8,0.0,0.0,,0.0,,P25025,0.6146598130384036
92,21948388,cxcr2_human,130,F,A,SB-265612,SMILES,N#CC1=C(N=NN2)C2=C(NC(NC3=C(Br)C=CC=C3)=O)C=C1,Antagonist (neutral/silent),pK(i),Binding - Radioligand competition/displacement,7.68,,=,,7.55,-1.35,,,125I-CXCL8,0.0,0.0,,0.0,,P25025,0.6146598130384036
106,21948388,cxcr2_human,130,F,A,imidazolylpyrimidine 1,SMILES,CCCCCCCCSC1=CC(N[C@@H](CCCN2CCCOCC)C2=O)=NC(N3C=NC=C3)=N1,Antagonist (neutral/silent),pK(i),Binding - Radioligand competition/displacement,7.18,,<,,4.0,-1000.0,,,radioligand: [125I]-CXCL23,0.0,0.0,,0.0,,P25025,0.6146598130384036
79,21948388,cxcr2_human,216,Q,E,IP8_HUMAN,UniProt Entry Code (peptide),P10145,Full agonist,pK(d),Binding - Radioligand kinetics (association/dissociation),9.4,,=,,9.01,-2.457,,,125I-CXCL8,0.0,0.0,,0.0,,P25025,0.3982712780395852
93,21948388,cxcr2_human,216,Q,E,SB-265613,SMILES,N#CC1=C(N=NN2)C2=C(NC(NC3=C(Br)C=CC=C3)=O)C=C1,Antagonist (neutral/silent),pK(i),Binding - Radioligand competition/displacement,7.68,,=,,7.56,-1.318,,,125I-CXCL8,0.0,0.0,,0.0,,P25025,0.3982712780395852
107,21948388,cxcr2_human,216,Q,E,imidazolylpyrimidine 1,SMILES,CCCCCCCCSC1=CC(N[C@@H](CCCN2CCCOCC)C2=O)=NC(N3C=NC=C3)=N1,Antagonist (neutral/silent),pK(i),Binding - Radioligand competition/displacement,7.18,,=,,6.47,-5.128,,,radioligand: [125I]-CXCL24,0.0,0.0,,0.0,,P25025,0.3982712780395852
81,21948388,cxcr2_human,271,L,A,IP8_HUMAN,UniProt Entry Code (peptide),P10145,Full agonist,pK(d),Binding - Radioligand kinetics (association/dissociation),9.4,,=,,9.18,-1.658,,,125I-CXCL8,0.0,0.0,,0.0,,P25025,0.4627423415030589
95,21948388,cxcr2_human,271,L,A,SB-265615,SMILES,N#CC1=C(N=NN2)C2=C(NC(NC3=C(Br)C=CC=C3)=O)C=C1,Antagonist (neutral/silent),pK(i),Binding - Radioligand competition/displacement,7.68,,=,,6.76,-8.333,,,125I-CXCL8,0.0,0.0,,0.0,,P25025,0.4627423415030589
109,21948388,cxcr2_human,271,L,A,imidazolylpyrimidine 1,SMILES,CCCCCCCCSC1=CC(N[C@@H](CCCN2CCCOCC)C2=O)=NC(N3C=NC=C3)=N1,Antagonist (neutral/silent),pK(i),Binding - Radioligand competition/displacement,7.18,,=,,6.22,-9.091,,,radioligand: [125I]-CXCL26,0.0,0.0,,0.0,,P25025,0.4627423415030589
82,21948388,cxcr2_human,300,E,S,IP8_HUMAN,UniProt Entry Code (peptide),P10145,Full agonist,pK(d),Binding - Radioligand kinetics (association/dissociation),9.4,,=,,9.04,-2.288,,,125I-CXCL8,0.0,0.0,,0.0,,P25025,0.4497862443997634
96,21948388,cxcr2_human,300,E,S,SB-265616,SMILES,N#CC1=C(N=NN2)C2=C(NC(NC3=C(Br)C=CC=C3)=O)C=C1,Antagonist (neutral/silent),pK(i),Binding - Radioligand competition/displacement,7.68,,=,,7.21,-2.95,,,125I-CXCL8,0.0,0.0,,0.0,,P25025,0.4497862443997634
110,21948388,cxcr2_human,300,E,S,imidazolylpyrimidine 1,SMILES,CCCCCCCCSC1=CC(N[C@@H](CCCN2CCCOCC)C2=O)=NC(N3C=NC=C3)=N1,Antagonist (neutral/silent),pK(i),Binding - Radioligand competition/displacement,7.18,,=,,6.79,-2.457,,,radioligand: [125I]-CXCL27,0.0,0.0,,0.0,,P25025,0.4497862443997634
112,12628493,cxcr2_human,203,N,D,IP8_HUMAN,UniProt Entry Code (peptide),P10145,Full agonist,EC50,Binding - Radioligand competition/displacement,1.2,nM,=,,0.1,12.0,,,125I-CXCL8,90.0,0.0,,0.0,,P25025,0.196615995213909
116,12628493,cxcr2_human,203,N,D,GROA_HUMAN,UniProt Entry Code (peptide),P10145,Full agonist,EC50,Binding - Radioligand competition/displacement,1.2,nM,=,,0.3,4.0,,,125I-CXCL8,90.0,0.0,,0.0,,P25025,0.196615995213909
120,12628493,cxcr2_human,203,N,D,SB-225002,ChEMBL ID,CHEMBL239767,Antagonist (neutral/silent),EC50,Binding - Radioligand competition/displacement,1.2,nM,=,,24.0,-20.0,,,125I-CXCL8,90.0,0.0,,0.0,,P25025,0.196615995213909
114,12628493,cxcr2_human,304,I,F,IP8_HUMAN,UniProt Entry Code (peptide),P10145,Full agonist,EC50,Binding - Radioligand competition/displacement,1.2,nM,=,,16.3,-13.514,,,125I-CXCL8,90.0,0.0,,0.0,,P25025,0.527178090882321
118,12628493,cxcr2_human,304,I,F,GROA_HUMAN,UniProt Entry Code (peptide),P10145,Full agonist,EC50,Binding - Radioligand competition/displacement,1.2,nM,=,,0.2,6.0,,,125I-CXCL8,90.0,0.0,,0.0,,P25025,0.527178090882321
122,12628493,cxcr2_human,304,I,F,SB-225002,ChEMBL ID,CHEMBL239767,Antagonist (neutral/silent),EC50,Binding - Radioligand competition/displacement,1.2,nM,=,,10.9,-9.091,,,125I-CXCL8,90.0,0.0,,0.0,,P25025,0.527178090882321
115,12628493,cxcr2_human,312,L,I,IP8_HUMAN,UniProt Entry Code (peptide),P10145,Full agonist,EC50,Binding - Radioligand competition/displacement,1.2,nM,=,,5.4,-4.505,,,125I-CXCL8,90.0,0.0,,0.0,,P25025,0.3691507994863852
119,12628493,cxcr2_human,312,L,I,GROA_HUMAN,UniProt Entry Code (peptide),P10145,Full agonist,EC50,Binding - Radioligand competition/displacement,1.2,nM,=,,0.8,1.5,,,125I-CXCL8,90.0,0.0,,0.0,,P25025,0.3691507994863852
5,26958838,acm4_human,85,S,A,[3H]QNB,ChEMBL Compound ID,CHEMBL12980,Binding - unknown pharmacological activity,pK(A),Binding - Radioligand saturation,10.57,,=,,10.52,-1.122,,,,69.5,0.0,,0.0,,P08173,0.4357081330166448
6,26958838,acm4_human,85,S,A,[3H]QNB,ChEMBL Compound ID,CHEMBL12980,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,10.57,,=,,10.52,-1.122,,,[3H]QNB (radioligand),69.5,0.0,,0.0,,P08173,0.4357081330166448
122,26958838,acm4_human,85,S,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.51,,=,,4.09,-2.632,,,[3H]QNB (radioligand),69.5,0.0,,0.0,,P08173,0.4357081330166448
123,26958838,acm4_human,85,S,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.51,,=,,4.09,-2.632,,,[3H]QNB,0.0,0.0,,0.0,,P08173,0.4357081330166448
217,26958838,acm4_human,85,S,A,LY2033298,PubChem CID,11536903,Binding - unknown pharmacological activity,pK(b),Binding - Radioligand competition/displacement,4.89,,=,,5.44,3.548,,,[3H]QNB,0.0,0.0,,0.0,,P08173,0.4357081330166448
218,26958838,acm4_human,85,S,A,LY2033298,PubChem CID,11536903,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.89,,=,,5.44,3.548,,,[3H]QNB (radioligand),69.5,0.0,,0.0,,P08173,0.4357081330166448
7,26958838,acm4_human,89,Y,A,[3H]QNB,ChEMBL Compound ID,CHEMBL12980,Binding - unknown pharmacological activity,pK(A),Binding - Radioligand saturation,10.57,,=,,10.43,-1.381,,,,35.6,0.0,,0.0,,P08173,0.5178076654289252
8,26958838,acm4_human,89,Y,A,[3H]QNB,ChEMBL Compound ID,CHEMBL12980,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,10.57,,=,,10.43,-1.381,,,[3H]QNB (radioligand),35.6,0.0,,0.0,,P08173,0.5178076654289252
124,26958838,acm4_human,89,Y,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.51,,=,,5.07,3.631,,,[3H]QNB (radioligand),35.6,0.0,,0.0,,P08173,0.5178076654289252
125,26958838,acm4_human,89,Y,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.51,,=,,5.07,3.631,,,[3H]QNB,0.0,0.0,,0.0,,P08173,0.5178076654289252
219,26958838,acm4_human,89,Y,A,LY2033298,PubChem CID,11536903,Binding - unknown pharmacological activity,pK(b),Binding - Radioligand competition/displacement,4.89,,=,,5.36,2.951,,,[3H]QNB,0.0,0.0,,0.0,,P08173,0.5178076654289252
220,26958838,acm4_human,89,Y,A,LY2033298,PubChem CID,11536903,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.89,,=,,5.36,2.951,,,[3H]QNB (radioligand),35.6,0.0,,0.0,,P08173,0.5178076654289252
9,26958838,acm4_human,92,Y,A,[3H]QNB,ChEMBL Compound ID,CHEMBL12980,Binding - unknown pharmacological activity,pK(A),Binding - Radioligand saturation,10.57,,=,,10.52,-1.122,,,,79.7,0.0,,0.0,,P08173,0.4813789690289164
10,26958838,acm4_human,92,Y,A,[3H]QNB,ChEMBL Compound ID,CHEMBL12980,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,10.57,,=,,10.52,-1.122,,,[3H]QNB (radioligand),79.7,0.0,,0.0,,P08173,0.4813789690289164
126,26958838,acm4_human,92,Y,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.51,,=,,4.15,-2.288,,,[3H]QNB (radioligand),79.7,0.0,,0.0,,P08173,0.4813789690289164
127,26958838,acm4_human,92,Y,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.51,,=,,4.15,-2.288,,,[3H]QNB,0.0,0.0,,0.0,,P08173,0.4813789690289164
221,26958838,acm4_human,92,Y,A,LY2033298,PubChem CID,11536903,Binding - unknown pharmacological activity,pK(b),Binding - Radioligand competition/displacement,4.89,,=,,4.53,-2.288,,,[3H]QNB,0.0,0.0,,0.0,,P08173,0.4813789690289164
222,26958838,acm4_human,92,Y,A,LY2033298,PubChem CID,11536903,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.89,,=,,4.53,-2.288,,,[3H]QNB (radioligand),79.7,0.0,,0.0,,P08173,0.4813789690289164
11,20406819,acm4_human,93,I,T,[3H]QNB,ChEMBL Compound ID,CHEMBL12980,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,10.33,,=,,10.76,2.692,,,[3H]QNB (radioligand),121.7,0.0,,0.0,,P08173,0.4523709528389201
69,20406819,acm4_human,93,I,T,Xanomeline,ChEMBL Compound ID,CHEMBL21536,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.67,,=,,7.22,3.548,,,[3H]QNB (radioligand),121.7,0.0,,0.0,,P08173,0.4523709528389201
91,20406819,acm4_human,93,I,T,McN-A343,ChEMBL Compound ID,CHEMBL40554,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.86,,=,,5.23,2.344,,,[3H]QNB (radioligand),121.7,0.0,,0.0,,P08173,0.4523709528389201
128,20406819,acm4_human,93,I,T,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.74,,=,,4.97,1.698,,,[3H]QNB (radioligand),121.7,0.0,,0.0,,P08173,0.4523709528389201
129,26958838,acm4_human,93,I,T,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.74,,=,,4.97,1.698,,,[3H]QNB,0.0,0.0,,0.0,,P08173,0.4523709528389201
223,20406819,acm4_human,93,I,T,LY2033298,PubChem CID,11536903,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.21,,=,,5.36,1.413,,,[3H]QNB (radioligand),121.7,0.0,,0.0,,P08173,0.4523709528389201
224,26958838,acm4_human,93,I,T,LY2033298,PubChem CID,11536903,Binding - unknown pharmacological activity,pK(b),Binding - Radioligand competition/displacement,5.21,,=,,5.36,1.413,,,[3H]QNB,0.0,0.0,,0.0,,P08173,0.4523709528389201
12,20406819,acm4_human,94,I,V,[3H]QNB,ChEMBL Compound ID,CHEMBL12980,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,10.33,,=,,10.32,-1.024,,,[3H]QNB (radioligand),95.7,0.0,,0.0,,P08173,0.176814696574727
70,20406819,acm4_human,94,I,V,Xanomeline,ChEMBL Compound ID,CHEMBL21536,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.67,,=,,6.47,-1.585,,,[3H]QNB (radioligand),95.7,0.0,,0.0,,P08173,0.176814696574727
92,20406819,acm4_human,94,I,V,McN-A343,ChEMBL Compound ID,CHEMBL40554,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.86,,=,,4.85,-1.024,,,[3H]QNB (radioligand),95.7,0.0,,0.0,,P08173,0.176814696574727
130,20406819,acm4_human,94,I,V,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.74,,=,,4.71,-1.072,,,[3H]QNB (radioligand),95.7,0.0,,0.0,,P08173,0.176814696574727
131,26958838,acm4_human,94,I,V,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.74,,=,,4.71,-1.072,,,[3H]QNB,0.0,0.0,,0.0,,P08173,0.176814696574727
225,20406819,acm4_human,94,I,V,LY2033298,PubChem CID,11536903,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.21,,=,,5.17,-1.096,,,[3H]QNB (radioligand),95.7,0.0,,0.0,,P08173,0.176814696574727
226,26958838,acm4_human,94,I,V,LY2033298,PubChem CID,11536903,Binding - unknown pharmacological activity,pK(b),Binding - Radioligand competition/displacement,5.21,,=,,5.17,-1.096,,,[3H]QNB,0.0,0.0,,0.0,,P08173,0.176814696574727
14,26958838,acm4_human,97,Y,A,[3H]QNB,ChEMBL Compound ID,CHEMBL12980,Binding - unknown pharmacological activity,pK(A),Binding - Radioligand saturation,10.57,,=,,10.49,-1.202,,,,86.4,0.0,,0.0,,P08173,0.3188651227207126
15,26958838,acm4_human,97,Y,A,[3H]QNB,ChEMBL Compound ID,CHEMBL12980,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,10.57,,=,,10.49,-1.202,,,[3H]QNB (radioligand),86.4,0.0,,0.0,,P08173,0.3188651227207126
134,26958838,acm4_human,97,Y,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.51,,=,,4.69,1.514,,,[3H]QNB (radioligand),86.4,0.0,,0.0,,P08173,0.3188651227207126
229,26958838,acm4_human,97,Y,A,LY2033298,PubChem CID,11536903,Binding - unknown pharmacological activity,pK(b),Binding - Radioligand competition/displacement,4.89,,=,,4.25,-4.367,,,[3H]QNB,0.0,0.0,,0.0,,P08173,0.3188651227207126
230,26958838,acm4_human,97,Y,A,LY2033298,PubChem CID,11536903,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.89,,=,,4.25,-4.367,,,[3H]QNB (radioligand),86.4,0.0,,0.0,,P08173,0.3188651227207126
16,26958838,acm4_human,98,W,A,[3H]QNB,ChEMBL Compound ID,CHEMBL12980,Binding - unknown pharmacological activity,pK(A),Binding - Radioligand saturation,10.57,,=,,9.54,-10.753,,,,50.8,0.0,,0.0,,P08173,0.7713859952025421
17,26958838,acm4_human,98,W,A,[3H]QNB,ChEMBL Compound ID,CHEMBL12980,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,10.57,,=,,9.54,-10.753,,,[3H]QNB (radioligand),50.8,0.0,,0.0,,P08173,0.7713859952025421
136,26958838,acm4_human,98,W,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.51,,=,,3.65,-7.246,,,[3H]QNB (radioligand),50.8,0.0,,0.0,,P08173,0.7713859952025421
137,26958838,acm4_human,98,W,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.51,,=,,3.65,-7.246,,,[3H]QNB,0.0,0.0,,0.0,,P08173,0.7713859952025421
231,26958838,acm4_human,98,W,A,LY2033298,PubChem CID,11536903,Binding - unknown pharmacological activity,pK(b),Binding - Radioligand competition/displacement,4.89,,=,,4.39,-3.165,,,[3H]QNB,0.0,0.0,,0.0,,P08173,0.7713859952025421
232,26958838,acm4_human,98,W,A,LY2033298,PubChem CID,11536903,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.89,,=,,4.39,-3.165,,,[3H]QNB (radioligand),50.8,0.0,,0.0,,P08173,0.7713859952025421
18,26958838,acm4_human,101,G,A,[3H]QNB,ChEMBL Compound ID,CHEMBL12980,Binding - unknown pharmacological activity,pK(A),Binding - Radioligand saturation,10.57,,=,,10.46,-1.289,,,,57.6,0.0,,0.0,,P08173,0.4962123461649164
19,26958838,acm4_human,101,G,A,[3H]QNB,ChEMBL Compound ID,CHEMBL12980,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,10.57,,=,,10.46,-1.289,,,[3H]QNB (radioligand),57.6,0.0,,0.0,,P08173,0.4962123461649164
138,26958838,acm4_human,101,G,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.51,,=,,4.37,-1.381,,,[3H]QNB (radioligand),57.6,0.0,,0.0,,P08173,0.4962123461649164
139,26958838,acm4_human,101,G,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.51,,=,,4.37,-1.381,,,[3H]QNB,0.0,0.0,,0.0,,P08173,0.4962123461649164
233,26958838,acm4_human,101,G,A,LY2033298,PubChem CID,11536903,Binding - unknown pharmacological activity,pK(b),Binding - Radioligand competition/displacement,4.89,,=,,5.03,1.38,,,[3H]QNB,0.0,0.0,,0.0,,P08173,0.4962123461649164
234,26958838,acm4_human,101,G,A,LY2033298,PubChem CID,11536903,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.89,,=,,5.03,1.38,,,[3H]QNB (radioligand),57.6,0.0,,0.0,,P08173,0.4962123461649164
20,21300722,acm4_human,106,D,A,[3H]QNB,ChEMBL Compound ID,CHEMBL12980,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,10.45,,=,,9.7,-5.618,,,[3H]QNB (radioligand),25.8,0.0,,0.0,,P08173,0.5188297182877857
78,21300722,acm4_human,106,D,A,C7/3-phth,ChEMBL Compound ID,CHEMBL28407,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.58,,=,,5.66,1.202,,,[3H]QNB (radioligand),25.8,0.0,,0.0,,P08173,0.5188297182877857
94,21300722,acm4_human,106,D,A,McN-A343,ChEMBL Compound ID,CHEMBL40554,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.92,,=,,4.7,-1.658,,,[3H]QNB (radioligand),25.8,0.0,,0.0,,P08173,0.5188297182877857
111,21300722,acm4_human,106,D,A,Pilocarpine,ChEMBL Compound ID,CHEMBL550,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.01,,=,,4.24,-5.882,,,[3H]QNB (radioligand),25.8,0.0,,0.0,,P08173,0.5188297182877857
140,21300722,acm4_human,106,D,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.89,,=,,3.95,-8.696,,,[3H]QNB (radioligand),25.8,0.0,,0.0,,P08173,0.5188297182877857
141,26958838,acm4_human,106,D,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.89,,=,,3.95,-8.696,,,[3H]QNB,0.0,0.0,,0.0,,P08173,0.5188297182877857
207,21300722,acm4_human,106,D,A,N-desmethylclozapine,ChEMBL Compound ID,CHEMBL845,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.66,,=,,6.67,1.023,,,[3H]QNB (radioligand),25.8,0.0,,0.0,,P08173,0.5188297182877857
235,21300722,acm4_human,106,D,A,LY2033298,PubChem CID,11536903,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.21,,=,,5.29,1.202,,,[3H]QNB (radioligand),25.8,0.0,,0.0,,P08173,0.5188297182877857
236,26958838,acm4_human,106,D,A,LY2033298,PubChem CID,11536903,Binding - unknown pharmacological activity,pK(b),Binding - Radioligand competition/displacement,5.21,,=,,5.29,1.202,,,[3H]QNB,0.0,0.0,,0.0,,P08173,0.5188297182877857
21,21300722,acm4_human,108,W,A,[3H]QNB,ChEMBL Compound ID,CHEMBL12980,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,10.45,,=,,9.77,-4.785,,,[3H]QNB (radioligand),69.8,0.0,,0.0,,P08173,0.6099987958446473
79,21300722,acm4_human,108,W,A,C7/3-phth,ChEMBL Compound ID,CHEMBL28407,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.58,,=,,4.83,-5.618,,,[3H]QNB (radioligand),69.8,0.0,,0.0,,P08173,0.6099987958446473
95,21300722,acm4_human,108,W,A,McN-A343,ChEMBL Compound ID,CHEMBL40554,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.92,,=,,4.88,-1.096,,,[3H]QNB (radioligand),69.8,0.0,,0.0,,P08173,0.6099987958446473
112,21300722,acm4_human,108,W,A,Pilocarpine,ChEMBL Compound ID,CHEMBL550,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.01,,=,,4.59,-2.632,,,[3H]QNB (radioligand),69.8,0.0,,0.0,,P08173,0.6099987958446473
142,21300722,acm4_human,108,W,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.89,,=,,4.01,-7.576,,,[3H]QNB (radioligand),69.8,0.0,,0.0,,P08173,0.6099987958446473
143,26958838,acm4_human,108,W,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.89,,=,,4.01,-7.576,,,[3H]QNB,0.0,0.0,,0.0,,P08173,0.6099987958446473
208,21300722,acm4_human,108,W,A,N-desmethylclozapine,ChEMBL Compound ID,CHEMBL845,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.66,,=,,7.08,2.63,,,[3H]QNB (radioligand),69.8,0.0,,0.0,,P08173,0.6099987958446473
237,21300722,acm4_human,108,W,A,LY2033298,PubChem CID,11536903,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.21,,=,,4.24,-9.346,,,[3H]QNB (radioligand),69.8,0.0,,0.0,,P08173,0.6099987958446473
238,26958838,acm4_human,108,W,A,LY2033298,PubChem CID,11536903,Binding - unknown pharmacological activity,pK(b),Binding - Radioligand competition/displacement,5.21,,=,,4.24,-9.346,,,[3H]QNB,0.0,0.0,,0.0,,P08173,0.6099987958446473
22,21300722,acm4_human,109,L,A,[3H]QNB,ChEMBL Compound ID,CHEMBL12980,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,10.45,,=,,9.12,-21.277,,,[3H]QNB (radioligand),67.3,0.0,,0.0,,P08173,0.5460958510844284
80,21300722,acm4_human,109,L,A,C7/3-phth,ChEMBL Compound ID,CHEMBL28407,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.58,,=,,4.89,-4.902,,,[3H]QNB (radioligand),67.3,0.0,,0.0,,P08173,0.5460958510844284
96,21300722,acm4_human,109,L,A,McN-A343,ChEMBL Compound ID,CHEMBL40554,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.92,,=,,4.83,-1.23,,,[3H]QNB (radioligand),67.3,0.0,,0.0,,P08173,0.5460958510844284
113,21300722,acm4_human,109,L,A,Pilocarpine,ChEMBL Compound ID,CHEMBL550,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.01,,=,,4.22,-6.173,,,[3H]QNB (radioligand),67.3,0.0,,0.0,,P08173,0.5460958510844284
144,21300722,acm4_human,109,L,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.89,,=,,3.11,-58.824,,,[3H]QNB (radioligand),67.3,0.0,,0.0,,P08173,0.5460958510844284
145,26958838,acm4_human,109,L,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.89,,=,,3.11,-58.824,,,[3H]QNB,0.0,0.0,,0.0,,P08173,0.5460958510844284
209,21300722,acm4_human,109,L,A,N-desmethylclozapine,ChEMBL Compound ID,CHEMBL845,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.66,,=,,5.93,-5.376,,,[3H]QNB (radioligand),67.3,0.0,,0.0,,P08173,0.5460958510844284
239,21300722,acm4_human,109,L,A,LY2033298,PubChem CID,11536903,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.21,,=,,4.28,-8.547,,,[3H]QNB (radioligand),67.3,0.0,,0.0,,P08173,0.5460958510844284
240,26958838,acm4_human,109,L,A,LY2033298,PubChem CID,11536903,Binding - unknown pharmacological activity,pK(b),Binding - Radioligand competition/displacement,5.21,,=,,4.28,-8.547,,,[3H]QNB,0.0,0.0,,0.0,,P08173,0.5460958510844284
24,21300722,acm4_human,112,D,N,[3H]QNB,ChEMBL Compound ID,CHEMBL12980,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,10.45,,=,,8.44,-100.0,,,[3H]QNB (radioligand),115.1,0.0,,0.0,,P08173,0.484625394022845
82,21300722,acm4_human,112,D,N,C7/3-phth,ChEMBL Compound ID,CHEMBL28407,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.58,,=,,3.64,-90.909,,,[3H]QNB (radioligand),115.1,0.0,,0.0,,P08173,0.484625394022845
89,23826889,acm4_human,112,D,N,N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.62,,=,,8.03,-38.462,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P08173,0.484625394022845
98,21300722,acm4_human,112,D,N,McN-A343,ChEMBL Compound ID,CHEMBL40554,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.92,,<,,3.0,-83.333,,,[3H]QNB (radioligand),115.1,0.0,,0.0,,P08173,0.484625394022845
99,23826889,acm4_human,112,D,N,McN-A343,ChEMBL Compound ID,CHEMBL40554,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.05,,=,,3.84,-16.129,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P08173,0.484625394022845
115,21300722,acm4_human,112,D,N,Pilocarpine,ChEMBL Compound ID,CHEMBL550,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.01,,<,,3.0,-100.0,,,[3H]QNB (radioligand),115.1,0.0,,0.0,,P08173,0.484625394022845
147,21300722,acm4_human,112,D,N,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.89,,<,,2.0,-1000.0,,,[3H]QNB (radioligand),115.1,0.0,,0.0,,P08173,0.484625394022845
148,23826889,acm4_human,112,D,N,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.81,,=,,2.06,-500.0,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P08173,0.484625394022845
150,26958838,acm4_human,112,D,N,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.89,,<,,2.0,-1000.0,,,[3H]QNB,0.0,0.0,,0.0,,P08173,0.484625394022845
211,21300722,acm4_human,112,D,N,N-desmethylclozapine,ChEMBL Compound ID,CHEMBL845,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.66,,<,,4.0,-500.0,,,[3H]QNB (radioligand),115.1,0.0,,0.0,,P08173,0.484625394022845
242,21300722,acm4_human,112,D,N,LY2033298,PubChem CID,11536903,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.21,,=,,5.79,3.802,,,[3H]QNB (radioligand),115.1,0.0,,0.0,,P08173,0.484625394022845
244,26958838,acm4_human,112,D,N,LY2033298,PubChem CID,11536903,Binding - unknown pharmacological activity,pK(b),Binding - Radioligand competition/displacement,5.21,,=,,5.79,3.802,,,[3H]QNB,0.0,0.0,,0.0,,P08173,0.484625394022845
25,26958838,acm4_human,113,Y,A,[3H]QNB,ChEMBL Compound ID,CHEMBL12980,Binding - unknown pharmacological activity,pK(A),Binding - Radioligand saturation,10.57,,=,,8.76,-66.667,,,,74.6,0.0,,0.0,,P08173,0.5756400467345542
26,26958838,acm4_human,113,Y,A,[3H]QNB,ChEMBL Compound ID,CHEMBL12980,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,10.57,,=,,8.76,-66.667,,,[3H]QNB (radioligand),74.6,0.0,,0.0,,P08173,0.5756400467345542
151,26958838,acm4_human,113,Y,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.51,,=,,2.98,-33.333,,,[3H]QNB (radioligand),74.6,0.0,,0.0,,P08173,0.5756400467345542
152,26958838,acm4_human,113,Y,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.51,,=,,2.98,-33.333,,,[3H]QNB,0.0,0.0,,0.0,,P08173,0.5756400467345542
245,26958838,acm4_human,113,Y,A,LY2033298,PubChem CID,11536903,Binding - unknown pharmacological activity,pK(b),Binding - Radioligand competition/displacement,4.89,,=,,4.97,1.202,,,[3H]QNB,0.0,0.0,,0.0,,P08173,0.5756400467345542
246,26958838,acm4_human,113,Y,A,LY2033298,PubChem CID,11536903,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.89,,=,,4.97,1.202,,,[3H]QNB (radioligand),74.6,0.0,,0.0,,P08173,0.5756400467345542
27,21300722,acm4_human,116,S,A,[3H]QNB,ChEMBL Compound ID,CHEMBL12980,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,10.45,,=,,10.51,1.148,,,[3H]QNB (radioligand),99.4,0.0,,0.0,,P08173,0.4673137006635519
83,21300722,acm4_human,116,S,A,C7/3-phth,ChEMBL Compound ID,CHEMBL28407,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.58,,=,,5.7,1.318,,,[3H]QNB (radioligand),99.4,0.0,,0.0,,P08173,0.4673137006635519
100,21300722,acm4_human,116,S,A,McN-A343,ChEMBL Compound ID,CHEMBL40554,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.92,,=,,5.07,1.413,,,[3H]QNB (radioligand),99.4,0.0,,0.0,,P08173,0.4673137006635519
116,21300722,acm4_human,116,S,A,Pilocarpine,ChEMBL Compound ID,CHEMBL550,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.01,,=,,5.09,1.202,,,[3H]QNB (radioligand),99.4,0.0,,0.0,,P08173,0.4673137006635519
153,21300722,acm4_human,116,S,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.89,,=,,3.61,-19.231,,,[3H]QNB (radioligand),99.4,0.0,,0.0,,P08173,0.4673137006635519
154,26958838,acm4_human,116,S,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.89,,=,,3.61,-19.231,,,[3H]QNB,0.0,0.0,,0.0,,P08173,0.4673137006635519
212,21300722,acm4_human,116,S,A,N-desmethylclozapine,ChEMBL Compound ID,CHEMBL845,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.66,,=,,6.63,-1.072,,,[3H]QNB (radioligand),99.4,0.0,,0.0,,P08173,0.4673137006635519
247,21300722,acm4_human,116,S,A,LY2033298,PubChem CID,11536903,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.21,,=,,5.12,-1.23,,,[3H]QNB (radioligand),99.4,0.0,,0.0,,P08173,0.4673137006635519
248,26958838,acm4_human,116,S,A,LY2033298,PubChem CID,11536903,Binding - unknown pharmacological activity,pK(b),Binding - Radioligand competition/displacement,5.21,,=,,5.12,-1.23,,,[3H]QNB,0.0,0.0,,0.0,,P08173,0.4673137006635519
29,21300722,acm4_human,120,V,A,[3H]QNB,ChEMBL Compound ID,CHEMBL12980,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,10.45,,=,,9.41,-10.989,,,[3H]QNB (radioligand),166.0,0.0,,0.0,,P08173,0.5054782767092215
85,21300722,acm4_human,120,V,A,C7/3-phth,ChEMBL Compound ID,CHEMBL28407,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.58,,=,,5.27,-2.041,,,[3H]QNB (radioligand),166.0,0.0,,0.0,,P08173,0.5054782767092215
102,21300722,acm4_human,120,V,A,McN-A343,ChEMBL Compound ID,CHEMBL40554,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.92,,=,,5.3,2.399,,,[3H]QNB (radioligand),166.0,0.0,,0.0,,P08173,0.5054782767092215
118,21300722,acm4_human,120,V,A,Pilocarpine,ChEMBL Compound ID,CHEMBL550,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.01,,=,,5.95,8.71,,,[3H]QNB (radioligand),166.0,0.0,,0.0,,P08173,0.5054782767092215
157,21300722,acm4_human,120,V,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.89,,=,,5.63,5.495,,,[3H]QNB (radioligand),166.0,0.0,,0.0,,P08173,0.5054782767092215
158,26958838,acm4_human,120,V,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.89,,=,,5.63,5.495,,,[3H]QNB,0.0,0.0,,0.0,,P08173,0.5054782767092215
214,21300722,acm4_human,120,V,A,N-desmethylclozapine,ChEMBL Compound ID,CHEMBL845,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.66,,=,,6.07,-3.891,,,[3H]QNB (radioligand),166.0,0.0,,0.0,,P08173,0.5054782767092215
251,21300722,acm4_human,120,V,A,LY2033298,PubChem CID,11536903,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.21,,=,,5.41,1.585,,,[3H]QNB (radioligand),166.0,0.0,,0.0,,P08173,0.5054782767092215
252,26958838,acm4_human,120,V,A,LY2033298,PubChem CID,11536903,Binding - unknown pharmacological activity,pK(b),Binding - Radioligand competition/displacement,5.21,,=,,5.41,1.585,,,[3H]QNB,0.0,0.0,,0.0,,P08173,0.5054782767092215
31,21300722,acm4_human,129,D,N,[3H]QNB,ChEMBL Compound ID,CHEMBL12980,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,10.45,,=,,10.11,-2.188,,,[3H]QNB (radioligand),34.0,0.0,,0.0,,P08173,0.7286128800107168
87,21300722,acm4_human,129,D,N,C7/3-phth,ChEMBL Compound ID,CHEMBL28407,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.58,,=,,5.16,-2.632,,,[3H]QNB (radioligand),34.0,0.0,,0.0,,P08173,0.7286128800107168
104,21300722,acm4_human,129,D,N,McN-A343,ChEMBL Compound ID,CHEMBL40554,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.92,,=,,5.05,1.349,,,[3H]QNB (radioligand),34.0,0.0,,0.0,,P08173,0.7286128800107168
120,21300722,acm4_human,129,D,N,Pilocarpine,ChEMBL Compound ID,CHEMBL550,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.01,,=,,5.08,1.175,,,[3H]QNB (radioligand),34.0,0.0,,0.0,,P08173,0.7286128800107168
160,21300722,acm4_human,129,D,N,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.89,,=,,5.54,4.467,,,[3H]QNB (radioligand),34.0,0.0,,0.0,,P08173,0.7286128800107168
162,26958838,acm4_human,129,D,N,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.89,,=,,5.54,4.467,,,[3H]QNB,0.0,0.0,,0.0,,P08173,0.7286128800107168
216,21300722,acm4_human,129,D,N,N-desmethylclozapine,ChEMBL Compound ID,CHEMBL845,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.66,,=,,6.57,-1.23,,,[3H]QNB (radioligand),34.0,0.0,,0.0,,P08173,0.7286128800107168
254,21300722,acm4_human,129,D,N,LY2033298,PubChem CID,11536903,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.21,,=,,5.37,1.445,,,[3H]QNB (radioligand),34.0,0.0,,0.0,,P08173,0.7286128800107168
256,26958838,acm4_human,129,D,N,LY2033298,PubChem CID,11536903,Binding - unknown pharmacological activity,pK(b),Binding - Radioligand competition/displacement,5.21,,=,,5.37,1.445,,,[3H]QNB,0.0,0.0,,0.0,,P08173,0.7286128800107168
33,26958838,acm4_human,170,F,A,[3H]QNB,ChEMBL Compound ID,CHEMBL12980,Binding - unknown pharmacological activity,pK(A),Binding - Radioligand saturation,10.57,,=,,10.61,1.096,,,,93.2,0.0,,0.0,,P08173,0.4417298969973765
34,26958838,acm4_human,170,F,A,[3H]QNB,ChEMBL Compound ID,CHEMBL12980,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,10.57,,=,,10.61,1.096,,,[3H]QNB (radioligand),93.2,0.0,,0.0,,P08173,0.4417298969973765
165,26958838,acm4_human,170,F,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.51,,=,,4.77,1.82,,,[3H]QNB (radioligand),93.2,0.0,,0.0,,P08173,0.4417298969973765
166,26958838,acm4_human,170,F,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.51,,=,,4.77,1.82,,,[3H]QNB,0.0,0.0,,0.0,,P08173,0.4417298969973765
259,26958838,acm4_human,170,F,A,LY2033298,PubChem CID,11536903,Binding - unknown pharmacological activity,pK(b),Binding - Radioligand competition/displacement,4.89,,=,,4.53,-2.288,,,[3H]QNB,0.0,0.0,,0.0,,P08173,0.4417298969973765
260,26958838,acm4_human,170,F,A,LY2033298,PubChem CID,11536903,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.89,,=,,4.53,-2.288,,,[3H]QNB (radioligand),93.2,0.0,,0.0,,P08173,0.4417298969973765
35,26958838,acm4_human,171,W,A,[3H]QNB,ChEMBL Compound ID,CHEMBL12980,Binding - unknown pharmacological activity,pK(A),Binding - Radioligand saturation,10.57,,=,,10.45,-1.318,,,,71.2,0.0,,0.0,,P08173,0.601365317112818
36,26958838,acm4_human,171,W,A,[3H]QNB,ChEMBL Compound ID,CHEMBL12980,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,10.57,,=,,10.45,-1.318,,,[3H]QNB (radioligand),71.2,0.0,,0.0,,P08173,0.601365317112818
167,26958838,acm4_human,171,W,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.51,,=,,3.91,-3.984,,,[3H]QNB (radioligand),71.2,0.0,,0.0,,P08173,0.601365317112818
168,26958838,acm4_human,171,W,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.51,,=,,3.91,-3.984,,,[3H]QNB,0.0,0.0,,0.0,,P08173,0.601365317112818
261,26958838,acm4_human,171,W,A,LY2033298,PubChem CID,11536903,Binding - unknown pharmacological activity,pK(b),Binding - Radioligand competition/displacement,4.89,,=,,4.56,-2.137,,,[3H]QNB,0.0,0.0,,0.0,,P08173,0.601365317112818
262,26958838,acm4_human,171,W,A,LY2033298,PubChem CID,11536903,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.89,,=,,4.56,-2.137,,,[3H]QNB (radioligand),71.2,0.0,,0.0,,P08173,0.601365317112818
37,26958838,acm4_human,172,Q,A,[3H]QNB,ChEMBL Compound ID,CHEMBL12980,Binding - unknown pharmacological activity,pK(A),Binding - Radioligand saturation,10.57,,=,,10.4,-1.479,,,,167.8,0.0,,0.0,,P08173,0.3566919910949068
38,26958838,acm4_human,172,Q,A,[3H]QNB,ChEMBL Compound ID,CHEMBL12980,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,10.57,,=,,10.4,-1.479,,,[3H]QNB (radioligand),167.8,0.0,,0.0,,P08173,0.3566919910949068
169,26958838,acm4_human,172,Q,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.51,,=,,4.02,-3.086,,,[3H]QNB (radioligand),167.8,0.0,,0.0,,P08173,0.3566919910949068
170,26958838,acm4_human,172,Q,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.51,,=,,4.02,-3.086,,,[3H]QNB,0.0,0.0,,0.0,,P08173,0.3566919910949068
263,26958838,acm4_human,172,Q,A,LY2033298,PubChem CID,11536903,Binding - unknown pharmacological activity,pK(b),Binding - Radioligand competition/displacement,4.89,,=,,4.99,1.259,,,[3H]QNB,0.0,0.0,,0.0,,P08173,0.3566919910949068
264,26958838,acm4_human,172,Q,A,LY2033298,PubChem CID,11536903,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.89,,=,,4.99,1.259,,,[3H]QNB (radioligand),167.8,0.0,,0.0,,P08173,0.3566919910949068
39,26958838,acm4_human,173,F,A,[3H]QNB,ChEMBL Compound ID,CHEMBL12980,Binding - unknown pharmacological activity,pK(A),Binding - Radioligand saturation,10.57,,=,,10.39,-1.513,,,,30.5,0.0,,0.0,,P08173,0.3334776190601533
40,26958838,acm4_human,173,F,A,[3H]QNB,ChEMBL Compound ID,CHEMBL12980,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,10.57,,=,,10.39,-1.513,,,[3H]QNB (radioligand),30.5,0.0,,0.0,,P08173,0.3334776190601533
171,26958838,acm4_human,173,F,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.51,,=,,4.09,-2.632,,,[3H]QNB (radioligand),30.5,0.0,,0.0,,P08173,0.3334776190601533
172,26958838,acm4_human,173,F,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.51,,=,,4.09,-2.632,,,[3H]QNB,0.0,0.0,,0.0,,P08173,0.3334776190601533
265,26958838,acm4_human,173,F,A,LY2033298,PubChem CID,11536903,Binding - unknown pharmacological activity,pK(b),Binding - Radioligand competition/displacement,4.89,,=,,4.78,-1.289,,,[3H]QNB,0.0,0.0,,0.0,,P08173,0.3334776190601533
266,26958838,acm4_human,173,F,A,LY2033298,PubChem CID,11536903,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.89,,=,,4.78,-1.289,,,[3H]QNB (radioligand),30.5,0.0,,0.0,,P08173,0.3334776190601533
41,26958838,acm4_human,184,Q,A,[3H]QNB,ChEMBL Compound ID,CHEMBL12980,Binding - unknown pharmacological activity,pK(A),Binding - Radioligand saturation,10.57,,=,,10.65,1.202,,,,59.3,0.0,,0.0,,P08173,0.4105582062139465
42,26958838,acm4_human,184,Q,A,[3H]QNB,ChEMBL Compound ID,CHEMBL12980,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,10.57,,=,,10.65,1.202,,,[3H]QNB (radioligand),59.3,0.0,,0.0,,P08173,0.4105582062139465
173,26958838,acm4_human,184,Q,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.51,,=,,4.25,-1.818,,,[3H]QNB (radioligand),59.3,0.0,,0.0,,P08173,0.4105582062139465
174,26958838,acm4_human,184,Q,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.51,,=,,4.25,-1.818,,,[3H]QNB,0.0,0.0,,0.0,,P08173,0.4105582062139465
267,26958838,acm4_human,184,Q,A,LY2033298,PubChem CID,11536903,Binding - unknown pharmacological activity,pK(b),Binding - Radioligand competition/displacement,4.89,,=,,5.36,2.951,,,[3H]QNB,0.0,0.0,,0.0,,P08173,0.4105582062139465
268,26958838,acm4_human,184,Q,A,LY2033298,PubChem CID,11536903,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.89,,=,,5.36,2.951,,,[3H]QNB (radioligand),59.3,0.0,,0.0,,P08173,0.4105582062139465
43,20406819,acm4_human,186,F,A,[3H]QNB,ChEMBL Compound ID,CHEMBL12980,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,10.33,,=,,10.29,-1.096,,,[3H]QNB (radioligand),113.0,0.0,,0.0,,P08173,0.4477349361160623
72,20406819,acm4_human,186,F,A,Xanomeline,ChEMBL Compound ID,CHEMBL21536,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.67,,=,,6.5,-1.479,,,[3H]QNB (radioligand),113.0,0.0,,0.0,,P08173,0.4477349361160623
105,20406819,acm4_human,186,F,A,McN-A343,ChEMBL Compound ID,CHEMBL40554,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.86,,=,,5.3,2.754,,,[3H]QNB (radioligand),113.0,0.0,,0.0,,P08173,0.4477349361160623
175,20406819,acm4_human,186,F,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.74,,=,,4.85,1.288,,,[3H]QNB (radioligand),113.0,0.0,,0.0,,P08173,0.4477349361160623
176,26958838,acm4_human,186,F,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.74,,=,,4.85,1.288,,,[3H]QNB,0.0,0.0,,0.0,,P08173,0.4477349361160623
44,26958838,acm4_human,187,I,A,[3H]QNB,ChEMBL Compound ID,CHEMBL12980,Binding - unknown pharmacological activity,pK(A),Binding - Radioligand saturation,10.57,,=,,10.16,-2.571,,,,140.7,0.0,,0.0,,P08173,0.5485763446733383
45,26958838,acm4_human,187,I,A,[3H]QNB,ChEMBL Compound ID,CHEMBL12980,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,10.57,,=,,10.16,-2.571,,,[3H]QNB (radioligand),140.7,0.0,,0.0,,P08173,0.5485763446733383
177,26958838,acm4_human,187,I,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.51,,=,,3.71,-6.329,,,[3H]QNB (radioligand),140.7,0.0,,0.0,,P08173,0.5485763446733383
178,26958838,acm4_human,187,I,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.51,,=,,3.71,-6.329,,,[3H]QNB,0.0,0.0,,0.0,,P08173,0.5485763446733383
270,26958838,acm4_human,187,I,A,LY2033298,PubChem CID,11536903,Binding - unknown pharmacological activity,pK(b),Binding - Radioligand competition/displacement,4.89,,=,,5.46,3.715,,,[3H]QNB,0.0,0.0,,0.0,,P08173,0.5485763446733383
271,26958838,acm4_human,187,I,A,LY2033298,PubChem CID,11536903,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.89,,=,,5.46,3.715,,,[3H]QNB (radioligand),140.7,0.0,,0.0,,P08173,0.5485763446733383
46,26958838,acm4_human,188,Q,A,[3H]QNB,ChEMBL Compound ID,CHEMBL12980,Binding - unknown pharmacological activity,pK(A),Binding - Radioligand saturation,10.57,,=,,10.3,-1.862,,,,35.6,0.0,,0.0,,P08173,0.4013235542783558
47,26958838,acm4_human,188,Q,A,[3H]QNB,ChEMBL Compound ID,CHEMBL12980,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,10.57,,=,,10.3,-1.862,,,[3H]QNB (radioligand),35.6,0.0,,0.0,,P08173,0.4013235542783558
179,26958838,acm4_human,188,Q,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.51,,=,,4.6,1.23,,,[3H]QNB (radioligand),35.6,0.0,,0.0,,P08173,0.4013235542783558
180,26958838,acm4_human,188,Q,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.51,,=,,4.6,1.23,,,[3H]QNB,0.0,0.0,,0.0,,P08173,0.4013235542783558
272,26958838,acm4_human,188,Q,A,LY2033298,PubChem CID,11536903,Binding - unknown pharmacological activity,pK(b),Binding - Radioligand competition/displacement,4.89,,=,,4.94,1.122,,,[3H]QNB,0.0,0.0,,0.0,,P08173,0.4013235542783558
273,26958838,acm4_human,188,Q,A,LY2033298,PubChem CID,11536903,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.89,,=,,4.94,1.122,,,[3H]QNB (radioligand),35.6,0.0,,0.0,,P08173,0.4013235542783558
48,26958838,acm4_human,189,F,A,[3H]QNB,ChEMBL Compound ID,CHEMBL12980,Binding - unknown pharmacological activity,pK(A),Binding - Radioligand saturation,10.57,,=,,10.44,-1.35,,,,84.7,0.0,,0.0,,P08173,0.5855629901937276
49,26958838,acm4_human,189,F,A,[3H]QNB,ChEMBL Compound ID,CHEMBL12980,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,10.57,,=,,10.44,-1.35,,,[3H]QNB (radioligand),84.7,0.0,,0.0,,P08173,0.5855629901937276
181,26958838,acm4_human,189,F,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.51,,=,,4.65,1.38,,,[3H]QNB (radioligand),84.7,0.0,,0.0,,P08173,0.5855629901937276
182,26958838,acm4_human,189,F,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.51,,=,,4.65,1.38,,,[3H]QNB,0.0,0.0,,0.0,,P08173,0.5855629901937276
274,26958838,acm4_human,189,F,A,LY2033298,PubChem CID,11536903,Binding - unknown pharmacological activity,pK(b),Binding - Radioligand competition/displacement,4.89,,=,,5.09,1.585,,,[3H]QNB,0.0,0.0,,0.0,,P08173,0.5855629901937276
275,26958838,acm4_human,189,F,A,LY2033298,PubChem CID,11536903,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.89,,=,,5.09,1.585,,,[3H]QNB (radioligand),84.7,0.0,,0.0,,P08173,0.5855629901937276
50,26958838,acm4_human,190,L,A,[3H]QNB,ChEMBL Compound ID,CHEMBL12980,Binding - unknown pharmacological activity,pK(A),Binding - Radioligand saturation,10.57,,=,,9.88,-4.902,,,,113.6,0.0,,0.0,,P08173,0.3484835201567558
51,26958838,acm4_human,190,L,A,[3H]QNB,ChEMBL Compound ID,CHEMBL12980,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,10.57,,=,,9.88,-4.902,,,[3H]QNB (radioligand),113.6,0.0,,0.0,,P08173,0.3484835201567558
183,26958838,acm4_human,190,L,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.51,,=,,4.2,-2.041,,,[3H]QNB (radioligand),113.6,0.0,,0.0,,P08173,0.3484835201567558
184,26958838,acm4_human,190,L,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.51,,=,,4.2,-2.041,,,[3H]QNB,0.0,0.0,,0.0,,P08173,0.3484835201567558
276,26958838,acm4_human,190,L,A,LY2033298,PubChem CID,11536903,Binding - unknown pharmacological activity,pK(b),Binding - Radioligand competition/displacement,4.89,,=,,4.92,1.072,,,[3H]QNB,0.0,0.0,,0.0,,P08173,0.3484835201567558
277,26958838,acm4_human,190,L,A,LY2033298,PubChem CID,11536903,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.89,,=,,4.92,1.072,,,[3H]QNB (radioligand),113.6,0.0,,0.0,,P08173,0.3484835201567558
52,26958838,acm4_human,413,W,A,[3H]QNB,ChEMBL Compound ID,CHEMBL12980,Binding - unknown pharmacological activity,pK(A),Binding - Radioligand saturation,10.57,,=,,8.4,-142.857,,,,55.9,0.0,,0.0,,P08173,0.8623273113127796
53,26958838,acm4_human,413,W,A,[3H]QNB,ChEMBL Compound ID,CHEMBL12980,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,10.57,,=,,8.4,-142.857,,,[3H]QNB (radioligand),55.9,0.0,,0.0,,P08173,0.8623273113127796
185,26958838,acm4_human,413,W,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.51,,=,,3.47,-10.989,,,[3H]QNB (radioligand),55.9,0.0,,0.0,,P08173,0.8623273113127796
186,26958838,acm4_human,413,W,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.51,,=,,3.47,-10.989,,,[3H]QNB,0.0,0.0,,0.0,,P08173,0.8623273113127796
278,26958838,acm4_human,413,W,A,LY2033298,PubChem CID,11536903,Binding - unknown pharmacological activity,pK(b),Binding - Radioligand competition/displacement,4.89,,=,,4.51,-2.398,,,[3H]QNB,0.0,0.0,,0.0,,P08173,0.8623273113127796
279,26958838,acm4_human,413,W,A,LY2033298,PubChem CID,11536903,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.89,,=,,4.51,-2.398,,,[3H]QNB (radioligand),55.9,0.0,,0.0,,P08173,0.8623273113127796
54,26958838,acm4_human,416,Y,A,[3H]QNB,ChEMBL Compound ID,CHEMBL12980,Binding - unknown pharmacological activity,pK(A),Binding - Radioligand saturation,10.57,,=,,9.86,-5.128,,,,16.9,0.0,,0.0,,P08173,0.60757580129987
55,26958838,acm4_human,416,Y,A,[3H]QNB,ChEMBL Compound ID,CHEMBL12980,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,10.57,,=,,9.86,-5.128,,,[3H]QNB (radioligand),16.9,0.0,,0.0,,P08173,0.60757580129987
187,26958838,acm4_human,416,Y,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.51,,=,,2.85,-45.455,,,[3H]QNB (radioligand),16.9,0.0,,0.0,,P08173,0.60757580129987
188,26958838,acm4_human,416,Y,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.51,,=,,2.85,-45.455,,,[3H]QNB,0.0,0.0,,0.0,,P08173,0.60757580129987
58,26958838,acm4_human,427,Q,A,[3H]QNB,ChEMBL Compound ID,CHEMBL12980,Binding - unknown pharmacological activity,pK(A),Binding - Radioligand saturation,10.57,,=,,10.73,1.445,,,,67.8,0.0,,0.0,,P08173,0.2804162798114053
59,26958838,acm4_human,427,Q,A,[3H]QNB,ChEMBL Compound ID,CHEMBL12980,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,10.57,,=,,10.73,1.445,,,[3H]QNB (radioligand),67.8,0.0,,0.0,,P08173,0.2804162798114053
191,26958838,acm4_human,427,Q,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.51,,=,,4.46,-1.122,,,[3H]QNB (radioligand),67.8,0.0,,0.0,,P08173,0.2804162798114053
192,26958838,acm4_human,427,Q,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.51,,=,,4.46,-1.122,,,[3H]QNB,0.0,0.0,,0.0,,P08173,0.2804162798114053
283,26958838,acm4_human,427,Q,A,LY2033298,PubChem CID,11536903,Binding - unknown pharmacological activity,pK(b),Binding - Radioligand competition/displacement,4.89,,=,,5.43,3.467,,,[3H]QNB,0.0,0.0,,0.0,,P08173,0.2804162798114053
284,26958838,acm4_human,427,Q,A,LY2033298,PubChem CID,11536903,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.89,,=,,5.43,3.467,,,[3H]QNB (radioligand),67.8,0.0,,0.0,,P08173,0.2804162798114053
60,20406819,acm4_human,428,S,P,[3H]QNB,ChEMBL Compound ID,CHEMBL12980,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,10.33,,=,,10.77,2.754,,,[3H]QNB (radioligand),47.8,0.0,,0.0,,P08173,0.2862052498258831
73,20406819,acm4_human,428,S,P,Xanomeline,ChEMBL Compound ID,CHEMBL21536,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.67,,=,,6.73,1.148,,,[3H]QNB (radioligand),47.8,0.0,,0.0,,P08173,0.2862052498258831
106,20406819,acm4_human,428,S,P,McN-A343,ChEMBL Compound ID,CHEMBL40554,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.86,,=,,5.31,2.818,,,[3H]QNB (radioligand),47.8,0.0,,0.0,,P08173,0.2862052498258831
193,20406819,acm4_human,428,S,P,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.74,,=,,5.14,2.512,,,[3H]QNB (radioligand),47.8,0.0,,0.0,,P08173,0.2862052498258831
194,26958838,acm4_human,428,S,P,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.74,,=,,5.14,2.512,,,[3H]QNB,0.0,0.0,,0.0,,P08173,0.2862052498258831
285,20406819,acm4_human,428,S,P,LY2033298,PubChem CID,11536903,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.21,,=,,5.17,-1.096,,,[3H]QNB (radioligand),47.8,0.0,,0.0,,P08173,0.2862052498258831
286,26958838,acm4_human,428,S,P,LY2033298,PubChem CID,11536903,Binding - unknown pharmacological activity,pK(b),Binding - Radioligand competition/displacement,5.21,,=,,5.17,-1.096,,,[3H]QNB,0.0,0.0,,0.0,,P08173,0.2862052498258831
61,20406819,acm4_human,432,D,N,[3H]QNB,ChEMBL Compound ID,CHEMBL12980,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,10.33,,=,,10.6,1.862,,,[3H]QNB (radioligand),56.5,0.0,,0.0,,P08173,0.2093849188294299
74,20406819,acm4_human,432,D,N,Xanomeline,ChEMBL Compound ID,CHEMBL21536,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.67,,=,,6.72,1.122,,,[3H]QNB (radioligand),56.5,0.0,,0.0,,P08173,0.2093849188294299
107,20406819,acm4_human,432,D,N,McN-A343,ChEMBL Compound ID,CHEMBL40554,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.86,,=,,5.15,1.95,,,[3H]QNB (radioligand),56.5,0.0,,0.0,,P08173,0.2093849188294299
195,20406819,acm4_human,432,D,N,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.74,,=,,5.19,2.818,,,[3H]QNB (radioligand),56.5,0.0,,0.0,,P08173,0.2093849188294299
196,26958838,acm4_human,432,D,N,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.74,,=,,5.19,2.818,,,[3H]QNB,0.0,0.0,,0.0,,P08173,0.2093849188294299
287,20406819,acm4_human,432,D,N,LY2033298,PubChem CID,11536903,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.21,,=,,5.21,1.0,,,[3H]QNB (radioligand),56.5,0.0,,0.0,,P08173,0.2093849188294299
288,26958838,acm4_human,432,D,N,LY2033298,PubChem CID,11536903,Binding - unknown pharmacological activity,pK(b),Binding - Radioligand competition/displacement,5.21,,=,,5.21,1.0,,,[3H]QNB,0.0,0.0,,0.0,,P08173,0.2093849188294299
62,26958838,acm4_human,435,W,A,[3H]QNB,ChEMBL Compound ID,CHEMBL12980,Binding - unknown pharmacological activity,pK(A),Binding - Radioligand saturation,10.57,,=,,10.21,-2.288,,,,61.0,0.0,,0.0,,P08173,0.5119524106899231
63,26958838,acm4_human,435,W,A,[3H]QNB,ChEMBL Compound ID,CHEMBL12980,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,10.57,,=,,10.21,-2.288,,,[3H]QNB (radioligand),61.0,0.0,,0.0,,P08173,0.5119524106899231
197,26958838,acm4_human,435,W,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.51,,=,,3.37,-13.889,,,[3H]QNB (radioligand),61.0,0.0,,0.0,,P08173,0.5119524106899231
198,26958838,acm4_human,435,W,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.51,,=,,3.37,-13.889,,,[3H]QNB,0.0,0.0,,0.0,,P08173,0.5119524106899231
64,20406819,acm4_human,439,Y,A,[3H]QNB,ChEMBL Compound ID,CHEMBL12980,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,10.33,,=,,10.24,-1.23,,,[3H]QNB (radioligand),95.7,0.0,,0.0,,P08173,0.5599873152896231
75,20406819,acm4_human,439,Y,A,Xanomeline,ChEMBL Compound ID,CHEMBL21536,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.67,,=,,6.3,-2.342,,,[3H]QNB (radioligand),95.7,0.0,,0.0,,P08173,0.5599873152896231
108,20406819,acm4_human,439,Y,A,McN-A343,ChEMBL Compound ID,CHEMBL40554,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.86,,=,,4.54,-2.088,,,[3H]QNB (radioligand),95.7,0.0,,0.0,,P08173,0.5599873152896231
199,20406819,acm4_human,439,Y,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.74,,=,,3.33,-25.641,,,[3H]QNB (radioligand),95.7,0.0,,0.0,,P08173,0.5599873152896231
200,26958838,acm4_human,439,Y,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.74,,=,,3.33,-25.641,,,[3H]QNB,0.0,0.0,,0.0,,P08173,0.5599873152896231
290,20406819,acm4_human,439,Y,A,LY2033298,PubChem CID,11536903,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.21,,=,,5.84,4.266,,,[3H]QNB (radioligand),95.7,0.0,,0.0,,P08173,0.5599873152896231
291,26958838,acm4_human,439,Y,A,LY2033298,PubChem CID,11536903,Binding - unknown pharmacological activity,pK(b),Binding - Radioligand competition/displacement,5.21,,=,,5.84,4.266,,,[3H]QNB,0.0,0.0,,0.0,,P08173,0.5599873152896231
65,26958838,acm4_human,440,W,A,[3H]QNB,ChEMBL Compound ID,CHEMBL12980,Binding - unknown pharmacological activity,pK(A),Binding - Radioligand saturation,10.57,,=,,10.01,-3.636,,,,61.0,0.0,,0.0,,P08173,0.6225890312313038
66,26958838,acm4_human,440,W,A,[3H]QNB,ChEMBL Compound ID,CHEMBL12980,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,10.57,,=,,10.01,-3.636,,,[3H]QNB (radioligand),61.0,0.0,,0.0,,P08173,0.6225890312313038
201,26958838,acm4_human,440,W,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.51,,=,,4.29,-1.658,,,[3H]QNB (radioligand),61.0,0.0,,0.0,,P08173,0.6225890312313038
202,26958838,acm4_human,440,W,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.51,,=,,4.29,-1.658,,,[3H]QNB,0.0,0.0,,0.0,,P08173,0.6225890312313038
292,26958838,acm4_human,440,W,A,LY2033298,PubChem CID,11536903,Binding - unknown pharmacological activity,pK(b),Binding - Radioligand competition/displacement,4.89,,=,,4.94,1.122,,,[3H]QNB,0.0,0.0,,0.0,,P08173,0.6225890312313038
293,26958838,acm4_human,440,W,A,LY2033298,PubChem CID,11536903,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.89,,=,,4.94,1.122,,,[3H]QNB (radioligand),61.0,0.0,,0.0,,P08173,0.6225890312313038
67,20406819,acm4_human,442,C,A,[3H]QNB,ChEMBL Compound ID,CHEMBL12980,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,10.33,,=,,10.01,-2.088,,,[3H]QNB (radioligand),113.0,0.0,,0.0,,P08173,0.4906296410781656
76,20406819,acm4_human,442,C,A,Xanomeline,ChEMBL Compound ID,CHEMBL21536,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.67,,=,,6.33,-2.188,,,[3H]QNB (radioligand),113.0,0.0,,0.0,,P08173,0.4906296410781656
109,20406819,acm4_human,442,C,A,McN-A343,ChEMBL Compound ID,CHEMBL40554,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.86,,=,,4.87,1.023,,,[3H]QNB (radioligand),113.0,0.0,,0.0,,P08173,0.4906296410781656
203,20406819,acm4_human,442,C,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.74,,=,,4.04,-5.0,,,[3H]QNB (radioligand),113.0,0.0,,0.0,,P08173,0.4906296410781656
204,26958838,acm4_human,442,C,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.74,,=,,4.04,-5.0,,,[3H]QNB,0.0,0.0,,0.0,,P08173,0.4906296410781656
294,20406819,acm4_human,442,C,A,LY2033298,PubChem CID,11536903,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.21,,=,,5.35,1.38,,,[3H]QNB (radioligand),113.0,0.0,,0.0,,P08173,0.4906296410781656
295,26958838,acm4_human,442,C,A,LY2033298,PubChem CID,11536903,Binding - unknown pharmacological activity,pK(b),Binding - Radioligand competition/displacement,5.21,,=,,5.35,1.38,,,[3H]QNB,0.0,0.0,,0.0,,P08173,0.4906296410781656
68,20406819,acm4_human,443,Y,A,[3H]QNB,ChEMBL Compound ID,CHEMBL12980,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,10.33,,=,,10.22,-1.289,,,[3H]QNB (radioligand),73.9,0.0,,0.0,,P08173,0.6149382777843232
77,20406819,acm4_human,443,Y,A,Xanomeline,ChEMBL Compound ID,CHEMBL21536,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.67,,=,,6.13,-3.472,,,[3H]QNB (radioligand),73.9,0.0,,0.0,,P08173,0.6149382777843232
110,20406819,acm4_human,443,Y,A,McN-A343,ChEMBL Compound ID,CHEMBL40554,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.86,,=,,4.44,-2.632,,,[3H]QNB (radioligand),73.9,0.0,,0.0,,P08173,0.6149382777843232
205,20406819,acm4_human,443,Y,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.74,,=,,3.36,-23.81,,,[3H]QNB (radioligand),73.9,0.0,,0.0,,P08173,0.6149382777843232
206,26958838,acm4_human,443,Y,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.74,,=,,3.36,-23.81,,,[3H]QNB,0.0,0.0,,0.0,,P08173,0.6149382777843232
296,20406819,acm4_human,443,Y,A,LY2033298,PubChem CID,11536903,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.21,,=,,6.22,10.233,,,[3H]QNB (radioligand),73.9,0.0,,0.0,,P08173,0.6149382777843232
297,26958838,acm4_human,443,Y,A,LY2033298,PubChem CID,11536903,Binding - unknown pharmacological activity,pK(b),Binding - Radioligand competition/displacement,5.21,,=,,6.22,10.233,,,[3H]QNB,0.0,0.0,,0.0,,P08173,0.6149382777843232
88,23826889,acm4_human,78,D,N,N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.62,,=,,10.05,2.692,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P08173,0.7454943980154609
90,23826889,acm4_human,78,D,N,McN-A343,ChEMBL Compound ID,CHEMBL40554,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.05,,=,,6.16,12.882,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P08173,0.7454943980154609
121,23826889,acm4_human,78,D,N,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.81,,=,,5.77,9.12,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P08173,0.7454943980154609
163,26958838,acm4_human,164,W,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.51,,=,,3.95,-3.636,,,[3H]QNB (radioligand),50.0,0.0,,0.0,,P08173,0.6207276284425767
164,26958838,acm4_human,164,W,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.51,,=,,3.95,-3.636,,,[3H]QNB,0.0,0.0,,0.0,,P08173,0.6207276284425767
257,26958838,acm4_human,164,W,A,LY2033298,PubChem CID,11536903,Binding - unknown pharmacological activity,pK(b),Binding - Radioligand competition/displacement,4.89,,=,,5.15,1.82,,,[3H]QNB,0.0,0.0,,0.0,,P08173,0.6207276284425767
258,26958838,acm4_human,164,W,A,LY2033298,PubChem CID,11536903,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.89,,=,,5.15,1.82,,,[3H]QNB (radioligand),50.0,0.0,,0.0,,P08173,0.6207276284425767
16,10936201,5ht1d_human,189,L,Q,5-HT,ChEMBL Compound ID,CHEMBL39,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,5.68,nM,=,,7.79,-1.372,,,[3H]5-CT,0.0,0.0,,0.0,,P28221,0.3557287447432465
18,10936201,5ht1d_human,189,L,Q,Ketanserin,ChEMBL Compound ID,ChEMBL51,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,10.4,nM,=,,61.55,-5.917,,,[3H]5-CT,0.0,0.0,,0.0,,P28221,0.3557287447432465
21,9855638,5ht1d_human,199,I,V,Ketanserin,ChEMBL Compound ID,ChEMBL51,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,58.0,nM,=,,125.0,-2.155,,,[3H]5-CT,0.0,0.0,,0.0,,P28221,0.2433085724475604
22,9855638,5ht1d_human,199,I,V,Ketanserin,ChEMBL Compound ID,ChEMBL51,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,43.0,nM,=,,45.0,-1.046,,,[3H]GR 125745,0.0,0.0,,0.0,,P28221,0.2433085724475604
23,9855638,5ht1d_human,203,C,V,Ketanserin,ChEMBL Compound ID,ChEMBL51,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,58.0,nM,=,,240.0,-4.132,,,[3H]5-CT,0.0,0.0,,0.0,,P28221,0.3406126501306134
24,9855638,5ht1d_human,203,C,V,Ketanserin,ChEMBL Compound ID,ChEMBL51,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,43.0,nM,=,,70.0,-1.629,,,[3H]GR 125746,0.0,0.0,,0.0,,P28221,0.3406126501306134
25,9855638,5ht1d_human,208,I,F,Ketanserin,ChEMBL Compound ID,ChEMBL51,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,58.0,nM,=,,170.0,-2.933,,,[3H]5-CT,0.0,0.0,,0.0,,P28221,0.3543309531769452
26,9855638,5ht1d_human,208,I,F,Ketanserin,ChEMBL Compound ID,ChEMBL51,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,43.0,nM,=,,57.0,-1.326,,,[3H]GR 125747,0.0,0.0,,0.0,,P28221,0.3543309531769452
32,15037200,5ht1a_human,50,A,V,Methiothepin,ChEMBL Compound ID,CHEMBL122536,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.2,,=,,8.5,1.995,,,[3H]WAY-100636,0.0,0.0,,0.0,,P08908,0.4575961395942569
39,15037200,5ht1a_human,50,A,V,5-CT,ChEMBL Compound ID,CHEMBL18840,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.0,,=,,8.1,1.259,,,[3H]WAY-100636,0.0,0.0,,0.0,,P08908,0.4575961395942569
51,15037200,5ht1a_human,50,A,V,[3H]WAY-100635,ChEMBL Compound ID,CHEMBL31354,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,10.0,,=,,10.2,1.585,,,,7.0,0.0,,0.0,,P08908,0.4575961395942569
53,15037200,5ht1a_human,50,A,V,WAY-100635,ChEMBL Compound ID,CHEMBL31354,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.7,,=,,9.6,-1.259,,,[3H]WAY-100636,0.0,0.0,,0.0,,P08908,0.4575961395942569
55,15037200,5ht1a_human,50,A,V,5-HT,ChEMBL Compound ID,CHEMBL39,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.9,,=,,6.8,-1.259,,,[3H]WAY-100635,0.0,0.0,,0.0,,P08908,0.4575961395942569
72,15037200,5ht1a_human,50,A,V,(+)8-OH-DPAT,ChEMBL Compound ID,CHEMBL56,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.3,,=,,7.9,3.981,,,[3H]WAY-100635,0.0,0.0,,0.0,,P08908,0.4575961395942569
33,1349154,5ht1a_human,386,N,V,Methiothepin,ChEMBL Compound ID,CHEMBL122536,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,37.0,nM,=,,11.0,3.364,,,[3H]8-OH-DPAT,0.0,0.0,,0.0,,P08908,0.5969684674082438
34,1349154,5ht1a_human,386,N,V,Mesulergine,ChEMBL Compound ID,CHEMBL12314,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,750.0,nM,=,,1000.0,-1.333,,,[3H]8-OH-DPAT,0.0,0.0,,0.0,,P08908,0.5969684674082438
35,9145928,5ht1a_human,386,N,V,Penbutolol (isomer R),ChEMBL Compound ID,CHEMBL1290,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,80.0,nM,=,,3400.0,-41.667,,,[3H]8-OH-DPAT,0.0,0.0,,0.0,,P08908,0.5969684674082438
36,9145928,5ht1a_human,386,N,V,Penbutolol (isomer S),ChEMBL Compound ID,CHEMBL1290,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,3.3,nM,=,,500.0,-142.857,,,[3H]8-OH-DPAT,0.0,0.0,,0.0,,P08908,0.5969684674082438
37,9145928,5ht1a_human,386,N,V,Cmp8,ChEMBL Compound ID,CHEMBL139737,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,1500.0,nM,=,,1300.0,1.154,,,[3H]8-OH-DPAT,0.0,0.0,,0.0,,P08908,0.5969684674082438
38,1349154,5ht1a_human,386,N,V,Lisuride,ChEMBL Compound ID,CHEMBL157138,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.76,nM,=,,0.42,1.81,,,[3H]8-OH-DPAT,0.0,0.0,,0.0,,P08908,0.5969684674082438
40,1349154,5ht1a_human,386,N,V,5-CT,ChEMBL Compound ID,CHEMBL18840,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.12,nM,=,,0.27,-2.252,,,[3H]8-OH-DPAT,0.0,0.0,,0.0,,P08908,0.5969684674082438
41,1349154,5ht1a_human,386,N,V,Metergoline,ChEMBL Compound ID,CHEMBL19215,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,2.2,nM,=,,3.2,-1.453,,,[3H]8-OH-DPAT,0.0,0.0,,0.0,,P08908,0.5969684674082438
42,1349154,5ht1a_human,386,N,V,Alprenolol,ChEMBL Compound ID,CHEMBL266195,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,28.0,nM,=,,4100.0,-142.857,,,[3H]8-OH-DPAT,0.0,0.0,,0.0,,P08908,0.5969684674082438
43,9145928,5ht1a_human,386,N,V,Alprenolol (isomer R),ChEMBL Compound ID,CHEMBL266195,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,5400.0,nM,=,,56000.0,-10.417,,,[3H]8-OH-DPAT,0.0,0.0,,0.0,,P08908,0.5969684674082438
44,9145928,5ht1a_human,386,N,V,Alprenolol (isomer S),ChEMBL Compound ID,CHEMBL266195,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,60.0,nM,=,,7200.0,-125.0,,,[3H]8-OH-DPAT,0.0,0.0,,0.0,,P08908,0.5969684674082438
47,1349154,5ht1a_human,386,N,V,Spiperone,ChEMBL Compound ID,CHEMBL267930,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,900.0,nM,=,,220.0,4.091,,,[3H]8-OH-DPAT,0.0,0.0,,0.0,,P08908,0.5969684674082438
48,1349154,5ht1a_human,386,N,V,Propranolol,ChEMBL Compound ID,CHEMBL27,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,150.0,nM,=,,6100.0,-40.0,,,[3H]8-OH-DPAT,0.0,0.0,,0.0,,P08908,0.5969684674082438
49,9145928,5ht1a_human,386,N,V,Propranolol (isomer R),ChEMBL Compound ID,CHEMBL27,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,2100.0,nM,=,,9800.0,-4.673,,,[3H]8-OH-DPAT,0.0,0.0,,0.0,,P08908,0.5969684674082438
50,9145928,5ht1a_human,386,N,V,Propranolol (isomer S),ChEMBL Compound ID,CHEMBL27,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,160.0,nM,=,,3600.0,-22.727,,,[3H]8-OH-DPAT,0.0,0.0,,0.0,,P08908,0.5969684674082438
54,9145928,5ht1a_human,386,N,V,WAY-100635,ChEMBL Compound ID,CHEMBL31354,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,2.8,nM,=,,6.5,-2.32,,,[3H]8-OH-DPAT,0.0,0.0,,0.0,,P08908,0.5969684674082438
62,1349154,5ht1a_human,386,N,V,5-HT,ChEMBL Compound ID,CHEMBL39,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,1.6,nM,=,,4.4,-2.747,,,[3H]8-OH-DPAT,0.0,0.0,,0.0,,P08908,0.5969684674082438
63,9145928,5ht1a_human,386,N,V,5-HT,ChEMBL Compound ID,CHEMBL39,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,3.3,nM,=,,14.0,-4.237,,,[3H]8-OH-DPAT,0.0,0.0,,0.0,,P08908,0.5969684674082438
64,1349154,5ht1a_human,386,N,V,Labetalol,ChEMBL Compound ID,CHEMBL429,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,240.0,nM,=,,160.0,1.5,,,[3H]8-OH-DPAT,0.0,0.0,,0.0,,P08908,0.5969684674082438
67,1349154,5ht1a_human,386,N,V,Buspirone,ChEMBL Compound ID,CHEMBL49,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,23.0,nM,=,,6.5,3.538,,,[3H]8-OH-DPAT,0.0,0.0,,0.0,,P08908,0.5969684674082438
71,1349154,5ht1a_human,386,N,V,Pindolol,ChEMBL Compound ID,CHEMBL500,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,24.0,nM,=,,2700.0,-111.111,,,[3H]8-OH-DPAT,0.0,0.0,,0.0,,P08908,0.5969684674082438
74,1349154,5ht1a_human,386,N,V,8-OH-DPAT,ChEMBL Compound ID,CHEMBL56,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,1.4,nM,=,,0.74,1.892,,,[3H]8-OH-DPAT,0.0,0.0,,0.0,,P08908,0.5969684674082438
83,9145928,5ht1a_human,386,N,V,8-OH-DPAT (isomer R),ChEMBL Compound ID,CHEMBL56,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,3.8,nM,=,,0.5,7.6,,,[3H]8-OH-DPAT,0.0,0.0,,0.0,,P08908,0.5969684674082438
84,9145928,5ht1a_human,386,N,V,8-OH-DPAT (isomer S),ChEMBL Compound ID,CHEMBL56,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,4.6,nM,=,,9.0,-1.957,,,[3H]8-OH-DPAT,0.0,0.0,,0.0,,P08908,0.5969684674082438
85,1349154,5ht1a_human,386,N,V,Ipsapirone,ChEMBL Compound ID,CHEMBL8412,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,1.9,nM,=,,2.5,-1.316,,,[3H]8-OH-DPAT,0.0,0.0,,0.0,,P08908,0.5969684674082438
86,9145928,5ht1a_human,386,N,V,Cmp9,PubChem CID,551839,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,4000.0,nM,=,,5910.0,-1.477,,,[3H]8-OH-DPAT,0.0,0.0,,0.0,,P08908,0.5969684674082438
87,9145928,5ht1a_human,386,N,V,Cmp12,PubChem CID,10017756,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,3800.0,nM,=,,7200.0,-1.894,,,[3H]8-OH-DPAT,0.0,0.0,,0.0,,P08908,0.5969684674082438
88,9145928,5ht1a_human,386,N,V,Cmp11,PubChem CID,10085460,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,1400.0,nM,=,,2000.0,-1.429,,,[3H]8-OH-DPAT,0.0,0.0,,0.0,,P08908,0.5969684674082438
89,9145928,5ht1a_human,386,N,V,Cmp10,PubChem CID,10107358,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,170.0,nM,=,,140.0,1.214,,,[3H]8-OH-DPAT,0.0,0.0,,0.0,,P08908,0.5969684674082438
90,9145928,5ht1a_human,386,N,V,Cmp10 (isomer R),PubChem CID,10107358,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,1700.0,nM,=,,1300.0,1.308,,,[3H]8-OH-DPAT,0.0,0.0,,0.0,,P08908,0.5969684674082438
91,9145928,5ht1a_human,386,N,V,Cmp10 (isomer S),PubChem CID,10107358,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,150.0,nM,=,,160.0,-1.066,,,[3H]8-OH-DPAT,0.0,0.0,,0.0,,P08908,0.5969684674082438
45,10936212,5ht1a_human,344,V,E,Spiperone,ChEMBL Compound ID,CHEMBL267930,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.41,,=,,8.15,-1.818,,,[3H]NAD-299,0.0,0.0,,0.0,,P08908,0.6018597401660885
46,10936212,5ht1a_human,344,V,E,Spiperone,ChEMBL Compound ID,CHEMBL267930,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.41,,=,,8.22,-1.548,,,[3H]NAD-299,0.0,0.0,,0.0,,P08908,0.6018597401660885
65,10936212,5ht1a_human,344,V,E,Buspirone,ChEMBL Compound ID,CHEMBL49,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.24,,=,,7.23,-1.024,,,[3H]NAD-299,0.0,0.0,,0.0,,P08908,0.6018597401660885
66,10936212,5ht1a_human,344,V,E,Buspirone,ChEMBL Compound ID,CHEMBL49,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.24,,=,,7.19,-1.122,,,[3H]NAD-299,0.0,0.0,,0.0,,P08908,0.6018597401660885
81,10936212,5ht1a_human,344,V,E,8-OH-DPAT (isomer R),ChEMBL Compound ID,CHEMBL56,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.59,,=,,7.89,1.995,,,[3H]NAD-299,0.0,0.0,,0.0,,P08908,0.6018597401660885
82,10936212,5ht1a_human,344,V,E,8-OH-DPAT (isomer R),ChEMBL Compound ID,CHEMBL56,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.59,,=,,7.8,1.622,,,[3H]NAD-299,0.0,0.0,,0.0,,P08908,0.6018597401660885
92,10936212,5ht1a_human,344,V,E,[3H]NAD-299,PubChem CID,120168990,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,9.58,,=,,9.34,-1.739,,,,0.0,0.0,,0.0,,P08908,0.6018597401660885
56,1426261,5ht1a_human,82,D,N,5-HT,ChEMBL Compound ID,CHEMBL39,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,1.8,nM,=,,110.0,-62.5,,,,0.0,0.0,,0.0,,P08908,0.7484023470005589
57,1426261,5ht1a_human,82,D,N,5-HT,ChEMBL Compound ID,CHEMBL39,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,1.1,nM,=,,240.0,-200.0,,,[3H]5-HT,0.0,0.0,,0.0,,P08908,0.7484023470005589
68,1426261,5ht1a_human,82,D,N,Pindolol,ChEMBL Compound ID,CHEMBL500,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,18.0,nM,=,,21.0,-1.167,,,[3H]5-HT,0.0,0.0,,0.0,,P08908,0.7484023470005589
58,1426261,5ht1a_human,116,D,N,5-HT,ChEMBL Compound ID,CHEMBL39,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,1.8,nM,=,,158.0,-90.909,,,,0.0,0.0,,0.0,,P08908,0.4769924262348636
59,1426261,5ht1a_human,116,D,N,5-HT,ChEMBL Compound ID,CHEMBL39,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,1.1,nM,=,,198.0,-166.667,,,[3H]5-HT,0.0,0.0,,0.0,,P08908,0.4769924262348636
69,1426261,5ht1a_human,116,D,N,Pindolol,ChEMBL Compound ID,CHEMBL500,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,18.0,nM,=,,30.0,-1.667,,,[3H]5-HT,0.0,0.0,,0.0,,P08908,0.4769924262348636
60,1426261,5ht1a_human,199,S,A,5-HT,ChEMBL Compound ID,CHEMBL39,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,1.8,nM,=,,172.0,-100.0,,,,0.0,0.0,,0.0,,P08908,0.4468584433082325
61,1426261,5ht1a_human,199,S,A,5-HT,ChEMBL Compound ID,CHEMBL39,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,1.1,nM,=,,250.0,-250.0,,,[3H]5-HT,0.0,0.0,,0.0,,P08908,0.4468584433082325
70,1426261,5ht1a_human,199,S,A,Pindolol,ChEMBL Compound ID,CHEMBL500,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,18.0,nM,=,,32.0,-1.779,,,[3H]5-HT,0.0,0.0,,0.0,,P08908,0.4468584433082325
73,8474430,5ht1a_human,82,D,A,8-OH-DPAT,ChEMBL Compound ID,CHEMBL56,Binding - unknown pharmacological activity,Specific binding,Binding - Radioligand saturation,277.5,fmol/mg,=,,2.4,115.625,,,,0.0,0.0,,0.0,,P08908,0.8362041286703208
75,8474430,5ht1a_human,391,S,A,8-OH-DPAT,ChEMBL Compound ID,CHEMBL56,Binding - unknown pharmacological activity,Specific binding,Binding - Radioligand saturation,277.5,fmol/mg,=,,274.4,1.011,,,,0.0,0.0,,0.0,,P08908,0.363268553166834
76,8474430,5ht1a_human,393,S,A,8-OH-DPAT,ChEMBL Compound ID,CHEMBL56,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,0.98,nM,=,,35.5,-35.714,,,,0.0,0.0,,0.0,,P08908,0.5440554581755078
78,8474430,5ht1a_human,396,N,F,8-OH-DPAT,ChEMBL Compound ID,CHEMBL56,Binding - unknown pharmacological activity,Specific binding,Binding - Radioligand saturation,277.5,fmol/mg,=,,1.2,231.25,,,,0.0,0.0,,0.0,,P08908,0.8858149986004795
80,8474430,5ht1a_human,396,N,V,8-OH-DPAT,ChEMBL Compound ID,CHEMBL56,Binding - unknown pharmacological activity,Specific binding,Binding - Radioligand saturation,277.5,fmol/mg,=,,1.0,277.5,,,,0.0,0.0,,0.0,,P08908,0.8858149986004795
0,10.1021/jm801442p,p2ry2_human,114,Y,A,UTP,CID,6133,Full agonist,EC50,Ca2+ accumulaion,59.0,nM,=,,37.2,1.586,,,,0.0,0.0,,77.53623188405797,,P41231,0.5830915802938094
1,10.1021/jm801442p,p2ry2_human,114,Y,A,ATP,CID,5957,Full agonist,EC50,Ca2+ accumulaion,63.1,nM,=,,30.1,2.096,,,,0.0,0.0,,79.0909090909091,,P41231,0.5830915802938094
2,10.1021/jm801442p,p2ry2_human,114,Y,A,Ap4A,CID,25243905,Full agonist,EC50,Ca2+ accumulaion,167.0,nM,=,,170.0,-1.018,,,,0.0,0.0,,128.0,,P41231,0.5830915802938094
3,10.1021/jm801442p,p2ry2_human,114,Y,A,Ip4U,SMILES,c1cn(c(=O)[nH]c1=O)C2C(C(C(O2)COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OCC3C(C(C(O3)n4cnc5c4nc[nH]c5=O)O)O)O)O,Full agonist,EC50,Ca2+ accumulaion,179.0,nM,=,,94.5,1.894,,,,0.0,0.0,,144.89795918367346,,P41231,0.5830915802938094
4,10.1021/jm801442p,p2ry2_human,114,Y,A,Reactive Blue 2,SMILES,c1ccc2c(c1)C(=O)c3c(cc(c(c3C2=O)N)S(=O)(=O)[O-])Nc4ccc(c(c4)S(=O)(=O)[O-])Nc5nc(nc(n5)Cl)Nc6cccc(c6)S(=O)(=O)[O-].[Na+].[Na+].[Na+],Antagonist,IC50,Ca2+ accumulaion,1.85,ÂµM,>,,100.0,-52.632,,,,0.0,0.0,,0.0,,P41231,0.5830915802938094
5,10.1021/jm801442p,p2ry2_human,114,Y,A,PSB-416,SMILES,COc1ccc(cc1)Nc2cc(c(c3c2C(=O)c4ccccc4C3=O)N)S(=O)(=O)[O-].[Na+],Antagonist,IC50,Ca2+ accumulaion,21.7,ÂµM,=,,24.6,-1.134,,,,0.0,0.0,,0.0,,P41231,0.5830915802938094
6,10.1021/jm801442p,p2ry2_human,118,Y,A,UTP,CID,6133,Full agonist,EC50,Ca2+ accumulaion,80.4,nM,=,,157.0,-1.953,,,,0.0,0.0,,43.0,,P41231,0.5883733962033169
7,10.1021/jm801442p,p2ry2_human,118,Y,A,ATP,CID,5957,Full agonist,EC50,Ca2+ accumulaion,95.8,nM,=,,299.0,-3.125,,,,0.0,0.0,,44.56521739130434,,P41231,0.5883733962033169
8,10.1021/jm801442p,p2ry2_human,118,Y,A,Ap4A,CID,25243905,Full agonist,EC50,Ca2+ accumulaion,145.0,nM,=,,345.0,-2.381,,,,0.0,0.0,,22.058823529411764,,P41231,0.5883733962033169
9,10.1021/jm801442p,p2ry2_human,118,Y,A,Ip4U,SMILES,c1cn(c(=O)[nH]c1=O)C2C(C(C(O2)COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OCC3C(C(C(O3)n4cnc5c4nc[nH]c5=O)O)O)O)O,Full agonist,EC50,Ca2+ accumulaion,112.0,nM,=,,145.0,-1.295,,,,0.0,0.0,,34.72222222222222,,P41231,0.5883733962033169
10,10.1021/jm801442p,p2ry2_human,118,Y,A,Reactive Blue 2,SMILES,c1ccc2c(c1)C(=O)c3c(cc(c(c3C2=O)N)S(=O)(=O)[O-])Nc4ccc(c(c4)S(=O)(=O)[O-])Nc5nc(nc(n5)Cl)Nc6cccc(c6)S(=O)(=O)[O-].[Na+].[Na+].[Na+],Antagonist,IC50,Ca2+ accumulaion,1.62,ÂµM,=,,1.57,1.032,,,,0.0,0.0,,0.0,,P41231,0.5883733962033169
11,10.1021/jm801442p,p2ry2_human,118,Y,A,PSB-416,SMILES,COc1ccc(cc1)Nc2cc(c(c3c2C(=O)c4ccccc4C3=O)N)S(=O)(=O)[O-].[Na+],Antagonist,IC50,Ca2+ accumulaion,21.9,ÂµM,=,,22.4,-1.022,,,,0.0,0.0,,0.0,,P41231,0.5883733962033169
12,10.1021/jm801442p,p2ry2_human,177,R,A,UTP,CID,6133,Full agonist,EC50,Ca2+ accumulaion,59.0,nM,=,,50.1,1.178,,,,0.0,0.0,,96.37681159420288,,P41231,0.289941021874352
13,10.1021/jm801442p,p2ry2_human,177,R,A,ATP,CID,5957,Full agonist,EC50,Ca2+ accumulaion,63.1,nM,=,,183.0,-2.899,,,,0.0,0.0,,106.36363636363636,,P41231,0.289941021874352
14,10.1021/jm801442p,p2ry2_human,177,R,A,Ap4A,CID,25243905,Full agonist,EC50,Ca2+ accumulaion,167.0,nM,=,,1230.0,-7.353,,,,0.0,0.0,,86.0,,P41231,0.289941021874352
15,10.1021/jm801442p,p2ry2_human,177,R,A,Ip4U,SMILES,c1cn(c(=O)[nH]c1=O)C2C(C(C(O2)COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OCC3C(C(C(O3)n4cnc5c4nc[nH]c5=O)O)O)O)O,Full agonist,EC50,Ca2+ accumulaion,179.0,nM,=,,572.0,-3.195,,,,0.0,0.0,,104.08163265306123,,P41231,0.289941021874352
16,10.1021/jm801442p,p2ry2_human,177,R,A,Reactive Blue 2,SMILES,c1ccc2c(c1)C(=O)c3c(cc(c(c3C2=O)N)S(=O)(=O)[O-])Nc4ccc(c(c4)S(=O)(=O)[O-])Nc5nc(nc(n5)Cl)Nc6cccc(c6)S(=O)(=O)[O-].[Na+].[Na+].[Na+],Antagonist,IC50,Ca2+ accumulaion,1.85,ÂµM,=,,3.36,-1.815,,,,0.0,0.0,,0.0,,P41231,0.289941021874352
17,10.1021/jm801442p,p2ry2_human,177,R,A,PSB-416,SMILES,COc1ccc(cc1)Nc2cc(c(c3c2C(=O)c4ccccc4C3=O)N)S(=O)(=O)[O-].[Na+],Antagonist,IC50,Ca2+ accumulaion,21.7,ÂµM,=,,30.8,-1.418,,,,0.0,0.0,,0.0,,P41231,0.289941021874352
18,10.1021/jm801442p,p2ry2_human,180,R,A,UTP,CID,6133,Full agonist,EC50,Ca2+ accumulaion,59.0,nM,=,,138.0,-2.336,,,,0.0,0.0,,94.20289855072464,,P41231,0.279072243612008
19,10.1021/jm801442p,p2ry2_human,180,R,A,ATP,CID,5957,Full agonist,EC50,Ca2+ accumulaion,63.1,nM,=,,237.0,-3.759,,,,0.0,0.0,,104.54545454545456,,P41231,0.279072243612008
20,10.1021/jm801442p,p2ry2_human,180,R,A,Ap4A,CID,25243905,Full agonist,EC50,Ca2+ accumulaion,167.0,nM,=,,423.0,-2.532,,,,0.0,0.0,,68.0,,P41231,0.279072243612008
21,10.1021/jm801442p,p2ry2_human,180,R,A,Ip4U,SMILES,c1cn(c(=O)[nH]c1=O)C2C(C(C(O2)COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OCC3C(C(C(O3)n4cnc5c4nc[nH]c5=O)O)O)O)O,Full agonist,EC50,Ca2+ accumulaion,179.0,nM,=,,419.0,-2.342,,,,0.0,0.0,,73.46938775510205,,P41231,0.279072243612008
22,10.1021/jm801442p,p2ry2_human,180,R,A,Reactive Blue 2,SMILES,c1ccc2c(c1)C(=O)c3c(cc(c(c3C2=O)N)S(=O)(=O)[O-])Nc4ccc(c(c4)S(=O)(=O)[O-])Nc5nc(nc(n5)Cl)Nc6cccc(c6)S(=O)(=O)[O-].[Na+].[Na+].[Na+],Antagonist,IC50,Ca2+ accumulaion,1.85,ÂµM,=,,2.1,-1.135,,,,0.0,0.0,,0.0,,P41231,0.279072243612008
23,10.1021/jm801442p,p2ry2_human,180,R,A,PSB-416,SMILES,COc1ccc(cc1)Nc2cc(c(c3c2C(=O)c4ccccc4C3=O)N)S(=O)(=O)[O-].[Na+],Antagonist,IC50,Ca2+ accumulaion,21.7,ÂµM,=,,23.4,-1.079,,,,0.0,0.0,,0.0,,P41231,0.279072243612008
24,10.1021/jm801442p,p2ry2_human,194,R,H,UTP,CID,6133,Full agonist,EC50,Ca2+ accumulaion,80.4,nM,=,,121.0,-1.506,,,,0.0,0.0,,127.0,,P41231,0.2248815948868167
25,10.1021/jm801442p,p2ry2_human,194,R,H,ATP,CID,5957,Full agonist,EC50,Ca2+ accumulaion,95.8,nM,=,,111.0,-1.159,,,,0.0,0.0,,141.30434782608697,,P41231,0.2248815948868167
26,10.1021/jm801442p,p2ry2_human,194,R,H,Ap4A,CID,25243905,Full agonist,EC50,Ca2+ accumulaion,145.0,nM,=,,185.0,-1.276,,,,0.0,0.0,,219.11764705882356,,P41231,0.2248815948868167
27,10.1021/jm801442p,p2ry2_human,194,R,H,Ip4U,SMILES,c1cn(c(=O)[nH]c1=O)C2C(C(C(O2)COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OCC3C(C(C(O3)n4cnc5c4nc[nH]c5=O)O)O)O)O,Full agonist,EC50,Ca2+ accumulaion,112.0,nM,=,,216.0,-1.927,,,,0.0,0.0,,118.05555555555556,,P41231,0.2248815948868167
28,10.1021/jm801442p,p2ry2_human,194,R,H,Reactive Blue 2,SMILES,c1ccc2c(c1)C(=O)c3c(cc(c(c3C2=O)N)S(=O)(=O)[O-])Nc4ccc(c(c4)S(=O)(=O)[O-])Nc5nc(nc(n5)Cl)Nc6cccc(c6)S(=O)(=O)[O-].[Na+].[Na+].[Na+],Antagonist,IC50,Ca2+ accumulaion,1.62,ÂµM,=,,1.0,1.62,,,,0.0,0.0,,0.0,,P41231,0.2248815948868167
29,10.1021/jm801442p,p2ry2_human,194,R,H,PSB-416,SMILES,COc1ccc(cc1)Nc2cc(c(c3c2C(=O)c4ccccc4C3=O)N)S(=O)(=O)[O-].[Na+],Antagonist,IC50,Ca2+ accumulaion,21.9,ÂµM,=,,17.6,1.244,,,,0.0,0.0,,0.0,,P41231,0.2248815948868167
30,10.1021/jm801442p,p2ry2_human,198,Y,A,UTP,CID,6133,Full agonist,EC50,Ca2+ accumulaion,80.4,nM,=,,108.0,-1.344,,,,0.0,0.0,,128.0,,P41231,0.5532818702736907
31,10.1021/jm801442p,p2ry2_human,198,Y,A,ATP,CID,5957,Full agonist,EC50,Ca2+ accumulaion,95.8,nM,=,,120.0,-1.253,,,,0.0,0.0,,136.95652173913044,,P41231,0.5532818702736907
32,10.1021/jm801442p,p2ry2_human,198,Y,A,Ap4A,CID,25243905,Full agonist,EC50,Ca2+ accumulaion,145.0,nM,=,,335.0,-2.309,,,,0.0,0.0,,172.05882352941177,,P41231,0.5532818702736907
33,10.1021/jm801442p,p2ry2_human,198,Y,A,Ip4U,SMILES,c1cn(c(=O)[nH]c1=O)C2C(C(C(O2)COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OCC3C(C(C(O3)n4cnc5c4nc[nH]c5=O)O)O)O)O,Full agonist,EC50,Ca2+ accumulaion,112.0,nM,=,,231.0,-2.062,,,,0.0,0.0,,176.38888888888889,,P41231,0.5532818702736907
34,10.1021/jm801442p,p2ry2_human,198,Y,A,Reactive Blue 2,SMILES,c1ccc2c(c1)C(=O)c3c(cc(c(c3C2=O)N)S(=O)(=O)[O-])Nc4ccc(c(c4)S(=O)(=O)[O-])Nc5nc(nc(n5)Cl)Nc6cccc(c6)S(=O)(=O)[O-].[Na+].[Na+].[Na+],Antagonist,IC50,Ca2+ accumulaion,1.62,ÂµM,=,,9.3,-5.747,,,,0.0,0.0,,0.0,,P41231,0.5532818702736907
35,10.1021/jm801442p,p2ry2_human,198,Y,A,PSB-416,SMILES,COc1ccc(cc1)Nc2cc(c(c3c2C(=O)c4ccccc4C3=O)N)S(=O)(=O)[O-].[Na+],Antagonist,IC50,Ca2+ accumulaion,21.9,ÂµM,=,,21.1,1.038,,,,0.0,0.0,,0.0,,P41231,0.5532818702736907
36,10.1021/jm801442p,p2ry2_human,272,R,A,UTP,CID,6133,Full agonist,EC50,Ca2+ accumulaion,0.059,ÂµM,=,,20.6,-333.333,,,,0.0,0.0,,71.73913043478261,,P41231,0.330562399486014
37,10.1021/jm801442p,p2ry2_human,272,R,A,ATP,CID,5957,Full agonist,EC50,Ca2+ accumulaion,0.0631,ÂµM,=,,11.7,-200.0,,,,0.0,0.0,,79.0909090909091,,P41231,0.330562399486014
0,10.1021/bi3012065,aa2br_human,282,N,D,NECA,CID,448222,Full agonist,EC50,cAMP accumulation,0.0269,ÂµM,=,,15.5,-500.0,,,,0.0,0.0,,0.0,,P29275,0.645278641294911
1,10.1021/bi3012065,aa2br_human,282,N,D,NECA,CID,448222,Full agonist,K(i),radioligand binding,6.32,nM,>,,100.0,-15.873,,,PSB-603,0.0,0.0,,0.0,,P29275,0.645278641294911
90,10.1021/bi3012065,aa2br_human,282,N,D,PSB-603,CID,44185871,Antagonist (neutral/silent),K(i),radioligand binding,2.45,nM,=,,1.38,1.775,,,,0.0,0.0,,0.0,,P29275,0.645278641294911
91,10.1021/bi3012065,aa2br_human,282,N,D,BAY60-6583,CID,11717831,Partial agonist,EC50,cAMP accumulation,37.5,nM,=,,908.0,-24.39,,,,0.0,0.0,,0.0,,P29275,0.645278641294911
92,10.1021/bi3012065,aa2br_human,282,N,D,BAY60-6583,CID,11717831,Partial agonist,K(i),radioligand binding,727.0,nM,=,,1800.0,-2.475,,,,0.0,0.0,,0.0,,P29275,0.645278641294911
2,10.1016/j.bcp.2013.03.005,aa2br_human,149,S,A,NECA,CID,448222,Full agonist,K(i),radioligand binding,1240.0,nM,=,,4150.0,-3.344,,,PSB-603,0.0,0.0,,0.0,,P29275,0.2253869321493221
99,10.1016/j.bcp.2013.03.005,aa2br_human,149,S,A,NECA,CID,448222,Full agonist,EC50,cAMP accumulation,230.0,nM,=,,183.0,1.257,,,,0.0,0.0,,0.0,,P29275,0.2253869321493221
101,10.1016/j.bcp.2013.03.005,aa2br_human,149,S,A,PSB-603,CID,44185871,Antagonist (neutral/silent),K(i),radioligand binding,0.37,nM,=,,0.44,-1.189,,,PSB-603,0.0,0.0,,0.0,,P29275,0.2253869321493221
102,10.1016/j.bcp.2013.03.005,aa2br_human,149,S,A,BAY60-6583,CID,11717831,Partial agonist,EC50,cAMP accumulation,165.0,nM,=,,126.0,1.31,,,,0.0,0.0,,0.0,,P29275,0.2253869321493221
103,10.1016/j.bcp.2013.03.005,aa2br_human,149,S,A,BAY60-6583,CID,11717831,Partial agonist,K(i),radioligand binding,114.0,nM,=,,286.0,-2.506,,,PSB-603,0.0,0.0,,0.0,,P29275,0.2253869321493221
3,10.1016/j.ejphar.2020.173126,aa2br_human,167,C,Y,NECA,PubChem CID,448222,Full agonist,pEC50,Functional - Other,6.79,,=,,6.65,-1.381,,,,36.0,100.0,,91.0,NECA,P29275,0.3571140952793732
4,10.1016/j.ejphar.2020.173126,aa2br_human,148,D,G,NECA,PubChem CID,448222,Full agonist,pEC50,Functional - Other,6.79,,=,,6.87,1.202,,,,90.0,250.0,,98.0,NECA,P29275,0.2881262664365174
5,10.1016/j.ejphar.2020.173126,aa2br_human,259,F,S,NECA,PubChem CID,448222,Full agonist,pEC50,Functional - Other,6.79,,=,,5.44,-22.222,,,,66.0,60.0,,57.0,NECA,P29275,0.3834577143100939
18,10.1016/j.ejphar.2020.173126,aa2br_human,259,F,S,BAY 60-6583,PubChem CID,11717831,Partial agonist,pEC50,Functional - Other,7.49,,=,,6.71,-6.024,,,,66.0,60.0,,20.0,BAY 60-6583,P29275,0.3834577143100939
6,10.1016/j.ejphar.2020.173126,aa2br_human,113,Y,F,NECA,PubChem CID,448222,Full agonist,pEC50,Functional - Other,6.79,,=,,5.28,-32.258,,,,101.0,60.0,,57.0,NECA,P29275,0.3812442954934581
19,10.1016/j.ejphar.2020.173126,aa2br_human,113,Y,F,BAY 60-6583,PubChem CID,11717831,Partial agonist,pEC50,Functional - Other,7.49,,=,,6.51,-9.524,,,,101.0,60.0,,15.0,BAY 60-6583,P29275,0.3812442954934581
7,10.1016/j.ejphar.2020.173126,aa2br_human,215,R,H,NECA,PubChem CID,448222,Full agonist,pEC50,Functional - Other,6.79,,=,,6.57,-1.658,,,,86.0,280.0,,94.0,NECA,P29275,0.3452460268568781
12,10.1016/j.ejphar.2020.173126,aa2br_human,202,Y,C,NECA,PubChem CID,448222,Full agonist,pEC50,Functional - Other,6.79,,=,,6.3,-3.086,,,,144.0,4800.0,Yes,73.0,NECA,P29275,0.7134968829820335
23,10.1016/j.ejphar.2020.173126,aa2br_human,202,Y,C,BAY 60-6583,PubChem CID,11717831,Partial agonist,pEC50,Functional - Other,7.49,,=,,7.21,-1.905,,,,144.0,4800.0,,74.0,BAY 60-6583,P29275,0.7134968829820335
14,10.1016/j.ejphar.2020.173126,aa2br_human,310,L,P,NECA,PubChem CID,448222,Full agonist,pEC50,Functional - Other,6.79,,=,,7.21,2.63,,,,92.0,2600.0,Yes,95.0,NECA,P29275,0.383487310519487
25,10.1016/j.ejphar.2020.173126,aa2br_human,310,L,P,BAY 60-6583,PubChem CID,11717831,Partial agonist,pEC50,Functional - Other,7.49,,=,,7.16,-2.137,,,,92.0,2600.0,,80.0,BAY 60-6583,P29275,0.383487310519487
28,10.1016/j.ejphar.2020.173126,aa2br_human,310,L,P,PSB603,PubChem CID,44185871,Antagonist (neutral/silent),pK(b),Functional - Other,8.47,,=,,8.27,-1.585,,,,92.0,2600.0,Yes,0.0,,P29275,0.383487310519487
15,10.1016/j.ejphar.2020.173126,aa2br_human,310,L,F,NECA,PubChem CID,448222,Full agonist,pEC50,Functional - Other,6.79,,=,,6.8,1.023,,,,101.0,200.0,,105.0,NECA,P29275,0.2660180034331438
16,10.1016/j.ejphar.2020.173126,aa2br_human,310,L,I,NECA,PubChem CID,448222,Full agonist,pEC50,Functional - Other,6.79,,=,,6.4,-2.457,,,,124.0,360.0,,88.0,NECA,P29275,0.2017995558506296
17,10.1016/j.ejphar.2020.173126,aa2br_human,315,V,G,NECA,PubChem CID,448222,Full agonist,pEC50,Functional - Other,6.79,,=,,6.89,1.259,,,,205.0,140.0,,94.0,NECA,P29275,0.3682373081882635
54,10.1021/bi3012065,aa2br_human,10,Y,A,NECA,CID,448222,Full agonist,EC50,cAMP accumulation,83.5,nM,=,,426.0,-5.102,,,,0.0,0.0,,120.0,,P29275,0.428871354572992
55,10.1021/bi3012065,aa2br_human,10,Y,A,NECA,CID,448222,Full agonist,K(i),radioligand binding,5.85,ÂµM,=,,11.5,-1.965,,,PSB-603,0.0,0.0,,0.0,,P29275,0.428871354572992
56,10.1021/bi3012065,aa2br_human,10,Y,A,PSB-603,CID,44185871,Antagonist (neutral/silent),K(i),radioligand binding,3.59,nM,=,,5.73,-1.595,,,,0.0,0.0,,0.0,,P29275,0.428871354572992
57,10.1021/bi3012065,aa2br_human,10,Y,A,BAY60-6583,CID,11717831,Partial agonist,EC50,cAMP accumulation,80.2,nM,=,,1160.0,-14.493,,,,0.0,0.0,,70.0,,P29275,0.428871354572992
59,10.1021/bi3012065,aa2br_human,81,L,A,NECA,CID,448222,Full agonist,EC50,cAMP accumulation,83.5,nM,=,,909.0,-10.87,,,,0.0,0.0,,100.0,,P29275,0.4535527315737974
62,10.1021/bi3012065,aa2br_human,81,L,A,BAY60-6583,CID,11717831,Partial agonist,EC50,cAMP accumulation,80.2,nM,=,,398.0,-4.95,,,,0.0,0.0,,100.0,,P29275,0.4535527315737974
69,10.1021/bi3012065,aa2br_human,198,M,A,NECA,CID,448222,Full agonist,EC50,cAMP accumulation,83.5,nM,=,,165.0,-1.976,,,,0.0,0.0,,90.0,,P29275,0.5466764844859153
70,10.1021/bi3012065,aa2br_human,198,M,A,NECA,CID,448222,Full agonist,K(i),radioligand binding,5850.0,nM,=,,5530.0,1.058,,,PSB-603,0.0,0.0,,0.0,,P29275,0.5466764844859153
71,10.1021/bi3012065,aa2br_human,198,M,A,PSB-603,CID,44185871,Antagonist (neutral/silent),K(i),radioligand binding,3.59,nM,=,,2.89,1.242,,,,0.0,0.0,,0.0,,P29275,0.5466764844859153
72,10.1021/bi3012065,aa2br_human,198,M,A,BAY60-6583,CID,11717831,Partial agonist,EC50,cAMP accumulation,80.2,nM,=,,128.0,-1.595,,,,0.0,0.0,,90.0,,P29275,0.5466764844859153
74,10.1021/bi3012065,aa2br_human,247,W,A,NECA,CID,448222,Full agonist,EC50,cAMP accumulation,0.0835,ÂµM,=,,10.4,-125.0,,,,0.0,0.0,,150.0,,P29275,0.7969894974008934
75,10.1021/bi3012065,aa2br_human,247,W,A,NECA,CID,448222,Full agonist,K(i),radioligand binding,5.85,ÂµM,=,,78.5,-13.333,,,PSB-603,0.0,0.0,,0.0,,P29275,0.7969894974008934
76,10.1021/bi3012065,aa2br_human,247,W,A,PSB-603,CID,44185871,Antagonist (neutral/silent),K(i),radioligand binding,3.59,nM,=,,12.8,-3.571,,,,0.0,0.0,,0.0,,P29275,0.7969894974008934
77,10.1021/bi3012065,aa2br_human,247,W,A,BAY60-6583,CID,11717831,Partial agonist,EC50,cAMP accumulation,80.2,nM,=,,241.0,-3.003,,,,0.0,0.0,,110.0,,P29275,0.7969894974008934
79,10.1021/bi3012065,aa2br_human,250,V,A,NECA,CID,448222,Full agonist,EC50,cAMP accumulation,0.0835,ÂµM,=,,13.9,-166.667,,,,0.0,0.0,,180.0,,P29275,0.4845009806316597
82,10.1021/bi3012065,aa2br_human,250,V,A,BAY60-6583,CID,11717831,Partial agonist,EC50,cAMP accumulation,80.2,nM,=,,164.0,-2.045,,,,0.0,0.0,,130.0,,P29275,0.4845009806316597
85,10.1021/bi3012065,aa2br_human,279,S,A,NECA,CID,448222,Full agonist,EC50,cAMP accumulation,0.0835,ÂµM,>,,100.0,-1000.0,,,,0.0,0.0,,0.0,,P29275,0.4626174769793421
87,10.1021/bi3012065,aa2br_human,279,S,A,PSB-603,CID,44185871,Antagonist (neutral/silent),K(i),radioligand binding,3.59,nM,=,,6.35,-1.77,,,,0.0,0.0,,0.0,,P29275,0.4626174769793421
88,10.1021/bi3012065,aa2br_human,279,S,A,BAY60-6583,CID,11717831,Partial agonist,EC50,cAMP accumulation,80.2,nM,=,,12.1,6.628,,,,0.0,0.0,,0.0,,P29275,0.4626174769793421
89,10.1021/bi3012065,aa2br_human,279,S,A,BAY60-6583,CID,11717831,Partial agonist,K(i),radioligand binding,548.0,nM,=,,436.0,1.257,,,,0.0,0.0,,0.0,,P29275,0.4626174769793421
93,10.1016/j.bcp.2013.03.005,aa2br_human,148,D,A,NECA,CID,448222,Full agonist,EC50,cAMP accumulation,230.0,nM,=,,158.0,1.456,,,,0.0,0.0,,0.0,,P29275,0.3264081029745466
94,10.1016/j.bcp.2013.03.005,aa2br_human,148,D,A,NECA,CID,448222,Full agonist,K(i),radioligand binding,1240.0,nM,=,,1140.0,1.088,,,PSB-603,0.0,0.0,,0.0,,P29275,0.3264081029745466
96,10.1016/j.bcp.2013.03.005,aa2br_human,148,D,A,PSB-603,CID,44185871,Antagonist (neutral/silent),K(i),radioligand binding,0.37,nM,=,,0.319,1.16,,,PSB-603,0.0,0.0,,0.0,,P29275,0.3264081029745466
97,10.1016/j.bcp.2013.03.005,aa2br_human,148,D,A,BAY60-6583,CID,11717831,Partial agonist,EC50,cAMP accumulation,165.0,nM,=,,72.4,2.279,,,,0.0,0.0,,0.0,,P29275,0.3264081029745466
98,10.1016/j.bcp.2013.03.005,aa2br_human,148,D,A,BAY60-6583,CID,11717831,Partial agonist,K(i),radioligand binding,114.0,nM,=,,339.0,-2.976,,,PSB-603,0.0,0.0,,0.0,,P29275,0.3264081029745466
104,10.1016/j.bcp.2013.03.005,aa2br_human,151,T,A,NECA,CID,448222,Full agonist,EC50,cAMP accumulation,230.0,nM,=,,287.0,-1.248,,,,0.0,0.0,,0.0,,P29275,0.2669123942213606
105,10.1016/j.bcp.2013.03.005,aa2br_human,151,T,A,NECA,CID,448222,Full agonist,K(i),radioligand binding,1240.0,nM,=,,2380.0,-1.919,,,PSB-603,0.0,0.0,,0.0,,P29275,0.2669123942213606
107,10.1016/j.bcp.2013.03.005,aa2br_human,151,T,A,PSB-603,CID,44185871,Antagonist (neutral/silent),K(i),radioligand binding,0.37,nM,=,,0.431,-1.166,,,PSB-603,0.0,0.0,,0.0,,P29275,0.2669123942213606
108,10.1016/j.bcp.2013.03.005,aa2br_human,151,T,A,BAY60-6583,CID,11717831,Partial agonist,EC50,cAMP accumulation,165.0,nM,=,,121.0,1.364,,,,0.0,0.0,,0.0,,P29275,0.2669123942213606
109,10.1016/j.bcp.2013.03.005,aa2br_human,151,T,A,BAY60-6583,CID,11717831,Partial agonist,K(i),radioligand binding,114.0,nM,=,,257.0,-2.252,,,PSB-603,0.0,0.0,,0.0,,P29275,0.2669123942213606
110,10.1016/j.bcp.2013.03.005,aa2br_human,164,E,A,NECA,CID,448222,Full agonist,EC50,cAMP accumulation,230.0,nM,=,,62.5,3.68,,,,0.0,0.0,,0.0,,P29275,0.3134369192593313
111,10.1016/j.bcp.2013.03.005,aa2br_human,164,E,A,NECA,CID,448222,Full agonist,K(i),radioligand binding,1240.0,nM,=,,1420.0,-1.145,,,PSB-603,0.0,0.0,,0.0,,P29275,0.3134369192593313
113,10.1016/j.bcp.2013.03.005,aa2br_human,164,E,A,PSB-603,CID,44185871,Antagonist (neutral/silent),K(i),radioligand binding,0.37,nM,=,,0.425,-1.148,,,PSB-603,0.0,0.0,,0.0,,P29275,0.3134369192593313
114,10.1016/j.bcp.2013.03.005,aa2br_human,164,E,A,BAY60-6583,CID,11717831,Partial agonist,EC50,cAMP accumulation,165.0,nM,=,,76.0,2.171,,,,0.0,0.0,,0.0,,P29275,0.3134369192593313
115,10.1016/j.bcp.2013.03.005,aa2br_human,164,E,A,BAY60-6583,CID,11717831,Partial agonist,K(i),radioligand binding,114.0,nM,=,,236.0,-2.07,,,PSB-603,0.0,0.0,,0.0,,P29275,0.3134369192593313
116,10.1016/j.bcp.2013.03.005,aa2br_human,165,S,A,NECA,CID,448222,Full agonist,EC50,cAMP accumulation,230.0,nM,=,,316.0,-1.374,,,,0.0,0.0,,0.0,,P29275,0.2326825913932447
117,10.1016/j.bcp.2013.03.005,aa2br_human,165,S,A,NECA,CID,448222,Full agonist,K(i),radioligand binding,1240.0,nM,=,,805.0,1.54,,,PSB-603,0.0,0.0,,0.0,,P29275,0.2326825913932447
119,10.1016/j.bcp.2013.03.005,aa2br_human,165,S,A,PSB-603,CID,44185871,Antagonist (neutral/silent),K(i),radioligand binding,0.37,nM,=,,0.253,1.462,,,PSB-603,0.0,0.0,,0.0,,P29275,0.2326825913932447
120,10.1016/j.bcp.2013.03.005,aa2br_human,165,S,A,BAY60-6583,CID,11717831,Partial agonist,EC50,cAMP accumulation,165.0,nM,=,,186.0,-1.127,,,,0.0,0.0,,0.0,,P29275,0.2326825913932447
121,10.1016/j.bcp.2013.03.005,aa2br_human,165,S,A,BAY60-6583,CID,11717831,Partial agonist,K(i),radioligand binding,114.0,nM,=,,275.0,-2.41,,,PSB-603,0.0,0.0,,0.0,,P29275,0.2326825913932447
122,10.1016/j.bcp.2013.03.005,aa2br_human,169,V,A,NECA,CID,448222,Full agonist,EC50,cAMP accumulation,230.0,nM,=,,90.1,2.553,,,,0.0,0.0,,0.0,,P29275,0.2559730536887745
123,10.1016/j.bcp.2013.03.005,aa2br_human,169,V,A,NECA,CID,448222,Full agonist,K(i),radioligand binding,1240.0,nM,=,,1190.0,1.042,,,PSB-603,0.0,0.0,,0.0,,P29275,0.2559730536887745
125,10.1016/j.bcp.2013.03.005,aa2br_human,169,V,A,PSB-603,CID,44185871,Antagonist (neutral/silent),K(i),radioligand binding,0.37,nM,=,,0.884,-2.387,,,PSB-603,0.0,0.0,,0.0,,P29275,0.2559730536887745
126,10.1016/j.bcp.2013.03.005,aa2br_human,169,V,A,BAY60-6583,CID,11717831,Partial agonist,EC50,cAMP accumulation,165.0,nM,=,,45.1,3.659,,,,0.0,0.0,,0.0,,P29275,0.2559730536887745
180,11093773,aa2br_human,12,A,T,NECA,PubChem CID,448222,Full agonist,K(i),Binding - Radioligand competition/displacement,2.2,ÂµM,=,,5.3,-2.41,,,DPCPX,0.0,0.0,=,0.0,,P29275,0.227760742941867
181,11093773,aa2br_human,12,A,T,R-PIA,PubChem CID,114854,Full agonist,K(i),Binding - Radioligand competition/displacement,21.0,ÂµM,=,,36.0,-1.715,,,DPCPX,0.0,0.0,=,0.0,,P29275,0.227760742941867
182,11093773,aa2br_human,12,A,T,2-ClAdo,PubChem CID,235481,Full agonist,K(i),Binding - Radioligand competition/displacement,8.9,ÂµM,=,,21.0,-2.358,,,DPCPX,0.0,0.0,=,0.0,,P29275,0.227760742941867
183,10.1124/mol.65.3.702,aa2br_human,36,N,D,NECA,PubChem CID,448222,Full agonist,EC50,Functional - Other,97.0,nM,=,,42.0,2.31,,,,0.0,0.0,=,0.0,,P29275,0.24246303759536
185,10.1124/mol.65.3.702,aa2br_human,42,T,A,NECA,PubChem CID,448222,Full agonist,EC50,Functional - Other,97.0,nM,=,,20.0,4.85,,,,0.0,0.0,=,0.0,,P29275,0.506210682721419
187,10.1124/mol.65.3.702,aa2br_human,42,T,A,NECA,PubChem CID,448222,Full agonist,EC50,Functional - cAMP accumulation,1.3,ÂµM,=,,0.15,8.667,,,,0.0,0.0,=,0.0,,P29275,0.506210682721419
200,10.1096/fj.10-164319,aa2br_human,71,F,I,NECA,PubChem CID,448222,Full agonist,EC50,Functional - Other,94.0,nM,=,,108.0,-1.149,,,,0.0,100.0,=,0.0,,P29275,0.256339217474892
214,10.1096/fj.10-164319,aa2br_human,71,F,I,Bay60-6583,PubChem CID,11717831,Full agonist,EC50,Functional - Other,81.0,nM,=,,132.0,-1.629,,,,0.0,100.0,=,0.0,,P29275,0.256339217474892
203,10.1096/fj.10-164319,aa2br_human,71,F,M,NECA,PubChem CID,448222,Full agonist,EC50,Functional - Other,94.0,nM,=,,130.0,-1.383,,,,0.0,100.0,=,0.0,,P29275,0.256339217474892
217,10.1096/fj.10-164319,aa2br_human,71,F,M,Bay60-6583,PubChem CID,11717831,Full agonist,EC50,Functional - Other,81.0,nM,=,,114.0,-1.406,,,,0.0,100.0,=,0.0,,P29275,0.256339217474892
204,10.1096/fj.10-164319,aa2br_human,71,F,Y,NECA,PubChem CID,448222,Full agonist,EC50,Functional - Other,94.0,nM,=,,147.0,-1.565,,,,0.0,100.0,=,0.0,,P29275,0.1672316716181218
218,10.1096/fj.10-164319,aa2br_human,71,F,Y,Bay60-6583,PubChem CID,11717831,Full agonist,EC50,Functional - Other,81.0,nM,=,,101.0,-1.247,,,,0.0,100.0,=,0.0,,P29275,0.1672316716181218
205,10.1096/fj.10-164319,aa2br_human,71,F,V,NECA,PubChem CID,448222,Full agonist,EC50,Functional - Other,94.0,nM,=,,167.0,-1.776,,,,0.0,100.0,=,0.0,,P29275,0.2921402402858623
219,10.1096/fj.10-164319,aa2br_human,71,F,V,Bay60-6583,PubChem CID,11717831,Full agonist,EC50,Functional - Other,81.0,nM,=,,171.0,-2.11,,,,0.0,100.0,=,0.0,,P29275,0.2921402402858623
206,10.1096/fj.10-164319,aa2br_human,71,F,H,NECA,PubChem CID,448222,Full agonist,EC50,Functional - Other,94.0,nM,=,,437.0,-4.651,,,,0.0,100.0,=,0.0,,P29275,0.2921402402858623
220,10.1096/fj.10-164319,aa2br_human,71,F,H,Bay60-6583,PubChem CID,11717831,Full agonist,EC50,Functional - Other,81.0,nM,=,,226.0,-2.793,,,,0.0,100.0,=,0.0,,P29275,0.2921402402858623
207,10.1096/fj.10-164319,aa2br_human,71,F,D,NECA,PubChem CID,448222,Full agonist,EC50,Functional - Other,94.0,nM,=,,442.0,-4.695,,,,0.0,95.0,=,0.0,,P29275,0.3716894154628454
221,10.1096/fj.10-164319,aa2br_human,71,F,D,Bay60-6583,PubChem CID,11717831,Full agonist,EC50,Functional - Other,81.0,nM,=,,387.0,-4.785,,,,0.0,95.0,=,0.0,,P29275,0.3716894154628454
208,10.1096/fj.10-164319,aa2br_human,71,F,C,NECA,PubChem CID,448222,Full agonist,EC50,Functional - Other,94.0,nM,=,,589.0,-6.25,,,,0.0,100.0,=,0.0,,P29275,0.3307107349744655
222,10.1096/fj.10-164319,aa2br_human,71,F,C,Bay60-6583,PubChem CID,11717831,Full agonist,EC50,Functional - Other,81.0,nM,=,,312.0,-3.846,,,,0.0,100.0,=,0.0,,P29275,0.3307107349744655
209,10.1096/fj.10-164319,aa2br_human,71,F,S,NECA,PubChem CID,448222,Full agonist,EC50,Functional - Other,94.0,nM,=,,933.0,-9.901,,,,0.0,82.0,=,0.0,,P29275,0.3307107349744655
223,10.1096/fj.10-164319,aa2br_human,71,F,S,Bay60-6583,PubChem CID,11717831,Full agonist,EC50,Functional - Other,81.0,nM,=,,319.0,-3.937,,,,0.0,82.0,=,0.0,,P29275,0.3307107349744655
227,10.1096/fj.10-164319,aa2br_human,74,D,G,NECA,PubChem CID,448222,Full agonist,EC50,Functional - Other,94.0,nM,=,,47.0,2.0,,,,0.0,107.0,=,0.0,107.0,P29275,0.3749138677247519
243,10.1096/fj.10-164319,aa2br_human,74,D,G,Bay60-6583,PubChem CID,11717831,Full agonist,EC50,Functional - Other,81.0,nM,=,,43.0,1.884,,,,0.0,107.0,=,0.0,,P29275,0.3749138677247519
230,10.1096/fj.10-164319,aa2br_human,74,D,N,NECA,PubChem CID,448222,Full agonist,EC50,Functional - Other,94.0,nM,=,,61.0,1.541,,,,0.0,103.0,=,0.0,,P29275,0.2949987232561839
246,10.1096/fj.10-164319,aa2br_human,74,D,N,Bay60-6583,PubChem CID,11717831,Full agonist,EC50,Functional - Other,81.0,nM,=,,45.0,1.8,,,,0.0,103.0,=,0.0,,P29275,0.2949987232561839
233,10.1096/fj.10-164319,aa2br_human,74,D,Y,NECA,PubChem CID,448222,Full agonist,EC50,Functional - Other,94.0,nM,=,,84.0,1.119,,,,0.0,104.0,=,0.0,,P29275,0.4622944113251771
249,10.1096/fj.10-164319,aa2br_human,74,D,Y,Bay60-6583,PubChem CID,11717831,Full agonist,EC50,Functional - Other,81.0,nM,=,,70.0,1.157,,,,0.0,104.0,=,0.0,,P29275,0.4622944113251771
234,10.1096/fj.10-164319,aa2br_human,74,D,A,NECA,PubChem CID,448222,Full agonist,EC50,Functional - Other,94.0,nM,=,,91.0,1.033,,,,0.0,108.0,=,0.0,,P29275,0.4179602356882188
250,10.1096/fj.10-164319,aa2br_human,74,D,A,Bay60-6583,PubChem CID,11717831,Full agonist,EC50,Functional - Other,81.0,nM,=,,144.0,-1.779,,,,0.0,108.0,=,0.0,,P29275,0.4179602356882188
235,10.1096/fj.10-164319,aa2br_human,74,D,R,NECA,PubChem CID,448222,Full agonist,EC50,Functional - Other,94.0,nM,=,,97.0,-1.032,,,,0.0,100.0,=,0.0,,P29275,0.4179602356882188
251,10.1096/fj.10-164319,aa2br_human,74,D,R,Bay60-6583,PubChem CID,11717831,Full agonist,EC50,Functional - Other,81.0,nM,=,,83.0,-1.025,,,,0.0,100.0,=,0.0,,P29275,0.4179602356882188
236,10.1096/fj.10-164319,aa2br_human,74,D,T,NECA,PubChem CID,448222,Full agonist,EC50,Functional - Other,94.0,nM,=,,108.0,-1.149,,,,0.0,106.0,=,0.0,,P29275,0.3749138677247519
252,10.1096/fj.10-164319,aa2br_human,74,D,T,Bay60-6583,PubChem CID,11717831,Full agonist,EC50,Functional - Other,81.0,nM,=,,135.0,-1.667,,,,0.0,106.0,=,0.0,,P29275,0.3749138677247519
237,10.1096/fj.10-164319,aa2br_human,74,D,W,NECA,PubChem CID,448222,Full agonist,EC50,Functional - Other,94.0,nM,=,,197.0,-2.096,,,,0.0,103.0,=,0.0,,P29275,0.5072310870091299
253,10.1096/fj.10-164319,aa2br_human,74,D,W,Bay60-6583,PubChem CID,11717831,Full agonist,EC50,Functional - Other,81.0,nM,=,,152.0,-1.876,,,,0.0,103.0,=,0.0,,P29275,0.5072310870091299
238,10.1096/fj.10-164319,aa2br_human,74,D,C,NECA,PubChem CID,448222,Full agonist,EC50,Functional - Other,94.0,nM,=,,256.0,-2.725,,,,0.0,107.0,=,0.0,,P29275,0.4622944113251771
254,10.1096/fj.10-164319,aa2br_human,74,D,C,Bay60-6583,PubChem CID,11717831,Full agonist,EC50,Functional - Other,81.0,nM,=,,156.0,-1.927,,,,0.0,107.0,=,0.0,,P29275,0.4622944113251771
239,10.1096/fj.10-164319,aa2br_human,74,D,L,NECA,PubChem CID,448222,Full agonist,EC50,Functional - Other,94.0,nM,=,,323.0,-3.436,,,,0.0,85.0,=,0.0,,P29275,0.5072310870091299
255,10.1096/fj.10-164319,aa2br_human,74,D,L,Bay60-6583,PubChem CID,11717831,Full agonist,EC50,Functional - Other,81.0,nM,=,,188.0,-2.32,,,,0.0,85.0,=,0.0,,P29275,0.5072310870091299
240,10.1096/fj.10-164319,aa2br_human,74,D,V,NECA,PubChem CID,448222,Full agonist,EC50,Functional - Other,94.0,nM,=,,333.0,-3.546,,,,0.0,100.0,=,0.0,,P29275,0.4622944113251771
256,10.1096/fj.10-164319,aa2br_human,74,D,V,Bay60-6583,PubChem CID,11717831,Full agonist,EC50,Functional - Other,81.0,nM,=,,242.0,-2.985,,,,0.0,100.0,=,0.0,,P29275,0.4622944113251771
241,10.1096/fj.10-164319,aa2br_human,74,D,F,NECA,PubChem CID,448222,Full agonist,EC50,Functional - Other,94.0,nM,=,,587.0,-6.25,,,,0.0,71.0,=,0.0,,P29275,0.4622944113251771
257,10.1096/fj.10-164319,aa2br_human,74,D,F,Bay60-6583,PubChem CID,11717831,Full agonist,EC50,Functional - Other,81.0,nM,=,,159.0,-1.965,,,,0.0,71.0,=,0.0,,P29275,0.4622944113251771
260,10.1124/mol.65.3.702,aa2br_human,84,F,S,NECA,PubChem CID,448222,Full agonist,EC50,Functional - Other,97.0,nM,=,,15.0,6.467,,,,0.0,0.0,=,0.0,,P29275,0.4840920017041641
262,10.1124/mol.65.3.702,aa2br_human,91,S,G,NECA,PubChem CID,448222,Full agonist,EC50,Functional - Other,97.0,nM,=,,61.0,1.59,,,,0.0,0.0,=,0.0,,P29275,0.4386399145141416
268,10.1007/s11302-011-9251-x,aa2br_human,136,I,T,NECA,PubChem CID,448222,Full agonist,EC50,Functional - Other,137.0,nM,=,,10.0,13.7,,,,0.0,150.0,=,0.0,,P29275,0.4257305451635278
280,10.1007/s11302-011-9251-x,aa2br_human,168,L,P,NECA,PubChem CID,448222,Full agonist,EC50,Functional - Other,137.0,nM,=,,11.0,12.455,,,,0.0,550.0,=,0.0,,P29275,0.3728476621692115
282,10.1007/s11302-011-9251-x,aa2br_human,200,V,G,NECA,PubChem CID,448222,Full agonist,EC50,Functional - Other,137.0,nM,=,,13.0,10.538,,,,500.0,0.0,=,0.0,,P29275,0.3109868149697338
283,10.1007/s11302-011-9251-x,aa2br_human,202,Y,S,NECA,PubChem CID,448222,Full agonist,EC50,Functional - Other,137.0,nM,=,,13.0,10.538,,,,0.0,130.0,=,0.0,,P29275,0.7134968829820335
284,10.1007/s11302-011-9251-x,aa2br_human,202,Y,S,Bay60-6583,PubChem CID,11717831,Full agonist,EC50,Functional - Other,48.0,nM,=,,4.9,9.796,,,,0.0,0.0,=,0.0,,P29275,0.7134968829820335
285,10.1007/s11302-014-9407-6,aa2br_human,213,L,A,NECA,PubChem CID,448222,Full agonist,EC50,Functional - Other,0.0,,=,,0.0,-1.667,,,,0.0,0.0,=,100.0,NECA,P29275,0.4093570258139135
286,10.1007/s11302-014-9407-6,aa2br_human,213,L,A,NECA,PubChem CID,448222,Full agonist,IC50,Binding - Radioligand competition/displacement,1.85,ÂµM,=,,1.9,-1.027,,,PSB-603,0.0,0.0,=,0.0,,P29275,0.4093570258139135
287,10.1007/s11302-014-9407-6,aa2br_human,235,S,A,NECA,PubChem CID,448222,Full agonist,EC50,Functional - Other,0.0,,=,,0.0,1.0,,,,0.0,0.0,=,85.0,NECA,P29275,0.4577079042315895
289,10.1007/s11302-014-9407-6,aa2br_human,236,L,A,NECA,PubChem CID,448222,Full agonist,EC50,Functional - Other,0.0,,=,,0.0,7.9,,,,0.0,0.0,=,102.0,NECA,P29275,0.5969431831049805
290,10.1007/s11302-014-9407-6,aa2br_human,236,L,A,NECA,PubChem CID,448222,Full agonist,IC50,Binding - Radioligand competition/displacement,1.85,ÂµM,=,,1.88,-1.016,,,PSB-603,0.0,0.0,=,0.0,,P29275,0.5969431831049805
291,11093773,aa2br_human,273,N,Y,NECA,PubChem CID,448222,Full agonist,K(i),Binding - Radioligand competition/displacement,2.2,ÂµM,=,,3.8,-1.727,,,DPCPX,0.0,0.0,=,0.0,,P29275,0.446521554162318
292,11093773,aa2br_human,273,N,Y,R-PIA,PubChem CID,114854,Full agonist,K(i),Binding - Radioligand competition/displacement,21.0,ÂµM,=,,13.0,1.615,,,DPCPX,0.0,0.0,=,0.0,,P29275,0.446521554162318
293,11093773,aa2br_human,273,N,Y,2-ClAdo,PubChem CID,235481,Full agonist,K(i),Binding - Radioligand competition/displacement,8.9,ÂµM,=,,26.0,-2.924,,,DPCPX,0.0,0.0,=,0.0,,P29275,0.446521554162318
294,11093773,aa2br_human,273,N,Y,2-(1-hexynyl)adenosine,PubChem CID,10020580,Full agonist,K(i),Binding - Radioligand competition/displacement,11.0,ÂµM,=,,0.18,61.111,,,DPCPX,0.0,0.0,=,0.0,,P29275,0.446521554162318
295,11093773,aa2br_human,273,N,Y,181873-18-7,PubChem CID,53720188,Full agonist,K(i),Binding - Radioligand competition/displacement,53.0,ÂµM,=,,2.5,21.2,,,DPCPX,0.0,0.0,=,0.0,,P29275,0.446521554162318
296,11093773,aa2br_human,273,N,Y,144348-17-4,PubChem CID,73232013,Full agonist,K(i),Binding - Radioligand competition/displacement,26.0,ÂµM,=,,7.4,3.514,,,DPCPX,0.0,0.0,=,0.0,,P29275,0.446521554162318
297,11093773,aa2br_human,273,N,Y,L005974,PubChem CID,14842876,Full agonist,K(i),Binding - Radioligand competition/displacement,47.0,ÂµM,=,,7.7,6.104,,,DPCPX,0.0,0.0,=,0.0,,P29275,0.446521554162318
298,11093773,aa2br_human,273,N,Y,CGS21680,PubChem CID,3086599,Full agonist,K(i),Binding - Radioligand competition/displacement,300.0,ÂµM,=,,95.0,3.158,,,DPCPX,0.0,0.0,=,0.0,,P29275,0.446521554162318
299,11093773,aa2br_human,273,N,Y,Cid13830107(R),PubChem CID,13830107,Full agonist,K(i),Binding - Radioligand competition/displacement,10.0,ÂµM,=,,2.9,3.448,,,DPCPX,0.0,0.0,=,0.0,,P29275,0.446521554162318
300,11093773,aa2br_human,273,N,Y,Cid13830107(S),PubChem CID,13830107,Full agonist,K(i),Binding - Radioligand competition/displacement,1.7,ÂµM,=,,0.19,8.947,,,DPCPX,0.0,0.0,=,0.0,,P29275,0.446521554162318
301,11093773,aa2br_human,273,N,Y,ZM241385,PubChem CID,176407,Inverse agonist,K(i),Binding - Radioligand competition/displacement,0.026,ÂµM,=,,0.064,-2.463,,,DPCPX,0.0,0.0,=,0.0,,P29275,0.446521554162318
302,11093773,aa2br_human,273,N,Y,SCH58261,PubChem CID,176408,Inverse agonist,K(i),Binding - Radioligand competition/displacement,0.34,ÂµM,=,,0.39,-1.147,,,DPCPX,0.0,0.0,=,0.0,,P29275,0.446521554162318
303,11093773,aa2br_human,273,N,Y,XAC,PubChem CID,5697,Inverse agonist,K(i),Binding - Radioligand competition/displacement,0.008,ÂµM,=,,0.003,2.667,,,DPCPX,0.0,0.0,=,0.0,,P29275,0.446521554162318
304,11093773,aa2br_human,273,N,Y,181873-18-7,PubChem CID,53720188,Full agonist,EC50,Functional - cAMP accumulation,5.6,ÂµM,=,,0.56,10.0,,,,0.0,0.0,=,0.0,,P29275,0.446521554162318
316,10.1042/BCJ20160272,aa2br_human,293,R,A,NECA,PubChem CID,448222,Full agonist,pmol/mg,Functional - cAMP accumulation,20.0,,=,,28.0,100000000.0,,,,100.0,0.0,=,0.0,,P29275,0.5208400037581532
318,10.1042/BCJ20160272,aa2br_human,295,R,A,NECA,PubChem CID,448222,Full agonist,pmol/mg,Functional - cAMP accumulation,20.0,,=,,25.0,100000.0,,,,100.0,0.0,=,0.0,,P29275,0.4186591830919305
319,10.1042/BCJ20160272,aa2br_human,296,D,A,NECA,PubChem CID,448222,Full agonist,pmol/mg,Functional - cAMP accumulation,20.0,,=,,29.0,1000000000.0,,,,100.0,0.0,=,0.0,,P29275,0.5470159219535639
322,10.1042/BCJ20160272,aa2br_human,299,Y,A,NECA,PubChem CID,448222,Full agonist,pmol/mg,Functional - cAMP accumulation,20.0,,=,,20.0,1.0,,,,100.0,0.0,=,0.0,,P29275,0.297205309993607
323,10.1042/BCJ20160272,aa2br_human,300,T,A,NECA,PubChem CID,448222,Full agonist,pmol/mg,Functional - cAMP accumulation,20.0,,=,,22.0,100.0,,,,100.0,0.0,=,0.0,,P29275,0.4923680586037592
324,10.1042/BCJ20160272,aa2br_human,301,F,A,NECA,PubChem CID,448222,Full agonist,pmol/mg,Functional - cAMP accumulation,20.0,,=,,23.0,1000.0,,,,100.0,0.0,=,0.0,,P29275,0.6144902605605294
325,10.1042/BCJ20160272,aa2br_human,302,H,A,NECA,PubChem CID,448222,Full agonist,pmol/mg,Functional - cAMP accumulation,20.0,,=,,19.0,-10.0,,,,100.0,0.0,=,0.0,,P29275,0.3549448935756802
2,https://doi.org/10.1038/s41467-021-27911-3,ada1b_human,197,V,L,RS79948,PubChem CID,19836887,Antagonist (neutral/silent),pK(i),Binding - Other,5.9,,=,,6.23,2.138,,,QAPB (quinazolinyl piperazine BODIPY),0.0,0.0,,0.0,,P35368,0.4434058090915014
6,https://doi.org/10.1038/s41467-021-27911-3,ada1b_human,197,V,L,cyclazosin,PubChem CID,16219097,Inverse agonist,pK(i),Binding - Other,8.99,,=,,8.96,-1.072,,,QAPB (quinazolinyl piperazine BODIPY),0.0,0.0,,0.0,,P35368,0.4434058090915014
10,https://doi.org/10.1038/s41467-021-27911-3,ada1b_human,197,V,L,QAPB (quinazolinyl piperazine BODIPY),SMILES,O=C(N1CCN(C2=NC(N)=C3C=C(OC)C(OC)=CC3=N2)CC1)CCC(C=C4)=[N]5C4=CC6=C(C)C=C(C)N6B5(F)F,Binding - unknown pharmacological activity,pK(d),Binding - Other,8.11,,=,,7.95,-1.445,,,,0.0,0.0,,0.0,,P35368,0.4434058090915014
17,17917257,ada1b_human,125,D,A,[3H]Prazosin,ChEMBL Compound ID,CHEMBL2,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,90.27,pM,>,,10000.0,-111.111,,,,0.0,0.0,,0.0,,P35368,0.6093191851781242
18,17917257,ada1b_human,130,T,A,[3H]Prazosin,ChEMBL Compound ID,CHEMBL2,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,90.27,pM,=,,674.27,-7.463,,,,112.5,0.0,,0.0,,P35368,0.4881105497698413
21,17917257,ada1b_human,130,T,A,Prazosin,ChEMBL Compound ID,CHEMBL2,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,10.76,,=,,9.8,-9.091,,,[3H]Prazosin,0.0,0.0,,0.0,,P35368,0.4881105497698413
34,17917257,ada1b_human,130,T,A,Tamsulosin,ChEMBL Compound ID,CHEMBL836,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.57,,=,,8.53,-10.989,,,[3H]Prazosin,0.0,0.0,,0.0,,P35368,0.4881105497698413
42,https://doi.org/10.1038/s41467-021-27911-3,ada1b_human,95,S,C,phenylephrine,PubChem CID,5284443,Full agonist,pEC50,Functional - IP accumulation,6.52,,,,5.78,-5.495,,,,0.0,0.0,,72.0,phenylephrine,P35368,0.5785806637423901
43,https://doi.org/10.1038/s41467-021-27911-3,ada1b_human,116,I,T,phenylephrine,PubChem CID,5284443,Full agonist,pEC50,Functional - IP accumulation,6.52,,,,6.84,2.089,,,,0.0,0.0,,71.0,phenylephrine,P35368,0.2639402724264101
44,https://doi.org/10.1038/s41467-021-27911-3,ada1b_human,124,V,M,phenylephrine,PubChem CID,5284443,Full agonist,pEC50,Functional - IP accumulation,6.52,,,,6.76,1.738,,,,0.0,0.0,,84.0,phenylephrine,P35368,0.3536746144342337
46,https://doi.org/10.1038/s41467-021-27911-3,ada1b_human,168,S,C,phenylephrine,PubChem CID,5284443,Full agonist,pEC50,Functional - IP accumulation,6.52,,,,6.45,-1.175,,,,0.0,0.0,,97.0,phenylephrine,P35368,0.2640253328133764
48,https://doi.org/10.1038/s41467-021-27911-3,ada1b_human,191,D,Y,phenylephrine,PubChem CID,5284443,Full agonist,pEC50,Functional - IP accumulation,6.52,,,,5.58,-8.696,,,,0.0,0.0,,90.0,phenylephrine,P35368,0.3631204664614614
49,https://doi.org/10.1038/s41467-021-27911-3,ada1b_human,194,E,V,phenylephrine,PubChem CID,5284443,Full agonist,pEC50,Functional - IP accumulation,6.52,,,,6.61,1.23,,,,0.0,0.0,,85.0,phenylephrine,P35368,0.3506675110924901
50,https://doi.org/10.1038/s41467-021-27911-3,ada1b_human,295,T,M,phenylephrine,PubChem CID,5284443,Full agonist,pEC50,Functional - IP accumulation,6.52,,,,5.67,-7.092,,,,0.0,0.0,,51.0,phenylephrine,P35368,0.5663987515967699
53,https://doi.org/10.1038/s41467-021-27911-3,ada1b_human,349,P,L,phenylephrine,PubChem CID,5284443,Full agonist,pEC50,Functional - IP accumulation,6.52,,,,5.82,-5.0,,,,0.0,0.0,,27.0,phenylephrine,P35368,0.6627732737698572
2,10.1074/jbc.M414287200,ts1r3_human,640,S,A,lactisole,PubChem CID,23670520,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - Ca2+ accumulation,41.0,ÂµM,=,,14.0,2.929,,,D-tryptophan,0.0,0.0,,0.0,,Q7RTX0,0.3659623070052935
144,10.1186/1472-6807-7-66,ts1r3_human,640,S,A,NHDC,PubChem CID,30231,Allosteric agonist,EC50,Functional - Ca2+ accumulation,0.1,mM,=,,0.8,-8.0,,,,0.0,0.0,,0.0,63.0,Q7RTX0,0.3659623070052935
15,10.1074/jbc.M414287200,ts1r3_human,733,A,V,lactisole,PubChem CID,23670520,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - Ca2+ accumulation,41.0,ÂµM,=,,1900.0,-45.455,,,D-tryptophan,0.0,0.0,,0.0,,Q7RTX0,0.3874349021242314
155,10.1186/1472-6807-7-66,ts1r3_human,733,A,V,NHDC,PubChem CID,30231,Allosteric agonist,EC50,Functional - Ca2+ accumulation,0.1,mM,=,,0.1,1.0,,,,0.0,0.0,,0.0,133.0,Q7RTX0,0.3874349021242314
22,10.1074/jbc.M414287200,ts1r3_human,778,F,A,lactisole,PubChem CID,23670520,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - Ca2+ accumulation,41.0,ÂµM,=,,1800.0,-43.478,,,D-tryptophan,0.0,0.0,,0.0,,Q7RTX0,0.6401896054426122
158,10.1186/1472-6807-7-66,ts1r3_human,778,F,A,NHDC,PubChem CID,30231,Allosteric agonist,EC50,Functional - Ca2+ accumulation,0.1,mM,=,,1.5,-14.925,,,,0.0,0.0,,0.0,50.0,Q7RTX0,0.6401896054426122
24,10.1074/jbc.M414287200,ts1r3_human,782,L,A,lactisole,PubChem CID,23670520,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - Ca2+ accumulation,41.0,ÂµM,=,,12.0,3.417,,,D-tryptophan,0.0,0.0,,0.0,,Q7RTX0,0.4999435843096081
160,10.1186/1472-6807-7-66,ts1r3_human,782,L,A,NHDC,PubChem CID,30231,Allosteric agonist,EC50,Functional - Ca2+ accumulation,0.1,mM,>,,3.0,-30.303,,,,0.0,0.0,,0.0,50.0,Q7RTX0,0.4999435843096081
27,10.1074/jbc.M414287200,ts1r3_human,790,R,Q,lactisole,PubChem CID,23670520,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - Ca2+ accumulation,41.0,ÂµM,=,,170.0,-4.149,Decreased effect,,D-tryptophan,0.0,0.0,,0.0,,Q7RTX0,0.4361715348686723
66,10.1074/jbc.M505255200,ts1r3_human,790,R,Q,cyclamate,PubChem CID,7533,Allosteric agonist,EC50,Functional - Ca2+ accumulation,3.1,mM,>,,40.0,-12.987,,,,0.0,0.0,,0.0,,Q7RTX0,0.4361715348686723
161,10.1186/1472-6807-7-66,ts1r3_human,790,R,Q,NHDC,PubChem CID,30231,Allosteric agonist,EC50,Functional - Ca2+ accumulation,0.1,mM,=,,0.1,1.0,,,,0.0,0.0,,0.0,77.0,Q7RTX0,0.4361715348686723
29,10.1074/jbc.M414287200,ts1r3_human,798,L,I,lactisole,PubChem CID,23670520,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - Ca2+ accumulation,41.0,ÂµM,=,,220.0,-5.376,Decreased effect,,D-tryptophan,0.0,0.0,,0.0,,Q7RTX0,0.3737433110885256
162,10.1186/1472-6807-7-66,ts1r3_human,798,L,I,NHDC,PubChem CID,30231,Allosteric agonist,EC50,Functional - Ca2+ accumulation,0.1,mM,=,,0.2,-2.0,,,,0.0,0.0,,0.0,66.0,Q7RTX0,0.3737433110885256
41,10.1074/jbc.M505255200,ts1r3_human,723,R,A,cyclamate,PubChem CID,7533,Allosteric agonist,EC50,Functional - Ca2+ accumulation,3.1,mM,=,,19.0,-6.135,,,,100.0,0.0,,0.0,,Q7RTX0,0.3452033637508245
149,10.1186/1472-6807-7-66,ts1r3_human,723,R,A,NHDC,PubChem CID,30231,Allosteric agonist,EC50,Functional - Ca2+ accumulation,0.1,mM,=,,0.2,-2.0,,,,0.0,0.0,,0.0,69.0,Q7RTX0,0.3452033637508245
75,10.1186/1472-6807-7-66,ts1r3_human,620,S,A,NHDC,PubChem CID,30231,Allosteric agonist,EC50,Functional - Ca2+ accumulation,0.1,mM,=,,1.3,-12.987,,,,0.0,0.0,,0.0,55.0,Q7RTX0,0.4261510128917471
76,10.1186/1472-6807-7-66,ts1r3_human,621,V,I,NHDC,PubChem CID,30231,Allosteric agonist,EC50,Functional - Ca2+ accumulation,0.1,mM,>,,1.0,-10.0,,,,0.0,0.0,,0.0,60.0,Q7RTX0,0.3355186801193147
91,10.1186/1472-6807-7-66,ts1r3_human,726,S,A,cyclamate,PubChem CID,7533,Allosteric agonist,EC50,Functional - Ca2+ accumulation,1.9,mM,>,,10.0,-5.263,,,,0.0,0.0,,0.0,,Q7RTX0,0.3580097642259803
92,10.1186/1472-6807-7-66,ts1r3_human,726,S,A,cyclamate,PubChem CID,7533,Allosteric agonist,EC50,Functional - Ca2+ accumulation,1.9,mM,>,,10.0,-5.263,,,,0.0,0.0,,0.0,,Q7RTX0,0.3580097642259803
152,10.1186/1472-6807-7-66,ts1r3_human,726,S,A,NHDC,PubChem CID,30231,Allosteric agonist,EC50,Functional - Ca2+ accumulation,0.1,mM,=,,0.9,-9.009,,,,0.0,0.0,,0.0,60.0,Q7RTX0,0.3580097642259803
118,10.1186/1472-6807-7-66,ts1r3_human,699,Y,F,lactisole,PubChem CID,23670520,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - Ca2+ accumulation,0.1,mM,=,,0.5,-5.0,,,aspartame,0.0,0.0,,0.0,,Q7RTX0,0.3223070996934304
146,10.1186/1472-6807-7-66,ts1r3_human,699,Y,F,NHDC,PubChem CID,30231,Allosteric agonist,EC50,Functional - Ca2+ accumulation,0.1,mM,=,,0.6,-5.988,,,,0.0,0.0,,0.0,72.0,Q7RTX0,0.3223070996934304
136,10.1186/1472-6807-7-66,ts1r3_human,801,C,I,lactisole,PubChem CID,23670520,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - Ca2+ accumulation,0.1,mM,=,,0.3,-3.003,,,aspartame,0.0,0.0,,0.0,,Q7RTX0,0.5110386078274125
164,10.1186/1472-6807-7-66,ts1r3_human,801,C,I,NHDC,PubChem CID,30231,Allosteric agonist,EC50,Functional - Ca2+ accumulation,0.1,mM,=,,1.6,-16.129,,,,0.0,0.0,,0.0,70.0,Q7RTX0,0.5110386078274125
142,10.1186/1472-6807-7-66,ts1r3_human,636,Q,A,NHDC,PubChem CID,30231,Allosteric agonist,EC50,Functional - Ca2+ accumulation,0.1,mM,=,,0.3,-3.003,,,,0.0,0.0,,0.0,61.0,Q7RTX0,0.5689291513342579
143,10.1186/1472-6807-7-66,ts1r3_human,637,Q,E,NHDC,PubChem CID,30231,Allosteric agonist,EC50,Functional - Ca2+ accumulation,0.1,mM,=,,1.5,-14.925,,,,0.0,0.0,,0.0,51.0,Q7RTX0,0.4175418169209727
145,10.1186/1472-6807-7-66,ts1r3_human,641,H,A,NHDC,PubChem CID,30231,Allosteric agonist,EC50,Functional - Ca2+ accumulation,0.1,mM,=,,1.2,-12.048,,,,0.0,0.0,,0.0,57.0,Q7RTX0,0.5199184985789644
148,10.1186/1472-6807-7-66,ts1r3_human,721,H,A,NHDC,PubChem CID,30231,Allosteric agonist,EC50,Functional - Ca2+ accumulation,0.1,mM,=,,0.8,-8.0,,,,0.0,0.0,,0.0,66.0,Q7RTX0,0.3808532056881165
151,10.1186/1472-6807-7-66,ts1r3_human,725,R,M,NHDC,PubChem CID,30231,Allosteric agonist,EC50,Functional - Ca2+ accumulation,0.1,mM,=,,1.3,-12.987,,,,0.0,0.0,,0.0,64.0,Q7RTX0,0.3454255055581167
153,10.1186/1472-6807-7-66,ts1r3_human,729,S,A,NHDC,PubChem CID,30231,Allosteric agonist,EC50,Functional - Ca2+ accumulation,0.1,mM,=,,0.2,-2.0,,,,0.0,0.0,,0.0,80.0,Q7RTX0,0.3889325176860853
157,10.1186/1472-6807-7-66,ts1r3_human,775,W,A,NHDC,PubChem CID,30231,Allosteric agonist,EC50,Functional - Ca2+ accumulation,0.1,mM,>,,3.0,-30.303,,,,0.0,0.0,,0.0,30.0,Q7RTX0,0.7923941287472823
159,10.1186/1472-6807-7-66,ts1r3_human,779,V,A,NHDC,PubChem CID,30231,Allosteric agonist,EC50,Functional - Ca2+ accumulation,0.1,mM,=,,0.2,-2.0,,,,0.0,0.0,,0.0,88.0,Q7RTX0,0.4505643226677126
163,10.1186/1472-6807-7-66,ts1r3_human,800,L,F,NHDC,PubChem CID,30231,Allosteric agonist,EC50,Functional - Ca2+ accumulation,0.1,mM,=,,0.2,-2.0,,,,0.0,0.0,,0.0,91.0,Q7RTX0,0.3643723504616036
166,10.1186/1472-6807-7-66,ts1r3_human,804,G,A,NHDC,PubChem CID,30231,Allosteric agonist,EC50,Functional - Ca2+ accumulation,0.1,mM,=,,1.3,-12.987,,,,0.0,0.0,,0.0,53.0,Q7RTX0,0.378959411916853
27,10807903,drd5_human,439,Q,A,NPA,ChEMBL Compound ID,CHEMBL225230,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,429.0,nM,=,,144.0,2.979,,,[3H]SCH23390,0.0,0.0,,0.0,,P21918,0.4095699576035236
29,10807903,drd5_human,439,Q,A,SKF-38393,ChEMBL Compound ID,CHEMBL24077,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,62.0,nM,=,,51.0,1.216,,,[3H]SCH23390,0.0,0.0,,0.0,,P21918,0.4095699576035236
31,10807903,drd5_human,439,Q,A,"6,7-ADTN",ChEMBL Compound ID,CHEMBL26736,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,568.0,nM,=,,91.0,6.242,,,[3H]SCH23390,0.0,0.0,,0.0,,P21918,0.4095699576035236
35,10807903,drd5_human,439,Q,A,Apomorphine,ChEMBL Compound ID,CHEMBL53,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,125.0,nM,=,,56.0,2.232,,,[3H]SCH23390,0.0,0.0,,0.0,,P21918,0.4095699576035236
37,10807903,drd5_human,439,Q,A,Haloperidol,ChEMBL Compound ID,CHEMBL54,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,81.0,nM,=,,47.0,1.723,,,[3H]SCH23390,0.0,0.0,,0.0,,P21918,0.4095699576035236
39,10807903,drd5_human,439,Q,A,Flupenthixol,ChEMBL Compound ID,CHEMBL54661,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,9.0,nM,=,,6.0,1.5,,,[3H]SCH23390,0.0,0.0,,0.0,,P21918,0.4095699576035236
41,10807903,drd5_human,439,Q,A,SKF-82526,ChEMBL Compound ID,CHEMBL588,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,8.0,nM,=,,4.0,2.0,,,[3H]SCH23390,0.0,0.0,,0.0,,P21918,0.4095699576035236
45,10807903,drd5_human,439,Q,A,Dopamine,ChEMBL Compound ID,CHEMBL59,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,220.0,nM,=,,62.0,3.548,,,[3H]SCH23390,0.0,0.0,,0.0,,P21918,0.4095699576035236
47,10807903,drd5_human,439,Q,A,[3H]SCH-23390,ChEMBL Compound ID,CHEMBL62,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,415.0,pM,=,,487.0,-1.174,,,,138.0,0.0,,0.0,,P21918,0.4095699576035236
49,10807903,drd5_human,439,Q,A,SCH-23390,ChEMBL Compound ID,CHEMBL62,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.401,nM,=,,0.354,1.133,,,[3H]SCH23390,0.0,0.0,,0.0,,P21918,0.4095699576035236
51,10807903,drd5_human,439,Q,A,Chlorpromazine,ChEMBL Compound ID,CHEMBL71,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,75.0,nM,=,,28.0,2.679,,,[3H]SCH23390,0.0,0.0,,0.0,,P21918,0.4095699576035236
55,10807903,drd5_human,439,Q,A,Butaclamol,ChEMBL Compound ID,CHEMBL8514,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,18.0,nM,=,,15.0,1.2,,,[3H]SCH23390,0.0,0.0,,0.0,,P21918,0.4095699576035236
33,8910419,drd5_human,288,I,F,[125I]CH23982,ChEMBL Compound ID,CHEMBL290118,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,0.6,nM,~,,0.6,1.0,,,,100.0,0.0,,0.0,,P21918,0.2897483755487284
43,8910419,drd5_human,288,I,F,Dopamine,ChEMBL Compound ID,CHEMBL59,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,1470.0,nM,=,,4085.0,-2.778,,,[125I]CH23982,0.0,0.0,,0.0,,P21918,0.2897483755487284
53,8910419,drd5_human,288,I,F,Butaclamol,ChEMBL Compound ID,CHEMBL8514,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,46.0,nM,=,,47.0,-1.021,,,[125I]CH23982,0.0,0.0,,0.0,,P21918,0.2897483755487284
34,8910419,drd5_human,290,K,R,[125I]CH23982,ChEMBL Compound ID,CHEMBL290118,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,0.6,nM,~,,0.6,1.0,,,,100.0,0.0,,0.0,,P21918,0.4063114759759306
44,8910419,drd5_human,290,K,R,Dopamine,ChEMBL Compound ID,CHEMBL59,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,1470.0,nM,=,,1330.0,1.105,,,[125I]CH23982,0.0,0.0,,0.0,,P21918,0.4063114759759306
54,8910419,drd5_human,290,K,R,Butaclamol,ChEMBL Compound ID,CHEMBL8514,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,46.0,nM,=,,45.0,1.022,,,[125I]CH23982,0.0,0.0,,0.0,,P21918,0.4063114759759306
0,10.1124/jpet.109.156687,p2y12_human,101,S,A,2-methylthio-ADP,CID,121990,Agonist,pIC50,CRE-luciferase,9.0,,=,,9.2,1.585,,,,0.0,0.0,,0.0,,Q9H244,0.4422235121364753
1,10.1124/jpet.109.156687,p2y12_human,101,S,A,PSB-0739,CID,44583582,Antagonist,pK(d),CRE-luciferase,9.8,,=,,9.4,-2.513,,,,0.0,0.0,,0.0,,Q9H244,0.4422235121364753
2,10.1124/jpet.109.156687,p2y12_human,101,S,A,Reactive red,CID,6509445,Antagonist,pK(b),CRE-luciferase,6.5,,=,,6.6,1.259,,,,0.0,0.0,,0.0,,Q9H244,0.4422235121364753
3,10.1124/jpet.109.156687,p2y12_human,101,S,A,Suramin,CID,5361,Antagonist,pK(b),CRE-luciferase,5.5,,=,,5.5,1.0,,,,0.0,0.0,,0.0,,Q9H244,0.4422235121364753
4,10.1124/jpet.109.156687,p2y12_human,101,S,A,BAY-9421,SMILES,c1ccc(c(c1)C(=O)Nc2cc(cc3c2c(cc(c3)S(=O)(=O)[O-])O)S(=O)(=O)[O-])Nc4nc(nc(n4)Cl)Nc5ccccc5C(=O)Nc6cc(cc7c6c(cc(c7)S(=O)(=O)[O-])O)S(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+],Antagonist,pK(b),CRE-luciferase,5.9,,=,,6.2,1.995,,,,0.0,0.0,,0.0,,Q9H244,0.4422235121364753
17,10.1111/jth.12719,p2y12_human,101,S,A,Ticagrelor,CID,9871419,Antagonist,pK(b),cAMP accumulation,8.59,,=,,8.78,1.549,,,,0.0,0.0,,0.0,,Q9H244,0.4422235121364753
26,10.1016/j.bcp.2008.08.029,p2y12_human,101,S,A,2-methylthio-ADP,CID,121990,Agonist,pIC50,cAMP accumulation,9.5,,=,,8.9,-3.984,,,,95.5,0.0,,0.0,,Q9H244,0.4422235121364753
27,10.1016/j.bcp.2008.08.029,p2y12_human,101,S,A,Cangrelor,CID,9854012,Antagonist,pK(b),cAMP accumulation,9.2,,=,,9.1,-1.259,,,,0.0,0.0,,0.0,,Q9H244,0.4422235121364753
28,10.1016/j.bcp.2008.08.029,p2y12_human,101,S,A,2-methylthio-ADP,CID,121990,Agonist,IC50,CRE-luciferase,1.4,nM,=,,0.8,1.75,,,,0.0,0.0,,0.0,,Q9H244,0.4422235121364753
29,10.1016/j.bcp.2008.08.029,p2y12_human,101,S,A,2-methylthio-ADP,CID,121990,Agonist,EC50,SRE-luciferase,3.5,nM,=,,2.9,1.207,,,,0.0,0.0,,0.0,,Q9H244,0.4422235121364753
30,10.1016/j.bcp.2008.08.029,p2y12_human,101,S,A,Reactive blue 2,SMILES,c1ccc2c(c1)C(=O)c3c(cc(c(c3C2=O)N)S(=O)(=O)[O-])Nc4ccc(c(c4)S(=O)(=O)[O-])Nc5nc(nc(n5)Cl)Nc6cccc(c6)S(=O)(=O)[O-].[Na+].[Na+].[Na+],Antagonist,pK(b),CRE-luciferase,7.4,,=,,7.6,1.585,,,,0.0,0.0,,0.0,,Q9H244,0.4422235121364753
5,10.1124/jpet.109.156687,p2y12_human,256,R,A,2-methylthio-ADP,CID,121990,Agonist,pIC50,CRE-luciferase,9.0,,=,,8.4,-3.984,,,,0.0,0.0,,0.0,,Q9H244,0.5141800108705523
6,10.1124/jpet.109.156687,p2y12_human,256,R,A,Reactive blue 2 meta,SMILES,c1ccc2c(c1)C(=O)c3c(cc(c(c3C2=O)N)S(=O)(=O)[O-])Nc4ccc(c(c4)S(=O)(=O)[O-])Nc5nc(nc(n5)Cl)Nc6cccc(c6)S(=O)(=O)[O-].[Na+].[Na+].[Na+],Antagonist,pK(b),CRE-luciferase,7.8,,=,,7.0,-6.329,,,,0.0,0.0,,0.0,,Q9H244,0.5141800108705523
7,10.1124/jpet.109.156687,p2y12_human,256,R,A,Reactive blue 2 para,SMILES,c1ccc2c(c1)C(=O)c3c(cc(c(c3C2=O)N)S(=O)(=O)[O-])Nc4ccc(c(c4)S(=O)(=O)[O-])Nc5nc(nc(n5)Cl)Nc6cccc(c6)S(=O)(=O)[O-].[Na+].[Na+].[Na+],Antagonist,pK(b),CRE-luciferase,7.3,,=,,6.7,-3.984,,,,0.0,0.0,,0.0,,Q9H244,0.5141800108705523
8,10.1124/jpet.109.156687,p2y12_human,256,R,A,Cibacron blue 3GA,CID,172469,Antagonist,pK(b),CRE-luciferase,7.2,,=,,5.7,-31.25,,,,0.0,0.0,,0.0,,Q9H244,0.5141800108705523
9,10.1124/jpet.109.156687,p2y12_human,256,R,A,MG 38-1,SMILES,c1ccc2c(c1)C(=O)c3c(cc(c(c3C2=O)N)S(=O)(=O)[O-])Nc4ccc(c(c4)S(=O)(=O)[O-])N.[Na+].[Na+],Antagonist,pK(b),CRE-luciferase,5.9,,=,,4.8,-12.658,,,,0.0,0.0,,0.0,,Q9H244,0.5141800108705523
10,10.1124/jpet.109.156687,p2y12_human,256,R,A,PSB-0739,CID,44583582,Antagonist,pK(d),CRE-luciferase,9.8,,=,,9.1,-5.0,,,,0.0,0.0,,0.0,,Q9H244,0.5141800108705523
11,10.1124/jpet.109.156687,p2y12_human,256,R,A,PSB-0801,SMILES,Cc1cc(c2c(c1N)C(=O)c3ccccc3C2=O)Nc4ccc(c(c4)S(=O)(=O)[O-])Nc5ccccc5.[Na+],Antagonist,pK(b),CRE-luciferase,7.4,,=,,6.7,-5.0,,,,0.0,0.0,,0.0,,Q9H244,0.5141800108705523
12,10.1124/jpet.109.156687,p2y12_human,256,R,A,PSB-0826,SMILES,c1ccc(cc1)Nc2ccc(cc2)Nc3cc(c(c4c3C(=O)c5ccccc5C4=O)N)S(=O)(=O)[O-].[Na+],Antagonist,pK(b),CRE-luciferase,8.4,,=,,8.3,-1.259,,,,0.0,0.0,,0.0,,Q9H244,0.5141800108705523
13,10.1124/jpet.109.156687,p2y12_human,256,R,A,Reactive red 2,CID,6509445,Antagonist,pK(b),CRE-luciferase,6.5,,=,,6.5,1.0,,,,0.0,0.0,,0.0,,Q9H244,0.5141800108705523
14,10.1124/jpet.109.156687,p2y12_human,256,R,A,Suramin,CID,5361,Antagonist,pK(b),CRE-luciferase,5.5,,=,,5.2,-1.996,,,,0.0,0.0,,0.0,,Q9H244,0.5141800108705523
15,10.1124/jpet.109.156687,p2y12_human,256,R,A,BAY-9421,SMILES,c1ccc(c(c1)C(=O)Nc2cc(cc3c2c(cc(c3)S(=O)(=O)[O-])O)S(=O)(=O)[O-])Nc4nc(nc(n4)Cl)Nc5ccccc5C(=O)Nc6cc(cc7c6c(cc(c7)S(=O)(=O)[O-])O)S(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+],Antagonist,pK(b),CRE-luciferase,5.9,,=,,5.9,1.0,,,,0.0,0.0,,0.0,,Q9H244,0.5141800108705523
16,10.1124/jpet.109.156687,p2y12_human,256,R,A,Cangrelor,CID,9854012,Antagonist,pK(b),CRE-luciferase,8.6,,=,,8.5,-1.259,,,,0.0,0.0,,0.0,,Q9H244,0.5141800108705523
24,10.1111/jth.12719,p2y12_human,256,R,A,2-methylthio-ADP,CID,121990,Agonist,EC50,cAMP accumulation,1.04,nM,=,,9.4,-9.009,,,,0.0,0.0,,0.0,,Q9H244,0.5141800108705523
25,10.1111/jth.12719,p2y12_human,256,R,A,Ticagrelor,CID,9871419,Antagonist,pK(b),cAMP accumulation,8.59,,=,,8.64,1.122,,,,0.0,0.0,,0.0,,Q9H244,0.5141800108705523
33,10.1016/j.bcp.2008.08.029,p2y12_human,256,R,A,2-methylthio-ADP,CID,121990,Agonist,pIC50,cAMP accumulation,9.5,,=,,7.6,-76.923,,,,95.5,0.0,,0.0,,Q9H244,0.5141800108705523
34,10.1016/j.bcp.2008.08.029,p2y12_human,256,R,A,Cangrelor,CID,9854012,Antagonist,pK(b),cAMP accumulation,9.2,,=,,9.2,1.0,,,,0.0,0.0,,0.0,,Q9H244,0.5141800108705523
35,10.1016/j.bcp.2008.08.029,p2y12_human,256,R,A,2-methylthio-ADP,CID,121990,Agonist,IC50,CRE-luciferase,1.4,nM,=,,9.0,-6.41,,,,0.0,0.0,,0.0,,Q9H244,0.5141800108705523
36,10.1016/j.bcp.2008.08.029,p2y12_human,256,R,A,2-methylthio-ADP,CID,121990,Agonist,EC50,SRE-luciferase,3.5,nM,=,,6.2,-1.77,,,,0.0,0.0,,0.0,,Q9H244,0.5141800108705523
37,10.1016/j.bcp.2008.08.029,p2y12_human,256,R,A,Reactive blue 2,SMILES,c1ccc2c(c1)C(=O)c3c(cc(c(c3C2=O)N)S(=O)(=O)[O-])Nc4ccc(c(c4)S(=O)(=O)[O-])Nc5nc(nc(n5)Cl)Nc6cccc(c6)S(=O)(=O)[O-].[Na+].[Na+].[Na+],Antagonist,pK(b),cAMP accumulation,7.6,,=,,6.7,-7.937,,,,0.0,0.0,,0.0,,Q9H244,0.5141800108705523
38,10.1016/j.bcp.2008.08.029,p2y12_human,256,R,A,Reactive blue 2,SMILES,c1ccc2c(c1)C(=O)c3c(cc(c(c3C2=O)N)S(=O)(=O)[O-])Nc4ccc(c(c4)S(=O)(=O)[O-])Nc5nc(nc(n5)Cl)Nc6cccc(c6)S(=O)(=O)[O-].[Na+].[Na+].[Na+],Antagonist,pK(b),CRE-luciferase,7.4,,=,,5.9,-31.25,,,,0.0,0.0,,0.0,,Q9H244,0.5141800108705523
18,10.1111/jth.12719,p2y12_human,194,C,A,2-methylthio-ADP,CID,121990,Agonist,EC50,cAMP accumulation,1.04,nM,=,,2.5,-2.404,,,,97.8,0.0,,0.0,,Q9H244,0.404450681575551
19,10.1111/jth.12719,p2y12_human,194,C,A,2-methylthio-ADP,CID,121990,Agonist,EC50,CRE-luciferase,0.52,nM,=,,1.13,-2.174,,,,0.0,0.0,,0.0,,Q9H244,0.404450681575551
20,10.1111/jth.12719,p2y12_human,194,C,A,Ticagrelor,CID,9871419,Antagonist,pK(b),CRE-luciferase,8.95,,=,,8.12,-6.757,,,,0.0,0.0,,0.0,,Q9H244,0.404450681575551
21,10.1111/jth.12719,p2y12_human,194,C,A,Reactive blue 2,SMILES,c1ccc2c(c1)C(=O)c3c(cc(c(c3C2=O)N)S(=O)(=O)[O-])Nc4ccc(c(c4)S(=O)(=O)[O-])Nc5nc(nc(n5)Cl)Nc6cccc(c6)S(=O)(=O)[O-].[Na+].[Na+].[Na+],Antagonist,pK(b),CRE-luciferase,9.64,,=,,10.2,3.631,,,,0.0,0.0,,0.0,,Q9H244,0.404450681575551
22,10.1111/jth.12719,p2y12_human,194,C,A,PSB-0739,CID,44583582,Antagonist,pK(b),CRE-luciferase,7.72,,=,,8.88,14.454,,,,0.0,0.0,,0.0,,Q9H244,0.404450681575551
23,10.1111/jth.12719,p2y12_human,248,C,A,Ticagrelor,CID,9871419,Antagonist,pK(b),cAMP accumulation,8.59,,=,,8.55,-1.096,,,,0.0,0.0,,0.0,,Q9H244,0.4823767727431639
31,10.1016/j.bcp.2008.08.029,p2y12_human,256,R,K,2-methylthio-ADP,CID,121990,Agonist,pIC50,cAMP accumulation,9.5,,=,,9.7,1.585,,,,94.0,0.0,,0.0,,Q9H244,0.3814565163267024
32,10.1016/j.bcp.2008.08.029,p2y12_human,256,R,K,Cangrelor,CID,9854012,Antagonist,pK(b),cAMP accumulation,9.2,,=,,8.9,-1.996,,,,0.0,0.0,,0.0,,Q9H244,0.3814565163267024
304,10510435,adrb2_human,203,S,A,Para-hydroxyl isoprenaline,ChEMBL Compound ID,CHEMBL109378,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,3.4,ÂµM,=,,2.4,1.417,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.4411522003628514
356,10510435,adrb2_human,203,S,A,(-)-isoproterenol,ChEMBL Compound ID,CHEMBL1160723,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.21,ÂµM,=,,2.9,-13.889,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.4411522003628514
375,10964911,adrb2_human,203,S,A,Phenylephrine,ChEMBL Compound ID,CHEMBL1215,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.5,,=,,4.81,-4.902,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.4411522003628514
381,10964911,adrb2_human,203,S,A,Halostachine,ChEMBL Compound ID,CHEMBL1241267,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.92,,=,,5.51,3.89,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.4411522003628514
419,10964911,adrb2_human,203,S,A,Epinephrine,ChEMBL Compound ID,CHEMBL1740,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.9,,=,,5.5,-25.0,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.4411522003628514
432,10964911,adrb2_human,203,S,A,Alprenolol,ChEMBL Compound ID,CHEMBL266195,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,10.17,,=,,10.33,1.445,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.4411522003628514
441,10964911,adrb2_human,203,S,A,Propranolol,ChEMBL Compound ID,CHEMBL27,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.87,,=,,10.92,11.22,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.4411522003628514
455,10510435,adrb2_human,203,S,A,Meta-hydroxyl isoprenaline,ChEMBL Compound ID,CHEMBL327122,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,2.2,ÂµM,=,,8.3,-3.774,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.4411522003628514
458,10964911,adrb2_human,203,S,A,Synephrine,ChEMBL Compound ID,CHEMBL33720,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.83,,=,,5.48,4.467,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.4411522003628514
468,10964911,adrb2_human,203,S,A,CGP-12177,ChEMBL Compound ID,CHEMBL420746,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.88,,=,,9.34,-3.472,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.4411522003628514
577,10964911,adrb2_human,203,S,A,Pindolol,ChEMBL Compound ID,CHEMBL500,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,10.16,,=,,8.77,-24.39,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.4411522003628514
614,10510435,adrb2_human,203,S,A,[125I]iodocyanopindolol,PubChem CID,73754996,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,24.4,pM,=,,46.1,-1.89,,,[125I]iodocyanopindolol (radioligand),25.5,0.0,,0.0,,P07550,0.4411522003628514
305,10510435,adrb2_human,204,S,A,Para-hydroxyl isoprenaline,ChEMBL Compound ID,CHEMBL109378,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,3.4,ÂµM,=,,5.6,-1.647,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.4318560180270306
307,9249239,adrb2_human,204,S,A,TA-2005,ChEMBL Compound ID,CHEMBL1094785,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,12.0,nM,=,,671.0,-55.556,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.4318560180270306
331,9249239,adrb2_human,204,S,A,(-)-Isoprenaline,ChEMBL Compound ID,CHEMBL1160723,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,904.0,nM,=,,24100.0,-26.316,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.4318560180270306
357,10510435,adrb2_human,204,S,A,(-)-isoproterenol,ChEMBL Compound ID,CHEMBL1160723,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.21,ÂµM,=,,6.9,-33.333,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.4318560180270306
379,10964911,adrb2_human,204,S,A,Phenylephrine,ChEMBL Compound ID,CHEMBL1215,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.5,,=,,4.68,-6.623,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.4318560180270306
385,10964911,adrb2_human,204,S,A,Halostachine,ChEMBL Compound ID,CHEMBL1241267,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.92,,=,,4.3,-4.167,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.4318560180270306
386,9249239,adrb2_human,204,S,A,Salmeterol,ChEMBL Compound ID,CHEMBL1263,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,21.0,nM,=,,66.2,-3.155,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.4318560180270306
423,10964911,adrb2_human,204,S,A,Epinephrine,ChEMBL Compound ID,CHEMBL1740,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.9,,=,,5.37,-33.333,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.4318560180270306
456,10510435,adrb2_human,204,S,A,Meta-hydroxyl isoprenaline,ChEMBL Compound ID,CHEMBL327122,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,2.2,ÂµM,=,,14.8,-6.711,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.4318560180270306
462,10964911,adrb2_human,204,S,A,Synephrine,ChEMBL Compound ID,CHEMBL33720,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.83,,=,,4.84,1.023,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.4318560180270306
494,10617695,adrb2_human,204,S,A,Isoproterenol,ChEMBL Compound ID,CHEMBL434,Binding - unknown pharmacological activity,K(d),Binding - Radioligand competition/displacement,199.526231,nM,=,,5011.872336,-25.0,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.4318560180270306
597,9249239,adrb2_human,204,S,A,Salbutamol,ChEMBL Compound ID,CHEMBL714,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,3340.0,nM,=,,8080.0,-2.421,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.4318560180270306
615,10510435,adrb2_human,204,S,A,[125I]iodocyanopindolol,PubChem CID,73754996,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,24.4,pM,=,,17.9,1.363,,,[125I]iodocyanopindolol (radioligand),63.1,0.0,,0.0,,P07550,0.4318560180270306
306,10510435,adrb2_human,207,S,A,Para-hydroxyl isoprenaline,ChEMBL Compound ID,CHEMBL109378,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,3.4,ÂµM,=,,2.5,1.36,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.4355229946451935
358,10510435,adrb2_human,207,S,A,(-)-isoproterenol,ChEMBL Compound ID,CHEMBL1160723,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.21,ÂµM,=,,2.3,-10.989,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.4355229946451935
457,10510435,adrb2_human,207,S,A,Meta-hydroxyl isoprenaline,ChEMBL Compound ID,CHEMBL327122,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,2.2,ÂµM,=,,1.4,1.571,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.4355229946451935
496,10617695,adrb2_human,207,S,A,Isoproterenol,ChEMBL Compound ID,CHEMBL434,Binding - unknown pharmacological activity,K(d),Binding - Radioligand competition/displacement,199.526231,nM,=,,3162.27766,-15.873,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.4355229946451935
497,10617695,adrb2_human,207,S,A,Isoproterenol,ChEMBL Compound ID,CHEMBL434,Binding - unknown pharmacological activity,K(d),Binding - Radioligand competition/displacement,199.526231,nM,=,,3981.071706,-20.0,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.4355229946451935
616,10510435,adrb2_human,207,S,A,[125I]iodocyanopindolol,PubChem CID,73754996,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,24.4,pM,=,,20.2,1.208,,,[125I]iodocyanopindolol (radioligand),57.2,0.0,,0.0,,P07550,0.4355229946451935
308,9443940,adrb2_human,306,E,A,TA-2005,ChEMBL Compound ID,CHEMBL1094785,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,4.3,nM,=,,4.7,-1.093,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.2455866206714706
387,9765503,adrb2_human,306,E,A,salmeterol,ChEMBL Compound ID,CHEMBL1263,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,1.584893,nM,=,,3.162278,-1.996,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.2455866206714706
514,9443940,adrb2_human,306,E,A,Isoproterenol,ChEMBL Compound ID,CHEMBL434,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,240.0,nM,=,,200.0,1.2,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.2455866206714706
620,9443940,adrb2_human,306,E,A,[125I]iodocyanopindolol,PubChem CID,73754996,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,31.0,pM,=,,33.0,-1.065,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.2455866206714706
621,9765503,adrb2_human,306,E,A,[125I]iodocyanopindolol,PubChem CID,73754996,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,23.2,pM,=,,22.3,1.04,,,[125I]iodocyanopindolol (radioligand),4.5,0.0,,0.0,,P07550,0.2455866206714706
309,9443940,adrb2_human,307,V,A,TA-2005,ChEMBL Compound ID,CHEMBL1094785,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,4.3,nM,=,,6.3,-1.464,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.3125185948185094
388,9765503,adrb2_human,307,V,A,salmeterol,ChEMBL Compound ID,CHEMBL1263,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,1.584893,nM,=,,2.3,-1.451,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.3125185948185094
515,9443940,adrb2_human,307,V,A,Isoproterenol,ChEMBL Compound ID,CHEMBL434,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,240.0,nM,=,,330.0,-1.376,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.3125185948185094
622,9443940,adrb2_human,307,V,A,[125I]iodocyanopindolol,PubChem CID,73754996,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,31.0,pM,=,,35.0,-1.129,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.3125185948185094
623,9765503,adrb2_human,307,V,A,[125I]iodocyanopindolol,PubChem CID,73754996,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,23.2,pM,=,,22.8,1.018,,,[125I]iodocyanopindolol (radioligand),59.1,0.0,,0.0,,P07550,0.3125185948185094
310,9443940,adrb2_human,308,Y,A,TA-2005,ChEMBL Compound ID,CHEMBL1094785,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,4.3,nM,=,,71.0,-16.393,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.436953387820263
389,9765503,adrb2_human,308,Y,A,salmeterol,ChEMBL Compound ID,CHEMBL1263,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,1.584893,nM,=,,184.0,-111.111,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.436953387820263
390,9765503,adrb2_human,308,Y,A,salmeterol,ChEMBL Compound ID,CHEMBL1263,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,1.584893,nM,=,,184.0,-111.111,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.436953387820263
426,9765503,adrb2_human,308,Y,A,Salmeterol-derivative 3,ChEMBL Compound ID,CHEMBL1800935,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,220.0,nM,=,,1300.0,-5.917,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.436953387820263
516,9443940,adrb2_human,308,Y,A,Isoproterenol,ChEMBL Compound ID,CHEMBL434,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,240.0,nM,=,,1300.0,-5.405,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.436953387820263
624,9443940,adrb2_human,308,Y,A,[125I]iodocyanopindolol,PubChem CID,73754996,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,31.0,pM,=,,27.0,1.148,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.436953387820263
625,9765503,adrb2_human,308,Y,A,[125I]iodocyanopindolol,PubChem CID,73754996,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,23.2,pM,=,,24.2,-1.043,,,[125I]iodocyanopindolol (radioligand),93.2,0.0,,0.0,,P07550,0.436953387820263
626,9765503,adrb2_human,308,Y,A,[125I]iodocyanopindolol,PubChem CID,73754996,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,31.2,pM,=,,29.8,1.047,,,[125I]iodocyanopindolol (radioligand),127.3,0.0,,0.0,,P07550,0.436953387820263
650,9765503,adrb2_human,308,Y,A,Salmeterol-derivative 2,SMILES,OCC1=C(O)C=CC([C@@H](CNCCCCCCCCOCCC2=CC=CC=C2)O)=C1,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,96.0,nM,=,,1400.0,-14.493,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.436953387820263
652,9765503,adrb2_human,308,Y,A,Salmeterol-derivative 1,SMILES,OCC1=C(O)C=CC([C@@H](CNCCCCOCCCCCCC2=CC=CC=C2)O)=C1,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,50.118723,nM,=,,542.0,-10.87,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.436953387820263
311,9443940,adrb2_human,309,I,A,TA-2005,ChEMBL Compound ID,CHEMBL1094785,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,4.3,nM,=,,21.0,-4.878,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.3563918184891397
391,9765503,adrb2_human,309,I,A,salmeterol,ChEMBL Compound ID,CHEMBL1263,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,1.584893,nM,=,,24.0,-15.152,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.3563918184891397
392,9765503,adrb2_human,309,I,A,salmeterol,ChEMBL Compound ID,CHEMBL1263,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,1.584893,nM,=,,18.7,-11.765,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.3563918184891397
427,9765503,adrb2_human,309,I,A,Salmeterol-derivative 3,ChEMBL Compound ID,CHEMBL1800935,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,220.0,nM,=,,3370.0,-15.385,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.3563918184891397
517,9443940,adrb2_human,309,I,A,Isoproterenol,ChEMBL Compound ID,CHEMBL434,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,240.0,nM,=,,360.0,-1.499,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.3563918184891397
627,9443940,adrb2_human,309,I,A,[125I]iodocyanopindolol,PubChem CID,73754996,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,31.0,pM,=,,34.0,-1.096,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.3563918184891397
628,9765503,adrb2_human,309,I,A,[125I]iodocyanopindolol,PubChem CID,73754996,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,23.2,pM,=,,26.6,-1.147,,,[125I]iodocyanopindolol (radioligand),75.0,0.0,,0.0,,P07550,0.3563918184891397
629,9765503,adrb2_human,309,I,A,[125I]iodocyanopindolol,PubChem CID,73754996,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,31.2,pM,=,,34.0,-1.089,,,[125I]iodocyanopindolol (radioligand),115.9,0.0,,0.0,,P07550,0.3563918184891397
651,9765503,adrb2_human,309,I,A,Salmeterol-derivative 2,SMILES,OCC1=C(O)C=CC([C@@H](CNCCCCCCCCOCCC2=CC=CC=C2)O)=C1,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,96.0,nM,=,,281.0,-2.924,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.3563918184891397
653,9765503,adrb2_human,309,I,A,Salmeterol-derivative 1,SMILES,OCC1=C(O)C=CC([C@@H](CNCCCCOCCCCCCC2=CC=CC=C2)O)=C1,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,50.118723,nM,=,,133.0,-2.653,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.3563918184891397
312,9443940,adrb2_human,310,L,A,TA-2005,ChEMBL Compound ID,CHEMBL1094785,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,4.3,nM,=,,5.5,-1.279,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.3397768789069698
393,9765503,adrb2_human,310,L,A,salmeterol,ChEMBL Compound ID,CHEMBL1263,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,1.584893,nM,=,,2.0,-1.263,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.3397768789069698
518,9443940,adrb2_human,310,L,A,Isoproterenol,ChEMBL Compound ID,CHEMBL434,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,240.0,nM,=,,280.0,-1.167,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.3397768789069698
630,9443940,adrb2_human,310,L,A,[125I]iodocyanopindolol,PubChem CID,73754996,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,31.0,pM,=,,39.0,-1.258,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.3397768789069698
631,9765503,adrb2_human,310,L,A,[125I]iodocyanopindolol,PubChem CID,73754996,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,23.2,pM,=,,25.7,-1.107,,,[125I]iodocyanopindolol (radioligand),79.5,0.0,,0.0,,P07550,0.3397768789069698
313,9443940,adrb2_human,311,L,A,TA-2005,ChEMBL Compound ID,CHEMBL1094785,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,4.3,nM,=,,12.0,-2.793,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.4936022972747958
394,9765503,adrb2_human,311,L,A,salmeterol,ChEMBL Compound ID,CHEMBL1263,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,1.584893,nM,=,,1.6,-1.009,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.4936022972747958
519,9443940,adrb2_human,311,L,A,Isoproterenol,ChEMBL Compound ID,CHEMBL434,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,240.0,nM,=,,360.0,-1.499,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.4936022972747958
632,9443940,adrb2_human,311,L,A,[125I]iodocyanopindolol,PubChem CID,73754996,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,31.0,pM,=,,28.0,1.107,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.4936022972747958
633,9765503,adrb2_human,311,L,A,[125I]iodocyanopindolol,PubChem CID,73754996,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,23.2,pM,=,,26.1,-1.125,,,[125I]iodocyanopindolol (radioligand),88.6,0.0,,0.0,,P07550,0.4936022972747958
314,9443940,adrb2_human,314,I,A,TA-2005,ChEMBL Compound ID,CHEMBL1094785,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,4.3,nM,=,,3.2,1.344,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.47040420441597
395,9765503,adrb2_human,314,I,A,salmeterol,ChEMBL Compound ID,CHEMBL1263,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,1.584893,nM,=,,2.0,-1.263,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.47040420441597
520,9443940,adrb2_human,314,I,A,Isoproterenol,ChEMBL Compound ID,CHEMBL434,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,240.0,nM,=,,150.0,1.6,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.47040420441597
634,9443940,adrb2_human,314,I,A,[125I]iodocyanopindolol,PubChem CID,73754996,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,31.0,pM,=,,28.0,1.107,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.47040420441597
635,9765503,adrb2_human,314,I,A,[125I]iodocyanopindolol,PubChem CID,73754996,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,23.2,pM,=,,21.5,1.079,,,[125I]iodocyanopindolol (radioligand),65.9,0.0,,0.0,,P07550,0.47040420441597
315,9443940,adrb2_human,317,V,A,TA-2005,ChEMBL Compound ID,CHEMBL1094785,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,4.3,nM,=,,5.9,-1.372,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.4493086944191534
396,9765503,adrb2_human,317,V,A,salmeterol,ChEMBL Compound ID,CHEMBL1263,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,1.584893,nM,=,,2.2,-1.389,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.4493086944191534
521,9443940,adrb2_human,317,V,A,Isoproterenol,ChEMBL Compound ID,CHEMBL434,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,240.0,nM,=,,310.0,-1.292,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.4493086944191534
636,9443940,adrb2_human,317,V,A,[125I]iodocyanopindolol,PubChem CID,73754996,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,31.0,pM,=,,32.0,-1.032,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.4493086944191534
637,9765503,adrb2_human,317,V,A,[125I]iodocyanopindolol,PubChem CID,73754996,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,23.2,pM,=,,25.8,-1.112,,,[125I]iodocyanopindolol (radioligand),81.8,0.0,,0.0,,P07550,0.4493086944191534
316,9443940,adrb2_human,320,G,A,TA-2005,ChEMBL Compound ID,CHEMBL1094785,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,4.3,nM,=,,9.0,-2.092,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.4758789823707009
397,9765503,adrb2_human,320,G,A,salmeterol,ChEMBL Compound ID,CHEMBL1263,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,1.584893,nM,=,,3.0,-1.894,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.4758789823707009
522,9443940,adrb2_human,320,G,A,Isoproterenol,ChEMBL Compound ID,CHEMBL434,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,240.0,nM,=,,480.0,-2.0,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.4758789823707009
638,9443940,adrb2_human,320,G,A,[125I]iodocyanopindolol,PubChem CID,73754996,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,31.0,pM,=,,49.0,-1.58,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.4758789823707009
639,9765503,adrb2_human,320,G,A,[125I]iodocyanopindolol,PubChem CID,73754996,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,23.2,pM,=,,44.7,-1.927,,,[125I]iodocyanopindolol (radioligand),140.9,0.0,,0.0,,P07550,0.4758789823707009
317,9443940,adrb2_human,324,L,A,TA-2005,ChEMBL Compound ID,CHEMBL1094785,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,4.3,nM,=,,21.0,-4.878,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.5090823379774154
398,9765503,adrb2_human,324,L,A,salmeterol,ChEMBL Compound ID,CHEMBL1263,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,1.584893,nM,=,,4.7,-2.967,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.5090823379774154
528,9443940,adrb2_human,324,L,A,Isoproterenol,ChEMBL Compound ID,CHEMBL434,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,240.0,nM,=,,280.0,-1.167,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.5090823379774154
640,9443940,adrb2_human,324,L,A,[125I]iodocyanopindolol,PubChem CID,73754996,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,31.0,pM,=,,36.0,-1.161,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.5090823379774154
641,9765503,adrb2_human,324,L,A,[125I]iodocyanopindolol,PubChem CID,73754996,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,23.2,pM,=,,32.9,-1.418,,,[125I]iodocyanopindolol (radioligand),104.5,0.0,,0.0,,P07550,0.5090823379774154
318,10385699,adrb2_human,130,D,A,[3H]dihydroalprenolol,ChEMBL Compound ID,CHEMBL1159723,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,0.2,nM,=,,0.2,1.0,,,[3H]dihydroalprenolol,41.4,0.0,,0.0,,P07550,0.8087523234538274
346,10385699,adrb2_human,130,D,A,(-)-isoproterenol,ChEMBL Compound ID,CHEMBL1160723,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,278.0,nM,=,,22.2,12.523,,,[3H]dihydroalprenolol,0.0,0.0,,0.0,,P07550,0.8087523234538274
348,10652295,adrb2_human,130,D,A,(-)-isoproterenol,ChEMBL Compound ID,CHEMBL1160723,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,124.0,nM,=,,42.0,2.952,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.8087523234538274
349,10652295,adrb2_human,130,D,A,(-)-isoproterenol,ChEMBL Compound ID,CHEMBL1160723,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,3.0,nM,=,,1.8,1.667,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.8087523234538274
373,10652295,adrb2_human,130,D,A,(-)-alprenolol,ChEMBL Compound ID,CHEMBL1160734,Binding - unknown pharmacological activity,K(d),Binding - Radioligand competition/displacement,0.36,nM,=,,1.3,-3.61,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.8087523234538274
573,10385699,adrb2_human,130,D,A,Pindolol,ChEMBL Compound ID,CHEMBL500,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.93,nM,=,,0.83,1.12,,,[3H]dihydroalprenolol,0.0,0.0,,0.0,,P07550,0.8087523234538274
319,10385699,adrb2_human,130,D,N,[3H]dihydroalprenolol,ChEMBL Compound ID,CHEMBL1159723,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,0.2,nM,=,,0.22,-1.1,,,[3H]dihydroalprenolol,7.1,0.0,,0.0,,P07550,0.711332219828275
344,2840663,adrb2_human,130,D,N,(-)-isoproterenol,ChEMBL Compound ID,CHEMBL1160723,Binding - unknown pharmacological activity,K(d),Binding - Radioligand competition/displacement,17.6,nM,=,,2.5,7.04,,,[125I]iodocyanopindolol,0.0,0.0,,0.0,,P07550,0.711332219828275
345,2840663,adrb2_human,130,D,N,(-)-isoproterenol,ChEMBL Compound ID,CHEMBL1160723,Binding - unknown pharmacological activity,K(d),Binding - Radioligand competition/displacement,120.0,nM,=,,9.3,12.903,,,[125I]iodocyanopindolol,0.0,0.0,,0.0,,P07550,0.711332219828275
347,10385699,adrb2_human,130,D,N,(-)-isoproterenol,ChEMBL Compound ID,CHEMBL1160723,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,278.0,nM,=,,11.5,24.174,,,[3H]dihydroalprenolol,0.0,0.0,,0.0,,P07550,0.711332219828275
401,2840663,adrb2_human,130,D,N,(-)-Norepinephrine,ChEMBL Compound ID,CHEMBL1437,Binding - unknown pharmacological activity,K(d),Binding - Radioligand competition/displacement,219.0,nM,=,,55.0,3.982,,,[125I]iodocyanopindolol,0.0,0.0,,0.0,,P07550,0.711332219828275
447,2840663,adrb2_human,130,D,N,(+)-propranolol,ChEMBL Compound ID,CHEMBL275742,Binding - unknown pharmacological activity,K(d),Binding - Radioligand competition/displacement,36.8,nM,=,,65.0,-1.767,,,[125I]iodocyanopindolol,0.0,0.0,,0.0,,P07550,0.711332219828275
466,11375997,adrb2_human,130,D,N,CGP-12177,ChEMBL Compound ID,CHEMBL420746,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.06,nM,=,,0.06,1.0,,,[3H]CGP-12177 (radioligand),9.1,0.0,,0.0,,P07550,0.711332219828275
474,2840663,adrb2_human,130,D,N,(+)-Epinephrine,ChEMBL Compound ID,CHEMBL42280,Binding - unknown pharmacological activity,K(d),Binding - Radioligand competition/displacement,500.0,nM,=,,75.0,6.667,,,[125I]iodocyanopindolol,0.0,0.0,,0.0,,P07550,0.711332219828275
490,11375997,adrb2_human,130,D,N,Isoproterenol,ChEMBL Compound ID,CHEMBL434,Binding - unknown pharmacological activity,K(d),Binding - Radioligand competition/displacement,45.0,nM,=,,0.398107,113.035,,,[3H]CGP-12177 (radioligand),9.1,0.0,,0.0,,P07550,0.711332219828275
547,2840663,adrb2_human,130,D,N,(-)-propranolol,ChEMBL Compound ID,CHEMBL452861,Binding - unknown pharmacological activity,K(d),Binding - Radioligand competition/displacement,0.22,nM,=,,0.36,-1.637,,,[125I]iodocyanopindolol,0.0,0.0,,0.0,,P07550,0.711332219828275
560,2840663,adrb2_human,130,D,N,(+)-isoproterenol,ChEMBL Compound ID,CHEMBL460574,Binding - unknown pharmacological activity,K(d),Binding - Radioligand competition/displacement,200.0,nM,=,,32.5,6.154,,,[125I]iodocyanopindolol,0.0,0.0,,0.0,,P07550,0.711332219828275
574,10385699,adrb2_human,130,D,N,Pindolol,ChEMBL Compound ID,CHEMBL500,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.93,nM,=,,0.92,1.011,,,[3H]dihydroalprenolol,0.0,0.0,,0.0,,P07550,0.711332219828275
575,11375997,adrb2_human,130,D,N,Pindolol,ChEMBL Compound ID,CHEMBL500,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.06,nM,=,,0.11,-1.835,,,[3H]CGP-12177 (radioligand),9.1,0.0,,0.0,,P07550,0.711332219828275
592,2840663,adrb2_human,130,D,N,(-)-Epinephrine,ChEMBL Compound ID,CHEMBL679,Binding - unknown pharmacological activity,K(d),Binding - Radioligand competition/displacement,56.5,nM,=,,4.3,13.14,,,[125I]iodocyanopindolol,0.0,0.0,,0.0,,P07550,0.711332219828275
607,2840663,adrb2_human,130,D,N,[125I]iodocyanopindolol,PubChem CID,73754996,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,21.0,nM,=,,32.0,-1.524,,,,0.0,0.0,,0.0,,P07550,0.711332219828275
320,12409304,adrb2_human,225,E,A,[3H]dihydroalprenolol,ChEMBL Compound ID,CHEMBL1159723,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,0.54,nM,=,,0.91,-1.686,,,,0.0,0.0,,0.0,,P07550,0.4874783227773758
321,12409304,adrb2_human,225,E,A,[3H]dihydroalprenolol,ChEMBL Compound ID,CHEMBL1159723,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,7.4,nM,=,,2.2,3.364,,,,0.0,0.0,,0.0,,P07550,0.4874783227773758
498,12409304,adrb2_human,225,E,A,Isoproterenol,ChEMBL Compound ID,CHEMBL434,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,110.0,nM,=,,91.0,1.209,,,[3H]dihydroalprenolol,0.0,0.0,,0.0,,P07550,0.4874783227773758
499,12409304,adrb2_human,225,E,A,Isoproterenol,ChEMBL Compound ID,CHEMBL434,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,18.5,nM,=,,35.0,-1.89,,,[3H]dihydroalprenolol,0.0,0.0,,0.0,,P07550,0.4874783227773758
322,12409304,adrb2_human,265,C,A,[3H]dihydroalprenolol,ChEMBL Compound ID,CHEMBL1159723,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,0.54,nM,=,,0.44,1.227,,,,0.0,0.0,,0.0,,P07550,0.2280804411070616
323,12409304,adrb2_human,265,C,A,[3H]dihydroalprenolol,ChEMBL Compound ID,CHEMBL1159723,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,7.4,nM,=,,0.84,8.81,,,,0.0,0.0,,0.0,,P07550,0.2280804411070616
500,12409304,adrb2_human,265,C,A,Isoproterenol,ChEMBL Compound ID,CHEMBL434,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,110.0,nM,=,,60.0,1.833,,,[3H]dihydroalprenolol,0.0,0.0,,0.0,,P07550,0.2280804411070616
501,12409304,adrb2_human,265,C,A,Isoproterenol,ChEMBL Compound ID,CHEMBL434,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,18.5,nM,=,,40.0,-2.16,,,[3H]dihydroalprenolol,0.0,0.0,,0.0,,P07550,0.2280804411070616
324,11118431,adrb2_human,269,H,C,[3H]dihydroalprenolol,ChEMBL Compound ID,CHEMBL1159723,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,0.66,nM,,,0.45,1.467,,,[3H]dihydroalprenolol,44.9,0.0,,0.0,,P07550,0.4862814570259825
505,11118431,adrb2_human,269,H,C,Isoproterenol,ChEMBL Compound ID,CHEMBL434,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.16,ÂµM,,,0.1,1.6,,,[3H]dihydroalprenolol,0.0,0.0,,0.0,,P07550,0.4862814570259825
325,12409304,adrb2_human,269,H,A,[3H]dihydroalprenolol,ChEMBL Compound ID,CHEMBL1159723,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,0.54,nM,=,,1.182,-2.188,,,,0.0,0.0,,0.0,,P07550,0.4415392649305125
326,12409304,adrb2_human,269,H,A,[3H]dihydroalprenolol,ChEMBL Compound ID,CHEMBL1159723,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,7.4,nM,=,,2.0,3.7,,,,0.0,0.0,,0.0,,P07550,0.4415392649305125
506,12409304,adrb2_human,269,H,A,Isoproterenol,ChEMBL Compound ID,CHEMBL434,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,110.0,nM,=,,220.0,-2.0,,,[3H]dihydroalprenolol,0.0,0.0,,0.0,,P07550,0.4415392649305125
507,12409304,adrb2_human,269,H,A,Isoproterenol,ChEMBL Compound ID,CHEMBL434,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,18.5,nM,=,,120.0,-6.494,,,[3H]dihydroalprenolol,0.0,0.0,,0.0,,P07550,0.4415392649305125
328,11118431,adrb2_human,271,A,C,[3H]dihydroalprenolol,ChEMBL Compound ID,CHEMBL1159723,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,0.66,nM,,,0.56,1.179,,,[3H]dihydroalprenolol,110.2,0.0,,0.0,,P07550,0.4854170297909895
509,11118431,adrb2_human,271,A,C,Isoproterenol,ChEMBL Compound ID,CHEMBL434,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.16,ÂµM,,,0.073,2.192,,,[3H]dihydroalprenolol,0.0,0.0,,0.0,,P07550,0.4854170297909895
329,11118431,adrb2_human,272,L,C,[3H]dihydroalprenolol,ChEMBL Compound ID,CHEMBL1159723,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,0.66,nM,,,0.46,1.435,,,[3H]dihydroalprenolol,71.4,0.0,,0.0,,P07550,0.5707895707698581
510,11118431,adrb2_human,272,L,C,Isoproterenol,ChEMBL Compound ID,CHEMBL434,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.16,ÂµM,,,0.043,3.721,,,[3H]dihydroalprenolol,0.0,0.0,,0.0,,P07550,0.5707895707698581
332,9356441,adrb2_human,339,L,A,(-)-Isoprenaline,ChEMBL Compound ID,CHEMBL1160723,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,7.0,nM,=,,7.0,1.0,,,[125I]iodocyanopindolol (radioligand),181.6,0.0,,0.0,,P07550,0.5262407643244872
333,9356441,adrb2_human,339,L,A,(-)-Isoprenaline,ChEMBL Compound ID,CHEMBL1160723,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,323.0,nM,=,,358.0,-1.109,,,[125I]iodocyanopindolol (radioligand),181.6,0.0,,0.0,,P07550,0.5262407643244872
370,9356441,adrb2_human,339,L,A,(-)-isoproterenol,ChEMBL Compound ID,CHEMBL1160723,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,361.0,nM,=,,421.0,-1.167,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.5262407643244872
645,9356441,adrb2_human,339,L,A,[125I]iodocyanopindolol,PubChem CID,73754996,Binding - unknown pharmacological activity,K(d),Binding - Radioligand competition/displacement,44.6,pM,=,,44.0,1.014,,,[125I]iodocyanopindolol (radioligand),181.6,0.0,,0.0,,P07550,0.5262407643244872
646,9356441,adrb2_human,339,L,A,[125I]iodocyanopindolol,PubChem CID,73754996,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,44.6,pM,=,,44.0,1.014,,,[125I]iodocyanopindolol (radioligand),181.6,0.0,,0.0,,P07550,0.5262407643244872
334,9356441,adrb2_human,340,L,A,(-)-Isoprenaline,ChEMBL Compound ID,CHEMBL1160723,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,7.0,nM,=,,5.0,1.4,,,[125I]iodocyanopindolol (radioligand),42.9,0.0,,0.0,,P07550,0.4465555945308595
335,9356441,adrb2_human,340,L,A,(-)-Isoprenaline,ChEMBL Compound ID,CHEMBL1160723,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,323.0,nM,=,,413.0,-1.279,,,[125I]iodocyanopindolol (radioligand),42.9,0.0,,0.0,,P07550,0.4465555945308595
371,9356441,adrb2_human,340,L,A,(-)-isoproterenol,ChEMBL Compound ID,CHEMBL1160723,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,361.0,nM,=,,441.0,-1.221,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.4465555945308595
647,9356441,adrb2_human,340,L,A,[125I]iodocyanopindolol,PubChem CID,73754996,Binding - unknown pharmacological activity,K(d),Binding - Radioligand competition/displacement,44.6,pM,=,,42.7,1.044,,,[125I]iodocyanopindolol (radioligand),42.9,0.0,,0.0,,P07550,0.4465555945308595
648,9356441,adrb2_human,340,L,A,[125I]iodocyanopindolol,PubChem CID,73754996,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,44.6,pM,=,,42.7,1.044,,,[125I]iodocyanopindolol (radioligand),42.9,0.0,,0.0,,P07550,0.4465555945308595
336,2159799,adrb2_human,77,C,V,(-)-isoproterenol,ChEMBL Compound ID,CHEMBL1160723,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.13,nM,=,,0.29,-2.232,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.327791311375485
409,2159799,adrb2_human,77,C,V,epinephrine,ChEMBL Compound ID,CHEMBL1740,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.36,nM,=,,1.1,-3.058,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.327791311375485
476,2159799,adrb2_human,77,C,V,Norepinephrine,ChEMBL Compound ID,CHEMBL432,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,5.8,nM,=,,23.0,-3.968,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.327791311375485
554,2159799,adrb2_human,77,C,V,(+)-isoproterenol,ChEMBL Compound ID,CHEMBL460574,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,3.981072,nM,=,,6.9,-1.733,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.327791311375485
602,2159799,adrb2_human,77,C,V,[125I]iodocyanopindolol,PubChem CID,73754996,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,11.0,pM,=,,13.0,-1.182,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.327791311375485
338,2831218,adrb2_human,79,D,N,(-)-isoproterenol,ChEMBL Compound ID,CHEMBL1160723,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,17.6,nM,=,,697.0,-40.0,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.7495525661182375
380,15102946,adrb2_human,79,D,N,Halostachine,ChEMBL Compound ID,CHEMBL1241267,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.08,,=,,4.32,-5.747,,,[3H]CGP-12177,0.0,0.0,,0.0,,P07550,0.7495525661182375
400,2831218,adrb2_human,79,D,N,(-)-norepinephrine,ChEMBL Compound ID,CHEMBL1437,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,219.0,nM,=,,52500.0,-250.0,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.7495525661182375
410,15102946,adrb2_human,79,D,N,Epinephrine,ChEMBL Compound ID,CHEMBL1740,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.16,,=,,5.32,-71.429,,,[3H]CGP-12177,0.0,0.0,,0.0,,P07550,0.7495525661182375
429,2831218,adrb2_human,79,D,N,(rac)-iodocyanopindolol,ChEMBL Compound ID,CHEMBL210309,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,21.0,nM,=,,22.0,-1.047,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.7495525661182375
446,2831218,adrb2_human,79,D,N,(+)-propranolol,ChEMBL Compound ID,CHEMBL275742,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,36.8,nM,=,,36.8,1.0,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.7495525661182375
454,15102946,adrb2_human,79,D,N,Methyldopamine,ChEMBL Compound ID,CHEMBL31088,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.37,,=,,4.46,-8.13,,,[3H]CGP-12177,0.0,0.0,,0.0,,P07550,0.7495525661182375
477,15102946,adrb2_human,79,D,N,Norepinephrine,ChEMBL Compound ID,CHEMBL432,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.4,,=,,4.21,-15.385,,,[3H]CGP-12177,0.0,0.0,,0.0,,P07550,0.7495525661182375
546,2831218,adrb2_human,79,D,N,(-)-propranolol,ChEMBL Compound ID,CHEMBL452861,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.22,nM,=,,0.22,1.0,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.7495525661182375
556,2831218,adrb2_human,79,D,N,(+)-isoproterenol,ChEMBL Compound ID,CHEMBL460574,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,199.526231,nM,=,,12167.0,-62.5,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.7495525661182375
591,2831218,adrb2_human,79,D,N,(-)-Epinephrine,ChEMBL Compound ID,CHEMBL679,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,56.5,nM,=,,7800.0,-142.857,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.7495525661182375
339,2159799,adrb2_human,106,C,V,(-)-isoproterenol,ChEMBL Compound ID,CHEMBL1160723,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.13,nM,=,,3.5,-27.027,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.7244927032552005
411,2159799,adrb2_human,106,C,V,epinephrine,ChEMBL Compound ID,CHEMBL1740,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.36,nM,=,,471.0,-1000.0,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.7244927032552005
478,2159799,adrb2_human,106,C,V,Norepinephrine,ChEMBL Compound ID,CHEMBL432,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,5.8,nM,=,,110.0,-18.868,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.7244927032552005
557,2159799,adrb2_human,106,C,V,(+)-isoproterenol,ChEMBL Compound ID,CHEMBL460574,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,3.981072,nM,=,,210.0,-52.632,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.7244927032552005
604,2159799,adrb2_human,106,C,V,[125I]iodocyanopindolol,PubChem CID,73754996,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,11.0,pM,=,,173.0,-15.625,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.7244927032552005
340,2159799,adrb2_human,116,C,V,(-)-isoproterenol,ChEMBL Compound ID,CHEMBL1160723,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.13,nM,=,,0.09,1.444,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.5632372829685254
412,2159799,adrb2_human,116,C,V,epinephrine,ChEMBL Compound ID,CHEMBL1740,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.36,nM,=,,0.3,1.2,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.5632372829685254
479,2159799,adrb2_human,116,C,V,Norepinephrine,ChEMBL Compound ID,CHEMBL432,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,5.8,nM,=,,4.2,1.381,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.5632372829685254
558,2159799,adrb2_human,116,C,V,(+)-isoproterenol,ChEMBL Compound ID,CHEMBL460574,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,3.981072,nM,=,,2.4,1.659,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.5632372829685254
605,2159799,adrb2_human,116,C,V,[125I]iodocyanopindolol,PubChem CID,73754996,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,11.0,pM,=,,25.0,-2.273,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.5632372829685254
341,10652295,adrb2_human,122,E,A,(-)-isoproterenol,ChEMBL Compound ID,CHEMBL1160723,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,124.0,nM,=,,712.0,-5.747,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.395532193965949
342,10652295,adrb2_human,122,E,A,(-)-isoproterenol,ChEMBL Compound ID,CHEMBL1160723,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,3.0,nM,=,,5.5,-1.835,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.395532193965949
372,10652295,adrb2_human,122,E,A,(-)-alprenolol,ChEMBL Compound ID,CHEMBL1160734,Binding - unknown pharmacological activity,K(d),Binding - Radioligand competition/displacement,0.36,nM,=,,1.5,-4.167,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.395532193965949
343,2159799,adrb2_human,125,C,V,(-)-isoproterenol,ChEMBL Compound ID,CHEMBL1160723,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.13,nM,=,,0.46,-3.534,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.5604406248746172
414,2159799,adrb2_human,125,C,V,epinephrine,ChEMBL Compound ID,CHEMBL1740,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.36,nM,=,,4.1,-11.364,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.5604406248746172
480,2159799,adrb2_human,125,C,V,Norepinephrine,ChEMBL Compound ID,CHEMBL432,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,5.8,nM,=,,27.0,-4.651,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.5604406248746172
559,2159799,adrb2_human,125,C,V,(+)-isoproterenol,ChEMBL Compound ID,CHEMBL460574,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,3.981072,nM,=,,16.0,-4.016,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.5604406248746172
606,2159799,adrb2_human,125,C,V,[125I]iodocyanopindolol,PubChem CID,73754996,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,11.0,pM,=,,11.0,1.0,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.5604406248746172
350,8799191,adrb2_human,165,S,A,(-)-isoproterenol,ChEMBL Compound ID,CHEMBL1160723,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.28,ÂµM,=,,0.19,1.474,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.4633328572656672
561,8799191,adrb2_human,165,S,A,(+)-isoproterenol,ChEMBL Compound ID,CHEMBL460574,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,10.6,ÂµM,=,,39.8,-3.759,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.4633328572656672
608,8799191,adrb2_human,165,S,A,[125I]iodocyanopindolol,PubChem CID,73754996,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,0.0071,nM,=,,0.012589,-1.773,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.4633328572656672
351,2159799,adrb2_human,184,C,V,(-)-isoproterenol,ChEMBL Compound ID,CHEMBL1160723,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.13,nM,=,,1.8,-13.889,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.3188081068980899
416,2159799,adrb2_human,184,C,V,epinephrine,ChEMBL Compound ID,CHEMBL1740,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.36,nM,=,,15.848932,-43.478,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.3188081068980899
482,2159799,adrb2_human,184,C,V,Norepinephrine,ChEMBL Compound ID,CHEMBL432,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,5.8,nM,=,,320.0,-55.556,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.3188081068980899
562,2159799,adrb2_human,184,C,V,(+)-isoproterenol,ChEMBL Compound ID,CHEMBL460574,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,3.981072,nM,=,,55.0,-13.889,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.3188081068980899
609,2159799,adrb2_human,184,C,V,[125I]iodocyanopindolol,PubChem CID,73754996,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,11.0,pM,=,,47.0,-4.274,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.3188081068980899
352,2159799,adrb2_human,190,C,V,(-)-isoproterenol,ChEMBL Compound ID,CHEMBL1160723,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.13,nM,=,,3.4,-26.316,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.3465867787594514
417,2159799,adrb2_human,190,C,V,epinephrine,ChEMBL Compound ID,CHEMBL1740,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.36,nM,=,,55.0,-142.857,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.3465867787594514
483,2159799,adrb2_human,190,C,V,Norepinephrine,ChEMBL Compound ID,CHEMBL432,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,5.8,nM,=,,130.0,-22.222,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.3465867787594514
563,2159799,adrb2_human,190,C,V,(+)-isoproterenol,ChEMBL Compound ID,CHEMBL460574,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,3.981072,nM,=,,153.0,-38.462,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.3465867787594514
610,2159799,adrb2_human,190,C,V,[125I]iodocyanopindolol,PubChem CID,73754996,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,11.0,pM,=,,124.0,-11.236,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.3465867787594514
354,2159799,adrb2_human,191,C,V,(-)-isoproterenol,ChEMBL Compound ID,CHEMBL1160723,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.13,nM,=,,2.9,-22.222,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.7686326350059927
418,2159799,adrb2_human,191,C,V,epinephrine,ChEMBL Compound ID,CHEMBL1740,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.36,nM,=,,57.0,-166.667,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.7686326350059927
484,2159799,adrb2_human,191,C,V,Norepinephrine,ChEMBL Compound ID,CHEMBL432,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,5.8,nM,=,,120.0,-20.833,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.7686326350059927
565,2159799,adrb2_human,191,C,V,(+)-isoproterenol,ChEMBL Compound ID,CHEMBL460574,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,3.981072,nM,=,,672.0,-166.667,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.7686326350059927
612,2159799,adrb2_human,191,C,V,[125I]iodocyanopindolol,PubChem CID,73754996,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,11.0,pM,=,,167.0,-15.152,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.7686326350059927
359,10652295,adrb2_human,268,E,A,(-)-isoproterenol,ChEMBL Compound ID,CHEMBL1160723,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,124.0,nM,=,,70.0,1.771,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.6197970176213248
360,10652295,adrb2_human,268,E,A,(-)-isoproterenol,ChEMBL Compound ID,CHEMBL1160723,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,3.0,nM,=,,1.3,2.308,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.6197970176213248
374,10652295,adrb2_human,268,E,A,(-)-alprenolol,ChEMBL Compound ID,CHEMBL1160734,Binding - unknown pharmacological activity,K(d),Binding - Radioligand competition/displacement,0.36,nM,=,,1.2,-3.333,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.6197970176213248
472,11375997,adrb2_human,268,E,A,CGP-12177,ChEMBL Compound ID,CHEMBL420746,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.06,nM,=,,0.14,-2.331,,,[3H]CGP-12177 (radioligand),92.4,0.0,,0.0,,P07550,0.6197970176213248
503,11375997,adrb2_human,268,E,A,Isoproterenol,ChEMBL Compound ID,CHEMBL434,Binding - unknown pharmacological activity,K(d),Binding - Radioligand competition/displacement,45.0,nM,=,,16.0,2.812,,,[3H]CGP-12177 (radioligand),92.4,0.0,,0.0,,P07550,0.6197970176213248
581,11375997,adrb2_human,268,E,A,Pindolol,ChEMBL Compound ID,CHEMBL500,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.06,nM,=,,0.2,-3.333,,,[3H]CGP-12177 (radioligand),92.4,0.0,,0.0,,P07550,0.6197970176213248
361,2159799,adrb2_human,285,C,V,(-)-isoproterenol,ChEMBL Compound ID,CHEMBL1160723,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.13,nM,=,,0.04,3.25,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.5482528891175924
424,2159799,adrb2_human,285,C,V,epinephrine,ChEMBL Compound ID,CHEMBL1740,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.36,nM,=,,0.095,3.789,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.5482528891175924
485,2159799,adrb2_human,285,C,V,Norepinephrine,ChEMBL Compound ID,CHEMBL432,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,5.8,nM,=,,2.4,2.417,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.5482528891175924
567,2159799,adrb2_human,285,C,V,(+)-isoproterenol,ChEMBL Compound ID,CHEMBL460574,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,3.981072,nM,=,,2.1,1.896,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.5482528891175924
617,2159799,adrb2_human,285,C,V,[125I]iodocyanopindolol,PubChem CID,73754996,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,11.0,pM,=,,19.0,-1.727,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.5482528891175924
363,8799191,adrb2_human,293,N,L,(-)-isoproterenol,ChEMBL Compound ID,CHEMBL1160723,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.28,ÂµM,=,,2.5,-8.929,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.6103027101630243
399,8799191,adrb2_human,293,N,L,(+)-clenbuterol,ChEMBL Compound ID,CHEMBL1396140,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.56,ÂµM,=,,0.3,1.867,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.6103027101630243
402,8799191,adrb2_human,293,N,L,(-)-norepinephrine,ChEMBL Compound ID,CHEMBL1437,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,3.9,ÂµM,=,,43.0,-10.989,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.6103027101630243
425,8799191,adrb2_human,293,N,L,(rac)-terbutaline,ChEMBL Compound ID,CHEMBL1760,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,5.4,ÂµM,=,,8.3,-1.536,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.6103027101630243
428,8799191,adrb2_human,293,N,L,(+)-norepinephrine,ChEMBL Compound ID,CHEMBL18824,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,174.0,ÂµM,=,,800.0,-4.608,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.6103027101630243
475,8799191,adrb2_human,293,N,L,(+)-Epinephrine,ChEMBL Compound ID,CHEMBL42280,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,2.1,ÂµM,=,,31.0,-14.706,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.6103027101630243
569,8799191,adrb2_human,293,N,L,(+)-isoproterenol,ChEMBL Compound ID,CHEMBL460574,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,10.6,ÂµM,=,,5.8,1.828,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.6103027101630243
571,8799191,adrb2_human,293,N,L,(rac)-clenbuterol,ChEMBL Compound ID,CHEMBL49080,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.024,ÂµM,=,,0.025,-1.042,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.6103027101630243
588,8799191,adrb2_human,293,N,L,dopamine,ChEMBL Compound ID,CHEMBL59,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,400.0,ÂµM,=,,550.0,-1.376,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.6103027101630243
593,8799191,adrb2_human,293,N,L,(-)-Epinephrine,ChEMBL Compound ID,CHEMBL679,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.17,ÂµM,=,,6.2,-37.037,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.6103027101630243
599,8799191,adrb2_human,293,N,L,(rac)-dobutamine,ChEMBL Compound ID,CHEMBL926,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,66.0,ÂµM,=,,63.0,1.048,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.6103027101630243
619,8799191,adrb2_human,293,N,L,[125I]iodocyanopindolol,PubChem CID,73754996,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,0.0071,nM,=,,0.007943,-1.119,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.6103027101630243
365,8101966,adrb2_human,312,N,T,(-)-isoproterenol,ChEMBL Compound ID,CHEMBL1160723,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.47,ÂµM,=,,58.0,-125.0,,,[3H]dihydroalprenolol,0.0,0.0,,0.0,,P07550,0.473719042382638
406,8101966,adrb2_human,312,N,T,Yohimbine,ChEMBL Compound ID,CHEMBL15245,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,81.0,ÂµM,=,,5.4,15.0,,,[3H]dihydroalprenolol,0.0,0.0,,0.0,,P07550,0.473719042382638
438,8101966,adrb2_human,312,N,T,Alprenolol,ChEMBL Compound ID,CHEMBL266195,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.29,nM,=,,31.622777,-111.111,,,[3H]dihydroalprenolol,0.0,0.0,,0.0,,P07550,0.473719042382638
552,8101966,adrb2_human,312,N,T,(-)-propranolol,ChEMBL Compound ID,CHEMBL452861,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.398107,nM,=,,794.328235,-1000.0,,,[3H]dihydroalprenolol,0.0,0.0,,0.0,,P07550,0.473719042382638
584,8101966,adrb2_human,312,N,T,Pindolol,ChEMBL Compound ID,CHEMBL500,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,1.584893,nM,=,,79.432823,-50.0,,,[3H]dihydroalprenolol,0.0,0.0,,0.0,,P07550,0.473719042382638
595,8101966,adrb2_human,312,N,T,(-)-Epinephrine,ChEMBL Compound ID,CHEMBL679,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,1.9,ÂµM,=,,10.0,-5.263,,,[3H]dihydroalprenolol,0.0,0.0,,0.0,,P07550,0.473719042382638
366,8832227,adrb2_human,326,Y,F,(-)-isoproterenol,ChEMBL Compound ID,CHEMBL1160723,Binding - unknown pharmacological activity,K(h),Binding - Radioligand competition/displacement,17.0,nM,=,,44.0,-2.591,,,[125I]iodocyanopindolol,0.0,0.0,,0.0,,P07550,0.5671622070565243
368,8832227,adrb2_human,326,Y,F,(-)-isoproterenol,ChEMBL Compound ID,CHEMBL1160723,Binding - unknown pharmacological activity,K(l),Binding - Radioligand competition/displacement,681.0,nM,=,,815.0,-1.196,,,[125I]iodocyanopindolol,0.0,0.0,,0.0,,P07550,0.5671622070565243
529,7492540,adrb2_human,326,Y,F,Isoproterenol,ChEMBL Compound ID,CHEMBL434,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,2.5,nM,=,,15.0,-5.988,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.5671622070565243
530,7492540,adrb2_human,326,Y,F,Isoproterenol,ChEMBL Compound ID,CHEMBL434,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,21.0,nM,=,,57.0,-2.717,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.5671622070565243
643,8832227,adrb2_human,326,Y,F,[125I]iodocyanopindolol,PubChem CID,73754996,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,40.9,pM,=,,45.5,-1.112,,,,91.5,0.0,,0.0,,P07550,0.5671622070565243
367,8832227,adrb2_human,326,Y,A,(-)-isoproterenol,ChEMBL Compound ID,CHEMBL1160723,Binding - unknown pharmacological activity,K(l),Binding - Radioligand competition/displacement,681.0,nM,=,,1101.0,-1.616,,,[125I]iodocyanopindolol,0.0,0.0,,0.0,,P07550,0.763190855558656
531,7507928,adrb2_human,326,Y,A,Isoproterenol,ChEMBL Compound ID,CHEMBL434,Binding - unknown pharmacological activity,K(h),Binding - Radioligand competition/displacement,4.1,nM,=,,0.2,20.5,,,[125I]-pindolol,0.0,64.3,,0.0,,P07550,0.763190855558656
532,7507928,adrb2_human,326,Y,A,Isoproterenol,ChEMBL Compound ID,CHEMBL434,Binding - unknown pharmacological activity,K(l),Binding - Radioligand competition/displacement,617.0,nM,=,,177.0,3.486,,,[125I]-pindolol,0.0,64.3,,0.0,,P07550,0.763190855558656
533,7507928,adrb2_human,326,Y,A,Isoproterenol,ChEMBL Compound ID,CHEMBL434,Binding - unknown pharmacological activity,K(l),Binding - Radioligand competition/displacement,379.0,nM,=,,327.0,1.159,,,[125I]-pindolol,0.0,64.3,,0.0,,P07550,0.763190855558656
642,8832227,adrb2_human,326,Y,A,[125I]iodocyanopindolol,PubChem CID,73754996,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,40.9,pM,=,,40.1,1.02,,,,68.9,0.0,,0.0,,P07550,0.763190855558656
376,10964911,adrb2_human,203,S,C,Phenylephrine,ChEMBL Compound ID,CHEMBL1215,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.5,,=,,4.83,-4.673,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.530841167095631
382,10964911,adrb2_human,203,S,C,Halostachine,ChEMBL Compound ID,CHEMBL1241267,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.92,,=,,5.02,1.259,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.530841167095631
420,10964911,adrb2_human,203,S,C,Epinephrine,ChEMBL Compound ID,CHEMBL1740,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.9,,=,,5.05,-71.429,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.530841167095631
433,10964911,adrb2_human,203,S,C,Alprenolol,ChEMBL Compound ID,CHEMBL266195,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,10.17,,=,,9.86,-2.041,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.530841167095631
442,10964911,adrb2_human,203,S,C,Propranolol,ChEMBL Compound ID,CHEMBL27,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.87,,=,,10.6,5.37,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.530841167095631
459,10964911,adrb2_human,203,S,C,Synephrine,ChEMBL Compound ID,CHEMBL33720,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.83,,=,,5.28,2.818,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.530841167095631
469,10964911,adrb2_human,203,S,C,CGP-12177,ChEMBL Compound ID,CHEMBL420746,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.88,,=,,8.9,-9.524,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.530841167095631
578,10964911,adrb2_human,203,S,C,Pindolol,ChEMBL Compound ID,CHEMBL500,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,10.16,,=,,8.35,-66.667,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.530841167095631
377,10964911,adrb2_human,203,S,T,Phenylephrine,ChEMBL Compound ID,CHEMBL1215,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.5,,=,,5.39,-1.289,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.4411522003628514
383,10964911,adrb2_human,203,S,T,Halostachine,ChEMBL Compound ID,CHEMBL1241267,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.92,,=,,4.89,-1.072,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.4411522003628514
421,10964911,adrb2_human,203,S,T,Epinephrine,ChEMBL Compound ID,CHEMBL1740,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.9,,=,,6.46,-2.755,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.4411522003628514
434,10964911,adrb2_human,203,S,T,Alprenolol,ChEMBL Compound ID,CHEMBL266195,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,10.17,,=,,9.83,-2.188,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.4411522003628514
443,10964911,adrb2_human,203,S,T,Propranolol,ChEMBL Compound ID,CHEMBL27,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.87,,=,,10.01,1.38,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.4411522003628514
460,10964911,adrb2_human,203,S,T,Synephrine,ChEMBL Compound ID,CHEMBL33720,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.83,,=,,4.97,1.38,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.4411522003628514
470,10964911,adrb2_human,203,S,T,CGP-12177,ChEMBL Compound ID,CHEMBL420746,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.88,,=,,10.11,1.698,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.4411522003628514
579,10964911,adrb2_human,203,S,T,Pindolol,ChEMBL Compound ID,CHEMBL500,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,10.16,,=,,9.45,-5.128,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.4411522003628514
378,10964911,adrb2_human,203,S,V,Phenylephrine,ChEMBL Compound ID,CHEMBL1215,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.5,,=,,5.3,-1.585,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.5752915352064709
384,10964911,adrb2_human,203,S,V,Halostachine,ChEMBL Compound ID,CHEMBL1241267,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.92,,=,,5.5,3.802,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.5752915352064709
422,10964911,adrb2_human,203,S,V,Epinephrine,ChEMBL Compound ID,CHEMBL1740,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.9,,=,,5.3,-40.0,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.5752915352064709
435,10964911,adrb2_human,203,S,V,Alprenolol,ChEMBL Compound ID,CHEMBL266195,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,10.17,,=,,10.2,1.072,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.5752915352064709
444,10964911,adrb2_human,203,S,V,Propranolol,ChEMBL Compound ID,CHEMBL27,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.87,,=,,10.22,2.239,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.5752915352064709
461,10964911,adrb2_human,203,S,V,Synephrine,ChEMBL Compound ID,CHEMBL33720,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.83,,=,,5.37,3.467,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.5752915352064709
471,10964911,adrb2_human,203,S,V,CGP-12177,ChEMBL Compound ID,CHEMBL420746,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.88,,=,,9.07,-6.452,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.5752915352064709
580,10964911,adrb2_human,203,S,V,Pindolol,ChEMBL Compound ID,CHEMBL500,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,10.16,,=,,8.33,-66.667,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.5752915352064709
413,9452461,adrb2_human,116,C,F,Epinephrine,ChEMBL Compound ID,CHEMBL1740,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,280.0,nM,=,,5.6,50.0,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.6068989948863017
430,9452461,adrb2_human,116,C,F,Alprenolol,ChEMBL Compound ID,CHEMBL266195,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.12,nM,=,,0.44,-3.663,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.6068989948863017
439,9452461,adrb2_human,116,C,F,Propranolol,ChEMBL Compound ID,CHEMBL27,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.36,nM,=,,0.67,-1.862,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.6068989948863017
453,9452461,adrb2_human,116,C,F,Dichloroisoproterenol,ChEMBL Compound ID,CHEMBL30816,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,170.0,nM,=,,9.3,18.28,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.6068989948863017
465,9452461,adrb2_human,116,C,F,CGP-12177,ChEMBL Compound ID,CHEMBL420746,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.62,nM,=,,0.078,7.949,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.6068989948863017
489,9452461,adrb2_human,116,C,F,Isoproterenol,ChEMBL Compound ID,CHEMBL434,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,120.0,nM,=,,1.6,75.0,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.6068989948863017
572,9452461,adrb2_human,116,C,F,Pindolol,ChEMBL Compound ID,CHEMBL500,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.087,nM,=,,2.3,-26.316,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.6068989948863017
585,9452461,adrb2_human,116,C,F,"ICI118,551",ChEMBL Compound ID,CHEMBL513389,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.22,nM,=,,8.7,-40.0,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.6068989948863017
596,9452461,adrb2_human,116,C,F,Albuterol,ChEMBL Compound ID,CHEMBL714,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,180.0,nM,=,,120.0,1.5,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.6068989948863017
598,9452461,adrb2_human,116,C,F,Metaproterenol,ChEMBL Compound ID,CHEMBL776,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,12000.0,nM,=,,1700.0,7.059,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.6068989948863017
415,7901205,adrb2_human,164,T,I,epinephrine,ChEMBL Compound ID,CHEMBL1740,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,368.0,nM,=,,1450.0,-3.937,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.458913085719819
431,7901205,adrb2_human,164,T,I,alprenolol,ChEMBL Compound ID,CHEMBL266195,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.11,nM,=,,0.18,-1.637,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.458913085719819
440,7901205,adrb2_human,164,T,I,propranolol,ChEMBL Compound ID,CHEMBL27,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.06,nM,=,,0.2,-3.333,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.458913085719819
452,7901205,adrb2_human,164,T,I,CGP-20712,ChEMBL Compound ID,CHEMBL280822,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,1110.0,nM,=,,6580.0,-5.917,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.458913085719819
467,7901205,adrb2_human,164,T,I,CGP-12177,ChEMBL Compound ID,CHEMBL420746,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,10.3,nM,=,,9.74,1.057,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.458913085719819
481,7901205,adrb2_human,164,T,I,norepinephrine,ChEMBL Compound ID,CHEMBL432,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,10395.0,nM,=,,45000.0,-4.329,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.458913085719819
493,7901205,adrb2_human,164,T,I,Isoproterenol,ChEMBL Compound ID,CHEMBL434,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,68.2,nM,=,,295.0,-4.329,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.458913085719819
576,7901205,adrb2_human,164,T,I,Pindolol,ChEMBL Compound ID,CHEMBL500,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,2.58,nM,=,,3.48,-1.35,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.458913085719819
586,7901205,adrb2_human,164,T,I,"ICI118,551",ChEMBL Compound ID,CHEMBL513389,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.43,nM,=,,1.97,-4.587,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.458913085719819
587,7901205,adrb2_human,164,T,I,dopamine,ChEMBL Compound ID,CHEMBL59,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,209.0,nM,=,,238.0,-1.139,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.458913085719819
600,7901205,adrb2_human,164,T,I,Dobutamine,ChEMBL Compound ID,CHEMBL926,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,2.31,nM,=,,4.48,-1.938,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.458913085719819
464,12167654,adrb2_human,285,C,T,[3H]CGP-12177,ChEMBL Compound ID,CHEMBL420746,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,0.073,nM,=,,0.081,-1.11,,,,0.0,0.0,,0.0,,P07550,0.5482528891175924
513,12167654,adrb2_human,285,C,T,Isoproterenol,ChEMBL Compound ID,CHEMBL434,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,71.3,nM,=,,13.8,5.167,,,[3H]CGP-12177,0.0,0.0,,0.0,,P07550,0.5482528891175924
473,11375997,adrb2_human,268,E,Q,CGP-12177,ChEMBL Compound ID,CHEMBL420746,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.06,nM,=,,0.12,-2.0,,,[3H]CGP-12177 (radioligand),166.7,0.0,,0.0,,P07550,0.4872219763877475
504,11375997,adrb2_human,268,E,Q,Isoproterenol,ChEMBL Compound ID,CHEMBL434,Binding - unknown pharmacological activity,K(d),Binding - Radioligand competition/displacement,45.0,nM,=,,32.0,1.406,,,[3H]CGP-12177 (radioligand),166.7,0.0,,0.0,,P07550,0.4872219763877475
582,11375997,adrb2_human,268,E,Q,Pindolol,ChEMBL Compound ID,CHEMBL500,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.06,nM,=,,0.36,-5.988,,,[3H]CGP-12177 (radioligand),166.7,0.0,,0.0,,P07550,0.4872219763877475
488,2846532,adrb2_human,64,L,G,Isoproterenol,ChEMBL Compound ID,CHEMBL434,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,406.0,nM,=,,37.59,10.801,,,[125I]iodocyanopindolol,384.6,0.0,,0.0,,P07550,0.7184287013597555
491,2846532,adrb2_human,138,P,T,Isoproterenol,ChEMBL Compound ID,CHEMBL434,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,406.0,nM,=,,390.38,1.04,,,[125I]iodocyanopindolol,128.2,0.0,,0.0,,P07550,0.6301946742660753
492,2846532,adrb2_human,138,P,T,Isoproterenol,ChEMBL Compound ID,CHEMBL434,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,406.0,nM,=,,418.56,-1.031,,,[125I]iodocyanopindolol,128.2,0.0,,0.0,,P07550,0.6301946742660753
495,10617695,adrb2_human,204,S,C,Isoproterenol,ChEMBL Compound ID,CHEMBL434,Binding - unknown pharmacological activity,K(d),Binding - Radioligand competition/displacement,199.526231,nM,=,,6309.573445,-31.25,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.5214159666689007
502,2846532,adrb2_human,268,E,G,Isoproterenol,ChEMBL Compound ID,CHEMBL434,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,406.0,nM,=,,88.84,4.57,,,[125I]iodocyanopindolol,70.3,0.0,,0.0,,P07550,0.6611735593445409
524,7492540,adrb2_human,322,N,D,Isoproterenol,ChEMBL Compound ID,CHEMBL434,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,2.5,nM,=,,3.7,-1.479,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.7794893388944233
525,7492540,adrb2_human,322,N,D,Isoproterenol,ChEMBL Compound ID,CHEMBL434,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,21.0,nM,=,,29.0,-1.381,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.7794893388944233
526,7492540,adrb2_human,323,P,A,Isoproterenol,ChEMBL Compound ID,CHEMBL434,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,2.5,nM,=,,12.0,-4.808,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.696879856689888
527,7492540,adrb2_human,323,P,A,Isoproterenol,ChEMBL Compound ID,CHEMBL434,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,21.0,nM,=,,48.0,-2.283,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.696879856689888
534,2846532,adrb2_human,327,C,R,Isoproterenol,ChEMBL Compound ID,CHEMBL434,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,406.0,nM,=,,1268.75,-3.125,,,[125I]iodocyanopindolol,222.2,0.0,,0.0,,P07550,0.6399994133414688
535,2846532,adrb2_human,327,C,R,Isoproterenol,ChEMBL Compound ID,CHEMBL434,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,406.0,nM,=,,1561.54,-3.846,,,[125I]iodocyanopindolol,222.2,0.0,,0.0,,P07550,0.6399994133414688
536,2540197,adrb2_human,341,C,G,Isoproterenol,ChEMBL Compound ID,CHEMBL434,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,185.0,nM,=,,206.0,-1.114,,,[125I]iodocyanopindolol,0.0,0.0,,0.0,,P07550,0.4523213925933619
537,2846532,adrb2_human,341,C,G,Isoproterenol,ChEMBL Compound ID,CHEMBL434,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,406.0,nM,=,,441.3,-1.087,,,[125I]iodocyanopindolol,105.3,0.0,,0.0,,P07550,0.4523213925933619
538,2846532,adrb2_human,341,C,G,Isoproterenol,ChEMBL Compound ID,CHEMBL434,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,406.0,nM,=,,390.38,1.04,,,[125I]iodocyanopindolol,105.3,0.0,,0.0,,P07550,0.4523213925933619
539,8381352,adrb2_human,341,C,G,Isoproterenol,ChEMBL Compound ID,CHEMBL434,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,233.0,nM,=,,287.0,-1.232,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.4523213925933619
540,8702933,adrb2_human,341,C,G,Isoproterenol,ChEMBL Compound ID,CHEMBL434,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,33.0,nM,=,,73.0,-2.212,,,[125I]iodocyanopindolol (radioligand),74.4,0.0,,0.0,,P07550,0.4523213925933619
601,8702933,adrb2_human,341,C,G,Iodocyanopindolol,PubChem CID,68618,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,51.3,pM,=,,70.0,-1.364,,,[125I]iodocyanopindolol (radioligand),74.4,0.0,,0.0,,P07550,0.4523213925933619
649,2540197,adrb2_human,341,C,G,[125I]iodocyanopindolol,PubChem CID,73754996,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,31.6,pM,=,,26.4,1.197,,,,70.1,0.0,,0.0,,P07550,0.4523213925933619
541,8388251,adrb2_human,350,Y,A,Isoproterenol,ChEMBL Compound ID,CHEMBL434,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,19.0,nM,=,,4.0,4.75,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.3479376884061312
542,8388251,adrb2_human,350,Y,A,Isoproterenol,ChEMBL Compound ID,CHEMBL434,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,377.0,nM,=,,289.0,1.304,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.3479376884061312
543,8388251,adrb2_human,354,Y,A,Isoproterenol,ChEMBL Compound ID,CHEMBL434,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,19.0,nM,=,,79.432823,-4.184,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.363135858232397
544,8388251,adrb2_human,354,Y,A,Isoproterenol,ChEMBL Compound ID,CHEMBL434,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,377.0,nM,=,,146.0,2.582,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P07550,0.363135858232397
111,20413650,acm1_human,77,F,I,AC-42,ChEMBL Compound ID,CHEMBL1242950,Binding - unknown pharmacological activity,pK(A),Binding - Radioligand competition/displacement,6.14,,=,,6.04,-1.259,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.2911786419683662
116,20413650,acm1_human,77,F,I,[3H]QNB,ChEMBL Compound ID,CHEMBL12980,Binding - unknown pharmacological activity,pK(A),Binding - Radioligand saturation,10.25,,=,,10.69,2.754,,,,90.8,0.0,,0.0,,P11229,0.2911786419683662
117,25006252,acm1_human,77,F,I,[3H]QNB,ChEMBL Compound ID,CHEMBL12980,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,10.76,,=,,10.83,1.175,,,,42.3,0.0,,0.0,,P11229,0.2911786419683662
183,25006252,acm1_human,77,F,I,Xanomeline,ChEMBL Compound ID,CHEMBL21536,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.79,,=,,6.83,1.096,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.2911786419683662
391,25006252,acm1_human,77,F,I,Atropine,ChEMBL Compound ID,CHEMBL517712,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.86,,=,,8.76,-1.259,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.2911786419683662
411,25006252,acm1_human,77,F,I,TBPB,ChEMBL Compound ID,CHEMBL522460,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.06,,=,,6.89,-1.479,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.2911786419683662
429,20413650,acm1_human,77,F,I,Pilocarpine,ChEMBL Compound ID,CHEMBL550,Binding - unknown pharmacological activity,pK(A),Binding - Radioligand competition/displacement,5.1,,=,,5.03,-1.175,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.2911786419683662
470,20413650,acm1_human,77,F,I,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(A),Binding - Radioligand competition/displacement,4.46,,=,,4.13,-2.137,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.2911786419683662
471,25006252,acm1_human,77,F,I,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.66,,=,,4.48,-1.513,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.2911786419683662
696,20413650,acm1_human,77,F,I,77-LH-28-1,PubChem CID,10236758,Binding - unknown pharmacological activity,pK(A),Binding - Radioligand competition/displacement,6.74,,=,,6.41,-2.137,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.2911786419683662
697,25006252,acm1_human,77,F,I,77-LH-28-1,PubChem CID,10236758,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.26,,=,,5.99,-1.862,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.2911786419683662
725,25006252,acm1_human,77,F,I,VCP813,SMILES,CN(C)C1CCN(Cc2ccccc2C)CC1,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.92,,=,,4.94,1.047,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.2911786419683662
754,25006252,acm1_human,77,F,I,VCP794,SMILES,O=c1[nH]c2ccccc2n1C1CCN(CC1)C1CCCCC1,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.29,,=,,5.68,-4.082,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.2911786419683662
112,20413650,acm1_human,101,W,A,AC-42,ChEMBL Compound ID,CHEMBL1242950,Binding - unknown pharmacological activity,pK(A),Binding - Radioligand competition/displacement,6.14,,=,,7.53,24.547,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.6033159347165583
121,20413650,acm1_human,101,W,A,[3H]QNB,ChEMBL Compound ID,CHEMBL12980,Binding - unknown pharmacological activity,pK(A),Binding - Radioligand saturation,10.25,,=,,9.36,-7.752,,,,171.3,0.0,,0.0,,P11229,0.6033159347165583
122,25006252,acm1_human,101,W,A,[3H]QNB,ChEMBL Compound ID,CHEMBL12980,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,10.76,,=,,9.5,-18.182,,,,18.9,0.0,,0.0,,P11229,0.6033159347165583
152,7838137,acm1_human,101,W,A,4-DAMP,ChEMBL Compound ID,CHEMBL168067,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.89,,=,,7.0,-76.923,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.6033159347165583
154,9334899,acm1_human,101,W,A,4-DAMP,ChEMBL Compound ID,CHEMBL168067,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.0,,=,,0.0,13.2,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.6033159347165583
177,7838137,acm1_human,101,W,A,Himbacine,ChEMBL Compound ID,CHEMBL1993504,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.06,,=,,7.35,1.95,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.6033159347165583
187,25006252,acm1_human,101,W,A,Xanomeline,ChEMBL Compound ID,CHEMBL21536,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.79,,=,,5.45,-21.739,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.6033159347165583
202,7838137,acm1_human,101,W,A,Methoctramine,ChEMBL Compound ID,CHEMBL27673,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.83,,=,,6.09,-5.495,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.6033159347165583
218,7838137,acm1_human,101,W,A,Gallamine,ChEMBL Compound ID,CHEMBL360055,Binding - unknown pharmacological activity,pK(i),Binding - Other,5.21,,=,,3.79,-26.316,,,,0.0,0.0,,0.0,,P11229,0.6033159347165583
219,7838137,acm1_human,101,W,A,Gallamine,ChEMBL Compound ID,CHEMBL360055,Binding - unknown pharmacological activity,pK(i),Binding - Other,3.67,,=,,2.6,-11.765,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.6033159347165583
275,7838137,acm1_human,101,W,A,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,9.92,,=,,8.97,-8.929,,,,0.0,0.0,,0.0,,P11229,0.6033159347165583
277,9334899,acm1_human,101,W,A,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,0.0,,=,,0.0,9.7,,,,0.0,0.0,,0.0,,P11229,0.6033159347165583
279,24443568,acm1_human,101,W,A,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,pK(A),Binding - Radioligand saturation,10.04,,=,,9.36,-4.785,,,,59.0,0.0,,0.0,,P11229,0.6033159347165583
344,21685390,acm1_human,101,W,A,N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,10.22,,=,,9.29,-8.547,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.6033159347165583
363,9334899,acm1_human,101,W,A,McN-A343,ChEMBL Compound ID,CHEMBL40554,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.0,,=,,0.0,-1.429,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.6033159347165583
369,9334899,acm1_human,101,W,A,Oxotremorine-M,ChEMBL Compound ID,CHEMBL44674,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.0,,=,,0.0,19.1,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.6033159347165583
397,25006252,acm1_human,101,W,A,Atropine,ChEMBL Compound ID,CHEMBL517712,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.86,,=,,8.11,-5.618,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.6033159347165583
415,25006252,acm1_human,101,W,A,TBPB,ChEMBL Compound ID,CHEMBL522460,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.06,,=,,8.57,32.359,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.6033159347165583
430,9334899,acm1_human,101,W,A,Pilocarpine,ChEMBL Compound ID,CHEMBL550,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.0,,=,,0.0,-1.667,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.6033159347165583
431,20413650,acm1_human,101,W,A,Pilocarpine,ChEMBL Compound ID,CHEMBL550,Binding - unknown pharmacological activity,pK(A),Binding - Radioligand competition/displacement,5.1,,=,,4.59,-3.236,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.6033159347165583
448,24443568,acm1_human,101,W,A,BQCA,ChEMBL Compound ID,CHEMBL608112,Binding - unknown pharmacological activity,pK(b),Binding - Radioligand competition/displacement,4.49,,=,,4.38,-1.289,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.6033159347165583
489,7838137,acm1_human,101,W,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.25,,=,,3.91,-21.739,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.6033159347165583
490,7838137,acm1_human,101,W,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.02,,=,,3.64,-23.81,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.6033159347165583
493,20413650,acm1_human,101,W,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(A),Binding - Radioligand competition/displacement,4.46,,=,,3.33,-13.514,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.6033159347165583
494,25006252,acm1_human,101,W,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.66,,=,,3.42,-17.241,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.6033159347165583
571,9334899,acm1_human,101,W,A,Arecoline,ChEMBL Compound ID,CHEMBL7303,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.0,,=,,0.0,-1.429,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.6033159347165583
579,9334899,acm1_human,101,W,A,Oxotremorine,ChEMBL Compound ID,CHEMBL7634,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.0,,=,,0.0,-1.25,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.6033159347165583
596,9334899,acm1_human,101,W,A,Carbachol,ChEMBL Compound ID,CHEMBL965,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.0,,=,,0.0,-1.111,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.6033159347165583
598,24443568,acm1_human,101,W,A,Carbachol,ChEMBL Compound ID,CHEMBL965,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.56,,=,,3.64,-8.333,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.6033159347165583
649,7838137,acm1_human,101,W,A,Pirenzepine,ChEMBL Compound ID,CHEMBL9967,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.09,,=,,5.9,-166.667,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.6033159347165583
651,9334899,acm1_human,101,W,A,Pirenzepine,ChEMBL Compound ID,CHEMBL9967,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.0,,=,,0.0,28.9,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.6033159347165583
672,21685390,acm1_human,101,W,A,MT7,FASTA sequence (peptide),LTCVKSNSIWFPTSEDCPDGQNLCFKRWQYISPRMYDFTRGCAATCPKAEYRDVINCCGTDKCNK,Binding - unknown pharmacological activity,pKx,Binding - Radioligand competition/displacement,10.47,,=,,9.79,-4.785,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.6033159347165583
701,20413650,acm1_human,101,W,A,77-LH-28-1,PubChem CID,10236758,Binding - unknown pharmacological activity,pK(A),Binding - Radioligand competition/displacement,6.74,,=,,8.64,79.433,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.6033159347165583
702,25006252,acm1_human,101,W,A,77-LH-28-1,PubChem CID,10236758,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.26,,=,,8.0,54.954,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.6033159347165583
729,25006252,acm1_human,101,W,A,VCP813,SMILES,CN(C)C1CCN(Cc2ccccc2C)CC1,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.92,,=,,4.39,-3.39,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.6033159347165583
758,25006252,acm1_human,101,W,A,VCP794,SMILES,O=c1[nH]c2ccccc2n1C1CCN(CC1)C1CCCCC1,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.29,,=,,7.99,50.119,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.6033159347165583
113,20413650,acm1_human,381,Y,A,AC-42,ChEMBL Compound ID,CHEMBL1242950,Binding - unknown pharmacological activity,pK(A),Binding - Radioligand competition/displacement,6.14,,=,,6.53,2.455,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.5989507400524735
135,20413650,acm1_human,381,Y,A,[3H]QNB,ChEMBL Compound ID,CHEMBL12980,Binding - unknown pharmacological activity,pK(A),Binding - Radioligand saturation,10.25,,=,,10.26,1.023,,,,113.9,0.0,,0.0,,P11229,0.5989507400524735
136,24443568,acm1_human,381,Y,A,[3H]QNB,ChEMBL Compound ID,CHEMBL12980,Binding - unknown pharmacological activity,pK(A),Binding - Radioligand saturation,9.85,,=,,9.82,-1.072,,,,60.0,0.0,,0.0,,P11229,0.5989507400524735
137,25006252,acm1_human,381,Y,A,[3H]QNB,ChEMBL Compound ID,CHEMBL12980,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,10.76,,=,,10.44,-2.088,,,,9.7,0.0,,0.0,,P11229,0.5989507400524735
195,25006252,acm1_human,381,Y,A,Xanomeline,ChEMBL Compound ID,CHEMBL21536,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.79,,=,,7.01,1.66,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.5989507400524735
406,25006252,acm1_human,381,Y,A,Atropine,ChEMBL Compound ID,CHEMBL517712,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.86,,=,,6.75,-125.0,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.5989507400524735
424,25006252,acm1_human,381,Y,A,TBPB,ChEMBL Compound ID,CHEMBL522460,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.06,,=,,8.36,19.953,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.5989507400524735
435,20413650,acm1_human,381,Y,A,Pilocarpine,ChEMBL Compound ID,CHEMBL550,Binding - unknown pharmacological activity,pK(A),Binding - Radioligand competition/displacement,5.1,,=,,3.56,-34.483,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.5989507400524735
530,20413650,acm1_human,381,Y,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(A),Binding - Radioligand competition/displacement,4.46,,=,,2.39,-111.111,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.5989507400524735
531,25006252,acm1_human,381,Y,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.66,,=,,3.02,-43.478,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.5989507400524735
627,24443568,acm1_human,381,Y,A,Carbachol,ChEMBL Compound ID,CHEMBL965,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.67,,=,,2.46,-166.667,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.5989507400524735
711,20413650,acm1_human,381,Y,A,77-LH-28-1,PubChem CID,10236758,Binding - unknown pharmacological activity,pK(A),Binding - Radioligand competition/displacement,6.74,,=,,7.16,2.63,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.5989507400524735
712,25006252,acm1_human,381,Y,A,77-LH-28-1,PubChem CID,10236758,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.26,,=,,6.94,4.786,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.5989507400524735
738,25006252,acm1_human,381,Y,A,VCP813,SMILES,CN(C)C1CCN(Cc2ccccc2C)CC1,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.92,,=,,5.22,1.995,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.5989507400524735
767,25006252,acm1_human,381,Y,A,VCP794,SMILES,O=c1[nH]c2ccccc2n1C1CCN(CC1)C1CCCCC1,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.29,,=,,6.75,2.884,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.5989507400524735
114,10188986,acm1_human,192,T,A,APE,ChEMBL Compound ID,CHEMBL1255649,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.32,ÂµM,=,,0.57,-1.783,,,[3H](R)-QNB,0.0,0.0,,0.0,,P11229,0.444010537779965
143,10188986,acm1_human,192,T,A,l-Hyoscyamine,ChEMBL Compound ID,CHEMBL1331216,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.088,nM,=,,0.21,-2.387,,,[3H](R)-QNB,0.0,0.0,,0.0,,P11229,0.444010537779965
147,10188986,acm1_human,192,T,A,Trihexyphenidyl,ChEMBL Compound ID,CHEMBL1490,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.1,nM,=,,0.063,1.587,,,[3H](R)-QNB,0.0,0.0,,0.0,,P11229,0.444010537779965
159,9334899,acm1_human,192,T,A,4-DAMP,ChEMBL Compound ID,CHEMBL168067,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.0,,=,,0.0,1.3,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.444010537779965
160,10188986,acm1_human,192,T,A,4-DAMP,ChEMBL Compound ID,CHEMBL168067,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.19,nM,=,,0.19,1.0,,,[3H](R)-QNB,0.0,0.0,,0.0,,P11229,0.444010537779965
171,10188986,acm1_human,192,T,A,AF-DX 116,ChEMBL Compound ID,CHEMBL17045,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,520.0,nM,=,,1400.0,-2.695,,,[3H](R)-QNB,0.0,0.0,,0.0,,P11229,0.444010537779965
257,10188986,acm1_human,192,T,A,(-)-N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.022,nM,=,,0.12,-5.464,,,[3H](R)-QNB,0.0,0.0,,0.0,,P11229,0.444010537779965
304,9334899,acm1_human,192,T,A,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,0.0,,=,,0.0,-1.25,,,,0.0,0.0,,0.0,,P11229,0.444010537779965
305,24443568,acm1_human,192,T,A,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,pK(A),Binding - Radioligand saturation,10.04,,=,,9.76,-1.905,,,,134.0,0.0,,0.0,,P11229,0.444010537779965
367,9334899,acm1_human,192,T,A,McN-A343,ChEMBL Compound ID,CHEMBL40554,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.0,,=,,0.0,-3.333,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.444010537779965
374,9334899,acm1_human,192,T,A,Oxotremorine-M,ChEMBL Compound ID,CHEMBL44674,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.0,,=,,0.0,2.7,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.444010537779965
375,10188986,acm1_human,192,T,A,Oxotremorine-M,ChEMBL Compound ID,CHEMBL44674,Binding - unknown pharmacological activity,K(h),Binding - Radioligand competition/displacement,1.1,ÂµM,=,,0.76,1.447,,,[3H](R)-QNB,0.0,0.0,,0.0,,P11229,0.444010537779965
376,10188986,acm1_human,192,T,A,Oxotremorine-M,ChEMBL Compound ID,CHEMBL44674,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,2.2,ÂµM,=,,10.0,-4.545,,,[3H](R)-QNB,0.0,0.0,,0.0,,P11229,0.444010537779965
377,10188986,acm1_human,192,T,A,Oxotremorine-M,ChEMBL Compound ID,CHEMBL44674,Binding - unknown pharmacological activity,K(l),Binding - Radioligand competition/displacement,33.0,ÂµM,=,,18.0,1.833,,,[3H](R)-QNB,0.0,0.0,,0.0,,P11229,0.444010537779965
390,10188986,acm1_human,192,T,A,[3H](R)-QNB,ChEMBL Compound ID,CHEMBL558910,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,0.032,nM,=,,0.0222,1.441,,,,87.4,0.0,,0.0,,P11229,0.444010537779965
433,9334899,acm1_human,192,T,A,Pilocarpine,ChEMBL Compound ID,CHEMBL550,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.0,,=,,0.0,-1.25,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.444010537779965
436,10188986,acm1_human,192,T,A,[3H](R)-QNB,ChEMBL Compound ID,CHEMBL558910,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,0.027,nM,=,,0.023,1.174,,,,720.0,0.0,,0.0,,P11229,0.444010537779965
461,24443568,acm1_human,192,T,A,BQCA,ChEMBL Compound ID,CHEMBL608112,Binding - unknown pharmacological activity,pK(b),Binding - Radioligand competition/displacement,4.49,,=,,4.06,-2.688,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.444010537779965
526,10188986,acm1_human,192,T,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,K(h),Binding - Radioligand competition/displacement,17.0,ÂµM,=,,1.2,14.167,,,[3H](R)-QNB,0.0,0.0,,0.0,,P11229,0.444010537779965
527,10188986,acm1_human,192,T,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,3.0,ÂµM,=,,110.0,-37.037,,,[3H](R)-QNB,0.0,0.0,,0.0,,P11229,0.444010537779965
528,10188986,acm1_human,192,T,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.51,ÂµM,=,,44.0,-83.333,,,[3H](R)-QNB,0.0,0.0,,0.0,,P11229,0.444010537779965
529,10188986,acm1_human,192,T,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,K(l),Binding - Radioligand competition/displacement,39.0,ÂµM,=,,83.0,-2.128,,,[3H](R)-QNB,0.0,0.0,,0.0,,P11229,0.444010537779965
573,9334899,acm1_human,192,T,A,Arecoline,ChEMBL Compound ID,CHEMBL7303,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.0,,=,,0.0,-2.0,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.444010537779965
574,10188986,acm1_human,192,T,A,Arecoline,ChEMBL Compound ID,CHEMBL7303,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,4.2,ÂµM,=,,5.4,-1.285,,,[3H](R)-QNB,0.0,0.0,,0.0,,P11229,0.444010537779965
581,9334899,acm1_human,192,T,A,Oxotremorine,ChEMBL Compound ID,CHEMBL7634,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.0,,=,,0.0,1.0,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.444010537779965
582,10188986,acm1_human,192,T,A,Oxotremorine,ChEMBL Compound ID,CHEMBL7634,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.18,ÂµM,=,,0.52,-2.89,,,[3H](R)-QNB,0.0,0.0,,0.0,,P11229,0.444010537779965
613,9334899,acm1_human,192,T,A,Carbachol,ChEMBL Compound ID,CHEMBL965,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.0,,=,,0.0,2.5,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.444010537779965
614,10188986,acm1_human,192,T,A,Carbachol,ChEMBL Compound ID,CHEMBL965,Binding - unknown pharmacological activity,K(h),Binding - Radioligand competition/displacement,1.6,ÂµM,=,,1.7,-1.063,,,[3H](R)-QNB,0.0,0.0,,0.0,,P11229,0.444010537779965
615,10188986,acm1_human,192,T,A,Carbachol,ChEMBL Compound ID,CHEMBL965,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,20.0,ÂµM,=,,190.0,-9.524,,,[3H](R)-QNB,0.0,0.0,,0.0,,P11229,0.444010537779965
616,10188986,acm1_human,192,T,A,Carbachol,ChEMBL Compound ID,CHEMBL965,Binding - unknown pharmacological activity,K(l),Binding - Radioligand competition/displacement,83.0,ÂµM,=,,320.0,-3.861,,,[3H](R)-QNB,0.0,0.0,,0.0,,P11229,0.444010537779965
617,24443568,acm1_human,192,T,A,Carbachol,ChEMBL Compound ID,CHEMBL965,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.56,,=,,3.22,-21.739,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.444010537779965
656,9334899,acm1_human,192,T,A,Pirenzepine,ChEMBL Compound ID,CHEMBL9967,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.0,,=,,0.0,-1.667,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.444010537779965
657,10188986,acm1_human,192,T,A,Pirenzepine,ChEMBL Compound ID,CHEMBL9967,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,4.4,nM,=,,5.8,-1.318,,,[3H](R)-QNB,0.0,0.0,,0.0,,P11229,0.444010537779965
689,10188986,acm1_human,192,T,A,p-F-HHSiD,PubChem CID,3603,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,2.6,nM,=,,2.6,1.0,,,[3H](R)-QNB,0.0,0.0,,0.0,,P11229,0.444010537779965
691,10188986,acm1_human,192,T,A,Scopolamine,PubChem CID,3000322,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.085,nM,=,,0.12,-1.412,,,[3H](R)-QNB,0.0,0.0,,0.0,,P11229,0.444010537779965
717,10188986,acm1_human,192,T,A,CDD-0098,SMILES,Cc1noc(n1)C1CNC=NC1,Binding - unknown pharmacological activity,K(h),Binding - Radioligand competition/displacement,0.12,ÂµM,=,,0.24,-2.0,,,[3H](R)-QNB,0.0,0.0,,0.0,,P11229,0.444010537779965
718,10188986,acm1_human,192,T,A,CDD-0098,SMILES,Cc1noc(n1)C1CNC=NC1,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,2.9,ÂµM,=,,8.7,-3.003,,,[3H](R)-QNB,0.0,0.0,,0.0,,P11229,0.444010537779965
719,10188986,acm1_human,192,T,A,CDD-0098,SMILES,Cc1noc(n1)C1CNC=NC1,Binding - unknown pharmacological activity,K(l),Binding - Radioligand competition/displacement,8.1,ÂµM,=,,15.0,-1.852,,,[3H](R)-QNB,0.0,0.0,,0.0,,P11229,0.444010537779965
721,10188986,acm1_human,192,T,A,CDD-0102,SMILES,CCc1noc(n1)C1CNC=NC1,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,2.0,ÂµM,=,,2.3,-1.149,,,[3H](R)-QNB,0.0,0.0,,0.0,,P11229,0.444010537779965
723,10188986,acm1_human,192,T,A,CDD-0078,SMILES,CCOC(=O)C1CNC=NC1,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,5.4,ÂµM,=,,9.8,-1.815,,,[3H](R)-QNB,0.0,0.0,,0.0,,P11229,0.444010537779965
752,10188986,acm1_human,192,T,A,CDD-0034,SMILES,COC(=O)C1CNC=NC1,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,39.0,ÂµM,=,,140.0,-3.584,,,[3H](R)-QNB,0.0,0.0,,0.0,,P11229,0.444010537779965
118,25006252,acm1_human,82,Y,A,[3H]QNB,ChEMBL Compound ID,CHEMBL12980,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,10.76,,=,,10.01,-5.618,,,,51.5,0.0,,0.0,,P11229,0.5237399660587501
184,25006252,acm1_human,82,Y,A,Xanomeline,ChEMBL Compound ID,CHEMBL21536,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.79,,=,,6.18,-4.082,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.5237399660587501
263,24443568,acm1_human,82,Y,A,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,pK(A),Binding - Radioligand saturation,10.04,,=,,9.76,-1.905,,,,75.0,0.0,,0.0,,P11229,0.5237399660587501
264,25326383,acm1_human,82,Y,A,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,pK(A),Binding - Radioligand saturation,9.92,,=,,9.76,-1.445,,,,54.2,0.0,,0.0,,P11229,0.5237399660587501
394,25006252,acm1_human,82,Y,A,Atropine,ChEMBL Compound ID,CHEMBL517712,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.86,,=,,8.19,-4.673,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.5237399660587501
412,25006252,acm1_human,82,Y,A,TBPB,ChEMBL Compound ID,CHEMBL522460,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.06,,=,,5.97,-12.346,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.5237399660587501
441,24443568,acm1_human,82,Y,A,BQCA,ChEMBL Compound ID,CHEMBL608112,Binding - unknown pharmacological activity,pK(b),Binding - Radioligand competition/displacement,4.49,,=,,4.7,1.622,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.5237399660587501
442,25326383,acm1_human,82,Y,A,BQCA,ChEMBL Compound ID,CHEMBL608112,Binding - unknown pharmacological activity,pK(b),Binding - Radioligand competition/displacement,4.82,,=,,4.73,-1.23,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.5237399660587501
472,25006252,acm1_human,82,Y,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.66,,=,,3.54,-13.158,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.5237399660587501
473,25326383,acm1_human,82,Y,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.11,,=,,4.29,-6.623,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.5237399660587501
593,24443568,acm1_human,82,Y,A,Carbachol,ChEMBL Compound ID,CHEMBL965,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.56,,=,,3.89,-4.673,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.5237399660587501
698,25006252,acm1_human,82,Y,A,77-LH-28-1,PubChem CID,10236758,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.26,,=,,5.79,-2.95,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.5237399660587501
726,25006252,acm1_human,82,Y,A,VCP813,SMILES,CN(C)C1CCN(Cc2ccccc2C)CC1,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.92,,=,,4.26,-4.566,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.5237399660587501
743,25326383,acm1_human,82,Y,A,Benzoquinazolinone 12,SMILES,Cn1cc(cn1)-c1ccc(Cc2cc3C(=O)N(CNc3c3ccccc23)C2CCCC[C@@H]2O)cn1,,pK(b),Binding - Radioligand competition/displacement,6.55,,=,,5.28,-18.519,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.5237399660587501
755,25006252,acm1_human,82,Y,A,VCP794,SMILES,O=c1[nH]c2ccccc2n1C1CCN(CC1)C1CCCCC1,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.29,,=,,4.83,-28.571,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.5237399660587501
119,25006252,acm1_human,85,Y,A,[3H]QNB,ChEMBL Compound ID,CHEMBL12980,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,10.76,,=,,10.49,-1.862,,,,26.0,0.0,,0.0,,P11229,0.4873611676438543
185,25006252,acm1_human,85,Y,A,Xanomeline,ChEMBL Compound ID,CHEMBL21536,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.79,,=,,6.33,-2.882,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.4873611676438543
210,7838137,acm1_human,85,Y,A,Gallamine,ChEMBL Compound ID,CHEMBL360055,Binding - unknown pharmacological activity,pK(i),Binding - Other,5.21,,=,,4.77,-2.755,,,,0.0,0.0,,0.0,,P11229,0.4873611676438543
211,7838137,acm1_human,85,Y,A,Gallamine,ChEMBL Compound ID,CHEMBL360055,Binding - unknown pharmacological activity,pK(i),Binding - Other,3.67,,=,,3.74,1.175,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.4873611676438543
268,7838137,acm1_human,85,Y,A,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,9.92,,=,,9.67,-1.779,,,,0.0,0.0,,0.0,,P11229,0.4873611676438543
269,24443568,acm1_human,85,Y,A,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,pK(A),Binding - Radioligand saturation,10.04,,=,,9.82,-1.658,,,,132.7,0.0,,0.0,,P11229,0.4873611676438543
270,25326383,acm1_human,85,Y,A,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,pK(A),Binding - Radioligand saturation,9.92,,=,,9.82,-1.259,,,,95.9,0.0,,0.0,,P11229,0.4873611676438543
395,25006252,acm1_human,85,Y,A,Atropine,ChEMBL Compound ID,CHEMBL517712,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.86,,=,,8.47,-2.457,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.4873611676438543
413,25006252,acm1_human,85,Y,A,TBPB,ChEMBL Compound ID,CHEMBL522460,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.06,,=,,6.29,-5.882,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.4873611676438543
445,24443568,acm1_human,85,Y,A,BQCA,ChEMBL Compound ID,CHEMBL608112,Binding - unknown pharmacological activity,pK(b),Binding - Radioligand competition/displacement,4.49,,=,,4.32,-1.479,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.4873611676438543
446,25326383,acm1_human,85,Y,A,BQCA,ChEMBL Compound ID,CHEMBL608112,Binding - unknown pharmacological activity,pK(b),Binding - Radioligand competition/displacement,4.82,,=,,4.86,1.096,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.4873611676438543
477,7838137,acm1_human,85,Y,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.25,,=,,4.92,-2.137,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.4873611676438543
478,7838137,acm1_human,85,Y,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.02,,=,,4.56,-2.882,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.4873611676438543
479,25006252,acm1_human,85,Y,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.66,,=,,3.54,-13.158,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.4873611676438543
480,25326383,acm1_human,85,Y,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.11,,=,,4.65,-2.882,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.4873611676438543
595,24443568,acm1_human,85,Y,A,Carbachol,ChEMBL Compound ID,CHEMBL965,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.56,,=,,3.84,-5.236,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.4873611676438543
699,25006252,acm1_human,85,Y,A,77-LH-28-1,PubChem CID,10236758,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.26,,=,,5.63,-4.274,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.4873611676438543
727,25006252,acm1_human,85,Y,A,VCP813,SMILES,CN(C)C1CCN(Cc2ccccc2C)CC1,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.92,,=,,4.48,-2.755,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.4873611676438543
745,25326383,acm1_human,85,Y,A,Benzoquinazolinone 12,SMILES,Cn1cc(cn1)-c1ccc(Cc2cc3C(=O)N(CNc3c3ccccc23)C2CCCC[C@@H]2O)cn1,,pK(b),Binding - Radioligand competition/displacement,6.55,,=,,5.37,-15.152,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.4873611676438543
756,25006252,acm1_human,85,Y,A,VCP794,SMILES,O=c1[nH]c2ccccc2n1C1CCN(CC1)C1CCCCC1,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.29,,=,,4.91,-23.81,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.4873611676438543
120,25006252,acm1_human,90,H,A,[3H]QNB,ChEMBL Compound ID,CHEMBL12980,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,10.76,,=,,10.76,1.0,,,,16.8,0.0,,0.0,,P11229,0.3203268288301558
186,25006252,acm1_human,90,H,A,Xanomeline,ChEMBL Compound ID,CHEMBL21536,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.79,,=,,6.66,-1.35,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.3203268288301558
342,21685390,acm1_human,90,H,A,N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,10.22,,=,,10.2,-1.047,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.3203268288301558
396,25006252,acm1_human,90,H,A,Atropine,ChEMBL Compound ID,CHEMBL517712,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.86,,=,,8.79,-1.175,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.3203268288301558
414,25006252,acm1_human,90,H,A,TBPB,ChEMBL Compound ID,CHEMBL522460,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.06,,=,,7.08,1.047,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.3203268288301558
482,25006252,acm1_human,90,H,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.66,,=,,4.17,-3.086,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.3203268288301558
670,21685390,acm1_human,90,H,A,MT7,FASTA sequence (peptide),LTCVKSNSIWFPTSEDCPDGQNLCFKRWQYISPRMYDFTRGCAATCPKAEYRDVINCCGTDKCNK,Binding - unknown pharmacological activity,pKx,Binding - Radioligand competition/displacement,10.47,,=,,10.66,1.549,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.3203268288301558
700,25006252,acm1_human,90,H,A,77-LH-28-1,PubChem CID,10236758,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.26,,=,,6.26,1.0,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.3203268288301558
728,25006252,acm1_human,90,H,A,VCP813,SMILES,CN(C)C1CCN(Cc2ccccc2C)CC1,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.92,,=,,4.84,-1.202,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.3203268288301558
757,25006252,acm1_human,90,H,A,VCP794,SMILES,O=c1[nH]c2ccccc2n1C1CCN(CC1)C1CCCCC1,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.29,,=,,5.96,-2.137,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.3203268288301558
123,25006252,acm1_human,102,L,A,[3H]QNB,ChEMBL Compound ID,CHEMBL12980,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,10.76,,=,,9.37,-24.39,,,,31.1,0.0,,0.0,,P11229,0.5388119782728887
188,25006252,acm1_human,102,L,A,Xanomeline,ChEMBL Compound ID,CHEMBL21536,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.79,,=,,5.21,-38.462,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.5388119782728887
280,24443568,acm1_human,102,L,A,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,pK(A),Binding - Radioligand saturation,10.04,,=,,9.4,-4.367,,,,49.0,0.0,,0.0,,P11229,0.5388119782728887
398,25006252,acm1_human,102,L,A,Atropine,ChEMBL Compound ID,CHEMBL517712,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.86,,=,,7.61,-17.857,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.5388119782728887
416,25006252,acm1_human,102,L,A,TBPB,ChEMBL Compound ID,CHEMBL522460,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.06,,=,,6.78,-1.905,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.5388119782728887
449,24443568,acm1_human,102,L,A,BQCA,ChEMBL Compound ID,CHEMBL608112,Binding - unknown pharmacological activity,pK(b),Binding - Radioligand competition/displacement,4.49,,=,,4.12,-2.342,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.5388119782728887
495,25006252,acm1_human,102,L,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.66,,=,,2.89,-58.824,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.5388119782728887
599,24443568,acm1_human,102,L,A,Carbachol,ChEMBL Compound ID,CHEMBL965,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.56,,=,,3.21,-22.222,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.5388119782728887
703,25006252,acm1_human,102,L,A,77-LH-28-1,PubChem CID,10236758,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.26,,=,,5.71,-3.546,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.5388119782728887
730,25006252,acm1_human,102,L,A,VCP813,SMILES,CN(C)C1CCN(Cc2ccccc2C)CC1,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.92,,=,,4.46,-2.882,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.5388119782728887
759,25006252,acm1_human,102,L,A,VCP794,SMILES,O=c1[nH]c2ccccc2n1C1CCN(CC1)C1CCCCC1,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.29,,=,,5.36,-8.547,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.5388119782728887
125,25006252,acm1_human,105,D,N,[3H]QNB,ChEMBL Compound ID,CHEMBL12980,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,10.76,,=,,8.19,-333.333,,,,26.0,0.0,,0.0,,P11229,0.4800422086389848
345,20643905,acm1_human,105,D,N,N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.36,,=,,7.81,-35.714,,,N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.4800422086389848
346,23826889,acm1_human,105,D,N,N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.2,,=,,7.7,-31.25,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.4800422086389848
364,20643905,acm1_human,105,D,N,McN-A343,ChEMBL Compound ID,CHEMBL40554,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.83,,=,,3.82,-10.204,,,N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.4800422086389848
365,23826889,acm1_human,105,D,N,McN-A343,ChEMBL Compound ID,CHEMBL40554,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.83,,=,,3.76,-11.765,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.4800422086389848
496,20643905,acm1_human,105,D,N,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,3.88,,=,,2.2,-47.619,,,N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.4800422086389848
497,23826889,acm1_human,105,D,N,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,3.87,,=,,2.12,-55.556,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.4800422086389848
694,20643905,acm1_human,105,D,N,BR-384,PubChem CID,3078975,Binding - unknown pharmacological activity,Single-point,Binding - Radioligand competition/displacement,21.0,%,=,,73.7,3.51,,,N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.4800422086389848
126,24443568,acm1_human,106,Y,A,[3H]QNB,ChEMBL Compound ID,CHEMBL12980,Binding - unknown pharmacological activity,pK(A),Binding - Radioligand saturation,9.85,,=,,9.15,-5.0,,,,75.9,0.0,,0.0,,P11229,0.5714891923568798
127,25006252,acm1_human,106,Y,A,[3H]QNB,ChEMBL Compound ID,CHEMBL12980,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,10.76,,=,,9.22,-34.483,,,,24.5,0.0,,0.0,,P11229,0.5714891923568798
400,25006252,acm1_human,106,Y,A,Atropine,ChEMBL Compound ID,CHEMBL517712,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.86,,=,,7.42,-27.778,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.5714891923568798
418,25006252,acm1_human,106,Y,A,TBPB,ChEMBL Compound ID,CHEMBL522460,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.06,,=,,6.4,-4.566,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.5714891923568798
499,25006252,acm1_human,106,Y,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.66,,=,,2.96,-50.0,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.5714891923568798
602,24443568,acm1_human,106,Y,A,Carbachol,ChEMBL Compound ID,CHEMBL965,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.67,,=,,1.73,-1000.0,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.5714891923568798
705,25006252,acm1_human,106,Y,A,77-LH-28-1,PubChem CID,10236758,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.26,,=,,5.66,-3.984,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.5714891923568798
732,25006252,acm1_human,106,Y,A,VCP813,SMILES,CN(C)C1CCN(Cc2ccccc2C)CC1,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.92,,=,,5.09,1.479,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.5714891923568798
761,25006252,acm1_human,106,Y,A,VCP794,SMILES,O=c1[nH]c2ccccc2n1C1CCN(CC1)C1CCCCC1,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.29,,=,,5.65,-4.367,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.5714891923568798
129,24443568,acm1_human,157,W,A,[3H]QNB,ChEMBL Compound ID,CHEMBL12980,Binding - unknown pharmacological activity,pK(A),Binding - Radioligand saturation,9.85,,=,,9.32,-3.39,,,,103.4,0.0,,0.0,,P11229,0.6224785314384575
605,24443568,acm1_human,157,W,A,Carbachol,ChEMBL Compound ID,CHEMBL965,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.67,,=,,1.85,-500.0,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.6224785314384575
130,25006252,acm1_human,179,Y,A,[3H]QNB,ChEMBL Compound ID,CHEMBL12980,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,10.76,,=,,10.39,-2.342,,,,32.1,0.0,,0.0,,P11229,0.4481035854362489
190,25006252,acm1_human,179,Y,A,Xanomeline,ChEMBL Compound ID,CHEMBL21536,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.79,,=,,6.33,-2.882,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.4481035854362489
291,24443568,acm1_human,179,Y,A,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,pK(A),Binding - Radioligand saturation,10.04,,=,,10.0,-1.096,,,,90.0,0.0,,0.0,,P11229,0.4481035854362489
292,25326383,acm1_human,179,Y,A,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,pK(A),Binding - Radioligand saturation,9.92,,=,,10.0,1.202,,,,65.1,0.0,,0.0,,P11229,0.4481035854362489
401,25006252,acm1_human,179,Y,A,Atropine,ChEMBL Compound ID,CHEMBL517712,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.86,,=,,8.35,-3.236,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.4481035854362489
419,25006252,acm1_human,179,Y,A,TBPB,ChEMBL Compound ID,CHEMBL522460,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.06,,=,,7.97,8.128,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.4481035854362489
451,24443568,acm1_human,179,Y,A,BQCA,ChEMBL Compound ID,CHEMBL608112,Binding - unknown pharmacological activity,pK(b),Binding - Radioligand competition/displacement,4.49,,=,,4.55,1.148,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.4481035854362489
452,25326383,acm1_human,179,Y,A,BQCA,ChEMBL Compound ID,CHEMBL608112,Binding - unknown pharmacological activity,pK(b),Binding - Radioligand competition/displacement,4.82,,=,,4.68,-1.381,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.4481035854362489
512,25006252,acm1_human,179,Y,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.66,,=,,3.99,-4.673,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.4481035854362489
513,25326383,acm1_human,179,Y,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.11,,=,,5.05,-1.148,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.4481035854362489
606,24443568,acm1_human,179,Y,A,Carbachol,ChEMBL Compound ID,CHEMBL965,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.56,,=,,4.63,1.175,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.4481035854362489
706,25006252,acm1_human,179,Y,A,77-LH-28-1,PubChem CID,10236758,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.26,,=,,6.59,2.138,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.4481035854362489
733,25006252,acm1_human,179,Y,A,VCP813,SMILES,CN(C)C1CCN(Cc2ccccc2C)CC1,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.92,,=,,4.6,-2.088,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.4481035854362489
747,25326383,acm1_human,179,Y,A,Benzoquinazolinone 12,SMILES,Cn1cc(cn1)-c1ccc(Cc2cc3C(=O)N(CNc3c3ccccc23)C2CCCC[C@@H]2O)cn1,,pK(b),Binding - Radioligand competition/displacement,6.55,,=,,4.56,-100.0,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.4481035854362489
762,25006252,acm1_human,179,Y,A,VCP794,SMILES,O=c1[nH]c2ccccc2n1C1CCN(CC1)C1CCCCC1,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.29,,=,,6.37,1.202,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.4481035854362489
131,25006252,acm1_human,180,I,A,[3H]QNB,ChEMBL Compound ID,CHEMBL12980,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,10.76,,=,,10.57,-1.548,,,,33.7,0.0,,0.0,,P11229,0.5481794205110606
191,25006252,acm1_human,180,I,A,Xanomeline,ChEMBL Compound ID,CHEMBL21536,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.79,,=,,5.85,-8.696,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.5481794205110606
295,24443568,acm1_human,180,I,A,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,pK(A),Binding - Radioligand saturation,10.04,,=,,9.95,-1.23,,,,62.0,0.0,,0.0,,P11229,0.5481794205110606
402,25006252,acm1_human,180,I,A,Atropine,ChEMBL Compound ID,CHEMBL517712,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.86,,=,,8.65,-1.621,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.5481794205110606
420,25006252,acm1_human,180,I,A,TBPB,ChEMBL Compound ID,CHEMBL522460,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.06,,=,,7.58,3.311,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.5481794205110606
455,24443568,acm1_human,180,I,A,BQCA,ChEMBL Compound ID,CHEMBL608112,Binding - unknown pharmacological activity,pK(b),Binding - Radioligand competition/displacement,4.49,,=,,5.03,3.467,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.5481794205110606
516,25006252,acm1_human,180,I,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.66,,=,,3.8,-7.246,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.5481794205110606
607,24443568,acm1_human,180,I,A,Carbachol,ChEMBL Compound ID,CHEMBL965,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.56,,=,,4.07,-3.086,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.5481794205110606
707,25006252,acm1_human,180,I,A,77-LH-28-1,PubChem CID,10236758,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.26,,=,,6.97,5.129,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.5481794205110606
734,25006252,acm1_human,180,I,A,VCP813,SMILES,CN(C)C1CCN(Cc2ccccc2C)CC1,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.92,,=,,4.91,-1.024,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.5481794205110606
763,25006252,acm1_human,180,I,A,VCP794,SMILES,O=c1[nH]c2ccccc2n1C1CCN(CC1)C1CCCCC1,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.29,,=,,6.93,4.365,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.5481794205110606
132,25006252,acm1_human,181,Q,A,[3H]QNB,ChEMBL Compound ID,CHEMBL12980,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,10.76,,=,,10.64,-1.318,,,,33.2,0.0,,0.0,,P11229,0.3984490930649191
192,25006252,acm1_human,181,Q,A,Xanomeline,ChEMBL Compound ID,CHEMBL21536,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.79,,=,,6.6,-1.548,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.3984490930649191
232,7838137,acm1_human,181,Q,A,Gallamine,ChEMBL Compound ID,CHEMBL360055,Binding - unknown pharmacological activity,pK(i),Binding - Other,5.21,,=,,5.08,-1.35,,,,0.0,0.0,,0.0,,P11229,0.3984490930649191
233,7838137,acm1_human,181,Q,A,Gallamine,ChEMBL Compound ID,CHEMBL360055,Binding - unknown pharmacological activity,pK(i),Binding - Other,3.67,,=,,3.65,-1.047,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.3984490930649191
296,7838137,acm1_human,181,Q,A,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,9.92,,=,,9.88,-1.096,,,,0.0,0.0,,0.0,,P11229,0.3984490930649191
297,24443568,acm1_human,181,Q,A,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,pK(A),Binding - Radioligand saturation,10.04,,=,,9.92,-1.318,,,,92.0,0.0,,0.0,,P11229,0.3984490930649191
403,25006252,acm1_human,181,Q,A,Atropine,ChEMBL Compound ID,CHEMBL517712,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.86,,=,,8.67,-1.548,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.3984490930649191
421,25006252,acm1_human,181,Q,A,TBPB,ChEMBL Compound ID,CHEMBL522460,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.06,,=,,7.3,1.738,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.3984490930649191
456,24443568,acm1_human,181,Q,A,BQCA,ChEMBL Compound ID,CHEMBL608112,Binding - unknown pharmacological activity,pK(b),Binding - Radioligand competition/displacement,4.49,,=,,5.12,4.266,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.3984490930649191
517,7838137,acm1_human,181,Q,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.25,,=,,5.68,2.692,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.3984490930649191
518,7838137,acm1_human,181,Q,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.02,,=,,5.33,2.042,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.3984490930649191
519,25006252,acm1_human,181,Q,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.66,,=,,4.57,-1.23,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.3984490930649191
608,24443568,acm1_human,181,Q,A,Carbachol,ChEMBL Compound ID,CHEMBL965,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.56,,=,,5.42,7.244,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.3984490930649191
708,25006252,acm1_human,181,Q,A,77-LH-28-1,PubChem CID,10236758,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.26,,=,,6.43,1.479,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.3984490930649191
735,25006252,acm1_human,181,Q,A,VCP813,SMILES,CN(C)C1CCN(Cc2ccccc2C)CC1,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.92,,=,,4.76,-1.445,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.3984490930649191
764,25006252,acm1_human,181,Q,A,VCP794,SMILES,O=c1[nH]c2ccccc2n1C1CCN(CC1)C1CCCCC1,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.29,,=,,6.24,-1.122,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.3984490930649191
133,25006252,acm1_human,182,F,A,[3H]QNB,ChEMBL Compound ID,CHEMBL12980,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,10.76,,=,,10.62,-1.381,,,,41.8,0.0,,0.0,,P11229,0.5800700221411074
193,25006252,acm1_human,182,F,A,Xanomeline,ChEMBL Compound ID,CHEMBL21536,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.79,,=,,6.39,-2.513,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.5800700221411074
234,7838137,acm1_human,182,F,A,Gallamine,ChEMBL Compound ID,CHEMBL360055,Binding - unknown pharmacological activity,pK(i),Binding - Other,5.21,,=,,5.19,-1.047,,,,0.0,0.0,,0.0,,P11229,0.5800700221411074
235,7838137,acm1_human,182,F,A,Gallamine,ChEMBL Compound ID,CHEMBL360055,Binding - unknown pharmacological activity,pK(i),Binding - Other,3.67,,=,,3.73,1.148,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.5800700221411074
298,7838137,acm1_human,182,F,A,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,9.92,,=,,9.44,-3.021,,,,0.0,0.0,,0.0,,P11229,0.5800700221411074
299,24443568,acm1_human,182,F,A,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,pK(A),Binding - Radioligand saturation,10.04,,=,,9.52,-3.311,,,,85.0,0.0,,0.0,,P11229,0.5800700221411074
404,25006252,acm1_human,182,F,A,Atropine,ChEMBL Compound ID,CHEMBL517712,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.86,,=,,8.36,-3.165,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.5800700221411074
422,25006252,acm1_human,182,F,A,TBPB,ChEMBL Compound ID,CHEMBL522460,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.06,,=,,7.18,1.318,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.5800700221411074
457,24443568,acm1_human,182,F,A,BQCA,ChEMBL Compound ID,CHEMBL608112,Binding - unknown pharmacological activity,pK(b),Binding - Radioligand competition/displacement,4.49,,=,,4.41,-1.202,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.5800700221411074
520,7838137,acm1_human,182,F,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.25,,=,,5.01,-1.739,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.5800700221411074
521,7838137,acm1_human,182,F,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.02,,=,,4.78,-1.739,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.5800700221411074
522,25006252,acm1_human,182,F,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.66,,=,,4.13,-3.39,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.5800700221411074
609,24443568,acm1_human,182,F,A,Carbachol,ChEMBL Compound ID,CHEMBL965,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.56,,=,,4.68,1.318,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.5800700221411074
709,25006252,acm1_human,182,F,A,77-LH-28-1,PubChem CID,10236758,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.26,,=,,6.26,1.0,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.5800700221411074
736,25006252,acm1_human,182,F,A,VCP813,SMILES,CN(C)C1CCN(Cc2ccccc2C)CC1,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.92,,=,,4.47,-2.817,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.5800700221411074
765,25006252,acm1_human,182,F,A,VCP794,SMILES,O=c1[nH]c2ccccc2n1C1CCN(CC1)C1CCCCC1,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.29,,=,,6.35,1.148,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.5800700221411074
134,25006252,acm1_human,183,L,A,[3H]QNB,ChEMBL Compound ID,CHEMBL12980,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,10.76,,=,,10.2,-3.636,,,,65.3,0.0,,0.0,,P11229,0.3508756216048354
194,25006252,acm1_human,183,L,A,Xanomeline,ChEMBL Compound ID,CHEMBL21536,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.79,,=,,6.64,-1.412,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.3508756216048354
300,24443568,acm1_human,183,L,A,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,pK(A),Binding - Radioligand saturation,10.04,,=,,9.31,-5.376,,,,100.0,0.0,,0.0,,P11229,0.3508756216048354
356,21685390,acm1_human,183,L,A,N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,10.22,,=,,10.0,-1.658,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.3508756216048354
405,25006252,acm1_human,183,L,A,Atropine,ChEMBL Compound ID,CHEMBL517712,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.86,,=,,8.29,-3.717,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.3508756216048354
423,25006252,acm1_human,183,L,A,TBPB,ChEMBL Compound ID,CHEMBL522460,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.06,,=,,7.33,1.862,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.3508756216048354
458,24443568,acm1_human,183,L,A,BQCA,ChEMBL Compound ID,CHEMBL608112,Binding - unknown pharmacological activity,pK(b),Binding - Radioligand competition/displacement,4.49,,=,,4.23,-1.818,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.3508756216048354
523,25006252,acm1_human,183,L,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.66,,=,,4.19,-2.95,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.3508756216048354
610,24443568,acm1_human,183,L,A,Carbachol,ChEMBL Compound ID,CHEMBL965,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.56,,=,,3.51,-11.236,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.3508756216048354
682,21685390,acm1_human,183,L,A,MT7,FASTA sequence (peptide),LTCVKSNSIWFPTSEDCPDGQNLCFKRWQYISPRMYDFTRGCAATCPKAEYRDVINCCGTDKCNK,Binding - unknown pharmacological activity,pKx,Binding - Radioligand competition/displacement,10.47,,=,,10.44,-1.072,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.3508756216048354
710,25006252,acm1_human,183,L,A,77-LH-28-1,PubChem CID,10236758,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.26,,=,,6.47,1.622,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.3508756216048354
737,25006252,acm1_human,183,L,A,VCP813,SMILES,CN(C)C1CCN(Cc2ccccc2C)CC1,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.92,,=,,4.66,-1.818,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.3508756216048354
766,25006252,acm1_human,183,L,A,VCP794,SMILES,O=c1[nH]c2ccccc2n1C1CCN(CC1)C1CCCCC1,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.29,,=,,6.48,1.549,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.3508756216048354
138,25006252,acm1_human,392,K,A,[3H]QNB,ChEMBL Compound ID,CHEMBL12980,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,10.76,,=,,10.61,-1.412,,,,68.9,0.0,,0.0,,P11229,0.2790445030723307
196,25006252,acm1_human,392,K,A,Xanomeline,ChEMBL Compound ID,CHEMBL21536,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.79,,=,,6.71,-1.202,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.2790445030723307
324,24443568,acm1_human,392,K,A,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,pK(A),Binding - Radioligand saturation,10.04,,=,,9.88,-1.445,,,,77.0,0.0,,0.0,,P11229,0.2790445030723307
358,21685390,acm1_human,392,K,A,N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,10.22,,=,,10.2,-1.047,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.2790445030723307
407,25006252,acm1_human,392,K,A,Atropine,ChEMBL Compound ID,CHEMBL517712,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.86,,=,,8.7,-1.445,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.2790445030723307
425,25006252,acm1_human,392,K,A,TBPB,ChEMBL Compound ID,CHEMBL522460,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.06,,=,,6.78,-1.905,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.2790445030723307
463,24443568,acm1_human,392,K,A,BQCA,ChEMBL Compound ID,CHEMBL608112,Binding - unknown pharmacological activity,pK(b),Binding - Radioligand competition/displacement,4.49,,=,,4.4,-1.23,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.2790445030723307
550,25006252,acm1_human,392,K,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.66,,=,,4.21,-2.817,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.2790445030723307
637,24443568,acm1_human,392,K,A,Carbachol,ChEMBL Compound ID,CHEMBL965,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.56,,=,,4.28,-1.905,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.2790445030723307
684,21685390,acm1_human,392,K,A,MT7,FASTA sequence (peptide),LTCVKSNSIWFPTSEDCPDGQNLCFKRWQYISPRMYDFTRGCAATCPKAEYRDVINCCGTDKCNK,Binding - unknown pharmacological activity,pKx,Binding - Radioligand competition/displacement,10.47,,=,,10.57,1.259,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.2790445030723307
713,25006252,acm1_human,392,K,A,77-LH-28-1,PubChem CID,10236758,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.26,,=,,5.98,-1.905,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.2790445030723307
739,25006252,acm1_human,392,K,A,VCP813,SMILES,CN(C)C1CCN(Cc2ccccc2C)CC1,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.92,,=,,4.72,-1.585,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.2790445030723307
768,25006252,acm1_human,392,K,A,VCP794,SMILES,O=c1[nH]c2ccccc2n1C1CCN(CC1)C1CCCCC1,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.29,,=,,5.84,-2.817,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.2790445030723307
139,25006252,acm1_human,393,D,A,[3H]QNB,ChEMBL Compound ID,CHEMBL12980,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,10.76,,=,,10.66,-1.259,,,,48.0,0.0,,0.0,,P11229,0.315099601764564
197,25006252,acm1_human,393,D,A,Xanomeline,ChEMBL Compound ID,CHEMBL21536,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.79,,=,,6.75,-1.096,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.315099601764564
359,21685390,acm1_human,393,D,A,N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,10.22,,=,,9.96,-1.818,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.315099601764564
408,25006252,acm1_human,393,D,A,Atropine,ChEMBL Compound ID,CHEMBL517712,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.86,,=,,8.75,-1.289,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.315099601764564
426,25006252,acm1_human,393,D,A,TBPB,ChEMBL Compound ID,CHEMBL522460,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.06,,=,,6.82,-1.739,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.315099601764564
551,25006252,acm1_human,393,D,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.66,,=,,4.42,-1.739,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.315099601764564
685,21685390,acm1_human,393,D,A,MT7,FASTA sequence (peptide),LTCVKSNSIWFPTSEDCPDGQNLCFKRWQYISPRMYDFTRGCAATCPKAEYRDVINCCGTDKCNK,Binding - unknown pharmacological activity,pKx,Binding - Radioligand competition/displacement,10.47,,=,,10.5,1.072,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.315099601764564
714,25006252,acm1_human,393,D,A,77-LH-28-1,PubChem CID,10236758,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.26,,=,,6.12,-1.381,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.315099601764564
740,25006252,acm1_human,393,D,A,VCP813,SMILES,CN(C)C1CCN(Cc2ccccc2C)CC1,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.92,,=,,4.81,-1.289,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.315099601764564
769,25006252,acm1_human,393,D,A,VCP794,SMILES,O=c1[nH]c2ccccc2n1C1CCN(CC1)C1CCCCC1,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.29,,=,,5.92,-2.342,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.315099601764564
140,24443568,acm1_human,395,V,A,[3H]QNB,ChEMBL Compound ID,CHEMBL12980,Binding - unknown pharmacological activity,pK(A),Binding - Radioligand saturation,9.85,,=,,9.3,-3.546,,,,108.6,0.0,,0.0,,P11229,0.3871674478731218
464,24443568,acm1_human,395,V,A,BQCA,ChEMBL Compound ID,CHEMBL608112,Binding - unknown pharmacological activity,pK(b),Binding - Radioligand competition/displacement,4.18,,=,,4.31,1.349,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.3871674478731218
638,24443568,acm1_human,395,V,A,Carbachol,ChEMBL Compound ID,CHEMBL965,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.67,,=,,2.03,-500.0,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.3871674478731218
141,25006252,acm1_human,400,W,A,[3H]QNB,ChEMBL Compound ID,CHEMBL12980,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,10.76,,=,,10.49,-1.862,,,,28.6,0.0,,0.0,,P11229,0.5005841683876635
165,7838137,acm1_human,400,W,A,4-DAMP,ChEMBL Compound ID,CHEMBL168067,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.89,,=,,9.0,1.288,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.5005841683876635
179,7838137,acm1_human,400,W,A,Himbacine,ChEMBL Compound ID,CHEMBL1993504,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.06,,=,,5.83,-16.949,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.5005841683876635
198,25006252,acm1_human,400,W,A,Xanomeline,ChEMBL Compound ID,CHEMBL21536,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.79,,=,,6.88,1.23,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.5005841683876635
204,7838137,acm1_human,400,W,A,Methoctramine,ChEMBL Compound ID,CHEMBL27673,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.83,,=,,6.2,-4.274,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.5005841683876635
250,7838137,acm1_human,400,W,A,Gallamine,ChEMBL Compound ID,CHEMBL360055,Binding - unknown pharmacological activity,pK(i),Binding - Other,5.21,,=,,3.95,-18.182,,,,0.0,0.0,,0.0,,P11229,0.5005841683876635
251,7838137,acm1_human,400,W,A,Gallamine,ChEMBL Compound ID,CHEMBL360055,Binding - unknown pharmacological activity,pK(i),Binding - Other,3.67,,=,,2.68,-9.804,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.5005841683876635
329,7838137,acm1_human,400,W,A,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,9.92,,=,,9.75,-1.479,,,,0.0,0.0,,0.0,,P11229,0.5005841683876635
331,24443568,acm1_human,400,W,A,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,pK(A),Binding - Radioligand saturation,10.04,,=,,9.95,-1.23,,,,46.0,0.0,,0.0,,P11229,0.5005841683876635
332,25326383,acm1_human,400,W,A,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,pK(A),Binding - Radioligand saturation,9.92,,=,,9.95,1.072,,,,33.3,0.0,,0.0,,P11229,0.5005841683876635
361,21685390,acm1_human,400,W,A,N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,10.22,,=,,10.12,-1.259,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.5005841683876635
409,25006252,acm1_human,400,W,A,Atropine,ChEMBL Compound ID,CHEMBL517712,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.86,,=,,8.53,-2.137,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.5005841683876635
427,25006252,acm1_human,400,W,A,TBPB,ChEMBL Compound ID,CHEMBL522460,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.06,,=,,6.19,-7.407,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.5005841683876635
558,7838137,acm1_human,400,W,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.25,,=,,4.29,-9.091,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.5005841683876635
559,7838137,acm1_human,400,W,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.02,,=,,4.12,-7.937,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.5005841683876635
562,25006252,acm1_human,400,W,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.66,,=,,3.41,-17.857,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.5005841683876635
563,25326383,acm1_human,400,W,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.11,,=,,4.62,-3.086,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.5005841683876635
640,24443568,acm1_human,400,W,A,Carbachol,ChEMBL Compound ID,CHEMBL965,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.56,,=,,4.18,-2.398,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.5005841683876635
664,7838137,acm1_human,400,W,A,Pirenzepine,ChEMBL Compound ID,CHEMBL9967,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.09,,=,,7.54,-3.546,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.5005841683876635
687,21685390,acm1_human,400,W,A,MT7,FASTA sequence (peptide),LTCVKSNSIWFPTSEDCPDGQNLCFKRWQYISPRMYDFTRGCAATCPKAEYRDVINCCGTDKCNK,Binding - unknown pharmacological activity,pKx,Binding - Radioligand competition/displacement,10.47,,=,,9.43,-10.989,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.5005841683876635
715,25006252,acm1_human,400,W,A,77-LH-28-1,PubChem CID,10236758,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.26,,=,,5.3,-9.091,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.5005841683876635
741,25006252,acm1_human,400,W,A,VCP813,SMILES,CN(C)C1CCN(Cc2ccccc2C)CC1,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.92,,=,,4.6,-2.088,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.5005841683876635
770,25006252,acm1_human,400,W,A,VCP794,SMILES,O=c1[nH]c2ccccc2n1C1CCN(CC1)C1CCCCC1,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.29,,=,,5.15,-13.889,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.5005841683876635
142,25006252,acm1_human,401,E,A,[3H]QNB,ChEMBL Compound ID,CHEMBL12980,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,10.76,,=,,10.56,-1.585,,,,27.6,0.0,,0.0,,P11229,0.3694317500277685
199,25006252,acm1_human,401,E,A,Xanomeline,ChEMBL Compound ID,CHEMBL21536,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.79,,=,,6.67,-1.318,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.3694317500277685
335,24443568,acm1_human,401,E,A,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,pK(A),Binding - Radioligand saturation,10.04,,=,,9.97,-1.175,,,,78.7,0.0,,0.0,,P11229,0.3694317500277685
362,21685390,acm1_human,401,E,A,N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,10.22,,=,,9.76,-2.882,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.3694317500277685
410,25006252,acm1_human,401,E,A,Atropine,ChEMBL Compound ID,CHEMBL517712,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.86,,=,,8.66,-1.585,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.3694317500277685
428,25006252,acm1_human,401,E,A,TBPB,ChEMBL Compound ID,CHEMBL522460,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.06,,=,,6.79,-1.862,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.3694317500277685
468,24443568,acm1_human,401,E,A,BQCA,ChEMBL Compound ID,CHEMBL608112,Binding - unknown pharmacological activity,pK(b),Binding - Radioligand competition/displacement,4.49,,=,,4.72,1.698,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.3694317500277685
566,25006252,acm1_human,401,E,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.66,,=,,4.1,-3.636,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.3694317500277685
641,24443568,acm1_human,401,E,A,Carbachol,ChEMBL Compound ID,CHEMBL965,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.56,,=,,4.6,1.096,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.3694317500277685
688,21685390,acm1_human,401,E,A,MT7,FASTA sequence (peptide),LTCVKSNSIWFPTSEDCPDGQNLCFKRWQYISPRMYDFTRGCAATCPKAEYRDVINCCGTDKCNK,Binding - unknown pharmacological activity,pKx,Binding - Radioligand competition/displacement,10.47,,=,,10.2,-1.862,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.3694317500277685
716,25006252,acm1_human,401,E,A,77-LH-28-1,PubChem CID,10236758,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.26,,=,,6.16,-1.259,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.3694317500277685
742,25006252,acm1_human,401,E,A,VCP813,SMILES,CN(C)C1CCN(Cc2ccccc2C)CC1,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.92,,=,,4.98,1.148,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.3694317500277685
771,25006252,acm1_human,401,E,A,VCP794,SMILES,O=c1[nH]c2ccccc2n1C1CCN(CC1)C1CCCCC1,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.29,,=,,5.88,-2.571,,,[3H]QNB,0.0,0.0,,0.0,,P11229,0.3694317500277685
145,10496961,acm1_human,388,S,Y,l-Hyoscyamine,ChEMBL Compound ID,CHEMBL1331216,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,10.06,,=,,9.59,-2.95,,,[3H](R)-QNB,0.0,0.0,,0.0,,P11229,0.5194694369578057
149,10496961,acm1_human,388,S,Y,Trihexyphenidyl,ChEMBL Compound ID,CHEMBL1490,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,10.02,,=,,9.66,-2.288,,,[3H](R)-QNB,0.0,0.0,,0.0,,P11229,0.5194694369578057
259,10496961,acm1_human,388,S,Y,(-)-N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,10.61,,=,,10.42,-1.548,,,[3H](R)-QNB,0.0,0.0,,0.0,,P11229,0.5194694369578057
384,10496961,acm1_human,388,S,Y,Oxotremorine-M,ChEMBL Compound ID,CHEMBL44674,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,2200.0,nM,=,,130.0,16.923,,,[3H](R)-QNB,0.0,0.0,,0.0,,P11229,0.5194694369578057
385,10496961,acm1_human,388,S,Y,Oxotremorine-M,ChEMBL Compound ID,CHEMBL44674,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,2200.0,nM,=,,760.0,2.895,,,[3H](R)-QNB,0.0,0.0,,0.0,,P11229,0.5194694369578057
386,10496961,acm1_human,388,S,Y,Oxotremorine-M,ChEMBL Compound ID,CHEMBL44674,Binding - unknown pharmacological activity,K(l),Binding - Radioligand competition/displacement,33000.0,nM,=,,1200.0,27.5,,,[3H](R)-QNB,0.0,0.0,,0.0,,P11229,0.5194694369578057
439,10496961,acm1_human,388,S,Y,[3H](R)-QNB,ChEMBL Compound ID,CHEMBL558910,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,10.57,,=,,10.23,-2.188,,,,0.0,0.0,,0.0,,P11229,0.5194694369578057
536,10496961,acm1_human,388,S,Y,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,510.0,nM,=,,42.0,12.143,,,[3H](R)-QNB,0.0,0.0,,0.0,,P11229,0.5194694369578057
537,10496961,acm1_human,388,S,Y,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,3000.0,nM,=,,28.0,107.143,,,[3H](R)-QNB,0.0,0.0,,0.0,,P11229,0.5194694369578057
538,10496961,acm1_human,388,S,Y,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,K(l),Binding - Radioligand competition/displacement,39.0,ÂµM,=,,72.0,-1.845,,,[3H](R)-QNB,0.0,0.0,,0.0,,P11229,0.5194694369578057
539,10496961,acm1_human,388,S,Y,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,K(l),Binding - Radioligand competition/displacement,13.0,ÂµM,=,,680.0,-52.632,,,[3H](R)-QNB,0.0,0.0,,0.0,,P11229,0.5194694369578057
577,10496961,acm1_human,388,S,Y,Arecoline,ChEMBL Compound ID,CHEMBL7303,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,4200.0,nM,=,,220.0,19.091,,,[3H](R)-QNB,0.0,0.0,,0.0,,P11229,0.5194694369578057
585,10496961,acm1_human,388,S,Y,Oxotremorine,ChEMBL Compound ID,CHEMBL7634,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,180.0,nM,=,,490.0,-2.725,,,[3H](R)-QNB,0.0,0.0,,0.0,,P11229,0.5194694369578057
587,10496961,acm1_human,388,S,Y,Choline,ChEMBL Compound ID,CHEMBL920,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,200.0,ÂµM,=,,230.0,-1.149,,,[3H](R)-QNB,0.0,0.0,,0.0,,P11229,0.5194694369578057
632,10496961,acm1_human,388,S,Y,Carbachol,ChEMBL Compound ID,CHEMBL965,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,20000.0,nM,=,,230.0,86.957,,,[3H](R)-QNB,0.0,0.0,,0.0,,P11229,0.5194694369578057
633,10496961,acm1_human,388,S,Y,Carbachol,ChEMBL Compound ID,CHEMBL965,Binding - unknown pharmacological activity,K(l),Binding - Radioligand competition/displacement,83.0,ÂµM,=,,360.0,-4.329,,,[3H](R)-QNB,0.0,0.0,,0.0,,P11229,0.5194694369578057
662,10496961,acm1_human,388,S,Y,Pirenzepine,ChEMBL Compound ID,CHEMBL9967,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.37,,=,,7.99,-2.398,,,[3H](R)-QNB,0.0,0.0,,0.0,,P11229,0.5194694369578057
146,10496961,acm1_human,389,T,P,l-Hyoscyamine,ChEMBL Compound ID,CHEMBL1331216,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,10.06,,=,,9.42,-4.367,,,[3H](R)-QNB,0.0,0.0,,0.0,,P11229,0.4752266651144438
260,10496961,acm1_human,389,T,P,(-)-N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,10.61,,=,,9.55,-11.494,,,[3H](R)-QNB,0.0,0.0,,0.0,,P11229,0.4752266651144438
387,10496961,acm1_human,389,T,P,Oxotremorine-M,ChEMBL Compound ID,CHEMBL44674,Binding - unknown pharmacological activity,K(l),Binding - Radioligand competition/displacement,33.0,ÂµM,=,,64.0,-1.938,,,[3H](R)-QNB,0.0,0.0,,0.0,,P11229,0.4752266651144438
440,10496961,acm1_human,389,T,P,[3H](R)-QNB,ChEMBL Compound ID,CHEMBL558910,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,10.57,,=,,9.93,-4.367,,,,0.0,0.0,,0.0,,P11229,0.4752266651144438
542,10496961,acm1_human,389,T,P,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,510.0,nM,=,,630.0,-1.235,,,[3H](R)-QNB,0.0,0.0,,0.0,,P11229,0.4752266651144438
543,10496961,acm1_human,389,T,P,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,3000.0,nM,=,,2800.0,1.071,,,[3H](R)-QNB,0.0,0.0,,0.0,,P11229,0.4752266651144438
544,10496961,acm1_human,389,T,P,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,K(l),Binding - Radioligand competition/displacement,39000.0,nM,=,,500.0,78.0,,,[3H](R)-QNB,0.0,0.0,,0.0,,P11229,0.4752266651144438
545,10496961,acm1_human,389,T,P,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,K(l),Binding - Radioligand competition/displacement,13.0,ÂµM,=,,0.23,56.522,,,[3H](R)-QNB,0.0,0.0,,0.0,,P11229,0.4752266651144438
578,10496961,acm1_human,389,T,P,Arecoline,ChEMBL Compound ID,CHEMBL7303,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,4200.0,nM,=,,380.0,11.053,,,[3H](R)-QNB,0.0,0.0,,0.0,,P11229,0.4752266651144438
586,10496961,acm1_human,389,T,P,Oxotremorine,ChEMBL Compound ID,CHEMBL7634,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,180.0,nM,=,,58.0,3.103,,,[3H](R)-QNB,0.0,0.0,,0.0,,P11229,0.4752266651144438
588,10496961,acm1_human,389,T,P,Choline,ChEMBL Compound ID,CHEMBL920,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,200.0,ÂµM,=,,620.0,-3.096,,,[3H](R)-QNB,0.0,0.0,,0.0,,P11229,0.4752266651144438
634,10496961,acm1_human,389,T,P,Carbachol,ChEMBL Compound ID,CHEMBL965,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,20000.0,nM,=,,4300.0,4.651,,,[3H](R)-QNB,0.0,0.0,,0.0,,P11229,0.4752266651144438
635,10496961,acm1_human,389,T,P,Carbachol,ChEMBL Compound ID,CHEMBL965,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,18.0,ÂµM,=,,18.0,1.0,,,[3H](R)-QNB,0.0,0.0,,0.0,,P11229,0.4752266651144438
636,10496961,acm1_human,389,T,P,Carbachol,ChEMBL Compound ID,CHEMBL965,Binding - unknown pharmacological activity,K(l),Binding - Radioligand competition/displacement,83.0,ÂµM,=,,2.8,29.643,,,[3H](R)-QNB,0.0,0.0,,0.0,,P11229,0.4752266651144438
663,10496961,acm1_human,389,T,P,Pirenzepine,ChEMBL Compound ID,CHEMBL9967,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.37,,=,,7.53,-6.897,,,[3H](R)-QNB,0.0,0.0,,0.0,,P11229,0.4752266651144438
150,7838137,acm1_human,91,W,A,4-DAMP,ChEMBL Compound ID,CHEMBL168067,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.89,,=,,7.33,-35.714,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.7663416947925815
175,7838137,acm1_human,91,W,A,Himbacine,ChEMBL Compound ID,CHEMBL1993504,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.06,,=,,5.92,-13.889,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.7663416947925815
200,7838137,acm1_human,91,W,A,Methoctramine,ChEMBL Compound ID,CHEMBL27673,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.83,,=,,6.35,-3.021,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.7663416947925815
212,7838137,acm1_human,91,W,A,Gallamine,ChEMBL Compound ID,CHEMBL360055,Binding - unknown pharmacological activity,pK(i),Binding - Other,5.21,,=,,4.65,-3.636,,,,0.0,0.0,,0.0,,P11229,0.7663416947925815
213,7838137,acm1_human,91,W,A,Gallamine,ChEMBL Compound ID,CHEMBL360055,Binding - unknown pharmacological activity,pK(i),Binding - Other,3.67,,=,,3.93,1.82,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.7663416947925815
272,7838137,acm1_human,91,W,A,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,9.92,,=,,9.02,-7.937,,,,0.0,0.0,,0.0,,P11229,0.7663416947925815
343,21685390,acm1_human,91,W,A,N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,10.22,,=,,9.23,-9.804,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.7663416947925815
483,7838137,acm1_human,91,W,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.25,,=,,3.68,-37.037,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.7663416947925815
484,7838137,acm1_human,91,W,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.02,,=,,3.36,-45.455,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.7663416947925815
647,7838137,acm1_human,91,W,A,Pirenzepine,ChEMBL Compound ID,CHEMBL9967,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.09,,=,,7.2,-7.752,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.7663416947925815
671,21685390,acm1_human,91,W,A,MT7,FASTA sequence (peptide),LTCVKSNSIWFPTSEDCPDGQNLCFKRWQYISPRMYDFTRGCAATCPKAEYRDVINCCGTDKCNK,Binding - unknown pharmacological activity,pKx,Binding - Radioligand competition/displacement,10.47,,=,,9.3,-14.706,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.7663416947925815
156,9334899,acm1_human,106,Y,F,4-DAMP,ChEMBL Compound ID,CHEMBL168067,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.0,,=,,0.0,1.3,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.3515972312746928
282,9334899,acm1_human,106,Y,F,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,0.0,,=,,0.0,2.8,,,,0.0,0.0,,0.0,,P11229,0.3515972312746928
371,9334899,acm1_human,106,Y,F,Oxotremorine-M,ChEMBL Compound ID,CHEMBL44674,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.0,,=,,0.0,2.3,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.3515972312746928
601,9334899,acm1_human,106,Y,F,Carbachol,ChEMBL Compound ID,CHEMBL965,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.0,,=,,0.0,3.6,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.3515972312746928
653,9334899,acm1_human,106,Y,F,Pirenzepine,ChEMBL Compound ID,CHEMBL9967,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.0,,=,,0.0,-1.25,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.3515972312746928
161,9334899,acm1_human,378,W,A,4-DAMP,ChEMBL Compound ID,CHEMBL168067,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.0,,=,,0.0,288.2,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.8611447009282843
318,9334899,acm1_human,378,W,A,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,0.0,,=,,0.0,115.0,,,,0.0,0.0,,0.0,,P11229,0.8611447009282843
368,9334899,acm1_human,378,W,A,McN-A343,ChEMBL Compound ID,CHEMBL40554,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.0,,=,,0.0,-10.0,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.8611447009282843
378,9334899,acm1_human,378,W,A,Oxotremorine-M,ChEMBL Compound ID,CHEMBL44674,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.0,,=,,0.0,-1.25,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.8611447009282843
434,9334899,acm1_human,378,W,A,Pilocarpine,ChEMBL Compound ID,CHEMBL550,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.0,,=,,0.0,4.8,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.8611447009282843
575,9334899,acm1_human,378,W,A,Arecoline,ChEMBL Compound ID,CHEMBL7303,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.0,,=,,0.0,-1.667,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.8611447009282843
583,9334899,acm1_human,378,W,A,Oxotremorine,ChEMBL Compound ID,CHEMBL7634,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.0,,=,,0.0,1.6,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.8611447009282843
625,9334899,acm1_human,378,W,A,Carbachol,ChEMBL Compound ID,CHEMBL965,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.0,,=,,0.0,-5.0,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.8611447009282843
658,9334899,acm1_human,378,W,A,Pirenzepine,ChEMBL Compound ID,CHEMBL9967,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.0,,=,,0.0,34.6,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.8611447009282843
167,7838137,acm1_human,404,Y,A,4-DAMP,ChEMBL Compound ID,CHEMBL168067,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.89,,=,,7.9,-9.804,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.5601393105982571
181,7838137,acm1_human,404,Y,A,Himbacine,ChEMBL Compound ID,CHEMBL1993504,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.06,,=,,5.7,-22.727,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.5601393105982571
206,7838137,acm1_human,404,Y,A,Methoctramine,ChEMBL Compound ID,CHEMBL27673,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.83,,=,,6.7,-1.35,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.5601393105982571
254,7838137,acm1_human,404,Y,A,Gallamine,ChEMBL Compound ID,CHEMBL360055,Binding - unknown pharmacological activity,pK(i),Binding - Other,5.21,,=,,5.33,1.318,,,,0.0,0.0,,0.0,,P11229,0.5601393105982571
336,7838137,acm1_human,404,Y,A,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,9.92,,=,,8.19,-52.632,,,,0.0,0.0,,0.0,,P11229,0.5601393105982571
567,7838137,acm1_human,404,Y,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.25,,=,,3.6,-45.455,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.5601393105982571
568,7838137,acm1_human,404,Y,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.02,,=,,3.25,-58.824,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.5601393105982571
666,7838137,acm1_human,404,Y,A,Pirenzepine,ChEMBL Compound ID,CHEMBL9967,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.09,,=,,7.19,-7.937,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.5601393105982571
168,7838137,acm1_human,404,Y,F,4-DAMP,ChEMBL Compound ID,CHEMBL168067,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.89,,=,,8.1,-6.173,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.3411407368287173
182,7838137,acm1_human,404,Y,F,Himbacine,ChEMBL Compound ID,CHEMBL1993504,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.06,,=,,6.71,-2.237,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.3411407368287173
207,7838137,acm1_human,404,Y,F,Methoctramine,ChEMBL Compound ID,CHEMBL27673,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.83,,=,,6.86,1.072,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.3411407368287173
255,7838137,acm1_human,404,Y,F,Gallamine,ChEMBL Compound ID,CHEMBL360055,Binding - unknown pharmacological activity,pK(i),Binding - Other,5.21,,=,,5.15,-1.148,,,,0.0,0.0,,0.0,,P11229,0.3411407368287173
256,7838137,acm1_human,404,Y,F,Gallamine,ChEMBL Compound ID,CHEMBL360055,Binding - unknown pharmacological activity,pK(i),Binding - Other,3.67,,=,,3.0,-4.673,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.3411407368287173
337,7838137,acm1_human,404,Y,F,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,9.92,,=,,9.06,-7.246,,,,0.0,0.0,,0.0,,P11229,0.3411407368287173
569,7838137,acm1_human,404,Y,F,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.25,,=,,3.89,-22.727,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.3411407368287173
570,7838137,acm1_human,404,Y,F,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.02,,=,,3.61,-25.641,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.3411407368287173
667,7838137,acm1_human,404,Y,F,Pirenzepine,ChEMBL Compound ID,CHEMBL9967,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.09,,=,,8.14,1.122,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.3411407368287173
169,9334899,acm1_human,411,S,A,4-DAMP,ChEMBL Compound ID,CHEMBL168067,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.0,,=,,0.0,1.1,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.6368644174902024
339,9334899,acm1_human,411,S,A,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,0.0,,=,,0.0,1.6,,,,0.0,0.0,,0.0,,P11229,0.6368644174902024
388,9334899,acm1_human,411,S,A,Oxotremorine-M,ChEMBL Compound ID,CHEMBL44674,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.0,,=,,0.0,2.1,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.6368644174902024
643,9334899,acm1_human,411,S,A,Carbachol,ChEMBL Compound ID,CHEMBL965,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.0,,=,,0.0,1.5,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.6368644174902024
668,9334899,acm1_human,411,S,A,Pirenzepine,ChEMBL Compound ID,CHEMBL9967,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.0,,=,,0.0,1.5,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.6368644174902024
170,9334899,acm1_human,412,T,A,4-DAMP,ChEMBL Compound ID,CHEMBL168067,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.0,,=,,0.0,-2.0,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.5036866085470495
340,9334899,acm1_human,412,T,A,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,0.0,,=,,0.0,-1.429,,,,0.0,0.0,,0.0,,P11229,0.5036866085470495
389,9334899,acm1_human,412,T,A,Oxotremorine-M,ChEMBL Compound ID,CHEMBL44674,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.0,,=,,0.0,1.0,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.5036866085470495
644,9334899,acm1_human,412,T,A,Carbachol,ChEMBL Compound ID,CHEMBL965,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.0,,=,,0.0,1.3,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.5036866085470495
669,9334899,acm1_human,412,T,A,Pirenzepine,ChEMBL Compound ID,CHEMBL9967,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.0,,=,,0.0,-1.111,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.5036866085470495
208,7838137,acm1_human,83,T,A,Gallamine,ChEMBL Compound ID,CHEMBL360055,Binding - unknown pharmacological activity,pK(i),Binding - Other,5.21,,=,,5.09,-1.318,,,,0.0,0.0,,0.0,,P11229,0.3953227476595686
209,7838137,acm1_human,83,T,A,Gallamine,ChEMBL Compound ID,CHEMBL360055,Binding - unknown pharmacological activity,pK(i),Binding - Other,3.67,,=,,3.74,1.175,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.3953227476595686
266,7838137,acm1_human,83,T,A,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,9.92,,=,,9.94,1.047,,,,0.0,0.0,,0.0,,P11229,0.3953227476595686
267,24443568,acm1_human,83,T,A,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,pK(A),Binding - Radioligand saturation,10.04,,=,,9.95,-1.23,,,,100.7,0.0,,0.0,,P11229,0.3953227476595686
444,24443568,acm1_human,83,T,A,BQCA,ChEMBL Compound ID,CHEMBL608112,Binding - unknown pharmacological activity,pK(b),Binding - Radioligand competition/displacement,4.49,,=,,4.39,-1.259,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.3953227476595686
475,7838137,acm1_human,83,T,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.25,,=,,5.29,1.096,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.3953227476595686
476,7838137,acm1_human,83,T,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.02,,=,,5.02,1.0,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.3953227476595686
594,24443568,acm1_human,83,T,A,Carbachol,ChEMBL Compound ID,CHEMBL965,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.56,,=,,4.62,1.148,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.3953227476595686
216,7838137,acm1_human,94,G,A,Gallamine,ChEMBL Compound ID,CHEMBL360055,Binding - unknown pharmacological activity,pK(i),Binding - Other,5.21,,=,,4.72,-3.086,,,,0.0,0.0,,0.0,,P11229,0.515235901502469
217,7838137,acm1_human,94,G,A,Gallamine,ChEMBL Compound ID,CHEMBL360055,Binding - unknown pharmacological activity,pK(i),Binding - Other,3.67,,=,,3.31,-2.288,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.515235901502469
274,7838137,acm1_human,94,G,A,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,9.92,,=,,9.77,-1.412,,,,0.0,0.0,,0.0,,P11229,0.515235901502469
487,7838137,acm1_human,94,G,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.25,,=,,5.39,1.38,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.515235901502469
488,7838137,acm1_human,94,G,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.02,,=,,4.6,-2.632,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.515235901502469
222,7838137,acm1_human,164,W,A,Gallamine,ChEMBL Compound ID,CHEMBL360055,Binding - unknown pharmacological activity,pK(i),Binding - Other,5.21,,=,,5.16,-1.122,,,,0.0,0.0,,0.0,,P11229,0.6063352406471443
223,7838137,acm1_human,164,W,A,Gallamine,ChEMBL Compound ID,CHEMBL360055,Binding - unknown pharmacological activity,pK(i),Binding - Other,3.67,,=,,3.85,1.514,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.6063352406471443
286,7838137,acm1_human,164,W,A,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,9.92,,=,,9.75,-1.479,,,,0.0,0.0,,0.0,,P11229,0.6063352406471443
502,7838137,acm1_human,164,W,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.25,,=,,4.43,-6.623,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.6063352406471443
503,7838137,acm1_human,164,W,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.02,,=,,4.28,-5.495,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.6063352406471443
224,7838137,acm1_human,165,Q,A,Gallamine,ChEMBL Compound ID,CHEMBL360055,Binding - unknown pharmacological activity,pK(i),Binding - Other,5.21,,=,,4.98,-1.698,,,,0.0,0.0,,0.0,,P11229,0.384731066088934
225,7838137,acm1_human,165,Q,A,Gallamine,ChEMBL Compound ID,CHEMBL360055,Binding - unknown pharmacological activity,pK(i),Binding - Other,3.67,,=,,3.55,-1.318,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.384731066088934
287,7838137,acm1_human,165,Q,A,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,9.92,,=,,9.84,-1.202,,,,0.0,0.0,,0.0,,P11229,0.384731066088934
504,7838137,acm1_human,165,Q,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.25,,=,,5.33,1.202,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.384731066088934
505,7838137,acm1_human,165,Q,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.02,,=,,4.87,-1.412,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.384731066088934
226,7838137,acm1_human,169,G,A,Gallamine,ChEMBL Compound ID,CHEMBL360055,Binding - unknown pharmacological activity,pK(i),Binding - Other,5.21,,=,,4.61,-3.984,,,,0.0,0.0,,0.0,,P11229,0.2522839514424024
227,7838137,acm1_human,169,G,A,Gallamine,ChEMBL Compound ID,CHEMBL360055,Binding - unknown pharmacological activity,pK(i),Binding - Other,3.67,,=,,3.55,-1.318,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.2522839514424024
288,7838137,acm1_human,169,G,A,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,9.92,,=,,9.54,-2.398,,,,0.0,0.0,,0.0,,P11229,0.2522839514424024
506,7838137,acm1_human,169,G,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.25,,=,,4.61,-4.367,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.2522839514424024
507,7838137,acm1_human,169,G,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.02,,=,,4.22,-6.329,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.2522839514424024
228,7838137,acm1_human,171,R,A,Gallamine,ChEMBL Compound ID,CHEMBL360055,Binding - unknown pharmacological activity,pK(i),Binding - Other,5.21,,=,,5.12,-1.23,,,,0.0,0.0,,0.0,,P11229,0.2873835630955648
229,7838137,acm1_human,171,R,A,Gallamine,ChEMBL Compound ID,CHEMBL360055,Binding - unknown pharmacological activity,pK(i),Binding - Other,3.67,,=,,4.15,3.02,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.2873835630955648
289,7838137,acm1_human,171,R,A,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,9.92,,=,,9.4,-3.311,,,,0.0,0.0,,0.0,,P11229,0.2873835630955648
351,21685390,acm1_human,171,R,A,N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,10.22,,=,,9.76,-2.882,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.2873835630955648
508,7838137,acm1_human,171,R,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.25,,=,,4.68,-3.717,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.2873835630955648
509,7838137,acm1_human,171,R,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.02,,=,,4.4,-4.167,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.2873835630955648
677,21685390,acm1_human,171,R,A,MT7,FASTA sequence (peptide),LTCVKSNSIWFPTSEDCPDGQNLCFKRWQYISPRMYDFTRGCAATCPKAEYRDVINCCGTDKCNK,Binding - unknown pharmacological activity,pKx,Binding - Radioligand competition/displacement,10.47,,=,,9.5,-9.346,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.2873835630955648
230,7838137,acm1_human,172,T,A,Gallamine,ChEMBL Compound ID,CHEMBL360055,Binding - unknown pharmacological activity,pK(i),Binding - Other,5.21,,=,,5.16,-1.122,,,,0.0,0.0,,0.0,,P11229,0.257318240149173
231,7838137,acm1_human,172,T,A,Gallamine,ChEMBL Compound ID,CHEMBL360055,Binding - unknown pharmacological activity,pK(i),Binding - Other,3.67,,=,,3.66,-1.024,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.257318240149173
290,7838137,acm1_human,172,T,A,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,9.92,,=,,9.85,-1.175,,,,0.0,0.0,,0.0,,P11229,0.257318240149173
510,7838137,acm1_human,172,T,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.25,,=,,5.13,-1.318,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.257318240149173
511,7838137,acm1_human,172,T,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.02,,=,,4.82,-1.585,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.257318240149173
236,7838137,acm1_human,184,S,A,Gallamine,ChEMBL Compound ID,CHEMBL360055,Binding - unknown pharmacological activity,pK(i),Binding - Other,5.21,,=,,5.23,1.047,,,,0.0,0.0,,0.0,,P11229,0.281849667163865
237,7838137,acm1_human,184,S,A,Gallamine,ChEMBL Compound ID,CHEMBL360055,Binding - unknown pharmacological activity,pK(i),Binding - Other,3.67,,=,,3.68,1.023,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.281849667163865
301,7838137,acm1_human,184,S,A,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,9.92,,=,,10.0,1.202,,,,0.0,0.0,,0.0,,P11229,0.281849667163865
302,24443568,acm1_human,184,S,A,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,pK(A),Binding - Radioligand saturation,10.04,,=,,10.04,1.0,,,,82.0,0.0,,0.0,,P11229,0.281849667163865
459,24443568,acm1_human,184,S,A,BQCA,ChEMBL Compound ID,CHEMBL608112,Binding - unknown pharmacological activity,pK(b),Binding - Radioligand competition/displacement,4.49,,=,,4.7,1.622,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.281849667163865
524,7838137,acm1_human,184,S,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.25,,=,,4.87,-2.398,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.281849667163865
525,7838137,acm1_human,184,S,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.02,,=,,4.62,-2.513,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.281849667163865
611,24443568,acm1_human,184,S,A,Carbachol,ChEMBL Compound ID,CHEMBL965,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.56,,=,,4.35,-1.621,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.281849667163865
238,7838137,acm1_human,389,T,A,Gallamine,ChEMBL Compound ID,CHEMBL360055,Binding - unknown pharmacological activity,pK(i),Binding - Other,5.21,,=,,4.98,-1.698,,,,0.0,0.0,,0.0,,P11229,0.4306665543258964
239,7838137,acm1_human,389,T,A,Gallamine,ChEMBL Compound ID,CHEMBL360055,Binding - unknown pharmacological activity,pK(i),Binding - Other,3.67,,=,,3.51,-1.445,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.4306665543258964
321,7838137,acm1_human,389,T,A,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,9.92,,=,,9.86,-1.148,,,,0.0,0.0,,0.0,,P11229,0.4306665543258964
540,7838137,acm1_human,389,T,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.25,,=,,5.03,-1.658,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.4306665543258964
541,7838137,acm1_human,389,T,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.02,,=,,4.9,-1.318,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.4306665543258964
240,7838137,acm1_human,390,F,A,Gallamine,ChEMBL Compound ID,CHEMBL360055,Binding - unknown pharmacological activity,pK(i),Binding - Other,5.21,,=,,5.04,-1.479,,,,0.0,0.0,,0.0,,P11229,0.3736040818481454
241,7838137,acm1_human,390,F,A,Gallamine,ChEMBL Compound ID,CHEMBL360055,Binding - unknown pharmacological activity,pK(i),Binding - Other,3.67,,=,,3.76,1.23,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.3736040818481454
322,7838137,acm1_human,390,F,A,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,9.92,,=,,9.77,-1.412,,,,0.0,0.0,,0.0,,P11229,0.3736040818481454
546,7838137,acm1_human,390,F,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.25,,=,,5.13,-1.318,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.3736040818481454
547,7838137,acm1_human,390,F,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.02,,=,,4.96,-1.148,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.3736040818481454
242,7838137,acm1_human,391,C,A,Gallamine,ChEMBL Compound ID,CHEMBL360055,Binding - unknown pharmacological activity,pK(i),Binding - Other,5.21,,=,,4.7,-3.236,,,,0.0,0.0,,0.0,,P11229,0.3032965119150544
243,7838137,acm1_human,391,C,A,Gallamine,ChEMBL Compound ID,CHEMBL360055,Binding - unknown pharmacological activity,pK(i),Binding - Other,3.67,,=,,3.63,-1.096,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.3032965119150544
323,7838137,acm1_human,391,C,A,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,9.92,,=,,9.94,1.047,,,,0.0,0.0,,0.0,,P11229,0.3032965119150544
548,7838137,acm1_human,391,C,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.25,,=,,5.53,1.905,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.3032965119150544
549,7838137,acm1_human,391,C,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.02,,=,,5.33,2.042,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.3032965119150544
244,7838137,acm1_human,394,C,A,Gallamine,ChEMBL Compound ID,CHEMBL360055,Binding - unknown pharmacological activity,pK(i),Binding - Other,5.21,,=,,5.03,-1.513,,,,0.0,0.0,,0.0,,P11229,0.2946469152313762
245,7838137,acm1_human,394,C,A,Gallamine,ChEMBL Compound ID,CHEMBL360055,Binding - unknown pharmacological activity,pK(i),Binding - Other,3.67,,=,,3.51,-1.445,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.2946469152313762
325,7838137,acm1_human,394,C,A,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,9.92,,=,,10.04,1.318,,,,0.0,0.0,,0.0,,P11229,0.2946469152313762
552,7838137,acm1_human,394,C,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.25,,=,,5.81,3.631,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.2946469152313762
553,7838137,acm1_human,394,C,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.02,,=,,5.35,2.138,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.2946469152313762
246,7838137,acm1_human,396,P,A,Gallamine,ChEMBL Compound ID,CHEMBL360055,Binding - unknown pharmacological activity,pK(i),Binding - Other,5.21,,=,,5.01,-1.585,,,,0.0,0.0,,0.0,,P11229,0.4551735943761197
247,7838137,acm1_human,396,P,A,Gallamine,ChEMBL Compound ID,CHEMBL360055,Binding - unknown pharmacological activity,pK(i),Binding - Other,3.67,,=,,3.75,1.202,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.4551735943761197
326,7838137,acm1_human,396,P,A,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,9.92,,=,,10.05,1.349,,,,0.0,0.0,,0.0,,P11229,0.4551735943761197
554,7838137,acm1_human,396,P,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.25,,=,,5.13,-1.318,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.4551735943761197
555,7838137,acm1_human,396,P,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.02,,=,,4.96,-1.148,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.4551735943761197
248,7838137,acm1_human,398,T,A,Gallamine,ChEMBL Compound ID,CHEMBL360055,Binding - unknown pharmacological activity,pK(i),Binding - Other,5.21,,=,,5.16,-1.122,,,,0.0,0.0,,0.0,,P11229,0.2341570530356085
249,7838137,acm1_human,398,T,A,Gallamine,ChEMBL Compound ID,CHEMBL360055,Binding - unknown pharmacological activity,pK(i),Binding - Other,3.67,,=,,3.6,-1.175,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.2341570530356085
328,7838137,acm1_human,398,T,A,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,9.92,,=,,9.94,1.047,,,,0.0,0.0,,0.0,,P11229,0.2341570530356085
556,7838137,acm1_human,398,T,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.25,,=,,5.1,-1.412,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.2341570530356085
557,7838137,acm1_human,398,T,A,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.02,,=,,4.87,-1.412,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.2341570530356085
261,1618842,acm1_human,71,D,N,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,Single-point,Binding - Radioligand saturation,55.0,%,=,,91.0,1.655,,,,85.4,0.0,,0.0,,P11229,0.7399339319633638
262,1488411,acm1_human,82,Y,F,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,0.85,nM,=,,0.54,1.574,,,[3H](R)-QNB,0.0,0.0,,0.0,,P11229,0.3090342519613377
265,25326383,acm1_human,82,Y,F,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,pK(A),Binding - Radioligand saturation,9.92,,=,,10.39,2.951,,,,67.5,0.0,,0.0,,P11229,0.3090342519613377
392,1488411,acm1_human,82,Y,F,Atropine,ChEMBL Compound ID,CHEMBL517712,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,0.44,nM,=,,0.42,1.048,,,[3H](R)-QNB,0.0,0.0,,0.0,,P11229,0.3090342519613377
393,1488411,acm1_human,82,Y,F,Atropine,ChEMBL Compound ID,CHEMBL517712,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,0.28,nM,=,,0.3,-1.072,,,[3H](R)-QNB,0.0,0.0,,0.0,,P11229,0.3090342519613377
443,25326383,acm1_human,82,Y,F,BQCA,ChEMBL Compound ID,CHEMBL608112,Binding - unknown pharmacological activity,pK(b),Binding - Radioligand competition/displacement,4.82,,=,,4.99,1.479,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.3090342519613377
474,25326383,acm1_human,82,Y,F,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.11,,=,,5.24,1.349,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.3090342519613377
590,1488411,acm1_human,82,Y,F,Carbachol,ChEMBL Compound ID,CHEMBL965,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,0.41,mM,=,,0.28,1.464,,,[3H](R)-QNB,0.0,0.0,,0.0,,P11229,0.3090342519613377
591,1488411,acm1_human,82,Y,F,Carbachol,ChEMBL Compound ID,CHEMBL965,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,0.41,mM,=,,0.22,1.864,,,[3H](R)-QNB,0.0,0.0,,0.0,,P11229,0.3090342519613377
592,1488411,acm1_human,82,Y,F,Carbachol,ChEMBL Compound ID,CHEMBL965,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,0.43,mM,=,,0.23,1.87,,,[3H](R)-QNB,0.0,0.0,,0.0,,P11229,0.3090342519613377
645,1488411,acm1_human,82,Y,F,Pirenzepine,ChEMBL Compound ID,CHEMBL9967,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,43.0,nM,=,,129.0,-3.003,,,[3H](R)-QNB,0.0,0.0,,0.0,,P11229,0.3090342519613377
646,1488411,acm1_human,82,Y,F,Pirenzepine,ChEMBL Compound ID,CHEMBL9967,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,57.0,nM,=,,146.0,-2.564,,,[3H](R)-QNB,0.0,0.0,,0.0,,P11229,0.3090342519613377
744,25326383,acm1_human,82,Y,F,Benzoquinazolinone 12,SMILES,Cn1cc(cn1)-c1ccc(Cc2cc3C(=O)N(CNc3c3ccccc23)C2CCCC[C@@H]2O)cn1,,pK(b),Binding - Radioligand competition/displacement,6.55,,=,,5.67,-7.576,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.3090342519613377
271,25326383,acm1_human,85,Y,F,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,pK(A),Binding - Radioligand saturation,9.92,,=,,10.04,1.318,,,,71.1,0.0,,0.0,,P11229,0.2789466287088141
447,25326383,acm1_human,85,Y,F,BQCA,ChEMBL Compound ID,CHEMBL608112,Binding - unknown pharmacological activity,pK(b),Binding - Radioligand competition/displacement,4.82,,=,,4.66,-1.445,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.2789466287088141
481,25326383,acm1_human,85,Y,F,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.11,,=,,4.98,-1.35,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.2789466287088141
746,25326383,acm1_human,85,Y,F,Benzoquinazolinone 12,SMILES,Cn1cc(cn1)-c1ccc(Cc2cc3C(=O)N(CNc3c3ccccc23)C2CCCC[C@@H]2O)cn1,,pK(b),Binding - Radioligand competition/displacement,6.55,,=,,5.86,-4.902,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.2789466287088141
293,25326383,acm1_human,179,Y,F,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,pK(A),Binding - Radioligand saturation,9.92,,=,,9.95,1.072,,,,67.5,0.0,,0.0,,P11229,0.2482013283946222
355,21685390,acm1_human,179,Y,F,N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,10.22,,=,,9.85,-2.342,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.2482013283946222
453,25326383,acm1_human,179,Y,F,BQCA,ChEMBL Compound ID,CHEMBL608112,Binding - unknown pharmacological activity,pK(b),Binding - Radioligand competition/displacement,4.82,,=,,4.72,-1.259,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.2482013283946222
514,25326383,acm1_human,179,Y,F,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.11,,=,,5.24,1.349,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.2482013283946222
681,21685390,acm1_human,179,Y,F,MT7,FASTA sequence (peptide),LTCVKSNSIWFPTSEDCPDGQNLCFKRWQYISPRMYDFTRGCAATCPKAEYRDVINCCGTDKCNK,Binding - unknown pharmacological activity,pKx,Binding - Radioligand competition/displacement,10.47,,=,,9.25,-16.667,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.2482013283946222
748,25326383,acm1_human,179,Y,F,Benzoquinazolinone 12,SMILES,Cn1cc(cn1)-c1ccc(Cc2cc3C(=O)N(CNc3c3ccccc23)C2CCCC[C@@H]2O)cn1,,pK(b),Binding - Radioligand competition/displacement,6.55,,=,,6.15,-2.513,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.2482013283946222
294,25326383,acm1_human,179,Y,W,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,pK(A),Binding - Radioligand saturation,9.92,,=,,9.85,-1.175,,,,73.3,0.0,,0.0,,P11229,0.2832664789020949
454,25326383,acm1_human,179,Y,W,BQCA,ChEMBL Compound ID,CHEMBL608112,Binding - unknown pharmacological activity,pK(b),Binding - Radioligand competition/displacement,4.82,,=,,5.06,1.738,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.2832664789020949
515,25326383,acm1_human,179,Y,W,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.11,,=,,5.08,-1.072,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.2832664789020949
749,25326383,acm1_human,179,Y,W,Benzoquinazolinone 12,SMILES,Cn1cc(cn1)-c1ccc(Cc2cc3C(=O)N(CNc3c3ccccc23)C2CCCC[C@@H]2O)cn1,,pK(b),Binding - Radioligand competition/displacement,6.55,,=,,6.69,1.38,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.2832664789020949
303,24443568,acm1_human,189,T,A,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,pK(A),Binding - Radioligand saturation,10.04,,=,,9.56,-3.021,,,,130.0,0.0,,0.0,,P11229,0.4787280320379894
460,24443568,acm1_human,189,T,A,BQCA,ChEMBL Compound ID,CHEMBL608112,Binding - unknown pharmacological activity,pK(b),Binding - Radioligand competition/displacement,4.49,,=,,4.68,1.549,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.4787280320379894
612,24443568,acm1_human,189,T,A,Carbachol,ChEMBL Compound ID,CHEMBL965,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.56,,=,,3.69,-7.407,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.4787280320379894
306,1618842,acm1_human,215,T,A,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,Single-point,Binding - Other,55.0,%,=,,55.0,1.0,,,,0.0,0.0,,0.0,,P11229,0.5090550669379563
307,1618842,acm1_human,228,S,A,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,Single-point,Binding - Other,55.0,%,=,,52.0,-1.058,,,,0.0,0.0,,0.0,,P11229,0.2673831787654491
308,17540859,acm1_human,252,P,A,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,9.57,,=,,9.23,-2.188,,,,142.2,0.0,,0.0,,P11229,0.3231375073170649
309,17540859,acm1_human,254,T,A,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,9.57,,=,,9.15,-2.632,,,,106.5,0.0,,0.0,,P11229,0.2844721639787252
310,17540859,acm1_human,263,C,A,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,9.57,,=,,9.25,-2.088,,,,141.9,0.0,,0.0,,P11229,0.2589684193127289
311,8463213,acm1_human,284,S,A,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,Single-point,Binding - Other,55.0,%,=,,46.0,-1.196,,,,0.0,0.0,,0.0,,P11229,0.3715065403501962
312,1618842,acm1_human,322,S,A,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,Single-point,Binding - Other,55.0,%,=,,52.0,-1.058,,,,0.0,0.0,,0.0,,P11229,0.2673387944939651
313,1618842,acm1_human,330,T,A,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,Single-point,Binding - Other,55.0,%,=,,56.0,1.018,,,,0.0,0.0,,0.0,,P11229,0.2764714230172828
314,1618842,acm1_human,354,T,A,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,Single-point,Binding - Other,55.0,%,=,,62.0,1.127,,,,0.0,0.0,,0.0,,P11229,0.3139945349453828
315,1618842,acm1_human,356,S,A,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,Single-point,Binding - Other,55.0,%,=,,60.0,1.091,,,,0.0,0.0,,0.0,,P11229,0.3788655278884164
316,1618842,acm1_human,368,S,A,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,Single-point,Binding - Other,55.0,%,=,,58.0,1.055,,,,0.0,0.0,,0.0,,P11229,0.421798171081953
317,24443568,acm1_human,374,F,A,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,pK(A),Binding - Radioligand saturation,10.04,,=,,9.29,-5.618,,,,30.0,0.0,,0.0,,P11229,0.8212603564557523
462,24443568,acm1_human,374,F,A,BQCA,ChEMBL Compound ID,CHEMBL608112,Binding - unknown pharmacological activity,pK(b),Binding - Radioligand competition/displacement,4.49,,=,,5.38,7.762,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.8212603564557523
624,24443568,acm1_human,374,F,A,Carbachol,ChEMBL Compound ID,CHEMBL965,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.56,,=,,5.43,7.413,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.8212603564557523
327,24443568,acm1_human,397,E,A,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,pK(A),Binding - Radioligand saturation,10.04,,=,,9.82,-1.658,,,,79.0,0.0,,0.0,,P11229,0.2693918407227453
360,21685390,acm1_human,397,E,A,N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,10.22,,=,,10.21,-1.024,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.2693918407227453
465,24443568,acm1_human,397,E,A,BQCA,ChEMBL Compound ID,CHEMBL608112,Binding - unknown pharmacological activity,pK(b),Binding - Radioligand competition/displacement,4.49,,=,,4.66,1.479,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.2693918407227453
639,24443568,acm1_human,397,E,A,Carbachol,ChEMBL Compound ID,CHEMBL965,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.56,,=,,4.64,1.202,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.2693918407227453
686,21685390,acm1_human,397,E,A,MT7,FASTA sequence (peptide),LTCVKSNSIWFPTSEDCPDGQNLCFKRWQYISPRMYDFTRGCAATCPKAEYRDVINCCGTDKCNK,Binding - unknown pharmacological activity,pKx,Binding - Radioligand competition/displacement,10.47,,=,,10.54,1.175,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.2693918407227453
338,24443568,acm1_human,405,W,A,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,pK(A),Binding - Radioligand saturation,10.04,,=,,9.95,-1.23,,,,63.0,0.0,,0.0,,P11229,0.6175047272617838
469,24443568,acm1_human,405,W,A,BQCA,ChEMBL Compound ID,CHEMBL608112,Binding - unknown pharmacological activity,pK(b),Binding - Radioligand competition/displacement,4.49,,=,,5.7,16.218,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.6175047272617838
642,24443568,acm1_human,405,W,A,Carbachol,ChEMBL Compound ID,CHEMBL965,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.56,,=,,5.4,6.918,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.6175047272617838
341,1618842,acm1_human,428,T,A,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,Single-point,Binding - Other,55.0,%,=,,53.0,-1.037,,,,0.0,0.0,,0.0,,P11229,0.5395751985394985
347,21685390,acm1_human,166,Y,A,N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,10.22,,=,,9.83,-2.457,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.3385096841282489
673,21685390,acm1_human,166,Y,A,MT7,FASTA sequence (peptide),LTCVKSNSIWFPTSEDCPDGQNLCFKRWQYISPRMYDFTRGCAATCPKAEYRDVINCCGTDKCNK,Binding - unknown pharmacological activity,pKx,Binding - Radioligand competition/displacement,10.47,,=,,10.33,-1.381,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.3385096841282489
349,21685390,acm1_human,170,E,A,N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,10.22,,=,,10.2,-1.047,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.2817562874135239
675,21685390,acm1_human,170,E,A,MT7,FASTA sequence (peptide),LTCVKSNSIWFPTSEDCPDGQNLCFKRWQYISPRMYDFTRGCAATCPKAEYRDVINCCGTDKCNK,Binding - unknown pharmacological activity,pKx,Binding - Radioligand competition/displacement,10.47,,=,,10.2,-1.862,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.2817562874135239
350,21685390,acm1_human,170,E,K,N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,10.22,,=,,10.16,-1.148,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.2148480743029467
676,21685390,acm1_human,170,E,K,MT7,FASTA sequence (peptide),LTCVKSNSIWFPTSEDCPDGQNLCFKRWQYISPRMYDFTRGCAATCPKAEYRDVINCCGTDKCNK,Binding - unknown pharmacological activity,pKx,Binding - Radioligand competition/displacement,10.47,,=,,9.31,-14.493,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.2148480743029467
352,21685390,acm1_human,174,L,A,N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,10.22,,=,,10.21,-1.024,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.2873580669578599
678,21685390,acm1_human,174,L,A,MT7,FASTA sequence (peptide),LTCVKSNSIWFPTSEDCPDGQNLCFKRWQYISPRMYDFTRGCAATCPKAEYRDVINCCGTDKCNK,Binding - unknown pharmacological activity,pKx,Binding - Radioligand competition/displacement,10.47,,=,,10.51,1.096,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.2873580669578599
353,21685390,acm1_human,174,L,P,N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,10.22,,=,,10.15,-1.175,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.3662866747999309
679,21685390,acm1_human,174,L,P,MT7,FASTA sequence (peptide),LTCVKSNSIWFPTSEDCPDGQNLCFKRWQYISPRMYDFTRGCAATCPKAEYRDVINCCGTDKCNK,Binding - unknown pharmacological activity,pKx,Binding - Radioligand competition/displacement,10.47,,=,,9.37,-12.658,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.3662866747999309
354,21685390,acm1_human,177,Q,E,N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,10.22,,=,,10.08,-1.381,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.2621455188953649
680,21685390,acm1_human,177,Q,E,MT7,FASTA sequence (peptide),LTCVKSNSIWFPTSEDCPDGQNLCFKRWQYISPRMYDFTRGCAATCPKAEYRDVINCCGTDKCNK,Binding - unknown pharmacological activity,pKx,Binding - Radioligand competition/displacement,10.47,,=,,10.58,1.288,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.2621455188953649
357,21685390,acm1_human,185,Q,A,N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,10.22,,=,,10.18,-1.096,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.4523316819472514
683,21685390,acm1_human,185,Q,A,MT7,FASTA sequence (peptide),LTCVKSNSIWFPTSEDCPDGQNLCFKRWQYISPRMYDFTRGCAATCPKAEYRDVINCCGTDKCNK,Binding - unknown pharmacological activity,pKx,Binding - Radioligand competition/displacement,10.47,,=,,10.59,1.318,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.4523316819472514
618,7706286,acm1_human,209,W,A,Carbachol,ChEMBL Compound ID,CHEMBL965,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,0.33,mM,=,,0.28,1.179,,,[3H]N-methyl scopolamine,0.0,93.1,,0.0,,P11229,0.3775573723291207
619,7706286,acm1_human,211,I,A,Carbachol,ChEMBL Compound ID,CHEMBL965,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,0.33,mM,=,,0.58,-1.757,,,[3H]N-methyl scopolamine,0.0,95.7,,0.0,,P11229,0.5642679954490848
620,7706286,acm1_human,212,Y,A,Carbachol,ChEMBL Compound ID,CHEMBL965,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,0.33,mM,=,,0.48,-1.453,,,[3H]N-methyl scopolamine,0.0,98.3,,0.0,,P11229,0.5707226925343736
621,7706286,acm1_human,360,E,A,Carbachol,ChEMBL Compound ID,CHEMBL965,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,0.33,mM,=,,0.03,11.0,,,[3H]N-methyl scopolamine,0.0,187.9,,0.0,,P11229,0.6974757217542025
622,7706286,acm1_human,362,K,A,Carbachol,ChEMBL Compound ID,CHEMBL965,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,0.33,mM,=,,1.6,-4.854,,,[3H]N-methyl scopolamine,0.0,74.1,,0.0,,P11229,0.5955759665839593
623,7706286,acm1_human,366,T,A,Carbachol,ChEMBL Compound ID,CHEMBL965,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,0.33,mM,=,,0.12,2.75,,,[3H]N-methyl scopolamine,0.0,87.9,,0.0,,P11229,0.4919430090315395
693,20643905,acm1_human,99,D,N,BR-384,PubChem CID,3078975,Binding - unknown pharmacological activity,Single-point,Binding - Radioligand competition/displacement,21.0,%,=,,7.4,-2.841,,,N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.3867023680097974
695,20643905,acm1_human,407,C,A,BR-384,PubChem CID,3078975,Binding - unknown pharmacological activity,Single-point,Binding - Radioligand competition/displacement,21.0,%,=,,1.6,-13.158,,,N-methyl scopolamine,0.0,0.0,,0.0,,P11229,0.4953828374397576
0,http://doi.org/10.1016/j.domaniend.2007.05.003,mc4r_human,298,D,N,NDP-MSH,PubChem CID,16154396,,IC50,Binding - Radioligand competition/displacement,7.7,nM,=,,14.07,-1.828,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.7092430081018672
1,http://doi.org/10.1016/j.domaniend.2007.05.003,mc4r_human,298,D,N,NDP-MSH,PubChem CID,16154396,,EC50,Functional - cAMP accumulation,1.63,nM,=,,12.96,-7.937,,,,0.0,0.0,,0.0,,P32245,0.7092430081018672
2,http://doi.org/10.1016/j.domaniend.2007.05.003,mc4r_human,298,D,N,Ag-RP (86-132),UniProt Entry Code (peptide),O00253Â ,,IC50,Binding - Radioligand competition/displacement,5.43,nM,=,,4.02,1.351,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.7092430081018672
3,10.1111/j.1582-4934.2009.00726.x,mc4r_human,7,R,C,NDP-MSH,PubChem CID,16154396,,IC50,Binding - Radioligand competition/displacement,13.16,nM,=,,12.32,1.068,,,125-I-NDP-MSH,70.0,0.0,,0.0,,P32245,0.4060450373978859
13,10.1111/j.1582-4934.2009.00726.x,mc4r_human,7,R,C,NDP-MSH,PubChem CID,16154396,,EC50,Functional - cAMP accumulation,1.22,nM,=,,3.06,-2.506,,,,0.0,0.0,,0.0,,P32245,0.4060450373978859
23,10.1111/j.1582-4934.2009.00726.x,mc4r_human,7,R,C,Ag-RP (86-132),UniProt Entry Code (peptide),O00253Â ,,IC50,Binding - Radioligand competition/displacement,4.16,nM,=,,3.6,1.156,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.4060450373978859
5,10.1111/j.1582-4934.2009.00726.x,mc4r_human,127,S,L,NDP-MSH,PubChem CID,16154396,,IC50,Binding - Radioligand competition/displacement,13.16,nM,=,,14.99,-1.139,,,125-I-NDP-MSH,100.0,0.0,,0.0,,P32245,0.4815488434035059
15,10.1111/j.1582-4934.2009.00726.x,mc4r_human,127,S,L,NDP-MSH,PubChem CID,16154396,,EC50,Functional - cAMP accumulation,1.22,nM,=,,1.78,-1.46,,,,0.0,0.0,,0.0,,P32245,0.4815488434035059
24,10.1111/j.1582-4934.2009.00726.x,mc4r_human,127,S,L,Ag-RP (86-132),UniProt Entry Code (peptide),O00253Â ,,IC50,Binding - Radioligand competition/displacement,4.16,nM,=,,18.25,-4.386,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.4815488434035059
346,10.1210/jc.2003-030233,mc4r_human,127,S,L,Alpha-MSH,PubChem CID,16133793,,EC50,Functional - cAMP accumulation,51.0,nM,=,,4003.0,-76.923,,,,0.0,0.0,,0.0,,P32245,0.4815488434035059
370,10.1677/joe-09-0336,mc4r_human,127,S,L,Alpha-MSH,PubChem CID,16133793,,K(i),Binding - Radioligand competition/displacement,26.0,nM,=,,160.0,-6.135,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.4815488434035059
371,10.1677/joe-09-0336,mc4r_human,127,S,L,IRC-022493,PubChem CID,11993702,,K(i),Binding - Radioligand competition/displacement,0.71,nM,=,,3.3,-4.651,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.4815488434035059
372,10.1677/joe-09-0336,mc4r_human,127,S,L,IRC-022511,PubChem CID,,,K(i),Binding - Radioligand competition/displacement,0.71,nM,=,,2.6,-3.663,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.4815488434035059
403,10.1677/joe-09-0336,mc4r_human,127,S,L,Alpha-MSH,PubChem CID,16133793,,EC50,Functional - cAMP accumulation,30.0,nM,=,,640.0,-21.277,,,,0.0,0.0,,0.0,,P32245,0.4815488434035059
404,10.1677/joe-09-0336,mc4r_human,127,S,L,IRC-022493,PubChem CID,11993702,,EC50,Functional - cAMP accumulation,1.5,nM,=,,17.0,-11.364,,,,0.0,0.0,,0.0,,P32245,0.4815488434035059
405,10.1677/joe-09-0336,mc4r_human,127,S,L,IRC-022511,PubChem CID,,,EC50,Functional - cAMP accumulation,0.7,nM,=,,5.2,-7.407,,,,0.0,0.0,,0.0,,P32245,0.4815488434035059
6,10.1111/j.1582-4934.2009.00726.x,mc4r_human,136,S,F,NDP-MSH,PubChem CID,16154396,,IC50,Binding - Radioligand competition/displacement,13.16,nM,=,,3.72,3.538,,,125-I-NDP-MSH,80.0,0.0,,0.0,,P32245,0.7113188569048297
16,10.1111/j.1582-4934.2009.00726.x,mc4r_human,136,S,F,NDP-MSH,PubChem CID,16154396,,EC50,Functional - cAMP accumulation,1.22,nM,=,,7.61,-6.25,,,,0.0,0.0,,0.0,,P32245,0.7113188569048297
25,10.1111/j.1582-4934.2009.00726.x,mc4r_human,136,S,F,Ag-RP (86-132),UniProt Entry Code (peptide),O00253Â ,,IC50,Binding - Radioligand competition/displacement,4.16,nM,=,,0.41,10.146,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.7113188569048297
8,10.1111/j.1582-4934.2009.00726.x,mc4r_human,219,A,V,NDP-MSH,PubChem CID,16154396,,IC50,Binding - Radioligand competition/displacement,13.16,nM,=,,20.11,-1.529,,,125-I-NDP-MSH,85.0,0.0,,0.0,,P32245,0.6208734426418704
18,10.1111/j.1582-4934.2009.00726.x,mc4r_human,219,A,V,NDP-MSH,PubChem CID,16154396,,EC50,Functional - cAMP accumulation,1.22,nM,=,,24.19,-20.0,,,,0.0,0.0,,0.0,,P32245,0.6208734426418704
26,10.1111/j.1582-4934.2009.00726.x,mc4r_human,219,A,V,Ag-RP (86-132),UniProt Entry Code (peptide),O00253Â ,,IC50,Binding - Radioligand competition/displacement,4.16,nM,=,,12.83,-3.086,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.6208734426418704
290,10.1021/jm500064t,mc4r_human,219,A,V,JRH887-9,FASTA sequence (peptide),Ac-His-Dphe-Arg-Trp-NH2,,EC50,Functional - cAMP accumulation,0.93,nM,=,,9.78,-10.526,,,,0.0,0.0,,0.0,,P32245,0.6208734426418704
296,10.1021/jm500064t,mc4r_human,219,A,V,CMPD4,FASTA sequence (peptide),Ac-His-(pI)DPhe-Tic-(pNO2)DPhe-NH2,,EC50,Functional - cAMP accumulation,0.24,nM,=,,4.5,-18.868,,,,0.0,0.0,,0.0,,P32245,0.6208734426418704
302,10.1021/jm500064t,mc4r_human,219,A,V,CMPD5,FASTA sequence (peptide),Ac-His-(pI)DPhe-Arg-(pI)Phe-NH2,,EC50,Functional - cAMP accumulation,0.14,nM,=,,3.2,-22.727,,,,0.0,0.0,,0.0,,P32245,0.6208734426418704
308,10.1021/jm500064t,mc4r_human,219,A,V,CMPD6,FASTA sequence (peptide),Ac-Arg-(pI)DPhe-Tic-(pNO2)DPhe-NH2,,EC50,Functional - cAMP accumulation,0.26,nM,=,,6.1,-23.256,,,,0.0,0.0,,0.0,,P32245,0.6208734426418704
314,10.1021/jm500064t,mc4r_human,219,A,V,CMPD7,FASTA sequence (peptide),Ac-Arg-(pI)DPhe-Arg-(pI)Phe-NH2,,EC50,Functional - cAMP accumulation,0.29,nM,=,,14.0,-47.619,,,,0.0,0.0,,0.0,,P32245,0.6208734426418704
320,10.1021/jm500064t,mc4r_human,219,A,V,CMPD8,FASTA sequence (peptide),Ac-His-(pCl)DPhe-Tic-(pNO2)DPhe-NH2,,EC50,Functional - cAMP accumulation,0.4,nM,=,,2.8,-6.993,,,,0.0,0.0,,0.0,,P32245,0.6208734426418704
326,10.1021/jm500064t,mc4r_human,219,A,V,CMPD9,FASTA sequence (peptide),Ac-His-(pCl)DPhe-Arg-(pI)Phe-NH2,,EC50,Functional - cAMP accumulation,0.45,nM,=,,6.1,-13.514,,,,0.0,0.0,,0.0,,P32245,0.6208734426418704
332,10.1021/jm500064t,mc4r_human,219,A,V,CMPD10,FASTA sequence (peptide),Ac-Arg-(pCl)DPhe-Tic-(pNO2)DPhe-NH2,,EC50,Functional - cAMP accumulation,0.21,nM,=,,4.2,-20.0,,,,0.0,0.0,,0.0,,P32245,0.6208734426418704
338,10.1021/jm500064t,mc4r_human,219,A,V,CMPD11,FASTA sequence (peptide),Ac-Arg-(pCl)DPhe-Arg-(pI)Phe-NH2,,EC50,Functional - cAMP accumulation,0.19,nM,=,,17.0,-90.909,,,,0.0,0.0,,0.0,,P32245,0.6208734426418704
9,10.1111/j.1582-4934.2009.00726.x,mc4r_human,230,P,L,NDP-MSH,PubChem CID,16154396,,IC50,Binding - Radioligand competition/displacement,13.16,nM,=,,12.82,1.027,,,125-I-NDP-MSH,90.0,0.0,,0.0,,P32245,0.4095647918797356
19,10.1111/j.1582-4934.2009.00726.x,mc4r_human,230,P,L,NDP-MSH,PubChem CID,16154396,,EC50,Functional - cAMP accumulation,1.22,nM,=,,12.31,-10.101,,,,0.0,0.0,,0.0,,P32245,0.4095647918797356
27,10.1111/j.1582-4934.2009.00726.x,mc4r_human,230,P,L,Ag-RP (86-132),UniProt Entry Code (peptide),O00253Â ,,IC50,Binding - Radioligand competition/displacement,4.16,nM,=,,4.01,1.037,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.4095647918797356
348,10.1210/jc.2003-030233,mc4r_human,230,P,L,Alpha-MSH,PubChem CID,16133793,,EC50,Functional - cAMP accumulation,51.0,nM,=,,107.0,-2.096,,,,0.0,0.0,,0.0,,P32245,0.4095647918797356
10,10.1111/j.1582-4934.2009.00726.x,mc4r_human,261,F,S,NDP-MSH,PubChem CID,16154396,,IC50,Binding - Radioligand competition/displacement,13.16,nM,=,,2.49,5.285,,,125-I-NDP-MSH,80.0,0.0,,0.0,,P32245,0.5682137148264276
20,10.1111/j.1582-4934.2009.00726.x,mc4r_human,261,F,S,NDP-MSH,PubChem CID,16154396,,EC50,Functional - cAMP accumulation,1.22,nM,=,,1.48,-1.214,,,,0.0,0.0,,0.0,,P32245,0.5682137148264276
28,10.1111/j.1582-4934.2009.00726.x,mc4r_human,261,F,S,Ag-RP (86-132),UniProt Entry Code (peptide),O00253Â ,,IC50,Binding - Radioligand competition/displacement,4.16,nM,=,,1.33,3.128,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.5682137148264276
11,10.1111/j.1582-4934.2009.00726.x,mc4r_human,317,I,V,NDP-MSH,PubChem CID,16154396,,IC50,Binding - Radioligand competition/displacement,13.16,nM,=,,18.44,-1.401,,,125-I-NDP-MSH,150.0,0.0,,0.0,,P32245,0.2411878580882963
21,10.1111/j.1582-4934.2009.00726.x,mc4r_human,317,I,V,NDP-MSH,PubChem CID,16154396,,EC50,Functional - cAMP accumulation,1.22,nM,=,,3.6,-2.95,,,,0.0,0.0,,0.0,,P32245,0.2411878580882963
29,10.1111/j.1582-4934.2009.00726.x,mc4r_human,317,I,V,Ag-RP (86-132),UniProt Entry Code (peptide),O00253Â ,,IC50,Binding - Radioligand competition/displacement,4.16,nM,=,,3.56,1.169,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.2411878580882963
12,10.1111/j.1582-4934.2009.00726.x,mc4r_human,325,L,F,NDP-MSH,PubChem CID,16154396,,IC50,Binding - Radioligand competition/displacement,13.16,nM,=,,5.12,2.57,,,125-I-NDP-MSH,140.0,0.0,,0.0,,P32245,0.2827240862807308
22,10.1111/j.1582-4934.2009.00726.x,mc4r_human,325,L,F,NDP-MSH,PubChem CID,16154396,,EC50,Functional - cAMP accumulation,1.22,nM,=,,2.62,-2.146,,,,0.0,0.0,,0.0,,P32245,0.2827240862807308
30,10.1111/j.1582-4934.2009.00726.x,mc4r_human,325,L,F,Ag-RP (86-132),UniProt Entry Code (peptide),O00253Â ,,IC50,Binding - Radioligand competition/displacement,4.16,nM,=,,6.17,-1.484,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.2827240862807308
14,10.1111/j.1582-4934.2009.00726.x,mc4r_human,84,C,R,NDP-MSH,PubChem CID,16154396,,EC50,Functional - cAMP accumulation,1.22,nM,=,,8.73,-7.143,,,,0.0,0.0,,0.0,,P32245,0.5841920384411499
31,10.1111/j.1582-4934.2009.00726.x,mc4r_human,136,S,A,NDP-MSH,PubChem CID,16154396,,IC50,Binding - Radioligand competition/displacement,25.21,nM,=,,24.84,1.015,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.5895252186220916
37,10.1111/j.1582-4934.2009.00726.x,mc4r_human,136,S,A,NDP-MSH,PubChem CID,16154396,,EC50,Functional - cAMP accumulation,1.5,nM,=,,8.06,-5.376,,,,0.0,0.0,,0.0,,P32245,0.5895252186220916
32,10.1111/j.1582-4934.2009.00726.x,mc4r_human,136,S,C,NDP-MSH,PubChem CID,16154396,,IC50,Binding - Radioligand competition/displacement,25.21,nM,=,,37.37,-1.481,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.6730264875804597
38,10.1111/j.1582-4934.2009.00726.x,mc4r_human,136,S,C,NDP-MSH,PubChem CID,16154396,,EC50,Functional - cAMP accumulation,1.5,nM,=,,1.07,1.402,,,,0.0,0.0,,0.0,,P32245,0.6730264875804597
33,10.1111/j.1582-4934.2009.00726.x,mc4r_human,136,S,D,NDP-MSH,PubChem CID,16154396,,IC50,Binding - Radioligand competition/displacement,25.21,nM,=,,26.74,-1.06,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.6322709053077615
39,10.1111/j.1582-4934.2009.00726.x,mc4r_human,136,S,D,NDP-MSH,PubChem CID,16154396,,EC50,Functional - cAMP accumulation,1.5,nM,=,,2.85,-1.901,,,,0.0,0.0,,0.0,,P32245,0.6322709053077615
35,10.1111/j.1582-4934.2009.00726.x,mc4r_human,136,S,R,NDP-MSH,PubChem CID,16154396,,IC50,Binding - Radioligand competition/displacement,25.21,nM,=,,151.8,-6.024,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.6730264875804597
41,10.1111/j.1582-4934.2009.00726.x,mc4r_human,136,S,R,NDP-MSH,PubChem CID,16154396,,EC50,Functional - cAMP accumulation,1.5,nM,=,,10.73,-7.143,,,,0.0,0.0,,0.0,,P32245,0.6730264875804597
36,10.1111/j.1582-4934.2009.00726.x,mc4r_human,136,S,T,NDP-MSH,PubChem CID,16154396,,IC50,Binding - Radioligand competition/displacement,25.21,nM,=,,43.77,-1.736,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.5895252186220916
42,10.1111/j.1582-4934.2009.00726.x,mc4r_human,136,S,T,NDP-MSH,PubChem CID,16154396,,EC50,Functional - cAMP accumulation,1.5,nM,=,,2.45,-1.634,,,,0.0,0.0,,0.0,,P32245,0.5895252186220916
43,http://doi.org/10.1016/j.bbadis.2011.06.008,mc4r_human,76,H,R,Alpha-MSH,PubChem CID,16133793,,IC50,Binding - Radioligand competition/displacement,1684.23,nM,=,,41.31,40.771,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.5313390541842239
57,http://doi.org/10.1016/j.bbadis.2011.06.008,mc4r_human,76,H,R,Alpha-MSH,PubChem CID,16133793,,EC50,Functional - cAMP accumulation,2.59,nM,=,,0.92,2.815,,,,0.0,0.0,,0.0,,P32245,0.5313390541842239
71,http://doi.org/10.1016/j.bbadis.2011.06.008,mc4r_human,76,H,R,Beta-MSH,PubChem CID,16132286,,IC50,Binding - Radioligand competition/displacement,1506.32,nM,=,,111.34,13.529,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.5313390541842239
85,http://doi.org/10.1016/j.bbadis.2011.06.008,mc4r_human,76,H,R,Beta-MSH,PubChem CID,16132286,,EC50,Functional - cAMP accumulation,3.24,nM,=,,1.18,2.746,,,,0.0,0.0,,0.0,,P32245,0.5313390541842239
45,http://doi.org/10.1016/j.bbadis.2011.06.008,mc4r_human,94,S,N,Alpha-MSH,PubChem CID,16133793,,IC50,Binding - Radioligand competition/displacement,1684.23,nM,=,,53.7,31.364,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.4644334826104172
59,http://doi.org/10.1016/j.bbadis.2011.06.008,mc4r_human,94,S,N,Alpha-MSH,PubChem CID,16133793,,EC50,Functional - cAMP accumulation,2.59,nM,=,,5.26,-2.033,,,,0.0,0.0,,0.0,,P32245,0.4644334826104172
73,http://doi.org/10.1016/j.bbadis.2011.06.008,mc4r_human,94,S,N,Beta-MSH,PubChem CID,16132286,,IC50,Binding - Radioligand competition/displacement,1506.32,nM,=,,239.64,6.286,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.4644334826104172
87,http://doi.org/10.1016/j.bbadis.2011.06.008,mc4r_human,94,S,N,Beta-MSH,PubChem CID,16132286,,EC50,Functional - cAMP accumulation,3.24,nM,=,,7.33,-2.262,,,,0.0,0.0,,0.0,,P32245,0.4644334826104172
46,http://doi.org/10.1016/j.bbadis.2011.06.008,mc4r_human,146,D,N,Alpha-MSH,PubChem CID,16133793,,IC50,Binding - Radioligand competition/displacement,1684.23,nM,=,,4.41,381.912,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.7443186139160237
60,http://doi.org/10.1016/j.bbadis.2011.06.008,mc4r_human,146,D,N,Alpha-MSH,PubChem CID,16133793,,EC50,Functional - cAMP accumulation,2.59,nM,=,,0.08,32.375,,,,0.0,0.0,,0.0,,P32245,0.7443186139160237
74,http://doi.org/10.1016/j.bbadis.2011.06.008,mc4r_human,146,D,N,Beta-MSH,PubChem CID,16132286,,IC50,Binding - Radioligand competition/displacement,1506.32,nM,=,,66.74,22.57,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.7443186139160237
88,http://doi.org/10.1016/j.bbadis.2011.06.008,mc4r_human,146,D,N,Beta-MSH,PubChem CID,16132286,,EC50,Functional - cAMP accumulation,3.24,nM,=,,0.47,6.894,,,,0.0,0.0,,0.0,,P32245,0.7443186139160237
47,http://doi.org/10.1016/j.bbadis.2011.06.008,mc4r_human,186,I,V,Alpha-MSH,PubChem CID,16133793,,IC50,Binding - Radioligand competition/displacement,1684.23,nM,=,,1084.7,1.553,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.1749270374495357
61,http://doi.org/10.1016/j.bbadis.2011.06.008,mc4r_human,186,I,V,Alpha-MSH,PubChem CID,16133793,,EC50,Functional - cAMP accumulation,2.59,nM,=,,0.6,4.317,,,,0.0,0.0,,0.0,,P32245,0.1749270374495357
75,http://doi.org/10.1016/j.bbadis.2011.06.008,mc4r_human,186,I,V,Beta-MSH,PubChem CID,16132286,,IC50,Binding - Radioligand competition/displacement,1506.32,nM,=,,1106.9,1.361,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.1749270374495357
89,http://doi.org/10.1016/j.bbadis.2011.06.008,mc4r_human,186,I,V,Beta-MSH,PubChem CID,16132286,,EC50,Functional - cAMP accumulation,3.24,nM,=,,1.06,3.057,,,,0.0,0.0,,0.0,,P32245,0.1749270374495357
48,http://doi.org/10.1016/j.bbadis.2011.06.008,mc4r_human,195,I,S,Alpha-MSH,PubChem CID,16133793,,IC50,Binding - Radioligand competition/displacement,1684.23,nM,=,,329.08,5.118,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.3237698594456707
62,http://doi.org/10.1016/j.bbadis.2011.06.008,mc4r_human,195,I,S,Alpha-MSH,PubChem CID,16133793,,EC50,Functional - cAMP accumulation,2.59,nM,=,,3.11,-1.2,,,,0.0,0.0,,0.0,,P32245,0.3237698594456707
76,http://doi.org/10.1016/j.bbadis.2011.06.008,mc4r_human,195,I,S,Beta-MSH,PubChem CID,16132286,,IC50,Binding - Radioligand competition/displacement,1506.32,nM,=,,593.4,2.538,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.3237698594456707
90,http://doi.org/10.1016/j.bbadis.2011.06.008,mc4r_human,195,I,S,Beta-MSH,PubChem CID,16132286,,EC50,Functional - cAMP accumulation,3.24,nM,=,,4.28,-1.321,,,,0.0,0.0,,0.0,,P32245,0.3237698594456707
50,http://doi.org/10.1016/j.bbadis.2011.06.008,mc4r_human,231,G,V,Alpha-MSH,PubChem CID,16133793,,IC50,Binding - Radioligand competition/displacement,1684.23,nM,=,,745.7,2.259,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.3902380733505737
64,http://doi.org/10.1016/j.bbadis.2011.06.008,mc4r_human,231,G,V,Alpha-MSH,PubChem CID,16133793,,EC50,Functional - cAMP accumulation,2.59,nM,=,,1.74,1.489,,,,0.0,0.0,,0.0,,P32245,0.3902380733505737
78,http://doi.org/10.1016/j.bbadis.2011.06.008,mc4r_human,231,G,V,Beta-MSH,PubChem CID,16132286,,IC50,Binding - Radioligand competition/displacement,1506.32,nM,=,,1450.2,1.039,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.3902380733505737
92,http://doi.org/10.1016/j.bbadis.2011.06.008,mc4r_human,231,G,V,Beta-MSH,PubChem CID,16132286,,EC50,Functional - cAMP accumulation,3.24,nM,=,,1.77,1.831,,,,0.0,0.0,,0.0,,P32245,0.3902380733505737
53,http://doi.org/10.1016/j.bbadis.2011.06.008,mc4r_human,300,L,P,Alpha-MSH,PubChem CID,16133793,,IC50,Binding - Radioligand competition/displacement,1684.23,nM,=,,53.6,31.422,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.5558855694959316
67,http://doi.org/10.1016/j.bbadis.2011.06.008,mc4r_human,300,L,P,Alpha-MSH,PubChem CID,16133793,,EC50,Functional - cAMP accumulation,2.59,nM,=,,3.3,-1.274,,,,0.0,0.0,,0.0,,P32245,0.5558855694959316
81,http://doi.org/10.1016/j.bbadis.2011.06.008,mc4r_human,300,L,P,Beta-MSH,PubChem CID,16132286,,IC50,Binding - Radioligand competition/displacement,1506.32,nM,=,,342.63,4.396,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.5558855694959316
95,http://doi.org/10.1016/j.bbadis.2011.06.008,mc4r_human,300,L,P,Beta-MSH,PubChem CID,16132286,,EC50,Functional - cAMP accumulation,3.24,nM,=,,5.83,-1.799,,,,0.0,0.0,,0.0,,P32245,0.5558855694959316
54,http://doi.org/10.1016/j.bbadis.2011.06.008,mc4r_human,305,R,S,Alpha-MSH,PubChem CID,16133793,,IC50,Binding - Radioligand competition/displacement,1684.23,nM,=,,2263.67,-1.344,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.6349401724051337
68,http://doi.org/10.1016/j.bbadis.2011.06.008,mc4r_human,305,R,S,Alpha-MSH,PubChem CID,16133793,,EC50,Functional - cAMP accumulation,2.59,nM,=,,8.75,-3.378,,,,0.0,0.0,,0.0,,P32245,0.6349401724051337
82,http://doi.org/10.1016/j.bbadis.2011.06.008,mc4r_human,305,R,S,Beta-MSH,PubChem CID,16132286,,IC50,Binding - Radioligand competition/displacement,1506.32,nM,=,,1327.4,1.135,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.6349401724051337
96,http://doi.org/10.1016/j.bbadis.2011.06.008,mc4r_human,305,R,S,Beta-MSH,PubChem CID,16132286,,EC50,Functional - cAMP accumulation,3.24,nM,=,,6.92,-2.137,,,,0.0,0.0,,0.0,,P32245,0.6349401724051337
55,http://doi.org/10.1016/j.bbadis.2011.06.008,mc4r_human,332,Y,C,Alpha-MSH,PubChem CID,16133793,,IC50,Binding - Radioligand competition/displacement,1684.23,nM,=,,957.03,1.76,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.511908677882125
69,http://doi.org/10.1016/j.bbadis.2011.06.008,mc4r_human,332,Y,C,Alpha-MSH,PubChem CID,16133793,,EC50,Functional - cAMP accumulation,2.59,nM,=,,0.34,7.618,,,,0.0,0.0,,0.0,,P32245,0.511908677882125
83,http://doi.org/10.1016/j.bbadis.2011.06.008,mc4r_human,332,Y,C,Beta-MSH,PubChem CID,16132286,,IC50,Binding - Radioligand competition/displacement,1506.32,nM,=,,832.13,1.81,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.511908677882125
97,http://doi.org/10.1016/j.bbadis.2011.06.008,mc4r_human,332,Y,C,Beta-MSH,PubChem CID,16132286,,EC50,Functional - cAMP accumulation,3.24,nM,=,,1.55,2.09,,,,0.0,0.0,,0.0,,P32245,0.511908677882125
56,http://doi.org/10.1016/j.bbadis.2011.06.008,mc4r_human,332,Y,H,Alpha-MSH,PubChem CID,16133793,,IC50,Binding - Radioligand competition/displacement,1684.23,nM,=,,1674.37,1.006,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.3379383580091696
70,http://doi.org/10.1016/j.bbadis.2011.06.008,mc4r_human,332,Y,H,Alpha-MSH,PubChem CID,16133793,,EC50,Functional - cAMP accumulation,2.59,nM,=,,0.76,3.408,,,,0.0,0.0,,0.0,,P32245,0.3379383580091696
84,http://doi.org/10.1016/j.bbadis.2011.06.008,mc4r_human,332,Y,H,Beta-MSH,PubChem CID,16132286,,IC50,Binding - Radioligand competition/displacement,1506.32,nM,=,,975.93,1.543,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.3379383580091696
98,http://doi.org/10.1016/j.bbadis.2011.06.008,mc4r_human,332,Y,H,Beta-MSH,PubChem CID,16132286,,EC50,Functional - cAMP accumulation,3.24,nM,=,,2.54,1.276,,,,0.0,0.0,,0.0,,P32245,0.3379383580091696
99,https://doi.org/10.1016/j.bbamem.2012.10.011,mc4r_human,84,C,A,NDP-MSH,PubChem CID,16154396,,IC50,Binding - Radioligand competition/displacement,7.98,nM,=,,7.25,1.101,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.4501866470939731
100,https://doi.org/10.1016/j.bbamem.2012.10.011,mc4r_human,318,C,A,NDP-MSH,PubChem CID,16154396,,K(d),Binding - Radioligand competition/displacement,7.6,nM,=,,7.05,1.078,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.3069793013066255
108,https://doi.org/10.1016/j.jmb.2010.06.028,mc4r_human,125,I,C,NDP-MSH,PubChem CID,16154396,,pEC50,Functional - CRE-luciferase,8.27,nM,=,,7.98,-1.949,,,,0.0,0.0,,0.0,,P32245,0.4743277627967499
110,https://doi.org/10.1016/j.jmb.2010.06.028,mc4r_human,264,H,C,NDP-MSH,PubChem CID,16154396,,pEC50,Functional - CRE-luciferase,8.27,nM,=,,5.67,-333.333,,,,0.0,0.0,,0.0,,P32245,0.5537508301361858
121,10.1093/hmg/ddg057,mc4r_human,62,N,S,Alpha-MSH,PubChem CID,16133793,,,Binding - Radioligand competition/displacement,100.0,%,=,,20.0,-5.0,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.7999089204175133
122,10.1093/hmg/ddg057,mc4r_human,97,N,D,Alpha-MSH,PubChem CID,16133793,,,Binding - Radioligand competition/displacement,100.0,%,=,,10.5,-9.524,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.4394929074699051
123,10.1093/hmg/ddg057,mc4r_human,106,L,P,Alpha-MSH,PubChem CID,16133793,,,Binding - Radioligand competition/displacement,100.0,%,=,,18.7,-5.348,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.3750024170240656
263,10.1021/jm500064t,mc4r_human,106,L,P,Beta-MSH,PubChem CID,16172929,,EC50,Functional - cAMP accumulation,0.42,nM,=,,365.0,-1000.0,,,,0.0,0.0,,0.0,,P32245,0.3750024170240656
264,10.1021/jm500064t,mc4r_human,106,L,P,Gamma-MSH,PubChem CID,16133814,,EC50,Functional - cAMP accumulation,73.0,nM,=,,2660.0,-37.037,,,,0.0,0.0,,0.0,,P32245,0.3750024170240656
266,10.1021/jm500064t,mc4r_human,106,L,P,JRH887-9,FASTA sequence (peptide),Ac-His-Dphe-Arg-Trp-NH2,,EC50,Functional - cAMP accumulation,2.6,nM,=,,215.0,-83.333,,,,0.0,0.0,,0.0,,P32245,0.3750024170240656
267,10.1021/jm500064t,mc4r_human,106,L,P,EMH4-91,FASTA sequence (peptide),Ac-Arg-Dphe-Arg-Trp-NH2,,EC50,Functional - cAMP accumulation,1.06,nM,=,,124.0,-111.111,,,,0.0,0.0,,0.0,,P32245,0.3750024170240656
268,10.1021/jm500064t,mc4r_human,106,L,P,EMH4-92,FASTA sequence (peptide),Ac-Trp-Dphe-Arg-Trp-NH2,,EC50,Functional - cAMP accumulation,32.0,nM,=,,170.0,-5.319,,,,0.0,0.0,,0.0,,P32245,0.3750024170240656
269,10.1021/jm500064t,mc4r_human,106,L,P,EMH4-93,FASTA sequence (peptide),Ac-Tyr-DPhe-Arg-Trp-NH2,,EC50,Functional - cAMP accumulation,6.2,nM,=,,540.0,-90.909,,,,0.0,0.0,,0.0,,P32245,0.3750024170240656
270,10.1021/jm500064t,mc4r_human,106,L,P,EMH4-94,FASTA sequence (peptide),Ac-DArg-DPhe-Arg-Trp-NH2,,EC50,Functional - cAMP accumulation,40.0,nM,=,,1242.0,-31.25,,,,0.0,0.0,,0.0,,P32245,0.3750024170240656
271,10.1021/jm500064t,mc4r_human,106,L,P,EMH4-95,FASTA sequence (peptide),Ac-His-Arg-Arg-Trp-NH2,,EC50,Functional - cAMP accumulation,75.0,nM,=,,4940.0,-66.667,,,,0.0,0.0,,0.0,,P32245,0.3750024170240656
272,10.1021/jm500064t,mc4r_human,106,L,P,EMH4-96,FASTA sequence (peptide),Ac-His-DPhe-Lys-Trp-NH2,,EC50,Functional - cAMP accumulation,40.0,nM,=,,6240.0,-166.667,,,,0.0,0.0,,0.0,,P32245,0.3750024170240656
273,10.1021/jm500064t,mc4r_human,106,L,P,EMH4-97,FASTA sequence (peptide),Ac-His-DPhe-Arg-(pCl)Phe-NH2,,EC50,Functional - cAMP accumulation,17.0,nM,=,,2096.0,-125.0,,,,0.0,0.0,,0.0,,P32245,0.3750024170240656
274,10.1021/jm500064t,mc4r_human,106,L,P,EMH4-98,FASTA sequence (peptide),Ac-His-DPhe-Arg-(pCl)DPhe-NH2,,EC50,Functional - cAMP accumulation,46.0,nM,=,,8230.0,-166.667,,,,0.0,0.0,,0.0,,P32245,0.3750024170240656
275,10.1021/jm500064t,mc4r_human,106,L,P,EMH4-99,FASTA sequence (peptide),Ac-Tic-DPhe-Arg-Trp-NH2,,EC50,Functional - cAMP accumulation,15.0,nM,=,,4940.0,-333.333,,,,0.0,0.0,,0.0,,P32245,0.3750024170240656
276,10.1021/jm500064t,mc4r_human,106,L,P,EMH4-100,FASTA sequence (peptide),Ac-DTic-DPhe-Arg-Trp-NH2,,EC50,Functional - cAMP accumulation,297.0,nM,>,,10000.0,-33.333,,,,0.0,0.0,,0.0,,P32245,0.3750024170240656
277,10.1021/jm500064t,mc4r_human,106,L,P,EMH4-101,FASTA sequence (peptide),Ac-(pCl)DPhe-DPhe-Arg-Trp-NH2,,EC50,Functional - cAMP accumulation,48.0,nM,=,,4440.0,-90.909,,,,0.0,0.0,,0.0,,P32245,0.3750024170240656
278,10.1021/jm500064t,mc4r_human,106,L,P,EMH4-102,FASTA sequence (peptide),Ac-(pI)DPhe-DPhe-Arg-Trp-NH2,,EC50,Functional - cAMP accumulation,76.0,nM,=,,4910.0,-66.667,,,,0.0,0.0,,0.0,,P32245,0.3750024170240656
279,10.1021/jm500064t,mc4r_human,106,L,P,EMH4-103,FASTA sequence (peptide),Ac-(3I)Tyr-DPhe-Arg-Trp-NH2,,EC50,Functional - cAMP accumulation,1.9,nM,=,,43.0,-22.727,,,,0.0,0.0,,0.0,,P32245,0.3750024170240656
280,10.1021/jm500064t,mc4r_human,106,L,P,EMH4-104,FASTA sequence (peptide),Ac-His(pCl)DPhe-Arg-Trp-NH2,,EC50,Functional - cAMP accumulation,0.28,nM,=,,48.0,-166.667,,,,0.0,0.0,,0.0,,P32245,0.3750024170240656
281,10.1021/jm500064t,mc4r_human,106,L,P,EMH4-105,FASTA sequence (peptide),Ac-His-(pI)DPhe-Arg-Trp-NH2,,EC50,Functional - cAMP accumulation,1.3,nM,=,,97.0,-76.923,,,,0.0,0.0,,0.0,,P32245,0.3750024170240656
282,10.1021/jm500064t,mc4r_human,106,L,P,EMH4-106,FASTA sequence (peptide),Ac-His-DPhe-Tic-Trp-NH2,,EC50,Functional - cAMP accumulation,204.0,nM,>,,10000.0,-50.0,,,,0.0,0.0,,0.0,,P32245,0.3750024170240656
283,10.1021/jm500064t,mc4r_human,106,L,P,EMH4-107,FASTA sequence (peptide),Ac-His-DPhe-Arg-Tic-NH2,,EC50,Functional - cAMP accumulation,10000.0,nM,>,,10000.0,1.0,,,,0.0,0.0,,0.0,,P32245,0.3750024170240656
284,10.1021/jm500064t,mc4r_human,106,L,P,EMH4-108,FASTA sequence (peptide),Ac-His-DPhe-Arg-(pI)Phe-NH2,,EC50,Functional - cAMP accumulation,5.3,nM,=,,680.0,-125.0,,,,0.0,0.0,,0.0,,P32245,0.3750024170240656
285,10.1021/jm500064t,mc4r_human,106,L,P,EMH4-109,FASTA sequence (peptide),Ac-His-DPhe-Arg-(pNO2)Phe-NH2,,EC50,Functional - cAMP accumulation,195.0,nM,>,,10000.0,-52.632,,,,0.0,0.0,,0.0,,P32245,0.3750024170240656
286,10.1021/jm500064t,mc4r_human,106,L,P,EMH4-110,FASTA sequence (peptide),Ac-His-DPhe-Arg-Nal(1')-NH2,,EC50,Functional - cAMP accumulation,28.0,nM,=,,4280.0,-142.857,,,,0.0,0.0,,0.0,,P32245,0.3750024170240656
287,10.1021/jm500064t,mc4r_human,106,L,P,JRH887-9,FASTA sequence (peptide),Ac-His-Dphe-Arg-Trp-NH2,,EC50,Functional - cAMP accumulation,0.93,nM,=,,191.0,-200.0,,,,0.0,0.0,,0.0,,P32245,0.3750024170240656
293,10.1021/jm500064t,mc4r_human,106,L,P,CMPD4,FASTA sequence (peptide),Ac-His-(pI)DPhe-Tic-(pNO2)DPhe-NH2,,EC50,Functional - cAMP accumulation,0.24,nM,=,,10.0,-41.667,,,,0.0,0.0,,0.0,,P32245,0.3750024170240656
299,10.1021/jm500064t,mc4r_human,106,L,P,CMPD5,FASTA sequence (peptide),Ac-His-(pI)DPhe-Arg-(pI)Phe-NH2,,EC50,Functional - cAMP accumulation,0.14,nM,=,,2.9,-20.833,,,,0.0,0.0,,0.0,,P32245,0.3750024170240656
305,10.1021/jm500064t,mc4r_human,106,L,P,CMPD6,FASTA sequence (peptide),Ac-Arg-(pI)DPhe-Tic-(pNO2)DPhe-NH2,,EC50,Functional - cAMP accumulation,0.26,nM,=,,2.6,-10.0,,,,0.0,0.0,,0.0,,P32245,0.3750024170240656
311,10.1021/jm500064t,mc4r_human,106,L,P,CMPD7,FASTA sequence (peptide),Ac-Arg-(pI)DPhe-Arg-(pI)Phe-NH2,,EC50,Functional - cAMP accumulation,0.29,nM,=,,4.4,-15.152,,,,0.0,0.0,,0.0,,P32245,0.3750024170240656
317,10.1021/jm500064t,mc4r_human,106,L,P,CMPD8,FASTA sequence (peptide),Ac-His-(pCl)DPhe-Tic-(pNO2)DPhe-NH2,,EC50,Functional - cAMP accumulation,0.4,nM,=,,15.0,-37.037,,,,0.0,0.0,,0.0,,P32245,0.3750024170240656
323,10.1021/jm500064t,mc4r_human,106,L,P,CMPD9,FASTA sequence (peptide),Ac-His-(pCl)DPhe-Arg-(pI)Phe-NH2,,EC50,Functional - cAMP accumulation,0.45,nM,=,,10.0,-22.222,,,,0.0,0.0,,0.0,,P32245,0.3750024170240656
329,10.1021/jm500064t,mc4r_human,106,L,P,CMPD10,FASTA sequence (peptide),Ac-Arg-(pCl)DPhe-Tic-(pNO2)DPhe-NH2,,EC50,Functional - cAMP accumulation,0.21,nM,=,,3.4,-16.129,,,,0.0,0.0,,0.0,,P32245,0.3750024170240656
335,10.1021/jm500064t,mc4r_human,106,L,P,CMPD11,FASTA sequence (peptide),Ac-Arg-(pCl)DPhe-Arg-(pI)Phe-NH2,,EC50,Functional - cAMP accumulation,0.19,nM,=,,13.0,-66.667,,,,0.0,0.0,,0.0,,P32245,0.3750024170240656
125,10.1093/hmg/ddg057,mc4r_human,165,R,Q,Alpha-MSH,PubChem CID,16133793,,,Binding - Radioligand competition/displacement,100.0,%,=,,29.9,-3.344,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.299225050425921
126,10.1093/hmg/ddg057,mc4r_human,175,A,T,Alpha-MSH,PubChem CID,16133793,,,Binding - Radioligand competition/displacement,100.0,%,=,,60.4,-1.656,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.216196483468624
127,10.1093/hmg/ddg057,mc4r_human,253,V,I,Alpha-MSH,PubChem CID,16133793,,,Binding - Radioligand competition/displacement,100.0,%,=,,80.3,-1.245,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.3088345709256107
129,10.1093/hmg/ddg057,mc4r_human,316,I,S,Alpha-MSH,PubChem CID,16133793,,,Binding - Radioligand competition/displacement,100.0,%,=,,28.0,-3.571,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.5204623737139308
130,10.1021/bi001684q,mc4r_human,49,E,A,NDP-MSH,PubChem CID,16154396,,K(i),Binding - Radioligand competition/displacement,1.54,nM,=,,2.2,-1.429,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.2612726861507643
156,10.1021/bi001684q,mc4r_human,49,E,A,Alpha-MSH,PubChem CID,16133793,,K(i),Binding - Radioligand competition/displacement,34.3,nM,=,,83.7,-2.439,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.2612726861507643
182,10.1021/bi001684q,mc4r_human,49,E,A,Ag-RP (86-132),UniProt Entry Code (peptide),O00253Â ,,K(i),Binding - Radioligand competition/displacement,2.95,nM,=,,3.87,-1.312,,,125-I-AGRP,0.0,0.0,,0.0,,P32245,0.2612726861507643
209,10.1021/bi001684q,mc4r_human,49,E,A,NDP-MSH,PubChem CID,16154396,,EC50,Functional - cAMP accumulation,0.27,nM,=,,0.42,-1.555,,,,0.0,0.0,,0.0,,P32245,0.2612726861507643
235,10.1021/bi001684q,mc4r_human,49,E,A,Alpha-MSH,PubChem CID,16133793,,EC50,Functional - cAMP accumulation,1.34,nM,=,,2.37,-1.77,,,,0.0,0.0,,0.0,,P32245,0.2612726861507643
131,10.1021/bi001684q,mc4r_human,61,E,A,NDP-MSH,PubChem CID,16154396,,K(i),Binding - Radioligand competition/displacement,1.54,nM,=,,4.04,-2.625,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.5333569449182762
157,10.1021/bi001684q,mc4r_human,61,E,A,Alpha-MSH,PubChem CID,16133793,,K(i),Binding - Radioligand competition/displacement,34.3,nM,=,,71.9,-2.096,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.5333569449182762
183,10.1021/bi001684q,mc4r_human,61,E,A,Ag-RP (86-132),UniProt Entry Code (peptide),O00253Â ,,K(i),Binding - Radioligand competition/displacement,2.95,nM,=,,4.3,-1.458,,,125-I-AGRP,0.0,0.0,,0.0,,P32245,0.5333569449182762
210,10.1021/bi001684q,mc4r_human,61,E,A,NDP-MSH,PubChem CID,16154396,,EC50,Functional - cAMP accumulation,0.27,nM,=,,0.51,-1.89,,,,0.0,0.0,,0.0,,P32245,0.5333569449182762
236,10.1021/bi001684q,mc4r_human,61,E,A,Alpha-MSH,PubChem CID,16133793,,EC50,Functional - cAMP accumulation,1.34,nM,=,,6.12,-4.566,,,,0.0,0.0,,0.0,,P32245,0.5333569449182762
132,10.1021/bi001684q,mc4r_human,90,D,A,NDP-MSH,PubChem CID,16154396,,K(i),Binding - Radioligand competition/displacement,1.54,nM,=,,5.61,-3.636,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.8430883374965996
158,10.1021/bi001684q,mc4r_human,90,D,A,Alpha-MSH,PubChem CID,16133793,,K(i),Binding - Radioligand competition/displacement,34.3,nM,=,,364.0,-10.638,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.8430883374965996
184,10.1021/bi001684q,mc4r_human,90,D,A,Ag-RP (86-132),UniProt Entry Code (peptide),O00253Â ,,K(i),Binding - Radioligand competition/displacement,2.95,nM,=,,3.12,-1.057,,,125-I-AGRP,0.0,0.0,,0.0,,P32245,0.8430883374965996
133,10.1021/bi001684q,mc4r_human,100,E,A,NDP-MSH,PubChem CID,16154396,,K(i),Binding - Radioligand competition/displacement,1.54,nM,=,,6.71,-4.348,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.4350325852366066
159,10.1021/bi001684q,mc4r_human,100,E,A,Alpha-MSH,PubChem CID,16133793,,K(i),Binding - Radioligand competition/displacement,34.3,nM,=,,132.0,-3.846,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.4350325852366066
185,10.1021/bi001684q,mc4r_human,100,E,A,Ag-RP (86-132),UniProt Entry Code (peptide),O00253Â ,,K(i),Binding - Radioligand competition/displacement,2.95,nM,=,,3.97,-1.346,,,125-I-AGRP,0.0,0.0,,0.0,,P32245,0.4350325852366066
212,10.1021/bi001684q,mc4r_human,100,E,A,NDP-MSH,PubChem CID,16154396,,EC50,Functional - cAMP accumulation,0.27,nM,=,,0.65,-2.41,,,,0.0,0.0,,0.0,,P32245,0.4350325852366066
238,10.1021/bi001684q,mc4r_human,100,E,A,Alpha-MSH,PubChem CID,16133793,,EC50,Functional - cAMP accumulation,1.34,nM,=,,4.45,-3.322,,,,0.0,0.0,,0.0,,P32245,0.4350325852366066
134,10.1021/bi001684q,mc4r_human,122,D,A,NDP-MSH,PubChem CID,16154396,,K(i),Binding - Radioligand competition/displacement,1.54,nM,=,,9.32,-6.061,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.4930886684680552
160,10.1021/bi001684q,mc4r_human,122,D,A,Alpha-MSH,PubChem CID,16133793,,K(i),Binding - Radioligand competition/displacement,34.3,nM,=,,722.7,-21.277,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.4930886684680552
186,10.1021/bi001684q,mc4r_human,122,D,A,Ag-RP (86-132),UniProt Entry Code (peptide),O00253Â ,,K(i),Binding - Radioligand competition/displacement,2.95,nM,=,,4.9,-1.661,,,125-I-AGRP,0.0,0.0,,0.0,,P32245,0.4930886684680552
213,10.1021/bi001684q,mc4r_human,122,D,A,NDP-MSH,PubChem CID,16154396,,EC50,Functional - cAMP accumulation,0.27,nM,=,,1.67,-6.173,,,,0.0,0.0,,0.0,,P32245,0.4930886684680552
260,10.1021/bi001684q,mc4r_human,122,D,A,NDP-MSH,PubChem CID,16154396,,K(i),Binding - Radioligand competition/displacement,1.3,nM,=,,9.3,-7.143,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.4930886684680552
261,10.1021/bi001684q,mc4r_human,122,D,A,NDP-MSH,PubChem CID,16154396,,K(i),Binding - Radioligand competition/displacement,1.2,nM,=,,26.0,-21.739,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.4930886684680552
135,10.1021/bi001684q,mc4r_human,122,D,N,NDP-MSH,PubChem CID,16154396,,K(i),Binding - Radioligand competition/displacement,1.54,nM,=,,5.56,-3.61,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.3617853174618604
161,10.1021/bi001684q,mc4r_human,122,D,N,Alpha-MSH,PubChem CID,16133793,,K(i),Binding - Radioligand competition/displacement,34.3,nM,=,,129.3,-3.774,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.3617853174618604
187,10.1021/bi001684q,mc4r_human,122,D,N,Ag-RP (86-132),UniProt Entry Code (peptide),O00253Â ,,K(i),Binding - Radioligand competition/displacement,2.95,nM,=,,3.98,-1.35,,,125-I-AGRP,0.0,0.0,,0.0,,P32245,0.3617853174618604
214,10.1021/bi001684q,mc4r_human,122,D,N,NDP-MSH,PubChem CID,16154396,,EC50,Functional - cAMP accumulation,0.27,nM,=,,0.69,-2.558,,,,0.0,0.0,,0.0,,P32245,0.3617853174618604
239,10.1021/bi001684q,mc4r_human,122,D,N,Alpha-MSH,PubChem CID,16133793,,EC50,Functional - cAMP accumulation,1.34,nM,=,,155.0,-111.111,,,,0.0,0.0,,0.0,,P32245,0.3617853174618604
138,10.1021/bi001684q,mc4r_human,130,C,A,NDP-MSH,PubChem CID,16154396,,K(i),Binding - Radioligand competition/displacement,1.54,nM,=,,2.82,-1.832,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.4409362834583409
164,10.1021/bi001684q,mc4r_human,130,C,A,Alpha-MSH,PubChem CID,16133793,,K(i),Binding - Radioligand competition/displacement,34.3,nM,=,,28.3,1.212,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.4409362834583409
190,10.1021/bi001684q,mc4r_human,130,C,A,Ag-RP (86-132),UniProt Entry Code (peptide),O00253Â ,,K(i),Binding - Radioligand competition/displacement,2.95,nM,=,,3.3,-1.119,,,125-I-AGRP,0.0,0.0,,0.0,,P32245,0.4409362834583409
217,10.1021/bi001684q,mc4r_human,130,C,A,NDP-MSH,PubChem CID,16154396,,EC50,Functional - cAMP accumulation,0.27,nM,=,,0.47,-1.742,,,,0.0,0.0,,0.0,,P32245,0.4409362834583409
242,10.1021/bi001684q,mc4r_human,130,C,A,Alpha-MSH,PubChem CID,16133793,,EC50,Functional - cAMP accumulation,1.34,nM,=,,1.23,1.089,,,,0.0,0.0,,0.0,,P32245,0.4409362834583409
139,10.1021/bi001684q,mc4r_human,164,K,A,NDP-MSH,PubChem CID,16154396,,K(i),Binding - Radioligand competition/displacement,1.54,nM,=,,1.73,-1.124,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.254146701820903
165,10.1021/bi001684q,mc4r_human,164,K,A,Alpha-MSH,PubChem CID,16133793,,K(i),Binding - Radioligand competition/displacement,34.3,nM,=,,35.1,-1.024,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.254146701820903
191,10.1021/bi001684q,mc4r_human,164,K,A,Ag-RP (86-132),UniProt Entry Code (peptide),O00253Â ,,K(i),Binding - Radioligand competition/displacement,2.95,nM,=,,3.89,-1.319,,,125-I-AGRP,0.0,0.0,,0.0,,P32245,0.254146701820903
218,10.1021/bi001684q,mc4r_human,164,K,A,NDP-MSH,PubChem CID,16154396,,EC50,Functional - cAMP accumulation,0.27,nM,=,,0.44,-1.629,,,,0.0,0.0,,0.0,,P32245,0.254146701820903
243,10.1021/bi001684q,mc4r_human,164,K,A,Alpha-MSH,PubChem CID,16133793,,EC50,Functional - cAMP accumulation,1.34,nM,=,,2.5,-1.866,,,,0.0,0.0,,0.0,,P32245,0.254146701820903
140,10.1021/bi001684q,mc4r_human,165,R,A,NDP-MSH,PubChem CID,16154396,,K(i),Binding - Radioligand competition/displacement,1.54,nM,=,,2.03,-1.318,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.3796331987411964
166,10.1021/bi001684q,mc4r_human,165,R,A,Alpha-MSH,PubChem CID,16133793,,K(i),Binding - Radioligand competition/displacement,34.3,nM,=,,54.5,-1.59,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.3796331987411964
192,10.1021/bi001684q,mc4r_human,165,R,A,Ag-RP (86-132),UniProt Entry Code (peptide),O00253Â ,,K(i),Binding - Radioligand competition/displacement,2.95,nM,=,,3.12,-1.057,,,125-I-AGRP,0.0,0.0,,0.0,,P32245,0.3796331987411964
219,10.1021/bi001684q,mc4r_human,165,R,A,NDP-MSH,PubChem CID,16154396,,EC50,Functional - cAMP accumulation,0.27,nM,=,,0.33,-1.222,,,,0.0,0.0,,0.0,,P32245,0.3796331987411964
244,10.1021/bi001684q,mc4r_human,165,R,A,Alpha-MSH,PubChem CID,16133793,,EC50,Functional - cAMP accumulation,1.34,nM,=,,3.1,-2.315,,,,0.0,0.0,,0.0,,P32245,0.3796331987411964
141,10.1021/bi001684q,mc4r_human,196,C,A,NDP-MSH,PubChem CID,16154396,,K(i),Binding - Radioligand competition/displacement,1.54,nM,=,,3.1,-2.012,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.2914854622371636
167,10.1021/bi001684q,mc4r_human,196,C,A,Alpha-MSH,PubChem CID,16133793,,K(i),Binding - Radioligand competition/displacement,34.3,nM,=,,30.9,1.11,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.2914854622371636
193,10.1021/bi001684q,mc4r_human,196,C,A,Ag-RP (86-132),UniProt Entry Code (peptide),O00253Â ,,K(i),Binding - Radioligand competition/displacement,2.95,nM,=,,3.18,-1.078,,,125-I-AGRP,0.0,0.0,,0.0,,P32245,0.2914854622371636
220,10.1021/bi001684q,mc4r_human,196,C,A,NDP-MSH,PubChem CID,16154396,,EC50,Functional - cAMP accumulation,0.27,nM,=,,0.42,-1.555,,,,0.0,0.0,,0.0,,P32245,0.2914854622371636
245,10.1021/bi001684q,mc4r_human,196,C,A,Alpha-MSH,PubChem CID,16133793,,EC50,Functional - cAMP accumulation,1.34,nM,=,,2.36,-1.761,,,,0.0,0.0,,0.0,,P32245,0.2914854622371636
142,10.1021/bi001684q,mc4r_human,199,T,A,NDP-MSH,PubChem CID,16154396,,K(i),Binding - Radioligand competition/displacement,1.54,nM,=,,1.6,-1.038,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.2408890880076302
168,10.1021/bi001684q,mc4r_human,199,T,A,Alpha-MSH,PubChem CID,16133793,,K(i),Binding - Radioligand competition/displacement,34.3,nM,=,,42.6,-1.242,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.2408890880076302
194,10.1021/bi001684q,mc4r_human,199,T,A,Ag-RP (86-132),UniProt Entry Code (peptide),O00253Â ,,K(i),Binding - Radioligand competition/displacement,2.95,nM,=,,2.5,1.18,,,125-I-AGRP,0.0,0.0,,0.0,,P32245,0.2408890880076302
221,10.1021/bi001684q,mc4r_human,199,T,A,NDP-MSH,PubChem CID,16154396,,EC50,Functional - cAMP accumulation,0.27,nM,=,,0.29,-1.074,,,,0.0,0.0,,0.0,,P32245,0.2408890880076302
246,10.1021/bi001684q,mc4r_human,199,T,A,Alpha-MSH,PubChem CID,16133793,,EC50,Functional - cAMP accumulation,1.34,nM,=,,2.5,-1.866,,,,0.0,0.0,,0.0,,P32245,0.2408890880076302
143,10.1021/bi001684q,mc4r_human,200,M,A,NDP-MSH,PubChem CID,16154396,,K(i),Binding - Radioligand competition/displacement,1.54,nM,=,,3.02,-1.961,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.3927663193525501
169,10.1021/bi001684q,mc4r_human,200,M,A,Alpha-MSH,PubChem CID,16133793,,K(i),Binding - Radioligand competition/displacement,34.3,nM,=,,579.7,-16.949,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.3927663193525501
195,10.1021/bi001684q,mc4r_human,200,M,A,Ag-RP (86-132),UniProt Entry Code (peptide),O00253Â ,,K(i),Binding - Radioligand competition/displacement,2.95,nM,=,,3.1,-1.05,,,125-I-AGRP,0.0,0.0,,0.0,,P32245,0.3927663193525501
222,10.1021/bi001684q,mc4r_human,200,M,A,NDP-MSH,PubChem CID,16154396,,EC50,Functional - cAMP accumulation,0.27,nM,=,,0.45,-1.667,,,,0.0,0.0,,0.0,,P32245,0.3927663193525501
247,10.1021/bi001684q,mc4r_human,200,M,A,Alpha-MSH,PubChem CID,16133793,,EC50,Functional - cAMP accumulation,1.34,nM,=,,9.1,-6.803,,,,0.0,0.0,,0.0,,P32245,0.3927663193525501
144,10.1021/bi001684q,mc4r_human,203,T,A,NDP-MSH,PubChem CID,16154396,,K(i),Binding - Radioligand competition/displacement,1.54,nM,=,,2.11,-1.37,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.2571397377610117
170,10.1021/bi001684q,mc4r_human,203,T,A,Alpha-MSH,PubChem CID,16133793,,K(i),Binding - Radioligand competition/displacement,34.3,nM,=,,45.3,-1.321,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.2571397377610117
196,10.1021/bi001684q,mc4r_human,203,T,A,Ag-RP (86-132),UniProt Entry Code (peptide),O00253Â ,,K(i),Binding - Radioligand competition/displacement,2.95,nM,=,,2.14,1.379,,,125-I-AGRP,0.0,0.0,,0.0,,P32245,0.2571397377610117
223,10.1021/bi001684q,mc4r_human,203,T,A,NDP-MSH,PubChem CID,16154396,,EC50,Functional - cAMP accumulation,0.27,nM,=,,0.33,-1.222,,,,0.0,0.0,,0.0,,P32245,0.2571397377610117
248,10.1021/bi001684q,mc4r_human,203,T,A,Alpha-MSH,PubChem CID,16133793,,EC50,Functional - cAMP accumulation,1.34,nM,=,,1.76,-1.314,,,,0.0,0.0,,0.0,,P32245,0.2571397377610117
145,10.1021/bi001684q,mc4r_human,204,M,A,NDP-MSH,PubChem CID,16154396,,K(i),Binding - Radioligand competition/displacement,1.54,nM,=,,2.31,-1.499,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.5008745064279396
171,10.1021/bi001684q,mc4r_human,204,M,A,Alpha-MSH,PubChem CID,16133793,,K(i),Binding - Radioligand competition/displacement,34.3,nM,>,,10000.0,-333.333,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.5008745064279396
197,10.1021/bi001684q,mc4r_human,204,M,A,Ag-RP (86-132),UniProt Entry Code (peptide),O00253Â ,,K(i),Binding - Radioligand competition/displacement,2.95,nM,=,,2.6,1.135,,,125-I-AGRP,0.0,0.0,,0.0,,P32245,0.5008745064279396
224,10.1021/bi001684q,mc4r_human,204,M,A,NDP-MSH,PubChem CID,16154396,,EC50,Functional - cAMP accumulation,0.27,nM,=,,0.54,-2.0,,,,0.0,0.0,,0.0,,P32245,0.5008745064279396
249,10.1021/bi001684q,mc4r_human,204,M,A,Alpha-MSH,PubChem CID,16133793,,EC50,Functional - cAMP accumulation,1.34,nM,=,,5.7,-4.255,,,,0.0,0.0,,0.0,,P32245,0.5008745064279396
146,10.1021/bi001684q,mc4r_human,214,H,A,NDP-MSH,PubChem CID,16154396,,K(i),Binding - Radioligand competition/displacement,1.54,nM,=,,1.41,1.092,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.5008794927651075
172,10.1021/bi001684q,mc4r_human,214,H,A,Alpha-MSH,PubChem CID,16133793,,K(i),Binding - Radioligand competition/displacement,34.3,nM,=,,42.8,-1.248,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.5008794927651075
198,10.1021/bi001684q,mc4r_human,214,H,A,Ag-RP (86-132),UniProt Entry Code (peptide),O00253Â ,,K(i),Binding - Radioligand competition/displacement,2.95,nM,=,,3.3,-1.119,,,125-I-AGRP,0.0,0.0,,0.0,,P32245,0.5008794927651075
225,10.1021/bi001684q,mc4r_human,214,H,A,NDP-MSH,PubChem CID,16154396,,EC50,Functional - cAMP accumulation,0.27,nM,=,,0.18,1.5,,,,0.0,0.0,,0.0,,P32245,0.5008794927651075
250,10.1021/bi001684q,mc4r_human,214,H,A,Alpha-MSH,PubChem CID,16133793,,EC50,Functional - cAMP accumulation,1.34,nM,=,,2.4,-1.792,,,,0.0,0.0,,0.0,,P32245,0.5008794927651075
147,10.1021/bi001684q,mc4r_human,258,W,A,NDP-MSH,PubChem CID,16154396,,K(i),Binding - Radioligand competition/displacement,1.54,nM,=,,4.01,-2.604,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.7811052565287822
173,10.1021/bi001684q,mc4r_human,258,W,A,Alpha-MSH,PubChem CID,16133793,,K(i),Binding - Radioligand competition/displacement,34.3,nM,=,,782.7,-22.727,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.7811052565287822
199,10.1021/bi001684q,mc4r_human,258,W,A,Ag-RP (86-132),UniProt Entry Code (peptide),O00253Â ,,K(i),Binding - Radioligand competition/displacement,2.95,nM,=,,2.31,1.277,,,125-I-AGRP,0.0,0.0,,0.0,,P32245,0.7811052565287822
226,10.1021/bi001684q,mc4r_human,258,W,A,NDP-MSH,PubChem CID,16154396,,EC50,Functional - cAMP accumulation,0.27,nM,=,,0.54,-2.0,,,,0.0,0.0,,0.0,,P32245,0.7811052565287822
251,10.1021/bi001684q,mc4r_human,258,W,A,Alpha-MSH,PubChem CID,16133793,,EC50,Functional - cAMP accumulation,1.34,nM,=,,16.0,-11.905,,,,0.0,0.0,,0.0,,P32245,0.7811052565287822
148,10.1021/bi001684q,mc4r_human,261,F,A,NDP-MSH,PubChem CID,16154396,,K(i),Binding - Radioligand competition/displacement,1.54,nM,=,,8.31,-5.405,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.5682137148264276
174,10.1021/bi001684q,mc4r_human,261,F,A,Alpha-MSH,PubChem CID,16133793,,K(i),Binding - Radioligand competition/displacement,34.3,nM,=,,160.0,-4.673,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.5682137148264276
200,10.1021/bi001684q,mc4r_human,261,F,A,Ag-RP (86-132),UniProt Entry Code (peptide),O00253Â ,,K(i),Binding - Radioligand competition/displacement,2.95,nM,=,,3.98,-1.35,,,125-I-AGRP,0.0,0.0,,0.0,,P32245,0.5682137148264276
227,10.1021/bi001684q,mc4r_human,261,F,A,NDP-MSH,PubChem CID,16154396,,EC50,Functional - cAMP accumulation,0.27,nM,=,,1.06,-3.922,,,,0.0,0.0,,0.0,,P32245,0.5682137148264276
252,10.1021/bi001684q,mc4r_human,261,F,A,Alpha-MSH,PubChem CID,16133793,,EC50,Functional - cAMP accumulation,1.34,nM,=,,5.43,-4.049,,,,0.0,0.0,,0.0,,P32245,0.5682137148264276
150,10.1021/bi001684q,mc4r_human,267,F,A,NDP-MSH,PubChem CID,16154396,,K(i),Binding - Radioligand competition/displacement,1.54,nM,=,,1.65,-1.072,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.3646578270111956
176,10.1021/bi001684q,mc4r_human,267,F,A,Alpha-MSH,PubChem CID,16133793,,K(i),Binding - Radioligand competition/displacement,34.3,nM,=,,22.0,1.559,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.3646578270111956
202,10.1021/bi001684q,mc4r_human,267,F,A,Ag-RP (86-132),UniProt Entry Code (peptide),O00253Â ,,K(i),Binding - Radioligand competition/displacement,2.95,nM,=,,1.9,1.553,,,125-I-AGRP,0.0,0.0,,0.0,,P32245,0.3646578270111956
229,10.1021/bi001684q,mc4r_human,267,F,A,NDP-MSH,PubChem CID,16154396,,EC50,Functional - cAMP accumulation,0.27,nM,=,,0.37,-1.37,,,,0.0,0.0,,0.0,,P32245,0.3646578270111956
254,10.1021/bi001684q,mc4r_human,267,F,A,Alpha-MSH,PubChem CID,16133793,,EC50,Functional - cAMP accumulation,1.34,nM,=,,2.9,-2.165,,,,0.0,0.0,,0.0,,P32245,0.3646578270111956
151,10.1021/bi001684q,mc4r_human,268,Y,A,NDP-MSH,PubChem CID,16154396,,K(i),Binding - Radioligand competition/displacement,1.54,nM,=,,1.87,-1.214,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.4780329710464805
177,10.1021/bi001684q,mc4r_human,268,Y,A,Alpha-MSH,PubChem CID,16133793,,K(i),Binding - Radioligand competition/displacement,34.3,nM,=,,16.0,2.144,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.4780329710464805
204,10.1021/bi001684q,mc4r_human,268,Y,A,Ag-RP (86-132),UniProt Entry Code (peptide),O00253Â ,,K(i),Binding - Radioligand competition/displacement,2.95,nM,=,,3.6,-1.221,,,125-I-AGRP,0.0,0.0,,0.0,,P32245,0.4780329710464805
230,10.1021/bi001684q,mc4r_human,268,Y,A,NDP-MSH,PubChem CID,16154396,,EC50,Functional - cAMP accumulation,0.27,nM,=,,0.5,-1.852,,,,0.0,0.0,,0.0,,P32245,0.4780329710464805
255,10.1021/bi001684q,mc4r_human,268,Y,A,Alpha-MSH,PubChem CID,16133793,,EC50,Functional - cAMP accumulation,1.34,nM,=,,90.0,-66.667,,,,0.0,0.0,,0.0,,P32245,0.4780329710464805
152,10.1021/bi001684q,mc4r_human,283,H,A,NDP-MSH,PubChem CID,16154396,,K(i),Binding - Radioligand competition/displacement,1.54,nM,=,,1.11,1.387,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.4154983413330905
178,10.1021/bi001684q,mc4r_human,283,H,A,Alpha-MSH,PubChem CID,16133793,,K(i),Binding - Radioligand competition/displacement,34.3,nM,=,,27.0,1.27,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.4154983413330905
205,10.1021/bi001684q,mc4r_human,283,H,A,Ag-RP (86-132),UniProt Entry Code (peptide),O00253Â ,,K(i),Binding - Radioligand competition/displacement,2.95,nM,=,,2.26,1.305,,,125-I-AGRP,0.0,0.0,,0.0,,P32245,0.4154983413330905
231,10.1021/bi001684q,mc4r_human,283,H,A,NDP-MSH,PubChem CID,16154396,,EC50,Functional - cAMP accumulation,0.27,nM,=,,0.27,1.0,,,,0.0,0.0,,0.0,,P32245,0.4154983413330905
256,10.1021/bi001684q,mc4r_human,283,H,A,Alpha-MSH,PubChem CID,16133793,,EC50,Functional - cAMP accumulation,1.34,nM,=,,2.54,-1.894,,,,0.0,0.0,,0.0,,P32245,0.4154983413330905
154,10.1021/bi001684q,mc4r_human,298,D,A,NDP-MSH,PubChem CID,16154396,,K(i),Binding - Radioligand competition/displacement,1.54,nM,=,,4.54,-2.95,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.8071753848601266
180,10.1021/bi001684q,mc4r_human,298,D,A,Alpha-MSH,PubChem CID,16133793,,K(i),Binding - Radioligand competition/displacement,34.3,nM,=,,79.4,-2.315,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.8071753848601266
207,10.1021/bi001684q,mc4r_human,298,D,A,Ag-RP (86-132),UniProt Entry Code (peptide),O00253Â ,,K(i),Binding - Radioligand competition/displacement,2.95,nM,=,,2.98,-1.01,,,125-I-AGRP,0.0,0.0,,0.0,,P32245,0.8071753848601266
155,10.1021/bi001684q,mc4r_human,305,R,A,NDP-MSH,PubChem CID,16154396,,K(i),Binding - Radioligand competition/displacement,1.54,nM,=,,1.9,-1.233,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.6349401724051337
181,10.1021/bi001684q,mc4r_human,305,R,A,Alpha-MSH,PubChem CID,16133793,,K(i),Binding - Radioligand competition/displacement,34.3,nM,=,,90.4,-2.639,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.6349401724051337
208,10.1021/bi001684q,mc4r_human,305,R,A,Ag-RP (86-132),UniProt Entry Code (peptide),O00253Â ,,K(i),Binding - Radioligand competition/displacement,2.95,nM,=,,2.7,1.093,,,125-I-AGRP,0.0,0.0,,0.0,,P32245,0.6349401724051337
234,10.1021/bi001684q,mc4r_human,305,R,A,NDP-MSH,PubChem CID,16154396,,EC50,Functional - cAMP accumulation,0.27,nM,=,,0.49,-1.815,,,,0.0,0.0,,0.0,,P32245,0.6349401724051337
259,10.1021/bi001684q,mc4r_human,305,R,A,Alpha-MSH,PubChem CID,16133793,,EC50,Functional - cAMP accumulation,1.34,nM,=,,1.31,1.023,,,,0.0,0.0,,0.0,,P32245,0.6349401724051337
188,10.1021/bi001684q,mc4r_human,126,D,A,Ag-RP (86-132),UniProt Entry Code (peptide),O00253Â ,,K(i),Binding - Radioligand competition/displacement,2.95,nM,=,,26.4,-8.929,,,125-I-AGRP,0.0,0.0,,0.0,,P32245,0.5522015436631065
189,10.1021/bi001684q,mc4r_human,126,D,N,Ag-RP (86-132),UniProt Entry Code (peptide),O00253Â ,,K(i),Binding - Radioligand competition/displacement,2.95,nM,=,,15.9,-5.376,,,125-I-AGRP,0.0,0.0,,0.0,,P32245,0.4181144677673981
216,10.1021/bi001684q,mc4r_human,126,D,N,NDP-MSH,PubChem CID,16154396,,EC50,Functional - cAMP accumulation,0.27,nM,=,,342.0,-1000.0,,,,0.0,0.0,,0.0,,P32245,0.4181144677673981
201,10.1021/bi001684q,mc4r_human,264,H,A,Ag-RP (86-132),UniProt Entry Code (peptide),O00253Â ,,K(i),Binding - Radioligand competition/displacement,2.95,nM,=,,4.1,-1.389,,,125-I-AGRP,0.0,0.0,,0.0,,P32245,0.5089590831434363
228,10.1021/bi001684q,mc4r_human,264,H,A,NDP-MSH,PubChem CID,16154396,,EC50,Functional - cAMP accumulation,0.27,nM,=,,134.0,-500.0,,,,0.0,0.0,,0.0,,P32245,0.5089590831434363
288,10.1021/jm500064t,mc4r_human,69,I,T,JRH887-9,FASTA sequence (peptide),Ac-His-Dphe-Arg-Trp-NH2,,EC50,Functional - cAMP accumulation,0.93,nM,=,,40.7,-43.478,,,,0.0,0.0,,0.0,,P32245,0.5543318318273642
294,10.1021/jm500064t,mc4r_human,69,I,T,CMPD4,FASTA sequence (peptide),Ac-His-(pI)DPhe-Tic-(pNO2)DPhe-NH2,,EC50,Functional - cAMP accumulation,0.24,nM,=,,3.8,-15.873,,,,0.0,0.0,,0.0,,P32245,0.5543318318273642
300,10.1021/jm500064t,mc4r_human,69,I,T,CMPD5,FASTA sequence (peptide),Ac-His-(pI)DPhe-Arg-(pI)Phe-NH2,,EC50,Functional - cAMP accumulation,0.14,nM,=,,1.5,-10.753,,,,0.0,0.0,,0.0,,P32245,0.5543318318273642
306,10.1021/jm500064t,mc4r_human,69,I,T,CMPD6,FASTA sequence (peptide),Ac-Arg-(pI)DPhe-Tic-(pNO2)DPhe-NH2,,EC50,Functional - cAMP accumulation,0.26,nM,=,,4.1,-15.873,,,,0.0,0.0,,0.0,,P32245,0.5543318318273642
312,10.1021/jm500064t,mc4r_human,69,I,T,CMPD7,FASTA sequence (peptide),Ac-Arg-(pI)DPhe-Arg-(pI)Phe-NH2,,EC50,Functional - cAMP accumulation,0.29,nM,=,,3.4,-11.765,,,,0.0,0.0,,0.0,,P32245,0.5543318318273642
318,10.1021/jm500064t,mc4r_human,69,I,T,CMPD8,FASTA sequence (peptide),Ac-His-(pCl)DPhe-Tic-(pNO2)DPhe-NH2,,EC50,Functional - cAMP accumulation,0.4,nM,=,,4.3,-10.753,,,,0.0,0.0,,0.0,,P32245,0.5543318318273642
324,10.1021/jm500064t,mc4r_human,69,I,T,CMPD9,FASTA sequence (peptide),Ac-His-(pCl)DPhe-Arg-(pI)Phe-NH2,,EC50,Functional - cAMP accumulation,0.45,nM,=,,2.9,-6.452,,,,0.0,0.0,,0.0,,P32245,0.5543318318273642
330,10.1021/jm500064t,mc4r_human,69,I,T,CMPD10,FASTA sequence (peptide),Ac-Arg-(pCl)DPhe-Tic-(pNO2)DPhe-NH2,,EC50,Functional - cAMP accumulation,0.21,nM,=,,5.2,-25.0,,,,0.0,0.0,,0.0,,P32245,0.5543318318273642
336,10.1021/jm500064t,mc4r_human,69,I,T,CMPD11,FASTA sequence (peptide),Ac-Arg-(pCl)DPhe-Arg-(pI)Phe-NH2,,EC50,Functional - cAMP accumulation,0.19,nM,=,,8.2,-43.478,,,,0.0,0.0,,0.0,,P32245,0.5543318318273642
289,10.1021/jm500064t,mc4r_human,102,I,S,JRH887-9,FASTA sequence (peptide),Ac-His-Dphe-Arg-Trp-NH2,,EC50,Functional - cAMP accumulation,0.93,nM,=,,720.0,-1000.0,,,,0.0,0.0,,0.0,,P32245,0.3993121407863195
295,10.1021/jm500064t,mc4r_human,102,I,S,CMPD4,FASTA sequence (peptide),Ac-His-(pI)DPhe-Tic-(pNO2)DPhe-NH2,,EC50,Functional - cAMP accumulation,0.24,nM,=,,14.0,-58.824,,,,0.0,0.0,,0.0,,P32245,0.3993121407863195
301,10.1021/jm500064t,mc4r_human,102,I,S,CMPD5,FASTA sequence (peptide),Ac-His-(pI)DPhe-Arg-(pI)Phe-NH2,,EC50,Functional - cAMP accumulation,0.14,nM,=,,4.0,-28.571,,,,0.0,0.0,,0.0,,P32245,0.3993121407863195
307,10.1021/jm500064t,mc4r_human,102,I,S,CMPD6,FASTA sequence (peptide),Ac-Arg-(pI)DPhe-Tic-(pNO2)DPhe-NH2,,EC50,Functional - cAMP accumulation,0.26,nM,=,,2.9,-11.111,,,,0.0,0.0,,0.0,,P32245,0.3993121407863195
313,10.1021/jm500064t,mc4r_human,102,I,S,CMPD7,FASTA sequence (peptide),Ac-Arg-(pI)DPhe-Arg-(pI)Phe-NH2,,EC50,Functional - cAMP accumulation,0.29,nM,=,,3.5,-12.048,,,,0.0,0.0,,0.0,,P32245,0.3993121407863195
319,10.1021/jm500064t,mc4r_human,102,I,S,CMPD8,FASTA sequence (peptide),Ac-His-(pCl)DPhe-Tic-(pNO2)DPhe-NH2,,EC50,Functional - cAMP accumulation,0.4,nM,=,,3.0,-7.519,,,,0.0,0.0,,0.0,,P32245,0.3993121407863195
325,10.1021/jm500064t,mc4r_human,102,I,S,CMPD9,FASTA sequence (peptide),Ac-His-(pCl)DPhe-Arg-(pI)Phe-NH2,,EC50,Functional - cAMP accumulation,0.45,nM,=,,20.0,-45.455,,,,0.0,0.0,,0.0,,P32245,0.3993121407863195
331,10.1021/jm500064t,mc4r_human,102,I,S,CMPD10,FASTA sequence (peptide),Ac-Arg-(pCl)DPhe-Tic-(pNO2)DPhe-NH2,,EC50,Functional - cAMP accumulation,0.21,nM,=,,4.4,-20.833,,,,0.0,0.0,,0.0,,P32245,0.3993121407863195
337,10.1021/jm500064t,mc4r_human,102,I,S,CMPD11,FASTA sequence (peptide),Ac-Arg-(pCl)DPhe-Arg-(pI)Phe-NH2,,EC50,Functional - cAMP accumulation,0.19,nM,=,,13.0,-66.667,,,,0.0,0.0,,0.0,,P32245,0.3993121407863195
355,10.1677/joe-09-0336,mc4r_human,102,I,S,Alpha-MSH,PubChem CID,16133793,,K(i),Binding - Radioligand competition/displacement,26.0,nM,=,,260.0,-10.0,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.3993121407863195
356,10.1677/joe-09-0336,mc4r_human,102,I,S,IRC-022493,PubChem CID,11993702,,K(i),Binding - Radioligand competition/displacement,0.71,nM,=,,4.7,-6.623,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.3993121407863195
357,10.1677/joe-09-0336,mc4r_human,102,I,S,IRC-022511,PubChem CID,,,K(i),Binding - Radioligand competition/displacement,0.71,nM,=,,0.84,-1.183,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.3993121407863195
385,10.1677/joe-09-0336,mc4r_human,102,I,S,Alpha-MSH,PubChem CID,16133793,,EC50,Functional - cAMP accumulation,30.0,nM,>,,10000.0,-333.333,,,,0.0,0.0,,0.0,,P32245,0.3993121407863195
386,10.1677/joe-09-0336,mc4r_human,102,I,S,IRC-022493,PubChem CID,11993702,,EC50,Functional - cAMP accumulation,1.5,nM,=,,100.0,-66.667,,,,0.0,0.0,,0.0,,P32245,0.3993121407863195
387,10.1677/joe-09-0336,mc4r_human,102,I,S,IRC-022511,PubChem CID,,,EC50,Functional - cAMP accumulation,0.7,nM,=,,21.0,-30.303,,,,0.0,0.0,,0.0,,P32245,0.3993121407863195
291,10.1021/jm500064t,mc4r_human,271,C,Y,JRH887-9,FASTA sequence (peptide),Ac-His-Dphe-Arg-Trp-NH2,,EC50,Functional - cAMP accumulation,0.93,nM,=,,1200.0,-1000.0,,,,0.0,0.0,,0.0,,P32245,0.4882797263133863
297,10.1021/jm500064t,mc4r_human,271,C,Y,CMPD4,FASTA sequence (peptide),Ac-His-(pI)DPhe-Tic-(pNO2)DPhe-NH2,,EC50,Functional - cAMP accumulation,0.24,nM,=,,190.0,-1000.0,,,,0.0,0.0,,0.0,,P32245,0.4882797263133863
321,10.1021/jm500064t,mc4r_human,271,C,Y,CMPD8,FASTA sequence (peptide),Ac-His-(pCl)DPhe-Tic-(pNO2)DPhe-NH2,,EC50,Functional - cAMP accumulation,0.4,nM,=,,82.0,-200.0,,,,0.0,0.0,,0.0,,P32245,0.4882797263133863
327,10.1021/jm500064t,mc4r_human,271,C,Y,CMPD9,FASTA sequence (peptide),Ac-His-(pCl)DPhe-Arg-(pI)Phe-NH2,,EC50,Functional - cAMP accumulation,0.45,nM,=,,260.0,-500.0,,,,0.0,0.0,,0.0,,P32245,0.4882797263133863
292,10.1021/jm500064t,mc4r_human,271,C,R,JRH887-9,FASTA sequence (peptide),Ac-His-Dphe-Arg-Trp-NH2,,EC50,Functional - cAMP accumulation,0.93,nM,=,,1600.0,-1000.0,,,,0.0,0.0,,0.0,,P32245,0.5332360856133234
298,10.1021/jm500064t,mc4r_human,271,C,R,CMPD4,FASTA sequence (peptide),Ac-His-(pI)DPhe-Tic-(pNO2)DPhe-NH2,,EC50,Functional - cAMP accumulation,0.24,nM,=,,295.0,-1000.0,,,,0.0,0.0,,0.0,,P32245,0.5332360856133234
322,10.1021/jm500064t,mc4r_human,271,C,R,CMPD8,FASTA sequence (peptide),Ac-His-(pCl)DPhe-Tic-(pNO2)DPhe-NH2,,EC50,Functional - cAMP accumulation,0.4,nM,=,,130.0,-333.333,,,,0.0,0.0,,0.0,,P32245,0.5332360856133234
328,10.1021/jm500064t,mc4r_human,271,C,R,CMPD9,FASTA sequence (peptide),Ac-His-(pCl)DPhe-Arg-(pI)Phe-NH2,,EC50,Functional - cAMP accumulation,0.45,nM,=,,210.0,-500.0,,,,0.0,0.0,,0.0,,P32245,0.5332360856133234
341,10.1210/jc.2003-030233,mc4r_human,30,S,F,Alpha-MSH,PubChem CID,16133793,,EC50,Functional - cAMP accumulation,51.0,nM,=,,23.0,2.217,,,,0.0,0.0,,0.0,,P32245,0.3718680690148053
342,10.1210/jc.2003-030233,mc4r_human,78,P,L,Alpha-MSH,PubChem CID,16133793,,EC50,Functional - cAMP accumulation,51.0,nM,=,,570.0,-11.236,,,,0.0,0.0,,0.0,,P32245,0.6546859211152516
345,10.1210/jc.2003-030233,mc4r_human,121,I,T,Alpha-MSH,PubChem CID,16133793,,EC50,Functional - cAMP accumulation,51.0,nM,=,,518.0,-10.204,,,,0.0,0.0,,0.0,,P32245,0.3385163414988052
349,10.1210/jc.2003-030233,mc4r_human,244,A,E,Alpha-MSH,PubChem CID,16133793,,EC50,Functional - cAMP accumulation,51.0,nM,=,,425.0,-8.333,,,,0.0,0.0,,0.0,,P32245,0.5718782833466064
350,10.1210/jc.2003-030233,mc4r_human,252,G,S,Alpha-MSH,PubChem CID,16133793,,EC50,Functional - cAMP accumulation,51.0,nM,=,,37.0,1.378,,,,0.0,0.0,,0.0,,P32245,0.3104248867310205
379,10.1677/joe-09-0336,mc4r_human,252,G,S,Alpha-MSH,PubChem CID,16133793,,K(i),Binding - Radioligand competition/displacement,26.0,nM,=,,160.0,-6.135,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.3104248867310205
380,10.1677/joe-09-0336,mc4r_human,252,G,S,IRC-022493,PubChem CID,11993702,,K(i),Binding - Radioligand competition/displacement,0.71,nM,=,,2.3,-3.236,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.3104248867310205
381,10.1677/joe-09-0336,mc4r_human,252,G,S,IRC-022511,PubChem CID,,,K(i),Binding - Radioligand competition/displacement,0.71,nM,=,,1.6,-2.252,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.3104248867310205
412,10.1677/joe-09-0336,mc4r_human,252,G,S,Alpha-MSH,PubChem CID,16133793,,EC50,Functional - cAMP accumulation,30.0,nM,=,,210.0,-6.993,,,,0.0,0.0,,0.0,,P32245,0.3104248867310205
413,10.1677/joe-09-0336,mc4r_human,252,G,S,IRC-022493,PubChem CID,11993702,,EC50,Functional - cAMP accumulation,1.5,nM,=,,13.0,-8.696,,,,0.0,0.0,,0.0,,P32245,0.3104248867310205
414,10.1677/joe-09-0336,mc4r_human,252,G,S,IRC-022511,PubChem CID,,,EC50,Functional - cAMP accumulation,0.7,nM,=,,8.0,-11.494,,,,0.0,0.0,,0.0,,P32245,0.3104248867310205
351,10.1210/jc.2003-030233,mc4r_human,317,I,T,Alpha-MSH,PubChem CID,16133793,,EC50,Functional - cAMP accumulation,51.0,nM,=,,57.0,-1.117,,,,0.0,0.0,,0.0,,P32245,0.3950032518820656
352,10.1210/jc.2003-030233,mc4r_human,103,V,I,Alpha-MSH,PubChem CID,16133793,,EC50,Functional - cAMP accumulation,51.0,nM,=,,29.0,1.759,,,,0.0,0.0,,0.0,,P32245,0.1748469198335101
354,10.1210/jc.2003-030233,mc4r_human,178,T,M,Alpha-MSH,PubChem CID,16133793,,EC50,Functional - cAMP accumulation,51.0,nM,=,,90.0,-1.764,,,,0.0,0.0,,0.0,,P32245,0.3188985717865804
358,10.1677/joe-09-0336,mc4r_human,18,R,C,Alpha-MSH,PubChem CID,16133793,,K(i),Binding - Radioligand competition/displacement,26.0,nM,=,,16.0,1.625,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.4110786173872831
359,10.1677/joe-09-0336,mc4r_human,18,R,C,IRC-022493,PubChem CID,11993702,,K(i),Binding - Radioligand competition/displacement,0.71,nM,=,,0.37,1.919,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.4110786173872831
360,10.1677/joe-09-0336,mc4r_human,18,R,C,IRC-022511,PubChem CID,,,K(i),Binding - Radioligand competition/displacement,0.71,nM,=,,0.65,1.092,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.4110786173872831
391,10.1677/joe-09-0336,mc4r_human,18,R,C,Alpha-MSH,PubChem CID,16133793,,EC50,Functional - cAMP accumulation,30.0,nM,=,,34.0,-1.134,,,,0.0,0.0,,0.0,,P32245,0.4110786173872831
392,10.1677/joe-09-0336,mc4r_human,18,R,C,IRC-022493,PubChem CID,11993702,,EC50,Functional - cAMP accumulation,1.5,nM,=,,1.9,-1.267,,,,0.0,0.0,,0.0,,P32245,0.4110786173872831
393,10.1677/joe-09-0336,mc4r_human,18,R,C,IRC-022511,PubChem CID,,,EC50,Functional - cAMP accumulation,0.7,nM,=,,0.92,-1.314,,,,0.0,0.0,,0.0,,P32245,0.4110786173872831
361,10.1677/joe-09-0336,mc4r_human,18,R,H,Alpha-MSH,PubChem CID,16133793,,K(i),Binding - Radioligand competition/displacement,26.0,nM,=,,16.0,1.625,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.2892146423878664
362,10.1677/joe-09-0336,mc4r_human,18,R,H,IRC-022493,PubChem CID,11993702,,K(i),Binding - Radioligand competition/displacement,0.71,nM,=,,0.49,1.449,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.2892146423878664
363,10.1677/joe-09-0336,mc4r_human,18,R,H,IRC-022511,PubChem CID,,,K(i),Binding - Radioligand competition/displacement,0.71,nM,=,,0.42,1.69,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.2892146423878664
394,10.1677/joe-09-0336,mc4r_human,18,R,H,Alpha-MSH,PubChem CID,16133793,,EC50,Functional - cAMP accumulation,30.0,nM,=,,16.0,1.875,,,,0.0,0.0,,0.0,,P32245,0.2892146423878664
395,10.1677/joe-09-0336,mc4r_human,18,R,H,IRC-022493,PubChem CID,11993702,,EC50,Functional - cAMP accumulation,1.5,nM,=,,0.93,1.613,,,,0.0,0.0,,0.0,,P32245,0.2892146423878664
396,10.1677/joe-09-0336,mc4r_human,18,R,H,IRC-022511,PubChem CID,,,EC50,Functional - cAMP accumulation,0.7,nM,=,,0.43,1.628,,,,0.0,0.0,,0.0,,P32245,0.2892146423878664
364,10.1677/joe-09-0336,mc4r_human,50,V,M,Alpha-MSH,PubChem CID,16133793,,K(i),Binding - Radioligand competition/displacement,26.0,nM,=,,22.0,1.182,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.3305877124804078
365,10.1677/joe-09-0336,mc4r_human,50,V,M,IRC-022493,PubChem CID,11993702,,K(i),Binding - Radioligand competition/displacement,0.71,nM,=,,0.79,-1.112,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.3305877124804078
366,10.1677/joe-09-0336,mc4r_human,50,V,M,IRC-022511,PubChem CID,,,K(i),Binding - Radioligand competition/displacement,0.71,nM,=,,0.63,1.127,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.3305877124804078
397,10.1677/joe-09-0336,mc4r_human,50,V,M,Alpha-MSH,PubChem CID,16133793,,EC50,Functional - cAMP accumulation,30.0,nM,=,,37.0,-1.233,,,,0.0,0.0,,0.0,,P32245,0.3305877124804078
398,10.1677/joe-09-0336,mc4r_human,50,V,M,IRC-022493,PubChem CID,11993702,,EC50,Functional - cAMP accumulation,1.5,nM,=,,2.0,-1.333,,,,0.0,0.0,,0.0,,P32245,0.3305877124804078
399,10.1677/joe-09-0336,mc4r_human,50,V,M,IRC-022511,PubChem CID,,,EC50,Functional - cAMP accumulation,0.7,nM,=,,0.96,-1.372,,,,0.0,0.0,,0.0,,P32245,0.3305877124804078
367,10.1677/joe-09-0336,mc4r_human,231,G,S,Alpha-MSH,PubChem CID,16133793,,K(i),Binding - Radioligand competition/displacement,26.0,nM,=,,28.0,-1.076,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.271613454652731
368,10.1677/joe-09-0336,mc4r_human,231,G,S,IRC-022493,PubChem CID,11993702,,K(i),Binding - Radioligand competition/displacement,0.71,nM,=,,0.58,1.224,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.271613454652731
369,10.1677/joe-09-0336,mc4r_human,231,G,S,IRC-022511,PubChem CID,,,K(i),Binding - Radioligand competition/displacement,0.71,nM,=,,0.68,1.044,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.271613454652731
400,10.1677/joe-09-0336,mc4r_human,231,G,S,Alpha-MSH,PubChem CID,16133793,,EC50,Functional - cAMP accumulation,30.0,nM,=,,33.0,-1.1,,,,0.0,0.0,,0.0,,P32245,0.271613454652731
401,10.1677/joe-09-0336,mc4r_human,231,G,S,IRC-022493,PubChem CID,11993702,,EC50,Functional - cAMP accumulation,1.5,nM,=,,1.9,-1.267,,,,0.0,0.0,,0.0,,P32245,0.271613454652731
402,10.1677/joe-09-0336,mc4r_human,231,G,S,IRC-022511,PubChem CID,,,EC50,Functional - cAMP accumulation,0.7,nM,=,,0.79,-1.129,,,,0.0,0.0,,0.0,,P32245,0.271613454652731
373,10.1677/joe-09-0336,mc4r_human,58,S,C,Alpha-MSH,PubChem CID,16133793,,K(i),Binding - Radioligand competition/displacement,26.0,nM,=,,53.0,-2.037,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.5881356138795926
374,10.1677/joe-09-0336,mc4r_human,58,S,C,IRC-022493,PubChem CID,11993702,,K(i),Binding - Radioligand competition/displacement,0.71,nM,=,,1.7,-2.392,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.5881356138795926
375,10.1677/joe-09-0336,mc4r_human,58,S,C,IRC-022511,PubChem CID,,,K(i),Binding - Radioligand competition/displacement,0.71,nM,=,,0.97,-1.366,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.5881356138795926
406,10.1677/joe-09-0336,mc4r_human,58,S,C,Alpha-MSH,PubChem CID,16133793,,EC50,Functional - cAMP accumulation,30.0,nM,=,,670.0,-22.222,,,,0.0,0.0,,0.0,,P32245,0.5881356138795926
407,10.1677/joe-09-0336,mc4r_human,58,S,C,IRC-022493,PubChem CID,11993702,,EC50,Functional - cAMP accumulation,1.5,nM,=,,46.0,-30.303,,,,0.0,0.0,,0.0,,P32245,0.5881356138795926
408,10.1677/joe-09-0336,mc4r_human,58,S,C,IRC-022511,PubChem CID,,,EC50,Functional - cAMP accumulation,0.7,nM,=,,19.0,-27.027,,,,0.0,0.0,,0.0,,P32245,0.5881356138795926
376,10.1677/joe-09-0336,mc4r_human,102,I,T,Alpha-MSH,PubChem CID,16133793,,K(i),Binding - Radioligand competition/displacement,26.0,nM,=,,210.0,-8.065,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.3570117560214777
377,10.1677/joe-09-0336,mc4r_human,102,I,T,IRC-022493,PubChem CID,11993702,,K(i),Binding - Radioligand competition/displacement,0.71,nM,=,,2.2,-3.096,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.3570117560214777
378,10.1677/joe-09-0336,mc4r_human,102,I,T,IRC-022511,PubChem CID,,,K(i),Binding - Radioligand competition/displacement,0.71,nM,=,,0.85,-1.198,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.3570117560214777
409,10.1677/joe-09-0336,mc4r_human,102,I,T,Alpha-MSH,PubChem CID,16133793,,EC50,Functional - cAMP accumulation,30.0,nM,=,,5800.0,-200.0,,,,0.0,0.0,,0.0,,P32245,0.3570117560214777
410,10.1677/joe-09-0336,mc4r_human,102,I,T,IRC-022493,PubChem CID,11993702,,EC50,Functional - cAMP accumulation,1.5,nM,=,,150.0,-100.0,,,,0.0,0.0,,0.0,,P32245,0.3570117560214777
411,10.1677/joe-09-0336,mc4r_human,102,I,T,IRC-022511,PubChem CID,,,EC50,Functional - cAMP accumulation,0.7,nM,=,,38.0,-55.556,,,,0.0,0.0,,0.0,,P32245,0.3570117560214777
382,10.1677/joe-09-0336,mc4r_human,305,R,W,Alpha-MSH,PubChem CID,16133793,,K(i),Binding - Radioligand competition/displacement,26.0,nM,=,,130.0,-5.0,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.7136512681928545
383,10.1677/joe-09-0336,mc4r_human,305,R,W,IRC-022493,PubChem CID,11993702,,K(i),Binding - Radioligand competition/displacement,0.71,nM,=,,2.5,-3.521,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.7136512681928545
384,10.1677/joe-09-0336,mc4r_human,305,R,W,IRC-022511,PubChem CID,,,K(i),Binding - Radioligand competition/displacement,0.71,nM,=,,2.2,-3.096,,,125-I-NDP-MSH,0.0,0.0,,0.0,,P32245,0.7136512681928545
415,10.1677/joe-09-0336,mc4r_human,305,R,W,Alpha-MSH,PubChem CID,16133793,,EC50,Functional - cAMP accumulation,30.0,nM,=,,15.0,2.0,,,,0.0,0.0,,0.0,,P32245,0.7136512681928545
416,10.1677/joe-09-0336,mc4r_human,305,R,W,IRC-022493,PubChem CID,11993702,,EC50,Functional - cAMP accumulation,1.5,nM,=,,0.87,1.724,,,,0.0,0.0,,0.0,,P32245,0.7136512681928545
417,10.1677/joe-09-0336,mc4r_human,305,R,W,IRC-022511,PubChem CID,,,EC50,Functional - cAMP accumulation,0.7,nM,=,,0.61,1.148,,,,0.0,0.0,,0.0,,P32245,0.7136512681928545
2,10.1111/bph.13065,grm2_human,635,R,A,BINA ,PubChem CID,9868580,Positive allosteric modulator,pEC50,Functional - [35S]GPTÎ³S binding,7.03,,=,,6.21,-6.623,,,Glutamate,0.0,0.0,,0.0,,Q14416,0.5437435468287809
38,10.1111/bph.13065,grm2_human,635,R,A,JNJ-35814376 ,PubChem CID,11523023,Positive allosteric modulator,pEC50,Functional - [35S]GPTÎ³S binding,6.19,,=,,6.07,-1.318,,,Glutamate,0.0,0.0,,0.0,,Q14416,0.5437435468287809
74,10.1111/bph.13065,grm2_human,635,R,A,JNJ-40068782 ,PubChem CID,59234231,Positive allosteric modulator,pEC50,Functional - [35S]GPTÎ³S binding,6.9,,=,,6.42,-3.021,,,Glutamate,0.0,0.0,,0.0,,Q14416,0.5437435468287809
4,10.1111/bph.13065,grm2_human,639,L,A,BINA ,PubChem CID,9868580,Positive allosteric modulator,pEC50,Functional - [35S]GPTÎ³S binding,7.03,,=,,5.86,-14.706,,,Glutamate,0.0,0.0,,0.0,,Q14416,0.5271118231861167
40,10.1111/bph.13065,grm2_human,639,L,A,JNJ-35814376 ,PubChem CID,11523023,Positive allosteric modulator,pEC50,Functional - [35S]GPTÎ³S binding,6.19,,=,,5.83,-2.288,,,Glutamate,0.0,0.0,,0.0,,Q14416,0.5271118231861167
76,10.1111/bph.13065,grm2_human,639,L,A,JNJ-40068782 ,PubChem CID,59234231,Positive allosteric modulator,pEC50,Functional - [35S]GPTÎ³S binding,6.9,,=,,6.27,-4.274,,,Glutamate,0.0,0.0,,0.0,,Q14416,0.5271118231861167
112,10.1111/bph.13065,grm2_human,639,L,A,JNJ-40297036 ,PubChem CID,46917791,Positive allosteric modulator,pEC50,Functional - [35S]GPTÎ³S binding,6.79,,=,,6.28,-3.236,,,Glutamate,0.0,0.0,,0.0,,Q14416,0.5271118231861167
256,10.1111/bph.13065,grm2_human,639,L,A,LY2607540 ,PubChem CID,44595851,Positive allosteric modulator,pEC50,Functional - [35S]GPTÎ³S binding,6.97,,=,,6.78,-1.548,,,Glutamate,0.0,0.0,,0.0,,Q14416,0.5271118231861167
292,10.1111/bph.13065,grm2_human,639,L,A,LY487379 ,PubChem CID,9825084,Positive allosteric modulator,pEC50,Functional - [35S]GPTÎ³S binding,6.78,,=,,6.16,-4.167,,,Glutamate,0.0,0.0,,0.0,,Q14416,0.5271118231861167
7,10.1111/bph.13065,grm2_human,643,F,A,BINA ,PubChem CID,9868580,Positive allosteric modulator,pEC50,Functional - [35S]GPTÎ³S binding,7.03,,=,,5.85,-15.152,,,Glutamate,0.0,0.0,,0.0,,Q14416,0.6062058975967548
79,10.1111/bph.13065,grm2_human,643,F,A,JNJ-40068782 ,PubChem CID,59234231,Positive allosteric modulator,pEC50,Functional - [35S]GPTÎ³S binding,6.9,,=,,5.64,-18.182,,,Glutamate,0.0,0.0,,0.0,,Q14416,0.6062058975967548
115,10.1111/bph.13065,grm2_human,643,F,A,JNJ-40297036 ,PubChem CID,46917791,Positive allosteric modulator,pEC50,Functional - [35S]GPTÎ³S binding,6.79,,<,,5.0,-62.5,,,Glutamate,0.0,0.0,,0.0,,Q14416,0.6062058975967548
151,10.1111/bph.13065,grm2_human,643,F,A,JNJ-41482012 ,PubChem CID,46227786,Positive allosteric modulator,pEC50,Functional - [35S]GPTÎ³S binding,6.74,,<,,5.0,-55.556,,,Glutamate,0.0,0.0,,0.0,,Q14416,0.6062058975967548
187,10.1111/bph.13065,grm2_human,643,F,A,JNJ-42329001 ,PubChem CID,49801368,Positive allosteric modulator,pEC50,Functional - [35S]GPTÎ³S binding,7.41,,=,,5.24,-142.857,,,Glutamate,0.0,0.0,,0.0,,Q14416,0.6062058975967548
223,10.1111/bph.13065,grm2_human,643,F,A,JNJ-46281222 ,PubChem CID,49822115,Positive allosteric modulator,pEC50,Functional - [35S]GPTÎ³S binding,8.09,,=,,6.32,-58.824,,,Glutamate,0.0,0.0,,0.0,,Q14416,0.6062058975967548
259,10.1111/bph.13065,grm2_human,643,F,A,LY2607540 ,PubChem CID,44595851,Positive allosteric modulator,pEC50,Functional - [35S]GPTÎ³S binding,6.97,,=,,6.08,-7.752,,,Glutamate,0.0,0.0,,0.0,,Q14416,0.6062058975967548
295,10.1111/bph.13065,grm2_human,643,F,A,LY487379 ,PubChem CID,9825084,Positive allosteric modulator,pEC50,Functional - [35S]GPTÎ³S binding,6.78,,<,,5.0,-58.824,,,Glutamate,0.0,0.0,,0.0,,Q14416,0.6062058975967548
10,10.1111/bph.13065,grm2_human,688,S,L,BINA ,PubChem CID,9868580,Positive allosteric modulator,pEC50,Functional - [35S]GPTÎ³S binding,7.11,,=,,6.93,-1.513,,,Glutamate,0.0,0.0,,0.0,,Q14416,0.3120619940876873
46,10.1111/bph.13065,grm2_human,688,S,L,JNJ-35814376 ,PubChem CID,11523023,Positive allosteric modulator,pEC50,Functional - [35S]GPTÎ³S binding,6.36,,=,,6.28,-1.202,,,Glutamate,0.0,0.0,,0.0,,Q14416,0.3120619940876873
82,10.1111/bph.13065,grm2_human,688,S,L,JNJ-40068782 ,PubChem CID,59234231,Positive allosteric modulator,pEC50,Functional - [35S]GPTÎ³S binding,7.08,,=,,6.92,-1.445,,,Glutamate,0.0,0.0,,0.0,,Q14416,0.3120619940876873
118,10.1111/bph.13065,grm2_human,688,S,L,JNJ-40297036 ,PubChem CID,46917791,Positive allosteric modulator,pEC50,Functional - [35S]GPTÎ³S binding,6.75,,=,,6.8,1.122,,,Glutamate,0.0,0.0,,0.0,,Q14416,0.3120619940876873
154,10.1111/bph.13065,grm2_human,688,S,L,JNJ-41482012 ,PubChem CID,46227786,Positive allosteric modulator,pEC50,Functional - [35S]GPTÎ³S binding,6.83,,=,,6.89,1.148,,,Glutamate,0.0,0.0,,0.0,,Q14416,0.3120619940876873
190,10.1111/bph.13065,grm2_human,688,S,L,JNJ-42329001 ,PubChem CID,49801368,Positive allosteric modulator,pEC50,Functional - [35S]GPTÎ³S binding,7.55,,=,,7.5,-1.122,,,Glutamate,0.0,0.0,,0.0,,Q14416,0.3120619940876873
226,10.1111/bph.13065,grm2_human,688,S,L,JNJ-46281222 ,PubChem CID,49822115,Positive allosteric modulator,pEC50,Functional - [35S]GPTÎ³S binding,8.22,,=,,7.69,-3.39,,,Glutamate,0.0,0.0,,0.0,,Q14416,0.3120619940876873
262,10.1111/bph.13065,grm2_human,688,S,L,LY2607540 ,PubChem CID,44595851,Positive allosteric modulator,pEC50,Functional - [35S]GPTÎ³S binding,6.97,,=,,6.91,-1.148,,,Glutamate,0.0,0.0,,0.0,,Q14416,0.3120619940876873
298,10.1111/bph.13065,grm2_human,688,S,L,LY487379 ,PubChem CID,9825084,Positive allosteric modulator,pEC50,Functional - [35S]GPTÎ³S binding,6.85,,=,,6.92,1.175,,,Glutamate,0.0,0.0,,0.0,,Q14416,0.3120619940876873
330,10.1124/jpet.108.138271,grm2_human,688,S,L,MRLSD-650,PubChem CID,11663353,Positive allosteric modulator,Single-point,Functional - IP accumulation,92.0,%,=,,98.0,1.065,,,Glutamate,0.0,0.0,,0.0,,Q14416,0.3120619940876873
338,10.1124/mol.64.4.798,grm2_human,688,S,L,LY487379,PubChem CID,9825084,Positive allosteric modulator,Single-point,Functional - IP accumulation,78.0,%,=,,97.0,1.244,,,Glutamate,0.0,0.0,,0.0,,Q14416,0.3120619940876873
11,10.1111/bph.13065,grm2_human,689,G,V,BINA ,PubChem CID,9868580,Positive allosteric modulator,pEC50,Functional - [35S]GPTÎ³S binding,7.03,,=,,6.2,-6.757,,,Glutamate,0.0,0.0,,0.0,,Q14416,0.3614835922432499
47,10.1111/bph.13065,grm2_human,689,G,V,JNJ-35814376 ,PubChem CID,11523023,Positive allosteric modulator,pEC50,Functional - [35S]GPTÎ³S binding,6.19,,=,,5.74,-2.817,,,Glutamate,0.0,0.0,,0.0,,Q14416,0.3614835922432499
83,10.1111/bph.13065,grm2_human,689,G,V,JNJ-40068782 ,PubChem CID,59234231,Positive allosteric modulator,pEC50,Functional - [35S]GPTÎ³S binding,6.9,,=,,6.27,-4.274,,,Glutamate,0.0,0.0,,0.0,,Q14416,0.3614835922432499
119,10.1111/bph.13065,grm2_human,689,G,V,JNJ-40297036 ,PubChem CID,46917791,Positive allosteric modulator,pEC50,Functional - [35S]GPTÎ³S binding,6.79,,=,,6.3,-3.086,,,Glutamate,0.0,0.0,,0.0,,Q14416,0.3614835922432499
155,10.1111/bph.13065,grm2_human,689,G,V,JNJ-41482012 ,PubChem CID,46227786,Positive allosteric modulator,pEC50,Functional - [35S]GPTÎ³S binding,6.74,,<,,5.0,-55.556,,,Glutamate,0.0,0.0,,0.0,,Q14416,0.3614835922432499
191,10.1111/bph.13065,grm2_human,689,G,V,JNJ-42329001 ,PubChem CID,49801368,Positive allosteric modulator,pEC50,Functional - [35S]GPTÎ³S binding,7.41,,=,,6.84,-3.717,,,Glutamate,0.0,0.0,,0.0,,Q14416,0.3614835922432499
227,10.1111/bph.13065,grm2_human,689,G,V,JNJ-46281222 ,PubChem CID,49822115,Positive allosteric modulator,pEC50,Functional - [35S]GPTÎ³S binding,8.09,,=,,7.21,-7.576,,,Glutamate,0.0,0.0,,0.0,,Q14416,0.3614835922432499
263,10.1111/bph.13065,grm2_human,689,G,V,LY2607540 ,PubChem CID,44595851,Positive allosteric modulator,pEC50,Functional - [35S]GPTÎ³S binding,6.97,,=,,6.22,-5.618,,,Glutamate,0.0,0.0,,0.0,,Q14416,0.3614835922432499
299,10.1111/bph.13065,grm2_human,689,G,V,LY487379 ,PubChem CID,9825084,Positive allosteric modulator,pEC50,Functional - [35S]GPTÎ³S binding,6.78,,=,,6.85,1.175,,,Glutamate,0.0,0.0,,0.0,,Q14416,0.3614835922432499
331,10.1124/jpet.108.138271,grm2_human,689,G,V,MRLSD-650,PubChem CID,11663353,Positive allosteric modulator,Single-point,Functional - IP accumulation,92.0,%,=,,79.0,-1.164,,,Glutamate,0.0,0.0,,0.0,,Q14416,0.3614835922432499
339,10.1124/mol.64.4.798,grm2_human,689,G,V,LY487379,PubChem CID,9825084,Positive allosteric modulator,Single-point,Functional - IP accumulation,78.0,%,=,,90.0,1.154,,,Glutamate,0.0,0.0,,0.0,,Q14416,0.3614835922432499
28,10.1111/bph.13065,grm2_human,732,L,A,BINA ,PubChem CID,9868580,Positive allosteric modulator,pEC50,Functional - [35S]GPTÎ³S binding,7.03,,=,,7.8,5.888,,,Glutamate,0.0,0.0,,0.0,,Q14416,0.4898558775564946
64,10.1111/bph.13065,grm2_human,732,L,A,JNJ-35814376 ,PubChem CID,11523023,Positive allosteric modulator,pEC50,Functional - [35S]GPTÎ³S binding,6.19,,=,,6.22,1.072,,,Glutamate,0.0,0.0,,0.0,,Q14416,0.4898558775564946
100,10.1111/bph.13065,grm2_human,732,L,A,JNJ-40068782 ,PubChem CID,59234231,Positive allosteric modulator,pEC50,Functional - [35S]GPTÎ³S binding,6.9,,=,,7.03,1.349,,,Glutamate,0.0,0.0,,0.0,,Q14416,0.4898558775564946
136,10.1111/bph.13065,grm2_human,732,L,A,JNJ-40297036 ,PubChem CID,46917791,Positive allosteric modulator,pEC50,Functional - [35S]GPTÎ³S binding,6.79,,=,,6.51,-1.905,,,Glutamate,0.0,0.0,,0.0,,Q14416,0.4898558775564946
172,10.1111/bph.13065,grm2_human,732,L,A,JNJ-41482012 ,PubChem CID,46227786,Positive allosteric modulator,pEC50,Functional - [35S]GPTÎ³S binding,6.74,,<,,5.0,-55.556,,,Glutamate,0.0,0.0,,0.0,,Q14416,0.4898558775564946
208,10.1111/bph.13065,grm2_human,732,L,A,JNJ-42329001 ,PubChem CID,49801368,Positive allosteric modulator,pEC50,Functional - [35S]GPTÎ³S binding,7.41,,=,,6.25,-14.493,,,Glutamate,0.0,0.0,,0.0,,Q14416,0.4898558775564946
244,10.1111/bph.13065,grm2_human,732,L,A,JNJ-46281222 ,PubChem CID,49822115,Positive allosteric modulator,pEC50,Functional - [35S]GPTÎ³S binding,8.09,,=,,7.31,-6.024,,,Glutamate,0.0,0.0,,0.0,,Q14416,0.4898558775564946
280,10.1111/bph.13065,grm2_human,732,L,A,LY2607540 ,PubChem CID,44595851,Positive allosteric modulator,pEC50,Functional - [35S]GPTÎ³S binding,6.97,,=,,6.49,-3.021,,,Glutamate,0.0,0.0,,0.0,,Q14416,0.4898558775564946
316,10.1111/bph.13065,grm2_human,732,L,A,LY487379 ,PubChem CID,9825084,Positive allosteric modulator,pEC50,Functional - [35S]GPTÎ³S binding,6.78,,<,,5.0,-58.824,,,Glutamate,0.0,0.0,,0.0,,Q14416,0.4898558775564946
30,10.1111/bph.13065,grm2_human,735,N,D,BINA ,PubChem CID,9868580,Positive allosteric modulator,pEC50,Functional - [35S]GPTÎ³S binding,7.03,,=,,5.13,-76.923,,,Glutamate,0.0,0.0,,0.0,,Q14416,0.4865858735034353
66,10.1111/bph.13065,grm2_human,735,N,D,JNJ-35814376 ,PubChem CID,11523023,Positive allosteric modulator,pEC50,Functional - [35S]GPTÎ³S binding,6.19,,<,,5.0,-15.385,,,Glutamate,0.0,0.0,,0.0,,Q14416,0.4865858735034353
102,10.1111/bph.13065,grm2_human,735,N,D,JNJ-40068782 ,PubChem CID,59234231,Positive allosteric modulator,pEC50,Functional - [35S]GPTÎ³S binding,6.9,,=,,5.52,-23.81,,,Glutamate,0.0,0.0,,0.0,,Q14416,0.4865858735034353
138,10.1111/bph.13065,grm2_human,735,N,D,JNJ-40297036 ,PubChem CID,46917791,Positive allosteric modulator,pEC50,Functional - [35S]GPTÎ³S binding,6.79,,<,,5.0,-62.5,,,Glutamate,0.0,0.0,,0.0,,Q14416,0.4865858735034353
174,10.1111/bph.13065,grm2_human,735,N,D,JNJ-41482012 ,PubChem CID,46227786,Positive allosteric modulator,pEC50,Functional - [35S]GPTÎ³S binding,6.74,,<,,5.0,-55.556,,,Glutamate,0.0,0.0,,0.0,,Q14416,0.4865858735034353
210,10.1111/bph.13065,grm2_human,735,N,D,JNJ-42329001 ,PubChem CID,49801368,Positive allosteric modulator,pEC50,Functional - [35S]GPTÎ³S binding,7.41,,=,,5.97,-27.778,,,Glutamate,0.0,0.0,,0.0,,Q14416,0.4865858735034353
246,10.1111/bph.13065,grm2_human,735,N,D,JNJ-46281222 ,PubChem CID,49822115,Positive allosteric modulator,pEC50,Functional - [35S]GPTÎ³S binding,8.09,,=,,6.67,-26.316,,,Glutamate,0.0,0.0,,0.0,,Q14416,0.4865858735034353
282,10.1111/bph.13065,grm2_human,735,N,D,LY2607540 ,PubChem CID,44595851,Positive allosteric modulator,pEC50,Functional - [35S]GPTÎ³S binding,6.97,,=,,5.53,-27.778,,,Glutamate,0.0,0.0,,0.0,,Q14416,0.4865858735034353
318,10.1111/bph.13065,grm2_human,735,N,D,LY487379 ,PubChem CID,9825084,Positive allosteric modulator,pEC50,Functional - [35S]GPTÎ³S binding,6.78,,<,,5.0,-58.824,,,Glutamate,0.0,0.0,,0.0,,Q14416,0.4865858735034353
326,10.1124/jpet.106.117093,grm2_human,735,N,D,MNI-135,PubChem CID,22224658,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - Ca2+ accumulation,21.4,nM,=,,24.4,-1.14,,,Glutamate,0.0,0.0,,0.0,,Q14416,0.4865858735034353
327,10.1124/jpet.106.117093,grm2_human,735,N,D,MNI-136,SMILES,C1(=CC2=C(C=C1)NC(CC(=N2)C3=CC=CC(=C3)C4=CC=CN=C4)=O)Br,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - Ca2+ accumulation,17.5,nM,=,,18.3,-1.046,,,Glutamate,0.0,0.0,,0.0,,Q14416,0.4865858735034353
328,10.1124/jpet.106.117093,grm2_human,735,N,D,MNI137,PubChem CID,25210562,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - Ca2+ accumulation,11.4,nM,=,,17.0,-1.49,,,Glutamate,0.0,0.0,,0.0,,Q14416,0.4865858735034353
335,10.1124/jpet.108.138271,grm2_human,735,N,D,MRLSD-650,PubChem CID,11663353,Positive allosteric modulator,Single-point,Functional - IP accumulation,92.0,%,=,,27.0,-3.413,,,Glutamate,0.0,0.0,,0.0,,Q14416,0.4865858735034353
343,10.1124/mol.64.4.798,grm2_human,735,N,D,LY487379,PubChem CID,9825084,Positive allosteric modulator,Single-point,Functional - IP accumulation,78.0,%,=,,14.0,-5.587,,,Glutamate,0.0,0.0,,0.0,,Q14416,0.4865858735034353
33,10.1111/bph.13065,grm2_human,773,W,A,BINA ,PubChem CID,9868580,Positive allosteric modulator,pEC50,Functional - [35S]GPTÎ³S binding,7.03,,<,,5.0,-111.111,,,Glutamate,0.0,0.0,,0.0,,Q14416,0.8249943114321827
69,10.1111/bph.13065,grm2_human,773,W,A,JNJ-35814376 ,PubChem CID,11523023,Positive allosteric modulator,pEC50,Functional - [35S]GPTÎ³S binding,6.19,,<,,5.0,-15.385,,,Glutamate,0.0,0.0,,0.0,,Q14416,0.8249943114321827
105,10.1111/bph.13065,grm2_human,773,W,A,JNJ-40068782 ,PubChem CID,59234231,Positive allosteric modulator,pEC50,Functional - [35S]GPTÎ³S binding,6.9,,<,,5.0,-76.923,,,Glutamate,0.0,0.0,,0.0,,Q14416,0.8249943114321827
141,10.1111/bph.13065,grm2_human,773,W,A,JNJ-40297036 ,PubChem CID,46917791,Positive allosteric modulator,pEC50,Functional - [35S]GPTÎ³S binding,6.79,,<,,5.0,-62.5,,,Glutamate,0.0,0.0,,0.0,,Q14416,0.8249943114321827
177,10.1111/bph.13065,grm2_human,773,W,A,JNJ-41482012 ,PubChem CID,46227786,Positive allosteric modulator,pEC50,Functional - [35S]GPTÎ³S binding,6.74,,<,,5.0,-55.556,,,Glutamate,0.0,0.0,,0.0,,Q14416,0.8249943114321827
213,10.1111/bph.13065,grm2_human,773,W,A,JNJ-42329001 ,PubChem CID,49801368,Positive allosteric modulator,pEC50,Functional - [35S]GPTÎ³S binding,7.41,,=,,5.9,-32.258,,,Glutamate,0.0,0.0,,0.0,,Q14416,0.8249943114321827
249,10.1111/bph.13065,grm2_human,773,W,A,JNJ-46281222 ,PubChem CID,49822115,Positive allosteric modulator,pEC50,Functional - [35S]GPTÎ³S binding,8.09,,=,,7.11,-9.524,,,Glutamate,0.0,0.0,,0.0,,Q14416,0.8249943114321827
285,10.1111/bph.13065,grm2_human,773,W,A,LY2607540 ,PubChem CID,44595851,Positive allosteric modulator,pEC50,Functional - [35S]GPTÎ³S binding,6.97,,<,,5.0,-90.909,,,Glutamate,0.0,0.0,,0.0,,Q14416,0.8249943114321827
321,10.1111/bph.13065,grm2_human,773,W,A,LY487379 ,PubChem CID,9825084,Positive allosteric modulator,pEC50,Functional - [35S]GPTÎ³S binding,6.78,,<,,5.0,-58.824,,,Glutamate,0.0,0.0,,0.0,,Q14416,0.8249943114321827
34,10.1111/bph.13065,grm2_human,776,F,A,BINA ,PubChem CID,9868580,Positive allosteric modulator,pEC50,Functional - [35S]GPTÎ³S binding,7.03,,=,,6.71,-2.088,,,Glutamate,0.0,0.0,,0.0,,Q14416,0.6847146524823569
106,10.1111/bph.13065,grm2_human,776,F,A,JNJ-40068782 ,PubChem CID,59234231,Positive allosteric modulator,pEC50,Functional - [35S]GPTÎ³S binding,6.9,,=,,6.38,-3.311,,,Glutamate,0.0,0.0,,0.0,,Q14416,0.6847146524823569
214,10.1111/bph.13065,grm2_human,776,F,A,JNJ-42329001 ,PubChem CID,49801368,Positive allosteric modulator,pEC50,Functional - [35S]GPTÎ³S binding,7.41,,=,,7.16,-1.779,,,Glutamate,0.0,0.0,,0.0,,Q14416,0.6847146524823569
286,10.1111/bph.13065,grm2_human,776,F,A,LY2607540 ,PubChem CID,44595851,Positive allosteric modulator,pEC50,Functional - [35S]GPTÎ³S binding,6.97,,=,,6.93,-1.096,,,Glutamate,0.0,0.0,,0.0,,Q14416,0.6847146524823569
322,10.1111/bph.13065,grm2_human,776,F,A,LY487379 ,PubChem CID,9825084,Positive allosteric modulator,pEC50,Functional - [35S]GPTÎ³S binding,6.78,,<,,5.0,-58.824,,,Glutamate,0.0,0.0,,0.0,,Q14416,0.6847146524823569
58,10.1111/bph.13065,grm2_human,723,H,V,JNJ-35814376 ,PubChem CID,11523023,Positive allosteric modulator,pEC50,Functional - [35S]GPTÎ³S binding,6.19,,=,,5.79,-2.513,,,,0.0,0.0,,0.0,,Q14416,0.5725532951509167
94,10.1111/bph.13065,grm2_human,723,H,V,JNJ-40068782 ,PubChem CID,59234231,Positive allosteric modulator,pEC50,Functional - [35S]GPTÎ³S binding,6.9,,=,,6.27,-4.274,,,,0.0,0.0,,0.0,,Q14416,0.5725532951509167
130,10.1111/bph.13065,grm2_human,723,H,V,JNJ-40297036 ,PubChem CID,46917791,Positive allosteric modulator,pEC50,Functional - [35S]GPTÎ³S binding,6.79,,=,,6.46,-2.137,,,,0.0,0.0,,0.0,,Q14416,0.5725532951509167
166,10.1111/bph.13065,grm2_human,723,H,V,JNJ-41482012 ,PubChem CID,46227786,Positive allosteric modulator,pEC50,Functional - [35S]GPTÎ³S binding,6.74,,=,,6.72,-1.047,,,,0.0,0.0,,0.0,,Q14416,0.5725532951509167
274,10.1111/bph.13065,grm2_human,723,H,V,LY2607540 ,PubChem CID,44595851,Positive allosteric modulator,pEC50,Functional - [35S]GPTÎ³S binding,6.97,,=,,6.56,-2.571,,,,0.0,0.0,,0.0,,Q14416,0.5725532951509167
332,10.1124/jpet.108.138271,grm2_human,723,H,V,MRLSD-650,PubChem CID,11663353,Positive allosteric modulator,Single-point,Functional - IP accumulation,92.0,%,=,,79.0,-1.164,,,Glutamate,0.0,0.0,,0.0,,Q14416,0.5725532951509167
340,10.1124/mol.64.4.798,grm2_human,723,H,V,LY487379,PubChem CID,9825084,Positive allosteric modulator,Single-point,Functional - IP accumulation,78.0,%,=,,62.0,-1.258,,,Glutamate,0.0,0.0,,0.0,,Q14416,0.5725532951509167
63,10.1111/bph.13065,grm2_human,731,S,A,JNJ-35814376 ,PubChem CID,11523023,Positive allosteric modulator,pEC50,Functional - [35S]GPTÎ³S binding,6.19,,=,,5.92,-1.862,,,Glutamate,0.0,0.0,,0.0,,Q14416,0.4214123561235862
279,10.1111/bph.13065,grm2_human,731,S,A,LY2607540 ,PubChem CID,44595851,Positive allosteric modulator,pEC50,Functional - [35S]GPTÎ³S binding,6.97,,=,,6.56,-2.571,,,Glutamate,0.0,0.0,,0.0,,Q14416,0.4214123561235862
315,10.1111/bph.13065,grm2_human,731,S,A,LY487379 ,PubChem CID,9825084,Positive allosteric modulator,pEC50,Functional - [35S]GPTÎ³S binding,6.78,,=,,6.08,-5.0,,,Glutamate,0.0,0.0,,0.0,,Q14416,0.4214123561235862
329,10.1124/jpet.108.138271,grm2_human,681,A,F,MRLSD-650,PubChem CID,11663353,Positive allosteric modulator,Single-point,Functional - IP accumulation,92.0,%,=,,80.0,-1.149,,,Glutamate,0.0,0.0,,0.0,,Q14416,0.3298130030134201
337,10.1124/mol.64.4.798,grm2_human,681,A,F,LY487379,PubChem CID,9825084,Positive allosteric modulator,Single-point,Functional - IP accumulation,78.0,%,=,,90.0,1.154,,,Glutamate,0.0,0.0,,0.0,,Q14416,0.3298130030134201
333,10.1124/jpet.108.138271,grm2_human,730,G,I,MRLSD-650,PubChem CID,11663353,Positive allosteric modulator,Single-point,Functional - IP accumulation,92.0,%,=,,89.0,-1.034,,,Glutamate,0.0,0.0,,0.0,,Q14416,0.453581613300252
341,10.1124/mol.64.4.798,grm2_human,730,G,I,LY487379,PubChem CID,9825084,Positive allosteric modulator,Single-point,Functional - IP accumulation,78.0,%,=,,73.0,-1.068,,,Glutamate,0.0,0.0,,0.0,,Q14416,0.453581613300252
334,10.1124/jpet.108.138271,grm2_human,733,A,T,MRLSD-650,PubChem CID,11663353,Positive allosteric modulator,Single-point,Functional - IP accumulation,92.0,%,=,,88.0,-1.045,,,Glutamate,0.0,0.0,,0.0,,Q14416,0.2878976601521134
342,10.1124/mol.64.4.798,grm2_human,733,A,T,LY487379,PubChem CID,9825084,Positive allosteric modulator,Single-point,Functional - IP accumulation,78.0,%,=,,85.0,1.09,,,Glutamate,0.0,0.0,,0.0,,Q14416,0.2878976601521134
0,16837468,ccr1_human,291,Y,A,BX-471,ChEMBL Compound ID,CHEMBL232656,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,10.0,nM,=,,542.0,-55.556,,,radioligand: [125I]-CCL3,100.0,0.0,,0.0,,P32246,0.6048196973204691
54,16837468,ccr1_human,291,Y,A,BX 471,SMILES,ClC1=CC=C(OCC(N2CCN(CC3=CC=C(F)C=C3)C[C@H]2C)=O)C(NC(C)=O)=C1,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,10.0,nM,=,,542.0,-55.556,,,radioligand: [125I]-CCL3,100.0,0.0,,0.0,,P32246,0.6048196973204691
1,16837468,ccr1_human,287,E,Q,BX-471,ChEMBL Compound ID,CHEMBL232656,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,10.0,nM,=,,344.0,-34.483,,,radioligand: [125I]-CCL3,100.0,0.0,,0.0,,P32246,0.3545725904996951
19,15548526,ccr1_human,287,E,Q,UCB-35625,SMILES,O=C(NC1CC[N+](CC2CCCCCC2)(CC)CC1)C3C4=C(C=CC=C4)OC5=CC=CC=C53.[I-],Antagonist (neutral/silent),Single-point,Binding - Radioligand competition/displacement,100.0,%,~,,0.0,40.0,,,radioligand: [125I]-CCL3,100.0,0.0,,0.0,,P32246,0.3545725904996951
57,16837468,ccr1_human,287,E,Q,BX 471,SMILES,ClC1=CC=C(OCC(N2CCN(CC3=CC=C(F)C=C3)C[C@H]2C)=O)C(NC(C)=O)=C1,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,10.0,nM,=,,344.0,-34.483,,,radioligand: [125I]-CCL3,100.0,0.0,,0.0,,P32246,0.3545725904996951
2,16837468,ccr1_human,260,L,A,BX-471,ChEMBL Compound ID,CHEMBL232656,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,10.0,nM,=,,58.0,-5.814,,,radioligand: [125I]-CCL3,100.0,0.0,,0.0,,P32246,0.4105577438601834
59,16837468,ccr1_human,260,L,A,BX 471,SMILES,ClC1=CC=C(OCC(N2CCN(CC3=CC=C(F)C=C3)C[C@H]2C)=O)C(NC(C)=O)=C1,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,10.0,nM,=,,58.0,-5.814,,,radioligand: [125I]-CCL3,100.0,0.0,,0.0,,P32246,0.4105577438601834
3,16837468,ccr1_human,259,I,A,BX-471,ChEMBL Compound ID,CHEMBL232656,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,10.0,nM,>,,10000.0,-1000.0,,,radioligand: [125I]-CCL3,100.0,0.0,,0.0,,P32246,0.445209359874536
21,15548526,ccr1_human,259,I,A,UCB-35625,SMILES,O=C(NC1CC[N+](CC2CCCCCC2)(CC)CC1)C3C4=C(C=CC=C4)OC5=CC=CC=C53.[I-],Antagonist (neutral/silent),Single-point,Binding - Radioligand competition/displacement,100.0,%,~,,0.0,80.0,,,radioligand: [125I]-CCL3,90.0,0.0,,0.0,,P32246,0.445209359874536
51,16837468,ccr1_human,259,I,A,BX 471,SMILES,ClC1=CC=C(OCC(N2CCN(CC3=CC=C(F)C=C3)C[C@H]2C)=O)C(NC(C)=O)=C1,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,10.0,nM,>,,10000.0,-1000.0,,,radioligand: [125I]-CCL3,100.0,0.0,,0.0,,P32246,0.445209359874536
8,16837468,ccr1_human,114,Y,A,BX-471,ChEMBL Compound ID,CHEMBL232656,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,10.0,nM,=,,5017.0,-500.0,,,radioligand: [125I]-CCL3,50.0,0.0,,0.0,,P32246,0.5150075054877001
34,15548526,ccr1_human,114,Y,A,UCB-35625,SMILES,O=C(NC1CC[N+](CC2CCCCCC2)(CC)CC1)C3C4=C(C=CC=C4)OC5=CC=CC=C53.[I-],Antagonist (neutral/silent),Single-point,Binding - Radioligand competition/displacement,100.0,%,~,,0.0,100.0,,,radioligand: [125I]-CCL3,90.0,0.0,,0.0,,P32246,0.5150075054877001
52,16837468,ccr1_human,114,Y,A,BX 471,SMILES,ClC1=CC=C(OCC(N2CCN(CC3=CC=C(F)C=C3)C[C@H]2C)=O)C(NC(C)=O)=C1,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,10.0,nM,=,,5017.0,-500.0,,,radioligand: [125I]-CCL3,55.0,0.0,,0.0,,P32246,0.5150075054877001
9,16837468,ccr1_human,113,Y,F,BX-471,ChEMBL Compound ID,CHEMBL232656,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,10.0,nM,=,,464.0,-45.455,,,radioligand: [125I]-CCL3,110.0,0.0,,0.0,,P32246,0.35541909758457
55,16837468,ccr1_human,113,Y,F,BX 471,SMILES,ClC1=CC=C(OCC(N2CCN(CC3=CC=C(F)C=C3)C[C@H]2C)=O)C(NC(C)=O)=C1,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,10.0,nM,=,,464.0,-45.455,,,radioligand: [125I]-CCL3,105.0,0.0,,0.0,,P32246,0.35541909758457
10,16837468,ccr1_human,113,Y,A,BX-471,ChEMBL Compound ID,CHEMBL232656,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,10.0,nM,>,,10000.0,-1000.0,,,radioligand: [125I]-CCL3,100.0,0.0,,0.0,,P32246,0.5756033753087302
35,15548526,ccr1_human,113,Y,A,UCB-35625,SMILES,O=C(NC1CC[N+](CC2CCCCCC2)(CC)CC1)C3C4=C(C=CC=C4)OC5=CC=CC=C53.[I-],Antagonist (neutral/silent),Single-point,Binding - Radioligand competition/displacement,100.0,%,~,,0.0,20.0,,,radioligand: [125I]-CCL3,100.0,0.0,,0.0,,P32246,0.5756033753087302
50,16837468,ccr1_human,113,Y,A,BX 471,SMILES,ClC1=CC=C(OCC(N2CCN(CC3=CC=C(F)C=C3)C[C@H]2C)=O)C(NC(C)=O)=C1,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,10.0,nM,>,,10000.0,-1000.0,,,radioligand: [125I]-CCL3,100.0,0.0,,0.0,,P32246,0.5756033753087302
13,16837468,ccr1_human,91,I,A,BX-471,ChEMBL Compound ID,CHEMBL232656,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,10.0,nM,=,,849.0,-83.333,,,radioligand: [125I]-CCL3,100.0,0.0,,0.0,,P32246,0.4372232739791101
41,15548526,ccr1_human,91,I,A,UCB-35625,SMILES,O=C(NC1CC[N+](CC2CCCCCC2)(CC)CC1)C3C4=C(C=CC=C4)OC5=CC=CC=C53.[I-],Antagonist (neutral/silent),Single-point,Binding - Radioligand competition/displacement,100.0,%,~,,0.0,60.0,,,radioligand: [125I]-CCL3,105.0,0.0,,0.0,,P32246,0.4372232739791101
53,16837468,ccr1_human,91,I,A,BX 471,SMILES,ClC1=CC=C(OCC(N2CCN(CC3=CC=C(F)C=C3)C[C@H]2C)=O)C(NC(C)=O)=C1,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,10.0,nM,=,,849.0,-83.333,,,radioligand: [125I]-CCL3,100.0,0.0,,0.0,,P32246,0.4372232739791101
15,16837468,ccr1_human,86,T,A,BX-471,ChEMBL Compound ID,CHEMBL232656,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,10.0,nM,=,,384.0,-38.462,,,radioligand: [125I]-CCL3,100.0,0.0,,0.0,,P32246,0.4610071815537203
44,15548526,ccr1_human,86,T,A,UCB-35625,SMILES,O=C(NC1CC[N+](CC2CCCCCC2)(CC)CC1)C3C4=C(C=CC=C4)OC5=CC=CC=C53.[I-],Antagonist (neutral/silent),Single-point,Binding - Radioligand competition/displacement,100.0,%,~,,0.0,50.0,,,radioligand: [125I]-CCL3,100.0,0.0,,0.0,,P32246,0.4610071815537203
56,16837468,ccr1_human,86,T,A,BX 471,SMILES,ClC1=CC=C(OCC(N2CCN(CC3=CC=C(F)C=C3)C[C@H]2C)=O)C(NC(C)=O)=C1,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,10.0,nM,=,,348.0,-34.483,,,radioligand: [125I]-CCL3,100.0,0.0,,0.0,,P32246,0.4610071815537203
16,16837468,ccr1_human,41,Y,A,BX-471,ChEMBL Compound ID,CHEMBL232656,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,10.0,nM,=,,264.0,-26.316,,,radioligand: [125I]-CCL3,105.0,0.0,,0.0,,P32246,0.5942853557467235
47,15548526,ccr1_human,41,Y,A,UCB-35625,SMILES,O=C(NC1CC[N+](CC2CCCCCC2)(CC)CC1)C3C4=C(C=CC=C4)OC5=CC=CC=C53.[I-],Antagonist (neutral/silent),Single-point,Binding - Radioligand competition/displacement,100.0,%,~,,0.0,10.0,,,radioligand: [125I]-CCL3,95.0,0.0,,0.0,,P32246,0.5942853557467235
58,16837468,ccr1_human,41,Y,A,BX 471,SMILES,ClC1=CC=C(OCC(N2CCN(CC3=CC=C(F)C=C3)C[C@H]2C)=O)C(NC(C)=O)=C1,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,10.0,nM,=,,264.0,-26.316,,,radioligand: [125I]-CCL3,105.0,0.0,,0.0,,P32246,0.5942853557467235
20,15548526,ccr1_human,262,S,A,UCB-35625,SMILES,O=C(NC1CC[N+](CC2CCCCCC2)(CC)CC1)C3C4=C(C=CC=C4)OC5=CC=CC=C53.[I-],Antagonist (neutral/silent),Single-point,Binding - Radioligand competition/displacement,100.0,%,~,,0.0,95.0,,,radioligand: [125I]-CCL3,100.0,0.0,,0.0,,P32246,0.2770724655940215
22,15548526,ccr1_human,255,Y,A,UCB-35625,SMILES,O=C(NC1CC[N+](CC2CCCCCC2)(CC)CC1)C3C4=C(C=CC=C4)OC5=CC=CC=C53.[I-],Antagonist (neutral/silent),Single-point,Binding - Radioligand competition/displacement,100.0,%,~,,0.0,60.0,,,radioligand: [125I]-CCL3,75.0,0.0,,0.0,,P32246,0.5834957692041154
23,15548526,ccr1_human,252,W,A,UCB-35625,SMILES,O=C(NC1CC[N+](CC2CCCCCC2)(CC)CC1)C3C4=C(C=CC=C4)OC5=CC=CC=C53.[I-],Antagonist (neutral/silent),Single-point,Binding - Radioligand competition/displacement,100.0,%,~,,0.0,80.0,,,radioligand: [125I]-CCL3,50.0,0.0,,0.0,,P32246,0.8031005445522477
24,15548526,ccr1_human,208,L,A,UCB-35625,SMILES,O=C(NC1CC[N+](CC2CCCCCC2)(CC)CC1)C3C4=C(C=CC=C4)OC5=CC=CC=C53.[I-],Antagonist (neutral/silent),Single-point,Binding - Radioligand competition/displacement,100.0,%,~,,0.0,100.0,,,radioligand: [125I]-CCL3,110.0,0.0,,0.0,,P32246,0.5347459360668841
25,15548526,ccr1_human,207,G,A,UCB-35625,SMILES,O=C(NC1CC[N+](CC2CCCCCC2)(CC)CC1)C3C4=C(C=CC=C4)OC5=CC=CC=C53.[I-],Antagonist (neutral/silent),Single-point,Binding - Radioligand competition/displacement,100.0,%,~,,0.0,100.0,,,radioligand: [125I]-CCL3,90.0,0.0,,0.0,,P32246,0.4579425791334731
26,15548526,ccr1_human,203,L,A,UCB-35625,SMILES,O=C(NC1CC[N+](CC2CCCCCC2)(CC)CC1)C3C4=C(C=CC=C4)OC5=CC=CC=C53.[I-],Antagonist (neutral/silent),Single-point,Binding - Radioligand competition/displacement,100.0,%,~,,0.0,100.0,,,radioligand: [125I]-CCL3,100.0,0.0,,0.0,,P32246,0.4412590238543812
27,15548526,ccr1_human,168,G,A,UCB-35625,SMILES,O=C(NC1CC[N+](CC2CCCCCC2)(CC)CC1)C3C4=C(C=CC=C4)OC5=CC=CC=C53.[I-],Antagonist (neutral/silent),Single-point,Binding - Radioligand competition/displacement,100.0,%,~,,0.0,100.0,,,radioligand: [125I]-CCL3,85.0,0.0,,0.0,,P32246,0.4109077405534422
28,15548526,ccr1_human,165,S,A,UCB-35625,SMILES,O=C(NC1CC[N+](CC2CCCCCC2)(CC)CC1)C3C4=C(C=CC=C4)OC5=CC=CC=C53.[I-],Antagonist (neutral/silent),Single-point,Binding - Radioligand competition/displacement,100.0,%,~,,0.0,98.0,,,radioligand: [125I]-CCL3,120.0,0.0,,0.0,,P32246,0.4564201548990158
29,15548526,ccr1_human,160,L,A,UCB-35625,SMILES,O=C(NC1CC[N+](CC2CCCCCC2)(CC)CC1)C3C4=C(C=CC=C4)OC5=CC=CC=C53.[I-],Antagonist (neutral/silent),Single-point,Binding - Radioligand competition/displacement,100.0,%,~,,0.0,100.0,,,radioligand: [125I]-CCL3,90.0,0.0,,0.0,,P32246,0.3081788500719158
30,15548526,ccr1_human,120,E,Q,UCB-35625,SMILES,O=C(NC1CC[N+](CC2CCCCCC2)(CC)CC1)C3C4=C(C=CC=C4)OC5=CC=CC=C53.[I-],Antagonist (neutral/silent),Single-point,Binding - Radioligand competition/displacement,100.0,%,~,,0.0,90.0,,,radioligand: [125I]-CCL3,100.0,0.0,,0.0,,P32246,0.3624014165194305
31,15548526,ccr1_human,119,S,A,UCB-35625,SMILES,O=C(NC1CC[N+](CC2CCCCCC2)(CC)CC1)C3C4=C(C=CC=C4)OC5=CC=CC=C53.[I-],Antagonist (neutral/silent),Single-point,Binding - Radioligand competition/displacement,100.0,%,~,,0.0,80.0,,,radioligand: [125I]-CCL3,100.0,0.0,,0.0,,P32246,0.4246047988642957
33,15548526,ccr1_human,115,T,A,UCB-35625,SMILES,O=C(NC1CC[N+](CC2CCCCCC2)(CC)CC1)C3C4=C(C=CC=C4)OC5=CC=CC=C53.[I-],Antagonist (neutral/silent),Single-point,Binding - Radioligand competition/displacement,100.0,%,~,,0.0,100.0,,,radioligand: [125I]-CCL3,140.0,0.0,,0.0,,P32246,0.3794820479904069
36,15548526,ccr1_human,111,G,A,UCB-35625,SMILES,O=C(NC1CC[N+](CC2CCCCCC2)(CC)CC1)C3C4=C(C=CC=C4)OC5=CC=CC=C53.[I-],Antagonist (neutral/silent),Single-point,Binding - Radioligand competition/displacement,100.0,%,~,,0.0,100.0,,,radioligand: [125I]-CCL3,125.0,0.0,,0.0,,P32246,0.3582495954286978
37,15548526,ccr1_human,109,L,A,UCB-35625,SMILES,O=C(NC1CC[N+](CC2CCCCCC2)(CC)CC1)C3C4=C(C=CC=C4)OC5=CC=CC=C53.[I-],Antagonist (neutral/silent),Single-point,Binding - Radioligand competition/displacement,100.0,%,~,,0.0,80.0,,,radioligand: [125I]-CCL3,105.0,0.0,,0.0,,P32246,0.4977788407543173
38,15548526,ccr1_human,105,M,A,UCB-35625,SMILES,O=C(NC1CC[N+](CC2CCCCCC2)(CC)CC1)C3C4=C(C=CC=C4)OC5=CC=CC=C53.[I-],Antagonist (neutral/silent),Single-point,Binding - Radioligand competition/displacement,100.0,%,~,,0.0,98.0,,,radioligand: [125I]-CCL3,115.0,0.0,,0.0,,P32246,0.3529368036644037
39,15548526,ccr1_human,94,K,A,UCB-35625,SMILES,O=C(NC1CC[N+](CC2CCCCCC2)(CC)CC1)C3C4=C(C=CC=C4)OC5=CC=CC=C53.[I-],Antagonist (neutral/silent),Single-point,Binding - Radioligand competition/displacement,100.0,%,~,,0.0,90.0,,,radioligand: [125I]-CCL3,105.0,0.0,,0.0,,P32246,0.4227257659324316
40,15548526,ccr1_human,92,D,N,UCB-35625,SMILES,O=C(NC1CC[N+](CC2CCCCCC2)(CC)CC1)C3C4=C(C=CC=C4)OC5=CC=CC=C53.[I-],Antagonist (neutral/silent),Single-point,Binding - Radioligand competition/displacement,100.0,%,~,,0.0,85.0,,,radioligand: [125I]-CCL3,100.0,0.0,,0.0,,P32246,0.218469141020507
42,15548526,ccr1_human,90,W,A,UCB-35625,SMILES,O=C(NC1CC[N+](CC2CCCCCC2)(CC)CC1)C3C4=C(C=CC=C4)OC5=CC=CC=C53.[I-],Antagonist (neutral/silent),Single-point,Binding - Radioligand competition/displacement,100.0,%,~,,0.0,80.0,,,radioligand: [125I]-CCL3,110.0,0.0,,0.0,,P32246,0.5221403380927659
45,15548526,ccr1_human,80,D,N,UCB-35625,SMILES,O=C(NC1CC[N+](CC2CCCCCC2)(CC)CC1)C3C4=C(C=CC=C4)OC5=CC=CC=C53.[I-],Antagonist (neutral/silent),Single-point,Binding - Radioligand competition/displacement,100.0,%,~,,0.0,100.0,,,radioligand: [125I]-CCL3,110.0,0.0,,0.0,,P32246,0.7749764893057176
46,15548526,ccr1_human,44,V,A,UCB-35625,SMILES,O=C(NC1CC[N+](CC2CCCCCC2)(CC)CC1)C3C4=C(C=CC=C4)OC5=CC=CC=C53.[I-],Antagonist (neutral/silent),Single-point,Binding - Radioligand competition/displacement,100.0,%,~,,0.0,100.0,,,radioligand: [125I]-CCL3,50.0,0.0,,0.0,,P32246,0.4783190707184571
48,15548526,ccr1_human,40,L,A,UCB-35625,SMILES,O=C(NC1CC[N+](CC2CCCCCC2)(CC)CC1)C3C4=C(C=CC=C4)OC5=CC=CC=C53.[I-],Antagonist (neutral/silent),Single-point,Binding - Radioligand competition/displacement,100.0,%,~,,0.0,100.0,,,radioligand: [125I]-CCL3,95.0,0.0,,0.0,,P32246,0.4333035963750761
49,15548526,ccr1_human,37,L,A,UCB-35625,SMILES,O=C(NC1CC[N+](CC2CCCCCC2)(CC)CC1)C3C4=C(C=CC=C4)OC5=CC=CC=C53.[I-],Antagonist (neutral/silent),Single-point,Binding - Radioligand competition/displacement,100.0,%,~,,0.0,90.0,,,radioligand: [125I]-CCL3,105.0,0.0,,0.0,,P32246,0.4619488477464881
122,10.1016/j.bcp.2012.03.008,aa1r_human,167,I,A,CPA,PubChem CID,4402,Full agonist,EC50,Functional - Other,0.1,nM,=,,4.5,-45.455,,,,0.0,14.0,=,0.0,,P30542,0.2965929349072215
704,10.1124/mol.116.105015,aa1r_human,167,I,A,PD81723,PubChem CID,122028,Allosteric agonist,pK(b),Binding - Radioligand competition/displacement,5.41,,=,,6.21,6.31,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.2965929349072215
727,10.1124/mol.116.105015,aa1r_human,167,I,A,VCP171,PubChem CID,24873485,Allosteric agonist,pK(b),Binding - Radioligand competition/displacement,5.65,,=,,5.9,1.778,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.2965929349072215
750,10.1124/mol.116.105007,aa1r_human,167,I,A,DPCPX,PubChem CID,1329,Inverse agonist,pK(d),Binding - Radioligand competition/displacement,9.17,,=,,8.42,-5.618,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.2965929349072215
776,10.1124/mol.116.105007,aa1r_human,167,I,A,NECA,PubChem CID,448222,Full agonist,pK(i),Binding - Radioligand competition/displacement,6.59,,=,,5.74,-7.092,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.2965929349072215
125,10.1074/jbc.274.6.3617,aa1r_human,14,G,T,CCPA,PubChem CID,123807,Full agonist,K(d),Binding - Radioligand saturation,0.6,nM,=,,0.007,85.714,,,,0.0,0.0,=,0.0,,P30542,0.2973085837113532
126,10.1074/jbc.274.6.3617,aa1r_human,14,G,T,DPCPX,PubChem CID,1329,Inverse agonist,K(d),Binding - Radioligand saturation,0.7,nM,=,,0.8,-1.143,,,,0.0,0.0,=,0.0,,P30542,0.2973085837113532
127,10.1074/jbc.274.6.3617,aa1r_human,14,G,T,NECA,PubChem CID,448222,Full agonist,K(i),Binding - Radioligand competition/displacement,5.1,ÂµM,=,,0.7,7.286,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.2973085837113532
128,10.1074/jbc.274.6.3617,aa1r_human,14,G,T,CADO,PubChem CID,8974,Full agonist,K(i),Binding - Radioligand competition/displacement,5.6,ÂµM,=,,0.006,933.333,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.2973085837113532
129,10.1074/jbc.274.6.3617,aa1r_human,14,G,T,R-PIA,PubChem CID,114854,Full agonist,K(i),Binding - Radioligand competition/displacement,370.0,nM,=,,2.7,137.037,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.2973085837113532
130,10.1074/jbc.274.6.3617,aa1r_human,14,G,T,N-0840,PubChem CID,657378,Full agonist,K(i),Binding - Radioligand competition/displacement,130.0,nM,=,,1.2,108.333,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.2973085837113532
131,10.1074/jbc.274.6.3617,aa1r_human,14,G,T,DPCPX,PubChem CID,1329,Inverse agonist,K(i),Binding - Radioligand competition/displacement,2.2,nM,=,,4.3,-1.953,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.2973085837113532
132,10.1016/j.ejphar.2005.01.007,aa1r_human,14,G,T,DPCPX,PubChem CID,1329,Inverse agonist,K(d),Binding - Radioligand saturation,1.8,nM,=,,2.2,-1.222,,,,0.0,0.0,=,0.0,,P30542,0.2973085837113532
133,10.1016/j.ejphar.2005.01.007,aa1r_human,14,G,T,CCPA,PubChem CID,123807,Full agonist,K(d),Binding - Radioligand saturation,0.93,nM,=,,1.3,-1.399,,,,0.0,0.0,,0.0,,P30542,0.2973085837113532
138,10.1016/j.ejphar.2005.01.007,aa1r_human,14,G,T,CPA,PubChem CID,4402,Full agonist,K(i),Binding - Radioligand competition/displacement,436.0,,=,,5.04,86.508,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.2973085837113532
141,10.1016/j.ejphar.2005.01.007,aa1r_human,14,G,T,DPCPX,PubChem CID,1329,Inverse agonist,K(i),Binding - Radioligand competition/displacement,2.96,,=,,4.45,-1.504,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.2973085837113532
144,10.1016/j.ejphar.2005.01.007,aa1r_human,14,G,T,CPA,PubChem CID,4402,Full agonist,,Functional - cAMP accumulation,49.0,%,=,,61.0,1.245,,,,0.0,0.0,=,0.0,,P30542,0.2973085837113532
147,10.1016/j.ejphar.2005.01.007,aa1r_human,14,G,T,DPCPX,PubChem CID,1329,Inverse agonist,,Functional - cAMP accumulation,125.0,%,=,,39.0,-3.205,,,,0.0,0.0,=,0.0,,P30542,0.2973085837113532
151,10.1016/j.ejphar.2005.01.007,aa1r_human,14,G,T,CPA,PubChem CID,4402,Full agonist,K(i),Binding - Radioligand competition/displacement,720.0,nM,=,,17.0,42.353,,,NaCl,0.0,0.0,=,0.0,,P30542,0.2973085837113532
152,10.1016/j.ejphar.2005.01.007,aa1r_human,14,G,T,CPA,PubChem CID,4402,Full agonist,K(i),Binding - Radioligand competition/displacement,81.0,nM,=,,2.74,29.562,,,PD81723,0.0,0.0,=,0.0,,P30542,0.2973085837113532
153,10.1016/j.ejphar.2005.01.007,aa1r_human,14,G,T,CPA,PubChem CID,4402,Full agonist,K(i),Binding - Radioligand competition/displacement,472.0,nM,=,,4.5,104.889,,,GTP,0.0,0.0,=,0.0,,P30542,0.2973085837113532
154,10.1016/j.ejphar.2005.01.007,aa1r_human,14,G,T,DPCPX,PubChem CID,1329,Inverse agonist,K(i),Binding - Radioligand competition/displacement,0.87,nM,=,,0.94,-1.08,,,NaCl,0.0,0.0,=,0.0,,P30542,0.2973085837113532
155,10.1016/j.ejphar.2005.01.007,aa1r_human,14,G,T,DPCPX,PubChem CID,1329,Inverse agonist,K(i),Binding - Radioligand competition/displacement,3.08,nM,=,,6.0,-1.949,,,PD81723,0.0,0.0,=,0.0,,P30542,0.2973085837113532
156,10.1016/j.ejphar.2005.01.007,aa1r_human,14,G,T,DPCPX,PubChem CID,1329,Inverse agonist,K(i),Binding - Radioligand competition/displacement,2.75,nM,=,,2.98,-1.083,,,GTP,0.0,0.0,=,0.0,,P30542,0.2973085837113532
157,10.1016/j.ejphar.2005.01.007,aa1r_human,14,G,T,CPA,PubChem CID,4402,Full agonist,K(i),Binding - Radioligand competition/displacement,289.0,nM,=,,3.45,83.768,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.2973085837113532
158,10.1016/j.ejphar.2005.01.007,aa1r_human,14,G,T,DPCPX,PubChem CID,1329,Inverse agonist,K(i),Binding - Radioligand competition/displacement,2.0,nM,=,,3.08,-1.541,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.2973085837113532
136,10.1016/j.ejphar.2005.01.007,aa1r_human,14,G,A,CPA,PubChem CID,4402,Full agonist,K(i),Binding - Radioligand competition/displacement,436.0,,=,,459.0,-1.053,,,DPCPX,0.0,0.0,,0.0,,P30542,0.2279490023094399
139,10.1016/j.ejphar.2005.01.007,aa1r_human,14,G,A,DPCPX,PubChem CID,1329,Inverse agonist,K(i),Binding - Radioligand competition/displacement,2.96,,=,,3.7,-1.25,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.2279490023094399
142,10.1016/j.ejphar.2005.01.007,aa1r_human,14,G,A,CPA,PubChem CID,4402,Full agonist,,Functional - cAMP accumulation,49.0,%,=,,69.0,1.408,,,,0.0,0.0,=,0.0,,P30542,0.2279490023094399
145,10.1016/j.ejphar.2005.01.007,aa1r_human,14,G,A,DPCPX,PubChem CID,1329,Inverse agonist,,Functional - cAMP accumulation,125.0,%,=,,102.0,-1.225,,,,0.0,0.0,=,0.0,,P30542,0.2279490023094399
162,10.1016/j.ejphar.2005.01.007,aa1r_human,14,G,A,CPA,PubChem CID,4402,Full agonist,EC50,Functional - [35S]GPTÎ³S binding,165.0,,=,,204.0,-1.236,,,,0.0,375.0,=,0.0,,P30542,0.2279490023094399
164,10.1016/j.ejphar.2005.01.007,aa1r_human,14,G,A,CPT,PubChem CID,1917,Inverse agonist,EC50,Functional - [35S]GPTÎ³S binding,26.0,,=,,23.0,1.13,,,,0.0,375.0,=,0.0,,P30542,0.2279490023094399
137,10.1016/j.ejphar.2005.01.007,aa1r_human,14,G,L,CPA,PubChem CID,4402,Full agonist,K(i),Binding - Radioligand competition/displacement,436.0,,=,,551.0,-1.264,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.3773730025226941
140,10.1016/j.ejphar.2005.01.007,aa1r_human,14,G,L,DPCPX,PubChem CID,1329,Inverse agonist,K(i),Binding - Radioligand competition/displacement,2.96,,=,,5.23,-1.767,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.3773730025226941
143,10.1016/j.ejphar.2005.01.007,aa1r_human,14,G,L,CPA,PubChem CID,4402,Full agonist,,Functional - cAMP accumulation,49.0,%,=,,43.0,-1.139,,,,0.0,0.0,=,0.0,,P30542,0.3773730025226941
146,10.1016/j.ejphar.2005.01.007,aa1r_human,14,G,L,DPCPX,PubChem CID,1329,Inverse agonist,,Functional - cAMP accumulation,125.0,%,=,,125.0,1.0,,,,0.0,0.0,=,0.0,,P30542,0.3773730025226941
165,10.1016/j.ejphar.2005.01.007,aa1r_human,14,G,L,CPA,PubChem CID,4402,Full agonist,EC50,Functional - [35S]GPTÎ³S binding,165.0,,=,,192.0,-1.164,,,,0.0,375.0,=,0.0,,P30542,0.3773730025226941
167,10.1016/j.ejphar.2005.01.007,aa1r_human,14,G,L,CPT,PubChem CID,1917,Inverse agonist,EC50,Functional - [35S]GPTÎ³S binding,26.0,,=,,32.0,-1.232,,,,0.0,375.0,=,0.0,,P30542,0.3773730025226941
168,8967987,aa1r_human,16,E,A,CCPA,PubChem CID,123807,Full agonist,K(d),Binding - Radioligand competition/displacement,0.6,nM,=,,5.3,-8.85,,,,0.0,0.0,=,0.0,,P30542,0.4924283154658594
170,8967987,aa1r_human,16,E,A,DPCPX,PubChem CID,1329,Inverse agonist,K(d),Binding - Radioligand competition/displacement,0.7,nM,=,,1.3,-1.859,,,,0.0,0.0,=,0.0,,P30542,0.4924283154658594
172,8967987,aa1r_human,16,E,A,NECA,PubChem CID,448222,Full agonist,K(i),Binding - Radioligand competition/displacement,5.0,ÂµM,=,,42.0,-8.403,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.4924283154658594
174,8967987,aa1r_human,16,E,A,2-ClAdo,PubChem CID,235481,Full agonist,K(i),Binding - Radioligand competition/displacement,8.4,ÂµM,=,,130.0,-15.385,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.4924283154658594
176,8967987,aa1r_human,16,E,A,R-PIA,PubChem CID,114854,Full agonist,K(i),Binding - Radioligand competition/displacement,0.37,ÂµM,=,,1.3,-3.509,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.4924283154658594
178,8967987,aa1r_human,16,E,A,CPA,PubChem CID,4402,Full agonist,K(i),Binding - Radioligand competition/displacement,0.13,ÂµM,=,,5.3,-40.0,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.4924283154658594
180,8967987,aa1r_human,16,E,A,Caffeine,PubChem CID,2519,Inverse agonist,K(i),Binding - Radioligand competition/displacement,750.0,ÂµM,=,,520.0,1.442,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.4924283154658594
182,8967987,aa1r_human,16,E,A,N6-cyclopentyl-9-methyladenine,PubChem CID,4401,Inverse agonist,K(i),Binding - Radioligand competition/displacement,1.3,ÂµM,=,,38.0,-29.412,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.4924283154658594
184,8967987,aa1r_human,16,E,A,Aminophylline,PubChem CID,9433,Inverse agonist,K(i),Binding - Radioligand competition/displacement,77.0,ÂµM,=,,83.0,-1.078,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.4924283154658594
188,8967987,aa1r_human,16,E,A,DPCPX,PubChem CID,1329,Inverse agonist,K(i),Binding - Radioligand competition/displacement,0.0022,ÂµM,=,,0.0023,-1.045,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.4924283154658594
169,8967987,aa1r_human,16,E,Q,CCPA,PubChem CID,123807,Full agonist,K(d),Binding - Radioligand competition/displacement,0.6,nM,=,,9.3,-15.385,,,,0.0,0.0,=,0.0,,P30542,0.3611908173961013
171,8967987,aa1r_human,16,E,Q,DPCPX,PubChem CID,1329,Inverse agonist,K(d),Binding - Radioligand competition/displacement,0.7,nM,=,,1.7,-2.427,,,,0.0,0.0,=,0.0,,P30542,0.3611908173961013
173,8967987,aa1r_human,16,E,Q,NECA,PubChem CID,448222,Full agonist,K(i),Binding - Radioligand competition/displacement,5.0,ÂµM,=,,150.0,-30.303,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.3611908173961013
175,8967987,aa1r_human,16,E,Q,2-ClAdo,PubChem CID,235481,Full agonist,K(i),Binding - Radioligand competition/displacement,8.4,ÂµM,=,,56.0,-6.667,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.3611908173961013
177,8967987,aa1r_human,16,E,Q,R-PIA,PubChem CID,114854,Full agonist,K(i),Binding - Radioligand competition/displacement,0.37,ÂµM,=,,4.1,-11.111,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.3611908173961013
179,8967987,aa1r_human,16,E,Q,CPA,PubChem CID,4402,Full agonist,K(i),Binding - Radioligand competition/displacement,0.13,ÂµM,=,,73.0,-500.0,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.3611908173961013
183,8967987,aa1r_human,16,E,Q,N6-cyclopentyl-9-methyladenine,PubChem CID,4401,Inverse agonist,K(i),Binding - Radioligand competition/displacement,1.3,ÂµM,=,,14.0,-10.753,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.3611908173961013
189,8967987,aa1r_human,16,E,Q,DPCPX,PubChem CID,1329,Inverse agonist,K(i),Binding - Radioligand competition/displacement,0.0022,ÂµM,=,,0.0033,-1.499,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.3611908173961013
192,10.1074/jbc.274.6.3617,aa1r_human,25,P,L,CCPA,PubChem CID,123807,Full agonist,K(d),Binding - Radioligand saturation,0.6,nM,=,,1.8,-3.003,,,,0.0,0.0,=,0.0,,P30542,0.4606319451745188
193,10.1074/jbc.274.6.3617,aa1r_human,25,P,L,DPCPX,PubChem CID,1329,Inverse agonist,K(d),Binding - Radioligand saturation,0.7,nM,=,,0.7,1.0,,,,0.0,0.0,=,0.0,,P30542,0.4606319451745188
194,10.1074/jbc.274.6.3617,aa1r_human,25,P,L,NECA,PubChem CID,448222,Full agonist,K(i),Binding - Radioligand competition/displacement,5.1,ÂµM,=,,15.0,-2.941,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.4606319451745188
195,10.1074/jbc.274.6.3617,aa1r_human,25,P,L,CADO,PubChem CID,8974,Full agonist,K(i),Binding - Radioligand competition/displacement,5.6,ÂµM,=,,22.0,-3.922,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.4606319451745188
196,10.1074/jbc.274.6.3617,aa1r_human,25,P,L,R-PIA,PubChem CID,114854,Full agonist,K(i),Binding - Radioligand competition/displacement,370.0,nM,=,,1300.0,-3.509,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.4606319451745188
197,10.1074/jbc.274.6.3617,aa1r_human,25,P,L,N-0840,PubChem CID,657378,Full agonist,K(i),Binding - Radioligand competition/displacement,130.0,nM,=,,7900.0,-62.5,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.4606319451745188
198,10.1074/jbc.274.6.3617,aa1r_human,25,P,L,DPCPX,PubChem CID,1329,Inverse agonist,K(i),Binding - Radioligand competition/displacement,2.2,nM,=,,3.3,-1.499,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.4606319451745188
199,10.1074/jbc.274.6.3617,aa1r_human,31,I,C,CCPA,PubChem CID,123807,Full agonist,K(d),Binding - Radioligand saturation,0.6,nM,=,,0.7,-1.167,,,,0.0,0.0,=,0.0,,P30542,0.5746362046558865
200,10.1074/jbc.274.6.3617,aa1r_human,31,I,C,DPCPX,PubChem CID,1329,Inverse agonist,K(d),Binding - Radioligand saturation,0.7,nM,=,,0.8,-1.143,,,,0.0,0.0,=,0.0,,P30542,0.5746362046558865
202,10.1016/S0006-2952(00)00474-3,aa1r_human,46,C,A,DPCPX,PubChem CID,1329,Inverse agonist,K(d),Binding - Radioligand saturation,0.92,nM,=,,1.15,-1.25,,,,0.0,0.0,=,0.0,,P30542,0.3821074352820945
204,10.1016/S0006-2952(00)00474-3,aa1r_human,46,C,A,Theophylline,PubChem CID,2153,Inverse agonist,K(i),Binding - Radioligand competition/displacement,2.41,ÂµM,=,,1.43,1.685,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.3821074352820945
206,10.1016/S0006-2952(00)00474-3,aa1r_human,46,C,A,NECA,PubChem CID,448222,Full agonist,K(i),Binding - Radioligand competition/displacement,0.74,ÂµM,=,,1.19,-1.608,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.3821074352820945
208,10.1016/S0006-2952(00)00474-3,aa1r_human,46,C,A,R-PIA,PubChem CID,114854,Full agonist,K(i),Binding - Radioligand competition/displacement,97.0,nM,=,,128.8,-1.328,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.3821074352820945
209,8967987,aa1r_human,50,S,A,CCPA,PubChem CID,123807,Full agonist,K(d),Binding - Radioligand competition/displacement,0.6,nM,=,,1.1,-1.835,,,,0.0,0.0,=,0.0,,P30542,0.4376618525793421
210,8967987,aa1r_human,50,S,A,DPCPX,PubChem CID,1329,Inverse agonist,K(d),Binding - Radioligand competition/displacement,0.7,nM,=,,0.5,1.4,,,,0.0,0.0,=,0.0,,P30542,0.4376618525793421
213,8967987,aa1r_human,55,D,A,CCPA,PubChem CID,123807,Full agonist,K(d),Binding - Radioligand competition/displacement,0.6,nM,=,,0.2,3.0,,,,0.0,0.0,=,0.0,,P30542,0.8395193516761108
214,8967987,aa1r_human,55,D,A,DPCPX,PubChem CID,1329,Inverse agonist,K(d),Binding - Radioligand competition/displacement,0.7,nM,=,,0.5,1.4,,,,0.0,0.0,=,0.0,,P30542,0.8395193516761108
215,8967987,aa1r_human,55,D,A,NECA,PubChem CID,448222,Full agonist,K(i),Binding - Radioligand competition/displacement,5.0,ÂµM,=,,0.007,714.286,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.8395193516761108
216,8967987,aa1r_human,55,D,A,2-ClAdo,PubChem CID,235481,Full agonist,K(i),Binding - Radioligand competition/displacement,8.4,ÂµM,=,,0.15,56.0,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.8395193516761108
217,8967987,aa1r_human,55,D,A,R-PIA,PubChem CID,114854,Full agonist,K(i),Binding - Radioligand competition/displacement,0.37,ÂµM,=,,0.0012,308.333,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.8395193516761108
218,8967987,aa1r_human,55,D,A,CPA,PubChem CID,4402,Full agonist,K(i),Binding - Radioligand competition/displacement,0.13,ÂµM,=,,0.00096,135.417,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.8395193516761108
219,8967987,aa1r_human,55,D,A,Caffeine,PubChem CID,2519,Inverse agonist,K(i),Binding - Radioligand competition/displacement,750.0,ÂµM,=,,630.0,1.19,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.8395193516761108
220,8967987,aa1r_human,55,D,A,N6-cyclopentyl-9-methyladenine,PubChem CID,4401,Inverse agonist,K(i),Binding - Radioligand competition/displacement,1.3,ÂµM,=,,4.1,-3.155,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.8395193516761108
221,8967987,aa1r_human,55,D,A,Aminophylline,PubChem CID,9433,Inverse agonist,K(i),Binding - Radioligand competition/displacement,77.0,ÂµM,=,,52.0,1.481,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.8395193516761108
222,8967987,aa1r_human,55,D,A,DPX,PubChem CID,15667089,Inverse agonist,K(i),Binding - Radioligand competition/displacement,0.18,ÂµM,=,,0.27,-1.499,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.8395193516761108
223,8967987,aa1r_human,55,D,A,DPCPX,PubChem CID,1329,Inverse agonist,K(i),Binding - Radioligand competition/displacement,0.0022,ÂµM,=,,0.0016,1.375,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.8395193516761108
224,10.1074/jbc.274.6.3617,aa1r_human,65,L,F,CCPA,PubChem CID,123807,Full agonist,K(d),Binding - Radioligand saturation,0.6,nM,=,,0.6,1.0,,,,0.0,0.0,=,0.0,,P30542,0.3920122973287309
225,10.1074/jbc.274.6.3617,aa1r_human,65,L,F,DPCPX,PubChem CID,1329,Inverse agonist,K(d),Binding - Radioligand saturation,0.7,nM,=,,0.7,1.0,,,,0.0,0.0,=,0.0,,P30542,0.3920122973287309
232,10.1016/S0006-2952(00)00474-3,aa1r_human,85,C,A,DPCPX,PubChem CID,1329,Inverse agonist,K(d),Binding - Radioligand saturation,0.92,nM,=,,1.18,-1.282,,,,0.0,0.0,=,0.0,,P30542,0.3972996942800325
234,10.1016/S0006-2952(00)00474-3,aa1r_human,85,C,A,Theophylline,PubChem CID,2153,Inverse agonist,K(i),Binding - Radioligand competition/displacement,2.41,ÂµM,=,,3.17,-1.316,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.3972996942800325
236,10.1016/S0006-2952(00)00474-3,aa1r_human,85,C,A,NECA,PubChem CID,448222,Full agonist,K(i),Binding - Radioligand competition/displacement,0.74,ÂµM,=,,0.56,1.321,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.3972996942800325
238,10.1016/S0006-2952(00)00474-3,aa1r_human,85,C,A,R-PIA,PubChem CID,114854,Full agonist,K(i),Binding - Radioligand competition/displacement,97.0,nM,=,,55.3,1.754,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.3972996942800325
244,10.1074/jbc.274.6.3617,aa1r_human,87,V,A,NECA,PubChem CID,448222,Full agonist,K(i),Binding - Radioligand competition/displacement,5.1,ÂµM,=,,4.2,1.214,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.472197572986111
245,10.1074/jbc.274.6.3617,aa1r_human,87,V,A,CADO,PubChem CID,8974,Full agonist,K(i),Binding - Radioligand competition/displacement,1.0,ÂµM,=,,1.3,-1.3,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.472197572986111
246,10.1074/jbc.274.6.3617,aa1r_human,87,V,A,R-PIA,PubChem CID,114854,Full agonist,K(i),Binding - Radioligand competition/displacement,0.36,ÂµM,=,,26.0,-71.429,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.472197572986111
247,10.1074/jbc.274.6.3617,aa1r_human,87,V,A,N-0840,PubChem CID,657378,Full agonist,K(i),Binding - Radioligand competition/displacement,0.56,ÂµM,=,,0.55,1.018,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.472197572986111
248,10.1074/jbc.274.6.3617,aa1r_human,87,V,A,N-0840,PubChem CID,4401,Full agonist,K(i),Binding - Radioligand competition/displacement,0.75,ÂµM,=,,2.3,-3.067,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.472197572986111
249,10.1074/jbc.274.6.3617,aa1r_human,88,L,A,NECA,PubChem CID,448222,Full agonist,K(i),Binding - Radioligand competition/displacement,5.1,ÂµM,=,,150.0,-29.412,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.5229217625212341
250,10.1074/jbc.274.6.3617,aa1r_human,88,L,A,CADO,PubChem CID,8974,Full agonist,K(i),Binding - Radioligand competition/displacement,1.0,ÂµM,=,,1.1,-1.1,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.5229217625212341
251,10.1074/jbc.274.6.3617,aa1r_human,88,L,A,R-PIA,PubChem CID,114854,Full agonist,K(i),Binding - Radioligand competition/displacement,0.36,ÂµM,=,,180.0,-500.0,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.5229217625212341
252,10.1074/jbc.274.6.3617,aa1r_human,88,L,A,N-0840,PubChem CID,657378,Full agonist,K(i),Binding - Radioligand competition/displacement,0.56,ÂµM,=,,42.0,-76.923,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.5229217625212341
254,10.1074/jbc.274.6.3617,aa1r_human,91,T,A,NECA,PubChem CID,448222,Full agonist,K(i),Binding - Radioligand competition/displacement,5.1,ÂµM,=,,770.0,-142.857,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.5246991924636151
256,10.1074/jbc.274.6.3617,aa1r_human,91,T,A,R-PIA,PubChem CID,114854,Full agonist,K(i),Binding - Radioligand competition/displacement,0.36,ÂµM,=,,72.0,-200.0,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.5246991924636151
257,10.1074/jbc.274.6.3617,aa1r_human,91,T,A,N-0840,PubChem CID,657378,Full agonist,K(i),Binding - Radioligand competition/displacement,0.56,ÂµM,=,,9.7,-17.241,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.5246991924636151
261,10.1016/j.bcp.2012.03.008,aa1r_human,166,V,A,CPA,PubChem CID,4402,Full agonist,EC50,Functional - Other,0.1,nM,=,,0.64,-6.41,,,,0.0,19.0,=,0.0,,P30542,0.2672923130564322
703,10.1124/mol.116.105015,aa1r_human,166,V,A,PD81723,PubChem CID,122028,Allosteric agonist,pK(b),Binding - Radioligand competition/displacement,5.41,,=,,5.95,3.467,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.2672923130564322
726,10.1124/mol.116.105015,aa1r_human,166,V,A,VCP171,PubChem CID,24873485,Allosteric agonist,pK(b),Binding - Radioligand competition/displacement,5.65,,=,,5.8,1.413,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.2672923130564322
749,10.1124/mol.116.105007,aa1r_human,166,V,A,DPCPX,PubChem CID,1329,Inverse agonist,pK(d),Binding - Radioligand competition/displacement,9.17,,=,,9.05,-1.318,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.2672923130564322
775,10.1124/mol.116.105007,aa1r_human,166,V,A,NECA,PubChem CID,448222,Full agonist,pK(i),Binding - Radioligand competition/displacement,6.59,,=,,6.45,-1.381,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.2672923130564322
263,10.1074/jbc.274.6.3617,aa1r_human,92,Q,A,N-0840,PubChem CID,657378,Full agonist,K(i),Binding - Radioligand competition/displacement,0.56,ÂµM,=,,13.0,-23.256,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.5297130121230242
265,8967987,aa1r_human,93,S,A,CCPA,PubChem CID,123807,Full agonist,K(d),Binding - Radioligand competition/displacement,0.6,nM,=,,1.0,-1.667,,,,0.0,0.0,=,0.0,,P30542,0.4341801754578471
266,8967987,aa1r_human,93,S,A,DPCPX,PubChem CID,1329,Inverse agonist,K(d),Binding - Radioligand competition/displacement,0.7,nM,=,,0.4,1.75,,,,0.0,0.0,=,0.0,,P30542,0.4341801754578471
271,10.1074/jbc.274.6.3617,aa1r_human,125,A,K,CCPA,PubChem CID,123807,Full agonist,K(d),Binding - Radioligand saturation,0.6,nM,=,,0.7,-1.167,,,,0.0,0.0,=,0.0,,P30542,0.2355117802976735
272,10.1074/jbc.274.6.3617,aa1r_human,125,A,K,DPCPX,PubChem CID,1329,Inverse agonist,K(d),Binding - Radioligand saturation,0.7,nM,=,,0.7,1.0,,,,0.0,0.0,=,0.0,,P30542,0.2355117802976735
274,10.1016/S0006-2952(00)00474-3,aa1r_human,131,C,A,DPCPX,PubChem CID,1329,Inverse agonist,K(d),Binding - Radioligand saturation,0.92,nM,=,,0.91,1.011,,,,0.0,0.0,=,0.0,,P30542,0.473945569729099
276,10.1016/S0006-2952(00)00474-3,aa1r_human,131,C,A,Theophylline,PubChem CID,2153,Inverse agonist,K(i),Binding - Radioligand competition/displacement,2.41,ÂµM,=,,2.78,-1.153,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.473945569729099
278,10.1016/S0006-2952(00)00474-3,aa1r_human,131,C,A,NECA,PubChem CID,448222,Full agonist,K(i),Binding - Radioligand competition/displacement,0.74,ÂµM,=,,1.55,-2.096,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.473945569729099
280,10.1016/S0006-2952(00)00474-3,aa1r_human,131,C,A,R-PIA,PubChem CID,114854,Full agonist,K(i),Binding - Radioligand competition/displacement,97.0,nM,=,,135.3,-1.395,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.473945569729099
281,8967987,aa1r_human,135,S,A,CCPA,PubChem CID,123807,Full agonist,K(d),Binding - Radioligand competition/displacement,0.6,nM,=,,0.6,1.0,,,,0.0,0.0,=,0.0,,P30542,0.4460507447058954
282,8967987,aa1r_human,135,S,A,DPCPX,PubChem CID,1329,Inverse agonist,K(d),Binding - Radioligand competition/displacement,0.7,nM,=,,0.72,-1.029,,,,0.0,0.0,=,0.0,,P30542,0.4460507447058954
285,8967987,aa1r_human,141,T,A,CCPA,PubChem CID,123807,Full agonist,K(d),Binding - Radioligand competition/displacement,0.6,nM,=,,0.4,1.5,,,,0.0,0.0,=,0.0,,P30542,0.3478384126194612
286,8967987,aa1r_human,141,T,A,DPCPX,PubChem CID,1329,Inverse agonist,K(d),Binding - Radioligand competition/displacement,0.7,nM,=,,0.74,-1.057,,,,0.0,0.0,=,0.0,,P30542,0.3478384126194612
291,10.1124/mol.113.088682,aa1r_human,150,S,A,I-ABA,PubChem CID,125348,Full agonist,K(d),Binding - Radioligand saturation,3.401,nM,=,,1.475,2.306,,,,0.0,0.0,=,0.0,,P30542,0.2215597098220342
292,10.1016/j.bcp.2012.03.008,aa1r_human,153,E,A,CPA,PubChem CID,4402,Full agonist,EC50,Functional - Other,0.1,nM,=,,0.43,-4.292,,,,0.0,23.0,=,0.0,,P30542,0.3045486561693537
696,10.1124/mol.116.105015,aa1r_human,153,E,A,PD81723,PubChem CID,122028,Allosteric agonist,pK(b),Binding - Radioligand competition/displacement,5.41,,=,,5.71,1.995,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.3045486561693537
719,10.1124/mol.116.105015,aa1r_human,153,E,A,VCP171,PubChem CID,24873485,Allosteric agonist,pK(b),Binding - Radioligand competition/displacement,5.65,,=,,5.38,-1.862,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.3045486561693537
742,10.1124/mol.116.105007,aa1r_human,153,E,A,DPCPX,PubChem CID,1329,Inverse agonist,pK(d),Binding - Radioligand competition/displacement,9.17,,=,,9.17,1.0,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.3045486561693537
768,10.1124/mol.116.105007,aa1r_human,153,E,A,NECA,PubChem CID,448222,Full agonist,pK(i),Binding - Radioligand competition/displacement,6.59,,=,,6.58,-1.024,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.3045486561693537
294,10.1016/j.bcp.2012.03.008,aa1r_human,154,R,A,CPA,PubChem CID,4402,Full agonist,EC50,Functional - Other,0.1,nM,=,,0.12,-1.2,,,,0.0,116.0,=,0.0,,P30542,0.3082305032159539
295,10.1016/j.bcp.2012.03.008,aa1r_human,154,R,A,CPA,PubChem CID,4402,Full agonist,IC50,Binding - Radioligand competition/displacement,167.0,nM,=,,166.0,1.006,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.3082305032159539
296,10.1016/j.bcp.2012.03.008,aa1r_human,154,R,A,PD81723,PubChem CID,122028,Allosteric agonist,IC50,Binding - Radioligand competition/displacement,69.0,nM,=,,72.0,-1.044,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.3082305032159539
697,10.1124/mol.116.105015,aa1r_human,154,R,A,PD81723,PubChem CID,122028,Allosteric agonist,pK(b),Binding - Radioligand competition/displacement,5.41,,=,,5.49,1.202,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.3082305032159539
720,10.1124/mol.116.105015,aa1r_human,154,R,A,VCP171,PubChem CID,24873485,Allosteric agonist,pK(b),Binding - Radioligand competition/displacement,5.65,,=,,5.91,1.82,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.3082305032159539
743,10.1124/mol.116.105007,aa1r_human,154,R,A,DPCPX,PubChem CID,1329,Inverse agonist,pK(d),Binding - Radioligand competition/displacement,9.17,,=,,9.06,-1.289,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.3082305032159539
769,10.1124/mol.116.105007,aa1r_human,154,R,A,NECA,PubChem CID,448222,Full agonist,pK(i),Binding - Radioligand competition/displacement,6.59,,=,,6.52,-1.175,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.3082305032159539
297,10.1016/j.bcp.2012.03.008,aa1r_human,156,W,A,CPA,PubChem CID,4402,Full agonist,IC50,Binding - Radioligand competition/displacement,167.0,nM,=,,161.0,1.037,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.4077236169391877
298,10.1016/j.bcp.2012.03.008,aa1r_human,156,W,A,PD81723,PubChem CID,122028,Allosteric agonist,IC50,Binding - Radioligand competition/displacement,69.0,nM,=,,141.0,-2.045,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.4077236169391877
698,10.1124/mol.116.105015,aa1r_human,156,W,A,PD81723,PubChem CID,122028,Allosteric agonist,pK(b),Binding - Radioligand competition/displacement,5.41,,=,,5.4,-1.024,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.4077236169391877
721,10.1124/mol.116.105015,aa1r_human,156,W,A,VCP171,PubChem CID,24873485,Allosteric agonist,pK(b),Binding - Radioligand competition/displacement,5.65,,=,,5.92,1.862,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.4077236169391877
744,10.1124/mol.116.105007,aa1r_human,156,W,A,DPCPX,PubChem CID,1329,Inverse agonist,pK(d),Binding - Radioligand competition/displacement,9.17,,=,,9.07,-1.259,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.4077236169391877
770,10.1124/mol.116.105007,aa1r_human,156,W,A,NECA,PubChem CID,448222,Full agonist,pK(i),Binding - Radioligand competition/displacement,6.59,,=,,6.5,-1.23,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.4077236169391877
301,10.1016/j.bcp.2012.03.008,aa1r_human,160,G,A,CPA,PubChem CID,4402,Full agonist,EC50,Functional - Other,0.1,nM,=,,0.71,-7.092,,,,0.0,21.0,=,0.0,,P30542,0.2779936689430307
700,10.1124/mol.116.105015,aa1r_human,160,G,A,PD81723,PubChem CID,122028,Allosteric agonist,pK(b),Binding - Radioligand competition/displacement,5.41,,=,,5.76,2.239,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.2779936689430307
723,10.1124/mol.116.105015,aa1r_human,160,G,A,VCP171,PubChem CID,24873485,Allosteric agonist,pK(b),Binding - Radioligand competition/displacement,5.65,,=,,5.96,2.042,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.2779936689430307
746,10.1124/mol.116.105007,aa1r_human,160,G,A,DPCPX,PubChem CID,1329,Inverse agonist,pK(d),Binding - Radioligand competition/displacement,9.17,,=,,9.3,1.349,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.2779936689430307
772,10.1124/mol.116.105007,aa1r_human,160,G,A,NECA,PubChem CID,448222,Full agonist,pK(i),Binding - Radioligand competition/displacement,6.59,,=,,6.8,1.622,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.2779936689430307
303,10.1016/j.bcp.2012.03.008,aa1r_human,161,S,A,CPA,PubChem CID,4402,Full agonist,EC50,Functional - Other,0.1,nM,=,,0.41,-4.098,,,,0.0,28.0,=,0.0,,P30542,0.2426113496884691
304,10.1016/j.bcp.2012.03.008,aa1r_human,161,S,A,CPA,PubChem CID,4402,Full agonist,IC50,Binding - Radioligand competition/displacement,167.0,nM,=,,169.0,-1.012,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.2426113496884691
305,10.1016/j.bcp.2012.03.008,aa1r_human,161,S,A,PD81723,PubChem CID,122028,Allosteric agonist,IC50,Binding - Radioligand competition/displacement,69.0,nM,=,,75.0,-1.087,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.2426113496884691
701,10.1124/mol.116.105015,aa1r_human,161,S,A,PD81723,PubChem CID,122028,Allosteric agonist,pK(b),Binding - Radioligand competition/displacement,5.41,,=,,6.18,5.888,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.2426113496884691
724,10.1124/mol.116.105015,aa1r_human,161,S,A,VCP171,PubChem CID,24873485,Allosteric agonist,pK(b),Binding - Radioligand competition/displacement,5.65,,=,,5.63,-1.047,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.2426113496884691
747,10.1124/mol.116.105007,aa1r_human,161,S,A,DPCPX,PubChem CID,1329,Inverse agonist,pK(d),Binding - Radioligand competition/displacement,9.17,,=,,8.66,-3.236,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.2426113496884691
773,10.1124/mol.116.105007,aa1r_human,161,S,A,NECA,PubChem CID,448222,Full agonist,pK(i),Binding - Radioligand competition/displacement,6.59,,=,,6.1,-3.086,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.2426113496884691
306,10.1016/j.bcp.2012.03.008,aa1r_human,162,M,A,CPA,PubChem CID,4402,Full agonist,EC50,Functional - Other,0.1,nM,=,,0.12,-1.2,,,,0.0,110.0,=,0.0,,P30542,0.330503254305921
307,10.1016/j.bcp.2012.03.008,aa1r_human,162,M,A,CPA,PubChem CID,4402,Full agonist,IC50,Binding - Radioligand competition/displacement,167.0,nM,=,,130.0,1.285,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.330503254305921
308,10.1016/j.bcp.2012.03.008,aa1r_human,162,M,A,PD81723,PubChem CID,122028,Allosteric agonist,IC50,Binding - Radioligand competition/displacement,69.0,nM,=,,55.0,1.255,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.330503254305921
309,10.1124/mol.113.088682,aa1r_human,162,M,A,I-ABA,PubChem CID,125348,Full agonist,K(d),Binding - Radioligand saturation,3.401,nM,=,,1.434,2.372,,,,0.0,0.0,=,0.0,,P30542,0.330503254305921
310,10.1016/j.bcp.2012.03.008,aa1r_human,163,G,S,CPA,PubChem CID,4402,Full agonist,EC50,Functional - Other,0.1,nM,=,,2.1,-20.833,,,,0.0,7.0,=,0.0,,P30542,0.2834060050623503
312,10.1016/j.bcp.2012.03.008,aa1r_human,164,E,A,CPA,PubChem CID,4402,Full agonist,EC50,Functional - Other,0.1,nM,=,,0.15,-1.499,,,,0.0,107.0,=,0.0,,P30542,0.3124800922864121
313,10.1016/j.bcp.2012.03.008,aa1r_human,164,E,A,CPA,PubChem CID,4402,Full agonist,IC50,Binding - Radioligand competition/displacement,167.0,nM,=,,192.0,-1.149,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.3124800922864121
314,10.1016/j.bcp.2012.03.008,aa1r_human,164,E,A,PD81723,PubChem CID,122028,Allosteric agonist,IC50,Binding - Radioligand competition/displacement,69.0,nM,=,,58.0,1.19,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.3124800922864121
315,10.1016/j.bcp.2012.03.008,aa1r_human,165,P,A,CPA,PubChem CID,4402,Full agonist,EC50,Functional - Other,0.1,nM,=,,0.61,-6.098,,,,0.0,35.0,=,0.0,,P30542,0.3111315943716357
702,10.1124/mol.116.105015,aa1r_human,165,P,A,PD81723,PubChem CID,122028,Allosteric agonist,pK(b),Binding - Radioligand competition/displacement,5.41,,=,,5.79,2.399,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.3111315943716357
725,10.1124/mol.116.105015,aa1r_human,165,P,A,VCP171,PubChem CID,24873485,Allosteric agonist,pK(b),Binding - Radioligand competition/displacement,5.65,,=,,5.95,1.995,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.3111315943716357
748,10.1124/mol.116.105007,aa1r_human,165,P,A,DPCPX,PubChem CID,1329,Inverse agonist,pK(d),Binding - Radioligand competition/displacement,9.17,,=,,9.05,-1.318,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.3111315943716357
774,10.1124/mol.116.105007,aa1r_human,165,P,A,NECA,PubChem CID,448222,Full agonist,pK(i),Binding - Radioligand competition/displacement,6.59,,=,,6.45,-1.381,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.3111315943716357
321,10.1016/j.bcp.2012.03.008,aa1r_human,170,E,A,CPA,PubChem CID,4402,Full agonist,EC50,Functional - Other,0.1,nM,=,,0.4,-4.0,,,,0.0,23.0,=,0.0,,P30542,0.3066526112127244
706,10.1124/mol.116.105015,aa1r_human,170,E,A,PD81723,PubChem CID,122028,Allosteric agonist,pK(b),Binding - Radioligand competition/displacement,5.41,,=,,6.0,3.89,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.3066526112127244
729,10.1124/mol.116.105015,aa1r_human,170,E,A,VCP171,PubChem CID,24873485,Allosteric agonist,pK(b),Binding - Radioligand competition/displacement,5.65,,=,,5.72,1.175,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.3066526112127244
752,10.1124/mol.116.105007,aa1r_human,170,E,A,DPCPX,PubChem CID,1329,Inverse agonist,pK(d),Binding - Radioligand competition/displacement,9.17,,=,,9.24,1.175,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.3066526112127244
778,10.1124/mol.116.105007,aa1r_human,170,E,A,NECA,PubChem CID,448222,Full agonist,pK(i),Binding - Radioligand competition/displacement,6.59,,=,,6.22,-2.342,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.3066526112127244
324,10.1016/S0006-2952(00)00474-3,aa1r_human,255,C,A,DPCPX,PubChem CID,1329,Inverse agonist,K(d),Binding - Radioligand saturation,0.92,nM,=,,1.06,-1.152,,,,0.0,0.0,=,0.0,,P30542,0.3397368556310648
326,10.1016/S0006-2952(00)00474-3,aa1r_human,255,C,A,Theophylline,PubChem CID,2153,Inverse agonist,K(i),Binding - Radioligand competition/displacement,2.41,ÂµM,=,,2.58,-1.071,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.3397368556310648
328,10.1016/S0006-2952(00)00474-3,aa1r_human,255,C,A,NECA,PubChem CID,448222,Full agonist,K(i),Binding - Radioligand competition/displacement,0.74,ÂµM,=,,1.5,-2.028,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.3397368556310648
330,10.1016/S0006-2952(00)00474-3,aa1r_human,255,C,A,R-PIA,PubChem CID,114854,Full agonist,K(i),Binding - Radioligand competition/displacement,97.0,nM,=,,94.0,1.032,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.3397368556310648
332,10.1016/S0006-2952(00)00474-3,aa1r_human,260,C,A,DPCPX,PubChem CID,1329,Inverse agonist,K(d),Binding - Radioligand saturation,0.92,nM,=,,1.28,-1.391,,,,0.0,0.0,=,0.0,,P30542,0.2613537314757209
334,10.1016/S0006-2952(00)00474-3,aa1r_human,260,C,A,Theophylline,PubChem CID,2153,Inverse agonist,K(i),Binding - Radioligand competition/displacement,2.41,ÂµM,=,,1.03,2.34,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.2613537314757209
336,10.1016/S0006-2952(00)00474-3,aa1r_human,260,C,A,NECA,PubChem CID,448222,Full agonist,K(i),Binding - Radioligand competition/displacement,0.74,ÂµM,=,,0.39,1.897,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.2613537314757209
338,10.1016/S0006-2952(00)00474-3,aa1r_human,260,C,A,R-PIA,PubChem CID,114854,Full agonist,K(i),Binding - Radioligand competition/displacement,97.0,nM,=,,82.5,1.176,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.2613537314757209
339,10.1016/j.bcp.2012.03.008,aa1r_human,260,C,A,CPA,PubChem CID,4402,Full agonist,EC50,Functional - Other,0.1,nM,=,,0.14,-1.401,,,,0.0,60.0,=,0.0,,P30542,0.2613537314757209
340,10.1016/j.bcp.2012.03.008,aa1r_human,261,P,A,CPA,PubChem CID,4402,Full agonist,EC50,Functional - Other,0.1,nM,=,,0.25,-2.5,,,,0.0,63.0,=,0.0,,P30542,0.3302396794050767
341,10.1016/j.bcp.2012.03.008,aa1r_human,262,S,A,CPA,PubChem CID,4402,Full agonist,EC50,Functional - Other,0.1,nM,=,,0.19,-1.901,,,,0.0,63.0,=,0.0,,P30542,0.2097481079332658
343,10.1016/S0006-2952(00)00474-3,aa1r_human,263,C,A,DPCPX,PubChem CID,1329,Inverse agonist,K(d),Binding - Radioligand saturation,0.92,nM,=,,1.94,-2.11,,,,0.0,0.0,=,0.0,,P30542,0.311684278863758
345,10.1016/S0006-2952(00)00474-3,aa1r_human,263,C,A,Theophylline,PubChem CID,2153,Inverse agonist,K(i),Binding - Radioligand competition/displacement,2.41,ÂµM,=,,2.52,-1.046,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.311684278863758
347,10.1016/S0006-2952(00)00474-3,aa1r_human,263,C,A,NECA,PubChem CID,448222,Full agonist,K(i),Binding - Radioligand competition/displacement,0.74,ÂµM,=,,0.65,1.138,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.311684278863758
349,10.1016/S0006-2952(00)00474-3,aa1r_human,263,C,A,R-PIA,PubChem CID,114854,Full agonist,K(i),Binding - Radioligand competition/displacement,97.0,nM,=,,71.1,1.364,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.311684278863758
350,10.1016/j.bcp.2012.03.008,aa1r_human,263,C,A,CPA,PubChem CID,4402,Full agonist,EC50,Functional - Other,0.1,nM,=,,0.1,1.0,,,,0.0,72.0,=,0.0,,P30542,0.311684278863758
351,11306703,aa1r_human,264,H,C,DPCPX,PubChem CID,1329,Inverse agonist,K(d),Binding - Radioligand saturation,1.24,nM,=,,1.36,-1.096,,,,0.0,0.0,=,0.0,,P30542,0.3533839731868745
356,10.1016/j.bcp.2012.03.008,aa1r_human,264,H,A,CPA,PubChem CID,4402,Full agonist,EC50,Functional - Other,0.1,nM,=,,0.16,-1.6,,,,0.0,88.0,=,0.0,,P30542,0.313416220786548
362,10.1016/j.bcp.2012.03.008,aa1r_human,265,K,A,CPA,PubChem CID,4402,Full agonist,EC50,Functional - Other,0.1,nM,=,,0.18,-1.799,,,,0.0,37.0,=,0.0,,P30542,0.344822905895207
760,10.1124/mol.116.105007,aa1r_human,265,K,A,DPCPX,PubChem CID,1329,Inverse agonist,pK(d),Binding - Radioligand competition/displacement,9.17,,=,,8.98,-1.548,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.344822905895207
786,10.1124/mol.116.105007,aa1r_human,265,K,A,NECA,PubChem CID,448222,Full agonist,pK(i),Binding - Radioligand competition/displacement,6.59,,=,,6.34,-1.779,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.344822905895207
363,11306703,aa1r_human,266,P,C,DPCPX,PubChem CID,1329,Inverse agonist,K(d),Binding - Radioligand saturation,1.24,nM,=,,0.97,1.278,,,,0.0,0.0,=,0.0,,P30542,0.4702302168820989
368,10.1016/j.bcp.2012.03.008,aa1r_human,266,P,A,CPA,PubChem CID,4402,Full agonist,EC50,Functional - Other,0.1,nM,=,,0.36,-3.597,,,,0.0,49.0,=,0.0,,P30542,0.3824217087322613
369,11306703,aa1r_human,267,S,C,DPCPX,PubChem CID,1329,Inverse agonist,K(d),Binding - Radioligand saturation,1.24,nM,=,,1.29,-1.041,,,,0.0,0.0,=,0.0,,P30542,0.2759223285068271
374,10.1016/j.bcp.2012.03.008,aa1r_human,267,S,A,CPA,PubChem CID,4402,Full agonist,EC50,Functional - Other,0.1,nM,=,,0.22,-2.198,,,,0.0,37.0,=,0.0,,P30542,0.2100017719180718
375,11306703,aa1r_human,268,I,C,DPCPX,PubChem CID,1329,Inverse agonist,K(d),Binding - Radioligand saturation,1.24,nM,=,,1.7,-1.372,,,,0.0,0.0,=,0.0,,P30542,0.2629418914239051
380,11306703,aa1r_human,269,L,C,DPCPX,PubChem CID,1329,Inverse agonist,K(d),Binding - Radioligand saturation,1.24,nM,=,,0.95,1.305,,,,0.0,0.0,=,0.0,,P30542,0.381225478043122
385,11306703,aa1r_human,270,T,C,DPCPX,PubChem CID,1329,Inverse agonist,K(d),Binding - Radioligand saturation,1.24,nM,=,,1.24,1.0,,,,0.0,0.0,=,0.0,,P30542,0.4497600280153565
386,11306703,aa1r_human,270,T,C,MTSEA,PubChem CID,53443082,Binding - unknown pharmacological activity,Specific binding,Binding - Radioligand competition/displacement,6.0,%,=,,20.2,3.367,,,,0.0,0.0,=,0.0,,P30542,0.4497600280153565
387,11306703,aa1r_human,270,T,C,MTSET,PubChem CID,107933,Binding - unknown pharmacological activity,Specific binding,Binding - Radioligand competition/displacement,7.0,%,=,,24.1,3.443,,,,0.0,0.0,=,0.0,,P30542,0.4497600280153565
388,11306703,aa1r_human,270,T,C,MTS-TEAH,PubChem CID,46783166,Binding - unknown pharmacological activity,Specific binding,Binding - Radioligand competition/displacement,3.1,%,=,,14.1,4.548,,,,0.0,0.0,=,0.0,,P30542,0.4497600280153565
390,11306703,aa1r_human,271,Y,C,DPCPX,PubChem CID,1329,Inverse agonist,K(d),Binding - Radioligand saturation,1.24,nM,=,,2.61,-2.105,,,,0.0,0.0,=,0.0,,P30542,0.4381389135652759
391,11306703,aa1r_human,271,Y,C,MTSEA,PubChem CID,53443082,Binding - unknown pharmacological activity,Specific binding,Binding - Radioligand competition/displacement,6.0,%,=,,1.0,-5.988,,,,0.0,0.0,=,0.0,,P30542,0.4381389135652759
392,11306703,aa1r_human,271,Y,C,MTSET,PubChem CID,107933,Binding - unknown pharmacological activity,Specific binding,Binding - Radioligand competition/displacement,7.0,%,=,,12.4,1.771,,,,0.0,0.0,=,0.0,,P30542,0.4381389135652759
393,11306703,aa1r_human,271,Y,C,MTS-TEAH,PubChem CID,46783166,Binding - unknown pharmacological activity,Specific binding,Binding - Radioligand competition/displacement,3.1,%,=,,1.1,-2.817,,,,0.0,0.0,=,0.0,,P30542,0.4381389135652759
395,11306703,aa1r_human,272,I,C,DPCPX,PubChem CID,1329,Inverse agonist,K(d),Binding - Radioligand saturation,1.24,nM,=,,1.0,1.24,,,,0.0,0.0,=,0.0,,P30542,0.3504260531324309
396,11306703,aa1r_human,272,I,C,MTSEA,PubChem CID,53443082,Binding - unknown pharmacological activity,Specific binding,Binding - Radioligand competition/displacement,6.0,%,=,,27.3,4.55,,,,0.0,0.0,=,0.0,,P30542,0.3504260531324309
397,11306703,aa1r_human,272,I,C,MTSET,PubChem CID,107933,Binding - unknown pharmacological activity,Specific binding,Binding - Radioligand competition/displacement,7.0,%,=,,12.0,1.714,,,,0.0,0.0,=,0.0,,P30542,0.3504260531324309
398,11306703,aa1r_human,272,I,C,MTS-TEAH,PubChem CID,46783166,Binding - unknown pharmacological activity,Specific binding,Binding - Radioligand competition/displacement,3.1,%,=,,9.1,2.935,,,,0.0,0.0,=,0.0,,P30542,0.3504260531324309
400,11306703,aa1r_human,273,A,C,DPCPX,PubChem CID,1329,Inverse agonist,K(d),Binding - Radioligand saturation,1.24,nM,=,,1.09,1.138,,,,0.0,0.0,=,0.0,,P30542,0.4545417388287762
401,11306703,aa1r_human,273,A,C,MTSEA,PubChem CID,53443082,Binding - unknown pharmacological activity,Specific binding,Binding - Radioligand competition/displacement,6.0,%,=,,96.8,16.133,,,,0.0,0.0,=,0.0,,P30542,0.4545417388287762
402,11306703,aa1r_human,273,A,C,MTSET,PubChem CID,107933,Binding - unknown pharmacological activity,Specific binding,Binding - Radioligand competition/displacement,7.0,%,=,,43.1,6.157,,,,0.0,0.0,=,0.0,,P30542,0.4545417388287762
403,11306703,aa1r_human,273,A,C,MTS-TEAH,PubChem CID,46783166,Binding - unknown pharmacological activity,Specific binding,Binding - Radioligand competition/displacement,3.1,%,=,,42.8,13.806,,,,0.0,0.0,=,0.0,,P30542,0.4545417388287762
405,11306703,aa1r_human,274,I,C,DPCPX,PubChem CID,1329,Inverse agonist,K(d),Binding - Radioligand saturation,1.24,nM,=,,3.55,-2.865,,,,0.0,0.0,=,0.0,,P30542,0.5034034961222545
406,11306703,aa1r_human,274,I,C,MTSEA,PubChem CID,53443082,Binding - unknown pharmacological activity,Specific binding,Binding - Radioligand competition/displacement,6.0,%,=,,85.1,14.183,,,,0.0,0.0,=,0.0,,P30542,0.5034034961222545
407,11306703,aa1r_human,274,I,C,MTSET,PubChem CID,107933,Binding - unknown pharmacological activity,Specific binding,Binding - Radioligand competition/displacement,7.0,%,=,,83.8,11.971,,,,0.0,0.0,=,0.0,,P30542,0.5034034961222545
408,11306703,aa1r_human,274,I,C,MTS-TEAH,PubChem CID,46783166,Binding - unknown pharmacological activity,Specific binding,Binding - Radioligand competition/displacement,3.1,%,=,,54.3,17.516,,,,0.0,0.0,=,0.0,,P30542,0.5034034961222545
410,11306703,aa1r_human,275,F,C,DPCPX,PubChem CID,1329,Inverse agonist,K(d),Binding - Radioligand saturation,1.24,nM,=,,0.68,1.824,,,,0.0,0.0,=,0.0,,P30542,0.4888930535365853
411,11306703,aa1r_human,275,F,C,MTSEA,PubChem CID,53443082,Binding - unknown pharmacological activity,Specific binding,Binding - Radioligand competition/displacement,6.0,%,=,,0.9,-6.667,,,,0.0,0.0,=,0.0,,P30542,0.4888930535365853
412,11306703,aa1r_human,275,F,C,MTSET,PubChem CID,107933,Binding - unknown pharmacological activity,Specific binding,Binding - Radioligand competition/displacement,7.0,%,=,,1.8,-3.891,,,,0.0,0.0,=,0.0,,P30542,0.4888930535365853
415,11306703,aa1r_human,276,L,C,DPCPX,PubChem CID,1329,Inverse agonist,K(d),Binding - Radioligand saturation,1.24,nM,=,,1.23,1.008,,,,0.0,0.0,=,0.0,,P30542,0.5279105505032814
416,11306703,aa1r_human,276,L,C,MTSEA,PubChem CID,53443082,Binding - unknown pharmacological activity,Specific binding,Binding - Radioligand competition/displacement,6.0,%,=,,24.6,4.1,,,,0.0,0.0,=,0.0,,P30542,0.5279105505032814
417,11306703,aa1r_human,276,L,C,MTSET,PubChem CID,107933,Binding - unknown pharmacological activity,Specific binding,Binding - Radioligand competition/displacement,7.0,%,=,,5.7,-1.229,,,,0.0,0.0,=,0.0,,P30542,0.5279105505032814
418,11306703,aa1r_human,276,L,C,MTS-TEAH,PubChem CID,46783166,Binding - unknown pharmacological activity,Specific binding,Binding - Radioligand competition/displacement,3.1,%,=,,10.5,3.387,,,,0.0,0.0,=,0.0,,P30542,0.5279105505032814
420,8300561,aa1r_human,277,T,S,DPCPX,PubChem CID,1329,Inverse agonist,K(d),Binding - Radioligand saturation,0.8,nM,=,,1.1,-1.376,,,,0.0,0.0,=,0.0,,P30542,0.4612225777297132
422,8300561,aa1r_human,277,T,S,R-PIA,PubChem CID,114854,Full agonist,K(i),Binding - Radioligand competition/displacement,210.0,nM,=,,920.0,-4.386,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.4612225777297132
424,8300561,aa1r_human,277,T,S,S-PIA,PubChem CID,114854,Full agonist,K(i),Binding - Radioligand competition/displacement,1.094,nM,=,,8.16,-7.463,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.4612225777297132
426,8300561,aa1r_human,277,T,S,NECA,PubChem CID,448222,Full agonist,K(i),Binding - Radioligand competition/displacement,366.0,nM,=,,3.16,115.823,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.4612225777297132
421,8300561,aa1r_human,277,T,A,DPCPX,PubChem CID,1329,Inverse agonist,K(d),Binding - Radioligand saturation,0.8,nM,=,,0.4,2.0,,,,0.0,0.0,=,0.0,,P30542,0.5061279250897724
423,8300561,aa1r_human,277,T,A,R-PIA,PubChem CID,114854,Full agonist,K(i),Binding - Radioligand competition/displacement,210.0,nM,=,,807.0,-3.846,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.5061279250897724
425,8300561,aa1r_human,277,T,A,S-PIA,PubChem CID,114854,Full agonist,K(i),Binding - Radioligand competition/displacement,1.094,nM,=,,7.49,-6.849,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.5061279250897724
427,8300561,aa1r_human,277,T,A,NECA,PubChem CID,448222,Full agonist,K(i),Binding - Radioligand competition/displacement,366.0,ÂµM,=,,160.0,2.288,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.5061279250897724
428,10.1016/S0006-2952(98)00202-0,aa1r_human,277,T,A,DPCPX,PubChem CID,1329,Inverse agonist,K(d),Binding - Radioligand saturation,0.69,nM,=,,0.75,-1.087,,,,0.0,0.0,=,0.0,,P30542,0.5061279250897724
430,10.1016/S0006-2952(98)00202-0,aa1r_human,277,T,A,8BCPA,PubChem CID,9887609,Partial agonist,K(i),Binding - Radioligand competition/displacement,4000.0,nM,=,,8300.0,-2.075,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.5061279250897724
431,10.1016/S0006-2952(98)00202-0,aa1r_human,277,T,A,CPT,PubChem CID,1917,Inverse agonist,K(i),Binding - Radioligand competition/displacement,10.0,nM,=,,35.3,-3.534,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.5061279250897724
432,10.1016/S0006-2952(98)00202-0,aa1r_human,277,T,A,DPCPX,PubChem CID,1329,Inverse agonist,K(d),Binding - Radioligand saturation,1.59,nM,=,,1.33,1.195,,,,0.0,0.0,=,0.0,,P30542,0.5061279250897724
433,10.1016/S0006-2952(98)00202-0,aa1r_human,277,T,A,CPA,PubChem CID,4402,Full agonist,K(i),Binding - Radioligand competition/displacement,76.0,nM,=,,8200.0,-111.111,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.5061279250897724
434,10.1016/S0006-2952(98)00202-0,aa1r_human,277,T,A,8BCPA,PubChem CID,9887609,Partial agonist,K(i),Binding - Radioligand competition/displacement,7.1,ÂµM,=,,33.2,-4.673,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.5061279250897724
435,10.1016/S0006-2952(98)00202-0,aa1r_human,277,T,A,CPT,PubChem CID,1917,Inverse agonist,K(i),Binding - Radioligand competition/displacement,31.8,nM,=,,70.9,-2.227,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.5061279250897724
440,10.1016/S0006-2952(00)00536-0,aa1r_human,277,T,A,DPCPX,PubChem CID,1329,Inverse agonist,K(d),Binding - Radioligand saturation,1.6,nM,=,,0.2,8.0,,,,0.0,0.0,=,0.0,,P30542,0.5061279250897724
441,10.1016/S0006-2952(00)00536-0,aa1r_human,277,T,A,DPCPX,PubChem CID,1329,Inverse agonist,K(d),Binding - Other,8.8,nM,=,,0.5,17.6,,,,0.0,0.0,=,0.0,,P30542,0.5061279250897724
442,10.1016/S0006-2952(00)00536-0,aa1r_human,277,T,A,DPCPX,PubChem CID,1329,Inverse agonist,K(d),Binding - Other,6.8,nM,=,,2.1,3.238,,,,0.0,0.0,=,0.0,,P30542,0.5061279250897724
445,10.1016/S0006-2952(00)00536-0,aa1r_human,277,T,A,R-PIA,PubChem CID,114854,Full agonist,K(i),Binding - Radioligand competition/displacement,0.00309,ÂµM,=,,1.73,-500.0,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.5061279250897724
449,10.1016/S0006-2952(00)00536-0,aa1r_human,277,T,A,PD81723,PubChem CID,122028,Allosteric agonist,,Functional - cAMP accumulation,75.0,%,=,,100.0,1.333,,,,0.0,0.0,=,0.0,,P30542,0.5061279250897724
450,10.1016/S0006-2952(00)00536-0,aa1r_human,277,T,A,CPA,PubChem CID,4402,Full agonist,,Functional - cAMP accumulation,70.0,%,=,,100.0,1.429,,,,0.0,0.0,=,0.0,,P30542,0.5061279250897724
451,10.1016/S0006-2952(00)00536-0,aa1r_human,277,T,A,PD81723,PubChem CID,122028,Allosteric agonist,,Functional - cAMP accumulation,5.0,%,=,,100.0,20.0,,,CPA,0.0,0.0,=,0.0,,P30542,0.5061279250897724
452,10.1016/S0006-2952(00)00536-0,aa1r_human,277,T,A,DPCPX,PubChem CID,1329,Inverse agonist,,Functional - cAMP accumulation,130.0,%,=,,100.0,-1.3,,,,0.0,0.0,=,0.0,,P30542,0.5061279250897724
458,10.1021/bi7001828,aa1r_human,277,T,A,DPCPX,PubChem CID,1329,Inverse agonist,K(d),Binding - Radioligand saturation,2.37,nM,=,,1.12,2.116,,,,140.0,0.0,=,0.0,,P30542,0.5061279250897724
461,10.1021/bi7001828,aa1r_human,277,T,A,DPCPX,PubChem CID,1329,Inverse agonist,K(i),Binding - Radioligand competition/displacement,4.5,nM,=,,3.5,1.286,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.5061279250897724
463,10.1021/bi7001828,aa1r_human,277,T,A,CGS15943,PubChem CID,2690,Inverse agonist,K(i),Binding - Radioligand competition/displacement,3.4,nM,=,,4.6,-1.353,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.5061279250897724
459,10.1021/bi7001828,aa1r_human,277,T,E,DPCPX,PubChem CID,1329,Inverse agonist,K(d),Binding - Radioligand saturation,2.37,nM,=,,5.14,-2.169,,,,57.0,0.0,=,0.0,,P30542,0.5509216440723551
460,10.1021/bi7001828,aa1r_human,277,T,E,DPCPX,PubChem CID,1329,Inverse agonist,K(i),Binding - Radioligand competition/displacement,4.5,nM,=,,18.3,-4.065,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.5509216440723551
462,10.1021/bi7001828,aa1r_human,277,T,E,CGS15943,PubChem CID,2690,Inverse agonist,K(i),Binding - Radioligand competition/displacement,3.4,nM,=,,8.6,-2.532,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.5509216440723551
476,10.1021/bi7001828,aa1r_human,277,T,E,CCPA,PubChem CID,123807,Full agonist,K(i),Binding - Radioligand competition/displacement,610.0,nM,=,,7000.0,-11.494,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.5509216440723551
499,11306703,aa1r_human,278,H,C,DPCPX,PubChem CID,1329,Inverse agonist,K(d),Binding - Radioligand saturation,1.24,nM,=,,1.26,-1.016,,,,0.0,0.0,=,0.0,,P30542,0.656364995501219
500,11306703,aa1r_human,278,H,C,MTSEA,PubChem CID,53443082,Binding - unknown pharmacological activity,Specific binding,Binding - Radioligand competition/displacement,6.0,%,=,,84.4,14.067,,,,0.0,0.0,=,0.0,,P30542,0.656364995501219
501,11306703,aa1r_human,278,H,C,MTSET,PubChem CID,107933,Binding - unknown pharmacological activity,Specific binding,Binding - Radioligand competition/displacement,7.0,%,=,,81.4,11.629,,,,0.0,0.0,=,0.0,,P30542,0.656364995501219
502,11306703,aa1r_human,278,H,C,MTS-TEAH,PubChem CID,46783166,Binding - unknown pharmacological activity,Specific binding,Binding - Radioligand competition/displacement,3.1,%,=,,87.5,28.226,,,,0.0,0.0,=,0.0,,P30542,0.656364995501219
504,10.1021/bi7001828,aa1r_human,278,H,A,DPCPX,PubChem CID,1329,Inverse agonist,K(d),Binding - Radioligand saturation,2.37,nM,=,,4.72,-1.992,,,,0.0,29.0,=,0.0,,P30542,0.6147470276109219
510,10.1021/bi7001828,aa1r_human,278,H,A,DPCPX,PubChem CID,1329,Inverse agonist,K(i),Binding - Radioligand competition/displacement,4.5,nM,=,,40.0,-8.85,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.6147470276109219
514,10.1021/bi7001828,aa1r_human,278,H,A,CGS15943,PubChem CID,2690,Inverse agonist,K(i),Binding - Radioligand competition/displacement,3.4,nM,=,,160.0,-47.619,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.6147470276109219
542,10.1021/bi7001828,aa1r_human,278,H,A,CCPA,PubChem CID,123807,Full agonist,K(i),Binding - Radioligand competition/displacement,610.0,nM,=,,1400.0,-2.294,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.6147470276109219
550,10.1021/bi7001828,aa1r_human,278,H,A,CID73019726,PubChem CID,73019726,Full agonist,K(i),Binding - Radioligand competition/displacement,15000.0,nM,=,,570.0,26.316,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.6147470276109219
554,10.1021/bi7001828,aa1r_human,278,H,A,CID73014720,PubChem CID,73014720,Full agonist,K(i),Binding - Radioligand competition/displacement,6200.0,nM,=,,220.0,28.182,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.6147470276109219
575,10.1021/bi7001828,aa1r_human,278,H,A,NECA,PubChem CID,448222,Full agonist,K(i),Binding - Radioligand competition/displacement,1600.0,nM,=,,8800.0,-5.495,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.6147470276109219
505,10.1021/bi7001828,aa1r_human,278,H,D,DPCPX,PubChem CID,1329,Inverse agonist,K(d),Binding - Radioligand saturation,2.37,nM,=,,3.11,-1.312,,,,0.0,21.0,=,0.0,,P30542,0.5713665998767059
509,10.1021/bi7001828,aa1r_human,278,H,D,DPCPX,PubChem CID,1329,Inverse agonist,K(i),Binding - Radioligand competition/displacement,4.5,nM,=,,50.0,-11.111,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.5713665998767059
513,10.1021/bi7001828,aa1r_human,278,H,D,CGS15943,PubChem CID,2690,Inverse agonist,K(i),Binding - Radioligand competition/displacement,3.4,nM,=,,110.0,-32.258,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.5713665998767059
541,10.1021/bi7001828,aa1r_human,278,H,D,CCPA,PubChem CID,123807,Full agonist,K(i),Binding - Radioligand competition/displacement,610.0,nM,=,,1000.0,-1.639,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.5713665998767059
549,10.1021/bi7001828,aa1r_human,278,H,D,CID73019726,PubChem CID,73019726,Full agonist,K(i),Binding - Radioligand competition/displacement,15000.0,nM,=,,450.0,33.333,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.5713665998767059
553,10.1021/bi7001828,aa1r_human,278,H,D,CID73014720,PubChem CID,73014720,Full agonist,K(i),Binding - Radioligand competition/displacement,6200.0,nM,=,,240.0,25.833,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.5713665998767059
574,10.1021/bi7001828,aa1r_human,278,H,D,NECA,PubChem CID,448222,Full agonist,K(i),Binding - Radioligand competition/displacement,1600.0,nM,=,,8500.0,-5.319,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.5713665998767059
507,10.1021/bi7001828,aa1r_human,278,H,L,DPCPX,PubChem CID,1329,Inverse agonist,K(d),Binding - Radioligand saturation,2.37,nM,=,,3.94,-1.661,,,,0.0,30.0,=,0.0,,P30542,0.656364995501219
511,10.1021/bi7001828,aa1r_human,278,H,L,DPCPX,PubChem CID,1329,Inverse agonist,K(i),Binding - Radioligand competition/displacement,4.5,nM,=,,35.0,-7.752,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.656364995501219
515,10.1021/bi7001828,aa1r_human,278,H,L,CGS15943,PubChem CID,2690,Inverse agonist,K(i),Binding - Radioligand competition/displacement,3.4,nM,=,,90.0,-26.316,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.656364995501219
543,10.1021/bi7001828,aa1r_human,278,H,L,CCPA,PubChem CID,123807,Full agonist,K(i),Binding - Radioligand competition/displacement,610.0,nM,=,,820.0,-1.344,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.656364995501219
551,10.1021/bi7001828,aa1r_human,278,H,L,CID73019726,PubChem CID,73019726,Full agonist,K(i),Binding - Radioligand competition/displacement,15000.0,nM,=,,550.0,27.273,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.656364995501219
555,10.1021/bi7001828,aa1r_human,278,H,L,CID73014720,PubChem CID,73014720,Full agonist,K(i),Binding - Radioligand competition/displacement,6200.0,nM,=,,290.0,21.379,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.656364995501219
576,10.1021/bi7001828,aa1r_human,278,H,L,NECA,PubChem CID,448222,Full agonist,K(i),Binding - Radioligand competition/displacement,1600.0,nM,=,,8800.0,-5.495,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.656364995501219
592,11306703,aa1r_human,279,G,C,DPCPX,PubChem CID,1329,Inverse agonist,K(d),Binding - Radioligand saturation,1.24,nM,=,,1.65,-1.33,,,,0.0,0.0,=,0.0,,P30542,0.5231210852653903
597,11306703,aa1r_human,280,N,C,DPCPX,PubChem CID,1329,Inverse agonist,K(d),Binding - Radioligand saturation,1.24,nM,=,,1.21,1.025,,,,0.0,0.0,=,0.0,,P30542,0.7945966293862183
607,11306703,aa1r_human,282,A,C,DPCPX,PubChem CID,1329,Inverse agonist,K(d),Binding - Radioligand saturation,1.24,nM,=,,1.08,1.148,,,,0.0,0.0,=,0.0,,P30542,0.5329036818841182
617,11306703,aa1r_human,284,N,C,DPCPX,PubChem CID,1329,Inverse agonist,K(d),Binding - Radioligand saturation,1.24,nM,=,,0.7,1.771,,,,0.0,0.0,=,0.0,,P30542,0.8815018316915026
618,11306703,aa1r_human,284,N,C,MTSEA,PubChem CID,53443082,Binding - unknown pharmacological activity,Specific binding,Binding - Radioligand competition/displacement,6.0,%,=,,9.3,1.55,,,,0.0,0.0,=,0.0,,P30542,0.8815018316915026
619,11306703,aa1r_human,284,N,C,MTSET,PubChem CID,107933,Binding - unknown pharmacological activity,Specific binding,Binding - Radioligand competition/displacement,7.0,%,=,,20.4,2.914,,,,0.0,0.0,=,0.0,,P30542,0.8815018316915026
620,11306703,aa1r_human,284,N,C,MTS-TEAH,PubChem CID,46783166,Binding - unknown pharmacological activity,Specific binding,Binding - Radioligand competition/displacement,3.1,%,=,,18.1,5.839,,,,0.0,0.0,=,0.0,,P30542,0.8815018316915026
622,11306703,aa1r_human,285,P,C,DPCPX,PubChem CID,1329,Inverse agonist,K(d),Binding - Radioligand saturation,1.24,nM,=,,1.1,1.127,,,,0.0,0.0,=,0.0,,P30542,0.7866884373469525
623,11306703,aa1r_human,285,P,C,MTSEA,PubChem CID,53443082,Binding - unknown pharmacological activity,Specific binding,Binding - Radioligand competition/displacement,6.0,%,=,,5.9,-1.017,,,,0.0,0.0,=,0.0,,P30542,0.7866884373469525
624,11306703,aa1r_human,285,P,C,MTSET,PubChem CID,107933,Binding - unknown pharmacological activity,Specific binding,Binding - Radioligand competition/displacement,7.0,%,=,,4.8,-1.458,,,,0.0,0.0,=,0.0,,P30542,0.7866884373469525
625,11306703,aa1r_human,285,P,C,MTS-TEAH,PubChem CID,46783166,Binding - unknown pharmacological activity,Specific binding,Binding - Radioligand competition/displacement,3.1,%,=,,6.1,1.968,,,,0.0,0.0,=,0.0,,P30542,0.7866884373469525
627,11306703,aa1r_human,286,I,C,DPCPX,PubChem CID,1329,Inverse agonist,K(d),Binding - Radioligand saturation,1.24,nM,=,,0.91,1.363,,,,0.0,0.0,=,0.0,,P30542,0.4969351289141123
628,11306703,aa1r_human,286,I,C,MTSEA,PubChem CID,53443082,Binding - unknown pharmacological activity,Specific binding,Binding - Radioligand competition/displacement,6.0,%,=,,5.5,-1.091,,,,0.0,0.0,=,0.0,,P30542,0.4969351289141123
629,11306703,aa1r_human,286,I,C,MTSET,PubChem CID,107933,Binding - unknown pharmacological activity,Specific binding,Binding - Radioligand competition/displacement,7.0,%,=,,4.1,-1.706,,,,0.0,0.0,=,0.0,,P30542,0.4969351289141123
630,11306703,aa1r_human,286,I,C,MTS-TEAH,PubChem CID,46783166,Binding - unknown pharmacological activity,Specific binding,Binding - Radioligand competition/displacement,3.1,%,=,,1.3,-2.387,,,,0.0,0.0,=,0.0,,P30542,0.4969351289141123
632,11306703,aa1r_human,287,V,C,DPCPX,PubChem CID,1329,Inverse agonist,K(d),Binding - Radioligand saturation,1.24,nM,=,,1.39,-1.121,,,,0.0,0.0,=,0.0,,P30542,0.5498139622211479
633,11306703,aa1r_human,287,V,C,MTSEA,PubChem CID,53443082,Binding - unknown pharmacological activity,Specific binding,Binding - Radioligand competition/displacement,6.0,%,=,,8.5,1.417,,,,0.0,0.0,=,0.0,,P30542,0.5498139622211479
634,11306703,aa1r_human,287,V,C,MTSET,PubChem CID,107933,Binding - unknown pharmacological activity,Specific binding,Binding - Radioligand competition/displacement,7.0,%,=,,4.6,-1.522,,,,0.0,0.0,=,0.0,,P30542,0.5498139622211479
635,11306703,aa1r_human,287,V,C,MTS-TEAH,PubChem CID,46783166,Binding - unknown pharmacological activity,Specific binding,Binding - Radioligand competition/displacement,3.1,%,=,,8.9,2.871,,,,0.0,0.0,=,0.0,,P30542,0.5498139622211479
637,11306703,aa1r_human,288,Y,C,DPCPX,PubChem CID,1329,Inverse agonist,K(d),Binding - Radioligand saturation,1.24,nM,=,,0.73,1.699,,,,0.0,0.0,=,0.0,,P30542,0.8313115986588185
638,11306703,aa1r_human,288,Y,C,MTSEA,PubChem CID,53443082,Binding - unknown pharmacological activity,Specific binding,Binding - Radioligand competition/displacement,6.0,%,=,,20.4,3.4,,,,0.0,0.0,=,0.0,,P30542,0.8313115986588185
639,11306703,aa1r_human,288,Y,C,MTSET,PubChem CID,107933,Binding - unknown pharmacological activity,Specific binding,Binding - Radioligand competition/displacement,7.0,%,=,,16.3,2.329,,,,0.0,0.0,=,0.0,,P30542,0.8313115986588185
640,11306703,aa1r_human,288,Y,C,MTS-TEAH,PubChem CID,46783166,Binding - unknown pharmacological activity,Specific binding,Binding - Radioligand competition/displacement,3.1,%,=,,15.5,5.0,,,,0.0,0.0,=,0.0,,P30542,0.8313115986588185
642,11306703,aa1r_human,289,A,C,DPCPX,PubChem CID,1329,Inverse agonist,K(d),Binding - Radioligand saturation,1.24,nM,=,,1.11,1.117,,,,0.0,0.0,=,0.0,,P30542,0.5370509954614447
643,11306703,aa1r_human,289,A,C,MTSEA,PubChem CID,53443082,Binding - unknown pharmacological activity,Specific binding,Binding - Radioligand competition/displacement,6.0,%,=,,6.4,1.067,,,,0.0,0.0,=,0.0,,P30542,0.5370509954614447
644,11306703,aa1r_human,289,A,C,MTSET,PubChem CID,107933,Binding - unknown pharmacological activity,Specific binding,Binding - Radioligand competition/displacement,7.0,%,=,,2.0,-3.497,,,,0.0,0.0,=,0.0,,P30542,0.5370509954614447
645,11306703,aa1r_human,289,A,C,MTS-TEAH,PubChem CID,46783166,Binding - unknown pharmacological activity,Specific binding,Binding - Radioligand competition/displacement,3.1,%,=,,1.2,-2.584,,,,0.0,0.0,=,0.0,,P30542,0.5370509954614447
647,11306703,aa1r_human,290,F,C,DPCPX,PubChem CID,1329,Inverse agonist,K(d),Binding - Radioligand saturation,1.24,nM,=,,1.4,-1.129,,,,0.0,0.0,=,0.0,,P30542,0.5859147525094119
652,11306703,aa1r_human,291,R,C,DPCPX,PubChem CID,1329,Inverse agonist,K(d),Binding - Radioligand saturation,1.24,nM,=,,1.44,-1.161,,,,0.0,0.0,=,0.0,,P30542,0.6211792428956988
657,11306703,aa1r_human,292,I,C,DPCPX,PubChem CID,1329,Inverse agonist,K(d),Binding - Radioligand saturation,1.24,nM,=,,1.62,-1.307,,,,0.0,0.0,=,0.0,,P30542,0.5693874375820595
672,11306703,aa1r_human,295,F,C,DPCPX,PubChem CID,1329,Inverse agonist,K(d),Binding - Radioligand saturation,1.24,nM,=,,1.42,-1.145,,,,0.0,0.0,=,0.0,,P30542,0.7672790456171026
677,11306703,aa1r_human,296,R,C,DPCPX,PubChem CID,1329,Inverse agonist,K(d),Binding - Radioligand saturation,1.24,nM,=,,1.11,1.117,,,,0.0,0.0,=,0.0,,P30542,0.698413379578402
683,10.1016/S0006-2952(00)00474-3,aa1r_human,309,C,A,DPCPX,PubChem CID,1329,Inverse agonist,K(d),Binding - Radioligand saturation,0.92,nM,=,,1.04,-1.13,,,,0.0,0.0,=,0.0,,P30542,0.2848374617523689
685,10.1016/S0006-2952(00)00474-3,aa1r_human,309,C,A,Theophylline,PubChem CID,2153,Inverse agonist,K(i),Binding - Radioligand competition/displacement,2.41,ÂµM,=,,1.8,1.339,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.2848374617523689
687,10.1016/S0006-2952(00)00474-3,aa1r_human,309,C,A,NECA,PubChem CID,448222,Full agonist,K(i),Binding - Radioligand competition/displacement,0.74,ÂµM,=,,0.62,1.194,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.2848374617523689
689,10.1016/S0006-2952(00)00474-3,aa1r_human,309,C,A,R-PIA,PubChem CID,114854,Full agonist,K(i),Binding - Radioligand competition/displacement,97.0,nM,=,,61.2,1.585,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.2848374617523689
690,10.1124/mol.116.105015,aa1r_human,144,F,A,PD81723,PubChem CID,122028,Allosteric agonist,pK(b),Binding - Radioligand competition/displacement,5.41,,=,,5.73,2.089,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.3645419744741036
713,10.1124/mol.116.105015,aa1r_human,144,F,A,VCP171,PubChem CID,24873485,Allosteric agonist,pK(b),Binding - Radioligand competition/displacement,5.65,,=,,5.48,-1.479,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.3645419744741036
736,10.1124/mol.116.105007,aa1r_human,144,F,A,DPCPX,PubChem CID,1329,Inverse agonist,pK(d),Binding - Radioligand competition/displacement,9.17,,=,,9.23,1.148,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.3645419744741036
762,10.1124/mol.116.105007,aa1r_human,144,F,A,NECA,PubChem CID,448222,Full agonist,pK(i),Binding - Radioligand competition/displacement,6.59,,=,,6.62,1.072,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.3645419744741036
691,10.1124/mol.116.105015,aa1r_human,145,G,A,PD81723,PubChem CID,122028,Allosteric agonist,pK(b),Binding - Radioligand competition/displacement,5.41,,=,,5.2,-1.621,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.4610868891445566
714,10.1124/mol.116.105015,aa1r_human,145,G,A,VCP171,PubChem CID,24873485,Allosteric agonist,pK(b),Binding - Radioligand competition/displacement,5.65,,=,,5.32,-2.137,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.4610868891445566
737,10.1124/mol.116.105007,aa1r_human,145,G,A,DPCPX,PubChem CID,1329,Inverse agonist,pK(d),Binding - Radioligand competition/displacement,9.17,,=,,9.0,-1.479,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.4610868891445566
763,10.1124/mol.116.105007,aa1r_human,145,G,A,NECA,PubChem CID,448222,Full agonist,pK(i),Binding - Radioligand competition/displacement,6.59,,=,,6.38,-1.621,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.4610868891445566
692,10.1124/mol.116.105015,aa1r_human,146,W,A,PD81723,PubChem CID,122028,Allosteric agonist,pK(b),Binding - Radioligand competition/displacement,5.41,,=,,5.49,1.202,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.6086111155480423
715,10.1124/mol.116.105015,aa1r_human,146,W,A,VCP171,PubChem CID,24873485,Allosteric agonist,pK(b),Binding - Radioligand competition/displacement,5.65,,=,,5.65,1.0,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.6086111155480423
738,10.1124/mol.116.105007,aa1r_human,146,W,A,DPCPX,PubChem CID,1329,Inverse agonist,pK(d),Binding - Radioligand competition/displacement,9.17,,=,,8.97,-1.585,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.6086111155480423
764,10.1124/mol.116.105007,aa1r_human,146,W,A,NECA,PubChem CID,448222,Full agonist,pK(i),Binding - Radioligand competition/displacement,6.59,,=,,6.2,-2.457,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.6086111155480423
695,10.1124/mol.116.105015,aa1r_human,149,L,A,PD81723,PubChem CID,122028,Allosteric agonist,pK(b),Binding - Radioligand competition/displacement,5.41,,=,,5.77,2.291,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.2971314494489767
718,10.1124/mol.116.105015,aa1r_human,149,L,A,VCP171,PubChem CID,24873485,Allosteric agonist,pK(b),Binding - Radioligand competition/displacement,5.65,,=,,5.67,1.047,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.2971314494489767
741,10.1124/mol.116.105007,aa1r_human,149,L,A,DPCPX,PubChem CID,1329,Inverse agonist,pK(d),Binding - Radioligand competition/displacement,9.17,,=,,9.35,1.514,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.2971314494489767
767,10.1124/mol.116.105007,aa1r_human,149,L,A,NECA,PubChem CID,448222,Full agonist,pK(i),Binding - Radioligand competition/displacement,6.59,,=,,6.94,2.239,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.2971314494489767
705,10.1124/mol.116.105015,aa1r_human,168,K,A,PD81723,PubChem CID,122028,Allosteric agonist,pK(b),Binding - Radioligand competition/displacement,5.41,,=,,5.86,2.818,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.3012949699864113
728,10.1124/mol.116.105015,aa1r_human,168,K,A,VCP171,PubChem CID,24873485,Allosteric agonist,pK(b),Binding - Radioligand competition/displacement,5.65,,=,,5.49,-1.445,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.3012949699864113
751,10.1124/mol.116.105007,aa1r_human,168,K,A,DPCPX,PubChem CID,1329,Inverse agonist,pK(d),Binding - Radioligand competition/displacement,9.17,,=,,9.12,-1.122,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.3012949699864113
777,10.1124/mol.116.105007,aa1r_human,168,K,A,NECA,PubChem CID,448222,Full agonist,pK(i),Binding - Radioligand competition/displacement,6.59,,=,,6.43,-1.445,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.3012949699864113
707,10.1124/mol.116.105015,aa1r_human,172,E,A,PD81723,PubChem CID,122028,Allosteric agonist,pK(b),Binding - Radioligand competition/displacement,5.41,,=,,4.89,-3.311,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.3380122031878089
730,10.1124/mol.116.105015,aa1r_human,172,E,A,VCP171,PubChem CID,24873485,Allosteric agonist,pK(b),Binding - Radioligand competition/displacement,5.65,,=,,5.26,-2.457,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.3380122031878089
754,10.1124/mol.116.105007,aa1r_human,172,E,A,DPCPX,PubChem CID,1329,Inverse agonist,pK(d),Binding - Radioligand competition/displacement,9.17,,=,,8.66,-3.236,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.3380122031878089
780,10.1124/mol.116.105007,aa1r_human,172,E,A,NECA,PubChem CID,448222,Full agonist,pK(i),Binding - Radioligand competition/displacement,6.59,,=,,5.84,-5.618,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.3380122031878089
708,10.1124/mol.116.105015,aa1r_human,173,K,A,PD81723,PubChem CID,122028,Allosteric agonist,pK(b),Binding - Radioligand competition/displacement,5.41,,=,,6.2,6.166,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.3571955854840624
731,10.1124/mol.116.105015,aa1r_human,173,K,A,VCP171,PubChem CID,24873485,Allosteric agonist,pK(b),Binding - Radioligand competition/displacement,5.65,,=,,5.37,-1.905,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.3571955854840624
755,10.1124/mol.116.105007,aa1r_human,173,K,A,DPCPX,PubChem CID,1329,Inverse agonist,pK(d),Binding - Radioligand competition/displacement,9.17,,=,,9.21,1.096,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.3571955854840624
781,10.1124/mol.116.105007,aa1r_human,173,K,A,NECA,PubChem CID,448222,Full agonist,pK(i),Binding - Radioligand competition/displacement,6.59,,=,,6.42,-1.479,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.3571955854840624
709,10.1124/mol.116.105015,aa1r_human,174,V,A,PD81723,PubChem CID,122028,Allosteric agonist,pK(b),Binding - Radioligand competition/displacement,5.41,,=,,5.91,3.162,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.2765852929166404
732,10.1124/mol.116.105015,aa1r_human,174,V,A,VCP171,PubChem CID,24873485,Allosteric agonist,pK(b),Binding - Radioligand competition/displacement,5.65,,=,,5.91,1.82,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.2765852929166404
756,10.1124/mol.116.105007,aa1r_human,174,V,A,DPCPX,PubChem CID,1329,Inverse agonist,pK(d),Binding - Radioligand competition/displacement,9.17,,=,,9.12,-1.122,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.2765852929166404
782,10.1124/mol.116.105007,aa1r_human,174,V,A,NECA,PubChem CID,448222,Full agonist,pK(i),Binding - Radioligand competition/displacement,6.59,,=,,6.46,-1.35,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.2765852929166404
710,10.1124/mol.116.105015,aa1r_human,175,I,A,PD81723,PubChem CID,122028,Allosteric agonist,pK(b),Binding - Radioligand competition/displacement,5.41,,=,,6.49,12.023,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.379630195687919
733,10.1124/mol.116.105015,aa1r_human,175,I,A,VCP171,PubChem CID,24873485,Allosteric agonist,pK(b),Binding - Radioligand competition/displacement,5.65,,=,,5.83,1.514,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.379630195687919
757,10.1124/mol.116.105007,aa1r_human,175,I,A,DPCPX,PubChem CID,1329,Inverse agonist,pK(d),Binding - Radioligand competition/displacement,9.17,,=,,8.45,-5.236,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.379630195687919
783,10.1124/mol.116.105007,aa1r_human,175,I,A,NECA,PubChem CID,448222,Full agonist,pK(i),Binding - Radioligand competition/displacement,6.59,,=,,5.56,-10.753,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.379630195687919
711,10.1124/mol.116.105015,aa1r_human,176,S,A,PD81723,PubChem CID,122028,Allosteric agonist,pK(b),Binding - Radioligand competition/displacement,5.41,,=,,5.78,2.344,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.3126518226846555
734,10.1124/mol.116.105015,aa1r_human,176,S,A,VCP171,PubChem CID,24873485,Allosteric agonist,pK(b),Binding - Radioligand competition/displacement,5.65,,=,,5.47,-1.513,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.3126518226846555
758,10.1124/mol.116.105007,aa1r_human,176,S,A,DPCPX,PubChem CID,1329,Inverse agonist,pK(d),Binding - Radioligand competition/displacement,9.17,,=,,9.08,-1.23,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.3126518226846555
784,10.1124/mol.116.105007,aa1r_human,176,S,A,NECA,PubChem CID,448222,Full agonist,pK(i),Binding - Radioligand competition/displacement,6.59,,=,,6.38,-1.621,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.3126518226846555
712,10.1124/mol.116.105015,aa1r_human,177,M,A,PD81723,PubChem CID,122028,Allosteric agonist,pK(b),Binding - Radioligand competition/displacement,5.41,,=,,5.73,2.089,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.3223836593758639
735,10.1124/mol.116.105015,aa1r_human,177,M,A,VCP171,PubChem CID,24873485,Allosteric agonist,pK(b),Binding - Radioligand competition/displacement,5.65,,=,,5.69,1.096,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.3223836593758639
759,10.1124/mol.116.105007,aa1r_human,177,M,A,DPCPX,PubChem CID,1329,Inverse agonist,pK(d),Binding - Radioligand competition/displacement,9.17,,=,,8.39,-6.024,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.3223836593758639
785,10.1124/mol.116.105007,aa1r_human,177,M,A,NECA,PubChem CID,448222,Full agonist,pK(i),Binding - Radioligand competition/displacement,6.59,,=,,5.81,-6.024,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.3223836593758639
761,10.1124/mol.116.105007,aa1r_human,270,T,A,DPCPX,PubChem CID,1329,Inverse agonist,pK(d),Binding - Radioligand competition/displacement,9.17,,=,,8.83,-2.188,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.4057658021195486
787,10.1124/mol.116.105007,aa1r_human,270,T,A,NECA,PubChem CID,448222,Full agonist,pK(i),Binding - Radioligand competition/displacement,6.59,,=,,5.76,-6.757,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.4057658021195486
788,10.1016/j.str.2017.06.012,aa1r_human,62,V,A,ZM241385,PubChem CID,5311506,Inverse agonist,K(i),Binding - Radioligand competition/displacement,0.0,,=,,0.0,1.15,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.5016968063577202
792,10.1016/j.str.2017.06.012,aa1r_human,62,V,A,SCH58261,PubChem CID,176408,Inverse agonist,K(i),Binding - Radioligand competition/displacement,0.0,,=,,0.0,1.01,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.5016968063577202
796,10.1016/j.str.2017.06.012,aa1r_human,62,V,A,SCH442416,PubChem CID,10668061,Inverse agonist,K(i),Binding - Radioligand competition/displacement,0.0,,=,,0.0,1.58,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.5016968063577202
800,10.1016/j.str.2017.06.012,aa1r_human,62,V,A,Istradefylline,PubChem CID,5311037,Inverse agonist,K(i),Binding - Radioligand competition/displacement,0.0,,=,,0.0,-1.149,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.5016968063577202
804,10.1016/j.str.2017.06.012,aa1r_human,62,V,A,PSB36,PubChem CID,11689583,Inverse agonist,K(i),Binding - Radioligand competition/displacement,0.0,,=,,0.0,1.15,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.5016968063577202
808,10.1016/j.str.2017.06.012,aa1r_human,62,V,A,DPCPX,PubChem CID,1329,Inverse agonist,K(i),Binding - Radioligand competition/displacement,0.0,,=,,0.0,1.08,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.5016968063577202
812,10.1016/j.str.2017.06.012,aa1r_human,62,V,A,KW3902,PubChem CID,64627,Inverse agonist,K(i),Binding - Radioligand competition/displacement,0.0,,=,,0.0,1.0,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.5016968063577202
816,10.1016/j.str.2017.06.012,aa1r_human,62,V,A,SLV320,PubChem CID,9953065,Inverse agonist,K(i),Binding - Radioligand competition/displacement,0.0,,=,,0.0,8.56,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.5016968063577202
820,10.1016/j.str.2017.06.012,aa1r_human,62,V,A,XAC,PubChem CID,5697,Inverse agonist,K(i),Binding - Radioligand competition/displacement,0.0,,=,,0.0,1.02,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.5016968063577202
824,10.1016/j.str.2017.06.012,aa1r_human,62,V,A,CGS15943,PubChem CID,2690,Inverse agonist,K(i),Binding - Radioligand competition/displacement,0.0,,=,,0.0,1.44,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.5016968063577202
789,10.1016/j.str.2017.06.012,aa1r_human,70,N,S,ZM241385,PubChem CID,5311506,Inverse agonist,K(i),Binding - Radioligand competition/displacement,0.0,,=,,0.0,2.16,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.3737324167629289
793,10.1016/j.str.2017.06.012,aa1r_human,70,N,S,SCH58261,PubChem CID,176408,Inverse agonist,K(i),Binding - Radioligand competition/displacement,0.0,,=,,0.0,2.83,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.3737324167629289
797,10.1016/j.str.2017.06.012,aa1r_human,70,N,S,SCH442416,PubChem CID,10668061,Inverse agonist,K(i),Binding - Radioligand competition/displacement,0.0,,=,,0.0,-1.19,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.3737324167629289
801,10.1016/j.str.2017.06.012,aa1r_human,70,N,S,Istradefylline,PubChem CID,5311037,Inverse agonist,K(i),Binding - Radioligand competition/displacement,0.0,,=,,0.0,1.34,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.3737324167629289
805,10.1016/j.str.2017.06.012,aa1r_human,70,N,S,PSB36,PubChem CID,11689583,Inverse agonist,K(i),Binding - Radioligand competition/displacement,0.0,,=,,0.0,1.73,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.3737324167629289
809,10.1016/j.str.2017.06.012,aa1r_human,70,N,S,DPCPX,PubChem CID,1329,Inverse agonist,K(i),Binding - Radioligand competition/displacement,0.0,,=,,0.0,1.11,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.3737324167629289
813,10.1016/j.str.2017.06.012,aa1r_human,70,N,S,KW3902,PubChem CID,64627,Inverse agonist,K(i),Binding - Radioligand competition/displacement,0.0,,=,,0.0,1.65,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.3737324167629289
817,10.1016/j.str.2017.06.012,aa1r_human,70,N,S,SLV320,PubChem CID,9953065,Inverse agonist,K(i),Binding - Radioligand competition/displacement,0.0,,=,,0.0,1.45,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.3737324167629289
821,10.1016/j.str.2017.06.012,aa1r_human,70,N,S,XAC,PubChem CID,5697,Inverse agonist,K(i),Binding - Radioligand competition/displacement,0.0,,=,,0.0,1.84,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.3737324167629289
825,10.1016/j.str.2017.06.012,aa1r_human,70,N,S,CGS15943,PubChem CID,2690,Inverse agonist,K(i),Binding - Radioligand competition/displacement,0.0,,=,,0.0,1.85,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.3737324167629289
791,10.1016/j.str.2017.06.012,aa1r_human,270,T,M,ZM241385,PubChem CID,5311506,Inverse agonist,K(i),Binding - Radioligand competition/displacement,0.0,,=,,0.0,-4.0,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.4497600280153565
795,10.1016/j.str.2017.06.012,aa1r_human,270,T,M,SCH58261,PubChem CID,176408,Inverse agonist,K(i),Binding - Radioligand competition/displacement,0.0,,=,,0.0,-1.724,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.4497600280153565
799,10.1016/j.str.2017.06.012,aa1r_human,270,T,M,SCH442416,PubChem CID,10668061,Inverse agonist,K(i),Binding - Radioligand competition/displacement,0.0,,=,,0.0,-3.333,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.4497600280153565
803,10.1016/j.str.2017.06.012,aa1r_human,270,T,M,Istradefylline,PubChem CID,5311037,Inverse agonist,K(i),Binding - Radioligand competition/displacement,0.0,,=,,0.0,-4.545,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.4497600280153565
807,10.1016/j.str.2017.06.012,aa1r_human,270,T,M,PSB36,PubChem CID,11689583,Inverse agonist,K(i),Binding - Radioligand competition/displacement,0.0,,=,,0.0,4.52,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.4497600280153565
811,10.1016/j.str.2017.06.012,aa1r_human,270,T,M,DPCPX,PubChem CID,1329,Inverse agonist,K(i),Binding - Radioligand competition/displacement,0.0,,=,,0.0,3.24,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.4497600280153565
815,10.1016/j.str.2017.06.012,aa1r_human,270,T,M,KW3902,PubChem CID,64627,Inverse agonist,K(i),Binding - Radioligand competition/displacement,0.0,,=,,0.0,3.39,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.4497600280153565
819,10.1016/j.str.2017.06.012,aa1r_human,270,T,M,SLV320,PubChem CID,9953065,Inverse agonist,K(i),Binding - Radioligand competition/displacement,0.0,,=,,0.0,2.16,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.4497600280153565
823,10.1016/j.str.2017.06.012,aa1r_human,270,T,M,XAC,PubChem CID,5697,Inverse agonist,K(i),Binding - Radioligand competition/displacement,0.0,,=,,0.0,-1.111,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.4497600280153565
827,10.1016/j.str.2017.06.012,aa1r_human,270,T,M,CGS15943,PubChem CID,2690,Inverse agonist,K(i),Binding - Radioligand competition/displacement,0.0,,=,,0.0,-1.333,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.4497600280153565
828,10.1016/j.cell.2017.01.042,aa1r_human,270,T,M,DPCPX,PubChem CID,1329,Inverse agonist,pK(i),Binding - Radioligand competition/displacement,8.9,,=,,8.0,-7.937,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.4497600280153565
829,10.1016/j.cell.2017.01.042,aa1r_human,270,T,M,ZM241385,PubChem CID,176408,Inverse agonist,pK(i),Binding - Radioligand competition/displacement,6.9,,=,,7.1,1.585,,,DPCPX,0.0,0.0,=,0.0,,P30542,0.4497600280153565
0,25834784,cxcr1_human,132,S,A,IL8_HUMAN,UniProt Entry Code (peptide),P10145,Full agonist,Kd,Binding - Radioligand competition/displacement,5.55,nM,=,,4.15,1.337,,,125I-IL-8,179.6,0.0,,0.0,,P25024,0.550536314778096
1,25834784,cxcr1_human,241,M,V,IL8_HUMAN,UniProt Entry Code (peptide),P10145,Full agonist,Kd,Binding - Radioligand competition/displacement,5.55,nM,=,,1.53,3.627,,,125I-IL-8,160.8,0.0,,0.0,,P25024,0.4798488322044097
2,25834784,cxcr1_human,251,F,A,IL8_HUMAN,UniProt Entry Code (peptide),P10145,Full agonist,Kd,Binding - Radioligand competition/displacement,5.55,nM,=,,1.026,5.409,,,125I-IL-8,30.2,0.0,,0.0,,P25024,0.814568075733688
3,25834784,cxcr1_human,251,F,H,IL8_HUMAN,UniProt Entry Code (peptide),P10145,Full agonist,Kd,Binding - Radioligand competition/displacement,5.55,nM,=,,4.86,1.142,,,125I-IL-8,256.9,0.0,,0.0,,P25024,0.7858295220197413
4,25834784,cxcr1_human,251,F,Y,IL8_HUMAN,UniProt Entry Code (peptide),P10145,Full agonist,Kd,Binding - Radioligand competition/displacement,5.55,nM,=,,3.478,1.596,,,125I-IL-8,213.0,0.0,,0.0,,P25024,0.6410161169243482
5,22936990,cxcr1_human,128,L,A,IL8_HUMAN,UniProt Entry Code (peptide),P10145,Full agonist,Kd,Binding - Radioligand competition/displacement,4.87,nM,=,,0.535,9.103,,,125I-IL-8,86.8,0.0,,0.0,,P25024,0.6012392271788503
6,22936990,cxcr1_human,128,L,Q,IL8_HUMAN,UniProt Entry Code (peptide),P10145,Full agonist,Kd,Binding - Radioligand competition/displacement,4.87,nM,=,,1.35,3.607,,,125I-IL-8,189.4,0.0,,0.0,,P25024,0.6434676833775365
8,22936990,cxcr1_human,247,V,A,IL8_HUMAN,UniProt Entry Code (peptide),P10145,Full agonist,Kd,Binding - Radioligand competition/displacement,4.87,nM,=,,0.55,8.855,,,125I-IL-8,109.9,0.0,,0.0,,P25024,0.5236111776383071
9,22936990,cxcr1_human,247,V,N,IL8_HUMAN,UniProt Entry Code (peptide),P10145,Full agonist,Kd,Binding - Radioligand competition/displacement,4.87,nM,=,,3.14,1.551,,,125I-IL-8,328.5,0.0,,0.0,,P25024,0.653368014550496
10,22936990,cxcr1_human,247,V,Y,IL8_HUMAN,UniProt Entry Code (peptide),P10145,Full agonist,Kd,Binding - Radioligand competition/displacement,4.87,nM,=,,0.693,7.027,,,125I-IL-8,126.2,0.0,,0.0,,P25024,0.5681642439842876
13,12077146,cxcr1_human,265,D,H,IL8_HUMAN,UniProt Entry Code (peptide),P10145,Full agonist,IC50,Binding - Radioligand competition/displacement,10.4,nM,=,,7.9,1.316,,,125I-IL-8,113.33333333333331,0.0,,0.0,,P25024,0.3570520704010467
16,12077146,cxcr1_human,265,D,H,IL8_HUMAN,UniProt Entry Code (peptide),P10145,Full agonist,EC50,Calcium mobilization assay,4.3,nM,=,,4.6,-1.07,,,,113.33333333333331,0.0,,0.0,,P25024,0.3570520704010467
17,8103045,cxcr1_human,6,D,A,IL8_HUMAN,UniProt Entry Code (peptide),P10145,Full agonist,Kd,Binding - Radioligand competition/displacement,0.97,nM,=,,0.89,1.09,,,125I-IL-8,54.43037974683544,0.0,,0.0,,P25024,0.4021583947647144
22,8103045,cxcr1_human,117,K,A,IL8_HUMAN,UniProt Entry Code (peptide),P10145,Full agonist,Kd,Binding - Radioligand competition/displacement,0.97,nM,=,,1.3,-1.34,,,125I-IL-8,60.75949367088608,0.0,,0.0,,P25024,0.480469598144513
23,8103045,cxcr1_human,118,E,A,IL8_HUMAN,UniProt Entry Code (peptide),P10145,Full agonist,Kd,Binding - Radioligand competition/displacement,0.97,nM,=,,4.1,-4.219,,,125I-IL-8,73.41772151898735,0.0,,0.0,,P25024,0.4536689119903535
24,8103045,cxcr1_human,189,E,A,IL8_HUMAN,UniProt Entry Code (peptide),P10145,Full agonist,Kd,Binding - Radioligand competition/displacement,0.97,nM,=,,1.45,-1.495,,,125I-IL-8,77.21518987341773,0.0,,0.0,,P25024,0.419150941666402
25,8103045,cxcr1_human,194,D,A,IL8_HUMAN,UniProt Entry Code (peptide),P10145,Full agonist,Kd,Binding - Radioligand competition/displacement,0.97,nM,=,,1.25,-1.289,,,125I-IL-8,81.0126582278481,0.0,,0.0,,P25024,0.2951235009985941
26,8103045,cxcr1_human,265,D,A,IL8_HUMAN,UniProt Entry Code (peptide),P10145,Full agonist,Kd,Binding - Radioligand competition/displacement,0.97,nM,=,,2.5,-2.577,,,125I-IL-8,13.924050632911392,0.0,,0.0,,P25024,0.3993540313480492
28,8103045,cxcr1_human,278,E,A,IL8_HUMAN,UniProt Entry Code (peptide),P10145,Full agonist,Kd,Binding - Radioligand competition/displacement,0.97,nM,=,,3.6,-3.717,,,125I-IL-8,74.68354430379746,0.0,,0.0,,P25024,0.2615853427657896
29,8103045,cxcr1_human,279,R,A,IL8_HUMAN,UniProt Entry Code (peptide),P10145,Full agonist,Kd,Binding - Radioligand competition/displacement,0.97,nM,=,,1.25,-1.289,,,125I-IL-8,72.15189873417721,0.0,,0.0,,P25024,0.2586329751585387
31,8103045,cxcr1_human,288,D,A,IL8_HUMAN,UniProt Entry Code (peptide),P10145,Full agonist,Kd,Binding - Radioligand competition/displacement,0.97,nM,=,,1.07,-1.103,,,125I-IL-8,108.86075949367088,0.0,,0.0,,P25024,0.4260727005321863
32,8103045,cxcr1_human,291,E,A,IL8_HUMAN,UniProt Entry Code (peptide),P10145,Full agonist,Kd,Binding - Radioligand competition/displacement,0.97,nM,=,,1.2,-1.238,,,125I-IL-8,30.37974683544304,0.0,,0.0,,P25024,0.4952567291664597
33,8034699,cxcr1_human,12,F,A,IL8_HUMAN,UniProt Entry Code (peptide),P10145,Full agonist,Kd,Binding - Radioligand competition/displacement,3.03,nM,=,,4.82,-1.59,,,125I-IL-8,121.0,0.0,,0.0,,P25024,0.3722385504373385
34,8034699,cxcr1_human,34,T,A,IL8_HUMAN,UniProt Entry Code (peptide),P10145,Full agonist,Kd,Binding - Radioligand competition/displacement,3.03,nM,=,,4.98,-1.645,,,125I-IL-8,100.0,0.0,,0.0,,P25024,0.2372190174390864
35,8034699,cxcr1_human,36,T,A,IL8_HUMAN,UniProt Entry Code (peptide),P10145,Full agonist,Kd,Binding - Radioligand competition/displacement,3.03,nM,=,,3.19,-1.053,,,125I-IL-8,101.0,0.0,,0.0,,P25024,0.2287067248984323
36,8034699,cxcr1_human,188,Y,A,IL8_HUMAN,UniProt Entry Code (peptide),P10145,Full agonist,Kd,Binding - Radioligand competition/displacement,3.03,nM,>,,25.0,-8.264,,,125I-IL-8,100.0,0.0,,0.0,,P25024,0.3093752475756926
38,8034699,cxcr1_human,19,G,A,IL8_HUMAN,UniProt Entry Code (peptide),P10145,Full agonist,Kd,Binding - Radioligand competition/displacement,3.03,nM,=,,1.818,1.667,,,125I-IL-8,101.0,0.0,,0.0,,P25024,0.2805809999337162
39,8034699,cxcr1_human,20,M,A,IL8_HUMAN,UniProt Entry Code (peptide),P10145,Full agonist,Kd,Binding - Radioligand competition/displacement,3.03,nM,=,,3.4845,-1.149,,,125I-IL-8,94.0,0.0,,0.0,,P25024,0.3196278825460669
40,8034699,cxcr1_human,21,P,A,IL8_HUMAN,UniProt Entry Code (peptide),P10145,Full agonist,Kd,Binding - Radioligand competition/displacement,3.03,nM,=,,0.3636,8.333,,,125I-IL-8,106.0,0.0,,0.0,,P25024,0.3203323108892343
41,8034699,cxcr1_human,22,P,A,IL8_HUMAN,UniProt Entry Code (peptide),P10145,Full agonist,Kd,Binding - Radioligand competition/displacement,3.03,nM,=,,0.909,3.333,,,125I-IL-8,106.0,0.0,,0.0,,P25024,0.3196138703384669
42,8034699,cxcr1_human,27,Y,A,IL8_HUMAN,UniProt Entry Code (peptide),P10145,Full agonist,Kd,Binding - Radioligand competition/displacement,3.03,nM,=,,0.1212,25.0,,,125I-IL-8,98.0,0.0,,0.0,,P25024,0.3415794266425916
44,8034699,cxcr1_human,102,G,A,IL8_HUMAN,UniProt Entry Code (peptide),P10145,Full agonist,Kd,Binding - Radioligand competition/displacement,3.03,nM,=,,1.0908,2.778,,,125I-IL-8,70.0,0.0,,0.0,,P25024,0.2381576194337621
46,8034699,cxcr1_human,104,I,A,IL8_HUMAN,UniProt Entry Code (peptide),P10145,Full agonist,Kd,Binding - Radioligand competition/displacement,3.03,nM,=,,2.1816,1.389,,,125I-IL-8,90.0,0.0,,0.0,,P25024,0.2649476324221487
47,8034699,cxcr1_human,105,F,A,IL8_HUMAN,UniProt Entry Code (peptide),P10145,Full agonist,Kd,Binding - Radioligand competition/displacement,3.03,nM,=,,0.909,3.333,,,125I-IL-8,71.0,0.0,,0.0,,P25024,0.4961787156584679
49,8034699,cxcr1_human,107,T,A,IL8_HUMAN,UniProt Entry Code (peptide),P10145,Full agonist,Kd,Binding - Radioligand competition/displacement,3.03,nM,=,,0.7272,4.167,,,125I-IL-8,81.0,0.0,,0.0,,P25024,0.2335638192769978
51,8034699,cxcr1_human,178,Y,A,IL8_HUMAN,UniProt Entry Code (peptide),P10145,Full agonist,Kd,Binding - Radioligand competition/displacement,3.03,nM,=,,0.1212,25.0,,,125I-IL-8,93.0,0.0,,0.0,,P25024,0.3157301071630075
52,8034699,cxcr1_human,179,H,A,IL8_HUMAN,UniProt Entry Code (peptide),P10145,Full agonist,Kd,Binding - Radioligand competition/displacement,3.03,nM,=,,3.8178,-1.259,,,125I-IL-8,114.0,0.0,,0.0,,P25024,0.3138433714142234
53,8034699,cxcr1_human,180,P,A,IL8_HUMAN,UniProt Entry Code (peptide),P10145,Full agonist,Kd,Binding - Radioligand competition/displacement,3.03,nM,=,,1.4847,2.041,,,125I-IL-8,75.0,0.0,,0.0,,P25024,0.2766247154525268
55,8034699,cxcr1_human,190,V,A,IL8_HUMAN,UniProt Entry Code (peptide),P10145,Full agonist,Kd,Binding - Radioligand competition/displacement,3.03,nM,=,,1.7877,1.695,,,125I-IL-8,91.0,0.0,,0.0,,P25024,0.2393720878773895
56,8034699,cxcr1_human,191,L,A,IL8_HUMAN,UniProt Entry Code (peptide),P10145,Full agonist,Kd,Binding - Radioligand competition/displacement,3.03,nM,=,,0.2727,11.111,,,125I-IL-8,106.0,0.0,,0.0,,P25024,0.3303314103577582
57,8034699,cxcr1_human,192,G,A,IL8_HUMAN,UniProt Entry Code (peptide),P10145,Full agonist,Kd,Binding - Radioligand competition/displacement,3.03,nM,=,,0.303,10.0,,,125I-IL-8,85.0,0.0,,0.0,,P25024,0.2317403516665042
59,8034699,cxcr1_human,200,M,A,IL8_HUMAN,UniProt Entry Code (peptide),P10145,Full agonist,Kd,Binding - Radioligand competition/displacement,3.03,nM,=,,0.0606,50.0,,,125I-IL-8,103.0,0.0,,0.0,,P25024,0.2601697400715587
60,8034699,cxcr1_human,201,V,A,IL8_HUMAN,UniProt Entry Code (peptide),P10145,Full agonist,Kd,Binding - Radioligand competition/displacement,3.03,nM,=,,1.3332,2.273,,,125I-IL-8,129.0,0.0,,0.0,,P25024,0.2199536126963231
61,8034699,cxcr1_human,202,L,A,IL8_HUMAN,UniProt Entry Code (peptide),P10145,Full agonist,Kd,Binding - Radioligand competition/displacement,3.03,nM,=,,1.4241,2.128,,,125I-IL-8,113.0,0.0,,0.0,,P25024,0.394964287020472
64,8034699,cxcr1_human,266,T,A,IL8_HUMAN,UniProt Entry Code (peptide),P10145,Full agonist,Kd,Binding - Radioligand competition/displacement,3.03,nM,=,,1.0605,2.857,,,125I-IL-8,81.0,0.0,,0.0,,P25024,0.3425960489057764
65,8034699,cxcr1_human,267,L,A,IL8_HUMAN,UniProt Entry Code (peptide),P10145,Full agonist,Kd,Binding - Radioligand competition/displacement,3.03,nM,=,,1.7574,1.724,,,125I-IL-8,101.0,0.0,,0.0,,P25024,0.3070846287649253
66,8034699,cxcr1_human,268,M,A,IL8_HUMAN,UniProt Entry Code (peptide),P10145,Full agonist,Kd,Binding - Radioligand competition/displacement,3.03,nM,=,,0.0606,50.0,,,125I-IL-8,105.0,0.0,,0.0,,P25024,0.2551906186423096
67,8034699,cxcr1_human,269,R,A,IL8_HUMAN,UniProt Entry Code (peptide),P10145,Full agonist,Kd,Binding - Radioligand competition/displacement,3.03,nM,=,,0.2121,14.286,,,125I-IL-8,103.0,0.0,,0.0,,P25024,0.27365513721792
68,8034699,cxcr1_human,270,T,A,IL8_HUMAN,UniProt Entry Code (peptide),P10145,Full agonist,Kd,Binding - Radioligand competition/displacement,3.03,nM,=,,0.5454,5.556,,,125I-IL-8,84.0,0.0,,0.0,,P25024,0.2119308131384504
69,8034699,cxcr1_human,271,Q,A,IL8_HUMAN,UniProt Entry Code (peptide),P10145,Full agonist,Kd,Binding - Radioligand competition/displacement,3.03,nM,=,,3.3936,-1.12,,,125I-IL-8,90.0,0.0,,0.0,,P25024,0.2620202045000748
70,8034699,cxcr1_human,272,V,A,IL8_HUMAN,UniProt Entry Code (peptide),P10145,Full agonist,Kd,Binding - Radioligand competition/displacement,3.03,nM,=,,1.9998,1.515,,,125I-IL-8,93.0,0.0,,0.0,,P25024,0.2325161890358616
71,8034699,cxcr1_human,273,I,A,IL8_HUMAN,UniProt Entry Code (peptide),P10145,Full agonist,Kd,Binding - Radioligand competition/displacement,3.03,nM,=,,0.0909,33.333,,,125I-IL-8,93.0,0.0,,0.0,,P25024,0.3244493750085652
72,8034699,cxcr1_human,274,Q,A,IL8_HUMAN,UniProt Entry Code (peptide),P10145,Full agonist,Kd,Binding - Radioligand competition/displacement,3.03,nM,=,,4.9389,-1.631,,,125I-IL-8,88.0,0.0,,0.0,,P25024,0.2696509718104355
76,8903513,cxcr1_human,136,Y,A,IL8_HUMAN,UniProt Entry Code (peptide),P10145,Full agonist,Kd,Binding - Radioligand competition/displacement,1.51,nM,=,,2.0,-1.325,,,125I-IL-8,98.94736842105264,0.0,,0.0,,P25024,0.6142042659729066
77,8903513,cxcr1_human,137,L,A,IL8_HUMAN,UniProt Entry Code (peptide),P10145,Full agonist,Kd,Binding - Radioligand competition/displacement,1.51,nM,=,,2.0,-1.325,,,125I-IL-8,97.89473684210527,0.0,,0.0,,P25024,0.4743926209891334
78,8903513,cxcr1_human,139,I,A,IL8_HUMAN,UniProt Entry Code (peptide),P10145,Full agonist,Kd,Binding - Radioligand competition/displacement,1.51,nM,=,,1.54,-1.019,,,125I-IL-8,100.0,0.0,,0.0,,P25024,0.5653913560949909
79,8903513,cxcr1_human,140,V,A,IL8_HUMAN,UniProt Entry Code (peptide),P10145,Full agonist,Kd,Binding - Radioligand competition/displacement,1.51,nM,=,,1.48,1.02,,,125I-IL-8,98.94736842105264,0.0,,0.0,,P25024,0.5212424438324106
81,8903513,cxcr1_human,241,M,A,IL8_HUMAN,UniProt Entry Code (peptide),P10145,Full agonist,Kd,Binding - Radioligand competition/displacement,1.51,nM,=,,0.9,1.678,,,125I-IL-8,95.78947368421052,0.0,,0.0,,P25024,0.5693297877012466
82,8903513,cxcr1_human,242,R,A,IL8_HUMAN,UniProt Entry Code (peptide),P10145,Full agonist,Kd,Binding - Radioligand competition/displacement,1.51,nM,=,,0.58,2.603,,,125I-IL-8,98.94736842105264,0.0,,0.0,,P25024,0.5418126444139945
2,10574939,ccr5_human,4,Q,A,CCL4_HUMAN,UniProt Entry Code (peptide),P13236,Full agonist,pIC50,Binding - Radioligand competition/displacement,9.29,M,=,,9.18,-1.289,,,[125I]-CCL4,116.76300578034682,0.0,,0.0,,P51681,0.3808027504257446
3,10574939,ccr5_human,5,V,A,CCL4_HUMAN,UniProt Entry Code (peptide),P13236,Full agonist,pIC50,Binding - Radioligand competition/displacement,9.29,M,=,,9.49,1.585,,,[125I]-CCL4,88.6319845857418,0.0,,0.0,,P51681,0.292810830273244
4,10574939,ccr5_human,6,S,A,CCL4_HUMAN,UniProt Entry Code (peptide),P13236,Full agonist,pIC50,Binding - Radioligand competition/displacement,9.29,M,=,,9.66,2.344,,,[125I]-CCL4,62.04238921001927,0.0,,0.0,,P51681,0.2963559208601617
5,10574939,ccr5_human,7,S,A,CCL4_HUMAN,UniProt Entry Code (peptide),P13236,Full agonist,pIC50,Binding - Radioligand competition/displacement,9.29,M,=,,9.44,1.413,,,[125I]-CCL4,84.20038535645472,0.0,,0.0,,P51681,0.3136349075681554
6,10574939,ccr5_human,8,P,A,CCL4_HUMAN,UniProt Entry Code (peptide),P13236,Full agonist,pIC50,Binding - Radioligand competition/displacement,9.29,M,=,,9.27,-1.047,,,[125I]-CCL4,76.10789980732177,0.0,,0.0,,P51681,0.3274986754404405
7,10574939,ccr5_human,9,I,A,CCL4_HUMAN,UniProt Entry Code (peptide),P13236,Full agonist,pIC50,Binding - Radioligand competition/displacement,9.29,M,=,,9.56,1.862,,,[125I]-CCL4,95.3757225433526,0.0,,0.0,,P51681,0.3178448756367787
10,10574939,ccr5_human,12,I,A,CCL4_HUMAN,UniProt Entry Code (peptide),P13236,Full agonist,pIC50,Binding - Radioligand competition/displacement,9.29,M,=,,9.35,1.148,,,[125I]-CCL4,94.02697495183044,0.0,,0.0,,P51681,0.3129588664407703
13,10602038,ccr5_human,6,S,P,CCL4_HUMAN,UniProt Entry Code (peptide),P13236,Full agonist,IC50,Binding - Radioligand competition/displacement,0.67,nM,=,,2.71,-4.049,,,[125I]-CCL4,110.28037383177572,0.0,,0.0,,P51681,0.37642812766181
16,10602038,ccr5_human,31,R,G,CCL4_HUMAN,UniProt Entry Code (peptide),P13236,Full agonist,IC50,Binding - Radioligand competition/displacement,0.67,nM,=,,8.33,-12.5,,,[125I]-CCL4,93.45794392523364,0.0,,0.0,,P51681,0.2691079313068746
17,10602038,ccr5_human,167,T,W,CCL4_HUMAN,UniProt Entry Code (peptide),P13236,Full agonist,IC50,Binding - Radioligand competition/displacement,0.67,nM,=,,2.49,-3.717,,,[125I]-CCL4,85.04672897196261,0.0,,0.0,,P51681,0.4428867302693356
18,10602038,ccr5_human,180,S,V,CCL4_HUMAN,UniProt Entry Code (peptide),P13236,Full agonist,IC50,Binding - Radioligand competition/displacement,0.67,nM,=,,2.7,-4.032,,,[125I]-CCL4,88.78504672897198,0.0,,0.0,,P51681,0.4401386345203092
21,12411445,ccr5_human,89,Y,S,CCL3_HUMAN,UniProt entry code,P10147,Full agonist,pIC50,Binding - Radioligand competition/displacement,9.42,M,=,,9.56,1.38,,,[125I]-CCL4,80.0,0.0,,0.0,,P51681,0.4241202190568292
27,12411445,ccr5_human,89,Y,S,CCL4_HUMAN,UniProt entry code,P13236,Full agonist,pIC50,Binding - Radioligand competition/displacement,9.59,M,=,,9.63,1.096,,,[125I]-CCL4,80.0,0.0,,0.0,,P51681,0.4241202190568292
28,12411445,ccr5_human,89,Y,S,CCL4_HUMAN,UniProt entry code,P13236,Full agonist,pIC50,Binding - Radioligand competition/displacement,8.75,M,=,,8.62,-1.35,,,[125I]-CCL5,80.0,0.0,,0.0,,P51681,0.4241202190568292
34,12411445,ccr5_human,89,Y,S,CCL5_HUMAN,UniProt entry code,P13501,Full agonist,pIC50,Binding - Radioligand competition/displacement,9.64,M,=,,9.31,-2.137,,,[125I]-CCL4,80.0,0.0,,0.0,,P51681,0.4241202190568292
35,12411445,ccr5_human,89,Y,S,CCL5_HUMAN,UniProt entry code,P13501,Full agonist,pIC50,Binding - Radioligand competition/displacement,9.13,M,=,,9.29,1.445,,,[125I]-CCL5,80.0,0.0,,0.0,,P51681,0.4241202190568292
40,12411445,ccr5_human,89,Y,S,CCL8_HUMAN,UniProt entry code,P80075,Full agonist,pIC50,Binding - Radioligand competition/displacement,9.59,M,=,,9.88,1.95,,,[125I]-CCL4,80.0,0.0,,0.0,,P51681,0.4241202190568292
23,12411445,ccr5_human,108,Y,A,CCL3_HUMAN,UniProt entry code,P10147,Full agonist,pIC50,Binding - Radioligand competition/displacement,9.42,M,=,,9.39,-1.072,,,[125I]-CCL4,40.0,0.0,,0.0,,P51681,0.5938700898751702
30,12411445,ccr5_human,108,Y,A,CCL4_HUMAN,UniProt entry code,P13236,Full agonist,pIC50,Binding - Radioligand competition/displacement,9.59,M,=,,9.78,1.549,,,[125I]-CCL4,40.0,0.0,,0.0,,P51681,0.5938700898751702
37,12411445,ccr5_human,108,Y,A,CCL5_HUMAN,UniProt entry code,P13501,Full agonist,pIC50,Binding - Radioligand competition/displacement,9.64,M,=,,9.92,1.905,,,[125I]-CCL4,40.0,0.0,,0.0,,P51681,0.5938700898751702
42,12411445,ccr5_human,108,Y,A,CCL8_HUMAN,UniProt entry code,P80075,Full agonist,pIC50,Binding - Radioligand competition/displacement,9.59,M,=,,8.73,-7.246,,,[125I]-CCL4,40.0,0.0,,0.0,,P51681,0.5938700898751702
46,16476734,ccr5_human,108,Y,A,Ancriviroc,ChEMBL Compound ID,CHEMBL78535,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,16.0,nM,=,,11.8,1.356,,,[3H]-Ancriviroc,100.0,0.0,,0.0,,P51681,0.5938700898751702
70,16476734,ccr5_human,108,Y,A,TAK-779,ChEMBL Compound ID,CHEMBL1178786,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,30.2,nM,=,,200.0,-6.623,,,[3H]-TAK-779,100.0,0.0,,0.0,,P51681,0.5938700898751702
118,18096812,ccr5_human,108,Y,A,Aplaviroc,ChEMBL Compound ID,CHEMBL1255794,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,10.0,nM,=,,57.0,-5.714,,,[125I]-CCL5,89.0,0.0,,0.0,,P51681,0.5938700898751702
138,18096812,ccr5_human,108,Y,A,Maraviroc,ChEMBL Compound ID,CHEMBL1201187,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,9.0,nM,=,,630.0,-71.429,,,[125I]-CCL5,89.0,0.0,,0.0,,P51681,0.5938700898751702
148,18096812,ccr5_human,108,Y,A,TAK-220,ChEMBL Compound ID,CHEMBL207004,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,17.0,nM,=,,12.0,1.417,,,[125I]-CCL5,89.0,0.0,,0.0,,P51681,0.5938700898751702
158,18096812,ccr5_human,108,Y,A,TAK-779,ChEMBL Compound ID,CHEMBL1178786,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,4.0,nM,=,,113.0,-28.571,,,[125I]-CCL5,89.0,0.0,,0.0,,P51681,0.5938700898751702
168,18096812,ccr5_human,108,Y,A,Vicriviroc,ChEMBL Compound ID,CHEMBL82301,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,14.0,nM,=,,840.0,-58.824,,,[125I]-CCL5,89.0,0.0,,0.0,,P51681,0.5938700898751702
181,18590744,ccr5_human,108,Y,A,AK317,ChEMBL Compound ID,CHEMBL1170878,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,16.7,nM,>,,100.0,-5.988,,,[3H]-AK317,100.0,0.0,,0.0,,P51681,0.5938700898751702
213,18590744,ccr5_human,108,Y,A,AK530,SMILES,O=C([C@@H]1[C@@H](O)C2CCCCC2)N(CC#CC)C3(CCN(CC4=C(C)N(C5=CC=CC=C5)N=C4C)CC3)C(N1)=O,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,1.4,nM,=,,60.7,-43.478,,,[3H]-AK530,100.0,0.0,,0.0,,P51681,0.5938700898751702
249,21775441,ccr5_human,108,Y,A,CCL3_HUMAN,UniProt entry code,P10147,Full agonist,Single-point,Binding - Radioligand competition/displacement,100.0,%,=,,44.0,-2.273,,,[125I]-CCL3,65.0,0.0,,0.0,,P51681,0.5938700898751702
290,21775441,ccr5_human,108,Y,A,Maraviroc,ChEMBL Compound ID,CHEMBL1201187,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,1.05,nM,=,,0.0,75.5,,,[125I]-CCL3,65.0,0.0,,0.0,,P51681,0.5938700898751702
344,24628038,ccr5_human,108,Y,A,Aplaviroc,ChEMBL Compound ID,CHEMBL1255794,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,3.7,nM,=,,200.0,-52.632,,,[3H]-Maraviroc,100.0,0.0,,0.0,,P51681,0.5938700898751702
356,24628038,ccr5_human,108,Y,A,Maraviroc,ChEMBL Compound ID,CHEMBL1201187,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,1.3,nM,=,,13.0,-10.0,,,[3H]-Maraviroc,100.0,0.0,,0.0,,P51681,0.5938700898751702
370,24628038,ccr5_human,108,Y,A,Vicriviroc,ChEMBL Compound ID,CHEMBL82301,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,7.1,nM,=,,94.0,-13.158,,,[3H]-Maraviroc,100.0,0.0,,0.0,,P51681,0.5938700898751702
384,18590744/16476734,ccr5_human,108,Y,A,Aplaviroc,ChEMBL Compound ID,CHEMBL1255794,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,3.6,nM,=,,19.8,-5.495,,,[3H]-Aplaviroc,100.0,0.0,,0.0,,P51681,0.5938700898751702
24,12411445,ccr5_human,109,F,H,CCL3_HUMAN,UniProt entry code,P10147,Full agonist,pIC50,Binding - Radioligand competition/displacement,9.42,M,=,,9.67,1.778,,,[125I]-CCL4,80.0,0.0,,0.0,,P51681,0.4799644540482369
31,12411445,ccr5_human,109,F,H,CCL4_HUMAN,UniProt entry code,P13236,Full agonist,pIC50,Binding - Radioligand competition/displacement,9.59,M,=,,9.89,1.995,,,[125I]-CCL4,80.0,0.0,,0.0,,P51681,0.4799644540482369
38,12411445,ccr5_human,109,F,H,CCL5_HUMAN,UniProt entry code,P13501,Full agonist,pIC50,Binding - Radioligand competition/displacement,9.64,M,=,,9.55,-1.23,,,[125I]-CCL4,80.0,0.0,,0.0,,P51681,0.4799644540482369
43,12411445,ccr5_human,109,F,H,CCL8_HUMAN,UniProt entry code,P80075,Full agonist,pIC50,Binding - Radioligand competition/displacement,9.59,M,=,,9.74,1.413,,,[125I]-CCL4,80.0,0.0,,0.0,,P51681,0.4799644540482369
251,21775441,ccr5_human,109,F,H,CCL3_HUMAN,UniProt entry code,P10147,Full agonist,Single-point,Binding - Radioligand competition/displacement,100.0,%,=,,179.0,1.79,,,[125I]-CCL3,106.0,0.0,,0.0,,P51681,0.4799644540482369
292,21775441,ccr5_human,109,F,H,Maraviroc,ChEMBL Compound ID,CHEMBL1201187,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,1.05,nM,=,,0.0,1.5,,,[125I]-CCL3,106.0,0.0,,0.0,,P51681,0.4799644540482369
32,12411445,ccr5_human,112,F,Y,CCL4_HUMAN,UniProt entry code,P13236,Full agonist,pIC50,Binding - Radioligand competition/displacement,9.59,M,=,,9.76,1.479,,,[125I]-CCL4,80.0,0.0,,0.0,,P51681,0.4084045806080085
48,16476734,ccr5_human,112,F,Y,Ancriviroc,ChEMBL Compound ID,CHEMBL78535,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,16.0,nM,=,,35.8,-2.237,,,[3H]-Ancriviroc,100.0,0.0,,0.0,,P51681,0.4084045806080085
72,16476734,ccr5_human,112,F,Y,TAK-779,ChEMBL Compound ID,CHEMBL1178786,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,30.2,nM,=,,28.5,1.06,,,[3H]-TAK-779,100.0,0.0,,0.0,,P51681,0.4084045806080085
184,18590744,ccr5_human,112,F,Y,AK317,ChEMBL Compound ID,CHEMBL1170878,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,16.7,nM,=,,21.1,-1.264,,,[3H]-AK317,100.0,0.0,,0.0,,P51681,0.4084045806080085
216,18590744,ccr5_human,112,F,Y,AK530,SMILES,O=C([C@@H]1[C@@H](O)C2CCCCC2)N(CC#CC)C3(CCN(CC4=C(C)N(C5=CC=CC=C5)N=C4C)CC3)C(N1)=O,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,1.4,nM,=,,5.2,-3.717,,,[3H]-AK530,100.0,0.0,,0.0,,P51681,0.4084045806080085
253,21775441,ccr5_human,112,F,Y,CCL3_HUMAN,UniProt entry code,P10147,Full agonist,Single-point,Binding - Radioligand competition/displacement,100.0,%,=,,104.0,1.04,,,[125I]-CCL3,125.0,0.0,,0.0,,P51681,0.4084045806080085
294,21775441,ccr5_human,112,F,Y,Maraviroc,ChEMBL Compound ID,CHEMBL1201187,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,1.05,nM,=,,0.0,1.1,,,[125I]-CCL3,125.0,0.0,,0.0,,P51681,0.4084045806080085
387,18590744/16476734,ccr5_human,112,F,Y,Aplaviroc,ChEMBL Compound ID,CHEMBL1255794,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,3.6,nM,=,,6.8,-1.89,,,[3H]-Aplaviroc,100.0,0.0,,0.0,,P51681,0.4084045806080085
44,16476734,ccr5_human,11,D,A,Ancriviroc,ChEMBL Compound ID,CHEMBL78535,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,16.0,nM,=,,12.4,1.29,,,[3H]-Ancriviroc,100.0,0.0,,0.0,,P51681,0.3874827756829154
68,16476734,ccr5_human,11,D,A,TAK-779,ChEMBL Compound ID,CHEMBL1178786,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,30.2,nM,=,,24.5,1.233,,,[3H]-TAK-779,100.0,0.0,,0.0,,P51681,0.3874827756829154
176,18590744,ccr5_human,11,D,A,AK317,ChEMBL Compound ID,CHEMBL1170878,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,16.7,nM,=,,14.6,1.144,,,[3H]-AK317,100.0,0.0,,0.0,,P51681,0.3874827756829154
208,18590744,ccr5_human,11,D,A,AK530,SMILES,O=C([C@@H]1[C@@H](O)C2CCCCC2)N(CC#CC)C3(CCN(CC4=C(C)N(C5=CC=CC=C5)N=C4C)CC3)C(N1)=O,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,1.4,nM,=,,1.1,1.273,,,[3H]-AK530,100.0,0.0,,0.0,,P51681,0.3874827756829154
379,18590744/16476734,ccr5_human,11,D,A,Aplaviroc,ChEMBL Compound ID,CHEMBL1255794,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,3.6,nM,=,,3.0,1.2,,,[3H]-Aplaviroc,0.0,0.0,,0.0,,P51681,0.3874827756829154
45,16476734,ccr5_human,37,Y,A,Ancriviroc,ChEMBL Compound ID,CHEMBL78535,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,16.0,nM,=,,200.0,-12.5,,,[3H]-Ancriviroc,100.0,0.0,,0.0,,P51681,0.5969997809526305
69,16476734,ccr5_human,37,Y,A,TAK-779,ChEMBL Compound ID,CHEMBL1178786,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,30.2,nM,=,,98.9,-3.279,,,[3H]-TAK-779,100.0,0.0,,0.0,,P51681,0.5969997809526305
177,18590744,ccr5_human,37,Y,A,AK317,ChEMBL Compound ID,CHEMBL1170878,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,16.7,nM,>,,100.0,-5.988,,,[3H]-AK317,100.0,0.0,,0.0,,P51681,0.5969997809526305
209,18590744,ccr5_human,37,Y,A,AK530,SMILES,O=C([C@@H]1[C@@H](O)C2CCCCC2)N(CC#CC)C3(CCN(CC4=C(C)N(C5=CC=CC=C5)N=C4C)CC3)C(N1)=O,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,1.4,nM,>,,100.0,-71.429,,,[3H]-AK530,100.0,0.0,,0.0,,P51681,0.5969997809526305
240,21775441,ccr5_human,37,Y,A,CCL3_HUMAN,UniProt entry code,P10147,Full agonist,Single-point,Binding - Radioligand competition/displacement,100.0,%,=,,14.0,-7.143,,,[125I]-CCL3,115.0,0.0,,0.0,,P51681,0.5969997809526305
282,21775441,ccr5_human,37,Y,A,Maraviroc,ChEMBL Compound ID,CHEMBL1201187,Antagonist (neutral/silent),K(d),Binding - Radioligand kinetics (association/dissociation),0.69,nM,=,,0.0,-1.25,,,[3H]-Maraviroc,115.0,0.0,,0.0,,P51681,0.5969997809526305
283,21775441,ccr5_human,37,Y,A,Maraviroc,ChEMBL Compound ID,CHEMBL1201187,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,1.05,nM,=,,0.0,2.2,,,[125I]-CCL3,115.0,0.0,,0.0,,P51681,0.5969997809526305
380,18590744/16476734,ccr5_human,37,Y,A,Aplaviroc,ChEMBL Compound ID,CHEMBL1255794,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,3.6,nM,=,,12.8,-3.559,,,[3H]-Aplaviroc,100.0,0.0,,0.0,,P51681,0.5969997809526305
49,16476734,ccr5_human,113,F,A,Ancriviroc,ChEMBL Compound ID,CHEMBL78535,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,16.0,nM,=,,43.8,-2.74,,,[3H]-Ancriviroc,100.0,0.0,,0.0,,P51681,0.5614587074378529
73,16476734,ccr5_human,113,F,A,TAK-779,ChEMBL Compound ID,CHEMBL1178786,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,30.2,nM,=,,32.7,-1.082,,,[3H]-TAK-779,100.0,0.0,,0.0,,P51681,0.5614587074378529
185,18590744,ccr5_human,113,F,A,AK317,ChEMBL Compound ID,CHEMBL1170878,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,16.7,nM,=,,43.3,-2.591,,,[3H]-AK317,100.0,0.0,,0.0,,P51681,0.5614587074378529
217,18590744,ccr5_human,113,F,A,AK530,SMILES,O=C([C@@H]1[C@@H](O)C2CCCCC2)N(CC#CC)C3(CCN(CC4=C(C)N(C5=CC=CC=C5)N=C4C)CC3)C(N1)=O,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,1.4,nM,=,,2.4,-1.715,,,[3H]-AK530,100.0,0.0,,0.0,,P51681,0.5614587074378529
388,18590744/16476734,ccr5_human,113,F,A,Aplaviroc,ChEMBL Compound ID,CHEMBL1255794,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,3.6,nM,=,,13.3,-3.69,,,[3H]-Aplaviroc,100.0,0.0,,0.0,,P51681,0.5614587074378529
50,16476734,ccr5_human,113,F,Y,Ancriviroc,ChEMBL Compound ID,CHEMBL78535,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,16.0,nM,=,,45.3,-2.833,,,[3H]-Ancriviroc,100.0,0.0,,0.0,,P51681,0.3424594184319237
74,16476734,ccr5_human,113,F,Y,TAK-779,ChEMBL Compound ID,CHEMBL1178786,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,30.2,nM,=,,32.4,-1.073,,,[3H]-TAK-779,100.0,0.0,,0.0,,P51681,0.3424594184319237
186,18590744,ccr5_human,113,F,Y,AK317,ChEMBL Compound ID,CHEMBL1170878,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,16.7,nM,=,,48.2,-2.89,,,[3H]-AK317,100.0,0.0,,0.0,,P51681,0.3424594184319237
218,18590744,ccr5_human,113,F,Y,AK530,SMILES,O=C([C@@H]1[C@@H](O)C2CCCCC2)N(CC#CC)C3(CCN(CC4=C(C)N(C5=CC=CC=C5)N=C4C)CC3)C(N1)=O,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,1.4,nM,=,,2.8,-2.0,,,[3H]-AK530,100.0,0.0,,0.0,,P51681,0.3424594184319237
389,18590744/16476734,ccr5_human,113,F,Y,Aplaviroc,ChEMBL Compound ID,CHEMBL1255794,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,3.6,nM,=,,12.9,-3.584,,,[3H]-Aplaviroc,100.0,0.0,,0.0,,P51681,0.3424594184319237
51,16476734,ccr5_human,163,G,A,Ancriviroc,ChEMBL Compound ID,CHEMBL78535,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,16.0,nM,=,,25.0,-1.562,,,[3H]-Ancriviroc,100.0,0.0,,0.0,,P51681,0.3807687401075716
75,16476734,ccr5_human,163,G,A,TAK-779,ChEMBL Compound ID,CHEMBL1178786,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,30.2,nM,=,,24.0,1.258,,,[3H]-TAK-779,100.0,0.0,,0.0,,P51681,0.3807687401075716
187,18590744,ccr5_human,163,G,A,AK317,ChEMBL Compound ID,CHEMBL1170878,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,16.7,nM,=,,14.7,1.136,,,[3H]-AK317,100.0,0.0,,0.0,,P51681,0.3807687401075716
219,18590744,ccr5_human,163,G,A,AK530,SMILES,O=C([C@@H]1[C@@H](O)C2CCCCC2)N(CC#CC)C3(CCN(CC4=C(C)N(C5=CC=CC=C5)N=C4C)CC3)C(N1)=O,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,1.4,nM,=,,5.9,-4.219,,,[3H]-AK530,100.0,0.0,,0.0,,P51681,0.3807687401075716
390,18590744/16476734,ccr5_human,163,G,A,Aplaviroc,ChEMBL Compound ID,CHEMBL1255794,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,3.6,nM,=,,8.0,-2.222,,,[3H]-Aplaviroc,100.0,0.0,,0.0,,P51681,0.3807687401075716
53,16476734,ccr5_human,168,R,A,Ancriviroc,ChEMBL Compound ID,CHEMBL78535,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,16.0,nM,=,,21.0,-1.312,,,[3H]-Ancriviroc,100.0,0.0,,0.0,,P51681,0.2475330150998285
77,16476734,ccr5_human,168,R,A,TAK-779,ChEMBL Compound ID,CHEMBL1178786,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,30.2,nM,=,,43.0,-1.425,,,[3H]-TAK-779,100.0,0.0,,0.0,,P51681,0.2475330150998285
189,18590744,ccr5_human,168,R,A,AK317,ChEMBL Compound ID,CHEMBL1170878,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,16.7,nM,=,,24.6,-1.473,,,[3H]-AK317,100.0,0.0,,0.0,,P51681,0.2475330150998285
221,18590744,ccr5_human,168,R,A,AK530,SMILES,O=C([C@@H]1[C@@H](O)C2CCCCC2)N(CC#CC)C3(CCN(CC4=C(C)N(C5=CC=CC=C5)N=C4C)CC3)C(N1)=O,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,1.4,nM,=,,2.2,-1.572,,,[3H]-AK530,100.0,0.0,,0.0,,P51681,0.2475330150998285
255,21775441,ccr5_human,168,R,A,CCL3_HUMAN,UniProt entry code,P10147,Full agonist,Single-point,Binding - Radioligand competition/displacement,100.0,%,=,,47.0,-2.128,,,[125I]-CCL3,77.0,0.0,,0.0,,P51681,0.2475330150998285
296,21775441,ccr5_human,168,R,A,Maraviroc,ChEMBL Compound ID,CHEMBL1201187,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,1.05,nM,=,,0.0,1.3,,,[125I]-CCL3,77.0,0.0,,0.0,,P51681,0.2475330150998285
392,18590744/16476734,ccr5_human,168,R,A,Aplaviroc,ChEMBL Compound ID,CHEMBL1255794,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,3.6,nM,=,,14.1,-3.922,,,[3H]-Aplaviroc,100.0,0.0,,0.0,,P51681,0.2475330150998285
54,16476734,ccr5_human,178,C,A,Ancriviroc,ChEMBL Compound ID,CHEMBL78535,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,16.0,nM,=,,27.1,-1.695,,,[3H]-Ancriviroc,100.0,0.0,,0.0,,P51681,0.7823502375967651
78,16476734,ccr5_human,178,C,A,TAK-779,ChEMBL Compound ID,CHEMBL1178786,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,30.2,nM,=,,34.5,-1.143,,,[3H]-TAK-779,100.0,0.0,,0.0,,P51681,0.7823502375967651
190,18590744,ccr5_human,178,C,A,AK317,ChEMBL Compound ID,CHEMBL1170878,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,16.7,nM,>,,100.0,-5.988,,,[3H]-AK317,100.0,0.0,,0.0,,P51681,0.7823502375967651
222,18590744,ccr5_human,178,C,A,AK530,SMILES,O=C([C@@H]1[C@@H](O)C2CCCCC2)N(CC#CC)C3(CCN(CC4=C(C)N(C5=CC=CC=C5)N=C4C)CC3)C(N1)=O,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,1.4,nM,>,,100.0,-71.429,,,[3H]-AK530,100.0,0.0,,0.0,,P51681,0.7823502375967651
258,21775441,ccr5_human,178,C,A,CCL3_HUMAN,UniProt entry code,P10147,Full agonist,Single-point,Binding - Radioligand competition/displacement,100.0,%,<,,10.0,-10.0,,,[125I]-CCL3,0.0,0.0,,0.0,,P51681,0.7823502375967651
393,18590744/16476734,ccr5_human,178,C,A,Aplaviroc,ChEMBL Compound ID,CHEMBL1255794,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,3.6,nM,>,,200.0,-55.556,,,[3H]-Aplaviroc,100.0,0.0,,0.0,,P51681,0.7823502375967651
55,16476734,ccr5_human,180,S,A,Ancriviroc,ChEMBL Compound ID,CHEMBL78535,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,16.0,nM,=,,31.8,-1.988,,,[3H]-Ancriviroc,100.0,0.0,,0.0,,P51681,0.3141994131193239
79,16476734,ccr5_human,180,S,A,TAK-779,ChEMBL Compound ID,CHEMBL1178786,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,30.2,nM,=,,18.2,1.659,,,[3H]-TAK-779,100.0,0.0,,0.0,,P51681,0.3141994131193239
191,18590744,ccr5_human,180,S,A,AK317,ChEMBL Compound ID,CHEMBL1170878,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,16.7,nM,=,,34.5,-2.066,,,[3H]-AK317,100.0,0.0,,0.0,,P51681,0.3141994131193239
223,18590744,ccr5_human,180,S,A,AK530,SMILES,O=C([C@@H]1[C@@H](O)C2CCCCC2)N(CC#CC)C3(CCN(CC4=C(C)N(C5=CC=CC=C5)N=C4C)CC3)C(N1)=O,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,1.4,nM,=,,7.4,-5.291,,,[3H]-AK530,100.0,0.0,,0.0,,P51681,0.3141994131193239
259,21775441,ccr5_human,180,S,A,CCL3_HUMAN,UniProt entry code,P10147,Full agonist,Single-point,Binding - Radioligand competition/displacement,100.0,%,=,,85.0,-1.176,,,[125I]-CCL3,124.0,0.0,,0.0,,P51681,0.3141994131193239
299,21775441,ccr5_human,180,S,A,Maraviroc,ChEMBL Compound ID,CHEMBL1201187,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,1.05,nM,=,,0.0,-1.111,,,[125I]-CCL3,124.0,0.0,,0.0,,P51681,0.3141994131193239
329,21775441,ccr5_human,180,S,A,Maraviroc,ChEMBL Compound ID,CHEMBL1201187,Antagonist (neutral/silent),K(d),Binding - Radioligand kinetics (association/dissociation),0.69,nM,=,,0.0,1.1,,,[3H]-Maraviroc,124.0,0.0,,0.0,,P51681,0.3141994131193239
359,24628038,ccr5_human,180,S,A,Maraviroc,ChEMBL Compound ID,CHEMBL1201187,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,1.3,nM,=,,3.0,-2.309,,,[3H]-Maraviroc,100.0,0.0,,0.0,,P51681,0.3141994131193239
394,18590744/16476734,ccr5_human,180,S,A,Aplaviroc,ChEMBL Compound ID,CHEMBL1255794,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,3.6,nM,=,,5.7,-1.582,,,[3H]-Aplaviroc,100.0,0.0,,0.0,,P51681,0.3141994131193239
57,16476734,ccr5_human,180,S,T,Ancriviroc,ChEMBL Compound ID,CHEMBL78535,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,16.0,nM,=,,25.4,-1.587,,,[3H]-Ancriviroc,100.0,0.0,,0.0,,P51681,0.3141994131193239
81,16476734,ccr5_human,180,S,T,TAK-779,ChEMBL Compound ID,CHEMBL1178786,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,30.2,nM,=,,41.0,-1.357,,,[3H]-TAK-779,100.0,0.0,,0.0,,P51681,0.3141994131193239
193,18590744,ccr5_human,180,S,T,AK317,ChEMBL Compound ID,CHEMBL1170878,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,16.7,nM,=,,14.9,1.121,,,[3H]-AK317,100.0,0.0,,0.0,,P51681,0.3141994131193239
225,18590744,ccr5_human,180,S,T,AK530,SMILES,O=C([C@@H]1[C@@H](O)C2CCCCC2)N(CC#CC)C3(CCN(CC4=C(C)N(C5=CC=CC=C5)N=C4C)CC3)C(N1)=O,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,1.4,nM,=,,1.4,1.0,,,[3H]-AK530,100.0,0.0,,0.0,,P51681,0.3141994131193239
395,18590744/16476734,ccr5_human,180,S,T,Aplaviroc,ChEMBL Compound ID,CHEMBL1255794,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,3.6,nM,=,,1.5,2.4,,,[3H]-Aplaviroc,100.0,0.0,,0.0,,P51681,0.3141994131193239
58,16476734,ccr5_human,188,Q,A,Ancriviroc,ChEMBL Compound ID,CHEMBL78535,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,16.0,nM,=,,23.8,-1.488,,,[3H]-Ancriviroc,100.0,0.0,,0.0,,P51681,0.2702186559306425
82,16476734,ccr5_human,188,Q,A,TAK-779,ChEMBL Compound ID,CHEMBL1178786,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,30.2,nM,=,,37.9,-1.255,,,[3H]-TAK-779,100.0,0.0,,0.0,,P51681,0.2702186559306425
194,18590744,ccr5_human,188,Q,A,AK317,ChEMBL Compound ID,CHEMBL1170878,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,16.7,nM,=,,14.6,1.144,,,[3H]-AK317,100.0,0.0,,0.0,,P51681,0.2702186559306425
226,18590744,ccr5_human,188,Q,A,AK530,SMILES,O=C([C@@H]1[C@@H](O)C2CCCCC2)N(CC#CC)C3(CCN(CC4=C(C)N(C5=CC=CC=C5)N=C4C)CC3)C(N1)=O,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,1.4,nM,=,,1.9,-1.357,,,[3H]-AK530,100.0,0.0,,0.0,,P51681,0.2702186559306425
397,18590744/16476734,ccr5_human,188,Q,A,Aplaviroc,ChEMBL Compound ID,CHEMBL1255794,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,3.6,nM,=,,6.6,-1.835,,,[3H]-Aplaviroc,100.0,0.0,,0.0,,P51681,0.2702186559306425
59,16476734,ccr5_human,191,K,A,Ancriviroc,ChEMBL Compound ID,CHEMBL78535,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,16.0,nM,=,,26.5,-1.656,,,[3H]-Ancriviroc,100.0,0.0,,0.0,,P51681,0.3001211142340971
83,16476734,ccr5_human,191,K,A,TAK-779,ChEMBL Compound ID,CHEMBL1178786,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,30.2,nM,=,,35.0,-1.159,,,[3H]-TAK-779,100.0,0.0,,0.0,,P51681,0.3001211142340971
195,18590744,ccr5_human,191,K,A,AK317,ChEMBL Compound ID,CHEMBL1170878,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,16.7,nM,>,,100.0,-5.988,,,[3H]-AK317,100.0,0.0,,0.0,,P51681,0.3001211142340971
227,18590744,ccr5_human,191,K,A,AK530,SMILES,O=C([C@@H]1[C@@H](O)C2CCCCC2)N(CC#CC)C3(CCN(CC4=C(C)N(C5=CC=CC=C5)N=C4C)CC3)C(N1)=O,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,1.4,nM,=,,6.0,-4.292,,,[3H]-AK530,100.0,0.0,,0.0,,P51681,0.3001211142340971
398,18590744/16476734,ccr5_human,191,K,A,Aplaviroc,ChEMBL Compound ID,CHEMBL1255794,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,3.6,nM,>,,200.0,-55.556,,,[3H]-Aplaviroc,100.0,0.0,,0.0,,P51681,0.3001211142340971
61,16476734,ccr5_human,191,K,R,Ancriviroc,ChEMBL Compound ID,CHEMBL78535,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,16.0,nM,=,,34.1,-2.132,,,[3H]-Ancriviroc,100.0,0.0,,0.0,,P51681,0.1999118618990777
85,16476734,ccr5_human,191,K,R,TAK-779,ChEMBL Compound ID,CHEMBL1178786,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,30.2,nM,=,,47.1,-1.56,,,[3H]-TAK-779,100.0,0.0,,0.0,,P51681,0.1999118618990777
197,18590744,ccr5_human,191,K,R,AK317,ChEMBL Compound ID,CHEMBL1170878,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,16.7,nM,=,,22.2,-1.33,,,[3H]-AK317,100.0,0.0,,0.0,,P51681,0.1999118618990777
229,18590744,ccr5_human,191,K,R,AK530,SMILES,O=C([C@@H]1[C@@H](O)C2CCCCC2)N(CC#CC)C3(CCN(CC4=C(C)N(C5=CC=CC=C5)N=C4C)CC3)C(N1)=O,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,1.4,nM,=,,5.2,-3.717,,,[3H]-AK530,100.0,0.0,,0.0,,P51681,0.1999118618990777
399,18590744/16476734,ccr5_human,191,K,R,Aplaviroc,ChEMBL Compound ID,CHEMBL1255794,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,3.6,nM,=,,9.0,-2.5,,,[3H]-Aplaviroc,100.0,0.0,,0.0,,P51681,0.1999118618990777
62,16476734,ccr5_human,197,K,A,Ancriviroc,ChEMBL Compound ID,CHEMBL78535,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,16.0,nM,=,,16.8,-1.05,,,[3H]-Ancriviroc,100.0,0.0,,0.0,,P51681,0.3737963310956381
86,16476734,ccr5_human,197,K,A,TAK-779,ChEMBL Compound ID,CHEMBL1178786,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,30.2,nM,=,,14.7,2.054,,,[3H]-TAK-779,100.0,0.0,,0.0,,P51681,0.3737963310956381
201,18590744,ccr5_human,197,K,A,AK317,ChEMBL Compound ID,CHEMBL1170878,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,16.7,nM,=,,58.3,-3.497,,,[3H]-AK317,100.0,0.0,,0.0,,P51681,0.3737963310956381
233,18590744,ccr5_human,197,K,A,AK530,SMILES,O=C([C@@H]1[C@@H](O)C2CCCCC2)N(CC#CC)C3(CCN(CC4=C(C)N(C5=CC=CC=C5)N=C4C)CC3)C(N1)=O,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,1.4,nM,=,,7.6,-5.435,,,[3H]-AK530,100.0,0.0,,0.0,,P51681,0.3737963310956381
404,18590744/16476734,ccr5_human,197,K,A,Aplaviroc,ChEMBL Compound ID,CHEMBL1255794,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,3.6,nM,=,,10.7,-2.976,,,[3H]-Aplaviroc,100.0,0.0,,0.0,,P51681,0.3737963310956381
63,16476734,ccr5_human,198,I,A,Ancriviroc,ChEMBL Compound ID,CHEMBL78535,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,16.0,nM,=,,52.4,-3.279,,,[3H]-Ancriviroc,100.0,0.0,,0.0,,P51681,0.4408758373996739
87,16476734,ccr5_human,198,I,A,TAK-779,ChEMBL Compound ID,CHEMBL1178786,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,30.2,nM,=,,54.9,-1.818,,,[3H]-TAK-779,100.0,0.0,,0.0,,P51681,0.4408758373996739
121,18096812,ccr5_human,198,I,A,Aplaviroc,ChEMBL Compound ID,CHEMBL1255794,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,10.0,nM,=,,354.0,-35.714,,,[125I]-CCL5,78.1,0.0,,0.0,,P51681,0.4408758373996739
131,18096812,ccr5_human,198,I,A,CCL5_HUMAN,UniProt entry code,P13501,Full agonist,K(d),Binding - Radioligand competition/displacement,0.6,nM,=,,0.4,1.5,,,[125I]-CCL5,78.1,0.0,,0.0,,P51681,0.4408758373996739
141,18096812,ccr5_human,198,I,A,Maraviroc,ChEMBL Compound ID,CHEMBL1201187,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,9.0,nM,=,,810.0,-90.909,,,[125I]-CCL5,78.1,0.0,,0.0,,P51681,0.4408758373996739
151,18096812,ccr5_human,198,I,A,TAK-220,ChEMBL Compound ID,CHEMBL207004,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,17.0,nM,=,,932.0,-55.556,,,[125I]-CCL5,78.1,0.0,,0.0,,P51681,0.4408758373996739
161,18096812,ccr5_human,198,I,A,TAK-779,ChEMBL Compound ID,CHEMBL1178786,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,4.0,nM,=,,26.0,-6.494,,,[125I]-CCL5,78.1,0.0,,0.0,,P51681,0.4408758373996739
171,18096812,ccr5_human,198,I,A,Vicriviroc,ChEMBL Compound ID,CHEMBL82301,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,14.0,nM,=,,350.0,-25.0,,,[125I]-CCL5,78.1,0.0,,0.0,,P51681,0.4408758373996739
202,18590744,ccr5_human,198,I,A,AK317,ChEMBL Compound ID,CHEMBL1170878,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,16.7,nM,>,,100.0,-5.988,,,[3H]-AK317,100.0,0.0,,0.0,,P51681,0.4408758373996739
234,18590744,ccr5_human,198,I,A,AK530,SMILES,O=C([C@@H]1[C@@H](O)C2CCCCC2)N(CC#CC)C3(CCN(CC4=C(C)N(C5=CC=CC=C5)N=C4C)CC3)C(N1)=O,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,1.4,nM,=,,9.8,-6.993,,,[3H]-AK530,100.0,0.0,,0.0,,P51681,0.4408758373996739
267,21775441,ccr5_human,198,I,A,CCL3_HUMAN,UniProt entry code,P10147,Full agonist,Single-point,Binding - Radioligand competition/displacement,100.0,%,=,,130.0,1.3,,,[125I]-CCL3,124.0,0.0,,0.0,,P51681,0.4408758373996739
306,21775441,ccr5_human,198,I,A,Maraviroc,ChEMBL Compound ID,CHEMBL1201187,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,1.05,nM,=,,0.0,131.0,,,[125I]-CCL3,124.0,0.0,,0.0,,P51681,0.4408758373996739
347,24628038,ccr5_human,198,I,A,Aplaviroc,ChEMBL Compound ID,CHEMBL1255794,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,3.7,nM,=,,109.0,-29.412,,,[3H]-Maraviroc,100.0,0.0,,0.0,,P51681,0.4408758373996739
361,24628038,ccr5_human,198,I,A,Maraviroc,ChEMBL Compound ID,CHEMBL1201187,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,1.3,nM,=,,17.0,-13.158,,,[3H]-Maraviroc,100.0,0.0,,0.0,,P51681,0.4408758373996739
373,24628038,ccr5_human,198,I,A,Vicriviroc,ChEMBL Compound ID,CHEMBL82301,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,7.1,nM,=,,14.5,-2.041,,,[3H]-Maraviroc,100.0,0.0,,0.0,,P51681,0.4408758373996739
405,18590744/16476734,ccr5_human,198,I,A,Aplaviroc,ChEMBL Compound ID,CHEMBL1255794,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,3.6,nM,=,,24.6,-6.849,,,[3H]-Aplaviroc,100.0,0.0,,0.0,,P51681,0.4408758373996739
64,16476734,ccr5_human,251,Y,A,Ancriviroc,ChEMBL Compound ID,CHEMBL78535,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,16.0,nM,=,,21.5,-1.344,,,[3H]-Ancriviroc,100.0,0.0,,0.0,,P51681,0.5794976374334038
88,16476734,ccr5_human,251,Y,A,TAK-779,ChEMBL Compound ID,CHEMBL1178786,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,30.2,nM,=,,43.0,-1.425,,,[3H]-TAK-779,100.0,0.0,,0.0,,P51681,0.5794976374334038
123,18096812,ccr5_human,251,Y,A,Aplaviroc,ChEMBL Compound ID,CHEMBL1255794,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,10.0,nM,=,,25.0,-2.5,,,[125I]-CCL5,63.7,0.0,,0.0,,P51681,0.5794976374334038
133,18096812,ccr5_human,251,Y,A,CCL5_HUMAN,UniProt entry code,P13501,Full agonist,K(d),Binding - Radioligand competition/displacement,0.6,nM,=,,0.2,3.0,,,[125I]-CCL5,63.7,0.0,,0.0,,P51681,0.5794976374334038
143,18096812,ccr5_human,251,Y,A,Maraviroc,ChEMBL Compound ID,CHEMBL1201187,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,9.0,nM,=,,113.0,-12.5,,,[125I]-CCL5,63.7,0.0,,0.0,,P51681,0.5794976374334038
153,18096812,ccr5_human,251,Y,A,TAK-220,ChEMBL Compound ID,CHEMBL207004,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,17.0,nM,=,,11.0,1.545,,,[125I]-CCL5,63.7,0.0,,0.0,,P51681,0.5794976374334038
163,18096812,ccr5_human,251,Y,A,TAK-779,ChEMBL Compound ID,CHEMBL1178786,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,4.0,nM,=,,11.0,-2.747,,,[125I]-CCL5,63.7,0.0,,0.0,,P51681,0.5794976374334038
173,18096812,ccr5_human,251,Y,A,Vicriviroc,ChEMBL Compound ID,CHEMBL82301,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,14.0,nM,=,,255.0,-18.182,,,[125I]-CCL5,63.7,0.0,,0.0,,P51681,0.5794976374334038
204,18590744,ccr5_human,251,Y,A,AK317,ChEMBL Compound ID,CHEMBL1170878,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,16.7,nM,>,,100.0,-5.988,,,[3H]-AK317,100.0,0.0,,0.0,,P51681,0.5794976374334038
236,18590744,ccr5_human,251,Y,A,AK530,SMILES,O=C([C@@H]1[C@@H](O)C2CCCCC2)N(CC#CC)C3(CCN(CC4=C(C)N(C5=CC=CC=C5)N=C4C)CC3)C(N1)=O,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,1.4,nM,>,,100.0,-71.429,,,[3H]-AK530,100.0,0.0,,0.0,,P51681,0.5794976374334038
269,21775441,ccr5_human,251,Y,A,CCL3_HUMAN,UniProt entry code,P10147,Full agonist,Single-point,Binding - Radioligand competition/displacement,100.0,%,=,,13.0,-7.692,,,[125I]-CCL3,10.0,0.0,,0.0,,P51681,0.5794976374334038
307,21775441,ccr5_human,251,Y,A,Maraviroc,ChEMBL Compound ID,CHEMBL1201187,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,1.05,nM,=,,0.0,7.7,,,[125I]-CCL3,10.0,0.0,,0.0,,P51681,0.5794976374334038
350,24628038,ccr5_human,251,Y,A,Aplaviroc,ChEMBL Compound ID,CHEMBL1255794,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,3.7,nM,=,,1.1,3.364,,,[3H]-Maraviroc,100.0,0.0,,0.0,,P51681,0.5794976374334038
364,24628038,ccr5_human,251,Y,A,Maraviroc,ChEMBL Compound ID,CHEMBL1201187,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,1.3,nM,=,,3.9,-3.003,,,[3H]-Maraviroc,100.0,0.0,,0.0,,P51681,0.5794976374334038
376,24628038,ccr5_human,251,Y,A,Vicriviroc,ChEMBL Compound ID,CHEMBL82301,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,7.1,nM,=,,2.9,2.448,,,[3H]-Maraviroc,100.0,0.0,,0.0,,P51681,0.5794976374334038
407,18590744/16476734,ccr5_human,251,Y,A,Aplaviroc,ChEMBL Compound ID,CHEMBL1255794,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,3.6,nM,=,,36.5,-10.101,,,[3H]-Aplaviroc,100.0,0.0,,0.0,,P51681,0.5794976374334038
65,16476734,ccr5_human,283,E,A,Ancriviroc,ChEMBL Compound ID,CHEMBL78535,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,16.0,nM,=,,200.0,-12.5,,,[3H]-Ancriviroc,100.0,0.0,,0.0,,P51681,0.4832672436979166
89,16476734,ccr5_human,283,E,A,TAK-779,ChEMBL Compound ID,CHEMBL1178786,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,30.2,nM,=,,200.0,-6.623,,,[3H]-TAK-779,100.0,0.0,,0.0,,P51681,0.4832672436979166
124,18096812,ccr5_human,283,E,A,Aplaviroc,ChEMBL Compound ID,CHEMBL1255794,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,10.0,nM,=,,603.0,-58.824,,,[125I]-CCL5,87.5,0.0,,0.0,,P51681,0.4832672436979166
134,18096812,ccr5_human,283,E,A,CCL5_HUMAN,UniProt entry code,P13501,Full agonist,K(d),Binding - Radioligand competition/displacement,0.6,nM,=,,13.0,-21.739,,,[125I]-CCL5,87.5,0.0,,0.0,,P51681,0.4832672436979166
154,18096812,ccr5_human,283,E,A,TAK-220,ChEMBL Compound ID,CHEMBL207004,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,17.0,nM,=,,11000.0,-500.0,,,[125I]-CCL5,87.5,0.0,,0.0,,P51681,0.4832672436979166
164,18096812,ccr5_human,283,E,A,TAK-779,ChEMBL Compound ID,CHEMBL1178786,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,4.0,nM,=,,43.0,-10.753,,,[125I]-CCL5,87.5,0.0,,0.0,,P51681,0.4832672436979166
174,18096812,ccr5_human,283,E,A,Vicriviroc,ChEMBL Compound ID,CHEMBL82301,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,14.0,nM,=,,9800.0,-1000.0,,,[125I]-CCL5,87.5,0.0,,0.0,,P51681,0.4832672436979166
205,18590744,ccr5_human,283,E,A,AK317,ChEMBL Compound ID,CHEMBL1170878,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,16.7,nM,>,,100.0,-5.988,,,[3H]-AK317,100.0,0.0,,0.0,,P51681,0.4832672436979166
237,18590744,ccr5_human,283,E,A,AK530,SMILES,O=C([C@@H]1[C@@H](O)C2CCCCC2)N(CC#CC)C3(CCN(CC4=C(C)N(C5=CC=CC=C5)N=C4C)CC3)C(N1)=O,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,1.4,nM,=,,19.1,-13.699,,,[3H]-AK530,100.0,0.0,,0.0,,P51681,0.4832672436979166
280,21775441,ccr5_human,283,E,A,CCL3_HUMAN,UniProt entry code,P10147,Full agonist,Single-point,Binding - Radioligand competition/displacement,100.0,%,=,,21.0,-4.762,,,[125I]-CCL3,70.0,0.0,,0.0,,P51681,0.4832672436979166
318,21775441,ccr5_human,283,E,A,Maraviroc,ChEMBL Compound ID,CHEMBL1201187,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,1.05,nM,>,,0.0,10.0,,,[125I]-CCL3,70.0,0.0,,0.0,,P51681,0.4832672436979166
351,24628038,ccr5_human,283,E,A,Aplaviroc,ChEMBL Compound ID,CHEMBL1255794,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,3.7,nM,=,,603.0,-166.667,,,[3H]-Maraviroc,100.0,0.0,,0.0,,P51681,0.4832672436979166
408,18590744/16476734,ccr5_human,283,E,A,Aplaviroc,ChEMBL Compound ID,CHEMBL1255794,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,3.6,nM,>,,200.0,-55.556,,,[3H]-Aplaviroc,100.0,0.0,,0.0,,P51681,0.4832672436979166
66,16476734,ccr5_human,287,M,A,Ancriviroc,ChEMBL Compound ID,CHEMBL78535,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,16.0,nM,=,,28.0,-1.751,,,[3H]-Ancriviroc,100.0,0.0,,0.0,,P51681,0.5856716243799505
90,16476734,ccr5_human,287,M,A,TAK-779,ChEMBL Compound ID,CHEMBL1178786,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,30.2,nM,=,,39.8,-1.318,,,[3H]-TAK-779,100.0,0.0,,0.0,,P51681,0.5856716243799505
125,18096812,ccr5_human,287,M,A,Aplaviroc,ChEMBL Compound ID,CHEMBL1255794,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,10.0,nM,=,,66.0,-6.579,,,[125I]-CCL5,112.20000000000002,0.0,,0.0,,P51681,0.5856716243799505
135,18096812,ccr5_human,287,M,A,CCL5_HUMAN,UniProt entry code,P13501,Full agonist,K(d),Binding - Radioligand competition/displacement,0.6,nM,=,,1.0,-1.667,,,[125I]-CCL5,112.20000000000002,0.0,,0.0,,P51681,0.5856716243799505
145,18096812,ccr5_human,287,M,A,Maraviroc,ChEMBL Compound ID,CHEMBL1201187,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,9.0,nM,=,,3.3,2.727,,,[125I]-CCL5,112.20000000000002,0.0,,0.0,,P51681,0.5856716243799505
155,18096812,ccr5_human,287,M,A,TAK-220,ChEMBL Compound ID,CHEMBL207004,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,17.0,nM,=,,29.0,-1.706,,,[125I]-CCL5,112.20000000000002,0.0,,0.0,,P51681,0.5856716243799505
165,18096812,ccr5_human,287,M,A,TAK-779,ChEMBL Compound ID,CHEMBL1178786,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,4.0,nM,=,,5.0,-1.25,,,[125I]-CCL5,112.20000000000002,0.0,,0.0,,P51681,0.5856716243799505
175,18096812,ccr5_human,287,M,A,Vicriviroc,ChEMBL Compound ID,CHEMBL82301,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,14.0,nM,=,,55.0,-3.922,,,[125I]-CCL5,112.20000000000002,0.0,,0.0,,P51681,0.5856716243799505
206,18590744,ccr5_human,287,M,A,AK317,ChEMBL Compound ID,CHEMBL1170878,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,16.7,nM,=,,16.1,1.037,,,[3H]-AK317,100.0,0.0,,0.0,,P51681,0.5856716243799505
238,18590744,ccr5_human,287,M,A,AK530,SMILES,O=C([C@@H]1[C@@H](O)C2CCCCC2)N(CC#CC)C3(CCN(CC4=C(C)N(C5=CC=CC=C5)N=C4C)CC3)C(N1)=O,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,1.4,nM,=,,2.4,-1.715,,,[3H]-AK530,100.0,0.0,,0.0,,P51681,0.5856716243799505
352,24628038,ccr5_human,287,M,A,Aplaviroc,ChEMBL Compound ID,CHEMBL1255794,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,3.7,nM,=,,4.5,-1.217,,,[3H]-Maraviroc,100.0,0.0,,0.0,,P51681,0.5856716243799505
366,24628038,ccr5_human,287,M,A,Maraviroc,ChEMBL Compound ID,CHEMBL1201187,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,1.3,nM,=,,0.56,2.321,,,[3H]-Maraviroc,100.0,0.0,,0.0,,P51681,0.5856716243799505
378,24628038,ccr5_human,287,M,A,Vicriviroc,ChEMBL Compound ID,CHEMBL82301,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,7.1,nM,=,,60.0,-8.475,,,[3H]-Maraviroc,100.0,0.0,,0.0,,P51681,0.5856716243799505
409,18590744/16476734,ccr5_human,287,M,A,Aplaviroc,ChEMBL Compound ID,CHEMBL1255794,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,3.6,nM,=,,6.8,-1.89,,,[3H]-Aplaviroc,100.0,0.0,,0.0,,P51681,0.5856716243799505
67,16476734,ccr5_human,287,M,E,Ancriviroc,ChEMBL Compound ID,CHEMBL78535,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,16.0,nM,=,,32.2,-2.012,,,[3H]-Ancriviroc,100.0,0.0,,0.0,,P51681,0.6285263119987656
91,16476734,ccr5_human,287,M,E,TAK-779,ChEMBL Compound ID,CHEMBL1178786,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,30.2,nM,=,,53.1,-1.757,,,[3H]-TAK-779,100.0,0.0,,0.0,,P51681,0.6285263119987656
207,18590744,ccr5_human,287,M,E,AK317,ChEMBL Compound ID,CHEMBL1170878,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,16.7,nM,=,,87.1,-5.208,,,[3H]-AK317,100.0,0.0,,0.0,,P51681,0.6285263119987656
239,18590744,ccr5_human,287,M,E,AK530,SMILES,O=C([C@@H]1[C@@H](O)C2CCCCC2)N(CC#CC)C3(CCN(CC4=C(C)N(C5=CC=CC=C5)N=C4C)CC3)C(N1)=O,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,1.4,nM,=,,62.7,-45.455,,,[3H]-AK530,100.0,0.0,,0.0,,P51681,0.6285263119987656
410,18590744/16476734,ccr5_human,287,M,E,Aplaviroc,ChEMBL Compound ID,CHEMBL1255794,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,3.6,nM,=,,14.8,-4.115,,,[3H]-Aplaviroc,100.0,0.0,,0.0,,P51681,0.6285263119987656
92,16920949,ccr5_human,9,I,T,CCL3_HUMAN,UniProt entry code,P10147,Full agonist,K(i),Binding - Radioligand competition/displacement,200.0,pM,=,,240.0,-1.2,,,[125I]-CCL3,100.0,0.0,,0.0,,P51681,0.3178448756367787
100,16920949,ccr5_human,9,I,T,CCL5_HUMAN,UniProt entry code,P13501,Full agonist,K(i),Binding - Radioligand competition/displacement,48.0,pM,=,,18.0,2.667,,,[125I]-CCL3,100.0,0.0,,0.0,,P51681,0.3178448756367787
108,16920949,ccr5_human,9,I,T,YM-370749,SMILES,Cl/C(Cl)=C(NC=O)/[P+](C1=CC=CC=C1)(C2=CC=CC=C2)C3=CC=CC=C3.O=Cl(=O)([O-])=O,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,2.7,ÂµM,=,,2.7,1.0,,,[125I]-CCL3,100.0,0.0,,0.0,,P51681,0.3178448756367787
93,16920949,ccr5_human,13,N,D,CCL3_HUMAN,UniProt entry code,P10147,Full agonist,K(i),Binding - Radioligand competition/displacement,200.0,pM,=,,210.0,-1.05,,,[125I]-CCL3,100.0,0.0,,0.0,,P51681,0.2606486415873009
101,16920949,ccr5_human,13,N,D,CCL5_HUMAN,UniProt entry code,P13501,Full agonist,K(i),Binding - Radioligand competition/displacement,48.0,pM,=,,52.0,-1.083,,,[125I]-CCL3,100.0,0.0,,0.0,,P51681,0.2606486415873009
109,16920949,ccr5_human,13,N,D,YM-370749,SMILES,Cl/C(Cl)=C(NC=O)/[P+](C1=CC=CC=C1)(C2=CC=CC=C2)C3=CC=CC=C3.O=Cl(=O)([O-])=O,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,2.7,ÂµM,=,,4.1,-1.517,,,[125I]-CCL3,100.0,0.0,,0.0,,P51681,0.2606486415873009
95,16920949,ccr5_human,52,I,V,CCL3_HUMAN,UniProt entry code,P10147,Full agonist,K(i),Binding - Radioligand competition/displacement,200.0,pM,=,,200.0,1.0,,,[125I]-CCL3,100.0,0.0,,0.0,,P51681,0.3734545956705702
103,16920949,ccr5_human,52,I,V,CCL5_HUMAN,UniProt entry code,P13501,Full agonist,K(i),Binding - Radioligand competition/displacement,48.0,pM,=,,24.0,2.0,,,[125I]-CCL3,100.0,0.0,,0.0,,P51681,0.3734545956705702
111,16920949,ccr5_human,52,I,V,YM-370749,SMILES,Cl/C(Cl)=C(NC=O)/[P+](C1=CC=CC=C1)(C2=CC=CC=C2)C3=CC=CC=C3.O=Cl(=O)([O-])=O,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,2.7,ÂµM,=,,2.1,1.286,,,[125I]-CCL3,100.0,0.0,,0.0,,P51681,0.3734545956705702
97,16920949,ccr5_human,130,V,I,CCL3_HUMAN,UniProt entry code,P10147,Full agonist,K(i),Binding - Radioligand competition/displacement,200.0,pM,=,,220.0,-1.1,,,[125I]-CCL3,100.0,0.0,,0.0,,P51681,0.3873091111458235
105,16920949,ccr5_human,130,V,I,CCL5_HUMAN,UniProt entry code,P13501,Full agonist,K(i),Binding - Radioligand competition/displacement,48.0,pM,=,,12.0,4.0,,,[125I]-CCL3,100.0,0.0,,0.0,,P51681,0.3873091111458235
113,16920949,ccr5_human,130,V,I,YM-370749,SMILES,Cl/C(Cl)=C(NC=O)/[P+](C1=CC=CC=C1)(C2=CC=CC=C2)C3=CC=CC=C3.O=Cl(=O)([O-])=O,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,2.7,ÂµM,=,,3.2,-1.185,,,[125I]-CCL3,100.0,0.0,,0.0,,P51681,0.3873091111458235
98,16920949,ccr5_human,171,K,R,CCL3_HUMAN,UniProt entry code,P10147,Full agonist,K(i),Binding - Radioligand competition/displacement,200.0,pM,=,,190.0,1.053,,,[125I]-CCL3,100.0,0.0,,0.0,,P51681,0.1837690926486614
106,16920949,ccr5_human,171,K,R,CCL5_HUMAN,UniProt entry code,P13501,Full agonist,K(i),Binding - Radioligand competition/displacement,48.0,pM,=,,42.0,1.143,,,[125I]-CCL3,100.0,0.0,,0.0,,P51681,0.1837690926486614
114,16920949,ccr5_human,171,K,R,YM-370749,SMILES,Cl/C(Cl)=C(NC=O)/[P+](C1=CC=CC=C1)(C2=CC=CC=C2)C3=CC=CC=C3.O=Cl(=O)([O-])=O,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,2.7,ÂµM,=,,4.6,-1.704,,,[125I]-CCL3,100.0,0.0,,0.0,,P51681,0.1837690926486614
99,16920949,ccr5_human,198,I,M,CCL3_HUMAN,UniProt entry code,P10147,Full agonist,K(i),Binding - Radioligand competition/displacement,200.0,pM,=,,220.0,-1.1,,,[125I]-CCL3,100.0,0.0,,0.0,,P51681,0.3551134120745932
107,16920949,ccr5_human,198,I,M,CCL5_HUMAN,UniProt entry code,P13501,Full agonist,K(i),Binding - Radioligand competition/displacement,48.0,pM,=,,49.0,-1.02,,,[125I]-CCL3,100.0,0.0,,0.0,,P51681,0.3551134120745932
115,16920949,ccr5_human,198,I,M,YM-370749,SMILES,Cl/C(Cl)=C(NC=O)/[P+](C1=CC=CC=C1)(C2=CC=CC=C2)C3=CC=CC=C3.O=Cl(=O)([O-])=O,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,2.7,ÂµM,=,,19.0,-7.042,,,[125I]-CCL3,100.0,0.0,,0.0,,P51681,0.3551134120745932
116,18096812,ccr5_human,86,W,A,Aplaviroc,ChEMBL Compound ID,CHEMBL1255794,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,10.0,nM,=,,387.0,-38.462,,,[125I]-CCL5,55.00000000000001,0.0,,0.0,,P51681,0.5387755118671032
126,18096812,ccr5_human,86,W,A,CCL5_HUMAN,UniProt entry code,P13501,Full agonist,K(d),Binding - Radioligand competition/displacement,0.6,nM,=,,3.0,-5.0,,,[125I]-CCL5,55.00000000000001,0.0,,0.0,,P51681,0.5387755118671032
136,18096812,ccr5_human,86,W,A,Maraviroc,ChEMBL Compound ID,CHEMBL1201187,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,9.0,nM,=,,90.0,-10.0,,,[125I]-CCL5,55.00000000000001,0.0,,0.0,,P51681,0.5387755118671032
146,18096812,ccr5_human,86,W,A,TAK-220,ChEMBL Compound ID,CHEMBL207004,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,17.0,nM,=,,30.0,-1.764,,,[125I]-CCL5,55.00000000000001,0.0,,0.0,,P51681,0.5387755118671032
156,18096812,ccr5_human,86,W,A,TAK-779,ChEMBL Compound ID,CHEMBL1178786,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,4.0,nM,=,,211.0,-52.632,,,[125I]-CCL5,55.00000000000001,0.0,,0.0,,P51681,0.5387755118671032
166,18096812,ccr5_human,86,W,A,Vicriviroc,ChEMBL Compound ID,CHEMBL82301,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,14.0,nM,=,,91.0,-6.494,,,[125I]-CCL5,55.00000000000001,0.0,,0.0,,P51681,0.5387755118671032
242,21775441,ccr5_human,86,W,A,CCL3_HUMAN,UniProt entry code,P10147,Full agonist,Single-point,Binding - Radioligand competition/displacement,100.0,%,=,,40.0,-2.5,,,[125I]-CCL3,117.0,0.0,,0.0,,P51681,0.5387755118671032
285,21775441,ccr5_human,86,W,A,Maraviroc,ChEMBL Compound ID,CHEMBL1201187,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,1.05,nM,=,,0.0,42.9,,,[125I]-CCL3,117.0,0.0,,0.0,,P51681,0.5387755118671032
342,24628038,ccr5_human,86,W,A,Aplaviroc,ChEMBL Compound ID,CHEMBL1255794,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,3.7,nM,=,,1150.0,-333.333,,,[3H]-Maraviroc,100.0,0.0,,0.0,,P51681,0.5387755118671032
354,24628038,ccr5_human,86,W,A,Maraviroc,ChEMBL Compound ID,CHEMBL1201187,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,1.3,nM,=,,16.0,-12.346,,,[3H]-Maraviroc,100.0,0.0,,0.0,,P51681,0.5387755118671032
368,24628038,ccr5_human,86,W,A,Vicriviroc,ChEMBL Compound ID,CHEMBL82301,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,7.1,nM,=,,4400.0,-500.0,,,[3H]-Maraviroc,100.0,0.0,,0.0,,P51681,0.5387755118671032
117,18096812,ccr5_human,94,W,A,Aplaviroc,ChEMBL Compound ID,CHEMBL1255794,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,10.0,nM,=,,33.0,-3.3,,,[125I]-CCL5,119.0,0.0,,0.0,,P51681,0.6484303447233017
137,18096812,ccr5_human,94,W,A,Maraviroc,ChEMBL Compound ID,CHEMBL1201187,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,9.0,nM,=,,10.0,-1.111,,,[125I]-CCL5,119.0,0.0,,0.0,,P51681,0.6484303447233017
147,18096812,ccr5_human,94,W,A,TAK-220,ChEMBL Compound ID,CHEMBL207004,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,17.0,nM,=,,24.0,-1.412,,,[125I]-CCL5,119.0,0.0,,0.0,,P51681,0.6484303447233017
157,18096812,ccr5_human,94,W,A,TAK-779,ChEMBL Compound ID,CHEMBL1178786,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,4.0,nM,=,,11.0,-2.747,,,[125I]-CCL5,119.0,0.0,,0.0,,P51681,0.6484303447233017
167,18096812,ccr5_human,94,W,A,Vicriviroc,ChEMBL Compound ID,CHEMBL82301,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,14.0,nM,=,,30.0,-2.141,,,[125I]-CCL5,119.0,0.0,,0.0,,P51681,0.6484303447233017
243,21775441,ccr5_human,94,W,A,CCL3_HUMAN,UniProt entry code,P10147,Full agonist,Single-point,Binding - Radioligand competition/displacement,100.0,%,<,,10.0,-10.0,,,[125I]-CCL3,140.0,0.0,,0.0,,P51681,0.6484303447233017
320,21775441,ccr5_human,94,W,A,Maraviroc,ChEMBL Compound ID,CHEMBL1201187,Antagonist (neutral/silent),K(d),Binding - Radioligand kinetics (association/dissociation),0.69,nM,=,,0.0,-1.266,,,[3H]-Maraviroc,140.0,0.0,,0.0,,P51681,0.6484303447233017
343,24628038,ccr5_human,94,W,A,Aplaviroc,ChEMBL Compound ID,CHEMBL1255794,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,3.7,nM,=,,100.0,-27.027,,,[3H]-Maraviroc,100.0,0.0,,0.0,,P51681,0.6484303447233017
355,24628038,ccr5_human,94,W,A,Maraviroc,ChEMBL Compound ID,CHEMBL1201187,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,1.3,nM,=,,0.6,2.167,,,[3H]-Maraviroc,100.0,0.0,,0.0,,P51681,0.6484303447233017
369,24628038,ccr5_human,94,W,A,Vicriviroc,ChEMBL Compound ID,CHEMBL82301,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,7.1,nM,=,,3.5,2.029,,,[3H]-Maraviroc,100.0,0.0,,0.0,,P51681,0.6484303447233017
119,18096812,ccr5_human,109,F,A,Aplaviroc,ChEMBL Compound ID,CHEMBL1255794,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,10.0,nM,=,,1577.0,-166.667,,,[125I]-CCL5,59.8,0.0,,0.0,,P51681,0.5248867022517058
129,18096812,ccr5_human,109,F,A,CCL5_HUMAN,UniProt entry code,P13501,Full agonist,K(d),Binding - Radioligand competition/displacement,0.6,nM,=,,6.0,-10.0,,,[125I]-CCL5,59.8,0.0,,0.0,,P51681,0.5248867022517058
139,18096812,ccr5_human,109,F,A,Maraviroc,ChEMBL Compound ID,CHEMBL1201187,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,9.0,nM,=,,7.9,1.139,,,[125I]-CCL5,59.8,0.0,,0.0,,P51681,0.5248867022517058
149,18096812,ccr5_human,109,F,A,TAK-220,ChEMBL Compound ID,CHEMBL207004,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,17.0,nM,=,,5.0,3.4,,,[125I]-CCL5,59.8,0.0,,0.0,,P51681,0.5248867022517058
159,18096812,ccr5_human,109,F,A,TAK-779,ChEMBL Compound ID,CHEMBL1178786,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,4.0,nM,=,,9.0,-2.252,,,[125I]-CCL5,59.8,0.0,,0.0,,P51681,0.5248867022517058
169,18096812,ccr5_human,109,F,A,Vicriviroc,ChEMBL Compound ID,CHEMBL82301,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,14.0,nM,=,,26.0,-1.859,,,[125I]-CCL5,59.8,0.0,,0.0,,P51681,0.5248867022517058
182,18590744,ccr5_human,109,F,A,AK317,ChEMBL Compound ID,CHEMBL1170878,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,16.7,nM,>,,100.0,-5.988,,,[3H]-AK317,100.0,0.0,,0.0,,P51681,0.5248867022517058
214,18590744,ccr5_human,109,F,A,AK530,SMILES,O=C([C@@H]1[C@@H](O)C2CCCCC2)N(CC#CC)C3(CCN(CC4=C(C)N(C5=CC=CC=C5)N=C4C)CC3)C(N1)=O,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,1.4,nM,>,,100.0,-71.429,,,[3H]-AK530,100.0,0.0,,0.0,,P51681,0.5248867022517058
250,21775441,ccr5_human,109,F,A,CCL3_HUMAN,UniProt entry code,P10147,Full agonist,Single-point,Binding - Radioligand competition/displacement,100.0,%,=,,159.0,1.59,,,[125I]-CCL3,91.0,0.0,,0.0,,P51681,0.5248867022517058
291,21775441,ccr5_human,109,F,A,Maraviroc,ChEMBL Compound ID,CHEMBL1201187,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,1.05,nM,=,,0.0,1.4,,,[125I]-CCL3,91.0,0.0,,0.0,,P51681,0.5248867022517058
325,21775441,ccr5_human,109,F,A,Maraviroc,ChEMBL Compound ID,CHEMBL1201187,Antagonist (neutral/silent),K(d),Binding - Radioligand kinetics (association/dissociation),0.69,nM,=,,0.0,1.43,,,[3H]-Maraviroc,91.0,0.0,,0.0,,P51681,0.5248867022517058
357,24628038,ccr5_human,109,F,A,Maraviroc,ChEMBL Compound ID,CHEMBL1201187,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,1.3,nM,=,,0.66,1.97,,,[3H]-Maraviroc,100.0,0.0,,0.0,,P51681,0.5248867022517058
371,24628038,ccr5_human,109,F,A,Vicriviroc,ChEMBL Compound ID,CHEMBL82301,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,7.1,nM,=,,40.0,-5.65,,,[3H]-Maraviroc,100.0,0.0,,0.0,,P51681,0.5248867022517058
385,18590744/16476734,ccr5_human,109,F,A,Aplaviroc,ChEMBL Compound ID,CHEMBL1255794,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,3.6,nM,>,,100.0,-27.778,,,[3H]-Aplaviroc,100.0,0.0,,0.0,,P51681,0.5248867022517058
120,18096812,ccr5_human,195,T,A,Aplaviroc,ChEMBL Compound ID,CHEMBL1255794,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,10.0,nM,=,,122.0,-12.195,,,[125I]-CCL5,71.1,0.0,,0.0,,P51681,0.3629286906654186
130,18096812,ccr5_human,195,T,A,CCL5_HUMAN,UniProt entry code,P13501,Full agonist,K(d),Binding - Radioligand competition/displacement,0.6,nM,=,,0.7,-1.167,,,[125I]-CCL5,71.1,0.0,,0.0,,P51681,0.3629286906654186
140,18096812,ccr5_human,195,T,A,Maraviroc,ChEMBL Compound ID,CHEMBL1201187,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,9.0,nM,=,,14.0,-1.555,,,[125I]-CCL5,71.1,0.0,,0.0,,P51681,0.3629286906654186
150,18096812,ccr5_human,195,T,A,TAK-220,ChEMBL Compound ID,CHEMBL207004,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,17.0,nM,=,,5.0,3.4,,,[125I]-CCL5,71.1,0.0,,0.0,,P51681,0.3629286906654186
160,18096812,ccr5_human,195,T,A,TAK-779,ChEMBL Compound ID,CHEMBL1178786,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,4.0,nM,=,,20.0,-5.0,,,[125I]-CCL5,71.1,0.0,,0.0,,P51681,0.3629286906654186
170,18096812,ccr5_human,195,T,A,Vicriviroc,ChEMBL Compound ID,CHEMBL82301,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,14.0,nM,=,,22.0,-1.572,,,[125I]-CCL5,71.1,0.0,,0.0,,P51681,0.3629286906654186
198,18590744,ccr5_human,195,T,A,AK317,ChEMBL Compound ID,CHEMBL1170878,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,16.7,nM,=,,14.7,1.136,,,[3H]-AK317,100.0,0.0,,0.0,,P51681,0.3629286906654186
230,18590744,ccr5_human,195,T,A,AK530,SMILES,O=C([C@@H]1[C@@H](O)C2CCCCC2)N(CC#CC)C3(CCN(CC4=C(C)N(C5=CC=CC=C5)N=C4C)CC3)C(N1)=O,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,1.4,nM,=,,5.6,-4.0,,,[3H]-AK530,100.0,0.0,,0.0,,P51681,0.3629286906654186
346,24628038,ccr5_human,195,T,A,Aplaviroc,ChEMBL Compound ID,CHEMBL1255794,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,3.7,nM,=,,4.5,-1.217,,,[3H]-Maraviroc,100.0,0.0,,0.0,,P51681,0.3629286906654186
360,24628038,ccr5_human,195,T,A,Maraviroc,ChEMBL Compound ID,CHEMBL1201187,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,1.3,nM,=,,2.1,-1.616,,,[3H]-Maraviroc,100.0,0.0,,0.0,,P51681,0.3629286906654186
372,24628038,ccr5_human,195,T,A,Vicriviroc,ChEMBL Compound ID,CHEMBL82301,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,7.1,nM,=,,11.0,-1.55,,,[3H]-Maraviroc,100.0,0.0,,0.0,,P51681,0.3629286906654186
401,18590744/16476734,ccr5_human,195,T,A,Aplaviroc,ChEMBL Compound ID,CHEMBL1255794,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,3.6,nM,=,,48.1,-13.333,,,[3H]-Aplaviroc,100.0,0.0,,0.0,,P51681,0.3629286906654186
122,18096812,ccr5_human,248,W,A,Aplaviroc,ChEMBL Compound ID,CHEMBL1255794,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,10.0,nM,=,,7.0,1.429,,,[125I]-CCL5,98.7,0.0,,0.0,,P51681,0.783915331677387
132,18096812,ccr5_human,248,W,A,CCL5_HUMAN,UniProt entry code,P13501,Full agonist,K(d),Binding - Radioligand competition/displacement,0.6,nM,=,,0.6,1.0,,,[125I]-CCL5,98.7,0.0,,0.0,,P51681,0.783915331677387
142,18096812,ccr5_human,248,W,A,Maraviroc,ChEMBL Compound ID,CHEMBL1201187,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,9.0,nM,=,,13.0,-1.445,,,[125I]-CCL5,98.7,0.0,,0.0,,P51681,0.783915331677387
152,18096812,ccr5_human,248,W,A,TAK-220,ChEMBL Compound ID,CHEMBL207004,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,17.0,nM,=,,4.0,4.25,,,[125I]-CCL5,98.7,0.0,,0.0,,P51681,0.783915331677387
162,18096812,ccr5_human,248,W,A,TAK-779,ChEMBL Compound ID,CHEMBL1178786,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,4.0,nM,=,,28.0,-6.993,,,[125I]-CCL5,98.7,0.0,,0.0,,P51681,0.783915331677387
172,18096812,ccr5_human,248,W,A,Vicriviroc,ChEMBL Compound ID,CHEMBL82301,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,14.0,nM,=,,20.0,-1.429,,,[125I]-CCL5,98.7,0.0,,0.0,,P51681,0.783915331677387
203,18590744,ccr5_human,248,W,A,AK317,ChEMBL Compound ID,CHEMBL1170878,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,16.7,nM,>,,100.0,-5.988,,,[3H]-AK317,100.0,0.0,,0.0,,P51681,0.783915331677387
235,18590744,ccr5_human,248,W,A,AK530,SMILES,O=C([C@@H]1[C@@H](O)C2CCCCC2)N(CC#CC)C3(CCN(CC4=C(C)N(C5=CC=CC=C5)N=C4C)CC3)C(N1)=O,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,1.4,nM,=,,43.4,-31.25,,,[3H]-AK530,100.0,0.0,,0.0,,P51681,0.783915331677387
268,21775441,ccr5_human,248,W,A,CCL3_HUMAN,UniProt entry code,P10147,Full agonist,Single-point,Binding - Radioligand competition/displacement,100.0,%,<,,10.0,-10.0,,,[125I]-CCL3,3.6,0.0,,0.0,,P51681,0.783915331677387
349,24628038,ccr5_human,248,W,A,Aplaviroc,ChEMBL Compound ID,CHEMBL1255794,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,3.7,nM,=,,3.1,1.194,,,[3H]-Maraviroc,100.0,0.0,,0.0,,P51681,0.783915331677387
363,24628038,ccr5_human,248,W,A,Maraviroc,ChEMBL Compound ID,CHEMBL1201187,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,1.3,nM,=,,0.51,2.549,,,[3H]-Maraviroc,100.0,0.0,,0.0,,P51681,0.783915331677387
375,24628038,ccr5_human,248,W,A,Vicriviroc,ChEMBL Compound ID,CHEMBL82301,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,7.1,nM,=,,5.1,1.392,,,[3H]-Maraviroc,100.0,0.0,,0.0,,P51681,0.783915331677387
406,18590744/16476734,ccr5_human,248,W,A,Aplaviroc,ChEMBL Compound ID,CHEMBL1255794,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,3.6,nM,=,,29.8,-8.264,,,[3H]-Aplaviroc,100.0,0.0,,0.0,,P51681,0.783915331677387
178,18590744,ccr5_human,84,P,H,AK317,ChEMBL Compound ID,CHEMBL1170878,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,16.7,nM,>,,100.0,-5.988,,,[3H]-AK317,100.0,0.0,,0.0,,P51681,0.6043851637101261
210,18590744,ccr5_human,84,P,H,AK530,SMILES,O=C([C@@H]1[C@@H](O)C2CCCCC2)N(CC#CC)C3(CCN(CC4=C(C)N(C5=CC=CC=C5)N=C4C)CC3)C(N1)=O,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,1.4,nM,=,,37.3,-26.316,,,[3H]-AK530,100.0,0.0,,0.0,,P51681,0.6043851637101261
381,18590744/16476734,ccr5_human,84,P,H,Aplaviroc,ChEMBL Compound ID,CHEMBL1255794,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,3.6,nM,>,,100.0,-27.778,,,[3H]-Aplaviroc,100.0,0.0,,0.0,,P51681,0.6043851637101261
179,18590744,ccr5_human,101,C,A,AK317,ChEMBL Compound ID,CHEMBL1170878,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,16.7,nM,>,,100.0,-5.988,,,[3H]-AK317,100.0,0.0,,0.0,,P51681,0.749747474085512
211,18590744,ccr5_human,101,C,A,AK530,SMILES,O=C([C@@H]1[C@@H](O)C2CCCCC2)N(CC#CC)C3(CCN(CC4=C(C)N(C5=CC=CC=C5)N=C4C)CC3)C(N1)=O,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,1.4,nM,>,,100.0,-71.429,,,[3H]-AK530,100.0,0.0,,0.0,,P51681,0.749747474085512
382,18590744/16476734,ccr5_human,101,C,A,Aplaviroc,ChEMBL Compound ID,CHEMBL1255794,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,3.6,nM,>,,100.0,-27.778,,,[3H]-Aplaviroc,100.0,0.0,,0.0,,P51681,0.749747474085512
199,18590744,ccr5_human,195,T,P,AK317,ChEMBL Compound ID,CHEMBL1170878,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,16.7,nM,>,,100.0,-5.988,,,[3H]-AK317,100.0,0.0,,0.0,,P51681,0.4054163720332518
231,18590744,ccr5_human,195,T,P,AK530,SMILES,O=C([C@@H]1[C@@H](O)C2CCCCC2)N(CC#CC)C3(CCN(CC4=C(C)N(C5=CC=CC=C5)N=C4C)CC3)C(N1)=O,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,1.4,nM,>,,100.0,-71.429,,,[3H]-AK530,100.0,0.0,,0.0,,P51681,0.4054163720332518
402,18590744/16476734,ccr5_human,195,T,P,Aplaviroc,ChEMBL Compound ID,CHEMBL1255794,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,3.6,nM,>,,100.0,-27.778,,,[3H]-Aplaviroc,100.0,0.0,,0.0,,P51681,0.4054163720332518
200,18590744,ccr5_human,195,T,S,AK317,ChEMBL Compound ID,CHEMBL1170878,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,16.7,nM,>,,100.0,-5.988,,,[3H]-AK317,100.0,0.0,,0.0,,P51681,0.3224909126699359
232,18590744,ccr5_human,195,T,S,AK530,SMILES,O=C([C@@H]1[C@@H](O)C2CCCCC2)N(CC#CC)C3(CCN(CC4=C(C)N(C5=CC=CC=C5)N=C4C)CC3)C(N1)=O,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,1.4,nM,>,,100.0,-71.429,,,[3H]-AK530,100.0,0.0,,0.0,,P51681,0.3224909126699359
403,18590744/16476734,ccr5_human,195,T,S,Aplaviroc,ChEMBL Compound ID,CHEMBL1255794,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,3.6,nM,>,,100.0,-27.778,,,[3H]-Aplaviroc,100.0,0.0,,0.0,,P51681,0.3224909126699359
241,21775441,ccr5_human,37,Y,F,CCL3_HUMAN,UniProt entry code,P10147,Full agonist,Single-point,Binding - Radioligand competition/displacement,100.0,%,=,,78.0,-1.282,,,[125I]-CCL3,86.0,0.0,,0.0,,P51681,0.3759313824822946
284,21775441,ccr5_human,37,Y,F,Maraviroc,ChEMBL Compound ID,CHEMBL1201187,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,1.05,nM,=,,0.0,-1.111,,,[125I]-CCL3,86.0,0.0,,0.0,,P51681,0.3759313824822946
244,21775441,ccr5_human,94,W,M,CCL3_HUMAN,UniProt entry code,P10147,Full agonist,Single-point,Binding - Radioligand competition/displacement,100.0,%,<,,10.0,-10.0,,,[125I]-CCL3,103.0,0.0,,0.0,,P51681,0.5627205680551958
321,21775441,ccr5_human,94,W,M,Maraviroc,ChEMBL Compound ID,CHEMBL1201187,Antagonist (neutral/silent),K(d),Binding - Radioligand kinetics (association/dissociation),0.69,nM,=,,0.0,1.18,,,[3H]-Maraviroc,103.0,0.0,,0.0,,P51681,0.5627205680551958
245,21775441,ccr5_human,100,M,A,CCL3_HUMAN,UniProt entry code,P10147,Full agonist,Single-point,Binding - Radioligand competition/displacement,100.0,%,=,,95.0,-1.053,,,[125I]-CCL3,114.0,0.0,,0.0,,P51681,0.3432671931481678
286,21775441,ccr5_human,100,M,A,Maraviroc,ChEMBL Compound ID,CHEMBL1201187,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,1.05,nM,=,,0.0,1.0,,,[125I]-CCL3,114.0,0.0,,0.0,,P51681,0.3432671931481678
246,21775441,ccr5_human,100,M,T,CCL3_HUMAN,UniProt entry code,P10147,Full agonist,Single-point,Binding - Radioligand competition/displacement,100.0,%,=,,42.0,-2.381,,,[125I]-CCL3,79.0,0.0,,0.0,,P51681,0.3432671931481678
287,21775441,ccr5_human,100,M,T,Maraviroc,ChEMBL Compound ID,CHEMBL1201187,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,1.05,nM,=,,0.0,1.3,,,[125I]-CCL3,79.0,0.0,,0.0,,P51681,0.3432671931481678
322,21775441,ccr5_human,100,M,T,Maraviroc,ChEMBL Compound ID,CHEMBL1201187,Antagonist (neutral/silent),K(d),Binding - Radioligand kinetics (association/dissociation),0.69,nM,=,,0.0,-1.587,,,[3H]-Maraviroc,79.0,0.0,,0.0,,P51681,0.3432671931481678
247,21775441,ccr5_human,104,L,A,CCL3_HUMAN,UniProt entry code,P10147,Full agonist,Single-point,Binding - Radioligand competition/displacement,100.0,%,=,,81.0,-1.235,,,[125I]-CCL3,131.0,0.0,,0.0,,P51681,0.4928440503733342
288,21775441,ccr5_human,104,L,A,Maraviroc,ChEMBL Compound ID,CHEMBL1201187,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,1.05,nM,=,,0.0,-1.111,,,[125I]-CCL3,131.0,0.0,,0.0,,P51681,0.4928440503733342
323,21775441,ccr5_human,104,L,A,Maraviroc,ChEMBL Compound ID,CHEMBL1201187,Antagonist (neutral/silent),K(d),Binding - Radioligand kinetics (association/dissociation),0.69,nM,=,,0.0,1.07,,,[3H]-Maraviroc,131.0,0.0,,0.0,,P51681,0.4928440503733342
252,21775441,ccr5_human,112,F,A,CCL3_HUMAN,UniProt entry code,P10147,Full agonist,Single-point,Binding - Radioligand competition/displacement,100.0,%,=,,23.0,-4.348,,,[125I]-CCL3,21.0,0.0,,0.0,,P51681,0.6292929911018993
293,21775441,ccr5_human,112,F,A,Maraviroc,ChEMBL Compound ID,CHEMBL1201187,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,1.05,nM,=,,0.0,-2.5,,,[125I]-CCL3,21.0,0.0,,0.0,,P51681,0.6292929911018993
254,21775441,ccr5_human,145,G,A,CCL3_HUMAN,UniProt entry code,P10147,Full agonist,Single-point,Binding - Radioligand competition/displacement,100.0,%,=,,103.0,1.03,,,[125I]-CCL3,137.0,0.0,,0.0,,P51681,0.5069192750946614
295,21775441,ccr5_human,145,G,A,Maraviroc,ChEMBL Compound ID,CHEMBL1201187,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,1.05,nM,=,,0.0,1.3,,,[125I]-CCL3,137.0,0.0,,0.0,,P51681,0.5069192750946614
326,21775441,ccr5_human,145,G,A,Maraviroc,ChEMBL Compound ID,CHEMBL1201187,Antagonist (neutral/silent),K(d),Binding - Radioligand kinetics (association/dissociation),0.69,nM,=,,0.0,-1.667,,,[3H]-Maraviroc,145.0,0.0,,0.0,,P51681,0.5069192750946614
256,21775441,ccr5_human,177,T,A,CCL3_HUMAN,UniProt entry code,P10147,Full agonist,Single-point,Binding - Radioligand competition/displacement,100.0,%,=,,13.0,-7.692,,,[125I]-CCL3,92.0,0.0,,0.0,,P51681,0.2721120323346385
297,21775441,ccr5_human,177,T,A,Maraviroc,ChEMBL Compound ID,CHEMBL1201187,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,1.05,nM,=,,0.0,1.4,,,[125I]-CCL3,92.0,0.0,,0.0,,P51681,0.2721120323346385
327,21775441,ccr5_human,177,T,A,Maraviroc,ChEMBL Compound ID,CHEMBL1201187,Antagonist (neutral/silent),K(d),Binding - Radioligand kinetics (association/dissociation),0.69,nM,=,,0.0,1.7,,,[3H]-Maraviroc,92.0,0.0,,0.0,,P51681,0.2721120323346385
358,24628038,ccr5_human,177,T,A,Maraviroc,ChEMBL Compound ID,CHEMBL1201187,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,1.3,nM,=,,3.7,-2.849,,,[3H]-Maraviroc,100.0,0.0,,0.0,,P51681,0.2721120323346385
260,21775441,ccr5_human,180,S,P,CCL3_HUMAN,UniProt entry code,P10147,Full agonist,Single-point,Binding - Radioligand competition/displacement,100.0,%,=,,58.0,-1.724,,,[125I]-CCL3,85.0,0.0,,0.0,,P51681,0.396370036199068
300,21775441,ccr5_human,180,S,P,Maraviroc,ChEMBL Compound ID,CHEMBL1201187,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,1.05,nM,=,,0.0,-1.111,,,[125I]-CCL3,85.0,0.0,,0.0,,P51681,0.396370036199068
330,21775441,ccr5_human,180,S,P,Maraviroc,ChEMBL Compound ID,CHEMBL1201187,Antagonist (neutral/silent),K(d),Binding - Radioligand kinetics (association/dissociation),0.69,nM,=,,0.0,-1.786,,,[3H]-Maraviroc,85.0,0.0,,0.0,,P51681,0.396370036199068
261,21775441,ccr5_human,184,Y,A,CCL3_HUMAN,UniProt entry code,P10147,Full agonist,Single-point,Binding - Radioligand competition/displacement,100.0,%,=,,33.0,-3.03,,,[125I]-CCL3,160.0,0.0,,0.0,,P51681,0.3072130860793581
301,21775441,ccr5_human,184,Y,A,Maraviroc,ChEMBL Compound ID,CHEMBL1201187,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,1.05,nM,=,,0.0,2.1,,,[125I]-CCL3,160.0,0.0,,0.0,,P51681,0.3072130860793581
262,21775441,ccr5_human,187,Y,A,CCL3_HUMAN,UniProt entry code,P10147,Full agonist,Single-point,Binding - Radioligand competition/displacement,100.0,%,<,,10.0,-10.0,,,[125I]-CCL3,88.0,0.0,,0.0,,P51681,0.3093319271025093
331,21775441,ccr5_human,187,Y,A,Maraviroc,ChEMBL Compound ID,CHEMBL1201187,Antagonist (neutral/silent),K(d),Binding - Radioligand kinetics (association/dissociation),0.69,nM,=,,0.0,1.19,,,[3H]-Maraviroc,88.0,0.0,,0.0,,P51681,0.3093319271025093
263,21775441,ccr5_human,189,F,A,CCL3_HUMAN,UniProt entry code,P10147,Full agonist,Single-point,Binding - Radioligand competition/displacement,100.0,%,=,,71.0,-1.408,,,[125I]-CCL3,57.0,0.0,,0.0,,P51681,0.3050430187062208
302,21775441,ccr5_human,189,F,A,Maraviroc,ChEMBL Compound ID,CHEMBL1201187,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,1.05,nM,=,,0.0,1.5,,,[125I]-CCL3,57.0,0.0,,0.0,,P51681,0.3050430187062208
264,21775441,ccr5_human,190,W,A,CCL3_HUMAN,UniProt entry code,P10147,Full agonist,Single-point,Binding - Radioligand competition/displacement,100.0,%,=,,16.0,-6.25,,,[125I]-CCL3,22.0,0.0,,0.0,,P51681,0.4072855391940909
303,21775441,ccr5_human,190,W,A,Maraviroc,ChEMBL Compound ID,CHEMBL1201187,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,1.05,nM,=,,0.0,1.6,,,[125I]-CCL3,22.0,0.0,,0.0,,P51681,0.4072855391940909
265,21775441,ccr5_human,194,Q,A,CCL3_HUMAN,UniProt entry code,P10147,Full agonist,Single-point,Binding - Radioligand competition/displacement,100.0,%,=,,84.0,-1.19,,,[125I]-CCL3,105.0,0.0,,0.0,,P51681,0.3616952962951046
304,21775441,ccr5_human,194,Q,A,Maraviroc,ChEMBL Compound ID,CHEMBL1201187,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,1.05,nM,=,,0.0,-1.667,,,[125I]-CCL3,105.0,0.0,,0.0,,P51681,0.3616952962951046
332,21775441,ccr5_human,194,Q,A,Maraviroc,ChEMBL Compound ID,CHEMBL1201187,Antagonist (neutral/silent),K(d),Binding - Radioligand kinetics (association/dissociation),0.69,nM,=,,0.0,-2.326,,,[3H]-Maraviroc,105.0,0.0,,0.0,,P51681,0.3616952962951046
270,21775441,ccr5_human,251,Y,F,CCL3_HUMAN,UniProt entry code,P10147,Full agonist,Single-point,Binding - Radioligand competition/displacement,100.0,%,=,,88.0,-1.136,,,[125I]-CCL3,68.0,0.0,,0.0,,P51681,0.3590741839710131
308,21775441,ccr5_human,251,Y,F,Maraviroc,ChEMBL Compound ID,CHEMBL1201187,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,1.05,nM,=,,0.0,3.3,,,[125I]-CCL3,68.0,0.0,,0.0,,P51681,0.3590741839710131
271,21775441,ccr5_human,251,Y,I,CCL3_HUMAN,UniProt entry code,P10147,Full agonist,Single-point,Binding - Radioligand competition/displacement,100.0,%,=,,14.0,-7.143,,,[125I]-CCL3,4.8,0.0,,0.0,,P51681,0.5351214721554745
309,21775441,ccr5_human,251,Y,I,Maraviroc,ChEMBL Compound ID,CHEMBL1201187,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,1.05,nM,=,,0.0,19.9,,,[125I]-CCL3,4.8,0.0,,0.0,,P51681,0.5351214721554745
273,21775441,ccr5_human,252,N,I,CCL3_HUMAN,UniProt entry code,P10147,Full agonist,Single-point,Binding - Radioligand competition/displacement,100.0,%,=,,16.0,-6.25,,,[125I]-CCL3,141.0,0.0,,0.0,,P51681,0.6373018312117795
311,21775441,ccr5_human,252,N,I,Maraviroc,ChEMBL Compound ID,CHEMBL1201187,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,1.05,nM,=,,0.0,1.2,,,[125I]-CCL3,141.0,0.0,,0.0,,P51681,0.6373018312117795
335,21775441,ccr5_human,252,N,I,Maraviroc,ChEMBL Compound ID,CHEMBL1201187,Antagonist (neutral/silent),K(d),Binding - Radioligand kinetics (association/dissociation),0.69,nM,=,,0.0,-2.273,,,[3H]-Maraviroc,141.0,0.0,,0.0,,P51681,0.6373018312117795
274,21775441,ccr5_human,255,L,A,CCL3_HUMAN,UniProt entry code,P10147,Full agonist,Single-point,Binding - Radioligand competition/displacement,100.0,%,=,,49.0,-2.041,,,[125I]-CCL3,39.0,0.0,,0.0,,P51681,0.4600003080488494
312,21775441,ccr5_human,255,L,A,Maraviroc,ChEMBL Compound ID,CHEMBL1201187,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,1.05,nM,=,,0.0,-1.111,,,[125I]-CCL3,39.0,0.0,,0.0,,P51681,0.4600003080488494
336,21775441,ccr5_human,255,L,A,Maraviroc,ChEMBL Compound ID,CHEMBL1201187,Antagonist (neutral/silent),K(d),Binding - Radioligand kinetics (association/dissociation),0.69,nM,=,,0.0,2.3,,,[3H]-Maraviroc,39.0,0.0,,0.0,,P51681,0.4600003080488494
276,21775441,ccr5_human,258,N,M,CCL3_HUMAN,UniProt entry code,P10147,Full agonist,Single-point,Binding - Radioligand competition/displacement,100.0,%,=,,71.0,-1.408,,,[125I]-CCL3,85.0,0.0,,0.0,,P51681,0.3982713384975122
314,21775441,ccr5_human,258,N,M,Maraviroc,ChEMBL Compound ID,CHEMBL1201187,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,1.05,nM,=,,0.0,-1.429,,,[125I]-CCL3,85.0,0.0,,0.0,,P51681,0.3982713384975122
338,21775441,ccr5_human,258,N,M,Maraviroc,ChEMBL Compound ID,CHEMBL1201187,Antagonist (neutral/silent),K(d),Binding - Radioligand kinetics (association/dissociation),0.69,nM,=,,0.0,1.27,,,[3H]-Maraviroc,85.0,0.0,,0.0,,P51681,0.3982713384975122
278,21775441,ccr5_human,260,F,A,CCL3_HUMAN,UniProt entry code,P10147,Full agonist,Single-point,Binding - Radioligand competition/displacement,100.0,%,=,,46.0,-2.174,,,[125I]-CCL3,40.0,0.0,,0.0,,P51681,0.2944470813269112
316,21775441,ccr5_human,260,F,A,Maraviroc,ChEMBL Compound ID,CHEMBL1201187,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,1.05,nM,=,,0.0,-1.25,,,[125I]-CCL3,40.0,0.0,,0.0,,P51681,0.2944470813269112
279,21775441,ccr5_human,280,Q,A,CCL3_HUMAN,UniProt entry code,P10147,Full agonist,Single-point,Binding - Radioligand competition/displacement,100.0,%,=,,84.0,-1.19,,,[125I]-CCL3,106.0,0.0,,0.0,,P51681,0.4607990333224534
317,21775441,ccr5_human,280,Q,A,Maraviroc,ChEMBL Compound ID,CHEMBL1201187,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,1.05,nM,=,,0.0,1.1,,,[125I]-CCL3,106.0,0.0,,0.0,,P51681,0.4607990333224534
340,21775441,ccr5_human,280,Q,A,Maraviroc,ChEMBL Compound ID,CHEMBL1201187,Antagonist (neutral/silent),K(d),Binding - Radioligand kinetics (association/dissociation),0.69,nM,=,,0.0,-1.351,,,[3H]-Maraviroc,106.0,0.0,,0.0,,P51681,0.4607990333224534
281,21775441,ccr5_human,283,E,Q,CCL3_HUMAN,UniProt entry code,P10147,Full agonist,Single-point,Binding - Radioligand competition/displacement,100.0,%,=,,33.0,-3.03,,,[125I]-CCL3,92.0,0.0,,0.0,,P51681,0.352838978664821
319,21775441,ccr5_human,283,E,Q,Maraviroc,ChEMBL Compound ID,CHEMBL1201187,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,1.05,nM,>,,0.0,10.0,,,[125I]-CCL3,92.0,0.0,,0.0,,P51681,0.352838978664821
348,24628038,ccr5_human,199,V,A,Aplaviroc,ChEMBL Compound ID,CHEMBL1255794,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,3.7,nM,=,,19.0,-5.128,,,[3H]-Maraviroc,100.0,0.0,,0.0,,P51681,0.4121910782465261
362,24628038,ccr5_human,199,V,A,Maraviroc,ChEMBL Compound ID,CHEMBL1201187,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,1.3,nM,=,,4.0,-3.077,,,[3H]-Maraviroc,100.0,0.0,,0.0,,P51681,0.4121910782465261
374,24628038,ccr5_human,199,V,A,Vicriviroc,ChEMBL Compound ID,CHEMBL82301,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,7.1,nM,=,,23.0,-3.236,,,[3H]-Maraviroc,100.0,0.0,,0.0,,P51681,0.4121910782465261
0,20434910,5ht6r_human,106,D,A,Cmp17l,ChEMBL Compound ID,CHEMBL1082508,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.7,,=,,9.7,1.0,,,[3H]LSD,0.0,0.0,,0.0,,P50406,0.6106875297738394
7,20434910,5ht6r_human,106,D,A,Cmp17e,ChEMBL Compound ID,CHEMBL1085037,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.9,,=,,9.2,-5.0,,,[3H]LSD,0.0,0.0,,0.0,,P50406,0.6106875297738394
14,20434910,5ht6r_human,106,D,A,Cmp16j,ChEMBL Compound ID,CHEMBL1085617,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.8,,=,,8.3,-31.25,,,[3H]LSD,0.0,0.0,,0.0,,P50406,0.6106875297738394
21,20434910,5ht6r_human,106,D,A,Cmp16d,ChEMBL Compound ID,CHEMBL1086326,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,10.1,,=,,9.0,-12.658,,,[3H]LSD,0.0,0.0,,0.0,,P50406,0.6106875297738394
34,20434910,5ht6r_human,106,D,A,Cmp21d,SMILES,CC(=O)NC[C@@H]1CCCc2cc(cc(F)c12)S(=O)(=O)c1ccccc1,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.5,,=,,9.3,-1.585,,,[3H]LSD,0.0,0.0,,0.0,,P50406,0.6106875297738394
1,20434910,5ht6r_human,110,C,A,Cmp17l,ChEMBL Compound ID,CHEMBL1082508,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.7,,=,,10.0,1.995,,,[3H]LSD,0.0,0.0,,0.0,,P50406,0.5237423638177241
8,20434910,5ht6r_human,110,C,A,Cmp17e,ChEMBL Compound ID,CHEMBL1085037,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.9,,=,,10.3,2.512,,,[3H]LSD,0.0,0.0,,0.0,,P50406,0.5237423638177241
15,20434910,5ht6r_human,110,C,A,Cmp16j,ChEMBL Compound ID,CHEMBL1085617,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.8,,=,,10.2,2.512,,,[3H]LSD,0.0,0.0,,0.0,,P50406,0.5237423638177241
22,20434910,5ht6r_human,110,C,A,Cmp16d,ChEMBL Compound ID,CHEMBL1086326,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,10.1,,=,,10.4,1.995,,,[3H]LSD,0.0,0.0,,0.0,,P50406,0.5237423638177241
35,20434910,5ht6r_human,110,C,A,Cmp21d,SMILES,CC(=O)NC[C@@H]1CCCc2cc(cc(F)c12)S(=O)(=O)c1ccccc1,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.5,,=,,9.9,2.512,,,[3H]LSD,0.0,0.0,,0.0,,P50406,0.5237423638177241
2,20434910,5ht6r_human,193,S,A,Cmp17l,ChEMBL Compound ID,CHEMBL1082508,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.7,,=,,9.3,-2.513,,,[3H]LSD,0.0,0.0,,0.0,,P50406,0.4578293313604306
9,20434910,5ht6r_human,193,S,A,Cmp17e,ChEMBL Compound ID,CHEMBL1085037,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.9,,=,,10.0,1.259,,,[3H]LSD,0.0,0.0,,0.0,,P50406,0.4578293313604306
23,20434910,5ht6r_human,193,S,A,Cmp16d,ChEMBL Compound ID,CHEMBL1086326,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,10.1,,=,,10.2,1.259,,,[3H]LSD,0.0,0.0,,0.0,,P50406,0.4578293313604306
36,20434910,5ht6r_human,193,S,A,Cmp21d,SMILES,CC(=O)NC[C@@H]1CCCc2cc(cc(F)c12)S(=O)(=O)c1ccccc1,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.5,,=,,9.1,-2.513,,,[3H]LSD,0.0,0.0,,0.0,,P50406,0.4578293313604306
3,20434910,5ht6r_human,196,T,A,Cmp17l,ChEMBL Compound ID,CHEMBL1082508,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.7,,=,,10.1,2.512,,,[3H]LSD,0.0,0.0,,0.0,,P50406,0.468003046611545
10,20434910,5ht6r_human,196,T,A,Cmp17e,ChEMBL Compound ID,CHEMBL1085037,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.9,,=,,10.4,3.162,,,[3H]LSD,0.0,0.0,,0.0,,P50406,0.468003046611545
17,20434910,5ht6r_human,196,T,A,Cmp16j,ChEMBL Compound ID,CHEMBL1085617,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.8,,=,,10.2,2.512,,,[3H]LSD,0.0,0.0,,0.0,,P50406,0.468003046611545
24,20434910,5ht6r_human,196,T,A,Cmp16d,ChEMBL Compound ID,CHEMBL1086326,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,10.1,,=,,10.3,1.585,,,[3H]LSD,0.0,0.0,,0.0,,P50406,0.468003046611545
37,20434910,5ht6r_human,196,T,A,Cmp21d,SMILES,CC(=O)NC[C@@H]1CCCc2cc(cc(F)c12)S(=O)(=O)c1ccccc1,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.5,,=,,9.9,2.512,,,[3H]LSD,0.0,0.0,,0.0,,P50406,0.468003046611545
4,20434910,5ht6r_human,281,W,A,Cmp17l,ChEMBL Compound ID,CHEMBL1082508,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.7,,=,,8.3,-25.0,,,[3H]LSD,0.0,0.0,,0.0,,P50406,0.8359984843951047
11,20434910,5ht6r_human,281,W,A,Cmp17e,ChEMBL Compound ID,CHEMBL1085037,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.9,,=,,9.4,-3.165,,,[3H]LSD,0.0,0.0,,0.0,,P50406,0.8359984843951047
18,20434910,5ht6r_human,281,W,A,Cmp16j,ChEMBL Compound ID,CHEMBL1085617,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.8,,=,,8.9,-7.937,,,[3H]LSD,0.0,0.0,,0.0,,P50406,0.8359984843951047
25,20434910,5ht6r_human,281,W,A,Cmp16d,ChEMBL Compound ID,CHEMBL1086326,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,10.1,,=,,8.1,-100.0,,,[3H]LSD,0.0,0.0,,0.0,,P50406,0.8359984843951047
31,20078106,5ht6r_human,281,W,A,SB-258585,ChEMBL Compound ID,CHEMBL60264,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.75,nM,=,,0.32,2.344,,,[3H]LSD,0.0,0.0,,0.0,,P50406,0.8359984843951047
38,20434910,5ht6r_human,281,W,A,Cmp21d,SMILES,CC(=O)NC[C@@H]1CCCc2cc(cc(F)c12)S(=O)(=O)c1ccccc1,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.5,,=,,7.5,-100.0,,,[3H]LSD,0.0,0.0,,0.0,,P50406,0.8359984843951047
5,20434910,5ht6r_human,284,F,A,Cmp17l,ChEMBL Compound ID,CHEMBL1082508,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.7,,=,,8.2,-31.25,,,[3H]LSD,0.0,0.0,,0.0,,P50406,0.624672690010325
12,20434910,5ht6r_human,284,F,A,Cmp17e,ChEMBL Compound ID,CHEMBL1085037,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.9,,=,,9.2,-5.0,,,[3H]LSD,0.0,0.0,,0.0,,P50406,0.624672690010325
19,20434910,5ht6r_human,284,F,A,Cmp16j,ChEMBL Compound ID,CHEMBL1085617,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.8,,=,,8.1,-50.0,,,[3H]LSD,0.0,0.0,,0.0,,P50406,0.624672690010325
26,20434910,5ht6r_human,284,F,A,Cmp16d,ChEMBL Compound ID,CHEMBL1086326,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,10.1,,=,,8.9,-15.873,,,[3H]LSD,0.0,0.0,,0.0,,P50406,0.624672690010325
39,20434910,5ht6r_human,284,F,A,Cmp21d,SMILES,CC(=O)NC[C@@H]1CCCc2cc(cc(F)c12)S(=O)(=O)c1ccccc1,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.5,,=,,8.0,-31.25,,,[3H]LSD,0.0,0.0,,0.0,,P50406,0.624672690010325
32,20078106,5ht6r_human,285,F,A,SB-258585,ChEMBL Compound ID,CHEMBL60264,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.75,nM,=,,114.0,-142.857,,,[3H]LSD,0.0,0.0,,0.0,,P50406,0.6188892104602147
0,17881091,5ht5a_human,6,N,S,[3H]5-HT,ChEMBL Compound ID,CHEMBL39,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,8.64,,=,,8.21,-2.688,,,,0.0,0.0,,0.0,,P47898,0.3240369496327934
1,17881091,5ht5a_human,21,N,S,[3H]5-HT,ChEMBL Compound ID,CHEMBL39,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,8.64,,=,,8.35,-1.949,,,,0.0,0.0,,0.0,,P47898,0.3588159362141118
160,21163968,drd2_human,393,H,F,Aripiprazole,ChEMBL Compound ID,CHEMBL1112,Binding - unknown pharmacological activity,pK(0.5),Binding - Radioligand competition/displacement,8.26,,=,,8.89,4.266,,,[3H]Spiperone,0.0,0.0,,0.0,,P14416,0.4945098212348372
214,21163968,drd2_human,393,H,F,Quinpirole,ChEMBL Compound ID,CHEMBL240773,Binding - unknown pharmacological activity,pK(0.5),Binding - Radioligand competition/displacement,6.21,,=,,6.51,1.995,,,[3H]Spiperone,0.0,0.0,,0.0,,P14416,0.4945098212348372
216,21163968,drd2_human,393,H,F,Quinpirole,ChEMBL Compound ID,CHEMBL240773,Binding - unknown pharmacological activity,pK(h),Binding - Radioligand competition/displacement,7.89,,=,,7.96,1.175,,,[3H]Spiperone,0.0,0.0,,0.0,,P14416,0.4945098212348372
218,21163968,drd2_human,393,H,F,Quinpirole,ChEMBL Compound ID,CHEMBL240773,Binding - unknown pharmacological activity,pK(l),Binding - Radioligand competition/displacement,5.68,,=,,5.96,1.905,,,[3H]Spiperone,0.0,0.0,,0.0,,P14416,0.4945098212348372
255,21163968,drd2_human,393,H,F,7-OH-DPAT,ChEMBL Compound ID,CHEMBL285755,Binding - unknown pharmacological activity,pK(0.5),Binding - Radioligand competition/displacement,7.16,,=,,7.05,-1.289,,,[3H]Spiperone,0.0,0.0,,0.0,,P14416,0.4945098212348372
257,21163968,drd2_human,393,H,F,7-OH-DPAT,ChEMBL Compound ID,CHEMBL285755,Binding - unknown pharmacological activity,pK(h),Binding - Radioligand competition/displacement,8.96,,=,,8.77,-1.548,,,[3H]Spiperone,0.0,0.0,,0.0,,P14416,0.4945098212348372
259,21163968,drd2_human,393,H,F,7-OH-DPAT,ChEMBL Compound ID,CHEMBL285755,Binding - unknown pharmacological activity,pK(l),Binding - Radioligand competition/displacement,6.72,,=,,6.62,-1.259,,,[3H]Spiperone,0.0,0.0,,0.0,,P14416,0.4945098212348372
273,21163968,drd2_human,393,H,F,Buspirone,ChEMBL Compound ID,CHEMBL49,Binding - unknown pharmacological activity,pK(0.5),Binding - Radioligand competition/displacement,6.64,,=,,7.7,11.482,,,[3H]Spiperone,0.0,0.0,,0.0,,P14416,0.4945098212348372
284,21163968,drd2_human,393,H,F,Haloperidol,ChEMBL Compound ID,CHEMBL54,Binding - unknown pharmacological activity,pK(0.5),Binding - Radioligand competition/displacement,9.41,,=,,9.46,1.122,,,[3H]Spiperone,0.0,0.0,,0.0,,P14416,0.4945098212348372
303,21163968,drd2_human,393,H,F,Dopamine,ChEMBL Compound ID,CHEMBL59,Binding - unknown pharmacological activity,pK(0.5),Binding - Radioligand competition/displacement,6.35,,=,,5.4,-8.929,,,[3H]Spiperone,0.0,0.0,,0.0,,P14416,0.4945098212348372
305,21163968,drd2_human,393,H,F,Dopamine,ChEMBL Compound ID,CHEMBL59,Binding - unknown pharmacological activity,pK(h),Binding - Radioligand competition/displacement,8.08,,=,,6.82,-18.182,,,[3H]Spiperone,0.0,0.0,,0.0,,P14416,0.4945098212348372
307,21163968,drd2_human,393,H,F,Dopamine,ChEMBL Compound ID,CHEMBL59,Binding - unknown pharmacological activity,pK(l),Binding - Radioligand competition/displacement,5.7,,=,,4.66,-10.989,,,[3H]Spiperone,0.0,0.0,,0.0,,P14416,0.4945098212348372
351,21163968,drd2_human,393,H,F,FAUC346,SMILES,COc1ccccc1N1CCN(CCCCNC(=O)C2=CSC3C=CC=CC23)CC1,Binding - unknown pharmacological activity,pK(0.5),Binding - Radioligand competition/displacement,6.61,,=,,6.76,1.413,,,[3H]Spiperone,0.0,0.0,,0.0,,P14416,0.4945098212348372
353,21163968,drd2_human,393,H,F,CPD1,SMILES,COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(cc2)-c2ccccc2)CC1,Binding - unknown pharmacological activity,pK(0.5),Binding - Radioligand competition/displacement,7.43,,=,,6.89,-3.472,,,[3H]Spiperone,0.0,0.0,,0.0,,P14416,0.4945098212348372
355,21163968,drd2_human,393,H,F,FAUC321,SMILES,COc1ccccc1N1CCN(CCCNC(=O)c2cnn3ccccc23)CC1,Binding - unknown pharmacological activity,pK(0.5),Binding - Radioligand competition/displacement,8.43,,=,,8.0,-2.688,,,[3H]Spiperone,0.0,0.0,,0.0,,P14416,0.4945098212348372
357,21163968,drd2_human,393,H,F,FAUC335,SMILES,CSc1ccccc1N1CCN(CCCNC(=O)c2cnn3ccccc23)CC1,Binding - unknown pharmacological activity,pK(0.5),Binding - Radioligand competition/displacement,8.85,,=,,8.72,-1.35,,,[3H]Spiperone,0.0,0.0,,0.0,,P14416,0.4945098212348372
361,21163968,drd2_human,393,H,F,FAUC350,SMILES,O=C(NCCCN1CCN(CC1)c1cccc2CCOc12)c1cnn2ccccc12,Binding - unknown pharmacological activity,pK(0.5),Binding - Radioligand competition/displacement,7.41,,=,,7.7,1.95,,,[3H]Spiperone,0.0,0.0,,0.0,,P14416,0.4945098212348372
161,29466326,drd2_human,94,L,A,Aripiprazole,ChEMBL Compound ID,CHEMBL1112,Binding - unknown pharmacological activity,K(d),Binding - Radioligand kinetics (association/dissociation),9.43,nM,=,,49.8,-5.291,,,[3H]-N-methylspiperone,0.0,0.0,,0.0,,P14416,0.3662697055422631
175,29466326,drd2_human,94,L,A,Nemonapride,ChEMBL Compound ID,CHEMBL20734,Binding - unknown pharmacological activity,K(d),Binding - Radioligand kinetics (association/dissociation),0.031,nM,=,,0.13,-4.202,,,[3H]-nemonapride,0.0,0.0,,0.0,,P14416,0.3662697055422631
239,29466326,drd2_human,94,L,A,N-methylspiperone,ChEMBL Compound ID,CHEMBL267932,Binding - unknown pharmacological activity,K(d),Binding - Radioligand kinetics (association/dissociation),0.018,nM,=,,0.062,-3.448,,,[3H]-N-methylspiperone,0.0,0.0,,0.0,,P14416,0.3662697055422631
309,29466326,drd2_human,94,L,A,Risperidone,ChEMBL Compound ID,CHEMBL85,Binding - unknown pharmacological activity,K(d),Binding - Radioligand kinetics (association/dissociation),2.51,nM,=,,0.48,5.229,,,[3H]-N-methylspiperone,0.0,0.0,,0.0,,P14416,0.3662697055422631
162,29466326,drd2_human,100,W,A,Aripiprazole,ChEMBL Compound ID,CHEMBL1112,Binding - unknown pharmacological activity,K(d),Binding - Radioligand kinetics (association/dissociation),9.43,nM,=,,273.0,-28.571,,,[3H]-N-methylspiperone,0.0,0.0,,0.0,,P14416,0.7021635360703418
176,29466326,drd2_human,100,W,A,Nemonapride,ChEMBL Compound ID,CHEMBL20734,Binding - unknown pharmacological activity,K(d),Binding - Radioligand kinetics (association/dissociation),0.031,nM,=,,0.19,-6.135,,,[3H]-nemonapride,0.0,0.0,,0.0,,P14416,0.7021635360703418
177,29466326,drd2_human,100,W,A,Nemonapride,ChEMBL Compound ID,CHEMBL20734,Binding - unknown pharmacological activity,K(d),Binding - Radioligand competition/displacement,0.21,nM,=,,1.97,-9.346,,,[3H]-nemonapride,0.0,0.0,,0.0,,P14416,0.7021635360703418
240,29466326,drd2_human,100,W,A,N-methylspiperone,ChEMBL Compound ID,CHEMBL267932,Binding - unknown pharmacological activity,K(d),Binding - Radioligand kinetics (association/dissociation),0.018,nM,=,,0.31,-17.241,,,[3H]-N-methylspiperone,0.0,0.0,,0.0,,P14416,0.7021635360703418
310,29466326,drd2_human,100,W,A,Risperidone,ChEMBL Compound ID,CHEMBL85,Binding - unknown pharmacological activity,K(d),Binding - Radioligand kinetics (association/dissociation),2.51,nM,=,,6.74,-2.688,,,[3H]-N-methylspiperone,0.0,0.0,,0.0,,P14416,0.7021635360703418
313,29466326,drd2_human,100,W,A,Risperidone,ChEMBL Compound ID,CHEMBL85,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,4.5,nM,=,,8.14,-1.808,,,[3H]-nemonapride,0.0,0.0,,0.0,,P14416,0.7021635360703418
164,29466326,drd2_human,100,W,L,Aripiprazole,ChEMBL Compound ID,CHEMBL1112,Binding - unknown pharmacological activity,K(d),Binding - Radioligand kinetics (association/dissociation),9.43,nM,=,,387.0,-41.667,,,[3H]-N-methylspiperone,0.0,0.0,,0.0,,P14416,0.6632285970152234
179,29466326,drd2_human,100,W,L,Nemonapride,ChEMBL Compound ID,CHEMBL20734,Binding - unknown pharmacological activity,K(d),Binding - Radioligand kinetics (association/dissociation),0.031,nM,=,,0.2,-6.452,,,[3H]-nemonapride,0.0,0.0,,0.0,,P14416,0.6632285970152234
242,29466326,drd2_human,100,W,L,N-methylspiperone,ChEMBL Compound ID,CHEMBL267932,Binding - unknown pharmacological activity,K(d),Binding - Radioligand kinetics (association/dissociation),0.018,nM,=,,0.29,-16.129,,,[3H]-N-methylspiperone,0.0,0.0,,0.0,,P14416,0.6632285970152234
312,29466326,drd2_human,100,W,L,Risperidone,ChEMBL Compound ID,CHEMBL85,Binding - unknown pharmacological activity,K(d),Binding - Radioligand kinetics (association/dissociation),2.51,nM,=,,6.77,-2.695,,,[3H]-N-methylspiperone,0.0,0.0,,0.0,,P14416,0.6632285970152234
165,29466326,drd2_human,184,I,A,Aripiprazole,ChEMBL Compound ID,CHEMBL1112,Binding - unknown pharmacological activity,K(d),Binding - Radioligand kinetics (association/dissociation),9.43,nM,=,,15.5,-1.645,,,[3H]-N-methylspiperone,0.0,0.0,,0.0,,P14416,0.5134165368555127
186,29466326,drd2_human,184,I,A,Nemonapride,ChEMBL Compound ID,CHEMBL20734,Binding - unknown pharmacological activity,K(d),Binding - Radioligand kinetics (association/dissociation),0.031,nM,=,,0.07,-2.257,,,[3H]-nemonapride,0.0,0.0,,0.0,,P14416,0.5134165368555127
245,29466326,drd2_human,184,I,A,N-methylspiperone,ChEMBL Compound ID,CHEMBL267932,Binding - unknown pharmacological activity,K(d),Binding - Radioligand kinetics (association/dissociation),0.018,nM,=,,0.048,-2.667,,,[3H]-N-methylspiperone,0.0,0.0,,0.0,,P14416,0.5134165368555127
320,29466326,drd2_human,184,I,A,Risperidone,ChEMBL Compound ID,CHEMBL85,Binding - unknown pharmacological activity,K(d),Binding - Radioligand kinetics (association/dissociation),2.51,nM,=,,0.54,4.648,,,[3H]-N-methylspiperone,0.0,0.0,,0.0,,P14416,0.5134165368555127
166,21163968,drd2_human,393,H,A,Aripiprazole,ChEMBL Compound ID,CHEMBL1112,Binding - unknown pharmacological activity,pK(0.5),Binding - Radioligand competition/displacement,8.26,,=,,8.51,1.778,,,[3H]Spiperone,0.0,0.0,,0.0,,P14416,0.5394280558785193
213,21163968,drd2_human,393,H,A,Quinpirole,ChEMBL Compound ID,CHEMBL240773,Binding - unknown pharmacological activity,pK(0.5),Binding - Radioligand competition/displacement,6.21,,=,,4.96,-17.857,,,[3H]Spiperone,0.0,0.0,,0.0,,P14416,0.5394280558785193
215,21163968,drd2_human,393,H,A,Quinpirole,ChEMBL Compound ID,CHEMBL240773,Binding - unknown pharmacological activity,pK(h),Binding - Radioligand competition/displacement,7.89,,=,,6.09,-62.5,,,[3H]Spiperone,0.0,0.0,,0.0,,P14416,0.5394280558785193
217,21163968,drd2_human,393,H,A,Quinpirole,ChEMBL Compound ID,CHEMBL240773,Binding - unknown pharmacological activity,pK(l),Binding - Radioligand competition/displacement,5.68,,=,,4.42,-18.182,,,[3H]Spiperone,0.0,0.0,,0.0,,P14416,0.5394280558785193
254,21163968,drd2_human,393,H,A,7-OH-DPAT,ChEMBL Compound ID,CHEMBL285755,Binding - unknown pharmacological activity,pK(0.5),Binding - Radioligand competition/displacement,7.16,,=,,5.92,-17.241,,,[3H]Spiperone,0.0,0.0,,0.0,,P14416,0.5394280558785193
256,21163968,drd2_human,393,H,A,7-OH-DPAT,ChEMBL Compound ID,CHEMBL285755,Binding - unknown pharmacological activity,pK(h),Binding - Radioligand competition/displacement,8.96,,=,,7.89,-11.765,,,[3H]Spiperone,0.0,0.0,,0.0,,P14416,0.5394280558785193
258,21163968,drd2_human,393,H,A,7-OH-DPAT,ChEMBL Compound ID,CHEMBL285755,Binding - unknown pharmacological activity,pK(l),Binding - Radioligand competition/displacement,6.72,,=,,5.55,-14.706,,,[3H]Spiperone,0.0,0.0,,0.0,,P14416,0.5394280558785193
272,21163968,drd2_human,393,H,A,Buspirone,ChEMBL Compound ID,CHEMBL49,Binding - unknown pharmacological activity,pK(0.5),Binding - Radioligand competition/displacement,6.64,,=,,7.0,2.291,,,[3H]Spiperone,0.0,0.0,,0.0,,P14416,0.5394280558785193
283,21163968,drd2_human,393,H,A,Haloperidol,ChEMBL Compound ID,CHEMBL54,Binding - unknown pharmacological activity,pK(0.5),Binding - Radioligand competition/displacement,9.41,,=,,9.6,1.549,,,[3H]Spiperone,0.0,0.0,,0.0,,P14416,0.5394280558785193
302,21163968,drd2_human,393,H,A,Dopamine,ChEMBL Compound ID,CHEMBL59,Binding - unknown pharmacological activity,pK(0.5),Binding - Radioligand competition/displacement,6.35,,=,,5.24,-12.821,,,[3H]Spiperone,0.0,0.0,,0.0,,P14416,0.5394280558785193
304,21163968,drd2_human,393,H,A,Dopamine,ChEMBL Compound ID,CHEMBL59,Binding - unknown pharmacological activity,pK(h),Binding - Radioligand competition/displacement,8.08,,=,,6.64,-27.778,,,[3H]Spiperone,0.0,0.0,,0.0,,P14416,0.5394280558785193
306,21163968,drd2_human,393,H,A,Dopamine,ChEMBL Compound ID,CHEMBL59,Binding - unknown pharmacological activity,pK(l),Binding - Radioligand competition/displacement,5.7,,=,,4.52,-15.152,,,[3H]Spiperone,0.0,0.0,,0.0,,P14416,0.5394280558785193
350,21163968,drd2_human,393,H,A,FAUC346,SMILES,COc1ccccc1N1CCN(CCCCNC(=O)C2=CSC3C=CC=CC23)CC1,Binding - unknown pharmacological activity,pK(0.5),Binding - Radioligand competition/displacement,6.61,,=,,7.77,14.454,,,[3H]Spiperone,0.0,0.0,,0.0,,P14416,0.5394280558785193
352,21163968,drd2_human,393,H,A,CPD1,SMILES,COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(cc2)-c2ccccc2)CC1,Binding - unknown pharmacological activity,pK(0.5),Binding - Radioligand competition/displacement,7.43,,=,,9.0,37.154,,,[3H]Spiperone,0.0,0.0,,0.0,,P14416,0.5394280558785193
354,21163968,drd2_human,393,H,A,FAUC321,SMILES,COc1ccccc1N1CCN(CCCNC(=O)c2cnn3ccccc23)CC1,Binding - unknown pharmacological activity,pK(0.5),Binding - Radioligand competition/displacement,8.43,,=,,9.11,4.786,,,[3H]Spiperone,0.0,0.0,,0.0,,P14416,0.5394280558785193
356,21163968,drd2_human,393,H,A,FAUC335,SMILES,CSc1ccccc1N1CCN(CCCNC(=O)c2cnn3ccccc23)CC1,Binding - unknown pharmacological activity,pK(0.5),Binding - Radioligand competition/displacement,8.85,,=,,9.35,3.162,,,[3H]Spiperone,0.0,0.0,,0.0,,P14416,0.5394280558785193
360,21163968,drd2_human,393,H,A,FAUC350,SMILES,O=C(NCCCN1CCN(CC1)c1cccc2CCOc12)c1cnn2ccccc12,Binding - unknown pharmacological activity,pK(0.5),Binding - Radioligand competition/displacement,7.41,,=,,8.3,7.762,,,[3H]Spiperone,0.0,0.0,,0.0,,P14416,0.5394280558785193
167,22416052,drd2_human,193,S,A,DNS,ChEMBL Compound ID,CHEMBL124561,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,144.0,nM,=,,660.0,-4.587,,,[3H]N-methylspiperone,0.0,0.0,,0.0,,P14416,0.4478706513267452
207,22416052,drd2_human,193,S,A,Quinpirole,ChEMBL Compound ID,CHEMBL240773,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,365.0,nM,=,,1040.0,-2.849,,,[3H]N-methylspiperone,0.0,0.0,,0.0,,P14416,0.4478706513267452
219,22416052,drd2_human,193,S,A,DHX,ChEMBL Compound ID,CHEMBL25856,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,490.0,nM,=,,7400.0,-15.152,,,[3H]N-methylspiperone,0.0,0.0,,0.0,,P14416,0.4478706513267452
294,22416052,drd2_human,193,S,A,Dopamine,ChEMBL Compound ID,CHEMBL59,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.45,ÂµM,=,,80.0,-166.667,,,[3H]N-methylspiperone,0.0,0.0,,0.0,,P14416,0.4478706513267452
335,22416052,drd2_human,193,S,A,DNX,PubChem CID,9819126,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,83.0,nM,=,,2700.0,-32.258,,,[3H]N-methylspiperone,0.0,0.0,,0.0,,P14416,0.4478706513267452
168,22416052,drd2_human,194,S,A,DNS,ChEMBL Compound ID,CHEMBL124561,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,144.0,nM,=,,750.0,-5.208,,,[3H]N-methylspiperone,0.0,0.0,,0.0,,P14416,0.457987062531339
208,22416052,drd2_human,194,S,A,Quinpirole,ChEMBL Compound ID,CHEMBL240773,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.365,ÂµM,=,,27.0,-71.429,,,[3H]N-methylspiperone,0.0,0.0,,0.0,,P14416,0.457987062531339
220,22416052,drd2_human,194,S,A,DHX,ChEMBL Compound ID,CHEMBL25856,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,490.0,nM,=,,2600.0,-5.319,,,[3H]N-methylspiperone,0.0,0.0,,0.0,,P14416,0.457987062531339
295,22416052,drd2_human,194,S,A,Dopamine,ChEMBL Compound ID,CHEMBL59,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.45,ÂµM,=,,31.0,-66.667,,,[3H]N-methylspiperone,0.0,0.0,,0.0,,P14416,0.457987062531339
336,22416052,drd2_human,194,S,A,DNX,PubChem CID,9819126,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,83.0,nM,=,,770.0,-9.259,,,[3H]N-methylspiperone,0.0,0.0,,0.0,,P14416,0.457987062531339
169,22416052,drd2_human,197,S,A,DNS,ChEMBL Compound ID,CHEMBL124561,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,144.0,nM,=,,330.0,-2.294,,,[3H]N-methylspiperone,0.0,0.0,,0.0,,P14416,0.4283089078464152
187,29466326,drd2_human,197,S,A,Nemonapride,ChEMBL Compound ID,CHEMBL20734,Binding - unknown pharmacological activity,K(d),Binding - Radioligand competition/displacement,0.21,nM,=,,0.43,-2.049,,,[3H]-nemonapride,0.0,0.0,,0.0,,P14416,0.4283089078464152
209,22416052,drd2_human,197,S,A,Quinpirole,ChEMBL Compound ID,CHEMBL240773,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,365.0,nM,=,,2900.0,-7.937,,,[3H]N-methylspiperone,0.0,0.0,,0.0,,P14416,0.4283089078464152
221,22416052,drd2_human,197,S,A,DHX,ChEMBL Compound ID,CHEMBL25856,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,490.0,nM,=,,1600.0,-3.268,,,[3H]N-methylspiperone,0.0,0.0,,0.0,,P14416,0.4283089078464152
296,22416052,drd2_human,197,S,A,Dopamine,ChEMBL Compound ID,CHEMBL59,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,450.0,nM,=,,3500.0,-7.752,,,[3H]N-methylspiperone,0.0,0.0,,0.0,,P14416,0.4283089078464152
321,29466326,drd2_human,197,S,A,Risperidone,ChEMBL Compound ID,CHEMBL85,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,4.5,nM,=,,1.22,3.689,,,[3H]-nemonapride,0.0,0.0,,0.0,,P14416,0.4283089078464152
337,22416052,drd2_human,197,S,A,DNX,PubChem CID,9819126,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,83.0,nM,=,,580.0,-6.993,,,[3H]N-methylspiperone,0.0,0.0,,0.0,,P14416,0.4283089078464152
171,7595496,drd2_human,387,L,A,[3H]N-0437,ChEMBL Compound ID,CHEMBL1303,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,1.7,nM,=,,1.2,1.417,,,,0.0,0.0,,0.0,,P14416,0.5353415661871989
197,7595496,drd2_human,387,L,A,NPA,ChEMBL Compound ID,CHEMBL225230,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,22.0,nM,=,,34.0,-1.546,,,[3H]Spiperone,0.0,0.0,,0.0,,P14416,0.5353415661871989
227,7595496,drd2_human,387,L,A,[3H]Spiperone,ChEMBL Compound ID,CHEMBL267930,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,0.083,nM,=,,0.085,-1.025,,,,0.0,0.0,,0.0,,P14416,0.5353415661871989
275,7595496,drd2_human,387,L,A,Bromocriptine,ChEMBL Compound ID,CHEMBL493,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,8.2,nM,=,,5.9,1.39,,,[3H]Spiperone,0.0,0.0,,0.0,,P14416,0.5353415661871989
279,7595496,drd2_human,387,L,A,Apomorphine,ChEMBL Compound ID,CHEMBL53,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,200.0,nM,=,,220.0,-1.1,,,[3H]Spiperone,0.0,0.0,,0.0,,P14416,0.5353415661871989
298,7595496,drd2_human,387,L,A,Dopamine,ChEMBL Compound ID,CHEMBL59,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,1.0,ÂµM,=,,10.0,-10.0,,,[3H]Spiperone,0.0,0.0,,0.0,,P14416,0.5353415661871989
331,7595496,drd2_human,387,L,A,[3H]Raclopride,ChEMBL Compound ID,CHEMBL8809,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,0.98,nM,=,,0.4,2.45,,,,0.0,0.0,,0.0,,P14416,0.5353415661871989
174,7595496,drd2_human,411,F,A,[3H]N-0437,ChEMBL Compound ID,CHEMBL1303,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,1.7,nM,=,,1.2,1.417,,,,0.0,0.0,,0.0,,P14416,0.5022340946422562
199,7595496,drd2_human,411,F,A,NPA,ChEMBL Compound ID,CHEMBL225230,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,22.0,nM,=,,25.0,-1.136,,,[3H]Spiperone,0.0,0.0,,0.0,,P14416,0.5022340946422562
230,7595496,drd2_human,411,F,A,[3H]Spiperone,ChEMBL Compound ID,CHEMBL267930,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,0.083,nM,=,,0.061,1.361,,,,0.0,0.0,,0.0,,P14416,0.5022340946422562
277,7595496,drd2_human,411,F,A,Bromocriptine,ChEMBL Compound ID,CHEMBL493,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,8.2,nM,=,,6.6,1.242,,,[3H]Spiperone,0.0,0.0,,0.0,,P14416,0.5022340946422562
281,7595496,drd2_human,411,F,A,Apomorphine,ChEMBL Compound ID,CHEMBL53,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,200.0,nM,=,,250.0,-1.25,,,[3H]Spiperone,0.0,0.0,,0.0,,P14416,0.5022340946422562
308,7595496,drd2_human,411,F,A,Dopamine,ChEMBL Compound ID,CHEMBL59,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,1.0,ÂµM,=,,0.89,1.124,,,[3H]Spiperone,0.0,0.0,,0.0,,P14416,0.5022340946422562
334,7595496,drd2_human,411,F,A,[3H]Raclopride,ChEMBL Compound ID,CHEMBL8809,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,0.98,nM,=,,0.4,2.45,,,,0.0,0.0,,0.0,,P14416,0.5022340946422562
180,29466326,drd2_human,110,F,A,Nemonapride,ChEMBL Compound ID,CHEMBL20734,Binding - unknown pharmacological activity,K(d),Binding - Radioligand competition/displacement,0.21,nM,=,,0.17,1.235,,,[3H]-nemonapride,0.0,0.0,,0.0,,P14416,0.5496563397816792
314,29466326,drd2_human,110,F,A,Risperidone,ChEMBL Compound ID,CHEMBL85,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,4.5,nM,=,,36.89,-8.197,,,[3H]-nemonapride,0.0,0.0,,0.0,,P14416,0.5496563397816792
181,29466326,drd2_human,114,D,A,Nemonapride,ChEMBL Compound ID,CHEMBL20734,Binding - unknown pharmacological activity,K(d),Binding - Radioligand competition/displacement,0.21,nM,=,,8.1,-38.462,,,[3H]-nemonapride,0.0,0.0,,0.0,,P14416,0.6256624378588524
182,29466326,drd2_human,115,V,A,Nemonapride,ChEMBL Compound ID,CHEMBL20734,Binding - unknown pharmacological activity,K(d),Binding - Radioligand competition/displacement,0.21,nM,=,,0.84,-4.0,,,[3H]-nemonapride,0.0,0.0,,0.0,,P14416,0.5641477306302628
316,29466326,drd2_human,115,V,A,Risperidone,ChEMBL Compound ID,CHEMBL85,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,4.5,nM,=,,3.07,1.466,,,[3H]-nemonapride,0.0,0.0,,0.0,,P14416,0.5641477306302628
183,29466326,drd2_human,118,C,A,Nemonapride,ChEMBL Compound ID,CHEMBL20734,Binding - unknown pharmacological activity,K(d),Binding - Radioligand competition/displacement,0.21,nM,=,,0.4,-1.905,,,[3H]-nemonapride,0.0,0.0,,0.0,,P14416,0.5287088209953339
232,10570038,drd2_human,118,C,A,[3H]N-methylspiperone,ChEMBL Compound ID,CHEMBL267932,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,0.0,,~,,0.0,2.0,,,,0.0,0.0,,0.0,,P14416,0.5287088209953339
317,29466326,drd2_human,118,C,A,Risperidone,ChEMBL Compound ID,CHEMBL85,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,4.5,nM,=,,4.84,-1.075,,,[3H]-nemonapride,0.0,0.0,,0.0,,P14416,0.5287088209953339
184,29466326,drd2_human,119,T,A,Nemonapride,ChEMBL Compound ID,CHEMBL20734,Binding - unknown pharmacological activity,K(d),Binding - Radioligand competition/displacement,0.21,nM,=,,0.43,-2.049,,,[3H]-nemonapride,0.0,0.0,,0.0,,P14416,0.5060593029354459
318,29466326,drd2_human,119,T,A,Risperidone,ChEMBL Compound ID,CHEMBL85,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,4.5,nM,=,,177.19,-40.0,,,[3H]-nemonapride,0.0,0.0,,0.0,,P14416,0.5060593029354459
185,29466326,drd2_human,122,I,A,Nemonapride,ChEMBL Compound ID,CHEMBL20734,Binding - unknown pharmacological activity,K(d),Binding - Radioligand competition/displacement,0.21,nM,=,,0.3,-1.429,,,[3H]-nemonapride,0.0,0.0,,0.0,,P14416,0.5513848416364491
319,29466326,drd2_human,122,I,A,Risperidone,ChEMBL Compound ID,CHEMBL85,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,4.5,nM,=,,13.87,-3.086,,,[3H]-nemonapride,0.0,0.0,,0.0,,P14416,0.5513848416364491
188,29466326,drd2_human,198,F,A,Nemonapride,ChEMBL Compound ID,CHEMBL20734,Binding - unknown pharmacological activity,K(d),Binding - Radioligand competition/displacement,0.21,nM,=,,0.76,-3.623,,,[3H]-nemonapride,0.0,0.0,,0.0,,P14416,0.6063682464202438
196,7595496,drd2_human,198,F,A,NPA,ChEMBL Compound ID,CHEMBL225230,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,22.0,nM,=,,23.0,-1.045,,,[3H]Spiperone,0.0,0.0,,0.0,,P14416,0.6063682464202438
226,7595496,drd2_human,198,F,A,[3H]Spiperone,ChEMBL Compound ID,CHEMBL267930,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,0.083,nM,=,,0.091,-1.096,,,,0.0,0.0,,0.0,,P14416,0.6063682464202438
274,7595496,drd2_human,198,F,A,Bromocriptine,ChEMBL Compound ID,CHEMBL493,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,8.2,nM,=,,6.3,1.302,,,[3H]Spiperone,0.0,0.0,,0.0,,P14416,0.6063682464202438
278,7595496,drd2_human,198,F,A,Apomorphine,ChEMBL Compound ID,CHEMBL53,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,200.0,nM,=,,39.0,5.128,,,[3H]Spiperone,0.0,0.0,,0.0,,P14416,0.6063682464202438
297,7595496,drd2_human,198,F,A,Dopamine,ChEMBL Compound ID,CHEMBL59,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,1.0,ÂµM,=,,1.6,-1.6,,,[3H]Spiperone,0.0,0.0,,0.0,,P14416,0.6063682464202438
322,29466326,drd2_human,198,F,A,Risperidone,ChEMBL Compound ID,CHEMBL85,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,4.5,nM,=,,41.95,-9.346,,,[3H]-nemonapride,0.0,0.0,,0.0,,P14416,0.6063682464202438
330,7595496,drd2_human,198,F,A,[3H]Raclopride,ChEMBL Compound ID,CHEMBL8809,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,0.98,nM,=,,1.4,-1.429,,,,0.0,0.0,,0.0,,P14416,0.6063682464202438
189,29466326,drd2_human,382,F,A,Nemonapride,ChEMBL Compound ID,CHEMBL20734,Binding - unknown pharmacological activity,K(d),Binding - Radioligand competition/displacement,0.21,nM,=,,0.3,-1.429,,,[3H]-nemonapride,0.0,0.0,,0.0,,P14416,0.8278200390516061
323,29466326,drd2_human,382,F,A,Risperidone,ChEMBL Compound ID,CHEMBL85,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,4.5,nM,=,,57.7,-12.821,,,[3H]-nemonapride,0.0,0.0,,0.0,,P14416,0.8278200390516061
190,29466326,drd2_human,386,W,A,Nemonapride,ChEMBL Compound ID,CHEMBL20734,Binding - unknown pharmacological activity,K(d),Binding - Radioligand competition/displacement,0.21,nM,=,,4.02,-19.231,,,[3H]-nemonapride,0.0,0.0,,0.0,,P14416,0.8460319921535888
191,29466326,drd2_human,389,F,A,Nemonapride,ChEMBL Compound ID,CHEMBL20734,Binding - unknown pharmacological activity,K(d),Binding - Radioligand competition/displacement,0.21,nM,=,,4.7,-22.222,,,[3H]-nemonapride,0.0,0.0,,0.0,,P14416,0.6535247918375596
198,7595496,drd2_human,389,F,A,NPA,ChEMBL Compound ID,CHEMBL225230,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,22.0,nM,=,,7200.0,-333.333,,,[3H]Spiperone,0.0,0.0,,0.0,,P14416,0.6535247918375596
228,7595496,drd2_human,389,F,A,[3H]Spiperone,ChEMBL Compound ID,CHEMBL267930,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,0.083,nM,=,,2.8,-33.333,,,,0.0,0.0,,0.0,,P14416,0.6535247918375596
276,7595496,drd2_human,389,F,A,Bromocriptine,ChEMBL Compound ID,CHEMBL493,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,8.2,nM,=,,850.0,-100.0,,,[3H]Spiperone,0.0,0.0,,0.0,,P14416,0.6535247918375596
280,7595496,drd2_human,389,F,A,Apomorphine,ChEMBL Compound ID,CHEMBL53,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,200.0,nM,=,,16000.0,-76.923,,,[3H]Spiperone,0.0,0.0,,0.0,,P14416,0.6535247918375596
299,7595496,drd2_human,389,F,A,Dopamine,ChEMBL Compound ID,CHEMBL59,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,1.0,ÂµM,=,,59.0,-58.824,,,[3H]Spiperone,0.0,0.0,,0.0,,P14416,0.6535247918375596
325,29466326,drd2_human,389,F,A,Risperidone,ChEMBL Compound ID,CHEMBL85,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,4.5,nM,=,,2992.0,-500.0,,,[3H]-nemonapride,0.0,0.0,,0.0,,P14416,0.6535247918375596
192,29466326,drd2_human,390,F,A,Nemonapride,ChEMBL Compound ID,CHEMBL20734,Binding - unknown pharmacological activity,K(d),Binding - Radioligand competition/displacement,0.21,nM,=,,1.3,-6.173,,,[3H]-nemonapride,0.0,0.0,,0.0,,P14416,0.6294273434367954
326,29466326,drd2_human,390,F,A,Risperidone,ChEMBL Compound ID,CHEMBL85,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,4.5,nM,=,,31.2,-6.944,,,[3H]-nemonapride,0.0,0.0,,0.0,,P14416,0.6294273434367954
193,29466326,drd2_human,408,Y,A,Nemonapride,ChEMBL Compound ID,CHEMBL20734,Binding - unknown pharmacological activity,K(d),Binding - Radioligand competition/displacement,0.21,nM,=,,0.18,1.167,,,[3H]-nemonapride,0.0,0.0,,0.0,,P14416,0.4389925620410434
327,29466326,drd2_human,408,Y,A,Risperidone,ChEMBL Compound ID,CHEMBL85,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,4.5,nM,=,,13.63,-3.03,,,[3H]-nemonapride,0.0,0.0,,0.0,,P14416,0.4389925620410434
194,29466326,drd2_human,412,T,A,Nemonapride,ChEMBL Compound ID,CHEMBL20734,Binding - unknown pharmacological activity,K(d),Binding - Radioligand competition/displacement,0.21,nM,=,,4.92,-23.256,,,[3H]-nemonapride,0.0,0.0,,0.0,,P14416,0.4955194690863352
328,29466326,drd2_human,412,T,A,Risperidone,ChEMBL Compound ID,CHEMBL85,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,4.5,nM,=,,102.68,-22.727,,,[3H]-nemonapride,0.0,0.0,,0.0,,P14416,0.4955194690863352
195,29466326,drd2_human,416,Y,A,Nemonapride,ChEMBL Compound ID,CHEMBL20734,Binding - unknown pharmacological activity,K(d),Binding - Radioligand competition/displacement,0.21,nM,=,,0.88,-4.184,,,[3H]-nemonapride,0.0,0.0,,0.0,,P14416,0.6158044550022075
329,29466326,drd2_human,416,Y,A,Risperidone,ChEMBL Compound ID,CHEMBL85,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,4.5,nM,=,,2772.0,-500.0,,,[3H]-nemonapride,0.0,0.0,,0.0,,P14416,0.6158044550022075
206,22778805,drd2_human,390,F,W,Nemonapride,ChEMBL Compound ID,CHEMBL2261102,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.14,nM,=,,1.5,-10.753,,,[3H]Spiperone,0.0,0.0,,0.0,,P14416,0.4975233170467182
210,22778805,drd2_human,390,F,W,Quinpirole,ChEMBL Compound ID,CHEMBL240773,Binding - unknown pharmacological activity,K(0.5),Binding - Radioligand competition/displacement,610.0,nM,=,,2500.0,-4.098,,,[3H]Spiperone,0.0,0.0,,0.0,,P14416,0.4975233170467182
211,22778805,drd2_human,390,F,W,Quinpirole,ChEMBL Compound ID,CHEMBL240773,Binding - unknown pharmacological activity,K(h),Binding - Radioligand competition/displacement,13.0,nM,=,,22.0,-1.692,,,[3H]Spiperone,0.0,0.0,,0.0,,P14416,0.4975233170467182
212,22778805,drd2_human,390,F,W,Quinpirole,ChEMBL Compound ID,CHEMBL240773,Binding - unknown pharmacological activity,K(l),Binding - Radioligand competition/displacement,2100.0,nM,=,,5000.0,-2.381,,,[3H]Spiperone,0.0,0.0,,0.0,,P14416,0.4975233170467182
231,22778805,drd2_human,390,F,W,Spiperone,ChEMBL Compound ID,CHEMBL267930,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.09,nM,=,,0.14,-1.555,,,[3H]Spiperone,0.0,0.0,,0.0,,P14416,0.4975233170467182
251,22778805,drd2_human,390,F,W,7-OH-DPAT,ChEMBL Compound ID,CHEMBL285755,Binding - unknown pharmacological activity,K(0.5),Binding - Radioligand competition/displacement,69.0,nM,=,,2200.0,-32.258,,,[3H]Spiperone,0.0,0.0,,0.0,,P14416,0.4975233170467182
252,22778805,drd2_human,390,F,W,7-OH-DPAT,ChEMBL Compound ID,CHEMBL285755,Binding - unknown pharmacological activity,K(h),Binding - Radioligand competition/displacement,1.1,nM,=,,21.0,-19.231,,,[3H]Spiperone,0.0,0.0,,0.0,,P14416,0.4975233170467182
253,22778805,drd2_human,390,F,W,7-OH-DPAT,ChEMBL Compound ID,CHEMBL285755,Binding - unknown pharmacological activity,K(l),Binding - Radioligand competition/displacement,190.0,nM,=,,5600.0,-29.412,,,[3H]Spiperone,0.0,0.0,,0.0,,P14416,0.4975233170467182
282,22778805,drd2_human,390,F,W,Haloperidol,ChEMBL Compound ID,CHEMBL54,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.41,nM,=,,0.6,-1.464,,,[3H]Spiperone,0.0,0.0,,0.0,,P14416,0.4975233170467182
300,22778805,drd2_human,390,F,W,Dopamine,ChEMBL Compound ID,CHEMBL59,Binding - unknown pharmacological activity,K(0.5),Binding - Radioligand competition/displacement,0.45,ÂµM,>,,20.0,-45.455,,,[3H]Spiperone,0.0,0.0,,0.0,,P14416,0.4975233170467182
301,22778805,drd2_human,390,F,W,Dopamine,ChEMBL Compound ID,CHEMBL59,Binding - unknown pharmacological activity,K(l),Binding - Radioligand competition/displacement,2.0,ÂµM,>,,20.0,-10.0,,,[3H]Spiperone,0.0,0.0,,0.0,,P14416,0.4975233170467182
234,10570038,drd2_human,118,C,M,[3H]N-methylspiperone,ChEMBL Compound ID,CHEMBL267932,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,0.0,,~,,0.0,5.0,,,,0.0,0.0,,0.0,,P14416,0.5731870863483339
236,10570038,drd2_human,90,W,L,N-methylspiperone,ChEMBL Compound ID,CHEMBL267932,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,79.0,pM,=,,150.0,-1.898,,,,0.0,0.0,,0.0,,P14416,0.4056512468300989
260,10570038,drd2_human,90,W,L,Clozapine,ChEMBL Compound ID,CHEMBL42,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,280.0,nM,=,,106.0,2.642,,,[3H]N-methylspiperone,0.0,0.0,,0.0,,P14416,0.4056512468300989
340,10570038,drd2_human,90,W,L,CPPMA,SMILES,Clc1ccc(cc1)N1CCN(Cc2c[nH]c3ncccc23)CC1,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,920.0,nM,=,,330.0,2.788,,,[3H]N-methylspiperone,0.0,0.0,,0.0,,P14416,0.4056512468300989
237,10570038,drd2_human,91,V,F,N-methylspiperone,ChEMBL Compound ID,CHEMBL267932,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,79.0,pM,=,,28.0,2.821,,,,0.0,0.0,,0.0,,P14416,0.4858352152632709
261,10570038,drd2_human,91,V,F,Clozapine,ChEMBL Compound ID,CHEMBL42,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,280.0,nM,=,,5.7,49.123,,,[3H]N-methylspiperone,0.0,0.0,,0.0,,P14416,0.4858352152632709
341,10570038,drd2_human,91,V,F,CPPMA,SMILES,Clc1ccc(cc1)N1CCN(Cc2c[nH]c3ncccc23)CC1,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,920.0,nM,=,,9.5,96.842,,,[3H]N-methylspiperone,0.0,0.0,,0.0,,P14416,0.4858352152632709
238,10570038,drd2_human,94,L,S,N-methylspiperone,ChEMBL Compound ID,CHEMBL267932,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,79.0,pM,=,,300.0,-3.802,,,,0.0,0.0,,0.0,,P14416,0.4089638908532683
262,10570038,drd2_human,94,L,S,Clozapine,ChEMBL Compound ID,CHEMBL42,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,280.0,nM,=,,780.0,-2.786,,,[3H]N-methylspiperone,0.0,0.0,,0.0,,P14416,0.4089638908532683
342,10570038,drd2_human,94,L,S,CPPMA,SMILES,Clc1ccc(cc1)N1CCN(Cc2c[nH]c3ncccc23)CC1,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,920.0,nM,=,,540.0,1.704,,,[3H]N-methylspiperone,0.0,0.0,,0.0,,P14416,0.4089638908532683
244,10570038,drd2_human,111,V,M,N-methylspiperone,ChEMBL Compound ID,CHEMBL267932,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,79.0,pM,=,,910.0,-11.494,,,,0.0,0.0,,0.0,,P14416,0.4746780205097268
264,10570038,drd2_human,111,V,M,Clozapine,ChEMBL Compound ID,CHEMBL42,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,280.0,nM,=,,370.0,-1.321,,,[3H]N-methylspiperone,0.0,0.0,,0.0,,P14416,0.4746780205097268
344,10570038,drd2_human,111,V,M,CPPMA,SMILES,Clc1ccc(cc1)N1CCN(Cc2c[nH]c3ncccc23)CC1,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,920.0,nM,=,,1650.0,-1.792,,,[3H]N-methylspiperone,0.0,0.0,,0.0,,P14416,0.4746780205097268
246,10570038,drd2_human,189,F,Y,N-methylspiperone,ChEMBL Compound ID,CHEMBL267932,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,79.0,pM,=,,33.0,2.394,,,,0.0,0.0,,0.0,,P14416,0.339146416317057
265,10570038,drd2_human,189,F,Y,Clozapine,ChEMBL Compound ID,CHEMBL42,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,280.0,nM,=,,51.0,5.49,,,[3H]N-methylspiperone,0.0,0.0,,0.0,,P14416,0.339146416317057
345,10570038,drd2_human,189,F,Y,CPPMA,SMILES,Clc1ccc(cc1)N1CCN(Cc2c[nH]c3ncccc23)CC1,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,920.0,nM,=,,340.0,2.706,,,[3H]N-methylspiperone,0.0,0.0,,0.0,,P14416,0.339146416317057
247,10570038,drd2_human,196,V,C,N-methylspiperone,ChEMBL Compound ID,CHEMBL267932,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,79.0,pM,=,,110.0,-1.393,,,,0.0,0.0,,0.0,,P14416,0.411708709601653
266,10570038,drd2_human,196,V,C,Clozapine,ChEMBL Compound ID,CHEMBL42,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,280.0,nM,=,,370.0,-1.321,,,[3H]N-methylspiperone,0.0,0.0,,0.0,,P14416,0.411708709601653
346,10570038,drd2_human,196,V,C,CPPMA,SMILES,Clc1ccc(cc1)N1CCN(Cc2c[nH]c3ncccc23)CC1,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,920.0,nM,=,,550.0,1.673,,,[3H]N-methylspiperone,0.0,0.0,,0.0,,P14416,0.411708709601653
248,10570038,drd2_human,392,T,V,N-methylspiperone,ChEMBL Compound ID,CHEMBL267932,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,79.0,pM,=,,110.0,-1.393,,,,0.0,0.0,,0.0,,P14416,0.4213014277287729
269,10570038,drd2_human,392,T,V,Clozapine,ChEMBL Compound ID,CHEMBL42,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,280.0,nM,=,,280.0,1.0,,,[3H]N-methylspiperone,0.0,0.0,,0.0,,P14416,0.4213014277287729
347,10570038,drd2_human,392,T,V,CPPMA,SMILES,Clc1ccc(cc1)N1CCN(Cc2c[nH]c3ncccc23)CC1,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,920.0,nM,=,,750.0,1.227,,,[3H]N-methylspiperone,0.0,0.0,,0.0,,P14416,0.4213014277287729
249,10570038,drd2_human,408,Y,V,N-methylspiperone,ChEMBL Compound ID,CHEMBL267932,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,79.0,pM,=,,310.0,-3.922,,,,0.0,0.0,,0.0,,P14416,0.3952879390065169
270,10570038,drd2_human,408,Y,V,Clozapine,ChEMBL Compound ID,CHEMBL42,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,280.0,nM,=,,60.0,4.667,,,[3H]N-methylspiperone,0.0,0.0,,0.0,,P14416,0.3952879390065169
348,10570038,drd2_human,408,Y,V,CPPMA,SMILES,Clc1ccc(cc1)N1CCN(Cc2c[nH]c3ncccc23)CC1,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,920.0,nM,=,,280.0,3.286,,,[3H]N-methylspiperone,0.0,0.0,,0.0,,P14416,0.3952879390065169
250,10570038,drd2_human,411,F,V,N-methylspiperone,ChEMBL Compound ID,CHEMBL267932,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,79.0,pM,=,,102.0,-1.29,,,,0.0,0.0,,0.0,,P14416,0.4573738167651055
271,10570038,drd2_human,411,F,V,Clozapine,ChEMBL Compound ID,CHEMBL42,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,280.0,nM,=,,200.0,1.4,,,[3H]N-methylspiperone,0.0,0.0,,0.0,,P14416,0.4573738167651055
349,10570038,drd2_human,411,F,V,CPPMA,SMILES,Clc1ccc(cc1)N1CCN(Cc2c[nH]c3ncccc23)CC1,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,920.0,nM,=,,790.0,1.165,,,[3H]N-methylspiperone,0.0,0.0,,0.0,,P14416,0.4573738167651055
267,18550344,drd2_human,311,S,C,Clozapine,ChEMBL Compound ID,CHEMBL42,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,654.0,nM,=,,429.0,1.524,,,[3H]Spiperone,0.0,0.0,,0.0,,P14416,0.3134788360372117
285,26258690,drd2_human,91,V,A,Dopamine,ChEMBL Compound ID,CHEMBL59,Binding - unknown pharmacological activity,pK(b),Binding - Radioligand competition/displacement,5.21,nM,=,,4.07,-13.889,,,[3H]Spiperone,0.0,0.0,,0.0,,P14416,0.4411128363060725
286,26258690,drd2_human,91,V,A,Dopamine,ChEMBL Compound ID,CHEMBL59,Binding - unknown pharmacological activity,pK(b),Binding - Radioligand competition/displacement,6.26,ÂµM,=,,6.26,1.0,,,[3H]Spiperone,0.0,0.0,,0.0,,P14416,0.4411128363060725
287,26258690,drd2_human,95,E,A,Dopamine,ChEMBL Compound ID,CHEMBL59,Binding - unknown pharmacological activity,pK(b),Binding - Radioligand competition/displacement,5.21,nM,=,,5.3,1.23,,,[3H]Spiperone,0.0,0.0,,0.0,,P14416,0.408870583029033
288,26258690,drd2_human,95,E,A,Dopamine,ChEMBL Compound ID,CHEMBL59,Binding - unknown pharmacological activity,pK(b),Binding - Radioligand competition/displacement,6.26,ÂµM,=,,5.31,-8.929,,,[3H]Spiperone,0.0,0.0,,0.0,,P14416,0.408870583029033
289,26258690,drd2_human,95,E,A,Dopamine,ChEMBL Compound ID,CHEMBL59,Binding - unknown pharmacological activity,pK(b),Binding - Radioligand competition/displacement,4.35,ÂµM,=,,6.38,107.152,,,[3H]Spiperone,0.0,0.0,,0.0,,P14416,0.408870583029033
338,24061855,drd2_human,99,E,V,NAPS,SMILES,C1CN(CCC12C(=O)N(CN2C3=CC=CC=C3)CCC4=CC(=C(C=C4)N=[N+]=[N-])I)CCCC(=O)C5=CC=C(C=C5)F,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.13,,=,,9.53,2.512,,,[3H]N-methylspiperone,0.0,0.0,,0.0,,P14416,0.2971485302233662
358,24061855,drd2_human,99,E,V,R-22,SMILES,O[C@H](CCNC(=O)c1cc2ccccc2[nH]1)CN1CCN(CC1)c1cccc(Cl)c1Cl,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.69,,=,,6.33,-2.288,,,[3H]N-methylspiperone,0.0,0.0,,0.0,,P14416,0.2971485302233662
339,24061855,drd2_human,181,E,V,NAPS,SMILES,C1CN(CCC12C(=O)N(CN2C3=CC=CC=C3)CCC4=CC(=C(C=C4)N=[N+]=[N-])I)CCCC(=O)C5=CC=C(C=C5)F,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.13,,=,,9.49,2.291,,,[3H]N-methylspiperone,0.0,0.0,,0.0,,P14416,0.37187868755257
359,24061855,drd2_human,181,E,V,R-22,SMILES,O[C@H](CCNC(=O)c1cc2ccccc2[nH]1)CN1CCN(CC1)c1cccc(Cl)c1Cl,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.69,,=,,6.28,-2.571,,,[3H]N-methylspiperone,0.0,0.0,,0.0,,P14416,0.37187868755257
33,9178745,pth2r_human,180,H,R,PTH,PubChem CID,16133850,Full agonist,Single-point,Functional - cAMP accumulation,0.0,,=,,0.0,-3.333,,,PTH,0.0,30.0,,0.0,,P49190,0.7124410038085488
34,9178745,pth2r_human,365,T,P,PTH,PubChem CID,16133850,Full agonist,Single-point,Functional - cAMP accumulation,0.0,,=,,0.0,-3.333,,,PTH,0.0,130.0,,0.0,,P49190,0.6341527125083057
4,10880516,lshr_human,56,L,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,21.0,-4.762,,,,0.0,0.0,,0.0,,P22888,0.5123059847853424
6,10880516,lshr_human,63,V,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,74.0,-1.351,,,,0.0,0.0,,0.0,,P22888,0.2327150903299616
10,10880516,lshr_human,65,P,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,36.0,-2.778,,,,0.0,0.0,,0.0,,P22888,0.359610484514281
12,10880516,lshr_human,66,S,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,67.0,-1.493,,,,0.0,0.0,,0.0,,P22888,0.2205566865168897
14,10880516,lshr_human,67,Q,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,103.0,1.03,,,,0.0,0.0,,0.0,,P22888,0.2515003700543948
18,10880516,lshr_human,70,R,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,55.0,-1.818,,,,0.0,0.0,,0.0,,P22888,0.2638850761459844
20,10880516,lshr_human,71,G,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,30.0,-3.333,,,,0.0,0.0,,0.0,,P22888,0.3188693839588049
26,10880516,lshr_human,72,L,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,23.0,-4.348,,,,0.0,0.0,,0.0,,P22888,0.4627707840936494
30,10880516,lshr_human,74,E,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,77.0,-1.299,,,,0.0,0.0,,0.0,,P22888,0.2988832379113241
32,10880516,lshr_human,75,V,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,99.0,-1.01,,,,0.0,0.0,,0.0,,P22888,0.4753945580191153
34,10880516,lshr_human,76,I,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,88.0,-1.136,,,,0.0,0.0,,0.0,,P22888,0.3016172530086246
36,10880516,lshr_human,77,K,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,66.0,-1.515,,,,0.0,0.0,,0.0,,P22888,0.3019526320015923
37,20736161,lshr_human,77,K,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,143.0,1.43,,,,0.0,0.0,,0.0,,P22888,0.3019526320015923
38,20736161,lshr_human,77,K,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Specific-binding,binding,100.0,%,,,143.0,1.43,,,,0.0,0.0,,0.0,,P22888,0.3019526320015923
39,20736161,lshr_human,77,K,E,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,228.0,2.28,,,,0.0,0.0,,0.0,,P22888,0.2318052630596504
40,20736161,lshr_human,77,K,E,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Specific-binding,binding,100.0,%,,,159.0,1.59,,,,0.0,0.0,,0.0,,P22888,0.2318052630596504
44,10880516,lshr_human,79,E,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,68.0,-1.471,,,,0.0,0.0,,0.0,,P22888,0.3594406664782584
48,10880516,lshr_human,81,S,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,47.0,-2.128,,,,0.0,0.0,,0.0,,P22888,0.324619439069032
49,20736161,lshr_human,81,S,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,165.0,1.65,,,,0.0,0.0,,0.0,,P22888,0.324619439069032
50,20736161,lshr_human,81,S,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Specific-binding,binding,100.0,%,,,217.0,2.17,,,,0.0,0.0,,0.0,,P22888,0.324619439069032
52,10880516,lshr_human,82,Q,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,68.0,-1.471,,,,0.0,0.0,,0.0,,P22888,0.3811948983763082
54,10880516,lshr_human,83,I,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,63.0,-1.587,,,,0.0,0.0,,0.0,,P22888,0.5177593757729981
56,10880516,lshr_human,84,D,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,97.0,-1.031,,,,0.0,0.0,,0.0,,P22888,0.3422653951136041
64,10880516,lshr_human,88,R,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,103.0,1.03,,,,0.0,0.0,,0.0,,P22888,0.2784639010058399
71,16709601,lshr_human,114,I,F,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,15.0,-6.667,,,,0.0,0.0,,0.0,,P22888,0.5160629880146781
72,16709601,lshr_human,114,I,F,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Specific-binding,binding,100.0,%,,,10.0,-10.0,,,,0.0,0.0,,0.0,,P22888,0.5160629880146781
75,16709601,lshr_human,114,I,V,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,40.0,-2.5,,,,0.0,0.0,,0.0,,P22888,0.383257910344623
76,16709601,lshr_human,114,I,V,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Specific-binding,binding,100.0,%,,,50.0,-2.0,,,,0.0,0.0,,0.0,,P22888,0.383257910344623
82,10884391,lshr_human,126,K,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,45.0,-2.222,,,,0.0,0.0,,0.0,,P22888,0.342274815441475
84,10884391,lshr_human,127,Y,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,79.0,-1.266,,,,0.0,0.0,,0.0,,P22888,0.3137396391609289
85,20736161,lshr_human,127,Y,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,83.0,-1.205,,,,0.0,0.0,,0.0,,P22888,0.3137396391609289
86,20736161,lshr_human,127,Y,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Specific-binding,binding,100.0,%,,,82.0,-1.22,,,,0.0,0.0,,0.0,,P22888,0.3137396391609289
106,10884391,lshr_human,129,S,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,53.0,-1.887,,,,0.0,0.0,,0.0,,P22888,0.3037279897556197
113,10884391,lshr_human,130,I,F,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,37.0,-2.703,,,,0.0,0.0,,0.0,,P22888,0.4872129822049754
117,10884391,lshr_human,130,I,L,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,43.0,-2.326,,,,0.0,0.0,,0.0,,P22888,0.3986179538212016
123,10884391,lshr_human,130,I,V,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,50.0,-2.0,,,,0.0,0.0,,0.0,,P22888,0.3563467491502075
125,10884391,lshr_human,131,C,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,53.0,-1.887,,,,0.0,0.0,,0.0,,P22888,0.3351635877055406
126,9215288,lshr_human,131,C,R,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Specific-binding,binding,100.0,%,,,5.0,-20.0,,,,0.0,0.0,,0.0,,P22888,0.4638653585249902
132,10884391,lshr_human,133,T,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,69.0,-1.449,,,,0.0,0.0,,0.0,,P22888,0.5915538927218229
133,20736161,lshr_human,133,T,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,93.0,-1.075,,,,0.0,0.0,,0.0,,P22888,0.5915538927218229
134,20736161,lshr_human,133,T,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Specific-binding,binding,100.0,%,,,103.0,1.03,,,,0.0,0.0,,0.0,,P22888,0.5915538927218229
136,10884391,lshr_human,134,G,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,20.0,-5.0,,,,0.0,0.0,,0.0,,P22888,0.3156099985851791
138,10884391,lshr_human,135,I,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,79.0,-1.266,,,,0.0,0.0,,0.0,,P22888,0.5545696712179972
140,10884391,lshr_human,136,R,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,45.0,-2.222,,,,0.0,0.0,,0.0,,P22888,0.3034272179775609
142,10884391,lshr_human,137,K,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,85.0,-1.176,,,,0.0,0.0,,0.0,,P22888,0.2615993466400604
146,20736161,lshr_human,154,E,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Specific-binding,binding,100.0,%,,,33.0,-3.03,,,,0.0,0.0,,0.0,,P22888,0.3820400435758073
150,20736161,lshr_human,154,E,K,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Specific-binding,binding,100.0,%,,,20.0,-5.0,,,,0.0,0.0,,0.0,,P22888,0.3013431932557194
151,20736161,lshr_human,154,E,Q,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Specific-binding,binding,100.0,%,,,62.0,-1.613,,,,0.0,0.0,,0.0,,P22888,0.2648572227232847
153,10880516,lshr_human,155,I,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,19.0,-5.263,,,,0.0,0.0,,0.0,,P22888,0.5394352037920725
154,20736161,lshr_human,157,D,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Specific-binding,binding,100.0,%,,,95.0,-1.053,,,,0.0,0.0,,0.0,,P22888,0.4490307419062269
162,10880516,lshr_human,181,L,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,43.0,-2.326,,,,0.0,0.0,,0.0,,P22888,0.5226151611084917
164,12444891,lshr_human,193,A,V,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,38.0,-2.632,,,,0.0,0.0,,0.0,,P22888,0.5729138600971142
167,12444891,lshr_human,194,F,V,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,15.0,-6.667,,,,0.0,0.0,,0.0,,P22888,0.6992896225656924
169,12444891,lshr_human,195,N,I,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,88.0,-1.136,,,,0.0,0.0,,0.0,,P22888,0.405967740748074
176,20736161,lshr_human,228,D,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,91.0,-1.099,,,,0.0,0.0,,0.0,,P22888,0.4959997365252047
177,20736161,lshr_human,228,D,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Specific-binding,binding,100.0,%,,,37.0,-2.703,,,,0.0,0.0,,0.0,,P22888,0.4959997365252047
180,10880516,lshr_human,229,I,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,44.0,-2.273,,,,0.0,0.0,,0.0,,P22888,0.5119959713619953
181,20736161,lshr_human,230,S,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,244.0,2.44,,,,0.0,0.0,,0.0,,P22888,0.3789904532582329
182,20736161,lshr_human,230,S,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Specific-binding,binding,100.0,%,,,95.0,-1.053,,,,0.0,0.0,,0.0,,P22888,0.3789904532582329
184,10889210,lshr_human,276,P,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,174.0,1.74,,,,0.0,0.0,,0.0,,P22888,0.4551528578904945
185,10889210,lshr_human,276,P,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Specific-binding,binding,100.0,%,,,23.0,-4.348,,,,0.0,0.0,,0.0,,P22888,0.4551528578904945
188,10889210,lshr_human,276,P,G,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,130.0,1.3,,,,0.0,0.0,,0.0,,P22888,0.5000415293664939
189,10889210,lshr_human,276,P,G,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Specific-binding,binding,100.0,%,,,19.0,-5.263,,,,0.0,0.0,,0.0,,P22888,0.5000415293664939
194,12356766,lshr_human,277,S,N,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,91.0,-1.099,,,,0.0,0.0,,0.0,,P22888,0.3873648654723373
195,12356766,lshr_human,277,S,N,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,57.0,-1.754,,,,0.0,0.0,,0.0,,P22888,0.3873648654723373
201,18641392,lshr_human,304,C,A,lutropin,IUPHAR/BPS Guide to pharmacology,1159,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,100.0,1.0,,,,0.0,0.0,,0.0,,P22888,0.7364459793506801
204,16901970,lshr_human,331,Y,F,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,88.0,-1.136,,,,0.0,0.0,,0.0,,P22888,0.1782403011846314
206,16901970,lshr_human,333,Y,F,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,94.0,-1.064,,,,0.0,0.0,,0.0,,P22888,0.1865953662543495
208,18641392,lshr_human,336,C,A,lutropin,IUPHAR/BPS Guide to pharmacology,1159,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,100.0,1.0,,,,0.0,0.0,,0.0,,P22888,0.6374352206021188
217,11134146,lshr_human,368,L,P,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,76.0,-1.316,,,,0.0,0.0,,0.0,,P22888,0.4239655286441574
218,11134146,lshr_human,368,L,P,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Specific-binding,binding,100.0,%,,,95.0,-1.053,,,,0.0,0.0,,0.0,,P22888,0.4239655286441574
221,16433250,lshr_human,374,I,T,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,52.0,-1.923,,,,0.0,0.0,,0.0,,P22888,0.4758038650559849
224,10967122,lshr_human,388,R,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,64.0,-1.562,,,,0.0,0.0,,0.0,,P22888,0.3993433318463256
225,10967122,lshr_human,388,R,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Specific-binding,binding,100.0,%,,,88.0,-1.136,,,,0.0,0.0,,0.0,,P22888,0.3993433318463256
228,10967122,lshr_human,390,K,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,41.0,-2.439,,,,0.0,0.0,,0.0,,P22888,0.4919175532331826
229,10967122,lshr_human,390,K,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Specific-binding,binding,100.0,%,,,63.0,-1.587,,,,0.0,0.0,,0.0,,P22888,0.4919175532331826
231,16433250,lshr_human,392,T,I,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,46.0,-2.174,,,,0.0,0.0,,0.0,,P22888,0.5653826628979477
234,10967122,lshr_human,395,R,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,74.0,-1.351,,,,0.0,0.0,,0.0,,P22888,0.5900249254181114
235,10967122,lshr_human,395,R,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Specific-binding,binding,100.0,%,,,24.0,-4.167,,,,0.0,0.0,,0.0,,P22888,0.5900249254181114
237,15016840,lshr_human,398,M,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,85.0,-1.176,,,,0.0,0.0,,0.0,,P22888,0.5374909744816604
238,15016840,lshr_human,398,M,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Specific-binding,binding,100.0,%,,,203.0,2.03,,,,0.0,0.0,,0.0,,P22888,0.5374909744816604
249,15016840,lshr_human,398,M,G,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,21.0,-4.762,,,,0.0,0.0,,0.0,,P22888,0.6247224386586392
250,15016840,lshr_human,398,M,G,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Specific-binding,binding,100.0,%,,,6.0,-16.667,,,,0.0,0.0,,0.0,,P22888,0.6247224386586392
255,15016840,lshr_human,398,M,K,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,4.0,-25.0,,,,0.0,0.0,,0.0,,P22888,0.5374909744816604
264,15016840,lshr_human,398,M,R,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,5.0,-20.0,,,,0.0,0.0,,0.0,,P22888,0.5374909744816604
265,15016840,lshr_human,398,M,R,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Specific-binding,binding,100.0,%,,,3.0,-33.333,,,,0.0,0.0,,0.0,,P22888,0.5374909744816604
271,15016840,lshr_human,398,M,T,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,58.0,-1.724,,,,0.0,0.0,,0.0,,P22888,0.5374909744816604
272,15016840,lshr_human,398,M,T,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Specific-binding,binding,100.0,%,,,16.0,-6.25,,,,0.0,0.0,,0.0,,P22888,0.5374909744816604
273,7593421,lshr_human,398,M,T,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,40.0,-2.5,,,,0.0,0.0,,0.0,,P22888,0.5374909744816604
275,15016840,lshr_human,398,M,V,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,80.0,-1.25,,,,0.0,0.0,,0.0,,P22888,0.4478311035692282
276,15016840,lshr_human,398,M,V,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Specific-binding,binding,100.0,%,,,66.0,-1.515,,,,0.0,0.0,,0.0,,P22888,0.4478311035692282
278,15016840,lshr_human,398,M,W,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,27.0,-3.704,,,,0.0,0.0,,0.0,,P22888,0.5374909744816604
279,15016840,lshr_human,398,M,W,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Specific-binding,binding,100.0,%,,,24.0,-4.167,,,,0.0,0.0,,0.0,,P22888,0.5374909744816604
284,20835841,lshr_human,400,N,W,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,81.0,-1.235,,,,0.0,0.0,,0.0,,P22888,0.7537009115893112
285,20835841,lshr_human,400,N,W,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Specific-binding,binding,100.0,%,,,32.0,-3.125,,,,0.0,0.0,,0.0,,P22888,0.7537009115893112
288,19616090,lshr_human,405,D,N,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,40.0,-2.5,,,,0.0,0.0,,0.0,,P22888,0.7718656137425405
289,20835841,lshr_human,405,D,N,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,28.0,-3.571,,,,0.0,0.0,,0.0,,P22888,0.7718656137425405
290,20835841,lshr_human,405,D,N,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Specific-binding,binding,100.0,%,,,143.0,1.43,,,,0.0,0.0,,0.0,,P22888,0.7718656137425405
291,17872379,lshr_human,459,V,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,63.0,-1.587,,,,0.0,0.0,,0.0,,P22888,0.4532849142933635
292,17872379,lshr_human,459,V,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Specific-binding,binding,100.0,%,,,49.0,-2.041,,,,0.0,0.0,,0.0,,P22888,0.4532849142933635
293,17872379,lshr_human,460,I,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,47.0,-2.128,,,,0.0,0.0,,0.0,,P22888,0.5962616969873328
294,17872379,lshr_human,460,I,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Specific-binding,binding,100.0,%,,,43.0,-2.326,,,,0.0,0.0,,0.0,,P22888,0.5962616969873328
296,17872379,lshr_human,461,T,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,51.0,-1.961,,,,0.0,0.0,,0.0,,P22888,0.5871742772764843
297,17872379,lshr_human,461,T,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Specific-binding,binding,100.0,%,,,108.0,1.08,,,,0.0,0.0,,0.0,,P22888,0.5871742772764843
298,17872379,lshr_human,462,L,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,89.0,-1.124,,,,0.0,0.0,,0.0,,P22888,0.4972539583686494
299,17872379,lshr_human,462,L,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Specific-binding,binding,100.0,%,,,69.0,-1.449,,,,0.0,0.0,,0.0,,P22888,0.4972539583686494
303,17872379,lshr_human,464,R,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,5.0,-20.0,,,,0.0,0.0,,0.0,,P22888,0.851073987976714
304,17872379,lshr_human,464,R,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Specific-binding,binding,100.0,%,,,6.0,-16.667,,,,0.0,0.0,,0.0,,P22888,0.851073987976714
305,9973249,lshr_human,464,R,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,30.0,-3.333,,,,0.0,0.0,,0.0,,P22888,0.851073987976714
306,17872379,lshr_human,465,W,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,26.0,-3.846,,,,0.0,0.0,,0.0,,P22888,0.6639545926768362
307,17872379,lshr_human,465,W,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Specific-binding,binding,100.0,%,,,10.0,-10.0,,,,0.0,0.0,,0.0,,P22888,0.6639545926768362
308,17872379,lshr_human,466,H,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,64.0,-1.562,,,,0.0,0.0,,0.0,,P22888,0.5324333004218699
309,17872379,lshr_human,466,H,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Specific-binding,binding,100.0,%,,,58.0,-1.724,,,,0.0,0.0,,0.0,,P22888,0.5324333004218699
311,17872379,lshr_human,467,T,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,124.0,1.24,,,,0.0,0.0,,0.0,,P22888,0.4804760751972391
312,17872379,lshr_human,467,T,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Specific-binding,binding,100.0,%,,,181.0,1.81,,,,0.0,0.0,,0.0,,P22888,0.4804760751972391
314,17872379,lshr_human,468,I,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,5.0,-20.0,,,,0.0,0.0,,0.0,,P22888,0.596941981291351
315,17872379,lshr_human,468,I,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Specific-binding,binding,100.0,%,,,19.0,-5.263,,,,0.0,0.0,,0.0,,P22888,0.596941981291351
316,17872379,lshr_human,469,T,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,200.0,2.0,,,,0.0,0.0,,0.0,,P22888,0.500072056109154
317,17872379,lshr_human,469,T,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Specific-binding,binding,100.0,%,,,207.0,2.07,,,,0.0,0.0,,0.0,,P22888,0.500072056109154
318,17872379,lshr_human,470,Y,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,136.0,1.36,,,,0.0,0.0,,0.0,,P22888,0.4943502734041765
319,17872379,lshr_human,470,Y,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Specific-binding,binding,100.0,%,,,159.0,1.59,,,,0.0,0.0,,0.0,,P22888,0.4943502734041765
321,17872379,lshr_human,472,I,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,91.0,-1.099,,,,0.0,0.0,,0.0,,P22888,0.5318394964933385
322,17872379,lshr_human,472,I,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Specific-binding,binding,100.0,%,,,187.0,1.87,,,,0.0,0.0,,0.0,,P22888,0.5318394964933385
323,17872379,lshr_human,473,H,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,169.0,1.69,,,,0.0,0.0,,0.0,,P22888,0.5169408876106851
324,17872379,lshr_human,473,H,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Specific-binding,binding,100.0,%,,,183.0,1.83,,,,0.0,0.0,,0.0,,P22888,0.5169408876106851
325,17872379,lshr_human,474,L,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,78.0,-1.282,,,,0.0,0.0,,0.0,,P22888,0.5261886413418886
326,17872379,lshr_human,474,L,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Specific-binding,binding,100.0,%,,,98.0,-1.02,,,,0.0,0.0,,0.0,,P22888,0.5261886413418886
327,17872379,lshr_human,475,D,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,160.0,1.6,,,,0.0,0.0,,0.0,,P22888,0.528808651233249
329,17872379,lshr_human,475,D,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Specific-binding,binding,100.0,%,,,178.0,1.78,,,,0.0,0.0,,0.0,,P22888,0.528808651233249
330,17872379,lshr_human,476,Q,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,90.0,-1.111,,,,0.0,0.0,,0.0,,P22888,0.4011529486058558
331,17872379,lshr_human,476,Q,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Specific-binding,binding,100.0,%,,,92.0,-1.087,,,,0.0,0.0,,0.0,,P22888,0.4011529486058558
333,18162522,lshr_human,476,Q,R,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,100.0,1.0,,,,0.0,0.0,,0.0,,P22888,0.3184993582638656
335,17872379,lshr_human,477,K,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,38.0,-2.632,,,,0.0,0.0,,0.0,,P22888,0.40115373458066
336,17872379,lshr_human,477,K,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Specific-binding,binding,100.0,%,,,9.0,-11.111,,,,0.0,0.0,,0.0,,P22888,0.40115373458066
337,9973249,lshr_human,477,K,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,100.0,1.0,,,,0.0,0.0,,0.0,,P22888,0.40115373458066
338,17872379,lshr_human,478,L,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,54.0,-1.852,,,,0.0,0.0,,0.0,,P22888,0.5488982073975525
339,17872379,lshr_human,478,L,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Specific-binding,binding,100.0,%,,,108.0,1.08,,,,0.0,0.0,,0.0,,P22888,0.5488982073975525
342,17872379,lshr_human,479,R,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,107.0,1.07,,,,0.0,0.0,,0.0,,P22888,0.4048879566727495
343,17872379,lshr_human,479,R,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Specific-binding,binding,100.0,%,,,110.0,1.1,,,,0.0,0.0,,0.0,,P22888,0.4048879566727495
344,9973249,lshr_human,479,R,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,100.0,1.0,,,,0.0,0.0,,0.0,,P22888,0.4048879566727495
345,17872379,lshr_human,480,L,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,81.0,-1.235,,,,0.0,0.0,,0.0,,P22888,0.2854400338335883
346,17872379,lshr_human,480,L,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Specific-binding,binding,100.0,%,,,44.0,-2.273,,,,0.0,0.0,,0.0,,P22888,0.2854400338335883
348,17872379,lshr_human,481,R,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,64.0,-1.562,,,,0.0,0.0,,0.0,,P22888,0.2658766570674242
349,17872379,lshr_human,481,R,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Specific-binding,binding,100.0,%,,,57.0,-1.754,,,,0.0,0.0,,0.0,,P22888,0.2658766570674242
350,9973249,lshr_human,481,R,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,60.0,-1.667,,,,0.0,0.0,,0.0,,P22888,0.2658766570674242
352,17872379,lshr_human,482,H,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,90.0,-1.111,,,,0.0,0.0,,0.0,,P22888,0.4539184692640168
353,17872379,lshr_human,482,H,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Specific-binding,binding,100.0,%,,,124.0,1.24,,,,0.0,0.0,,0.0,,P22888,0.4539184692640168
354,9973249,lshr_human,482,H,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,70.0,-1.429,,,,0.0,0.0,,0.0,,P22888,0.4539184692640168
359,15372531,lshr_human,502,L,P,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Specific-binding,binding,100.0,%,,,10.0,-10.0,,,,0.0,0.0,,0.0,,P22888,0.561895139589399
369,9497355,lshr_human,509,M,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,82.0,-1.22,,,,0.0,0.0,,0.0,,P22888,0.4745000504766697
372,9497355,lshr_human,510,K,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,129.0,1.29,,,,0.0,0.0,,0.0,,P22888,0.4799537784095101
374,9497355,lshr_human,511,V,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,129.0,1.29,,,,0.0,0.0,,0.0,,P22888,0.4721652095182655
377,11118455,lshr_human,512,S,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,94.0,-1.064,,,,0.0,0.0,,0.0,,P22888,0.5177120793687818
378,11118455,lshr_human,512,S,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Specific-binding,binding,100.0,%,,,91.0,-1.099,,,,0.0,0.0,,0.0,,P22888,0.5177120793687818
379,9497355,lshr_human,512,S,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,88.0,-1.136,,,,0.0,0.0,,0.0,,P22888,0.5177120793687818
381,9497355,lshr_human,513,I,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,48.0,-2.083,,,,0.0,0.0,,0.0,,P22888,0.5888593120260587
386,11118455,lshr_human,515,F,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,69.0,-1.449,,,,0.0,0.0,,0.0,,P22888,0.613915976194821
387,11118455,lshr_human,515,F,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Specific-binding,binding,100.0,%,,,100.0,1.0,,,,0.0,0.0,,0.0,,P22888,0.613915976194821
388,9497355,lshr_human,515,F,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,112.0,1.12,,,,0.0,0.0,,0.0,,P22888,0.613915976194821
392,9497355,lshr_human,517,M,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,78.0,-1.282,,,,0.0,0.0,,0.0,,P22888,0.521712601149025
395,9497355,lshr_human,518,D,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,122.0,1.22,,,,0.0,0.0,,0.0,,P22888,0.5519523948483893
398,11118455,lshr_human,519,V,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,106.0,1.06,,,,0.0,0.0,,0.0,,P22888,0.4007991472344828
399,11118455,lshr_human,519,V,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Specific-binding,binding,100.0,%,,,75.0,-1.333,,,,0.0,0.0,,0.0,,P22888,0.4007991472344828
400,9497355,lshr_human,519,V,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,85.0,-1.176,,,,0.0,0.0,,0.0,,P22888,0.4007991472344828
402,9497355,lshr_human,520,E,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,108.0,1.08,,,,0.0,0.0,,0.0,,P22888,0.3911041294967589
405,11118455,lshr_human,521,T,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,78.0,-1.282,,,,0.0,0.0,,0.0,,P22888,0.3240805143197638
406,11118455,lshr_human,521,T,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Specific-binding,binding,100.0,%,,,100.0,1.0,,,,0.0,0.0,,0.0,,P22888,0.3240805143197638
407,9497355,lshr_human,521,T,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,82.0,-1.22,,,,0.0,0.0,,0.0,,P22888,0.3240805143197638
409,9497355,lshr_human,522,T,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,112.0,1.12,,,,0.0,0.0,,0.0,,P22888,0.2516545205909873
411,9497355,lshr_human,523,L,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,80.0,-1.25,,,,0.0,0.0,,0.0,,P22888,0.2936722830898607
413,9497355,lshr_human,524,S,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,71.0,-1.408,,,,0.0,0.0,,0.0,,P22888,0.4344082345791391
415,9497355,lshr_human,525,Q,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,97.0,-1.031,,,,0.0,0.0,,0.0,,P22888,0.3806379778473946
421,19616090,lshr_human,546,Y,F,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,40.0,-2.5,,,,0.0,0.0,,0.0,,P22888,0.6262368325708866
424,10967122,lshr_human,548,K,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,142.0,1.42,,,,0.0,0.0,,0.0,,P22888,0.4392180440754417
425,10967122,lshr_human,548,K,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Specific-binding,binding,100.0,%,,,62.0,-1.613,,,,0.0,0.0,,0.0,,P22888,0.4392180440754417
426,17872379,lshr_human,548,K,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,123.0,1.23,,,,0.0,0.0,,0.0,,P22888,0.4392180440754417
427,17872379,lshr_human,548,K,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Specific-binding,binding,100.0,%,,,117.0,1.17,,,,0.0,0.0,,0.0,,P22888,0.4392180440754417
428,17872379,lshr_human,549,I,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,14.0,-7.143,,,,0.0,0.0,,0.0,,P22888,0.6303596052322201
429,17872379,lshr_human,549,I,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Specific-binding,binding,100.0,%,,,13.0,-7.692,,,,0.0,0.0,,0.0,,P22888,0.6303596052322201
430,17872379,lshr_human,550,Y,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,82.0,-1.22,,,,0.0,0.0,,0.0,,P22888,0.5663656322102117
431,17872379,lshr_human,550,Y,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Specific-binding,binding,100.0,%,,,84.0,-1.19,,,,0.0,0.0,,0.0,,P22888,0.5663656322102117
432,17872379,lshr_human,551,F,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,131.0,1.31,,,,0.0,0.0,,0.0,,P22888,0.3076394035493793
433,17872379,lshr_human,551,F,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Specific-binding,binding,100.0,%,,,155.0,1.55,,,,0.0,0.0,,0.0,,P22888,0.3076394035493793
434,17872379,lshr_human,553,V,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,96.0,-1.042,,,,0.0,0.0,,0.0,,P22888,0.5447361219882435
435,17872379,lshr_human,553,V,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Specific-binding,binding,100.0,%,,,130.0,1.3,,,,0.0,0.0,,0.0,,P22888,0.5447361219882435
436,17872379,lshr_human,554,R,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,66.0,-1.515,,,,0.0,0.0,,0.0,,P22888,0.4560495091141439
437,17872379,lshr_human,554,R,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Specific-binding,binding,100.0,%,,,56.0,-1.786,,,,0.0,0.0,,0.0,,P22888,0.4560495091141439
440,17872379,lshr_human,556,P,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,87.0,-1.149,,,,0.0,0.0,,0.0,,P22888,0.5468687001432291
441,17872379,lshr_human,556,P,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Specific-binding,binding,100.0,%,,,157.0,1.57,,,,0.0,0.0,,0.0,,P22888,0.5468687001432291
442,17872379,lshr_human,557,E,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,126.0,1.26,,,,0.0,0.0,,0.0,,P22888,0.4407360074304159
443,17872379,lshr_human,557,E,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Specific-binding,binding,100.0,%,,,175.0,1.75,,,,0.0,0.0,,0.0,,P22888,0.4407360074304159
444,17872379,lshr_human,558,L,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,94.0,-1.064,,,,0.0,0.0,,0.0,,P22888,0.4175086619190179
445,17872379,lshr_human,558,L,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Specific-binding,binding,100.0,%,,,133.0,1.33,,,,0.0,0.0,,0.0,,P22888,0.4175086619190179
446,17872379,lshr_human,559,M,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,117.0,1.17,,,,0.0,0.0,,0.0,,P22888,0.3855077246988475
447,17872379,lshr_human,559,M,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Specific-binding,binding,100.0,%,,,99.0,-1.01,,,,0.0,0.0,,0.0,,P22888,0.3855077246988475
448,17872379,lshr_human,561,T,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,108.0,1.08,,,,0.0,0.0,,0.0,,P22888,0.3506852317102944
449,17872379,lshr_human,561,T,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Specific-binding,binding,100.0,%,,,170.0,1.7,,,,0.0,0.0,,0.0,,P22888,0.3506852317102944
452,17872379,lshr_human,563,K,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,95.0,-1.053,,,,0.0,0.0,,0.0,,P22888,0.5200939368765423
453,17872379,lshr_human,563,K,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Specific-binding,binding,100.0,%,,,125.0,1.25,,,,0.0,0.0,,0.0,,P22888,0.5200939368765423
456,17872379,lshr_human,564,D,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,84.0,-1.19,,,,0.0,0.0,,0.0,,P22888,0.6886736978628003
457,17872379,lshr_human,564,D,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Specific-binding,binding,100.0,%,,,87.0,-1.149,,,,0.0,0.0,,0.0,,P22888,0.6886736978628003
458,9584216,lshr_human,564,D,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,73.0,-1.37,,,,0.0,0.0,,0.0,,P22888,0.6886736978628003
459,9584216,lshr_human,564,D,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,130.0,1.3,,,,0.0,0.0,,0.0,,P22888,0.6886736978628003
460,9584216,lshr_human,564,D,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Specific-binding,binding,100.0,%,,,127.0,1.27,,,,0.0,0.0,,0.0,,P22888,0.6886736978628003
472,9584216,lshr_human,564,D,F,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,84.0,-1.19,,,,0.0,0.0,,0.0,,P22888,0.7258694793614326
473,9584216,lshr_human,564,D,F,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,68.0,-1.471,,,,0.0,0.0,,0.0,,P22888,0.7258694793614326
474,9584216,lshr_human,564,D,F,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Specific-binding,binding,100.0,%,,,80.0,-1.25,,,,0.0,0.0,,0.0,,P22888,0.7258694793614326
480,10889210,lshr_human,564,D,G,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,61.0,-1.639,,,,0.0,0.0,,0.0,,P22888,0.6488608549545318
481,10889210,lshr_human,564,D,G,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Specific-binding,binding,100.0,%,,,27.0,-3.704,,,,0.0,0.0,,0.0,,P22888,0.6488608549545318
482,7892197,lshr_human,564,D,G,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,50.0,-2.0,,,,0.0,0.0,,0.0,,P22888,0.6488608549545318
483,9584216,lshr_human,564,D,G,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,101.0,1.01,,,,0.0,0.0,,0.0,,P22888,0.6488608549545318
484,9584216,lshr_human,564,D,G,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,87.0,-1.149,,,,0.0,0.0,,0.0,,P22888,0.6488608549545318
485,9584216,lshr_human,564,D,G,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Specific-binding,binding,100.0,%,,,79.0,-1.266,,,,0.0,0.0,,0.0,,P22888,0.6488608549545318
486,9973249,lshr_human,564,D,G,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,74.0,-1.351,,,,0.0,0.0,,0.0,,P22888,0.6488608549545318
487,9973249,lshr_human,564,D,G,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,184.0,1.84,,,,0.0,0.0,,0.0,,P22888,0.6488608549545318
488,9973249,lshr_human,564,D,G,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Specific-binding,binding,100.0,%,,,73.0,-1.37,,,,0.0,0.0,,0.0,,P22888,0.6488608549545318
495,9584216,lshr_human,564,D,L,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,60.0,-1.667,,,,0.0,0.0,,0.0,,P22888,0.7601588871505693
496,9584216,lshr_human,564,D,L,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,86.0,-1.163,,,,0.0,0.0,,0.0,,P22888,0.7601588871505693
497,9584216,lshr_human,564,D,L,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Specific-binding,binding,100.0,%,,,70.0,-1.429,,,,0.0,0.0,,0.0,,P22888,0.7601588871505693
501,9584216,lshr_human,564,D,N,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,121.0,1.21,,,,0.0,0.0,,0.0,,P22888,0.5631926169164065
502,9584216,lshr_human,564,D,N,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,154.0,1.54,,,,0.0,0.0,,0.0,,P22888,0.5631926169164065
503,9584216,lshr_human,564,D,N,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Specific-binding,binding,100.0,%,,,94.0,-1.064,,,,0.0,0.0,,0.0,,P22888,0.5631926169164065
504,9973249,lshr_human,564,D,N,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,76.0,-1.316,,,,0.0,0.0,,0.0,,P22888,0.5631926169164065
505,9973249,lshr_human,564,D,N,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,237.0,2.37,,,,0.0,0.0,,0.0,,P22888,0.5631926169164065
506,9973249,lshr_human,564,D,N,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Specific-binding,binding,100.0,%,,,98.0,-1.02,,,,0.0,0.0,,0.0,,P22888,0.5631926169164065
507,17872379,lshr_human,564,D,R,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,27.0,-3.704,,,,0.0,0.0,,0.0,,P22888,0.6886736978628003
508,17872379,lshr_human,564,D,R,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Specific-binding,binding,100.0,%,,,156.0,1.56,,,,0.0,0.0,,0.0,,P22888,0.6886736978628003
511,9584216,lshr_human,564,D,V,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,72.0,-1.389,,,,0.0,0.0,,0.0,,P22888,0.7258694793614326
512,9584216,lshr_human,564,D,V,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,86.0,-1.163,,,,0.0,0.0,,0.0,,P22888,0.7258694793614326
513,9584216,lshr_human,564,D,V,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Specific-binding,binding,100.0,%,,,73.0,-1.37,,,,0.0,0.0,,0.0,,P22888,0.7258694793614326
515,10967122,lshr_human,566,K,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,103.0,1.03,,,,0.0,0.0,,0.0,,P22888,0.5143473731725008
516,10967122,lshr_human,566,K,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Specific-binding,binding,100.0,%,,,89.0,-1.124,,,,0.0,0.0,,0.0,,P22888,0.5143473731725008
521,10967122,lshr_human,569,K,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,138.0,1.38,,,,0.0,0.0,,0.0,,P22888,0.5451345436020645
522,10967122,lshr_human,569,K,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Specific-binding,binding,100.0,%,,,72.0,-1.389,,,,0.0,0.0,,0.0,,P22888,0.5451345436020645
525,10967122,lshr_human,570,K,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,65.0,-1.538,,,,0.0,0.0,,0.0,,P22888,0.6514442379586458
526,10967122,lshr_human,570,K,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Specific-binding,binding,100.0,%,,,32.0,-3.125,,,,0.0,0.0,,0.0,,P22888,0.6514442379586458
534,7714085,lshr_human,572,A,V,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,89.0,-1.124,,,,0.0,0.0,,0.0,,P22888,0.4851553809181582
535,7714085,lshr_human,572,A,V,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,74.0,-1.351,,,,0.0,0.0,,0.0,,P22888,0.4851553809181582
542,9253338,lshr_human,576,F,I,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,100.0,1.0,,,,0.0,0.0,,0.0,,P22888,0.3805230625657446
543,9253338,lshr_human,576,F,I,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,107.0,1.07,,,,0.0,0.0,,0.0,,P22888,0.3805230625657446
544,9253338,lshr_human,576,F,I,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Specific-binding,binding,100.0,%,,,87.0,-1.149,,,,0.0,0.0,,0.0,,P22888,0.3805230625657446
546,9253338,lshr_human,576,F,Y,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,56.0,-1.786,,,,0.0,0.0,,0.0,,P22888,0.2636821525253632
547,9253338,lshr_human,576,F,Y,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,52.0,-1.923,,,,0.0,0.0,,0.0,,P22888,0.2636821525253632
548,9253338,lshr_human,576,F,Y,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Specific-binding,binding,100.0,%,,,47.0,-2.128,,,,0.0,0.0,,0.0,,P22888,0.2636821525253632
551,7757065,lshr_human,577,T,I,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Specific-binding,binding,100.0,%,,,60.0,-1.667,,,,0.0,0.0,,0.0,,P22888,0.5376426908193161
561,8943222,lshr_human,578,D,F,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,93.0,-1.075,,,,0.0,0.0,,0.0,,P22888,0.7865201095832073
562,8943222,lshr_human,578,D,F,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,104.0,1.04,,,,0.0,0.0,,0.0,,P22888,0.7865201095832073
563,8943222,lshr_human,578,D,F,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Specific-binding,binding,100.0,%,,,65.0,-1.538,,,,0.0,0.0,,0.0,,P22888,0.7865201095832073
572,21490077,lshr_human,578,D,G,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,25.0,-4.0,,,,0.0,0.0,,0.0,,P22888,0.7199546306152509
573,21490077,lshr_human,578,D,G,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,125.0,1.25,,,,0.0,0.0,,0.0,,P22888,0.7199546306152509
574,7692306,lshr_human,578,D,G,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,42.0,-2.381,,,,0.0,0.0,,0.0,,P22888,0.7199546306152509
575,7892197,lshr_human,578,D,G,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,80.0,-1.25,,,,0.0,0.0,,0.0,,P22888,0.7199546306152509
576,8943222,lshr_human,578,D,G,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,82.0,-1.22,,,,0.0,0.0,,0.0,,P22888,0.7199546306152509
577,8943222,lshr_human,578,D,G,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,81.0,-1.235,,,,0.0,0.0,,0.0,,P22888,0.7199546306152509
578,8943222,lshr_human,578,D,G,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Specific-binding,binding,100.0,%,,,56.0,-1.786,,,,0.0,0.0,,0.0,,P22888,0.7199546306152509
579,9584216,lshr_human,578,D,G,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,103.0,1.03,,,,0.0,0.0,,0.0,,P22888,0.7199546306152509
580,9584216,lshr_human,578,D,G,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,80.0,-1.25,,,,0.0,0.0,,0.0,,P22888,0.7199546306152509
581,9584216,lshr_human,578,D,G,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Specific-binding,binding,100.0,%,,,80.0,-1.25,,,,0.0,0.0,,0.0,,P22888,0.7199546306152509
582,9973550,lshr_human,578,D,G,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,25.0,-4.0,,,,0.0,0.0,,0.0,,P22888,0.7199546306152509
591,10580072,lshr_human,578,D,H,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Specific-binding,binding,100.0,%,,,400.0,4.0,,,,0.0,0.0,,0.0,,P22888,0.7199546306152509
592,12356766,lshr_human,578,D,H,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,65.0,-1.538,,,,0.0,0.0,,0.0,,P22888,0.7199546306152509
593,12356766,lshr_human,578,D,H,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,123.0,1.23,,,,0.0,0.0,,0.0,,P22888,0.7199546306152509
594,17872379,lshr_human,578,D,H,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Specific-binding,binding,100.0,%,,,533.0,5.33,,,,0.0,0.0,,0.0,,P22888,0.7199546306152509
596,20835841,lshr_human,578,D,H,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Specific-binding,binding,100.0,%,,,116.0,1.16,,,,0.0,0.0,,0.0,,P22888,0.7199546306152509
598,21490077,lshr_human,578,D,H,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,80.0,-1.25,,,,0.0,0.0,,0.0,,P22888,0.7199546306152509
601,8943222,lshr_human,578,D,L,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,48.0,-2.083,,,,0.0,0.0,,0.0,,P22888,0.8151653453494662
602,8943222,lshr_human,578,D,L,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,34.0,-2.941,,,,0.0,0.0,,0.0,,P22888,0.8151653453494662
603,8943222,lshr_human,578,D,L,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Specific-binding,binding,100.0,%,,,11.0,-9.091,,,,0.0,0.0,,0.0,,P22888,0.8151653453494662
606,8943222,lshr_human,578,D,N,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,84.0,-1.19,,,,0.0,0.0,,0.0,,P22888,0.642046644455453
607,8943222,lshr_human,578,D,N,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,86.0,-1.163,,,,0.0,0.0,,0.0,,P22888,0.642046644455453
608,8943222,lshr_human,578,D,N,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Specific-binding,binding,100.0,%,,,165.0,1.65,,,,0.0,0.0,,0.0,,P22888,0.642046644455453
611,8943222,lshr_human,578,D,P,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,8.0,-12.5,,,,0.0,0.0,,0.0,,P22888,0.7199546306152509
612,8943222,lshr_human,578,D,P,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,24.0,-4.167,,,,0.0,0.0,,0.0,,P22888,0.7199546306152509
625,9973550,lshr_human,578,D,W,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,51.0,-1.961,,,,0.0,0.0,,0.0,,P22888,0.8151653453494662
634,10580072,lshr_human,578,D,Y,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Specific-binding,binding,100.0,%,,,300.0,3.0,,,,0.0,0.0,,0.0,,P22888,0.7865201095832073
635,10889210,lshr_human,578,D,Y,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,65.0,-1.538,,,,0.0,0.0,,0.0,,P22888,0.7865201095832073
636,10889210,lshr_human,578,D,Y,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Specific-binding,binding,100.0,%,,,57.0,-1.754,,,,0.0,0.0,,0.0,,P22888,0.7865201095832073
637,8943222,lshr_human,578,D,Y,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,100.0,1.0,,,,0.0,0.0,,0.0,,P22888,0.7865201095832073
638,8943222,lshr_human,578,D,Y,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,70.0,-1.429,,,,0.0,0.0,,0.0,,P22888,0.7865201095832073
639,8943222,lshr_human,578,D,Y,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Specific-binding,binding,100.0,%,,,135.0,1.35,,,,0.0,0.0,,0.0,,P22888,0.7865201095832073
640,9584216,lshr_human,578,D,Y,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,134.0,1.34,,,,0.0,0.0,,0.0,,P22888,0.7865201095832073
641,9584216,lshr_human,578,D,Y,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,146.0,1.46,,,,0.0,0.0,,0.0,,P22888,0.7865201095832073
642,9584216,lshr_human,578,D,Y,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Specific-binding,binding,100.0,%,,,166.0,1.66,,,,0.0,0.0,,0.0,,P22888,0.7865201095832073
643,9973550,lshr_human,578,D,Y,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,50.0,-2.0,,,,0.0,0.0,,0.0,,P22888,0.7865201095832073
646,9100567,lshr_human,588,F,S,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,30.0,-3.333,,,,0.0,0.0,,0.0,,P22888,0.5543101775809652
649,7719343,lshr_human,593,A,P,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Specific-binding,binding,100.0,%,,,20.0,-5.0,,,,0.0,0.0,,0.0,,P22888,0.5119128336049679
656,20835841,lshr_human,615,N,D,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,8.0,-12.5,,,,0.0,0.0,,0.0,,P22888,0.7587092211516241
657,20835841,lshr_human,615,N,D,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Specific-binding,binding,100.0,%,,,34.0,-2.941,,,,0.0,0.0,,0.0,,P22888,0.7587092211516241
664,9626653,lshr_human,616,S,Y,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,47.0,-2.128,,,,0.0,0.0,,0.0,,P22888,0.8010880946807463
665,9626653,lshr_human,616,S,Y,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Specific-binding,binding,100.0,%,,,14.0,-7.143,,,,0.0,0.0,,0.0,,P22888,0.8010880946807463
666,8559204,lshr_human,616,S,Y,human lutropin,IUPHAR/BPS Guide to pharmacology,1159,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,3.0,-33.333,,,,0.0,0.0,,0.0,,P22888,0.8010880946807463
672,20835841,lshr_human,619,N,D,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,32.0,-3.125,,,,0.0,0.0,,0.0,,P22888,0.7948604719206255
673,20835841,lshr_human,619,N,D,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Specific-binding,binding,100.0,%,,,97.0,-1.031,,,,0.0,0.0,,0.0,,P22888,0.7948604719206255
678,20835841,lshr_human,623,Y,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Specific-binding,binding,100.0,%,,,12.0,-8.333,,,,0.0,0.0,,0.0,,P22888,0.8272838743446131
680,9626653,lshr_human,625,I,K,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,60.0,-1.667,,,,0.0,0.0,,0.0,,P22888,0.6389234402418905
681,9626653,lshr_human,625,I,K,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Specific-binding,binding,100.0,%,,,68.0,-1.471,,,,0.0,0.0,,0.0,,P22888,0.6389234402418905
684,10967122,lshr_human,628,K,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,63.0,-1.587,,,,0.0,0.0,,0.0,,P22888,0.5084155481225482
685,10967122,lshr_human,628,K,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Specific-binding,binding,100.0,%,,,43.0,-2.326,,,,0.0,0.0,,0.0,,P22888,0.5084155481225482
688,10967122,lshr_human,632,R,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,116.0,1.16,,,,0.0,0.0,,0.0,,P22888,0.411188917397321
689,10967122,lshr_human,632,R,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Specific-binding,binding,100.0,%,,,32.0,-3.125,,,,0.0,0.0,,0.0,,P22888,0.411188917397321
692,10967122,lshr_human,640,K,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,76.0,-1.316,,,,0.0,0.0,,0.0,,P22888,0.3434252385984588
693,10967122,lshr_human,640,K,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Specific-binding,binding,100.0,%,,,66.0,-1.515,,,,0.0,0.0,,0.0,,P22888,0.3434252385984588
696,10967122,lshr_human,645,K,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,113.0,1.13,,,,0.0,0.0,,0.0,,P22888,0.3248815254801512
697,10967122,lshr_human,645,K,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Specific-binding,binding,100.0,%,,,57.0,-1.754,,,,0.0,0.0,,0.0,,P22888,0.3248815254801512
700,10967122,lshr_human,646,R,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,96.0,-1.042,,,,0.0,0.0,,0.0,,P22888,0.3136364461065055
701,10967122,lshr_human,646,R,A,human choriogonadotropin,IUPHAR/BPS Guide to pharmacology,1160,Full agonist,Specific-binding,binding,100.0,%,,,64.0,-1.562,,,,0.0,0.0,,0.0,,P22888,0.3136364461065055
3,10.1038/s41594-018-0116-7,5ht2b_human,225,A,S,Methylergonovine,PubChem CID,8226,Partial agonist,EC50,Functional - Ca2+ accumulation,23.0,nM,=,,15.0,1.533,,,,0.0,0.0,,91.0,,P41595,0.4423172795922698
24,10.1038/s41594-018-0116-7,5ht2b_human,225,A,S,5-HT,PubChem CID,5202,Full agonist,EC50,Functional - Ca2+ accumulation,3.2,nM,=,,1.4,2.286,,,,0.0,0.0,,0.0,,P41595,0.4423172795922698
42,10.1038/s41594-018-0116-7,5ht2b_human,225,A,S,LSD,PubChem CID,5761,Partial agonist,K(d),Binding - Radioligand competition/displacement,0.58,nM,=,,0.28,2.071,,,[3H]-LSD,0.0,0.0,,0.0,,P41595,0.4423172795922698
47,10.1038/s41594-018-0116-7,5ht2b_human,225,A,S,Methylergonovine,PubChem CID,8226,Partial agonist,K(i),Binding - Radioligand competition/displacement,0.37,nM,=,,0.3,1.233,,,[3H]-LSD,0.0,0.0,,0.0,,P41595,0.4423172795922698
52,10.1038/s41594-018-0116-7,5ht2b_human,225,A,S,Methysergide,PubChem CID,9681,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.16,nM,=,,1.77,-11.111,,,[3H]-LSD,0.0,0.0,,0.0,,P41595,0.4423172795922698
104,23519210,5ht2b_human,225,A,S,5-HT,ChEMBL Compound ID,CHEMBL39,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.41,,=,,8.44,1.072,,,[3H]LSD,0.0,0.0,,0.0,,P41595,0.4423172795922698
130,23519210,5ht2b_human,225,A,S,Ergotamine,ChEMBL Compound ID,CHEMBL442,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.56,,=,,8.24,4.786,,,[3H]LSD,0.0,0.0,,0.0,,P41595,0.4423172795922698
148,23519210,5ht2b_human,225,A,S,LSD,ChEMBL Compound ID,CHEMBL463207,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.38,,=,,8.81,2.692,,,[3H]LSD,0.0,0.0,,0.0,,P41595,0.4423172795922698
4,10.1038/s41594-018-0116-7,5ht2b_human,225,A,G,Methylergonovine,PubChem CID,8226,Partial agonist,EC50,Functional - Ca2+ accumulation,23.0,nM,=,,12.0,1.917,,,,0.0,0.0,,86.0,,P41595,0.487059719567104
25,10.1038/s41594-018-0116-7,5ht2b_human,225,A,G,5-HT,PubChem CID,5202,Full agonist,EC50,Functional - Ca2+ accumulation,3.2,nM,=,,1.5,2.133,,,,0.0,0.0,,0.0,,P41595,0.487059719567104
29,10.1038/s41594-018-0116-7,5ht2b_human,225,A,G,5-HT,PubChem CID,5202,Full agonist,EC50,Functional - Ca2+ accumulation,2.2,nM,=,,1.5,1.467,,,,0.0,0.0,,0.0,,P41595,0.487059719567104
30,10.1038/s41594-018-0116-7,5ht2b_human,225,A,G,5-HT,PubChem CID,5202,Full agonist,EC50,Functional - Î²-arrestin recruitment,3.6,nM,=,,4.6,-1.277,,,,0.0,0.0,,0.0,,P41595,0.487059719567104
43,10.1038/s41594-018-0116-7,5ht2b_human,225,A,G,LSD,PubChem CID,5761,Partial agonist,K(d),Binding - Radioligand competition/displacement,0.58,nM,=,,1.31,-2.257,,,[3H]-LSD,0.0,0.0,,0.0,,P41595,0.487059719567104
48,10.1038/s41594-018-0116-7,5ht2b_human,225,A,G,Methylergonovine,PubChem CID,8226,Partial agonist,K(i),Binding - Radioligand competition/displacement,0.37,nM,=,,0.96,-2.597,,,[3H]-LSD,0.0,0.0,,0.0,,P41595,0.487059719567104
53,10.1038/s41594-018-0116-7,5ht2b_human,225,A,G,Methysergide,PubChem CID,9681,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.16,nM,=,,0.24,-1.499,,,[3H]-LSD,0.0,0.0,,0.0,,P41595,0.487059719567104
10,10.1038/s41594-018-0116-7,5ht2b_human,362,L,A,LSD,PubChem CID,5761,Partial agonist,EC50,Functional - Ca2+ accumulation,37.0,nM,=,,340.0,-9.174,,,,0.0,0.0,,85.0,,P41595,0.422879191329525
116,23519210,5ht2b_human,362,L,A,5-HT,ChEMBL Compound ID,CHEMBL39,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.41,,=,,7.9,-3.236,,,[3H]LSD,0.0,0.0,,0.0,,P41595,0.422879191329525
136,23519210,5ht2b_human,362,L,A,Ergotamine,ChEMBL Compound ID,CHEMBL442,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.56,,=,,7.74,1.514,,,[3H]LSD,0.0,0.0,,0.0,,P41595,0.422879191329525
154,23519210,5ht2b_human,362,L,A,LSD,ChEMBL Compound ID,CHEMBL463207,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.38,,=,,8.3,-1.202,,,[3H]LSD,0.0,0.0,,0.0,,P41595,0.422879191329525
21,10.1038/s41594-018-0116-7,5ht2b_human,140,T,A,5-HT,PubChem CID,5202,Full agonist,EC50,Functional - Ca2+ accumulation,5.2,nM,=,,73.0,-14.085,,,,0.0,0.0,,0.0,,P41595,0.5023494082103358
27,10.1038/s41594-018-0116-7,5ht2b_human,140,T,A,5-HT,PubChem CID,5202,Full agonist,EC50,Functional - Ca2+ accumulation,5.2,nM,=,,130.0,-25.0,,,,0.0,0.0,,0.0,,P41595,0.5023494082103358
28,10.1038/s41594-018-0116-7,5ht2b_human,140,T,A,5-HT,PubChem CID,5202,Full agonist,EC50,Functional - Î²-arrestin recruitment,3.6,nM,=,,178.0,-50.0,,,,0.0,0.0,,0.0,,P41595,0.5023494082103358
39,10.1038/s41594-018-0116-7,5ht2b_human,140,T,A,LSD,PubChem CID,5761,Partial agonist,K(d),Binding - Radioligand competition/displacement,0.58,nM,=,,1.41,-2.433,,,[3H]-LSD,0.0,0.0,,0.0,,P41595,0.5023494082103358
44,10.1038/s41594-018-0116-7,5ht2b_human,140,T,A,Methylergonovine,PubChem CID,8226,Partial agonist,K(i),Binding - Radioligand competition/displacement,0.37,nM,=,,4.18,-11.236,,,[3H]-LSD,0.0,0.0,,0.0,,P41595,0.5023494082103358
49,10.1038/s41594-018-0116-7,5ht2b_human,140,T,A,Methysergide,PubChem CID,9681,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.16,nM,=,,0.39,-2.439,,,[3H]-LSD,0.0,0.0,,0.0,,P41595,0.5023494082103358
97,23519210,5ht2b_human,140,T,A,5-HT,ChEMBL Compound ID,CHEMBL39,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.41,,=,,6.35,-111.111,,,[3H]LSD,0.0,0.0,,0.0,,P41595,0.5023494082103358
125,23519210,5ht2b_human,140,T,A,Ergotamine,ChEMBL Compound ID,CHEMBL442,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.56,,=,,7.72,1.445,,,[3H]LSD,0.0,0.0,,0.0,,P41595,0.5023494082103358
143,23519210,5ht2b_human,140,T,A,LSD,ChEMBL Compound ID,CHEMBL463207,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.38,,=,,7.9,-3.021,,,[3H]LSD,0.0,0.0,,0.0,,P41595,0.5023494082103358
22,10.1038/s41594-018-0116-7,5ht2b_human,140,T,V,5-HT,PubChem CID,5202,Full agonist,EC50,Functional - Ca2+ accumulation,5.2,nM,=,,93.0,-17.857,,,,0.0,0.0,,0.0,,P41595,0.5023494082103358
40,10.1038/s41594-018-0116-7,5ht2b_human,140,T,V,LSD,PubChem CID,5761,Partial agonist,K(d),Binding - Radioligand competition/displacement,0.58,nM,=,,1.33,-2.294,,,[3H]-LSD,0.0,0.0,,0.0,,P41595,0.5023494082103358
45,10.1038/s41594-018-0116-7,5ht2b_human,140,T,V,Methylergonovine,PubChem CID,8226,Partial agonist,K(i),Binding - Radioligand competition/displacement,0.37,nM,=,,8.03,-21.739,,,[3H]-LSD,0.0,0.0,,0.0,,P41595,0.5023494082103358
50,10.1038/s41594-018-0116-7,5ht2b_human,140,T,V,Methysergide,PubChem CID,9681,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.16,nM,=,,0.3,-1.876,,,[3H]-LSD,0.0,0.0,,0.0,,P41595,0.5023494082103358
63,11859080,5ht2b_human,100,D,N,5-HT,ChEMBL Compound ID,CHEMBL39,Full agonist,EC50,Functional - IP accumulation,9.0,nM,=,,120.0,-13.333,,,,45.0,0.0,,0.0,,P41595,0.763177517235978
91,11859080,5ht2b_human,100,D,N,5-HT,ChEMBL Compound ID,CHEMBL39,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,12.0,nM,=,,148.0,-12.346,,,,0.0,0.0,,0.0,,P41595,0.763177517235978
64,11859080,5ht2b_human,135,D,A,5-HT,ChEMBL Compound ID,CHEMBL39,Full agonist,EC50,Functional - IP accumulation,9.0,nM,>,,10000.0,-1000.0,,,,0.0,0.0,,0.0,,P41595,0.6307731996122283
93,11859080,5ht2b_human,135,D,A,5-HT,ChEMBL Compound ID,CHEMBL39,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,12.0,nM,>,,10000.0,-1000.0,,,,0.0,0.0,,0.0,,P41595,0.6307731996122283
65,11859080,5ht2b_human,139,S,A,5-HT,ChEMBL Compound ID,CHEMBL39,Full agonist,EC50,Functional - IP accumulation,9.0,nM,=,,17.0,-1.89,,,,98.0,0.0,,0.0,,P41595,0.4556280940799757
95,11859080,5ht2b_human,139,S,A,5-HT,ChEMBL Compound ID,CHEMBL39,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,12.0,nM,=,,347.0,-28.571,,,,0.0,0.0,,0.0,,P41595,0.4556280940799757
96,23519210,5ht2b_human,139,S,A,5-HT,ChEMBL Compound ID,CHEMBL39,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.41,,=,,7.12,-19.608,,,[3H]LSD,0.0,0.0,,0.0,,P41595,0.4556280940799757
124,23519210,5ht2b_human,139,S,A,Ergotamine,ChEMBL Compound ID,CHEMBL442,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.56,,=,,7.39,-1.479,,,[3H]LSD,0.0,0.0,,0.0,,P41595,0.4556280940799757
142,23519210,5ht2b_human,139,S,A,LSD,ChEMBL Compound ID,CHEMBL463207,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.38,,=,,8.38,1.0,,,[3H]LSD,0.0,0.0,,0.0,,P41595,0.4556280940799757
66,11859080,5ht2b_human,187,A,S,5-HT,ChEMBL Compound ID,CHEMBL39,Full agonist,EC50,Functional - IP accumulation,9.0,nM,=,,9.0,1.0,,,,100.0,0.0,,0.0,,P41595,0.4474032032947946
98,11859080,5ht2b_human,187,A,S,5-HT,ChEMBL Compound ID,CHEMBL39,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,12.0,nM,=,,9.0,1.333,,,,0.0,0.0,,0.0,,P41595,0.4474032032947946
67,11859080,5ht2b_human,222,S,A,5-HT,ChEMBL Compound ID,CHEMBL39,Full agonist,EC50,Functional - IP accumulation,9.0,nM,=,,11.0,-1.222,,,,99.0,0.0,,0.0,,P41595,0.4601432384842727
103,11859080,5ht2b_human,222,S,A,5-HT,ChEMBL Compound ID,CHEMBL39,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,12.0,nM,=,,11.0,1.091,,,,0.0,0.0,,0.0,,P41595,0.4601432384842727
68,11859080,5ht2b_human,228,T,A,5-HT,ChEMBL Compound ID,CHEMBL39,Full agonist,EC50,Functional - IP accumulation,9.0,nM,=,,186.0,-20.833,,,,21.0,0.0,,0.0,,P41595,0.3614180613341011
105,11859080,5ht2b_human,228,T,A,5-HT,ChEMBL Compound ID,CHEMBL39,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,12.0,nM,=,,1096.0,-90.909,,,,0.0,0.0,,0.0,,P41595,0.3614180613341011
69,11859080,5ht2b_human,229,P,A,5-HT,ChEMBL Compound ID,CHEMBL39,Full agonist,EC50,Functional - IP accumulation,9.0,nM,=,,7.0,1.286,,,,101.0,0.0,,0.0,,P41595,0.7612296391298722
106,11859080,5ht2b_human,229,P,A,5-HT,ChEMBL Compound ID,CHEMBL39,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,12.0,nM,=,,10.0,1.2,,,,0.0,0.0,,0.0,,P41595,0.7612296391298722
70,11859080,5ht2b_human,231,A,T,5-HT,ChEMBL Compound ID,CHEMBL39,Full agonist,EC50,Functional - IP accumulation,9.0,nM,=,,56.0,-6.211,,,,23.0,0.0,,0.0,,P41595,0.2313635870960649
107,11859080,5ht2b_human,231,A,T,5-HT,ChEMBL Compound ID,CHEMBL39,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,12.0,nM,=,,93.0,-7.752,,,,0.0,0.0,,0.0,,P41595,0.2313635870960649
71,11859080,5ht2b_human,337,W,A,5-HT,ChEMBL Compound ID,CHEMBL39,Full agonist,EC50,Functional - IP accumulation,9.0,nM,=,,13.0,-1.445,,,,98.0,0.0,,0.0,,P41595,0.8507753964837438
108,11859080,5ht2b_human,337,W,A,5-HT,ChEMBL Compound ID,CHEMBL39,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,12.0,nM,=,,132.0,-10.989,,,,0.0,0.0,,0.0,,P41595,0.8507753964837438
109,23519210,5ht2b_human,337,W,A,5-HT,ChEMBL Compound ID,CHEMBL39,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.41,,=,,7.16,-17.857,,,[3H]LSD,0.0,0.0,,0.0,,P41595,0.8507753964837438
131,23519210,5ht2b_human,337,W,A,Ergotamine,ChEMBL Compound ID,CHEMBL442,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.56,,=,,8.21,4.467,,,[3H]LSD,0.0,0.0,,0.0,,P41595,0.8507753964837438
149,23519210,5ht2b_human,337,W,A,LSD,ChEMBL Compound ID,CHEMBL463207,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.38,,=,,7.41,-9.346,,,[3H]LSD,0.0,0.0,,0.0,,P41595,0.8507753964837438
72,11859080,5ht2b_human,341,F,A,5-HT,ChEMBL Compound ID,CHEMBL39,Full agonist,EC50,Functional - IP accumulation,9.0,nM,=,,14.0,-1.555,,,,98.0,0.0,,0.0,,P41595,0.6274383990092366
111,11859080,5ht2b_human,341,F,A,5-HT,ChEMBL Compound ID,CHEMBL39,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,12.0,nM,=,,174.0,-14.493,,,,0.0,0.0,,0.0,,P41595,0.6274383990092366
74,11859080,5ht2b_human,363,E,A,5-HT,ChEMBL Compound ID,CHEMBL39,Full agonist,EC50,Functional - IP accumulation,9.0,nM,=,,11.0,-1.222,,,,99.0,0.0,,0.0,,P41595,0.3921914672692065
117,11859080,5ht2b_human,363,E,A,5-HT,ChEMBL Compound ID,CHEMBL39,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,12.0,nM,=,,58.0,-4.831,,,,0.0,0.0,,0.0,,P41595,0.3921914672692065
118,23519210,5ht2b_human,363,E,A,5-HT,ChEMBL Compound ID,CHEMBL39,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.41,,=,,8.69,1.905,,,[3H]LSD,0.0,0.0,,0.0,,P41595,0.3921914672692065
137,23519210,5ht2b_human,363,E,A,Ergotamine,ChEMBL Compound ID,CHEMBL442,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.56,,=,,8.57,10.233,,,[3H]LSD,0.0,0.0,,0.0,,P41595,0.3921914672692065
155,23519210,5ht2b_human,363,E,A,LSD,ChEMBL Compound ID,CHEMBL463207,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.38,,=,,8.54,1.445,,,[3H]LSD,0.0,0.0,,0.0,,P41595,0.3921914672692065
75,11859080,5ht2b_human,376,N,D,5-HT,ChEMBL Compound ID,CHEMBL39,Full agonist,EC50,Functional - IP accumulation,9.0,nM,=,,120.0,-13.333,,,,37.0,0.0,,0.0,,P41595,0.7977869782845055
121,11859080,5ht2b_human,376,N,D,5-HT,ChEMBL Compound ID,CHEMBL39,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,12.0,nM,=,,141.0,-11.765,,,,0.0,0.0,,0.0,,P41595,0.7977869782845055
92,23519210,5ht2b_human,132,L,A,5-HT,ChEMBL Compound ID,CHEMBL39,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.41,,=,,7.75,-4.566,,,[3H]LSD,0.0,0.0,,0.0,,P41595,0.5505163965992799
122,23519210,5ht2b_human,132,L,A,Ergotamine,ChEMBL Compound ID,CHEMBL442,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.56,,=,,8.39,6.761,,,[3H]LSD,0.0,0.0,,0.0,,P41595,0.5505163965992799
140,23519210,5ht2b_human,132,L,A,LSD,ChEMBL Compound ID,CHEMBL463207,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.38,,=,,8.58,1.585,,,[3H]LSD,0.0,0.0,,0.0,,P41595,0.5505163965992799
94,23519210,5ht2b_human,136,V,A,5-HT,ChEMBL Compound ID,CHEMBL39,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.41,,=,,6.91,-31.25,,,[3H]LSD,0.0,0.0,,0.0,,P41595,0.5498273124505764
123,23519210,5ht2b_human,136,V,A,Ergotamine,ChEMBL Compound ID,CHEMBL442,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.56,,=,,8.0,2.754,,,[3H]LSD,0.0,0.0,,0.0,,P41595,0.5498273124505764
141,23519210,5ht2b_human,136,V,A,LSD,ChEMBL Compound ID,CHEMBL463207,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.38,,=,,7.51,-7.407,,,[3H]LSD,0.0,0.0,,0.0,,P41595,0.5498273124505764
99,23519210,5ht2b_human,208,V,A,5-HT,ChEMBL Compound ID,CHEMBL39,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.41,,=,,8.33,-1.202,,,[3H]LSD,0.0,0.0,,0.0,,P41595,0.2910802165867409
126,23519210,5ht2b_human,208,V,A,Ergotamine,ChEMBL Compound ID,CHEMBL442,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.56,,=,,7.54,-1.047,,,[3H]LSD,0.0,0.0,,0.0,,P41595,0.2910802165867409
144,23519210,5ht2b_human,208,V,A,LSD,ChEMBL Compound ID,CHEMBL463207,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.38,,=,,8.32,-1.148,,,[3H]LSD,0.0,0.0,,0.0,,P41595,0.2910802165867409
100,23519210,5ht2b_human,209,L,A,5-HT,ChEMBL Compound ID,CHEMBL39,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.41,,=,,7.78,-4.274,,,[3H]LSD,0.0,0.0,,0.0,,P41595,0.4890330790248816
127,23519210,5ht2b_human,209,L,A,Ergotamine,ChEMBL Compound ID,CHEMBL442,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.56,,=,,8.49,8.511,,,[3H]LSD,0.0,0.0,,0.0,,P41595,0.4890330790248816
145,23519210,5ht2b_human,209,L,A,LSD,ChEMBL Compound ID,CHEMBL463207,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.38,,=,,7.94,-2.755,,,[3H]LSD,0.0,0.0,,0.0,,P41595,0.4890330790248816
101,23519210,5ht2b_human,217,F,A,5-HT,ChEMBL Compound ID,CHEMBL39,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.41,,=,,7.02,-24.39,,,[3H]LSD,0.0,0.0,,0.0,,P41595,0.5579773717743403
128,23519210,5ht2b_human,217,F,A,Ergotamine,ChEMBL Compound ID,CHEMBL442,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.56,,=,,9.03,29.512,,,[3H]LSD,0.0,0.0,,0.0,,P41595,0.5579773717743403
146,23519210,5ht2b_human,217,F,A,LSD,ChEMBL Compound ID,CHEMBL463207,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.38,,=,,7.69,-4.902,,,[3H]LSD,0.0,0.0,,0.0,,P41595,0.5579773717743403
102,23519210,5ht2b_human,218,M,A,5-HT,ChEMBL Compound ID,CHEMBL39,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.41,,=,,7.75,-4.566,,,[3H]LSD,0.0,0.0,,0.0,,P41595,0.5339062381296152
129,23519210,5ht2b_human,218,M,A,Ergotamine,ChEMBL Compound ID,CHEMBL442,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.56,,=,,8.51,8.913,,,[3H]LSD,0.0,0.0,,0.0,,P41595,0.5339062381296152
147,23519210,5ht2b_human,218,M,A,LSD,ChEMBL Compound ID,CHEMBL463207,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.38,,=,,8.42,1.096,,,[3H]LSD,0.0,0.0,,0.0,,P41595,0.5339062381296152
110,23519210,5ht2b_human,340,F,A,5-HT,ChEMBL Compound ID,CHEMBL39,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.41,,=,,6.22,-166.667,,,[3H]LSD,0.0,0.0,,0.0,,P41595,0.6127437542691746
132,23519210,5ht2b_human,340,F,A,Ergotamine,ChEMBL Compound ID,CHEMBL442,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.56,,=,,8.23,4.677,,,[3H]LSD,0.0,0.0,,0.0,,P41595,0.6127437542691746
150,23519210,5ht2b_human,340,F,A,LSD,ChEMBL Compound ID,CHEMBL463207,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.38,,=,,7.61,-5.882,,,[3H]LSD,0.0,0.0,,0.0,,P41595,0.6127437542691746
114,23519210,5ht2b_human,347,L,A,5-HT,ChEMBL Compound ID,CHEMBL39,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.41,,=,,8.18,-1.698,,,[3H]LSD,0.0,0.0,,0.0,,P41595,0.3940262284413556
134,23519210,5ht2b_human,347,L,A,Ergotamine,ChEMBL Compound ID,CHEMBL442,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.56,,=,,7.85,1.95,,,[3H]LSD,0.0,0.0,,0.0,,P41595,0.3940262284413556
152,23519210,5ht2b_human,347,L,A,LSD,ChEMBL Compound ID,CHEMBL463207,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.38,,=,,8.54,1.445,,,[3H]LSD,0.0,0.0,,0.0,,P41595,0.3940262284413556
115,23519210,5ht2b_human,348,V,A,5-HT,ChEMBL Compound ID,CHEMBL39,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.41,,=,,8.52,1.288,,,[3H]LSD,0.0,0.0,,0.0,,P41595,0.3902624806210228
135,23519210,5ht2b_human,348,V,A,Ergotamine,ChEMBL Compound ID,CHEMBL442,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.56,,=,,7.3,-1.818,,,[3H]LSD,0.0,0.0,,0.0,,P41595,0.3902624806210228
153,23519210,5ht2b_human,348,V,A,LSD,ChEMBL Compound ID,CHEMBL463207,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.38,,=,,8.4,1.047,,,[3H]LSD,0.0,0.0,,0.0,,P41595,0.3902624806210228
119,23519210,5ht2b_human,366,V,A,5-HT,ChEMBL Compound ID,CHEMBL39,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.41,,=,,8.49,1.202,,,[3H]LSD,0.0,0.0,,0.0,,P41595,0.4871346891907889
138,23519210,5ht2b_human,366,V,A,Ergotamine,ChEMBL Compound ID,CHEMBL442,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.56,,=,,7.16,-2.513,,,[3H]LSD,0.0,0.0,,0.0,,P41595,0.4871346891907889
156,23519210,5ht2b_human,366,V,A,LSD,ChEMBL Compound ID,CHEMBL463207,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.38,,=,,8.65,1.862,,,[3H]LSD,0.0,0.0,,0.0,,P41595,0.4871346891907889
120,23519210,5ht2b_human,370,Y,A,5-HT,ChEMBL Compound ID,CHEMBL39,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.41,,=,,6.46,-90.909,,,[3H]LSD,0.0,0.0,,0.0,,P41595,0.6148616494313683
139,23519210,5ht2b_human,370,Y,A,Ergotamine,ChEMBL Compound ID,CHEMBL442,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.56,,=,,7.22,-2.188,,,[3H]LSD,0.0,0.0,,0.0,,P41595,0.6148616494313683
157,23519210,5ht2b_human,370,Y,A,LSD,ChEMBL Compound ID,CHEMBL463207,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.38,,=,,7.04,-21.739,,,[3H]LSD,0.0,0.0,,0.0,,P41595,0.6148616494313683
2,9671119,5ht1b_human,185,F,A,8-OH-DPAT,ChEMBL Compound ID,CHEMBL56,Full agonist,EC50,Functional - cAMP accumulation,1098.0,nM,=,,1730.0,-1.575,,,Forskolin,0.0,0.0,,0.0,,P28222,0.5028712564833482
71,9671119,5ht1b_human,185,F,A,Methysergide,ChEMBL Compound ID,CHEMBL1065,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,18.7,nM,=,,5.5,3.4,,,[3H]5-HT,0.0,0.0,,0.0,,P28222,0.5028712564833482
79,9671119,5ht1b_human,185,F,A,Methiothepin,ChEMBL Compound ID,CHEMBL122536,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,6.5,nM,=,,4.6,1.413,,,[3H]5-HT,0.0,0.0,,0.0,,P28222,0.5028712564833482
88,9671119,5ht1b_human,185,F,A,Sumatriptan,ChEMBL Compound ID,CHEMBL128,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,8.7,nM,=,,2.4,3.625,,,[3H]5-HT,0.0,0.0,,0.0,,P28222,0.5028712564833482
101,9671119,5ht1b_human,185,F,A,5-CT,ChEMBL Compound ID,CHEMBL18840,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,1.5,nM,=,,1.1,1.364,,,[3H]5-HT,0.0,0.0,,0.0,,P28222,0.5028712564833482
110,11399261,5ht1b_human,185,F,A,[3H]GR125743,ChEMBL Compound ID,CHEMBL1908856,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,0.7,nM,=,,1.0,-1.429,,,,0.0,0.0,,0.0,,P28222,0.5028712564833482
124,9671119,5ht1b_human,185,F,A,[3H]5-HT,ChEMBL Compound ID,CHEMBL39,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,3.1,nM,=,,2.5,1.24,,,,16.7,0.0,,0.0,,P28222,0.5028712564833482
126,11399261,5ht1b_human,185,F,A,[3H]5-HT,ChEMBL Compound ID,CHEMBL39,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,3.5,nM,=,,3.3,1.061,,,,0.0,0.0,,0.0,,P28222,0.5028712564833482
139,9671119,5ht1b_human,185,F,A,5-HT,ChEMBL Compound ID,CHEMBL39,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,3.4,nM,=,,3.1,1.097,,,[3H]5-HT,0.0,0.0,,0.0,,P28222,0.5028712564833482
141,11399261,5ht1b_human,185,F,A,5-HT,ChEMBL Compound ID,CHEMBL39,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,100.0,nM,=,,565.0,-5.65,,,[3H]GR125743,0.0,0.0,,0.0,,P28222,0.5028712564833482
142,11399261,5ht1b_human,185,F,A,5-HT,ChEMBL Compound ID,CHEMBL39,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,3.4,nM,=,,3.1,1.097,,,[3H]5-HT,0.0,0.0,,0.0,,P28222,0.5028712564833482
179,9671119,5ht1b_human,185,F,A,"L-694,247",ChEMBL Compound ID,CHEMBL39317,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.2,nM,=,,0.17,1.176,,,[3H]5-HT,0.0,0.0,,0.0,,P28222,0.5028712564833482
219,9671119,5ht1b_human,185,F,A,8-OH-DPAT,ChEMBL Compound ID,CHEMBL56,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,747.0,nM,=,,291.0,2.567,,,[3H]5-HT,0.0,0.0,,0.0,,P28222,0.5028712564833482
3,9671119,5ht1b_human,185,F,M,8-OH-DPAT,ChEMBL Compound ID,CHEMBL56,Full agonist,EC50,Functional - cAMP accumulation,1098.0,nM,=,,1034.0,1.062,,,Forskolin,0.0,0.0,,0.0,,P28222,0.4138691799504634
72,9671119,5ht1b_human,185,F,M,Methysergide,ChEMBL Compound ID,CHEMBL1065,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,18.7,nM,=,,9.9,1.889,,,[3H]5-HT,0.0,0.0,,0.0,,P28222,0.4138691799504634
80,9671119,5ht1b_human,185,F,M,Methiothepin,ChEMBL Compound ID,CHEMBL122536,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,6.5,nM,=,,2.4,2.708,,,[3H]5-HT,0.0,0.0,,0.0,,P28222,0.4138691799504634
89,9671119,5ht1b_human,185,F,M,Sumatriptan,ChEMBL Compound ID,CHEMBL128,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,8.7,nM,=,,3.2,2.719,,,[3H]5-HT,0.0,0.0,,0.0,,P28222,0.4138691799504634
102,9671119,5ht1b_human,185,F,M,5-CT,ChEMBL Compound ID,CHEMBL18840,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,1.5,nM,=,,1.1,1.364,,,[3H]5-HT,0.0,0.0,,0.0,,P28222,0.4138691799504634
111,11399261,5ht1b_human,185,F,M,[3H]GR125743,ChEMBL Compound ID,CHEMBL1908856,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,0.7,nM,=,,1.2,-1.715,,,,0.0,0.0,,0.0,,P28222,0.4138691799504634
125,9671119,5ht1b_human,185,F,M,[3H]5-HT,ChEMBL Compound ID,CHEMBL39,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,3.1,nM,=,,1.7,1.824,,,,15.7,0.0,,0.0,,P28222,0.4138691799504634
127,11399261,5ht1b_human,185,F,M,[3H]5-HT,ChEMBL Compound ID,CHEMBL39,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,3.5,nM,=,,2.4,1.458,,,,0.0,0.0,,0.0,,P28222,0.4138691799504634
140,9671119,5ht1b_human,185,F,M,5-HT,ChEMBL Compound ID,CHEMBL39,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,3.4,nM,=,,4.2,-1.235,,,[3H]5-HT,0.0,0.0,,0.0,,P28222,0.4138691799504634
143,11399261,5ht1b_human,185,F,M,5-HT,ChEMBL Compound ID,CHEMBL39,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,100.0,nM,=,,279.0,-2.793,,,[3H]GR125743,0.0,0.0,,0.0,,P28222,0.4138691799504634
144,11399261,5ht1b_human,185,F,M,5-HT,ChEMBL Compound ID,CHEMBL39,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,3.4,nM,=,,4.2,-1.235,,,[3H]5-HT,0.0,0.0,,0.0,,P28222,0.4138691799504634
180,9671119,5ht1b_human,185,F,M,"L-694,247",ChEMBL Compound ID,CHEMBL39317,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.2,nM,=,,0.34,-1.701,,,[3H]5-HT,0.0,0.0,,0.0,,P28222,0.4138691799504634
220,9671119,5ht1b_human,185,F,M,8-OH-DPAT,ChEMBL Compound ID,CHEMBL56,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,747.0,nM,=,,425.0,1.758,,,[3H]5-HT,0.0,0.0,,0.0,,P28222,0.4138691799504634
4,9879059,5ht1b_human,212,S,A,[3H]5-HT,PubChem CID,53317992,Full agonist,K(d),Binding - Radioligand saturation,3.1,nM,=,,2.2,1.409,,,,30.0,0.0,,0.0,,P28222,0.4468227346343744
6,9879059,5ht1b_human,212,S,A,5-HT,PubChem CID,5202,Full agonist,K(i),Binding - Radioligand competition/displacement,3.4,nM,=,,3.3,1.03,,,[3H]5-HT,0.0,0.0,,0.0,,P28222,0.4468227346343744
7,9879059,5ht1b_human,212,S,A,5-CT,PubChem CID,1809,Full agonist,K(i),Binding - Radioligand competition/displacement,1.5,nM,=,,22.7,-15.152,,,[3H]5-HT,0.0,0.0,,0.0,,P28222,0.4468227346343744
8,9879059,5ht1b_human,212,S,A,Sumatriptan,PubChem CID,5358,Partial agonist,K(i),Binding - Radioligand competition/displacement,8.7,nM,=,,7.1,1.225,,,[3H]5-HT,0.0,0.0,,0.0,,P28222,0.4468227346343744
9,9879059,5ht1b_human,212,S,A,Methysergide,PubChem CID,9681,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,18.7,nM,=,,7.0,2.671,,,[3H]5-HT,0.0,0.0,,0.0,,P28222,0.4468227346343744
10,9879059,5ht1b_human,212,S,A,Methiothepin,PubChem CID,4106,Inverse agonist,K(i),Binding - Radioligand competition/displacement,6.5,nM,=,,1.4,4.643,,,[3H]5-HT,0.0,0.0,,0.0,,P28222,0.4468227346343744
112,11399261,5ht1b_human,212,S,A,[3H]GR125743,ChEMBL Compound ID,CHEMBL1908856,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,0.7,nM,=,,0.6,1.167,,,,0.0,0.0,,0.0,,P28222,0.4468227346343744
128,11399261,5ht1b_human,212,S,A,[3H]5-HT,ChEMBL Compound ID,CHEMBL39,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,3.5,nM,=,,2.2,1.591,,,,0.0,0.0,,0.0,,P28222,0.4468227346343744
149,11399261,5ht1b_human,212,S,A,5-HT,ChEMBL Compound ID,CHEMBL39,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,100.0,nM,=,,97.3,1.028,,,[3H]GR125743,0.0,0.0,,0.0,,P28222,0.4468227346343744
150,11399261,5ht1b_human,212,S,A,5-HT,ChEMBL Compound ID,CHEMBL39,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,3.4,nM,=,,3.3,1.03,,,[3H]5-HT,0.0,0.0,,0.0,,P28222,0.4468227346343744
151,23519210,5ht1b_human,212,S,A,5-HT,ChEMBL Compound ID,CHEMBL39,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.09,,=,,7.98,-1.289,,,[3H]LSD,0.0,0.0,,0.0,,P28222,0.4468227346343744
192,23519210,5ht1b_human,212,S,A,Ergotamine,ChEMBL Compound ID,CHEMBL442,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.32,,=,,8.24,-1.202,,,[3H]LSD,0.0,0.0,,0.0,,P28222,0.4468227346343744
208,23519210,5ht1b_human,212,S,A,LSD,ChEMBL Compound ID,CHEMBL463207,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.7,,=,,7.7,1.0,,,[3H]LSD,0.0,0.0,,0.0,,P28222,0.4468227346343744
5,9879059,5ht1b_human,331,F,A,[3H]5-HT,PubChem CID,53317992,Full agonist,K(d),Binding - Radioligand saturation,3.1,nM,=,,1.2,2.583,,,,61.0,0.0,,0.0,,P28222,0.6300740405858429
11,9879059,5ht1b_human,331,F,A,5-HT,PubChem CID,5202,Full agonist,K(i),Binding - Radioligand competition/displacement,3.4,nM,=,,1.6,2.125,,,[3H]5-HT,0.0,0.0,,0.0,,P28222,0.6300740405858429
12,9879059,5ht1b_human,331,F,A,5-CT,PubChem CID,1809,Full agonist,K(i),Binding - Radioligand competition/displacement,1.5,nM,=,,0.8,1.875,,,[3H]5-HT,0.0,0.0,,0.0,,P28222,0.6300740405858429
13,9879059,5ht1b_human,331,F,A,Sumatriptan,PubChem CID,5358,Partial agonist,K(i),Binding - Radioligand competition/displacement,8.7,nM,=,,5.6,1.554,,,[3H]5-HT,0.0,0.0,,0.0,,P28222,0.6300740405858429
14,9879059,5ht1b_human,331,F,A,Methysergide,PubChem CID,9681,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,18.7,nM,=,,8.7,2.149,,,[3H]5-HT,0.0,0.0,,0.0,,P28222,0.6300740405858429
15,9879059,5ht1b_human,331,F,A,Methiothepin,PubChem CID,4106,Inverse agonist,K(i),Binding - Radioligand competition/displacement,6.5,nM,=,,110.0,-16.949,,,[3H]5-HT,0.0,0.0,,0.0,,P28222,0.6300740405858429
113,11399261,5ht1b_human,331,F,A,[3H]GR125743,ChEMBL Compound ID,CHEMBL1908856,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,0.7,nM,=,,0.3,2.333,,,,0.0,0.0,,0.0,,P28222,0.6300740405858429
129,11399261,5ht1b_human,331,F,A,[3H]5-HT,ChEMBL Compound ID,CHEMBL39,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,3.5,nM,=,,1.2,2.917,,,,0.0,0.0,,0.0,,P28222,0.6300740405858429
155,11399261,5ht1b_human,331,F,A,5-HT,ChEMBL Compound ID,CHEMBL39,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,100.0,nM,=,,9.3,10.753,,,[3H]GR125743,0.0,0.0,,0.0,,P28222,0.6300740405858429
156,11399261,5ht1b_human,331,F,A,5-HT,ChEMBL Compound ID,CHEMBL39,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,3.4,nM,=,,1.6,2.125,,,[3H]5-HT,0.0,0.0,,0.0,,P28222,0.6300740405858429
157,23519210,5ht1b_human,331,F,A,5-HT,ChEMBL Compound ID,CHEMBL39,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.09,,=,,7.96,-1.35,,,[3H]LSD,0.0,0.0,,0.0,,P28222,0.6300740405858429
194,23519210,5ht1b_human,331,F,A,Ergotamine,ChEMBL Compound ID,CHEMBL442,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.32,,=,,8.13,-1.548,,,[3H]LSD,0.0,0.0,,0.0,,P28222,0.6300740405858429
210,23519210,5ht1b_human,331,F,A,LSD,ChEMBL Compound ID,CHEMBL463207,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.7,,=,,7.7,1.0,,,[3H]LSD,0.0,0.0,,0.0,,P28222,0.6300740405858429
70,9671119,5ht1b_human,181,S,A,Methysergide,ChEMBL Compound ID,CHEMBL1065,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,18.7,nM,=,,22.0,-1.176,,,[3H]5-HT,0.0,0.0,,0.0,,P28222,0.4609633282252272
78,9671119,5ht1b_human,181,S,A,Methiothepin,ChEMBL Compound ID,CHEMBL122536,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,6.5,nM,=,,5.9,1.102,,,[3H]5-HT,0.0,0.0,,0.0,,P28222,0.4609633282252272
87,9671119,5ht1b_human,181,S,A,Sumatriptan,ChEMBL Compound ID,CHEMBL128,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,8.7,nM,=,,12.3,-1.414,,,[3H]5-HT,0.0,0.0,,0.0,,P28222,0.4609633282252272
100,9671119,5ht1b_human,181,S,A,5-CT,ChEMBL Compound ID,CHEMBL18840,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,1.5,nM,=,,1.9,-1.267,,,[3H]5-HT,0.0,0.0,,0.0,,P28222,0.4609633282252272
123,9671119,5ht1b_human,181,S,A,[3H]5-HT,ChEMBL Compound ID,CHEMBL39,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,3.1,nM,=,,2.0,1.55,,,,43.9,0.0,,0.0,,P28222,0.4609633282252272
138,9671119,5ht1b_human,181,S,A,5-HT,ChEMBL Compound ID,CHEMBL39,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,3.4,nM,=,,3.8,-1.117,,,[3H]5-HT,0.0,0.0,,0.0,,P28222,0.4609633282252272
178,9671119,5ht1b_human,181,S,A,"L-694,247",ChEMBL Compound ID,CHEMBL39317,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.2,nM,=,,0.14,1.429,,,[3H]5-HT,0.0,0.0,,0.0,,P28222,0.4609633282252272
73,9671119,5ht1b_human,334,S,A,Methysergide,ChEMBL Compound ID,CHEMBL1065,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,18.7,nM,=,,13.7,1.365,,,[3H]5-HT,0.0,0.0,,0.0,,P28222,0.4468208955805283
83,9671119,5ht1b_human,334,S,A,Methiothepin,ChEMBL Compound ID,CHEMBL122536,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,6.5,nM,=,,4.8,1.354,,,[3H]5-HT,0.0,0.0,,0.0,,P28222,0.4468208955805283
92,9671119,5ht1b_human,334,S,A,Sumatriptan,ChEMBL Compound ID,CHEMBL128,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,8.7,nM,=,,5.8,1.5,,,[3H]5-HT,0.0,0.0,,0.0,,P28222,0.4468208955805283
105,9671119,5ht1b_human,334,S,A,5-CT,ChEMBL Compound ID,CHEMBL18840,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,1.5,nM,=,,0.6,2.5,,,[3H]5-HT,0.0,0.0,,0.0,,P28222,0.4468208955805283
114,11399261,5ht1b_human,334,S,A,[3H]GR125743,ChEMBL Compound ID,CHEMBL1908856,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,0.7,nM,=,,0.2,3.5,,,,0.0,0.0,,0.0,,P28222,0.4468208955805283
130,9671119,5ht1b_human,334,S,A,[3H]5-HT,ChEMBL Compound ID,CHEMBL39,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,3.1,nM,=,,3.0,1.033,,,,18.1,0.0,,0.0,,P28222,0.4468208955805283
131,11399261,5ht1b_human,334,S,A,[3H]5-HT,ChEMBL Compound ID,CHEMBL39,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,3.5,nM,=,,3.6,-1.029,,,,0.0,0.0,,0.0,,P28222,0.4468208955805283
160,9671119,5ht1b_human,334,S,A,5-HT,ChEMBL Compound ID,CHEMBL39,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,3.4,nM,=,,3.8,-1.117,,,[3H]5-HT,0.0,0.0,,0.0,,P28222,0.4468208955805283
161,11399261,5ht1b_human,334,S,A,5-HT,ChEMBL Compound ID,CHEMBL39,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,100.0,nM,=,,414.0,-4.132,,,[3H]GR125743,0.0,0.0,,0.0,,P28222,0.4468208955805283
162,11399261,5ht1b_human,334,S,A,5-HT,ChEMBL Compound ID,CHEMBL39,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,3.4,nM,=,,3.8,-1.117,,,[3H]5-HT,0.0,0.0,,0.0,,P28222,0.4468208955805283
163,23519210,5ht1b_human,334,S,A,5-HT,ChEMBL Compound ID,CHEMBL39,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.09,,=,,7.31,-6.024,,,[3H]LSD,0.0,0.0,,0.0,,P28222,0.4468208955805283
181,9671119,5ht1b_human,334,S,A,"L-694,247",ChEMBL Compound ID,CHEMBL39317,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.2,nM,=,,0.25,-1.25,,,[3H]5-HT,0.0,0.0,,0.0,,P28222,0.4468208955805283
195,23519210,5ht1b_human,334,S,A,Ergotamine,ChEMBL Compound ID,CHEMBL442,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.32,,=,,8.29,-1.072,,,[3H]LSD,0.0,0.0,,0.0,,P28222,0.4468208955805283
211,23519210,5ht1b_human,334,S,A,LSD,ChEMBL Compound ID,CHEMBL463207,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.7,,=,,8.0,1.995,,,[3H]LSD,0.0,0.0,,0.0,,P28222,0.4468208955805283
221,9671119,5ht1b_human,334,S,A,8-OH-DPAT,ChEMBL Compound ID,CHEMBL56,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,747.0,nM,=,,151.0,4.947,,,[3H]5-HT,0.0,0.0,,0.0,,P28222,0.4468208955805283
74,9671119,5ht1b_human,354,F,A,Methysergide,ChEMBL Compound ID,CHEMBL1065,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,18.7,nM,=,,21.1,-1.129,,,[3H]5-HT,0.0,0.0,,0.0,,P28222,0.4942319839294157
84,9671119,5ht1b_human,354,F,A,Methiothepin,ChEMBL Compound ID,CHEMBL122536,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,6.5,nM,=,,3.2,2.031,,,[3H]5-HT,0.0,0.0,,0.0,,P28222,0.4942319839294157
93,9671119,5ht1b_human,354,F,A,Sumatriptan,ChEMBL Compound ID,CHEMBL128,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,8.7,nM,=,,8.4,1.036,,,[3H]5-HT,0.0,0.0,,0.0,,P28222,0.4942319839294157
106,9671119,5ht1b_human,354,F,A,5-CT,ChEMBL Compound ID,CHEMBL18840,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,1.5,nM,=,,1.0,1.5,,,[3H]5-HT,0.0,0.0,,0.0,,P28222,0.4942319839294157
115,11399261,5ht1b_human,354,F,A,[3H]GR125743,ChEMBL Compound ID,CHEMBL1908856,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,0.7,nM,=,,0.9,-1.285,,,,0.0,0.0,,0.0,,P28222,0.4942319839294157
132,9671119,5ht1b_human,354,F,A,[3H]5-HT,ChEMBL Compound ID,CHEMBL39,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,3.1,nM,=,,1.8,1.722,,,,97.9,0.0,,0.0,,P28222,0.4942319839294157
134,11399261,5ht1b_human,354,F,A,[3H]5-HT,ChEMBL Compound ID,CHEMBL39,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,3.5,nM,=,,3.0,1.167,,,,0.0,0.0,,0.0,,P28222,0.4942319839294157
168,9671119,5ht1b_human,354,F,A,5-HT,ChEMBL Compound ID,CHEMBL39,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,3.4,nM,=,,1.9,1.789,,,[3H]5-HT,0.0,0.0,,0.0,,P28222,0.4942319839294157
170,11399261,5ht1b_human,354,F,A,5-HT,ChEMBL Compound ID,CHEMBL39,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,100.0,nM,=,,60.1,1.664,,,[3H]GR125743,0.0,0.0,,0.0,,P28222,0.4942319839294157
171,11399261,5ht1b_human,354,F,A,5-HT,ChEMBL Compound ID,CHEMBL39,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,3.4,nM,=,,1.9,1.789,,,[3H]5-HT,0.0,0.0,,0.0,,P28222,0.4942319839294157
182,9671119,5ht1b_human,354,F,A,"L-694,247",ChEMBL Compound ID,CHEMBL39317,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.2,nM,=,,0.12,1.667,,,[3H]5-HT,0.0,0.0,,0.0,,P28222,0.4942319839294157
75,9671119,5ht1b_human,354,F,Y,Methysergide,ChEMBL Compound ID,CHEMBL1065,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,18.7,nM,=,,18.0,1.039,,,[3H]5-HT,0.0,0.0,,0.0,,P28222,0.2847337637666212
85,9671119,5ht1b_human,354,F,Y,Methiothepin,ChEMBL Compound ID,CHEMBL122536,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,6.5,nM,=,,2.3,2.826,,,[3H]5-HT,0.0,0.0,,0.0,,P28222,0.2847337637666212
94,9671119,5ht1b_human,354,F,Y,Sumatriptan,ChEMBL Compound ID,CHEMBL128,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,8.7,nM,=,,10.5,-1.206,,,[3H]5-HT,0.0,0.0,,0.0,,P28222,0.2847337637666212
107,9671119,5ht1b_human,354,F,Y,5-CT,ChEMBL Compound ID,CHEMBL18840,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,1.5,nM,=,,0.9,1.667,,,[3H]5-HT,0.0,0.0,,0.0,,P28222,0.2847337637666212
116,11399261,5ht1b_human,354,F,Y,[3H]GR125743,ChEMBL Compound ID,CHEMBL1908856,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,0.7,nM,=,,1.2,-1.715,,,,0.0,0.0,,0.0,,P28222,0.2847337637666212
133,9671119,5ht1b_human,354,F,Y,[3H]5-HT,ChEMBL Compound ID,CHEMBL39,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,3.1,nM,=,,1.6,1.938,,,,20.2,0.0,,0.0,,P28222,0.2847337637666212
135,11399261,5ht1b_human,354,F,Y,[3H]5-HT,ChEMBL Compound ID,CHEMBL39,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,3.5,nM,=,,2.2,1.591,,,,0.0,0.0,,0.0,,P28222,0.2847337637666212
169,9671119,5ht1b_human,354,F,Y,5-HT,ChEMBL Compound ID,CHEMBL39,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,3.4,nM,=,,2.5,1.36,,,[3H]5-HT,0.0,0.0,,0.0,,P28222,0.2847337637666212
172,11399261,5ht1b_human,354,F,Y,5-HT,ChEMBL Compound ID,CHEMBL39,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,100.0,nM,=,,46.5,2.151,,,[3H]GR125743,0.0,0.0,,0.0,,P28222,0.2847337637666212
173,11399261,5ht1b_human,354,F,Y,5-HT,ChEMBL Compound ID,CHEMBL39,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,3.4,nM,=,,2.5,1.36,,,[3H]5-HT,0.0,0.0,,0.0,,P28222,0.2847337637666212
183,9671119,5ht1b_human,354,F,Y,"L-694,247",ChEMBL Compound ID,CHEMBL39317,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.2,nM,=,,0.42,-2.101,,,[3H]5-HT,0.0,0.0,,0.0,,P28222,0.2847337637666212
82,10513577,5ht1b_human,327,W,A,Methiothepin,ChEMBL Compound ID,CHEMBL122536,Binding - unknown pharmacological activity,,Binding - Radioligand competition/displacement,0.0,,,,0.0,300.0,,,[3H]GR125743,0.0,0.0,,0.0,,P28222,0.8465547686247186
91,10513577,5ht1b_human,327,W,A,Sumatriptan,ChEMBL Compound ID,CHEMBL128,Binding - unknown pharmacological activity,,Binding - Radioligand competition/displacement,0.0,,,,0.0,60.0,,,[3H]GR125743,0.0,0.0,,0.0,,P28222,0.8465547686247186
136,23519210,5ht1b_human,126,L,A,5-HT,ChEMBL Compound ID,CHEMBL39,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.09,,=,,7.47,-4.167,,,[3H]LSD,0.0,0.0,,0.0,,P28222,0.5568043981095709
186,23519210,5ht1b_human,126,L,A,Ergotamine,ChEMBL Compound ID,CHEMBL442,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.32,,=,,8.5,1.514,,,[3H]LSD,0.0,0.0,,0.0,,P28222,0.5568043981095709
202,23519210,5ht1b_human,126,L,A,LSD,ChEMBL Compound ID,CHEMBL463207,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.7,,=,,8.0,1.995,,,[3H]LSD,0.0,0.0,,0.0,,P28222,0.5568043981095709
137,23519210,5ht1b_human,134,T,A,5-HT,ChEMBL Compound ID,CHEMBL39,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.09,,=,,6.75,-21.739,,,[3H]LSD,0.0,0.0,,0.0,,P28222,0.4726627656383108
187,23519210,5ht1b_human,134,T,A,Ergotamine,ChEMBL Compound ID,CHEMBL442,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.32,,=,,8.4,1.202,,,[3H]LSD,0.0,0.0,,0.0,,P28222,0.4726627656383108
203,23519210,5ht1b_human,134,T,A,LSD,ChEMBL Compound ID,CHEMBL463207,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.7,,=,,7.1,-3.984,,,[3H]LSD,0.0,0.0,,0.0,,P28222,0.4726627656383108
145,23519210,5ht1b_human,200,V,A,5-HT,ChEMBL Compound ID,CHEMBL39,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.09,,=,,7.98,-1.289,,,[3H]LSD,0.0,0.0,,0.0,,P28222,0.278806538589836
188,23519210,5ht1b_human,200,V,A,Ergotamine,ChEMBL Compound ID,CHEMBL442,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.32,,=,,8.33,1.023,,,[3H]LSD,0.0,0.0,,0.0,,P28222,0.278806538589836
204,23519210,5ht1b_human,200,V,A,LSD,ChEMBL Compound ID,CHEMBL463207,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.7,,=,,8.0,1.995,,,[3H]LSD,0.0,0.0,,0.0,,P28222,0.278806538589836
146,23519210,5ht1b_human,201,V,A,5-HT,ChEMBL Compound ID,CHEMBL39,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.09,,=,,8.09,1.0,,,[3H]LSD,0.0,0.0,,0.0,,P28222,0.4393317644999761
189,23519210,5ht1b_human,201,V,A,Ergotamine,ChEMBL Compound ID,CHEMBL442,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.32,,=,,8.61,1.95,,,[3H]LSD,0.0,0.0,,0.0,,P28222,0.4393317644999761
205,23519210,5ht1b_human,201,V,A,LSD,ChEMBL Compound ID,CHEMBL463207,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.7,,=,,8.2,3.162,,,[3H]LSD,0.0,0.0,,0.0,,P28222,0.4393317644999761
147,23519210,5ht1b_human,203,T,A,5-HT,ChEMBL Compound ID,CHEMBL39,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.09,,=,,8.03,-1.148,,,[3H]LSD,0.0,0.0,,0.0,,P28222,0.3839185784376747
190,23519210,5ht1b_human,203,T,A,Ergotamine,ChEMBL Compound ID,CHEMBL442,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.32,,=,,8.09,-1.698,,,[3H]LSD,0.0,0.0,,0.0,,P28222,0.3839185784376747
206,23519210,5ht1b_human,203,T,A,LSD,ChEMBL Compound ID,CHEMBL463207,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.7,,=,,7.7,1.0,,,[3H]LSD,0.0,0.0,,0.0,,P28222,0.3839185784376747
148,23519210,5ht1b_human,209,T,A,5-HT,ChEMBL Compound ID,CHEMBL39,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.09,,=,,8.22,1.349,,,[3H]LSD,0.0,0.0,,0.0,,P28222,0.4367149557527988
191,23519210,5ht1b_human,209,T,A,Ergotamine,ChEMBL Compound ID,CHEMBL442,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.32,,=,,8.44,1.318,,,[3H]LSD,0.0,0.0,,0.0,,P28222,0.4367149557527988
207,23519210,5ht1b_human,209,T,A,LSD,ChEMBL Compound ID,CHEMBL463207,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.7,,=,,7.9,1.585,,,[3H]LSD,0.0,0.0,,0.0,,P28222,0.4367149557527988
152,23519210,5ht1b_human,216,A,S,5-HT,ChEMBL Compound ID,CHEMBL39,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.09,,=,,7.85,-1.739,,,[3H]LSD,0.0,0.0,,0.0,,P28222,0.4372656861967012
193,23519210,5ht1b_human,216,A,S,Ergotamine,ChEMBL Compound ID,CHEMBL442,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.32,,=,,8.44,1.318,,,[3H]LSD,0.0,0.0,,0.0,,P28222,0.4372656861967012
209,23519210,5ht1b_human,216,A,S,LSD,ChEMBL Compound ID,CHEMBL463207,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.7,,=,,8.1,2.512,,,[3H]LSD,0.0,0.0,,0.0,,P28222,0.4372656861967012
164,23519210,5ht1b_human,337,M,A,5-HT,ChEMBL Compound ID,CHEMBL39,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.09,,=,,8.13,1.096,,,[3H]LSD,0.0,0.0,,0.0,,P28222,0.4016524996324476
196,23519210,5ht1b_human,337,M,A,Ergotamine,ChEMBL Compound ID,CHEMBL442,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.32,,=,,8.39,1.175,,,[3H]LSD,0.0,0.0,,0.0,,P28222,0.4016524996324476
212,23519210,5ht1b_human,337,M,A,LSD,ChEMBL Compound ID,CHEMBL463207,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.7,,=,,8.1,2.512,,,[3H]LSD,0.0,0.0,,0.0,,P28222,0.4016524996324476
165,23519210,5ht1b_human,351,F,A,5-HT,ChEMBL Compound ID,CHEMBL39,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.09,,=,,7.79,-1.996,,,[3H]LSD,0.0,0.0,,0.0,,P28222,0.4390723619822145
197,23519210,5ht1b_human,351,F,A,Ergotamine,ChEMBL Compound ID,CHEMBL442,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.32,,=,,8.26,-1.148,,,[3H]LSD,0.0,0.0,,0.0,,P28222,0.4390723619822145
213,23519210,5ht1b_human,351,F,A,LSD,ChEMBL Compound ID,CHEMBL463207,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.7,,=,,8.0,1.995,,,[3H]LSD,0.0,0.0,,0.0,,P28222,0.4390723619822145
167,23519210,5ht1b_human,352,D,A,5-HT,ChEMBL Compound ID,CHEMBL39,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.09,,=,,8.42,2.138,,,[3H]LSD,0.0,0.0,,0.0,,P28222,0.3806555454983761
198,23519210,5ht1b_human,352,D,A,Ergotamine,ChEMBL Compound ID,CHEMBL442,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.32,,=,,8.42,1.259,,,[3H]LSD,0.0,0.0,,0.0,,P28222,0.3806555454983761
214,23519210,5ht1b_human,352,D,A,LSD,ChEMBL Compound ID,CHEMBL463207,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.7,,=,,8.1,2.512,,,[3H]LSD,0.0,0.0,,0.0,,P28222,0.3806555454983761
176,23519210,5ht1b_human,355,T,A,5-HT,ChEMBL Compound ID,CHEMBL39,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.09,,=,,7.81,-1.905,,,[3H]LSD,0.0,0.0,,0.0,,P28222,0.4925197819943353
199,23519210,5ht1b_human,355,T,A,Ergotamine,ChEMBL Compound ID,CHEMBL442,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.32,,=,,8.39,1.175,,,[3H]LSD,0.0,0.0,,0.0,,P28222,0.4925197819943353
215,23519210,5ht1b_human,355,T,A,LSD,ChEMBL Compound ID,CHEMBL463207,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.7,,=,,7.8,1.259,,,[3H]LSD,0.0,0.0,,0.0,,P28222,0.4925197819943353
177,23519210,5ht1b_human,359,Y,A,5-HT,ChEMBL Compound ID,CHEMBL39,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.09,,=,,8.45,2.291,,,[3H]LSD,0.0,0.0,,0.0,,P28222,0.6019060887592154
200,23519210,5ht1b_human,359,Y,A,Ergotamine,ChEMBL Compound ID,CHEMBL442,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.32,,=,,8.81,3.09,,,[3H]LSD,0.0,0.0,,0.0,,P28222,0.6019060887592154
216,23519210,5ht1b_human,359,Y,A,LSD,ChEMBL Compound ID,CHEMBL463207,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.7,,=,,7.6,-1.259,,,[3H]LSD,0.0,0.0,,0.0,,P28222,0.6019060887592154
36,24903527,hrh4_human,169,F,V,UR-PI376,ChEMBL Compound ID,CHEMBL1078642,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.27,,=,,6.33,-8.696,,,[3H]-histamine (radioligand),99.5,0.0,,0.0,,Q9H3N8,0.3150752380881192
45,18635748,hrh4_human,169,F,V,VUF8430,ChEMBL Compound ID,CHEMBL1196470,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.46,,=,,7.05,-2.571,,,[3H]-histamine (radioligand),0.0,0.0,,0.0,,Q9H3N8,0.3150752380881192
47,24903527,hrh4_human,169,F,V,VUF8430,ChEMBL Compound ID,CHEMBL1196470,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.84,,=,,7.44,-2.513,,,[3H]-histamine (radioligand),99.5,0.0,,0.0,,Q9H3N8,0.3150752380881192
65,24903527,hrh4_human,169,F,V,JNJ-7777120,ChEMBL Compound ID,CHEMBL129198,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.16,,=,,6.83,-2.137,,,[3H]-histamine (radioligand),99.5,0.0,,0.0,,Q9H3N8,0.3150752380881192
78,24903527,hrh4_human,169,F,V,Clobenpropit,ChEMBL Compound ID,CHEMBL14690,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.73,,=,,7.21,-3.311,,,[3H]-histamine (radioligand),99.5,0.0,,0.0,,Q9H3N8,0.3150752380881192
85,24903527,hrh4_human,169,F,V,Immepip,ChEMBL Compound ID,CHEMBL18661,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.73,,=,,7.47,-1.818,,,[3H]-histamine (radioligand),99.5,0.0,,0.0,,Q9H3N8,0.3150752380881192
88,24903527,hrh4_human,169,F,V,Thioperamide,ChEMBL Compound ID,CHEMBL260374,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.75,,=,,6.98,1.698,,,[3H]-histamine (radioligand),99.5,0.0,,0.0,,Q9H3N8,0.3150752380881192
97,18635748,hrh4_human,169,F,V,Clozapine,ChEMBL Compound ID,CHEMBL42,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.35,,=,,5.52,-6.757,,,[3H]-histamine (radioligand),0.0,0.0,,0.0,,Q9H3N8,0.3150752380881192
99,24903527,hrh4_human,169,F,V,Clozapine,ChEMBL Compound ID,CHEMBL42,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.18,,=,,5.51,-4.673,,,[3H]-histamine (radioligand),99.5,0.0,,0.0,,Q9H3N8,0.3150752380881192
117,24903527,hrh4_human,169,F,V,UR-PI294,ChEMBL Compound ID,CHEMBL475621,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.84,,=,,7.83,-1.024,,,[3H]-histamine (radioligand),99.5,0.0,,0.0,,Q9H3N8,0.3150752380881192
124,24903527,hrh4_human,169,F,V,Isoloxapine,ChEMBL Compound ID,CHEMBL7828,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.93,,=,,6.05,-7.576,,,[3H]-histamine (radioligand),99.5,0.0,,0.0,,Q9H3N8,0.3150752380881192
129,24903527,hrh4_human,169,F,V,[3H]-histamine,ChEMBL Compound ID,CHEMBL90,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,11.16,nM,=,,20.15,-1.805,,,[3H]-histamine (radioligand),99.5,0.0,,0.0,,Q9H3N8,0.3150752380881192
152,18635748,hrh4_human,169,F,V,Histamine,ChEMBL Compound ID,CHEMBL90,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.89,,=,,7.12,-5.882,,,[3H]-histamine (radioligand),0.0,0.0,,0.0,,Q9H3N8,0.3150752380881192
153,18635748,hrh4_human,169,F,V,Histamine,ChEMBL Compound ID,CHEMBL90,Binding - unknown pharmacological activity,K(d),Binding - Radioligand competition/displacement,9.0,nM,=,,42.4,-4.717,,,[3H]-histamine (radioligand),0.0,0.0,,0.0,,Q9H3N8,0.3150752380881192
156,24903527,hrh4_human,169,F,V,Histamine,ChEMBL Compound ID,CHEMBL90,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.89,,=,,7.59,-1.996,,,[3H]-histamine (radioligand),99.5,0.0,,0.0,,Q9H3N8,0.3150752380881192
37,24903527,hrh4_human,179,S,A,UR-PI376,ChEMBL Compound ID,CHEMBL1078642,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.27,,=,,7.6,2.138,,,[3H]-histamine (radioligand),116.6,0.0,,0.0,,Q9H3N8,0.4062882693624014
53,24903527,hrh4_human,179,S,A,VUF8430,ChEMBL Compound ID,CHEMBL1196470,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.84,,=,,7.81,-1.072,,,[3H]-histamine (radioligand),116.6,0.0,,0.0,,Q9H3N8,0.4062882693624014
70,24903527,hrh4_human,179,S,A,JNJ-7777120,ChEMBL Compound ID,CHEMBL129198,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.16,,=,,7.78,4.169,,,[3H]-histamine (radioligand),116.6,0.0,,0.0,,Q9H3N8,0.4062882693624014
80,24903527,hrh4_human,179,S,A,Clobenpropit,ChEMBL Compound ID,CHEMBL14690,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.73,,=,,7.56,-1.479,,,[3H]-histamine (radioligand),116.6,0.0,,0.0,,Q9H3N8,0.4062882693624014
86,24903527,hrh4_human,179,S,A,Immepip,ChEMBL Compound ID,CHEMBL18661,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.73,,=,,7.44,-1.949,,,[3H]-histamine (radioligand),116.6,0.0,,0.0,,Q9H3N8,0.4062882693624014
89,24903527,hrh4_human,179,S,A,Thioperamide,ChEMBL Compound ID,CHEMBL260374,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.75,,=,,7.34,3.89,,,[3H]-histamine (radioligand),116.6,0.0,,0.0,,Q9H3N8,0.4062882693624014
106,24903527,hrh4_human,179,S,A,Clozapine,ChEMBL Compound ID,CHEMBL42,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.18,,=,,6.59,2.57,,,[3H]-histamine (radioligand),116.6,0.0,,0.0,,Q9H3N8,0.4062882693624014
118,24903527,hrh4_human,179,S,A,UR-PI294,ChEMBL Compound ID,CHEMBL475621,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.84,,=,,7.9,1.148,,,[3H]-histamine (radioligand),116.6,0.0,,0.0,,Q9H3N8,0.4062882693624014
125,24903527,hrh4_human,179,S,A,Isoloxapine,ChEMBL Compound ID,CHEMBL7828,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.93,,=,,7.47,3.467,,,[3H]-histamine (radioligand),116.6,0.0,,0.0,,Q9H3N8,0.4062882693624014
130,24903527,hrh4_human,179,S,A,[3H]-histamine,ChEMBL Compound ID,CHEMBL90,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,11.16,nM,=,,14.81,-1.326,,,[3H]-histamine (radioligand),116.6,0.0,,0.0,,Q9H3N8,0.4062882693624014
166,12065753,hrh4_human,179,S,A,Histamine,ChEMBL Compound ID,CHEMBL90,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,15.3,nM,=,,34.4,-2.247,,,[3H]-histamine (radioligand),135.9,0.0,,0.0,,Q9H3N8,0.4062882693624014
171,24903527,hrh4_human,179,S,A,Histamine,ChEMBL Compound ID,CHEMBL90,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.89,,=,,7.61,-1.905,,,[3H]-histamine (radioligand),116.6,0.0,,0.0,,Q9H3N8,0.4062882693624014
38,24903527,hrh4_human,179,S,M,UR-PI376,ChEMBL Compound ID,CHEMBL1078642,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.27,,=,,7.1,-1.479,,,[3H]-histamine (radioligand),107.8,0.0,,0.0,,Q9H3N8,0.495147453745286
51,18635748,hrh4_human,179,S,M,VUF8430,ChEMBL Compound ID,CHEMBL1196470,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.46,,=,,7.52,1.148,,,[3H]-histamine (radioligand),0.0,0.0,,0.0,,Q9H3N8,0.495147453745286
54,24903527,hrh4_human,179,S,M,VUF8430,ChEMBL Compound ID,CHEMBL1196470,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.84,,=,,7.55,-1.949,,,[3H]-histamine (radioligand),107.8,0.0,,0.0,,Q9H3N8,0.495147453745286
71,24903527,hrh4_human,179,S,M,JNJ-7777120,ChEMBL Compound ID,CHEMBL129198,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.16,,=,,7.23,1.175,,,[3H]-histamine (radioligand),107.8,0.0,,0.0,,Q9H3N8,0.495147453745286
81,24903527,hrh4_human,179,S,M,Clobenpropit,ChEMBL Compound ID,CHEMBL14690,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.73,,=,,7.14,-3.891,,,[3H]-histamine (radioligand),107.8,0.0,,0.0,,Q9H3N8,0.495147453745286
87,24903527,hrh4_human,179,S,M,Immepip,ChEMBL Compound ID,CHEMBL18661,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.73,,=,,7.49,-1.739,,,[3H]-histamine (radioligand),107.8,0.0,,0.0,,Q9H3N8,0.495147453745286
90,24903527,hrh4_human,179,S,M,Thioperamide,ChEMBL Compound ID,CHEMBL260374,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.75,,=,,6.67,-1.202,,,[3H]-histamine (radioligand),107.8,0.0,,0.0,,Q9H3N8,0.495147453745286
104,18635748,hrh4_human,179,S,M,Clozapine,ChEMBL Compound ID,CHEMBL42,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.35,,=,,6.27,-1.202,,,[3H]-histamine (radioligand),0.0,0.0,,0.0,,Q9H3N8,0.495147453745286
107,24903527,hrh4_human,179,S,M,Clozapine,ChEMBL Compound ID,CHEMBL42,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.18,,=,,6.36,1.514,,,[3H]-histamine (radioligand),107.8,0.0,,0.0,,Q9H3N8,0.495147453745286
119,24903527,hrh4_human,179,S,M,UR-PI294,ChEMBL Compound ID,CHEMBL475621,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.84,,=,,7.93,1.23,,,[3H]-histamine (radioligand),107.8,0.0,,0.0,,Q9H3N8,0.495147453745286
126,24903527,hrh4_human,179,S,M,Isoloxapine,ChEMBL Compound ID,CHEMBL7828,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.93,,=,,7.02,1.23,,,[3H]-histamine (radioligand),107.8,0.0,,0.0,,Q9H3N8,0.495147453745286
131,24903527,hrh4_human,179,S,M,[3H]-histamine,ChEMBL Compound ID,CHEMBL90,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,11.16,nM,=,,17.81,-1.595,,,[3H]-histamine (radioligand),107.8,0.0,,0.0,,Q9H3N8,0.495147453745286
167,18635748,hrh4_human,179,S,M,Histamine,ChEMBL Compound ID,CHEMBL90,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.89,,=,,7.57,-2.088,,,[3H]-histamine (radioligand),0.0,0.0,,0.0,,Q9H3N8,0.495147453745286
168,18635748,hrh4_human,179,S,M,Histamine,ChEMBL Compound ID,CHEMBL90,Binding - unknown pharmacological activity,K(d),Binding - Radioligand competition/displacement,9.0,nM,=,,18.0,-2.0,,,[3H]-histamine (radioligand),0.0,0.0,,0.0,,Q9H3N8,0.495147453745286
172,24903527,hrh4_human,179,S,M,Histamine,ChEMBL Compound ID,CHEMBL90,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.89,,=,,7.49,-2.513,,,[3H]-histamine (radioligand),107.8,0.0,,0.0,,Q9H3N8,0.495147453745286
40,20103609,hrh4_human,147,N,H,VUF8430,ChEMBL Compound ID,CHEMBL1196470,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.5,,=,,6.8,-5.0,,,[3H]-histamine (radioligand),71.0,0.0,,0.0,,Q9H3N8,0.4374205741381025
61,20103609,hrh4_human,147,N,H,JNJ-7777120,ChEMBL Compound ID,CHEMBL129198,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.3,,=,,7.7,-3.984,,,[3H]-histamine (radioligand),71.0,0.0,,0.0,,Q9H3N8,0.4374205741381025
92,20103609,hrh4_human,147,N,H,Clozapine,ChEMBL Compound ID,CHEMBL42,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.4,,=,,4.7,-50.0,,,[3H]-histamine (radioligand),71.0,0.0,,0.0,,Q9H3N8,0.4374205741381025
142,20103609,hrh4_human,147,N,H,Histamine,ChEMBL Compound ID,CHEMBL90,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.9,,=,,7.4,-3.165,,,[3H]-histamine (radioligand),71.0,0.0,,0.0,,Q9H3N8,0.4374205741381025
143,20103609,hrh4_human,147,N,H,Histamine,ChEMBL Compound ID,CHEMBL90,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,9.0,nM,=,,51.0,-5.682,,,[3H]-histamine (radioligand),71.0,0.0,,0.0,,Q9H3N8,0.4374205741381025
41,20103609,hrh4_human,150,M,V,VUF8430,ChEMBL Compound ID,CHEMBL1196470,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.5,,=,,7.2,-1.996,,,[3H]-histamine (radioligand),77.4,0.0,,0.0,,Q9H3N8,0.4264784226920464
62,20103609,hrh4_human,150,M,V,JNJ-7777120,ChEMBL Compound ID,CHEMBL129198,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.3,,=,,8.2,-1.259,,,[3H]-histamine (radioligand),77.4,0.0,,0.0,,Q9H3N8,0.4264784226920464
93,20103609,hrh4_human,150,M,V,Clozapine,ChEMBL Compound ID,CHEMBL42,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.4,,=,,6.2,-1.585,,,[3H]-histamine (radioligand),77.4,0.0,,0.0,,Q9H3N8,0.4264784226920464
144,20103609,hrh4_human,150,M,V,Histamine,ChEMBL Compound ID,CHEMBL90,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.9,,=,,7.8,-1.259,,,[3H]-histamine (radioligand),77.4,0.0,,0.0,,Q9H3N8,0.4264784226920464
145,20103609,hrh4_human,150,M,V,Histamine,ChEMBL Compound ID,CHEMBL90,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,9.0,nM,=,,14.0,-1.555,,,[3H]-histamine (radioligand),77.4,0.0,,0.0,,Q9H3N8,0.4264784226920464
42,18635748,hrh4_human,153,V,A,VUF8430,ChEMBL Compound ID,CHEMBL1196470,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.46,,=,,7.46,1.0,,,[3H]-histamine (radioligand),0.0,0.0,,0.0,,Q9H3N8,0.3267105074818303
94,18635748,hrh4_human,153,V,A,Clozapine,ChEMBL Compound ID,CHEMBL42,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.35,,=,,6.23,-1.318,,,[3H]-histamine (radioligand),0.0,0.0,,0.0,,Q9H3N8,0.3267105074818303
146,18635748,hrh4_human,153,V,A,Histamine,ChEMBL Compound ID,CHEMBL90,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.89,,=,,7.72,-1.479,,,[3H]-histamine (radioligand),0.0,0.0,,0.0,,Q9H3N8,0.3267105074818303
147,18635748,hrh4_human,153,V,A,Histamine,ChEMBL Compound ID,CHEMBL90,Binding - unknown pharmacological activity,K(d),Binding - Radioligand competition/displacement,9.0,nM,=,,12.9,-1.433,,,[3H]-histamine (radioligand),0.0,0.0,,0.0,,Q9H3N8,0.3267105074818303
44,20103609,hrh4_human,156,S,A,VUF8430,ChEMBL Compound ID,CHEMBL1196470,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.5,,=,,7.5,1.0,,,[3H]-histamine (radioligand),6.5,0.0,,0.0,,Q9H3N8,0.2084959062922987
63,20103609,hrh4_human,156,S,A,JNJ-7777120,ChEMBL Compound ID,CHEMBL129198,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.3,,=,,8.2,-1.259,,,[3H]-histamine (radioligand),6.5,0.0,,0.0,,Q9H3N8,0.2084959062922987
150,20103609,hrh4_human,156,S,A,Histamine,ChEMBL Compound ID,CHEMBL90,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.9,,=,,7.8,-1.259,Abolished effect,,[3H]-histamine (radioligand),6.5,0.0,,0.0,,Q9H3N8,0.2084959062922987
48,18635748,hrh4_human,170,S,T,VUF8430,ChEMBL Compound ID,CHEMBL1196470,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.46,,=,,7.6,1.38,,,[3H]-histamine (radioligand),0.0,0.0,,0.0,,Q9H3N8,0.2210634686010247
100,18635748,hrh4_human,170,S,T,Clozapine,ChEMBL Compound ID,CHEMBL42,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.35,,=,,6.02,-2.137,,,[3H]-histamine (radioligand),0.0,0.0,,0.0,,Q9H3N8,0.2210634686010247
157,18635748,hrh4_human,170,S,T,Histamine,ChEMBL Compound ID,CHEMBL90,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.89,,=,,7.82,-1.175,,,[3H]-histamine (radioligand),0.0,0.0,,0.0,,Q9H3N8,0.2210634686010247
158,18635748,hrh4_human,170,S,T,Histamine,ChEMBL Compound ID,CHEMBL90,Binding - unknown pharmacological activity,K(d),Binding - Radioligand competition/displacement,9.0,nM,=,,11.9,-1.323,,,[3H]-histamine (radioligand),0.0,0.0,,0.0,,Q9H3N8,0.2210634686010247
49,20103609,hrh4_human,174,I,V,VUF8430,ChEMBL Compound ID,CHEMBL1196470,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.5,,=,,7.4,-1.259,,,[3H]-histamine (radioligand),112.9,0.0,,0.0,,Q9H3N8,0.2668110582862576
66,20103609,hrh4_human,174,I,V,JNJ-7777120,ChEMBL Compound ID,CHEMBL129198,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.3,,=,,8.3,1.0,,,[3H]-histamine (radioligand),112.9,0.0,,0.0,,Q9H3N8,0.2668110582862576
101,20103609,hrh4_human,174,I,V,Clozapine,ChEMBL Compound ID,CHEMBL42,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.4,,=,,6.2,-1.585,,,[3H]-histamine (radioligand),112.9,0.0,,0.0,,Q9H3N8,0.2668110582862576
159,20103609,hrh4_human,174,I,V,Histamine,ChEMBL Compound ID,CHEMBL90,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.9,,=,,7.9,1.0,,,[3H]-histamine (radioligand),112.9,0.0,,0.0,,Q9H3N8,0.2668110582862576
160,20103609,hrh4_human,174,I,V,Histamine,ChEMBL Compound ID,CHEMBL90,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,9.0,nM,=,,10.0,-1.111,,,[3H]-histamine (radioligand),112.9,0.0,,0.0,,Q9H3N8,0.2668110582862576
50,18635748,hrh4_human,176,A,T,VUF8430,ChEMBL Compound ID,CHEMBL1196470,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.46,,=,,7.52,1.148,,,[3H]-histamine (radioligand),0.0,0.0,,0.0,,Q9H3N8,0.3048725073759798
103,18635748,hrh4_human,176,A,T,Clozapine,ChEMBL Compound ID,CHEMBL42,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.35,,=,,6.18,-1.479,,,[3H]-histamine (radioligand),0.0,0.0,,0.0,,Q9H3N8,0.3048725073759798
163,18635748,hrh4_human,176,A,T,Histamine,ChEMBL Compound ID,CHEMBL90,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.89,,=,,7.76,-1.35,,,[3H]-histamine (radioligand),0.0,0.0,,0.0,,Q9H3N8,0.3048725073759798
164,18635748,hrh4_human,176,A,T,Histamine,ChEMBL Compound ID,CHEMBL90,Binding - unknown pharmacological activity,K(d),Binding - Radioligand competition/displacement,9.0,nM,=,,8.5,1.059,,,[3H]-histamine (radioligand),0.0,0.0,,0.0,,Q9H3N8,0.3048725073759798
52,20103609,hrh4_human,179,S,L,VUF8430,ChEMBL Compound ID,CHEMBL1196470,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.5,,=,,7.3,-1.585,,,[3H]-histamine (radioligand),106.5,0.0,,0.0,,Q9H3N8,0.540057223248029
69,20103609,hrh4_human,179,S,L,JNJ-7777120,ChEMBL Compound ID,CHEMBL129198,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.3,,=,,7.8,-3.165,,,[3H]-histamine (radioligand),106.5,0.0,,0.0,,Q9H3N8,0.540057223248029
105,20103609,hrh4_human,179,S,L,Clozapine,ChEMBL Compound ID,CHEMBL42,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.4,,=,,6.6,1.585,,,[3H]-histamine (radioligand),106.5,0.0,,0.0,,Q9H3N8,0.540057223248029
169,20103609,hrh4_human,179,S,L,Histamine,ChEMBL Compound ID,CHEMBL90,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.9,,=,,7.7,-1.585,,,[3H]-histamine (radioligand),106.5,0.0,,0.0,,Q9H3N8,0.540057223248029
170,20103609,hrh4_human,179,S,L,Histamine,ChEMBL Compound ID,CHEMBL90,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,9.0,nM,=,,12.0,-1.333,,,[3H]-histamine (radioligand),106.5,0.0,,0.0,,Q9H3N8,0.540057223248029
57,18553960,hrh4_human,182,E,Q,VUF8430,ChEMBL Compound ID,CHEMBL1196470,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.57,,=,,5.04,-333.333,,,[3H]-JNJ 7777120 (radioligand),0.0,0.0,,0.0,,Q9H3N8,0.3544324014569009
60,18553960,hrh4_human,182,E,Q,[3H]-JNJ-7777120,ChEMBL Compound ID,CHEMBL129198,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,9.5,nM,=,,7.5,1.267,,,[3H]-JNJ 7777120 (radioligand),0.0,0.0,,0.0,,Q9H3N8,0.3544324014569009
73,10.1039/C2MD20212C,hrh4_human,182,E,Q,JNJ-7777120,ChEMBL Compound ID,CHEMBL129198,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.7,,=,,7.5,-1.585,,,[3H]-JNJ 7777120 (radioligand),100.0,0.0,,0.0,,Q9H3N8,0.3544324014569009
75,10.1039/C2MD20212C,hrh4_human,182,E,Q,1H-indol-2-yl-(4-methylpiperazin-1-yl)methanone,ChEMBL Compound ID,CHEMBL129199,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.1,,=,,6.7,-2.513,,,[3H]-JNJ 7777120 (radioligand),100.0,0.0,,0.0,,Q9H3N8,0.3544324014569009
82,22003888,hrh4_human,182,E,Q,Clobenpropit,ChEMBL Compound ID,CHEMBL14690,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.1,,=,,7.3,-6.329,,,[3H]-JNJ 7777120 (radioligand),100.0,0.0,,0.0,,Q9H3N8,0.3544324014569009
110,18553960,hrh4_human,182,E,Q,Clozapine,ChEMBL Compound ID,CHEMBL42,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.25,,=,,6.15,-1.259,,,[3H]-JNJ 7777120 (radioligand),0.0,0.0,,0.0,,Q9H3N8,0.3544324014569009
114,22003888,hrh4_human,182,E,Q,VUF5228,ChEMBL Compound ID,CHEMBL43934,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.5,,=,,6.8,-5.0,,,[3H]-JNJ 7777120 (radioligand),100.0,0.0,,0.0,,Q9H3N8,0.3544324014569009
121,10.1039/C2MD20212C,hrh4_human,182,E,Q,VUF10460,ChEMBL Compound ID,CHEMBL492884,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.3,,=,,7.2,-12.658,,,[3H]-JNJ 7777120 (radioligand),100.0,0.0,,0.0,,Q9H3N8,0.3544324014569009
123,10.1039/C2MD20212C,hrh4_human,182,E,Q,4-(4-chlorophenyl)-6-(4-methylpiperazin-1-yl)pyrimidin-2-amine,ChEMBL Compound ID,CHEMBL493720,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.7,,=,,6.7,-100.0,,,[3H]-JNJ 7777120 (radioligand),100.0,0.0,,0.0,,Q9H3N8,0.3544324014569009
180,18553960,hrh4_human,182,E,Q,Histamine,ChEMBL Compound ID,CHEMBL90,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.74,,=,,4.95,-500.0,,,[3H]-JNJ 7777120 (radioligand),0.0,0.0,,0.0,,Q9H3N8,0.3544324014569009
67,20103609,hrh4_human,175,L,V,JNJ-7777120,ChEMBL Compound ID,CHEMBL129198,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.3,,=,,7.1,-15.873,,,[3H]-histamine (radioligand),112.9,0.0,,0.0,,Q9H3N8,0.3836231466909894
68,10.1039/C2MD20212C,hrh4_human,175,L,V,JNJ-7777120,ChEMBL Compound ID,CHEMBL129198,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.7,,=,,6.4,-20.0,,,[3H]-histamine (radioligand),100.0,0.0,,0.0,,Q9H3N8,0.3836231466909894
74,10.1039/C2MD20212C,hrh4_human,175,L,V,1H-indol-2-yl-(4-methylpiperazin-1-yl)methanone,ChEMBL Compound ID,CHEMBL129199,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.1,,=,,6.5,-3.984,,,[3H]-histamine (radioligand),100.0,0.0,,0.0,,Q9H3N8,0.3836231466909894
102,20103609,hrh4_human,175,L,V,Clozapine,ChEMBL Compound ID,CHEMBL42,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.4,,=,,7.0,3.981,,,[3H]-histamine (radioligand),112.9,0.0,,0.0,,Q9H3N8,0.3836231466909894
120,10.1039/C2MD20212C,hrh4_human,175,L,V,VUF10460,ChEMBL Compound ID,CHEMBL492884,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.3,,=,,7.7,-3.984,,,[3H]-histamine (radioligand),100.0,0.0,,0.0,,Q9H3N8,0.3836231466909894
122,10.1039/C2MD20212C,hrh4_human,175,L,V,4-(4-chlorophenyl)-6-(4-methylpiperazin-1-yl)pyrimidin-2-amine,ChEMBL Compound ID,CHEMBL493720,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.7,,=,,7.2,-31.25,,,[3H]-histamine (radioligand),100.0,0.0,,0.0,,Q9H3N8,0.3836231466909894
161,20103609,hrh4_human,175,L,V,Histamine,ChEMBL Compound ID,CHEMBL90,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.9,,=,,8.0,1.259,,,[3H]-histamine (radioligand),112.9,0.0,,0.0,,Q9H3N8,0.3836231466909894
162,20103609,hrh4_human,175,L,V,Histamine,ChEMBL Compound ID,CHEMBL90,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,9.0,nM,=,,10.0,-1.111,,,[3H]-histamine (radioligand),112.9,0.0,,0.0,,Q9H3N8,0.3836231466909894
76,22003888,hrh4_human,102,V,A,Clobenpropit,ChEMBL Compound ID,CHEMBL14690,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.1,,=,,8.0,-1.259,,,[3H]-histamine (radioligand),100.0,0.0,,0.0,,Q9H3N8,0.5175975443727885
111,22003888,hrh4_human,102,V,A,VUF5228,ChEMBL Compound ID,CHEMBL43934,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.5,,=,,7.2,-1.996,,,[3H]-histamine (radioligand),100.0,0.0,,0.0,,Q9H3N8,0.5175975443727885
77,22003888,hrh4_human,147,N,Y,Clobenpropit,ChEMBL Compound ID,CHEMBL14690,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.1,,=,,7.8,-1.996,,,[3H]-histamine (radioligand),100.0,0.0,,0.0,,Q9H3N8,0.5716105780442376
112,22003888,hrh4_human,147,N,Y,VUF5228,ChEMBL Compound ID,CHEMBL43934,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.5,,=,,6.5,-10.0,,,[3H]-histamine (radioligand),100.0,0.0,,0.0,,Q9H3N8,0.5716105780442376
79,22003888,hrh4_human,178,T,A,Clobenpropit,ChEMBL Compound ID,CHEMBL14690,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.1,,=,,8.6,3.162,,,[3H]-histamine (radioligand),100.0,0.0,,0.0,,Q9H3N8,0.420251928074619
113,22003888,hrh4_human,178,T,A,VUF5228,ChEMBL Compound ID,CHEMBL43934,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.5,,=,,7.9,2.512,,,[3H]-histamine (radioligand),100.0,0.0,,0.0,,Q9H3N8,0.420251928074619
165,12065753,hrh4_human,178,T,A,Histamine,ChEMBL Compound ID,CHEMBL90,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,15.3,nM,=,,47.9,-3.135,,,[3H]-histamine (radioligand),68.5,0.0,,0.0,,Q9H3N8,0.420251928074619
83,22003888,hrh4_human,323,T,M,Clobenpropit,ChEMBL Compound ID,CHEMBL14690,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.1,,=,,8.8,5.012,,,[3H]-histamine (radioligand),100.0,0.0,,0.0,,Q9H3N8,0.5008210717262191
115,22003888,hrh4_human,323,T,M,VUF5228,ChEMBL Compound ID,CHEMBL43934,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.5,,=,,7.9,2.512,,,[3H]-histamine (radioligand),100.0,0.0,,0.0,,Q9H3N8,0.5008210717262191
84,22003888,hrh4_human,347,Q,L,Clobenpropit,ChEMBL Compound ID,CHEMBL14690,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.1,,=,,9.0,7.943,,,[3H]-histamine (radioligand),100.0,0.0,,0.0,,Q9H3N8,0.5802408626730935
116,22003888,hrh4_human,347,Q,L,VUF5228,ChEMBL Compound ID,CHEMBL43934,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.5,,=,,7.9,2.512,,,[3H]-histamine (radioligand),100.0,0.0,,0.0,,Q9H3N8,0.5802408626730935
141,12065753,hrh4_human,147,N,T,Histamine,ChEMBL Compound ID,CHEMBL90,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,15.3,nM,=,,31.4,-2.053,,,[3H]-histamine (radioligand),126.1,0.0,,0.0,,Q9H3N8,0.4821066587431741
181,12065753,hrh4_human,320,S,A,Histamine,ChEMBL Compound ID,CHEMBL90,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,15.3,nM,=,,32.1,-2.096,,,[3H]-histamine (radioligand),58.7,0.0,,0.0,,Q9H3N8,0.4602015357711112
182,12065753,hrh4_human,320,S,F,Histamine,ChEMBL Compound ID,CHEMBL90,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,15.3,nM,=,,76.1,-4.975,,,[3H]-histamine (radioligand),42.4,0.0,,0.0,,Q9H3N8,0.5939552906899591
43,16489127,acm3_human,514,N,Y,4-DAMP,ChEMBL Compound ID,CHEMBL168067,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.0,,=,,8.6,-2.513,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P20309,0.5377708379974019
121,16489127,acm3_human,514,N,Y,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,169.0,pM,=,,269.0,-1.592,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P20309,0.5377708379974019
160,16489127,acm3_human,514,N,Y,Atropine,ChEMBL Compound ID,CHEMBL517712,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.2,,=,,8.9,-1.996,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P20309,0.5377708379974019
44,24088171,acm3_human,149,Y,A,[3H]Tiotropium,ChEMBL Compound ID,CHEMBL1900528,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,11.5,,=,,8.8,-500.0,,,[3H]Tiotropium (radioligand),0.0,0.0,,0.0,,P20309,0.5943987587015576
61,24088171,acm3_human,149,Y,A,Tiotropium,ChEMBL Compound ID,CHEMBL1900528,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,10.8,,=,,8.6,-166.667,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P20309,0.5943987587015576
88,24088171,acm3_human,149,Y,A,Cpd4,ChEMBL Compound ID,CHEMBL3139994,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,10.2,,=,,8.7,-31.25,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P20309,0.5943987587015576
95,24088171,acm3_human,149,Y,A,Cpd5,ChEMBL Compound ID,CHEMBL3139995,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,10.3,,=,,8.4,-76.923,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P20309,0.5943987587015576
104,24088171,acm3_human,149,Y,A,Cpd7,ChEMBL Compound ID,CHEMBL3140016,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.8,,=,,6.4,-250.0,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P20309,0.5943987587015576
112,24088171,acm3_human,149,Y,A,Cpd3,ChEMBL Compound ID,CHEMBL3140032,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.5,,=,,7.2,-200.0,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P20309,0.5943987587015576
133,24088171,acm3_human,149,Y,A,N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.8,,=,,7.9,-76.923,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P20309,0.5943987587015576
164,24088171,acm3_human,149,Y,A,Cpd10,SMILES,C[N+]1(C)[C@H]2C[C@@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)C(C1CCCC1)C1CCCC1,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.4,,=,,6.6,-500.0,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P20309,0.5943987587015576
171,24088171,acm3_human,149,Y,A,Cpd9,SMILES,C[N+]1(C)[C@H]2C[C@@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)C(c1cccs1)c1cccs1,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,10.0,,=,,7.3,-500.0,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P20309,0.5943987587015576
45,24088171,acm3_human,200,W,A,[3H]Tiotropium,ChEMBL Compound ID,CHEMBL1900528,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,11.5,,=,,8.3,-1000.0,,,[3H]Tiotropium (radioligand),0.0,0.0,,0.0,,P20309,0.6355670858955828
64,24088171,acm3_human,200,W,A,Tiotropium,ChEMBL Compound ID,CHEMBL1900528,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,10.8,,=,,8.2,-333.333,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P20309,0.6355670858955828
89,24088171,acm3_human,200,W,A,Cpd4,ChEMBL Compound ID,CHEMBL3139994,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,10.2,,=,,7.4,-500.0,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P20309,0.6355670858955828
96,24088171,acm3_human,200,W,A,Cpd5,ChEMBL Compound ID,CHEMBL3139995,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,10.3,,=,,7.6,-500.0,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P20309,0.6355670858955828
136,24088171,acm3_human,200,W,A,N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.8,,=,,6.9,-1000.0,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P20309,0.6355670858955828
46,24088171,acm3_human,220,E,A,[3H]Tiotropium,ChEMBL Compound ID,CHEMBL1900528,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,11.5,,=,,11.5,1.0,,,[3H]Tiotropium (radioligand),0.0,0.0,,0.0,,P20309,0.3622987979098223
68,24088171,acm3_human,220,E,A,Tiotropium,ChEMBL Compound ID,CHEMBL1900528,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,10.8,,=,,10.8,1.0,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P20309,0.3622987979098223
140,24088171,acm3_human,220,E,A,N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.8,,=,,9.8,1.0,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P20309,0.3622987979098223
47,24088171,acm3_human,224,Q,A,[3H]Tiotropium,ChEMBL Compound ID,CHEMBL1900528,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,11.5,,=,,11.4,-1.259,,,[3H]Tiotropium (radioligand),0.0,0.0,,0.0,,P20309,0.4096336787654168
70,24088171,acm3_human,224,Q,A,Tiotropium,ChEMBL Compound ID,CHEMBL1900528,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,10.8,,=,,10.6,-1.585,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P20309,0.4096336787654168
142,24088171,acm3_human,224,Q,A,N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.8,,=,,9.8,1.0,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P20309,0.4096336787654168
48,24088171,acm3_human,225,F,A,[3H]Tiotropium,ChEMBL Compound ID,CHEMBL1900528,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,11.5,,=,,11.3,-1.585,,,[3H]Tiotropium (radioligand),0.0,0.0,,0.0,,P20309,0.5926199799771461
71,24088171,acm3_human,225,F,A,Tiotropium,ChEMBL Compound ID,CHEMBL1900528,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,10.8,,=,,10.8,1.0,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P20309,0.5926199799771461
143,24088171,acm3_human,225,F,A,N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.8,,=,,9.7,-1.259,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P20309,0.5926199799771461
49,24088171,acm3_human,240,F,A,[3H]Tiotropium,ChEMBL Compound ID,CHEMBL1900528,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,11.5,,=,,10.3,-15.873,,,[3H]Tiotropium (radioligand),0.0,0.0,,0.0,,P20309,0.6175862085566444
74,24088171,acm3_human,240,F,A,Tiotropium,ChEMBL Compound ID,CHEMBL1900528,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,10.8,,=,,10.2,-3.984,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P20309,0.6175862085566444
85,24088171,acm3_human,240,F,A,Cpd1,ChEMBL Compound ID,CHEMBL3139993,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.3,,=,,7.6,-5.0,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P20309,0.6175862085566444
90,24088171,acm3_human,240,F,A,Cpd4,ChEMBL Compound ID,CHEMBL3139994,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,10.2,,=,,10.2,1.0,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P20309,0.6175862085566444
97,24088171,acm3_human,240,F,A,Cpd5,ChEMBL Compound ID,CHEMBL3139995,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,10.3,,=,,10.4,1.259,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P20309,0.6175862085566444
105,24088171,acm3_human,240,F,A,Cpd7,ChEMBL Compound ID,CHEMBL3140016,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.8,,=,,9.7,7.943,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P20309,0.6175862085566444
110,24088171,acm3_human,240,F,A,Cpd2,ChEMBL Compound ID,CHEMBL3140031,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.7,,=,,7.8,-7.937,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P20309,0.6175862085566444
113,24088171,acm3_human,240,F,A,Cpd3,ChEMBL Compound ID,CHEMBL3140032,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.5,,=,,9.1,-2.513,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P20309,0.6175862085566444
146,24088171,acm3_human,240,F,A,N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.8,,=,,8.6,-15.873,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P20309,0.6175862085566444
166,24088171,acm3_human,240,F,A,Cpd10,SMILES,C[N+]1(C)[C@H]2C[C@@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)C(C1CCCC1)C1CCCC1,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.4,,=,,9.2,-1.585,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P20309,0.6175862085566444
172,24088171,acm3_human,240,F,A,Cpd9,SMILES,C[N+]1(C)[C@H]2C[C@@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)C(c1cccs1)c1cccs1,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,10.0,,=,,9.3,-5.0,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P20309,0.6175862085566444
50,24088171,acm3_human,504,W,A,[3H]Tiotropium,ChEMBL Compound ID,CHEMBL1900528,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,11.5,,=,,9.2,-200.0,,,[3H]Tiotropium (radioligand),0.0,0.0,,0.0,,P20309,0.8668575503614342
76,24088171,acm3_human,504,W,A,Tiotropium,ChEMBL Compound ID,CHEMBL1900528,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,10.8,,=,,9.2,-40.0,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P20309,0.8668575503614342
92,24088171,acm3_human,504,W,A,Cpd4,ChEMBL Compound ID,CHEMBL3139994,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,10.2,,=,,8.5,-50.0,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P20309,0.8668575503614342
99,24088171,acm3_human,504,W,A,Cpd5,ChEMBL Compound ID,CHEMBL3139995,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,10.3,,=,,8.5,-62.5,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P20309,0.8668575503614342
148,24088171,acm3_human,504,W,A,N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.8,,=,,7.9,-76.923,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P20309,0.8668575503614342
168,24088171,acm3_human,504,W,A,Cpd10,SMILES,C[N+]1(C)[C@H]2C[C@@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)C(C1CCCC1)C1CCCC1,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.4,,=,,8.1,-20.0,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P20309,0.8668575503614342
51,24088171,acm3_human,507,Y,A,[3H]Tiotropium,ChEMBL Compound ID,CHEMBL1900528,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,11.5,,=,,9.2,-200.0,,,[3H]Tiotropium (radioligand),0.0,0.0,,0.0,,P20309,0.6110888492249609
77,24088171,acm3_human,507,Y,A,Tiotropium,ChEMBL Compound ID,CHEMBL1900528,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,10.8,,=,,9.4,-25.0,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P20309,0.6110888492249609
86,24088171,acm3_human,507,Y,A,Cpd1,ChEMBL Compound ID,CHEMBL3139993,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.3,,=,,6.1,-166.667,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P20309,0.6110888492249609
93,24088171,acm3_human,507,Y,A,Cpd4,ChEMBL Compound ID,CHEMBL3139994,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,10.2,,=,,9.2,-10.0,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P20309,0.6110888492249609
100,24088171,acm3_human,507,Y,A,Cpd5,ChEMBL Compound ID,CHEMBL3139995,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,10.3,,=,,8.1,-166.667,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P20309,0.6110888492249609
106,24088171,acm3_human,507,Y,A,Cpd7,ChEMBL Compound ID,CHEMBL3140016,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.8,,=,,6.7,-125.0,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P20309,0.6110888492249609
114,24088171,acm3_human,507,Y,A,Cpd3,ChEMBL Compound ID,CHEMBL3140032,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.5,,=,,7.9,-40.0,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P20309,0.6110888492249609
149,24088171,acm3_human,507,Y,A,N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.8,,=,,6.9,-1000.0,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P20309,0.6110888492249609
159,24088171,acm3_human,507,Y,A,Atropine,ChEMBL Compound ID,CHEMBL517712,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.1,,=,,7.0,-125.0,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P20309,0.6110888492249609
161,24088171,acm3_human,507,Y,A,Scopolamine,ChEMBL Compound ID,CHEMBL569713,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.5,,=,,7.2,-200.0,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P20309,0.6110888492249609
169,24088171,acm3_human,507,Y,A,Cpd10,SMILES,C[N+]1(C)[C@H]2C[C@@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)C(C1CCCC1)C1CCCC1,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.4,,=,,7.3,-125.0,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P20309,0.6110888492249609
173,24088171,acm3_human,507,Y,A,Cpd9,SMILES,C[N+]1(C)[C@H]2C[C@@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)C(c1cccs1)c1cccs1,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,10.0,,=,,8.1,-76.923,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P20309,0.6110888492249609
178,24088171,acm3_human,507,Y,A,Cpd6,SMILES,C[N+]1(C)[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)C(O)(c1cccs1)c1cccs1,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,10.4,,=,,9.0,-25.0,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P20309,0.6110888492249609
52,24088171,acm3_human,511,V,A,[3H]Tiotropium,ChEMBL Compound ID,CHEMBL1900528,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,11.5,,=,,11.3,-1.585,,,[3H]Tiotropium (radioligand),0.0,0.0,,0.0,,P20309,0.4836146510038947
79,24088171,acm3_human,511,V,A,Tiotropium,ChEMBL Compound ID,CHEMBL1900528,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,10.8,,=,,11.1,1.995,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P20309,0.4836146510038947
151,24088171,acm3_human,511,V,A,N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.8,,=,,10.0,1.585,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P20309,0.4836146510038947
53,24088171,acm3_human,523,K,A,[3H]Tiotropium,ChEMBL Compound ID,CHEMBL1900528,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,11.5,,=,,11.6,1.259,,,[3H]Tiotropium (radioligand),0.0,0.0,,0.0,,P20309,0.277197027308656
81,24088171,acm3_human,523,K,A,Tiotropium,ChEMBL Compound ID,CHEMBL1900528,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,10.8,,=,,11.0,1.585,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P20309,0.277197027308656
102,24088171,acm3_human,523,K,A,Cpd5,ChEMBL Compound ID,CHEMBL3139995,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,10.3,,=,,10.7,2.512,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P20309,0.277197027308656
108,24088171,acm3_human,523,K,A,Cpd7,ChEMBL Compound ID,CHEMBL3140016,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.8,,=,,9.1,1.995,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P20309,0.277197027308656
116,24088171,acm3_human,523,K,A,Cpd3,ChEMBL Compound ID,CHEMBL3140032,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.5,,=,,9.8,1.995,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P20309,0.277197027308656
153,24088171,acm3_human,523,K,A,N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.8,,=,,10.0,1.585,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P20309,0.277197027308656
176,24088171,acm3_human,523,K,A,Cpd9,SMILES,C[N+]1(C)[C@H]2C[C@@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)C(c1cccs1)c1cccs1,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,10.0,,=,,10.1,1.259,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P20309,0.277197027308656
54,24088171,acm3_human,525,F,A,[3H]Tiotropium,ChEMBL Compound ID,CHEMBL1900528,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,11.5,,=,,11.5,1.0,,,[3H]Tiotropium (radioligand),0.0,0.0,,0.0,,P20309,0.3988270193311286
82,24088171,acm3_human,525,F,A,Tiotropium,ChEMBL Compound ID,CHEMBL1900528,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,10.8,,=,,11.1,1.995,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P20309,0.3988270193311286
154,24088171,acm3_human,525,F,A,N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.8,,=,,10.1,1.995,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P20309,0.3988270193311286
55,24088171,acm3_human,530,Y,A,[3H]Tiotropium,ChEMBL Compound ID,CHEMBL1900528,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,11.5,,=,,10.2,-20.0,,,[3H]Tiotropium (radioligand),0.0,0.0,,0.0,,P20309,0.5701506457996052
83,24088171,acm3_human,530,Y,A,Tiotropium,ChEMBL Compound ID,CHEMBL1900528,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,10.8,,=,,10.2,-3.984,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P20309,0.5701506457996052
103,24088171,acm3_human,530,Y,A,Cpd5,ChEMBL Compound ID,CHEMBL3139995,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,10.3,,=,,9.2,-12.658,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P20309,0.5701506457996052
109,24088171,acm3_human,530,Y,A,Cpd7,ChEMBL Compound ID,CHEMBL3140016,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.8,,=,,7.3,-31.25,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P20309,0.5701506457996052
117,24088171,acm3_human,530,Y,A,Cpd3,ChEMBL Compound ID,CHEMBL3140032,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.5,,=,,8.6,-7.937,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P20309,0.5701506457996052
155,24088171,acm3_human,530,Y,A,N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.8,,=,,8.1,-50.0,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P20309,0.5701506457996052
177,24088171,acm3_human,530,Y,A,Cpd9,SMILES,C[N+]1(C)[C@H]2C[C@@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)C(c1cccs1)c1cccs1,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,10.0,,=,,8.9,-12.658,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P20309,0.5701506457996052
56,24088171,acm3_human,133,R,A,Tiotropium,ChEMBL Compound ID,CHEMBL1900528,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,10.8,,=,,11.0,1.585,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P20309,0.2955371480204884
127,24088171,acm3_human,133,R,A,N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.8,,=,,10.0,1.585,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P20309,0.2955371480204884
57,24088171,acm3_human,142,D,A,Tiotropium,ChEMBL Compound ID,CHEMBL1900528,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,10.8,,=,,9.9,-7.937,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P20309,0.5422556697676006
128,24088171,acm3_human,142,D,A,N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.8,,=,,9.1,-5.0,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P20309,0.5422556697676006
58,24088171,acm3_human,148,D,A,Tiotropium,ChEMBL Compound ID,CHEMBL1900528,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,10.8,,=,,9.2,-40.0,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P20309,0.622153569652661
130,24088171,acm3_human,148,D,A,N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.8,,=,,7.7,-125.0,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P20309,0.622153569652661
60,24088171,acm3_human,148,D,N,Tiotropium,ChEMBL Compound ID,CHEMBL1900528,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,10.8,,=,,9.1,-50.0,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P20309,0.4897690206652392
129,23826889,acm3_human,148,D,N,N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.05,,=,,7.69,-22.727,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P20309,0.4897690206652392
132,24088171,acm3_human,148,D,N,N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.8,,=,,7.9,-76.923,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P20309,0.4897690206652392
158,23826889,acm3_human,148,D,N,McN-A343,ChEMBL Compound ID,CHEMBL40554,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.89,,=,,3.7,-15.385,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P20309,0.4897690206652392
163,23826889,acm3_human,148,D,N,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.4,,=,,2.04,-250.0,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P20309,0.4897690206652392
62,24088171,acm3_human,156,V,A,Tiotropium,ChEMBL Compound ID,CHEMBL1900528,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,10.8,,=,,10.1,-5.0,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P20309,0.4983642997163368
134,24088171,acm3_human,156,V,A,N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.8,,=,,9.0,-6.329,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P20309,0.4983642997163368
63,24088171,acm3_human,197,F,A,Tiotropium,ChEMBL Compound ID,CHEMBL1900528,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,10.8,,=,,10.7,-1.259,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P20309,0.4834490820491186
135,24088171,acm3_human,197,F,A,N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.8,,=,,9.8,1.0,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P20309,0.4834490820491186
65,24088171,acm3_human,204,I,A,Tiotropium,ChEMBL Compound ID,CHEMBL1900528,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,10.8,,=,,10.6,-1.585,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P20309,0.5226133968835178
137,24088171,acm3_human,204,I,A,N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.8,,=,,9.7,-1.259,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P20309,0.5226133968835178
66,24088171,acm3_human,206,F,A,Tiotropium,ChEMBL Compound ID,CHEMBL1900528,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,10.8,,=,,10.8,1.0,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P20309,0.4523532555116649
138,24088171,acm3_human,206,F,A,N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.8,,=,,9.8,1.0,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P20309,0.4523532555116649
67,24088171,acm3_human,213,K,V,Tiotropium,ChEMBL Compound ID,CHEMBL1900528,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,10.8,,=,,11.0,1.585,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P20309,0.3131002140764366
139,24088171,acm3_human,213,K,V,N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.8,,=,,9.9,1.259,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P20309,0.3131002140764366
69,24088171,acm3_human,222,F,A,Tiotropium,ChEMBL Compound ID,CHEMBL1900528,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,10.8,,=,,10.8,1.0,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P20309,0.4434485728806104
141,24088171,acm3_human,222,F,A,N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.8,,=,,9.7,-1.259,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P20309,0.4434485728806104
72,24088171,acm3_human,228,E,A,Tiotropium,ChEMBL Compound ID,CHEMBL1900528,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,10.8,,=,,10.7,-1.259,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P20309,0.4417544831471383
144,24088171,acm3_human,228,E,A,N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.8,,=,,9.9,1.259,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P20309,0.4417544831471383
73,24088171,acm3_human,233,F,A,Tiotropium,ChEMBL Compound ID,CHEMBL1900528,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,10.8,,=,,10.7,-1.259,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P20309,0.4713491593358226
145,24088171,acm3_human,233,F,A,N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.8,,=,,9.9,1.259,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P20309,0.4713491593358226
75,24088171,acm3_human,241,Y,A,Tiotropium,ChEMBL Compound ID,CHEMBL1900528,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,10.8,,=,,10.9,1.259,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P20309,0.4656136083310514
91,24088171,acm3_human,241,Y,A,Cpd4,ChEMBL Compound ID,CHEMBL3139994,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,10.2,,=,,10.0,-1.585,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P20309,0.4656136083310514
98,24088171,acm3_human,241,Y,A,Cpd5,ChEMBL Compound ID,CHEMBL3139995,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,10.3,,=,,10.7,2.512,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P20309,0.4656136083310514
147,24088171,acm3_human,241,Y,A,N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.8,,=,,9.8,1.0,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P20309,0.4656136083310514
167,24088171,acm3_human,241,Y,A,Cpd10,SMILES,C[N+]1(C)[C@H]2C[C@@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)C(C1CCCC1)C1CCCC1,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.4,,=,,9.6,1.585,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P20309,0.4656136083310514
80,24088171,acm3_human,518,D,A,Tiotropium,ChEMBL Compound ID,CHEMBL1900528,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,10.8,,=,,11.0,1.585,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P20309,0.3162487989874158
152,24088171,acm3_human,518,D,A,N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.8,,=,,10.0,1.585,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P20309,0.3162487989874158
84,24088171,acm3_human,534,Y,A,Tiotropium,ChEMBL Compound ID,CHEMBL1900528,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,10.8,,=,,10.1,-5.0,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P20309,0.6164316759624515
156,24088171,acm3_human,534,Y,A,N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.8,,=,,8.0,-62.5,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P20309,0.6164316759624515
118,11562438,acm3_human,133,R,G,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,0.29,nM,=,,0.49,-1.689,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P20309,0.3343365394635372
119,11562438,acm3_human,213,K,T,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,0.29,nM,=,,0.33,-1.138,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P20309,0.2757411608229728
120,11562438,acm3_human,217,P,D,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,0.29,nM,=,,0.31,-1.07,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P20309,0.2807964570035615
124,8264552,acm3_human,550,T,A,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,110.0,pM,=,,100.0,1.1,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P20309,0.4986292836894395
125,8264552,acm3_human,553,T,A,[3H]N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,110.0,pM,=,,124.0,-1.127,,,[3H]N-methyl scopolamine (radioligand),0.0,0.0,,0.0,,P20309,0.3405487402859564
126,23826889,acm3_human,114,D,N,N-methyl scopolamine,ChEMBL Compound ID,CHEMBL376897,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.05,,=,,9.37,2.089,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P20309,0.7587653907148855
157,23826889,acm3_human,114,D,N,McN-A343,ChEMBL Compound ID,CHEMBL40554,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.89,,=,,5.8,8.128,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P20309,0.7587653907148855
162,23826889,acm3_human,114,D,N,Acetylcholine,ChEMBL Compound ID,CHEMBL667,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.4,,=,,5.49,12.303,,,[3H]N-methyl scopolamine,0.0,0.0,,0.0,,P20309,0.7587653907148855
0,19861722,glp1r_human,32,L,A,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Full agonist,EC50,Functional - cAMP accumulation,11.0,pM,=,,12.0,-1.091,,,,109.09090909090908,0.0,,0.0,,P43220,0.3646351410144172
1,19861722,glp1r_human,32,L,A,exendin 4,PubChem CID,56927919,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,0.76,nM,=,,5.4,-7.092,,,[125I]-glucagon-like peptide 1-(7-36) (radioligand),109.09090909090908,0.0,,0.0,,P43220,0.3646351410144172
2,19861722,glp1r_human,32,L,A,exendin 4,PubChem CID,56927919,Full agonist,EC50,Functional - cAMP accumulation,5.5,pM,=,,52.0,-9.434,,,,109.09090909090908,0.0,,0.0,,P43220,0.3646351410144172
3,19861722,glp1r_human,32,L,A,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,1.0,nM,=,,1.1,-1.1,,,[125I]-glucagon-like peptide 1-(7-36) (radioligand),109.09090909090908,0.0,,0.0,,P43220,0.3646351410144172
323,24199154,glp1r_human,32,L,A,Chimer 2,FASTA sequence (peptide),HSQGTFTSDYSKYLDEEAAKEFIAWLMNT,Full agonist,EC50,Functional - cAMP accumulation,0.083,nM,=,,0.076,1.092,,,,100.0,0.0,,0.0,,P43220,0.3646351410144172
324,24199154,glp1r_human,32,L,A,Chimer 2X,FASTA sequence (peptide),HSQGTFTSDYSKYLDEEAVRLFIEWLMNT,Full agonist,EC50,Functional - cAMP accumulation,0.038,nM,=,,0.076,-2.0,,,,100.0,0.0,,0.0,,P43220,0.3646351410144172
325,24199154,glp1r_human,32,L,A,compound 2,PubChem CID,16007289,Allosteric agonist,EC50,Functional - cAMP accumulation,300.0,nM,=,,450.0,-1.499,,,,100.0,0.0,,0.0,,P43220,0.3646351410144172
326,24199154,glp1r_human,32,L,A,exendin-4(1-30),FASTA sequence (peptide),HGEGTFTSDLSKQMEEEAVRLFIEWLKNGG,Full agonist,EC50,Functional - cAMP accumulation,0.007,nM,=,,0.044,-6.289,,,,100.0,0.0,,0.0,,P43220,0.3646351410144172
327,24199154,glp1r_human,32,L,A,exendin-4(1-30)(Gly2Ala),FASTA sequence (peptide),HAEGTFTSDLSKQMEEEAVRLFIEWLKNGG,Full agonist,EC50,Functional - cAMP accumulation,0.005,nM,=,,0.01,-2.0,,,,100.0,0.0,,0.0,,P43220,0.3646351410144172
328,24199154,glp1r_human,32,L,A,GLP-1-(Ala8Gly),FASTA sequence (peptide),HGEGTFTSDVSSYLEGQAAKEFIAWLVKGR,Full agonist,EC50,Functional - cAMP accumulation,0.25,nM,=,,2.4,-9.615,,,,100.0,0.0,,0.0,,P43220,0.3646351410144172
329,24199154,glp1r_human,32,L,A,GLP-1-(Ala8Gly/Gly16Glu/Glu21Leu/Ala24Glu),FASTA sequence (peptide),HGEGTFTSDVSSYLEEQAAKLFIEWLVKGR,Full agonist,EC50,Functional - cAMP accumulation,0.011,nM,=,,0.095,-8.621,,,,100.0,0.0,,0.0,,P43220,0.3646351410144172
330,24199154,glp1r_human,32,L,A,GLP-1-(Gly16Glu/Glu21Leu/Ala24Glu),FASTA sequence (peptide),HAEGTFTSDVSSYLEEQAAKLFIEWLVKGR,Full agonist,EC50,Functional - cAMP accumulation,0.007,nM,=,,0.014,-2.0,,,,100.0,0.0,,0.0,,P43220,0.3646351410144172
331,24199154,glp1r_human,32,L,A,glucagon-(Ser22Glu),FASTA sequence (peptide),HSQGTFTSDYSKYLDERRAQDFVQWLMNT,Full agonist,EC50,Functional - cAMP accumulation,0.06,nM,=,,0.43,-7.143,,,,100.0,0.0,,0.0,,P43220,0.3646351410144172
332,24199154,glp1r_human,32,L,A,glucagon-(Ser22Glu/Gln26Lys),FASTA sequence (peptide),HSQGTFTSDYSKYLDERRAEDFVKWLMNT,Full agonist,EC50,Functional - cAMP accumulation,0.076,nM,=,,0.17,-2.237,,,,100.0,0.0,,0.0,,P43220,0.3646351410144172
333,24199154,glp1r_human,32,L,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,EC50,Functional - cAMP accumulation,0.017,nM,=,,0.037,-2.179,,,,100.0,0.0,,0.0,,P43220,0.3646351410144172
4,19861722,glp1r_human,35,T,A,exendin 4,PubChem CID,56927919,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,0.76,nM,=,,0.44,1.727,,,[125I]-glucagon-like peptide 1-(7-36) (radioligand),6.909090909090909,0.0,,0.0,,P43220,0.3646904306602061
5,19861722,glp1r_human,35,T,A,exendin 4,PubChem CID,56927919,Full agonist,EC50,Functional - cAMP accumulation,5.5,pM,=,,23.0,-4.184,,,,6.909090909090909,0.0,,0.0,,P43220,0.3646904306602061
6,19861722,glp1r_human,35,T,A,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,1.0,nM,=,,3.1,-3.096,,,[125I]-glucagon-like peptide 1-(7-36) (radioligand),6.909090909090909,0.0,,0.0,,P43220,0.3646904306602061
7,19861722,glp1r_human,35,T,A,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Full agonist,EC50,Functional - cAMP accumulation,11.0,pM,=,,30.0,-2.725,,,,6.909090909090909,0.0,,0.0,,P43220,0.3646904306602061
8,19861722,glp1r_human,36,V,A,exendin 4,PubChem CID,56927919,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,0.76,nM,=,,0.98,-1.289,,,[125I]-glucagon-like peptide 1-(7-36) (radioligand),103.63636363636364,0.0,,0.0,,P43220,0.3331339473094871
9,19861722,glp1r_human,36,V,A,exendin 4,PubChem CID,56927919,Full agonist,EC50,Functional - cAMP accumulation,5.5,pM,=,,36.0,-6.536,,,,103.63636363636364,0.0,,0.0,,P43220,0.3331339473094871
10,19861722,glp1r_human,36,V,A,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,1.0,nM,=,,2.8,-2.801,,,[125I]-glucagon-like peptide 1-(7-36) (radioligand),103.63636363636364,0.0,,0.0,,P43220,0.3331339473094871
11,19861722,glp1r_human,36,V,A,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Full agonist,EC50,Functional - cAMP accumulation,11.0,pM,=,,57.0,-5.181,,,,103.63636363636364,0.0,,0.0,,P43220,0.3331339473094871
12,19861722,glp1r_human,68,E,A,exendin 4,PubChem CID,56927919,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,0.76,nM,=,,0.48,1.583,,,[125I]-glucagon-like peptide 1-(7-36) (radioligand),103.63636363636364,0.0,,0.0,,P43220,0.3689758977077987
13,19861722,glp1r_human,68,E,A,exendin 4,PubChem CID,56927919,Full agonist,EC50,Functional - cAMP accumulation,5.5,pM,=,,9.5,-1.727,,,,103.63636363636364,0.0,,0.0,,P43220,0.3689758977077987
14,19861722,glp1r_human,68,E,A,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,1.0,nM,=,,1.9,-1.901,,,[125I]-glucagon-like peptide 1-(7-36) (radioligand),103.63636363636364,0.0,,0.0,,P43220,0.3689758977077987
15,19861722,glp1r_human,68,E,A,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Full agonist,EC50,Functional - cAMP accumulation,11.0,pM,=,,15.0,-1.364,,,,103.63636363636364,0.0,,0.0,,P43220,0.3689758977077987
28,19861722,glp1r_human,90,P,A,exendin 4,PubChem CID,56927919,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,0.76,nM,=,,1.6,-2.105,,,[125I]-glucagon-like peptide 1-(7-36) (radioligand),101.8181818181818,0.0,,0.0,,P43220,0.4055925101125665
29,19861722,glp1r_human,90,P,A,exendin 4,PubChem CID,56927919,Full agonist,EC50,Functional - cAMP accumulation,5.5,pM,=,,30.0,-5.464,,,,101.8181818181818,0.0,,0.0,,P43220,0.4055925101125665
30,19861722,glp1r_human,90,P,A,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,1.0,nM,=,,2.8,-2.801,,,[125I]-glucagon-like peptide 1-(7-36) (radioligand),101.8181818181818,0.0,,0.0,,P43220,0.4055925101125665
31,19861722,glp1r_human,90,P,A,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Full agonist,EC50,Functional - cAMP accumulation,11.0,pM,=,,55.0,-5.0,,,,101.8181818181818,0.0,,0.0,,P43220,0.4055925101125665
32,19861722,glp1r_human,121,R,A,exendin 4,PubChem CID,56927919,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,0.76,nM,=,,1.2,-1.58,,,[125I]-glucagon-like peptide 1-(7-36) (radioligand),103.63636363636364,0.0,,0.0,,P43220,0.4378280481185525
33,19861722,glp1r_human,121,R,A,exendin 4,PubChem CID,56927919,Full agonist,EC50,Functional - cAMP accumulation,5.5,pM,=,,44.0,-8.0,,,,103.63636363636364,0.0,,0.0,,P43220,0.4378280481185525
34,19861722,glp1r_human,121,R,A,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,1.0,nM,=,,2.3,-2.299,,,[125I]-glucagon-like peptide 1-(7-36) (radioligand),103.63636363636364,0.0,,0.0,,P43220,0.4378280481185525
35,19861722,glp1r_human,121,R,A,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Full agonist,EC50,Functional - cAMP accumulation,11.0,pM,=,,51.0,-4.63,,,,103.63636363636364,0.0,,0.0,,P43220,0.4378280481185525
36,19861722,glp1r_human,123,L,A,exendin 4,PubChem CID,56927919,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,0.76,nM,=,,0.33,2.303,,,[125I]-glucagon-like peptide 1-(7-36) (radioligand),47.27272727272727,0.0,,0.0,,P43220,0.5040631623123605
37,19861722,glp1r_human,123,L,A,exendin 4,PubChem CID,56927919,Full agonist,EC50,Functional - cAMP accumulation,5.5,pM,=,,9.5,-1.727,,,,47.27272727272727,0.0,,0.0,,P43220,0.5040631623123605
38,19861722,glp1r_human,123,L,A,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,1.0,nM,=,,1.1,-1.1,,,[125I]-glucagon-like peptide 1-(7-36) (radioligand),47.27272727272727,0.0,,0.0,,P43220,0.5040631623123605
39,19861722,glp1r_human,123,L,A,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Full agonist,EC50,Functional - cAMP accumulation,11.0,pM,=,,17.0,-1.546,,,,47.27272727272727,0.0,,0.0,,P43220,0.5040631623123605
40,19861722,glp1r_human,127,E,A,exendin 4,PubChem CID,56927919,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,0.76,nM,=,,5.2,-6.849,,,[125I]-glucagon-like peptide 1-(7-36) (radioligand),101.8181818181818,0.0,,0.0,,P43220,0.3485328451768331
42,19861722,glp1r_human,127,E,A,exendin 4,PubChem CID,56927919,Full agonist,EC50,Functional - cAMP accumulation,5.5,pM,=,,11.0,-2.0,,,,101.8181818181818,0.0,,0.0,,P43220,0.3485328451768331
44,19861722,glp1r_human,127,E,A,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,1.0,nM,=,,1.7,-1.701,,,[125I]-glucagon-like peptide 1-(7-36) (radioligand),101.8181818181818,0.0,,0.0,,P43220,0.3485328451768331
46,19861722,glp1r_human,127,E,A,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Full agonist,EC50,Functional - cAMP accumulation,11.0,pM,=,,13.0,-1.182,,,,101.8181818181818,0.0,,0.0,,P43220,0.3485328451768331
334,24199154,glp1r_human,127,E,A,compound 2,PubChem CID,16007289,Allosteric agonist,EC50,Functional - cAMP accumulation,300.0,nM,=,,420.0,-1.401,,,,100.0,0.0,,0.0,,P43220,0.3485328451768331
335,24199154,glp1r_human,127,E,A,exendin-4(1-30),FASTA sequence (peptide),HGEGTFTSDLSKQMEEEAVRLFIEWLKNGG,Full agonist,EC50,Functional - cAMP accumulation,0.007,nM,=,,0.011,-1.572,,,,100.0,0.0,,0.0,,P43220,0.3485328451768331
336,24199154,glp1r_human,127,E,A,exendin-4(1-30)(Gly2Ala),FASTA sequence (peptide),HAEGTFTSDLSKQMEEEAVRLFIEWLKNGG,Full agonist,EC50,Functional - cAMP accumulation,0.005,nM,=,,0.006,-1.2,,,,100.0,0.0,,0.0,,P43220,0.3485328451768331
337,24199154,glp1r_human,127,E,A,GLP-1-(Ala8Gly),FASTA sequence (peptide),HGEGTFTSDVSSYLEGQAAKEFIAWLVKGR,Full agonist,EC50,Functional - cAMP accumulation,0.25,nM,=,,0.46,-1.842,,,,100.0,0.0,,0.0,,P43220,0.3485328451768331
338,24199154,glp1r_human,127,E,A,GLP-1-(Ala8Gly/Gly16Glu/Glu21Leu/Ala24Glu),FASTA sequence (peptide),HGEGTFTSDVSSYLEEQAAKLFIEWLVKGR,Full agonist,EC50,Functional - cAMP accumulation,0.011,nM,=,,0.014,-1.272,,,,100.0,0.0,,0.0,,P43220,0.3485328451768331
339,24199154,glp1r_human,127,E,A,GLP-1-(Gly16Glu/Glu21Leu/Ala24Glu),FASTA sequence (peptide),HAEGTFTSDVSSYLEEQAAKLFIEWLVKGR,Full agonist,EC50,Functional - cAMP accumulation,0.007,nM,=,,0.008,-1.143,,,,100.0,0.0,,0.0,,P43220,0.3485328451768331
340,24199154,glp1r_human,127,E,A,glucagon-(Ser22Glu),FASTA sequence (peptide),HSQGTFTSDYSKYLDERRAQDFVQWLMNT,Full agonist,EC50,Functional - cAMP accumulation,0.06,nM,=,,0.072,-1.2,,,,100.0,0.0,,0.0,,P43220,0.3485328451768331
341,24199154,glp1r_human,127,E,A,glucagon-(Ser22Glu/Gln26Lys),FASTA sequence (peptide),HSQGTFTSDYSKYLDERRAEDFVKWLMNT,Full agonist,EC50,Functional - cAMP accumulation,0.083,nM,=,,0.1,-1.205,,,,100.0,0.0,,0.0,,P43220,0.3485328451768331
342,24199154,glp1r_human,127,E,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,EC50,Functional - cAMP accumulation,0.017,nM,=,,0.021,-1.235,,,,100.0,0.0,,0.0,,P43220,0.3485328451768331
41,19861722,glp1r_human,127,E,Q,exendin 4,PubChem CID,56927919,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,0.76,nM,=,,0.82,-1.079,,,[125I]-glucagon-like peptide 1-(7-36) (radioligand),111.09090909090912,0.0,,0.0,,P43220,0.2376518968398275
43,19861722,glp1r_human,127,E,Q,exendin 4,PubChem CID,56927919,Full agonist,EC50,Functional - cAMP accumulation,5.5,pM,=,,6.8,-1.236,,,,111.09090909090912,0.0,,0.0,,P43220,0.2376518968398275
45,19861722,glp1r_human,127,E,Q,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,1.0,nM,=,,1.1,-1.1,,,[125I]-glucagon-like peptide 1-(7-36) (radioligand),111.09090909090912,0.0,,0.0,,P43220,0.2376518968398275
47,19861722,glp1r_human,127,E,Q,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Full agonist,EC50,Functional - cAMP accumulation,11.0,pM,=,,12.0,-1.091,,,,111.09090909090912,0.0,,0.0,,P43220,0.2376518968398275
48,19861722,glp1r_human,128,E,A,exendin 4,PubChem CID,56927919,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,0.76,nM,=,,1.8,-2.37,,,[125I]-glucagon-like peptide 1-(7-36) (radioligand),109.09090909090908,0.0,,0.0,,P43220,0.3359725958615777
50,19861722,glp1r_human,128,E,A,exendin 4,PubChem CID,56927919,Full agonist,EC50,Functional - cAMP accumulation,5.5,pM,=,,25.0,-4.545,,,,109.09090909090908,0.0,,0.0,,P43220,0.3359725958615777
52,19861722,glp1r_human,128,E,A,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,1.0,nM,=,,2.7,-2.703,,,[125I]-glucagon-like peptide 1-(7-36) (radioligand),109.09090909090908,0.0,,0.0,,P43220,0.3359725958615777
54,19861722,glp1r_human,128,E,A,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Full agonist,EC50,Functional - cAMP accumulation,11.0,pM,=,,28.0,-2.545,,,,109.09090909090908,0.0,,0.0,,P43220,0.3359725958615777
343,24199154,glp1r_human,128,E,A,Chimer 2,FASTA sequence (peptide),HSQGTFTSDYSKYLDEEAAKEFIAWLMNT,Full agonist,EC50,Functional - cAMP accumulation,0.038,nM,=,,0.051,-1.342,,,,100.0,0.0,,0.0,,P43220,0.3359725958615777
344,24199154,glp1r_human,128,E,A,Chimer 2,FASTA sequence (peptide),HSQGTFTSDYSKYLDEEAAKEFIAWLMNT,Full agonist,EC50,Functional - cAMP accumulation,0.038,nM,=,,0.04,-1.053,,,,100.0,0.0,,0.0,,P43220,0.3359725958615777
345,24199154,glp1r_human,128,E,A,Chimer 2X,FASTA sequence (peptide),HSQGTFTSDYSKYLDEEAVRLFIEWLMNT,Full agonist,EC50,Functional - cAMP accumulation,0.076,nM,=,,0.084,-1.105,,,,100.0,0.0,,0.0,,P43220,0.3359725958615777
346,24199154,glp1r_human,128,E,A,Chimer 2X,FASTA sequence (peptide),HSQGTFTSDYSKYLDEEAVRLFIEWLMNT,Full agonist,EC50,Functional - cAMP accumulation,0.076,nM,=,,0.078,-1.027,,,,100.0,0.0,,0.0,,P43220,0.3359725958615777
347,24199154,glp1r_human,128,E,A,compound 2,PubChem CID,16007289,Allosteric agonist,EC50,Functional - cAMP accumulation,300.0,nM,=,,570.0,-1.901,,,,100.0,0.0,,0.0,,P43220,0.3359725958615777
348,24199154,glp1r_human,128,E,A,exendin-4(1-30),FASTA sequence (peptide),HGEGTFTSDLSKQMEEEAVRLFIEWLKNGG,Full agonist,EC50,Functional - cAMP accumulation,0.007,nM,=,,0.012,-1.715,,,,100.0,0.0,,0.0,,P43220,0.3359725958615777
349,24199154,glp1r_human,128,E,A,exendin-4(1-30)(Gly2Ala),FASTA sequence (peptide),HAEGTFTSDLSKQMEEEAVRLFIEWLKNGG,Full agonist,EC50,Functional - cAMP accumulation,0.005,nM,=,,0.007,-1.401,,,,100.0,0.0,,0.0,,P43220,0.3359725958615777
350,24199154,glp1r_human,128,E,A,GLP-1-(Ala8Gly),FASTA sequence (peptide),HGEGTFTSDVSSYLEGQAAKEFIAWLVKGR,Full agonist,EC50,Functional - cAMP accumulation,0.25,nM,=,,0.49,-1.961,,,,100.0,0.0,,0.0,,P43220,0.3359725958615777
351,24199154,glp1r_human,128,E,A,GLP-1-(Ala8Gly/Gly16Glu/Glu21Leu/Ala24Glu),FASTA sequence (peptide),HGEGTFTSDVSSYLEEQAAKLFIEWLVKGR,Full agonist,EC50,Functional - cAMP accumulation,0.011,nM,=,,0.017,-1.546,,,,100.0,0.0,,0.0,,P43220,0.3359725958615777
352,24199154,glp1r_human,128,E,A,GLP-1-(Gly16Glu/Glu21Leu/Ala24Glu),FASTA sequence (peptide),HAEGTFTSDVSSYLEEQAAKLFIEWLVKGR,Full agonist,EC50,Functional - cAMP accumulation,0.007,nM,=,,0.008,-1.143,,,,100.0,0.0,,0.0,,P43220,0.3359725958615777
353,24199154,glp1r_human,128,E,A,glucagon-(Ser22Glu),FASTA sequence (peptide),HSQGTFTSDYSKYLDERRAQDFVQWLMNT,Full agonist,EC50,Functional - cAMP accumulation,0.06,nM,=,,0.059,1.017,,,,100.0,0.0,,0.0,,P43220,0.3359725958615777
354,24199154,glp1r_human,128,E,A,glucagon-(Ser22Glu/Gln26Lys),FASTA sequence (peptide),HSQGTFTSDYSKYLDERRAEDFVKWLMNT,Full agonist,EC50,Functional - cAMP accumulation,0.083,nM,=,,0.14,-1.686,,,,100.0,0.0,,0.0,,P43220,0.3359725958615777
355,24199154,glp1r_human,128,E,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,EC50,Functional - cAMP accumulation,0.017,nM,=,,0.026,-1.529,,,,100.0,0.0,,0.0,,P43220,0.3359725958615777
49,19861722,glp1r_human,128,E,Q,exendin 4,PubChem CID,56927919,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,0.76,nM,=,,0.45,1.689,,,[125I]-glucagon-like peptide 1-(7-36) (radioligand),94.54545454545456,0.0,,0.0,,P43220,0.2276850429157333
51,19861722,glp1r_human,128,E,Q,exendin 4,PubChem CID,56927919,Full agonist,EC50,Functional - cAMP accumulation,5.5,pM,=,,8.0,-1.453,,,,94.54545454545456,0.0,,0.0,,P43220,0.2276850429157333
53,19861722,glp1r_human,128,E,Q,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,1.0,nM,=,,0.66,1.515,,,[125I]-glucagon-like peptide 1-(7-36) (radioligand),94.54545454545456,0.0,,0.0,,P43220,0.2276850429157333
55,19861722,glp1r_human,128,E,Q,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Full agonist,EC50,Functional - cAMP accumulation,11.0,pM,=,,10.0,1.1,,,,94.54545454545456,0.0,,0.0,,P43220,0.2276850429157333
56,20407008,glp1r_human,63,N,L,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,2.8,nM,=,,2.9,-1.035,,,[125I]-glucagon-like peptide 1-(7-36) (radioligand),79.16666666666666,0.0,,0.0,,P43220,0.651472652235195
57,20407008,glp1r_human,63,N,L,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Full agonist,EC50,Functional - cAMP accumulation,26.0,pM,=,,63.0,-2.421,,,,79.16666666666666,0.0,,0.0,,P43220,0.651472652235195
58,20407008,glp1r_human,82,N,L,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Binding - unknown pharmacological activity,IC50,Binding - unknown pharmacological activity,2.8,nM,=,,1.7,1.647,,,[125I]-glucagon-like peptide 1-(7-36) (radioligand),84.72222222222221,0.0,,0.0,,P43220,0.4620205209593201
59,20407008,glp1r_human,82,N,L,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Full agonist,EC50,Functional - cAMP accumulation,26.0,pM,=,,61.0,-2.347,,,,84.72222222222221,0.0,,0.0,,P43220,0.4620205209593201
60,20407008,glp1r_human,115,N,L,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Binding - unknown pharmacological activity,IC50,Binding - unknown pharmacological activity,2.8,nM,=,,2.8,1.0,,,[125I]-glucagon-like peptide 1-(7-36) (radioligand),86.80555555555556,0.0,,0.0,,P43220,0.501497282848786
61,20407008,glp1r_human,115,N,L,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Full agonist,EC50,Functional - cAMP accumulation,26.0,pM,=,,56.0,-2.155,,,,86.80555555555556,0.0,,0.0,,P43220,0.501497282848786
62,21308878,glp1r_human,68,E,K,glucagon,PubChem CID,44278361,Full agonist,EC50,Functional - cAMP accumulation,0.061,nM,=,,0.12,-1.969,,,,0.0,0.0,,0.0,,P43220,0.2897424945974339
63,21308878,glp1r_human,68,E,K,glucagon-(Ser22Glu),FASTA sequence (peptide),HSQGTFTSDYSKYLDERRAQDFVQWLMNT,Full agonist,EC50,Functional - cAMP accumulation,0.022,nM,=,,0.039,-1.773,,,,0.0,0.0,,0.0,,P43220,0.2897424945974339
64,21308878,glp1r_human,68,E,K,glucagon-like peptide 1-(7-35),FASTA sequence (peptide),HAEGTFTSDVSSYLEGQAAKEFIAWLVKR,Full agonist,EC50,Functional - cAMP accumulation,0.0084,nM,=,,0.036,-4.292,,,,0.0,0.0,,0.0,,P43220,0.2897424945974339
65,21308878,glp1r_human,68,E,K,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Full agonist,EC50,Functional - cAMP accumulation,0.0089,nM,=,,0.075,-8.403,,,,0.0,0.0,,0.0,,P43220,0.2897424945974339
66,21308878,glp1r_human,68,E,K,glucagon-like peptide 1-(Arg36Gly),FASTA sequence (peptide),HAEGTFTSDVSSYLEGQAAKEFIAWLVKGG,Full agonist,EC50,Functional - cAMP accumulation,0.0049,nM,=,,0.022,-4.484,,,,0.0,0.0,,0.0,,P43220,0.2897424945974339
67,21308878,glp1r_human,68,E,K,glucagon-like peptide 1-(Gln22Glu)-(7-35),FASTA sequence (peptide),HAEGTFTSDVSSYLEEQAAKEFIAWLVKR,Full agonist,EC50,Functional - cAMP accumulation,0.0024,nM,=,,0.011,-4.587,,,,0.0,0.0,,0.0,,P43220,0.2897424945974339
68,21308878,glp1r_human,68,E,K,Oxyntomodulin(30-37),PubChem CID,11766473,Full agonist,EC50,Functional - cAMP accumulation,0.15,nM,=,,1.6,-10.638,,,,0.0,0.0,,0.0,,P43220,0.2897424945974339
69,21308878,glp1r_human,128,E,M,glucagon,PubChem CID,44278361,Full agonist,EC50,Functional - cAMP accumulation,0.061,nM,=,,0.096,-1.575,,,,0.0,0.0,,0.0,,P43220,0.3772483453077736
70,21308878,glp1r_human,128,E,M,glucagon-(Ser22Glu),FASTA sequence (peptide),HSQGTFTSDYSKYLDERRAQDFVQWLMNT,Full agonist,EC50,Functional - cAMP accumulation,0.022,nM,=,,0.026,-1.182,,,,0.0,0.0,,0.0,,P43220,0.3772483453077736
71,21308878,glp1r_human,128,E,M,glucagon-(Ser26Lys),FASTA sequence (peptide),HSQGTFTSDYSKYLDSRRAKDFVQWLMNT,Full agonist,EC50,Functional - cAMP accumulation,0.045,nM,=,,0.03,1.5,,,,0.0,0.0,,0.0,,P43220,0.3772483453077736
72,21308878,glp1r_human,128,E,M,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Full agonist,EC50,Functional - cAMP accumulation,0.0056,nM,=,,0.015,-2.681,,,,0.0,0.0,,0.0,,P43220,0.3772483453077736
73,21868452,glp1r_human,152,Y,A,exendin(9-39),PubChem CID,16198321,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,9.15,M,=,,8.13,-10.526,,,[125I]-exendin(9-39) (radioligand),6.690909090909091,0.0,,0.0,,P43220,0.6340906331795177
74,21868452,glp1r_human,152,Y,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.22,M,=,,6.72,-31.25,,,[125I]-exendin(9-39) (radioligand),6.690909090909091,0.0,,0.0,,P43220,0.6340906331795177
75,21868452,glp1r_human,152,Y,A,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Full agonist,pEC50,Functional - cAMP accumulation,10.16,M,=,,8.92,-17.241,,,,0.0,0.0,,96.0,,P43220,0.6340906331795177
76,21868452,glp1r_human,152,Y,A,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Full agonist,pEC50,Functional - cAMP accumulation,10.16,M,=,,8.92,-17.241,,,,6.690909090909091,0.0,,0.0,,P43220,0.6340906331795177
77,21868452,glp1r_human,190,R,A,exendin(9-39),PubChem CID,16198321,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,9.15,M,=,,8.36,-6.173,,,[125I]-exendin(9-39) (radioligand),6.690909090909091,0.0,,0.0,,P43220,0.6227574617713317
78,21868452,glp1r_human,190,R,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.22,M,=,,6.78,-27.778,,,[125I]-exendin(9-39) (radioligand),6.690909090909091,0.0,,0.0,,P43220,0.6227574617713317
79,21868452,glp1r_human,190,R,A,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Full agonist,pEC50,Functional - cAMP accumulation,10.16,M,=,,7.93,-166.667,,,,0.0,0.0,,112.0,,P43220,0.6227574617713317
80,21868452,glp1r_human,190,R,A,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Full agonist,pEC50,Functional - cAMP accumulation,10.16,M,=,,7.93,-166.667,,,,6.690909090909091,0.0,,0.0,,P43220,0.6227574617713317
283,23479653,glp1r_human,190,R,A,exendin 4,PubChem CID,56927919,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.97,M,=,,7.43,-34.483,,,[125I]-exendin(9-39) (radioligand),44.0,0.0,,0.0,,P43220,0.6227574617713317
284,23479653,glp1r_human,190,R,A,exendin(9-39),PubChem CID,16198321,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.11,M,=,,8.64,3.388,,,[125I]-exendin(9-39) (radioligand),44.0,0.0,,0.0,,P43220,0.6227574617713317
285,23479653,glp1r_human,190,R,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.67,M,=,,7.37,-20.0,,,[125I]-exendin(9-39) (radioligand),44.0,0.0,,0.0,,P43220,0.6227574617713317
286,23479653,glp1r_human,190,R,A,Oxyntomodulin(30-37),PubChem CID,11766473,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.26,M,=,,7.6,2.188,,,[125I]-exendin(9-39) (radioligand),44.0,0.0,,0.0,,P43220,0.6227574617713317
81,21868452,glp1r_human,197,K,A,exendin(9-39),PubChem CID,16198321,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,9.15,M,=,,8.67,-3.021,,,[125I]-exendin(9-39) (radioligand),57.345454545454544,0.0,,0.0,,P43220,0.4925736975783658
82,21868452,glp1r_human,197,K,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.22,M,=,,6.86,-22.727,,,[125I]-exendin(9-39) (radioligand),57.345454545454544,0.0,,0.0,,P43220,0.4925736975783658
83,21868452,glp1r_human,197,K,A,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Full agonist,pEC50,Functional - cAMP accumulation,10.16,M,=,,7.36,-500.0,,,,0.0,0.0,,85.0,,P43220,0.4925736975783658
84,21868452,glp1r_human,197,K,A,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Full agonist,pEC50,Functional - cAMP accumulation,10.16,M,=,,7.36,-500.0,,,,57.345454545454544,0.0,,0.0,,P43220,0.4925736975783658
85,21868452,glp1r_human,198,D,A,exendin(9-39),PubChem CID,16198321,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,9.15,M,=,,8.74,-2.571,,,[125I]-exendin(9-39) (radioligand),66.10909090909091,0.0,,0.0,,P43220,0.5451424753904951
86,21868452,glp1r_human,198,D,A,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Full agonist,pEC50,Functional - cAMP accumulation,10.16,M,=,,7.17,-1000.0,,,,0.0,0.0,,77.0,,P43220,0.5451424753904951
87,21868452,glp1r_human,198,D,A,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.22,M,=,,6.59,-43.478,,,[125I]-exendin(9-39) (radioligand),66.10909090909091,0.0,,0.0,,P43220,0.5451424753904951
88,21868452,glp1r_human,198,D,A,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Full agonist,pEC50,Functional - cAMP accumulation,10.16,M,=,,7.17,-1000.0,,,,66.10909090909091,0.0,,0.0,,P43220,0.5451424753904951
612,27059958,glp1r_human,198,D,A,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Full agonist,EC50,Functional - cAMP accumulation,10.0,nM,=,,892.0,-90.909,,,,124.0,0.0,,0.0,,P43220,0.5451424753904951
89,21868452,glp1r_human,234,Q,A,exendin(9-39),PubChem CID,16198321,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,9.15,M,=,,8.63,-3.311,,,[125I]-exendin(9-39) (radioligand),26.618181818181817,0.0,,0.0,,P43220,0.5833828774621788
90,21868452,glp1r_human,234,Q,A,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Full agonist,pEC50,Functional - cAMP accumulation,10.16,M,=,,8.51,-45.455,,,,0.0,0.0,,179.0,,P43220,0.5833828774621788
91,21868452,glp1r_human,234,Q,A,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.22,M,=,,7.12,-12.658,,,[125I]-exendin(9-39) (radioligand),26.618181818181817,0.0,,0.0,,P43220,0.5833828774621788
92,21868452,glp1r_human,234,Q,A,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Full agonist,pEC50,Functional - cAMP accumulation,10.16,M,=,,8.51,-45.455,,,,26.618181818181817,0.0,,0.0,,P43220,0.5833828774621788
665,27059958,glp1r_human,234,Q,A,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Full agonist,EC50,Functional - cAMP accumulation,10.0,nM,=,,1506.0,-142.857,,,,35.0,0.0,,0.0,,P43220,0.5833828774621788
93,21868452,glp1r_human,235,Y,A,exendin(9-39),PubChem CID,16198321,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,9.15,M,=,,7.88,-18.519,,,[125I]-exendin(9-39) (radioligand),11.963636363636365,0.0,,0.0,,P43220,0.5907448392784795
94,21868452,glp1r_human,235,Y,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - cAMP accumulation,10.16,M,=,,8.82,-21.739,,,,0.0,0.0,,80.0,,P43220,0.5907448392784795
95,21868452,glp1r_human,235,Y,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.22,M,=,,6.84,-23.81,,,[125I]-exendin(9-39) (radioligand),11.963636363636365,0.0,,0.0,,P43220,0.5907448392784795
96,21868452,glp1r_human,235,Y,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - cAMP accumulation,10.16,M,=,,8.82,-21.739,,,,11.963636363636365,0.0,,0.0,,P43220,0.5907448392784795
97,21868452,glp1r_human,284,W,A,exendin(9-39),PubChem CID,16198321,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,9.15,M,=,,8.49,-4.566,,,[125I]-exendin(9-39) (radioligand),33.92727272727273,0.0,,0.0,,P43220,0.6356738785133864
98,21868452,glp1r_human,284,W,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - cAMP accumulation,10.16,M,=,,7.03,-1000.0,,,,0.0,0.0,,183.0,,P43220,0.6356738785133864
99,21868452,glp1r_human,284,W,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.22,M,=,,6.77,-28.571,,,[125I]-exendin(9-39) (radioligand),33.92727272727273,0.0,,0.0,,P43220,0.6356738785133864
100,21868452,glp1r_human,284,W,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - cAMP accumulation,10.16,M,=,,7.03,-1000.0,,,,33.92727272727273,0.0,,0.0,,P43220,0.6356738785133864
101,21868452,glp1r_human,310,R,A,exendin(9-39),PubChem CID,16198321,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,9.15,M,=,,8.81,-2.188,,,[125I]-exendin(9-39) (radioligand),17.200000000000003,0.0,,0.0,,P43220,0.5935550667446617
102,21868452,glp1r_human,310,R,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.22,M,=,,7.22,-10.0,,,[125I]-exendin(9-39) (radioligand),17.200000000000003,0.0,,0.0,,P43220,0.5935550667446617
103,21868452,glp1r_human,310,R,A,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Full agonist,pEC50,Functional - cAMP accumulation,10.16,M,=,,7.06,-1000.0,,,,0.0,0.0,,130.0,,P43220,0.5935550667446617
104,21868452,glp1r_human,310,R,A,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Full agonist,pEC50,Functional - cAMP accumulation,10.16,M,=,,7.06,-1000.0,,,,17.200000000000003,0.0,,0.0,,P43220,0.5935550667446617
485,26598711,glp1r_human,310,R,A,exendin(9-39),PubChem CID,16198321,Binding - unknown pharmacological activity,pIC50,Binding - Radioligand competition/displacement,8.35,M,=,,8.37,1.047,,,[125I]-exendin(9-39) (radioligand),18.80733944954128,0.0,,0.0,,P43220,0.5935550667446617
486,26598711,glp1r_human,310,R,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Binding - unknown pharmacological activity,pIC50,Binding - Radioligand competition/displacement,9.45,M,=,,8.91,-3.472,,,[125I]-exendin(9-39) (radioligand),18.80733944954128,0.0,,0.0,,P43220,0.5935550667446617
487,26598711,glp1r_human,310,R,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,EC50,Functional - cAMP accumulation,11.38,M,=,,8.31,1.369,,,,18.80733944954128,0.0,,0.0,,P43220,0.5935550667446617
105,21868452,glp1r_human,363,H,A,exendin(9-39),PubChem CID,16198321,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,9.15,M,=,,7.53,-41.667,,,[125I]-exendin(9-39) (radioligand),24.181818181818183,0.0,,0.0,,P43220,0.5858832020101995
106,21868452,glp1r_human,363,H,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.22,M,=,,6.23,-100.0,,,[125I]-exendin(9-39) (radioligand),24.181818181818183,0.0,,0.0,,P43220,0.5858832020101995
303,23479653,glp1r_human,363,H,A,exendin 4,PubChem CID,56927919,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.97,M,=,,7.54,-27.027,,,[125I]-exendin(9-39) (radioligand),53.0,0.0,,0.0,,P43220,0.5858832020101995
304,23479653,glp1r_human,363,H,A,exendin(9-39),PubChem CID,16198321,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.11,M,=,,7.41,-5.0,,,[125I]-exendin(9-39) (radioligand),53.0,0.0,,0.0,,P43220,0.5858832020101995
305,23479653,glp1r_human,363,H,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.67,M,=,,7.31,-22.727,,,[125I]-exendin(9-39) (radioligand),53.0,0.0,,0.0,,P43220,0.5858832020101995
306,23479653,glp1r_human,363,H,A,Oxyntomodulin(30-37),PubChem CID,11766473,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.26,M,=,,6.46,-6.329,,,[125I]-exendin(9-39) (radioligand),53.0,0.0,,0.0,,P43220,0.5858832020101995
108,21868452,glp1r_human,364,E,A,exendin(9-39),PubChem CID,16198321,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,9.15,M,=,,7.28,-76.923,,,[125I]-exendin(9-39) (radioligand),42.14545454545455,0.0,,0.0,,P43220,0.6578850775168121
109,21868452,glp1r_human,364,E,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.22,M,=,,6.46,-58.824,,,[125I]-exendin(9-39) (radioligand),42.14545454545455,0.0,,0.0,,P43220,0.6578850775168121
110,21868452,glp1r_human,364,E,A,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Full agonist,pEC50,Functional - cAMP accumulation,10.16,M,=,,8.99,-14.706,,,,0.0,0.0,,44.0,,P43220,0.6578850775168121
111,21868452,glp1r_human,364,E,A,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Full agonist,pEC50,Functional - cAMP accumulation,10.16,M,=,,8.99,-14.706,,,,42.14545454545455,0.0,,0.0,,P43220,0.6578850775168121
543,26700562,glp1r_human,364,E,A,exendin 4,PubChem CID,56927919,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.0,M,=,,7.5,-31.25,,,[125I]-exendin(9-39) (radioligand),41.0,0.0,,0.0,,P43220,0.6578850775168121
544,26700562,glp1r_human,364,E,A,exendin(9-39),PubChem CID,16198321,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.1,M,=,,7.5,-3.984,,,[125I]-exendin(9-39) (radioligand),41.0,0.0,,0.0,,P43220,0.6578850775168121
545,26700562,glp1r_human,364,E,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.7,M,=,,7.3,-25.0,,,[125I]-exendin(9-39) (radioligand),41.0,0.0,,0.0,,P43220,0.6578850775168121
546,26700562,glp1r_human,364,E,A,Oxyntomodulin(30-37),PubChem CID,11766473,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.3,M,=,,7.1,-1.585,,,[125I]-exendin(9-39) (radioligand),41.0,0.0,,0.0,,P43220,0.6578850775168121
112,21868452,glp1r_human,387,E,A,exendin(9-39),PubChem CID,16198321,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,9.15,M,=,,8.56,-3.891,,,[125I]-exendin(9-39) (radioligand),102.69090909090907,0.0,,0.0,,P43220,0.5518712271774366
113,21868452,glp1r_human,387,E,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.22,M,=,,8.09,-1.35,,,[125I]-exendin(9-39) (radioligand),102.69090909090907,0.0,,0.0,,P43220,0.5518712271774366
114,21868452,glp1r_human,387,E,A,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Full agonist,pEC50,Functional - cAMP accumulation,10.16,M,=,,9.77,-2.457,,,,0.0,0.0,,172.0,,P43220,0.5518712271774366
115,21868452,glp1r_human,387,E,A,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Full agonist,pEC50,Functional - cAMP accumulation,10.16,M,=,,9.77,-2.457,,,,102.69090909090907,0.0,,0.0,,P43220,0.5518712271774366
536,26598711,glp1r_human,387,E,A,exendin(9-39),PubChem CID,16198321,Binding - unknown pharmacological activity,pIC50,Binding - Radioligand competition/displacement,8.35,M,=,,8.08,-1.862,,,[125I]-exendin(9-39) (radioligand),42.6605504587156,0.0,,0.0,,P43220,0.5518712271774366
537,26598711,glp1r_human,387,E,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Binding - unknown pharmacological activity,pIC50,Binding - Radioligand competition/displacement,9.45,M,=,,9.91,2.884,,,[125I]-exendin(9-39) (radioligand),42.6605504587156,0.0,,0.0,,P43220,0.5518712271774366
538,26598711,glp1r_human,387,E,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,EC50,Functional - cAMP accumulation,11.38,M,=,,11.03,1.032,,,,42.6605504587156,0.0,,0.0,,P43220,0.5518712271774366
1143,27315480,glp1r_human,387,E,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - cAMP accumulation,10.0,M,=,,9.9,-1.259,,,,0.0,0.0,,108.0,,P43220,0.5518712271774366
1168,27315480,glp1r_human,387,E,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Full agonist,pEC50,Functional - Ca2+ accumulation,7.99,M,=,,8.12,1.349,,,,0.0,0.0,,106.0,,P43220,0.5518712271774366
1169,27315480,glp1r_human,387,E,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Full agonist,pEC50,Functional - cAMP accumulation,10.6,M,=,,10.3,-1.996,,,,0.0,0.0,,106.0,,P43220,0.5518712271774366
1170,27315480,glp1r_human,387,E,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.22,M,=,,8.83,-2.457,,,[125I]-exendin(9-39) (radioligand),104.0,0.0,,0.0,,P43220,0.5518712271774366
1171,27315480,glp1r_human,387,E,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Full agonist,pEC50,Functional - ERK activation,10.6,M,=,,8.14,-333.333,,,,0.0,0.0,,72.0,,P43220,0.5518712271774366
1172,27315480,glp1r_human,387,E,A,exendin(9-39),PubChem CID,16198321,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.22,M,=,,8.03,-1.548,,,[125I]-exendin(9-39) (radioligand),104.0,0.0,,0.0,,P43220,0.5518712271774366
1173,27315480,glp1r_human,387,E,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.75,M,=,,8.55,-1.585,,,[125I]-exendin(9-39) (radioligand),104.0,0.0,,0.0,,P43220,0.5518712271774366
1174,27315480,glp1r_human,387,E,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - Ca2+ accumulation,7.87,M,=,,7.69,-1.513,,,,0.0,0.0,,98.0,,P43220,0.5518712271774366
1175,27315480,glp1r_human,387,E,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - ERK activation,8.28,M,=,,7.79,-3.086,,,,0.0,0.0,,45.0,,P43220,0.5518712271774366
1176,27315480,glp1r_human,387,E,A,Oxyntomodulin(30-37),PubChem CID,11766473,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.3,M,=,,6.86,-2.755,,,[125I]-exendin(9-39) (radioligand),104.0,0.0,,0.0,,P43220,0.5518712271774366
1177,27315480,glp1r_human,387,E,A,Oxyntomodulin(30-37),PubChem CID,11766473,Full agonist,pEC50,Functional - cAMP accumulation,8.43,M,=,,7.23,-15.873,,,,0.0,0.0,,61.0,,P43220,0.5518712271774366
1178,27315480,glp1r_human,387,E,A,Oxyntomodulin(30-37),PubChem CID,11766473,Full agonist,pEC50,Functional - ERK activation,7.57,M,=,,7.23,-2.188,,,,0.0,0.0,,6.96,,P43220,0.5518712271774366
116,21868452,glp1r_human,391,T,A,exendin(9-39),PubChem CID,16198321,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,9.15,M,=,,8.7,-2.817,,,[125I]-exendin(9-39) (radioligand),64.54545454545455,0.0,,0.0,,P43220,0.4893168392808157
117,21868452,glp1r_human,391,T,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,8.22,M,=,,7.22,1.139,,,[125I]-exendin(9-39) (radioligand),64.54545454545455,0.0,,0.0,,P43220,0.4893168392808157
118,21868452,glp1r_human,391,T,A,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Full agonist,pEC50,Functional - cAMP accumulation,10.16,M,=,,10.21,1.122,,,,0.0,0.0,,93.0,,P43220,0.4893168392808157
119,21868452,glp1r_human,391,T,A,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Full agonist,pEC50,Functional - cAMP accumulation,10.16,M,=,,10.21,1.122,,,,64.54545454545455,0.0,,0.0,,P43220,0.4893168392808157
131,22134089,glp1r_human,391,T,A,compound 3,PubChem CID,16133830,Allosteric agonist,EC50,Functional - cAMP accumulation,1.9,ÂµM,=,,6.3,-3.311,,,,0.0,0.0,,15.0,glucagon-like peptide 1-(7-37),P43220,0.4893168392808157
132,22134089,glp1r_human,391,T,A,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Full agonist,EC50,Functional - cAMP accumulation,2182.1,pM,=,,2689.7,-1.233,,,,0.0,0.0,,0.0,,P43220,0.4893168392808157
123,22134089,glp1r_human,192,L,S,compound 3,PubChem CID,22341103,Allosteric agonist,EC50,Functional - cAMP accumulation,1.9,ÂµM,=,,2.1,-1.105,,,,0.0,0.0,,44.0,glucagon-like peptide 1-(7-37),P43220,0.3700037747450899
124,22134089,glp1r_human,192,L,S,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Full agonist,EC50,Functional - cAMP accumulation,2182.1,pM,=,,1981.4,1.101,,,,0.0,0.0,,0.0,,P43220,0.3700037747450899
590,27059958,glp1r_human,192,L,S,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,6.9,nM,=,,8.5,-1.232,,,[125I]-glucagon-like peptide 1-(7-36) (radioligand),82.0,0.0,,0.0,,P43220,0.3700037747450899
591,27059958,glp1r_human,192,L,S,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Full agonist,EC50,Functional - cAMP accumulation,10.0,nM,=,,3.1,3.226,,,,82.0,0.0,,0.0,,P43220,0.3700037747450899
127,22134089,glp1r_human,241,Y,A,compound 3,PubChem CID,16133830,Allosteric agonist,EC50,Functional - cAMP accumulation,1.9,ÂµM,=,,4.2,-2.212,,,,0.0,0.0,,25.0,glucagon-like peptide 1-(7-37),P43220,0.6095161552032193
128,22134089,glp1r_human,241,Y,A,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Full agonist,EC50,Functional - cAMP accumulation,2182.1,pM,=,,3387.4,-1.553,,,,0.0,0.0,,0.0,,P43220,0.6095161552032193
667,27059958,glp1r_human,241,Y,A,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,6.9,nM,=,,6.6,1.045,,,[125I]-glucagon-like peptide 1-(7-36) (radioligand),78.0,0.0,,0.0,,P43220,0.6095161552032193
668,27059958,glp1r_human,241,Y,A,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Full agonist,EC50,Functional - cAMP accumulation,10.0,nM,=,,22.0,-2.198,,,,78.0,0.0,,0.0,,P43220,0.6095161552032193
129,22134089,glp1r_human,278,L,M,compound 3,PubChem CID,16133830,Allosteric agonist,EC50,Functional - cAMP accumulation,1.9,ÂµM,=,,1.8,1.056,,,,0.0,0.0,,37.0,glucagon-like peptide 1-(7-37),P43220,0.2683939292891484
130,22134089,glp1r_human,278,L,M,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Full agonist,EC50,Functional - cAMP accumulation,2182.1,pM,=,,2687.5,-1.232,,,,0.0,0.0,,0.0,,P43220,0.2683939292891484
133,22147710,glp1r_human,285,G,A,exendin(9-39),PubChem CID,16198321,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.7,M,=,,7.7,1.0,,,[125I]-exendin(9-39) (radioligand),88.0,0.0,,0.0,,P43220,0.3755125286956978
134,22147710,glp1r_human,285,G,A,glucagon-like peptide 1-(1-36),PubChem CID,16131070,Full agonist,pEC50,Functional - ERK activation,7.2,M,=,,7.1,-1.259,,,,0.0,0.0,,145.61403508771932,,P43220,0.3755125286956978
135,22147710,glp1r_human,285,G,A,glucagon-like peptide 1-(1-36),PubChem CID,16131070,Full agonist,pEC50,Functional - cAMP accumulation,7.3,M,=,,7.7,2.512,,,,0.0,0.0,,83.44331133773245,,P43220,0.3755125286956978
136,22147710,glp1r_human,285,G,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - cAMP accumulation,9.0,M,=,,9.1,1.259,,,,0.0,0.0,,92.71206690561527,,P43220,0.3755125286956978
137,22147710,glp1r_human,285,G,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.7,M,=,,9.1,2.512,,,[125I]-exendin(9-39) (radioligand),88.0,0.0,,0.0,,P43220,0.3755125286956978
138,22147710,glp1r_human,285,G,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - ERK activation,7.8,M,=,,8.1,1.995,,,,0.0,0.0,,86.79245283018867,,P43220,0.3755125286956978
139,22147710,glp1r_human,286,I,A,exendin(9-39),PubChem CID,16198321,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.7,M,=,,7.7,1.0,,,[125I]-exendin(9-39) (radioligand),79.0,0.0,,0.0,,P43220,0.2835963514775615
140,22147710,glp1r_human,286,I,A,glucagon-like peptide 1-(1-36),PubChem CID,16131070,Full agonist,pEC50,Functional - ERK activation,7.2,M,=,,7.2,1.0,,,,0.0,0.0,,114.03508771929825,,P43220,0.2835963514775615
141,22147710,glp1r_human,286,I,A,glucagon-like peptide 1-(1-36),PubChem CID,16131070,Full agonist,pEC50,Functional - cAMP accumulation,7.3,M,=,,7.6,1.995,,,,0.0,0.0,,76.60467906418717,,P43220,0.2835963514775615
142,22147710,glp1r_human,286,I,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - ERK activation,7.8,M,=,,7.8,1.0,,,,0.0,0.0,,107.54716981132076,,P43220,0.2835963514775615
143,22147710,glp1r_human,286,I,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - cAMP accumulation,9.0,M,=,,8.8,-1.585,,,,0.0,0.0,,92.71206690561527,,P43220,0.2835963514775615
144,22147710,glp1r_human,286,I,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.7,M,=,,8.8,1.259,,,[125I]-exendin(9-39) (radioligand),79.0,0.0,,0.0,,P43220,0.2835963514775615
145,22147710,glp1r_human,287,V,A,exendin(9-39),PubChem CID,16198321,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.7,M,=,,7.7,1.0,,,[125I]-exendin(9-39) (radioligand),92.0,0.0,,0.0,,P43220,0.3271263700204322
146,22147710,glp1r_human,287,V,A,glucagon-like peptide 1-(1-36),PubChem CID,16131070,Full agonist,pEC50,Functional - ERK activation,7.2,M,=,,6.9,-1.996,,,,0.0,0.0,,119.29824561403508,,P43220,0.3271263700204322
147,22147710,glp1r_human,287,V,A,glucagon-like peptide 1-(1-36),PubChem CID,16131070,Full agonist,pEC50,Functional - cAMP accumulation,7.3,M,=,,7.2,-1.259,,,,0.0,0.0,,80.62387522495501,,P43220,0.3271263700204322
148,22147710,glp1r_human,287,V,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - ERK activation,7.8,M,=,,7.6,-1.585,,,,0.0,0.0,,100.0,,P43220,0.3271263700204322
149,22147710,glp1r_human,287,V,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.7,M,=,,8.5,-1.585,,,[125I]-exendin(9-39) (radioligand),92.0,0.0,,0.0,,P43220,0.3271263700204322
150,22147710,glp1r_human,287,V,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - cAMP accumulation,9.0,M,=,,8.4,-3.984,,,,0.0,0.0,,82.01911589008364,,P43220,0.3271263700204322
151,22147710,glp1r_human,288,K,A,exendin(9-39),PubChem CID,16198321,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.7,M,=,,8.0,1.995,,,[125I]-exendin(9-39) (radioligand),92.0,0.0,,0.0,,P43220,0.5244690761204518
152,22147710,glp1r_human,288,K,A,glucagon-like peptide 1-(1-36),PubChem CID,16131070,Full agonist,pEC50,Functional - ERK activation,7.2,M,=,,6.6,-3.984,,,,0.0,0.0,,57.89473684210525,,P43220,0.5244690761204518
154,22147710,glp1r_human,288,K,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.7,M,=,,6.6,-125.0,,,[125I]-exendin(9-39) (radioligand),88.0,0.0,,0.0,,P43220,0.5244690761204518
155,22147710,glp1r_human,288,K,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - ERK activation,7.8,M,=,,6.7,-12.658,,,,0.0,0.0,,54.71698113207547,,P43220,0.5244690761204518
464,26598711,glp1r_human,288,K,A,exendin(9-39),PubChem CID,16198321,Binding - unknown pharmacological activity,pIC50,Binding - Radioligand competition/displacement,8.35,M,=,,8.2,-1.412,,,[125I]-exendin(9-39) (radioligand),83.02752293577981,0.0,,0.0,,P43220,0.5244690761204518
465,26598711,glp1r_human,288,K,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Binding - unknown pharmacological activity,pIC50,Binding - Radioligand competition/displacement,9.45,M,=,,8.09,-22.727,,,[125I]-exendin(9-39) (radioligand),83.02752293577981,0.0,,0.0,,P43220,0.5244690761204518
466,26598711,glp1r_human,288,K,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,EC50,Functional - cAMP accumulation,11.38,M,=,,7.66,1.486,,,,83.02752293577981,0.0,,0.0,,P43220,0.5244690761204518
157,22147710,glp1r_human,289,Y,A,exendin(9-39),PubChem CID,16198321,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.7,M,=,,7.6,-1.259,,,[125I]-exendin(9-39) (radioligand),84.0,0.0,,0.0,,P43220,0.3010885160296489
158,22147710,glp1r_human,289,Y,A,glucagon-like peptide 1-(1-36),PubChem CID,16131070,Full agonist,pEC50,Functional - ERK activation,7.2,M,=,,7.3,1.259,,,,0.0,0.0,,85.96491228070175,,P43220,0.3010885160296489
159,22147710,glp1r_human,289,Y,A,glucagon-like peptide 1-(1-36),PubChem CID,16131070,Full agonist,pEC50,Functional - cAMP accumulation,7.3,M,=,,7.6,1.995,,,,0.0,0.0,,71.56568686262747,,P43220,0.3010885160296489
160,22147710,glp1r_human,289,Y,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - ERK activation,7.8,M,=,,7.4,-2.513,,,,0.0,0.0,,94.33962264150944,,P43220,0.3010885160296489
161,22147710,glp1r_human,289,Y,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.7,M,=,,8.9,1.585,,,[125I]-exendin(9-39) (radioligand),84.0,0.0,,0.0,,P43220,0.3010885160296489
162,22147710,glp1r_human,289,Y,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - cAMP accumulation,9.0,M,=,,8.9,-1.259,,,,0.0,0.0,,66.24850657108722,,P43220,0.3010885160296489
467,26598711,glp1r_human,289,Y,A,exendin(9-39),PubChem CID,16198321,Binding - unknown pharmacological activity,pIC50,Binding - Radioligand competition/displacement,8.35,M,=,,8.48,1.349,,,[125I]-exendin(9-39) (radioligand),19.724770642201836,0.0,,0.0,,P43220,0.3010885160296489
468,26598711,glp1r_human,289,Y,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Binding - unknown pharmacological activity,pIC50,Binding - Radioligand competition/displacement,9.45,M,=,,9.33,-1.318,,,[125I]-exendin(9-39) (radioligand),19.724770642201836,0.0,,0.0,,P43220,0.3010885160296489
469,26598711,glp1r_human,289,Y,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,EC50,Functional - cAMP accumulation,11.38,M,=,,10.38,1.096,,,,19.724770642201836,0.0,,0.0,,P43220,0.3010885160296489
163,22147710,glp1r_human,290,L,A,exendin(9-39),PubChem CID,16198321,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.7,M,=,,7.6,-1.259,,,[125I]-exendin(9-39) (radioligand),77.0,0.0,,0.0,,P43220,0.2632760773594139
164,22147710,glp1r_human,290,L,A,glucagon-like peptide 1-(1-36),PubChem CID,16131070,Full agonist,pEC50,Functional - ERK activation,7.2,M,=,,7.0,-1.585,,,,0.0,0.0,,96.49122807017544,,P43220,0.2632760773594139
165,22147710,glp1r_human,290,L,A,glucagon-like peptide 1-(1-36),PubChem CID,16131070,Full agonist,pEC50,Functional - cAMP accumulation,7.3,M,=,,7.3,1.0,,,,0.0,0.0,,61.54769046190762,,P43220,0.2632760773594139
166,22147710,glp1r_human,290,L,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - cAMP accumulation,9.0,M,=,,8.7,-1.996,,,,0.0,0.0,,80.10752688172043,,P43220,0.2632760773594139
167,22147710,glp1r_human,290,L,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.7,M,=,,8.9,1.585,,,[125I]-glucagon-like peptide 1-(7-36) (radioligand),77.0,0.0,,0.0,,P43220,0.2632760773594139
168,22147710,glp1r_human,290,L,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - ERK activation,7.8,M,=,,7.9,1.259,,,,0.0,0.0,,64.15094339622641,,P43220,0.2632760773594139
169,22147710,glp1r_human,291,Y,A,exendin(9-39),PubChem CID,16198321,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.7,M,=,,7.8,1.259,,,[125I]-exendin(9-39) (radioligand),84.0,0.0,,0.0,,P43220,0.4168548642438624
170,22147710,glp1r_human,291,Y,A,glucagon-like peptide 1-(1-36),PubChem CID,16131070,Full agonist,pEC50,Functional - ERK activation,7.2,M,=,,6.9,-1.996,,,,0.0,0.0,,100.0,,P43220,0.4168548642438624
171,22147710,glp1r_human,291,Y,A,glucagon-like peptide 1-(1-36),PubChem CID,16131070,Full agonist,pEC50,Functional - cAMP accumulation,7.3,M,=,,7.2,-1.259,,,,0.0,0.0,,71.56568686262747,,P43220,0.4168548642438624
172,22147710,glp1r_human,291,Y,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.7,M,=,,8.3,-2.513,,,[125I]-glucagon-like peptide 1-(7-36) (radioligand),84.0,0.0,,0.0,,P43220,0.4168548642438624
173,22147710,glp1r_human,291,Y,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - ERK activation,7.8,M,=,,7.8,1.0,,,,0.0,0.0,,77.35849056603773,,P43220,0.4168548642438624
174,22147710,glp1r_human,291,Y,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - cAMP accumulation,9.0,M,=,,8.6,-2.513,,,,0.0,0.0,,75.80645161290323,,P43220,0.4168548642438624
175,22147710,glp1r_human,292,E,A,exendin(9-39),PubChem CID,16198321,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.7,M,=,,7.7,1.0,,,[125I]-exendin(9-39) (radioligand),103.0,0.0,,0.0,,P43220,0.3542145971986663
176,22147710,glp1r_human,292,E,A,glucagon-like peptide 1-(1-36),PubChem CID,16131070,Full agonist,pEC50,Functional - ERK activation,7.2,M,=,,6.7,-3.165,,,,0.0,0.0,,68.42105263157895,,P43220,0.3542145971986663
178,22147710,glp1r_human,292,E,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.7,M,=,,6.7,-100.0,,,[125I]-exendin(9-39) (radioligand),103.0,0.0,,0.0,,P43220,0.3542145971986663
179,22147710,glp1r_human,292,E,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - cAMP accumulation,9.0,M,=,,6.9,-125.0,,,,0.0,0.0,,56.69056152927121,,P43220,0.3542145971986663
180,22147710,glp1r_human,292,E,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - ERK activation,7.8,M,=,,7.2,-3.984,,,,0.0,0.0,,37.735849056603776,,P43220,0.3542145971986663
672,27059958,glp1r_human,292,E,A,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Full agonist,EC50,Functional - cAMP accumulation,10.0,nM,=,,332.0,-33.333,,,,39.0,0.0,,0.0,,P43220,0.3542145971986663
181,22147710,glp1r_human,293,D,A,exendin(9-39),PubChem CID,16198321,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.7,M,=,,7.9,1.585,,,[125I]-exendin(9-39) (radioligand),62.0,0.0,,0.0,,P43220,0.3390011657913747
182,22147710,glp1r_human,293,D,A,glucagon-like peptide 1-(1-36),PubChem CID,16131070,Full agonist,pEC50,Functional - ERK activation,7.2,M,=,,7.2,1.0,,,,0.0,0.0,,70.17543859649122,,P43220,0.3390011657913747
183,22147710,glp1r_human,293,D,A,glucagon-like peptide 1-(1-36),PubChem CID,16131070,Full agonist,pEC50,Functional - cAMP accumulation,7.3,M,=,,6.8,-3.165,,,,0.0,0.0,,38.45230953809239,,P43220,0.3390011657913747
184,22147710,glp1r_human,293,D,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - cAMP accumulation,9.0,M,=,,7.8,-15.873,,,,0.0,0.0,,70.48984468339306,,P43220,0.3390011657913747
185,22147710,glp1r_human,293,D,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.7,M,=,,7.3,-25.0,,,[125I]-exendin(9-39) (radioligand),62.0,0.0,,0.0,,P43220,0.3390011657913747
186,22147710,glp1r_human,293,D,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - ERK activation,7.8,M,=,,7.5,-1.996,,,,0.0,0.0,,50.943396226415096,,P43220,0.3390011657913747
187,22147710,glp1r_human,294,E,A,exendin(9-39),PubChem CID,16198321,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.7,M,=,,7.9,1.585,,,[125I]-exendin(9-39) (radioligand),81.0,0.0,,0.0,,P43220,0.2857165420017053
188,22147710,glp1r_human,294,E,A,glucagon-like peptide 1-(1-36),PubChem CID,16131070,Full agonist,pEC50,Functional - ERK activation,7.2,M,=,,7.1,-1.259,,,,0.0,0.0,,105.26315789473684,,P43220,0.2857165420017053
189,22147710,glp1r_human,294,E,A,glucagon-like peptide 1-(1-36),PubChem CID,16131070,Full agonist,pEC50,Functional - cAMP accumulation,7.3,M,=,,7.4,1.259,,,,0.0,0.0,,86.56268746250751,,P43220,0.2857165420017053
190,22147710,glp1r_human,294,E,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.7,M,=,,7.3,-25.0,,,[125I]-glucagon-like peptide 1-(7-36) (radioligand),81.0,0.0,,0.0,,P43220,0.2857165420017053
191,22147710,glp1r_human,294,E,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - ERK activation,7.8,M,=,,7.8,1.0,,,,0.0,0.0,,75.47169811320755,,P43220,0.2857165420017053
192,22147710,glp1r_human,294,E,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - cAMP accumulation,9.0,M,=,,9.1,1.259,,,,0.0,0.0,,73.17801672640381,,P43220,0.2857165420017053
199,22147710,glp1r_human,296,C,A,exendin(9-39),PubChem CID,16198321,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.7,M,=,,7.8,1.259,,,[125I]-exendin(9-39) (radioligand),68.0,0.0,,0.0,,P43220,0.7965421158334627
200,22147710,glp1r_human,296,C,A,glucagon-like peptide 1-(1-36),PubChem CID,16131070,Full agonist,pEC50,Functional - ERK activation,7.2,M,=,,7.8,3.981,,,,0.0,0.0,,35.08771929824561,,P43220,0.7965421158334627
202,22147710,glp1r_human,296,C,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - ERK activation,7.8,M,=,,6.9,-7.937,,,,0.0,0.0,,88.67924528301887,,P43220,0.7965421158334627
203,22147710,glp1r_human,296,C,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.7,M,=,,7.6,-12.658,,,[125I]-exendin(9-39) (radioligand),68.0,0.0,,0.0,,P43220,0.7965421158334627
204,22147710,glp1r_human,296,C,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - cAMP accumulation,9.0,M,=,,6.9,-125.0,,,,0.0,0.0,,59.37873357228196,,P43220,0.7965421158334627
205,22147710,glp1r_human,297,W,A,exendin(9-39),PubChem CID,16198321,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.7,M,=,,7.9,1.585,,,[125I]-exendin(9-39) (radioligand),60.0,0.0,,0.0,,P43220,0.7182983091521715
206,22147710,glp1r_human,297,W,A,glucagon-like peptide 1-(1-36),PubChem CID,16131070,Full agonist,pEC50,Functional - ERK activation,7.2,M,=,,7.9,5.012,,,,0.0,0.0,,38.59649122807018,,P43220,0.7182983091521715
208,22147710,glp1r_human,297,W,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.7,M,=,,6.9,-62.5,,,[125I]-exendin(9-39) (radioligand),60.0,0.0,,0.0,,P43220,0.7182983091521715
209,22147710,glp1r_human,297,W,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - ERK activation,7.8,M,=,,7.3,-3.165,,,,0.0,0.0,,56.60377358490566,,P43220,0.7182983091521715
210,22147710,glp1r_human,297,W,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - cAMP accumulation,9.0,M,=,,6.5,-333.333,,,,0.0,0.0,,27.120669056152924,,P43220,0.7182983091521715
211,22147710,glp1r_human,298,T,A,exendin(9-39),PubChem CID,16198321,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.7,M,=,,8.1,2.512,,,[125I]-exendin(9-39) (radioligand),85.0,0.0,,0.0,,P43220,0.451246570037215
212,22147710,glp1r_human,298,T,A,glucagon-like peptide 1-(1-36),PubChem CID,16131070,Full agonist,pEC50,Functional - ERK activation,7.2,M,=,,7.8,3.981,,,,0.0,0.0,,121.05263157894736,,P43220,0.451246570037215
213,22147710,glp1r_human,298,T,A,glucagon-like peptide 1-(1-36),PubChem CID,16131070,Full agonist,pEC50,Functional - cAMP accumulation,7.3,M,=,,7.8,3.162,,,,0.0,0.0,,76.12477504499101,,P43220,0.451246570037215
214,22147710,glp1r_human,298,T,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - ERK activation,7.8,M,=,,8.0,1.585,,,,0.0,0.0,,115.09433962264151,,P43220,0.451246570037215
215,22147710,glp1r_human,298,T,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.7,M,=,,9.1,2.512,,,[125I]-exendin(9-39) (radioligand),85.0,0.0,,0.0,,P43220,0.451246570037215
216,22147710,glp1r_human,298,T,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - cAMP accumulation,9.0,M,=,,9.7,5.012,,,,0.0,0.0,,69.41457586618877,,P43220,0.451246570037215
217,22147710,glp1r_human,299,R,A,exendin(9-39),PubChem CID,16198321,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.7,M,=,,7.4,-1.996,,,[125I]-exendin(9-39) (radioligand),60.0,0.0,,0.0,,P43220,0.3952028651806795
218,22147710,glp1r_human,299,R,A,glucagon-like peptide 1-(1-36),PubChem CID,16131070,Full agonist,pEC50,Functional - ERK activation,7.2,M,=,,7.5,1.995,,,,0.0,0.0,,94.73684210526316,,P43220,0.3952028651806795
219,22147710,glp1r_human,299,R,A,glucagon-like peptide 1-(1-36),PubChem CID,16131070,Full agonist,pEC50,Functional - cAMP accumulation,7.3,M,=,,7.2,-1.259,,,,0.0,0.0,,9.358128374325135,,P43220,0.3952028651806795
220,22147710,glp1r_human,299,R,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - ERK activation,7.8,M,=,,7.5,-1.996,,,,0.0,0.0,,79.24528301886792,,P43220,0.3952028651806795
221,22147710,glp1r_human,299,R,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.7,M,=,,7.2,-31.25,,,[125I]-exendin(9-39) (radioligand),60.0,0.0,,0.0,,P43220,0.3952028651806795
222,22147710,glp1r_human,299,R,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - cAMP accumulation,9.0,M,=,,7.6,-25.0,,,,0.0,0.0,,55.19713261648745,,P43220,0.3952028651806795
470,26598711,glp1r_human,299,R,A,exendin(9-39),PubChem CID,16198321,Binding - unknown pharmacological activity,pIC50,Binding - Radioligand competition/displacement,8.35,M,=,,8.59,1.738,,,[125I]-exendin(9-39) (radioligand),40.36697247706422,0.0,,0.0,,P43220,0.3952028651806795
471,26598711,glp1r_human,299,R,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Binding - unknown pharmacological activity,pIC50,Binding - Radioligand competition/displacement,9.45,M,=,,9.87,2.63,,,[125I]-exendin(9-39) (radioligand),40.36697247706422,0.0,,0.0,,P43220,0.3952028651806795
472,26598711,glp1r_human,299,R,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,EC50,Functional - cAMP accumulation,11.38,M,=,,10.5,1.084,,,,40.36697247706422,0.0,,0.0,,P43220,0.3952028651806795
229,22147710,glp1r_human,301,S,A,exendin(9-39),PubChem CID,16198321,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.7,M,=,,8.1,2.512,,,[125I]-exendin(9-39) (radioligand),63.0,0.0,,0.0,,P43220,0.2779092401815751
230,22147710,glp1r_human,301,S,A,glucagon-like peptide 1-(1-36),PubChem CID,16131070,Full agonist,pEC50,Functional - ERK activation,7.2,M,=,,7.3,1.259,,,,0.0,0.0,,84.21052631578947,,P43220,0.2779092401815751
231,22147710,glp1r_human,301,S,A,glucagon-like peptide 1-(1-36),PubChem CID,16131070,Full agonist,pEC50,Functional - cAMP accumulation,7.3,M,=,,7.5,1.585,,,,0.0,0.0,,61.72765446910618,,P43220,0.2779092401815751
232,22147710,glp1r_human,301,S,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - ERK activation,7.8,M,=,,7.8,1.0,,,,0.0,0.0,,84.90566037735849,,P43220,0.2779092401815751
233,22147710,glp1r_human,301,S,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - cAMP accumulation,9.0,M,=,,9.0,1.0,,,,0.0,0.0,,63.26164874551972,,P43220,0.2779092401815751
234,22147710,glp1r_human,301,S,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.7,M,=,,8.8,1.259,,,[125I]-exendin(9-39) (radioligand),63.0,0.0,,0.0,,P43220,0.2779092401815751
241,22147710,glp1r_human,303,M,A,exendin(9-39),PubChem CID,16198321,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.7,M,=,,8.1,2.512,,,[125I]-exendin(9-39) (radioligand),125.0,0.0,,0.0,,P43220,0.2837030436988664
242,22147710,glp1r_human,303,M,A,glucagon-like peptide 1-(1-36),PubChem CID,16131070,Full agonist,pEC50,Functional - ERK activation,7.2,M,=,,7.2,1.0,,,,0.0,0.0,,96.49122807017544,,P43220,0.2837030436988664
243,22147710,glp1r_human,303,M,A,glucagon-like peptide 1-(1-36),PubChem CID,16131070,Full agonist,pEC50,Functional - cAMP accumulation,7.3,M,=,,7.3,1.0,,,,0.0,0.0,,60.167966406718655,,P43220,0.2837030436988664
244,22147710,glp1r_human,303,M,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.7,M,=,,8.1,-3.984,,,[125I]-exendin(9-39) (radioligand),125.0,0.0,,0.0,,P43220,0.2837030436988664
245,22147710,glp1r_human,303,M,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - ERK activation,7.8,M,=,,7.8,1.0,,,,0.0,0.0,,103.77358490566036,,P43220,0.2837030436988664
246,22147710,glp1r_human,303,M,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - cAMP accumulation,9.0,M,=,,8.5,-3.165,,,,0.0,0.0,,71.14695340501792,,P43220,0.2837030436988664
253,22147710,glp1r_human,305,Y,A,exendin(9-39),PubChem CID,16198321,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.7,M,=,,7.7,1.0,,,[125I]-exendin(9-39) (radioligand),52.0,0.0,,0.0,,P43220,0.5001514511599917
254,22147710,glp1r_human,305,Y,A,glucagon-like peptide 1-(1-36),PubChem CID,16131070,Full agonist,pEC50,Functional - ERK activation,7.2,M,=,,7.5,1.995,,,,0.0,0.0,,59.64912280701754,,P43220,0.5001514511599917
255,22147710,glp1r_human,305,Y,A,glucagon-like peptide 1-(1-36),PubChem CID,16131070,Full agonist,pEC50,Functional - cAMP accumulation,7.3,M,=,,6.9,-2.513,,,,0.0,0.0,,26.93461307738452,,P43220,0.5001514511599917
256,22147710,glp1r_human,305,Y,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - cAMP accumulation,9.0,M,=,,7.4,-40.0,,,,0.0,0.0,,81.24253285543608,,P43220,0.5001514511599917
257,22147710,glp1r_human,305,Y,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - ERK activation,7.8,M,=,,7.5,-1.996,,,,0.0,0.0,,62.264150943396224,,P43220,0.5001514511599917
258,22147710,glp1r_human,305,Y,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.7,M,=,,6.8,-76.923,,,[125I]-exendin(9-39) (radioligand),52.0,0.0,,0.0,,P43220,0.5001514511599917
476,26598711,glp1r_human,305,Y,A,exendin(9-39),PubChem CID,16198321,Binding - unknown pharmacological activity,pIC50,Binding - Radioligand competition/displacement,8.35,M,=,,8.29,-1.148,,,[125I]-exendin(9-39) (radioligand),22.47706422018349,0.0,,0.0,,P43220,0.5001514511599917
477,26598711,glp1r_human,305,Y,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Binding - unknown pharmacological activity,pIC50,Binding - Radioligand competition/displacement,9.45,M,=,,9.26,-1.548,,,[125I]-exendin(9-39) (radioligand),22.47706422018349,0.0,,0.0,,P43220,0.5001514511599917
478,26598711,glp1r_human,305,Y,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,EC50,Functional - cAMP accumulation,11.38,M,=,,10.7,1.064,,,,22.47706422018349,0.0,,0.0,,P43220,0.5001514511599917
259,22147710,glp1r_human,306,W,A,exendin(9-39),PubChem CID,16198321,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.7,M,=,,7.9,1.585,,,[125I]-exendin(9-39) (radioligand),60.0,0.0,,0.0,,P43220,0.5898917074578922
262,22147710,glp1r_human,306,W,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.7,M,=,,7.3,-25.0,,,[125I]-exendin(9-39) (radioligand),60.0,0.0,,0.0,,P43220,0.5898917074578922
479,26598711,glp1r_human,306,W,A,exendin(9-39),PubChem CID,16198321,Binding - unknown pharmacological activity,pIC50,Binding - Radioligand competition/displacement,8.35,M,=,,8.61,1.82,,,[125I]-exendin(9-39) (radioligand),41.28440366972477,0.0,,0.0,,P43220,0.5898917074578922
480,26598711,glp1r_human,306,W,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Binding - unknown pharmacological activity,pIC50,Binding - Radioligand competition/displacement,9.45,M,=,,7.41,-111.111,,,[125I]-exendin(9-39) (radioligand),41.28440366972477,0.0,,0.0,,P43220,0.5898917074578922
481,26598711,glp1r_human,306,W,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,EC50,Functional - cAMP accumulation,11.38,M,=,,9.1,1.251,,,,41.28440366972477,0.0,,0.0,,P43220,0.5898917074578922
265,22147710,glp1r_human,307,L,A,exendin(9-39),PubChem CID,16198321,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.7,M,=,,8.0,1.995,,,[125I]-exendin(9-39) (radioligand),60.0,0.0,,0.0,,P43220,0.4278502759250218
266,22147710,glp1r_human,307,L,A,glucagon-like peptide 1-(1-36),PubChem CID,16131070,Full agonist,pEC50,Functional - ERK activation,7.2,M,=,,7.4,1.585,,,,0.0,0.0,,49.122807017543856,,P43220,0.4278502759250218
267,22147710,glp1r_human,307,L,A,glucagon-like peptide 1-(1-36),PubChem CID,16131070,Full agonist,pEC50,Functional - cAMP accumulation,7.3,M,=,,7.0,-1.996,,,,0.0,0.0,,31.433713257348533,,P43220,0.4278502759250218
268,22147710,glp1r_human,307,L,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - cAMP accumulation,9.0,M,=,,7.6,-25.0,,,,0.0,0.0,,60.33452807646356,,P43220,0.4278502759250218
269,22147710,glp1r_human,307,L,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.7,M,=,,7.6,-12.658,,,[125I]-exendin(9-39) (radioligand),60.0,0.0,,0.0,,P43220,0.4278502759250218
270,22147710,glp1r_human,307,L,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - ERK activation,7.8,M,=,,7.6,-1.585,,,,0.0,0.0,,58.490566037735846,,P43220,0.4278502759250218
271,23479653,glp1r_human,155,S,A,exendin 4,PubChem CID,56927919,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.97,M,=,,8.43,-3.472,,,[125I]-exendin(9-39) (radioligand),48.0,0.0,,0.0,,P43220,0.7507085407448353
272,23479653,glp1r_human,155,S,A,exendin(9-39),PubChem CID,16198321,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.11,M,=,,8.08,-1.072,,,[125I]-exendin(9-39) (radioligand),48.0,0.0,,0.0,,P43220,0.7507085407448353
273,23479653,glp1r_human,155,S,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.67,M,=,,8.29,-2.398,,,[125I]-exendin(9-39) (radioligand),48.0,0.0,,0.0,,P43220,0.7507085407448353
274,23479653,glp1r_human,155,S,A,Oxyntomodulin(30-37),PubChem CID,11766473,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.26,M,=,,7.28,1.047,,,[125I]-exendin(9-39) (radioligand),48.0,0.0,,0.0,,P43220,0.7507085407448353
279,23479653,glp1r_human,186,S,A,exendin 4,PubChem CID,56927919,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.97,M,=,,9.02,1.122,,,[125I]-exendin(9-39) (radioligand),114.0,0.0,,0.0,,P43220,0.4670330332245095
280,23479653,glp1r_human,186,S,A,exendin(9-39),PubChem CID,16198321,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.11,M,=,,7.94,-1.479,,,[125I]-exendin(9-39) (radioligand),114.0,0.0,,0.0,,P43220,0.4670330332245095
281,23479653,glp1r_human,186,S,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.67,M,=,,8.6,-1.175,,,[125I]-exendin(9-39) (radioligand),114.0,0.0,,0.0,,P43220,0.4670330332245095
282,23479653,glp1r_human,186,S,A,Oxyntomodulin(30-37),PubChem CID,11766473,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.26,M,=,,7.26,1.0,,,[125I]-exendin(9-39) (radioligand),114.0,0.0,,0.0,,P43220,0.4670330332245095
291,23479653,glp1r_human,247,E,A,exendin 4,PubChem CID,56927919,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.97,M,=,,8.64,-2.137,,,[125I]-exendin(9-39) (radioligand),0.0,0.0,,0.0,,P43220,0.8173340147147614
292,23479653,glp1r_human,247,E,A,exendin(9-39),PubChem CID,16198321,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.11,M,=,,8.29,1.514,,,[125I]-exendin(9-39) (radioligand),0.0,0.0,,0.0,,P43220,0.8173340147147614
293,23479653,glp1r_human,247,E,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.67,M,=,,8.19,-3.021,,,[125I]-exendin(9-39) (radioligand),0.0,0.0,,0.0,,P43220,0.8173340147147614
294,23479653,glp1r_human,247,E,A,Oxyntomodulin(30-37),PubChem CID,11766473,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.26,M,=,,7.43,1.479,,,[125I]-exendin(9-39) (radioligand),0.0,0.0,,0.0,,P43220,0.8173340147147614
307,23479653,glp1r_human,392,S,A,exendin 4,PubChem CID,56927919,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.97,M,=,,8.72,-1.779,,,[125I]-exendin(9-39) (radioligand),92.0,0.0,,0.0,,P43220,0.4789415412202916
308,23479653,glp1r_human,392,S,A,exendin(9-39),PubChem CID,16198321,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.11,M,=,,8.45,2.188,,,[125I]-exendin(9-39) (radioligand),92.0,0.0,,0.0,,P43220,0.4789415412202916
309,23479653,glp1r_human,392,S,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.67,M,=,,8.42,-1.779,,,[125I]-exendin(9-39) (radioligand),92.0,0.0,,0.0,,P43220,0.4789415412202916
310,23479653,glp1r_human,392,S,A,Oxyntomodulin(30-37),PubChem CID,11766473,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.26,M,=,,7.09,-1.479,,,[125I]-exendin(9-39) (radioligand),92.0,0.0,,0.0,,P43220,0.4789415412202916
311,23479653,glp1r_human,394,Q,A,exendin 4,PubChem CID,56927919,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.97,M,=,,8.72,-1.779,,,[125I]-exendin(9-39) (radioligand),111.0,0.0,,0.0,,P43220,0.799589843102827
312,23479653,glp1r_human,394,Q,A,exendin(9-39),PubChem CID,16198321,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.11,M,=,,8.45,2.188,,,[125I]-exendin(9-39) (radioligand),111.0,0.0,,0.0,,P43220,0.799589843102827
313,23479653,glp1r_human,394,Q,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.67,M,=,,8.42,-1.779,,,[125I]-exendin(9-39) (radioligand),111.0,0.0,,0.0,,P43220,0.799589843102827
314,23479653,glp1r_human,394,Q,A,Oxyntomodulin(30-37),PubChem CID,11766473,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.26,M,=,,7.09,-1.479,,,[125I]-exendin(9-39) (radioligand),111.0,0.0,,0.0,,P43220,0.799589843102827
315,23479653,glp1r_human,402,Y,A,exendin 4,PubChem CID,56927919,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.97,M,=,,8.72,-1.779,,,[125I]-exendin(9-39) (radioligand),0.0,0.0,,0.0,,P43220,0.7307202545898319
316,23479653,glp1r_human,402,Y,A,exendin(9-39),PubChem CID,16198321,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.11,M,=,,8.45,2.188,,,[125I]-exendin(9-39) (radioligand),0.0,0.0,,0.0,,P43220,0.7307202545898319
317,23479653,glp1r_human,402,Y,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.67,M,=,,8.42,-1.779,,,[125I]-exendin(9-39) (radioligand),0.0,0.0,,0.0,,P43220,0.7307202545898319
318,23479653,glp1r_human,402,Y,A,Oxyntomodulin(30-37),PubChem CID,11766473,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.26,M,=,,7.09,-1.479,,,[125I]-exendin(9-39) (radioligand),0.0,0.0,,0.0,,P43220,0.7307202545898319
356,25561730,glp1r_human,379,L,R,GLP-1-(Asp15Arg),FASTA sequence (peptide),HAEGTFTSKVSSYLRGQAAKEFIAWLVKGR,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,0.83,ÂµM,=,,1.41,-1.698,,,[125I]-glucagon-like peptide 1-(7-36) (radioligand),83.3,0.0,,0.0,,P43220,0.3805137271051672
357,25561730,glp1r_human,379,L,R,GLP-1-(Asp15Arg),FASTA sequence (peptide),HAEGTFTSKVSSYLRGQAAKEFIAWLVKGR,Full agonist,EC50,Functional - cAMP accumulation,28.84,nM,=,,91.2,-3.165,,,,83.3,0.0,,0.0,,P43220,0.3805137271051672
360,25561730,glp1r_human,379,L,R,GLP-1-(Asp15Glu),FASTA sequence (peptide),HAEGTFTSEVSSYLEGQAAKEFIAWLVKGR,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,0.29,ÂµM,=,,4.68,-16.129,,,[125I]-glucagon-like peptide 1-(7-36) (radioligand),83.3,0.0,,0.0,,P43220,0.3805137271051672
361,25561730,glp1r_human,379,L,R,GLP-1-(Asp15Glu),FASTA sequence (peptide),HAEGTFTSEVSSYLEGQAAKEFIAWLVKGR,Full agonist,EC50,Functional - cAMP accumulation,0.33,nM,=,,47.86,-142.857,,,,83.3,0.0,,0.0,,P43220,0.3805137271051672
364,25561730,glp1r_human,379,L,R,GLP-1-(Asp15Lys),FASTA sequence (peptide),HAEGTFTSKVSSYLEGQAAKEFIAWLVKGR,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,1.41,ÂµM,=,,1.02,1.382,,,[125I]-glucagon-like peptide 1-(7-36) (radioligand),83.3,0.0,,0.0,,P43220,0.3805137271051672
365,25561730,glp1r_human,379,L,R,GLP-1-(Asp15Lys),FASTA sequence (peptide),HAEGTFTSKVSSYLEGQAAKEFIAWLVKGR,Full agonist,EC50,Functional - cAMP accumulation,52.48,nM,=,,186.21,-3.546,,,,83.3,0.0,,0.0,,P43220,0.3805137271051672
368,25561730,glp1r_human,379,L,R,GLP-1-(Gly10Arg),FASTA sequence (peptide),HAEETFTSDVSSYLEGQAAKEFIAWLVKGR,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,1.78,ÂµM,>,,10.0,-5.618,,,[125I]-glucagon-like peptide 1-(7-36) (radioligand),83.3,0.0,,0.0,,P43220,0.3805137271051672
369,25561730,glp1r_human,379,L,R,GLP-1-(Gly10Arg),FASTA sequence (peptide),HAEETFTSDVSSYLEGQAAKEFIAWLVKGR,Full agonist,EC50,Functional - cAMP accumulation,123.03,nM,>,,1000.0,-8.13,,,,83.3,0.0,,0.0,,P43220,0.3805137271051672
372,25561730,glp1r_human,379,L,R,GLP-1-(Gly10Asp),FASTA sequence (peptide),HAEDTFTSDVSSYLEGQAAKEFIAWLVKGR,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,1.0,ÂµM,>,,10.0,-10.0,,,[125I]-glucagon-like peptide 1-(7-36) (radioligand),83.3,0.0,,0.0,,P43220,0.3805137271051672
373,25561730,glp1r_human,379,L,R,GLP-1-(Gly10Asp),FASTA sequence (peptide),HAEDTFTSDVSSYLEGQAAKEFIAWLVKGR,Full agonist,EC50,Functional - cAMP accumulation,190.55,nM,>,,1000.0,-5.236,,,,83.3,0.0,,0.0,,P43220,0.3805137271051672
376,25561730,glp1r_human,379,L,R,GLP-1-(Gly10Glu),FASTA sequence (peptide),HAEETFTSDVSSYLEGQAAKEFIAWLVKGR,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,1.82,ÂµM,>,,10.0,-5.495,,,[125I]-glucagon-like peptide 1-(7-36) (radioligand),83.3,0.0,,0.0,,P43220,0.3805137271051672
377,25561730,glp1r_human,379,L,R,GLP-1-(Gly10Glu),FASTA sequence (peptide),HAEETFTSDVSSYLEGQAAKEFIAWLVKGR,Full agonist,EC50,Functional - cAMP accumulation,85.11,nM,=,,851.14,-10.0,,,,83.3,0.0,,0.0,,P43220,0.3805137271051672
380,25561730,glp1r_human,379,L,R,GLP-1-(Gly10His),FASTA sequence (peptide),HAEHTFTSDVSSYLEGQAAKEFIAWLVKGR,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,1.29,ÂµM,>,,10.0,-7.752,,,[125I]-glucagon-like peptide 1-(7-36) (radioligand),83.3,0.0,,0.0,,P43220,0.3805137271051672
381,25561730,glp1r_human,379,L,R,GLP-1-(Gly10His),FASTA sequence (peptide),HAEHTFTSDVSSYLEGQAAKEFIAWLVKGR,Full agonist,EC50,Functional - cAMP accumulation,45.71,nM,>,,1000.0,-21.739,,,,83.3,0.0,,0.0,,P43220,0.3805137271051672
384,25561730,glp1r_human,379,L,R,GLP-1-(Gly10Lys),FASTA sequence (peptide),HAEKTFTSDVSSYLEGQAAKEFIAWLVKGR,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,10.0,ÂµM,>,,10.0,1.0,,,[125I]-glucagon-like peptide 1-(7-36) (radioligand),83.3,0.0,,0.0,,P43220,0.3805137271051672
385,25561730,glp1r_human,379,L,R,GLP-1-(Gly10Lys),FASTA sequence (peptide),HAEKTFTSDVSSYLEGQAAKEFIAWLVKGR,Full agonist,EC50,Functional - cAMP accumulation,1000.0,nM,>,,1000.0,1.0,,,,83.3,0.0,,0.0,,P43220,0.3805137271051672
388,25561730,glp1r_human,379,L,R,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,0.05,ÂµM,=,,0.59,-11.765,,,[125I]-glucagon-like peptide 1-(7-36) (radioligand),83.3,0.0,,0.0,,P43220,0.3805137271051672
389,25561730,glp1r_human,379,L,R,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,EC50,Functional - cAMP accumulation,0.31,nM,=,,43.65,-142.857,,,,83.3,0.0,,0.0,,P43220,0.3805137271051672
358,25561730,glp1r_human,379,L,E,GLP-1-(Asp15Arg),FASTA sequence (peptide),HAEGTFTSKVSSYLRGQAAKEFIAWLVKGR,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,0.83,ÂµM,>,,10.0,-12.048,,,[125I]-glucagon-like peptide 1-(7-36) (radioligand),80.5,0.0,,0.0,,P43220,0.4237692070140454
359,25561730,glp1r_human,379,L,E,GLP-1-(Asp15Arg),FASTA sequence (peptide),HAEGTFTSKVSSYLRGQAAKEFIAWLVKGR,Full agonist,EC50,Functional - cAMP accumulation,28.84,nM,>,,1000.0,-34.483,,,,80.5,0.0,,0.0,,P43220,0.4237692070140454
362,25561730,glp1r_human,379,L,E,GLP-1-(Asp15Glu),FASTA sequence (peptide),HAEGTFTSEVSSYLEGQAAKEFIAWLVKGR,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,0.29,ÂµM,>,,10.0,-34.483,,,[125I]-glucagon-like peptide 1-(7-36) (radioligand),80.5,0.0,,0.0,,P43220,0.4237692070140454
363,25561730,glp1r_human,379,L,E,GLP-1-(Asp15Glu),FASTA sequence (peptide),HAEGTFTSEVSSYLEGQAAKEFIAWLVKGR,Full agonist,EC50,Functional - cAMP accumulation,0.33,nM,=,,104.71,-333.333,,,,80.5,0.0,,0.0,,P43220,0.4237692070140454
366,25561730,glp1r_human,379,L,E,GLP-1-(Asp15Lys),FASTA sequence (peptide),HAEGTFTSKVSSYLEGQAAKEFIAWLVKGR,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,1.41,ÂµM,>,,10.0,-7.092,,,[125I]-glucagon-like peptide 1-(7-36) (radioligand),80.5,0.0,,0.0,,P43220,0.4237692070140454
367,25561730,glp1r_human,379,L,E,GLP-1-(Asp15Lys),FASTA sequence (peptide),HAEGTFTSKVSSYLEGQAAKEFIAWLVKGR,Full agonist,EC50,Functional - cAMP accumulation,52.48,nM,>,,1000.0,-19.231,,,,80.5,0.0,,0.0,,P43220,0.4237692070140454
370,25561730,glp1r_human,379,L,E,GLP-1-(Gly10Arg),FASTA sequence (peptide),HAEETFTSDVSSYLEGQAAKEFIAWLVKGR,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,1.78,ÂµM,>,,10.0,-5.618,,,[125I]-glucagon-like peptide 1-(7-36) (radioligand),80.5,0.0,,0.0,,P43220,0.4237692070140454
371,25561730,glp1r_human,379,L,E,GLP-1-(Gly10Arg),FASTA sequence (peptide),HAEETFTSDVSSYLEGQAAKEFIAWLVKGR,Full agonist,EC50,Functional - cAMP accumulation,123.03,nM,>,,1000.0,-8.13,,,,80.5,0.0,,0.0,,P43220,0.4237692070140454
374,25561730,glp1r_human,379,L,E,GLP-1-(Gly10Asp),FASTA sequence (peptide),HAEDTFTSDVSSYLEGQAAKEFIAWLVKGR,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,1.0,ÂµM,>,,10.0,-10.0,,,[125I]-glucagon-like peptide 1-(7-36) (radioligand),80.5,0.0,,0.0,,P43220,0.4237692070140454
375,25561730,glp1r_human,379,L,E,GLP-1-(Gly10Asp),FASTA sequence (peptide),HAEDTFTSDVSSYLEGQAAKEFIAWLVKGR,Full agonist,EC50,Functional - cAMP accumulation,190.55,nM,>,,1000.0,-5.236,,,,80.5,0.0,,0.0,,P43220,0.4237692070140454
378,25561730,glp1r_human,379,L,E,GLP-1-(Gly10Glu),FASTA sequence (peptide),HAEETFTSDVSSYLEGQAAKEFIAWLVKGR,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,1.82,ÂµM,>,,10.0,-5.495,,,[125I]-glucagon-like peptide 1-(7-36) (radioligand),80.5,0.0,,0.0,,P43220,0.4237692070140454
379,25561730,glp1r_human,379,L,E,GLP-1-(Gly10Glu),FASTA sequence (peptide),HAEETFTSDVSSYLEGQAAKEFIAWLVKGR,Full agonist,EC50,Functional - cAMP accumulation,85.11,nM,>,,1000.0,-11.765,,,,80.5,0.0,,0.0,,P43220,0.4237692070140454
382,25561730,glp1r_human,379,L,E,GLP-1-(Gly10His),FASTA sequence (peptide),HAEHTFTSDVSSYLEGQAAKEFIAWLVKGR,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,1.29,ÂµM,>,,10.0,-7.752,,,[125I]-glucagon-like peptide 1-(7-36) (radioligand),80.5,0.0,,0.0,,P43220,0.4237692070140454
383,25561730,glp1r_human,379,L,E,GLP-1-(Gly10His),FASTA sequence (peptide),HAEHTFTSDVSSYLEGQAAKEFIAWLVKGR,Full agonist,EC50,Functional - cAMP accumulation,45.71,nM,>,,1000.0,-21.739,,,,80.5,0.0,,0.0,,P43220,0.4237692070140454
386,25561730,glp1r_human,379,L,E,GLP-1-(Gly10Lys),FASTA sequence (peptide),HAEKTFTSDVSSYLEGQAAKEFIAWLVKGR,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,10.0,ÂµM,>,,10.0,1.0,,,[125I]-glucagon-like peptide 1-(7-36) (radioligand),80.5,0.0,,0.0,,P43220,0.4237692070140454
387,25561730,glp1r_human,379,L,E,GLP-1-(Gly10Lys),FASTA sequence (peptide),HAEKTFTSDVSSYLEGQAAKEFIAWLVKGR,Full agonist,EC50,Functional - cAMP accumulation,1000.0,nM,>,,1000.0,1.0,,,,80.5,0.0,,0.0,,P43220,0.4237692070140454
390,25561730,glp1r_human,379,L,E,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,0.05,ÂµM,=,,0.54,-10.753,,,[125I]-glucagon-like peptide 1-(7-36) (radioligand),80.5,0.0,,0.0,,P43220,0.4237692070140454
391,25561730,glp1r_human,379,L,E,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,EC50,Binding - Radioligand competition/displacement,0.31,nM,=,,51.29,-166.667,,,,80.5,0.0,,0.0,,P43220,0.4237692070140454
392,25561730,glp1r_human,380,R,G,GLP-1-(Asp15Arg),FASTA sequence (peptide),HAEGTFTSKVSSYLRGQAAKEFIAWLVKGR,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,0.83,ÂµM,=,,0.23,3.609,,,[125I]-glucagon-like peptide 1-(7-36) (radioligand),202.6,0.0,,0.0,,P43220,0.4833284641422652
393,25561730,glp1r_human,380,R,G,GLP-1-(Asp15Arg),FASTA sequence (peptide),HAEGTFTSKVSSYLRGQAAKEFIAWLVKGR,Full agonist,EC50,Functional - cAMP accumulation,28.84,nM,=,,7.59,3.8,,,,202.6,0.0,,0.0,,P43220,0.4833284641422652
397,25561730,glp1r_human,380,R,G,GLP-1-(Asp15Glu),FASTA sequence (peptide),HAEGTFTSEVSSYLEGQAAKEFIAWLVKGR,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,0.29,ÂµM,=,,0.27,1.074,,,[125I]-glucagon-like peptide 1-(7-36) (radioligand),202.6,0.0,,0.0,,P43220,0.4833284641422652
398,25561730,glp1r_human,380,R,G,GLP-1-(Asp15Glu),FASTA sequence (peptide),HAEGTFTSEVSSYLEGQAAKEFIAWLVKGR,Full agonist,EC50,Functional - cAMP accumulation,0.33,nM,=,,17.78,-52.632,,,,202.6,0.0,,0.0,,P43220,0.4833284641422652
401,25561730,glp1r_human,380,R,G,GLP-1-(Asp15Lys),FASTA sequence (peptide),HAEGTFTSKVSSYLEGQAAKEFIAWLVKGR,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,1.41,ÂµM,=,,0.14,10.071,,,[125I]-glucagon-like peptide 1-(7-36) (radioligand),202.6,0.0,,0.0,,P43220,0.4833284641422652
402,25561730,glp1r_human,380,R,G,GLP-1-(Asp15Lys),FASTA sequence (peptide),HAEGTFTSKVSSYLEGQAAKEFIAWLVKGR,Full agonist,EC50,Functional - cAMP accumulation,52.48,nM,=,,19.05,2.755,,,,202.6,0.0,,0.0,,P43220,0.4833284641422652
405,25561730,glp1r_human,380,R,G,GLP-1-(Gly10Arg),FASTA sequence (peptide),HAEETFTSDVSSYLEGQAAKEFIAWLVKGR,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,1.78,ÂµM,=,,0.15,11.867,,,[125I]-glucagon-like peptide 1-(7-36) (radioligand),202.6,0.0,,0.0,,P43220,0.4833284641422652
406,25561730,glp1r_human,380,R,G,GLP-1-(Gly10Arg),FASTA sequence (peptide),HAEETFTSDVSSYLEGQAAKEFIAWLVKGR,Full agonist,EC50,Functional - cAMP accumulation,123.03,nM,=,,16.6,7.411,,,,202.6,0.0,,0.0,,P43220,0.4833284641422652
409,25561730,glp1r_human,380,R,G,GLP-1-(Gly10Asp),FASTA sequence (peptide),HAEDTFTSDVSSYLEGQAAKEFIAWLVKGR,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,1.0,ÂµM,>,,0.52,1.923,,,[125I]-glucagon-like peptide 1-(7-36) (radioligand),202.6,0.0,,0.0,,P43220,0.4833284641422652
410,25561730,glp1r_human,380,R,G,GLP-1-(Gly10Asp),FASTA sequence (peptide),HAEDTFTSDVSSYLEGQAAKEFIAWLVKGR,Full agonist,EC50,Functional - cAMP accumulation,190.55,nM,=,,575.44,-3.021,,,,202.6,0.0,,0.0,,P43220,0.4833284641422652
413,25561730,glp1r_human,380,R,G,GLP-1-(Gly10Glu),FASTA sequence (peptide),HAEETFTSDVSSYLEGQAAKEFIAWLVKGR,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,1.82,ÂµM,>,,0.65,2.8,,,[125I]-glucagon-like peptide 1-(7-36) (radioligand),202.6,0.0,,0.0,,P43220,0.4833284641422652
414,25561730,glp1r_human,380,R,G,GLP-1-(Gly10Glu),FASTA sequence (peptide),HAEETFTSDVSSYLEGQAAKEFIAWLVKGR,Full agonist,EC50,Functional - cAMP accumulation,85.11,nM,=,,616.6,-7.246,,,,202.6,0.0,,0.0,,P43220,0.4833284641422652
417,25561730,glp1r_human,380,R,G,GLP-1-(Gly10His),FASTA sequence (peptide),HAEHTFTSDVSSYLEGQAAKEFIAWLVKGR,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,1.29,ÂµM,>,,0.45,2.867,,,[125I]-glucagon-like peptide 1-(7-36) (radioligand),202.6,0.0,,0.0,,P43220,0.4833284641422652
418,25561730,glp1r_human,380,R,G,GLP-1-(Gly10His),FASTA sequence (peptide),HAEHTFTSDVSSYLEGQAAKEFIAWLVKGR,Full agonist,EC50,Functional - cAMP accumulation,45.71,nM,=,,141.25,-3.086,,,,202.6,0.0,,0.0,,P43220,0.4833284641422652
422,25561730,glp1r_human,380,R,G,GLP-1-(Gly10Lys),FASTA sequence (peptide),HAEKTFTSDVSSYLEGQAAKEFIAWLVKGR,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,10.0,ÂµM,>,,0.68,14.706,,,[125I]-glucagon-like peptide 1-(7-36) (radioligand),202.6,0.0,,0.0,,P43220,0.4833284641422652
423,25561730,glp1r_human,380,R,G,GLP-1-(Gly10Lys),FASTA sequence (peptide),HAEKTFTSDVSSYLEGQAAKEFIAWLVKGR,Full agonist,EC50,Functional - cAMP accumulation,1000.0,nM,=,,575.44,1.738,,,,202.6,0.0,,0.0,,P43220,0.4833284641422652
426,25561730,glp1r_human,380,R,G,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,0.05,ÂµM,=,,0.21,-4.202,,,[125I]-glucagon-like peptide 1-(7-36) (radioligand),202.6,0.0,,0.0,,P43220,0.4833284641422652
427,25561730,glp1r_human,380,R,G,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,EC50,Binding - Radioligand competition/displacement,0.31,nM,=,,12.3,-40.0,,,,202.6,0.0,,0.0,,P43220,0.4833284641422652
394,25561730,glp1r_human,381,F,R,GLP-1-(Gly10Asp),FASTA sequence (peptide),HAEDTFTSDVSSYLEGQAAKEFIAWLVKGR,Full agonist,EC50,Functional - cAMP accumulation,190.55,nM,=,,302.0,-1.585,,,,218.2,0.0,,0.0,,P43220,0.395338518182213
430,25561730,glp1r_human,381,F,R,GLP-1-(Asp15Arg),FASTA sequence (peptide),HAEGTFTSKVSSYLRGQAAKEFIAWLVKGR,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,0.83,ÂµM,=,,1.32,-1.59,,,[125I]-glucagon-like peptide 1-(7-36) (radioligand),218.2,0.0,,0.0,,P43220,0.395338518182213
432,25561730,glp1r_human,381,F,R,GLP-1-(Asp15Arg),FASTA sequence (peptide),HAEGTFTSKVSSYLRGQAAKEFIAWLVKGR,Full agonist,EC50,Functional - cAMP accumulation,28.84,nM,=,,30.2,-1.047,,,,218.2,0.0,,0.0,,P43220,0.395338518182213
434,25561730,glp1r_human,381,F,R,GLP-1-(Asp15Glu),FASTA sequence (peptide),HAEGTFTSEVSSYLEGQAAKEFIAWLVKGR,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,0.29,ÂµM,=,,0.47,-1.621,,,[125I]-glucagon-like peptide 1-(7-36) (radioligand),218.2,0.0,,0.0,,P43220,0.395338518182213
436,25561730,glp1r_human,381,F,R,GLP-1-(Asp15Glu),FASTA sequence (peptide),HAEGTFTSEVSSYLEGQAAKEFIAWLVKGR,Full agonist,EC50,Functional - cAMP accumulation,0.33,nM,=,,3.39,-10.309,,,,218.2,0.0,,0.0,,P43220,0.395338518182213
438,25561730,glp1r_human,381,F,R,GLP-1-(Asp15Lys),FASTA sequence (peptide),HAEGTFTSKVSSYLEGQAAKEFIAWLVKGR,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,1.41,ÂµM,=,,0.59,2.39,,,[125I]-glucagon-like peptide 1-(7-36) (radioligand),218.2,0.0,,0.0,,P43220,0.395338518182213
440,25561730,glp1r_human,381,F,R,GLP-1-(Asp15Lys),FASTA sequence (peptide),HAEGTFTSKVSSYLEGQAAKEFIAWLVKGR,Full agonist,EC50,Functional - cAMP accumulation,52.48,nM,=,,34.67,1.514,,,,218.2,0.0,,0.0,,P43220,0.395338518182213
442,25561730,glp1r_human,381,F,R,GLP-1-(Gly10Arg),FASTA sequence (peptide),HAEETFTSDVSSYLEGQAAKEFIAWLVKGR,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,1.78,ÂµM,=,,2.14,-1.202,,,[125I]-glucagon-like peptide 1-(7-36) (radioligand),218.2,0.0,,0.0,,P43220,0.395338518182213
444,25561730,glp1r_human,381,F,R,GLP-1-(Gly10Arg),FASTA sequence (peptide),HAEETFTSDVSSYLEGQAAKEFIAWLVKGR,Full agonist,EC50,Functional - cAMP accumulation,123.03,nM,=,,125.89,-1.024,,,,218.2,0.0,,0.0,,P43220,0.395338518182213
446,25561730,glp1r_human,381,F,R,GLP-1-(Gly10Asp),FASTA sequence (peptide),HAEDTFTSDVSSYLEGQAAKEFIAWLVKGR,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,1.0,ÂµM,=,,1.0,1.0,,,[125I]-glucagon-like peptide 1-(7-36) (radioligand),218.2,0.0,,0.0,,P43220,0.395338518182213
448,25561730,glp1r_human,381,F,R,GLP-1-(Gly10Glu),FASTA sequence (peptide),HAEETFTSDVSSYLEGQAAKEFIAWLVKGR,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,1.82,ÂµM,=,,1.0,1.82,,,[125I]-glucagon-like peptide 1-(7-36) (radioligand),218.2,0.0,,0.0,,P43220,0.395338518182213
450,25561730,glp1r_human,381,F,R,GLP-1-(Gly10Glu),FASTA sequence (peptide),HAEETFTSDVSSYLEGQAAKEFIAWLVKGR,Full agonist,EC50,Functional - cAMP accumulation,85.11,nM,=,,87.1,-1.024,,,,218.2,0.0,,0.0,,P43220,0.395338518182213
452,25561730,glp1r_human,381,F,R,GLP-1-(Gly10His),FASTA sequence (peptide),HAEHTFTSDVSSYLEGQAAKEFIAWLVKGR,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,1.29,ÂµM,=,,0.8,1.613,,,[125I]-glucagon-like peptide 1-(7-36) (radioligand),218.2,0.0,,0.0,,P43220,0.395338518182213
454,25561730,glp1r_human,381,F,R,GLP-1-(Gly10His),FASTA sequence (peptide),HAEHTFTSDVSSYLEGQAAKEFIAWLVKGR,Full agonist,EC50,Functional - cAMP accumulation,45.71,nM,=,,24.55,1.862,,,,218.2,0.0,,0.0,,P43220,0.395338518182213
456,25561730,glp1r_human,381,F,R,GLP-1-(Gly10Lys),FASTA sequence (peptide),HAEKTFTSDVSSYLEGQAAKEFIAWLVKGR,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,10.0,ÂµM,=,,2.88,3.472,,,[125I]-glucagon-like peptide 1-(7-36) (radioligand),218.2,0.0,,0.0,,P43220,0.395338518182213
458,25561730,glp1r_human,381,F,R,GLP-1-(Gly10Lys),FASTA sequence (peptide),HAEKTFTSDVSSYLEGQAAKEFIAWLVKGR,Full agonist,EC50,Functional - cAMP accumulation,1000.0,nM,=,,398.11,2.512,,,,218.2,0.0,,0.0,,P43220,0.395338518182213
460,25561730,glp1r_human,381,F,R,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,0.05,ÂµM,=,,0.06,-1.2,,,[125I]-glucagon-like peptide 1-(7-36) (radioligand),218.2,0.0,,0.0,,P43220,0.395338518182213
462,25561730,glp1r_human,381,F,R,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,EC50,Binding - Radioligand competition/displacement,0.31,nM,=,,0.15,2.067,,,,218.2,0.0,,0.0,,P43220,0.395338518182213
395,25561730,glp1r_human,380,R,D,GLP-1-(Asp15Arg),FASTA sequence (peptide),HAEGTFTSKVSSYLRGQAAKEFIAWLVKGR,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,0.83,ÂµM,=,,0.19,4.368,,,[125I]-glucagon-like peptide 1-(7-36) (radioligand),95.0,0.0,,0.0,,P43220,0.4833284641422652
396,25561730,glp1r_human,380,R,D,GLP-1-(Asp15Arg),FASTA sequence (peptide),HAEGTFTSKVSSYLRGQAAKEFIAWLVKGR,Full agonist,EC50,Functional - cAMP accumulation,28.84,nM,=,,4.79,6.021,,,,95.0,0.0,,0.0,,P43220,0.4833284641422652
399,25561730,glp1r_human,380,R,D,GLP-1-(Asp15Glu),FASTA sequence (peptide),HAEGTFTSEVSSYLEGQAAKEFIAWLVKGR,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,0.29,ÂµM,=,,0.41,-1.414,,,[125I]-glucagon-like peptide 1-(7-36) (radioligand),95.0,0.0,,0.0,,P43220,0.4833284641422652
400,25561730,glp1r_human,380,R,D,GLP-1-(Asp15Glu),FASTA sequence (peptide),HAEGTFTSEVSSYLEGQAAKEFIAWLVKGR,Full agonist,EC50,Functional - cAMP accumulation,0.33,nM,=,,104.71,-333.333,,,,95.0,0.0,,0.0,,P43220,0.4833284641422652
403,25561730,glp1r_human,380,R,D,GLP-1-(Asp15Lys),FASTA sequence (peptide),HAEGTFTSKVSSYLEGQAAKEFIAWLVKGR,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,1.41,ÂµM,=,,0.15,9.4,,,[125I]-glucagon-like peptide 1-(7-36) (radioligand),95.0,0.0,,0.0,,P43220,0.4833284641422652
404,25561730,glp1r_human,380,R,D,GLP-1-(Asp15Lys),FASTA sequence (peptide),HAEGTFTSKVSSYLEGQAAKEFIAWLVKGR,Full agonist,EC50,Functional - cAMP accumulation,52.48,nM,=,,12.88,4.075,,,,95.0,0.0,,0.0,,P43220,0.4833284641422652
407,25561730,glp1r_human,380,R,D,GLP-1-(Gly10Arg),FASTA sequence (peptide),HAEETFTSDVSSYLEGQAAKEFIAWLVKGR,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,1.78,ÂµM,=,,0.35,5.086,,,[125I]-glucagon-like peptide 1-(7-36) (radioligand),95.0,0.0,,0.0,,P43220,0.4833284641422652
408,25561730,glp1r_human,380,R,D,GLP-1-(Gly10Arg),FASTA sequence (peptide),HAEETFTSDVSSYLEGQAAKEFIAWLVKGR,Full agonist,EC50,Functional - cAMP accumulation,123.03,nM,=,,64.57,1.905,,,,95.0,0.0,,0.0,,P43220,0.4833284641422652
411,25561730,glp1r_human,380,R,D,GLP-1-(Gly10Asp),FASTA sequence (peptide),HAEDTFTSDVSSYLEGQAAKEFIAWLVKGR,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,1.0,ÂµM,>,,10.0,-10.0,,,[125I]-glucagon-like peptide 1-(7-36) (radioligand),95.0,0.0,,0.0,,P43220,0.4833284641422652
412,25561730,glp1r_human,380,R,D,GLP-1-(Gly10Asp),FASTA sequence (peptide),HAEDTFTSDVSSYLEGQAAKEFIAWLVKGR,Full agonist,EC50,Functional - cAMP accumulation,190.55,nM,>,,1000.0,-5.236,,,,95.0,0.0,,0.0,,P43220,0.4833284641422652
415,25561730,glp1r_human,380,R,D,GLP-1-(Gly10Glu),FASTA sequence (peptide),HAEETFTSDVSSYLEGQAAKEFIAWLVKGR,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,1.82,ÂµM,>,,10.0,-5.495,,,[125I]-glucagon-like peptide 1-(7-36) (radioligand),95.0,0.0,,0.0,,P43220,0.4833284641422652
416,25561730,glp1r_human,380,R,D,GLP-1-(Gly10Glu),FASTA sequence (peptide),HAEETFTSDVSSYLEGQAAKEFIAWLVKGR,Full agonist,EC50,Functional - cAMP accumulation,85.11,nM,>,,1000.0,-11.765,,,,95.0,0.0,,0.0,,P43220,0.4833284641422652
419,25561730,glp1r_human,380,R,D,GLP-1-(Gly10His),FASTA sequence (peptide),HAEHTFTSDVSSYLEGQAAKEFIAWLVKGR,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,1.29,ÂµM,>,,10.0,-7.752,,,[125I]-glucagon-like peptide 1-(7-36) (radioligand),95.0,0.0,,0.0,,P43220,0.4833284641422652
420,25561730,glp1r_human,380,R,D,GLP-1-(Gly10His),FASTA sequence (peptide),HAEHTFTSDVSSYLEGQAAKEFIAWLVKGR,Full agonist,EC50,Functional - cAMP accumulation,45.71,nM,>,,1000.0,-21.739,,,,95.0,0.0,,0.0,,P43220,0.4833284641422652
424,25561730,glp1r_human,380,R,D,GLP-1-(Gly10Lys),FASTA sequence (peptide),HAEKTFTSDVSSYLEGQAAKEFIAWLVKGR,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,10.0,ÂµM,>,,10.0,1.0,,,[125I]-glucagon-like peptide 1-(7-36) (radioligand),95.0,0.0,,0.0,,P43220,0.4833284641422652
425,25561730,glp1r_human,380,R,D,GLP-1-(Gly10Lys),FASTA sequence (peptide),HAEKTFTSDVSSYLEGQAAKEFIAWLVKGR,Full agonist,EC50,Functional - cAMP accumulation,1000.0,nM,>,,1000.0,1.0,,,,95.0,0.0,,0.0,,P43220,0.4833284641422652
428,25561730,glp1r_human,380,R,D,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,0.05,ÂµM,=,,1.05,-20.833,,,[125I]-glucagon-like peptide 1-(7-36) (radioligand),95.0,0.0,,0.0,,P43220,0.4833284641422652
429,25561730,glp1r_human,380,R,D,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,EC50,Binding - Radioligand competition/displacement,0.31,nM,=,,574.44,-1000.0,,,,95.0,0.0,,0.0,,P43220,0.4833284641422652
482,26598711,glp1r_human,309,I,A,exendin(9-39),PubChem CID,16198321,Binding - unknown pharmacological activity,pIC50,Binding - Radioligand competition/displacement,8.35,M,=,,8.31,-1.096,,,[125I]-exendin(9-39) (radioligand),75.22935779816513,0.0,,0.0,,P43220,0.5403487167583937
483,26598711,glp1r_human,309,I,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Binding - unknown pharmacological activity,pIC50,Binding - Radioligand competition/displacement,9.45,M,=,,8.93,-3.311,,,[125I]-exendin(9-39) (radioligand),75.22935779816513,0.0,,0.0,,P43220,0.5403487167583937
484,26598711,glp1r_human,309,I,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,EC50,Functional - cAMP accumulation,11.38,M,=,,10.2,1.116,,,,75.22935779816513,0.0,,0.0,,P43220,0.5403487167583937
488,26598711,glp1r_human,371,M,A,exendin(9-39),PubChem CID,16198321,Binding - unknown pharmacological activity,pIC50,Binding - Radioligand competition/displacement,8.35,M,=,,8.26,-1.23,,,[125I]-exendin(9-39) (radioligand),54.12844036697248,0.0,,0.0,,P43220,0.4450109791906207
489,26598711,glp1r_human,371,M,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Binding - unknown pharmacological activity,pIC50,Binding - Radioligand competition/displacement,9.45,M,=,,8.65,-6.329,,,[125I]-exendin(9-39) (radioligand),54.12844036697248,0.0,,0.0,,P43220,0.4450109791906207
490,26598711,glp1r_human,371,M,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,EC50,Functional - cAMP accumulation,11.38,M,=,,10.88,1.046,,,,54.12844036697248,0.0,,0.0,,P43220,0.4450109791906207
491,26598711,glp1r_human,372,D,A,exendin(9-39),PubChem CID,16198321,Binding - unknown pharmacological activity,pIC50,Binding - Radioligand competition/displacement,8.35,M,=,,8.25,-1.259,,,[125I]-exendin(9-39) (radioligand),13.30275229357798,0.0,,0.0,,P43220,0.4229918177313882
492,26598711,glp1r_human,372,D,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Binding - unknown pharmacological activity,pIC50,Binding - Radioligand competition/displacement,9.45,M,=,,8.85,-3.984,,,[125I]-exendin(9-39) (radioligand),13.30275229357798,0.0,,0.0,,P43220,0.4229918177313882
493,26598711,glp1r_human,372,D,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,EC50,Functional - cAMP accumulation,11.38,M,=,,9.65,1.179,,,,13.30275229357798,0.0,,0.0,,P43220,0.4229918177313882
1000,27315480,glp1r_human,372,D,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Full agonist,pEC50,Functional - cAMP accumulation,10.6,M,=,,9.1,-31.25,,,,0.0,0.0,,99.0,,P43220,0.4229918177313882
1001,27315480,glp1r_human,372,D,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.22,M,=,,8.12,-12.658,,,[125I]-exendin(9-39) (radioligand),86.0,0.0,,0.0,,P43220,0.4229918177313882
1002,27315480,glp1r_human,372,D,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Full agonist,pEC50,Functional - ERK activation,10.6,M,=,,7.88,-500.0,,,,0.0,0.0,,60.0,,P43220,0.4229918177313882
1003,27315480,glp1r_human,372,D,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Full agonist,pEC50,Functional - Ca2+ accumulation,7.99,M,=,,6.79,-15.873,,,,0.0,0.0,,18.0,,P43220,0.4229918177313882
1004,27315480,glp1r_human,372,D,A,exendin(9-39),PubChem CID,16198321,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.22,M,=,,7.63,-3.891,,,[125I]-exendin(9-39) (radioligand),86.0,0.0,,0.0,,P43220,0.4229918177313882
1005,27315480,glp1r_human,372,D,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - ERK activation,8.28,M,=,,6.45,-66.667,,,,0.0,0.0,,99.0,,P43220,0.4229918177313882
1006,27315480,glp1r_human,372,D,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.75,M,=,,7.15,-40.0,,,[125I]-exendin(9-39) (radioligand),86.0,0.0,,0.0,,P43220,0.4229918177313882
1007,27315480,glp1r_human,372,D,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - cAMP accumulation,10.0,M,=,,7.82,-142.857,,,,0.0,0.0,,80.0,,P43220,0.4229918177313882
1008,27315480,glp1r_human,372,D,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - Ca2+ accumulation,7.87,M,=,,6.83,-10.989,,,,0.0,0.0,,35.0,,P43220,0.4229918177313882
1009,27315480,glp1r_human,372,D,A,Oxyntomodulin(30-37),PubChem CID,11766473,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.3,M,=,,6.81,-3.086,,,[125I]-exendin(9-39) (radioligand),86.0,0.0,,0.0,,P43220,0.4229918177313882
1010,27315480,glp1r_human,372,D,A,Oxyntomodulin(30-37),PubChem CID,11766473,Full agonist,pEC50,Functional - cAMP accumulation,8.43,M,=,,6.63,-62.5,,,,0.0,0.0,,75.0,,P43220,0.4229918177313882
1011,27315480,glp1r_human,372,D,A,Oxyntomodulin(30-37),PubChem CID,11766473,Full agonist,pEC50,Functional - ERK activation,7.57,M,=,,6.63,-8.696,,,,0.0,0.0,,6.01,,P43220,0.4229918177313882
494,26598711,glp1r_human,373,E,A,exendin(9-39),PubChem CID,16198321,Binding - unknown pharmacological activity,pIC50,Binding - Radioligand competition/displacement,8.35,M,=,,8.39,1.096,,,[125I]-exendin(9-39) (radioligand),27.522935779816518,0.0,,0.0,,P43220,0.3265022878576661
495,26598711,glp1r_human,373,E,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Binding - unknown pharmacological activity,pIC50,Binding - Radioligand competition/displacement,9.45,M,=,,9.46,1.023,,,[125I]-exendin(9-39) (radioligand),27.522935779816518,0.0,,0.0,,P43220,0.3265022878576661
496,26598711,glp1r_human,373,E,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,EC50,Functional - cAMP accumulation,11.38,M,=,,11.16,1.02,,,,27.522935779816518,0.0,,0.0,,P43220,0.3265022878576661
1012,27315480,glp1r_human,373,E,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.22,M,=,,7.95,-18.519,,,[125I]-exendin(9-39) (radioligand),94.0,0.0,,0.0,,P43220,0.3265022878576661
1013,27315480,glp1r_human,373,E,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Full agonist,pEC50,Functional - cAMP accumulation,10.6,M,=,,8.81,-62.5,,,,0.0,0.0,,80.0,,P43220,0.3265022878576661
1016,27315480,glp1r_human,373,E,A,exendin(9-39),PubChem CID,16198321,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.22,M,=,,8.15,-1.175,,,[125I]-exendin(9-39) (radioligand),94.0,0.0,,0.0,,P43220,0.3265022878576661
1017,27315480,glp1r_human,373,E,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.75,M,=,,7.08,-47.619,,,[125I]-exendin(9-39) (radioligand),94.0,0.0,,0.0,,P43220,0.3265022878576661
1018,27315480,glp1r_human,373,E,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - cAMP accumulation,10.0,M,=,,6.97,-1000.0,,,,0.0,0.0,,64.0,,P43220,0.3265022878576661
1019,27315480,glp1r_human,373,E,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - ERK activation,8.28,M,=,,6.78,-31.25,,,,0.0,0.0,,59.0,,P43220,0.3265022878576661
1021,27315480,glp1r_human,373,E,A,Oxyntomodulin(30-37),PubChem CID,11766473,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.3,M,=,,6.43,-7.407,,,[125I]-exendin(9-39) (radioligand),94.0,0.0,,0.0,,P43220,0.3265022878576661
1022,27315480,glp1r_human,373,E,A,Oxyntomodulin(30-37),PubChem CID,11766473,Full agonist,pEC50,Functional - cAMP accumulation,8.43,M,=,,6.92,-32.258,,,,0.0,0.0,,40.0,,P43220,0.3265022878576661
1023,27315480,glp1r_human,373,E,A,Oxyntomodulin(30-37),PubChem CID,11766473,Full agonist,pEC50,Functional - ERK activation,7.57,M,=,,6.92,-4.464,,,,0.0,0.0,,6.48,,P43220,0.3265022878576661
497,26598711,glp1r_human,374,H,A,exendin(9-39),PubChem CID,16198321,Binding - unknown pharmacological activity,pIC50,Binding - Radioligand competition/displacement,8.35,M,=,,8.32,-1.072,,,[125I]-exendin(9-39) (radioligand),22.01834862385321,0.0,,0.0,,P43220,0.3484078193957273
498,26598711,glp1r_human,374,H,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Binding - unknown pharmacological activity,pIC50,Binding - Radioligand competition/displacement,9.45,M,=,,9.23,-1.658,,,[125I]-exendin(9-39) (radioligand),22.01834862385321,0.0,,0.0,,P43220,0.3484078193957273
499,26598711,glp1r_human,374,H,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,EC50,Functional - cAMP accumulation,11.38,M,=,,11.43,-1.004,,,,22.01834862385321,0.0,,0.0,,P43220,0.3484078193957273
721,27059958,glp1r_human,374,H,A,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,6.9,nM,=,,5.2,1.327,,,[125I]-glucagon-like peptide 1-(7-36) (radioligand),76.0,0.0,,0.0,,P43220,0.3484078193957273
722,27059958,glp1r_human,374,H,A,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Full agonist,EC50,Functional - cAMP accumulation,10.0,nM,=,,14.0,-1.401,,,,76.0,0.0,,0.0,,P43220,0.3484078193957273
967,27315480,glp1r_human,374,H,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Full agonist,pEC50,Functional - ERK activation,10.6,M,=,,9.01,-38.462,,,,0.0,0.0,,64.0,,P43220,0.3484078193957273
1024,27315480,glp1r_human,374,H,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Full agonist,pEC50,Functional - cAMP accumulation,10.6,M,=,,10.7,1.259,,,,0.0,0.0,,101.0,,P43220,0.3484078193957273
1025,27315480,glp1r_human,374,H,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Full agonist,pEC50,Functional - Ca2+ accumulation,7.99,M,=,,7.98,-1.024,,,,0.0,0.0,,92.0,,P43220,0.3484078193957273
1026,27315480,glp1r_human,374,H,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.22,M,=,,9.1,-1.318,,,[125I]-exendin(9-39) (radioligand),82.0,0.0,,0.0,,P43220,0.3484078193957273
1027,27315480,glp1r_human,374,H,A,exendin(9-39),PubChem CID,16198321,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.22,M,=,,7.35,-7.407,,,[125I]-exendin(9-39) (radioligand),82.0,0.0,,0.0,,P43220,0.3484078193957273
1028,27315480,glp1r_human,374,H,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - cAMP accumulation,10.0,M,=,,10.11,1.288,,,,0.0,0.0,,102.0,,P43220,0.3484078193957273
1029,27315480,glp1r_human,374,H,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - Ca2+ accumulation,7.87,M,=,,7.69,-1.513,,,,0.0,0.0,,97.0,,P43220,0.3484078193957273
1030,27315480,glp1r_human,374,H,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - ERK activation,8.28,M,=,,8.62,2.188,,,,0.0,0.0,,88.0,,P43220,0.3484078193957273
1031,27315480,glp1r_human,374,H,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.75,M,=,,8.59,-1.445,,,[125I]-exendin(9-39) (radioligand),82.0,0.0,,0.0,,P43220,0.3484078193957273
1032,27315480,glp1r_human,374,H,A,Oxyntomodulin(30-37),PubChem CID,11766473,Full agonist,pEC50,Functional - cAMP accumulation,8.43,M,=,,8.49,1.148,,,,0.0,0.0,,93.0,,P43220,0.3484078193957273
1033,27315480,glp1r_human,374,H,A,Oxyntomodulin(30-37),PubChem CID,11766473,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.3,M,=,,7.08,-1.658,,,[125I]-exendin(9-39) (radioligand),82.0,0.0,,0.0,,P43220,0.3484078193957273
1034,27315480,glp1r_human,374,H,A,Oxyntomodulin(30-37),PubChem CID,11766473,Full agonist,pEC50,Functional - ERK activation,7.57,M,=,,8.49,8.318,,,,0.0,0.0,,7.71,,P43220,0.3484078193957273
500,26598711,glp1r_human,375,A,G,exendin(9-39),PubChem CID,16198321,Binding - unknown pharmacological activity,pIC50,Binding - Radioligand competition/displacement,8.35,M,=,,7.67,-4.785,,,[125I]-exendin(9-39) (radioligand),185.77981651376143,0.0,,0.0,,P43220,0.2959921935933204
501,26598711,glp1r_human,375,A,G,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Binding - unknown pharmacological activity,pIC50,Binding - Radioligand competition/displacement,9.45,M,=,,8.46,-9.804,,,[125I]-exendin(9-39) (radioligand),185.77981651376143,0.0,,0.0,,P43220,0.2959921935933204
502,26598711,glp1r_human,375,A,G,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,EC50,Functional - cAMP accumulation,11.38,M,=,,10.52,1.082,,,,185.77981651376143,0.0,,0.0,,P43220,0.2959921935933204
503,26598711,glp1r_human,376,R,A,exendin(9-39),PubChem CID,16198321,Binding - unknown pharmacological activity,pIC50,Binding - Radioligand competition/displacement,8.35,M,=,,8.13,-1.658,,,[125I]-exendin(9-39) (radioligand),137.15596330275227,0.0,,0.0,,P43220,0.3121355139010744
504,26598711,glp1r_human,376,R,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Binding - unknown pharmacological activity,pIC50,Binding - Radioligand competition/displacement,9.45,M,=,,9.23,-1.658,,,[125I]-exendin(9-39) (radioligand),137.15596330275227,0.0,,0.0,,P43220,0.3121355139010744
505,26598711,glp1r_human,376,R,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,EC50,Functional - cAMP accumulation,11.38,M,=,,11.32,1.005,,,,137.15596330275227,0.0,,0.0,,P43220,0.3121355139010744
1035,27315480,glp1r_human,376,R,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Full agonist,pEC50,Functional - cAMP accumulation,10.6,M,=,,10.4,-1.585,,,,0.0,0.0,,97.0,,P43220,0.3121355139010744
1036,27315480,glp1r_human,376,R,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Full agonist,pEC50,Functional - Ca2+ accumulation,7.99,M,=,,8.01,1.047,,,,0.0,0.0,,95.0,,P43220,0.3121355139010744
1037,27315480,glp1r_human,376,R,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.22,M,=,,8.9,-2.088,,,[125I]-exendin(9-39) (radioligand),92.0,0.0,,0.0,,P43220,0.3121355139010744
1038,27315480,glp1r_human,376,R,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Full agonist,pEC50,Functional - ERK activation,10.6,M,=,,8.33,-200.0,,,,0.0,0.0,,79.0,,P43220,0.3121355139010744
1039,27315480,glp1r_human,376,R,A,exendin(9-39),PubChem CID,16198321,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.22,M,=,,7.79,-2.688,,,[125I]-exendin(9-39) (radioligand),92.0,0.0,,0.0,,P43220,0.3121355139010744
1040,27315480,glp1r_human,376,R,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - Ca2+ accumulation,7.87,M,=,,7.88,1.023,,,,0.0,0.0,,102.0,,P43220,0.3121355139010744
1041,27315480,glp1r_human,376,R,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - cAMP accumulation,10.0,M,=,,9.58,-2.632,,,,0.0,0.0,,101.0,,P43220,0.3121355139010744
1042,27315480,glp1r_human,376,R,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.75,M,=,,8.15,-3.984,,,[125I]-exendin(9-39) (radioligand),92.0,0.0,,0.0,,P43220,0.3121355139010744
1043,27315480,glp1r_human,376,R,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - ERK activation,8.28,M,=,,8.09,-1.548,,,,0.0,0.0,,77.0,,P43220,0.3121355139010744
1044,27315480,glp1r_human,376,R,A,Oxyntomodulin(30-37),PubChem CID,11766473,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.3,M,=,,7.14,-1.445,,,[125I]-exendin(9-39) (radioligand),92.0,0.0,,0.0,,P43220,0.3121355139010744
1045,27315480,glp1r_human,376,R,A,Oxyntomodulin(30-37),PubChem CID,11766473,Full agonist,pEC50,Functional - cAMP accumulation,8.43,M,=,,8.29,-1.381,,,,0.0,0.0,,92.0,,P43220,0.3121355139010744
1046,27315480,glp1r_human,376,R,A,Oxyntomodulin(30-37),PubChem CID,11766473,Full agonist,pEC50,Functional - ERK activation,7.57,M,=,,8.29,5.248,,,,0.0,0.0,,6.99,,P43220,0.3121355139010744
506,26598711,glp1r_human,377,G,A,exendin(9-39),PubChem CID,16198321,Binding - unknown pharmacological activity,pIC50,Binding - Radioligand competition/displacement,8.35,M,=,,8.32,-1.072,,,[125I]-exendin(9-39) (radioligand),18.80733944954128,0.0,,0.0,,P43220,0.2791225707395374
507,26598711,glp1r_human,377,G,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Binding - unknown pharmacological activity,pIC50,Binding - Radioligand competition/displacement,9.45,M,=,,9.03,-2.632,,,[125I]-exendin(9-39) (radioligand),18.80733944954128,0.0,,0.0,,P43220,0.2791225707395374
508,26598711,glp1r_human,377,G,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,EC50,Functional - cAMP accumulation,11.38,M,=,,11.01,1.034,,,,18.80733944954128,0.0,,0.0,,P43220,0.2791225707395374
1047,27315480,glp1r_human,377,G,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.22,M,=,,8.79,-2.688,,,[125I]-exendin(9-39) (radioligand),96.0,0.0,,0.0,,P43220,0.2791225707395374
1048,27315480,glp1r_human,377,G,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Full agonist,pEC50,Functional - ERK activation,10.6,M,=,,8.78,-66.667,,,,0.0,0.0,,94.0,,P43220,0.2791225707395374
1049,27315480,glp1r_human,377,G,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Full agonist,pEC50,Functional - cAMP accumulation,10.6,M,=,,10.5,-1.259,,,,0.0,0.0,,92.0,,P43220,0.2791225707395374
1050,27315480,glp1r_human,377,G,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Full agonist,pEC50,Functional - Ca2+ accumulation,7.99,M,=,,7.94,-1.122,,,,0.0,0.0,,86.0,,P43220,0.2791225707395374
1051,27315480,glp1r_human,377,G,A,exendin(9-39),PubChem CID,16198321,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.22,M,=,,8.18,-1.096,,,[125I]-exendin(9-39) (radioligand),96.0,0.0,,0.0,,P43220,0.2791225707395374
1052,27315480,glp1r_human,377,G,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - cAMP accumulation,10.0,M,=,,9.45,-3.546,,,,0.0,0.0,,98.0,,P43220,0.2791225707395374
1053,27315480,glp1r_human,377,G,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.75,M,=,,7.85,-7.937,,,[125I]-exendin(9-39) (radioligand),96.0,0.0,,0.0,,P43220,0.2791225707395374
1054,27315480,glp1r_human,377,G,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - Ca2+ accumulation,7.87,M,=,,7.47,-2.513,,,,0.0,0.0,,89.0,,P43220,0.2791225707395374
1055,27315480,glp1r_human,377,G,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - ERK activation,8.28,M,=,,7.8,-3.021,,,,0.0,0.0,,87.0,,P43220,0.2791225707395374
1056,27315480,glp1r_human,377,G,A,Oxyntomodulin(30-37),PubChem CID,11766473,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.3,M,=,,6.89,-2.571,,,[125I]-exendin(9-39) (radioligand),96.0,0.0,,0.0,,P43220,0.2791225707395374
1057,27315480,glp1r_human,377,G,A,Oxyntomodulin(30-37),PubChem CID,11766473,Full agonist,pEC50,Functional - cAMP accumulation,8.43,M,=,,8.09,-2.188,,,,0.0,0.0,,88.0,,P43220,0.2791225707395374
1058,27315480,glp1r_human,377,G,A,Oxyntomodulin(30-37),PubChem CID,11766473,Full agonist,pEC50,Functional - ERK activation,7.57,M,=,,8.09,3.311,,,,0.0,0.0,,7.05,,P43220,0.2791225707395374
509,26598711,glp1r_human,378,T,A,exendin(9-39),PubChem CID,16198321,Binding - unknown pharmacological activity,pIC50,Binding - Radioligand competition/displacement,8.35,M,=,,8.31,-1.096,,,[125I]-exendin(9-39) (radioligand),12.385321100917432,0.0,,0.0,,P43220,0.2524167816006839
510,26598711,glp1r_human,378,T,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Binding - unknown pharmacological activity,pIC50,Binding - Radioligand competition/displacement,9.45,M,=,,9.5,1.122,,,[125I]-exendin(9-39) (radioligand),12.385321100917432,0.0,,0.0,,P43220,0.2524167816006839
511,26598711,glp1r_human,378,T,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,EC50,Functional - cAMP accumulation,11.38,M,=,,11.19,1.017,,,,12.385321100917432,0.0,,0.0,,P43220,0.2524167816006839
1059,27315480,glp1r_human,378,T,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.22,M,=,,8.71,-3.236,,,[125I]-exendin(9-39) (radioligand),173.0,0.0,,0.0,,P43220,0.2524167816006839
1060,27315480,glp1r_human,378,T,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Full agonist,pEC50,Functional - Ca2+ accumulation,7.99,M,=,,8.55,3.631,,,,0.0,0.0,,157.0,,P43220,0.2524167816006839
1061,27315480,glp1r_human,378,T,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Full agonist,pEC50,Functional - ERK activation,10.6,M,=,,9.05,-35.714,,,,0.0,0.0,,136.0,,P43220,0.2524167816006839
1062,27315480,glp1r_human,378,T,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Full agonist,pEC50,Functional - cAMP accumulation,10.6,M,=,,11.0,2.512,,,,0.0,0.0,,108.0,,P43220,0.2524167816006839
1063,27315480,glp1r_human,378,T,A,exendin(9-39),PubChem CID,16198321,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.22,M,=,,8.1,-1.318,,,[125I]-exendin(9-39) (radioligand),173.0,0.0,,0.0,,P43220,0.2524167816006839
1064,27315480,glp1r_human,378,T,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - Ca2+ accumulation,7.87,M,=,,8.42,3.548,,,,0.0,0.0,,179.0,,P43220,0.2524167816006839
1065,27315480,glp1r_human,378,T,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.75,M,=,,8.79,1.096,,,[125I]-exendin(9-39) (radioligand),173.0,0.0,,0.0,,P43220,0.2524167816006839
1066,27315480,glp1r_human,378,T,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - ERK activation,8.28,M,=,,8.77,3.09,,,,0.0,0.0,,136.0,,P43220,0.2524167816006839
1067,27315480,glp1r_human,378,T,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - cAMP accumulation,10.0,M,=,,10.6,3.981,,,,0.0,0.0,,101.0,,P43220,0.2524167816006839
1068,27315480,glp1r_human,378,T,A,Oxyntomodulin(30-37),PubChem CID,11766473,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.3,M,=,,6.67,-4.274,,,[125I]-exendin(9-39) (radioligand),173.0,0.0,,0.0,,P43220,0.2524167816006839
1069,27315480,glp1r_human,378,T,A,Oxyntomodulin(30-37),PubChem CID,11766473,Full agonist,pEC50,Functional - cAMP accumulation,8.43,M,=,,8.44,1.023,,,,0.0,0.0,,105.0,,P43220,0.2524167816006839
1070,27315480,glp1r_human,378,T,A,Oxyntomodulin(30-37),PubChem CID,11766473,Full agonist,pEC50,Functional - ERK activation,7.57,M,=,,8.44,7.413,,,,0.0,0.0,,7.64,,P43220,0.2524167816006839
512,26598711,glp1r_human,379,L,A,exendin(9-39),PubChem CID,16198321,Binding - unknown pharmacological activity,pIC50,Binding - Radioligand competition/displacement,8.35,M,=,,8.17,-1.513,,,[125I]-exendin(9-39) (radioligand),31.19266055045871,0.0,,0.0,,P43220,0.3390741563890764
513,26598711,glp1r_human,379,L,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Binding - unknown pharmacological activity,pIC50,Binding - Radioligand competition/displacement,9.45,M,=,,9.08,-2.342,,,[125I]-exendin(9-39) (radioligand),31.19266055045871,0.0,,0.0,,P43220,0.3390741563890764
514,26598711,glp1r_human,379,L,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,EC50,Functional - cAMP accumulation,11.38,M,=,,11.08,1.027,,,,31.19266055045871,0.0,,0.0,,P43220,0.3390741563890764
1071,27315480,glp1r_human,379,L,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.22,M,=,,8.47,-5.618,,,[125I]-exendin(9-39) (radioligand),90.0,0.0,,0.0,,P43220,0.3390741563890764
1072,27315480,glp1r_human,379,L,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Full agonist,pEC50,Functional - ERK activation,10.6,M,=,,7.7,-1000.0,,,,0.0,0.0,,87.0,,P43220,0.3390741563890764
1073,27315480,glp1r_human,379,L,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Full agonist,pEC50,Functional - cAMP accumulation,10.6,M,=,,10.0,-3.984,,,,0.0,0.0,,78.0,,P43220,0.3390741563890764
1074,27315480,glp1r_human,379,L,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Full agonist,pEC50,Functional - Ca2+ accumulation,7.99,M,=,,6.61,-23.81,,,,0.0,0.0,,38.0,,P43220,0.3390741563890764
1075,27315480,glp1r_human,379,L,A,exendin(9-39),PubChem CID,16198321,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.22,M,=,,8.3,1.202,,,[125I]-exendin(9-39) (radioligand),90.0,0.0,,0.0,,P43220,0.3390741563890764
1076,27315480,glp1r_human,379,L,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.75,M,=,,7.08,-47.619,,,[125I]-exendin(9-39) (radioligand),90.0,0.0,,0.0,,P43220,0.3390741563890764
1077,27315480,glp1r_human,379,L,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - cAMP accumulation,10.0,M,=,,8.23,-58.824,,,,0.0,0.0,,80.0,,P43220,0.3390741563890764
1078,27315480,glp1r_human,379,L,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - ERK activation,8.28,M,=,,7.87,-2.571,,,,0.0,0.0,,52.0,,P43220,0.3390741563890764
1080,27315480,glp1r_human,379,L,A,Oxyntomodulin(30-37),PubChem CID,11766473,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.3,M,=,,6.45,-7.092,,,[125I]-exendin(9-39) (radioligand),90.0,0.0,,0.0,,P43220,0.3390741563890764
1081,27315480,glp1r_human,379,L,A,Oxyntomodulin(30-37),PubChem CID,11766473,Full agonist,pEC50,Functional - cAMP accumulation,8.43,M,=,,6.95,-30.303,,,,0.0,0.0,,62.0,,P43220,0.3390741563890764
1082,27315480,glp1r_human,379,L,A,Oxyntomodulin(30-37),PubChem CID,11766473,Full agonist,pEC50,Functional - ERK activation,7.57,M,=,,6.95,-4.167,,,,0.0,0.0,,6.89,,P43220,0.3390741563890764
515,26598711,glp1r_human,380,R,A,exendin(9-39),PubChem CID,16198321,Binding - unknown pharmacological activity,pIC50,Binding - Radioligand competition/displacement,8.35,M,=,,7.92,-2.688,,,[125I]-exendin(9-39) (radioligand),67.88990825688074,0.0,,0.0,,P43220,0.438637629493546
516,26598711,glp1r_human,380,R,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Binding - unknown pharmacological activity,pIC50,Binding - Radioligand competition/displacement,9.45,M,=,,7.34,-125.0,,,[125I]-exendin(9-39) (radioligand),67.88990825688074,0.0,,0.0,,P43220,0.438637629493546
517,26598711,glp1r_human,380,R,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,EC50,Functional - cAMP accumulation,11.38,M,=,,9.0,1.264,,,,67.88990825688074,0.0,,0.0,,P43220,0.438637629493546
1083,27315480,glp1r_human,380,R,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.22,M,=,,7.75,-29.412,,,[125I]-exendin(9-39) (radioligand),73.0,0.0,,0.0,,P43220,0.438637629493546
1084,27315480,glp1r_human,380,R,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Full agonist,pEC50,Functional - cAMP accumulation,10.6,M,=,,8.33,-200.0,,,,0.0,0.0,,69.0,,P43220,0.438637629493546
1087,27315480,glp1r_human,380,R,A,exendin(9-39),PubChem CID,16198321,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.22,M,=,,8.03,-1.548,,,[125I]-exendin(9-39) (radioligand),73.0,0.0,,0.0,,P43220,0.438637629493546
1088,27315480,glp1r_human,380,R,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - cAMP accumulation,10.0,M,=,,6.73,-1000.0,,,,0.0,0.0,,74.0,,P43220,0.438637629493546
1089,27315480,glp1r_human,380,R,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.75,M,=,,7.65,-12.658,,,[125I]-exendin(9-39) (radioligand),73.0,0.0,,0.0,,P43220,0.438637629493546
1090,27315480,glp1r_human,380,R,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - ERK activation,8.28,M,=,,7.15,-13.514,,,,0.0,0.0,,25.0,,P43220,0.438637629493546
1092,27315480,glp1r_human,380,R,A,Oxyntomodulin(30-37),PubChem CID,11766473,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.3,M,=,,6.71,-3.891,,,[125I]-exendin(9-39) (radioligand),73.0,0.0,,0.0,,P43220,0.438637629493546
518,26598711,glp1r_human,381,F,A,exendin(9-39),PubChem CID,16198321,Binding - unknown pharmacological activity,pIC50,Binding - Radioligand competition/displacement,8.35,M,=,,8.31,-1.096,,,[125I]-exendin(9-39) (radioligand),16.05504587155963,0.0,,0.0,,P43220,0.3532130221770612
519,26598711,glp1r_human,381,F,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Binding - unknown pharmacological activity,pIC50,Binding - Radioligand competition/displacement,9.45,M,=,,9.23,-1.658,,,[125I]-exendin(9-39) (radioligand),16.05504587155963,0.0,,0.0,,P43220,0.3532130221770612
520,26598711,glp1r_human,381,F,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,EC50,Functional - cAMP accumulation,11.38,M,=,,11.18,1.018,,,,16.05504587155963,0.0,,0.0,,P43220,0.3532130221770612
1095,27315480,glp1r_human,381,F,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Full agonist,pEC50,Functional - ERK activation,10.6,M,=,,8.5,-125.0,,,,0.0,0.0,,125.0,,P43220,0.3532130221770612
1096,27315480,glp1r_human,381,F,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Full agonist,pEC50,Functional - Ca2+ accumulation,7.99,M,=,,7.58,-2.571,,,,0.0,0.0,,110.0,,P43220,0.3532130221770612
1097,27315480,glp1r_human,381,F,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.22,M,=,,8.97,-1.779,,,[125I]-exendin(9-39) (radioligand),92.0,0.0,,0.0,,P43220,0.3532130221770612
1098,27315480,glp1r_human,381,F,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Full agonist,pEC50,Functional - cAMP accumulation,10.6,M,=,,10.5,-1.259,,,,0.0,0.0,,88.0,,P43220,0.3532130221770612
1099,27315480,glp1r_human,381,F,A,exendin(9-39),PubChem CID,16198321,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.22,M,=,,6.86,-22.727,,,[125I]-exendin(9-39) (radioligand),92.0,0.0,,0.0,,P43220,0.3532130221770612
1100,27315480,glp1r_human,381,F,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - ERK activation,8.28,M,=,,8.98,5.012,,,,0.0,0.0,,115.0,,P43220,0.3532130221770612
1101,27315480,glp1r_human,381,F,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.75,M,=,,8.42,-2.137,,,[125I]-exendin(9-39) (radioligand),92.0,0.0,,0.0,,P43220,0.3532130221770612
1102,27315480,glp1r_human,381,F,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - Ca2+ accumulation,7.87,M,=,,7.16,-5.128,,,,0.0,0.0,,83.0,,P43220,0.3532130221770612
1103,27315480,glp1r_human,381,F,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - cAMP accumulation,10.0,M,=,,9.71,-1.949,,,,0.0,0.0,,74.0,,P43220,0.3532130221770612
1104,27315480,glp1r_human,381,F,A,Oxyntomodulin(30-37),PubChem CID,11766473,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.3,M,=,,6.18,-13.158,,,[125I]-exendin(9-39) (radioligand),92.0,0.0,,0.0,,P43220,0.3532130221770612
1105,27315480,glp1r_human,381,F,A,Oxyntomodulin(30-37),PubChem CID,11766473,Full agonist,pEC50,Functional - cAMP accumulation,8.43,M,=,,7.96,-2.95,,,,0.0,0.0,,80.0,,P43220,0.3532130221770612
1106,27315480,glp1r_human,381,F,A,Oxyntomodulin(30-37),PubChem CID,11766473,Full agonist,pEC50,Functional - ERK activation,7.57,M,=,,7.96,2.455,,,,0.0,0.0,,6.92,,P43220,0.3532130221770612
521,26598711,glp1r_human,382,I,A,exendin(9-39),PubChem CID,16198321,Binding - unknown pharmacological activity,pIC50,Binding - Radioligand competition/displacement,8.35,M,=,,8.46,1.288,,,[125I]-exendin(9-39) (radioligand),22.93577981651376,0.0,,0.0,,P43220,0.3183599993573883
522,26598711,glp1r_human,382,I,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Binding - unknown pharmacological activity,pIC50,Binding - Radioligand competition/displacement,9.45,M,=,,9.1,-2.237,,,[125I]-exendin(9-39) (radioligand),22.93577981651376,0.0,,0.0,,P43220,0.3183599993573883
523,26598711,glp1r_human,382,I,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,EC50,Functional - cAMP accumulation,11.38,M,=,,11.09,1.026,,,,22.93577981651376,0.0,,0.0,,P43220,0.3183599993573883
1107,27315480,glp1r_human,382,I,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Full agonist,pEC50,Functional - ERK activation,10.6,M,=,,8.51,-125.0,,,,0.0,0.0,,125.0,,P43220,0.3183599993573883
1108,27315480,glp1r_human,382,I,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.22,M,=,,9.1,-1.318,,,[125I]-exendin(9-39) (radioligand),115.0,0.0,,0.0,,P43220,0.3183599993573883
1109,27315480,glp1r_human,382,I,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Full agonist,pEC50,Functional - cAMP accumulation,10.6,M,=,,10.2,-2.513,,,,0.0,0.0,,86.0,,P43220,0.3183599993573883
1110,27315480,glp1r_human,382,I,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Full agonist,pEC50,Functional - Ca2+ accumulation,7.99,M,=,,7.83,-1.445,,,,0.0,0.0,,85.0,,P43220,0.3183599993573883
1111,27315480,glp1r_human,382,I,A,exendin(9-39),PubChem CID,16198321,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.22,M,=,,8.18,-1.096,,,[125I]-exendin(9-39) (radioligand),115.0,0.0,,0.0,,P43220,0.3183599993573883
1112,27315480,glp1r_human,382,I,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - ERK activation,8.28,M,=,,8.71,2.692,,,,0.0,0.0,,117.0,,P43220,0.3183599993573883
1113,27315480,glp1r_human,382,I,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.75,M,=,,8.82,1.175,,,[125I]-exendin(9-39) (radioligand),115.0,0.0,,0.0,,P43220,0.3183599993573883
1114,27315480,glp1r_human,382,I,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - cAMP accumulation,10.0,M,=,,9.55,-2.817,,,,0.0,0.0,,96.0,,P43220,0.3183599993573883
1115,27315480,glp1r_human,382,I,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - Ca2+ accumulation,7.87,M,=,,7.21,-4.566,,,,0.0,0.0,,79.0,,P43220,0.3183599993573883
1116,27315480,glp1r_human,382,I,A,Oxyntomodulin(30-37),PubChem CID,11766473,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.3,M,=,,7.37,1.175,,,[125I]-exendin(9-39) (radioligand),115.0,0.0,,0.0,,P43220,0.3183599993573883
1117,27315480,glp1r_human,382,I,A,Oxyntomodulin(30-37),PubChem CID,11766473,Full agonist,pEC50,Functional - cAMP accumulation,8.43,M,=,,8.02,-2.571,,,,0.0,0.0,,86.0,,P43220,0.3183599993573883
1118,27315480,glp1r_human,382,I,A,Oxyntomodulin(30-37),PubChem CID,11766473,Full agonist,pEC50,Functional - ERK activation,7.57,M,=,,8.02,2.818,,,,0.0,0.0,,7.54,,P43220,0.3183599993573883
524,26598711,glp1r_human,383,K,A,exendin(9-39),PubChem CID,16198321,Binding - unknown pharmacological activity,pIC50,Binding - Radioligand competition/displacement,8.35,M,=,,8.17,-1.513,,,[125I]-exendin(9-39) (radioligand),123.8532110091743,0.0,,0.0,,P43220,0.4779408791319042
525,26598711,glp1r_human,383,K,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Binding - unknown pharmacological activity,pIC50,Binding - Radioligand competition/displacement,9.45,M,=,,8.92,-3.39,,,[125I]-exendin(9-39) (radioligand),123.8532110091743,0.0,,0.0,,P43220,0.4779408791319042
526,26598711,glp1r_human,383,K,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,EC50,Functional - cAMP accumulation,11.38,M,=,,9.67,1.177,,,,123.8532110091743,0.0,,0.0,,P43220,0.4779408791319042
1119,27315480,glp1r_human,383,K,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.22,M,=,,8.17,-11.236,,,[125I]-exendin(9-39) (radioligand),78.0,0.0,,0.0,,P43220,0.4779408791319042
1120,27315480,glp1r_human,383,K,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Full agonist,pEC50,Functional - cAMP accumulation,10.6,M,=,,8.7,-76.923,,,,0.0,0.0,,73.0,,P43220,0.4779408791319042
1123,27315480,glp1r_human,383,K,A,exendin(9-39),PubChem CID,16198321,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.22,M,=,,7.29,-8.547,,,[125I]-exendin(9-39) (radioligand),78.0,0.0,,0.0,,P43220,0.4779408791319042
1124,27315480,glp1r_human,383,K,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - cAMP accumulation,10.0,M,=,,6.89,-1000.0,,,,0.0,0.0,,87.0,,P43220,0.4779408791319042
1125,27315480,glp1r_human,383,K,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.75,M,=,,7.76,-9.804,,,[125I]-exendin(9-39) (radioligand),78.0,0.0,,0.0,,P43220,0.4779408791319042
1126,27315480,glp1r_human,383,K,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - ERK activation,8.28,M,=,,6.68,-40.0,,,,0.0,0.0,,38.0,,P43220,0.4779408791319042
1128,27315480,glp1r_human,383,K,A,Oxyntomodulin(30-37),PubChem CID,11766473,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.3,M,=,,6.4,-7.937,,,[125I]-exendin(9-39) (radioligand),78.0,0.0,,0.0,,P43220,0.4779408791319042
1129,27315480,glp1r_human,383,K,A,Oxyntomodulin(30-37),PubChem CID,11766473,Full agonist,pEC50,Functional - cAMP accumulation,8.43,M,=,,7.22,-16.129,,,,0.0,0.0,,32.0,,P43220,0.4779408791319042
1130,27315480,glp1r_human,383,K,A,Oxyntomodulin(30-37),PubChem CID,11766473,Full agonist,pEC50,Functional - ERK activation,7.57,M,=,,7.22,-2.237,,,,0.0,0.0,,0.0,,P43220,0.4779408791319042
527,26598711,glp1r_human,384,L,A,exendin(9-39),PubChem CID,16198321,Binding - unknown pharmacological activity,pIC50,Binding - Radioligand competition/displacement,8.35,M,=,,8.42,1.175,,,[125I]-exendin(9-39) (radioligand),77.5229357798165,0.0,,0.0,,P43220,0.4947800220756574
528,26598711,glp1r_human,384,L,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Binding - unknown pharmacological activity,pIC50,Binding - Radioligand competition/displacement,9.45,M,=,,8.66,-6.173,,,[125I]-exendin(9-39) (radioligand),77.5229357798165,0.0,,0.0,,P43220,0.4947800220756574
529,26598711,glp1r_human,384,L,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,EC50,Functional - cAMP accumulation,11.38,M,=,,10.81,1.053,,,,77.5229357798165,0.0,,0.0,,P43220,0.4947800220756574
729,27059958,glp1r_human,384,L,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,12.0,nM,=,,60.0,-5.0,,,[125I]-exendin(9-39) (radioligand),105.0,0.0,,0.0,,P43220,0.4947800220756574
730,27059958,glp1r_human,384,L,A,exendin(9-39),PubChem CID,16198321,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,26.0,nM,=,,8.0,3.25,,,[125I]-exendin(9-39) (radioligand),105.0,0.0,,0.0,,P43220,0.4947800220756574
731,27059958,glp1r_human,384,L,A,glucagon-like peptide 1-(15-36),PubChem CID,16133830,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,104.0,nM,=,,97.0,1.072,,,[125I]-exendin(9-39) (radioligand),105.0,0.0,,0.0,,P43220,0.4947800220756574
732,27059958,glp1r_human,384,L,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,6.1,nM,=,,191.0,-31.25,,,[125I]-exendin(9-39) (radioligand),105.0,0.0,,0.0,,P43220,0.4947800220756574
736,27059958,glp1r_human,384,L,A,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Full agonist,EC50,Functional - cAMP accumulation,10.0,nM,=,,407.0,-40.0,,,,105.0,0.0,,0.0,,P43220,0.4947800220756574
737,27059958,glp1r_human,384,L,A,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,15.0,nM,=,,718.0,-47.619,,,[125I]-exendin(9-39) (radioligand),105.0,0.0,,0.0,,P43220,0.4947800220756574
738,27059958,glp1r_human,384,L,A,glucagon-like peptide 1-(9-36),PubChem CID,90488821,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,234.0,nM,=,,209.0,1.12,Abolished effect,,[125I]-exendin(9-39) (radioligand),105.0,0.0,,0.0,,P43220,0.4947800220756574
1131,27315480,glp1r_human,384,L,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Full agonist,pEC50,Functional - ERK activation,10.6,M,=,,7.8,-500.0,,,,0.0,0.0,,108.0,,P43220,0.4947800220756574
1132,27315480,glp1r_human,384,L,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Full agonist,pEC50,Functional - cAMP accumulation,10.6,M,=,,10.0,-3.984,,,,0.0,0.0,,82.0,,P43220,0.4947800220756574
1133,27315480,glp1r_human,384,L,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Full agonist,pEC50,Functional - Ca2+ accumulation,7.99,M,=,,6.89,-12.658,,,,0.0,0.0,,75.0,,P43220,0.4947800220756574
1134,27315480,glp1r_human,384,L,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.22,M,=,,8.06,-14.493,,,[125I]-exendin(9-39) (radioligand),74.0,0.0,,0.0,,P43220,0.4947800220756574
1135,27315480,glp1r_human,384,L,A,exendin(9-39),PubChem CID,16198321,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.22,M,=,,7.89,-2.137,,,[125I]-exendin(9-39) (radioligand),74.0,0.0,,0.0,,P43220,0.4947800220756574
1136,27315480,glp1r_human,384,L,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - ERK activation,8.28,M,=,,7.06,-16.667,,,,0.0,0.0,,99.0,,P43220,0.4947800220756574
1137,27315480,glp1r_human,384,L,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - cAMP accumulation,10.0,M,=,,8.65,-22.222,,,,0.0,0.0,,91.0,,P43220,0.4947800220756574
1138,27315480,glp1r_human,384,L,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - Ca2+ accumulation,7.87,M,=,,7.47,-2.513,,,,0.0,0.0,,82.0,,P43220,0.4947800220756574
1139,27315480,glp1r_human,384,L,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.75,M,=,,7.69,-11.494,,,[125I]-exendin(9-39) (radioligand),74.0,0.0,,0.0,,P43220,0.4947800220756574
1140,27315480,glp1r_human,384,L,A,Oxyntomodulin(30-37),PubChem CID,11766473,Full agonist,pEC50,Functional - cAMP accumulation,8.43,M,=,,7.34,-12.346,,,,0.0,0.0,,92.0,,P43220,0.4947800220756574
1141,27315480,glp1r_human,384,L,A,Oxyntomodulin(30-37),PubChem CID,11766473,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.3,M,=,,6.47,-6.757,,,[125I]-exendin(9-39) (radioligand),74.0,0.0,,0.0,,P43220,0.4947800220756574
1142,27315480,glp1r_human,384,L,A,Oxyntomodulin(30-37),PubChem CID,11766473,Full agonist,pEC50,Functional - ERK activation,7.57,M,=,,7.34,-1.698,,,,0.0,0.0,,6.63,,P43220,0.4947800220756574
530,26598711,glp1r_human,385,F,A,exendin(9-39),PubChem CID,16198321,Binding - unknown pharmacological activity,pIC50,Binding - Radioligand competition/displacement,8.35,M,=,,8.32,-1.072,,,[125I]-exendin(9-39) (radioligand),84.86238532110092,0.0,,0.0,,P43220,0.4343573923044769
531,26598711,glp1r_human,385,F,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Binding - unknown pharmacological activity,pIC50,Binding - Radioligand competition/displacement,9.45,M,=,,8.94,-3.236,,,[125I]-exendin(9-39) (radioligand),84.86238532110092,0.0,,0.0,,P43220,0.4343573923044769
532,26598711,glp1r_human,385,F,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,EC50,Functional - cAMP accumulation,11.38,M,=,,11.42,-1.004,,,,84.86238532110092,0.0,,0.0,,P43220,0.4343573923044769
1144,27315480,glp1r_human,385,F,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.22,M,=,,9.0,-1.658,,,[125I]-exendin(9-39) (radioligand),110.0,0.0,,0.0,,P43220,0.4343573923044769
1145,27315480,glp1r_human,385,F,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Full agonist,pEC50,Functional - Ca2+ accumulation,7.99,M,=,,8.12,1.349,,,,0.0,0.0,,99.0,,P43220,0.4343573923044769
1146,27315480,glp1r_human,385,F,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Full agonist,pEC50,Functional - ERK activation,10.6,M,=,,8.47,-142.857,,,,0.0,0.0,,93.0,,P43220,0.4343573923044769
1147,27315480,glp1r_human,385,F,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Full agonist,pEC50,Functional - cAMP accumulation,10.6,M,=,,10.3,-1.996,,,,0.0,0.0,,90.0,,P43220,0.4343573923044769
1148,27315480,glp1r_human,385,F,A,exendin(9-39),PubChem CID,16198321,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.22,M,=,,8.29,1.175,,,[125I]-exendin(9-39) (radioligand),110.0,0.0,,0.0,,P43220,0.4343573923044769
1149,27315480,glp1r_human,385,F,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.75,M,=,,8.97,1.66,,,[125I]-exendin(9-39) (radioligand),110.0,0.0,,0.0,,P43220,0.4343573923044769
1150,27315480,glp1r_human,385,F,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - ERK activation,8.28,M,=,,7.94,-2.188,,,,0.0,0.0,,91.0,,P43220,0.4343573923044769
1151,27315480,glp1r_human,385,F,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - cAMP accumulation,10.0,M,=,,9.41,-3.891,,,,0.0,0.0,,91.0,,P43220,0.4343573923044769
1152,27315480,glp1r_human,385,F,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - Ca2+ accumulation,7.87,M,=,,7.81,-1.148,,,,0.0,0.0,,85.0,,P43220,0.4343573923044769
1153,27315480,glp1r_human,385,F,A,Oxyntomodulin(30-37),PubChem CID,11766473,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.3,M,=,,7.17,-1.35,,,[125I]-exendin(9-39) (radioligand),110.0,0.0,,0.0,,P43220,0.4343573923044769
1154,27315480,glp1r_human,385,F,A,Oxyntomodulin(30-37),PubChem CID,11766473,Full agonist,pEC50,Functional - cAMP accumulation,8.43,M,=,,7.84,-3.891,,,,0.0,0.0,,101.0,,P43220,0.4343573923044769
1155,27315480,glp1r_human,385,F,A,Oxyntomodulin(30-37),PubChem CID,11766473,Full agonist,pEC50,Functional - ERK activation,7.57,M,=,,7.84,1.862,,,,0.0,0.0,,7.24,,P43220,0.4343573923044769
533,26598711,glp1r_human,386,T,A,exendin(9-39),PubChem CID,16198321,Binding - unknown pharmacological activity,pIC50,Binding - Radioligand competition/displacement,8.35,M,=,,8.36,1.023,,,[125I]-exendin(9-39) (radioligand),17.889908256880734,0.0,,0.0,,P43220,0.3796467588950264
534,26598711,glp1r_human,386,T,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Binding - unknown pharmacological activity,pIC50,Binding - Radioligand competition/displacement,9.45,M,=,,8.91,-3.472,,,[125I]-exendin(9-39) (radioligand),17.889908256880734,0.0,,0.0,,P43220,0.3796467588950264
535,26598711,glp1r_human,386,T,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,EC50,Functional - cAMP accumulation,11.38,M,=,,11.17,1.019,,,,17.889908256880734,0.0,,0.0,,P43220,0.3796467588950264
1156,27315480,glp1r_human,386,T,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.22,M,=,,8.66,-3.636,,,[125I]-exendin(9-39) (radioligand),128.0,0.0,,0.0,,P43220,0.3796467588950264
1157,27315480,glp1r_human,386,T,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Full agonist,pEC50,Functional - cAMP accumulation,10.6,M,=,,10.7,1.259,,,,0.0,0.0,,98.0,,P43220,0.3796467588950264
1158,27315480,glp1r_human,386,T,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Full agonist,pEC50,Functional - ERK activation,10.6,M,=,,8.34,-200.0,,,,0.0,0.0,,74.0,,P43220,0.3796467588950264
1159,27315480,glp1r_human,386,T,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Full agonist,pEC50,Functional - Ca2+ accumulation,7.99,M,=,,7.29,-5.0,,,,0.0,0.0,,73.0,,P43220,0.3796467588950264
1160,27315480,glp1r_human,386,T,A,exendin(9-39),PubChem CID,16198321,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.22,M,=,,8.22,1.0,,,[125I]-exendin(9-39) (radioligand),128.0,0.0,,0.0,,P43220,0.3796467588950264
1161,27315480,glp1r_human,386,T,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.75,M,=,,8.41,-2.188,,,[125I]-exendin(9-39) (radioligand),128.0,0.0,,0.0,,P43220,0.3796467588950264
1162,27315480,glp1r_human,386,T,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - cAMP accumulation,10.0,M,=,,10.0,1.0,,,,0.0,0.0,,101.0,,P43220,0.3796467588950264
1163,27315480,glp1r_human,386,T,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - Ca2+ accumulation,7.87,M,=,,7.78,-1.23,,,,0.0,0.0,,95.0,,P43220,0.3796467588950264
1164,27315480,glp1r_human,386,T,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - ERK activation,8.28,M,=,,7.76,-3.311,,,,0.0,0.0,,88.0,,P43220,0.3796467588950264
1165,27315480,glp1r_human,386,T,A,Oxyntomodulin(30-37),PubChem CID,11766473,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.3,M,=,,7.23,-1.175,,,[125I]-exendin(9-39) (radioligand),128.0,0.0,,0.0,,P43220,0.3796467588950264
1166,27315480,glp1r_human,386,T,A,Oxyntomodulin(30-37),PubChem CID,11766473,Full agonist,pEC50,Functional - cAMP accumulation,8.43,M,=,,8.56,1.349,,,,0.0,0.0,,101.0,,P43220,0.3796467588950264
1167,27315480,glp1r_human,386,T,A,Oxyntomodulin(30-37),PubChem CID,11766473,Full agonist,pEC50,Functional - ERK activation,7.57,M,=,,8.56,9.772,,,,0.0,0.0,,7.26,,P43220,0.3796467588950264
551,27059958,glp1r_human,141,L,A,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,6.9,nM,=,,6.9,1.0,,,[125I]-glucagon-like peptide 1-(7-36) (radioligand),67.0,0.0,,0.0,,P43220,0.4338579896078031
552,27059958,glp1r_human,141,L,A,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Full agonist,EC50,Functional - cAMP accumulation,10.0,nM,=,,36.0,-3.597,,,,67.0,0.0,,0.0,,P43220,0.4338579896078031
553,27059958,glp1r_human,145,Y,A,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,6.9,nM,=,,3.4,2.029,,,[125I]-glucagon-like peptide 1-(7-36) (radioligand),47.0,0.0,,0.0,,P43220,0.4877094360771855
554,27059958,glp1r_human,145,Y,A,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Full agonist,EC50,Functional - cAMP accumulation,10.0,nM,=,,13.0,-1.3,,,,47.0,0.0,,0.0,,P43220,0.4877094360771855
555,27059958,glp1r_human,148,Y,F,exendin 4,PubChem CID,56927919,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,12.0,nM,=,,87.0,-7.246,,,[125I]-exendin(9-39) (radioligand),89.0,0.0,,0.0,,P43220,0.3833812873616359
556,27059958,glp1r_human,148,Y,F,exendin(9-39),PubChem CID,16198321,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,26.0,nM,=,,6.1,4.262,,,[125I]-exendin(9-39) (radioligand),89.0,0.0,,0.0,,P43220,0.3833812873616359
557,27059958,glp1r_human,148,Y,F,glucagon-like peptide 1-(15-36),PubChem CID,16133830,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,104.0,nM,=,,70.0,1.486,,,[125I]-exendin(9-39) (radioligand),89.0,0.0,,0.0,,P43220,0.3833812873616359
558,27059958,glp1r_human,148,Y,F,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,6.1,nM,=,,72.0,-11.765,,,[125I]-exendin(9-39) (radioligand),89.0,0.0,,0.0,,P43220,0.3833812873616359
560,27059958,glp1r_human,148,Y,F,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Full agonist,EC50,Functional - cAMP accumulation,10.0,nM,=,,144.0,-14.493,,,,89.0,0.0,,0.0,,P43220,0.3833812873616359
561,27059958,glp1r_human,148,Y,F,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,15.0,nM,=,,147.0,-9.804,,,[125I]-exendin(9-39) (radioligand),89.0,0.0,,0.0,,P43220,0.3833812873616359
566,27059958,glp1r_human,148,Y,F,glucagon-like peptide 1-(9-36),PubChem CID,90488821,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,234.0,nM,=,,169.0,1.385,,,[125I]-exendin(9-39) (radioligand),89.0,0.0,,0.0,,P43220,0.3833812873616359
563,27059958,glp1r_human,148,Y,A,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Full agonist,EC50,Functional - cAMP accumulation,10.0,nM,=,,259.0,-25.641,,,,88.0,0.0,,0.0,,P43220,0.6045535662317918
564,27059958,glp1r_human,148,Y,N,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,6.9,nM,=,,102.0,-14.706,,,[125I]-glucagon-like peptide 1-(7-36) (radioligand),84.0,0.0,,0.0,,P43220,0.6045535662317918
565,27059958,glp1r_human,148,Y,N,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Full agonist,EC50,Functional - cAMP accumulation,10.0,nM,=,,80.0,-8.0,,,,84.0,0.0,,0.0,,P43220,0.6045535662317918
568,27059958,glp1r_human,149,T,A,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Full agonist,EC50,Functional - cAMP accumulation,10.0,nM,=,,594.0,-58.824,,,,131.0,0.0,,0.0,,P43220,0.3607933002326006
569,27059958,glp1r_human,149,T,S,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,6.9,nM,=,,10.0,-1.449,,,[125I]-glucagon-like peptide 1-(7-36) (radioligand),123.0,0.0,,0.0,,P43220,0.3204172193770999
570,27059958,glp1r_human,149,T,S,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Full agonist,EC50,Functional - cAMP accumulation,10.0,nM,=,,817.0,-83.333,,,,123.0,0.0,,0.0,,P43220,0.3204172193770999
571,27059958,glp1r_human,152,Y,H,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,6.9,nM,=,,3.8,1.816,,,[125I]-glucagon-like peptide 1-(7-36) (radioligand),88.0,0.0,,0.0,,P43220,0.457634257447959
572,27059958,glp1r_human,152,Y,H,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Full agonist,EC50,Functional - cAMP accumulation,10.0,nM,=,,9.0,1.111,,,,88.0,0.0,,0.0,,P43220,0.457634257447959
575,27059958,glp1r_human,190,R,K,exendin 4,PubChem CID,56927919,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,12.0,nM,=,,61.0,-5.076,,,[125I]-exendin(9-39) (radioligand),87.0,0.0,,0.0,,P43220,0.4903508795555904
576,27059958,glp1r_human,190,R,K,exendin(9-39),PubChem CID,16198321,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,26.0,nM,=,,12.0,2.167,,,[125I]-exendin(9-39) (radioligand),87.0,0.0,,0.0,,P43220,0.4903508795555904
577,27059958,glp1r_human,190,R,K,GLP-1-(Ala8Ser),FASTA sequence (peptide),HSEGTFTSDVSSYLEGQAAKEFIAWLVKGR,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,61.0,nM,=,,109.0,-1.786,,,[125I]-exendin(9-39) (radioligand),87.0,0.0,,0.0,,P43220,0.4903508795555904
578,27059958,glp1r_human,190,R,K,GLP-1(Glu9Gln),FASTA sequence (peptide),HAQGTFTSDVSSYLEGQAAKEFIAWLVKGR,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,36.0,nM,=,,25.0,1.44,,,[125I]-exendin(9-39) (radioligand),87.0,0.0,,0.0,,P43220,0.4903508795555904
579,27059958,glp1r_human,190,R,K,glucagon-like peptide 1-(15-36),PubChem CID,16133830,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,104.0,nM,=,,110.0,-1.058,,,[125I]-exendin(9-39) (radioligand),87.0,0.0,,0.0,,P43220,0.4903508795555904
580,27059958,glp1r_human,190,R,K,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,6.1,nM,=,,173.0,-28.571,,,[125I]-exendin(9-39) (radioligand),87.0,0.0,,0.0,,P43220,0.4903508795555904
585,27059958,glp1r_human,190,R,K,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Full agonist,EC50,Functional - cAMP accumulation,10.0,nM,=,,168.0,-16.667,,,,87.0,0.0,,0.0,,P43220,0.4903508795555904
586,27059958,glp1r_human,190,R,K,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,15.0,nM,=,,474.0,-31.25,,,[125I]-exendin(9-39) (radioligand),87.0,0.0,,0.0,,P43220,0.4903508795555904
589,27059958,glp1r_human,190,R,K,glucagon-like peptide 1-(9-36),PubChem CID,90488821,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,234.0,nM,=,,270.0,-1.153,,,[125I]-exendin(9-39) (radioligand),87.0,0.0,,0.0,,P43220,0.4903508795555904
592,27059958,glp1r_human,194,V,A,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,6.9,nM,=,,9.1,-1.319,,,[125I]-glucagon-like peptide 1-(7-36) (radioligand),89.0,0.0,,0.0,,P43220,0.457909462182013
593,27059958,glp1r_human,194,V,A,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Full agonist,EC50,Functional - cAMP accumulation,10.0,nM,=,,37.0,-3.704,,,,89.0,0.0,,0.0,,P43220,0.457909462182013
599,27059958,glp1r_human,197,K,R,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Full agonist,EC50,Functional - cAMP accumulation,10.0,nM,=,,227.0,-22.727,,,,130.0,0.0,,0.0,,P43220,0.3613241306606519
621,27059958,glp1r_human,203,W,A,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,6.9,nM,=,,11.0,-1.595,,,[125I]-glucagon-like peptide 1-(7-36) (radioligand),113.0,0.0,,0.0,,P43220,0.3394276716990957
622,27059958,glp1r_human,203,W,A,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Full agonist,EC50,Functional - cAMP accumulation,10.0,nM,=,,14.0,-1.401,,,,113.0,0.0,,0.0,,P43220,0.3394276716990957
783,27315480,glp1r_human,203,W,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.11,M,=,,9.0,-1.289,,,[125I]-exendin(9-39) (radioligand),94.0,0.0,,0.0,,P43220,0.3394276716990957
784,27315480,glp1r_human,203,W,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Full agonist,pEC50,Functional - cAMP accumulation,10.45,M,=,,10.43,-1.047,,,,0.0,0.0,,94.0,,P43220,0.3394276716990957
785,27315480,glp1r_human,203,W,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Full agonist,pEC50,Functional - Ca2+ accumulation,7.94,M,=,,7.89,-1.122,,,,0.0,0.0,,74.0,,P43220,0.3394276716990957
786,27315480,glp1r_human,203,W,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Full agonist,pEC50,Functional - ERK activation,10.45,M,=,,7.39,-1000.0,,,,0.0,0.0,,55.0,,P43220,0.3394276716990957
787,27315480,glp1r_human,203,W,A,exendin(9-39),PubChem CID,16198321,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.96,M,=,,7.89,-1.175,,,[125I]-exendin(9-39) (radioligand),94.0,0.0,,0.0,,P43220,0.3394276716990957
788,27315480,glp1r_human,203,W,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - cAMP accumulation,9.66,M,=,,9.13,-3.39,,,,0.0,0.0,,96.0,,P43220,0.3394276716990957
789,27315480,glp1r_human,203,W,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.76,M,=,,8.52,-1.739,,,[125I]-exendin(9-39) (radioligand),94.0,0.0,,0.0,,P43220,0.3394276716990957
790,27315480,glp1r_human,203,W,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - ERK activation,8.33,M,=,,7.79,-3.472,,,,0.0,0.0,,74.0,,P43220,0.3394276716990957
791,27315480,glp1r_human,203,W,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - Ca2+ accumulation,7.81,M,=,,7.31,-3.165,,,,0.0,0.0,,51.0,,P43220,0.3394276716990957
792,27315480,glp1r_human,203,W,A,Oxyntomodulin(30-37),PubChem CID,11766473,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.66,M,=,,7.5,-1.445,,,[125I]-exendin(9-39) (radioligand),94.0,0.0,,0.0,,P43220,0.3394276716990957
793,27315480,glp1r_human,203,W,A,Oxyntomodulin(30-37),PubChem CID,11766473,Full agonist,pEC50,Functional - cAMP accumulation,8.7,M,=,,8.81,1.288,,,,0.0,0.0,,90.0,,P43220,0.3394276716990957
794,27315480,glp1r_human,203,W,A,Oxyntomodulin(30-37),PubChem CID,11766473,Full agonist,pEC50,Functional - ERK activation,7.63,M,=,,8.81,15.136,,,,0.0,0.0,,6.87,,P43220,0.3394276716990957
624,27059958,glp1r_human,204,M,R,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Full agonist,EC50,Functional - cAMP accumulation,10.0,nM,=,,927.0,-90.909,,,,138.0,0.0,,0.0,,P43220,0.3097327563849936
626,27059958,glp1r_human,204,M,A,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Full agonist,EC50,Functional - cAMP accumulation,10.0,nM,=,,3341.0,-333.333,,,,109.0,0.0,,0.0,,P43220,0.3097327563849936
795,27315480,glp1r_human,204,M,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Full agonist,pEC50,Functional - cAMP accumulation,10.45,M,=,,9.71,-5.495,,,,0.0,0.0,,107.0,,P43220,0.3097327563849936
796,27315480,glp1r_human,204,M,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.11,M,=,,7.98,-13.514,,,[125I]-exendin(9-39) (radioligand),99.0,0.0,,0.0,,P43220,0.3097327563849936
797,27315480,glp1r_human,204,M,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Full agonist,pEC50,Functional - ERK activation,10.45,M,=,,7.61,-1000.0,,,,0.0,0.0,,77.0,,P43220,0.3097327563849936
799,27315480,glp1r_human,204,M,A,exendin(9-39),PubChem CID,16198321,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.96,M,=,,7.78,-1.513,,,[125I]-exendin(9-39) (radioligand),99.0,0.0,,0.0,,P43220,0.3097327563849936
800,27315480,glp1r_human,204,M,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - cAMP accumulation,9.66,M,=,,7.93,-52.632,,,,0.0,0.0,,105.0,,P43220,0.3097327563849936
801,27315480,glp1r_human,204,M,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.76,M,=,,7.09,-47.619,,,[125I]-exendin(9-39) (radioligand),99.0,0.0,,0.0,,P43220,0.3097327563849936
802,27315480,glp1r_human,204,M,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - ERK activation,8.33,M,=,,6.98,-22.222,,,,0.0,0.0,,67.0,,P43220,0.3097327563849936
804,27315480,glp1r_human,204,M,A,Oxyntomodulin(30-37),PubChem CID,11766473,Full agonist,pEC50,Functional - cAMP accumulation,8.7,M,=,,7.58,-13.158,,,,0.0,0.0,,100.0,,P43220,0.3097327563849936
805,27315480,glp1r_human,204,M,A,Oxyntomodulin(30-37),PubChem CID,11766473,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.66,M,=,,6.21,-28.571,,,[125I]-exendin(9-39) (radioligand),99.0,0.0,,0.0,,P43220,0.3097327563849936
806,27315480,glp1r_human,204,M,A,Oxyntomodulin(30-37),PubChem CID,11766473,Full agonist,pEC50,Functional - ERK activation,7.63,M,=,,7.58,-1.122,,,,0.0,0.0,,7.35,,P43220,0.3097327563849936
628,27059958,glp1r_human,205,Y,A,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Full agonist,EC50,Functional - cAMP accumulation,10.0,nM,=,,617.0,-62.5,,,,99.0,0.0,,0.0,,P43220,0.3524247585372141
807,27315480,glp1r_human,205,Y,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.11,M,=,,8.18,-8.547,,,[125I]-exendin(9-39) (radioligand),68.0,0.0,,0.0,,P43220,0.3524247585372141
808,27315480,glp1r_human,205,Y,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Full agonist,pEC50,Functional - cAMP accumulation,10.45,M,=,,9.32,-13.514,,,,0.0,0.0,,47.0,,P43220,0.3524247585372141
809,27315480,glp1r_human,205,Y,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Full agonist,pEC50,Functional - ERK activation,10.45,M,=,,7.55,-1000.0,,,,0.0,0.0,,24.0,,P43220,0.3524247585372141
810,27315480,glp1r_human,205,Y,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Full agonist,pEC50,Functional - Ca2+ accumulation,7.94,M,=,,6.84,-12.658,,,,0.0,0.0,,22.0,,P43220,0.3524247585372141
811,27315480,glp1r_human,205,Y,A,exendin(9-39),PubChem CID,16198321,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.96,M,=,,7.9,-1.148,,,[125I]-exendin(9-39) (radioligand),68.0,0.0,,0.0,,P43220,0.3524247585372141
812,27315480,glp1r_human,205,Y,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.76,M,=,,8.25,-3.236,,,[125I]-exendin(9-39) (radioligand),68.0,0.0,,0.0,,P43220,0.3524247585372141
813,27315480,glp1r_human,205,Y,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - ERK activation,8.33,M,=,,7.87,-2.882,,,,0.0,0.0,,44.0,,P43220,0.3524247585372141
814,27315480,glp1r_human,205,Y,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - cAMP accumulation,9.66,M,=,,8.9,-5.747,,,,0.0,0.0,,30.0,,P43220,0.3524247585372141
815,27315480,glp1r_human,205,Y,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - Ca2+ accumulation,7.81,M,=,,7.26,-3.546,,,,0.0,0.0,,14.0,,P43220,0.3524247585372141
816,27315480,glp1r_human,205,Y,A,Oxyntomodulin(30-37),PubChem CID,11766473,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.66,M,=,,7.33,-2.137,,,[125I]-exendin(9-39) (radioligand),68.0,0.0,,0.0,,P43220,0.3524247585372141
817,27315480,glp1r_human,205,Y,A,Oxyntomodulin(30-37),PubChem CID,11766473,Full agonist,pEC50,Functional - cAMP accumulation,8.7,M,=,,7.9,-6.329,,,,0.0,0.0,,40.0,,P43220,0.3524247585372141
818,27315480,glp1r_human,205,Y,A,Oxyntomodulin(30-37),PubChem CID,11766473,Full agonist,pEC50,Functional - ERK activation,7.63,M,=,,7.9,1.862,,,,0.0,0.0,,6.15,,P43220,0.3524247585372141
629,27059958,glp1r_human,211,Q,R,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,6.9,nM,=,,7.0,-1.014,,,[125I]-glucagon-like peptide 1-(7-36) (radioligand),173.0,0.0,,0.0,,P43220,0.2271070982696124
630,27059958,glp1r_human,211,Q,R,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Full agonist,EC50,Functional - cAMP accumulation,10.0,nM,=,,28.0,-2.801,,,,173.0,0.0,,0.0,,P43220,0.2271070982696124
633,27059958,glp1r_human,212,H,A,glucagon-like peptide 1-(7-36),PubChem CID,16133830,Full agonist,EC50,Functional - cAMP accumulation,10.0,nM,=,,5.7,1.754,,,,135.0,0.0,,0.0,,P43220,0.3351876537100086
634,27059958,glp1r_human,212,H,A,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,6.9,nM,=,,12.0,-1.739,,,[125I]-glucagon-like peptide 1-(7-36) (radioligand),135.0,0.0,,0.0,,P43220,0.3351876537100086
867,27315480,glp1r_human,212,H,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Full agonist,pEC50,Functional - ERK activation,10.45,M,=,,8.6,-71.429,,,,0.0,0.0,,105.0,,P43220,0.3351876537100086
868,27315480,glp1r_human,212,H,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.11,M,=,,9.43,2.089,,,[125I]-exendin(9-39) (radioligand),103.0,0.0,,0.0,,P43220,0.3351876537100086
869,27315480,glp1r_human,212,H,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Full agonist,pEC50,Functional - cAMP accumulation,10.45,M,=,,10.45,1.0,,,,0.0,0.0,,96.0,,P43220,0.3351876537100086
870,27315480,glp1r_human,212,H,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Full agonist,pEC50,Functional - Ca2+ accumulation,7.94,M,=,,8.24,1.995,,,,0.0,0.0,,87.0,,P43220,0.3351876537100086
871,27315480,glp1r_human,212,H,A,exendin(9-39),PubChem CID,16198321,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.96,M,=,,7.96,1.0,,,[125I]-exendin(9-39) (radioligand),103.0,0.0,,0.0,,P43220,0.3351876537100086
872,27315480,glp1r_human,212,H,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - Ca2+ accumulation,7.81,M,=,,7.87,1.148,,,,0.0,0.0,,109.0,,P43220,0.3351876537100086
873,27315480,glp1r_human,212,H,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - ERK activation,8.33,M,=,,7.97,-2.288,,,,0.0,0.0,,109.0,,P43220,0.3351876537100086
874,27315480,glp1r_human,212,H,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.76,M,=,,8.81,1.122,,,[125I]-exendin(9-39) (radioligand),103.0,0.0,,0.0,,P43220,0.3351876537100086
875,27315480,glp1r_human,212,H,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - cAMP accumulation,9.66,M,=,,9.62,-1.096,,,,0.0,0.0,,99.0,,P43220,0.3351876537100086
876,27315480,glp1r_human,212,H,A,Oxyntomodulin(30-37),PubChem CID,11766473,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.66,M,=,,7.84,1.514,,,[125I]-exendin(9-39) (radioligand),103.0,0.0,,0.0,,P43220,0.3351876537100086
877,27315480,glp1r_human,212,H,A,Oxyntomodulin(30-37),PubChem CID,11766473,Full agonist,pEC50,Functional - cAMP accumulation,8.7,M,=,,8.64,-1.148,,,,0.0,0.0,,100.0,,P43220,0.3351876537100086
878,27315480,glp1r_human,212,H,A,Oxyntomodulin(30-37),PubChem CID,11766473,Full agonist,pEC50,Functional - ERK activation,7.63,M,=,,8.64,10.233,,,,0.0,0.0,,7.6,,P43220,0.3351876537100086
635,27059958,glp1r_human,214,W,V,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,6.9,nM,=,,16.0,-2.32,,,[125I]-glucagon-like peptide 1-(7-36) (radioligand),152.0,0.0,,0.0,,P43220,0.3834101461424452
636,27059958,glp1r_human,214,W,V,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Full agonist,EC50,Functional - cAMP accumulation,10.0,nM,=,,36.0,-3.597,,,,152.0,0.0,,0.0,,P43220,0.3834101461424452
637,27059958,glp1r_human,217,L,A,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,6.9,nM,=,,7.0,-1.014,,,[125I]-glucagon-like peptide 1-(7-36) (radioligand),112.0,0.0,,0.0,,P43220,0.295504303082498
638,27059958,glp1r_human,217,L,A,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Full agonist,EC50,Functional - cAMP accumulation,10.0,nM,=,,25.0,-2.5,,,,112.0,0.0,,0.0,,P43220,0.295504303082498
915,27315480,glp1r_human,217,L,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Full agonist,pEC50,Functional - cAMP accumulation,10.45,M,=,,10.25,-1.585,,,,0.0,0.0,,112.0,,P43220,0.295504303082498
916,27315480,glp1r_human,217,L,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.11,M,=,,8.69,-2.632,,,[125I]-exendin(9-39) (radioligand),109.0,0.0,,0.0,,P43220,0.295504303082498
917,27315480,glp1r_human,217,L,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Full agonist,pEC50,Functional - Ca2+ accumulation,7.94,M,=,,8.13,1.549,,,,0.0,0.0,,78.0,,P43220,0.295504303082498
918,27315480,glp1r_human,217,L,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Full agonist,pEC50,Functional - ERK activation,10.45,M,=,,8.03,-250.0,,,,0.0,0.0,,64.0,,P43220,0.295504303082498
919,27315480,glp1r_human,217,L,A,exendin(9-39),PubChem CID,16198321,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.96,M,=,,7.91,-1.122,,,[125I]-exendin(9-39) (radioligand),109.0,0.0,,0.0,,P43220,0.295504303082498
920,27315480,glp1r_human,217,L,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.76,M,=,,8.72,-1.096,,,[125I]-exendin(9-39) (radioligand),109.0,0.0,,0.0,,P43220,0.295504303082498
921,27315480,glp1r_human,217,L,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - ERK activation,8.33,M,=,,7.37,-9.091,,,,0.0,0.0,,108.0,,P43220,0.295504303082498
922,27315480,glp1r_human,217,L,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - cAMP accumulation,9.66,M,=,,9.55,-1.289,,,,0.0,0.0,,97.0,,P43220,0.295504303082498
923,27315480,glp1r_human,217,L,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - Ca2+ accumulation,7.81,M,=,,7.4,-2.571,,,,0.0,0.0,,84.0,,P43220,0.295504303082498
924,27315480,glp1r_human,217,L,A,Oxyntomodulin(30-37),PubChem CID,11766473,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.66,M,=,,7.47,-1.548,,,[125I]-exendin(9-39) (radioligand),109.0,0.0,,0.0,,P43220,0.295504303082498
925,27315480,glp1r_human,217,L,A,Oxyntomodulin(30-37),PubChem CID,11766473,Full agonist,pEC50,Functional - cAMP accumulation,8.7,M,=,,8.66,-1.096,,,,0.0,0.0,,106.0,,P43220,0.295504303082498
926,27315480,glp1r_human,217,L,A,Oxyntomodulin(30-37),PubChem CID,11766473,Full agonist,pEC50,Functional - ERK activation,7.63,M,=,,8.66,10.715,,,,0.0,0.0,,7.43,,P43220,0.295504303082498
640,27059958,glp1r_human,220,Y,D,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Full agonist,EC50,Functional - cAMP accumulation,10.0,nM,=,,1045.0,-100.0,,,,100.0,0.0,,0.0,,P43220,0.3665383213816945
641,27059958,glp1r_human,233,M,A,exendin 4,PubChem CID,56927919,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,12.0,nM,=,,46.0,-3.831,,,[125I]-exendin(9-39) (radioligand),125.0,0.0,,0.0,,P43220,0.5314354879216798
642,27059958,glp1r_human,233,M,A,exendin(9-39),PubChem CID,16198321,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,26.0,nM,=,,11.0,2.364,,,[125I]-exendin(9-39) (radioligand),125.0,0.0,,0.0,,P43220,0.5314354879216798
643,27059958,glp1r_human,233,M,A,glucagon-like peptide 1-(15-36),PubChem CID,16133830,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,104.0,nM,=,,120.0,-1.153,,,[125I]-exendin(9-39) (radioligand),125.0,0.0,,0.0,,P43220,0.5314354879216798
644,27059958,glp1r_human,233,M,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,6.1,nM,=,,134.0,-21.739,,,[125I]-exendin(9-39) (radioligand),125.0,0.0,,0.0,,P43220,0.5314354879216798
648,27059958,glp1r_human,233,M,A,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Full agonist,EC50,Functional - cAMP accumulation,10.0,nM,=,,697.0,-71.429,,,,125.0,0.0,,0.0,,P43220,0.5314354879216798
649,27059958,glp1r_human,233,M,A,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,15.0,nM,=,,235.0,-15.625,,,[125I]-exendin(9-39) (radioligand),125.0,0.0,,0.0,,P43220,0.5314354879216798
652,27059958,glp1r_human,233,M,A,glucagon-like peptide 1-(9-36),PubChem CID,90488821,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,234.0,nM,=,,220.0,1.064,,,[125I]-exendin(9-39) (radioligand),125.0,0.0,,0.0,,P43220,0.5314354879216798
651,27059958,glp1r_human,233,M,T,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Full agonist,EC50,Functional - cAMP accumulation,10.0,nM,=,,618.0,-62.5,,,,98.0,0.0,,0.0,,P43220,0.5314354879216798
653,27059958,glp1r_human,234,Q,E,exendin 4,PubChem CID,56927919,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,12.0,nM,=,,38.0,-3.165,,,[125I]-exendin(9-39) (radioligand),87.0,0.0,,0.0,,P43220,0.4493741313935119
654,27059958,glp1r_human,234,Q,E,exendin(9-39),PubChem CID,16198321,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,26.0,nM,=,,6.3,4.127,,,[125I]-exendin(9-39) (radioligand),87.0,0.0,,0.0,,P43220,0.4493741313935119
655,27059958,glp1r_human,234,Q,E,GLP-1-(Ala8Ser),FASTA sequence (peptide),HSEGTFTSDVSSYLEGQAAKEFIAWLVKGR,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,61.0,nM,=,,118.0,-1.934,,,[125I]-exendin(9-39) (radioligand),87.0,0.0,,0.0,,P43220,0.4493741313935119
656,27059958,glp1r_human,234,Q,E,GLP-1(Glu9Gln),FASTA sequence (peptide),HAQGTFTSDVSSYLEGQAAKEFIAWLVKGR,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,36.0,nM,=,,8.0,4.5,,,[125I]-exendin(9-39) (radioligand),87.0,0.0,,0.0,,P43220,0.4493741313935119
657,27059958,glp1r_human,234,Q,E,glucagon-like peptide 1-(15-36),PubChem CID,16133830,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,104.0,nM,=,,139.0,-1.337,,,[125I]-exendin(9-39) (radioligand),87.0,0.0,,0.0,,P43220,0.4493741313935119
658,27059958,glp1r_human,234,Q,E,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,6.1,nM,=,,88.0,-14.493,,,[125I]-exendin(9-39) (radioligand),87.0,0.0,,0.0,,P43220,0.4493741313935119
661,27059958,glp1r_human,234,Q,E,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,15.0,nM,=,,244.0,-16.393,,,[125I]-exendin(9-39) (radioligand),87.0,0.0,,0.0,,P43220,0.4493741313935119
663,27059958,glp1r_human,234,Q,E,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Full agonist,EC50,Functional - cAMP accumulation,10.0,nM,=,,294.0,-29.412,,,,69.0,0.0,,0.0,,P43220,0.4493741313935119
666,27059958,glp1r_human,234,Q,E,glucagon-like peptide 1-(9-36),PubChem CID,90488821,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,234.0,nM,=,,268.0,-1.145,,,[125I]-exendin(9-39) (radioligand),87.0,0.0,,0.0,,P43220,0.4493741313935119
687,27059958,glp1r_human,364,E,Q,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,12.0,nM,=,,0.3,40.0,,,[125I]-exendin(9-39) (radioligand),87.0,0.0,,0.0,,P43220,0.5284544274052005
688,27059958,glp1r_human,364,E,Q,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,12.0,nM,=,,0.3,40.0,,,[125I]-exendin(9-39) (radioligand),45.0,0.0,,0.0,,P43220,0.5284544274052005
689,27059958,glp1r_human,364,E,Q,exendin(9-39),PubChem CID,16198321,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,26.0,nM,=,,13.0,2.0,,,[125I]-exendin(9-39) (radioligand),87.0,0.0,,0.0,,P43220,0.5284544274052005
690,27059958,glp1r_human,364,E,Q,exendin(9-39),PubChem CID,16198321,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,26.0,nM,=,,13.0,2.0,,,[125I]-exendin(9-39) (radioligand),45.0,0.0,,0.0,,P43220,0.5284544274052005
691,27059958,glp1r_human,364,E,Q,GLP-1-(Ala8Ser),FASTA sequence (peptide),HSEGTFTSDVSSYLEGQAAKEFIAWLVKGR,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,61.0,nM,=,,0.4,152.5,,,[125I]-exendin(9-39) (radioligand),87.0,0.0,,0.0,,P43220,0.5284544274052005
692,27059958,glp1r_human,364,E,Q,GLP-1(Glu9Gln),FASTA sequence (peptide),HAQGTFTSDVSSYLEGQAAKEFIAWLVKGR,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,36.0,nM,=,,0.3,120.0,,,[125I]-exendin(9-39) (radioligand),87.0,0.0,,0.0,,P43220,0.5284544274052005
693,27059958,glp1r_human,364,E,Q,glucagon-like peptide 1-(15-36),PubChem CID,16133830,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,104.0,nM,=,,21.0,4.952,,,[125I]-exendin(9-39) (radioligand),87.0,0.0,,0.0,,P43220,0.5284544274052005
694,27059958,glp1r_human,364,E,Q,glucagon-like peptide 1-(15-36),PubChem CID,16133830,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,104.0,nM,=,,21.0,4.952,,,[125I]-exendin(9-39) (radioligand),45.0,0.0,,0.0,,P43220,0.5284544274052005
695,27059958,glp1r_human,364,E,Q,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,6.1,nM,=,,0.3,20.333,,,[125I]-exendin(9-39) (radioligand),87.0,0.0,,0.0,,P43220,0.5284544274052005
696,27059958,glp1r_human,364,E,Q,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,6.1,nM,=,,0.3,20.333,,,[125I]-exendin(9-39) (radioligand),45.0,0.0,,0.0,,P43220,0.5284544274052005
699,27059958,glp1r_human,364,E,Q,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,15.0,nM,=,,0.3,50.0,,,[125I]-exendin(9-39) (radioligand),87.0,0.0,,0.0,,P43220,0.5284544274052005
702,27059958,glp1r_human,364,E,Q,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,6.9,nM,=,,2.2,3.136,,,[125I]-glucagon-like peptide 1-(7-36) (radioligand),45.0,0.0,,0.0,,P43220,0.5284544274052005
703,27059958,glp1r_human,364,E,Q,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Full agonist,EC50,Functional - cAMP accumulation,10.0,nM,=,,8.7,1.149,,,,45.0,0.0,,0.0,,P43220,0.5284544274052005
704,27059958,glp1r_human,364,E,Q,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,15.0,nM,=,,0.3,50.0,,,[125I]-exendin(9-39) (radioligand),45.0,0.0,,0.0,,P43220,0.5284544274052005
707,27059958,glp1r_human,364,E,Q,glucagon-like peptide 1-(9-36),PubChem CID,90488821,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,234.0,nM,=,,22.0,10.636,,,[125I]-exendin(9-39) (radioligand),87.0,0.0,,0.0,,P43220,0.5284544274052005
708,27059958,glp1r_human,364,E,Q,glucagon-like peptide 1-(9-36),PubChem CID,90488821,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,234.0,nM,=,,22.0,10.636,,,[125I]-exendin(9-39) (radioligand),45.0,0.0,,0.0,,P43220,0.5284544274052005
709,27059958,glp1r_human,367,F,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,12.0,nM,=,,130.0,-10.87,,,[125I]-exendin(9-39) (radioligand),118.0,0.0,,0.0,,P43220,0.5532734620404288
710,27059958,glp1r_human,367,F,A,exendin(9-39),PubChem CID,16198321,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,26.0,nM,=,,69.0,-2.653,,,[125I]-exendin(9-39) (radioligand),118.0,0.0,,0.0,,P43220,0.5532734620404288
711,27059958,glp1r_human,367,F,A,glucagon-like peptide 1-(15-36),PubChem CID,16133830,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,104.0,nM,=,,517.0,-4.975,,,[125I]-exendin(9-39) (radioligand),118.0,0.0,,0.0,,P43220,0.5532734620404288
712,27059958,glp1r_human,367,F,A,glucagon-like peptide 1-(7-36),PubChem CID,16133830,Full agonist,EC50,Functional - cAMP accumulation,10.0,nM,=,,719.0,-71.429,,,,118.0,0.0,,0.0,,P43220,0.5532734620404288
713,27059958,glp1r_human,367,F,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,6.1,nM,=,,219.0,-35.714,,,[125I]-exendin(9-39) (radioligand),118.0,0.0,,0.0,,P43220,0.5532734620404288
715,27059958,glp1r_human,367,F,A,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,15.0,nM,=,,482.0,-32.258,,,[125I]-exendin(9-39) (radioligand),118.0,0.0,,0.0,,P43220,0.5532734620404288
716,27059958,glp1r_human,367,F,H,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,6.9,nM,=,,53.0,-7.692,,,[125I]-glucagon-like peptide 1-(7-36) (radioligand),108.0,0.0,,0.0,,P43220,0.508476250718377
717,27059958,glp1r_human,367,F,H,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Full agonist,EC50,Functional - cAMP accumulation,10.0,nM,=,,1314.0,-125.0,,,,108.0,0.0,,0.0,,P43220,0.508476250718377
719,27059958,glp1r_human,367,F,I,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Full agonist,EC50,Functional - cAMP accumulation,10.0,nM,=,,196.0,-19.608,,,,93.0,0.0,,0.0,,P43220,0.4635357811150548
723,27059958,glp1r_human,376,R,Q,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,6.9,nM,=,,6.3,1.095,,,[125I]-glucagon-like peptide 1-(7-36) (radioligand),138.0,0.0,,0.0,,P43220,0.2404325364836272
724,27059958,glp1r_human,376,R,Q,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Full agonist,EC50,Functional - cAMP accumulation,10.0,nM,=,,28.0,-2.801,,,,138.0,0.0,,0.0,,P43220,0.2404325364836272
727,27059958,glp1r_human,381,F,S,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,6.9,nM,=,,15.0,-2.174,,,[125I]-glucagon-like peptide 1-(7-36) (radioligand),127.0,0.0,,0.0,,P43220,0.3532130221770612
728,27059958,glp1r_human,381,F,S,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Full agonist,EC50,Functional - cAMP accumulation,10.0,nM,=,,24.0,-2.398,,,,127.0,0.0,,0.0,,P43220,0.3532130221770612
734,27059958,glp1r_human,384,L,V,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Full agonist,EC50,Functional - cAMP accumulation,10.0,nM,=,,164.0,-16.393,,,,114.0,0.0,,0.0,,P43220,0.4059179100439294
751,27059958,glp1r_human,388,L,F,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,6.9,nM,=,,9.3,-1.348,,,[125I]-glucagon-like peptide 1-(7-36) (radioligand),114.0,0.0,,0.0,,P43220,0.4855126151845497
752,27059958,glp1r_human,388,L,F,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Full agonist,EC50,Functional - cAMP accumulation,10.0,nM,=,,40.0,-4.0,,,,114.0,0.0,,0.0,,P43220,0.4855126151845497
754,27059958,glp1r_human,388,L,A,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Full agonist,EC50,Functional - cAMP accumulation,10.0,nM,=,,2083.0,-200.0,,,,95.0,0.0,,0.0,,P43220,0.5304764445274377
755,27059958,glp1r_human,388,L,I,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,6.9,nM,=,,35.0,-5.076,,,[125I]-glucagon-like peptide 1-(7-36) (radioligand),93.0,0.0,,0.0,,P43220,0.3969896238711384
756,27059958,glp1r_human,388,L,I,glucagon-like peptide 1-(7-37),PubChem CID,16133830,Full agonist,EC50,Functional - cAMP accumulation,10.0,nM,=,,807.0,-83.333,,,,93.0,0.0,,0.0,,P43220,0.3969896238711384
759,27315480,glp1r_human,201,L,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Full agonist,pEC50,Functional - cAMP accumulation,10.45,M,=,,9.3,-14.085,,,,0.0,0.0,,100.0,,P43220,0.4019830241342689
760,27315480,glp1r_human,201,L,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.11,M,=,,8.83,-1.905,,,[125I]-exendin(9-39) (radioligand),94.0,0.0,,0.0,,P43220,0.4019830241342689
761,27315480,glp1r_human,201,L,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Full agonist,pEC50,Functional - ERK activation,10.45,M,=,,7.94,-333.333,,,,0.0,0.0,,78.0,,P43220,0.4019830241342689
762,27315480,glp1r_human,201,L,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Full agonist,pEC50,Functional - Ca2+ accumulation,7.94,M,=,,6.76,-15.152,,,,0.0,0.0,,17.0,,P43220,0.4019830241342689
763,27315480,glp1r_human,201,L,A,exendin(9-39),PubChem CID,16198321,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.96,M,=,,7.66,-1.996,,,[125I]-exendin(9-39) (radioligand),94.0,0.0,,0.0,,P43220,0.4019830241342689
764,27315480,glp1r_human,201,L,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.76,M,=,,8.05,-5.128,,,[125I]-exendin(9-39) (radioligand),94.0,0.0,,0.0,,P43220,0.4019830241342689
765,27315480,glp1r_human,201,L,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - cAMP accumulation,9.66,M,=,,8.47,-15.385,,,,0.0,0.0,,92.0,,P43220,0.4019830241342689
766,27315480,glp1r_human,201,L,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - ERK activation,8.33,M,=,,7.37,-9.091,,,,0.0,0.0,,82.0,,P43220,0.4019830241342689
768,27315480,glp1r_human,201,L,A,Oxyntomodulin(30-37),PubChem CID,11766473,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.66,M,=,,6.74,-8.333,,,[125I]-exendin(9-39) (radioligand),94.0,0.0,,0.0,,P43220,0.4019830241342689
769,27315480,glp1r_human,201,L,A,Oxyntomodulin(30-37),PubChem CID,11766473,Full agonist,pEC50,Functional - cAMP accumulation,8.7,M,=,,7.43,-18.519,,,,0.0,0.0,,61.0,,P43220,0.4019830241342689
770,27315480,glp1r_human,201,L,A,Oxyntomodulin(30-37),PubChem CID,11766473,Full agonist,pEC50,Functional - ERK activation,7.63,M,=,,7.43,-1.585,,,,0.0,0.0,,7.93,,P43220,0.4019830241342689
771,27315480,glp1r_human,202,K,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Full agonist,pEC50,Functional - ERK activation,10.45,M,=,,8.72,-52.632,,,,0.0,0.0,,129.0,,P43220,0.3000345336786883
772,27315480,glp1r_human,202,K,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Full agonist,pEC50,Functional - cAMP accumulation,10.45,M,=,,9.8,-4.464,,,,0.0,0.0,,104.0,,P43220,0.3000345336786883
773,27315480,glp1r_human,202,K,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.11,M,=,,8.88,-1.698,,,[125I]-exendin(9-39) (radioligand),94.0,0.0,,0.0,,P43220,0.3000345336786883
774,27315480,glp1r_human,202,K,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Full agonist,pEC50,Functional - Ca2+ accumulation,7.94,M,=,,6.76,-15.152,,,,0.0,0.0,,39.0,,P43220,0.3000345336786883
775,27315480,glp1r_human,202,K,A,exendin(9-39),PubChem CID,16198321,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.96,M,=,,7.59,-2.342,,,[125I]-exendin(9-39) (radioligand),94.0,0.0,,0.0,,P43220,0.3000345336786883
776,27315480,glp1r_human,202,K,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - ERK activation,8.33,M,=,,8.32,-1.024,,,,0.0,0.0,,111.0,,P43220,0.3000345336786883
777,27315480,glp1r_human,202,K,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - cAMP accumulation,9.66,M,=,,8.39,-18.519,,,,0.0,0.0,,97.0,,P43220,0.3000345336786883
778,27315480,glp1r_human,202,K,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.76,M,=,,8.42,-2.188,,,[125I]-exendin(9-39) (radioligand),94.0,0.0,,0.0,,P43220,0.3000345336786883
779,27315480,glp1r_human,202,K,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - Ca2+ accumulation,7.81,M,=,,6.86,-8.929,,,,0.0,0.0,,40.0,,P43220,0.3000345336786883
780,27315480,glp1r_human,202,K,A,Oxyntomodulin(30-37),PubChem CID,11766473,Full agonist,pEC50,Functional - cAMP accumulation,8.7,M,=,,8.14,-3.636,,,,0.0,0.0,,98.0,,P43220,0.3000345336786883
781,27315480,glp1r_human,202,K,A,Oxyntomodulin(30-37),PubChem CID,11766473,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.66,M,=,,6.77,-7.752,,,[125I]-exendin(9-39) (radioligand),94.0,0.0,,0.0,,P43220,0.3000345336786883
782,27315480,glp1r_human,202,K,A,Oxyntomodulin(30-37),PubChem CID,11766473,Full agonist,pEC50,Functional - ERK activation,7.63,M,=,,8.14,3.236,,,,0.0,0.0,,7.62,,P43220,0.3000345336786883
819,27315480,glp1r_human,206,S,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Full agonist,pEC50,Functional - cAMP accumulation,10.45,M,=,,10.84,2.455,,,,0.0,0.0,,120.0,,P43220,0.2070466028560533
820,27315480,glp1r_human,206,S,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.11,M,=,,8.83,-1.905,,,[125I]-exendin(9-39) (radioligand),111.0,0.0,,0.0,,P43220,0.2070466028560533
821,27315480,glp1r_human,206,S,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Full agonist,pEC50,Functional - Ca2+ accumulation,7.94,M,=,,8.25,2.042,,,,0.0,0.0,,82.0,,P43220,0.2070466028560533
822,27315480,glp1r_human,206,S,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Full agonist,pEC50,Functional - ERK activation,10.45,M,=,,7.98,-333.333,,,,0.0,0.0,,72.0,,P43220,0.2070466028560533
823,27315480,glp1r_human,206,S,A,exendin(9-39),PubChem CID,16198321,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.96,M,=,,8.12,1.445,,,[125I]-exendin(9-39) (radioligand),111.0,0.0,,0.0,,P43220,0.2070466028560533
824,27315480,glp1r_human,206,S,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - cAMP accumulation,9.66,M,=,,9.78,1.318,,,,0.0,0.0,,112.0,,P43220,0.2070466028560533
825,27315480,glp1r_human,206,S,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.76,M,=,,8.64,-1.318,,,[125I]-exendin(9-39) (radioligand),111.0,0.0,,0.0,,P43220,0.2070466028560533
826,27315480,glp1r_human,206,S,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - Ca2+ accumulation,7.81,M,=,,7.92,1.288,,,,0.0,0.0,,97.0,,P43220,0.2070466028560533
827,27315480,glp1r_human,206,S,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - ERK activation,8.33,M,=,,8.01,-2.088,,,,0.0,0.0,,83.0,,P43220,0.2070466028560533
828,27315480,glp1r_human,206,S,A,Oxyntomodulin(30-37),PubChem CID,11766473,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.66,M,=,,7.76,1.259,,,[125I]-exendin(9-39) (radioligand),111.0,0.0,,0.0,,P43220,0.2070466028560533
829,27315480,glp1r_human,206,S,A,Oxyntomodulin(30-37),PubChem CID,11766473,Full agonist,pEC50,Functional - cAMP accumulation,8.7,M,=,,8.83,1.349,,,,0.0,0.0,,109.0,,P43220,0.2070466028560533
830,27315480,glp1r_human,206,S,A,Oxyntomodulin(30-37),PubChem CID,11766473,Full agonist,pEC50,Functional - ERK activation,7.63,M,=,,8.83,15.849,,,,0.0,0.0,,7.68,,P43220,0.2070466028560533
831,27315480,glp1r_human,207,T,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Full agonist,pEC50,Functional - cAMP accumulation,10.45,M,=,,10.34,-1.289,,,,0.0,0.0,,102.0,,P43220,0.2442147902042185
832,27315480,glp1r_human,207,T,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.11,M,=,,8.85,-1.818,,,[125I]-exendin(9-39) (radioligand),75.0,0.0,,0.0,,P43220,0.2442147902042185
833,27315480,glp1r_human,207,T,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Full agonist,pEC50,Functional - ERK activation,10.45,M,=,,8.26,-166.667,,,,0.0,0.0,,36.0,,P43220,0.2442147902042185
834,27315480,glp1r_human,207,T,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Full agonist,pEC50,Functional - Ca2+ accumulation,7.94,M,=,,7.65,-1.949,,,,0.0,0.0,,13.0,,P43220,0.2442147902042185
835,27315480,glp1r_human,207,T,A,exendin(9-39),PubChem CID,16198321,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.96,M,=,,7.89,-1.175,,,[125I]-exendin(9-39) (radioligand),75.0,0.0,,0.0,,P43220,0.2442147902042185
836,27315480,glp1r_human,207,T,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - cAMP accumulation,9.66,M,=,,9.1,-3.636,,,,0.0,0.0,,102.0,,P43220,0.2442147902042185
837,27315480,glp1r_human,207,T,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.76,M,=,,8.67,-1.23,,,[125I]-exendin(9-39) (radioligand),75.0,0.0,,0.0,,P43220,0.2442147902042185
838,27315480,glp1r_human,207,T,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - ERK activation,8.33,M,=,,7.85,-3.021,,,,0.0,0.0,,58.0,,P43220,0.2442147902042185
839,27315480,glp1r_human,207,T,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - Ca2+ accumulation,7.81,M,=,,7.81,1.0,,,,0.0,0.0,,22.0,,P43220,0.2442147902042185
840,27315480,glp1r_human,207,T,A,Oxyntomodulin(30-37),PubChem CID,11766473,Full agonist,pEC50,Functional - cAMP accumulation,8.7,M,=,,7.92,-6.024,,,,0.0,0.0,,94.0,,P43220,0.2442147902042185
841,27315480,glp1r_human,207,T,A,Oxyntomodulin(30-37),PubChem CID,11766473,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.66,M,=,,7.65,-1.024,,,[125I]-exendin(9-39) (radioligand),75.0,0.0,,0.0,,P43220,0.2442147902042185
842,27315480,glp1r_human,207,T,A,Oxyntomodulin(30-37),PubChem CID,11766473,Full agonist,pEC50,Functional - ERK activation,7.63,M,=,,7.92,1.95,,,,0.0,0.0,,7.61,,P43220,0.2442147902042185
843,27315480,glp1r_human,210,Q,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Full agonist,pEC50,Functional - cAMP accumulation,10.45,M,=,,10.78,2.138,,,,0.0,0.0,,99.0,,P43220,0.2951152450327807
844,27315480,glp1r_human,210,Q,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.11,M,=,,8.81,-1.996,,,[125I]-exendin(9-39) (radioligand),88.0,0.0,,0.0,,P43220,0.2951152450327807
845,27315480,glp1r_human,210,Q,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Full agonist,pEC50,Functional - Ca2+ accumulation,7.94,M,=,,7.78,-1.445,,,,0.0,0.0,,83.0,,P43220,0.2951152450327807
846,27315480,glp1r_human,210,Q,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Full agonist,pEC50,Functional - ERK activation,10.45,M,=,,8.22,-166.667,,,,0.0,0.0,,78.0,,P43220,0.2951152450327807
847,27315480,glp1r_human,210,Q,A,exendin(9-39),PubChem CID,16198321,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.96,M,=,,7.93,-1.072,,,[125I]-exendin(9-39) (radioligand),88.0,0.0,,0.0,,P43220,0.2951152450327807
848,27315480,glp1r_human,210,Q,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - Ca2+ accumulation,7.81,M,=,,7.62,-1.548,,,,0.0,0.0,,113.0,,P43220,0.2951152450327807
849,27315480,glp1r_human,210,Q,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - ERK activation,8.33,M,=,,8.71,2.399,,,,0.0,0.0,,96.0,,P43220,0.2951152450327807
850,27315480,glp1r_human,210,Q,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - cAMP accumulation,9.66,M,=,,9.63,-1.072,,,,0.0,0.0,,96.0,,P43220,0.2951152450327807
851,27315480,glp1r_human,210,Q,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.76,M,=,,8.64,-1.318,,,[125I]-exendin(9-39) (radioligand),88.0,0.0,,0.0,,P43220,0.2951152450327807
852,27315480,glp1r_human,210,Q,A,Oxyntomodulin(30-37),PubChem CID,11766473,Full agonist,pEC50,Functional - cAMP accumulation,8.7,M,=,,8.17,-3.39,,,,0.0,0.0,,92.0,,P43220,0.2951152450327807
853,27315480,glp1r_human,210,Q,A,Oxyntomodulin(30-37),PubChem CID,11766473,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.66,M,=,,7.02,-4.367,,,[125I]-exendin(9-39) (radioligand),88.0,0.0,,0.0,,P43220,0.2951152450327807
854,27315480,glp1r_human,210,Q,A,Oxyntomodulin(30-37),PubChem CID,11766473,Full agonist,pEC50,Functional - ERK activation,7.63,M,=,,8.17,3.467,,,,0.0,0.0,,7.71,,P43220,0.2951152450327807
855,27315480,glp1r_human,211,Q,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Full agonist,pEC50,Functional - Ca2+ accumulation,7.94,M,=,,8.06,1.318,,,,0.0,0.0,,123.0,,P43220,0.2963845337177272
856,27315480,glp1r_human,211,Q,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.11,M,=,,8.73,-2.398,,,[125I]-exendin(9-39) (radioligand),112.0,0.0,,0.0,,P43220,0.2963845337177272
857,27315480,glp1r_human,211,Q,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Full agonist,pEC50,Functional - cAMP accumulation,10.45,M,=,,10.51,1.148,,,,0.0,0.0,,104.0,,P43220,0.2963845337177272
858,27315480,glp1r_human,211,Q,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Full agonist,pEC50,Functional - ERK activation,10.45,M,=,,8.17,-200.0,,,,0.0,0.0,,95.0,,P43220,0.2963845337177272
859,27315480,glp1r_human,211,Q,A,exendin(9-39),PubChem CID,16198321,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.96,M,=,,8.05,1.23,,,[125I]-exendin(9-39) (radioligand),112.0,0.0,,0.0,,P43220,0.2963845337177272
860,27315480,glp1r_human,211,Q,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - Ca2+ accumulation,7.81,M,=,,7.83,1.047,,,,0.0,0.0,,135.0,,P43220,0.2963845337177272
861,27315480,glp1r_human,211,Q,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - ERK activation,8.33,M,=,,7.71,-4.167,,,,0.0,0.0,,117.0,,P43220,0.2963845337177272
862,27315480,glp1r_human,211,Q,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.76,M,=,,8.66,-1.259,,,[125I]-exendin(9-39) (radioligand),112.0,0.0,,0.0,,P43220,0.2963845337177272
863,27315480,glp1r_human,211,Q,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - cAMP accumulation,9.66,M,=,,9.14,-3.311,,,,0.0,0.0,,98.0,,P43220,0.2963845337177272
864,27315480,glp1r_human,211,Q,A,Oxyntomodulin(30-37),PubChem CID,11766473,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.66,M,=,,7.63,-1.072,,,[125I]-exendin(9-39) (radioligand),112.0,0.0,,0.0,,P43220,0.2963845337177272
865,27315480,glp1r_human,211,Q,A,Oxyntomodulin(30-37),PubChem CID,11766473,Full agonist,pEC50,Functional - cAMP accumulation,8.7,M,=,,8.2,-3.165,,,,0.0,0.0,,101.0,,P43220,0.2963845337177272
866,27315480,glp1r_human,211,Q,A,Oxyntomodulin(30-37),PubChem CID,11766473,Full agonist,pEC50,Functional - ERK activation,7.63,M,=,,8.2,3.715,,,,0.0,0.0,,7.89,,P43220,0.2963845337177272
879,27315480,glp1r_human,213,Q,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.11,M,=,,8.72,-2.457,,,[125I]-exendin(9-39) (radioligand),101.0,0.0,,0.0,,P43220,0.2982391508427936
880,27315480,glp1r_human,213,Q,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Full agonist,pEC50,Functional - cAMP accumulation,10.45,M,=,,10.38,-1.175,,,,0.0,0.0,,100.0,,P43220,0.2982391508427936
881,27315480,glp1r_human,213,Q,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Full agonist,pEC50,Functional - Ca2+ accumulation,7.94,M,=,,7.83,-1.289,,,,0.0,0.0,,85.0,,P43220,0.2982391508427936
882,27315480,glp1r_human,213,Q,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Full agonist,pEC50,Functional - ERK activation,10.45,M,=,,7.88,-333.333,,,,0.0,0.0,,80.0,,P43220,0.2982391508427936
883,27315480,glp1r_human,213,Q,A,exendin(9-39),PubChem CID,16198321,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.96,M,=,,7.96,1.0,,,[125I]-exendin(9-39) (radioligand),101.0,0.0,,0.0,,P43220,0.2982391508427936
884,27315480,glp1r_human,213,Q,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.76,M,=,,8.88,1.318,,,[125I]-exendin(9-39) (radioligand),101.0,0.0,,0.0,,P43220,0.2982391508427936
885,27315480,glp1r_human,213,Q,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - cAMP accumulation,9.66,M,=,,9.42,-1.739,,,,0.0,0.0,,100.0,,P43220,0.2982391508427936
886,27315480,glp1r_human,213,Q,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - Ca2+ accumulation,7.81,M,=,,7.39,-2.632,,,,0.0,0.0,,74.0,,P43220,0.2982391508427936
887,27315480,glp1r_human,213,Q,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - ERK activation,8.33,M,=,,7.79,-3.472,,,,0.0,0.0,,45.0,,P43220,0.2982391508427936
888,27315480,glp1r_human,213,Q,A,Oxyntomodulin(30-37),PubChem CID,11766473,Full agonist,pEC50,Functional - cAMP accumulation,8.7,M,=,,8.7,1.0,,,,0.0,0.0,,102.0,,P43220,0.2982391508427936
889,27315480,glp1r_human,213,Q,A,Oxyntomodulin(30-37),PubChem CID,11766473,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.66,M,=,,7.74,1.202,,,[125I]-exendin(9-39) (radioligand),101.0,0.0,,0.0,,P43220,0.2982391508427936
890,27315480,glp1r_human,213,Q,A,Oxyntomodulin(30-37),PubChem CID,11766473,Full agonist,pEC50,Functional - ERK activation,7.63,M,=,,8.7,11.749,,,,0.0,0.0,,7.25,,P43220,0.2982391508427936
891,27315480,glp1r_human,214,W,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Full agonist,pEC50,Functional - ERK activation,10.45,M,=,,8.02,-250.0,,,,0.0,0.0,,105.0,,P43220,0.3834101461424452
892,27315480,glp1r_human,214,W,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Full agonist,pEC50,Functional - cAMP accumulation,10.45,M,=,,10.29,-1.445,,,,0.0,0.0,,104.0,,P43220,0.3834101461424452
893,27315480,glp1r_human,214,W,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.11,M,=,,8.9,-1.621,,,[125I]-exendin(9-39) (radioligand),99.0,0.0,,0.0,,P43220,0.3834101461424452
894,27315480,glp1r_human,214,W,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Full agonist,pEC50,Functional - Ca2+ accumulation,7.94,M,=,,7.68,-1.818,,,,0.0,0.0,,90.0,,P43220,0.3834101461424452
895,27315480,glp1r_human,214,W,A,exendin(9-39),PubChem CID,16198321,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.96,M,=,,7.78,-1.513,,,[125I]-exendin(9-39) (radioligand),99.0,0.0,,0.0,,P43220,0.3834101461424452
896,27315480,glp1r_human,214,W,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - ERK activation,8.33,M,=,,7.62,-5.128,,,,0.0,0.0,,106.0,,P43220,0.3834101461424452
897,27315480,glp1r_human,214,W,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.76,M,=,,8.2,-3.636,,,[125I]-exendin(9-39) (radioligand),99.0,0.0,,0.0,,P43220,0.3834101461424452
898,27315480,glp1r_human,214,W,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - Ca2+ accumulation,7.81,M,=,,6.8,-10.204,,,,0.0,0.0,,97.0,,P43220,0.3834101461424452
899,27315480,glp1r_human,214,W,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - cAMP accumulation,9.66,M,=,,8.95,-5.128,,,,0.0,0.0,,97.0,,P43220,0.3834101461424452
900,27315480,glp1r_human,214,W,A,Oxyntomodulin(30-37),PubChem CID,11766473,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.66,M,=,,7.44,-1.658,,,[125I]-exendin(9-39) (radioligand),99.0,0.0,,0.0,,P43220,0.3834101461424452
901,27315480,glp1r_human,214,W,A,Oxyntomodulin(30-37),PubChem CID,11766473,Full agonist,pEC50,Functional - cAMP accumulation,8.7,M,=,,8.24,-2.882,,,,0.0,0.0,,92.0,,P43220,0.3834101461424452
902,27315480,glp1r_human,214,W,A,Oxyntomodulin(30-37),PubChem CID,11766473,Full agonist,pEC50,Functional - ERK activation,7.63,M,=,,8.24,4.074,,,,0.0,0.0,,7.65,,P43220,0.3834101461424452
903,27315480,glp1r_human,215,D,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Full agonist,pEC50,Functional - Ca2+ accumulation,7.94,M,=,,8.08,1.38,,,,0.0,0.0,,117.0,,P43220,0.3368900145256693
904,27315480,glp1r_human,215,D,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Full agonist,pEC50,Functional - cAMP accumulation,10.45,M,=,,10.02,-2.688,,,,0.0,0.0,,107.0,,P43220,0.3368900145256693
905,27315480,glp1r_human,215,D,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Full agonist,pEC50,Functional - ERK activation,10.45,M,=,,8.65,-62.5,,,,0.0,0.0,,105.0,,P43220,0.3368900145256693
906,27315480,glp1r_human,215,D,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.11,M,=,,8.92,-1.548,,,[125I]-exendin(9-39) (radioligand),90.0,0.0,,0.0,,P43220,0.3368900145256693
907,27315480,glp1r_human,215,D,A,exendin(9-39),PubChem CID,16198321,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.96,M,=,,7.9,-1.148,,,[125I]-exendin(9-39) (radioligand),90.0,0.0,,0.0,,P43220,0.3368900145256693
908,27315480,glp1r_human,215,D,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - Ca2+ accumulation,7.81,M,=,,7.83,1.047,,,,0.0,0.0,,125.0,,P43220,0.3368900145256693
909,27315480,glp1r_human,215,D,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - ERK activation,8.33,M,=,,7.75,-3.802,,,,0.0,0.0,,109.0,,P43220,0.3368900145256693
910,27315480,glp1r_human,215,D,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - cAMP accumulation,9.66,M,=,,9.49,-1.479,,,,0.0,0.0,,105.0,,P43220,0.3368900145256693
911,27315480,glp1r_human,215,D,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.76,M,=,,8.34,-2.632,,,[125I]-exendin(9-39) (radioligand),90.0,0.0,,0.0,,P43220,0.3368900145256693
912,27315480,glp1r_human,215,D,A,Oxyntomodulin(30-37),PubChem CID,11766473,Full agonist,pEC50,Functional - cAMP accumulation,8.7,M,=,,8.4,-1.996,,,,0.0,0.0,,104.0,,P43220,0.3368900145256693
913,27315480,glp1r_human,215,D,A,Oxyntomodulin(30-37),PubChem CID,11766473,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.66,M,=,,7.5,-1.445,,,[125I]-exendin(9-39) (radioligand),90.0,0.0,,0.0,,P43220,0.3368900145256693
914,27315480,glp1r_human,215,D,A,Oxyntomodulin(30-37),PubChem CID,11766473,Full agonist,pEC50,Functional - ERK activation,7.63,M,=,,8.4,5.888,,,,0.0,0.0,,7.74,,P43220,0.3368900145256693
927,27315480,glp1r_human,218,L,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Full agonist,pEC50,Functional - cAMP accumulation,10.45,M,=,,9.51,-8.696,,,,0.0,0.0,,100.0,,P43220,0.303199580233566
928,27315480,glp1r_human,218,L,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.11,M,=,,8.14,-9.346,,,[125I]-exendin(9-39) (radioligand),89.0,0.0,,0.0,,P43220,0.303199580233566
929,27315480,glp1r_human,218,L,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Full agonist,pEC50,Functional - Ca2+ accumulation,7.94,M,=,,7.64,-1.996,,,,0.0,0.0,,85.0,,P43220,0.303199580233566
930,27315480,glp1r_human,218,L,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Full agonist,pEC50,Functional - ERK activation,10.45,M,=,,7.85,-333.333,,,,0.0,0.0,,82.0,,P43220,0.303199580233566
931,27315480,glp1r_human,218,L,A,exendin(9-39),PubChem CID,16198321,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.96,M,=,,7.64,-2.088,,,[125I]-exendin(9-39) (radioligand),89.0,0.0,,0.0,,P43220,0.303199580233566
932,27315480,glp1r_human,218,L,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - cAMP accumulation,9.66,M,=,,8.92,-5.495,,,,0.0,0.0,,99.0,,P43220,0.303199580233566
933,27315480,glp1r_human,218,L,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - Ca2+ accumulation,7.81,M,=,,7.03,-6.024,,,,0.0,0.0,,95.0,,P43220,0.303199580233566
934,27315480,glp1r_human,218,L,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.76,M,=,,7.91,-7.092,,,[125I]-exendin(9-39) (radioligand),89.0,0.0,,0.0,,P43220,0.303199580233566
935,27315480,glp1r_human,218,L,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - ERK activation,8.33,M,=,,7.69,-4.367,,,,0.0,0.0,,83.0,,P43220,0.303199580233566
936,27315480,glp1r_human,218,L,A,Oxyntomodulin(30-37),PubChem CID,11766473,Full agonist,pEC50,Functional - cAMP accumulation,8.7,M,=,,7.59,-12.821,,,,0.0,0.0,,94.0,,P43220,0.303199580233566
937,27315480,glp1r_human,218,L,A,Oxyntomodulin(30-37),PubChem CID,11766473,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.66,M,=,,7.15,-3.236,,,[125I]-exendin(9-39) (radioligand),89.0,0.0,,0.0,,P43220,0.303199580233566
938,27315480,glp1r_human,218,L,A,Oxyntomodulin(30-37),PubChem CID,11766473,Full agonist,pEC50,Functional - ERK activation,7.63,M,=,,7.59,-1.096,,,,0.0,0.0,,7.26,,P43220,0.303199580233566
939,27315480,glp1r_human,219,S,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Full agonist,pEC50,Functional - cAMP accumulation,10.45,M,=,,10.23,-1.658,,,,0.0,0.0,,108.0,,P43220,0.2255517600758658
940,27315480,glp1r_human,219,S,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.11,M,=,,9.05,-1.148,,,[125I]-exendin(9-39) (radioligand),104.0,0.0,,0.0,,P43220,0.2255517600758658
941,27315480,glp1r_human,219,S,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Full agonist,pEC50,Functional - ERK activation,10.45,M,=,,8.77,-47.619,,,,0.0,0.0,,91.0,,P43220,0.2255517600758658
942,27315480,glp1r_human,219,S,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Full agonist,pEC50,Functional - Ca2+ accumulation,7.94,M,=,,8.26,2.089,,,,0.0,0.0,,90.0,,P43220,0.2255517600758658
943,27315480,glp1r_human,219,S,A,exendin(9-39),PubChem CID,16198321,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.96,M,=,,8.23,1.862,,,[125I]-exendin(9-39) (radioligand),104.0,0.0,,0.0,,P43220,0.2255517600758658
944,27315480,glp1r_human,219,S,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - ERK activation,8.33,M,=,,8.43,1.259,,,,0.0,0.0,,125.0,,P43220,0.2255517600758658
945,27315480,glp1r_human,219,S,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.76,M,=,,8.82,1.148,,,[125I]-exendin(9-39) (radioligand),104.0,0.0,,0.0,,P43220,0.2255517600758658
946,27315480,glp1r_human,219,S,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - Ca2+ accumulation,7.81,M,=,,8.14,2.138,,,,0.0,0.0,,101.0,,P43220,0.2255517600758658
947,27315480,glp1r_human,219,S,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - cAMP accumulation,9.66,M,=,,9.76,1.259,,,,0.0,0.0,,101.0,,P43220,0.2255517600758658
948,27315480,glp1r_human,219,S,A,Oxyntomodulin(30-37),PubChem CID,11766473,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.66,M,=,,7.79,1.349,,,[125I]-exendin(9-39) (radioligand),104.0,0.0,,0.0,,P43220,0.2255517600758658
949,27315480,glp1r_human,219,S,A,Oxyntomodulin(30-37),PubChem CID,11766473,Full agonist,pEC50,Functional - cAMP accumulation,8.7,M,=,,8.55,-1.412,,,,0.0,0.0,,97.0,,P43220,0.2255517600758658
950,27315480,glp1r_human,219,S,A,Oxyntomodulin(30-37),PubChem CID,11766473,Full agonist,pEC50,Functional - ERK activation,7.63,M,=,,8.55,8.318,,,,0.0,0.0,,7.86,,P43220,0.2255517600758658
951,27315480,glp1r_human,220,Y,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Full agonist,pEC50,Functional - cAMP accumulation,10.45,M,=,,10.53,1.202,,,,0.0,0.0,,104.0,,P43220,0.3258268167735939
952,27315480,glp1r_human,220,Y,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Full agonist,pEC50,Functional - ERK activation,10.45,M,=,,8.12,-200.0,,,,0.0,0.0,,100.0,,P43220,0.3258268167735939
953,27315480,glp1r_human,220,Y,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.11,M,=,,9.23,1.318,,,[125I]-exendin(9-39) (radioligand),94.0,0.0,,0.0,,P43220,0.3258268167735939
954,27315480,glp1r_human,220,Y,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Full agonist,pEC50,Functional - Ca2+ accumulation,7.94,M,=,,7.36,-3.802,,,,0.0,0.0,,90.0,,P43220,0.3258268167735939
955,27315480,glp1r_human,220,Y,A,exendin(9-39),PubChem CID,16198321,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.96,M,=,,7.88,-1.202,,,[125I]-exendin(9-39) (radioligand),94.0,0.0,,0.0,,P43220,0.3258268167735939
956,27315480,glp1r_human,220,Y,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - Ca2+ accumulation,7.81,M,=,,7.73,-1.202,,,,0.0,0.0,,118.0,,P43220,0.3258268167735939
957,27315480,glp1r_human,220,Y,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - cAMP accumulation,9.66,M,=,,9.47,-1.548,,,,0.0,0.0,,105.0,,P43220,0.3258268167735939
958,27315480,glp1r_human,220,Y,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.76,M,=,,8.49,-1.862,,,[125I]-exendin(9-39) (radioligand),94.0,0.0,,0.0,,P43220,0.3258268167735939
959,27315480,glp1r_human,220,Y,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - ERK activation,8.33,M,=,,8.13,-1.585,,,,0.0,0.0,,90.0,,P43220,0.3258268167735939
960,27315480,glp1r_human,220,Y,A,Oxyntomodulin(30-37),PubChem CID,11766473,Full agonist,pEC50,Functional - cAMP accumulation,8.7,M,=,,8.05,-4.464,,,,0.0,0.0,,95.0,,P43220,0.3258268167735939
961,27315480,glp1r_human,220,Y,A,Oxyntomodulin(30-37),PubChem CID,11766473,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.66,M,=,,7.33,-2.137,,,[125I]-exendin(9-39) (radioligand),94.0,0.0,,0.0,,P43220,0.3258268167735939
962,27315480,glp1r_human,220,Y,A,Oxyntomodulin(30-37),PubChem CID,11766473,Full agonist,pEC50,Functional - ERK activation,7.63,M,=,,8.05,2.63,,,,0.0,0.0,,7.48,,P43220,0.3258268167735939
963,27315480,glp1r_human,221,Q,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Full agonist,pEC50,Functional - cAMP accumulation,10.45,M,=,,9.75,-5.0,,,,0.0,0.0,,102.0,,P43220,0.2791831692216212
964,27315480,glp1r_human,221,Q,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.11,M,=,,8.91,-1.585,,,[125I]-exendin(9-39) (radioligand),97.0,0.0,,0.0,,P43220,0.2791831692216212
965,27315480,glp1r_human,221,Q,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Full agonist,pEC50,Functional - Ca2+ accumulation,7.94,M,=,,7.96,1.047,,,,0.0,0.0,,93.0,,P43220,0.2791831692216212
966,27315480,glp1r_human,221,Q,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Full agonist,pEC50,Functional - ERK activation,10.45,M,=,,8.14,-200.0,,,,0.0,0.0,,89.0,,P43220,0.2791831692216212
968,27315480,glp1r_human,221,Q,A,exendin(9-39),PubChem CID,16198321,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.96,M,=,,7.69,-1.862,,,[125I]-exendin(9-39) (radioligand),97.0,0.0,,0.0,,P43220,0.2791831692216212
969,27315480,glp1r_human,221,Q,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - cAMP accumulation,9.66,M,=,,9.85,1.549,,,,0.0,0.0,,108.0,,P43220,0.2791831692216212
970,27315480,glp1r_human,221,Q,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.76,M,=,,8.53,-1.698,,,[125I]-exendin(9-39) (radioligand),97.0,0.0,,0.0,,P43220,0.2791831692216212
971,27315480,glp1r_human,221,Q,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - Ca2+ accumulation,7.81,M,=,,7.46,-2.237,,,,0.0,0.0,,94.0,,P43220,0.2791831692216212
972,27315480,glp1r_human,221,Q,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - ERK activation,8.33,M,=,,8.14,-1.548,,,,0.0,0.0,,86.0,,P43220,0.2791831692216212
973,27315480,glp1r_human,221,Q,A,Oxyntomodulin(30-37),PubChem CID,11766473,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.66,M,=,,7.81,1.413,,,[125I]-exendin(9-39) (radioligand),97.0,0.0,,0.0,,P43220,0.2791831692216212
974,27315480,glp1r_human,221,Q,A,Oxyntomodulin(30-37),PubChem CID,11766473,Full agonist,pEC50,Functional - cAMP accumulation,8.7,M,=,,8.39,-2.041,,,,0.0,0.0,,92.0,,P43220,0.2791831692216212
975,27315480,glp1r_human,221,Q,A,Oxyntomodulin(30-37),PubChem CID,11766473,Full agonist,pEC50,Functional - ERK activation,7.63,M,=,,8.39,5.754,,,,0.0,0.0,,7.81,,P43220,0.2791831692216212
976,27315480,glp1r_human,222,D,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Full agonist,pEC50,Functional - ERK activation,10.45,M,=,,8.3,-142.857,,,,0.0,0.0,,104.0,,P43220,0.4136319315257138
977,27315480,glp1r_human,222,D,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Full agonist,pEC50,Functional - cAMP accumulation,10.45,M,=,,10.73,1.905,,,,0.0,0.0,,103.0,,P43220,0.4136319315257138
978,27315480,glp1r_human,222,D,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.11,M,=,,8.95,-1.445,,,[125I]-exendin(9-39) (radioligand),102.0,0.0,,0.0,,P43220,0.4136319315257138
979,27315480,glp1r_human,222,D,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Full agonist,pEC50,Functional - Ca2+ accumulation,7.94,M,=,,7.85,-1.23,,,,0.0,0.0,,101.0,,P43220,0.4136319315257138
980,27315480,glp1r_human,222,D,A,exendin(9-39),PubChem CID,16198321,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.96,M,=,,7.99,1.072,,,[125I]-exendin(9-39) (radioligand),102.0,0.0,,0.0,,P43220,0.4136319315257138
981,27315480,glp1r_human,222,D,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - ERK activation,8.33,M,=,,8.13,-1.585,,,,0.0,0.0,,108.0,,P43220,0.4136319315257138
982,27315480,glp1r_human,222,D,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.76,M,=,,8.62,-1.381,,,[125I]-exendin(9-39) (radioligand),102.0,0.0,,0.0,,P43220,0.4136319315257138
983,27315480,glp1r_human,222,D,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - cAMP accumulation,9.66,M,=,,9.94,1.905,,,,0.0,0.0,,99.0,,P43220,0.4136319315257138
984,27315480,glp1r_human,222,D,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - Ca2+ accumulation,7.81,M,=,,7.84,1.072,,,,0.0,0.0,,97.0,,P43220,0.4136319315257138
985,27315480,glp1r_human,222,D,A,Oxyntomodulin(30-37),PubChem CID,11766473,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.66,M,=,,7.35,-2.041,,,[125I]-exendin(9-39) (radioligand),102.0,0.0,,0.0,,P43220,0.4136319315257138
986,27315480,glp1r_human,222,D,A,Oxyntomodulin(30-37),PubChem CID,11766473,Full agonist,pEC50,Functional - cAMP accumulation,8.7,M,=,,8.48,-1.658,,,,0.0,0.0,,101.0,,P43220,0.4136319315257138
987,27315480,glp1r_human,222,D,A,Oxyntomodulin(30-37),PubChem CID,11766473,Full agonist,pEC50,Functional - ERK activation,7.63,M,=,,8.48,7.079,,,,0.0,0.0,,7.39,,P43220,0.4136319315257138
988,27315480,glp1r_human,223,S,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Full agonist,pEC50,Functional - cAMP accumulation,10.45,M,=,,9.86,-3.891,,,,0.0,0.0,,103.0,,P43220,0.2814059645107404
989,27315480,glp1r_human,223,S,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Full agonist,pEC50,Functional - ERK activation,10.45,M,=,,8.64,-66.667,,,,0.0,0.0,,100.0,,P43220,0.2814059645107404
990,27315480,glp1r_human,223,S,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.11,M,=,,8.68,-2.688,,,[125I]-exendin(9-39) (radioligand),90.0,0.0,,0.0,,P43220,0.2814059645107404
991,27315480,glp1r_human,223,S,A,exendin 4,FASTA sequence (peptide),DVSSYLEGQAAKEFIAWLVKGR,Full agonist,pEC50,Functional - Ca2+ accumulation,7.94,M,=,,7.99,1.122,,,,0.0,0.0,,71.0,,P43220,0.2814059645107404
992,27315480,glp1r_human,223,S,A,exendin(9-39),PubChem CID,16198321,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.96,M,=,,8.07,1.288,,,[125I]-exendin(9-39) (radioligand),90.0,0.0,,0.0,,P43220,0.2814059645107404
993,27315480,glp1r_human,223,S,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - ERK activation,8.33,M,=,,8.06,-1.862,,,,0.0,0.0,,141.0,,P43220,0.2814059645107404
994,27315480,glp1r_human,223,S,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - cAMP accumulation,9.66,M,=,,9.36,-1.996,,,,0.0,0.0,,98.0,,P43220,0.2814059645107404
995,27315480,glp1r_human,223,S,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.76,M,=,,8.32,-2.755,,,[125I]-exendin(9-39) (radioligand),90.0,0.0,,0.0,,P43220,0.2814059645107404
996,27315480,glp1r_human,223,S,A,glucagon-like peptide 1-(7-36),PubChem CID,16135499,Full agonist,pEC50,Functional - Ca2+ accumulation,7.81,M,=,,7.45,-2.288,,,,0.0,0.0,,74.0,,P43220,0.2814059645107404
997,27315480,glp1r_human,223,S,A,Oxyntomodulin(30-37),PubChem CID,11766473,Full agonist,pEC50,Functional - cAMP accumulation,8.7,M,=,,8.12,-3.802,,,,0.0,0.0,,102.0,,P43220,0.2814059645107404
998,27315480,glp1r_human,223,S,A,Oxyntomodulin(30-37),PubChem CID,11766473,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.66,M,=,,7.32,-2.188,,,[125I]-exendin(9-39) (radioligand),90.0,0.0,,0.0,,P43220,0.2814059645107404
999,27315480,glp1r_human,223,S,A,Oxyntomodulin(30-37),PubChem CID,11766473,Full agonist,pEC50,Functional - ERK activation,7.63,M,=,,8.12,3.09,,,,0.0,0.0,,7.76,,P43220,0.2814059645107404
8,11517171,sctr_human,323,K,I,secretin,PubChem CID,16129665,Full agonist,EC50,Functional - cAMP accumulation,3.0,nM,=,,17.0,-5.682,,,,0.0,0.0,,0.0,,P47872,0.6593172706008429
9,11517171,sctr_human,323,K,I,secretin,PubChem CID,16129665,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,14.1,nM,=,,3.8,3.711,,,[125]secretin (radioligand),0.0,0.0,,0.0,,P47872,0.6593172706008429
10,11517171,sctr_human,330,R,I,secretin,PubChem CID,16129665,Full agonist,EC50,Functional - cAMP accumulation,3.0,nM,=,,3.0,1.0,,,,0.0,0.0,,0.0,,P47872,0.3790561495117758
11,11517171,sctr_human,330,R,I,secretin,PubChem CID,16129665,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,14.1,nM,=,,10.7,1.318,,,[125]secretin (radioligand),0.0,0.0,,0.0,,P47872,0.3790561495117758
12,11517171,sctr_human,339,R,A,secretin,PubChem CID,16129665,Full agonist,EC50,Functional - cAMP accumulation,3.0,nM,=,,0.5,6.0,,,,0.0,0.0,,0.0,,P47872,0.577879482258366
14,11517171,sctr_human,339,R,A,secretin,PubChem CID,16129665,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,14.1,nM,=,,49.7,-3.521,,,[125]secretin (radioligand),0.0,0.0,,0.0,,P47872,0.577879482258366
13,11517171,sctr_human,339,R,I,secretin,PubChem CID,16129665,Full agonist,EC50,Functional - cAMP accumulation,3.0,nM,=,,0.4,7.5,,,,0.0,0.0,,0.0,,P47872,0.6623545007440246
15,11517171,sctr_human,339,R,I,secretin,PubChem CID,16129665,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,14.1,nM,=,,26.8,-1.901,,,[125]secretin (radioligand),0.0,0.0,,0.0,,P47872,0.6623545007440246
17,11517171,sctr_human,342,R,A,secretin,PubChem CID,16129665,Full agonist,EC50,Functional - cAMP accumulation,3.0,nM,=,,0.6,5.0,,,,0.0,0.0,,0.0,,P47872,0.6513363834140387
18,11517171,sctr_human,342,R,A,secretin,PubChem CID,16129665,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,14.1,nM,=,,32.5,-2.304,,,[125]secretin (radioligand),0.0,0.0,,0.0,,P47872,0.6513363834140387
20,22964305,sctr_human,209,D,C,secretin,PubChem CID,16129665,Full agonist,EC50,Functional - cAMP accumulation,0.02,nM,=,,0.3,-14.925,,,secretin,0.0,0.0,,100.52910052910052,secretin,P47872,0.3595288599838387
21,22964305,sctr_human,209,D,C,secretin,PubChem CID,16129665,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,1.2,nM,=,,2.7,-2.252,,,[125]secretin (radioligand),6.177260519247986,0.0,,0.0,,P47872,0.3595288599838387
22,22964305,sctr_human,210,A,C,secretin,PubChem CID,16129665,Full agonist,EC50,Functional - cAMP accumulation,0.02,nM,=,,2.2,-111.111,,,secretin,0.0,0.0,,94.17989417989418,secretin,P47872,0.2426929961182846
23,22964305,sctr_human,210,A,C,secretin,PubChem CID,16129665,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,1.2,nM,=,,3.9,-3.247,,,[125]secretin (radioligand),4.2972247090420765,0.0,,0.0,,P47872,0.2426929961182846
24,22964305,sctr_human,211,H,C,secretin,PubChem CID,16129665,Full agonist,EC50,Functional - cAMP accumulation,0.02,nM,=,,2.1,-100.0,,,secretin,0.0,0.0,,93.12169312169311,secretin,P47872,0.4502371441944482
30,22964305,sctr_human,214,G,C,secretin,PubChem CID,16129665,Full agonist,EC50,Functional - cAMP accumulation,0.02,nM,=,,0.08,-4.0,,,secretin,0.0,0.0,,106.34920634920636,secretin,P47872,0.400652749167527
31,22964305,sctr_human,214,G,C,secretin,PubChem CID,16129665,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,1.2,nM,=,,4.8,-4.0,,,[125]secretin (radioligand),19.78513876454789,0.0,,0.0,,P47872,0.400652749167527
36,22964305,sctr_human,218,V,C,secretin,PubChem CID,16129665,Full agonist,EC50,Functional - cAMP accumulation,0.02,nM,=,,0.04,-2.0,,,secretin,0.0,0.0,,87.83068783068782,secretin,P47872,0.5031045714446037
37,22964305,sctr_human,218,V,C,secretin,PubChem CID,16129665,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,1.2,nM,=,,6.6,-5.495,,,[125]secretin (radioligand),47.71709937332139,0.0,,0.0,,P47872,0.5031045714446037
44,22964305,sctr_human,222,F,C,secretin,PubChem CID,16129665,Full agonist,EC50,Functional - cAMP accumulation,0.02,nM,=,,1.5,-76.923,,,secretin,0.0,0.0,,87.83068783068782,secretin,P47872,0.5729791733526847
45,22964305,sctr_human,222,F,C,secretin,PubChem CID,16129665,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,1.2,nM,=,,19.7,-16.393,,,[125]secretin (radioligand),50.044762757385854,0.0,,0.0,,P47872,0.5729791733526847
48,22964305,sctr_human,279,F,C,secretin,PubChem CID,16129665,Full agonist,EC50,Functional - cAMP accumulation,0.02,nM,=,,0.04,-2.0,,,secretin,0.0,0.0,,110.58201058201058,secretin,P47872,0.2992317136681627
49,22964305,sctr_human,279,F,C,secretin,PubChem CID,16129665,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,1.2,nM,=,,9.0,-7.519,,,[125]secretin (radioligand),80.30438675022381,0.0,,0.0,,P47872,0.2992317136681627
54,22964305,sctr_human,282,D,C,secretin,PubChem CID,16129665,Full agonist,EC50,Functional - cAMP accumulation,0.02,nM,=,,0.3,-14.925,Abolished effect,,secretin,0.0,0.0,,105.2910052910053,secretin,P47872,0.3838375945441767
56,22964305,sctr_human,283,V,C,secretin,PubChem CID,16129665,Full agonist,EC50,Functional - cAMP accumulation,0.02,nM,=,,0.2,-10.0,,,secretin,0.0,0.0,,88.35978835978835,secretin,P47872,0.2776354048645262
57,22964305,sctr_human,283,V,C,secretin,PubChem CID,16129665,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,1.2,nM,=,,2.7,-2.252,,,[125]secretin (radioligand),6.177260519247986,0.0,,0.0,,P47872,0.2776354048645262
62,22964305,sctr_human,287,D,C,secretin,PubChem CID,16129665,Full agonist,EC50,Functional - cAMP accumulation,0.02,nM,=,,0.8,-40.0,,,secretin,0.0,0.0,,93.65079365079364,secretin,P47872,0.5965855834205984
63,22964305,sctr_human,287,D,C,secretin,PubChem CID,16129665,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,1.2,nM,=,,2.5,-2.083,,,[125]secretin (radioligand),2.506714413607878,0.0,,0.0,,P47872,0.5965855834205984
64,22964305,sctr_human,288,I,C,secretin,PubChem CID,16129665,Full agonist,EC50,Functional - cAMP accumulation,0.02,nM,=,,0.5,-25.0,,,secretin,0.0,0.0,,104.23280423280424,secretin,P47872,0.4057076024972329
65,22964305,sctr_human,288,I,C,secretin,PubChem CID,16129665,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,1.2,nM,=,,7.9,-6.579,,,[125]secretin (radioligand),20.859444941808416,0.0,,0.0,,P47872,0.4057076024972329
66,22964305,sctr_human,289,N,C,secretin,PubChem CID,16129665,Full agonist,EC50,Functional - cAMP accumulation,0.02,nM,=,,0.3,-14.925,,,secretin,0.0,0.0,,94.17989417989418,secretin,P47872,0.5132260545447919
67,22964305,sctr_human,289,N,C,secretin,PubChem CID,16129665,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,1.2,nM,=,,5.9,-4.926,,,[125]secretin (radioligand),20.680393912265,0.0,,0.0,,P47872,0.5132260545447919
68,22964305,sctr_human,290,A,C,secretin,PubChem CID,16129665,Full agonist,EC50,Functional - cAMP accumulation,0.02,nM,=,,0.1,-5.0,,,secretin,0.0,0.0,,93.65079365079364,secretin,P47872,0.2920178231064665
69,22964305,sctr_human,290,A,C,secretin,PubChem CID,16129665,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,1.2,nM,=,,3.4,-2.833,,,[125]secretin (radioligand),9.489704565801253,0.0,,0.0,,P47872,0.2920178231064665
70,22964305,sctr_human,291,N,C,secretin,PubChem CID,16129665,Full agonist,EC50,Functional - cAMP accumulation,0.02,nM,=,,0.03,-1.499,,,secretin,0.0,0.0,,104.23280423280424,secretin,P47872,0.4663878268294925
71,22964305,sctr_human,291,N,C,secretin,PubChem CID,16129665,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,1.2,nM,=,,6.5,-5.405,,,[125]secretin (radioligand),41.00268576544315,0.0,,0.0,,P47872,0.4663878268294925
74,22964305,sctr_human,293,S,C,secretin,PubChem CID,16129665,Full agonist,EC50,Functional - cAMP accumulation,0.02,nM,=,,0.1,-5.0,,,secretin,0.0,0.0,,93.12169312169311,secretin,P47872,0.2913345098863499
75,22964305,sctr_human,293,S,C,secretin,PubChem CID,16129665,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,1.2,nM,=,,9.3,-7.752,,,[125]secretin (radioligand),47.00089525514772,0.0,,0.0,,P47872,0.2913345098863499
76,22964305,sctr_human,294,I,C,secretin,PubChem CID,16129665,Full agonist,EC50,Functional - cAMP accumulation,0.02,nM,=,,0.2,-10.0,,,secretin,0.0,0.0,,99.47089947089948,secretin,P47872,0.4237548863123832
77,22964305,sctr_human,294,I,C,secretin,PubChem CID,16129665,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,1.2,nM,=,,9.2,-7.692,,,[125]secretin (radioligand),36.61593554162936,0.0,,0.0,,P47872,0.4237548863123832
82,22964305,sctr_human,297,I,C,secretin,PubChem CID,16129665,Full agonist,EC50,Functional - cAMP accumulation,0.02,nM,=,,0.04,-2.0,,,secretin,0.0,0.0,,103.7037037037037,secretin,P47872,0.4646834055715997
83,22964305,sctr_human,297,I,C,secretin,PubChem CID,16129665,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,1.2,nM,=,,5.5,-4.587,,,[125]secretin (radioligand),32.13965980304386,0.0,,0.0,,P47872,0.4646834055715997
84,22964305,sctr_human,358,F,C,secretin,PubChem CID,16129665,Full agonist,EC50,Functional - cAMP accumulation,0.02,nM,=,,3.2,-166.667,,,secretin,0.0,0.0,,82.53968253968253,secretin,P47872,0.5670100033666559
85,22964305,sctr_human,358,F,C,secretin,PubChem CID,16129665,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,1.2,nM,=,,23.1,-19.231,,,[125]secretin (radioligand),79.319606087735,0.0,,0.0,,P47872,0.5670100033666559
86,22964305,sctr_human,359,A,C,secretin,PubChem CID,16129665,Full agonist,EC50,Functional - cAMP accumulation,0.02,nM,=,,0.07,-3.497,,,secretin,0.0,0.0,,92.5925925925926,secretin,P47872,0.494136300179206
87,22964305,sctr_human,359,A,C,secretin,PubChem CID,16129665,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,1.2,nM,=,,7.6,-6.329,,,[125]secretin (radioligand),47.806624888093104,0.0,,0.0,,P47872,0.494136300179206
88,22964305,sctr_human,360,F,C,secretin,PubChem CID,16129665,Full agonist,EC50,Functional - cAMP accumulation,0.02,nM,=,,0.1,-5.0,,,secretin,0.0,0.0,,97.88359788359789,secretin,P47872,0.4763930351614956
89,22964305,sctr_human,360,F,C,secretin,PubChem CID,16129665,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,1.2,nM,=,,10.0,-8.333,,,[125]secretin (radioligand),40.107430617726045,0.0,,0.0,,P47872,0.4763930351614956
90,22964305,sctr_human,361,S,C,secretin,PubChem CID,16129665,Full agonist,EC50,Functional - cAMP accumulation,0.02,nM,=,,0.05,-2.5,,,secretin,0.0,0.0,,98.94179894179894,secretin,P47872,0.4632055987575909
91,22964305,sctr_human,361,S,C,secretin,PubChem CID,16129665,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,1.2,nM,=,,12.3,-10.204,,,[125]secretin (radioligand),57.117278424350935,0.0,,0.0,,P47872,0.4632055987575909
96,22964305,sctr_human,364,D,C,secretin,PubChem CID,16129665,Full agonist,EC50,Functional - cAMP accumulation,0.02,nM,=,,0.06,-3.003,,,secretin,0.0,0.0,,95.76719576719576,secretin,P47872,0.3516975378105128
97,22964305,sctr_human,364,D,C,secretin,PubChem CID,16129665,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,1.2,nM,=,,9.2,-7.692,,,[125]secretin (radioligand),31.7905102954342,0.0,,0.0,,P47872,0.3516975378105128
98,22964305,sctr_human,365,A,C,secretin,PubChem CID,16129665,Full agonist,EC50,Functional - cAMP accumulation,0.02,nM,=,,0.06,-3.003,,,secretin,0.0,0.0,,105.8201058201058,secretin,P47872,0.2766701712846988
99,22964305,sctr_human,365,A,C,secretin,PubChem CID,16129665,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,1.2,nM,=,,5.2,-4.329,,,[125]secretin (radioligand),19.57923008057296,0.0,,0.0,,P47872,0.2766701712846988
104,22964305,sctr_human,368,I,C,secretin,PubChem CID,16129665,Full agonist,EC50,Functional - cAMP accumulation,0.02,nM,=,,0.1,-5.0,,,secretin,0.0,0.0,,106.87830687830689,secretin,P47872,0.3278198442354004
105,22964305,sctr_human,368,I,C,secretin,PubChem CID,16129665,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,1.2,nM,=,,5.0,-4.167,,,[125]secretin (radioligand),24.79856759176365,0.0,,0.0,,P47872,0.3278198442354004
110,22964305,sctr_human,371,F,C,secretin,PubChem CID,16129665,Full agonist,EC50,Functional - cAMP accumulation,0.02,nM,=,,0.03,-1.499,,,secretin,0.0,0.0,,89.94708994708994,secretin,P47872,0.4247483421328738
111,22964305,sctr_human,371,F,C,secretin,PubChem CID,16129665,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,1.2,nM,=,,3.7,-3.086,,,[125]secretin (radioligand),23.724261414503133,0.0,,0.0,,P47872,0.4247483421328738
112,22964305,sctr_human,372,F,C,secretin,PubChem CID,16129665,Full agonist,EC50,Functional - cAMP accumulation,0.02,nM,=,,0.2,-10.0,,,secretin,0.0,0.0,,89.41798941798942,secretin,P47872,0.4550615422353549
113,22964305,sctr_human,372,F,C,secretin,PubChem CID,16129665,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,1.2,nM,=,,11.0,-9.174,,,[125]secretin (radioligand),32.945389435989256,0.0,,0.0,,P47872,0.4550615422353549
3,12630808,calrl_human,212,C,A,adrenomedullin,UniProt Entry Code (peptide),ADM2_HUMAN,Full agonist,EC50,Functional - cAMP accumulation,1.6,nM,=,,68.0,-41.667,,,adrenomedullin 2,100.0,0.0,,0.0,,Q16602,0.8051145360993758
47,21703310,calrl_human,212,C,A,calcitonin gene-related peptide 1,UniProt Entry Code (peptide),CALCA_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,9.71,M,=,,8.78,-8.547,,,calcitonin gene-related peptide 1,0.0,0.0,,130.2,,Q16602,0.8051145360993758
48,21703310,calrl_human,212,C,A,calcitonin gene-related peptide 1,UniProt Entry Code (peptide),CALCA_HUMAN,Binding - unknown pharmacological activity,pIC50,Binding - Radioligand competition/displacement,9.04,M,=,,6.94,-125.0,,,calcitonin gene-related peptide 1,69.71,0.0,,0.0,,Q16602,0.8051145360993758
49,21703310,calrl_human,212,C,A,calcitonin gene-related peptide 1,UniProt Entry Code (peptide),CALCA_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,9.71,M,=,,8.78,-8.547,,,calcitonin gene-related peptide 1,0.0,-6.7,,0.0,,Q16602,0.8051145360993758
4,12630808,calrl_human,225,C,A,adrenomedullin,UniProt Entry Code (peptide),ADM2_HUMAN,Full agonist,EC50,Functional - cAMP accumulation,1.6,nM,=,,0.62,2.581,,,adrenomedullin 2,100.0,0.0,,0.0,,Q16602,0.4855714365272187
5,12630808,calrl_human,282,C,A,adrenomedullin,UniProt Entry Code (peptide),ADM2_HUMAN,Full agonist,EC50,Functional - cAMP accumulation,1.6,nM,=,,22.0,-13.699,,,adrenomedullin 2,100.0,0.0,,0.0,,Q16602,0.7911720962083896
6,15615699,calrl_human,263,P,A,calcitonin gene-related peptide 1,UniProt Entry Code (peptide),CALCA_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,9.15,M,=,,8.79,-2.288,,,calcitonin gene-related peptide 1,0.0,0.0,,97.0,,Q16602,0.7556278928271467
7,15615699,calrl_human,263,P,A,calcitonin gene-related peptide 1,UniProt Entry Code (peptide),CALCA_HUMAN,Binding - unknown pharmacological activity,pIC50,Binding - Radioligand competition/displacement,8.66,M,=,,8.8,1.38,,,[I125]calcitonin gene-related peptide 1,0.0,0.0,,0.0,,Q16602,0.7556278928271467
8,15615699,calrl_human,266,P,A,calcitonin gene-related peptide 1,UniProt Entry Code (peptide),CALCA_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,9.05,M,=,,9.01,-1.096,,,calcitonin gene-related peptide 1,0.0,0.0,,112.0,,Q16602,0.4577077861317374
9,15615699,calrl_human,266,P,A,calcitonin gene-related peptide 1,UniProt Entry Code (peptide),CALCA_HUMAN,Binding - unknown pharmacological activity,pIC50,Binding - Radioligand competition/displacement,8.31,M,=,,8.64,2.138,,,[I125]calcitonin gene-related peptide 1,0.0,0.0,,0.0,,Q16602,0.4577077861317374
10,15615699,calrl_human,297,P,A,calcitonin gene-related peptide 1,UniProt Entry Code (peptide),CALCA_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,9.8,M,=,,9.56,-1.739,,,calcitonin gene-related peptide 1,0.0,0.0,,97.0,,Q16602,0.5937399524265816
11,15615699,calrl_human,297,P,A,calcitonin gene-related peptide 1,UniProt Entry Code (peptide),CALCA_HUMAN,Binding - unknown pharmacological activity,pIC50,Binding - Radioligand competition/displacement,8.86,M,=,,8.91,1.122,,,[I125]calcitonin gene-related peptide 1,0.0,0.0,,0.0,,Q16602,0.5937399524265816
12,15615699,calrl_human,343,P,A,calcitonin gene-related peptide 1,UniProt Entry Code (peptide),CALCA_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,9.18,M,=,,6.86,-200.0,,,calcitonin gene-related peptide 1,0.0,0.0,,59.0,,Q16602,0.7045092735430263
13,15615699,calrl_human,343,P,A,calcitonin gene-related peptide 1,UniProt Entry Code (peptide),CALCA_HUMAN,Binding - unknown pharmacological activity,pIC50,Binding - Radioligand competition/displacement,8.84,M,=,,7.69,-14.085,,,[I125]calcitonin gene-related peptide 1,0.0,0.0,,0.0,,Q16602,0.7045092735430263
14,15615699,calrl_human,353,P,A,calcitonin gene-related peptide 1,UniProt Entry Code (peptide),CALCA_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,9.57,M,=,,8.54,-10.753,,,calcitonin gene-related peptide 1,0.0,0.0,,121.0,,Q16602,0.4918666951300895
15,15615699,calrl_human,353,P,A,calcitonin gene-related peptide 1,UniProt Entry Code (peptide),CALCA_HUMAN,Binding - unknown pharmacological activity,pIC50,Binding - Radioligand competition/displacement,9.18,M,=,,8.65,-3.39,,,[I125]calcitonin gene-related peptide 1,0.0,0.0,,0.0,,Q16602,0.4918666951300895
79,21703310,calrl_human,353,P,A,calcitonin gene-related peptide 1,UniProt Entry Code (peptide),CALCA_HUMAN,Binding - unknown pharmacological activity,pIC50,Binding - Radioligand competition/displacement,9.18,M,=,,8.65,-3.39,,,calcitonin gene-related peptide 1,133.3,0.0,,0.0,,Q16602,0.4918666951300895
80,21703310,calrl_human,353,P,A,calcitonin gene-related peptide 1,UniProt Entry Code (peptide),CALCA_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,9.79,M,=,,9.06,-5.376,,,calcitonin gene-related peptide 1,133.3,0.0,,0.0,,Q16602,0.4918666951300895
17,21703310,calrl_human,194,H,A,calcitonin gene-related peptide 1,UniProt Entry Code (peptide),CALCA_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,9.97,M,=,,9.41,-3.636,,,calcitonin gene-related peptide 1,106.5,0.0,,0.0,,Q16602,0.4881066361975533
18,21703310,calrl_human,195,L,A,calcitonin gene-related peptide 1,UniProt Entry Code (peptide),CALCA_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,10.36,M,=,,8.87,-31.25,,,calcitonin gene-related peptide 1,92.7,0.0,,0.0,,Q16602,0.4493574844429305
19,21703310,calrl_human,196,T,A,calcitonin gene-related peptide 1,UniProt Entry Code (peptide),CALCA_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,9.73,M,=,,10.18,2.818,,,calcitonin gene-related peptide 1,96.0,0.0,,0.0,,Q16602,0.2281049075151792
21,21703310,calrl_human,198,V,A,calcitonin gene-related peptide 1,UniProt Entry Code (peptide),CALCA_HUMAN,Binding - unknown pharmacological activity,pIC50,Binding - Radioligand competition/displacement,8.86,M,=,,8.07,-6.173,,,calcitonin gene-related peptide 1,133.4,0.0,,0.0,,Q16602,0.3087533610527884
22,21703310,calrl_human,198,V,A,calcitonin gene-related peptide 1,UniProt Entry Code (peptide),CALCA_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,9.67,M,=,,8.87,-6.329,,,calcitonin gene-related peptide 1,133.4,0.0,,0.0,,Q16602,0.3087533610527884
23,21703310,calrl_human,199,A,L,calcitonin gene-related peptide 1,UniProt Entry Code (peptide),CALCA_HUMAN,Binding - unknown pharmacological activity,pIC50,Binding - Radioligand competition/displacement,8.88,M,=,,7.26,-41.667,,,calcitonin gene-related peptide 1,130.2,0.0,,0.0,,Q16602,0.2809143306229279
24,21703310,calrl_human,199,A,L,calcitonin gene-related peptide 1,UniProt Entry Code (peptide),CALCA_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,10.2,M,=,,8.87,-21.277,,,calcitonin gene-related peptide 1,130.2,0.0,,0.0,,Q16602,0.2809143306229279
27,21703310,calrl_human,202,Q,A,calcitonin gene-related peptide 1,UniProt Entry Code (peptide),CALCA_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,9.49,M,=,,9.17,-2.088,,,calcitonin gene-related peptide 1,81.4,0.0,,0.0,,Q16602,0.2768730737597769
28,21703310,calrl_human,203,A,L,calcitonin gene-related peptide 1,UniProt Entry Code (peptide),CALCA_HUMAN,Binding - unknown pharmacological activity,pIC50,Binding - Radioligand competition/displacement,9.33,M,=,,9.77,2.754,,,calcitonin gene-related peptide 1,112.4,0.0,,0.0,,Q16602,0.2792960625042399
29,21703310,calrl_human,203,A,L,calcitonin gene-related peptide 1,UniProt Entry Code (peptide),CALCA_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,9.75,M,=,,10.77,10.471,,,calcitonin gene-related peptide 1,112.4,0.0,,0.0,,Q16602,0.2792960625042399
30,21703310,calrl_human,204,L,A,calcitonin gene-related peptide 1,UniProt Entry Code (peptide),CALCA_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,9.73,M,=,,9.68,-1.122,,,calcitonin gene-related peptide 1,0.0,0.0,,142.3,,Q16602,0.2788841224323571
31,21703310,calrl_human,204,L,A,calcitonin gene-related peptide 1,UniProt Entry Code (peptide),CALCA_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,9.73,M,=,,9.68,-1.122,,,calcitonin gene-related peptide 1,0.0,37.3,,0.0,,Q16602,0.2788841224323571
32,21703310,calrl_human,205,V,A,calcitonin gene-related peptide 1,UniProt Entry Code (peptide),CALCA_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,9.62,M,=,,10.04,2.63,,,calcitonin gene-related peptide 1,81.3,0.0,,0.0,,Q16602,0.255853299815701
33,21703310,calrl_human,206,A,L,calcitonin gene-related peptide 1,UniProt Entry Code (peptide),CALCA_HUMAN,Binding - unknown pharmacological activity,pIC50,Binding - Radioligand competition/displacement,9.0,M,,,9.19,1.549,,,calcitonin gene-related peptide 1,114.5,0.0,,0.0,,Q16602,0.2757175029631691
34,21703310,calrl_human,206,A,L,calcitonin gene-related peptide 1,UniProt Entry Code (peptide),CALCA_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,9.43,M,=,,10.37,8.71,,,calcitonin gene-related peptide 1,114.5,0.0,,0.0,,Q16602,0.2757175029631691
35,21703310,calrl_human,207,T,A,calcitonin gene-related peptide 1,UniProt Entry Code (peptide),CALCA_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,9.98,M,=,,10.5,3.311,,,calcitonin gene-related peptide 1,0.0,0.0,,122.5,,Q16602,0.2321516466686086
36,21703310,calrl_human,207,T,A,calcitonin gene-related peptide 1,UniProt Entry Code (peptide),CALCA_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,9.98,M,=,,10.5,3.311,,,calcitonin gene-related peptide 1,0.0,0.4,,0.0,,Q16602,0.2321516466686086
39,21703310,calrl_human,209,P,A,calcitonin gene-related peptide 1,UniProt Entry Code (peptide),CALCA_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,9.85,M,=,,9.91,1.148,,,calcitonin gene-related peptide 1,133.0,0.0,,0.0,,Q16602,0.2973364903298192
40,21703310,calrl_human,209,P,A,calcitonin gene-related peptide 1,UniProt Entry Code (peptide),CALCA_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,9.85,M,=,,9.91,1.148,,,calcitonin gene-related peptide 1,0.0,0.0,,122.5,,Q16602,0.2973364903298192
41,21703310,calrl_human,209,P,A,calcitonin gene-related peptide 1,UniProt Entry Code (peptide),CALCA_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,9.85,M,=,,9.91,1.148,,,calcitonin gene-related peptide 1,0.0,41.5,,0.0,,Q16602,0.2973364903298192
42,21703310,calrl_human,210,V,A,calcitonin gene-related peptide 1,UniProt Entry Code (peptide),CALCA_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,9.95,M,=,,9.95,1.0,,,calcitonin gene-related peptide 1,0.0,0.0,,117.9,,Q16602,0.2399693253823161
43,21703310,calrl_human,210,V,A,calcitonin gene-related peptide 1,UniProt Entry Code (peptide),CALCA_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,9.95,M,=,,10.44,3.09,,,calcitonin gene-related peptide 1,111.9,0.0,,0.0,,Q16602,0.2399693253823161
44,21703310,calrl_human,210,V,A,calcitonin gene-related peptide 1,UniProt Entry Code (peptide),CALCA_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,9.95,M,=,,10.44,3.09,,,calcitonin gene-related peptide 1,0.0,33.7,,0.0,,Q16602,0.2399693253823161
45,21703310,calrl_human,211,S,A,calcitonin gene-related peptide 1,UniProt Entry Code (peptide),CALCA_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,9.49,M,=,,9.6,1.288,,,calcitonin gene-related peptide 1,92.62,0.0,,0.0,,Q16602,0.2352565926680651
46,21703310,calrl_human,211,S,A,calcitonin gene-related peptide 1,UniProt Entry Code (peptide),CALCA_HUMAN,Full agonist,EC50,Functional - cAMP accumulation,9.49,M,=,,9.6,-1.011,,,calcitonin gene-related peptide 1,92.62,0.0,,0.0,,Q16602,0.2352565926680651
50,21703310,calrl_human,213,K,A,calcitonin gene-related peptide 1,UniProt Entry Code (peptide),CALCA_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,9.49,M,=,,8.78,-5.128,,,calcitonin gene-related peptide 1,94.54,0.0,,0.0,,Q16602,0.448301338580152
51,21703310,calrl_human,214,V,A,calcitonin gene-related peptide 1,UniProt Entry Code (peptide),CALCA_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,9.83,M,=,,9.97,1.38,,,calcitonin gene-related peptide 1,88.17,0.0,,0.0,,Q16602,0.2706437884951461
52,21703310,calrl_human,215,S,A,calcitonin gene-related peptide 1,UniProt Entry Code (peptide),CALCA_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,9.39,M,=,,9.41,1.047,,,calcitonin gene-related peptide 1,101.6,0.0,,0.0,,Q16602,0.3904223087079708
53,21703310,calrl_human,216,Q,A,calcitonin gene-related peptide 1,UniProt Entry Code (peptide),CALCA_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,9.63,M,=,,9.94,2.042,,,calcitonin gene-related peptide 1,0.0,0.0,,144.0,,Q16602,0.5450916202571505
54,21703310,calrl_human,216,Q,A,calcitonin gene-related peptide 1,UniProt Entry Code (peptide),CALCA_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,9.63,M,=,,9.94,2.042,,,calcitonin gene-related peptide 1,107.3,0.0,,0.0,,Q16602,0.5450916202571505
55,21703310,calrl_human,216,Q,A,calcitonin gene-related peptide 1,UniProt Entry Code (peptide),CALCA_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,9.63,M,=,,9.94,2.042,,,calcitonin gene-related peptide 1,0.0,22.7,,0.0,,Q16602,0.5450916202571505
56,21703310,calrl_human,217,F,A,calcitonin gene-related peptide 1,UniProt Entry Code (peptide),CALCA_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,9.94,M,=,,9.37,-3.717,,,calcitonin gene-related peptide 1,72.78,0.0,,0.0,,Q16602,0.5353769786740942
57,21703310,calrl_human,218,I,A,calcitonin gene-related peptide 1,UniProt Entry Code (peptide),CALCA_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,9.27,M,=,,9.6,2.138,,,calcitonin gene-related peptide 1,73.05,0.0,,0.0,,Q16602,0.3716660030752505
58,21703310,calrl_human,219,H,A,calcitonin gene-related peptide 1,UniProt Entry Code (peptide),CALCA_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,9.41,M,=,,8.35,-11.494,,,calcitonin gene-related peptide 1,68.81,0.0,,0.0,,Q16602,0.5375428019957529
59,21703310,calrl_human,219,H,A,calcitonin gene-related peptide 1,UniProt Entry Code (peptide),CALCA_HUMAN,Binding - unknown pharmacological activity,pIC50,Binding - Radioligand competition/displacement,9.01,M,=,,7.91,-12.658,,,calcitonin gene-related peptide 1,68.81,0.0,,0.0,,Q16602,0.5375428019957529
60,21703310,calrl_human,220,L,A,calcitonin gene-related peptide 1,UniProt Entry Code (peptide),CALCA_HUMAN,Binding - unknown pharmacological activity,pIC50,Binding - Radioligand competition/displacement,9.36,M,=,,10.21,7.079,,,calcitonin gene-related peptide 1,79.21,0.0,,0.0,,Q16602,0.4998338975635798
61,21703310,calrl_human,220,L,A,calcitonin gene-related peptide 1,UniProt Entry Code (peptide),CALCA_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,9.53,M,=,,10.93,25.119,,,calcitonin gene-related peptide 1,79.21,0.0,,0.0,,Q16602,0.4998338975635798
62,21703310,calrl_human,221,Y,A,calcitonin gene-related peptide 1,UniProt Entry Code (peptide),CALCA_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,9.73,M,=,,9.01,-5.236,,,calcitonin gene-related peptide 1,107.3,0.0,,0.0,,Q16602,0.5773657199993114
63,21703310,calrl_human,222,L,A,calcitonin gene-related peptide 1,UniProt Entry Code (peptide),CALCA_HUMAN,Binding - unknown pharmacological activity,pIC50,Binding - Radioligand competition/displacement,9.84,M,=,,10.76,8.318,,,calcitonin gene-related peptide 1,94.33,0.0,,0.0,,Q16602,0.5055768510118888
64,21703310,calrl_human,222,L,A,calcitonin gene-related peptide 1,UniProt Entry Code (peptide),CALCA_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,9.95,M,=,,10.75,6.31,,,calcitonin gene-related peptide 1,94.33,0.0,,0.0,,Q16602,0.5055768510118888
65,21703310,calrl_human,223,M,A,calcitonin gene-related peptide 1,UniProt Entry Code (peptide),CALCA_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,9.71,M,=,,9.65,-1.148,,,calcitonin gene-related peptide 1,0.0,0.0,,128.8,,Q16602,0.4762464907292734
66,21703310,calrl_human,223,M,A,calcitonin gene-related peptide 1,UniProt Entry Code (peptide),CALCA_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,9.71,M,=,,9.65,-1.148,,,calcitonin gene-related peptide 1,58.97,0.0,,0.0,,Q16602,0.4762464907292734
67,21703310,calrl_human,223,M,A,calcitonin gene-related peptide 1,UniProt Entry Code (peptide),CALCA_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,9.71,M,=,,9.65,-1.148,,,calcitonin gene-related peptide 1,0.0,13.2,,0.0,,Q16602,0.4762464907292734
68,21703310,calrl_human,349,F,A,calcitonin gene-related peptide 1,UniProt Entry Code (peptide),CALCA_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,10.59,M,=,,10.72,1.349,,,calcitonin gene-related peptide 1,0.0,0.0,,122.1,,Q16602,0.5899456766812039
69,21703310,calrl_human,349,F,A,calcitonin gene-related peptide 1,UniProt Entry Code (peptide),CALCA_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,10.59,M,=,,10.72,1.349,,,calcitonin gene-related peptide 1,69.0,0.0,,0.0,,Q16602,0.5899456766812039
70,21703310,calrl_human,349,F,A,calcitonin gene-related peptide 1,UniProt Entry Code (peptide),CALCA_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,10.59,M,=,,10.72,1.349,,,calcitonin gene-related peptide 1,0.0,10.3,,0.0,,Q16602,0.5899456766812039
71,21703310,calrl_human,350,V,A,calcitonin gene-related peptide 1,UniProt Entry Code (peptide),CALCA_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,9.89,M,=,,9.74,-1.412,,,calcitonin gene-related peptide 1,0.0,0.0,,142.3,,Q16602,0.4096521173848709
72,21703310,calrl_human,350,V,A,calcitonin gene-related peptide 1,UniProt Entry Code (peptide),CALCA_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,9.89,M,=,,9.74,-1.412,,,calcitonin gene-related peptide 1,78.9,0.0,,0.0,,Q16602,0.4096521173848709
73,21703310,calrl_human,350,V,A,calcitonin gene-related peptide 1,UniProt Entry Code (peptide),CALCA_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,9.89,M,=,,9.74,-1.412,,,calcitonin gene-related peptide 1,0.0,19.3,,0.0,,Q16602,0.4096521173848709
74,21703310,calrl_human,351,L,A,calcitonin gene-related peptide 1,UniProt Entry Code (peptide),CALCA_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,9.36,M,=,,9.54,1.514,,,calcitonin gene-related peptide 1,27.2,0.0,,0.0,,Q16602,0.4845730072364874
76,21703310,calrl_human,352,I,A,calcitonin gene-related peptide 1,UniProt Entry Code (peptide),CALCA_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,10.0,M,=,,9.33,-4.673,,,calcitonin gene-related peptide 1,0.0,0.0,,121.1,,Q16602,0.4893619647130655
77,21703310,calrl_human,352,I,A,calcitonin gene-related peptide 1,UniProt Entry Code (peptide),CALCA_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,10.0,M,=,,9.33,-4.673,,,calcitonin gene-related peptide 1,70.5,0.0,,0.0,,Q16602,0.4893619647130655
78,21703310,calrl_human,352,I,A,calcitonin gene-related peptide 1,UniProt Entry Code (peptide),CALCA_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,10.0,M,=,,9.33,-4.673,,,calcitonin gene-related peptide 1,0.0,25.8,,0.0,,Q16602,0.4893619647130655
81,21703310,calrl_human,354,W,A,calcitonin gene-related peptide 1,UniProt Entry Code (peptide),CALCA_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,9.08,M,=,,8.91,-1.479,,,calcitonin gene-related peptide 1,88.1,0.0,,0.0,,Q16602,0.4663795871743498
82,21703310,calrl_human,354,W,A,calcitonin gene-related peptide 1,UniProt Entry Code (peptide),CALCA_HUMAN,Binding - unknown pharmacological activity,pIC50,Binding - Radioligand competition/displacement,9.01,M,=,,8.75,-1.818,,,calcitonin gene-related peptide 1,88.1,0.0,,0.0,,Q16602,0.4663795871743498
83,21703310,calrl_human,355,R,A,calcitonin gene-related peptide 1,UniProt Entry Code (peptide),CALCA_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,9.86,M,=,,9.55,-2.041,,,calcitonin gene-related peptide 1,0.0,0.0,,151.5,,Q16602,0.4390584424627483
84,21703310,calrl_human,355,R,A,calcitonin gene-related peptide 1,UniProt Entry Code (peptide),CALCA_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,9.86,M,=,,9.55,-2.041,,,calcitonin gene-related peptide 1,66.2,0.0,,0.0,,Q16602,0.4390584424627483
85,21703310,calrl_human,355,R,A,calcitonin gene-related peptide 1,UniProt Entry Code (peptide),CALCA_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,9.86,M,=,,9.55,-2.041,,,calcitonin gene-related peptide 1,0.0,39.7,,0.0,,Q16602,0.4390584424627483
86,21703310,calrl_human,356,P,A,calcitonin gene-related peptide 1,UniProt Entry Code (peptide),CALCA_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,10.39,M,=,,9.95,-2.755,,,calcitonin gene-related peptide 1,85.0,0.0,,0.0,,Q16602,0.3835106839094491
87,21703310,calrl_human,357,E,A,calcitonin gene-related peptide 1,UniProt Entry Code (peptide),CALCA_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,10.44,M,=,,8.92,-33.333,,,calcitonin gene-related peptide 1,11.0,0.0,,0.0,,Q16602,0.2856149339164952
89,21703310,calrl_human,358,G,A,calcitonin gene-related peptide 1,UniProt Entry Code (peptide),CALCA_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,9.68,M,=,,9.46,-1.658,,,calcitonin gene-related peptide 1,61.4,0.0,,0.0,,Q16602,0.2823198096566413
90,21703310,calrl_human,359,K,A,calcitonin gene-related peptide 1,UniProt Entry Code (peptide),CALCA_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,9.76,M,=,,9.94,1.514,,,calcitonin gene-related peptide 1,0.0,12.6,,0.0,,Q16602,0.2862452123444314
91,21703310,calrl_human,359,K,A,calcitonin gene-related peptide 1,UniProt Entry Code (peptide),CALCA_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,9.76,M,=,,9.94,1.514,,,calcitonin gene-related peptide 1,0.0,0.0,,121.7,,Q16602,0.2862452123444314
92,21703310,calrl_human,359,K,A,calcitonin gene-related peptide 1,UniProt Entry Code (peptide),CALCA_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,9.76,M,=,,9.94,1.514,,,calcitonin gene-related peptide 1,71.8,0.0,,0.0,,Q16602,0.2862452123444314
93,21703310,calrl_human,360,I,A,calcitonin gene-related peptide 1,UniProt Entry Code (peptide),CALCA_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,9.26,M,=,,8.4,-7.246,,,calcitonin gene-related peptide 1,107.7,0.0,,0.0,,Q16602,0.282395901962904
94,21703310,calrl_human,360,I,L,calcitonin gene-related peptide 1,UniProt Entry Code (peptide),CALCA_HUMAN,Binding - unknown pharmacological activity,pIC50,Binding - Radioligand competition/displacement,8.77,M,=,,7.83,-8.696,,,calcitonin gene-related peptide 1,107.7,0.0,,0.0,,Q16602,0.1865037926161087
98,21703310,calrl_human,362,E,A,calcitonin gene-related peptide 1,UniProt Entry Code (peptide),CALCA_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,9.7,M,=,,9.65,-1.122,,,calcitonin gene-related peptide 1,83.8,0.0,,0.0,,Q16602,0.3884008079410883
99,21703310,calrl_human,362,E,A,calcitonin gene-related peptide 1,UniProt Entry Code (peptide),CALCA_HUMAN,Binding - unknown pharmacological activity,pIC50,Binding - Radioligand competition/displacement,9.05,M,=,,8.74,-2.041,,,calcitonin gene-related peptide 1,83.8,0.0,,0.0,,Q16602,0.3884008079410883
100,21703310,calrl_human,363,E,A,calcitonin gene-related peptide 1,UniProt Entry Code (peptide),CALCA_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,10.32,M,=,,9.8,-3.311,,,calcitonin gene-related peptide 1,0.0,0.0,,127.5,,Q16602,0.331278358245836
101,21703310,calrl_human,363,E,A,calcitonin gene-related peptide 1,UniProt Entry Code (peptide),CALCA_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,10.32,M,=,,9.8,-3.311,,,calcitonin gene-related peptide 1,89.6,0.0,,0.0,,Q16602,0.331278358245836
102,21703310,calrl_human,363,E,A,calcitonin gene-related peptide 1,UniProt Entry Code (peptide),CALCA_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,10.32,M,=,,9.8,-3.311,,,calcitonin gene-related peptide 1,0.0,7.6,,0.0,,Q16602,0.331278358245836
103,21703310,calrl_human,364,V,A,calcitonin gene-related peptide 1,UniProt Entry Code (peptide),CALCA_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,9.78,M,=,,9.94,1.445,,,calcitonin gene-related peptide 1,135.3,0.0,,0.0,,Q16602,0.285700919126926
104,21703310,calrl_human,365,Y,A,calcitonin gene-related peptide 1,UniProt Entry Code (peptide),CALCA_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,10.2,M,=,,10.33,1.349,,,calcitonin gene-related peptide 1,0.0,0.0,,119.7,,Q16602,0.5013136871922915
105,21703310,calrl_human,365,Y,A,calcitonin gene-related peptide 1,UniProt Entry Code (peptide),CALCA_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,10.2,M,=,,10.33,1.349,,,calcitonin gene-related peptide 1,60.0,0.0,,0.0,,Q16602,0.5013136871922915
106,21703310,calrl_human,365,Y,A,calcitonin gene-related peptide 1,UniProt Entry Code (peptide),CALCA_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,10.2,M,=,,10.33,1.349,,,calcitonin gene-related peptide 1,0.0,22.5,,0.0,,Q16602,0.5013136871922915
107,21703310,calrl_human,366,D,A,calcitonin gene-related peptide 1,UniProt Entry Code (peptide),CALCA_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,9.54,M,=,,9.72,1.514,,,calcitonin gene-related peptide 1,85.9,0.0,,0.0,,Q16602,0.5051610746932471
108,21703310,calrl_human,367,Y,A,calcitonin gene-related peptide 1,UniProt Entry Code (peptide),CALCA_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,9.92,M,=,,9.64,-1.905,,,calcitonin gene-related peptide 1,0.0,0.0,,123.2,,Q16602,0.4978750029185348
109,21703310,calrl_human,367,Y,A,calcitonin gene-related peptide 1,UniProt Entry Code (peptide),CALCA_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,9.64,M,=,,9.92,1.905,,,calcitonin gene-related peptide 1,56.6,0.0,,0.0,,Q16602,0.4978750029185348
110,21703310,calrl_human,367,Y,A,calcitonin gene-related peptide 1,UniProt Entry Code (peptide),CALCA_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,9.64,M,=,,9.92,1.905,,,calcitonin gene-related peptide 1,0.0,16.9,,0.0,,Q16602,0.4978750029185348
111,21703310,calrl_human,368,I,A,calcitonin gene-related peptide 1,UniProt Entry Code (peptide),CALCA_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,10.13,M,=,,10.3,1.479,,,calcitonin gene-related peptide 1,129.0,0.0,,0.0,,Q16602,0.3755917697295053
112,21703310,calrl_human,369,M,A,calcitonin gene-related peptide 1,UniProt Entry Code (peptide),CALCA_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,9.92,M,=,,10.53,4.074,,,calcitonin gene-related peptide 1,0.0,0.0,,139.5,,Q16602,0.4938831778056188
113,21703310,calrl_human,369,M,A,calcitonin gene-related peptide 1,UniProt Entry Code (peptide),CALCA_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,9.92,M,=,,10.53,4.074,,,calcitonin gene-related peptide 1,99.9,0.0,,0.0,,Q16602,0.4938831778056188
114,21703310,calrl_human,369,M,A,calcitonin gene-related peptide 1,UniProt Entry Code (peptide),CALCA_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,9.92,M,=,,10.53,4.074,,,calcitonin gene-related peptide 1,0.0,19.2,,0.0,,Q16602,0.4938831778056188
115,21703310,calrl_human,370,H,A,calcitonin gene-related peptide 1,UniProt Entry Code (peptide),CALCA_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,9.42,M,=,,9.19,-1.698,,,calcitonin gene-related peptide 1,141.1,0.0,,0.0,,Q16602,0.5632945341180086
116,21703310,calrl_human,371,I,A,calcitonin gene-related peptide 1,UniProt Entry Code (peptide),CALCA_HUMAN,Binding - unknown pharmacological activity,pIC50,Binding - Radioligand competition/displacement,9.84,M,=,,10.16,2.089,,,calcitonin gene-related peptide 1,70.5,0.0,,0.0,,Q16602,0.435198623382761
117,21703310,calrl_human,371,I,A,calcitonin gene-related peptide 1,UniProt Entry Code (peptide),CALCA_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,9.96,M,=,,10.18,1.66,,,calcitonin gene-related peptide 1,70.5,0.0,,0.0,,Q16602,0.435198623382761
118,21703310,calrl_human,372,L,A,calcitonin gene-related peptide 1,UniProt Entry Code (peptide),CALCA_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,9.93,M,=,,10.08,1.413,,,calcitonin gene-related peptide 1,102.3,0.0,,0.0,,Q16602,0.5067984412933143
119,21703310,calrl_human,372,L,A,calcitonin gene-related peptide 1,UniProt Entry Code (peptide),CALCA_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,9.93,M,=,,10.08,1.413,,,calcitonin gene-related peptide 1,102.3,0.0,,0.0,,Q16602,0.5067984412933143
120,21703310,calrl_human,373,M,A,calcitonin gene-related peptide 1,UniProt Entry Code (peptide),CALCA_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,10.21,M,=,,10.51,1.995,,,calcitonin gene-related peptide 1,0.0,0.0,,0.0,,Q16602,0.5136955451042848
121,24199627,calrl_human,32,I,A,adrenomedullin,UniProt Entry Code (peptide),ADML_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,9.54,M,=,,9.36,-1.513,,,adrenomedullin,0.0,0.0,,135.2,,Q16602,0.3189280457519222
122,24199627,calrl_human,32,I,A,adrenomedullin,UniProt Entry Code (peptide),ADML_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,9.07,M,=,,9.21,1.38,,,adrenomedullin,0.0,0.0,,133.9,,Q16602,0.3189280457519222
123,24199627,calrl_human,32,I,A,adrenomedullin,UniProt Entry Code (peptide),ADM2_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,9.83,M,=,,9.47,-2.288,,,adrenomedullin 2,0.0,0.0,,129.3,,Q16602,0.3189280457519222
124,24199627,calrl_human,32,I,A,adrenomedullin,UniProt Entry Code (peptide),ADM2_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,8.23,M,=,,8.24,1.023,,,adrenomedullin 2,0.0,0.0,,110.7,,Q16602,0.3189280457519222
125,24199627,calrl_human,32,I,A,calcitonin gene-related peptide 1,UniProt Entry Code (peptide),CALCA_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,7.2,M,=,,7.33,1.349,,,calcitonin gene-related peptide 1,0.0,0.0,,72.7,,Q16602,0.3189280457519222
126,24199627,calrl_human,33,Q,A,adrenomedullin,UniProt Entry Code (peptide),ADM2_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,8.12,M,=,,7.89,-1.698,,,adrenomedullin 2,0.0,0.0,,281.0,,Q16602,0.3511419950640069
127,24199627,calrl_human,33,Q,A,adrenomedullin,UniProt Entry Code (peptide),ADML_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,9.06,M,=,,9.15,1.23,,,adrenomedullin,0.0,0.0,,269.4,,Q16602,0.3511419950640069
128,24199627,calrl_human,33,Q,A,adrenomedullin,UniProt Entry Code (peptide),ADM2_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,8.59,M,=,,8.56,-1.072,,,adrenomedullin 2,0.0,0.0,,155.2,,Q16602,0.3511419950640069
129,24199627,calrl_human,33,Q,A,adrenomedullin,UniProt Entry Code (peptide),ADML_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,9.46,M,=,,9.61,1.413,,,adrenomedullin,0.0,0.0,,127.2,,Q16602,0.3511419950640069
130,24199627,calrl_human,33,Q,A,calcitonin gene-related peptide 1,UniProt Entry Code (peptide),CALCA_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,7.68,M,=,,7.42,-1.818,,,calcitonin gene-related peptide 1,0.0,0.0,,196.6,,Q16602,0.3511419950640069
131,24199627,calrl_human,34,L,A,adrenomedullin,UniProt Entry Code (peptide),ADML_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,9.59,M,=,,8.88,-5.128,,,adrenomedullin,0.0,0.0,,139.5,,Q16602,0.3324095160927193
132,24199627,calrl_human,34,L,A,adrenomedullin,UniProt Entry Code (peptide),ADM2_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,8.25,M,=,,7.64,-4.082,,,adrenomedullin 2,0.0,0.0,,117.9,,Q16602,0.3324095160927193
133,24199627,calrl_human,34,L,A,adrenomedullin,UniProt Entry Code (peptide),ADML_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,8.89,M,=,,8.5,-2.457,,,adrenomedullin,0.0,0.0,,104.7,,Q16602,0.3324095160927193
134,24199627,calrl_human,34,L,A,adrenomedullin,UniProt Entry Code (peptide),ADM2_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,9.42,M,=,,9.13,-1.949,,,adrenomedullin 2,0.0,0.0,,104.5,,Q16602,0.3324095160927193
135,24199627,calrl_human,34,L,A,calcitonin gene-related peptide 1,UniProt Entry Code (peptide),CALCA_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,7.13,M,=,,7.24,1.288,,,calcitonin gene-related peptide 1,0.0,0.0,,99.8,,Q16602,0.3324095160927193
136,24199627,calrl_human,35,G,A,adrenomedullin,UniProt Entry Code (peptide),ADML_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,9.07,M,=,,8.91,-1.445,,,adrenomedullin,0.0,0.0,,139.9,,Q16602,0.2928220566146821
137,24199627,calrl_human,35,G,A,adrenomedullin,UniProt Entry Code (peptide),ADM2_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,9.09,M,=,,8.78,-2.041,,,adrenomedullin 2,0.0,0.0,,97.9,,Q16602,0.2928220566146821
138,24199627,calrl_human,35,G,A,adrenomedullin,UniProt Entry Code (peptide),ADM2_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,8.22,M,=,,7.92,-1.996,,,adrenomedullin 2,0.0,0.0,,92.9,,Q16602,0.2928220566146821
139,24199627,calrl_human,35,G,A,adrenomedullin,UniProt Entry Code (peptide),ADML_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,9.29,M,=,,8.77,-3.311,,,adrenomedullin,0.0,0.0,,71.0,,Q16602,0.2928220566146821
140,24199627,calrl_human,35,G,A,calcitonin gene-related peptide 1,UniProt Entry Code (peptide),CALCA_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,7.15,M,=,,6.5,-4.464,,,calcitonin gene-related peptide 1,0.0,0.0,,53.3,,Q16602,0.2928220566146821
141,24199627,calrl_human,36,V,A,adrenomedullin,UniProt Entry Code (peptide),ADM2_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,8.22,M,=,,7.89,-2.137,,,adrenomedullin 2,0.0,0.0,,153.9,,Q16602,0.2806716041676259
142,24199627,calrl_human,36,V,A,adrenomedullin,UniProt Entry Code (peptide),ADML_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,9.07,M,=,,8.92,-1.412,,,adrenomedullin,0.0,0.0,,138.2,,Q16602,0.2806716041676259
143,24199627,calrl_human,36,V,A,adrenomedullin,UniProt Entry Code (peptide),ADM2_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,9.09,M,=,,8.62,-2.95,,,adrenomedullin 2,0.0,0.0,,121.0,,Q16602,0.2806716041676259
144,24199627,calrl_human,36,V,A,adrenomedullin,UniProt Entry Code (peptide),ADML_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,9.29,M,=,,9.06,-1.698,,,adrenomedullin,0.0,0.0,,89.9,,Q16602,0.2806716041676259
145,24199627,calrl_human,36,V,A,calcitonin gene-related peptide 1,UniProt Entry Code (peptide),CALCA_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,7.16,M,=,,6.91,-1.779,,,calcitonin gene-related peptide 1,0.0,0.0,,70.5,,Q16602,0.2806716041676259
146,24199627,calrl_human,37,T,A,adrenomedullin,UniProt Entry Code (peptide),ADML_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,9.61,M,=,,8.63,-9.524,,,adrenomedullin,0.0,0.0,,90.1,,Q16602,0.348184393764594
147,24199627,calrl_human,37,T,A,adrenomedullin,UniProt Entry Code (peptide),ADML_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,8.94,M,=,,8.25,-4.902,,,adrenomedullin,0.0,0.0,,89.0,,Q16602,0.348184393764594
148,24199627,calrl_human,37,T,A,adrenomedullin,UniProt Entry Code (peptide),ADM2_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,8.12,M,=,,6.99,-13.514,,,adrenomedullin 2,0.0,0.0,,70.6,,Q16602,0.348184393764594
149,24199627,calrl_human,37,T,A,adrenomedullin,UniProt Entry Code (peptide),ADM2_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,9.13,M,=,,7.7,-27.027,,,adrenomedullin 2,0.0,0.0,,68.5,,Q16602,0.348184393764594
150,24199627,calrl_human,37,T,A,calcitonin gene-related peptide 1,UniProt Entry Code (peptide),CALCA_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,7.21,M,=,,7.17,-1.096,,,calcitonin gene-related peptide 1,0.0,0.0,,59.1,,Q16602,0.348184393764594
151,24199627,calrl_human,41,I,A,adrenomedullin,UniProt Entry Code (peptide),ADM2_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,9.32,M,=,,8.47,-7.092,,,adrenomedullin 2,0.0,0.0,,87.4,,Q16602,0.4253618074574593
152,24199627,calrl_human,41,I,A,adrenomedullin,UniProt Entry Code (peptide),ADML_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,9.8,M,=,,8.51,-19.608,,,adrenomedullin,0.0,0.0,,77.6,,Q16602,0.4253618074574593
153,24199627,calrl_human,41,I,A,adrenomedullin,UniProt Entry Code (peptide),ADML_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,9.14,M,=,,7.91,-16.949,,,adrenomedullin,0.0,0.0,,33.7,,Q16602,0.4253618074574593
156,24199627,calrl_human,42,M,A,adrenomedullin,UniProt Entry Code (peptide),ADM2_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,8.82,M,=,,8.61,-1.621,,,adrenomedullin 2,0.0,0.0,,262.8,,Q16602,0.2970876453118092
157,24199627,calrl_human,42,M,A,adrenomedullin,UniProt Entry Code (peptide),ADML_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,9.66,M,=,,9.52,-1.381,,,adrenomedullin,0.0,0.0,,150.1,,Q16602,0.2970876453118092
158,24199627,calrl_human,42,M,A,adrenomedullin,UniProt Entry Code (peptide),ADML_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,9.11,M,=,,8.48,-4.274,,,adrenomedullin,0.0,0.0,,139.6,,Q16602,0.2970876453118092
159,24199627,calrl_human,42,M,A,adrenomedullin,UniProt Entry Code (peptide),ADM2_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,8.21,M,=,,7.86,-2.237,,,adrenomedullin 2,0.0,0.0,,89.9,,Q16602,0.2970876453118092
160,24199627,calrl_human,42,M,A,calcitonin gene-related peptide 1,UniProt Entry Code (peptide),CALCA_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,7.36,M,=,,7.33,-1.072,,,calcitonin gene-related peptide 1,0.0,0.0,,67.4,,Q16602,0.2970876453118092
161,24199627,calrl_human,45,Q,A,adrenomedullin,UniProt Entry Code (peptide),ADML_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,9.61,M,=,,9.4,-1.621,,,adrenomedullin,0.0,0.0,,138.3,,Q16602,0.4832895029377878
162,24199627,calrl_human,45,Q,A,adrenomedullin,UniProt Entry Code (peptide),ADM2_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,8.95,M,=,,8.94,-1.024,,,adrenomedullin 2,0.0,0.0,,104.6,,Q16602,0.4832895029377878
163,24199627,calrl_human,45,Q,A,adrenomedullin,UniProt Entry Code (peptide),ADML_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,9.03,M,=,,8.45,-3.802,,,adrenomedullin,0.0,0.0,,26.1,,Q16602,0.4832895029377878
165,24199627,calrl_human,45,Q,A,calcitonin gene-related peptide 1,UniProt Entry Code (peptide),CALCA_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,7.5,M,=,,7.21,-1.949,,,calcitonin gene-related peptide 1,0.0,0.0,,112.2,,Q16602,0.4832895029377878
166,24199627,calrl_human,52,I,A,adrenomedullin,UniProt Entry Code (peptide),ADML_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,9.05,M,=,,8.66,-2.457,,,adrenomedullin,0.0,0.0,,136.1,,Q16602,0.4037806503420096
167,24199627,calrl_human,52,I,A,adrenomedullin,UniProt Entry Code (peptide),ADML_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,9.55,M,=,,9.36,-1.548,,,adrenomedullin,0.0,0.0,,97.5,,Q16602,0.4037806503420096
168,24199627,calrl_human,52,I,A,adrenomedullin,UniProt Entry Code (peptide),ADM2_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,8.03,M,=,,8.11,1.202,,,adrenomedullin 2,0.0,0.0,,94.6,,Q16602,0.4037806503420096
169,24199627,calrl_human,52,I,A,adrenomedullin,UniProt Entry Code (peptide),ADM2_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,9.29,M,=,,9.12,-1.479,,,adrenomedullin 2,0.0,0.0,,71.8,,Q16602,0.4037806503420096
170,24199627,calrl_human,52,I,A,calcitonin gene-related peptide 1,UniProt Entry Code (peptide),CALCA_HUMAN,Full agonist,pEC50,Functional - cAMP accumulation,7.42,M,=,,6.91,-3.236,,,calcitonin gene-related peptide 1,0.0,0.0,,108.8,,Q16602,0.4037806503420096
1,20061446,gipr_human,183,R,A,GIP,PubChem CID,90488736,Binding - unknown pharmacological activity,EC50,Binding - Radioligand competition/displacement,1.96,nM,=,,149.7,-76.923,,,[125I]-GIP (radioligand),76.0,0.0,,0.0,,P48546,0.6145060027387654
2,20061446,gipr_human,190,R,A,GIP,PubChem CID,90488736,Binding - unknown pharmacological activity,EC50,Functional - cAMP accumulation,1.96,nM,=,,139.3,-71.429,,,[125I]-GIP (radioligand),85.0,0.0,,0.0,,P48546,0.5076849524414639
3,20061446,gipr_human,220,Q,A,GIP,PubChem CID,90488736,Binding - unknown pharmacological activity,EC50,Functional - cAMP accumulation,1.96,nM,=,,9.2,-4.695,,,[125I]-GIP (radioligand),110.0,0.0,,0.0,,P48546,0.546159767657522
4,20061446,gipr_human,223,T,A,GIP,PubChem CID,90488736,Binding - unknown pharmacological activity,EC50,Functional - cAMP accumulation,1.96,nM,=,,6.7,-3.413,,,[125I]-GIP (radioligand),116.0,0.0,,0.0,,P48546,0.4728926302746902
5,20061446,gipr_human,224,Q,A,GIP,PubChem CID,90488736,Binding - unknown pharmacological activity,EC50,Functional - cAMP accumulation,1.96,nM,=,,11.0,-5.618,,,[125I]-GIP (radioligand),77.0,0.0,,0.0,,P48546,0.5412938321280436
7,20061446,gipr_human,231,Y,A,GIP,PubChem CID,90488736,Binding - unknown pharmacological activity,EC50,Functional - cAMP accumulation,1.96,nM,=,,4.2,-2.141,,,[125I]-GIP (radioligand),103.0,0.0,,0.0,,P48546,0.6139046236389036
8,20061446,gipr_human,231,Y,F,GIP,PubChem CID,90488736,Binding - unknown pharmacological activity,EC50,Functional - cAMP accumulation,1.96,nM,=,,7.9,-4.032,,,[125I]-GIP (radioligand),96.0,0.0,,0.0,,P48546,0.3926674229154699
9,20061446,gipr_human,300,R,A,GIP,PubChem CID,90488736,Binding - unknown pharmacological activity,EC50,Functional - cAMP accumulation,1.96,nM,=,,82.3,-41.667,,,[125I]-GIP (radioligand),75.0,0.0,,0.0,,P48546,0.6046449034755479
10,20061446,gipr_human,353,H,A,GIP,PubChem CID,90488736,Binding - unknown pharmacological activity,EC50,Functional - cAMP accumulation,1.96,nM,=,,2.5,-1.276,,,[125I]-GIP (radioligand),97.0,0.0,,0.0,,P48546,0.575587685583021
11,20061446,gipr_human,357,F,A,GIP,PubChem CID,90488736,Binding - unknown pharmacological activity,EC50,Functional - cAMP accumulation,1.96,nM,=,,30.8,-15.625,,,[125I]-GIP (radioligand),77.0,0.0,,0.0,,P48546,0.553403745606343
12,20061446,gipr_human,384,Q,A,GIP,PubChem CID,90488736,,EC50,Functional - cAMP accumulation,1.96,nM,=,,5.2,-2.653,,,,115.0,0.0,,0.0,,P48546,0.8022869730649191
13,20061446,gipr_human,384,Q,A,GIP,PubChem CID,90488736,,EC50,Functional - cAMP accumulation,1.96,nM,=,,3.2,-1.634,,,,109.0,0.0,,0.0,,P48546,0.8022869730649191
14,20061446,gipr_human,392,Y,A,GIP,PubChem CID,90488736,,EC50,Functional - cAMP accumulation,1.96,nM,=,,9.5,-4.854,,,,90.0,0.0,,0.0,,P48546,0.7387318836549117
43,26043830,gipr_human,392,Y,A,GIP,PubChem CID,90488736,Full agonist,EC50,Functional - cAMP accumulation,0.49,nM,=,,1.46,-2.976,,,GIP,0.0,0.0,,100.0,,P48546,0.7387318836549117
44,26043830,gipr_human,392,Y,A,GIP,PubChem CID,90488736,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,6.01,nM,=,,1.2,5.008,,,[125I]GIP-(Tyr1Phe) (radioligand),37.6,0.0,,0.0,,P48546,0.7387318836549117
15,26043830,gipr_human,169,R,A,GIP,PubChem CID,90488736,Full agonist,EC50,Functional - cAMP accumulation,0.49,nM,=,,3.33,-6.803,,,GIP,0.0,0.0,,100.0,,P48546,0.7058528292381063
16,26043830,gipr_human,169,R,A,GIP,PubChem CID,90488736,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,6.01,nM,=,,7.2,-1.198,,,[125I]GIP-(Tyr1Phe) (radioligand),70.9,0.0,,0.0,,P48546,0.7058528292381063
17,26043830,gipr_human,173,H,N,GIP,PubChem CID,90488736,Full agonist,EC50,Functional - cAMP accumulation,0.49,nM,=,,2.01,-4.098,,,GIP,0.0,0.0,,79.0,,P48546,0.6550434064930736
18,26043830,gipr_human,173,H,N,GIP,PubChem CID,90488736,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,6.01,nM,=,,6.4,-1.065,,,[125I]GIP-(Tyr1Phe) (radioligand),48.2,0.0,,0.0,,P48546,0.6550434064930736
21,26043830,gipr_human,237,E,A,GIP,PubChem CID,90488736,Full agonist,EC50,Functional - cAMP accumulation,0.49,nM,=,,4.98,-10.204,,,GIP,0.0,0.0,,34.0,,P48546,0.8023632549842225
23,26043830,gipr_human,245,L,S,GIP,PubChem CID,90488736,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,6.01,nM,=,,0.85,7.071,,,[125I]GIP-(Tyr1Phe) (radioligand),105.9,0.0,,0.0,,P48546,0.5969095702576568
24,26043830,gipr_human,245,L,S,GIP,PubChem CID,90488736,Full agonist,EC50,Functional - cAMP accumulation,0.49,nM,=,,1.23,-2.513,,,GIP,0.0,0.0,,100.0,,P48546,0.5969095702576568
27,26043830,gipr_human,317,I,S,GIP,PubChem CID,90488736,Full agonist,EC50,Functional - cAMP accumulation,0.49,nM,=,,3.25,-6.623,,,GIP,0.0,0.0,,100.0,,P48546,0.6649915828262605
28,26043830,gipr_human,317,I,S,GIP,PubChem CID,90488736,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,6.01,nM,=,,3.0,2.003,,,[125I]GIP-(Tyr1Phe) (radioligand),55.7,0.0,,0.0,,P48546,0.6649915828262605
29,26043830,gipr_human,320,I,A,GIP,PubChem CID,90488736,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,6.01,nM,=,,4.12,1.459,,,[125I]GIP-(Tyr1Phe) (radioligand),176.9,0.0,,0.0,,P48546,0.5240196797056276
30,26043830,gipr_human,320,I,A,GIP,PubChem CID,90488736,Full agonist,EC50,Functional - cAMP accumulation,0.49,nM,=,,0.95,-1.938,,,GIP,0.0,0.0,,100.0,,P48546,0.5240196797056276
33,26043830,gipr_human,339,L,S,GIP,PubChem CID,90488736,Full agonist,EC50,Functional - cAMP accumulation,0.49,nM,=,,2.59,-5.291,,,GIP,0.0,0.0,,100.0,,P48546,0.6397222994915484
34,26043830,gipr_human,339,L,S,GIP,PubChem CID,90488736,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,6.01,nM,=,,1.43,4.203,,,[125I]GIP-(Tyr1Phe) (radioligand),23.4,0.0,,0.0,,P48546,0.6397222994915484
35,26043830,gipr_human,343,T,S,GIP,PubChem CID,90488736,Full agonist,EC50,Functional - cAMP accumulation,0.49,nM,=,,0.22,2.227,,,GIP,0.0,0.0,,100.0,,P48546,0.5513591786191275
37,26043830,gipr_human,343,T,S,GIP,PubChem CID,90488736,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,6.01,nM,=,,1.27,4.732,,,[125I]GIP-(Tyr1Phe) (radioligand),64.3,0.0,,0.0,,P48546,0.5513591786191275
36,26043830,gipr_human,343,T,A,GIP,PubChem CID,90488736,Full agonist,EC50,Functional - cAMP accumulation,0.49,nM,=,,0.08,6.125,,,GIP,0.0,0.0,,100.0,,P48546,0.5953471737461283
38,26043830,gipr_human,343,T,A,GIP,PubChem CID,90488736,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,6.01,nM,=,,0.9,6.678,,,[125I]GIP-(Tyr1Phe) (radioligand),57.3,0.0,,0.0,,P48546,0.5953471737461283
39,26043830,gipr_human,354,E,A,GIP,PubChem CID,90488736,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,6.01,nM,=,,2.23,2.695,,,[125I]GIP-(Tyr1Phe) (radioligand),134.8,0.0,,0.0,,P48546,0.6387909837251736
40,26043830,gipr_human,354,E,A,GIP,PubChem CID,90488736,Full agonist,EC50,Functional - cAMP accumulation,0.49,nM,=,,0.1,4.9,,,GIP,0.0,0.0,,100.0,,P48546,0.6387909837251736
41,26043830,gipr_human,381,S,A,GIP,PubChem CID,90488736,Full agonist,EC50,Functional - cAMP accumulation,0.49,nM,=,,0.3,1.633,,,GIP,0.0,0.0,,100.0,,P48546,0.4481893771979849
42,26043830,gipr_human,381,S,A,GIP,PubChem CID,90488736,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,6.01,nM,=,,3.33,1.805,,,[125I]GIP-(Tyr1Phe) (radioligand),57.1,0.0,,0.0,,P48546,0.4481893771979849
73,12947048,pth1r_human,232,L,A,[I125][M3]PTH(1â15) Aib-V-Aib-E-I-Q-L-Nle-H-Q-Har-A-K-W-Y*-NH2,PubChem CID,16129665,Binding - unknown pharmacological activity,Single-point,Binding - Radioligand saturation,100.0,%,=,,98.0,-1.02,,,[I125][M3]PTH(1â15) Aib-V-Aib-E-I-Q-L-Nle-H-Q-Har-A-K-W-Y*-NH2,100.0,0.0,,0.0,,Q03431,0.4013677768245839
74,12947048,pth1r_human,232,L,A,[I125][M3]PTH(1â21) Aib-V-Aib-E-I-Q-L-Nle-H-Q-Har-A-K-W-L-A-S-V-R-R-Y,,,Binding - unknown pharmacological activity,Single-point,Binding - Radioligand saturation,100.0,%,=,,96.0,-1.042,,,[I125][M3]PTH(1â21) Aib-V-Aib-E-I-Q-L-Nle-H-Q-Har-A-K-W-L-A-S-V-R-R-Y,100.0,0.0,,0.0,,Q03431,0.4013677768245839
75,12947048,pth1r_human,232,L,A,[I125]PTHrP[5-36],FASTA sequence (peptide),IQLLHDKGKSIQDLRRRFFLHHLIAEIHTAEY,Binding - unknown pharmacological activity,Single-point,Binding - Radioligand saturation,100.0,%,=,,97.0,-1.031,,,[125I]PTHrP[5-36] (radioligand),100.0,0.0,,0.0,,Q03431,0.4013677768245839
77,12947048,pth1r_human,233,R,A,[I125][M3]PTH(1â21) Aib-V-Aib-E-I-Q-L-Nle-H-Q-Har-A-K-W-L-A-S-V-R-R-Y,,,Binding - unknown pharmacological activity,Single-point,Binding - Radioligand saturation,100.0,%,=,,15.0,-6.667,,,[I125][M3]PTH(1â21) Aib-V-Aib-E-I-Q-L-Nle-H-Q-Har-A-K-W-L-A-S-V-R-R-Y,100.0,0.0,,0.0,,Q03431,0.6477116152313522
78,12947048,pth1r_human,233,R,A,[I125]PTHrP[5-36],FASTA sequence (peptide),IQLLHDKGKSIQDLRRRFFLHHLIAEIHTAEY,Binding - unknown pharmacological activity,Single-point,Binding - Radioligand saturation,100.0,%,=,,92.0,-1.087,,,[125I]PTHrP[5-36] (radioligand),100.0,0.0,,0.0,,Q03431,0.6477116152313522
80,12947048,pth1r_human,234,A,V,[I125][M3]PTH(1â21) Aib-V-Aib-E-I-Q-L-Nle-H-Q-Har-A-K-W-L-A-S-V-R-R-Y,,,Binding - unknown pharmacological activity,Single-point,Binding - Radioligand saturation,100.0,%,=,,20.0,-5.0,,,[I125][M3]PTH(1â21) Aib-V-Aib-E-I-Q-L-Nle-H-Q-Har-A-K-W-L-A-S-V-R-R-Y,100.0,0.0,,0.0,,Q03431,0.5342900993828288
81,12947048,pth1r_human,234,A,V,[I125]PTHrP[5-36],FASTA sequence (peptide),IQLLHDKGKSIQDLRRRFFLHHLIAEIHTAEY,Binding - unknown pharmacological activity,Single-point,Binding - Radioligand saturation,100.0,%,=,,76.0,-1.316,,,[125I]PTHrP[5-36] (radioligand),100.0,0.0,,0.0,,Q03431,0.5342900993828288
82,12947048,pth1r_human,235,V,A,[I125][M3]PTH(1â15) Aib-V-Aib-E-I-Q-L-Nle-H-Q-Har-A-K-W-Y*-NH2,PubChem CID,16129665,Binding - unknown pharmacological activity,Single-point,Binding - Radioligand saturation,100.0,%,=,,131.0,1.31,,,[I125][M3]PTH(1â15) Aib-V-Aib-E-I-Q-L-Nle-H-Q-Har-A-K-W-Y*-NH2,100.0,0.0,,0.0,,Q03431,0.2942076599583706
83,12947048,pth1r_human,235,V,A,[I125][M3]PTH(1â21) Aib-V-Aib-E-I-Q-L-Nle-H-Q-Har-A-K-W-L-A-S-V-R-R-Y,,,Binding - unknown pharmacological activity,Single-point,Binding - Radioligand saturation,100.0,%,=,,93.0,-1.075,,,[I125][M3]PTH(1â21) Aib-V-Aib-E-I-Q-L-Nle-H-Q-Har-A-K-W-L-A-S-V-R-R-Y,100.0,0.0,,0.0,,Q03431,0.2942076599583706
84,12947048,pth1r_human,235,V,A,[I125]PTHrP[5-36],FASTA sequence (peptide),IQLLHDKGKSIQDLRRRFFLHHLIAEIHTAEY,Binding - unknown pharmacological activity,Single-point,Binding - Radioligand saturation,100.0,%,=,,72.0,-1.389,,,[125I]PTHrP[5-36] (radioligand),100.0,0.0,,0.0,,Q03431,0.2942076599583706
85,12947048,pth1r_human,236,S,A,[I125][M]PTH(1â20) A-V-A-E-I-Q-L-M-H-Q-Har-A-K-W-L-N-S-M-E-R-NH2,,,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,850.0,nM,=,,920.0,-1.082,,,[I125][M3]PTH(1â15) Aib-V-Aib-E-I-Q-L-Nle-H-Q-Har-A-K-W-Y*-NH2,100.0,0.0,,0.0,,Q03431,0.4054824823806629
86,12947048,pth1r_human,236,S,A,[I125][M]PTH(1â20) A-V-A-E-I-Q-L-M-H-Q-Har-A-K-W-L-N-S-M-R-R-NH2,,,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,50.0,nM,=,,47.0,1.064,,,[I125][M3]PTH(1â15) Aib-V-Aib-E-I-Q-L-Nle-H-Q-Har-A-K-W-Y*-NH2,100.0,0.0,,0.0,,Q03431,0.4054824823806629
87,12947048,pth1r_human,236,S,A,[I125][M3]PTH(1â15) Aib-V-Aib-E-I-Q-L-Nle-H-Q-Har-A-K-W-Y*-NH2,PubChem CID,16129665,Binding - unknown pharmacological activity,Single-point,Binding - Radioligand saturation,100.0,%,=,,194.0,1.94,,,[I125][M3]PTH(1â15) Aib-V-Aib-E-I-Q-L-Nle-H-Q-Har-A-K-W-Y*-NH2,100.0,0.0,,0.0,,Q03431,0.4054824823806629
88,12947048,pth1r_human,236,S,A,[I125][M3]PTH(1â21) Aib-V-Aib-E-I-Q-L-Nle-H-Q-Har-A-K-W-L-A-S-V-R-R-Y,,,Binding - unknown pharmacological activity,Single-point,Binding - Radioligand saturation,100.0,%,=,,109.0,1.09,,,[I125][M3]PTH(1â21) Aib-V-Aib-E-I-Q-L-Nle-H-Q-Har-A-K-W-L-A-S-V-R-R-Y,100.0,0.0,,0.0,,Q03431,0.4054824823806629
89,12947048,pth1r_human,236,S,A,[I125]PTHrP[5-36],FASTA sequence (peptide),IQLLHDKGKSIQDLRRRFFLHHLIAEIHTAEY,Binding - unknown pharmacological activity,Single-point,Binding - Radioligand saturation,100.0,%,=,,89.0,-1.124,,,[125I]PTHrP[5-36] (radioligand),100.0,0.0,,0.0,,Q03431,0.4054824823806629
90,12947048,pth1r_human,237,I,A,[I125][M3]PTH(1â15) Aib-V-Aib-E-I-Q-L-Nle-H-Q-Har-A-K-W-Y*-NH2,PubChem CID,16129665,Binding - unknown pharmacological activity,Single-point,Binding - Radioligand saturation,100.0,%,=,,2.0,-50.0,,,[I125][M3]PTH(1â15) Aib-V-Aib-E-I-Q-L-Nle-H-Q-Har-A-K-W-Y*-NH2,100.0,0.0,,0.0,,Q03431,0.5278349593829537
91,12947048,pth1r_human,237,I,A,[I125][M3]PTH(1â21) Aib-V-Aib-E-I-Q-L-Nle-H-Q-Har-A-K-W-L-A-S-V-R-R-Y,,,Binding - unknown pharmacological activity,Single-point,Binding - Radioligand saturation,100.0,%,=,,47.0,-2.128,,,[I125][M3]PTH(1â21) Aib-V-Aib-E-I-Q-L-Nle-H-Q-Har-A-K-W-L-A-S-V-R-R-Y,100.0,0.0,,0.0,,Q03431,0.5278349593829537
92,12947048,pth1r_human,237,I,A,[I125]PTHrP[5-36],FASTA sequence (peptide),IQLLHDKGKSIQDLRRRFFLHHLIAEIHTAEY,Binding - unknown pharmacological activity,Single-point,Binding - Radioligand saturation,100.0,%,=,,68.0,-1.471,,,[125I]PTHrP[5-36] (radioligand),100.0,0.0,,0.0,,Q03431,0.5278349593829537
93,12947048,pth1r_human,238,F,A,[I125][M3]PTH(1â15) Aib-V-Aib-E-I-Q-L-Nle-H-Q-Har-A-K-W-Y*-NH2,PubChem CID,16129665,Binding - unknown pharmacological activity,Single-point,Binding - Radioligand saturation,100.0,%,=,,1.0,-100.0,,,[I125][M3]PTH(1â15) Aib-V-Aib-E-I-Q-L-Nle-H-Q-Har-A-K-W-Y*-NH2,100.0,0.0,,0.0,,Q03431,0.5091882884067657
94,12947048,pth1r_human,238,F,A,[I125][M3]PTH(1â21) Aib-V-Aib-E-I-Q-L-Nle-H-Q-Har-A-K-W-L-A-S-V-R-R-Y,,,Binding - unknown pharmacological activity,Single-point,Binding - Radioligand saturation,100.0,%,=,,30.0,-3.333,,,[I125][M3]PTH(1â21) Aib-V-Aib-E-I-Q-L-Nle-H-Q-Har-A-K-W-L-A-S-V-R-R-Y,100.0,0.0,,0.0,,Q03431,0.5091882884067657
95,12947048,pth1r_human,238,F,A,[I125]PTHrP[5-36],FASTA sequence (peptide),IQLLHDKGKSIQDLRRRFFLHHLIAEIHTAEY,Binding - unknown pharmacological activity,Single-point,Binding - Radioligand saturation,100.0,%,=,,66.0,-1.515,,,[125I]PTHrP[5-36] (radioligand),100.0,0.0,,0.0,,Q03431,0.5091882884067657
96,12947048,pth1r_human,239,V,A,[I125][M3]PTH(1â15) Aib-V-Aib-E-I-Q-L-Nle-H-Q-Har-A-K-W-Y*-NH2,PubChem CID,16129665,Binding - unknown pharmacological activity,Single-point,Binding - Radioligand saturation,100.0,%,=,,74.0,-1.351,,,[I125][M3]PTH(1â15) Aib-V-Aib-E-I-Q-L-Nle-H-Q-Har-A-K-W-Y*-NH2,100.0,0.0,,0.0,,Q03431,0.3250547100753903
97,12947048,pth1r_human,239,V,A,[I125][M3]PTH(1â21) Aib-V-Aib-E-I-Q-L-Nle-H-Q-Har-A-K-W-L-A-S-V-R-R-Y,,,Binding - unknown pharmacological activity,Single-point,Binding - Radioligand saturation,100.0,%,=,,89.0,-1.124,,,[I125][M3]PTH(1â21) Aib-V-Aib-E-I-Q-L-Nle-H-Q-Har-A-K-W-L-A-S-V-R-R-Y,100.0,0.0,,0.0,,Q03431,0.3250547100753903
98,12947048,pth1r_human,239,V,A,[I125]PTHrP[5-36],FASTA sequence (peptide),IQLLHDKGKSIQDLRRRFFLHHLIAEIHTAEY,Binding - unknown pharmacological activity,Single-point,Binding - Radioligand saturation,100.0,%,=,,87.0,-1.149,,,[125I]PTHrP[5-36] (radioligand),100.0,0.0,,0.0,,Q03431,0.3250547100753903
99,12947048,pth1r_human,240,K,A,[I125][M]PTH(1â20) A-V-A-E-I-Q-L-M-H-Q-Har-A-K-W-L-N-S-M-E-R-NH2,,,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,850.0,nM,=,,5500.0,-6.452,,,[I125][M3]PTH(1â15) Aib-V-Aib-E-I-Q-L-Nle-H-Q-Har-A-K-W-Y*-NH2,100.0,0.0,,0.0,,Q03431,0.5060991287653248
100,12947048,pth1r_human,240,K,A,[I125][M]PTH(1â20) A-V-A-E-I-Q-L-M-H-Q-Har-A-K-W-L-N-S-M-R-R-NH2,,,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,50.0,nM,=,,220.0,-4.405,,,[I125][M3]PTH(1â15) Aib-V-Aib-E-I-Q-L-Nle-H-Q-Har-A-K-W-Y*-NH2,100.0,0.0,,0.0,,Q03431,0.5060991287653248
101,12947048,pth1r_human,240,K,A,[I125][M3]PTH(1â15) Aib-V-Aib-E-I-Q-L-Nle-H-Q-Har-A-K-W-Y*-NH2,PubChem CID,16129665,Binding - unknown pharmacological activity,Single-point,Binding - Radioligand saturation,100.0,%,=,,145.0,1.45,,,[I125][M3]PTH(1â15) Aib-V-Aib-E-I-Q-L-Nle-H-Q-Har-A-K-W-Y*-NH2,100.0,0.0,,0.0,,Q03431,0.5060991287653248
102,12947048,pth1r_human,240,K,A,[I125][M3]PTH(1â21) Aib-V-Aib-E-I-Q-L-Nle-H-Q-Har-A-K-W-L-A-S-V-R-R-Y,,,Binding - unknown pharmacological activity,Single-point,Binding - Radioligand saturation,100.0,%,=,,59.0,-1.695,,,[I125][M3]PTH(1â21) Aib-V-Aib-E-I-Q-L-Nle-H-Q-Har-A-K-W-L-A-S-V-R-R-Y,100.0,0.0,,0.0,,Q03431,0.5060991287653248
103,12947048,pth1r_human,240,K,A,[I125]PTHrP[5-36],FASTA sequence (peptide),IQLLHDKGKSIQDLRRRFFLHHLIAEIHTAEY,Binding - unknown pharmacological activity,Single-point,Binding - Radioligand saturation,100.0,%,=,,101.0,1.01,,,[125I]PTHrP[5-36] (radioligand),100.0,0.0,,0.0,,Q03431,0.5060991287653248
104,12947048,pth1r_human,240,K,A,[M]PTH(1â14) A-V-A-E-I-Q-L-M-H-Q-Har-A-K-W-NH2,,,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20000.0,nM,=,,4500.0,4.444,,,[I125][M3]PTH(1â15) Aib-V-Aib-E-I-Q-L-Nle-H-Q-Har-A-K-W-Y*-NH2,100.0,0.0,,0.0,,Q03431,0.5060991287653248
105,12947048,pth1r_human,240,K,A,[M3]PTH(1â15) Aib-V-Aib-E-I-Q-L-Nle-H-Q-Har-A-K-W-Y*-NH2,,,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,61.0,nM,=,,360.0,-5.917,,,[I125][M3]PTH(1â15) Aib-V-Aib-E-I-Q-L-Nle-H-Q-Har-A-K-W-Y*-NH2,100.0,0.0,,0.0,,Q03431,0.5060991287653248
106,12947048,pth1r_human,240,K,A,[M3]PTH(1â19) Aib-V-Aib-E-I-Q-L-M-H-Q-Har-A-K-W-L-N-S-M-R-NH2,,,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,16.0,nM,=,,270.0,-16.949,,,[I125][M3]PTH(1â15) Aib-V-Aib-E-I-Q-L-Nle-H-Q-Har-A-K-W-Y*-NH2,100.0,0.0,,0.0,,Q03431,0.5060991287653248
0,12954060,ccr2_human,49,Y,F,[125I]-CCL2,UniProt Entry Code (peptide),P13500,Full agonist,pK(d),Binding - Radioligand saturation,10.18,,=,,10.01,-1.479,,,,76.98017059931317,0.0,,0.0,,P41597,0.3742823882021161
9,12954060,ccr2_human,49,Y,F,SB-282241,SMILES,OC1=CC=C(NC=C2C3CCN(CCCCCNC(/C=C/C4=CC(Cl)=C(Cl)C=C4)=O)CC3)C2=C1,Antagonist (neutral/silent),pK(i),Binding - Radioligand competition/displacement,7.0,,=,,7.78,6.026,,,radioligand: [125I]-CXCL2,76.98017059931317,0.0,,0.0,,P41597,0.3742823882021161
18,12954060,ccr2_human,49,Y,F,RS-504393,SMILES,CC1=CC=C(NC(OC23CCN(CCC4=C(C)OC(C5=CC=CC=C5)=N4)CC3)=O)C2=C1,Antagonist (neutral/silent),pK(i),Binding - Radioligand competition/displacement,6.66,,=,,7.23,3.715,,,radioligand: [125I]-CXCL2,76.98017059931317,0.0,,0.0,,P41597,0.3742823882021161
27,12954060,ccr2_human,49,Y,F,TAK-779 BASE,ChEMBL Compound ID,CHEMBL131243,Antagonist (neutral/silent),pK(i),Binding - Radioligand competition/displacement,7.16,,=,,6.82,-2.188,,,radioligand: [125I]-CXCL2,76.98017059931317,0.0,,0.0,,P41597,0.3742823882021161
36,12954060,ccr2_human,49,Y,F,TAK-779,ChEMBL Compound ID,CHEMBL1178786,Antagonist (neutral/silent),pK(i),Binding - Radioligand competition/displacement,8.16,,=,,7.56,-3.984,,,radioligand: [125I]-CXCL2,76.98017059931317,0.0,,0.0,,P41597,0.3742823882021161
45,12954060,ccr2_human,49,Y,F,Teijin,SMILES,O=C(NCC(N[C@@H]1CCN(CC2=CC=C(C)C=C2C)C1)=O)C3=CC=CC(C(F)(F)F)=C3,Antagonist (neutral/silent),pK(i),Binding - Radioligand competition/displacement,6.47,,=,,6.5,1.072,,,radioligand: [125I]-CXCL2,76.98017059931317,0.0,,0.0,,P41597,0.3742823882021161
74,15629146,ccr2_human,49,Y,F,CCL2_HUMAN,UniProt Entry Code (peptide),P13500,Full agonist,Kd,Binding - Radioligand competition/displacement,4.4,nM,=,,48.0,-10.87,,,125I-CCL2,100.0,0.0,,0.0,,P41597,0.3742823882021161
1,12954060,ccr2_human,120,Y,A,[125I]-CCL2,UniProt Entry Code (peptide),P13500,Full agonist,pK(d),Binding - Radioligand saturation,10.18,,=,,9.99,-1.548,,,,52.70854104353606,0.0,,0.0,,P41597,0.5431251488133904
10,12954060,ccr2_human,120,Y,A,SB-282241,SMILES,OC1=CC=C(NC=C2C3CCN(CCCCCNC(/C=C/C4=CC(Cl)=C(Cl)C=C4)=O)CC3)C2=C1,Antagonist (neutral/silent),pK(i),Binding - Radioligand competition/displacement,7.0,,=,,6.25,-5.618,,,radioligand: [125I]-CXCL2,52.70854104353606,0.0,,0.0,,P41597,0.5431251488133904
28,12954060,ccr2_human,120,Y,A,TAK-779 BASE,ChEMBL Compound ID,CHEMBL131243,Antagonist (neutral/silent),pK(i),Binding - Radioligand competition/displacement,7.16,,=,,5.59,-37.037,,,radioligand: [125I]-CXCL2,52.70854104353606,0.0,,0.0,,P41597,0.5431251488133904
37,12954060,ccr2_human,120,Y,A,TAK-779,ChEMBL Compound ID,CHEMBL1178786,Antagonist (neutral/silent),pK(i),Binding - Radioligand competition/displacement,8.16,,=,,6.98,-15.152,,,radioligand: [125I]-CXCL2,52.70854104353606,0.0,,0.0,,P41597,0.5431251488133904
46,12954060,ccr2_human,120,Y,A,Teijin,SMILES,O=C(NCC(N[C@@H]1CCN(CC2=CC=C(C)C=C2C)C1)=O)C3=CC=CC(C(F)(F)F)=C3,Antagonist (neutral/silent),pK(i),Binding - Radioligand competition/displacement,6.47,,=,,5.74,-5.376,,,radioligand: [125I]-CXCL2,52.70854104353606,0.0,,0.0,,P41597,0.5431251488133904
77,15629146,ccr2_human,120,Y,A,CCL2_HUMAN,UniProt Entry Code (peptide),P13500,Full agonist,Kd,Binding - Radioligand competition/displacement,4.4,nM,=,,6.7,-1.522,,,125I-CCL2,100.0,0.0,,0.0,,P41597,0.5431251488133904
2,12954060,ccr2_human,121,H,A,[125I]-CCL2,UniProt Entry Code (peptide),P13500,Full agonist,pK(d),Binding - Radioligand saturation,10.18,,=,,10.22,1.096,,,,110.60152874709206,0.0,,0.0,,P41597,0.4978100814848996
11,12954060,ccr2_human,121,H,A,SB-282241,SMILES,OC1=CC=C(NC=C2C3CCN(CCCCCNC(/C=C/C4=CC(Cl)=C(Cl)C=C4)=O)CC3)C2=C1,Antagonist (neutral/silent),pK(i),Binding - Radioligand competition/displacement,7.0,,=,,5.6,-25.0,,,radioligand: [125I]-CXCL2,110.60152874709206,0.0,,0.0,,P41597,0.4978100814848996
20,12954060,ccr2_human,121,H,A,RS-504393,SMILES,CC1=CC=C(NC(OC23CCN(CCC4=C(C)OC(C5=CC=CC=C5)=N4)CC3)=O)C2=C1,Antagonist (neutral/silent),pK(i),Binding - Radioligand competition/displacement,6.66,,=,,5.6,-11.494,,,radioligand: [125I]-CXCL2,110.60152874709206,0.0,,0.0,,P41597,0.4978100814848996
29,12954060,ccr2_human,121,H,A,TAK-779 BASE,ChEMBL Compound ID,CHEMBL131243,Antagonist (neutral/silent),pK(i),Binding - Radioligand competition/displacement,7.16,,=,,6.52,-4.367,,,radioligand: [125I]-CXCL2,110.60152874709206,0.0,,0.0,,P41597,0.4978100814848996
38,12954060,ccr2_human,121,H,A,TAK-779,ChEMBL Compound ID,CHEMBL1178786,Antagonist (neutral/silent),pK(i),Binding - Radioligand competition/displacement,8.16,,=,,7.75,-2.571,,,radioligand: [125I]-CXCL2,110.60152874709206,0.0,,0.0,,P41597,0.4978100814848996
47,12954060,ccr2_human,121,H,A,Teijin,SMILES,O=C(NCC(N[C@@H]1CCN(CC2=CC=C(C)C=C2C)C1)=O)C3=CC=CC(C(F)(F)F)=C3,Antagonist (neutral/silent),pK(i),Binding - Radioligand competition/displacement,6.47,,=,,5.59,-7.576,,,radioligand: [125I]-CXCL2,110.60152874709206,0.0,,0.0,,P41597,0.4978100814848996
57,19297521,ccr2_human,121,H,A,CCL2_HUMAN,UniProt Entry Code (peptide),P13500,Full agonist,IC50,Binding - Radioligand competition/displacement,9.6,nM,=,,4.18,2.297,,,125I-CCL2,85.0,0.0,,0.0,,P41597,0.4978100814848996
64,19297521,ccr2_human,121,H,A,TAK-779,ChEMBL Compound ID,CHEMBL1178786,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,49.3,nM,=,,19.9,2.477,,,125I-CCL2,85.0,0.0,,0.0,,P41597,0.4978100814848996
71,19297521,ccr2_human,121,H,A,Teijin,SMILES,O=C(NCC(N[C@@H]1CCN(CC2=CC=C(C)C=C2C)C1)=O)C3=CC=CC(C(F)(F)F)=C3,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,405.51,nM,=,,1127.2,-2.778,,,125I-CCL2,85.0,0.0,,0.0,,P41597,0.4978100814848996
89,19297521,ccr2_human,121,H,A,CCL2_HUMAN,UniProt Entry Code (peptide),P13500,Full agonist,IC50,Binding - Radioligand competition/displacement,9.6,nM,=,,4.18,2.297,,,125I-CCL2,85.0,0.0,,0.0,,P41597,0.4978100814848996
96,19297521,ccr2_human,121,H,A,TAK-779,ChEMBL Compound ID,CHEMBL1178786,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,49.3,nM,=,,19.9,2.477,,,125I-CCL2,85.0,0.0,,0.0,,P41597,0.4978100814848996
103,19297521,ccr2_human,121,H,A,Teijin,SMILES,O=C(NCC(N[C@@H]1CCN(CC2=CC=C(C)C=C2C)C1)=O)C3=CC=CC(C(F)(F)F)=C3,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,405.51,nM,=,,1127.2,-2.778,,,125I-CCL2,85.0,0.0,,0.0,,P41597,0.4978100814848996
3,12954060,ccr2_human,121,H,F,[125I]-CCL2,UniProt Entry Code (peptide),P13500,Full agonist,pK(d),Binding - Radioligand saturation,10.18,,=,,10.47,1.95,,,,56.419629998892205,0.0,,0.0,,P41597,0.4530269960079849
12,12954060,ccr2_human,121,H,F,SB-282241,SMILES,OC1=CC=C(NC=C2C3CCN(CCCCCNC(/C=C/C4=CC(Cl)=C(Cl)C=C4)=O)CC3)C2=C1,Antagonist (neutral/silent),pK(i),Binding - Radioligand competition/displacement,7.0,,=,,6.78,-1.658,,,radioligand: [125I]-CXCL2,56.419629998892205,0.0,,0.0,,P41597,0.4530269960079849
21,12954060,ccr2_human,121,H,F,RS-504393,SMILES,CC1=CC=C(NC(OC23CCN(CCC4=C(C)OC(C5=CC=CC=C5)=N4)CC3)=O)C2=C1,Antagonist (neutral/silent),pK(i),Binding - Radioligand competition/displacement,6.66,,=,,6.35,-2.041,,,radioligand: [125I]-CXCL2,56.419629998892205,0.0,,0.0,,P41597,0.4530269960079849
30,12954060,ccr2_human,121,H,F,TAK-779 BASE,ChEMBL Compound ID,CHEMBL131243,Antagonist (neutral/silent),pK(i),Binding - Radioligand competition/displacement,7.16,,=,,7.62,2.884,,,radioligand: [125I]-CXCL2,56.419629998892205,0.0,,0.0,,P41597,0.4530269960079849
39,12954060,ccr2_human,121,H,F,TAK-779,ChEMBL Compound ID,CHEMBL1178786,Antagonist (neutral/silent),pK(i),Binding - Radioligand competition/displacement,8.16,,=,,8.58,2.63,,,radioligand: [125I]-CXCL2,56.419629998892205,0.0,,0.0,,P41597,0.4530269960079849
48,12954060,ccr2_human,121,H,F,Teijin,SMILES,O=C(NCC(N[C@@H]1CCN(CC2=CC=C(C)C=C2C)C1)=O)C3=CC=CC(C(F)(F)F)=C3,Antagonist (neutral/silent),pK(i),Binding - Radioligand competition/displacement,6.47,,=,,6.18,-1.949,,,radioligand: [125I]-CXCL2,56.419629998892205,0.0,,0.0,,P41597,0.4530269960079849
4,12954060,ccr2_human,284,D,A,[125I]-CCL2,UniProt Entry Code (peptide),P13500,Full agonist,pK(d),Binding - Radioligand saturation,10.18,,=,,10.03,-1.412,,,,79.89365237620471,0.0,,0.0,,P41597,0.3279564407640781
13,12954060,ccr2_human,284,D,A,SB-282241,SMILES,OC1=CC=C(NC=C2C3CCN(CCCCCNC(/C=C/C4=CC(Cl)=C(Cl)C=C4)=O)CC3)C2=C1,Antagonist (neutral/silent),pK(i),Binding - Radioligand competition/displacement,7.0,,=,,6.64,-2.288,,,radioligand: [125I]-CXCL2,79.89365237620471,0.0,,0.0,,P41597,0.3279564407640781
22,12954060,ccr2_human,284,D,A,RS-504393,SMILES,CC1=CC=C(NC(OC23CCN(CCC4=C(C)OC(C5=CC=CC=C5)=N4)CC3)=O)C2=C1,Antagonist (neutral/silent),pK(i),Binding - Radioligand competition/displacement,6.66,,=,,6.07,-3.891,,,radioligand: [125I]-CXCL2,79.89365237620471,0.0,,0.0,,P41597,0.3279564407640781
31,12954060,ccr2_human,284,D,A,TAK-779 BASE,ChEMBL Compound ID,CHEMBL131243,Antagonist (neutral/silent),pK(i),Binding - Radioligand competition/displacement,7.16,,=,,6.23,-8.547,,,radioligand: [125I]-CXCL2,79.89365237620471,0.0,,0.0,,P41597,0.3279564407640781
40,12954060,ccr2_human,284,D,A,TAK-779,ChEMBL Compound ID,CHEMBL1178786,Antagonist (neutral/silent),pK(i),Binding - Radioligand competition/displacement,8.16,,=,,7.9,-1.818,,,radioligand: [125I]-CXCL2,79.89365237620471,0.0,,0.0,,P41597,0.3279564407640781
49,12954060,ccr2_human,284,D,A,Teijin,SMILES,O=C(NCC(N[C@@H]1CCN(CC2=CC=C(C)C=C2C)C1)=O)C3=CC=CC(C(F)(F)F)=C3,Antagonist (neutral/silent),pK(i),Binding - Radioligand competition/displacement,6.47,,=,,6.1,-2.342,,,radioligand: [125I]-CXCL2,79.89365237620471,0.0,,0.0,,P41597,0.3279564407640781
5,12954060,ccr2_human,288,Q,A,[125I]-CCL2,UniProt Entry Code (peptide),P13500,Full agonist,pK(d),Binding - Radioligand saturation,10.18,,=,,9.78,-2.513,,,,137.80879583471807,0.0,,0.0,,P41597,0.4611988810785589
14,12954060,ccr2_human,288,Q,A,SB-282241,SMILES,OC1=CC=C(NC=C2C3CCN(CCCCCNC(/C=C/C4=CC(Cl)=C(Cl)C=C4)=O)CC3)C2=C1,Antagonist (neutral/silent),pK(i),Binding - Radioligand competition/displacement,7.0,,=,,6.77,-1.698,,,radioligand: [125I]-CXCL2,137.80879583471807,0.0,,0.0,,P41597,0.4611988810785589
23,12954060,ccr2_human,288,Q,A,RS-504393,SMILES,CC1=CC=C(NC(OC23CCN(CCC4=C(C)OC(C5=CC=CC=C5)=N4)CC3)=O)C2=C1,Antagonist (neutral/silent),pK(i),Binding - Radioligand competition/displacement,6.66,,=,,6.76,1.259,,,radioligand: [125I]-CXCL2,137.80879583471807,0.0,,0.0,,P41597,0.4611988810785589
32,12954060,ccr2_human,288,Q,A,TAK-779 BASE,ChEMBL Compound ID,CHEMBL131243,Antagonist (neutral/silent),pK(i),Binding - Radioligand competition/displacement,7.16,,=,,6.64,-3.311,,,radioligand: [125I]-CXCL2,137.80879583471807,0.0,,0.0,,P41597,0.4611988810785589
41,12954060,ccr2_human,288,Q,A,TAK-779,ChEMBL Compound ID,CHEMBL1178786,Antagonist (neutral/silent),pK(i),Binding - Radioligand competition/displacement,8.16,,=,,8.01,-1.412,,,radioligand: [125I]-CXCL2,137.80879583471807,0.0,,0.0,,P41597,0.4611988810785589
50,12954060,ccr2_human,288,Q,A,Teijin,SMILES,O=C(NCC(N[C@@H]1CCN(CC2=CC=C(C)C=C2C)C1)=O)C3=CC=CC(C(F)(F)F)=C3,Antagonist (neutral/silent),pK(i),Binding - Radioligand competition/displacement,6.47,,=,,6.5,1.072,,,radioligand: [125I]-CXCL2,137.80879583471807,0.0,,0.0,,P41597,0.4611988810785589
6,12954060,ccr2_human,290,T,A,[125I]-CCL2,UniProt Entry Code (peptide),P13500,Full agonist,pK(d),Binding - Radioligand saturation,10.18,,=,,10.1,-1.202,,,,94.73800819762933,0.0,,0.0,,P41597,0.4430469153201968
15,12954060,ccr2_human,290,T,A,SB-282241,SMILES,OC1=CC=C(NC=C2C3CCN(CCCCCNC(/C=C/C4=CC(Cl)=C(Cl)C=C4)=O)CC3)C2=C1,Antagonist (neutral/silent),pK(i),Binding - Radioligand competition/displacement,7.0,,=,,6.89,-1.289,,,radioligand: [125I]-CXCL2,94.73800819762933,0.0,,0.0,,P41597,0.4430469153201968
24,12954060,ccr2_human,290,T,A,RS-504393,SMILES,CC1=CC=C(NC(OC23CCN(CCC4=C(C)OC(C5=CC=CC=C5)=N4)CC3)=O)C2=C1,Antagonist (neutral/silent),pK(i),Binding - Radioligand competition/displacement,6.66,,=,,6.28,-2.398,,,radioligand: [125I]-CXCL2,94.73800819762933,0.0,,0.0,,P41597,0.4430469153201968
33,12954060,ccr2_human,290,T,A,TAK-779 BASE,ChEMBL Compound ID,CHEMBL131243,Antagonist (neutral/silent),pK(i),Binding - Radioligand competition/displacement,7.16,,=,,6.98,-1.513,,,radioligand: [125I]-CXCL2,94.73800819762933,0.0,,0.0,,P41597,0.4430469153201968
42,12954060,ccr2_human,290,T,A,TAK-779,ChEMBL Compound ID,CHEMBL1178786,Antagonist (neutral/silent),pK(i),Binding - Radioligand competition/displacement,8.16,,=,,7.67,-3.086,,,radioligand: [125I]-CXCL2,94.73800819762933,0.0,,0.0,,P41597,0.4430469153201968
81,15629146,ccr2_human,290,T,A,CCL2_HUMAN,UniProt Entry Code (peptide),P13500,Full agonist,Kd,Binding - Radioligand competition/displacement,4.4,nM,=,,0.65,6.769,,,125I-CCL2,100.0,0.0,,0.0,,P41597,0.4430469153201968
7,12954060,ccr2_human,291,E,Q,[125I]-CCL2,UniProt Entry Code (peptide),P13500,Full agonist,pK(d),Binding - Radioligand saturation,10.18,,=,,9.02,-14.493,,,,104.02126952475903,0.0,,0.0,,P41597,0.3503625681423137
34,12954060,ccr2_human,291,E,Q,TAK-779 BASE,ChEMBL Compound ID,CHEMBL131243,Antagonist (neutral/silent),pK(i),Binding - Radioligand competition/displacement,7.16,,=,,5.69,-29.412,,,radioligand: [125I]-CXCL2,104.02126952475903,0.0,,0.0,,P41597,0.3503625681423137
43,12954060,ccr2_human,291,E,Q,TAK-779,ChEMBL Compound ID,CHEMBL1178786,Antagonist (neutral/silent),pK(i),Binding - Radioligand competition/displacement,8.16,,=,,6.83,-21.277,,,radioligand: [125I]-CXCL2,104.02126952475903,0.0,,0.0,,P41597,0.3503625681423137
8,12954060,ccr2_human,292,T,A,[125I]-CCL2,UniProt Entry Code (peptide),P13500,Full agonist,pK(d),Binding - Radioligand saturation,10.18,,=,,10.09,-1.23,,,,114.86651157638197,0.0,,0.0,,P41597,0.399761520935405
17,12954060,ccr2_human,292,T,A,SB-282241,SMILES,OC1=CC=C(NC=C2C3CCN(CCCCCNC(/C=C/C4=CC(Cl)=C(Cl)C=C4)=O)CC3)C2=C1,Antagonist (neutral/silent),pK(i),Binding - Radioligand competition/displacement,7.0,,=,,6.14,-7.246,,,radioligand: [125I]-CXCL2,114.86651157638197,0.0,,0.0,,P41597,0.399761520935405
26,12954060,ccr2_human,292,T,A,RS-504393,SMILES,CC1=CC=C(NC(OC23CCN(CCC4=C(C)OC(C5=CC=CC=C5)=N4)CC3)=O)C2=C1,Antagonist (neutral/silent),pK(i),Binding - Radioligand competition/displacement,6.66,,=,,5.2,-28.571,,,radioligand: [125I]-CXCL2,114.86651157638197,0.0,,0.0,,P41597,0.399761520935405
35,12954060,ccr2_human,292,T,A,TAK-779 BASE,ChEMBL Compound ID,CHEMBL131243,Antagonist (neutral/silent),pK(i),Binding - Radioligand competition/displacement,7.16,,=,,6.12,-10.989,,,radioligand: [125I]-CXCL2,114.86651157638197,0.0,,0.0,,P41597,0.399761520935405
44,12954060,ccr2_human,292,T,A,TAK-779,ChEMBL Compound ID,CHEMBL1178786,Antagonist (neutral/silent),pK(i),Binding - Radioligand competition/displacement,8.16,,=,,7.54,-4.167,,,radioligand: [125I]-CXCL2,114.86651157638197,0.0,,0.0,,P41597,0.399761520935405
53,12954060,ccr2_human,292,T,A,Teijin,SMILES,O=C(NCC(N[C@@H]1CCN(CC2=CC=C(C)C=C2C)C1)=O)C3=CC=CC(C(F)(F)F)=C3,Antagonist (neutral/silent),pK(i),Binding - Radioligand competition/displacement,6.47,,=,,5.11,-22.727,,,radioligand: [125I]-CXCL2,114.86651157638197,0.0,,0.0,,P41597,0.399761520935405
58,19297521,ccr2_human,263,I,A,CCL2_HUMAN,UniProt Entry Code (peptide),P13500,Full agonist,IC50,Binding - Radioligand competition/displacement,9.6,nM,=,,3.18,3.019,,,125I-CCL2,60.0,0.0,,0.0,,P41597,0.4409717118295875
65,19297521,ccr2_human,263,I,A,TAK-779,ChEMBL Compound ID,CHEMBL1178786,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,49.3,nM,=,,12.85,3.837,,,125I-CCL2,60.0,0.0,,0.0,,P41597,0.4409717118295875
72,19297521,ccr2_human,263,I,A,Teijin,SMILES,O=C(NCC(N[C@@H]1CCN(CC2=CC=C(C)C=C2C)C1)=O)C3=CC=CC(C(F)(F)F)=C3,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,405.51,nM,=,,787.05,-1.942,,,125I-CCL2,60.0,0.0,,0.0,,P41597,0.4409717118295875
90,19297521,ccr2_human,263,I,A,CCL2_HUMAN,UniProt Entry Code (peptide),P13500,Full agonist,IC50,Binding - Radioligand competition/displacement,9.6,nM,=,,3.18,3.019,,,125I-CCL2,60.0,0.0,,0.0,,P41597,0.4409717118295875
97,19297521,ccr2_human,263,I,A,TAK-779,ChEMBL Compound ID,CHEMBL1178786,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,49.3,nM,=,,12.85,3.837,,,125I-CCL2,60.0,0.0,,0.0,,P41597,0.4409717118295875
104,19297521,ccr2_human,263,I,A,Teijin,SMILES,O=C(NCC(N[C@@H]1CCN(CC2=CC=C(C)C=C2C)C1)=O)C3=CC=CC(C(F)(F)F)=C3,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,405.51,nM,=,,787.05,-1.942,,,125I-CCL2,60.0,0.0,,0.0,,P41597,0.4409717118295875
60,19297521,ccr2_human,292,T,V,CCL2_HUMAN,UniProt Entry Code (peptide),P13500,Full agonist,IC50,Binding - Radioligand competition/displacement,9.6,nM,=,,9.18,1.046,,,125I-CCL2,98.0,0.0,,0.0,,P41597,0.399761520935405
67,19297521,ccr2_human,292,T,V,TAK-779,ChEMBL Compound ID,CHEMBL1178786,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,49.3,nM,=,,663.74,-13.514,,,125I-CCL2,98.0,0.0,,0.0,,P41597,0.399761520935405
92,19297521,ccr2_human,292,T,V,CCL2_HUMAN,UniProt Entry Code (peptide),P13500,Full agonist,IC50,Binding - Radioligand competition/displacement,9.6,nM,=,,9.18,1.046,,,125I-CCL2,98.0,0.0,,0.0,,P41597,0.399761520935405
99,19297521,ccr2_human,292,T,V,TAK-779,ChEMBL Compound ID,CHEMBL1178786,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,49.3,nM,=,,663.74,-13.514,,,125I-CCL2,98.0,0.0,,0.0,,P41597,0.399761520935405
75,15629146,ccr2_human,95,L,A,CCL2_HUMAN,UniProt Entry Code (peptide),P13500,Full agonist,Kd,Binding - Radioligand competition/displacement,4.4,nM,=,,17.1,-3.891,,,125I-CCL2,100.0,0.0,,0.0,,P41597,0.5451470655116015
76,15629146,ccr2_human,117,T,A,CCL2_HUMAN,UniProt Entry Code (peptide),P13500,Full agonist,Kd,Binding - Radioligand competition/displacement,4.4,nM,=,,18.0,-4.098,,,125I-CCL2,100.0,0.0,,0.0,,P41597,0.3840728267932768
78,15629146,ccr2_human,278,E,A,CCL2_HUMAN,UniProt Entry Code (peptide),P13500,Full agonist,Kd,Binding - Radioligand competition/displacement,4.4,nM,=,,2.8,1.571,,,125I-CCL2,100.0,0.0,,0.0,,P41597,0.2588048522010649
79,15629146,ccr2_human,278,E,K,CCL2_HUMAN,UniProt Entry Code (peptide),P13500,Full agonist,Kd,Binding - Radioligand competition/displacement,4.4,nM,=,,0.74,5.946,,,125I-CCL2,100.0,0.0,,0.0,,P41597,0.1958825218714915
80,15629146,ccr2_human,286,A,V,CCL2_HUMAN,UniProt Entry Code (peptide),P13500,Full agonist,Kd,Binding - Radioligand competition/displacement,4.4,nM,=,,2.5,1.76,,,125I-CCL2,100.0,0.0,,0.0,,P41597,0.353637486737895
82,15629146,ccr2_human,291,E,A,CCL2_HUMAN,UniProt Entry Code (peptide),P13500,Full agonist,Kd,Binding - Radioligand competition/displacement,4.4,nM,=,,5.4,-1.227,,,125I-CCL2,100.0,0.0,,0.0,,P41597,0.480535580980036
84,15629146,ccr2_human,297,H,A,CCL2_HUMAN,UniProt Entry Code (peptide),P13500,Full agonist,Kd,Binding - Radioligand competition/displacement,4.4,nM,=,,1.3,3.385,,,125I-CCL2,100.0,0.0,,0.0,,P41597,0.5677115437753423
0,10.1038/nature12393,glr_human,30,D,L,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,17.0,1.176,,,[125I]-glucagon (radioligand),71.9,0.0,,0.0,,P47871,0.5137704310743649
257,23863937,glr_human,30,D,L,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,17.0,1.176,,,[125I]-glucagon (radioligand),71.9,0.0,,0.0,,P47871,0.5137704310743649
1,10.1038/nature12393,glr_human,31,F,W,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,13.2,1.515,,,[125I]-glucagon (radioligand),147.9,0.0,,0.0,,P47871,0.2432759492233236
258,23863937,glr_human,31,F,W,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,13.2,1.515,,,[125I]-glucagon (radioligand),147.9,0.0,,0.0,,P47871,0.2432759492233236
7,10.1038/nature12393,glr_human,122,Q,E,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,14.9,1.342,,,[125I]-glucagon (radioligand),56.7,0.0,,0.0,,P47871,0.2145991340625648
265,23863937,glr_human,122,Q,E,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,14.9,1.342,,,[125I]-glucagon (radioligand),56.7,0.0,,0.0,,P47871,0.2145991340625648
8,10.1038/nature12393,glr_human,122,Q,A,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,27.6,-1.379,,,[125I]-glucagon (radioligand),125.0,0.0,,0.0,,P47871,0.3192439522074356
264,23863937,glr_human,122,Q,A,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,27.6,-1.379,,,[125I]-glucagon (radioligand),125.0,0.0,,0.0,,P47871,0.3192439522074356
9,10.1038/nature12393,glr_human,123,M,E,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,20.5,-1.025,,,[125I]-glucagon (radioligand),105.3,0.0,,0.0,,P47871,0.3777268284482042
266,23863937,glr_human,123,M,E,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,20.5,-1.025,,,[125I]-glucagon (radioligand),105.3,0.0,,0.0,,P47871,0.3777268284482042
12,10.1038/nature12393,glr_human,127,E,K,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,23.9,-1.195,,,[125I]-glucagon (radioligand),203.0,0.0,,0.0,,P47871,0.2404016129174113
269,23863937,glr_human,127,E,K,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,23.9,-1.195,,,[125I]-glucagon (radioligand),203.0,0.0,,0.0,,P47871,0.2404016129174113
15,10.1038/nature12393,glr_human,131,Q,R,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,29.8,-1.49,,,[125I]-glucagon (radioligand),82.5,0.0,,0.0,,P47871,0.2376047830131124
272,23863937,glr_human,131,Q,R,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,29.8,-1.49,,,[125I]-glucagon (radioligand),82.5,0.0,,0.0,,P47871,0.2376047830131124
17,10.1038/nature12393,glr_human,133,E,P,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,59.1,-2.959,,,[125I]-glucagon (radioligand),186.1,0.0,,0.0,,P47871,0.2722569026171449
274,23863937,glr_human,133,E,P,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,59.1,-2.959,,,[125I]-glucagon (radioligand),186.1,0.0,,0.0,,P47871,0.2722569026171449
20,10.1038/nature12393,glr_human,140,S,F,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,28.6,-1.431,,,[125I]-glucagon (radioligand),77.8,0.0,,0.0,,P47871,0.3766873854568398
277,23863937,glr_human,140,S,F,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,28.6,-1.431,,,[125I]-glucagon (radioligand),77.8,0.0,,0.0,,P47871,0.3766873854568398
26,10.1038/nature12393,glr_human,145,Y,N,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,215.4,-10.753,,,[125I]-glucagon (radioligand),114.4,0.0,,0.0,,P47871,0.5954201670715388
283,23863937,glr_human,145,Y,N,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,215.4,-10.753,,,[125I]-glucagon (radioligand),114.4,0.0,,0.0,,P47871,0.5954201670715388
28,10.1038/nature12393,glr_human,149,Y,H,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,128.0,-6.41,,,[125I]-glucagon (radioligand),108.9,0.0,,0.0,,P47871,0.4638678107464142
284,23863937,glr_human,149,Y,H,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,128.0,-6.41,,,[125I]-glucagon (radioligand),108.9,0.0,,0.0,,P47871,0.4638678107464142
29,10.1038/nature12393,glr_human,150,S,A,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,14.5,1.379,,,[125I]-glucagon (radioligand),57.9,0.0,,0.0,,P47871,0.2631623946193495
286,23863937,glr_human,150,S,A,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,14.5,1.379,,,[125I]-glucagon (radioligand),57.9,0.0,,0.0,,P47871,0.2631623946193495
31,10.1038/nature12393,glr_human,154,G,S,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,20.6,-1.03,,,[125I]-glucagon (radioligand),55.2,0.0,,0.0,,P47871,0.2440111074688253
288,23863937,glr_human,154,G,S,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,20.6,-1.03,,,[125I]-glucagon (radioligand),55.2,0.0,,0.0,,P47871,0.2440111074688253
32,10.1038/nature12393,glr_human,184,F,A,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,19.1,1.047,,,[125I]-glucagon (radioligand),33.9,0.0,,0.0,,P47871,0.6836107083288999
164,10085108,glr_human,184,F,A,"L168,049",PubChem CID,5311276,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,1.3,nM,=,,46.0,-35.714,,,[125I]-glucagon (radioligand),0.0,0.0,,0.0,,P47871,0.6836107083288999
289,23863937,glr_human,184,F,A,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,19.1,1.047,,,[125I]-glucagon (radioligand),33.9,0.0,,0.0,,P47871,0.6836107083288999
33,10.1038/nature12393,glr_human,187,K,R,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,21.3,-1.065,,,[125I]-glucagon (radioligand),81.9,0.0,,0.0,,P47871,0.4113276941535961
290,23863937,glr_human,187,K,R,glucagon,PubChem CID,44278361,Full agonist,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,21.3,-1.065,,,[125I]-glucagon (radioligand),81.9,0.0,,0.0,,P47871,0.4113276941535961
37,10.1038/nature12393,glr_human,189,S,L,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,14.7,1.361,,,[125I]-glucagon (radioligand),99.9,0.0,,0.0,,P47871,0.3324212726567818
294,23863937,glr_human,189,S,L,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,14.7,1.361,,,[125I]-glucagon (radioligand),99.9,0.0,,0.0,,P47871,0.3324212726567818
38,10.1038/nature12393,glr_human,191,V,A,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,107.1,-5.348,,,[125I]-glucagon (radioligand),124.9,0.0,,0.0,,P47871,0.4632789724931579
295,23863937,glr_human,191,V,A,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,107.1,-5.348,,,[125I]-glucagon (radioligand),124.9,0.0,,0.0,,P47871,0.4632789724931579
40,10.1038/nature12393,glr_human,194,I,A,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,16.3,1.227,,,[125I]-glucagon (radioligand),34.3,0.0,,0.0,,P47871,0.4699413940135682
298,23863937,glr_human,194,I,A,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,16.3,1.227,,,[125I]-glucagon (radioligand),34.3,0.0,,0.0,,P47871,0.4699413940135682
42,10.1038/nature12393,glr_human,195,D,N,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,111.1,-5.556,,,[125I]-glucagon (radioligand),50.5,0.0,,0.0,,P47871,0.3865928454250427
300,23863937,glr_human,195,D,N,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,111.1,-5.556,,,[125I]-glucagon (radioligand),50.5,0.0,,0.0,,P47871,0.3865928454250427
43,10.1038/nature12393,glr_human,195,D,A,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,170.9,-8.547,,,[125I]-glucagon (radioligand),54.1,0.0,,0.0,,P47871,0.5195385349257599
299,23863937,glr_human,195,D,A,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,170.9,-8.547,,,[125I]-glucagon (radioligand),54.1,0.0,,0.0,,P47871,0.5195385349257599
44,10.1038/nature12393,glr_human,198,L,V,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,56.4,-2.817,,,[125I]-glucagon (radioligand),175.9,0.0,,0.0,,P47871,0.3011143737097591
301,23863937,glr_human,198,L,V,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,56.4,-2.817,,,[125I]-glucagon (radioligand),175.9,0.0,,0.0,,P47871,0.3011143737097591
46,10.1038/nature12393,glr_human,200,T,W,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,10.3,1.942,,,[125I]-glucagon (radioligand),160.5,0.0,,0.0,,P47871,0.3013161576439435
303,23863937,glr_human,200,T,W,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,10.3,1.942,,,[125I]-glucagon (radioligand),160.5,0.0,,0.0,,P47871,0.3013161576439435
47,10.1038/nature12393,glr_human,201,R,M,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,50.0,-2.5,,,[125I]-glucagon (radioligand),75.7,0.0,,0.0,,P47871,0.2740688624385335
305,23863937,glr_human,201,R,M,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,50.0,-2.5,,,[125I]-glucagon (radioligand),75.7,0.0,,0.0,,P47871,0.2740688624385335
48,10.1038/nature12393,glr_human,201,R,A,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,131.8,-6.579,,,[125I]-glucagon (radioligand),39.8,0.0,,0.0,,P47871,0.2740688624385335
306,23863937,glr_human,201,R,A,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,131.8,-6.579,,,[125I]-glucagon (radioligand),39.8,0.0,,0.0,,P47871,0.2740688624385335
51,10.1038/nature12393,glr_human,204,Q,T,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,16.9,1.183,,,[125I]-glucagon (radioligand),77.3,0.0,,0.0,,P47871,0.2827746081384158
308,23863937,glr_human,204,Q,T,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,16.9,1.183,,,[125I]-glucagon (radioligand),77.3,0.0,,0.0,,P47871,0.2827746081384158
52,10.1038/nature12393,glr_human,205,K,A,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,15.1,1.325,,,[125I]-glucagon (radioligand),108.0,0.0,,0.0,,P47871,0.2798130128652578
309,23863937,glr_human,205,K,A,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,15.1,1.325,,,[125I]-glucagon (radioligand),108.0,0.0,,0.0,,P47871,0.2798130128652578
54,10.1038/nature12393,glr_human,208,D,R,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,100.8,-5.051,,,[125I]-glucagon (radioligand),150.9,0.0,,0.0,,P47871,0.3292816929662117
310,23863937,glr_human,208,D,R,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,100.8,-5.051,,,[125I]-glucagon (radioligand),150.9,0.0,,0.0,,P47871,0.3292816929662117
56,10.1038/nature12393,glr_human,212,V,W,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,8.5,2.353,,,[125I]-glucagon (radioligand),52.3,0.0,,0.0,,P47871,0.3766319479781989
313,23863937,glr_human,212,V,W,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,8.5,2.353,,,[125I]-glucagon (radioligand),52.3,0.0,,0.0,,P47871,0.3766319479781989
58,10.1038/nature12393,glr_human,217,S,A,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,18.7,1.07,,,[125I]-glucagon (radioligand),115.6,0.0,,0.0,,P47871,0.2390964102325939
315,23863937,glr_human,217,S,A,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,18.7,1.07,,,[125I]-glucagon (radioligand),115.6,0.0,,0.0,,P47871,0.2390964102325939
59,10.1038/nature12393,glr_human,218,D,Y,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,30.6,-1.529,,,[125I]-glucagon (radioligand),184.4,0.0,,0.0,,P47871,0.3600952347042398
316,23863937,glr_human,218,D,Y,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,30.6,-1.529,,,[125I]-glucagon (radioligand),184.4,0.0,,0.0,,P47871,0.3600952347042398
61,10.1038/nature12393,glr_human,228,A,V,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,56.8,-2.841,,,[125I]-glucagon (radioligand),119.6,0.0,,0.0,,P47871,0.5004149555396268
319,23863937,glr_human,228,A,V,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,56.8,-2.841,,,[125I]-glucagon (radioligand),119.6,0.0,,0.0,,P47871,0.5004149555396268
63,10.1038/nature12393,glr_human,231,M,A,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,19.3,1.036,,,[125I]-glucagon (radioligand),48.8,0.0,,0.0,,P47871,0.5245548255163766
320,23863937,glr_human,231,M,A,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,19.3,1.036,,,[125I]-glucagon (radioligand),48.8,0.0,,0.0,,P47871,0.5245548255163766
65,10.1038/nature12393,glr_human,232,Q,A,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,148.3,-7.407,,,[125I]-glucagon (radioligand),147.1,0.0,,0.0,,P47871,0.6239842908907389
323,23863937,glr_human,232,Q,A,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,148.3,-7.407,,,[125I]-glucagon (radioligand),147.1,0.0,,0.0,,P47871,0.6239842908907389
69,10.1038/nature12393,glr_human,235,I,V,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,21.6,-1.08,,,[125I]-glucagon (radioligand),108.0,0.0,,0.0,,P47871,0.3234364541838178
326,23863937,glr_human,235,I,V,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,21.6,-1.08,,,[125I]-glucagon (radioligand),108.0,0.0,,0.0,,P47871,0.3234364541838178
72,10.1038/nature12393,glr_human,239,Y,A,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,20.6,-1.03,,,[125I]-glucagon (radioligand),50.3,0.0,,0.0,,P47871,0.6053958483938399
165,10085108,glr_human,239,Y,A,"L168,049",PubChem CID,5311276,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,1.3,nM,=,,4.5,-3.46,,,[125I]-glucagon (radioligand),0.0,0.0,,0.0,,P47871,0.6053958483938399
329,23863937,glr_human,239,Y,A,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,20.6,-1.03,,,[125I]-glucagon (radioligand),50.3,0.0,,0.0,,P47871,0.6053958483938399
73,10.1038/nature12393,glr_human,240,C,Y,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,23.0,-1.149,,,[125I]-glucagon (radioligand),102.7,0.0,,0.0,,P47871,0.5802355653524617
330,23863937,glr_human,240,C,Y,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,23.0,-1.149,,,[125I]-glucagon (radioligand),102.7,0.0,,0.0,,P47871,0.5802355653524617
74,10.1038/nature12393,glr_human,278,F,C,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,16.2,1.235,,,[125I]-glucagon (radioligand),82.4,0.0,,0.0,,P47871,0.5366841292787552
331,23863937,glr_human,278,F,C,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,16.2,1.235,,,[125I]-glucagon (radioligand),82.4,0.0,,0.0,,P47871,0.5366841292787552
78,10.1038/nature12393,glr_human,291,N,D,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,40.3,-2.016,,,[125I]-glucagon (radioligand),63.0,0.0,,0.0,,P47871,0.2741988955729921
335,23863937,glr_human,291,N,D,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,40.3,-2.016,,,[125I]-glucagon (radioligand),63.0,0.0,,0.0,,P47871,0.2741988955729921
83,10.1038/nature12393,glr_human,295,W,L,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,28.1,-1.404,,,[125I]-glucagon (radioligand),39.0,0.0,,0.0,,P47871,0.6961021015346675
341,23863937,glr_human,295,W,L,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,28.1,-1.404,,,[125I]-glucagon (radioligand),39.0,0.0,,0.0,,P47871,0.6961021015346675
86,10.1038/nature12393,glr_human,297,S,A,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,22.8,-1.14,,,[125I]-glucagon (radioligand),66.9,0.0,,0.0,,P47871,0.3711347337688157
344,23863937,glr_human,297,S,A,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,22.8,-1.14,,,[125I]-glucagon (radioligand),66.9,0.0,,0.0,,P47871,0.3711347337688157
88,10.1038/nature12393,glr_human,298,N,D,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,82.4,-4.115,,,[125I]-glucagon (radioligand),105.7,0.0,,0.0,,P47871,0.3421029624128784
346,23863937,glr_human,298,N,D,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,82.4,-4.115,,,[125I]-glucagon (radioligand),105.7,0.0,,0.0,,P47871,0.3421029624128784
93,10.1038/nature12393,glr_human,302,G,N,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,33.8,-1.689,,,[125I]-glucagon (radioligand),74.7,0.0,,0.0,,P47871,0.245399563950051
350,23863937,glr_human,302,G,N,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,33.8,-1.689,,,[125I]-glucagon (radioligand),74.7,0.0,,0.0,,P47871,0.245399563950051
94,10.1038/nature12393,glr_human,303,F,A,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,101.1,-5.051,,,[125I]-glucagon (radioligand),95.2,0.0,,0.0,,P47871,0.5019319547219727
351,23863937,glr_human,303,F,A,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,101.1,-5.051,,,[125I]-glucagon (radioligand),95.2,0.0,,0.0,,P47871,0.5019319547219727
95,10.1038/nature12393,glr_human,303,F,Y,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,25.3,-1.264,,,[125I]-glucagon (radioligand),68.3,0.0,,0.0,,P47871,0.2909169833360944
352,23863937,glr_human,303,F,Y,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,25.3,-1.264,,,[125I]-glucagon (radioligand),68.3,0.0,,0.0,,P47871,0.2909169833360944
96,10.1038/nature12393,glr_human,304,W,A,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,280.7,-14.085,,,[125I]-glucagon (radioligand),125.1,0.0,,0.0,,P47871,0.5940584992813565
355,23863937,glr_human,304,W,A,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,280.7,-14.085,,,[125I]-glucagon (radioligand),125.1,0.0,,0.0,,P47871,0.5940584992813565
97,10.1038/nature12393,glr_human,304,W,L,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,93.0,-4.651,,,[125I]-glucagon (radioligand),136.3,0.0,,0.0,,P47871,0.5500226642221275
354,23863937,glr_human,304,W,L,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,93.0,-4.651,,,[125I]-glucagon (radioligand),136.3,0.0,,0.0,,P47871,0.5500226642221275
99,10.1038/nature12393,glr_human,305,W,L,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,35.7,-1.786,,,[125I]-glucagon (radioligand),68.1,0.0,,0.0,,P47871,0.5141468538987148
356,23863937,glr_human,305,W,L,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,35.7,-1.786,,,[125I]-glucagon (radioligand),68.1,0.0,,0.0,,P47871,0.5141468538987148
100,10.1038/nature12393,glr_human,305,W,A,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,73.1,-3.65,,,[125I]-glucagon (radioligand),45.1,0.0,,0.0,,P47871,0.5588688859681892
357,23863937,glr_human,305,W,A,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,73.1,-3.65,,,[125I]-glucagon (radioligand),45.1,0.0,,0.0,,P47871,0.5588688859681892
101,10.1038/nature12393,glr_human,306,I,A,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,82.3,-4.115,,,[125I]-glucagon (radioligand),49.2,0.0,,0.0,,P47871,0.4512363582100565
358,23863937,glr_human,306,I,A,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,82.3,-4.115,,,[125I]-glucagon (radioligand),49.2,0.0,,0.0,,P47871,0.4512363582100565
103,10.1038/nature12393,glr_human,308,R,Q,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,46.5,-2.326,,,[125I]-glucagon (radioligand),45.6,0.0,,0.0,,P47871,0.5512066179171711
360,23863937,glr_human,308,R,Q,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,46.5,-2.326,,,[125I]-glucagon (radioligand),45.6,0.0,,0.0,,P47871,0.5512066179171711
104,10.1038/nature12393,glr_human,308,R,A,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,88.1,-4.405,,,[125I]-glucagon (radioligand),35.6,0.0,,0.0,,P47871,0.6377168410386639
361,23863937,glr_human,308,R,A,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,88.1,-4.405,,,[125I]-glucagon (radioligand),35.6,0.0,,0.0,,P47871,0.6377168410386639
106,10.1038/nature12393,glr_human,361,H,A,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,43.7,-2.183,,,[125I]-glucagon (radioligand),33.8,0.0,,0.0,,P47871,0.5885610610215958
376,23863937,glr_human,361,H,A,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,43.7,-2.183,,,[125I]-glucagon (radioligand),33.8,0.0,,0.0,,P47871,0.5885610610215958
107,10.1038/nature12393,glr_human,362,E,A,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,133.0,-6.667,,,[125I]-glucagon (radioligand),67.0,0.0,,0.0,,P47871,0.6516660769844644
378,23863937,glr_human,362,E,A,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,133.0,-6.667,,,[125I]-glucagon (radioligand),67.0,0.0,,0.0,,P47871,0.6516660769844644
108,10.1038/nature12393,glr_human,362,E,Q,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,213.8,-10.638,,,[125I]-glucagon (radioligand),83.3,0.0,,0.0,,P47871,0.5215980304531094
377,23863937,glr_human,362,E,Q,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,213.8,-10.638,,,[125I]-glucagon (radioligand),83.3,0.0,,0.0,,P47871,0.5215980304531094
110,10.1038/nature12393,glr_human,365,F,A,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,67.7,-3.39,,,[125I]-glucagon (radioligand),80.1,0.0,,0.0,,P47871,0.5512276501032936
380,23863937,glr_human,365,F,A,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,67.7,-3.39,,,[125I]-glucagon (radioligand),80.1,0.0,,0.0,,P47871,0.5512276501032936
111,10.1038/nature12393,glr_human,365,F,I,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,550.0,-27.778,,,[125I]-glucagon (radioligand),49.5,0.0,,0.0,,P47871,0.4614792208883101
381,23863937,glr_human,365,F,I,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,550.0,-27.778,,,[125I]-glucagon (radioligand),49.5,0.0,,0.0,,P47871,0.4614792208883101
112,10.1038/nature12393,glr_human,366,A,M,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,16.5,1.212,,,[125I]-glucagon (radioligand),101.8,0.0,,0.0,,P47871,0.5290223202796243
382,23863937,glr_human,366,A,M,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,16.5,1.212,,,[125I]-glucagon (radioligand),101.8,0.0,,0.0,,P47871,0.5290223202796243
113,10.1038/nature12393,glr_human,369,T,M,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,11.2,1.786,,,[125I]-glucagon (radioligand),34.8,0.0,,0.0,,P47871,0.4247066543642819
176,12029097,glr_human,369,T,M,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,2.1,nM,=,,1.4,1.5,,,[125I]-glucagon (radioligand),100.0,0.0,,0.0,,P47871,0.4247066543642819
177,12029097,glr_human,369,T,M,glucagon,PubChem CID,44278361,Full agonist,EC50,Binding - Radioligand competition/displacement,11.0,pM,=,,8.2,1.341,,,,100.0,0.0,,0.0,,P47871,0.4247066543642819
178,12029097,glr_human,369,T,M,glucagon-(Ser8Ala),FASTA sequence (peptide),HAQGTFTSDYSKYLDSRRAQDFVQWLMNT,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,30.0,nM,=,,24.0,1.25,,,[125I]-glucagon (radioligand),100.0,0.0,,0.0,,P47871,0.4247066543642819
179,12029097,glr_human,369,T,M,glucagon-(Ser8Ala),FASTA sequence (peptide),HAQGTFTSDYSKYLDSRRAQDFVQWLMNT,Full agonist,EC50,Binding - Radioligand competition/displacement,160.0,pM,=,,69.0,2.319,,,,100.0,0.0,,0.0,,P47871,0.4247066543642819
383,23863937,glr_human,369,T,M,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,11.2,1.786,,,[125I]-glucagon (radioligand),34.8,0.0,,0.0,,P47871,0.4247066543642819
114,10.1038/nature12393,glr_human,374,Q,R,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,13.7,1.46,,,[125I]-glucagon (radioligand),62.9,0.0,,0.0,,P47871,0.2359071633593503
180,12029097,glr_human,374,Q,R,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,2.1,nM,=,,1.4,1.5,,,[125I]-glucagon (radioligand),100.0,0.0,,0.0,,P47871,0.2359071633593503
181,12029097,glr_human,374,Q,R,glucagon,PubChem CID,44278361,Full agonist,EC50,Binding - Radioligand competition/displacement,11.0,pM,=,,12.0,-1.091,,,,100.0,0.0,,0.0,,P47871,0.2359071633593503
182,12029097,glr_human,374,Q,R,glucagon-(Ser8Ala),FASTA sequence (peptide),HAQGTFTSDYSKYLDSRRAQDFVQWLMNT,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,30.0,nM,=,,36.0,-1.2,,,[125I]-glucagon (radioligand),100.0,0.0,,0.0,,P47871,0.2359071633593503
183,12029097,glr_human,374,Q,R,glucagon-(Ser8Ala),FASTA sequence (peptide),HAQGTFTSDYSKYLDSRRAQDFVQWLMNT,Full agonist,EC50,Binding - Radioligand competition/displacement,160.0,pM,=,,230.0,-1.437,,,,100.0,0.0,,0.0,,P47871,0.2359071633593503
384,23863937,glr_human,374,Q,R,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,13.7,1.46,,,[125I]-glucagon (radioligand),62.9,0.0,,0.0,,P47871,0.2359071633593503
115,10.1038/nature12393,glr_human,378,R,A,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,129.5,-6.494,,,[125I]-glucagon (radioligand),108.0,0.0,,0.0,,P47871,0.4525706253076152
385,23863937,glr_human,378,R,A,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,129.5,-6.494,,,[125I]-glucagon (radioligand),108.0,0.0,,0.0,,P47871,0.4525706253076152
118,10.1038/nature12393,glr_human,381,K,A,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,73.3,-3.663,,,[125I]-glucagon (radioligand),165.7,0.0,,0.0,,P47871,0.4964284080061765
386,23863937,glr_human,381,K,A,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,73.3,-3.663,,,[125I]-glucagon (radioligand),165.7,0.0,,0.0,,P47871,0.4964284080061765
120,10.1038/nature12393,glr_human,382,L,V,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,107.2,-5.348,,,[125I]-glucagon (radioligand),108.4,0.0,,0.0,,P47871,0.4364343366954766
389,23863937,glr_human,382,L,V,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,107.2,-5.348,,,[125I]-glucagon (radioligand),108.4,0.0,,0.0,,P47871,0.4364343366954766
121,10.1038/nature12393,glr_human,383,F,A,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,6.3,3.175,,,[125I]-glucagon (radioligand),52.7,0.0,,0.0,,P47871,0.4827692807096967
391,23863937,glr_human,383,F,A,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,6.3,3.175,,,[125I]-glucagon (radioligand),52.7,0.0,,0.0,,P47871,0.4827692807096967
122,10.1038/nature12393,glr_human,384,F,T,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,71.6,-3.584,,,[125I]-glucagon (radioligand),54.2,0.0,,0.0,,P47871,0.4754164059746167
195,12029097,glr_human,384,F,T,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,2.1,nM,=,,1.3,1.615,,,[125I]-glucagon (radioligand),100.0,0.0,,0.0,,P47871,0.4754164059746167
196,12029097,glr_human,384,F,T,glucagon,PubChem CID,44278361,Full agonist,EC50,Binding - Radioligand competition/displacement,11.0,pM,=,,90.0,-8.197,,,,100.0,0.0,,0.0,,P47871,0.4754164059746167
197,12029097,glr_human,384,F,T,glucagon-(Ser8Ala),FASTA sequence (peptide),HAQGTFTSDYSKYLDSRRAQDFVQWLMNT,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,30.0,nM,=,,14.0,2.143,,,[125I]-glucagon (radioligand),100.0,0.0,,0.0,,P47871,0.4754164059746167
198,12029097,glr_human,384,F,T,glucagon-(Ser8Ala),FASTA sequence (peptide),HAQGTFTSDYSKYLDSRRAQDFVQWLMNT,Full agonist,EC50,Binding - Radioligand competition/displacement,160.0,pM,=,,600.0,-3.745,,,,100.0,0.0,,0.0,,P47871,0.4754164059746167
392,23863937,glr_human,384,F,T,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,71.6,-3.584,,,[125I]-glucagon (radioligand),54.2,0.0,,0.0,,P47871,0.4754164059746167
124,10.1038/nature12393,glr_human,386,L,A,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,182.5,-9.091,,,[125I]-glucagon (radioligand),156.1,0.0,,0.0,,P47871,0.5418939172252826
393,23863937,glr_human,386,L,A,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,182.5,-9.091,,,[125I]-glucagon (radioligand),156.1,0.0,,0.0,,P47871,0.5418939172252826
125,10.1038/nature12393,glr_human,386,L,V,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,47.4,-2.37,,,[125I]-glucagon (radioligand),155.7,0.0,,0.0,,P47871,0.4521349763994584
394,23863937,glr_human,386,L,V,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,47.4,-2.37,,,[125I]-glucagon (radioligand),155.7,0.0,,0.0,,P47871,0.4521349763994584
126,10.1038/nature12393,glr_human,387,F,S,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,46.8,-2.342,,,[125I]-glucagon (radioligand),60.5,0.0,,0.0,,P47871,0.4823688098006567
396,23863937,glr_human,387,F,S,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,46.8,-2.342,,,[125I]-glucagon (radioligand),60.5,0.0,,0.0,,P47871,0.4823688098006567
127,10.1038/nature12393,glr_human,389,S,A,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,30.0,-1.499,,,[125I]-glucagon (radioligand),49.4,0.0,,0.0,,P47871,0.4444909305525947
398,23863937,glr_human,389,S,A,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,30.0,-1.499,,,[125I]-glucagon (radioligand),49.4,0.0,,0.0,,P47871,0.4444909305525947
128,10.1038/nature12393,glr_human,389,S,T,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,32.1,-1.605,,,[125I]-glucagon (radioligand),86.9,0.0,,0.0,,P47871,0.4444909305525947
397,23863937,glr_human,389,S,T,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,32.1,-1.605,,,[125I]-glucagon (radioligand),86.9,0.0,,0.0,,P47871,0.4444909305525947
158,8635644,glr_human,40,G,S,glucagon,PubChem CID,44278361,Full agonist,pEC50,Functional - cAMP accumulation,0.2,nM,=,,0.8,3.981,,,,100.0,0.0,,0.0,,P47871,0.2966182358670565
159,8635644,glr_human,40,G,S,glucagon,PubChem CID,44278361,Full agonist,pEC50,Functional - cAMP accumulation,2.0,pM,=,,5.0,1000.0,,,,160.0,0.0,,0.0,,P47871,0.2966182358670565
160,8635644,glr_human,40,G,S,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,10.3,nM,=,,39.0,-3.788,,,[125I]-glucagon (radioligand),160.0,0.0,,0.0,,P47871,0.2966182358670565
161,8635644,glr_human,40,G,S,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,10.3,nM,=,,32.0,-3.106,,,[125I]-glucagon (radioligand),160.0,0.0,,0.0,,P47871,0.2966182358670565
162,8635644,glr_human,40,G,S,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,12.9,nM,=,,69.5,-5.376,,,[125I]-glucagon (radioligand),160.0,0.0,,0.0,,P47871,0.2966182358670565
163,8635644,glr_human,40,G,S,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,12.9,nM,=,,88.7,-6.897,,,[125I]-glucagon (radioligand),160.0,0.0,,0.0,,P47871,0.2966182358670565
168,12029097,glr_human,360,V,T,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,2.1,nM,=,,1.9,1.105,,,[125I]-glucagon (radioligand),100.0,0.0,,0.0,,P47871,0.4014208667543858
169,12029097,glr_human,360,V,T,glucagon,PubChem CID,44278361,Full agonist,EC50,Binding - Radioligand competition/displacement,11.0,pM,=,,11.0,1.0,,,,100.0,0.0,,0.0,,P47871,0.4014208667543858
170,12029097,glr_human,360,V,T,glucagon-(Ser8Ala),FASTA sequence (peptide),HAQGTFTSDYSKYLDSRRAQDFVQWLMNT,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,30.0,nM,=,,69.0,-2.299,,,[125I]-glucagon (radioligand),100.0,0.0,,0.0,,P47871,0.4014208667543858
171,12029097,glr_human,360,V,T,glucagon-(Ser8Ala),FASTA sequence (peptide),HAQGTFTSDYSKYLDSRRAQDFVQWLMNT,Full agonist,EC50,Binding - Radioligand competition/displacement,160.0,pM,=,,240.0,-1.499,,,,100.0,0.0,,0.0,,P47871,0.4014208667543858
172,12029097,glr_human,364,V,I,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,2.1,nM,=,,1.4,1.5,,,[125I]-glucagon (radioligand),100.0,0.0,,0.0,,P47871,0.2872249954911924
173,12029097,glr_human,364,V,I,glucagon,PubChem CID,44278361,Full agonist,EC50,Binding - Radioligand competition/displacement,11.0,pM,=,,21.0,-1.908,,,,100.0,0.0,,0.0,,P47871,0.2872249954911924
174,12029097,glr_human,364,V,I,glucagon-(Ser8Ala),FASTA sequence (peptide),HAQGTFTSDYSKYLDSRRAQDFVQWLMNT,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,30.0,nM,=,,22.0,1.364,,,[125I]-glucagon (radioligand),100.0,0.0,,0.0,,P47871,0.2872249954911924
175,12029097,glr_human,364,V,I,glucagon-(Ser8Ala),FASTA sequence (peptide),HAQGTFTSDYSKYLDSRRAQDFVQWLMNT,Full agonist,EC50,Binding - Radioligand competition/displacement,160.0,pM,=,,530.0,-3.311,,,,100.0,0.0,,0.0,,P47871,0.2872249954911924
184,12029097,glr_human,379,S,F,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,2.1,nM,=,,2.1,1.0,,,[125I]-glucagon (radioligand),100.0,0.0,,0.0,,P47871,0.3783560749744795
185,12029097,glr_human,379,S,F,glucagon,PubChem CID,44278361,Full agonist,EC50,Binding - Radioligand competition/displacement,11.0,pM,=,,19.0,-1.727,,,,100.0,0.0,,0.0,,P47871,0.3783560749744795
186,12029097,glr_human,379,S,F,glucagon-(Gln9Glu),FASTA sequence (peptide),HSEGTFTSDYSKYLDSRRAQDFVQWLMNT,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,640.0,nM,=,,130.0,4.923,,,[125I]-glucagon (radioligand),100.0,0.0,,0.0,,P47871,0.3783560749744795
187,12029097,glr_human,379,S,F,glucagon-(Lys19Ser),FASTA sequence (peptide),HSQGTFTSDYSSYLDSRRAQDFVQWLMNT,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,150.0,nM,=,,140.0,1.071,,,[125I]-glucagon (radioligand),100.0,0.0,,0.0,,P47871,0.3783560749744795
188,12029097,glr_human,379,S,F,glucagon-(Lys19Ser),FASTA sequence (peptide),HSQGTFTSDYSSYLDSRRAQDFVQWLMNT,Full agonist,EC50,Binding - Radioligand competition/displacement,310.0,pM,=,,570.0,-1.838,,,,100.0,0.0,,0.0,,P47871,0.3783560749744795
189,12029097,glr_human,379,S,F,glucagon-(Ser8Ala),FASTA sequence (peptide),HAQGTFTSDYSKYLDSRRAQDFVQWLMNT,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,30.0,nM,=,,35.0,-1.167,,,[125I]-glucagon (radioligand),100.0,0.0,,0.0,,P47871,0.3783560749744795
190,12029097,glr_human,379,S,F,glucagon-(Ser8Ala),FASTA sequence (peptide),HAQGTFTSDYSKYLDSRRAQDFVQWLMNT,Full agonist,EC50,Binding - Radioligand competition/displacement,160.0,pM,=,,210.0,-1.312,,,,100.0,0.0,,0.0,,P47871,0.3783560749744795
409,27059958,glr_human,379,S,F,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,29.0,-1.449,,,[125I]-glucagon (radioligand),121.0,0.0,,0.0,,P47871,0.3783560749744795
191,12029097,glr_human,380,A,I,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,2.1,nM,=,,1.4,1.5,,,[125I]-glucagon (radioligand),100.0,0.0,,0.0,,P47871,0.3540062823895345
192,12029097,glr_human,380,A,I,glucagon,PubChem CID,44278361,Full agonist,EC50,Binding - Radioligand competition/displacement,11.0,pM,=,,8.6,1.279,,,,100.0,0.0,,0.0,,P47871,0.3540062823895345
193,12029097,glr_human,380,A,I,glucagon-(Ser8Ala),FASTA sequence (peptide),HAQGTFTSDYSKYLDSRRAQDFVQWLMNT,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,30.0,nM,=,,38.0,-1.267,,,[125I]-glucagon (radioligand),100.0,0.0,,0.0,,P47871,0.3540062823895345
194,12029097,glr_human,380,A,I,glucagon-(Ser8Ala),FASTA sequence (peptide),HAQGTFTSDYSKYLDSRRAQDFVQWLMNT,Full agonist,EC50,Binding - Radioligand competition/displacement,160.0,pM,=,,250.0,-1.562,,,,100.0,0.0,,0.0,,P47871,0.3540062823895345
209,20647307,glr_human,45,H,C,glucagon,PubChem CID,44278361,Full agonist,pEC50,Functional - cAMP accumulation,8.5,M,=,,6.5,-100.0,,,,100.0,0.0,,0.0,,P47871,0.3572080745041192
213,20647307,glr_human,61,T,C,glucagon,PubChem CID,44278361,Full agonist,pEC50,Functional - cAMP accumulation,8.5,M,=,,5.9,-333.333,,,,0.0,0.0,,0.0,,P47871,0.4652402707426894
217,20647307,glr_human,71,T,C,glucagon,PubChem CID,44278361,Full agonist,pEC50,Functional - cAMP accumulation,8.5,M,=,,7.0,-31.25,,,,100.0,0.0,,0.0,,P47871,0.5341964640945271
220,20647307,glr_human,94,R,C,glucagon,PubChem CID,44278361,Full agonist,pEC50,Functional - cAMP accumulation,8.5,M,=,,5.3,-1000.0,,,,100.0,0.0,,0.0,,P47871,0.5332795249102749
223,20647307,glr_human,108,R,C,glucagon,PubChem CID,44278361,Full agonist,pEC50,Functional - cAMP accumulation,8.5,M,=,,6.5,-100.0,,,,100.0,0.0,,0.0,,P47871,0.3989882283952525
228,21704096,glr_human,198,L,C,glucagon,PubChem CID,44278361,Full agonist,pEC50,Functional - cAMP accumulation,8.4,M,=,,6.3,-125.0,,,,100.0,0.0,,0.0,,P47871,0.3817655886764601
230,21704096,glr_human,200,T,C,glucagon,PubChem CID,44278361,Full agonist,pEC50,Functional - cAMP accumulation,8.4,M,=,,7.4,-10.0,,,,100.0,0.0,,0.0,,P47871,0.2648218508515384
231,21704096,glr_human,201,R,C,glucagon,PubChem CID,44278361,Full agonist,pEC50,Functional - cAMP accumulation,8.4,M,=,,6.5,-76.923,,,,100.0,0.0,,0.0,,P47871,0.351112029068798
232,21704096,glr_human,202,Y,C,glucagon,PubChem CID,44278361,Full agonist,pEC50,Functional - cAMP accumulation,8.4,M,=,,5.9,-333.333,,,,100.0,0.0,,0.0,,P47871,0.3359081402487022
233,21704096,glr_human,203,S,C,glucagon,PubChem CID,44278361,Full agonist,pEC50,Functional - cAMP accumulation,8.4,M,=,,7.7,-5.0,,,,100.0,0.0,,0.0,,P47871,0.282628241843356
236,21704096,glr_human,206,I,C,glucagon,PubChem CID,44278361,Full agonist,pEC50,Functional - cAMP accumulation,8.4,M,=,,6.7,-50.0,,,,100.0,0.0,,0.0,,P47871,0.2936076914230387
237,21704096,glr_human,207,G,C,glucagon,PubChem CID,44278361,Full agonist,pEC50,Functional - cAMP accumulation,8.4,M,=,,8.2,-1.585,,,,100.0,0.0,,0.0,,P47871,0.3720753890331917
238,21704096,glr_human,209,D,C,glucagon,PubChem CID,44278361,Full agonist,pEC50,Functional - cAMP accumulation,8.4,M,=,,7.6,-6.329,,,,100.0,0.0,,0.0,,P47871,0.3714758419302556
239,21704096,glr_human,210,L,C,glucagon,PubChem CID,44278361,Full agonist,pEC50,Functional - cAMP accumulation,8.4,M,=,,8.6,1.585,,,,100.0,0.0,,0.0,,P47871,0.2965779160084862
240,21704096,glr_human,211,S,C,glucagon,PubChem CID,44278361,Full agonist,pEC50,Functional - cAMP accumulation,8.4,M,=,,7.6,-6.329,,,,100.0,0.0,,0.0,,P47871,0.2971761714951977
241,21704096,glr_human,212,V,C,glucagon,PubChem CID,44278361,Full agonist,pEC50,Functional - cAMP accumulation,8.4,M,=,,7.4,-10.0,,,,100.0,0.0,,0.0,,P47871,0.2965333924630203
242,21704096,glr_human,213,S,C,glucagon,PubChem CID,44278361,Full agonist,pEC50,Functional - cAMP accumulation,8.4,M,=,,6.7,-50.0,,,,100.0,0.0,,0.0,,P47871,0.302196444961903
243,21704096,glr_human,214,T,C,glucagon,PubChem CID,44278361,Full agonist,pEC50,Functional - cAMP accumulation,8.4,M,=,,7.6,-6.329,,,,100.0,0.0,,0.0,,P47871,0.2950032468234044
245,21704096,glr_human,216,L,C,glucagon,PubChem CID,44278361,Full agonist,pEC50,Functional - cAMP accumulation,8.4,M,=,,6.5,-76.923,,,,100.0,0.0,,0.0,,P47871,0.3085855368073182
246,21704096,glr_human,217,S,C,glucagon,PubChem CID,44278361,Full agonist,pEC50,Functional - cAMP accumulation,8.4,M,=,,6.9,-31.25,,,,100.0,0.0,,0.0,,P47871,0.3105642077416887
247,21704096,glr_human,218,D,C,glucagon,PubChem CID,44278361,Full agonist,pEC50,Functional - cAMP accumulation,8.4,M,=,,6.8,-40.0,,,,100.0,0.0,,0.0,,P47871,0.3600952347042398
251,21704096,glr_human,222,A,C,glucagon,PubChem CID,44278361,Full agonist,pEC50,Functional - cAMP accumulation,8.4,M,=,,8.2,-1.585,,,,100.0,0.0,,0.0,,P47871,0.2377065923954823
252,21704096,glr_human,223,G,C,glucagon,PubChem CID,44278361,Full agonist,pEC50,Functional - cAMP accumulation,8.4,M,=,,7.8,-3.984,,,,100.0,0.0,,0.0,,P47871,0.4027362041858762
254,22908259,glr_human,113,Q,E,glucagon,PubChem CID,44278361,Full agonist,EC50,Functional - cAMP accumulation,0.0,,=,,0.0,4.0,,,,0.0,0.0,,0.0,,P47871,0.2008464077148017
368,23863937,glr_human,349,K,A,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.9,M,=,,8.86,-1.096,,,[125I]-glucagon (radioligand),100.0,0.0,,0.0,,P47871,0.7105316870714107
370,23863937,glr_human,349,K,A,Mk-0893,PubChem CID,11570626,Negative allosteric modulator - noncompetitive antagonist,pK(b),Functional - cAMP accumulation,7.3,M,=,,6.5,-6.329,,,glucagon,100.0,0.0,,0.0,,P47871,0.7105316870714107
372,23863937,glr_human,349,K,A,Mk-0893,PubChem CID,11570626,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,9.21,M,=,,8.7,-3.236,,,[125I]-Mk-0893 (radioligand),100.0,0.0,,0.0,,P47871,0.7105316870714107
369,23863937,glr_human,349,K,M,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.9,M,=,,8.86,-1.096,,,[125I]-glucagon (radioligand),100.0,0.0,,0.0,,P47871,0.7105316870714107
371,23863937,glr_human,349,K,M,Mk-0893,PubChem CID,11570626,Negative allosteric modulator - noncompetitive antagonist,pK(b),Functional - cAMP accumulation,7.3,M,=,,6.3,-10.0,,,glucagon,100.0,0.0,,0.0,,P47871,0.7105316870714107
373,23863937,glr_human,349,K,M,Mk-0893,PubChem CID,11570626,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,9.21,M,=,,8.91,-1.996,,,[125I]-Mk-0893 (radioligand),100.0,0.0,,0.0,,P47871,0.7105316870714107
374,23863937,glr_human,350,S,A,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.9,M,=,,8.86,-1.096,,,[125I]-glucagon (radioligand),100.0,0.0,,0.0,,P47871,0.5168823987837217
375,23863937,glr_human,350,S,A,Mk-0893,PubChem CID,11570626,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,9.21,M,=,,9.18,-1.072,,,[125I]-Mk-0893 (radioligand),100.0,0.0,,0.0,,P47871,0.5168823987837217
402,27059958,glr_human,145,Y,F,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,43.0,-2.151,,,[125I]-glucagon (radioligand),120.0,0.0,,0.0,,P47871,0.37443281706996
411,27059958,glr_human,385,D,N,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,170.0,-8.475,,,[125I]-glucagon (radioligand),78.0,0.0,,0.0,,P47871,0.4505939885982337
412,27059958,glr_human,386,L,I,glucagon,PubChem CID,44278361,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,64.0,-3.205,,,[125I]-glucagon (radioligand),143.0,0.0,,0.0,,P47871,0.4080383173588436
23,29343833,drd3_human,36,Y,F,GSK598809 ,ChEMBL Compound ID,CHEMBL1081023,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,2.5,nM,=,,13.0,-5.208,,,[3H]7-OH-DPAT,0.0,0.0,,0.0,,P35462,0.3526868697117655
24,29343833,drd3_human,36,Y,F,GSK598809 ,ChEMBL Compound ID,CHEMBL1081023,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,2.5,nM,=,,4.5,-1.799,,,[3H]7-OH-DPAT,0.0,0.0,,0.0,,P35462,0.3526868697117655
140,29343833,drd3_human,36,Y,F,Haloperidol,ChEMBL Compound ID,CHEMBL54,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,6.5,nM,=,,4.0,1.625,,,[3H]7-OH-DPAT,0.0,0.0,,0.0,,P35462,0.3526868697117655
141,29343833,drd3_human,36,Y,F,Haloperidol,ChEMBL Compound ID,CHEMBL54,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,6.5,nM,=,,3.6,1.806,,,[3H]7-OH-DPAT,0.0,0.0,,0.0,,P35462,0.3526868697117655
223,29343833,drd3_human,36,Y,F,Eticlopride,ChEMBL Compound ID,CHEMBL8946,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.5,nM,=,,0.3,1.667,,,[3H]7-OH-DPAT,0.0,0.0,,0.0,,P35462,0.3526868697117655
224,29343833,drd3_human,36,Y,F,Eticlopride,ChEMBL Compound ID,CHEMBL8946,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.5,nM,=,,0.2,2.5,,,[3H]7-OH-DPAT,0.0,0.0,,0.0,,P35462,0.3526868697117655
245,29343833,drd3_human,36,Y,F,PF-4363467,SMILES,CCN1CCO[C@H](C1)c1ccc(NS(=O)(=O)c2ccc(cc2)C(C)C)c(C)c1,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,3.4,nM,=,,3.2,1.062,,,[3H]7-OH-DPAT,0.0,0.0,,0.0,,P35462,0.3526868697117655
246,29343833,drd3_human,36,Y,F,PF-4363467,SMILES,CCN1CCO[C@H](C1)c1ccc(NS(=O)(=O)c2ccc(cc2)C(C)C)c(C)c1,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,3.4,nM,=,,2.5,1.36,,,[3H]7-OH-DPAT,0.0,0.0,,0.0,,P35462,0.3526868697117655
29,29343833,drd3_human,90,E,Q,GSK598809 ,ChEMBL Compound ID,CHEMBL1081023,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,2.5,nM,=,,25.0,-10.0,,,[3H]7-OH-DPAT,0.0,0.0,,0.0,,P35462,0.2805920398467754
30,29343833,drd3_human,90,E,Q,GSK598809 ,ChEMBL Compound ID,CHEMBL1081023,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,2.5,nM,=,,30.9,-12.346,,,[3H]7-OH-DPAT,0.0,0.0,,0.0,,P35462,0.2805920398467754
146,29343833,drd3_human,90,E,Q,Haloperidol,ChEMBL Compound ID,CHEMBL54,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,6.5,nM,=,,43.6,-6.711,,,[3H]7-OH-DPAT,0.0,0.0,,0.0,,P35462,0.2805920398467754
147,29343833,drd3_human,90,E,Q,Haloperidol,ChEMBL Compound ID,CHEMBL54,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,6.5,nM,=,,36.5,-5.618,,,[3H]7-OH-DPAT,0.0,0.0,,0.0,,P35462,0.2805920398467754
229,29343833,drd3_human,90,E,Q,Eticlopride,ChEMBL Compound ID,CHEMBL8946,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.5,nM,=,,0.6,-1.2,,,[3H]7-OH-DPAT,0.0,0.0,,0.0,,P35462,0.2805920398467754
230,29343833,drd3_human,90,E,Q,Eticlopride,ChEMBL Compound ID,CHEMBL8946,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.5,nM,=,,0.5,1.0,,,[3H]7-OH-DPAT,0.0,0.0,,0.0,,P35462,0.2805920398467754
251,29343833,drd3_human,90,E,Q,PF-4363467,SMILES,CCN1CCO[C@H](C1)c1ccc(NS(=O)(=O)c2ccc(cc2)C(C)C)c(C)c1,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,3.4,nM,=,,6.0,-1.764,,,[3H]7-OH-DPAT,0.0,0.0,,0.0,,P35462,0.2805920398467754
252,29343833,drd3_human,90,E,Q,PF-4363467,SMILES,CCN1CCO[C@H](C1)c1ccc(NS(=O)(=O)c2ccc(cc2)C(C)C)c(C)c1,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,3.4,nM,=,,5.4,-1.587,,,[3H]7-OH-DPAT,0.0,0.0,,0.0,,P35462,0.2805920398467754
33,29343833,drd3_human,182,S,I,GSK598809 ,ChEMBL Compound ID,CHEMBL1081023,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,2.5,nM,=,,0.8,3.125,,,[3H]7-OH-DPAT,0.0,0.0,,0.0,,P35462,0.425611381768855
34,29343833,drd3_human,182,S,I,GSK598809 ,ChEMBL Compound ID,CHEMBL1081023,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,2.5,nM,=,,1.9,1.316,,,[3H]7-OH-DPAT,0.0,0.0,,0.0,,P35462,0.425611381768855
152,29343833,drd3_human,182,S,I,Haloperidol,ChEMBL Compound ID,CHEMBL54,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,6.5,nM,=,,34.1,-5.236,,,[3H]7-OH-DPAT,0.0,0.0,,0.0,,P35462,0.425611381768855
153,29343833,drd3_human,182,S,I,Haloperidol,ChEMBL Compound ID,CHEMBL54,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,6.5,nM,=,,21.8,-3.356,,,[3H]7-OH-DPAT,0.0,0.0,,0.0,,P35462,0.425611381768855
233,29343833,drd3_human,182,S,I,Eticlopride,ChEMBL Compound ID,CHEMBL8946,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.5,nM,=,,0.5,1.0,,,[3H]7-OH-DPAT,0.0,0.0,,0.0,,P35462,0.425611381768855
234,29343833,drd3_human,182,S,I,Eticlopride,ChEMBL Compound ID,CHEMBL8946,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.5,nM,=,,0.2,2.5,,,[3H]7-OH-DPAT,0.0,0.0,,0.0,,P35462,0.425611381768855
255,29343833,drd3_human,182,S,I,PF-4363467,SMILES,CCN1CCO[C@H](C1)c1ccc(NS(=O)(=O)c2ccc(cc2)C(C)C)c(C)c1,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,3.4,nM,=,,3.6,-1.059,,,[3H]7-OH-DPAT,0.0,0.0,,0.0,,P35462,0.425611381768855
256,29343833,drd3_human,182,S,I,PF-4363467,SMILES,CCN1CCO[C@H](C1)c1ccc(NS(=O)(=O)c2ccc(cc2)C(C)C)c(C)c1,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,3.4,nM,=,,2.1,1.619,,,[3H]7-OH-DPAT,0.0,0.0,,0.0,,P35462,0.425611381768855
35,29343833,drd3_human,183,I,F,GSK598809 ,ChEMBL Compound ID,CHEMBL1081023,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,2.5,nM,=,,6.6,-2.639,,,[3H]7-OH-DPAT,0.0,0.0,,0.0,,P35462,0.4592527224158533
154,29343833,drd3_human,183,I,F,Haloperidol,ChEMBL Compound ID,CHEMBL54,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,6.5,nM,=,,100.0,-15.385,,,[3H]7-OH-DPAT,0.0,0.0,,0.0,,P35462,0.4592527224158533
155,29343833,drd3_human,183,I,F,Haloperidol,ChEMBL Compound ID,CHEMBL54,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,6.5,nM,=,,18.0,-2.77,,,[3H]7-OH-DPAT,0.0,0.0,,0.0,,P35462,0.4592527224158533
235,29343833,drd3_human,183,I,F,Eticlopride,ChEMBL Compound ID,CHEMBL8946,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.5,nM,=,,0.9,-1.799,,,[3H]7-OH-DPAT,0.0,0.0,,0.0,,P35462,0.4592527224158533
236,29343833,drd3_human,183,I,F,Eticlopride,ChEMBL Compound ID,CHEMBL8946,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.5,nM,=,,0.6,-1.2,,,[3H]7-OH-DPAT,0.0,0.0,,0.0,,P35462,0.4592527224158533
257,29343833,drd3_human,183,I,F,PF-4363467,SMILES,CCN1CCO[C@H](C1)c1ccc(NS(=O)(=O)c2ccc(cc2)C(C)C)c(C)c1,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,3.4,nM,=,,55.0,-16.129,,,[3H]7-OH-DPAT,0.0,0.0,,0.0,,P35462,0.4592527224158533
258,29343833,drd3_human,183,I,F,PF-4363467,SMILES,CCN1CCO[C@H](C1)c1ccc(NS(=O)(=O)c2ccc(cc2)C(C)C)c(C)c1,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,3.4,nM,=,,43.0,-12.658,,,[3H]7-OH-DPAT,0.0,0.0,,0.0,,P35462,0.4592527224158533
36,29343833,drd3_human,189,V,A,GSK598809 ,ChEMBL Compound ID,CHEMBL1081023,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,2.5,nM,=,,4.0,-1.6,,,[3H]7-OH-DPAT,0.0,0.0,,0.0,,P35462,0.4791402512750733
37,29343833,drd3_human,189,V,A,GSK598809 ,ChEMBL Compound ID,CHEMBL1081023,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,2.5,nM,=,,3.6,-1.441,,,[3H]7-OH-DPAT,0.0,0.0,,0.0,,P35462,0.4791402512750733
156,29343833,drd3_human,189,V,A,Haloperidol,ChEMBL Compound ID,CHEMBL54,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,6.5,nM,=,,8.1,-1.247,,,[3H]7-OH-DPAT,0.0,0.0,,0.0,,P35462,0.4791402512750733
157,29343833,drd3_human,189,V,A,Haloperidol,ChEMBL Compound ID,CHEMBL54,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,6.5,nM,=,,8.5,-1.307,,,[3H]7-OH-DPAT,0.0,0.0,,0.0,,P35462,0.4791402512750733
237,29343833,drd3_human,189,V,A,Eticlopride,ChEMBL Compound ID,CHEMBL8946,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.5,nM,=,,0.5,1.0,,,[3H]7-OH-DPAT,0.0,0.0,,0.0,,P35462,0.4791402512750733
238,29343833,drd3_human,189,V,A,Eticlopride,ChEMBL Compound ID,CHEMBL8946,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.5,nM,=,,0.7,-1.401,,,[3H]7-OH-DPAT,0.0,0.0,,0.0,,P35462,0.4791402512750733
259,29343833,drd3_human,189,V,A,PF-4363467,SMILES,CCN1CCO[C@H](C1)c1ccc(NS(=O)(=O)c2ccc(cc2)C(C)C)c(C)c1,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,3.4,nM,=,,24.0,-7.042,,,[3H]7-OH-DPAT,0.0,0.0,,0.0,,P35462,0.4791402512750733
260,29343833,drd3_human,189,V,A,PF-4363467,SMILES,CCN1CCO[C@H](C1)c1ccc(NS(=O)(=O)c2ccc(cc2)C(C)C)c(C)c1,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,3.4,nM,=,,30.0,-8.85,,,[3H]7-OH-DPAT,0.0,0.0,,0.0,,P35462,0.4791402512750733
38,29343833,drd3_human,189,V,I,GSK598809 ,ChEMBL Compound ID,CHEMBL1081023,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,2.5,nM,=,,10.7,-4.274,,,[3H]7-OH-DPAT,0.0,0.0,,0.0,,P35462,0.3490018595006964
39,29343833,drd3_human,189,V,I,GSK598809 ,ChEMBL Compound ID,CHEMBL1081023,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,2.5,nM,=,,6.3,-2.519,,,[3H]7-OH-DPAT,0.0,0.0,,0.0,,P35462,0.3490018595006964
158,29343833,drd3_human,189,V,I,Haloperidol,ChEMBL Compound ID,CHEMBL54,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,6.5,nM,=,,14.2,-2.183,,,[3H]7-OH-DPAT,0.0,0.0,,0.0,,P35462,0.3490018595006964
159,29343833,drd3_human,189,V,I,Haloperidol,ChEMBL Compound ID,CHEMBL54,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,6.5,nM,=,,9.8,-1.508,,,[3H]7-OH-DPAT,0.0,0.0,,0.0,,P35462,0.3490018595006964
239,29343833,drd3_human,189,V,I,Eticlopride,ChEMBL Compound ID,CHEMBL8946,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.5,nM,=,,0.8,-1.6,,,[3H]7-OH-DPAT,0.0,0.0,,0.0,,P35462,0.3490018595006964
240,29343833,drd3_human,189,V,I,Eticlopride,ChEMBL Compound ID,CHEMBL8946,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.5,nM,=,,1.2,-2.398,,,[3H]7-OH-DPAT,0.0,0.0,,0.0,,P35462,0.3490018595006964
261,29343833,drd3_human,189,V,I,PF-4363467,SMILES,CCN1CCO[C@H](C1)c1ccc(NS(=O)(=O)c2ccc(cc2)C(C)C)c(C)c1,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,3.4,nM,=,,8.2,-2.41,,,[3H]7-OH-DPAT,0.0,0.0,,0.0,,P35462,0.3490018595006964
262,29343833,drd3_human,189,V,I,PF-4363467,SMILES,CCN1CCO[C@H](C1)c1ccc(NS(=O)(=O)c2ccc(cc2)C(C)C)c(C)c1,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,3.4,nM,=,,6.5,-1.912,,,[3H]7-OH-DPAT,0.0,0.0,,0.0,,P35462,0.3490018595006964
42,29343833,drd3_human,373,Y,F,GSK598809 ,ChEMBL Compound ID,CHEMBL1081023,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,2.5,nM,=,,136.8,-55.556,,,[3H]7-OH-DPAT,0.0,0.0,,0.0,,P35462,0.3878221645498724
43,29343833,drd3_human,373,Y,F,GSK598809 ,ChEMBL Compound ID,CHEMBL1081023,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,2.5,nM,=,,98.4,-40.0,,,[3H]7-OH-DPAT,0.0,0.0,,0.0,,P35462,0.3878221645498724
168,29343833,drd3_human,373,Y,F,Haloperidol,ChEMBL Compound ID,CHEMBL54,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,6.5,nM,=,,26.7,-4.115,,,[3H]7-OH-DPAT,0.0,0.0,,0.0,,P35462,0.3878221645498724
169,29343833,drd3_human,373,Y,F,Haloperidol,ChEMBL Compound ID,CHEMBL54,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,6.5,nM,=,,23.0,-3.534,,,[3H]7-OH-DPAT,0.0,0.0,,0.0,,P35462,0.3878221645498724
243,29343833,drd3_human,373,Y,F,Eticlopride,ChEMBL Compound ID,CHEMBL8946,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.5,nM,=,,0.7,-1.401,,,[3H]7-OH-DPAT,0.0,0.0,,0.0,,P35462,0.3878221645498724
244,29343833,drd3_human,373,Y,F,Eticlopride,ChEMBL Compound ID,CHEMBL8946,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.5,nM,=,,1.4,-2.801,,,[3H]7-OH-DPAT,0.0,0.0,,0.0,,P35462,0.3878221645498724
265,29343833,drd3_human,373,Y,F,PF-4363467,SMILES,CCN1CCO[C@H](C1)c1ccc(NS(=O)(=O)c2ccc(cc2)C(C)C)c(C)c1,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,3.4,nM,=,,14.8,-4.348,,,[3H]7-OH-DPAT,0.0,0.0,,0.0,,P35462,0.3878221645498724
266,29343833,drd3_human,373,Y,F,PF-4363467,SMILES,CCN1CCO[C@H](C1)c1ccc(NS(=O)(=O)c2ccc(cc2)C(C)C)c(C)c1,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,3.4,nM,=,,15.8,-4.651,,,[3H]7-OH-DPAT,0.0,0.0,,0.0,,P35462,0.3878221645498724
49,19606869,drd3_human,349,H,A,paper-2a,ChEMBL Compound ID,CHEMBL140612,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,320.0,nM,=,,56.0,5.714,,,[3H]Spiperone,75.0,0.0,,0.0,,P35462,0.5275805241544649
53,19606869,drd3_human,349,H,A,paper-3a,ChEMBL Compound ID,CHEMBL142020,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,7.4,nM,=,,2.0,3.7,,,[3H]Spiperone,75.0,0.0,,0.0,,P35462,0.5275805241544649
73,19606869,drd3_human,349,H,A,[3H]spiperone,ChEMBL Compound ID,CHEMBL267930,Binding - unknown pharmacological activity,K(d),Binding - Radioligand competition/displacement,0.54,nM,=,,1.0,-1.852,,,[3H]Spiperone,75.0,0.0,,0.0,,P35462,0.5275805241544649
115,19606869,drd3_human,349,H,A,paper-1a,ChEMBL Compound ID,CHEMBL310843,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,8300.0,nM,=,,46.0,180.435,,,[3H]Spiperone,75.0,0.0,,0.0,,P35462,0.5275805241544649
173,19606869,drd3_human,349,H,A,paper-3b,ChEMBL Compound ID,CHEMBL550222,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.5,nM,=,,0.63,-1.259,,,[3H]Spiperone,75.0,0.0,,0.0,,P35462,0.5275805241544649
179,19606869,drd3_human,349,H,A,paper-2b,ChEMBL Compound ID,CHEMBL561763,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,26.0,nM,=,,12.0,2.167,,,[3H]Spiperone,75.0,0.0,,0.0,,P35462,0.5275805241544649
271,19606869,drd3_human,349,H,A,paper-1c,SMILES,COC1=CC=CC=C1N1CCN(CC2=C3C=CC=CN3N=C2)CC1,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,770.0,nM,=,,61.0,12.623,,,[3H]Spiperone,75.0,0.0,,0.0,,P35462,0.5275805241544649
56,18834111,drd3_human,345,F,W,FAUC73,ChEMBL Compound ID,CHEMBL162762,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,190.0,nM,=,,5700.0,-30.303,,,[3H]Spiperone,0.0,0.0,,0.0,,P35462,0.5275102321763157
72,18834111,drd3_human,345,F,W,[3H]spiperone,ChEMBL Compound ID,CHEMBL267930,Binding - unknown pharmacological activity,K(d),Binding - Radioligand competition/displacement,0.52,nM,=,,0.23,2.261,,,[3H]Spiperone,0.0,0.0,,0.0,,P35462,0.5275102321763157
93,18834111,drd3_human,345,F,W,7-OH-DPAT,ChEMBL Compound ID,CHEMBL285755,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,3.6,nM,=,,270.0,-76.923,,,[3H]Spiperone,0.0,0.0,,0.0,,P35462,0.5275102321763157
131,18834111,drd3_human,345,F,W,paper-5c,ChEMBL Compound ID,CHEMBL484202,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,2.5,nM,=,,33.0,-13.158,,,[3H]Spiperone,0.0,0.0,,0.0,,P35462,0.5275102321763157
133,18834111,drd3_human,345,F,W,paper-4c,ChEMBL Compound ID,CHEMBL484358,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.78,nM,=,,20.0,-25.641,,,[3H]Spiperone,0.0,0.0,,0.0,,P35462,0.5275102321763157
188,18834111,drd3_human,345,F,W,Dopamine,ChEMBL Compound ID,CHEMBL59,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,72.0,nM,>,,80000.0,-1000.0,,,[3H]Spiperone,0.0,0.0,,0.0,,P35462,0.5275102321763157
60,10349875,drd3_human,192,S,A,Quinpirole,ChEMBL Compound ID,CHEMBL240773,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,69.8,nM,=,,81.2,-1.163,,,[3H]Spiperone,0.0,0.0,,0.0,,P35462,0.4467722528354018
69,10349875,drd3_human,192,S,A,[3H]spiperone,ChEMBL Compound ID,CHEMBL267930,Binding - unknown pharmacological activity,K(d),Binding - Radioligand competition/displacement,0.18,nM,=,,0.13,1.385,,,[3H]Spiperone,0.0,0.0,,0.0,,P35462,0.4467722528354018
76,20833147,drd3_human,192,S,A,Spiperone,ChEMBL Compound ID,CHEMBL267930,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,0.329,nM,=,,0.332,-1.009,,,[3H]Spiperone,0.0,0.0,,0.0,,P35462,0.4467722528354018
78,20833147,drd3_human,192,S,A,5-OH-DPAT (D323),ChEMBL Compound ID,CHEMBL269004,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,5.94,nM,=,,110.0,-18.519,,,[3H]Spiperone,0.0,0.0,,0.0,,P35462,0.4467722528354018
89,10349875,drd3_human,192,S,A,7-OH-DPAT,ChEMBL Compound ID,CHEMBL285755,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,16.6,nM,=,,53.2,-3.205,,,[3H]Spiperone,0.0,0.0,,0.0,,P35462,0.4467722528354018
90,20833147,drd3_human,192,S,A,7-OH-DPAT,ChEMBL Compound ID,CHEMBL285755,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,5.64,nM,=,,28.1,-4.975,,,[3H]Spiperone,0.0,0.0,,0.0,,P35462,0.4467722528354018
126,20833147,drd3_human,192,S,A,D315,ChEMBL Compound ID,CHEMBL456825,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.503,nM,=,,3.16,-6.289,,,[3H]Spiperone,0.0,0.0,,0.0,,P35462,0.4467722528354018
128,20833147,drd3_human,192,S,A,D237,ChEMBL Compound ID,CHEMBL457024,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,3.65,nM,=,,40.0,-10.989,,,[3H]Spiperone,0.0,0.0,,0.0,,P35462,0.4467722528354018
134,20833147,drd3_human,192,S,A,D264,ChEMBL Compound ID,CHEMBL514885,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,5.81,nM,=,,15.5,-2.667,,,[3H]Spiperone,0.0,0.0,,0.0,,P35462,0.4467722528354018
185,10349875,drd3_human,192,S,A,Dopamine,ChEMBL Compound ID,CHEMBL59,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,36.1,nM,=,,2234.0,-62.5,,,[3H]Spiperone,0.0,0.0,,0.0,,P35462,0.4467722528354018
61,10349875,drd3_human,193,S,A,Quinpirole,ChEMBL Compound ID,CHEMBL240773,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,69.8,nM,=,,73.6,-1.055,,,[3H]Spiperone,0.0,0.0,,0.0,,P35462,0.4573403763042332
70,10349875,drd3_human,193,S,A,[3H]spiperone,ChEMBL Compound ID,CHEMBL267930,Binding - unknown pharmacological activity,K(d),Binding - Radioligand competition/displacement,0.18,nM,=,,0.065,2.769,,,[3H]Spiperone,0.0,0.0,,0.0,,P35462,0.4573403763042332
91,10349875,drd3_human,193,S,A,7-OH-DPAT,ChEMBL Compound ID,CHEMBL285755,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,16.6,nM,=,,15.1,1.099,,,[3H]Spiperone,0.0,0.0,,0.0,,P35462,0.4573403763042332
186,10349875,drd3_human,193,S,A,Dopamine,ChEMBL Compound ID,CHEMBL59,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,36.1,nM,=,,74.9,-2.075,,,[3H]Spiperone,0.0,0.0,,0.0,,P35462,0.4573403763042332
62,10349875,drd3_human,196,S,A,Quinpirole,ChEMBL Compound ID,CHEMBL240773,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,69.8,nM,=,,56.9,1.227,,,[3H]Spiperone,0.0,0.0,,0.0,,P35462,0.424672026196763
71,10349875,drd3_human,196,S,A,[3H]spiperone,ChEMBL Compound ID,CHEMBL267930,Binding - unknown pharmacological activity,K(d),Binding - Radioligand competition/displacement,0.18,nM,=,,0.11,1.636,,,[3H]Spiperone,0.0,0.0,,0.0,,P35462,0.424672026196763
92,10349875,drd3_human,196,S,A,7-OH-DPAT,ChEMBL Compound ID,CHEMBL285755,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,16.6,nM,=,,9.5,1.747,,,[3H]Spiperone,0.0,0.0,,0.0,,P35462,0.424672026196763
187,10349875,drd3_human,196,S,A,Dopamine,ChEMBL Compound ID,CHEMBL59,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,36.1,nM,=,,30.8,1.172,,,[3H]Spiperone,0.0,0.0,,0.0,,P35462,0.424672026196763
77,20833147,drd3_human,369,T,V,Spiperone,ChEMBL Compound ID,CHEMBL267930,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,0.329,nM,=,,0.203,1.621,,,[3H]Spiperone,0.0,0.0,,0.0,,P35462,0.4872499013705608
79,20833147,drd3_human,369,T,V,5-OH-DPAT (D323),ChEMBL Compound ID,CHEMBL269004,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,5.94,nM,=,,5.29,1.123,,,[3H]Spiperone,0.0,0.0,,0.0,,P35462,0.4872499013705608
99,9651882,drd3_human,369,T,V,7-OH-DPAT,ChEMBL Compound ID,CHEMBL285755,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.3,,=,,9.3,10.0,,,[3H]Spiperone,100.0,0.0,,0.0,,P35462,0.4872499013705608
100,20833147,drd3_human,369,T,V,7-OH-DPAT,ChEMBL Compound ID,CHEMBL285755,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,5.64,nM,=,,2.4,2.35,,,[3H]Spiperone,0.0,0.0,,0.0,,P35462,0.4872499013705608
110,9651882,drd3_human,369,T,V,GR103691,ChEMBL Compound ID,CHEMBL294747,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.6,,=,,9.6,1.0,,,[3H]Spiperone,100.0,0.0,,0.0,,P35462,0.4872499013705608
124,9651882,drd3_human,369,T,V,GR218231,ChEMBL Compound ID,CHEMBL334529,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.6,,=,,9.4,6.31,,,[3H]Spiperone,100.0,0.0,,0.0,,P35462,0.4872499013705608
127,20833147,drd3_human,369,T,V,D315,ChEMBL Compound ID,CHEMBL456825,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.503,nM,=,,0.31,1.623,,,[3H]Spiperone,0.0,0.0,,0.0,,P35462,0.4872499013705608
129,20833147,drd3_human,369,T,V,D237,ChEMBL Compound ID,CHEMBL457024,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,3.65,nM,=,,3.28,1.113,,,[3H]Spiperone,0.0,0.0,,0.0,,P35462,0.4872499013705608
135,20833147,drd3_human,369,T,V,D264,ChEMBL Compound ID,CHEMBL514885,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,5.81,nM,=,,9.14,-1.572,,,[3H]Spiperone,0.0,0.0,,0.0,,P35462,0.4872499013705608
167,9651882,drd3_human,369,T,V,Haloperidol,ChEMBL Compound ID,CHEMBL54,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.4,,=,,8.8,2.512,,,[3H]Spiperone,100.0,0.0,,0.0,,P35462,0.4872499013705608
194,9651882,drd3_human,369,T,V,Dopamine,ChEMBL Compound ID,CHEMBL59,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.2,,=,,7.9,5.012,,,[3H]Spiperone,100.0,0.0,,0.0,,P35462,0.4872499013705608
206,9651882,drd3_human,369,T,V,Chlorpromazine,ChEMBL Compound ID,CHEMBL71,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.0,,=,,8.5,3.162,,,[3H]Spiperone,100.0,0.0,,0.0,,P35462,0.4872499013705608
222,9651882,drd3_human,369,T,V,Raclopride,ChEMBL Compound ID,CHEMBL8809,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.6,,=,,9.1,3.162,,,[3H]Spiperone,100.0,0.0,,0.0,,P35462,0.4872499013705608
87,9651882,drd3_human,102,C,H,7-OH-DPAT,ChEMBL Compound ID,CHEMBL285755,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.3,,=,,8.9,3.981,,,[3H]Spiperone,100.0,0.0,,0.0,,P35462,0.4279504562904983
104,9651882,drd3_human,102,C,H,GR103691,ChEMBL Compound ID,CHEMBL294747,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.6,,=,,9.3,-1.996,,,[3H]Spiperone,100.0,0.0,,0.0,,P35462,0.4279504562904983
118,9651882,drd3_human,102,C,H,GR218231,ChEMBL Compound ID,CHEMBL334529,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.6,,=,,9.1,3.162,,,[3H]Spiperone,100.0,0.0,,0.0,,P35462,0.4279504562904983
148,9651882,drd3_human,102,C,H,Haloperidol,ChEMBL Compound ID,CHEMBL54,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.4,,=,,8.2,-1.585,,,[3H]Spiperone,100.0,0.0,,0.0,,P35462,0.4279504562904983
183,9651882,drd3_human,102,C,H,Dopamine,ChEMBL Compound ID,CHEMBL59,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.2,,=,,7.1,-1.259,,,[3H]Spiperone,100.0,0.0,,0.0,,P35462,0.4279504562904983
199,9651882,drd3_human,102,C,H,Chlorpromazine,ChEMBL Compound ID,CHEMBL71,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.0,,=,,8.6,3.981,,,[3H]Spiperone,100.0,0.0,,0.0,,P35462,0.4279504562904983
215,9651882,drd3_human,102,C,H,Raclopride,ChEMBL Compound ID,CHEMBL8809,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.6,,=,,8.8,1.585,,,[3H]Spiperone,100.0,0.0,,0.0,,P35462,0.4279504562904983
94,9651882,drd3_human,349,H,L,7-OH-DPAT,ChEMBL Compound ID,CHEMBL285755,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.3,,=,,8.4,1.259,,,[3H]Spiperone,100.0,0.0,,0.0,,P35462,0.5721038072688586
105,9651882,drd3_human,349,H,L,GR103691,ChEMBL Compound ID,CHEMBL294747,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.6,,=,,9.5,-1.259,,,[3H]Spiperone,100.0,0.0,,0.0,,P35462,0.5721038072688586
119,9651882,drd3_human,349,H,L,GR218231,ChEMBL Compound ID,CHEMBL334529,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.6,,=,,7.9,-5.0,,,[3H]Spiperone,100.0,0.0,,0.0,,P35462,0.5721038072688586
160,9651882,drd3_human,349,H,L,Haloperidol,ChEMBL Compound ID,CHEMBL54,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.4,,=,,8.5,1.259,,,[3H]Spiperone,100.0,0.0,,0.0,,P35462,0.5721038072688586
189,9651882,drd3_human,349,H,L,Dopamine,ChEMBL Compound ID,CHEMBL59,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.2,,=,,6.0,-15.873,,,[3H]Spiperone,100.0,0.0,,0.0,,P35462,0.5721038072688586
201,9651882,drd3_human,349,H,L,Chlorpromazine,ChEMBL Compound ID,CHEMBL71,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.0,,=,,8.3,1.995,,,[3H]Spiperone,100.0,0.0,,0.0,,P35462,0.5721038072688586
217,9651882,drd3_human,349,H,L,Raclopride,ChEMBL Compound ID,CHEMBL8809,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.6,,=,,7.6,-10.0,,,[3H]Spiperone,100.0,0.0,,0.0,,P35462,0.5721038072688586
95,9651882,drd3_human,361,S,A,7-OH-DPAT,ChEMBL Compound ID,CHEMBL285755,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.3,,=,,8.6,1.995,,,[3H]Spiperone,100.0,0.0,,0.0,,P35462,0.2983158528384629
106,9651882,drd3_human,361,S,A,GR103691,ChEMBL Compound ID,CHEMBL294747,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.6,,=,,9.5,-1.259,,,[3H]Spiperone,100.0,0.0,,0.0,,P35462,0.2983158528384629
120,9651882,drd3_human,361,S,A,GR218231,ChEMBL Compound ID,CHEMBL334529,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.6,,=,,9.1,3.162,,,[3H]Spiperone,100.0,0.0,,0.0,,P35462,0.2983158528384629
161,9651882,drd3_human,361,S,A,Haloperidol,ChEMBL Compound ID,CHEMBL54,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.4,,=,,8.2,-1.585,,,[3H]Spiperone,100.0,0.0,,0.0,,P35462,0.2983158528384629
190,9651882,drd3_human,361,S,A,Dopamine,ChEMBL Compound ID,CHEMBL59,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.2,,=,,7.1,-1.259,,,[3H]Spiperone,100.0,0.0,,0.0,,P35462,0.2983158528384629
202,9651882,drd3_human,361,S,A,Chlorpromazine,ChEMBL Compound ID,CHEMBL71,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.0,,=,,8.2,1.585,,,[3H]Spiperone,100.0,0.0,,0.0,,P35462,0.2983158528384629
218,9651882,drd3_human,361,S,A,Raclopride,ChEMBL Compound ID,CHEMBL8809,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.6,,=,,8.7,1.259,,,[3H]Spiperone,100.0,0.0,,0.0,,P35462,0.2983158528384629
96,9651882,drd3_human,361,S,P,7-OH-DPAT,ChEMBL Compound ID,CHEMBL285755,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.3,,=,,8.5,1.585,,,[3H]Spiperone,100.0,0.0,,0.0,,P35462,0.3786156221209278
107,9651882,drd3_human,361,S,P,GR103691,ChEMBL Compound ID,CHEMBL294747,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.6,,=,,9.1,-3.165,,,[3H]Spiperone,100.0,0.0,,0.0,,P35462,0.3786156221209278
121,9651882,drd3_human,361,S,P,GR218231,ChEMBL Compound ID,CHEMBL334529,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.6,,=,,8.8,1.585,,,[3H]Spiperone,100.0,0.0,,0.0,,P35462,0.3786156221209278
162,9651882,drd3_human,361,S,P,Haloperidol,ChEMBL Compound ID,CHEMBL54,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.4,,=,,7.7,-5.0,,,[3H]Spiperone,100.0,0.0,,0.0,,P35462,0.3786156221209278
191,9651882,drd3_human,361,S,P,Dopamine,ChEMBL Compound ID,CHEMBL59,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.2,,=,,6.6,-3.984,,,[3H]Spiperone,100.0,0.0,,0.0,,P35462,0.3786156221209278
203,9651882,drd3_human,361,S,P,Chlorpromazine,ChEMBL Compound ID,CHEMBL71,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.0,,=,,8.0,1.0,,,[3H]Spiperone,100.0,0.0,,0.0,,P35462,0.3786156221209278
219,9651882,drd3_human,361,S,P,Raclopride,ChEMBL Compound ID,CHEMBL8809,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.6,,=,,8.4,-1.585,,,[3H]Spiperone,100.0,0.0,,0.0,,P35462,0.3786156221209278
98,9651882,drd3_human,368,T,V,7-OH-DPAT,ChEMBL Compound ID,CHEMBL285755,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.3,,=,,8.8,3.162,,,[3H]Spiperone,100.0,0.0,,0.0,,P35462,0.4437218652596402
109,9651882,drd3_human,368,T,V,GR103691,ChEMBL Compound ID,CHEMBL294747,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.6,,=,,9.8,1.585,,,[3H]Spiperone,100.0,0.0,,0.0,,P35462,0.4437218652596402
123,9651882,drd3_human,368,T,V,GR218231,ChEMBL Compound ID,CHEMBL334529,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.6,,=,,9.1,3.162,,,[3H]Spiperone,100.0,0.0,,0.0,,P35462,0.4437218652596402
166,9651882,drd3_human,368,T,V,Haloperidol,ChEMBL Compound ID,CHEMBL54,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.4,,=,,8.3,-1.259,,,[3H]Spiperone,100.0,0.0,,0.0,,P35462,0.4437218652596402
193,9651882,drd3_human,368,T,V,Dopamine,ChEMBL Compound ID,CHEMBL59,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.2,,=,,6.9,-1.996,,,[3H]Spiperone,100.0,0.0,,0.0,,P35462,0.4437218652596402
205,9651882,drd3_human,368,T,V,Chlorpromazine,ChEMBL Compound ID,CHEMBL71,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.0,,=,,8.4,2.512,,,[3H]Spiperone,100.0,0.0,,0.0,,P35462,0.4437218652596402
221,9651882,drd3_human,368,T,V,Raclopride,ChEMBL Compound ID,CHEMBL8809,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.6,,=,,8.7,1.259,,,[3H]Spiperone,100.0,0.0,,0.0,,P35462,0.4437218652596402
1,10.1111/bph.15756,5ht2a_human,210,I,V,pimavanserin,SMILES,CC(C)COC1=CC=C(C=C1)CNC(=O)N(CC2=CC=C(C=C2)F)C3CCN(CC3)C,Inverse agonist,pK(b),Functional - IP accumulation,8.24,,=,,8.25,1.023,,,Inhibition,0.0,0.0,,0.0,,P28223,0.3580530280631738
6,10.1111/bph.15756,5ht2a_human,210,I,V,risperidone,SMILES,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,Inverse agonist,pK(b),Functional - IP accumulation,8.88,,=,,8.81,-1.175,,,Functional,0.0,0.0,,0.0,,P28223,0.3580530280631738
11,10.1111/bph.15756,5ht2a_human,210,I,V,"(2S,4R)-2a",SMILES,CN(C)[C@@H]1CC2=C(C=CC=C2)[C@@H](C3=CC=CC(Br)=C3)C1,Inverse agonist,pK(b),Functional - IP accumulation,6.97,,=,,7.1,1.349,,,Inhibition,0.0,0.0,,0.0,,P28223,0.3580530280631738
16,10.1111/bph.15756,5ht2a_human,210,I,V,"(2S,4R)-2k",SMILES,CN(C)[C@@H]1CC2=C(C=CC=C2)[C@@H](C3=CC(C4=CC=C(N(C)C)C=C4)=CC=C3)C1,Inverse agonist,pK(b),Functional - IP accumulation,7.91,,=,,8.06,1.413,,,Inhibition,0.0,0.0,,0.0,,P28223,0.3580530280631738
21,10.1111/bph.15756,5ht2a_human,210,I,V,"(2R,4R)-3h",SMILES,CN(C)[C@H]1CC2=C(C=CC=C2)[C@@H](C3=CC(C4=CC=CC(F)=C4)=CC=C3)C1,Inverse agonist,pK(b),Functional - IP accumulation,6.97,,=,,7.18,1.622,,,Inhibition,0.0,0.0,,0.0,,P28223,0.3580530280631738
26,10.1111/bph.15756,5ht2a_human,210,I,V,5-HT,SMILES,C1=CC2=C(C=C1O)C(=CN2)CCN,Full agonist,pEC50,Functional - IP accumulation,7.53,,=,,7.44,-1.23,,,Inhibition,0.0,0.0,,0.0,,P28223,0.3580530280631738
3,10.1111/bph.15756,5ht2a_human,235,V,M,pimavanserin,SMILES,CC(C)COC1=CC=C(C=C1)CNC(=O)N(CC2=CC=C(C=C2)F)C3CCN(CC3)C,Inverse agonist,pK(b),Functional - IP accumulation,8.24,,=,,8.62,2.399,,,Inhibition,0.0,0.0,,0.0,,P28223,0.4181121795722536
8,10.1111/bph.15756,5ht2a_human,235,V,M,risperidone,SMILES,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,Inverse agonist,pK(b),Functional - IP accumulation,8.88,,=,,8.93,1.122,,,Inhibition,0.0,0.0,,0.0,,P28223,0.4181121795722536
13,10.1111/bph.15756,5ht2a_human,235,V,M,"(2S,4R)-2a",SMILES,CN(C)[C@@H]1CC2=C(C=CC=C2)[C@@H](C3=CC=CC(Br)=C3)C1,Inverse agonist,pK(b),Functional - IP accumulation,6.97,,=,,7.25,1.905,,,Inhibition,0.0,0.0,,0.0,,P28223,0.4181121795722536
18,10.1111/bph.15756,5ht2a_human,235,V,M,"(2S,4R)-2k",SMILES,CN(C)[C@@H]1CC2=C(C=CC=C2)[C@@H](C3=CC(C4=CC=C(N(C)C)C=C4)=CC=C3)C1,Inverse agonist,pK(b),Functional - IP accumulation,7.91,,=,,8.35,2.754,,,Inhibition,0.0,0.0,,0.0,,P28223,0.4181121795722536
23,10.1111/bph.15756,5ht2a_human,235,V,M,"(2R,4R)-3h",SMILES,CN(C)[C@H]1CC2=C(C=CC=C2)[C@@H](C3=CC(C4=CC=CC(F)=C4)=CC=C3)C1,Inverse agonist,pK(b),Functional - IP accumulation,6.97,,=,,7.02,1.122,,,Inhibition,0.0,0.0,,0.0,,P28223,0.4181121795722536
29,10.1111/bph.15756,5ht2a_human,235,V,M,5-HT,SMILES,C1=CC2=C(C=C1O)C(=CN2)CCN,Full agonist,pEC50,Functional - IP accumulation,7.53,,=,,7.34,-1.548,,,Inhibition,0.0,0.0,,0.0,,P28223,0.4181121795722536
5,10.1111/bph.15756,5ht2a_human,242,S,A,pimavanserin,SMILES,CC(C)COC1=CC=C(C=C1)CNC(=O)N(CC2=CC=C(C=C2)F)C3CCN(CC3)C,Inverse agonist,pK(b),Functional - IP accumulation,8.24,,=,,8.22,-1.047,,,Inhibition,0.0,0.0,,0.0,,P28223,0.4313089317765065
10,10.1111/bph.15756,5ht2a_human,242,S,A,risperidone,SMILES,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,Inverse agonist,pK(b),Functional - IP accumulation,8.88,,=,,8.95,1.175,,,Inhibition,0.0,0.0,,0.0,,P28223,0.4313089317765065
15,10.1111/bph.15756,5ht2a_human,242,S,A,"(2S,4R)-2a",SMILES,CN(C)[C@@H]1CC2=C(C=CC=C2)[C@@H](C3=CC=CC(Br)=C3)C1,Inverse agonist,pK(b),Functional - IP accumulation,6.97,,=,,6.9,-1.175,,,Inhibition,0.0,0.0,,0.0,,P28223,0.4313089317765065
20,10.1111/bph.15756,5ht2a_human,242,S,A,"(2S,4R)-2k",SMILES,CN(C)[C@@H]1CC2=C(C=CC=C2)[C@@H](C3=CC(C4=CC=C(N(C)C)C=C4)=CC=C3)C1,Inverse agonist,pK(b),Functional - IP accumulation,7.91,,=,,7.95,1.096,,,Inhibition,0.0,0.0,,0.0,,P28223,0.4313089317765065
25,10.1111/bph.15756,5ht2a_human,242,S,A,"(2R,4R)-3h",SMILES,CN(C)[C@H]1CC2=C(C=CC=C2)[C@@H](C3=CC(C4=CC=CC(F)=C4)=CC=C3)C1,Inverse agonist,pK(b),Functional - IP accumulation,6.97,,=,,6.85,-1.318,,,Inhibition,0.0,0.0,,0.0,,P28223,0.4313089317765065
31,10.1111/bph.15756,5ht2a_human,242,S,A,5-HT,SMILES,C1=CC2=C(C=C1O)C(=CN2)CCN,Full agonist,pEC50,Functional - IP accumulation,7.53,,=,,7.29,-1.739,,,Inhibition,0.0,0.0,,0.0,,P28223,0.4313089317765065
84,8700116,5ht2a_human,242,S,A,Ergonovine,ChEMBL Compound ID,CHEMBL119443,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.46,nM,=,,9.9,-21.739,,,[3H]Ketanserin,0.0,0.0,,0.0,,P28223,0.4313089317765065
85,1644189,5ht2a_human,242,S,A,[3H]Mesulergine,ChEMBL Compound ID,CHEMBL12314,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,174.0,nM,=,,2.6,66.923,,,,0.0,0.0,,0.0,,P28223,0.4313089317765065
86,1644189,5ht2a_human,242,S,A,Mesulergine,ChEMBL Compound ID,CHEMBL12314,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,129.0,nM,=,,4.2,30.714,,,[3H]Ketanserin,0.0,0.0,,0.0,,P28223,0.4313089317765065
87,8700116,5ht2a_human,242,S,A,Mesulergine,ChEMBL Compound ID,CHEMBL12314,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,28.0,nM,=,,3.9,7.179,,,[3H]Ketanserin,0.0,0.0,,0.0,,P28223,0.4313089317765065
88,8700116,5ht2a_human,242,S,A,Lisuride,ChEMBL Compound ID,CHEMBL157138,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.33,nM,=,,2.0,-6.061,,,[3H]Ketanserin,0.0,0.0,,0.0,,P28223,0.4313089317765065
89,8700116,5ht2a_human,242,S,A,4-HT,ChEMBL Compound ID,CHEMBL18845,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,410.0,nM,=,,1023.0,-2.494,,,[3H]Ketanserin,0.0,0.0,,0.0,,P28223,0.4313089317765065
103,8700116,5ht2a_human,242,S,A,5-HT,ChEMBL Compound ID,CHEMBL39,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,316.0,nM,=,,1150.0,-3.636,,,[3H]Ketanserin,0.0,0.0,,0.0,,P28223,0.4313089317765065
109,8700116,5ht2a_human,242,S,A,Bufotenine,ChEMBL Compound ID,CHEMBL416526,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,182.0,nM,=,,473.0,-2.597,,,[3H]Ketanserin,0.0,0.0,,0.0,,P28223,0.4313089317765065
114,8700116,5ht2a_human,242,S,A,LSD,ChEMBL Compound ID,CHEMBL463207,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.24,nM,=,,2.1,-8.772,,,[3H]Ketanserin,0.0,0.0,,0.0,,P28223,0.4313089317765065
118,8700116,5ht2a_human,242,S,A,Ketanserin,ChEMBL Compound ID,CHEMBL51,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,0.75,nM,=,,0.49,1.531,,,,0.0,0.0,,0.0,,P28223,0.4313089317765065
130,8700116,5ht2a_human,242,S,A,Psilocin,ChEMBL Compound ID,CHEMBL65547,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,81.0,nM,=,,259.0,-3.195,,,[3H]Ketanserin,0.0,0.0,,0.0,,P28223,0.4313089317765065
135,8700116,5ht2a_human,242,S,A,DOI,ChEMBL Compound ID,CHEMBL6616,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,15.0,nM,=,,51.0,-3.401,,,[3H]Ketanserin,0.0,0.0,,0.0,,P28223,0.4313089317765065
136,8700116,5ht2a_human,242,S,A,Tryptamine,ChEMBL Compound ID,CHEMBL6640,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,929.0,nM,=,,3493.0,-3.759,,,[3H]Ketanserin,0.0,0.0,,0.0,,P28223,0.4313089317765065
9,10.1111/bph.15756,5ht2a_human,238,G,S,risperidone,SMILES,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,Inverse agonist,pK(b),Functional - IP accumulation,8.88,,=,,8.69,-1.548,,,Inhibition,0.0,0.0,,0.0,,P28223,0.4330082232463093
14,10.1111/bph.15756,5ht2a_human,238,G,S,"(2S,4R)-2a",SMILES,CN(C)[C@@H]1CC2=C(C=CC=C2)[C@@H](C3=CC=CC(Br)=C3)C1,Inverse agonist,pK(b),Functional - IP accumulation,6.97,,=,,5.87,-12.658,,,Inhibition,0.0,0.0,,0.0,,P28223,0.4330082232463093
19,10.1111/bph.15756,5ht2a_human,238,G,S,"(2S,4R)-2k",SMILES,CN(C)[C@@H]1CC2=C(C=CC=C2)[C@@H](C3=CC(C4=CC=C(N(C)C)C=C4)=CC=C3)C1,Inverse agonist,pK(b),Functional - IP accumulation,7.91,,=,,4.92,-1000.0,,,Inhibition,0.0,0.0,,0.0,,P28223,0.4330082232463093
24,10.1111/bph.15756,5ht2a_human,238,G,S,"(2R,4R)-3h",SMILES,CN(C)[C@H]1CC2=C(C=CC=C2)[C@@H](C3=CC(C4=CC=CC(F)=C4)=CC=C3)C1,Inverse agonist,pK(b),Functional - IP accumulation,6.97,,=,,4.59,-250.0,,,Inhibition,0.0,0.0,,0.0,,P28223,0.4330082232463093
30,10.1111/bph.15756,5ht2a_human,238,G,S,5-HT,SMILES,C1=CC2=C(C=C1O)C(=CN2)CCN,Full agonist,pEC50,Functional - IP accumulation,7.53,,=,,6.37,-14.493,,,Inhibition,0.0,0.0,,0.0,,P28223,0.4330082232463093
99,7622478,5ht2a_human,120,D,N,5-HT,ChEMBL Compound ID,CHEMBL39,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,296.0,nM,=,,353.0,-1.192,,,[3H]Ketanserin,0.0,0.0,,0.0,,P28223,0.7389930947978057
100,7622478,5ht2a_human,120,D,N,5-HT,ChEMBL Compound ID,CHEMBL39,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,296.0,nM,=,,556.0,-1.88,,,[3H]Ketanserin,0.0,0.0,,0.0,,P28223,0.7389930947978057
111,7622478,5ht2a_human,120,D,N,LSD,ChEMBL Compound ID,CHEMBL463207,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.25,nM,=,,0.17,1.471,,,[3H]Ketanserin,0.0,0.0,,0.0,,P28223,0.7389930947978057
117,7622478,5ht2a_human,120,D,N,Ketanserin,ChEMBL Compound ID,CHEMBL51,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,0.64,nM,=,,0.92,-1.437,,,,0.0,0.0,,0.0,,P28223,0.7389930947978057
126,7622478,5ht2a_human,120,D,N,Haloperidol,ChEMBL Compound ID,CHEMBL54,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,66.0,nM,=,,74.0,-1.121,,,[3H]Ketanserin,0.0,0.0,,0.0,,P28223,0.7389930947978057
129,7622478,5ht2a_human,120,D,N,Mianserin,ChEMBL Compound ID,CHEMBL6437,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,2.95,nM,=,,3.75,-1.271,,,[3H]Ketanserin,0.0,0.0,,0.0,,P28223,0.7389930947978057
134,7622478,5ht2a_human,120,D,N,DOI,ChEMBL Compound ID,CHEMBL6616,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,15.0,nM,=,,24.0,-1.6,,,[3H]Ketanserin,0.0,0.0,,0.0,,P28223,0.7389930947978057
139,7622478,5ht2a_human,120,D,N,5-Metoxygramine,PubChem CID,27965,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,1012.0,nM,=,,703.0,1.44,,,[3H]Ketanserin,0.0,0.0,,0.0,,P28223,0.7389930947978057
101,8663249,5ht2a_human,159,S,A,5-HT,ChEMBL Compound ID,CHEMBL39,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,396.0,nM,=,,6960.0,-17.544,,,[3H]Ketanserin,0.0,0.0,,0.0,,P28223,0.4599927893731991
107,8663249,5ht2a_human,159,S,A,Bufotenine,ChEMBL Compound ID,CHEMBL416526,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,162.0,nM,=,,645.0,-3.984,,,[3H]Ketanserin,0.0,0.0,,0.0,,P28223,0.4599927893731991
112,8663249,5ht2a_human,159,S,A,LSD,ChEMBL Compound ID,CHEMBL463207,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.38,nM,=,,0.54,-1.42,,,[3H]Ketanserin,0.0,0.0,,0.0,,P28223,0.4599927893731991
127,8663249,5ht2a_human,159,S,A,Ketanserin,ChEMBL Compound ID,CHEMBL54,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,0.84,nM,=,,1.1,-1.309,,,,0.0,0.0,,0.0,,P28223,0.4599927893731991
102,8663249,5ht2a_human,159,S,C,5-HT,ChEMBL Compound ID,CHEMBL39,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,396.0,nM,=,,1947.0,-4.926,,,[3H]Ketanserin,0.0,0.0,,0.0,,P28223,0.5496793914945197
108,8663249,5ht2a_human,159,S,C,Bufotenine,ChEMBL Compound ID,CHEMBL416526,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,162.0,nM,=,,224.0,-1.383,,,[3H]Ketanserin,0.0,0.0,,0.0,,P28223,0.5496793914945197
113,8663249,5ht2a_human,159,S,C,LSD,ChEMBL Compound ID,CHEMBL463207,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.38,nM,=,,0.33,1.152,,,[3H]Ketanserin,0.0,0.0,,0.0,,P28223,0.5496793914945197
128,8663249,5ht2a_human,159,S,C,Ketanserin,ChEMBL Compound ID,CHEMBL54,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,0.84,nM,=,,0.66,1.273,,,,0.0,0.0,,0.0,,P28223,0.5496793914945197
121,7622478,5ht2a_human,120,D,A,Ketanserin,ChEMBL Compound ID,CHEMBL52,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,0.64,nM,=,,0.55,1.164,,,,0.0,0.0,,0.0,,P28223,0.8293263367880164
123,7622478,5ht2a_human,376,N,D,Ketanserin,ChEMBL Compound ID,CHEMBL53,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,0.64,nM,=,,0.77,-1.203,,,,0.0,0.0,,0.0,,P28223,0.7956437904192831
2,16847335,cxcr3_human,4,E,K,CXL10_HUMAN,UniProt Entry Code (peptide),P02778,Full agonist,IC50,Binding - Radioligand competition/displacement,0.062,nM,=,,0.049,1.265,,,[125I]-CXCL10,140.0,0.0,,0.0,,P49682,0.2865257982852599
15,16847335,cxcr3_human,4,E,K,CXL11_HUMAN,UniProt Entry Code (peptide),O14625,Full agonist,IC50,Binding - Radioligand competition/displacement,0.5,nM,=,,1.2,-2.398,,,[125I]-CXCL11,140.0,0.0,,0.0,,P49682,0.2865257982852599
3,16847335,cxcr3_human,21,E,K,CXL10_HUMAN,UniProt Entry Code (peptide),P02778,Full agonist,IC50,Binding - Radioligand competition/displacement,0.062,nM,=,,0.108,-1.742,,,[125I]-CXCL10,125.0,0.0,,0.0,,P49682,0.2952574063870345
16,16847335,cxcr3_human,21,E,K,CXL11_HUMAN,UniProt Entry Code (peptide),O14625,Full agonist,IC50,Binding - Radioligand competition/displacement,0.5,nM,=,,1.82,-3.636,,,[125I]-CXCL11,125.0,0.0,,0.0,,P49682,0.2952574063870345
8,16847335,cxcr3_human,216,R,A,CXL10_HUMAN,UniProt Entry Code (peptide),P02778,Full agonist,IC50,Binding - Radioligand competition/displacement,0.062,nM,=,,0.016,3.875,,,[125I]-CXCL10,121.0,0.0,,0.0,,P49682,0.4654513150550191
21,16847335,cxcr3_human,216,R,A,CXL11_HUMAN,UniProt Entry Code (peptide),O14625,Full agonist,IC50,Binding - Radioligand competition/displacement,0.5,nM,=,,1.35,-2.703,,,[125I]-CXCL11,121.0,0.0,,0.0,,P49682,0.4654513150550191
28,17170198,cxcr3_human,128,G,H,Cu(II)-Bipyridine,SMILES,C1=CC=NC(=C1)C2=CC=CC=N2.C1=CC=NC(=C1)C2=CC=CC=N2.[Cu],Full agonist,EC50,Functional - IP accumulation,0.937,ÂµM,=,,22.0,-23.256,,,,0.0,0.0,,347.0,,P49682,0.5202917510520574
44,17170198,cxcr3_human,128,G,H,CXL11_HUMAN,UniProt Entry Code (peptide),O14625,Full agonist,EC50,,1.7,nM,=,,15.0,-8.85,,,,0.0,0.0,,39.52205882352941,,P49682,0.5202917510520574
59,17170198,cxcr3_human,128,G,H,Zn(II)-Bipyridine,SMILES,C1=CC=NC(=C1)C2=CC=CC=N2.C1=CC=NC(=C1)C2=CC=CC=N2.[Zn],Full agonist,pEC50,,2.9,,=,,4.3,25.119,,,,0.0,0.0,,0.0,,P49682,0.5202917510520574
94,24174496,cxcr3_human,128,G,H,CXL11_HUMAN,UniProt Entry Code (peptide),O14625,Full agonist,pK(d),Binding - Radioligand competition/displacement,9.7,,=,,9.0,-5.0,,,[125I]-CXCL11,80.0,0.0,,0.0,,P49682,0.5202917510520574
120,24174496,cxcr3_human,128,G,H,NBI-74330,ChEMBL Compound ID,CHEMBL1077819,Antagonist (neutral/silent),pIC50,Binding - Radioligand competition/displacement,7.2,,=,,5.2,-100.0,,,[125I]-CXCL11,80.0,0.0,,0.0,,P49682,0.5202917510520574
146,24174496,cxcr3_human,128,G,H,VUF10661,ChEMBL Compound ID,CHEMBL2181467,Full agonist,pIC50,Binding - Radioligand competition/displacement,6.0,,=,,4.8,-15.873,,,[125I]-CXCL11,80.0,0.0,,0.0,,P49682,0.5202917510520574
172,24174496,cxcr3_human,128,G,H,VUF11211,SMILES,CC[C@H]1CN(C2=NC=C(C(NCC)=O)C=C2Cl)CCN1C3CCN(CC4=CC=C(Cl)C=C4)CC3,Antagonist (neutral/silent),pIC50,Binding - Radioligand competition/displacement,7.8,,=,,4.9,-1000.0,,,[125I]-CXCL11,80.0,0.0,,0.0,,P49682,0.5202917510520574
29,17170198,cxcr3_human,131,F,A,Cu(II)-Bipyridine,SMILES,C1=CC=NC(=C1)C2=CC=CC=N2.C1=CC=NC(=C1)C2=CC=CC=N2.[Cu],Full agonist,EC50,Functional - IP accumulation,0.937,ÂµM,=,,1415.0,-1000.0,,,,0.0,0.0,,0.0,,P49682,0.5832897124276578
45,17170198,cxcr3_human,131,F,A,CXL11_HUMAN,UniProt Entry Code (peptide),O14625,Full agonist,EC50,,1.7,nM,=,,35.0,-20.408,,,,0.0,0.0,,13.23529411764706,,P49682,0.5832897124276578
60,17170198,cxcr3_human,131,F,A,Zn(II)-Bipyridine,SMILES,C1=CC=NC(=C1)C2=CC=CC=N2.C1=CC=NC(=C1)C2=CC=CC=N2.[Zn],Full agonist,pEC50,,2.9,,=,,3.0,1.259,,,,0.0,0.0,,0.0,,P49682,0.5832897124276578
95,24174496,cxcr3_human,131,F,A,CXL11_HUMAN,UniProt Entry Code (peptide),O14625,Full agonist,pK(d),Binding - Radioligand competition/displacement,9.7,,=,,9.6,-1.259,,,[125I]-CXCL11,74.0,0.0,,0.0,,P49682,0.5832897124276578
121,24174496,cxcr3_human,131,F,A,NBI-74330,ChEMBL Compound ID,CHEMBL1077819,Antagonist (neutral/silent),pIC50,Binding - Radioligand competition/displacement,7.2,,=,,6.3,-7.937,,,[125I]-CXCL11,74.0,0.0,,0.0,,P49682,0.5832897124276578
147,24174496,cxcr3_human,131,F,A,VUF10661,ChEMBL Compound ID,CHEMBL2181467,Full agonist,pIC50,Binding - Radioligand competition/displacement,6.0,,=,,4.5,-31.25,,,[125I]-CXCL11,74.0,0.0,,0.0,,P49682,0.5832897124276578
173,24174496,cxcr3_human,131,F,A,VUF11211,SMILES,CC[C@H]1CN(C2=NC=C(C(NCC)=O)C=C2Cl)CCN1C3CCN(CC4=CC=C(Cl)C=C4)CC3,Antagonist (neutral/silent),pIC50,Binding - Radioligand competition/displacement,7.8,,=,,6.5,-20.0,,,[125I]-CXCL11,74.0,0.0,,0.0,,P49682,0.5832897124276578
186,25425280,cxcr3_human,131,F,A,CXL11_HUMAN,UniProt Entry Code (peptide),O14625,Full agonist,K(d),Binding - Radioligand competition/displacement,7.7,nM,=,,1.1,7.0,,,[125I]-CXCL11,77.6,0.0,,0.0,,P49682,0.5832897124276578
191,25425280,cxcr3_human,131,F,A,TAK-779,ChEMBL Compound ID,CHEMBL1178786,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,31.3,ÂµM,=,,23.3,1.343,,,[125I]-CXCL11,77.6,0.0,,0.0,,P49682,0.5832897124276578
196,25425280,cxcr3_human,131,F,A,VUF10085,SMILES,O=C(CC1=CC=C(OC(F)(F)F)C=C1)N(C(C(N2C3=CC=C(OCC)C=C3)=NC4=NC=CC=C4C2=O)C)CC5=CC=CN=C5,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,0.241,ÂµM,=,,0.161,1.497,,,[125I]-CXCL11,77.6,0.0,,0.0,,P49682,0.5832897124276578
31,17170198,cxcr3_human,186,D,N,Cu(II)-Bipyridine,SMILES,C1=CC=NC(=C1)C2=CC=CC=N2.C1=CC=NC(=C1)C2=CC=CC=N2.[Cu],Full agonist,EC50,Functional - IP accumulation,0.937,ÂµM,=,,885.0,-1000.0,,,,0.0,0.0,,0.0,,P49682,0.358965017278625
47,17170198,cxcr3_human,186,D,N,CXL11_HUMAN,UniProt Entry Code (peptide),O14625,Full agonist,EC50,,1.7,nM,=,,9.0,-5.291,,,,0.0,0.0,,12.316176470588236,,P49682,0.358965017278625
61,17170198,cxcr3_human,186,D,N,Zn(II)-Bipyridine,SMILES,C1=CC=NC(=C1)C2=CC=CC=N2.C1=CC=NC(=C1)C2=CC=CC=N2.[Zn],Full agonist,pEC50,,2.9,,=,,2.9,1.0,,,,0.0,0.0,,0.0,,P49682,0.358965017278625
84,24174496,cxcr3_human,186,D,N,CXL11_HUMAN,UniProt Entry Code (peptide),O14625,Full agonist,pK(d),Binding - Radioligand competition/displacement,9.7,,=,,9.8,1.259,,,[125I]-CXCL11,68.0,0.0,,0.0,,P49682,0.358965017278625
110,24174496,cxcr3_human,186,D,N,NBI-74330,ChEMBL Compound ID,CHEMBL1077819,Antagonist (neutral/silent),pIC50,Binding - Radioligand competition/displacement,7.2,,=,,7.7,3.162,,,[125I]-CXCL11,68.0,0.0,,0.0,,P49682,0.358965017278625
136,24174496,cxcr3_human,186,D,N,VUF10661,ChEMBL Compound ID,CHEMBL2181467,Full agonist,pIC50,Binding - Radioligand competition/displacement,6.0,,=,,5.7,-1.996,,,[125I]-CXCL11,68.0,0.0,,0.0,,P49682,0.358965017278625
162,24174496,cxcr3_human,186,D,N,VUF11211,SMILES,CC[C@H]1CN(C2=NC=C(C(NCC)=O)C=C2Cl)CCN1C3CCN(CC4=CC=C(Cl)C=C4)CC3,Antagonist (neutral/silent),pIC50,Binding - Radioligand competition/displacement,7.8,,=,,6.8,-10.0,,,[125I]-CXCL11,68.0,0.0,,0.0,,P49682,0.358965017278625
32,17170198,cxcr3_human,202,H,A,Cu(II)-Bipyridine,SMILES,C1=CC=NC(=C1)C2=CC=CC=N2.C1=CC=NC(=C1)C2=CC=CC=N2.[Cu],Full agonist,EC50,Functional - IP accumulation,0.937,ÂµM,=,,58.0,-62.5,,,,0.0,0.0,,153.0,,P49682,0.4021378616192168
48,17170198,cxcr3_human,202,H,A,CXL11_HUMAN,UniProt Entry Code (peptide),O14625,Full agonist,EC50,,1.7,nM,=,,17.0,-10.0,,,,0.0,0.0,,15.625,,P49682,0.4021378616192168
187,25425280,cxcr3_human,202,H,A,CXL11_HUMAN,UniProt Entry Code (peptide),O14625,Full agonist,K(d),Binding - Radioligand competition/displacement,7.7,nM,=,,2.9,2.655,,,[125I]-CXCL11,95.3,0.0,,0.0,,P49682,0.4021378616192168
192,25425280,cxcr3_human,202,H,A,TAK-779,ChEMBL Compound ID,CHEMBL1178786,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,31.3,ÂµM,=,,25.3,1.237,,,[125I]-CXCL11,95.3,0.0,,0.0,,P49682,0.4021378616192168
197,25425280,cxcr3_human,202,H,A,VUF10085,SMILES,O=C(CC1=CC=C(OC(F)(F)F)C=C1)N(C(C(N2C3=CC=C(OCC)C=C3)=NC4=NC=CC=C4C2=O)C)CC5=CC=CN=C5,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,0.241,ÂµM,=,,0.299,-1.241,,,[125I]-CXCL11,95.3,0.0,,0.0,,P49682,0.4021378616192168
34,17170198,cxcr3_human,212,R,H,Cu(II)-Bipyridine,SMILES,C1=CC=NC(=C1)C2=CC=CC=N2.C1=CC=NC(=C1)C2=CC=CC=N2.[Cu],Full agonist,EC50,Functional - IP accumulation,0.937,ÂµM,=,,19.0,-20.408,,,,0.0,0.0,,526.0,,P49682,0.3221432727146242
49,17170198,cxcr3_human,212,R,H,CXL11_HUMAN,UniProt Entry Code (peptide),O14625,Full agonist,EC50,,1.7,nM,=,,16.0,-9.434,,,,0.0,0.0,,42.64705882352941,,P49682,0.3221432727146242
35,17170198,cxcr3_human,268,W,A,Cu(II)-Bipyridine,SMILES,C1=CC=NC(=C1)C2=CC=CC=N2.C1=CC=NC(=C1)C2=CC=CC=N2.[Cu],Full agonist,EC50,Functional - IP accumulation,0.937,ÂµM,=,,50.0,-52.632,,,,0.0,0.0,,313.0,,P49682,0.807041219139772
50,17170198,cxcr3_human,268,W,A,CXL11_HUMAN,UniProt Entry Code (peptide),O14625,Full agonist,EC50,,1.7,nM,=,,27.0,-15.873,,,,0.0,0.0,,12.5,,P49682,0.807041219139772
63,17170198,cxcr3_human,268,W,A,Zn(II)-Bipyridine,SMILES,C1=CC=NC(=C1)C2=CC=CC=N2.C1=CC=NC(=C1)C2=CC=CC=N2.[Zn],Full agonist,pEC50,,2.9,,=,,3.7,6.31,,,,0.0,0.0,,0.0,,P49682,0.807041219139772
36,17170198,cxcr3_human,271,Y,A,Cu(II)-Bipyridine,SMILES,C1=CC=NC(=C1)C2=CC=CC=N2.C1=CC=NC(=C1)C2=CC=CC=N2.[Cu],Full agonist,EC50,Functional - IP accumulation,0.937,ÂµM,=,,794.0,-1000.0,,,,0.0,0.0,,0.0,,P49682,0.5695185326111121
51,17170198,cxcr3_human,271,Y,A,CXL11_HUMAN,UniProt Entry Code (peptide),O14625,Full agonist,EC50,,1.7,nM,=,,1.7,1.0,,,,0.0,0.0,,7.904411764705882,,P49682,0.5695185326111121
64,17170198,cxcr3_human,271,Y,A,Zn(II)-Bipyridine,SMILES,C1=CC=NC(=C1)C2=CC=CC=N2.C1=CC=NC(=C1)C2=CC=CC=N2.[Zn],Full agonist,pEC50,,2.9,,=,,2.9,1.0,,,,0.0,0.0,,0.0,,P49682,0.5695185326111121
99,24174496,cxcr3_human,271,Y,A,CXL11_HUMAN,UniProt Entry Code (peptide),O14625,Full agonist,pK(d),Binding - Radioligand competition/displacement,9.7,,=,,9.6,-1.259,,,[125I]-CXCL11,41.0,0.0,,0.0,,P49682,0.5695185326111121
125,24174496,cxcr3_human,271,Y,A,NBI-74330,ChEMBL Compound ID,CHEMBL1077819,Antagonist (neutral/silent),pIC50,Binding - Radioligand competition/displacement,7.2,,=,,6.4,-6.329,,,[125I]-CXCL11,41.0,0.0,,0.0,,P49682,0.5695185326111121
151,24174496,cxcr3_human,271,Y,A,VUF10661,ChEMBL Compound ID,CHEMBL2181467,Full agonist,pIC50,Binding - Radioligand competition/displacement,6.0,,=,,5.7,-1.996,,,[125I]-CXCL11,41.0,0.0,,0.0,,P49682,0.5695185326111121
177,24174496,cxcr3_human,271,Y,A,VUF11211,SMILES,CC[C@H]1CN(C2=NC=C(C(NCC)=O)C=C2Cl)CCN1C3CCN(CC4=CC=C(Cl)C=C4)CC3,Antagonist (neutral/silent),pIC50,Binding - Radioligand competition/displacement,7.8,,=,,6.8,-10.0,,,[125I]-CXCL11,41.0,0.0,,0.0,,P49682,0.5695185326111121
38,17170198,cxcr3_human,271,Y,N,Cu(II)-Bipyridine,SMILES,C1=CC=NC(=C1)C2=CC=CC=N2.C1=CC=NC(=C1)C2=CC=CC=N2.[Cu],Full agonist,EC50,Functional - IP accumulation,0.937,ÂµM,=,,693.0,-1000.0,,,,0.0,0.0,,0.0,,P49682,0.5695185326111121
53,17170198,cxcr3_human,271,Y,N,CXL11_HUMAN,UniProt Entry Code (peptide),O14625,Full agonist,EC50,,1.7,nM,=,,5.6,-3.289,,,,0.0,0.0,,7.169117647058823,,P49682,0.5695185326111121
39,17170198,cxcr3_human,271,Y,F,Cu(II)-Bipyridine,SMILES,C1=CC=NC(=C1)C2=CC=CC=N2.C1=CC=NC(=C1)C2=CC=CC=N2.[Cu],Full agonist,EC50,Functional - IP accumulation,0.937,ÂµM,=,,51.0,-55.556,,,,0.0,0.0,,263.0,,P49682,0.349732441091097
54,17170198,cxcr3_human,271,Y,F,CXL11_HUMAN,UniProt Entry Code (peptide),O14625,Full agonist,EC50,,1.7,nM,=,,7.6,-4.464,,,,0.0,0.0,,29.59558823529412,,P49682,0.349732441091097
40,17170198,cxcr3_human,271,Y,H,Cu(II)-Bipyridine,SMILES,C1=CC=NC(=C1)C2=CC=CC=N2.C1=CC=NC(=C1)C2=CC=CC=N2.[Cu],Full agonist,EC50,Functional - IP accumulation,0.937,ÂµM,=,,108.0,-111.111,,,,0.0,0.0,,196.0,,P49682,0.391690106821167
55,17170198,cxcr3_human,271,Y,H,CXL11_HUMAN,UniProt Entry Code (peptide),O14625,Full agonist,EC50,,1.7,nM,=,,9.6,-5.65,,,,0.0,0.0,,18.933823529411764,,P49682,0.391690106821167
41,17170198,cxcr3_human,278,D,N,Cu(II)-Bipyridine,SMILES,C1=CC=NC(=C1)C2=CC=CC=N2.C1=CC=NC(=C1)C2=CC=CC=N2.[Cu],Full agonist,EC50,Functional - IP accumulation,0.937,ÂµM,=,,55.0,-58.824,,,,0.0,0.0,,195.0,,P49682,0.3356388641685601
56,17170198,cxcr3_human,278,D,N,CXL11_HUMAN,UniProt Entry Code (peptide),O14625,Full agonist,EC50,,1.7,nM,=,,13.0,-7.634,,,,0.0,0.0,,13.419117647058822,,P49682,0.3356388641685601
65,17170198,cxcr3_human,278,D,N,Zn(II)-Bipyridine,SMILES,C1=CC=NC(=C1)C2=CC=CC=N2.C1=CC=NC(=C1)C2=CC=CC=N2.[Zn],Full agonist,pEC50,,2.9,,=,,3.7,6.31,,,,0.0,0.0,,0.0,,P49682,0.3356388641685601
70,21895630,cxcr3_human,278,D,N,CXL10_HUMAN,UniProt Entry Code (peptide),P02778,Full agonist,K(d),Binding - Radioligand competition/displacement,4.7,nM,=,,30.9,-6.579,,,[125I]-CXCL11,92.6,0.0,,0.0,,P49682,0.3356388641685601
77,21895630,cxcr3_human,278,D,N,CXL11_HUMAN,UniProt Entry Code (peptide),O14625,Full agonist,K(d),Binding - Radioligand competition/displacement,10.9,nM,=,,2.6,4.192,,,[125I]-CXCL11,92.6,0.0,,0.0,,P49682,0.3356388641685601
87,24174496,cxcr3_human,278,D,N,CXL11_HUMAN,UniProt Entry Code (peptide),O14625,Full agonist,pK(d),Binding - Radioligand competition/displacement,9.7,,=,,9.6,-1.259,,,[125I]-CXCL11,84.0,0.0,,0.0,,P49682,0.3356388641685601
113,24174496,cxcr3_human,278,D,N,NBI-74330,ChEMBL Compound ID,CHEMBL1077819,Antagonist (neutral/silent),pIC50,Binding - Radioligand competition/displacement,7.2,,=,,7.7,3.162,,,[125I]-CXCL11,84.0,0.0,,0.0,,P49682,0.3356388641685601
139,24174496,cxcr3_human,278,D,N,VUF10661,ChEMBL Compound ID,CHEMBL2181467,Full agonist,pIC50,Binding - Radioligand competition/displacement,6.0,,=,,6.2,1.585,,,[125I]-CXCL11,84.0,0.0,,0.0,,P49682,0.3356388641685601
165,24174496,cxcr3_human,278,D,N,VUF11211,SMILES,CC[C@H]1CN(C2=NC=C(C(NCC)=O)C=C2Cl)CCN1C3CCN(CC4=CC=C(Cl)C=C4)CC3,Antagonist (neutral/silent),pIC50,Binding - Radioligand competition/displacement,7.8,,=,,7.9,1.259,,,[125I]-CXCL11,84.0,0.0,,0.0,,P49682,0.3356388641685601
42,17170198,cxcr3_human,300,K,A,Cu(II)-Bipyridine,SMILES,C1=CC=NC(=C1)C2=CC=CC=N2.C1=CC=NC(=C1)C2=CC=CC=N2.[Cu],Full agonist,EC50,Functional - IP accumulation,0.937,ÂµM,=,,20.0,-21.277,,,,0.0,0.0,,151.0,,P49682,0.4729958415595908
57,17170198,cxcr3_human,300,K,A,CXL11_HUMAN,UniProt Entry Code (peptide),O14625,Full agonist,EC50,,1.7,nM,=,,4.2,-2.469,,,,0.0,0.0,,18.56617647058824,,P49682,0.4729958415595908
66,17170198,cxcr3_human,300,K,A,Zn(II)-Bipyridine,SMILES,C1=CC=NC(=C1)C2=CC=CC=N2.C1=CC=NC(=C1)C2=CC=CC=N2.[Zn],Full agonist,pEC50,,2.9,,=,,4.3,25.119,,,,0.0,0.0,,0.0,,P49682,0.4729958415595908
43,17170198,cxcr3_human,308,Y,A,Cu(II)-Bipyridine,SMILES,C1=CC=NC(=C1)C2=CC=CC=N2.C1=CC=NC(=C1)C2=CC=CC=N2.[Cu],Full agonist,EC50,Functional - IP accumulation,0.937,ÂµM,=,,631.0,-1000.0,,,,0.0,0.0,,0.0,,P49682,0.6177079328855097
58,17170198,cxcr3_human,308,Y,A,CXL11_HUMAN,UniProt Entry Code (peptide),O14625,Full agonist,EC50,,1.7,nM,=,,7.4,-4.348,,,,0.0,0.0,,15.257352941176473,,P49682,0.6177079328855097
67,17170198,cxcr3_human,308,Y,A,Zn(II)-Bipyridine,SMILES,C1=CC=NC(=C1)C2=CC=CC=N2.C1=CC=NC(=C1)C2=CC=CC=N2.[Zn],Full agonist,pEC50,,2.9,,=,,3.2,1.995,,,,0.0,0.0,,0.0,,P49682,0.6177079328855097
105,24174496,cxcr3_human,308,Y,A,CXL11_HUMAN,UniProt Entry Code (peptide),O14625,Full agonist,pK(d),Binding - Radioligand competition/displacement,9.7,,=,,9.5,-1.585,,,[125I]-CXCL11,75.0,0.0,,0.0,,P49682,0.6177079328855097
131,24174496,cxcr3_human,308,Y,A,NBI-74330,ChEMBL Compound ID,CHEMBL1077819,Antagonist (neutral/silent),pIC50,Binding - Radioligand competition/displacement,7.2,,=,,5.7,-31.25,,,[125I]-CXCL11,75.0,0.0,,0.0,,P49682,0.6177079328855097
157,24174496,cxcr3_human,308,Y,A,VUF10661,ChEMBL Compound ID,CHEMBL2181467,Full agonist,pIC50,Binding - Radioligand competition/displacement,6.0,,=,,5.0,-10.0,,,[125I]-CXCL11,75.0,0.0,,0.0,,P49682,0.6177079328855097
183,24174496,cxcr3_human,308,Y,A,VUF11211,SMILES,CC[C@H]1CN(C2=NC=C(C(NCC)=O)C=C2Cl)CCN1C3CCN(CC4=CC=C(Cl)C=C4)CC3,Antagonist (neutral/silent),pIC50,Binding - Radioligand competition/displacement,7.8,,=,,6.9,-7.937,,,[125I]-CXCL11,75.0,0.0,,0.0,,P49682,0.6177079328855097
194,25425280,cxcr3_human,308,Y,A,TAK-779,ChEMBL Compound ID,CHEMBL1178786,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,31.3,ÂµM,=,,14.2,2.204,,,[125I]-CXCL11,75.0,0.0,,0.0,,P49682,0.6177079328855097
62,17170198,cxcr3_human,212,R,A,Zn(II)-Bipyridine,SMILES,C1=CC=NC(=C1)C2=CC=CC=N2.C1=CC=NC(=C1)C2=CC=CC=N2.[Zn],Full agonist,pEC50,,2.9,,=,,4.5,39.811,,,,0.0,0.0,,0.0,,P49682,0.3626423775087263
68,21895630,cxcr3_human,195,D,N,CXL10_HUMAN,UniProt Entry Code (peptide),P02778,Full agonist,K(d),Binding - Radioligand competition/displacement,4.7,nM,=,,4.7,1.0,,,[125I]-CXCL11,74.2,0.0,,0.0,,P49682,0.2516915201246928
75,21895630,cxcr3_human,195,D,N,CXL11_HUMAN,UniProt Entry Code (peptide),O14625,Full agonist,K(d),Binding - Radioligand competition/displacement,10.9,nM,=,,16.0,-1.468,,,[125I]-CXCL11,74.2,0.0,,0.0,,P49682,0.2516915201246928
85,24174496,cxcr3_human,195,D,N,CXL11_HUMAN,UniProt Entry Code (peptide),O14625,Full agonist,pK(d),Binding - Radioligand competition/displacement,9.7,,=,,9.8,1.259,,,[125I]-CXCL11,94.0,0.0,,0.0,,P49682,0.2516915201246928
111,24174496,cxcr3_human,195,D,N,NBI-74330,ChEMBL Compound ID,CHEMBL1077819,Antagonist (neutral/silent),pIC50,Binding - Radioligand competition/displacement,7.2,,=,,7.1,-1.259,,,[125I]-CXCL11,94.0,0.0,,0.0,,P49682,0.2516915201246928
137,24174496,cxcr3_human,195,D,N,VUF10661,ChEMBL Compound ID,CHEMBL2181467,Full agonist,pIC50,Binding - Radioligand competition/displacement,6.0,,=,,6.2,1.585,,,[125I]-CXCL11,94.0,0.0,,0.0,,P49682,0.2516915201246928
163,24174496,cxcr3_human,195,D,N,VUF11211,SMILES,CC[C@H]1CN(C2=NC=C(C(NCC)=O)C=C2Cl)CCN1C3CCN(CC4=CC=C(Cl)C=C4)CC3,Antagonist (neutral/silent),pIC50,Binding - Radioligand competition/displacement,7.8,,=,,8.0,1.585,,,[125I]-CXCL11,94.0,0.0,,0.0,,P49682,0.2516915201246928
69,21895630,cxcr3_human,196,E,Q,CXL10_HUMAN,UniProt Entry Code (peptide),P02778,Full agonist,K(d),Binding - Radioligand competition/displacement,4.7,nM,=,,7.6,-1.618,,,[125I]-CXCL11,188.0,0.0,,0.0,,P49682,0.2013758363510648
76,21895630,cxcr3_human,196,E,Q,CXL11_HUMAN,UniProt Entry Code (peptide),O14625,Full agonist,K(d),Binding - Radioligand competition/displacement,10.9,nM,=,,0.4,27.25,,,[125I]-CXCL11,188.0,0.0,,0.0,,P49682,0.2013758363510648
71,21895630,cxcr3_human,282,D,N,CXL10_HUMAN,UniProt Entry Code (peptide),P02778,Full agonist,K(d),Binding - Radioligand competition/displacement,4.7,nM,=,,2.9,1.621,,,[125I]-CXCL11,62.1,0.0,,0.0,,P49682,0.2287770237499964
78,21895630,cxcr3_human,282,D,N,CXL11_HUMAN,UniProt Entry Code (peptide),O14625,Full agonist,K(d),Binding - Radioligand competition/displacement,10.9,nM,=,,1.4,7.786,,,[125I]-CXCL11,62.1,0.0,,0.0,,P49682,0.2287770237499964
72,21895630,cxcr3_human,293,E,Q,CXL10_HUMAN,UniProt Entry Code (peptide),P02778,Full agonist,K(d),Binding - Radioligand competition/displacement,4.7,nM,=,,1.2,3.917,,,[125I]-CXCL11,134.8,0.0,,0.0,,P49682,0.2236180986929038
79,21895630,cxcr3_human,293,E,Q,CXL11_HUMAN,UniProt Entry Code (peptide),O14625,Full agonist,K(d),Binding - Radioligand competition/displacement,10.9,nM,=,,3.7,2.946,,,[125I]-CXCL11,134.8,0.0,,0.0,,P49682,0.2236180986929038
73,21895630,cxcr3_human,297,D,N,CXL10_HUMAN,UniProt Entry Code (peptide),P02778,Full agonist,K(d),Binding - Radioligand competition/displacement,4.7,nM,=,,7.1,-1.511,,,[125I]-CXCL11,90.2,0.0,,0.0,,P49682,0.2666381506139022
80,21895630,cxcr3_human,297,D,N,CXL11_HUMAN,UniProt Entry Code (peptide),O14625,Full agonist,K(d),Binding - Radioligand competition/displacement,10.9,nM,=,,26.3,-2.415,,,[125I]-CXCL11,90.2,0.0,,0.0,,P49682,0.2666381506139022
90,24174496,cxcr3_human,297,D,N,CXL11_HUMAN,UniProt Entry Code (peptide),O14625,Full agonist,pK(d),Binding - Radioligand competition/displacement,9.7,,=,,9.6,-1.259,,,[125I]-CXCL11,110.0,0.0,,0.0,,P49682,0.2666381506139022
116,24174496,cxcr3_human,297,D,N,NBI-74330,ChEMBL Compound ID,CHEMBL1077819,Antagonist (neutral/silent),pIC50,Binding - Radioligand competition/displacement,7.2,,=,,7.6,2.512,,,[125I]-CXCL11,110.0,0.0,,0.0,,P49682,0.2666381506139022
142,24174496,cxcr3_human,297,D,N,VUF10661,ChEMBL Compound ID,CHEMBL2181467,Full agonist,pIC50,Binding - Radioligand competition/displacement,6.0,,=,,6.9,7.943,,,[125I]-CXCL11,110.0,0.0,,0.0,,P49682,0.2666381506139022
168,24174496,cxcr3_human,297,D,N,VUF11211,SMILES,CC[C@H]1CN(C2=NC=C(C(NCC)=O)C=C2Cl)CCN1C3CCN(CC4=CC=C(Cl)C=C4)CC3,Antagonist (neutral/silent),pIC50,Binding - Radioligand competition/displacement,7.8,,=,,8.1,1.995,,,[125I]-CXCL11,110.0,0.0,,0.0,,P49682,0.2666381506139022
74,21895630,cxcr3_human,112,D,N,CXL11_HUMAN,UniProt Entry Code (peptide),O14625,Full agonist,K(d),Binding - Radioligand competition/displacement,10.9,nM,=,,3.8,2.868,,,[125I]-CXCL11,76.8,0.0,,0.0,,P49682,0.3444742152218123
83,24174496,cxcr3_human,112,D,N,CXL11_HUMAN,UniProt Entry Code (peptide),O14625,Full agonist,pK(d),Binding - Radioligand competition/displacement,9.7,,=,,9.6,-1.259,,,[125I]-CXCL11,96.0,0.0,,0.0,,P49682,0.3444742152218123
109,24174496,cxcr3_human,112,D,N,NBI-74330,ChEMBL Compound ID,CHEMBL1077819,Antagonist (neutral/silent),pIC50,Binding - Radioligand competition/displacement,7.2,,=,,6.1,-12.658,,,[125I]-CXCL11,96.0,0.0,,0.0,,P49682,0.3444742152218123
135,24174496,cxcr3_human,112,D,N,VUF10661,ChEMBL Compound ID,CHEMBL2181467,Full agonist,pIC50,Binding - Radioligand competition/displacement,6.0,,=,,5.5,-3.165,,,[125I]-CXCL11,96.0,0.0,,0.0,,P49682,0.3444742152218123
161,24174496,cxcr3_human,112,D,N,VUF11211,SMILES,CC[C@H]1CN(C2=NC=C(C(NCC)=O)C=C2Cl)CCN1C3CCN(CC4=CC=C(Cl)C=C4)CC3,Antagonist (neutral/silent),pIC50,Binding - Radioligand competition/displacement,7.8,,=,,7.8,1.0,,,[125I]-CXCL11,96.0,0.0,,0.0,,P49682,0.3444742152218123
81,24174496,cxcr3_human,46,D,N,CXL11_HUMAN,UniProt Entry Code (peptide),O14625,Full agonist,pK(d),Binding - Radioligand competition/displacement,9.7,,=,,9.3,-2.513,,,[125I]-CXCL11,100.0,0.0,,0.0,,P49682,0.2449909827961405
107,24174496,cxcr3_human,46,D,N,NBI-74330,ChEMBL Compound ID,CHEMBL1077819,Antagonist (neutral/silent),pIC50,Binding - Radioligand competition/displacement,7.2,,=,,7.2,1.0,,,[125I]-CXCL11,100.0,0.0,,0.0,,P49682,0.2449909827961405
133,24174496,cxcr3_human,46,D,N,VUF10661,ChEMBL Compound ID,CHEMBL2181467,Full agonist,pIC50,Binding - Radioligand competition/displacement,6.0,,=,,6.0,1.0,,,[125I]-CXCL11,100.0,0.0,,0.0,,P49682,0.2449909827961405
159,24174496,cxcr3_human,46,D,N,VUF11211,SMILES,CC[C@H]1CN(C2=NC=C(C(NCC)=O)C=C2Cl)CCN1C3CCN(CC4=CC=C(Cl)C=C4)CC3,Antagonist (neutral/silent),pIC50,Binding - Radioligand competition/displacement,7.8,,=,,7.8,1.0,,,[125I]-CXCL11,100.0,0.0,,0.0,,P49682,0.2449909827961405
82,24174496,cxcr3_human,52,D,N,CXL11_HUMAN,UniProt Entry Code (peptide),O14625,Full agonist,pK(d),Binding - Radioligand competition/displacement,9.7,,=,,9.6,-1.259,,,[125I]-CXCL11,121.0,0.0,,0.0,,P49682,0.2995605239574969
108,24174496,cxcr3_human,52,D,N,NBI-74330,ChEMBL Compound ID,CHEMBL1077819,Antagonist (neutral/silent),pIC50,Binding - Radioligand competition/displacement,7.2,,=,,7.5,1.995,,,[125I]-CXCL11,121.0,0.0,,0.0,,P49682,0.2995605239574969
134,24174496,cxcr3_human,52,D,N,VUF10661,ChEMBL Compound ID,CHEMBL2181467,Full agonist,pIC50,Binding - Radioligand competition/displacement,6.0,,=,,6.9,7.943,,,[125I]-CXCL11,121.0,0.0,,0.0,,P49682,0.2995605239574969
160,24174496,cxcr3_human,52,D,N,VUF11211,SMILES,CC[C@H]1CN(C2=NC=C(C(NCC)=O)C=C2Cl)CCN1C3CCN(CC4=CC=C(Cl)C=C4)CC3,Antagonist (neutral/silent),pIC50,Binding - Radioligand competition/displacement,7.8,,=,,8.1,1.995,,,[125I]-CXCL11,121.0,0.0,,0.0,,P49682,0.2995605239574969
91,24174496,cxcr3_human,60,Y,A,CXL11_HUMAN,UniProt Entry Code (peptide),O14625,Full agonist,pK(d),Binding - Radioligand competition/displacement,9.7,,=,,9.8,1.259,,,[125I]-CXCL11,75.0,0.0,,0.0,,P49682,0.6040181375424293
117,24174496,cxcr3_human,60,Y,A,NBI-74330,ChEMBL Compound ID,CHEMBL1077819,Antagonist (neutral/silent),pIC50,Binding - Radioligand competition/displacement,7.2,,=,,6.9,-1.996,,,[125I]-CXCL11,75.0,0.0,,0.0,,P49682,0.6040181375424293
143,24174496,cxcr3_human,60,Y,A,VUF10661,ChEMBL Compound ID,CHEMBL2181467,Full agonist,pIC50,Binding - Radioligand competition/displacement,6.0,,=,,5.0,-10.0,,,[125I]-CXCL11,75.0,0.0,,0.0,,P49682,0.6040181375424293
169,24174496,cxcr3_human,60,Y,A,VUF11211,SMILES,CC[C@H]1CN(C2=NC=C(C(NCC)=O)C=C2Cl)CCN1C3CCN(CC4=CC=C(Cl)C=C4)CC3,Antagonist (neutral/silent),pIC50,Binding - Radioligand competition/displacement,7.8,,=,,7.5,-1.996,,,[125I]-CXCL11,75.0,0.0,,0.0,,P49682,0.6040181375424293
185,25425280,cxcr3_human,60,Y,A,CXL11_HUMAN,UniProt Entry Code (peptide),O14625,Full agonist,K(d),Binding - Radioligand competition/displacement,7.7,nM,=,,1.8,4.278,,,[125I]-CXCL11,49.8,0.0,,0.0,,P49682,0.6040181375424293
190,25425280,cxcr3_human,60,Y,A,TAK-779,ChEMBL Compound ID,CHEMBL1178786,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,31.3,ÂµM,=,,14.0,2.236,,,[125I]-CXCL11,49.8,0.0,,0.0,,P49682,0.6040181375424293
195,25425280,cxcr3_human,60,Y,A,VUF10085,SMILES,O=C(CC1=CC=C(OC(F)(F)F)C=C1)N(C(C(N2C3=CC=C(OCC)C=C3)=NC4=NC=CC=C4C2=O)C)CC5=CC=CN=C5,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,0.241,ÂµM,=,,0.236,1.021,,,[125I]-CXCL11,49.8,0.0,,0.0,,P49682,0.6040181375424293
92,24174496,cxcr3_human,60,Y,F,CXL11_HUMAN,UniProt Entry Code (peptide),O14625,Full agonist,pK(d),Binding - Radioligand competition/displacement,9.7,,=,,9.5,-1.585,,,[125I]-CXCL11,81.0,0.0,,0.0,,P49682,0.3828583713910926
118,24174496,cxcr3_human,60,Y,F,NBI-74330,ChEMBL Compound ID,CHEMBL1077819,Antagonist (neutral/silent),pIC50,Binding - Radioligand competition/displacement,7.2,,=,,7.3,1.259,,,[125I]-CXCL11,81.0,0.0,,0.0,,P49682,0.3828583713910926
144,24174496,cxcr3_human,60,Y,F,VUF10661,ChEMBL Compound ID,CHEMBL2181467,Full agonist,pIC50,Binding - Radioligand competition/displacement,6.0,,=,,4.9,-12.658,,,[125I]-CXCL11,81.0,0.0,,0.0,,P49682,0.3828583713910926
170,24174496,cxcr3_human,60,Y,F,VUF11211,SMILES,CC[C@H]1CN(C2=NC=C(C(NCC)=O)C=C2Cl)CCN1C3CCN(CC4=CC=C(Cl)C=C4)CC3,Antagonist (neutral/silent),pIC50,Binding - Radioligand competition/displacement,7.8,,=,,7.5,-1.996,,,[125I]-CXCL11,81.0,0.0,,0.0,,P49682,0.3828583713910926
93,24174496,cxcr3_human,109,W,Q,CXL11_HUMAN,UniProt Entry Code (peptide),O14625,Full agonist,pK(d),Binding - Radioligand competition/displacement,9.7,,=,,9.9,1.585,,,[125I]-CXCL11,81.0,0.0,,0.0,,P49682,0.5003528472572227
119,24174496,cxcr3_human,109,W,Q,NBI-74330,ChEMBL Compound ID,CHEMBL1077819,Antagonist (neutral/silent),pIC50,Binding - Radioligand competition/displacement,7.2,,<,,4.5,-500.0,,,[125I]-CXCL11,81.0,0.0,,0.0,,P49682,0.5003528472572227
145,24174496,cxcr3_human,109,W,Q,VUF10661,ChEMBL Compound ID,CHEMBL2181467,Full agonist,pIC50,Binding - Radioligand competition/displacement,6.0,,<,,4.5,-31.25,,,[125I]-CXCL11,81.0,0.0,,0.0,,P49682,0.5003528472572227
171,24174496,cxcr3_human,109,W,Q,VUF11211,SMILES,CC[C@H]1CN(C2=NC=C(C(NCC)=O)C=C2Cl)CCN1C3CCN(CC4=CC=C(Cl)C=C4)CC3,Antagonist (neutral/silent),pIC50,Binding - Radioligand competition/displacement,7.8,,<,,5.0,-500.0,,,[125I]-CXCL11,81.0,0.0,,0.0,,P49682,0.5003528472572227
96,24174496,cxcr3_human,131,F,H,CXL11_HUMAN,UniProt Entry Code (peptide),O14625,Full agonist,pK(d),Binding - Radioligand competition/displacement,9.7,,=,,9.6,-1.259,,,[125I]-CXCL11,55.0,0.0,,0.0,,P49682,0.5390067775016221
122,24174496,cxcr3_human,131,F,H,NBI-74330,ChEMBL Compound ID,CHEMBL1077819,Antagonist (neutral/silent),pIC50,Binding - Radioligand competition/displacement,7.2,,=,,7.0,-1.585,,,[125I]-CXCL11,55.0,0.0,,0.0,,P49682,0.5390067775016221
148,24174496,cxcr3_human,131,F,H,VUF10661,ChEMBL Compound ID,CHEMBL2181467,Full agonist,pIC50,Binding - Radioligand competition/displacement,6.0,,=,,5.1,-7.937,,,[125I]-CXCL11,55.0,0.0,,0.0,,P49682,0.5390067775016221
174,24174496,cxcr3_human,131,F,H,VUF11211,SMILES,CC[C@H]1CN(C2=NC=C(C(NCC)=O)C=C2Cl)CCN1C3CCN(CC4=CC=C(Cl)C=C4)CC3,Antagonist (neutral/silent),pIC50,Binding - Radioligand competition/displacement,7.8,,=,,7.2,-3.984,,,[125I]-CXCL11,55.0,0.0,,0.0,,P49682,0.5390067775016221
97,24174496,cxcr3_human,135,F,A,CXL11_HUMAN,UniProt Entry Code (peptide),O14625,Full agonist,pK(d),Binding - Radioligand competition/displacement,9.7,,=,,9.4,-1.996,,,[125I]-CXCL11,106.0,0.0,,0.0,,P49682,0.610915234461886
123,24174496,cxcr3_human,135,F,A,NBI-74330,ChEMBL Compound ID,CHEMBL1077819,Antagonist (neutral/silent),pIC50,Binding - Radioligand competition/displacement,7.2,,=,,7.5,1.995,,,[125I]-CXCL11,106.0,0.0,,0.0,,P49682,0.610915234461886
149,24174496,cxcr3_human,135,F,A,VUF10661,ChEMBL Compound ID,CHEMBL2181467,Full agonist,pIC50,Binding - Radioligand competition/displacement,6.0,,<,,4.5,-31.25,,,[125I]-CXCL11,106.0,0.0,,0.0,,P49682,0.610915234461886
175,24174496,cxcr3_human,135,F,A,VUF11211,SMILES,CC[C@H]1CN(C2=NC=C(C(NCC)=O)C=C2Cl)CCN1C3CCN(CC4=CC=C(Cl)C=C4)CC3,Antagonist (neutral/silent),pIC50,Binding - Radioligand competition/displacement,7.8,,=,,7.5,-1.996,,,[125I]-CXCL11,106.0,0.0,,0.0,,P49682,0.610915234461886
98,24174496,cxcr3_human,268,W,Q,CXL11_HUMAN,UniProt Entry Code (peptide),O14625,Full agonist,pK(d),Binding - Radioligand competition/displacement,9.7,,=,,9.8,1.259,,,[125I]-CXCL11,60.0,0.0,,0.0,,P49682,0.7774690158346749
124,24174496,cxcr3_human,268,W,Q,NBI-74330,ChEMBL Compound ID,CHEMBL1077819,Antagonist (neutral/silent),pIC50,Binding - Radioligand competition/displacement,7.2,,=,,7.4,1.585,,,[125I]-CXCL11,60.0,0.0,,0.0,,P49682,0.7774690158346749
150,24174496,cxcr3_human,268,W,Q,VUF10661,ChEMBL Compound ID,CHEMBL2181467,Full agonist,pIC50,Binding - Radioligand competition/displacement,6.0,,=,,5.6,-2.513,,,[125I]-CXCL11,60.0,0.0,,0.0,,P49682,0.7774690158346749
176,24174496,cxcr3_human,268,W,Q,VUF11211,SMILES,CC[C@H]1CN(C2=NC=C(C(NCC)=O)C=C2Cl)CCN1C3CCN(CC4=CC=C(Cl)C=C4)CC3,Antagonist (neutral/silent),pIC50,Binding - Radioligand competition/displacement,7.8,,=,,7.0,-6.329,,,[125I]-CXCL11,60.0,0.0,,0.0,,P49682,0.7774690158346749
101,24174496,cxcr3_human,301,S,A,CXL11_HUMAN,UniProt Entry Code (peptide),O14625,Full agonist,pK(d),Binding - Radioligand competition/displacement,9.7,,=,,9.2,-3.165,,,[125I]-CXCL11,96.0,0.0,,0.0,,P49682,0.362209913856244
127,24174496,cxcr3_human,301,S,A,NBI-74330,ChEMBL Compound ID,CHEMBL1077819,Antagonist (neutral/silent),pIC50,Binding - Radioligand competition/displacement,7.2,,=,,6.9,-1.996,,,[125I]-CXCL11,96.0,0.0,,0.0,,P49682,0.362209913856244
153,24174496,cxcr3_human,301,S,A,VUF10661,ChEMBL Compound ID,CHEMBL2181467,Full agonist,pIC50,Binding - Radioligand competition/displacement,6.0,,=,,5.8,-1.585,,,[125I]-CXCL11,96.0,0.0,,0.0,,P49682,0.362209913856244
179,24174496,cxcr3_human,301,S,A,VUF11211,SMILES,CC[C@H]1CN(C2=NC=C(C(NCC)=O)C=C2Cl)CCN1C3CCN(CC4=CC=C(Cl)C=C4)CC3,Antagonist (neutral/silent),pIC50,Binding - Radioligand competition/displacement,7.8,,=,,8.1,1.995,,,[125I]-CXCL11,96.0,0.0,,0.0,,P49682,0.362209913856244
102,24174496,cxcr3_human,304,S,A,CXL11_HUMAN,UniProt Entry Code (peptide),O14625,Full agonist,pK(d),Binding - Radioligand competition/displacement,9.7,,=,,9.0,-5.0,,,[125I]-CXCL11,111.0,0.0,,0.0,,P49682,0.3954658850876888
128,24174496,cxcr3_human,304,S,A,NBI-74330,ChEMBL Compound ID,CHEMBL1077819,Antagonist (neutral/silent),pIC50,Binding - Radioligand competition/displacement,7.2,,=,,7.3,1.259,,,[125I]-CXCL11,111.0,0.0,,0.0,,P49682,0.3954658850876888
154,24174496,cxcr3_human,304,S,A,VUF10661,ChEMBL Compound ID,CHEMBL2181467,Full agonist,pIC50,Binding - Radioligand competition/displacement,6.0,,<,,4.5,-31.25,,,[125I]-CXCL11,111.0,0.0,,0.0,,P49682,0.3954658850876888
180,24174496,cxcr3_human,304,S,A,VUF11211,SMILES,CC[C@H]1CN(C2=NC=C(C(NCC)=O)C=C2Cl)CCN1C3CCN(CC4=CC=C(Cl)C=C4)CC3,Antagonist (neutral/silent),pIC50,Binding - Radioligand competition/displacement,7.8,,=,,7.7,-1.259,,,[125I]-CXCL11,111.0,0.0,,0.0,,P49682,0.3954658850876888
103,24174496,cxcr3_human,304,S,E,CXL11_HUMAN,UniProt Entry Code (peptide),O14625,Full agonist,pK(d),Binding - Radioligand competition/displacement,9.7,,=,,9.6,-1.259,,,[125I]-CXCL11,91.0,0.0,,0.0,,P49682,0.4391838365773828
129,24174496,cxcr3_human,304,S,E,NBI-74330,ChEMBL Compound ID,CHEMBL1077819,Antagonist (neutral/silent),pIC50,Binding - Radioligand competition/displacement,7.2,,=,,5.3,-76.923,,,[125I]-CXCL11,91.0,0.0,,0.0,,P49682,0.4391838365773828
155,24174496,cxcr3_human,304,S,E,VUF10661,ChEMBL Compound ID,CHEMBL2181467,Full agonist,pIC50,Binding - Radioligand competition/displacement,6.0,,<,,4.0,-100.0,,,[125I]-CXCL11,91.0,0.0,,0.0,,P49682,0.4391838365773828
181,24174496,cxcr3_human,304,S,E,VUF11211,SMILES,CC[C@H]1CN(C2=NC=C(C(NCC)=O)C=C2Cl)CCN1C3CCN(CC4=CC=C(Cl)C=C4)CC3,Antagonist (neutral/silent),pIC50,Binding - Radioligand competition/displacement,7.8,,=,,7.6,-1.585,,,[125I]-CXCL11,91.0,0.0,,0.0,,P49682,0.4391838365773828
104,24174496,cxcr3_human,304,S,L,CXL11_HUMAN,UniProt Entry Code (peptide),O14625,Full agonist,pK(d),Binding - Radioligand competition/displacement,9.7,,=,,9.5,-1.585,,,[125I]-CXCL11,95.0,0.0,,0.0,,P49682,0.5288365322817057
130,24174496,cxcr3_human,304,S,L,NBI-74330,ChEMBL Compound ID,CHEMBL1077819,Antagonist (neutral/silent),pIC50,Binding - Radioligand competition/displacement,7.2,,=,,5.9,-20.0,,,[125I]-CXCL11,95.0,0.0,,0.0,,P49682,0.5288365322817057
156,24174496,cxcr3_human,304,S,L,VUF10661,ChEMBL Compound ID,CHEMBL2181467,Full agonist,pIC50,Binding - Radioligand competition/displacement,6.0,,=,,5.1,-7.937,,,[125I]-CXCL11,95.0,0.0,,0.0,,P49682,0.5288365322817057
182,24174496,cxcr3_human,304,S,L,VUF11211,SMILES,CC[C@H]1CN(C2=NC=C(C(NCC)=O)C=C2Cl)CCN1C3CCN(CC4=CC=C(Cl)C=C4)CC3,Antagonist (neutral/silent),pIC50,Binding - Radioligand competition/displacement,7.8,,=,,6.5,-20.0,,,[125I]-CXCL11,95.0,0.0,,0.0,,P49682,0.5288365322817057
106,24174496,cxcr3_human,308,Y,F,CXL11_HUMAN,UniProt Entry Code (peptide),O14625,Full agonist,pK(d),Binding - Radioligand competition/displacement,9.7,,=,,9.3,-2.513,,,[125I]-CXCL11,95.0,0.0,,0.0,,P49682,0.3965310966821234
132,24174496,cxcr3_human,308,Y,F,NBI-74330,ChEMBL Compound ID,CHEMBL1077819,Antagonist (neutral/silent),pIC50,Binding - Radioligand competition/displacement,7.2,,=,,6.7,-3.165,,,[125I]-CXCL11,95.0,0.0,,0.0,,P49682,0.3965310966821234
158,24174496,cxcr3_human,308,Y,F,VUF10661,ChEMBL Compound ID,CHEMBL2181467,Full agonist,pIC50,Binding - Radioligand competition/displacement,6.0,,=,,4.9,-12.658,,,[125I]-CXCL11,95.0,0.0,,0.0,,P49682,0.3965310966821234
184,24174496,cxcr3_human,308,Y,F,VUF11211,SMILES,CC[C@H]1CN(C2=NC=C(C(NCC)=O)C=C2Cl)CCN1C3CCN(CC4=CC=C(Cl)C=C4)CC3,Antagonist (neutral/silent),pIC50,Binding - Radioligand competition/displacement,7.8,,=,,7.3,-3.165,,,[125I]-CXCL11,95.0,0.0,,0.0,,P49682,0.3965310966821234
188,25425280,cxcr3_human,205,Y,A,CXL11_HUMAN,UniProt Entry Code (peptide),O14625,Full agonist,K(d),Binding - Radioligand competition/displacement,7.7,nM,=,,10.4,-1.351,,,[125I]-CXCL11,82.0,0.0,,0.0,,P49682,0.5252341656231528
189,25425280,cxcr3_human,275,V,A,CXL11_HUMAN,UniProt Entry Code (peptide),O14625,Full agonist,K(d),Binding - Radioligand competition/displacement,7.7,nM,=,,7.4,1.041,,,[125I]-CXCL11,66.3,0.0,,0.0,,P49682,0.4209555701915904
193,25425280,cxcr3_human,279,I,A,TAK-779,ChEMBL Compound ID,CHEMBL1178786,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,31.3,ÂµM,=,,39.4,-1.259,,,[125I]-CXCL11,70.2,0.0,,0.0,,P49682,0.4265888247262607
198,25425280,cxcr3_human,279,I,A,VUF10085,SMILES,O=C(CC1=CC=C(OC(F)(F)F)C=C1)N(C(C(N2C3=CC=C(OCC)C=C3)=NC4=NC=CC=C4C2=O)C)CC5=CC=CN=C5,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,0.241,ÂµM,=,,0.483,-2.004,,,[125I]-CXCL11,70.2,0.0,,0.0,,P49682,0.4265888247262607
35,19580817,adrb1_human,104,D,A,(-)-Isoproterenol,ChEMBL Compound ID,CHEMBL1160723,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.8,,=,,5.7,-12.658,,,[3H]CGP-12177,0.0,0.0,,0.0,,P08588,0.8300667466838737
99,19580817,adrb1_human,104,D,A,[3H]CGP-12177,ChEMBL Compound ID,CHEMBL420746,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,127.4,pM,=,,228.4,-1.792,,,,698.1,0.0,,0.0,,P08588,0.8300667466838737
37,10471797,adrb1_human,323,L,A,(-)-alprenolol,ChEMBL Compound ID,CHEMBL1160734,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.17,,=,,8.29,1.318,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P08588,0.5783036429626327
44,10471797,adrb1_human,323,L,A,(rac)-Metoprolol,ChEMBL Compound ID,CHEMBL13,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.74,,=,,7.16,2.63,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P08588,0.5783036429626327
71,10471797,adrb1_human,323,L,A,Atenolol,ChEMBL Compound ID,CHEMBL24,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.26,,=,,6.59,2.138,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P08588,0.5783036429626327
78,10471797,adrb1_human,323,L,A,(rac)-propranolol,ChEMBL Compound ID,CHEMBL27,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.22,,=,,8.35,1.349,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P08588,0.5783036429626327
85,10471797,adrb1_human,323,L,A,(+)-propranolol,ChEMBL Compound ID,CHEMBL275742,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.36,,=,,6.35,-1.024,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P08588,0.5783036429626327
92,10471797,adrb1_human,323,L,A,CGP-20712A,ChEMBL Compound ID,CHEMBL280822,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.69,,=,,8.12,2.692,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P08588,0.5783036429626327
101,10471797,adrb1_human,323,L,A,Betaxolol,ChEMBL Compound ID,CHEMBL423,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.8,,=,,8.07,1.862,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P08588,0.5783036429626327
108,10471797,adrb1_human,323,L,A,Labetalol,ChEMBL Compound ID,CHEMBL429,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.13,,=,,7.32,1.549,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P08588,0.5783036429626327
116,10471797,adrb1_human,323,L,A,Isoproterenol,ChEMBL Compound ID,CHEMBL434,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.55,,=,,7.52,9.333,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P08588,0.5783036429626327
124,10471797,adrb1_human,323,L,A,(-)-propranolol,ChEMBL Compound ID,CHEMBL452861,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.47,,=,,8.65,1.514,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P08588,0.5783036429626327
131,10471797,adrb1_human,323,L,A,Sotalol,ChEMBL Compound ID,CHEMBL471,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.28,,=,,5.65,2.344,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P08588,0.5783036429626327
138,10471797,adrb1_human,323,L,A,(-)-timolol,ChEMBL Compound ID,CHEMBL499,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.19,,=,,8.67,3.02,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P08588,0.5783036429626327
145,10471797,adrb1_human,323,L,A,"ICI118,551",ChEMBL Compound ID,CHEMBL513389,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.15,,=,,6.25,1.259,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P08588,0.5783036429626327
152,10471797,adrb1_human,323,L,A,(-)-Epinephrine,ChEMBL Compound ID,CHEMBL679,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.84,,=,,5.9,11.482,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P08588,0.5783036429626327
159,10471797,adrb1_human,323,L,A,Practolol,ChEMBL Compound ID,CHEMBL6995,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.77,,=,,6.0,1.698,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P08588,0.5783036429626327
38,10471797,adrb1_human,323,L,C,(-)-alprenolol,ChEMBL Compound ID,CHEMBL1160734,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.17,,=,,8.18,1.023,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P08588,0.5783036429626327
45,10471797,adrb1_human,323,L,C,(rac)-Metoprolol,ChEMBL Compound ID,CHEMBL13,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.74,,=,,6.98,1.738,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P08588,0.5783036429626327
72,10471797,adrb1_human,323,L,C,Atenolol,ChEMBL Compound ID,CHEMBL24,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.26,,=,,6.78,3.311,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P08588,0.5783036429626327
79,10471797,adrb1_human,323,L,C,(rac)-propranolol,ChEMBL Compound ID,CHEMBL27,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.22,,=,,8.4,1.514,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P08588,0.5783036429626327
86,10471797,adrb1_human,323,L,C,(+)-propranolol,ChEMBL Compound ID,CHEMBL275742,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.36,,=,,6.25,-1.289,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P08588,0.5783036429626327
93,10471797,adrb1_human,323,L,C,CGP-20712A,ChEMBL Compound ID,CHEMBL280822,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.69,,=,,7.93,1.738,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P08588,0.5783036429626327
102,10471797,adrb1_human,323,L,C,Betaxolol,ChEMBL Compound ID,CHEMBL423,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.8,,=,,7.88,1.202,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P08588,0.5783036429626327
109,10471797,adrb1_human,323,L,C,Labetalol,ChEMBL Compound ID,CHEMBL429,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.13,,=,,7.19,1.148,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P08588,0.5783036429626327
117,10471797,adrb1_human,323,L,C,Isoproterenol,ChEMBL Compound ID,CHEMBL434,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.55,,=,,7.23,4.786,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P08588,0.5783036429626327
125,10471797,adrb1_human,323,L,C,(-)-propranolol,ChEMBL Compound ID,CHEMBL452861,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.47,,=,,8.72,1.778,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P08588,0.5783036429626327
132,10471797,adrb1_human,323,L,C,Sotalol,ChEMBL Compound ID,CHEMBL471,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.28,,=,,5.57,1.95,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P08588,0.5783036429626327
139,10471797,adrb1_human,323,L,C,(-)-timolol,ChEMBL Compound ID,CHEMBL499,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.19,,=,,8.12,-1.175,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P08588,0.5783036429626327
146,10471797,adrb1_human,323,L,C,"ICI118,551",ChEMBL Compound ID,CHEMBL513389,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.15,,=,,6.05,-1.259,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P08588,0.5783036429626327
153,10471797,adrb1_human,323,L,C,(-)-Epinephrine,ChEMBL Compound ID,CHEMBL679,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.84,,=,,5.55,5.129,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P08588,0.5783036429626327
160,10471797,adrb1_human,323,L,C,Practolol,ChEMBL Compound ID,CHEMBL6995,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.77,,=,,5.86,1.23,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P08588,0.5783036429626327
40,10471797,adrb1_human,323,L,F,(-)-alprenolol,ChEMBL Compound ID,CHEMBL1160734,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.17,,=,,8.24,1.175,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P08588,0.5339329002537725
47,10471797,adrb1_human,323,L,F,(rac)-Metoprolol,ChEMBL Compound ID,CHEMBL13,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.74,,=,,7.04,1.995,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P08588,0.5339329002537725
74,10471797,adrb1_human,323,L,F,Atenolol,ChEMBL Compound ID,CHEMBL24,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.26,,=,,6.77,3.236,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P08588,0.5339329002537725
81,10471797,adrb1_human,323,L,F,(rac)-propranolol,ChEMBL Compound ID,CHEMBL27,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.22,,=,,8.46,1.738,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P08588,0.5339329002537725
88,10471797,adrb1_human,323,L,F,(+)-propranolol,ChEMBL Compound ID,CHEMBL275742,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.36,,=,,6.3,-1.148,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P08588,0.5339329002537725
95,10471797,adrb1_human,323,L,F,CGP-20712A,ChEMBL Compound ID,CHEMBL280822,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.69,,=,,8.06,2.344,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P08588,0.5339329002537725
104,10471797,adrb1_human,323,L,F,Betaxolol,ChEMBL Compound ID,CHEMBL423,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.8,,=,,8.07,1.862,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P08588,0.5339329002537725
111,10471797,adrb1_human,323,L,F,Labetalol,ChEMBL Compound ID,CHEMBL429,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.13,,=,,7.24,1.288,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P08588,0.5339329002537725
119,10471797,adrb1_human,323,L,F,Isoproterenol,ChEMBL Compound ID,CHEMBL434,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.55,,=,,7.39,6.918,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P08588,0.5339329002537725
127,10471797,adrb1_human,323,L,F,(-)-propranolol,ChEMBL Compound ID,CHEMBL452861,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.47,,=,,8.84,2.344,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P08588,0.5339329002537725
134,10471797,adrb1_human,323,L,F,Sotalol,ChEMBL Compound ID,CHEMBL471,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.28,,=,,5.66,2.399,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P08588,0.5339329002537725
141,10471797,adrb1_human,323,L,F,(-)-timolol,ChEMBL Compound ID,CHEMBL499,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.19,,=,,8.22,1.072,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P08588,0.5339329002537725
148,10471797,adrb1_human,323,L,F,"ICI118,551",ChEMBL Compound ID,CHEMBL513389,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.15,,=,,6.09,-1.148,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P08588,0.5339329002537725
155,10471797,adrb1_human,323,L,F,(-)-Epinephrine,ChEMBL Compound ID,CHEMBL679,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.84,,=,,5.61,5.888,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P08588,0.5339329002537725
162,10471797,adrb1_human,323,L,F,Practolol,ChEMBL Compound ID,CHEMBL6995,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.77,,=,,5.89,1.318,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P08588,0.5339329002537725
41,10471797,adrb1_human,323,L,I,(-)-alprenolol,ChEMBL Compound ID,CHEMBL1160734,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.17,,=,,8.21,1.096,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P08588,0.4442491379302994
48,10471797,adrb1_human,323,L,I,(rac)-Metoprolol,ChEMBL Compound ID,CHEMBL13,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.74,,=,,6.69,-1.122,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P08588,0.4442491379302994
75,10471797,adrb1_human,323,L,I,Atenolol,ChEMBL Compound ID,CHEMBL24,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.26,,=,,6.43,1.479,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P08588,0.4442491379302994
82,10471797,adrb1_human,323,L,I,(rac)-propranolol,ChEMBL Compound ID,CHEMBL27,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.22,,=,,8.47,1.778,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P08588,0.4442491379302994
89,10471797,adrb1_human,323,L,I,(+)-propranolol,ChEMBL Compound ID,CHEMBL275742,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.36,,=,,6.29,-1.175,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P08588,0.4442491379302994
96,10471797,adrb1_human,323,L,I,CGP-20712A,ChEMBL Compound ID,CHEMBL280822,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.69,,=,,7.86,1.479,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P08588,0.4442491379302994
105,10471797,adrb1_human,323,L,I,Betaxolol,ChEMBL Compound ID,CHEMBL423,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.8,,=,,7.66,-1.381,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P08588,0.4442491379302994
112,10471797,adrb1_human,323,L,I,Labetalol,ChEMBL Compound ID,CHEMBL429,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.13,,=,,7.12,-1.024,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P08588,0.4442491379302994
120,10471797,adrb1_human,323,L,I,Isoproterenol,ChEMBL Compound ID,CHEMBL434,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.55,,=,,6.33,-1.658,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P08588,0.4442491379302994
128,10471797,adrb1_human,323,L,I,(-)-propranolol,ChEMBL Compound ID,CHEMBL452861,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.47,,=,,8.52,1.122,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P08588,0.4442491379302994
135,10471797,adrb1_human,323,L,I,Sotalol,ChEMBL Compound ID,CHEMBL471,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.28,,=,,5.39,1.288,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P08588,0.4442491379302994
142,10471797,adrb1_human,323,L,I,(-)-timolol,ChEMBL Compound ID,CHEMBL499,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.19,,=,,8.33,1.38,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P08588,0.4442491379302994
149,10471797,adrb1_human,323,L,I,"ICI118,551",ChEMBL Compound ID,CHEMBL513389,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.15,,=,,5.99,-1.445,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P08588,0.4442491379302994
156,10471797,adrb1_human,323,L,I,(-)-Epinephrine,ChEMBL Compound ID,CHEMBL679,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.84,,=,,4.68,-1.445,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P08588,0.4442491379302994
163,10471797,adrb1_human,323,L,I,Practolol,ChEMBL Compound ID,CHEMBL6995,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.77,,=,,5.58,-1.548,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P08588,0.4442491379302994
43,10471797,adrb1_human,323,L,T,(-)-alprenolol,ChEMBL Compound ID,CHEMBL1160734,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.17,,=,,8.18,1.023,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P08588,0.5783036429626327
50,10471797,adrb1_human,323,L,T,(rac)-Metoprolol,ChEMBL Compound ID,CHEMBL13,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.74,,=,,7.05,2.042,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P08588,0.5783036429626327
77,10471797,adrb1_human,323,L,T,Atenolol,ChEMBL Compound ID,CHEMBL24,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.26,,=,,6.52,1.82,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P08588,0.5783036429626327
84,10471797,adrb1_human,323,L,T,(rac)-propranolol,ChEMBL Compound ID,CHEMBL27,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.22,,=,,8.58,2.291,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P08588,0.5783036429626327
91,10471797,adrb1_human,323,L,T,(+)-propranolol,ChEMBL Compound ID,CHEMBL275742,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.36,,=,,6.33,-1.072,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P08588,0.5783036429626327
98,10471797,adrb1_human,323,L,T,CGP-20712A,ChEMBL Compound ID,CHEMBL280822,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.69,,=,,8.05,2.291,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P08588,0.5783036429626327
107,10471797,adrb1_human,323,L,T,Betaxolol,ChEMBL Compound ID,CHEMBL423,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.8,,=,,8.08,1.905,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P08588,0.5783036429626327
114,10471797,adrb1_human,323,L,T,Labetalol,ChEMBL Compound ID,CHEMBL429,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.13,,=,,7.26,1.349,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P08588,0.5783036429626327
122,10471797,adrb1_human,323,L,T,Isoproterenol,ChEMBL Compound ID,CHEMBL434,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.55,,=,,6.96,2.57,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P08588,0.5783036429626327
130,10471797,adrb1_human,323,L,T,(-)-propranolol,ChEMBL Compound ID,CHEMBL452861,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.47,,=,,8.67,1.585,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P08588,0.5783036429626327
137,10471797,adrb1_human,323,L,T,Sotalol,ChEMBL Compound ID,CHEMBL471,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.28,,=,,5.72,2.754,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P08588,0.5783036429626327
144,10471797,adrb1_human,323,L,T,(-)-timolol,ChEMBL Compound ID,CHEMBL499,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.19,,=,,8.29,1.259,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P08588,0.5783036429626327
151,10471797,adrb1_human,323,L,T,"ICI118,551",ChEMBL Compound ID,CHEMBL513389,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.15,,=,,6.15,1.0,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P08588,0.5783036429626327
158,10471797,adrb1_human,323,L,T,(-)-Epinephrine,ChEMBL Compound ID,CHEMBL679,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.84,,=,,5.44,3.981,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P08588,0.5783036429626327
165,10471797,adrb1_human,323,L,T,Practolol,ChEMBL Compound ID,CHEMBL6995,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.77,,=,,5.94,1.479,,,[125I]iodocyanopindolol (radioligand),0.0,0.0,,0.0,,P08588,0.5783036429626327
52,11907156,adrb1_human,98,M,A,[125I]Cyanopindolol,ChEMBL Compound ID,CHEMBL210309,Binding - unknown pharmacological activity,K(d),Binding - Radioligand competition/displacement,57.0,pM,=,,78.0,-1.368,,,[125I]iodocyanopindolol (radioligand),86.8,0.0,,0.0,,P08588,0.4648351654904427
166,11907156,adrb1_human,98,M,A,(-)-RO363,SMILES,COc1c(OC)ccc(CCNC[C@@H](O)COc2cc(O)c(O)cc2)c1,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,22.0,nM,=,,20.0,1.1,,,[125I]iodocyanopindolol (radioligand),86.8,0.0,,0.0,,P08588,0.4648351654904427
53,11907156,adrb1_human,102,S,A,[125I]Cyanopindolol,ChEMBL Compound ID,CHEMBL210309,Binding - unknown pharmacological activity,K(d),Binding - Radioligand competition/displacement,57.0,pM,=,,60.0,-1.053,,,[125I]iodocyanopindolol (radioligand),255.3,0.0,,0.0,,P08588,0.2757665389471846
167,11907156,adrb1_human,102,S,A,(-)-RO363,SMILES,COc1c(OC)ccc(CCNC[C@@H](O)COc2cc(O)c(O)cc2)c1,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,22.0,nM,=,,24.0,-1.091,,,[125I]iodocyanopindolol (radioligand),255.3,0.0,,0.0,,P08588,0.2757665389471846
54,11907156,adrb1_human,110,L,A,[125I]Cyanopindolol,ChEMBL Compound ID,CHEMBL210309,Binding - unknown pharmacological activity,K(d),Binding - Radioligand competition/displacement,57.0,pM,=,,65.0,-1.14,,,[125I]iodocyanopindolol (radioligand),44.7,0.0,,0.0,,P08588,0.3947364260416163
168,11907156,adrb1_human,110,L,A,(-)-RO363,SMILES,COc1c(OC)ccc(CCNC[C@@H](O)COc2cc(O)c(O)cc2)c1,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,22.0,nM,=,,140.0,-6.369,,,[125I]iodocyanopindolol (radioligand),44.7,0.0,,0.0,,P08588,0.3947364260416163
55,11907156,adrb1_human,117,T,A,[125I]Cyanopindolol,ChEMBL Compound ID,CHEMBL210309,Binding - unknown pharmacological activity,K(d),Binding - Radioligand competition/displacement,57.0,pM,=,,75.0,-1.316,,,[125I]iodocyanopindolol (radioligand),34.2,0.0,,0.0,,P08588,0.3317299069123381
169,11907156,adrb1_human,117,T,A,(-)-RO363,SMILES,COc1c(OC)ccc(CCNC[C@@H](O)COc2cc(O)c(O)cc2)c1,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,22.0,nM,=,,54.0,-2.457,,,[125I]iodocyanopindolol (radioligand),34.2,0.0,,0.0,,P08588,0.3317299069123381
56,11907156,adrb1_human,118,I,A,[125I]Cyanopindolol,ChEMBL Compound ID,CHEMBL210309,Binding - unknown pharmacological activity,K(d),Binding - Radioligand competition/displacement,57.0,pM,=,,56.0,1.018,,,[125I]iodocyanopindolol (radioligand),157.9,0.0,,0.0,,P08588,0.4437533738087912
170,11907156,adrb1_human,118,I,A,(-)-RO363,SMILES,COc1c(OC)ccc(CCNC[C@@H](O)COc2cc(O)c(O)cc2)c1,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,22.0,nM,=,,20.0,1.1,,,[125I]iodocyanopindolol (radioligand),157.9,0.0,,0.0,,P08588,0.4437533738087912
57,11907156,adrb1_human,119,V,A,[125I]Cyanopindolol,ChEMBL Compound ID,CHEMBL210309,Binding - unknown pharmacological activity,K(d),Binding - Radioligand competition/displacement,57.0,pM,=,,49.0,1.163,,,[125I]iodocyanopindolol (radioligand),63.2,0.0,,0.0,,P08588,0.3668752801005183
171,11907156,adrb1_human,119,V,A,(-)-RO363,SMILES,COc1c(OC)ccc(CCNC[C@@H](O)COc2cc(O)c(O)cc2)c1,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,22.0,nM,=,,20.0,1.1,,,[125I]iodocyanopindolol (radioligand),63.2,0.0,,0.0,,P08588,0.3668752801005183
58,11907156,adrb1_human,120,V,A,[125I]Cyanopindolol,ChEMBL Compound ID,CHEMBL210309,Binding - unknown pharmacological activity,K(d),Binding - Radioligand competition/displacement,57.0,pM,=,,79.0,-1.385,,,[125I]iodocyanopindolol (radioligand),52.6,0.0,,0.0,,P08588,0.2482822971022095
172,11907156,adrb1_human,120,V,A,(-)-RO363,SMILES,COc1c(OC)ccc(CCNC[C@@H](O)COc2cc(O)c(O)cc2)c1,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,22.0,nM,=,,28.0,-1.272,,,[125I]iodocyanopindolol (radioligand),52.6,0.0,,0.0,,P08588,0.2482822971022095
59,11907156,adrb1_human,121,W,A,[125I]Cyanopindolol,ChEMBL Compound ID,CHEMBL210309,Binding - unknown pharmacological activity,K(d),Binding - Radioligand competition/displacement,57.0,pM,=,,59.0,-1.035,,,[125I]iodocyanopindolol (radioligand),92.1,0.0,,0.0,,P08588,0.3248942595530384
173,11907156,adrb1_human,121,W,A,(-)-RO363,SMILES,COc1c(OC)ccc(CCNC[C@@H](O)COc2cc(O)c(O)cc2)c1,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,22.0,nM,=,,20.0,1.1,,,[125I]iodocyanopindolol (radioligand),92.1,0.0,,0.0,,P08588,0.3248942595530384
61,11907156,adrb1_human,355,P,A,[125I]Cyanopindolol,ChEMBL Compound ID,CHEMBL210309,Binding - unknown pharmacological activity,K(d),Binding - Radioligand competition/displacement,57.0,pM,=,,27.0,2.111,,,[125I]iodocyanopindolol (radioligand),9.7,0.0,,0.0,,P08588,0.4441424662372241
175,11907156,adrb1_human,355,P,A,(-)-RO363,SMILES,COc1c(OC)ccc(CCNC[C@@H](O)COc2cc(O)c(O)cc2)c1,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,22.0,nM,=,,22.0,1.0,,,[125I]iodocyanopindolol (radioligand),9.7,0.0,,0.0,,P08588,0.4441424662372241
62,11907156,adrb1_human,356,D,A,[125I]Cyanopindolol,ChEMBL Compound ID,CHEMBL210309,Binding - unknown pharmacological activity,K(d),Binding - Radioligand competition/displacement,57.0,pM,=,,47.0,1.213,,,[125I]iodocyanopindolol (radioligand),12.1,0.0,,0.0,,P08588,0.3000891072759972
176,11907156,adrb1_human,356,D,A,(-)-RO363,SMILES,COc1c(OC)ccc(CCNC[C@@H](O)COc2cc(O)c(O)cc2)c1,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,22.0,nM,=,,36.0,-1.637,,,[125I]iodocyanopindolol (radioligand),12.1,0.0,,0.0,,P08588,0.3000891072759972
63,11907156,adrb1_human,357,R,A,[125I]Cyanopindolol,ChEMBL Compound ID,CHEMBL210309,Binding - unknown pharmacological activity,K(d),Binding - Radioligand competition/displacement,57.0,pM,=,,40.0,1.425,,,[125I]iodocyanopindolol (radioligand),65.8,0.0,,0.0,,P08588,0.2369762861649955
177,11907156,adrb1_human,357,R,A,(-)-RO363,SMILES,COc1c(OC)ccc(CCNC[C@@H](O)COc2cc(O)c(O)cc2)c1,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,22.0,nM,=,,32.0,-1.453,,,[125I]iodocyanopindolol (radioligand),65.8,0.0,,0.0,,P08588,0.2369762861649955
64,11907156,adrb1_human,358,L,A,[125I]Cyanopindolol,ChEMBL Compound ID,CHEMBL210309,Binding - unknown pharmacological activity,K(d),Binding - Radioligand competition/displacement,57.0,pM,=,,25.0,2.28,,,[125I]iodocyanopindolol (radioligand),9.7,0.0,,0.0,,P08588,0.3607376436381502
178,11907156,adrb1_human,358,L,A,(-)-RO363,SMILES,COc1c(OC)ccc(CCNC[C@@H](O)COc2cc(O)c(O)cc2)c1,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,22.0,nM,=,,25.0,-1.136,,,[125I]iodocyanopindolol (radioligand),9.7,0.0,,0.0,,P08588,0.3607376436381502
65,11907156,adrb1_human,359,F,A,[125I]Cyanopindolol,ChEMBL Compound ID,CHEMBL210309,Binding - unknown pharmacological activity,K(d),Binding - Radioligand competition/displacement,57.0,pM,=,,50.0,1.14,,,[125I]iodocyanopindolol (radioligand),34.2,0.0,,0.0,,P08588,0.4692330156145291
179,11907156,adrb1_human,359,F,A,(-)-RO363,SMILES,COc1c(OC)ccc(CCNC[C@@H](O)COc2cc(O)c(O)cc2)c1,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,22.0,nM,=,,90.0,-4.098,,,[125I]iodocyanopindolol (radioligand),34.2,0.0,,0.0,,P08588,0.4692330156145291
66,11907156,adrb1_human,360,V,A,[125I]Cyanopindolol,ChEMBL Compound ID,CHEMBL210309,Binding - unknown pharmacological activity,K(d),Binding - Radioligand competition/displacement,57.0,pM,=,,37.0,1.541,,,[125I]iodocyanopindolol (radioligand),50.0,0.0,,0.0,,P08588,0.3396829900280903
180,11907156,adrb1_human,360,V,A,(-)-RO363,SMILES,COc1c(OC)ccc(CCNC[C@@H](O)COc2cc(O)c(O)cc2)c1,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,22.0,nM,=,,40.0,-1.818,,,[125I]iodocyanopindolol (radioligand),50.0,0.0,,0.0,,P08588,0.3396829900280903
67,11907156,adrb1_human,362,F,A,[125I]Cyanopindolol,ChEMBL Compound ID,CHEMBL210309,Binding - unknown pharmacological activity,K(d),Binding - Radioligand competition/displacement,57.0,pM,=,,27.0,2.111,,,[125I]iodocyanopindolol (radioligand),6.6,0.0,,0.0,,P08588,0.4821103975911227
181,11907156,adrb1_human,362,F,A,(-)-RO363,SMILES,COc1c(OC)ccc(CCNC[C@@H](O)COc2cc(O)c(O)cc2)c1,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,22.0,nM,=,,23.0,-1.045,,,[125I]iodocyanopindolol (radioligand),6.6,0.0,,0.0,,P08588,0.4821103975911227
68,11907156,adrb1_human,365,L,A,[125I]Cyanopindolol,ChEMBL Compound ID,CHEMBL210309,Binding - unknown pharmacological activity,K(d),Binding - Radioligand competition/displacement,57.0,pM,=,,26.0,2.192,,,[125I]iodocyanopindolol (radioligand),22.6,0.0,,0.0,,P08588,0.5301626265784869
182,11907156,adrb1_human,365,L,A,(-)-RO363,SMILES,COc1c(OC)ccc(CCNC[C@@H](O)COc2cc(O)c(O)cc2)c1,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,22.0,nM,=,,22.0,1.0,,,[125I]iodocyanopindolol (radioligand),22.6,0.0,,0.0,,P08588,0.5301626265784869
69,11907156,adrb1_human,375,I,A,[125I]Cyanopindolol,ChEMBL Compound ID,CHEMBL210309,Binding - unknown pharmacological activity,K(d),Binding - Radioligand competition/displacement,57.0,pM,=,,31.0,1.839,,,[125I]iodocyanopindolol (radioligand),31.6,0.0,,0.0,,P08588,0.5207512658342839
183,11907156,adrb1_human,375,I,A,(-)-RO363,SMILES,COc1c(OC)ccc(CCNC[C@@H](O)COc2cc(O)c(O)cc2)c1,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,22.0,nM,=,,19.0,1.158,,,[125I]iodocyanopindolol (radioligand),31.6,0.0,,0.0,,P08588,0.5207512658342839
0,16102831,ccr3_human,6,D,A,CCL11_HUMAN,UniProt Entry Code (peptide),P51671,Full agonist,IC50,Binding - Radioligand competition/displacement,8.89,nM,=,,12.33,-1.387,,,125I-CCL11,94.95781024902244,0.0,,0.0,,P51677,0.3694542605340076
1,16102831,ccr3_human,9,E,A,CCL11_HUMAN,UniProt Entry Code (peptide),P51671,Full agonist,IC50,Binding - Radioligand competition/displacement,8.89,nM,=,,12.16,-1.368,,,125I-CCL11,95.49289977361596,0.0,,0.0,,P51677,0.3055224596536409
2,16102831,ccr3_human,18,D,A,CCL11_HUMAN,UniProt Entry Code (peptide),P51671,Full agonist,IC50,Binding - Radioligand competition/displacement,8.89,nM,=,,8.07,1.102,,,125I-CCL11,91.10928174521509,0.0,,0.0,,P51677,0.3573288547994759
3,16102831,ccr3_human,19,D,A,CCL11_HUMAN,UniProt Entry Code (peptide),P51671,Full agonist,IC50,Binding - Radioligand competition/displacement,8.89,nM,=,,6.76,1.315,,,125I-CCL11,94.69026548672564,0.0,,0.0,,P51677,0.3468762217545094
4,16102831,ccr3_human,25,E,A,CCL11_HUMAN,UniProt Entry Code (peptide),P51671,Full agonist,IC50,Binding - Radioligand competition/displacement,8.89,nM,=,,11.94,-1.342,,,125I-CCL11,89.54517390409549,0.0,,0.0,,P51677,0.2720519435472598
5,16102831,ccr3_human,26,K,A,CCL11_HUMAN,UniProt Entry Code (peptide),P51671,Full agonist,IC50,Binding - Radioligand competition/displacement,8.89,nM,=,,9.12,-1.026,,,125I-CCL11,89.09240584482403,0.0,,0.0,,P51677,0.2824902420090577
6,16102831,ccr3_human,28,D,A,CCL11_HUMAN,UniProt Entry Code (peptide),P51671,Full agonist,IC50,Binding - Radioligand competition/displacement,8.89,nM,=,,11.35,-1.277,,,125I-CCL11,72.60753241407697,0.0,,0.0,,P51677,0.3068076552052727
7,16102831,ccr3_human,30,R,A,CCL11_HUMAN,UniProt Entry Code (peptide),P51671,Full agonist,IC50,Binding - Radioligand competition/displacement,8.89,nM,=,,14.13,-1.59,,,125I-CCL11,94.93722988269192,0.0,,0.0,,P51677,0.286902794570737
8,16102831,ccr3_human,173,E,A,CCL11_HUMAN,UniProt Entry Code (peptide),P51671,Full agonist,IC50,Binding - Radioligand competition/displacement,8.89,nM,=,,11.71,-1.318,,,125I-CCL11,95.10187281333609,0.0,,0.0,,P51677,0.2455886365727436
11,16102831,ccr3_human,179,E,A,CCL11_HUMAN,UniProt Entry Code (peptide),P51671,Full agonist,IC50,Binding - Radioligand competition/displacement,8.89,nM,=,,9.91,-1.115,,,125I-CCL11,67.99753035604033,0.0,,0.0,,P51677,0.267753889075644
12,16102831,ccr3_human,180,E,A,CCL11_HUMAN,UniProt Entry Code (peptide),P51671,Full agonist,IC50,Binding - Radioligand competition/displacement,8.89,nM,=,,10.89,-1.225,,,125I-CCL11,91.37682650751182,0.0,,0.0,,P51677,0.2648794224226762
13,16102831,ccr3_human,189,E,A,CCL11_HUMAN,UniProt Entry Code (peptide),P51671,Full agonist,IC50,Binding - Radioligand competition/displacement,8.89,nM,=,,14.77,-1.661,,,125I-CCL11,94.79316731837828,0.0,,0.0,,P51677,0.2516885355859489
14,16102831,ccr3_human,190,D,A,CCL11_HUMAN,UniProt Entry Code (peptide),P51671,Full agonist,IC50,Binding - Radioligand competition/displacement,8.89,nM,=,,19.17,-2.155,,,125I-CCL11,108.52027166083556,0.0,,0.0,,P51677,0.300841181081933
15,16102831,ccr3_human,196,R,A,CCL11_HUMAN,UniProt Entry Code (peptide),P51671,Full agonist,IC50,Binding - Radioligand competition/displacement,8.89,nM,=,,14.16,-1.592,,,125I-CCL11,94.69026548672564,0.0,,0.0,,P51677,0.325925585759761
16,16102831,ccr3_human,272,D,A,CCL11_HUMAN,UniProt Entry Code (peptide),P51671,Full agonist,IC50,Binding - Radioligand competition/displacement,8.89,nM,=,,4.4,2.02,,,125I-CCL11,88.94834328051039,0.0,,0.0,,P51677,0.3234418815076798
17,16102831,ccr3_human,274,E,A,CCL11_HUMAN,UniProt Entry Code (peptide),P51671,Full agonist,IC50,Binding - Radioligand competition/displacement,8.89,nM,=,,4.91,1.811,,,125I-CCL11,88.94834328051039,0.0,,0.0,,P51677,0.2627046956875293
18,16102831,ccr3_human,275,R,A,CCL11_HUMAN,UniProt Entry Code (peptide),P51671,Full agonist,IC50,Binding - Radioligand competition/displacement,8.89,nM,=,,4.81,1.848,,,125I-CCL11,98.5182136242025,0.0,,0.0,,P51677,0.2697729997880672
19,16102831,ccr3_human,277,K,A,CCL11_HUMAN,UniProt Entry Code (peptide),P51671,Full agonist,IC50,Binding - Radioligand competition/displacement,8.89,nM,=,,5.39,1.649,,,125I-CCL11,97.63325787199012,0.0,,0.0,,P51677,0.2654096854988369
30,12681376,hrh3_human,119,T,A,Imoproxifan,ChEMBL Compound ID,CHEMBL1180120,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,42.0,nM,=,,15.0,2.8,,,[3H]N-alpha-methylhistamine (radioligand),0.0,0.0,,0.0,,Q9Y5N1,0.490351829457233
32,12681376,hrh3_human,119,T,A,Ciproxifan,ChEMBL Compound ID,CHEMBL14638,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,65.0,nM,=,,6.5,10.0,,,[3H]N-alpha-methylhistamine (radioligand),0.0,0.0,,0.0,,Q9Y5N1,0.490351829457233
34,12681376,hrh3_human,119,T,A,Clobenpropit,ChEMBL Compound ID,CHEMBL14690,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.36,nM,=,,0.78,-2.165,,,[3H]N-alpha-methylhistamine (radioligand),0.0,0.0,,0.0,,Q9Y5N1,0.490351829457233
50,12681376,hrh3_human,119,T,A,Thioperamide,ChEMBL Compound ID,CHEMBL260374,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,66.0,nM,=,,32.0,2.062,,,[3H]N-alpha-methylhistamine (radioligand),0.0,0.0,,0.0,,Q9Y5N1,0.490351829457233
52,12681376,hrh3_human,119,T,A,R-alfa methylhistamine,ChEMBL Compound ID,CHEMBL268229,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.56,nM,=,,0.49,1.143,,,[3H]N-alpha-methylhistamine (radioligand),0.0,0.0,,0.0,,Q9Y5N1,0.490351829457233
68,12681376,hrh3_human,119,T,A,[3H]N-alpha-methylhistamine,ChEMBL Compound ID,CHEMBL268490,Binding - unknown pharmacological activity,K(d),Binding - Radioligand competition/displacement,0.34,nM,=,,0.32,1.062,,,[3H]N-alpha-methylhistamine (radioligand),0.0,0.0,,0.0,,Q9Y5N1,0.490351829457233
70,12681376,hrh3_human,119,T,A,A-304121,ChEMBL Compound ID,CHEMBL302196,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,727.0,nM,=,,23.0,31.609,,,[3H]N-alpha-methylhistamine (radioligand),0.0,0.0,,0.0,,Q9Y5N1,0.490351829457233
72,12681376,hrh3_human,119,T,A,GT-2331,ChEMBL Compound ID,CHEMBL354374,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,3.9,nM,=,,0.7,5.571,,,[3H]N-alpha-methylhistamine (radioligand),0.0,0.0,,0.0,,Q9Y5N1,0.490351829457233
81,12681376,hrh3_human,119,T,A,Histamine,ChEMBL Compound ID,CHEMBL90,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,2.8,nM,=,,2.3,1.217,,,[3H]N-alpha-methylhistamine (radioligand),0.0,0.0,,0.0,,Q9Y5N1,0.490351829457233
31,12681376,hrh3_human,122,A,V,Imoproxifan,ChEMBL Compound ID,CHEMBL1180120,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,42.0,nM,=,,4.0,10.5,,,[3H]N-alpha-methylhistamine (radioligand),0.0,0.0,,0.0,,Q9Y5N1,0.5192020006313849
33,12681376,hrh3_human,122,A,V,Ciproxifan,ChEMBL Compound ID,CHEMBL14638,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,65.0,nM,=,,4.4,14.773,,,[3H]N-alpha-methylhistamine (radioligand),0.0,0.0,,0.0,,Q9Y5N1,0.5192020006313849
35,12681376,hrh3_human,122,A,V,Clobenpropit,ChEMBL Compound ID,CHEMBL14690,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.36,nM,=,,0.03,12.0,,,[3H]N-alpha-methylhistamine (radioligand),0.0,0.0,,0.0,,Q9Y5N1,0.5192020006313849
51,12681376,hrh3_human,122,A,V,Thioperamide,ChEMBL Compound ID,CHEMBL260374,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,66.0,nM,=,,2.8,23.571,,,[3H]N-alpha-methylhistamine (radioligand),0.0,0.0,,0.0,,Q9Y5N1,0.5192020006313849
53,12681376,hrh3_human,122,A,V,R-alfa methylhistamine,ChEMBL Compound ID,CHEMBL268229,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.56,nM,=,,0.61,-1.089,,,[3H]N-alpha-methylhistamine (radioligand),0.0,0.0,,0.0,,Q9Y5N1,0.5192020006313849
69,12681376,hrh3_human,122,A,V,[3H]N-alpha-methylhistamine,ChEMBL Compound ID,CHEMBL268490,Binding - unknown pharmacological activity,K(d),Binding - Radioligand competition/displacement,0.34,nM,=,,0.53,-1.558,,,[3H]N-alpha-methylhistamine (radioligand),0.0,0.0,,0.0,,Q9Y5N1,0.5192020006313849
71,12681376,hrh3_human,122,A,V,A-304121,ChEMBL Compound ID,CHEMBL302196,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,727.0,nM,=,,39.0,18.641,,,[3H]N-alpha-methylhistamine (radioligand),0.0,0.0,,0.0,,Q9Y5N1,0.5192020006313849
73,12681376,hrh3_human,122,A,V,GT-2331,ChEMBL Compound ID,CHEMBL354374,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,3.9,nM,=,,1.7,2.294,,,[3H]N-alpha-methylhistamine (radioligand),0.0,0.0,,0.0,,Q9Y5N1,0.5192020006313849
82,12681376,hrh3_human,122,A,V,Histamine,ChEMBL Compound ID,CHEMBL90,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,2.8,nM,=,,3.2,-1.143,,,[3H]N-alpha-methylhistamine (radioligand),0.0,0.0,,0.0,,Q9Y5N1,0.5192020006313849
36,11961043,hrh3_human,196,W,A,Imetit,ChEMBL Compound ID,CHEMBL19439,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,9.34,nM,=,,68.1,-7.299,,,[125I]-iodoproxyfan,0.0,0.0,,0.0,,Q9Y5N1,0.3746538370719997
37,11961043,hrh3_human,196,W,A,Imetit,ChEMBL Compound ID,CHEMBL19439,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.45,nM,=,,68.1,-142.857,,,[125I]-iodoproxyfan,0.0,0.0,,0.0,,Q9Y5N1,0.3746538370719997
54,11961043,hrh3_human,196,W,A,R-alfa methylhistamine,ChEMBL Compound ID,CHEMBL268229,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,12.74,nM,=,,5.68,2.243,,,[125I]-iodoproxyfan,0.0,0.0,,0.0,,Q9Y5N1,0.3746538370719997
55,11961043,hrh3_human,196,W,A,R-alfa methylhistamine,ChEMBL Compound ID,CHEMBL268229,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.77,nM,=,,5.68,-7.353,,,[125I]-iodoproxyfan,0.0,0.0,,0.0,,Q9Y5N1,0.3746538370719997
74,11961043,hrh3_human,196,W,A,Impentamine,ChEMBL Compound ID,CHEMBL417096,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,15.52,nM,=,,11.06,1.403,,,[125I]-iodoproxyfan,0.0,0.0,,0.0,,Q9Y5N1,0.3746538370719997
83,11961043,hrh3_human,196,W,A,Histamine,ChEMBL Compound ID,CHEMBL90,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,15.86,nM,=,,25.38,-1.6,,,[125I]-iodoproxyfan,0.0,0.0,,0.0,,Q9Y5N1,0.3746538370719997
38,11961043,hrh3_human,199,L,A,Imetit,ChEMBL Compound ID,CHEMBL19439,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,9.34,nM,=,,28.34,-3.03,,,[125I]-iodoproxyfan,0.0,0.0,,0.0,,Q9Y5N1,0.5118025306914162
39,11961043,hrh3_human,199,L,A,Imetit,ChEMBL Compound ID,CHEMBL19439,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.45,nM,=,,28.34,-62.5,,,[125I]-iodoproxyfan,0.0,0.0,,0.0,,Q9Y5N1,0.5118025306914162
56,11961043,hrh3_human,199,L,A,R-alfa methylhistamine,ChEMBL Compound ID,CHEMBL268229,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,12.74,nM,=,,2.77,4.599,,,[125I]-iodoproxyfan,0.0,0.0,,0.0,,Q9Y5N1,0.5118025306914162
57,11961043,hrh3_human,199,L,A,R-alfa methylhistamine,ChEMBL Compound ID,CHEMBL268229,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.77,nM,=,,2.77,-3.597,,,[125I]-iodoproxyfan,0.0,0.0,,0.0,,Q9Y5N1,0.5118025306914162
75,11961043,hrh3_human,199,L,A,Impentamine,ChEMBL Compound ID,CHEMBL417096,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,15.52,nM,=,,10.2,1.522,,,[125I]-iodoproxyfan,0.0,0.0,,0.0,,Q9Y5N1,0.5118025306914162
84,11961043,hrh3_human,199,L,A,Histamine,ChEMBL Compound ID,CHEMBL90,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,15.86,nM,=,,18.69,-1.178,,,[125I]-iodoproxyfan,0.0,0.0,,0.0,,Q9Y5N1,0.5118025306914162
40,11961043,hrh3_human,201,T,A,Imetit,ChEMBL Compound ID,CHEMBL19439,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,9.34,nM,=,,56.07,-5.988,,,[125I]-iodoproxyfan,0.0,0.0,,0.0,,Q9Y5N1,0.3273360584260579
41,11961043,hrh3_human,201,T,A,Imetit,ChEMBL Compound ID,CHEMBL19439,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.45,nM,=,,56.07,-125.0,,,[125I]-iodoproxyfan,0.0,0.0,,0.0,,Q9Y5N1,0.3273360584260579
58,11961043,hrh3_human,201,T,A,R-alfa methylhistamine,ChEMBL Compound ID,CHEMBL268229,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,12.74,nM,=,,6.61,1.927,,,[125I]-iodoproxyfan,0.0,0.0,,0.0,,Q9Y5N1,0.3273360584260579
59,11961043,hrh3_human,201,T,A,R-alfa methylhistamine,ChEMBL Compound ID,CHEMBL268229,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.77,nM,=,,6.61,-8.621,,,[125I]-iodoproxyfan,0.0,0.0,,0.0,,Q9Y5N1,0.3273360584260579
76,11961043,hrh3_human,201,T,A,Impentamine,ChEMBL Compound ID,CHEMBL417096,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,15.52,nM,=,,14.36,1.081,,,[125I]-iodoproxyfan,0.0,0.0,,0.0,,Q9Y5N1,0.3273360584260579
85,11961043,hrh3_human,201,T,A,Histamine,ChEMBL Compound ID,CHEMBL90,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,15.86,nM,=,,17.91,-1.129,,,[125I]-iodoproxyfan,0.0,0.0,,0.0,,Q9Y5N1,0.3273360584260579
44,11961043,hrh3_human,204,T,A,Imetit,ChEMBL Compound ID,CHEMBL19439,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,9.34,nM,=,,86.63,-9.259,,,[125I]-iodoproxyfan,0.0,0.0,,0.0,,Q9Y5N1,0.3024222237442829
45,11961043,hrh3_human,204,T,A,Imetit,ChEMBL Compound ID,CHEMBL19439,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.45,nM,=,,86.63,-200.0,,,[125I]-iodoproxyfan,0.0,0.0,,0.0,,Q9Y5N1,0.3024222237442829
62,11961043,hrh3_human,204,T,A,R-alfa methylhistamine,ChEMBL Compound ID,CHEMBL268229,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,12.74,nM,=,,13.94,-1.094,,,[125I]-iodoproxyfan,0.0,0.0,,0.0,,Q9Y5N1,0.3024222237442829
63,11961043,hrh3_human,204,T,A,R-alfa methylhistamine,ChEMBL Compound ID,CHEMBL268229,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.77,nM,=,,13.94,-18.182,,,[125I]-iodoproxyfan,0.0,0.0,,0.0,,Q9Y5N1,0.3024222237442829
78,11961043,hrh3_human,204,T,A,Impentamine,ChEMBL Compound ID,CHEMBL417096,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,15.52,nM,=,,35.38,-2.278,,,[125I]-iodoproxyfan,0.0,0.0,,0.0,,Q9Y5N1,0.3024222237442829
87,11961043,hrh3_human,204,T,A,Histamine,ChEMBL Compound ID,CHEMBL90,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,15.86,nM,=,,91.0,-5.747,,,[125I]-iodoproxyfan,0.0,0.0,,0.0,,Q9Y5N1,0.3024222237442829
46,11961043,hrh3_human,206,E,A,Imetit,ChEMBL Compound ID,CHEMBL19439,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,9.34,nM,=,,888.3,-90.909,,,[125I]-iodoproxyfan,0.0,0.0,,0.0,,Q9Y5N1,0.4916797458134486
47,11961043,hrh3_human,206,E,A,Imetit,ChEMBL Compound ID,CHEMBL19439,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.45,nM,=,,888.3,-1000.0,,,[125I]-iodoproxyfan,0.0,0.0,,0.0,,Q9Y5N1,0.4916797458134486
79,11961043,hrh3_human,206,E,A,Impentamine,ChEMBL Compound ID,CHEMBL417096,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,15.52,nM,=,,295.15,-18.868,,,[125I]-iodoproxyfan,0.0,0.0,,0.0,,Q9Y5N1,0.4916797458134486
48,11961043,hrh3_human,208,F,A,Imetit,ChEMBL Compound ID,CHEMBL19439,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,9.34,nM,=,,70.0,-7.519,,,[125I]-iodoproxyfan,0.0,0.0,,0.0,,Q9Y5N1,0.3920878702544769
49,11961043,hrh3_human,208,F,A,Imetit,ChEMBL Compound ID,CHEMBL19439,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.45,nM,=,,70.0,-166.667,,,[125I]-iodoproxyfan,0.0,0.0,,0.0,,Q9Y5N1,0.3920878702544769
66,11961043,hrh3_human,208,F,A,R-alfa methylhistamine,ChEMBL Compound ID,CHEMBL268229,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,12.74,nM,=,,2.17,5.871,,,[125I]-iodoproxyfan,0.0,0.0,,0.0,,Q9Y5N1,0.3920878702544769
67,11961043,hrh3_human,208,F,A,R-alfa methylhistamine,ChEMBL Compound ID,CHEMBL268229,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.77,nM,=,,2.17,-2.817,,,[125I]-iodoproxyfan,0.0,0.0,,0.0,,Q9Y5N1,0.3920878702544769
80,11961043,hrh3_human,208,F,A,Impentamine,ChEMBL Compound ID,CHEMBL417096,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,15.52,nM,=,,14.16,1.096,,,[125I]-iodoproxyfan,0.0,0.0,,0.0,,Q9Y5N1,0.3920878702544769
89,11961043,hrh3_human,208,F,A,Histamine,ChEMBL Compound ID,CHEMBL90,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,15.86,nM,=,,36.81,-2.32,,,[125I]-iodoproxyfan,0.0,0.0,,0.0,,Q9Y5N1,0.3920878702544769
1,26005408,5ht7r_human,364,W,V,[3H]5-CT,ChEMBL Compound ID,CHEMBL18840,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,9.51,,=,,9.57,1.148,,,,0.0,0.0,,0.0,,P34969,0.3405754097635738
13,26005408,5ht7r_human,364,W,V,[3H]SB269970,ChEMBL Compound ID,CHEMBL282199,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,9.51,,=,,9.3,-1.621,,,,0.0,0.0,,0.0,,P34969,0.3405754097635738
2,26005408,5ht7r_human,366,E,A,[3H]5-CT,ChEMBL Compound ID,CHEMBL18840,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,9.51,,=,,8.74,-5.882,,,,0.0,0.0,,0.0,,P34969,0.4136729233430184
14,26005408,5ht7r_human,366,E,A,[3H]SB269970,ChEMBL Compound ID,CHEMBL282199,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,9.51,,=,,9.41,-1.259,,,,0.0,0.0,,0.0,,P34969,0.4136729233430184
7,26005408,5ht7r_human,374,Y,A,[3H]5-CT,ChEMBL Compound ID,CHEMBL18840,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,9.51,,=,,8.17,-21.739,,,,0.0,0.0,,0.0,,P34969,0.612589749376483
19,26005408,5ht7r_human,374,Y,A,[3H]SB269970,ChEMBL Compound ID,CHEMBL282199,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,9.51,,=,,9.77,1.82,,,,0.0,0.0,,0.0,,P34969,0.612589749376483
8,26005408,5ht7r_human,374,Y,F,[3H]5-CT,ChEMBL Compound ID,CHEMBL18840,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,9.51,,=,,8.55,-9.091,,,,0.0,0.0,,0.0,,P34969,0.3913437378236774
20,26005408,5ht7r_human,374,Y,F,[3H]SB269970,ChEMBL Compound ID,CHEMBL282199,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,9.51,,=,,8.98,-3.39,,,,0.0,0.0,,0.0,,P34969,0.3913437378236774
9,26005408,5ht7r_human,374,Y,T,[3H]5-CT,ChEMBL Compound ID,CHEMBL18840,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,9.51,,=,,8.55,-9.091,,,,0.0,0.0,,0.0,,P34969,0.612589749376483
21,26005408,5ht7r_human,374,Y,T,[3H]SB269970,ChEMBL Compound ID,CHEMBL282199,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,9.51,,=,,8.56,-8.929,,,,0.0,0.0,,0.0,,P34969,0.612589749376483
0,17652183,ccr8_human,110,S,A,CCL1,UniProt Entry Code,P22362,Full agonist,EC50,Functional - IP accumulation,8.7,nM,=,,1.6,5.437,,,[125I]-CCL1,0.0,120.92696629213484,,0.0,,P51685,0.3540750167792145
33,17652183,ccr8_human,110,S,A,LMD-009,SMILES,COC1=CC=CC=C1OC2=CC=CC(CN3CCC4(C(NCN4CCC5=CC=CC=C5)=O)CC3)=C2,Full agonist,EC50,Functional - IP accumulation,11.0,nM,=,,1.5,7.333,,,[125I]-CCL1,0.0,120.92696629213484,,0.0,,P51685,0.3540750167792145
62,17652183,ccr8_human,110,S,A,LMD-584,SMILES,OC(C1=C(C2(O)CCN(CC3=CC(OC4=C(OC)C=CC=C4)=CC=C3)CC2)C=CC=C1)=O,Full agonist,EC50,Functional - IP accumulation,29.0,nM,=,,6.0,4.833,,,[125I]-CCL1,0.0,0.0,,0.0,,P51685,0.3540750167792145
91,17652183,ccr8_human,110,S,A,LMD-902,SMILES,CCNS(C1=CC=C(OC)C=C1C2(O)CCN(CC3=CC(OC4=C(OC)C=CC=C4)=CC=C3)CC2)(=O)=O,Full agonist,EC50,Functional - IP accumulation,15.0,nM,=,,2.0,7.5,,,[125I]-CCL1,0.0,0.0,,0.0,,P51685,0.3540750167792145
120,17652183,ccr8_human,110,S,A,LMD-268,SMILES,O=C(NC1CCN(CC2=CC(OC3=C(OC)C=CC=C3)=CC=C2)CC1)C(CCN4CCCC4)C5=CC=CC=C5,Full agonist,EC50,Functional - IP accumulation,9.0,nM,=,,1.6,5.625,,,[125I]-CCL1,0.0,0.0,,0.0,,P51685,0.3540750167792145
149,17652183,ccr8_human,110,S,A,LMD-174,SMILES,O=C(NC1CCN(CC2=CC(OC3=C(OC)C=CC=C3)=CC=C2)CC1)C4CC(NC5=C4C=CC=C5)=O,Full agonist,EC50,Functional - IP accumulation,30.0,nM,=,,3.6,8.333,,,[125I]-CCL1,0.0,0.0,,0.0,,P51685,0.3540750167792145
1,17652183,ccr8_human,110,S,H,CCL1,UniProt Entry Code,P22362,Full agonist,EC50,Functional - IP accumulation,8.7,nM,>,,1000.0,-111.111,,,[125I]-CCL1,0.0,78.08988764044943,,0.0,,P51685,0.4397855817240059
34,17652183,ccr8_human,110,S,H,LMD-009,SMILES,COC1=CC=CC=C1OC2=CC=CC(CN3CCC4(C(NCN4CCC5=CC=CC=C5)=O)CC3)=C2,Full agonist,EC50,Functional - IP accumulation,11.0,nM,>,,10000.0,-1000.0,,,[125I]-CCL1,0.0,78.08988764044943,,0.0,,P51685,0.4397855817240059
63,17652183,ccr8_human,110,S,H,LMD-584,SMILES,OC(C1=C(C2(O)CCN(CC3=CC(OC4=C(OC)C=CC=C4)=CC=C3)CC2)C=CC=C1)=O,Full agonist,EC50,Functional - IP accumulation,29.0,nM,>,,10000.0,-333.333,,,[125I]-CCL1,0.0,0.0,,0.0,,P51685,0.4397855817240059
92,17652183,ccr8_human,110,S,H,LMD-902,SMILES,CCNS(C1=CC=C(OC)C=C1C2(O)CCN(CC3=CC(OC4=C(OC)C=CC=C4)=CC=C3)CC2)(=O)=O,Full agonist,EC50,Functional - IP accumulation,15.0,nM,=,,10000.0,-500.0,,,[125I]-CCL1,0.0,0.0,,0.0,,P51685,0.4397855817240059
121,17652183,ccr8_human,110,S,H,LMD-268,SMILES,O=C(NC1CCN(CC2=CC(OC3=C(OC)C=CC=C3)=CC=C2)CC1)C(CCN4CCCC4)C5=CC=CC=C5,Full agonist,EC50,Functional - IP accumulation,9.0,nM,=,,10000.0,-1000.0,,,[125I]-CCL1,0.0,0.0,,0.0,,P51685,0.4397855817240059
150,17652183,ccr8_human,110,S,H,LMD-174,SMILES,O=C(NC1CCN(CC2=CC(OC3=C(OC)C=CC=C3)=CC=C2)CC1)C4CC(NC5=C4C=CC=C5)=O,Full agonist,EC50,Functional - IP accumulation,30.0,nM,=,,10000.0,-333.333,,,[125I]-CCL1,0.0,0.0,,0.0,,P51685,0.4397855817240059
2,17652183,ccr8_human,110,S,W,CCL1,UniProt Entry Code,P22362,Full agonist,EC50,Functional - IP accumulation,8.7,nM,>,,1000.0,-111.111,,,[125I]-CCL1,0.0,56.17977528089888,,0.0,,P51685,0.5293165720254037
35,17652183,ccr8_human,110,S,W,LMD-009,SMILES,COC1=CC=CC=C1OC2=CC=CC(CN3CCC4(C(NCN4CCC5=CC=CC=C5)=O)CC3)=C2,Full agonist,EC50,Functional - IP accumulation,11.0,nM,>,,10000.0,-1000.0,,,[125I]-CCL1,0.0,56.17977528089888,,0.0,,P51685,0.5293165720254037
64,17652183,ccr8_human,110,S,W,LMD-584,SMILES,OC(C1=C(C2(O)CCN(CC3=CC(OC4=C(OC)C=CC=C4)=CC=C3)CC2)C=CC=C1)=O,Full agonist,EC50,Functional - IP accumulation,29.0,nM,>,,10000.0,-333.333,,,[125I]-CCL1,0.0,0.0,,0.0,,P51685,0.5293165720254037
93,17652183,ccr8_human,110,S,W,LMD-902,SMILES,CCNS(C1=CC=C(OC)C=C1C2(O)CCN(CC3=CC(OC4=C(OC)C=CC=C4)=CC=C3)CC2)(=O)=O,Full agonist,EC50,Functional - IP accumulation,15.0,nM,>,,10000.0,-500.0,,,[125I]-CCL1,0.0,0.0,,0.0,,P51685,0.5293165720254037
122,17652183,ccr8_human,110,S,W,LMD-268,SMILES,O=C(NC1CCN(CC2=CC(OC3=C(OC)C=CC=C3)=CC=C2)CC1)C(CCN4CCCC4)C5=CC=CC=C5,Full agonist,EC50,Functional - IP accumulation,9.0,nM,>,,10000.0,-1000.0,,,[125I]-CCL1,0.0,0.0,,0.0,,P51685,0.5293165720254037
151,17652183,ccr8_human,110,S,W,LMD-174,SMILES,O=C(NC1CCN(CC2=CC(OC3=C(OC)C=CC=C3)=CC=C2)CC1)C4CC(NC5=C4C=CC=C5)=O,Full agonist,EC50,Functional - IP accumulation,30.0,nM,>,,10000.0,-333.333,,,[125I]-CCL1,0.0,0.0,,0.0,,P51685,0.5293165720254037
3,17652183,ccr8_human,112,F,A,CCL1,UniProt Entry Code,P22362,Full agonist,EC50,Functional - IP accumulation,8.7,nM,=,,4.6,1.891,,,[125I]-CCL1,0.0,91.43258426966293,,0.0,,P51685,0.4820563327110714
36,17652183,ccr8_human,112,F,A,LMD-009,SMILES,COC1=CC=CC=C1OC2=CC=CC(CN3CCC4(C(NCN4CCC5=CC=CC=C5)=O)CC3)=C2,Full agonist,EC50,Functional - IP accumulation,11.0,nM,=,,11.0,1.0,,,[125I]-CCL1,0.0,91.43258426966293,,0.0,,P51685,0.4820563327110714
65,17652183,ccr8_human,112,F,A,LMD-584,SMILES,OC(C1=C(C2(O)CCN(CC3=CC(OC4=C(OC)C=CC=C4)=CC=C3)CC2)C=CC=C1)=O,Full agonist,EC50,Functional - IP accumulation,29.0,nM,=,,51.0,-1.757,,,[125I]-CCL1,0.0,0.0,,0.0,,P51685,0.4820563327110714
94,17652183,ccr8_human,112,F,A,LMD-902,SMILES,CCNS(C1=CC=C(OC)C=C1C2(O)CCN(CC3=CC(OC4=C(OC)C=CC=C4)=CC=C3)CC2)(=O)=O,Full agonist,EC50,Functional - IP accumulation,15.0,nM,>,,13.0,1.154,,,[125I]-CCL1,0.0,0.0,,0.0,,P51685,0.4820563327110714
123,17652183,ccr8_human,112,F,A,LMD-268,SMILES,O=C(NC1CCN(CC2=CC(OC3=C(OC)C=CC=C3)=CC=C2)CC1)C(CCN4CCCC4)C5=CC=CC=C5,Full agonist,EC50,Functional - IP accumulation,9.0,nM,>,,7.1,1.268,,,[125I]-CCL1,0.0,0.0,,0.0,,P51685,0.4820563327110714
152,17652183,ccr8_human,112,F,A,LMD-174,SMILES,O=C(NC1CCN(CC2=CC(OC3=C(OC)C=CC=C3)=CC=C2)CC1)C4CC(NC5=C4C=CC=C5)=O,Full agonist,EC50,Functional - IP accumulation,30.0,nM,>,,37.0,-1.233,,,[125I]-CCL1,0.0,0.0,,0.0,,P51685,0.4820563327110714
4,17652183,ccr8_human,42,Y,A,CCL1,UniProt Entry Code,P22362,Full agonist,EC50,Functional - IP accumulation,8.7,nM,=,,11.0,-1.264,,,[125I]-CCL1,0.0,110.3932584269663,,0.0,,P51685,0.5922152615512222
28,17652183,ccr8_human,42,Y,A,LMD-009,SMILES,COC1=CC=CC=C1OC2=CC=CC(CN3CCC4(C(NCN4CCC5=CC=CC=C5)=O)CC3)=C2,Full agonist,EC50,Functional - IP accumulation,11.0,nM,=,,158.0,-14.286,,,[125I]-CCL1,0.0,110.3932584269663,,0.0,,P51685,0.5922152615512222
56,17652183,ccr8_human,42,Y,A,LMD-584,SMILES,OC(C1=C(C2(O)CCN(CC3=CC(OC4=C(OC)C=CC=C4)=CC=C3)CC2)C=CC=C1)=O,Full agonist,EC50,Functional - IP accumulation,29.0,nM,=,,131.0,-4.525,,,[125I]-CCL1,0.0,0.0,,0.0,,P51685,0.5922152615512222
85,17652183,ccr8_human,42,Y,A,LMD-902,SMILES,CCNS(C1=CC=C(OC)C=C1C2(O)CCN(CC3=CC(OC4=C(OC)C=CC=C4)=CC=C3)CC2)(=O)=O,Full agonist,EC50,Functional - IP accumulation,15.0,nM,=,,178.0,-11.905,,,[125I]-CCL1,0.0,0.0,,0.0,,P51685,0.5922152615512222
114,17652183,ccr8_human,42,Y,A,LMD-268,SMILES,O=C(NC1CCN(CC2=CC(OC3=C(OC)C=CC=C3)=CC=C2)CC1)C(CCN4CCCC4)C5=CC=CC=C5,Full agonist,EC50,Functional - IP accumulation,9.0,nM,=,,172.0,-19.231,,,[125I]-CCL1,0.0,0.0,,0.0,,P51685,0.5922152615512222
143,17652183,ccr8_human,42,Y,A,LMD-174,SMILES,O=C(NC1CCN(CC2=CC(OC3=C(OC)C=CC=C3)=CC=C2)CC1)C4CC(NC5=C4C=CC=C5)=O,Full agonist,EC50,Functional - IP accumulation,30.0,nM,=,,199.0,-6.623,,,[125I]-CCL1,0.0,0.0,,0.0,,P51685,0.5922152615512222
5,17652183,ccr8_human,84,F,A,CCL1,UniProt Entry Code,P22362,Full agonist,EC50,Functional - IP accumulation,8.7,nM,=,,4.0,2.175,,,[125I]-CCL1,0.0,141.71348314606743,,0.0,,P51685,0.5583608302543367
29,17652183,ccr8_human,84,F,A,LMD-009,SMILES,COC1=CC=CC=C1OC2=CC=CC(CN3CCC4(C(NCN4CCC5=CC=CC=C5)=O)CC3)=C2,Full agonist,EC50,Functional - IP accumulation,11.0,nM,=,,14.0,-1.272,,,[125I]-CCL1,0.0,141.71348314606743,,0.0,,P51685,0.5583608302543367
58,17652183,ccr8_human,84,F,A,LMD-584,SMILES,OC(C1=C(C2(O)CCN(CC3=CC(OC4=C(OC)C=CC=C4)=CC=C3)CC2)C=CC=C1)=O,Full agonist,EC50,Functional - IP accumulation,29.0,nM,=,,7.0,4.143,,,[125I]-CCL1,0.0,0.0,,0.0,,P51685,0.5583608302543367
87,17652183,ccr8_human,84,F,A,LMD-902,SMILES,CCNS(C1=CC=C(OC)C=C1C2(O)CCN(CC3=CC(OC4=C(OC)C=CC=C4)=CC=C3)CC2)(=O)=O,Full agonist,EC50,Functional - IP accumulation,15.0,nM,=,,12.0,1.25,,,[125I]-CCL1,0.0,0.0,,0.0,,P51685,0.5583608302543367
116,17652183,ccr8_human,84,F,A,LMD-268,SMILES,O=C(NC1CCN(CC2=CC(OC3=C(OC)C=CC=C3)=CC=C2)CC1)C(CCN4CCCC4)C5=CC=CC=C5,Full agonist,EC50,Functional - IP accumulation,9.0,nM,=,,4.8,1.875,,,[125I]-CCL1,0.0,0.0,,0.0,,P51685,0.5583608302543367
145,17652183,ccr8_human,84,F,A,LMD-174,SMILES,O=C(NC1CCN(CC2=CC(OC3=C(OC)C=CC=C3)=CC=C2)CC1)C4CC(NC5=C4C=CC=C5)=O,Full agonist,EC50,Functional - IP accumulation,30.0,nM,=,,133.0,-4.425,,,[125I]-CCL1,0.0,0.0,,0.0,,P51685,0.5583608302543367
6,17652183,ccr8_human,88,F,A,CCL1,UniProt Entry Code,P22362,Full agonist,EC50,Functional - IP accumulation,8.7,nM,=,,10.0,-1.149,,,[125I]-CCL1,0.0,112.2191011235955,,0.0,,P51685,0.5922364040637433
30,17652183,ccr8_human,88,F,A,LMD-009,SMILES,COC1=CC=CC=C1OC2=CC=CC(CN3CCC4(C(NCN4CCC5=CC=CC=C5)=O)CC3)=C2,Full agonist,EC50,Functional - IP accumulation,11.0,nM,=,,108.0,-9.804,,,[125I]-CCL1,0.0,112.2191011235955,,0.0,,P51685,0.5922364040637433
59,17652183,ccr8_human,88,F,A,LMD-584,SMILES,OC(C1=C(C2(O)CCN(CC3=CC(OC4=C(OC)C=CC=C4)=CC=C3)CC2)C=CC=C1)=O,Full agonist,EC50,Functional - IP accumulation,29.0,nM,=,,251.0,-8.621,,,[125I]-CCL1,0.0,0.0,,0.0,,P51685,0.5922364040637433
88,17652183,ccr8_human,88,F,A,LMD-902,SMILES,CCNS(C1=CC=C(OC)C=C1C2(O)CCN(CC3=CC(OC4=C(OC)C=CC=C4)=CC=C3)CC2)(=O)=O,Full agonist,EC50,Functional - IP accumulation,15.0,nM,=,,197.0,-13.158,,,[125I]-CCL1,0.0,0.0,,0.0,,P51685,0.5922364040637433
117,17652183,ccr8_human,88,F,A,LMD-268,SMILES,O=C(NC1CCN(CC2=CC(OC3=C(OC)C=CC=C3)=CC=C2)CC1)C(CCN4CCCC4)C5=CC=CC=C5,Full agonist,EC50,Functional - IP accumulation,9.0,nM,=,,31.0,-3.448,,,[125I]-CCL1,0.0,0.0,,0.0,,P51685,0.5922364040637433
146,17652183,ccr8_human,88,F,A,LMD-174,SMILES,O=C(NC1CCN(CC2=CC(OC3=C(OC)C=CC=C3)=CC=C2)CC1)C4CC(NC5=C4C=CC=C5)=O,Full agonist,EC50,Functional - IP accumulation,30.0,nM,=,,94.0,-3.135,,,[125I]-CCL1,0.0,0.0,,0.0,,P51685,0.5922364040637433
7,17652183,ccr8_human,91,Q,W,CCL1,UniProt Entry Code,P22362,Full agonist,EC50,Functional - IP accumulation,8.7,nM,=,,69.0,-7.937,,,[125I]-CCL1,0.0,93.39887640449436,,0.0,,P51685,0.5064473701878205
31,17652183,ccr8_human,91,Q,W,LMD-009,SMILES,COC1=CC=CC=C1OC2=CC=CC(CN3CCC4(C(NCN4CCC5=CC=CC=C5)=O)CC3)=C2,Full agonist,EC50,Functional - IP accumulation,11.0,nM,=,,108.0,-9.804,,,[125I]-CCL1,0.0,93.39887640449436,,0.0,,P51685,0.5064473701878205
60,17652183,ccr8_human,91,Q,W,LMD-584,SMILES,OC(C1=C(C2(O)CCN(CC3=CC(OC4=C(OC)C=CC=C4)=CC=C3)CC2)C=CC=C1)=O,Full agonist,EC50,Functional - IP accumulation,29.0,nM,=,,368.0,-12.658,,,[125I]-CCL1,0.0,0.0,,0.0,,P51685,0.5064473701878205
89,17652183,ccr8_human,91,Q,W,LMD-902,SMILES,CCNS(C1=CC=C(OC)C=C1C2(O)CCN(CC3=CC(OC4=C(OC)C=CC=C4)=CC=C3)CC2)(=O)=O,Full agonist,EC50,Functional - IP accumulation,15.0,nM,=,,180.0,-12.048,,,[125I]-CCL1,0.0,0.0,,0.0,,P51685,0.5064473701878205
118,17652183,ccr8_human,91,Q,W,LMD-268,SMILES,O=C(NC1CCN(CC2=CC(OC3=C(OC)C=CC=C3)=CC=C2)CC1)C(CCN4CCCC4)C5=CC=CC=C5,Full agonist,EC50,Functional - IP accumulation,9.0,nM,=,,161.0,-17.857,,,[125I]-CCL1,0.0,0.0,,0.0,,P51685,0.5064473701878205
147,17652183,ccr8_human,91,Q,W,LMD-174,SMILES,O=C(NC1CCN(CC2=CC(OC3=C(OC)C=CC=C3)=CC=C2)CC1)C4CC(NC5=C4C=CC=C5)=O,Full agonist,EC50,Functional - IP accumulation,30.0,nM,=,,201.0,-6.711,,,[125I]-CCL1,0.0,0.0,,0.0,,P51685,0.5064473701878205
8,17652183,ccr8_human,109,V,A,CCL1,UniProt Entry Code,P22362,Full agonist,EC50,Functional - IP accumulation,8.7,nM,=,,8.2,1.061,,,[125I]-CCL1,0.0,132.02247191011236,,0.0,,P51685,0.438297518241182
32,17652183,ccr8_human,109,V,A,LMD-009,SMILES,COC1=CC=CC=C1OC2=CC=CC(CN3CCC4(C(NCN4CCC5=CC=CC=C5)=O)CC3)=C2,Full agonist,EC50,Functional - IP accumulation,11.0,nM,=,,7.7,1.429,,,[125I]-CCL1,0.0,132.02247191011236,,0.0,,P51685,0.438297518241182
61,17652183,ccr8_human,109,V,A,LMD-584,SMILES,OC(C1=C(C2(O)CCN(CC3=CC(OC4=C(OC)C=CC=C4)=CC=C3)CC2)C=CC=C1)=O,Full agonist,EC50,Functional - IP accumulation,29.0,nM,=,,34.0,-1.172,,,[125I]-CCL1,0.0,0.0,,0.0,,P51685,0.438297518241182
90,17652183,ccr8_human,109,V,A,LMD-902,SMILES,CCNS(C1=CC=C(OC)C=C1C2(O)CCN(CC3=CC(OC4=C(OC)C=CC=C4)=CC=C3)CC2)(=O)=O,Full agonist,EC50,Functional - IP accumulation,15.0,nM,=,,8.0,1.875,,,[125I]-CCL1,0.0,0.0,,0.0,,P51685,0.438297518241182
119,17652183,ccr8_human,109,V,A,LMD-268,SMILES,O=C(NC1CCN(CC2=CC(OC3=C(OC)C=CC=C3)=CC=C2)CC1)C(CCN4CCCC4)C5=CC=CC=C5,Full agonist,EC50,Functional - IP accumulation,9.0,nM,=,,2.6,3.462,,,[125I]-CCL1,0.0,0.0,,0.0,,P51685,0.438297518241182
148,17652183,ccr8_human,109,V,A,LMD-174,SMILES,O=C(NC1CCN(CC2=CC(OC3=C(OC)C=CC=C3)=CC=C2)CC1)C4CC(NC5=C4C=CC=C5)=O,Full agonist,EC50,Functional - IP accumulation,30.0,nM,=,,33.0,-1.1,,,[125I]-CCL1,0.0,0.0,,0.0,,P51685,0.438297518241182
9,17652183,ccr8_human,113,Y,A,CCL1,UniProt Entry Code,P22362,Full agonist,EC50,Functional - IP accumulation,8.7,nM,=,,323.0,-37.037,,,[125I]-CCL1,0.0,80.0561797752809,,0.0,,P51685,0.5486642149140082
37,17652183,ccr8_human,113,Y,A,LMD-009,SMILES,COC1=CC=CC=C1OC2=CC=CC(CN3CCC4(C(NCN4CCC5=CC=CC=C5)=O)CC3)=C2,Full agonist,EC50,Functional - IP accumulation,11.0,nM,>,,10000.0,-1000.0,,,[125I]-CCL1,0.0,80.0561797752809,,0.0,,P51685,0.5486642149140082
66,17652183,ccr8_human,113,Y,A,LMD-584,SMILES,OC(C1=C(C2(O)CCN(CC3=CC(OC4=C(OC)C=CC=C4)=CC=C3)CC2)C=CC=C1)=O,Full agonist,EC50,Functional - IP accumulation,29.0,nM,>,,10000.0,-333.333,,,[125I]-CCL1,0.0,0.0,,0.0,,P51685,0.5486642149140082
95,17652183,ccr8_human,113,Y,A,LMD-902,SMILES,CCNS(C1=CC=C(OC)C=C1C2(O)CCN(CC3=CC(OC4=C(OC)C=CC=C4)=CC=C3)CC2)(=O)=O,Full agonist,EC50,Functional - IP accumulation,15.0,nM,=,,10000.0,-500.0,,,[125I]-CCL1,0.0,0.0,,0.0,,P51685,0.5486642149140082
124,17652183,ccr8_human,113,Y,A,LMD-268,SMILES,O=C(NC1CCN(CC2=CC(OC3=C(OC)C=CC=C3)=CC=C2)CC1)C(CCN4CCCC4)C5=CC=CC=C5,Full agonist,EC50,Functional - IP accumulation,9.0,nM,=,,10000.0,-1000.0,,,[125I]-CCL1,0.0,0.0,,0.0,,P51685,0.5486642149140082
153,17652183,ccr8_human,113,Y,A,LMD-174,SMILES,O=C(NC1CCN(CC2=CC(OC3=C(OC)C=CC=C3)=CC=C2)CC1)C4CC(NC5=C4C=CC=C5)=O,Full agonist,EC50,Functional - IP accumulation,30.0,nM,=,,10000.0,-333.333,,,[125I]-CCL1,0.0,0.0,,0.0,,P51685,0.5486642149140082
10,17652183,ccr8_human,114,Y,A,CCL1,UniProt Entry Code,P22362,Full agonist,EC50,Functional - IP accumulation,8.7,nM,=,,131.0,-15.152,,,[125I]-CCL1,0.0,130.1966292134831,,0.0,,P51685,0.4979055088121153
38,17652183,ccr8_human,114,Y,A,LMD-009,SMILES,COC1=CC=CC=C1OC2=CC=CC(CN3CCC4(C(NCN4CCC5=CC=CC=C5)=O)CC3)=C2,Full agonist,EC50,Functional - IP accumulation,11.0,nM,=,,42.0,-3.817,,,[125I]-CCL1,0.0,130.1966292134831,,0.0,,P51685,0.4979055088121153
67,17652183,ccr8_human,114,Y,A,LMD-584,SMILES,OC(C1=C(C2(O)CCN(CC3=CC(OC4=C(OC)C=CC=C4)=CC=C3)CC2)C=CC=C1)=O,Full agonist,EC50,Functional - IP accumulation,29.0,nM,=,,430.0,-14.925,,,[125I]-CCL1,0.0,0.0,,0.0,,P51685,0.4979055088121153
96,17652183,ccr8_human,114,Y,A,LMD-902,SMILES,CCNS(C1=CC=C(OC)C=C1C2(O)CCN(CC3=CC(OC4=C(OC)C=CC=C4)=CC=C3)CC2)(=O)=O,Full agonist,EC50,Functional - IP accumulation,15.0,nM,>,,191.0,-12.658,,,[125I]-CCL1,0.0,0.0,,0.0,,P51685,0.4979055088121153
125,17652183,ccr8_human,114,Y,A,LMD-268,SMILES,O=C(NC1CCN(CC2=CC(OC3=C(OC)C=CC=C3)=CC=C2)CC1)C(CCN4CCCC4)C5=CC=CC=C5,Full agonist,EC50,Functional - IP accumulation,9.0,nM,>,,579.0,-62.5,,,[125I]-CCL1,0.0,0.0,,0.0,,P51685,0.4979055088121153
154,17652183,ccr8_human,114,Y,A,LMD-174,SMILES,O=C(NC1CCN(CC2=CC(OC3=C(OC)C=CC=C3)=CC=C2)CC1)C4CC(NC5=C4C=CC=C5)=O,Full agonist,EC50,Functional - IP accumulation,30.0,nM,>,,945.0,-31.25,,,[125I]-CCL1,0.0,0.0,,0.0,,P51685,0.4979055088121153
11,17652183,ccr8_human,123,F,A,CCL1,UniProt Entry Code,P22362,Full agonist,EC50,Functional - IP accumulation,8.7,nM,=,,4.4,1.977,,,[125I]-CCL1,0.0,59.8314606741573,,0.0,,P51685,0.606447541416945
39,17652183,ccr8_human,123,F,A,LMD-009,SMILES,COC1=CC=CC=C1OC2=CC=CC(CN3CCC4(C(NCN4CCC5=CC=CC=C5)=O)CC3)=C2,Full agonist,EC50,Functional - IP accumulation,11.0,nM,=,,7.0,1.571,,,[125I]-CCL1,0.0,59.8314606741573,,0.0,,P51685,0.606447541416945
68,17652183,ccr8_human,123,F,A,LMD-584,SMILES,OC(C1=C(C2(O)CCN(CC3=CC(OC4=C(OC)C=CC=C4)=CC=C3)CC2)C=CC=C1)=O,Full agonist,EC50,Functional - IP accumulation,29.0,nM,=,,21.0,1.381,,,[125I]-CCL1,0.0,0.0,,0.0,,P51685,0.606447541416945
97,17652183,ccr8_human,123,F,A,LMD-902,SMILES,CCNS(C1=CC=C(OC)C=C1C2(O)CCN(CC3=CC(OC4=C(OC)C=CC=C4)=CC=C3)CC2)(=O)=O,Full agonist,EC50,Functional - IP accumulation,15.0,nM,=,,12.0,1.25,,,[125I]-CCL1,0.0,0.0,,0.0,,P51685,0.606447541416945
126,17652183,ccr8_human,123,F,A,LMD-268,SMILES,O=C(NC1CCN(CC2=CC(OC3=C(OC)C=CC=C3)=CC=C2)CC1)C(CCN4CCCC4)C5=CC=CC=C5,Full agonist,EC50,Functional - IP accumulation,9.0,nM,=,,5.0,1.8,,,[125I]-CCL1,0.0,0.0,,0.0,,P51685,0.606447541416945
155,17652183,ccr8_human,123,F,A,LMD-174,SMILES,O=C(NC1CCN(CC2=CC(OC3=C(OC)C=CC=C3)=CC=C2)CC1)C4CC(NC5=C4C=CC=C5)=O,Full agonist,EC50,Functional - IP accumulation,30.0,nM,=,,19.0,1.579,,,[125I]-CCL1,0.0,0.0,,0.0,,P51685,0.606447541416945
13,17652183,ccr8_human,172,Y,A,CCL1,UniProt Entry Code,P22362,Full agonist,EC50,Functional - IP accumulation,8.7,nM,=,,11.0,-1.264,,,[125I]-CCL1,0.0,184.69101123595507,,0.0,,P51685,0.4148443691696942
41,17652183,ccr8_human,172,Y,A,LMD-009,SMILES,COC1=CC=CC=C1OC2=CC=CC(CN3CCC4(C(NCN4CCC5=CC=CC=C5)=O)CC3)=C2,Full agonist,EC50,Functional - IP accumulation,11.0,nM,=,,21.0,-1.908,,,[125I]-CCL1,0.0,184.69101123595507,,0.0,,P51685,0.4148443691696942
69,17652183,ccr8_human,172,Y,A,LMD-584,SMILES,OC(C1=C(C2(O)CCN(CC3=CC(OC4=C(OC)C=CC=C4)=CC=C3)CC2)C=CC=C1)=O,Full agonist,EC50,Functional - IP accumulation,29.0,nM,=,,56.0,-1.931,,,[125I]-CCL1,0.0,0.0,,0.0,,P51685,0.4148443691696942
98,17652183,ccr8_human,172,Y,A,LMD-902,SMILES,CCNS(C1=CC=C(OC)C=C1C2(O)CCN(CC3=CC(OC4=C(OC)C=CC=C4)=CC=C3)CC2)(=O)=O,Full agonist,EC50,Functional - IP accumulation,15.0,nM,=,,31.0,-2.066,,,[125I]-CCL1,0.0,0.0,,0.0,,P51685,0.4148443691696942
127,17652183,ccr8_human,172,Y,A,LMD-268,SMILES,O=C(NC1CCN(CC2=CC(OC3=C(OC)C=CC=C3)=CC=C2)CC1)C(CCN4CCCC4)C5=CC=CC=C5,Full agonist,EC50,Functional - IP accumulation,9.0,nM,=,,28.0,-3.115,,,[125I]-CCL1,0.0,0.0,,0.0,,P51685,0.4148443691696942
156,17652183,ccr8_human,172,Y,A,LMD-174,SMILES,O=C(NC1CCN(CC2=CC(OC3=C(OC)C=CC=C3)=CC=C2)CC1)C4CC(NC5=C4C=CC=C5)=O,Full agonist,EC50,Functional - IP accumulation,30.0,nM,=,,93.0,-3.096,,,[125I]-CCL1,0.0,0.0,,0.0,,P51685,0.4148443691696942
14,17652183,ccr8_human,193,K,A,CCL1,UniProt Entry Code,P22362,Full agonist,EC50,Functional - IP accumulation,8.7,nM,=,,22.0,-2.532,,,[125I]-CCL1,0.0,92.5561797752809,,0.0,,P51685,0.2652537923500074
42,17652183,ccr8_human,193,K,A,LMD-009,SMILES,COC1=CC=CC=C1OC2=CC=CC(CN3CCC4(C(NCN4CCC5=CC=CC=C5)=O)CC3)=C2,Full agonist,EC50,Functional - IP accumulation,11.0,nM,=,,8.5,1.294,,,[125I]-CCL1,0.0,92.5561797752809,,0.0,,P51685,0.2652537923500074
70,17652183,ccr8_human,193,K,A,LMD-584,SMILES,OC(C1=C(C2(O)CCN(CC3=CC(OC4=C(OC)C=CC=C4)=CC=C3)CC2)C=CC=C1)=O,Full agonist,EC50,Functional - IP accumulation,29.0,nM,=,,31.0,-1.07,,,[125I]-CCL1,0.0,0.0,,0.0,,P51685,0.2652537923500074
99,17652183,ccr8_human,193,K,A,LMD-902,SMILES,CCNS(C1=CC=C(OC)C=C1C2(O)CCN(CC3=CC(OC4=C(OC)C=CC=C4)=CC=C3)CC2)(=O)=O,Full agonist,EC50,Functional - IP accumulation,15.0,nM,=,,17.0,-1.134,,,[125I]-CCL1,0.0,0.0,,0.0,,P51685,0.2652537923500074
128,17652183,ccr8_human,193,K,A,LMD-268,SMILES,O=C(NC1CCN(CC2=CC(OC3=C(OC)C=CC=C3)=CC=C2)CC1)C(CCN4CCCC4)C5=CC=CC=C5,Full agonist,EC50,Functional - IP accumulation,9.0,nM,=,,4.7,1.915,,,[125I]-CCL1,0.0,0.0,,0.0,,P51685,0.2652537923500074
157,17652183,ccr8_human,193,K,A,LMD-174,SMILES,O=C(NC1CCN(CC2=CC(OC3=C(OC)C=CC=C3)=CC=C2)CC1)C4CC(NC5=C4C=CC=C5)=O,Full agonist,EC50,Functional - IP accumulation,30.0,nM,=,,30.0,1.0,,,[125I]-CCL1,0.0,0.0,,0.0,,P51685,0.2652537923500074
15,17652183,ccr8_human,194,W,A,CCL1,UniProt Entry Code,P22362,Full agonist,EC50,Functional - IP accumulation,8.7,nM,=,,128.0,-14.706,,,[125I]-CCL1,0.0,94.52247191011236,,0.0,,P51685,0.4631945300696253
43,17652183,ccr8_human,194,W,A,LMD-009,SMILES,COC1=CC=CC=C1OC2=CC=CC(CN3CCC4(C(NCN4CCC5=CC=CC=C5)=O)CC3)=C2,Full agonist,EC50,Functional - IP accumulation,11.0,nM,=,,7.6,1.447,,,[125I]-CCL1,0.0,94.52247191011236,,0.0,,P51685,0.4631945300696253
71,17652183,ccr8_human,194,W,A,LMD-584,SMILES,OC(C1=C(C2(O)CCN(CC3=CC(OC4=C(OC)C=CC=C4)=CC=C3)CC2)C=CC=C1)=O,Full agonist,EC50,Functional - IP accumulation,29.0,nM,=,,12.0,2.417,,,[125I]-CCL1,0.0,0.0,,0.0,,P51685,0.4631945300696253
100,17652183,ccr8_human,194,W,A,LMD-902,SMILES,CCNS(C1=CC=C(OC)C=C1C2(O)CCN(CC3=CC(OC4=C(OC)C=CC=C4)=CC=C3)CC2)(=O)=O,Full agonist,EC50,Functional - IP accumulation,15.0,nM,=,,4.0,3.75,,,[125I]-CCL1,0.0,0.0,,0.0,,P51685,0.4631945300696253
129,17652183,ccr8_human,194,W,A,LMD-268,SMILES,O=C(NC1CCN(CC2=CC(OC3=C(OC)C=CC=C3)=CC=C2)CC1)C(CCN4CCCC4)C5=CC=CC=C5,Full agonist,EC50,Functional - IP accumulation,9.0,nM,=,,6.0,1.5,,,[125I]-CCL1,0.0,0.0,,0.0,,P51685,0.4631945300696253
158,17652183,ccr8_human,194,W,A,LMD-174,SMILES,O=C(NC1CCN(CC2=CC(OC3=C(OC)C=CC=C3)=CC=C2)CC1)C4CC(NC5=C4C=CC=C5)=O,Full agonist,EC50,Functional - IP accumulation,30.0,nM,=,,32.0,-1.066,,,[125I]-CCL1,0.0,0.0,,0.0,,P51685,0.4631945300696253
16,17652183,ccr8_human,195,K,A,CCL1,UniProt Entry Code,P22362,Full agonist,EC50,Functional - IP accumulation,8.7,nM,=,,7.5,1.16,,,[125I]-CCL1,0.0,93.53932584269664,,0.0,,P51685,0.3006529490613599
44,17652183,ccr8_human,195,K,A,LMD-009,SMILES,COC1=CC=CC=C1OC2=CC=CC(CN3CCC4(C(NCN4CCC5=CC=CC=C5)=O)CC3)=C2,Full agonist,EC50,Functional - IP accumulation,11.0,nM,=,,6.2,1.774,,,[125I]-CCL1,0.0,93.53932584269664,,0.0,,P51685,0.3006529490613599
72,17652183,ccr8_human,195,K,A,LMD-584,SMILES,OC(C1=C(C2(O)CCN(CC3=CC(OC4=C(OC)C=CC=C4)=CC=C3)CC2)C=CC=C1)=O,Full agonist,EC50,Functional - IP accumulation,29.0,nM,=,,20.0,1.45,,,[125I]-CCL1,0.0,0.0,,0.0,,P51685,0.3006529490613599
101,17652183,ccr8_human,195,K,A,LMD-902,SMILES,CCNS(C1=CC=C(OC)C=C1C2(O)CCN(CC3=CC(OC4=C(OC)C=CC=C4)=CC=C3)CC2)(=O)=O,Full agonist,EC50,Functional - IP accumulation,15.0,nM,=,,7.0,2.143,,,[125I]-CCL1,0.0,0.0,,0.0,,P51685,0.3006529490613599
130,17652183,ccr8_human,195,K,A,LMD-268,SMILES,O=C(NC1CCN(CC2=CC(OC3=C(OC)C=CC=C3)=CC=C2)CC1)C(CCN4CCCC4)C5=CC=CC=C5,Full agonist,EC50,Functional - IP accumulation,9.0,nM,=,,0.22,40.909,,,[125I]-CCL1,0.0,0.0,,0.0,,P51685,0.3006529490613599
159,17652183,ccr8_human,195,K,A,LMD-174,SMILES,O=C(NC1CCN(CC2=CC(OC3=C(OC)C=CC=C3)=CC=C2)CC1)C4CC(NC5=C4C=CC=C5)=O,Full agonist,EC50,Functional - IP accumulation,30.0,nM,=,,30.0,1.0,,,[125I]-CCL1,0.0,0.0,,0.0,,P51685,0.3006529490613599
17,17652183,ccr8_human,206,G,A,CCL1,UniProt Entry Code,P22362,Full agonist,EC50,Functional - IP accumulation,8.7,nM,=,,67.0,-7.692,,,[125I]-CCL1,0.0,71.34831460674157,,0.0,,P51685,0.4573764577785833
45,17652183,ccr8_human,206,G,A,LMD-009,SMILES,COC1=CC=CC=C1OC2=CC=CC(CN3CCC4(C(NCN4CCC5=CC=CC=C5)=O)CC3)=C2,Full agonist,EC50,Functional - IP accumulation,11.0,nM,=,,19.0,-1.727,,,[125I]-CCL1,0.0,71.34831460674157,,0.0,,P51685,0.4573764577785833
73,17652183,ccr8_human,206,G,A,LMD-584,SMILES,OC(C1=C(C2(O)CCN(CC3=CC(OC4=C(OC)C=CC=C4)=CC=C3)CC2)C=CC=C1)=O,Full agonist,EC50,Functional - IP accumulation,29.0,nM,=,,47.0,-1.621,,,[125I]-CCL1,0.0,0.0,,0.0,,P51685,0.4573764577785833
102,17652183,ccr8_human,206,G,A,LMD-902,SMILES,CCNS(C1=CC=C(OC)C=C1C2(O)CCN(CC3=CC(OC4=C(OC)C=CC=C4)=CC=C3)CC2)(=O)=O,Full agonist,EC50,Functional - IP accumulation,15.0,nM,=,,12.0,1.25,,,[125I]-CCL1,0.0,0.0,,0.0,,P51685,0.4573764577785833
131,17652183,ccr8_human,206,G,A,LMD-268,SMILES,O=C(NC1CCN(CC2=CC(OC3=C(OC)C=CC=C3)=CC=C2)CC1)C(CCN4CCCC4)C5=CC=CC=C5,Full agonist,EC50,Functional - IP accumulation,9.0,nM,=,,2.0,4.5,,,[125I]-CCL1,0.0,0.0,,0.0,,P51685,0.4573764577785833
160,17652183,ccr8_human,206,G,A,LMD-174,SMILES,O=C(NC1CCN(CC2=CC(OC3=C(OC)C=CC=C3)=CC=C2)CC1)C4CC(NC5=C4C=CC=C5)=O,Full agonist,EC50,Functional - IP accumulation,30.0,nM,=,,62.0,-2.066,,,[125I]-CCL1,0.0,0.0,,0.0,,P51685,0.4573764577785833
19,17652183,ccr8_human,251,W,A,CCL1,UniProt Entry Code,P22362,Full agonist,EC50,Functional - IP accumulation,8.7,nM,=,,3.4,2.559,,,[125I]-CCL1,0.0,160.95505617977528,,0.0,,P51685,0.7404731991799578
47,17652183,ccr8_human,251,W,A,LMD-009,SMILES,COC1=CC=CC=C1OC2=CC=CC(CN3CCC4(C(NCN4CCC5=CC=CC=C5)=O)CC3)=C2,Full agonist,EC50,Functional - IP accumulation,11.0,nM,=,,44.0,-4.0,,,[125I]-CCL1,0.0,160.95505617977528,,0.0,,P51685,0.7404731991799578
75,17652183,ccr8_human,251,W,A,LMD-584,SMILES,OC(C1=C(C2(O)CCN(CC3=CC(OC4=C(OC)C=CC=C4)=CC=C3)CC2)C=CC=C1)=O,Full agonist,EC50,Functional - IP accumulation,29.0,nM,=,,20.0,1.45,,,[125I]-CCL1,0.0,0.0,,0.0,,P51685,0.7404731991799578
104,17652183,ccr8_human,251,W,A,LMD-902,SMILES,CCNS(C1=CC=C(OC)C=C1C2(O)CCN(CC3=CC(OC4=C(OC)C=CC=C4)=CC=C3)CC2)(=O)=O,Full agonist,EC50,Functional - IP accumulation,15.0,nM,=,,4.7,3.191,,,[125I]-CCL1,0.0,0.0,,0.0,,P51685,0.7404731991799578
133,17652183,ccr8_human,251,W,A,LMD-268,SMILES,O=C(NC1CCN(CC2=CC(OC3=C(OC)C=CC=C3)=CC=C2)CC1)C(CCN4CCCC4)C5=CC=CC=C5,Full agonist,EC50,Functional - IP accumulation,9.0,nM,=,,42.0,-4.673,,,[125I]-CCL1,0.0,0.0,,0.0,,P51685,0.7404731991799578
162,17652183,ccr8_human,251,W,A,LMD-174,SMILES,O=C(NC1CCN(CC2=CC(OC3=C(OC)C=CC=C3)=CC=C2)CC1)C4CC(NC5=C4C=CC=C5)=O,Full agonist,EC50,Functional - IP accumulation,30.0,nM,=,,29.0,1.034,,,[125I]-CCL1,0.0,0.0,,0.0,,P51685,0.7404731991799578
20,17652183,ccr8_human,251,W,Q,CCL1,UniProt Entry Code,P22362,Full agonist,EC50,Functional - IP accumulation,8.7,nM,=,,6.6,1.318,,,[125I]-CCL1,0.0,154.07303370786516,,0.0,,P51685,0.7044516053877942
48,17652183,ccr8_human,251,W,Q,LMD-009,SMILES,COC1=CC=CC=C1OC2=CC=CC(CN3CCC4(C(NCN4CCC5=CC=CC=C5)=O)CC3)=C2,Full agonist,EC50,Functional - IP accumulation,11.0,nM,=,,44.0,-4.0,,,[125I]-CCL1,0.0,154.07303370786516,,0.0,,P51685,0.7044516053877942
76,17652183,ccr8_human,251,W,Q,LMD-584,SMILES,OC(C1=C(C2(O)CCN(CC3=CC(OC4=C(OC)C=CC=C4)=CC=C3)CC2)C=CC=C1)=O,Full agonist,EC50,Functional - IP accumulation,29.0,nM,=,,22.0,1.318,,,[125I]-CCL1,0.0,0.0,,0.0,,P51685,0.7044516053877942
105,17652183,ccr8_human,251,W,Q,LMD-902,SMILES,CCNS(C1=CC=C(OC)C=C1C2(O)CCN(CC3=CC(OC4=C(OC)C=CC=C4)=CC=C3)CC2)(=O)=O,Full agonist,EC50,Functional - IP accumulation,15.0,nM,=,,15.0,1.0,,,[125I]-CCL1,0.0,0.0,,0.0,,P51685,0.7044516053877942
134,17652183,ccr8_human,251,W,Q,LMD-268,SMILES,O=C(NC1CCN(CC2=CC(OC3=C(OC)C=CC=C3)=CC=C2)CC1)C(CCN4CCCC4)C5=CC=CC=C5,Full agonist,EC50,Functional - IP accumulation,9.0,nM,=,,10.0,-1.111,,,[125I]-CCL1,0.0,0.0,,0.0,,P51685,0.7044516053877942
163,17652183,ccr8_human,251,W,Q,LMD-174,SMILES,O=C(NC1CCN(CC2=CC(OC3=C(OC)C=CC=C3)=CC=C2)CC1)C4CC(NC5=C4C=CC=C5)=O,Full agonist,EC50,Functional - IP accumulation,30.0,nM,=,,29.0,1.034,,,[125I]-CCL1,0.0,0.0,,0.0,,P51685,0.7044516053877942
21,17652183,ccr8_human,254,F,A,CCL1,UniProt Entry Code,P22362,Full agonist,EC50,Functional - IP accumulation,8.7,nM,=,,109.0,-12.5,,,[125I]-CCL1,0.0,117.2752808988764,,0.0,,P51685,0.5741752022136012
49,17652183,ccr8_human,254,F,A,LMD-009,SMILES,COC1=CC=CC=C1OC2=CC=CC(CN3CCC4(C(NCN4CCC5=CC=CC=C5)=O)CC3)=C2,Full agonist,EC50,Functional - IP accumulation,11.0,nM,=,,0.57,19.298,,,[125I]-CCL1,0.0,117.2752808988764,,0.0,,P51685,0.5741752022136012
77,17652183,ccr8_human,254,F,A,LMD-584,SMILES,OC(C1=C(C2(O)CCN(CC3=CC(OC4=C(OC)C=CC=C4)=CC=C3)CC2)C=CC=C1)=O,Full agonist,EC50,Functional - IP accumulation,29.0,nM,=,,278.0,-9.615,,,[125I]-CCL1,0.0,0.0,,0.0,,P51685,0.5741752022136012
106,17652183,ccr8_human,254,F,A,LMD-902,SMILES,CCNS(C1=CC=C(OC)C=C1C2(O)CCN(CC3=CC(OC4=C(OC)C=CC=C4)=CC=C3)CC2)(=O)=O,Full agonist,EC50,Functional - IP accumulation,15.0,nM,=,,80.0,-5.319,,,[125I]-CCL1,0.0,0.0,,0.0,,P51685,0.5741752022136012
135,17652183,ccr8_human,254,F,A,LMD-268,SMILES,O=C(NC1CCN(CC2=CC(OC3=C(OC)C=CC=C3)=CC=C2)CC1)C(CCN4CCCC4)C5=CC=CC=C5,Full agonist,EC50,Functional - IP accumulation,9.0,nM,=,,10.0,-1.111,,,[125I]-CCL1,0.0,0.0,,0.0,,P51685,0.5741752022136012
164,17652183,ccr8_human,254,F,A,LMD-174,SMILES,O=C(NC1CCN(CC2=CC(OC3=C(OC)C=CC=C3)=CC=C2)CC1)C4CC(NC5=C4C=CC=C5)=O,Full agonist,EC50,Functional - IP accumulation,30.0,nM,=,,42.0,-1.401,,,[125I]-CCL1,0.0,0.0,,0.0,,P51685,0.5741752022136012
22,17652183,ccr8_human,258,L,A,CCL1,UniProt Entry Code,P22362,Full agonist,EC50,Functional - IP accumulation,8.7,nM,=,,27.0,-3.106,,,[125I]-CCL1,0.0,83.00561797752809,,0.0,,P51685,0.4386944599227235
50,17652183,ccr8_human,258,L,A,LMD-009,SMILES,COC1=CC=CC=C1OC2=CC=CC(CN3CCC4(C(NCN4CCC5=CC=CC=C5)=O)CC3)=C2,Full agonist,EC50,Functional - IP accumulation,11.0,nM,=,,13.0,-1.182,,,[125I]-CCL1,0.0,83.00561797752809,,0.0,,P51685,0.4386944599227235
78,17652183,ccr8_human,258,L,A,LMD-584,SMILES,OC(C1=C(C2(O)CCN(CC3=CC(OC4=C(OC)C=CC=C4)=CC=C3)CC2)C=CC=C1)=O,Full agonist,EC50,Functional - IP accumulation,29.0,nM,=,,329.0,-11.364,,,[125I]-CCL1,0.0,0.0,,0.0,,P51685,0.4386944599227235
107,17652183,ccr8_human,258,L,A,LMD-902,SMILES,CCNS(C1=CC=C(OC)C=C1C2(O)CCN(CC3=CC(OC4=C(OC)C=CC=C4)=CC=C3)CC2)(=O)=O,Full agonist,EC50,Functional - IP accumulation,15.0,nM,=,,35.0,-2.331,,,[125I]-CCL1,0.0,0.0,,0.0,,P51685,0.4386944599227235
136,17652183,ccr8_human,258,L,A,LMD-268,SMILES,O=C(NC1CCN(CC2=CC(OC3=C(OC)C=CC=C3)=CC=C2)CC1)C(CCN4CCCC4)C5=CC=CC=C5,Full agonist,EC50,Functional - IP accumulation,9.0,nM,=,,65.0,-7.246,,,[125I]-CCL1,0.0,0.0,,0.0,,P51685,0.4386944599227235
165,17652183,ccr8_human,258,L,A,LMD-174,SMILES,O=C(NC1CCN(CC2=CC(OC3=C(OC)C=CC=C3)=CC=C2)CC1)C4CC(NC5=C4C=CC=C5)=O,Full agonist,EC50,Functional - IP accumulation,30.0,nM,=,,64.0,-2.132,,,[125I]-CCL1,0.0,0.0,,0.0,,P51685,0.4386944599227235
23,17652183,ccr8_human,262,S,A,CCL1,UniProt Entry Code,P22362,Full agonist,EC50,Functional - IP accumulation,8.7,nM,=,,5.2,1.673,,,[125I]-CCL1,0.0,87.21910112359551,,0.0,,P51685,0.2983077234749408
51,17652183,ccr8_human,262,S,A,LMD-009,SMILES,COC1=CC=CC=C1OC2=CC=CC(CN3CCC4(C(NCN4CCC5=CC=CC=C5)=O)CC3)=C2,Full agonist,EC50,Functional - IP accumulation,11.0,nM,=,,21.0,-1.908,,,[125I]-CCL1,0.0,87.21910112359551,,0.0,,P51685,0.2983077234749408
79,17652183,ccr8_human,262,S,A,LMD-584,SMILES,OC(C1=C(C2(O)CCN(CC3=CC(OC4=C(OC)C=CC=C4)=CC=C3)CC2)C=CC=C1)=O,Full agonist,EC50,Functional - IP accumulation,29.0,nM,=,,61.0,-2.105,,,[125I]-CCL1,0.0,0.0,,0.0,,P51685,0.2983077234749408
108,17652183,ccr8_human,262,S,A,LMD-902,SMILES,CCNS(C1=CC=C(OC)C=C1C2(O)CCN(CC3=CC(OC4=C(OC)C=CC=C4)=CC=C3)CC2)(=O)=O,Full agonist,EC50,Functional - IP accumulation,15.0,nM,=,,13.0,1.154,,,[125I]-CCL1,0.0,0.0,,0.0,,P51685,0.2983077234749408
137,17652183,ccr8_human,262,S,A,LMD-268,SMILES,O=C(NC1CCN(CC2=CC(OC3=C(OC)C=CC=C3)=CC=C2)CC1)C(CCN4CCCC4)C5=CC=CC=C5,Full agonist,EC50,Functional - IP accumulation,9.0,nM,=,,8.9,1.011,,,[125I]-CCL1,0.0,0.0,,0.0,,P51685,0.2983077234749408
166,17652183,ccr8_human,262,S,A,LMD-174,SMILES,O=C(NC1CCN(CC2=CC(OC3=C(OC)C=CC=C3)=CC=C2)CC1)C4CC(NC5=C4C=CC=C5)=O,Full agonist,EC50,Functional - IP accumulation,30.0,nM,=,,39.0,-1.3,,,[125I]-CCL1,0.0,0.0,,0.0,,P51685,0.2983077234749408
24,17652183,ccr8_human,283,H,A,CCL1,UniProt Entry Code,P22362,Full agonist,EC50,Functional - IP accumulation,8.7,nM,=,,12.0,-1.379,,,[125I]-CCL1,0.0,99.01685393258428,,0.0,,P51685,0.444344196237363
52,17652183,ccr8_human,283,H,A,LMD-009,SMILES,COC1=CC=CC=C1OC2=CC=CC(CN3CCC4(C(NCN4CCC5=CC=CC=C5)=O)CC3)=C2,Full agonist,EC50,Functional - IP accumulation,11.0,nM,=,,24.0,-2.183,,,[125I]-CCL1,0.0,99.01685393258428,,0.0,,P51685,0.444344196237363
81,17652183,ccr8_human,283,H,A,LMD-584,SMILES,OC(C1=C(C2(O)CCN(CC3=CC(OC4=C(OC)C=CC=C4)=CC=C3)CC2)C=CC=C1)=O,Full agonist,EC50,Functional - IP accumulation,29.0,nM,=,,30.0,-1.034,,,[125I]-CCL1,0.0,0.0,,0.0,,P51685,0.444344196237363
110,17652183,ccr8_human,283,H,A,LMD-902,SMILES,CCNS(C1=CC=C(OC)C=C1C2(O)CCN(CC3=CC(OC4=C(OC)C=CC=C4)=CC=C3)CC2)(=O)=O,Full agonist,EC50,Functional - IP accumulation,15.0,nM,=,,34.0,-2.268,,,[125I]-CCL1,0.0,0.0,,0.0,,P51685,0.444344196237363
139,17652183,ccr8_human,283,H,A,LMD-268,SMILES,O=C(NC1CCN(CC2=CC(OC3=C(OC)C=CC=C3)=CC=C2)CC1)C(CCN4CCCC4)C5=CC=CC=C5,Full agonist,EC50,Functional - IP accumulation,9.0,nM,=,,17.0,-1.89,,,[125I]-CCL1,0.0,0.0,,0.0,,P51685,0.444344196237363
168,17652183,ccr8_human,283,H,A,LMD-174,SMILES,O=C(NC1CCN(CC2=CC(OC3=C(OC)C=CC=C3)=CC=C2)CC1)C4CC(NC5=C4C=CC=C5)=O,Full agonist,EC50,Functional - IP accumulation,30.0,nM,=,,46.0,-1.534,,,[125I]-CCL1,0.0,0.0,,0.0,,P51685,0.444344196237363
25,17652183,ccr8_human,286,E,A,CCL1,UniProt Entry Code,P22362,Full agonist,EC50,Functional - IP accumulation,8.7,nM,=,,12.0,-1.379,,,[125I]-CCL1,0.0,130.61797752808988,,0.0,,P51685,0.47958259833571
53,17652183,ccr8_human,286,E,A,LMD-009,SMILES,COC1=CC=CC=C1OC2=CC=CC(CN3CCC4(C(NCN4CCC5=CC=CC=C5)=O)CC3)=C2,Full agonist,EC50,Functional - IP accumulation,11.0,nM,>,,10000.0,-1000.0,,,[125I]-CCL1,0.0,130.61797752808988,,0.0,,P51685,0.47958259833571
82,17652183,ccr8_human,286,E,A,LMD-584,SMILES,OC(C1=C(C2(O)CCN(CC3=CC(OC4=C(OC)C=CC=C4)=CC=C3)CC2)C=CC=C1)=O,Full agonist,EC50,Functional - IP accumulation,29.0,nM,=,,10000.0,-333.333,,,[125I]-CCL1,0.0,0.0,,0.0,,P51685,0.47958259833571
111,17652183,ccr8_human,286,E,A,LMD-902,SMILES,CCNS(C1=CC=C(OC)C=C1C2(O)CCN(CC3=CC(OC4=C(OC)C=CC=C4)=CC=C3)CC2)(=O)=O,Full agonist,EC50,Functional - IP accumulation,15.0,nM,=,,10000.0,-500.0,,,[125I]-CCL1,0.0,0.0,,0.0,,P51685,0.47958259833571
140,17652183,ccr8_human,286,E,A,LMD-268,SMILES,O=C(NC1CCN(CC2=CC(OC3=C(OC)C=CC=C3)=CC=C2)CC1)C(CCN4CCCC4)C5=CC=CC=C5,Full agonist,EC50,Functional - IP accumulation,9.0,nM,=,,10000.0,-1000.0,,,[125I]-CCL1,0.0,0.0,,0.0,,P51685,0.47958259833571
169,17652183,ccr8_human,286,E,A,LMD-174,SMILES,O=C(NC1CCN(CC2=CC(OC3=C(OC)C=CC=C3)=CC=C2)CC1)C4CC(NC5=C4C=CC=C5)=O,Full agonist,EC50,Functional - IP accumulation,30.0,nM,=,,10000.0,-333.333,,,[125I]-CCL1,0.0,0.0,,0.0,,P51685,0.47958259833571
26,17652183,ccr8_human,289,S,A,CCL1,UniProt Entry Code,P22362,Full agonist,EC50,Functional - IP accumulation,8.7,nM,=,,18.0,-2.07,,,[125I]-CCL1,0.0,118.25842696629212,,0.0,,P51685,0.4370954877377451
54,17652183,ccr8_human,289,S,A,LMD-009,SMILES,COC1=CC=CC=C1OC2=CC=CC(CN3CCC4(C(NCN4CCC5=CC=CC=C5)=O)CC3)=C2,Full agonist,EC50,Functional - IP accumulation,11.0,nM,=,,16.0,-1.453,,,[125I]-CCL1,0.0,118.25842696629212,,0.0,,P51685,0.4370954877377451
83,17652183,ccr8_human,289,S,A,LMD-584,SMILES,OC(C1=C(C2(O)CCN(CC3=CC(OC4=C(OC)C=CC=C4)=CC=C3)CC2)C=CC=C1)=O,Full agonist,EC50,Functional - IP accumulation,29.0,nM,>,,211.0,-7.299,,,[125I]-CCL1,0.0,0.0,,0.0,,P51685,0.4370954877377451
112,17652183,ccr8_human,289,S,A,LMD-902,SMILES,CCNS(C1=CC=C(OC)C=C1C2(O)CCN(CC3=CC(OC4=C(OC)C=CC=C4)=CC=C3)CC2)(=O)=O,Full agonist,EC50,Functional - IP accumulation,15.0,nM,>,,34.0,-2.268,,,[125I]-CCL1,0.0,0.0,,0.0,,P51685,0.4370954877377451
141,17652183,ccr8_human,289,S,A,LMD-268,SMILES,O=C(NC1CCN(CC2=CC(OC3=C(OC)C=CC=C3)=CC=C2)CC1)C(CCN4CCCC4)C5=CC=CC=C5,Full agonist,EC50,Functional - IP accumulation,9.0,nM,>,,17.0,-1.89,,,[125I]-CCL1,0.0,0.0,,0.0,,P51685,0.4370954877377451
170,17652183,ccr8_human,289,S,A,LMD-174,SMILES,O=C(NC1CCN(CC2=CC(OC3=C(OC)C=CC=C3)=CC=C2)CC1)C4CC(NC5=C4C=CC=C5)=O,Full agonist,EC50,Functional - IP accumulation,30.0,nM,>,,36.0,-1.2,,,[125I]-CCL1,0.0,0.0,,0.0,,P51685,0.4370954877377451
27,17652183,ccr8_human,290,F,A,CCL1,UniProt Entry Code,P22362,Full agonist,EC50,Functional - IP accumulation,8.7,nM,=,,6.0,1.45,,,[125I]-CCL1,0.0,350.7022471910112,,0.0,,P51685,0.6094566130980722
55,17652183,ccr8_human,290,F,A,LMD-009,SMILES,COC1=CC=CC=C1OC2=CC=CC(CN3CCC4(C(NCN4CCC5=CC=CC=C5)=O)CC3)=C2,Full agonist,EC50,Functional - IP accumulation,11.0,nM,=,,20.0,-1.818,,,[125I]-CCL1,0.0,350.7022471910112,,0.0,,P51685,0.6094566130980722
84,17652183,ccr8_human,290,F,A,LMD-584,SMILES,OC(C1=C(C2(O)CCN(CC3=CC(OC4=C(OC)C=CC=C4)=CC=C3)CC2)C=CC=C1)=O,Full agonist,EC50,Functional - IP accumulation,29.0,nM,=,,41.0,-1.414,,,[125I]-CCL1,0.0,0.0,,0.0,,P51685,0.6094566130980722
113,17652183,ccr8_human,290,F,A,LMD-902,SMILES,CCNS(C1=CC=C(OC)C=C1C2(O)CCN(CC3=CC(OC4=C(OC)C=CC=C4)=CC=C3)CC2)(=O)=O,Full agonist,EC50,Functional - IP accumulation,15.0,nM,=,,26.0,-1.733,,,[125I]-CCL1,0.0,0.0,,0.0,,P51685,0.6094566130980722
142,17652183,ccr8_human,290,F,A,LMD-268,SMILES,O=C(NC1CCN(CC2=CC(OC3=C(OC)C=CC=C3)=CC=C2)CC1)C(CCN4CCCC4)C5=CC=CC=C5,Full agonist,EC50,Functional - IP accumulation,9.0,nM,=,,21.0,-2.331,,,[125I]-CCL1,0.0,0.0,,0.0,,P51685,0.6094566130980722
171,17652183,ccr8_human,290,F,A,LMD-174,SMILES,O=C(NC1CCN(CC2=CC(OC3=C(OC)C=CC=C3)=CC=C2)CC1)C4CC(NC5=C4C=CC=C5)=O,Full agonist,EC50,Functional - IP accumulation,30.0,nM,=,,29.0,1.034,,,[125I]-CCL1,0.0,0.0,,0.0,,P51685,0.6094566130980722
57,17652183,ccr8_human,46,F,A,LMD-584,SMILES,OC(C1=C(C2(O)CCN(CC3=CC(OC4=C(OC)C=CC=C4)=CC=C3)CC2)C=CC=C1)=O,Full agonist,EC50,Functional - IP accumulation,29.0,nM,=,,126.0,-4.348,,,[125I]-CCL1,0.0,0.0,,0.0,,P51685,0.5933870557785912
86,17652183,ccr8_human,46,F,A,LMD-902,SMILES,CCNS(C1=CC=C(OC)C=C1C2(O)CCN(CC3=CC(OC4=C(OC)C=CC=C4)=CC=C3)CC2)(=O)=O,Full agonist,EC50,Functional - IP accumulation,15.0,nM,=,,50.0,-3.333,,,[125I]-CCL1,0.0,0.0,,0.0,,P51685,0.5933870557785912
115,17652183,ccr8_human,46,F,A,LMD-268,SMILES,O=C(NC1CCN(CC2=CC(OC3=C(OC)C=CC=C3)=CC=C2)CC1)C(CCN4CCCC4)C5=CC=CC=C5,Full agonist,EC50,Functional - IP accumulation,9.0,nM,=,,43.0,-4.785,,,[125I]-CCL1,0.0,0.0,,0.0,,P51685,0.5933870557785912
144,17652183,ccr8_human,46,F,A,LMD-174,SMILES,O=C(NC1CCN(CC2=CC(OC3=C(OC)C=CC=C3)=CC=C2)CC1)C4CC(NC5=C4C=CC=C5)=O,Full agonist,EC50,Functional - IP accumulation,30.0,nM,=,,52.0,-1.733,,,[125I]-CCL1,0.0,0.0,,0.0,,P51685,0.5933870557785912
80,17652183,ccr8_human,282,T,A,LMD-584,SMILES,OC(C1=C(C2(O)CCN(CC3=CC(OC4=C(OC)C=CC=C4)=CC=C3)CC2)C=CC=C1)=O,Full agonist,EC50,Functional - IP accumulation,29.0,nM,=,,77.0,-2.653,,,[125I]-CCL1,0.0,0.0,,0.0,,P51685,0.3227506004851248
109,17652183,ccr8_human,282,T,A,LMD-902,SMILES,CCNS(C1=CC=C(OC)C=C1C2(O)CCN(CC3=CC(OC4=C(OC)C=CC=C4)=CC=C3)CC2)(=O)=O,Full agonist,EC50,Functional - IP accumulation,15.0,nM,=,,31.0,-2.066,,,[125I]-CCL1,0.0,0.0,,0.0,,P51685,0.3227506004851248
138,17652183,ccr8_human,282,T,A,LMD-268,SMILES,O=C(NC1CCN(CC2=CC(OC3=C(OC)C=CC=C3)=CC=C2)CC1)C(CCN4CCCC4)C5=CC=CC=C5,Full agonist,EC50,Functional - IP accumulation,9.0,nM,=,,40.0,-4.444,,,[125I]-CCL1,0.0,0.0,,0.0,,P51685,0.3227506004851248
167,17652183,ccr8_human,282,T,A,LMD-174,SMILES,O=C(NC1CCN(CC2=CC(OC3=C(OC)C=CC=C3)=CC=C2)CC1)C4CC(NC5=C4C=CC=C5)=O,Full agonist,EC50,Functional - IP accumulation,30.0,nM,=,,93.0,-3.096,,,[125I]-CCL1,0.0,0.0,,0.0,,P51685,0.3227506004851248
22,9178745,ghrhr_human,165,H,R,GHRH 1â 44 amide ,PubChem CID,16132353,Full agonist,Single-point,Functional - cAMP accumulation,0.0,,=,,0.0,-8.5,,,GHRH 1â 44 amide ,0.0,90.0,,0.0,,Q02643,0.6751891959967123
23,11502843,ghrhr_human,57,A,T,GHRH 1â 44 amide ,PubChem CID,16132353,Binding - unknown pharmacological activity,Single-point,Binding - Radioligand competition/displacement,0.0,%,=,,0.0,1.07,,,[125I]GHRH 1â 44 amide ,100.0,0.0,,0.0,,Q02643,0.279263945686599
24,11502843,ghrhr_human,57,A,T,GHRH 1â 44 amide ,PubChem CID,16132353,Full agonist,Single-point,Functional - cAMP accumulation,0.0,%,=,,0.0,1.4,,,GHRH 1â 44 amide ,100.0,0.0,,0.0,,Q02643,0.279263945686599
25,11502843,ghrhr_human,113,P,L,GHRH 1â 44 amide ,PubChem CID,16132353,Full agonist,Single-point,Functional - cAMP accumulation,0.0,%,=,,0.0,-2.0,,,GHRH 1â 44 amide ,100.0,0.0,,0.0,,Q02643,0.4980400377013031
26,11502843,ghrhr_human,113,P,L,GHRH 1â 44 amide ,PubChem CID,16132353,Binding - unknown pharmacological activity,Single-point,Binding - Radioligand competition/displacement,0.0,%,=,,0.0,-1.667,,,[125I]GHRH 1â 44 amide ,100.0,0.0,,0.0,,Q02643,0.4980400377013031
29,11502843,ghrhr_human,137,H,Y,GHRH 1â 44 amide ,PubChem CID,16132353,Binding - unknown pharmacological activity,Single-point,Binding - Radioligand competition/displacement,0.0,%,=,,0.0,1.0,,,[125I]GHRH 1â 44 amide ,100.0,0.0,,0.0,,Q02643,0.4276531848426358
30,11502843,ghrhr_human,137,H,Y,GHRH 1â 44 amide ,PubChem CID,16132353,Full agonist,Single-point,Functional - cAMP accumulation,0.0,%,=,,0.0,1.0,,,GHRH 1â 44 amide ,100.0,0.0,,0.0,,Q02643,0.4276531848426358
31,11502843,ghrhr_human,183,D,N,GHRH 1â 44 amide ,PubChem CID,16132353,Full agonist,Single-point,Functional - cAMP accumulation,0.0,%,=,,0.0,-2.0,,,GHRH 1â 44 amide ,100.0,0.0,,0.0,,Q02643,0.4253498356634284
32,11502843,ghrhr_human,183,D,N,GHRH 1â 44 amide ,PubChem CID,16132353,Binding - unknown pharmacological activity,Single-point,Binding - Radioligand competition/displacement,0.0,%,=,,0.0,-1.667,,,[125I]GHRH 1â 44 amide ,100.0,0.0,,0.0,,Q02643,0.4253498356634284
33,11502843,ghrhr_human,225,V,I,GHRH 1â 44 amide ,PubChem CID,16132353,Binding - unknown pharmacological activity,Single-point,Binding - Radioligand competition/displacement,0.0,%,=,,0.0,-1.429,,,[125I]GHRH 1â 44 amide ,100.0,0.0,,0.0,,Q02643,0.3515585556201152
34,11502843,ghrhr_human,225,V,I,GHRH 1â 44 amide ,PubChem CID,16132353,Full agonist,Single-point,Functional - cAMP accumulation,0.0,%,=,,0.0,-1.429,,,GHRH 1â 44 amide ,100.0,0.0,,0.0,,Q02643,0.3515585556201152
35,11502843,ghrhr_human,254,V,M,GHRH 1â 44 amide ,PubChem CID,16132353,Binding - unknown pharmacological activity,Single-point,Binding - Radioligand competition/displacement,0.0,%,=,,0.0,1.0,,,[125I]GHRH 1â 44 amide ,100.0,0.0,,0.0,,Q02643,0.3037921621744209
36,11502843,ghrhr_human,254,V,M,GHRH 1â 44 amide ,PubChem CID,16132353,Full agonist,Single-point,Functional - cAMP accumulation,0.0,%,=,,0.0,1.6,,,GHRH 1â 44 amide ,100.0,0.0,,0.0,,Q02643,0.3037921621744209
37,11502843,ghrhr_human,262,S,N,GHRH 1â 44 amide ,PubChem CID,16132353,Full agonist,Single-point,Functional - cAMP accumulation,0.0,%,=,,0.0,-2.0,,,GHRH 1â 44 amide ,100.0,0.0,,0.0,,Q02643,0.2016555844770304
38,11502843,ghrhr_human,262,S,N,GHRH 1â 44 amide ,PubChem CID,16132353,Binding - unknown pharmacological activity,Single-point,Binding - Radioligand competition/displacement,0.0,%,=,,0.0,-1.667,,,[125I]GHRH 1â 44 amide ,100.0,0.0,,0.0,,Q02643,0.2016555844770304
41,11502843,ghrhr_human,423,C,Y,GHRH 1â 44 amide ,PubChem CID,16132353,Full agonist,Single-point,Functional - cAMP accumulation,0.0,%,=,,0.0,-1.429,,,GHRH 1â 44 amide ,100.0,0.0,,0.0,,Q02643,0.5565584640256727
42,11502843,ghrhr_human,423,C,Y,GHRH 1â 44 amide ,PubChem CID,16132353,Binding - unknown pharmacological activity,Single-point,Binding - Radioligand competition/displacement,0.0,%,=,,0.0,-1.25,,,GHRH 1â 44 amide ,100.0,0.0,,0.0,,Q02643,0.5565584640256727
47,7818527,vipr1_human,87,P,G,VIP,PubChem CID,16129679,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,0.6,nM,=,,0.59,1.017,,,"[125I]-VIP(wild-type), [125I]-VIP-[Gln3] (mutant) radioligand",11.35303265940902,0.0,,0.0,,P32241,0.6478817313049705
51,7818527,vipr1_human,110,W,G,VIP,PubChem CID,16129679,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,0.6,nM,=,,0.62,-1.033,,,"[125I]-VIP(wild-type), [125I]-VIP-[Gln3] (mutant) radioligand",80.40435458786936,0.0,,0.0,,P32241,0.7648992023885582
52,11013258,vipr1_human,188,R,Q,PG 97-269,FASTA sequence (peptide),HFDAVFTNSYRKVLKRLSARKLLQDIL,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,4.0,nM,=,,5.0,-1.25,,,"[125I]-VIP(wild-type), [125I]-VIP-[Gln3] (mutant) radioligand",100.0,0.0,,0.0,,P32241,0.5903614982722825
53,11013258,vipr1_human,188,R,Q,PG 97-269-[Asp3Asn],FASTA sequence (peptide),HFNAVFTNSYRKVLKRLSARKLLQDIL,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,2.0,nM,=,,3.0,-1.499,,,"[125I]-VIP(wild-type), [125I]-VIP-[Gln3] (mutant) radioligand",100.0,0.0,,0.0,,P32241,0.5903614982722825
54,11013258,vipr1_human,188,R,Q,VIP,PubChem CID,16129679,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,3.0,nM,=,,300.0,-100.0,,,"[125I]-VIP(wild-type), [125I]-VIP-[Gln3] (mutant) radioligand",100.0,0.0,,0.0,,P32241,0.5903614982722825
55,11013258,vipr1_human,188,R,Q,VIP,PubChem CID,16129679,Full agonist,EC50,Functional - cAMP accumulation,5.0,nM,=,,30.0,-5.988,,,VIP,0.0,0.0,,100.0,VIP,P32241,0.5903614982722825
56,11013258,vipr1_human,188,R,Q,VIP-[Asp3Asn] ,FASTA sequence (peptide),HSNAVFTDNYTRLRKQMAVKKYLNSILN,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,100.0,nM,=,,5.0,20.0,,,"[125I]-VIP(wild-type), [125I]-VIP-[Gln3] (mutant) radioligand",100.0,0.0,,0.0,,P32241,0.5903614982722825
57,11013258,vipr1_human,188,R,Q,VIP-[Asp3Asn] ,FASTA sequence (peptide),HSNAVFTDNYTRLRKQMAVKKYLNSILN,Full agonist,EC50,Functional - cAMP accumulation,150.0,nM,=,,4.0,37.5,,,VIP,0.0,0.0,,680.0,VIP,P32241,0.5903614982722825
58,11013258,vipr1_human,188,R,Q,VIP-[Asp3Gln] ,FASTA sequence (peptide),HSQAVFTDNYTRLRKQMAVKKYLNSILN,Full agonist,EC50,Functional - cAMP accumulation,100.0,nM,=,,4.0,25.0,,,VIP,0.0,0.0,,300.0,VIP,P32241,0.5903614982722825
59,11013258,vipr1_human,188,R,Q,VIP-[Asp3Gln] ,FASTA sequence (peptide),HSQAVFTDNYTRLRKQMAVKKYLNSILN,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,300.0,nM,=,,5.0,60.0,,,"[125I]-VIP(wild-type), [125I]-VIP-[Gln3] (mutant) radioligand",100.0,0.0,,0.0,,P32241,0.5903614982722825
60,11013258,vipr1_human,188,R,Q,VIP-[Asp3Glu] ,FASTA sequence (peptide),HSEAVFTDNYTRLRKQMAVKKYLNSILN,Full agonist,EC50,Functional - cAMP accumulation,30.0,nM,=,,200.0,-6.667,,,VIP,0.0,0.0,,25.0,VIP,P32241,0.5903614982722825
61,11013258,vipr1_human,188,R,Q,VIP-[Asp3Glu] ,FASTA sequence (peptide),HSEAVFTDNYTRLRKQMAVKKYLNSILN,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,40.0,nM,=,,1000.0,-25.0,,,"[125I]-VIP(wild-type), [125I]-VIP-[Gln3] (mutant) radioligand",100.0,0.0,,0.0,,P32241,0.5903614982722825
62,11013258,vipr1_human,188,R,Q,VIP-[Thr16Arg] ,FASTA sequence (peptide),HSDAVFTDNYTRLRKRMAVKKYLNSILN,Full agonist,EC50,Functional - cAMP accumulation,0.2,nM,=,,10.0,-50.0,,,VIP,0.0,0.0,,150.0,VIP,P32241,0.5903614982722825
63,11013258,vipr1_human,188,R,Q,VIP-[Thr16Arg] ,FASTA sequence (peptide),HSDAVFTDNYTRLRKRMAVKKYLNSILN,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,0.6,nM,=,,15.0,-25.0,,,"[125I]-VIP(wild-type), [125I]-VIP-[Gln3] (mutant) radioligand",100.0,0.0,,0.0,,P32241,0.5903614982722825
64,11013258,vipr1_human,188,R,Q,VIP(1-7)[Asp3Asn]/GRF(8-27)-amide,FASTA sequence (peptide),HSNAVFTNSYRKVLKRLSARKLLQDIL,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,4.0,5.0,,,"[125I]-VIP(wild-type), [125I]-VIP-[Gln3] (mutant) radioligand",100.0,0.0,,0.0,,P32241,0.5903614982722825
65,11013258,vipr1_human,188,R,Q,VIP(1-7)[Asp3Asn]/GRF(8-27)-amide,FASTA sequence (peptide),HSNAVFTNSYRKVLKRLSARKLLQDIL,Full agonist,EC50,Functional - cAMP accumulation,200.0,nM,=,,5.0,40.0,,,VIP,0.0,0.0,,0.0,,P32241,0.5903614982722825
66,11013258,vipr1_human,188,R,Q,VIP(1-7)/GRF(8-27)-amide,FASTA sequence (peptide),HSDAVFTNSYRKVLKRLSARKLLQDIL,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,2.0,nM,=,,20.0,-10.0,,,"[125I]-VIP(wild-type), [125I]-VIP-[Gln3] (mutant) radioligand",100.0,0.0,,0.0,,P32241,0.5903614982722825
67,11013258,vipr1_human,188,R,Q,VIP(1-7)/GRF(8-27)-amide,FASTA sequence (peptide),HSDAVFTNSYRKVLKRLSARKLLQDIL,Full agonist,EC50,Functional - cAMP accumulation,5.0,nM,=,,20.0,-4.0,,,VIP,0.0,0.0,,62.5,VIP,P32241,0.5903614982722825
68,11013258,vipr1_human,195,K,Q,PG 97-269,FASTA sequence (peptide),HFDAVFTNSYRKVLKRLSARKLLQDIL,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,4.0,nM,=,,1.0,4.0,,,"[125I]-VIP(wild-type), [125I]-VIP1 agonist (mutant) radioligand",100.0,0.0,,0.0,,P32241,0.3969935840803176
69,11013258,vipr1_human,195,K,Q,PG 97-269-[Asp3Asn],FASTA sequence (peptide),HFNAVFTNSYRKVLKRLSARKLLQDIL,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,2.0,nM,=,,0.3,6.667,,,"[125I]-VIP(wild-type), [125I]-VIP1 agonist (mutant) radioligand",100.0,0.0,,0.0,,P32241,0.3969935840803176
70,11013258,vipr1_human,195,K,Q,VIP,PubChem CID,16129679,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,3.0,nM,=,,200.0,-66.667,,,"[125I]-VIP(wild-type), [125I]-VIP1 agonist (mutant) radioligand",100.0,0.0,,0.0,,P32241,0.3969935840803176
71,11013258,vipr1_human,195,K,Q,VIP,PubChem CID,16129679,Full agonist,EC50,Functional - cAMP accumulation,5.0,nM,=,,200.0,-40.0,,,VIP,0.0,0.0,,100.0,VIP,P32241,0.3969935840803176
72,11013258,vipr1_human,195,K,Q,VIP-[Asp3Asn] ,FASTA sequence (peptide),HSNAVFTDNYTRLRKQMAVKKYLNSILN,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,100.0,nM,=,,30.0,3.333,,,"[125I]-VIP(wild-type), [125I]-VIP1 agonist (mutant) radioligand",100.0,0.0,,0.0,,P32241,0.3969935840803176
73,11013258,vipr1_human,195,K,Q,VIP-[Asp3Asn] ,FASTA sequence (peptide),HSNAVFTDNYTRLRKQMAVKKYLNSILN,Full agonist,EC50,Functional - cAMP accumulation,150.0,nM,=,,100.0,1.5,,,VIP,0.0,0.0,,80.0,VIP,P32241,0.3969935840803176
74,11013258,vipr1_human,195,K,Q,VIP-[Asp3Gln] ,FASTA sequence (peptide),HSQAVFTDNYTRLRKQMAVKKYLNSILN,Full agonist,EC50,Functional - cAMP accumulation,100.0,nM,=,,30.0,3.333,,,VIP,0.0,0.0,,80.0,VIP,P32241,0.3969935840803176
75,11013258,vipr1_human,195,K,Q,VIP-[Asp3Gln] ,FASTA sequence (peptide),HSQAVFTDNYTRLRKQMAVKKYLNSILN,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,300.0,nM,=,,15.0,20.0,,,"[125I]-VIP(wild-type), [125I]-VIP1 agonist (mutant) radioligand",100.0,0.0,,0.0,,P32241,0.3969935840803176
76,11013258,vipr1_human,195,K,Q,VIP-[Asp3Glu] ,FASTA sequence (peptide),HSEAVFTDNYTRLRKQMAVKKYLNSILN,Full agonist,EC50,Functional - cAMP accumulation,30.0,nM,=,,200.0,-6.667,,,VIP,0.0,0.0,,62.5,VIP,P32241,0.3969935840803176
77,11013258,vipr1_human,195,K,Q,VIP-[Asp3Glu] ,FASTA sequence (peptide),HSEAVFTDNYTRLRKQMAVKKYLNSILN,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,40.0,nM,=,,150.0,-3.745,,,"[125I]-VIP(wild-type), [125I]-VIP1 agonist (mutant) radioligand",100.0,0.0,,0.0,,P32241,0.3969935840803176
78,11013258,vipr1_human,195,K,Q,VIP-[Thr16Arg] ,FASTA sequence (peptide),HSDAVFTDNYTRLRKRMAVKKYLNSILN,Full agonist,EC50,Functional - cAMP accumulation,0.2,nM,=,,20.0,-100.0,,,VIP,0.0,0.0,,150.0,VIP,P32241,0.3969935840803176
79,11013258,vipr1_human,195,K,Q,VIP-[Thr16Arg] ,FASTA sequence (peptide),HSDAVFTDNYTRLRKRMAVKKYLNSILN,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,0.6,nM,=,,20.0,-33.333,,,"[125I]-VIP(wild-type), [125I]-VIP1 agonist (mutant) radioligand",100.0,0.0,,0.0,,P32241,0.3969935840803176
80,11013258,vipr1_human,195,K,Q,VIP(1-7)[Asn3]/GRF(8-27)-amide,FASTA sequence (peptide),HSNAVFTNSYRKVLKRLSARKLLQDIL,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,20.0,nM,=,,1.0,20.0,,,"[125I]-VIP(wild-type), [125I]-VIP1 agonist (mutant) radioligand",100.0,0.0,,0.0,,P32241,0.3969935840803176
82,11013258,vipr1_human,195,K,Q,VIP(1-7)/GRF(8-27)-amide,FASTA sequence (peptide),HSDAVFTNSYRKVLKRLSARKLLQDIL,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,2.0,nM,=,,2.0,1.0,,,"[125I]-VIP(wild-type), [125I]-VIP1 agonist (mutant) radioligand",100.0,0.0,,0.0,,P32241,0.3969935840803176
83,11027527,vipr1_human,41,Q,A,VIP,PubChem CID,16129679,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,0.6,nM,=,,0.3,2.0,,,"[125I]-VIP(wild-type), [125I]-VIP-[Gln3] (mutant) radioligand",62.96296296296296,0.0,,0.0,,P32241,0.3209288507500792
84,11027527,vipr1_human,46,Q,A,VIP,PubChem CID,16129679,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,0.6,nM,=,,1.2,-2.0,,,"[125I]-VIP(wild-type), [125I]-VIP-[Gln3] (mutant) radioligand",103.7037037037037,0.0,,0.0,,P32241,0.4566668076458636
85,11027527,vipr1_human,47,H,A,VIP,PubChem CID,16129679,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,0.6,nM,=,,1.0,-1.667,,,"[125I]-VIP(wild-type), [125I]-VIP-[Gln3] (mutant) radioligand",81.4814814814815,0.0,,0.0,,P32241,0.4031333858941152
86,11027527,vipr1_human,48,K,A,VIP,PubChem CID,16129679,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,0.6,nM,=,,1.0,-1.667,,,"[125I]-VIP(wild-type), [125I]-VIP-[Gln3] (mutant) radioligand",114.8148148148148,0.0,,0.0,,P32241,0.2820866749374727
87,11027527,vipr1_human,49,Q,A,VIP,PubChem CID,16129679,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,0.6,nM,=,,1.0,-1.667,,,"[125I]-VIP(wild-type), [125I]-VIP-[Gln3] (mutant) radioligand",118.5185185185185,0.0,,0.0,,P32241,0.2902529261535861
88,11027527,vipr1_human,53,E,A,VIP,PubChem CID,16129679,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,0.6,nM,=,,0.4,1.5,,,"[125I]-VIP(wild-type), [125I]-VIP-[Gln3] (mutant) radioligand",100.0,0.0,,0.0,,P32241,0.3358773344931989
89,11027527,vipr1_human,55,Q,A,VIP,PubChem CID,16129679,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,0.6,nM,=,,0.7,-1.167,,,"[125I]-VIP(wild-type), [125I]-VIP-[Gln3] (mutant) radioligand",148.14814814814815,0.0,,0.0,,P32241,0.3072470996184325
90,11027527,vipr1_human,57,E,A,VIP,PubChem CID,16129679,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,0.6,nM,=,,0.5,1.2,,,"[125I]-VIP(wild-type), [125I]-VIP-[Gln3] (mutant) radioligand",118.5185185185185,0.0,,0.0,,P32241,0.3083975830620831
92,11027527,vipr1_human,59,E,A,VIP,PubChem CID,16129679,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,0.6,nM,=,,0.6,1.0,,,"[125I]-VIP(wild-type), [125I]-VIP-[Gln3] (mutant) radioligand",111.1111111111111,0.0,,0.0,,P32241,0.308902060486352
100,12145104,vipr1_human,146,Y,A,PG 97-269,FASTA sequence (peptide),HFDAVFTNSYRKVLKRLSARKLLQDIL,Full agonist,IC50,Binding - Radioligand competition/displacement,0.8,nM,=,,3.0,-3.745,,,[125I]-PG 97-269 (radioligand),69.23076923076923,0.0,,0.0,,P32241,0.5969057325752265
101,12145104,vipr1_human,146,Y,A,VIP,PubChem CID,16129679,Full agonist,EC50,Functional - cAMP accumulation,5.0,nM,=,,40.0,-8.0,,,VIP,0.0,0.0,,78.0,VIP,P32241,0.5969057325752265
102,12145104,vipr1_human,146,Y,A,VIP,PubChem CID,16129679,Full agonist,IC50,Binding - Radioligand competition/displacement,0.8,nM,=,,49.0,-62.5,,,[125I]-PG 97-269 (radioligand),69.23076923076923,0.0,,0.0,,P32241,0.5969057325752265
103,12145104,vipr1_human,146,Y,A,VIP-[Asp3Asn] ,FASTA sequence (peptide),HSNAVFTDNYTRLRKQMAVKKYLNSILN,Full agonist,EC50,Functional - cAMP accumulation,45.0,nM,=,,60.0,-1.333,,,VIP,0.0,0.0,,25.71428571428571,VIP,P32241,0.5969057325752265
104,12145104,vipr1_human,146,Y,A,VIP-[Asp3Asn] ,FASTA sequence (peptide),HSNAVFTDNYTRLRKQMAVKKYLNSILN,Full agonist,IC50,Binding - Radioligand competition/displacement,400.0,nM,=,,350.0,1.143,,,[125I]-PG 97-269 (radioligand),69.23076923076923,0.0,,0.0,,P32241,0.5969057325752265
105,12145104,vipr1_human,146,Y,A,VIP-[Asp3Glu] ,FASTA sequence (peptide),HSEAVFTDNYTRLRKQMAVKKYLNSILN,Full agonist,EC50,Functional - cAMP accumulation,90.0,nM,=,,140.0,-1.555,,,VIP,0.0,0.0,,58.44155844155844,VIP,P32241,0.5969057325752265
106,12145104,vipr1_human,146,Y,A,VIP-[Asp3Glu] ,FASTA sequence (peptide),HSEAVFTDNYTRLRKQMAVKKYLNSILN,Full agonist,IC50,Binding - Radioligand competition/displacement,200.0,nM,=,,550.0,-2.747,,,[125I]-PG 97-269 (radioligand),69.23076923076923,0.0,,0.0,,P32241,0.5969057325752265
107,12145104,vipr1_human,146,Y,A,VIP-[Gln16Arg] ,FASTA sequence (peptide),HSDAVFTDNYTRLRKRMAVKKYLNSILN,Full agonist,EC50,Functional - cAMP accumulation,0.3,nM,=,,4.0,-13.333,,,VIP,0.0,0.0,,100.0,VIP,P32241,0.5969057325752265
108,12145104,vipr1_human,146,Y,A,VIP-[Gln16Arg] ,FASTA sequence (peptide),HSDAVFTDNYTRLRKRMAVKKYLNSILN,Full agonist,IC50,Binding - Radioligand competition/displacement,0.9,nM,=,,25.0,-27.778,,,[125I]-PG 97-269 (radioligand),69.23076923076923,0.0,,0.0,,P32241,0.5969057325752265
109,12145104,vipr1_human,146,Y,A,VIP-[His1Ala] ,FASTA sequence (peptide),ASDAVFTDNYTRLRKQMAVKKYLNSILN,Full agonist,EC50,Functional - cAMP accumulation,60.0,nM,=,,2000.0,-33.333,,,VIP,0.0,0.0,,40.625,VIP,P32241,0.5969057325752265
110,12145104,vipr1_human,146,Y,A,VIP-[His1Ala] ,FASTA sequence (peptide),ASDAVFTDNYTRLRKQMAVKKYLNSILN,Full agonist,IC50,Binding - Radioligand competition/displacement,200.0,nM,=,,1200.0,-5.988,,,[125I]-PG 97-269 (radioligand),69.23076923076923,0.0,,0.0,,P32241,0.5969057325752265
111,12145104,vipr1_human,146,Y,A,VIP-[His1Phe] ,FASTA sequence (peptide),FSDAVFTDNYTRLRKQMAVKKYLNSILN,Full agonist,EC50,Functional - cAMP accumulation,20.0,nM,=,,500.0,-25.0,,,VIP,0.0,0.0,,66.23376623376623,VIP,P32241,0.5969057325752265
112,12145104,vipr1_human,146,Y,A,VIP-[His1Phe] ,FASTA sequence (peptide),FSDAVFTDNYTRLRKQMAVKKYLNSILN,Full agonist,IC50,Binding - Radioligand competition/displacement,50.0,nM,=,,360.0,-7.194,,,[125I]-PG 97-269 (radioligand),69.23076923076923,0.0,,0.0,,P32241,0.5969057325752265
114,12145104,vipr1_human,146,Y,A,VIP-[Phe6Cys] ,FASTA sequence (peptide),HSDAVCTDNYTRLRKQMAVKKYLNSILN,Full agonist,IC50,Binding - Radioligand competition/displacement,650.0,nM,=,,250.0,2.6,,,[125I]-PG 97-269 (radioligand),69.23076923076923,0.0,,0.0,,P32241,0.5969057325752265
116,12145104,vipr1_human,146,Y,A,VIP-[Phe6His] ,FASTA sequence (peptide),HSDAVHTDNYTRLRKQMAVKKYLNSILN,Full agonist,IC50,Binding - Radioligand competition/displacement,1500.0,nM,=,,900.0,1.667,,,[125I]-PG 97-269 (radioligand),69.23076923076923,0.0,,0.0,,P32241,0.5969057325752265
117,12145104,vipr1_human,146,Y,A,VIP-[Phe6Tyr] ,FASTA sequence (peptide),HSDAVYTDNYTRLRKQMAVKKYLNSILN,Full agonist,EC50,Functional - cAMP accumulation,6.0,nM,=,,2000.0,-333.333,,,VIP,0.0,0.0,,18.6046511627907,VIP,P32241,0.5969057325752265
118,12145104,vipr1_human,146,Y,A,VIP-[Phe6Tyr] ,FASTA sequence (peptide),HSDAVYTDNYTRLRKQMAVKKYLNSILN,Full agonist,IC50,Binding - Radioligand competition/displacement,180.0,nM,=,,450.0,-2.5,,,[125I]-PG 97-269 (radioligand),69.23076923076923,0.0,,0.0,,P32241,0.5969057325752265
119,12145104,vipr1_human,150,Y,A,PG 97-269,FASTA sequence (peptide),HFDAVFTNSYRKVLKRLSARKLLQDIL,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,0.8,nM,=,,4.0,-5.0,,,[125I]-PG 97-269 (radioligand),69.23076923076923,0.0,,0.0,,P32241,0.6361118139125187
120,12145104,vipr1_human,150,Y,A,VIP,PubChem CID,16129679,Full agonist,EC50,Functional - cAMP accumulation,5.0,nM,=,,80.0,-16.129,,,VIP,0.0,0.0,,87.0,VIP,P32241,0.6361118139125187
121,12145104,vipr1_human,150,Y,A,VIP,PubChem CID,16129679,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,0.8,nM,=,,2.6,-3.247,,,[125I]-PG 97-269 (radioligand),69.23076923076923,0.0,,0.0,,P32241,0.6361118139125187
122,12145104,vipr1_human,150,Y,A,VIP-[Asp3Asn] ,FASTA sequence (peptide),HSNAVFTDNYTRLRKQMAVKKYLNSILN,Full agonist,EC50,Functional - cAMP accumulation,45.0,nM,=,,170.0,-3.774,,,VIP,0.0,0.0,,148.57142857142858,VIP,P32241,0.6361118139125187
123,12145104,vipr1_human,150,Y,A,VIP-[Asp3Asn] ,FASTA sequence (peptide),HSNAVFTDNYTRLRKQMAVKKYLNSILN,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,400.0,nM,=,,190.0,2.105,,,[125I]-PG 97-269 (radioligand),69.23076923076923,0.0,,0.0,,P32241,0.6361118139125187
124,12145104,vipr1_human,150,Y,A,VIP-[Asp3Glu] ,FASTA sequence (peptide),HSEAVFTDNYTRLRKQMAVKKYLNSILN,Full agonist,EC50,Functional - cAMP accumulation,90.0,nM,=,,115.0,-1.277,,,VIP,0.0,0.0,,62.33766233766234,VIP,P32241,0.6361118139125187
125,12145104,vipr1_human,150,Y,A,VIP-[Asp3Glu] ,FASTA sequence (peptide),HSEAVFTDNYTRLRKQMAVKKYLNSILN,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,200.0,nM,=,,150.0,1.333,,,[125I]-PG 97-269 (radioligand),69.23076923076923,0.0,,0.0,,P32241,0.6361118139125187
126,12145104,vipr1_human,150,Y,A,VIP-[Gln16Arg] ,FASTA sequence (peptide),HSDAVFTDNYTRLRKRMAVKKYLNSILN,Full agonist,EC50,Functional - cAMP accumulation,0.3,nM,=,,8.0,-27.027,,,VIP,0.0,0.0,,100.0,VIP,P32241,0.6361118139125187
127,12145104,vipr1_human,150,Y,A,VIP-[Gln16Arg] ,FASTA sequence (peptide),HSDAVFTDNYTRLRKRMAVKKYLNSILN,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,0.9,nM,=,,0.2,4.5,,,[125I]-PG 97-269 (radioligand),69.23076923076923,0.0,,0.0,,P32241,0.6361118139125187
128,12145104,vipr1_human,150,Y,A,VIP-[His1Ala] ,FASTA sequence (peptide),ASDAVFTDNYTRLRKQMAVKKYLNSILN,Full agonist,EC50,Functional - cAMP accumulation,60.0,nM,=,,920.0,-15.385,,,VIP,0.0,0.0,,57.8125,VIP,P32241,0.6361118139125187
129,12145104,vipr1_human,150,Y,A,VIP-[His1Ala] ,FASTA sequence (peptide),ASDAVFTDNYTRLRKQMAVKKYLNSILN,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,200.0,nM,=,,230.0,-1.149,,,[125I]-PG 97-269 (radioligand),69.23076923076923,0.0,,0.0,,P32241,0.6361118139125187
130,12145104,vipr1_human,150,Y,A,VIP-[His1Phe] ,FASTA sequence (peptide),FSDAVFTDNYTRLRKQMAVKKYLNSILN,Full agonist,EC50,Functional - cAMP accumulation,20.0,nM,=,,200.0,-10.0,,,VIP,0.0,0.0,,90.9090909090909,VIP,P32241,0.6361118139125187
131,12145104,vipr1_human,150,Y,A,VIP-[His1Phe] ,FASTA sequence (peptide),FSDAVFTDNYTRLRKQMAVKKYLNSILN,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,50.0,nM,=,,75.0,-1.499,,,[125I]-PG 97-269 (radioligand),69.23076923076923,0.0,,0.0,,P32241,0.6361118139125187
132,12145104,vipr1_human,150,Y,A,VIP-[Phe6Cys] ,FASTA sequence (peptide),HSDAVCTDNYTRLRKQMAVKKYLNSILN,Full agonist,EC50,Functional - cAMP accumulation,10.0,nM,=,,4500.0,-500.0,,,VIP,0.0,0.0,,0.0,VIP,P32241,0.6361118139125187
133,12145104,vipr1_human,150,Y,A,VIP-[Phe6Cys] ,FASTA sequence (peptide),HSDAVCTDNYTRLRKQMAVKKYLNSILN,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,650.0,nM,=,,200.0,3.25,,,[125I]-PG 97-269 (radioligand),69.23076923076923,0.0,,0.0,,P32241,0.6361118139125187
134,12145104,vipr1_human,150,Y,A,VIP-[Phe6His] ,FASTA sequence (peptide),HSDAVHTDNYTRLRKQMAVKKYLNSILN,Full agonist,EC50,Functional - cAMP accumulation,80.0,nM,=,,4500.0,-55.556,,,VIP,0.0,0.0,,0.0,VIP,P32241,0.6361118139125187
135,12145104,vipr1_human,150,Y,A,VIP-[Phe6His] ,FASTA sequence (peptide),HSDAVHTDNYTRLRKQMAVKKYLNSILN,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,1500.0,nM,=,,600.0,2.5,,,[125I]-PG 97-269 (radioligand),69.23076923076923,0.0,,0.0,,P32241,0.6361118139125187
136,12145104,vipr1_human,150,Y,A,VIP-[Phe6Tyr] ,FASTA sequence (peptide),HSDAVYTDNYTRLRKQMAVKKYLNSILN,Full agonist,EC50,Functional - cAMP accumulation,6.0,nM,=,,290.0,-47.619,,,VIP,0.0,0.0,,66.27906976744185,VIP,P32241,0.6361118139125187
137,12145104,vipr1_human,150,Y,A,VIP-[Phe6Tyr] ,FASTA sequence (peptide),HSDAVYTDNYTRLRKQMAVKKYLNSILN,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,180.0,nM,=,,120.0,1.5,,,[125I]-PG 97-269 (radioligand),69.23076923076923,0.0,,0.0,,P32241,0.6361118139125187
138,12475394,vipr1_human,200,F,Y,VIP,PubChem CID,16129679,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.57,M,=,,8.5,-1.175,,,[125I]-VIP,100.0,0.0,,0.0,,P32241,0.1707182794005548
139,12475394,vipr1_human,200,F,Y,VIP,PubChem CID,16129679,Full agonist,pEC50,Functional - cAMP accumulation,8.71,M,=,,8.4,-2.041,Abolished effect,,VIP,0.0,0.0,,100.0,VIP,P32241,0.1707182794005548
140,12475394,vipr1_human,200,F,Y,VIP-[Thr11Arg] ,FASTA sequence (peptide),HSDAVFTDNYRRLRKQMAVKKYLNSILN,Full agonist,pEC50,Functional - cAMP accumulation,9.15,M,=,,6.67,-333.333,Abolished effect,,VIP,0.0,0.0,,42.85714285714285,VIP,P32241,0.1707182794005548
141,12475394,vipr1_human,200,F,Y,VIP-[Thr11Arg] ,FASTA sequence (peptide),HSDAVFTDNYRRLRKQMAVKKYLNSILN,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.45,M,=,,7.8,-45.455,,,[125I]-VIP,100.0,0.0,,0.0,,P32241,0.1707182794005548
142,12475394,vipr1_human,200,F,Y,VIP-[Thr11Citrullinel] ,,,Full agonist,pEC50,Functional - cAMP accumulation,8.45,M,=,,7.13,-20.833,Abolished effect,,VIP,0.0,0.0,,74.03846153846155,VIP,P32241,0.1707182794005548
143,12475394,vipr1_human,200,F,Y,VIP-[Thr11Citrullinel] ,,,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.55,M,=,,7.45,-12.658,,,[125I]-VIP,100.0,0.0,,0.0,,P32241,0.1707182794005548
144,12475394,vipr1_human,200,F,Y,VIP-[Thr11Val] ,FASTA sequence (peptide),HSDAVFTDNYVRLRKQMAVKKYLNSILN,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.63,M,=,,8.63,1.0,,,[125I]-VIP,100.0,0.0,,0.0,,P32241,0.1707182794005548
145,12475394,vipr1_human,200,F,Y,VIP-[Thr11Val] ,FASTA sequence (peptide),HSDAVFTDNYVRLRKQMAVKKYLNSILN,Full agonist,pEC50,Functional - cAMP accumulation,9.18,M,=,,8.26,-8.333,Abolished effect,,VIP,0.0,0.0,,83.33333333333334,VIP,P32241,0.1707182794005548
146,14645688,vipr1_human,250,S,A,VIP,PubChem CID,16129679,Binding - unknown pharmacological activity,EC50,Functional - cAMP accumulation,0.27,nM,=,,0.11,2.455,,,,258.0,0.0,,0.0,,P32241,0.3957598792368171
147,14645688,vipr1_human,250,S,A,VIP,PubChem CID,16129679,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,0.3,nM,=,,0.7,-2.331,,,"[125I]-VIP(wild-type), [125I]-VIP-[Gln3] (mutant) radioligand",258.0,0.0,,0.0,,P32241,0.3957598792368171
148,14645688,vipr1_human,250,S,A,VIP,PubChem CID,16129679,Binding - unknown pharmacological activity,EC50,Functional - cAMP accumulation,3.15,nM,=,,1.08,2.917,,,,258.0,0.0,,0.0,,P32241,0.3957598792368171
149,14645688,vipr1_human,447,S,A,VIP,PubChem CID,16129679,Binding - unknown pharmacological activity,EC50,Functional - cAMP accumulation,0.27,nM,=,,0.57,-2.11,,,,160.66666666666666,0.0,,0.0,,P32241,0.3244185622354427
151,14645688,vipr1_human,447,S,A,VIP,PubChem CID,16129679,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,0.3,nM,=,,0.5,-1.667,,,"[125I]-VIP(wild-type), [125I]-VIP-[Gln3] (mutant) radioligand",160.66666666666666,0.0,,0.0,,P32241,0.3244185622354427
153,14645688,vipr1_human,447,S,A,VIP,PubChem CID,16129679,Binding - unknown pharmacological activity,EC50,Functional - cAMP accumulation,3.15,nM,=,,0.55,5.727,,,,160.66666666666666,0.0,,0.0,,P32241,0.3244185622354427
150,14645688,vipr1_human,447,S,D,VIP,PubChem CID,16129679,Binding - unknown pharmacological activity,EC50,Functional - cAMP accumulation,0.27,nM,=,,0.37,-1.37,,,,167.33333333333334,0.0,,0.0,,P32241,0.3650535237871494
152,14645688,vipr1_human,447,S,D,VIP,PubChem CID,16129679,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,0.3,nM,=,,0.8,-2.667,,,"[125I]-VIP(wild-type), [125I]-VIP-[Gln3] (mutant) radioligand",167.33333333333334,0.0,,0.0,,P32241,0.3650535237871494
154,14645688,vipr1_human,447,S,D,VIP,PubChem CID,16129679,Binding - unknown pharmacological activity,EC50,Functional - cAMP accumulation,3.15,nM,=,,0.54,5.833,,,,167.33333333333334,0.0,,0.0,,P32241,0.3650535237871494
155,22291440,vipr1_human,80,Q,A,PG 97-269,FASTA sequence (peptide),HFDAVFTNSYRKVLKRLSARKLLQDIL,Full agonist,EC50,Functional - cAMP accumulation,3.5,nM,=,,6.96,-1.988,,,,100.0,0.0,,0.0,,P32241,0.3434583331119603
156,22291440,vipr1_human,80,Q,A,VIP,PubChem CID,16129679,Full agonist,EC50,Functional - cAMP accumulation,2.53,nM,=,,9.09,-3.597,,,,100.0,0.0,,0.0,,P32241,0.3434583331119603
157,22291440,vipr1_human,104,S,A,PG 97-269,FASTA sequence (peptide),HFDAVFTNSYRKVLKRLSARKLLQDIL,Full agonist,EC50,Functional - cAMP accumulation,3.5,nM,=,,3.32,1.054,,,,100.0,0.0,,0.0,,P32241,0.2959989438691571
158,22291440,vipr1_human,104,S,A,VIP,PubChem CID,16129679,Full agonist,EC50,Functional - cAMP accumulation,2.53,nM,=,,2.6,-1.028,,,,100.0,0.0,,0.0,,P32241,0.2959989438691571
159,22291440,vipr1_human,106,T,A,PG 97-269,FASTA sequence (peptide),HFDAVFTNSYRKVLKRLSARKLLQDIL,Full agonist,EC50,Functional - cAMP accumulation,3.5,nM,=,,16.69,-4.762,,,,100.0,0.0,,0.0,,P32241,0.3537751927356435
160,22291440,vipr1_human,106,T,A,VIP,PubChem CID,16129679,Full agonist,EC50,Functional - cAMP accumulation,2.53,nM,=,,20.0,-7.874,,,,100.0,0.0,,0.0,,P32241,0.3537751927356435
161,22291440,vipr1_human,108,E,A,PG 97-269,FASTA sequence (peptide),HFDAVFTNSYRKVLKRLSARKLLQDIL,Full agonist,EC50,Functional - cAMP accumulation,3.5,nM,=,,3.22,1.087,,,,100.0,0.0,,0.0,,P32241,0.2745344567928564
162,22291440,vipr1_human,108,E,A,VIP,PubChem CID,16129679,Full agonist,EC50,Functional - cAMP accumulation,2.53,nM,=,,2.35,1.077,,,,100.0,0.0,,0.0,,P32241,0.2745344567928564
163,22291440,vipr1_human,112,H,A,PG 97-269,FASTA sequence (peptide),HFDAVFTNSYRKVLKRLSARKLLQDIL,Full agonist,EC50,Functional - cAMP accumulation,3.5,nM,=,,296.0,-83.333,,,,100.0,0.0,,0.0,,P32241,0.3362007589162262
164,22291440,vipr1_human,112,H,A,VIP,PubChem CID,16129679,Full agonist,EC50,Functional - cAMP accumulation,2.53,nM,=,,229.0,-90.909,,,,100.0,0.0,,0.0,,P32241,0.3362007589162262
165,22291440,vipr1_human,117,P,A,PG 97-269,FASTA sequence (peptide),HFDAVFTNSYRKVLKRLSARKLLQDIL,Full agonist,EC50,Functional - cAMP accumulation,3.5,nM,=,,14.21,-4.065,,,,100.0,0.0,,0.0,,P32241,0.4194821141034215
166,22291440,vipr1_human,117,P,A,VIP,PubChem CID,16129679,Full agonist,EC50,Functional - cAMP accumulation,2.53,nM,=,,21.0,-8.333,,,,100.0,0.0,,0.0,,P32241,0.4194821141034215
167,22291440,vipr1_human,119,P,A,PG 97-269,FASTA sequence (peptide),HFDAVFTNSYRKVLKRLSARKLLQDIL,Full agonist,EC50,Functional - cAMP accumulation,3.5,nM,=,,4.01,-1.145,,,,100.0,0.0,,0.0,,P32241,0.3964824132655255
168,22291440,vipr1_human,119,P,A,VIP,PubChem CID,16129679,Full agonist,EC50,Functional - cAMP accumulation,2.53,nM,=,,2.67,-1.055,,,,100.0,0.0,,0.0,,P32241,0.3964824132655255
169,22291440,vipr1_human,120,I,A,PG 97-269,FASTA sequence (peptide),HFDAVFTNSYRKVLKRLSARKLLQDIL,Full agonist,EC50,Functional - cAMP accumulation,3.5,nM,=,,3.55,-1.014,,,,100.0,0.0,,0.0,,P32241,0.3146664372162555
170,22291440,vipr1_human,120,I,A,VIP,PubChem CID,16129679,Full agonist,EC50,Functional - cAMP accumulation,2.53,nM,=,,2.33,1.086,,,,100.0,0.0,,0.0,,P32241,0.3146664372162555
171,22291440,vipr1_human,125,D,A,PG 97-269,FASTA sequence (peptide),HFDAVFTNSYRKVLKRLSARKLLQDIL,Full agonist,EC50,Functional - cAMP accumulation,3.5,nM,=,,3.17,1.104,,,,100.0,0.0,,0.0,,P32241,0.3723326473551003
172,22291440,vipr1_human,125,D,A,VIP,PubChem CID,16129679,Full agonist,EC50,Functional - cAMP accumulation,2.53,nM,=,,3.67,-1.451,,,,100.0,0.0,,0.0,,P32241,0.3723326473551003
173,22291440,vipr1_human,126,D,A,PG 97-269,FASTA sequence (peptide),HFDAVFTNSYRKVLKRLSARKLLQDIL,Full agonist,EC50,Functional - cAMP accumulation,3.5,nM,=,,3.11,1.125,,,,100.0,0.0,,0.0,,P32241,0.3444007957878603
174,22291440,vipr1_human,126,D,A,VIP,PubChem CID,16129679,Full agonist,EC50,Functional - cAMP accumulation,2.53,nM,=,,3.62,-1.431,,,,100.0,0.0,,0.0,,P32241,0.3444007957878603
175,22291440,vipr1_human,131,L,A,PG 97-269,FASTA sequence (peptide),HFDAVFTNSYRKVLKRLSARKLLQDIL,Full agonist,EC50,Functional - cAMP accumulation,3.5,nM,=,,253.0,-71.429,,,,100.0,0.0,,0.0,,P32241,0.2911322663195809
176,22291440,vipr1_human,131,L,A,VIP,PubChem CID,16129679,Full agonist,EC50,Functional - cAMP accumulation,2.53,nM,=,,264.0,-100.0,,,,100.0,0.0,,0.0,,P32241,0.2911322663195809
177,22291440,vipr1_human,132,D,A,PG 97-269,FASTA sequence (peptide),HFDAVFTNSYRKVLKRLSARKLLQDIL,Full agonist,EC50,Functional - cAMP accumulation,3.5,nM,=,,3.54,-1.011,,,,100.0,0.0,,0.0,,P32241,0.3314012347549342
178,22291440,vipr1_human,132,D,A,VIP,PubChem CID,16129679,Full agonist,EC50,Functional - cAMP accumulation,2.53,nM,=,,3.65,-1.443,,,,100.0,0.0,,0.0,,P32241,0.3314012347549342
179,22291440,vipr1_human,134,Q,A,PG 97-269,FASTA sequence (peptide),HFDAVFTNSYRKVLKRLSARKLLQDIL,Full agonist,EC50,Functional - cAMP accumulation,3.5,nM,=,,332.0,-90.909,,,,100.0,0.0,,0.0,,P32241,0.2714042540120136
180,22291440,vipr1_human,134,Q,A,VIP,PubChem CID,16129679,Full agonist,EC50,Functional - cAMP accumulation,2.53,nM,=,,270.0,-111.111,,,,100.0,0.0,,0.0,,P32241,0.2714042540120136
181,22291440,vipr1_human,135,Q,A,PG 97-269,FASTA sequence (peptide),HFDAVFTNSYRKVLKRLSARKLLQDIL,Full agonist,EC50,Functional - cAMP accumulation,3.5,nM,=,,5.5,-1.572,,,,100.0,0.0,,0.0,,P32241,0.3339291396845967
182,22291440,vipr1_human,135,Q,A,VIP,PubChem CID,16129679,Full agonist,EC50,Functional - cAMP accumulation,2.53,nM,=,,2.52,1.004,,,,100.0,0.0,,0.0,,P32241,0.3339291396845967
183,22291440,vipr1_human,143,K,A,PG 97-269,FASTA sequence (peptide),HFDAVFTNSYRKVLKRLSARKLLQDIL,Full agonist,EC50,Functional - cAMP accumulation,3.5,nM,=,,5.18,-1.479,,,,100.0,0.0,,0.0,,P32241,0.4893465743818669
184,22291440,vipr1_human,143,K,A,VIP,PubChem CID,16129679,Full agonist,EC50,Functional - cAMP accumulation,2.53,nM,=,,1035.0,-500.0,,,,100.0,0.0,,0.0,,P32241,0.4893465743818669
185,22291440,vipr1_human,144,T,A,PG 97-269,FASTA sequence (peptide),HFDAVFTNSYRKVLKRLSARKLLQDIL,Full agonist,EC50,Functional - cAMP accumulation,3.5,nM,=,,10.25,-2.933,,,,100.0,0.0,,0.0,,P32241,0.2183340731932443
186,22291440,vipr1_human,144,T,A,VIP,PubChem CID,16129679,Full agonist,EC50,Functional - cAMP accumulation,2.53,nM,=,,874.0,-333.333,,,,100.0,0.0,,0.0,,P32241,0.2183340731932443
187,22291440,vipr1_human,147,T,A,PG 97-269,FASTA sequence (peptide),HFDAVFTNSYRKVLKRLSARKLLQDIL,Full agonist,EC50,Functional - cAMP accumulation,3.5,nM,=,,8.5,-2.427,,,VIP,100.0,0.0,,0.0,,P32241,0.3381766718759729
188,22291440,vipr1_human,147,T,A,VIP,PubChem CID,16129679,Full agonist,EC50,Functional - cAMP accumulation,2.53,nM,=,,2070.0,-1000.0,,,VIP,100.0,0.0,,0.0,,P32241,0.3381766718759729
189,22291440,vipr1_human,193,F,A,PG 97-269,FASTA sequence (peptide),HFDAVFTNSYRKVLKRLSARKLLQDIL,Binding - unknown pharmacological activity,EC50,Functional - cAMP accumulation,3.5,nM,=,,3.98,-1.138,,,,100.0,0.0,,0.0,,P32241,0.5027412552038342
190,22291440,vipr1_human,193,F,A,VIP,PubChem CID,16129679,Binding - unknown pharmacological activity,EC50,Functional - cAMP accumulation,2.53,nM,=,,3.52,-1.391,,,,100.0,0.0,,0.0,,P32241,0.5027412552038342
191,22291440,vipr1_human,373,E,A,PG 97-269,FASTA sequence (peptide),HFDAVFTNSYRKVLKRLSARKLLQDIL,Binding - unknown pharmacological activity,EC50,Functional - cAMP accumulation,3.5,nM,=,,6.33,-1.808,,,,100.0,0.0,,0.0,,P32241,0.5446259561133562
192,22291440,vipr1_human,373,E,A,VIP,PubChem CID,16129679,Binding - unknown pharmacological activity,EC50,Functional - cAMP accumulation,2.53,nM,=,,6.24,-2.469,,,,100.0,0.0,,0.0,,P32241,0.5446259561133562
193,22291440,vipr1_human,374,L,A,PG 97-269,FASTA sequence (peptide),HFDAVFTNSYRKVLKRLSARKLLQDIL,Binding - unknown pharmacological activity,EC50,Functional - cAMP accumulation,3.5,nM,=,,5.05,-1.443,,,,100.0,0.0,,0.0,,P32241,0.5361227588046986
194,22291440,vipr1_human,374,L,A,VIP,PubChem CID,16129679,Binding - unknown pharmacological activity,EC50,Functional - cAMP accumulation,2.53,nM,=,,414.0,-166.667,,,,100.0,0.0,,0.0,,P32241,0.5361227588046986
195,22291440,vipr1_human,378,S,A,PG 97-269,FASTA sequence (peptide),HFDAVFTNSYRKVLKRLSARKLLQDIL,Binding - unknown pharmacological activity,EC50,Functional - cAMP accumulation,3.5,nM,=,,3.65,-1.043,,,,100.0,0.0,,0.0,,P32241,0.4721261448526645
196,22291440,vipr1_human,378,S,A,VIP,PubChem CID,16129679,Binding - unknown pharmacological activity,EC50,Functional - cAMP accumulation,2.53,nM,=,,11.57,-4.566,,,,100.0,0.0,,0.0,,P32241,0.4721261448526645
0,10.1074/jbc.M006230200,grm5_human,649,I,L,[3H]M-MPEP,PubChem CID,5311462,Negative allosteric modulator - noncompetitive antagonist,K(d),Binding - Radioligand saturation,3.5,nM,=,,3.0,1.167,,,,0.0,0.0,,0.0,,P41594,0.3655320915815455
1,10.1074/jbc.M006230200,grm5_human,650,G,L,[3H]M-MPEP,PubChem CID,5311462,Negative allosteric modulator - noncompetitive antagonist,K(d),Binding - Radioligand saturation,3.5,nM,=,,2.6,1.346,,,,0.0,0.0,,0.0,,P41594,0.6068165071104101
2,10.1074/jbc.M006230200,grm5_human,651,I,V,[3H]M-MPEP,PubChem CID,5311462,Negative allosteric modulator - noncompetitive antagonist,K(d),Binding - Radioligand saturation,3.5,nM,=,,5.1,-1.458,,,,0.0,0.0,,0.0,,P41594,0.3680260263958704
3,10.1074/jbc.M006230200,grm5_human,655,P,S,[3H]M-MPEP,PubChem CID,5311462,Negative allosteric modulator - noncompetitive antagonist,K(d),Binding - Radioligand saturation,3.5,nM,=,,27.1,-7.752,,,,0.0,0.0,,0.0,,P41594,0.5312810881742267
15,10.1124/mol.112.078808,grm5_human,655,P,S,2-BisPEB,PubChem CID,57328469,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - Ca2+ accumulation,79.0,nM,=,,160.0,-2.024,,,Glutamate,0.0,0.0,,77.0,Glutamate,P41594,0.5312810881742267
34,10.1124/mol.112.078808,grm5_human,655,P,S,3-BisPEB,SMILES,C1(=CC(=CC=C1)C#CC2=CN=CC=C2)C#CC3=CC=CN=C3,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - Ca2+ accumulation,2200.0,nM,>,,45000.0,-20.408,,,Glutamate,0.0,0.0,,0.0,,P41594,0.5312810881742267
53,10.1124/mol.112.078808,grm5_human,655,P,S,4-BisPEB,PubChem CID,69032688,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - Ca2+ accumulation,2100.0,nM,=,,3200.0,-1.524,,,Glutamate,0.0,0.0,,0.0,,P41594,0.5312810881742267
72,10.1124/mol.112.078808,grm5_human,655,P,S,MPEP,PubChem CID,3025961,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - Ca2+ accumulation,8.1,nM,=,,60.0,-7.407,,,Glutamate,80.0,0.0,,0.0,,P41594,0.5312810881742267
4,10.1074/jbc.M006230200,grm5_human,658,S,C,[3H]M-MPEP,PubChem CID,5311462,Negative allosteric modulator - noncompetitive antagonist,K(d),Binding - Radioligand saturation,3.5,nM,=,,16.5,-4.717,,,,0.0,0.0,,0.0,,P41594,0.5750052654863318
5,10.1074/jbc.M006230200,grm5_human,802,M,T,[3H]M-MPEP,PubChem CID,5311462,Negative allosteric modulator - noncompetitive antagonist,K(d),Binding - Radioligand saturation,3.5,nM,=,,3.8,-1.086,,,,0.0,0.0,,0.0,,P41594,0.5512647712064694
6,10.1074/jbc.M006230200,grm5_human,805,S,A,[3H]M-MPEP,PubChem CID,5311462,Negative allosteric modulator - noncompetitive antagonist,K(d),Binding - Radioligand saturation,3.5,nM,=,,6.7,-1.916,,,,0.0,0.0,,0.0,,P41594,0.4489448914445213
8,10.1074/jbc.M006230200,grm5_human,819,V,T,[3H]M-MPEP,PubChem CID,5311462,Negative allosteric modulator - noncompetitive antagonist,K(d),Binding - Radioligand saturation,3.5,nM,=,,4.1,-1.171,,,,0.0,0.0,,0.0,,P41594,0.4794163127780508
9,10.1074/jbc.M006230200,grm5_human,822,V,M,[3H]M-MPEP,PubChem CID,5311462,Negative allosteric modulator - noncompetitive antagonist,K(d),Binding - Radioligand saturation,3.5,nM,=,,3.1,1.129,,,,0.0,0.0,,0.0,,P41594,0.4913126984097168
11,10.1124/mol.112.078808,grm5_human,632,T,A,2-BisPEB,PubChem CID,57328469,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - Ca2+ accumulation,79.0,nM,=,,83.0,-1.05,,,Glutamate,0.0,0.0,,58.0,Glutamate,P41594,0.4869554016309061
30,10.1124/mol.112.078808,grm5_human,632,T,A,3-BisPEB,SMILES,C1(=CC(=CC=C1)C#CC2=CN=CC=C2)C#CC3=CC=CN=C3,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - Ca2+ accumulation,2200.0,nM,=,,1800.0,1.222,,,Glutamate,0.0,0.0,,0.0,,P41594,0.4869554016309061
49,10.1124/mol.112.078808,grm5_human,632,T,A,4-BisPEB,PubChem CID,69032688,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - Ca2+ accumulation,2100.0,nM,=,,3500.0,-1.667,,,Glutamate,0.0,0.0,,0.0,,P41594,0.4869554016309061
68,10.1124/mol.112.078808,grm5_human,632,T,A,MPEP,PubChem CID,3025961,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - Ca2+ accumulation,8.1,nM,=,,4.5,1.8,,,Glutamate,63.33333333333333,0.0,,0.0,,P41594,0.4869554016309061
12,10.1124/mol.112.078808,grm5_human,632,T,P,2-BisPEB,PubChem CID,57328469,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - Ca2+ accumulation,79.0,nM,=,,13.0,6.077,,,Glutamate,0.0,0.0,,67.0,Glutamate,P41594,0.531901566221775
31,10.1124/mol.112.078808,grm5_human,632,T,P,3-BisPEB,SMILES,C1(=CC(=CC=C1)C#CC2=CN=CC=C2)C#CC3=CC=CN=C3,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - Ca2+ accumulation,2200.0,nM,=,,790.0,2.785,,,Glutamate,0.0,0.0,,0.0,,P41594,0.531901566221775
50,10.1124/mol.112.078808,grm5_human,632,T,P,4-BisPEB,PubChem CID,69032688,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - Ca2+ accumulation,2100.0,nM,=,,2500.0,-1.19,,,Glutamate,0.0,0.0,,0.0,,P41594,0.531901566221775
69,10.1124/mol.112.078808,grm5_human,632,T,P,MPEP,PubChem CID,3025961,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - Ca2+ accumulation,8.1,nM,=,,2.0,4.05,,,Glutamate,80.0,0.0,,0.0,,P41594,0.531901566221775
13,10.1124/mol.112.078808,grm5_human,648,R,E,2-BisPEB,PubChem CID,57328469,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - Ca2+ accumulation,79.0,nM,=,,12.0,6.583,,,Glutamate,0.0,0.0,,23.0,Glutamate,P41594,0.5327204009311763
32,10.1124/mol.112.078808,grm5_human,648,R,E,3-BisPEB,SMILES,C1(=CC(=CC=C1)C#CC2=CN=CC=C2)C#CC3=CC=CN=C3,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - Ca2+ accumulation,2200.0,nM,=,,590.0,3.729,,,Glutamate,0.0,0.0,,0.0,,P41594,0.5327204009311763
51,10.1124/mol.112.078808,grm5_human,648,R,E,4-BisPEB,PubChem CID,69032688,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - Ca2+ accumulation,2100.0,nM,=,,2000.0,1.05,,,Glutamate,0.0,0.0,,0.0,,P41594,0.5327204009311763
70,10.1124/mol.112.078808,grm5_human,648,R,E,MPEP,PubChem CID,3025961,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - Ca2+ accumulation,8.1,nM,=,,0.91,8.901,,,Glutamate,17.77777777777778,0.0,,0.0,,P41594,0.5327204009311763
14,10.1124/mol.112.078808,grm5_human,651,I,F,2-BisPEB,PubChem CID,57328469,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - Ca2+ accumulation,79.0,nM,=,,3200.0,-40.0,,,Glutamate,0.0,0.0,,105.0,Glutamate,P41594,0.4998079998676886
33,10.1124/mol.112.078808,grm5_human,651,I,F,3-BisPEB,SMILES,C1(=CC(=CC=C1)C#CC2=CN=CC=C2)C#CC3=CC=CN=C3,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - Ca2+ accumulation,2200.0,nM,>,,45000.0,-20.408,,,Glutamate,0.0,0.0,,0.0,,P41594,0.4998079998676886
52,10.1124/mol.112.078808,grm5_human,651,I,F,4-BisPEB,PubChem CID,69032688,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - Ca2+ accumulation,2100.0,nM,>,,45000.0,-21.277,,,Glutamate,0.0,0.0,,0.0,,P41594,0.4998079998676886
71,10.1124/mol.112.078808,grm5_human,651,I,F,MPEP,PubChem CID,3025961,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - Ca2+ accumulation,8.1,nM,=,,500.0,-62.5,,,Glutamate,103.33333333333334,0.0,,0.0,,P41594,0.4998079998676886
16,10.1124/mol.112.078808,grm5_human,659,Y,A,2-BisPEB,PubChem CID,57328469,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - Ca2+ accumulation,79.0,nM,=,,1100.0,-13.889,,,Glutamate,0.0,0.0,,81.0,Glutamate,P41594,0.6349435107965326
35,10.1124/mol.112.078808,grm5_human,659,Y,A,3-BisPEB,SMILES,C1(=CC(=CC=C1)C#CC2=CN=CC=C2)C#CC3=CC=CN=C3,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - Ca2+ accumulation,2200.0,nM,>,,45000.0,-20.408,,,Glutamate,0.0,0.0,,0.0,,P41594,0.6349435107965326
54,10.1124/mol.112.078808,grm5_human,659,Y,A,4-BisPEB,PubChem CID,69032688,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - Ca2+ accumulation,2100.0,nM,>,,45000.0,-21.277,,,Glutamate,0.0,0.0,,0.0,,P41594,0.6349435107965326
73,10.1124/mol.112.078808,grm5_human,659,Y,A,MPEP,PubChem CID,3025961,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - Ca2+ accumulation,8.1,nM,=,,950.0,-111.111,,,Glutamate,110.0,0.0,,0.0,,P41594,0.6349435107965326
17,10.1124/mol.112.078808,grm5_human,659,Y,F,2-BisPEB,PubChem CID,57328469,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - Ca2+ accumulation,79.0,nM,=,,38.0,2.079,,,Glutamate,0.0,0.0,,91.0,Glutamate,P41594,0.4142830711516021
36,10.1124/mol.112.078808,grm5_human,659,Y,F,3-BisPEB,SMILES,C1(=CC(=CC=C1)C#CC2=CN=CC=C2)C#CC3=CC=CN=C3,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - Ca2+ accumulation,2200.0,nM,=,,1200.0,1.833,,,Glutamate,0.0,0.0,,0.0,,P41594,0.4142830711516021
55,10.1124/mol.112.078808,grm5_human,659,Y,F,4-BisPEB,PubChem CID,69032688,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - Ca2+ accumulation,2100.0,nM,=,,630.0,3.333,,,Glutamate,0.0,0.0,,0.0,,P41594,0.4142830711516021
74,10.1124/mol.112.078808,grm5_human,659,Y,F,MPEP,PubChem CID,3025961,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - Ca2+ accumulation,8.1,nM,=,,5.5,1.473,,,Glutamate,86.66666666666667,0.0,,0.0,,P41594,0.4142830711516021
19,10.1124/mol.112.078808,grm5_human,747,N,S,2-BisPEB,PubChem CID,57328469,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - Ca2+ accumulation,79.0,nM,=,,430.0,-5.435,,,Glutamate,0.0,0.0,,108.0,Glutamate,P41594,0.5018278266708839
38,10.1124/mol.112.078808,grm5_human,747,N,S,3-BisPEB,SMILES,C1(=CC(=CC=C1)C#CC2=CN=CC=C2)C#CC3=CC=CN=C3,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - Ca2+ accumulation,2200.0,nM,=,,25000.0,-11.364,,,Glutamate,0.0,0.0,,0.0,,P41594,0.5018278266708839
57,10.1124/mol.112.078808,grm5_human,747,N,S,4-BisPEB,PubChem CID,69032688,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - Ca2+ accumulation,2100.0,nM,=,,5000.0,-2.381,,,Glutamate,0.0,0.0,,0.0,,P41594,0.5018278266708839
76,10.1124/mol.112.078808,grm5_human,747,N,S,MPEP,PubChem CID,3025961,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - Ca2+ accumulation,8.1,nM,=,,34.0,-4.202,,,Glutamate,84.44444444444444,0.0,,0.0,,P41594,0.5018278266708839
21,10.1124/mol.112.078808,grm5_human,785,W,A,2-BisPEB,PubChem CID,57328469,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - Ca2+ accumulation,79.0,nM,=,,890.0,-11.236,,,Glutamate,0.0,0.0,,59.0,Glutamate,P41594,0.830341031419034
40,10.1124/mol.112.078808,grm5_human,785,W,A,3-BisPEB,SMILES,C1(=CC(=CC=C1)C#CC2=CN=CC=C2)C#CC3=CC=CN=C3,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - Ca2+ accumulation,2200.0,nM,=,,4300.0,-1.953,,,Glutamate,0.0,0.0,,0.0,,P41594,0.830341031419034
59,10.1124/mol.112.078808,grm5_human,785,W,A,4-BisPEB,PubChem CID,69032688,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - Ca2+ accumulation,2100.0,nM,=,,6000.0,-2.857,,,Glutamate,0.0,0.0,,0.0,,P41594,0.830341031419034
78,10.1124/mol.112.078808,grm5_human,785,W,A,MPEP,PubChem CID,3025961,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - Ca2+ accumulation,8.1,nM,=,,2300.0,-250.0,,,Glutamate,60.0,0.0,,0.0,,P41594,0.830341031419034
22,10.1124/mol.112.078808,grm5_human,788,F,A,2-BisPEB,PubChem CID,57328469,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - Ca2+ accumulation,79.0,nM,=,,98.0,-1.241,,,Glutamate,0.0,0.0,,102.0,Glutamate,P41594,0.6250151268933531
41,10.1124/mol.112.078808,grm5_human,788,F,A,3-BisPEB,SMILES,C1(=CC(=CC=C1)C#CC2=CN=CC=C2)C#CC3=CC=CN=C3,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - Ca2+ accumulation,2200.0,nM,=,,1900.0,1.158,,,Glutamate,0.0,0.0,,0.0,,P41594,0.6250151268933531
60,10.1124/mol.112.078808,grm5_human,788,F,A,4-BisPEB,PubChem CID,69032688,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - Ca2+ accumulation,2100.0,nM,>,,45000.0,-21.277,,,Glutamate,0.0,0.0,,0.0,,P41594,0.6250151268933531
79,10.1124/mol.112.078808,grm5_human,788,F,A,MPEP,PubChem CID,3025961,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - Ca2+ accumulation,8.1,nM,=,,220.0,-27.027,,,Glutamate,103.33333333333334,0.0,,0.0,,P41594,0.6250151268933531
23,10.1124/mol.112.078808,grm5_human,788,F,W,2-BisPEB,PubChem CID,57328469,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - Ca2+ accumulation,79.0,nM,=,,260.0,-3.289,,,Glutamate,0.0,0.0,,84.0,Glutamate,P41594,0.4927872474607235
42,10.1124/mol.112.078808,grm5_human,788,F,W,3-BisPEB,SMILES,C1(=CC(=CC=C1)C#CC2=CN=CC=C2)C#CC3=CC=CN=C3,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - Ca2+ accumulation,2200.0,nM,>,,45000.0,-20.408,,,Glutamate,0.0,0.0,,0.0,,P41594,0.4927872474607235
61,10.1124/mol.112.078808,grm5_human,788,F,W,4-BisPEB,PubChem CID,69032688,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - Ca2+ accumulation,2100.0,nM,~,,4500.0,-2.141,,,Glutamate,0.0,0.0,,0.0,,P41594,0.4927872474607235
80,10.1124/mol.112.078808,grm5_human,788,F,W,MPEP,PubChem CID,3025961,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - Ca2+ accumulation,8.1,nM,=,,79.0,-9.709,,,Glutamate,82.22222222222221,0.0,,0.0,,P41594,0.4927872474607235
24,10.1124/mol.112.078808,grm5_human,792,Y,A,2-BisPEB,PubChem CID,57328469,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - Ca2+ accumulation,79.0,nM,=,,160.0,-2.024,,,Glutamate,0.0,0.0,,58.0,Glutamate,P41594,0.5722751790806976
43,10.1124/mol.112.078808,grm5_human,792,Y,A,3-BisPEB,SMILES,C1(=CC(=CC=C1)C#CC2=CN=CC=C2)C#CC3=CC=CN=C3,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - Ca2+ accumulation,2200.0,nM,>,,45000.0,-20.408,,,Glutamate,0.0,0.0,,0.0,,P41594,0.5722751790806976
62,10.1124/mol.112.078808,grm5_human,792,Y,A,4-BisPEB,PubChem CID,69032688,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - Ca2+ accumulation,2100.0,nM,=,,6300.0,-3.003,,,Glutamate,0.0,0.0,,0.0,,P41594,0.5722751790806976
81,10.1124/mol.112.078808,grm5_human,792,Y,A,MPEP,PubChem CID,3025961,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - Ca2+ accumulation,8.1,nM,=,,66.0,-8.13,,,Glutamate,66.66666666666666,0.0,,0.0,,P41594,0.5722751790806976
25,10.1124/mol.112.078808,grm5_human,792,Y,F,2-BisPEB,PubChem CID,57328469,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - Ca2+ accumulation,79.0,nM,=,,110.0,-1.393,,,Glutamate,0.0,0.0,,109.0,Glutamate,P41594,0.3523079453072776
44,10.1124/mol.112.078808,grm5_human,792,Y,F,3-BisPEB,SMILES,C1(=CC(=CC=C1)C#CC2=CN=CC=C2)C#CC3=CC=CN=C3,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - Ca2+ accumulation,2200.0,nM,=,,2500.0,-1.136,,,Glutamate,0.0,0.0,,0.0,,P41594,0.3523079453072776
63,10.1124/mol.112.078808,grm5_human,792,Y,F,4-BisPEB,PubChem CID,69032688,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - Ca2+ accumulation,2100.0,nM,=,,1600.0,1.312,,,Glutamate,0.0,0.0,,0.0,,P41594,0.3523079453072776
82,10.1124/mol.112.078808,grm5_human,792,Y,F,MPEP,PubChem CID,3025961,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - Ca2+ accumulation,8.1,nM,=,,13.0,-1.605,,,Glutamate,66.66666666666666,0.0,,0.0,,P41594,0.3523079453072776
26,10.1124/mol.112.078808,grm5_human,809,S,A,2-BisPEB,PubChem CID,57328469,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - Ca2+ accumulation,79.0,nM,=,,1500.0,-18.868,,,Glutamate,0.0,0.0,,85.0,Glutamate,P41594,0.4597973765955671
45,10.1124/mol.112.078808,grm5_human,809,S,A,3-BisPEB,SMILES,C1(=CC(=CC=C1)C#CC2=CN=CC=C2)C#CC3=CC=CN=C3,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - Ca2+ accumulation,2200.0,nM,=,,2500.0,-1.136,,,Glutamate,0.0,0.0,,0.0,,P41594,0.4597973765955671
64,10.1124/mol.112.078808,grm5_human,809,S,A,4-BisPEB,PubChem CID,69032688,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - Ca2+ accumulation,2100.0,nM,=,,1000.0,2.1,,,Glutamate,0.0,0.0,,0.0,,P41594,0.4597973765955671
83,10.1124/mol.112.078808,grm5_human,809,S,A,MPEP,PubChem CID,3025961,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - Ca2+ accumulation,8.1,nM,=,,420.0,-52.632,,,Glutamate,66.66666666666666,0.0,,0.0,,P41594,0.4597973765955671
27,10.1124/mol.112.078808,grm5_human,809,S,F,2-BisPEB,PubChem CID,57328469,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - Ca2+ accumulation,79.0,nM,=,,5000.0,-62.5,,,Glutamate,0.0,0.0,,37.0,Glutamate,P41594,0.5934827370859943
46,10.1124/mol.112.078808,grm5_human,809,S,F,3-BisPEB,SMILES,C1(=CC(=CC=C1)C#CC2=CN=CC=C2)C#CC3=CC=CN=C3,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - Ca2+ accumulation,2200.0,nM,=,,6300.0,-2.865,,,Glutamate,0.0,0.0,,0.0,,P41594,0.5934827370859943
65,10.1124/mol.112.078808,grm5_human,809,S,F,4-BisPEB,PubChem CID,69032688,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - Ca2+ accumulation,2100.0,nM,=,,5000.0,-2.381,,,Glutamate,0.0,0.0,,0.0,,P41594,0.5934827370859943
84,10.1124/mol.112.078808,grm5_human,809,S,F,MPEP,PubChem CID,3025961,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - Ca2+ accumulation,8.1,nM,=,,4000.0,-500.0,,,Glutamate,52.22222222222221,0.0,,0.0,,P41594,0.5934827370859943
28,10.1124/mol.112.078808,grm5_human,810,A,V,2-BisPEB,PubChem CID,57328469,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - Ca2+ accumulation,79.0,nM,=,,790.0,-10.0,,,Glutamate,0.0,0.0,,92.0,Glutamate,P41594,0.5090762853883264
47,10.1124/mol.112.078808,grm5_human,810,A,V,3-BisPEB,SMILES,C1(=CC(=CC=C1)C#CC2=CN=CC=C2)C#CC3=CC=CN=C3,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - Ca2+ accumulation,2200.0,nM,>,,45000.0,-20.408,,,Glutamate,0.0,0.0,,0.0,,P41594,0.5090762853883264
66,10.1124/mol.112.078808,grm5_human,810,A,V,4-BisPEB,PubChem CID,69032688,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - Ca2+ accumulation,2100.0,nM,=,,7600.0,-3.623,,,Glutamate,0.0,0.0,,0.0,,P41594,0.5090762853883264
85,10.1124/mol.112.078808,grm5_human,810,A,V,MPEP,PubChem CID,3025961,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - Ca2+ accumulation,8.1,nM,=,,510.0,-62.5,,,Glutamate,88.8888888888889,0.0,,0.0,,P41594,0.5090762853883264
29,10.1124/mol.112.078808,grm5_human,813,A,F,2-BisPEB,PubChem CID,57328469,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - Ca2+ accumulation,79.0,nM,=,,120.0,-1.52,,,Glutamate,0.0,0.0,,69.0,Glutamate,P41594,0.5914767964228783
48,10.1124/mol.112.078808,grm5_human,813,A,F,3-BisPEB,SMILES,C1(=CC(=CC=C1)C#CC2=CN=CC=C2)C#CC3=CC=CN=C3,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - Ca2+ accumulation,2200.0,nM,=,,3400.0,-1.546,,,Glutamate,0.0,0.0,,0.0,,P41594,0.5914767964228783
67,10.1124/mol.112.078808,grm5_human,813,A,F,4-BisPEB,PubChem CID,69032688,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - Ca2+ accumulation,2100.0,nM,=,,3500.0,-1.667,,,Glutamate,0.0,0.0,,0.0,,P41594,0.5914767964228783
86,10.1124/mol.112.078808,grm5_human,813,A,F,MPEP,PubChem CID,3025961,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - Ca2+ accumulation,8.1,nM,=,,10.0,-1.235,,,Glutamate,66.66666666666666,0.0,,0.0,,P41594,0.5914767964228783
3,10.1074/jbc.M400724200,casr_human,684,F,A,NPS-2143,PubChem CID,6918446,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - IP accumulation,0.35,ÂµM,>,,100.0,-333.333,,,Ca2+,0.0,0.0,,0.0,,P41180,0.5654966683681446
20,10.1074/jbc.M308010200,casr_human,684,F,A,Calhex231,PubChem CID,11849514,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - IP accumulation,0.39,ÂµM,>,,100.0,-250.0,,,Ca2+,0.0,0.0,,50.0,Ca2+,P41180,0.5654966683681446
91,10.1038/cr.2016.36,casr_human,684,F,A,CInacalcet,PubChem CID,156419,Positive allosteric modulator,pK(b),Functional - Ca2+ accumulation,6.34,,=,,5.4,-8.696,,,Ca2+,120.0,0.0,,0.0,,P41180,0.5654966683681446
163,10.1038/cr.2016.36,casr_human,684,F,A,AC-265347,PubChem CID,52943938,Positive allosteric modulator,pK(b),Functional - Ca2+ accumulation,6.27,,=,,5.19,-12.048,,,Ca2+,0.0,0.0,,0.0,,P41180,0.5654966683681446
21,10.1074/jbc.M308010200,casr_human,688,F,A,Calhex231,PubChem CID,11849514,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - IP accumulation,0.39,ÂµM,=,,3.2,-8.197,,,Ca2+,0.0,0.0,,50.0,Ca2+,P41180,0.6612682483221779
45,10.1074/jbc.M400724200,casr_human,688,F,A,NPS-2143,PubChem CID,6918446,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - IP accumulation,0.35,ÂµM,>,,100.0,-333.333,,,Ca2+,0.0,0.0,,0.0,,P41180,0.6612682483221779
92,10.1038/cr.2016.36,casr_human,688,F,A,CInacalcet,PubChem CID,156419,Positive allosteric modulator,pK(b),Functional - Ca2+ accumulation,6.34,,=,,5.65,-4.902,,,Ca2+,104.0,0.0,,0.0,,P41180,0.6612682483221779
164,10.1038/cr.2016.36,casr_human,688,F,A,AC-265347,PubChem CID,52943938,Positive allosteric modulator,pK(b),Functional - Ca2+ accumulation,6.27,,=,,5.61,-4.566,,,Ca2+,0.0,0.0,,0.0,,P41180,0.6612682483221779
191,10.1038/cr.2016.36,casr_human,688,F,A,CInacalcet,PubChem CID,156419,Positive allosteric modulator,pK(b),Functional - ERK activation,6.52,,=,,7.02,3.162,,,Ca2+,0.0,0.0,,0.0,,P41180,0.6612682483221779
198,10.1038/cr.2016.36,casr_human,688,F,A,NPS-2143,PubChem CID,6918446,Negative allosteric modulator - noncompetitive antagonist,pK(b),Functional - ERK activation,6.36,,=,,6.28,-1.202,,,Ca2+,0.0,0.0,,0.0,,P41180,0.6612682483221779
205,10.1038/cr.2016.36,casr_human,688,F,A,AC-265347,PubChem CID,52943938,Positive allosteric modulator,pK(b),Functional - ERK activation,6.68,,=,,6.74,1.148,,,Ca2+,0.0,0.0,,0.0,,P41180,0.6612682483221779
22,10.1074/jbc.M308010200,casr_human,764,T,A,Calhex231,PubChem CID,11849514,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - IP accumulation,0.39,ÂµM,=,,0.28,1.393,,,Ca2+,0.0,0.0,,120.0,Ca2+,P41180,0.3347098174651988
46,10.1074/jbc.M400724200,casr_human,764,T,A,NPS-2143,PubChem CID,6918446,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - IP accumulation,0.35,ÂµM,=,,0.44,-1.258,,,Ca2+,0.0,0.0,,0.0,,P41180,0.3347098174651988
23,10.1074/jbc.M308010200,casr_human,766,H,A,Calhex231,PubChem CID,11849514,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - IP accumulation,0.39,ÂµM,=,,0.64,-1.642,,,Ca2+,0.0,0.0,,102.0,Ca2+,P41180,0.4050354051102732
47,10.1074/jbc.M400724200,casr_human,766,H,A,NPS-2143,PubChem CID,6918446,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - IP accumulation,0.35,ÂµM,=,,0.54,-1.543,,,Ca2+,0.0,0.0,,0.0,,P41180,0.4050354051102732
24,10.1074/jbc.M308010200,casr_human,776,L,A,Calhex231,PubChem CID,11849514,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - IP accumulation,0.39,ÂµM,=,,0.07,5.571,,,Ca2+,0.0,0.0,,121.0,Ca2+,P41180,0.5092246885187579
48,10.1074/jbc.M400724200,casr_human,776,L,A,NPS-2143,PubChem CID,6918446,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - IP accumulation,0.35,ÂµM,=,,0.37,-1.057,,,Ca2+,0.0,0.0,,0.0,,P41180,0.5092246885187579
100,10.1038/cr.2016.36,casr_human,776,L,A,CInacalcet,PubChem CID,156419,Positive allosteric modulator,pK(b),Functional - Ca2+ accumulation,6.34,,=,,6.28,-1.148,,,Ca2+,76.0,0.0,,0.0,,P41180,0.5092246885187579
137,10.1038/cr.2016.36,casr_human,776,L,A,NPS-2143,PubChem CID,6918446,Negative allosteric modulator - noncompetitive antagonist,pK(b),Functional - Ca2+ accumulation,6.66,,=,,6.21,-2.817,,,Ca2+,0.0,0.0,,102.38095238095238,Ca2+,P41180,0.5092246885187579
171,10.1038/cr.2016.36,casr_human,776,L,A,AC-265347,PubChem CID,52943938,Positive allosteric modulator,pK(b),Functional - Ca2+ accumulation,6.27,,=,,6.66,2.455,,,Ca2+,0.0,0.0,,0.0,,P41180,0.5092246885187579
192,10.1038/cr.2016.36,casr_human,776,L,A,CInacalcet,PubChem CID,156419,Positive allosteric modulator,pK(b),Functional - ERK activation,6.52,,=,,6.95,2.692,,,Ca2+,0.0,0.0,,0.0,,P41180,0.5092246885187579
199,10.1038/cr.2016.36,casr_human,776,L,A,NPS-2143,PubChem CID,6918446,Negative allosteric modulator - noncompetitive antagonist,pK(b),Functional - ERK activation,6.36,,=,,6.22,-1.381,,,Ca2+,0.0,0.0,,0.0,,P41180,0.5092246885187579
206,10.1038/cr.2016.36,casr_human,776,L,A,AC-265347,PubChem CID,52943938,Positive allosteric modulator,pK(b),Functional - ERK activation,6.68,,=,,7.53,7.079,,,Ca2+,0.0,0.0,,0.0,,P41180,0.5092246885187579
25,10.1074/jbc.M308010200,casr_human,818,W,A,Calhex231,PubChem CID,11849514,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - IP accumulation,0.39,ÂµM,=,,3.3,-8.475,,,Ca2+,0.0,0.0,,72.0,Ca2+,P41180,0.844219736942984
49,10.1074/jbc.M400724200,casr_human,818,W,A,NPS-2143,PubChem CID,6918446,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - IP accumulation,0.35,ÂµM,=,,0.65,-1.859,,,Ca2+,0.0,0.0,,0.0,,P41180,0.844219736942984
103,10.1038/cr.2016.36,casr_human,818,W,A,CInacalcet,PubChem CID,156419,Positive allosteric modulator,pK(b),Functional - Ca2+ accumulation,6.34,,=,,5.81,-3.39,,,Ca2+,118.0,0.0,,0.0,,P41180,0.844219736942984
140,10.1038/cr.2016.36,casr_human,818,W,A,NPS-2143,PubChem CID,6918446,Negative allosteric modulator - noncompetitive antagonist,pK(b),Functional - Ca2+ accumulation,6.66,,=,,6.47,-1.548,,,Ca2+,0.0,0.0,,96.42857142857144,Ca2+,P41180,0.844219736942984
174,10.1038/cr.2016.36,casr_human,818,W,A,AC-265347,PubChem CID,52943938,Positive allosteric modulator,pK(b),Functional - Ca2+ accumulation,6.27,,=,,5.21,-11.494,,,Ca2+,0.0,0.0,,0.0,,P41180,0.844219736942984
193,10.1038/cr.2016.36,casr_human,818,W,A,CInacalcet,PubChem CID,156419,Positive allosteric modulator,pK(b),Functional - ERK activation,6.52,,=,,5.92,-3.984,,,Ca2+,0.0,0.0,,0.0,,P41180,0.844219736942984
200,10.1038/cr.2016.36,casr_human,818,W,A,NPS-2143,PubChem CID,6918446,Negative allosteric modulator - noncompetitive antagonist,pK(b),Functional - ERK activation,6.36,,=,,6.18,-1.513,,,Ca2+,0.0,0.0,,0.0,,P41180,0.844219736942984
207,10.1038/cr.2016.36,casr_human,818,W,A,AC-265347,PubChem CID,52943938,Positive allosteric modulator,pK(b),Functional - ERK activation,6.68,,=,,6.36,-2.088,,,Ca2+,0.0,0.0,,0.0,,P41180,0.844219736942984
26,10.1074/jbc.M308010200,casr_human,821,F,A,Calhex231,PubChem CID,11849514,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - IP accumulation,0.39,ÂµM,=,,0.06,6.5,,,Ca2+,0.0,0.0,,112.0,Ca2+,P41180,0.6827001537490627
50,10.1074/jbc.M400724200,casr_human,821,F,A,NPS-2143,PubChem CID,6918446,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - IP accumulation,0.35,ÂµM,=,,0.57,-1.629,,,Ca2+,0.0,0.0,,0.0,,P41180,0.6827001537490627
104,10.1038/cr.2016.36,casr_human,821,F,A,CInacalcet,PubChem CID,156419,Positive allosteric modulator,pK(b),Functional - Ca2+ accumulation,6.34,,=,,6.8,2.884,,,Ca2+,61.0,0.0,,0.0,,P41180,0.6827001537490627
141,10.1038/cr.2016.36,casr_human,821,F,A,NPS-2143,PubChem CID,6918446,Negative allosteric modulator - noncompetitive antagonist,pK(b),Functional - Ca2+ accumulation,6.66,,=,,6.03,-4.274,,,Ca2+,0.0,0.0,,127.38095238095238,Ca2+,P41180,0.6827001537490627
175,10.1038/cr.2016.36,casr_human,821,F,A,AC-265347,PubChem CID,52943938,Positive allosteric modulator,pK(b),Functional - Ca2+ accumulation,6.27,,=,,6.79,3.311,,,Ca2+,0.0,0.0,,0.0,,P41180,0.6827001537490627
27,10.1074/jbc.M308010200,casr_human,837,E,A,Calhex231,PubChem CID,11849514,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - IP accumulation,0.39,ÂµM,>,,100.0,-250.0,,,Ca2+,0.0,0.0,,72.0,Ca2+,P41180,0.5770890304061219
51,10.1074/jbc.M400724200,casr_human,837,E,A,NPS-2143,PubChem CID,6918446,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - IP accumulation,0.35,ÂµM,>,,100.0,-333.333,,,Ca2+,0.0,0.0,,0.0,,P41180,0.5770890304061219
28,10.1074/jbc.M308010200,casr_human,841,I,A,Calhex231,PubChem CID,11849514,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - IP accumulation,0.39,ÂµM,=,,2.71,-6.944,,,Ca2+,0.0,0.0,,98.0,Ca2+,P41180,0.5596931507825411
52,10.1074/jbc.M400724200,casr_human,841,I,A,NPS-2143,PubChem CID,6918446,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - IP accumulation,0.35,ÂµM,=,,4.17,-11.905,,,Ca2+,0.0,0.0,,0.0,,P41180,0.5596931507825411
186,10.1038/cr.2016.36,casr_human,841,I,A,AC-265347,PubChem CID,52943938,Positive allosteric modulator,pK(b),Functional - Ca2+ accumulation,6.27,,=,,6.04,-1.698,,,Ca2+,0.0,0.0,,0.0,,P41180,0.5596931507825411
29,10.1074/jbc.M400724200,casr_human,680,R,A,Calhex231,PubChem CID,11849514,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - IP accumulation,0.39,ÂµM,=,,0.12,3.25,,,Ca2+,0.0,0.0,,0.0,,P41180,0.5615148976254699
44,10.1074/jbc.M400724200,casr_human,680,R,A,NPS-2143,PubChem CID,6918446,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - IP accumulation,0.35,ÂµM,=,,4.1,-11.765,,,Ca2+,0.0,0.0,,0.0,,P41180,0.5615148976254699
89,10.1038/cr.2016.36,casr_human,680,R,A,CInacalcet,PubChem CID,156419,Positive allosteric modulator,pK(b),Functional - Ca2+ accumulation,6.34,,=,,6.11,-1.698,,,Ca2+,130.0,0.0,,0.0,,P41180,0.5615148976254699
126,10.1038/cr.2016.36,casr_human,680,R,A,NPS-2143,PubChem CID,6918446,Negative allosteric modulator - noncompetitive antagonist,pK(b),Functional - Ca2+ accumulation,6.66,,=,,5.93,-5.376,,,Ca2+,0.0,0.0,,126.1904761904762,Ca2+,P41180,0.5615148976254699
161,10.1038/cr.2016.36,casr_human,680,R,A,AC-265347,PubChem CID,52943938,Positive allosteric modulator,pK(b),Functional - Ca2+ accumulation,6.27,,=,,6.16,-1.289,,,Ca2+,0.0,0.0,,0.0,,P41180,0.5615148976254699
60,10.1210/en.2012-1887,casr_human,185,R,Q,Cinacalcet,PubChem CID,156419,Positive allosteric modulator,pK(b),Functional - Other,5.9,,=,,6.24,2.188,,,Ca2+,0.0,0.0,,0.0,,P41180,0.7800940318308779
61,10.1210/en.2012-1887,casr_human,657,S,Y,Cinacalcet,PubChem CID,156419,Positive allosteric modulator,pK(b),Functional - Other,5.9,,=,,5.25,-4.464,,,Ca2+,16.0,0.0,,0.0,,P41180,0.559049793049048
62,10.1210/en.2012-1887,casr_human,670,G,E,Cinacalcet,PubChem CID,156419,Positive allosteric modulator,pK(b),Functional - Other,5.9,,=,,5.97,1.175,,,Ca2+,13.0,0.0,,0.0,,P41180,0.6118014223939386
64,10.1210/en.2012-1887,casr_human,680,R,C,Cinacalcet,PubChem CID,156419,Positive allosteric modulator,pK(b),Functional - Other,5.9,,=,,5.63,-1.862,,,Ca2+,9.0,0.0,,0.0,,P41180,0.6472456569304209
65,10.1210/en.2012-1887,casr_human,680,R,H,Cinacalcet,PubChem CID,156419,Positive allosteric modulator,pK(b),Functional - Other,5.9,,=,,5.65,-1.779,,,Ca2+,7.0,0.0,,0.0,,P41180,0.5168448308059478
69,10.1210/en.2012-1887,casr_human,804,A,D,Cinacalcet,PubChem CID,156419,Positive allosteric modulator,pK(b),Functional - Other,5.9,,=,,6.38,3.02,,,Ca2+,0.0,0.0,,0.0,,P41180,0.8017209160150808
70,10.1210/en.2012-1887,casr_human,817,V,I,Cinacalcet,PubChem CID,156419,Positive allosteric modulator,pK(b),Functional - Other,5.9,,=,,6.04,1.38,,,Ca2+,77.0,0.0,,0.0,,P41180,0.3649869871953208
71,10.1210/en.2012-1887,casr_human,612,F,S,NPS-2143,PubChem CID,6918446,Negative allosteric modulator - noncompetitive antagonist,pK(b),Functional - Other,6.2,,=,,6.42,1.66,,,Ca2+,0.0,0.0,,0.0,,P41180,0.4866184323925769
73,10.1210/en.2012-1887,casr_human,727,L,Q,NPS-2143,PubChem CID,6918446,Negative allosteric modulator - noncompetitive antagonist,pK(b),Functional - Other,6.2,,=,,6.45,1.778,,,Ca2+,0.0,0.0,,0.0,,P41180,0.5092236899602673
74,10.1210/en.2012-1887,casr_human,767,E,K,NPS-2143,PubChem CID,6918446,Negative allosteric modulator - noncompetitive antagonist,pK(b),Functional - Other,6.2,,=,,6.29,1.23,,,Ca2+,0.0,0.0,,0.0,,P41180,0.4256571052933304
75,10.1210/en.2012-1887,casr_human,773,L,R,NPS-2143,PubChem CID,6918446,Negative allosteric modulator - noncompetitive antagonist,pK(b),Functional - Other,6.2,,=,,5.49,-5.128,,,Ca2+,0.0,0.0,,0.0,,P41180,0.5719024631451953
76,10.1210/en.2012-1887,casr_human,820,S,F,NPS-2143,PubChem CID,6918446,Negative allosteric modulator - noncompetitive antagonist,pK(b),Functional - Other,6.2,,=,,6.61,2.57,,,Ca2+,0.0,0.0,,0.0,,P41180,0.5919298562488796
78,10.1210/en.2012-1887,casr_human,832,F,S,NPS-2143,PubChem CID,6918446,Negative allosteric modulator - noncompetitive antagonist,pK(b),Functional - Other,6.2,,=,,6.64,2.754,,,Ca2+,55.0,0.0,,0.0,,P41180,0.4314906179493752
81,10.1038/cr.2016.36,casr_human,612,F,A,CInacalcet,PubChem CID,156419,Positive allosteric modulator,pK(b),Functional - Ca2+ accumulation,6.34,,=,,6.69,2.239,,,Ca2+,59.0,0.0,,0.0,,P41180,0.4866184323925769
118,10.1038/cr.2016.36,casr_human,612,F,A,NPS-2143,PubChem CID,6918446,Negative allosteric modulator - noncompetitive antagonist,pK(b),Functional - Ca2+ accumulation,6.66,,=,,7.32,4.571,,,Ca2+,0.0,0.0,,100.0,Ca2+,P41180,0.4866184323925769
155,10.1038/cr.2016.36,casr_human,612,F,A,AC-265347,PubChem CID,52943938,Positive allosteric modulator,pK(b),Functional - Ca2+ accumulation,6.27,,=,,6.7,2.692,,,Ca2+,0.0,0.0,,0.0,,P41180,0.4866184323925769
82,10.1038/cr.2016.36,casr_human,615,A,V,CInacalcet,PubChem CID,156419,Positive allosteric modulator,pK(b),Functional - Ca2+ accumulation,6.34,,=,,6.05,-1.949,,,Ca2+,79.0,0.0,,0.0,,P41180,0.2850263159230021
119,10.1038/cr.2016.36,casr_human,615,A,V,NPS-2143,PubChem CID,6918446,Negative allosteric modulator - noncompetitive antagonist,pK(b),Functional - Ca2+ accumulation,6.66,,=,,6.74,1.202,,,Ca2+,0.0,0.0,,123.8095238095238,Ca2+,P41180,0.2850263159230021
156,10.1038/cr.2016.36,casr_human,615,A,V,AC-265347,PubChem CID,52943938,Positive allosteric modulator,pK(b),Functional - Ca2+ accumulation,6.27,,=,,7.12,7.079,,,Ca2+,0.0,0.0,,0.0,,P41180,0.2850263159230021
189,10.1038/cr.2016.36,casr_human,615,A,V,CInacalcet,PubChem CID,156419,Positive allosteric modulator,pK(b),Functional - ERK activation,6.52,,=,,6.52,1.0,,,Ca2+,0.0,0.0,,0.0,,P41180,0.2850263159230021
196,10.1038/cr.2016.36,casr_human,615,A,V,NPS-2143,PubChem CID,6918446,Negative allosteric modulator - noncompetitive antagonist,pK(b),Functional - ERK activation,6.36,,=,,6.86,3.162,,,Ca2+,0.0,0.0,,0.0,,P41180,0.2850263159230021
203,10.1038/cr.2016.36,casr_human,615,A,V,AC-265347,PubChem CID,52943938,Positive allosteric modulator,pK(b),Functional - ERK activation,6.68,,=,,7.54,7.244,,,Ca2+,0.0,0.0,,0.0,,P41180,0.2850263159230021
83,10.1038/cr.2016.36,casr_human,616,L,A,CInacalcet,PubChem CID,156419,Positive allosteric modulator,pK(b),Functional - Ca2+ accumulation,6.34,,=,,6.21,-1.35,,,Ca2+,28.0,0.0,,0.0,,P41180,0.5464278668656378
120,10.1038/cr.2016.36,casr_human,616,L,A,NPS-2143,PubChem CID,6918446,Negative allosteric modulator - noncompetitive antagonist,pK(b),Functional - Ca2+ accumulation,6.66,,=,,6.63,-1.072,,,Ca2+,0.0,0.0,,109.52380952380952,Ca2+,P41180,0.5464278668656378
157,10.1038/cr.2016.36,casr_human,616,L,A,AC-265347,PubChem CID,52943938,Positive allosteric modulator,pK(b),Functional - Ca2+ accumulation,6.27,,=,,6.09,-1.513,,,Ca2+,0.0,0.0,,0.0,,P41180,0.5464278668656378
84,10.1038/cr.2016.36,casr_human,668,F,A,CInacalcet,PubChem CID,156419,Positive allosteric modulator,pK(b),Functional - Ca2+ accumulation,6.34,,=,,5.21,-13.514,,,Ca2+,20.0,0.0,,0.0,,P41180,0.63412861650452
121,10.1038/cr.2016.36,casr_human,668,F,A,NPS-2143,PubChem CID,6918446,Negative allosteric modulator - noncompetitive antagonist,pK(b),Functional - Ca2+ accumulation,6.66,,=,,5.77,-7.752,,,Ca2+,0.0,0.0,,97.61904761904762,Ca2+,P41180,0.63412861650452
158,10.1038/cr.2016.36,casr_human,668,F,A,AC-265347,PubChem CID,52943938,Positive allosteric modulator,pK(b),Functional - Ca2+ accumulation,6.27,,=,,6.08,-1.548,,,Ca2+,0.0,0.0,,0.0,,P41180,0.63412861650452
190,10.1038/cr.2016.36,casr_human,668,F,A,CInacalcet,PubChem CID,156419,Positive allosteric modulator,pK(b),Functional - ERK activation,6.52,,=,,5.3,-16.667,,,Ca2+,0.0,0.0,,0.0,,P41180,0.63412861650452
197,10.1038/cr.2016.36,casr_human,668,F,A,NPS-2143,PubChem CID,6918446,Negative allosteric modulator - noncompetitive antagonist,pK(b),Functional - ERK activation,6.36,,=,,5.15,-16.129,,,Ca2+,0.0,0.0,,0.0,,P41180,0.63412861650452
204,10.1038/cr.2016.36,casr_human,668,F,A,AC-265347,PubChem CID,52943938,Positive allosteric modulator,pK(b),Functional - ERK activation,6.68,,=,,6.57,-1.289,,,Ca2+,0.0,0.0,,0.0,,P41180,0.63412861650452
85,10.1038/cr.2016.36,casr_human,669,I,A,CInacalcet,PubChem CID,156419,Positive allosteric modulator,pK(b),Functional - Ca2+ accumulation,6.34,,=,,6.05,-1.949,,,Ca2+,8.0,0.0,,0.0,,P41180,0.5119928598759185
122,10.1038/cr.2016.36,casr_human,669,I,A,NPS-2143,PubChem CID,6918446,Negative allosteric modulator - noncompetitive antagonist,pK(b),Functional - Ca2+ accumulation,6.66,,=,,6.61,-1.122,,,Ca2+,0.0,0.0,,103.57142857142858,Ca2+,P41180,0.5119928598759185
159,10.1038/cr.2016.36,casr_human,669,I,A,AC-265347,PubChem CID,52943938,Positive allosteric modulator,pK(b),Functional - Ca2+ accumulation,6.27,,=,,6.18,-1.23,,,Ca2+,0.0,0.0,,0.0,,P41180,0.5119928598759185
86,10.1038/cr.2016.36,casr_human,670,G,A,CInacalcet,PubChem CID,156419,Positive allosteric modulator,pK(b),Functional - Ca2+ accumulation,6.34,,=,,6.47,1.349,,,Ca2+,6.0,0.0,,0.0,,P41180,0.523709168615281
123,10.1038/cr.2016.36,casr_human,670,G,A,NPS-2143,PubChem CID,6918446,Negative allosteric modulator - noncompetitive antagonist,pK(b),Functional - Ca2+ accumulation,6.66,,=,,7.38,5.248,,,Ca2+,0.0,0.0,,89.28571428571429,Ca2+,P41180,0.523709168615281
160,10.1038/cr.2016.36,casr_human,670,G,A,AC-265347,PubChem CID,52943938,Positive allosteric modulator,pK(b),Functional - Ca2+ accumulation,6.27,,=,,6.16,-1.289,,,Ca2+,0.0,0.0,,0.0,,P41180,0.523709168615281
87,10.1038/cr.2016.36,casr_human,672,P,A,CInacalcet,PubChem CID,156419,Positive allosteric modulator,pK(b),Functional - Ca2+ accumulation,6.34,,=,,6.23,-1.289,,,Ca2+,40.0,0.0,,0.0,,P41180,0.5706870174445923
124,10.1038/cr.2016.36,casr_human,672,P,A,NPS-2143,PubChem CID,6918446,Negative allosteric modulator - noncompetitive antagonist,pK(b),Functional - Ca2+ accumulation,6.66,,=,,7.11,2.818,,,Ca2+,0.0,0.0,,77.38095238095238,Ca2+,P41180,0.5706870174445923
88,10.1038/cr.2016.36,casr_human,679,L,A,CInacalcet,PubChem CID,156419,Positive allosteric modulator,pK(b),Functional - Ca2+ accumulation,6.34,,=,,6.09,-1.779,,,Ca2+,55.0,0.0,,0.0,,P41180,0.4651764959845943
125,10.1038/cr.2016.36,casr_human,679,L,A,NPS-2143,PubChem CID,6918446,Negative allosteric modulator - noncompetitive antagonist,pK(b),Functional - Ca2+ accumulation,6.66,,=,,6.87,1.622,,,Ca2+,0.0,0.0,,132.14285714285714,Ca2+,P41180,0.4651764959845943
90,10.1038/cr.2016.36,casr_human,682,P,A,CInacalcet,PubChem CID,156419,Positive allosteric modulator,pK(b),Functional - Ca2+ accumulation,6.34,,=,,6.41,1.175,,,Ca2+,75.0,0.0,,0.0,,P41180,0.4093567535935691
127,10.1038/cr.2016.36,casr_human,682,P,A,NPS-2143,PubChem CID,6918446,Negative allosteric modulator - noncompetitive antagonist,pK(b),Functional - Ca2+ accumulation,6.66,,=,,7.22,3.631,,,Ca2+,0.0,0.0,,110.71428571428572,Ca2+,P41180,0.4093567535935691
162,10.1038/cr.2016.36,casr_human,682,P,A,AC-265347,PubChem CID,52943938,Positive allosteric modulator,pK(b),Functional - Ca2+ accumulation,6.27,,=,,6.17,-1.259,,,Ca2+,0.0,0.0,,0.0,,P41180,0.4093567535935691
94,10.1038/cr.2016.36,casr_human,744,Y,A,CInacalcet,PubChem CID,156419,Positive allosteric modulator,pK(b),Functional - Ca2+ accumulation,6.34,,=,,6.48,1.38,,,Ca2+,42.0,0.0,,0.0,,P41180,0.3049268785127945
131,10.1038/cr.2016.36,casr_human,744,Y,A,NPS-2143,PubChem CID,6918446,Negative allosteric modulator - noncompetitive antagonist,pK(b),Functional - Ca2+ accumulation,6.66,,=,,6.57,-1.23,,,Ca2+,0.0,0.0,,130.95238095238096,Ca2+,P41180,0.3049268785127945
166,10.1038/cr.2016.36,casr_human,744,Y,A,AC-265347,PubChem CID,52943938,Positive allosteric modulator,pK(b),Functional - Ca2+ accumulation,6.27,,=,,6.13,-1.381,,,Ca2+,0.0,0.0,,0.0,,P41180,0.3049268785127945
95,10.1038/cr.2016.36,casr_human,748,P,A,CInacalcet,PubChem CID,156419,Positive allosteric modulator,pK(b),Functional - Ca2+ accumulation,6.34,,=,,6.46,1.318,,,Ca2+,133.0,0.0,,0.0,,P41180,0.6182268601201145
132,10.1038/cr.2016.36,casr_human,748,P,A,NPS-2143,PubChem CID,6918446,Negative allosteric modulator - noncompetitive antagonist,pK(b),Functional - Ca2+ accumulation,6.66,,=,,6.86,1.585,,,Ca2+,0.0,0.0,,102.38095238095238,Ca2+,P41180,0.6182268601201145
96,10.1038/cr.2016.36,casr_human,767,E,A,CInacalcet,PubChem CID,156419,Positive allosteric modulator,pK(b),Functional - Ca2+ accumulation,6.34,,=,,6.86,3.311,,,Ca2+,113.0,0.0,,0.0,,P41180,0.5151055633662812
133,10.1038/cr.2016.36,casr_human,767,E,A,NPS-2143,PubChem CID,6918446,Negative allosteric modulator - noncompetitive antagonist,pK(b),Functional - Ca2+ accumulation,6.66,,=,,6.62,-1.096,,,Ca2+,0.0,0.0,,92.85714285714286,Ca2+,P41180,0.5151055633662812
167,10.1038/cr.2016.36,casr_human,767,E,A,AC-265347,PubChem CID,52943938,Positive allosteric modulator,pK(b),Functional - Ca2+ accumulation,6.27,,=,,7.21,8.71,,,Ca2+,0.0,0.0,,0.0,,P41180,0.5151055633662812
97,10.1038/cr.2016.36,casr_human,772,A,V,CInacalcet,PubChem CID,156419,Positive allosteric modulator,pK(b),Functional - Ca2+ accumulation,6.34,,=,,6.79,2.818,,,Ca2+,67.0,0.0,,0.0,,P41180,0.4298312360439838
134,10.1038/cr.2016.36,casr_human,772,A,V,NPS-2143,PubChem CID,6918446,Negative allosteric modulator - noncompetitive antagonist,pK(b),Functional - Ca2+ accumulation,6.66,,=,,6.92,1.82,,,Ca2+,0.0,0.0,,86.90476190476191,Ca2+,P41180,0.4298312360439838
168,10.1038/cr.2016.36,casr_human,772,A,V,AC-265347,PubChem CID,52943938,Positive allosteric modulator,pK(b),Functional - Ca2+ accumulation,6.27,,=,,6.49,1.66,,,Ca2+,0.0,0.0,,0.0,,P41180,0.4298312360439838
98,10.1038/cr.2016.36,casr_human,773,L,A,CInacalcet,PubChem CID,156419,Positive allosteric modulator,pK(b),Functional - Ca2+ accumulation,6.34,,=,,6.46,1.318,,,Ca2+,82.0,0.0,,0.0,,P41180,0.5273724944159592
135,10.1038/cr.2016.36,casr_human,773,L,A,NPS-2143,PubChem CID,6918446,Negative allosteric modulator - noncompetitive antagonist,pK(b),Functional - Ca2+ accumulation,6.66,,=,,6.56,-1.259,,,Ca2+,0.0,0.0,,72.61904761904762,Ca2+,P41180,0.5273724944159592
169,10.1038/cr.2016.36,casr_human,773,L,A,AC-265347,PubChem CID,52943938,Positive allosteric modulator,pK(b),Functional - Ca2+ accumulation,6.27,,=,,6.28,1.023,,,Ca2+,0.0,0.0,,0.0,,P41180,0.5273724944159592
99,10.1038/cr.2016.36,casr_human,775,F,A,CInacalcet,PubChem CID,156419,Positive allosteric modulator,pK(b),Functional - Ca2+ accumulation,6.34,,=,,6.46,1.318,,,Ca2+,129.0,0.0,,0.0,,P41180,0.4294871521362324
136,10.1038/cr.2016.36,casr_human,775,F,A,NPS-2143,PubChem CID,6918446,Negative allosteric modulator - noncompetitive antagonist,pK(b),Functional - Ca2+ accumulation,6.66,,=,,6.79,1.349,,,Ca2+,0.0,0.0,,98.8095238095238,Ca2+,P41180,0.4294871521362324
170,10.1038/cr.2016.36,casr_human,775,F,A,AC-265347,PubChem CID,52943938,Positive allosteric modulator,pK(b),Functional - Ca2+ accumulation,6.27,,=,,6.63,2.291,,,Ca2+,0.0,0.0,,0.0,,P41180,0.4294871521362324
101,10.1038/cr.2016.36,casr_human,780,T,A,CInacalcet,PubChem CID,156419,Positive allosteric modulator,pK(b),Functional - Ca2+ accumulation,6.34,,=,,6.03,-2.041,,,Ca2+,72.0,0.0,,0.0,,P41180,0.4833459821689693
138,10.1038/cr.2016.36,casr_human,780,T,A,NPS-2143,PubChem CID,6918446,Negative allosteric modulator - noncompetitive antagonist,pK(b),Functional - Ca2+ accumulation,6.66,,=,,6.31,-2.237,,,Ca2+,0.0,0.0,,108.33333333333331,Ca2+,P41180,0.4833459821689693
172,10.1038/cr.2016.36,casr_human,780,T,A,AC-265347,PubChem CID,52943938,Positive allosteric modulator,pK(b),Functional - Ca2+ accumulation,6.27,,=,,6.23,-1.096,,,Ca2+,0.0,0.0,,0.0,,P41180,0.4833459821689693
102,10.1038/cr.2016.36,casr_human,817,V,A,CInacalcet,PubChem CID,156419,Positive allosteric modulator,pK(b),Functional - Ca2+ accumulation,6.34,,=,,6.41,1.175,,,Ca2+,38.0,0.0,,0.0,,P41180,0.4965319471663134
139,10.1038/cr.2016.36,casr_human,817,V,A,NPS-2143,PubChem CID,6918446,Negative allosteric modulator - noncompetitive antagonist,pK(b),Functional - Ca2+ accumulation,6.66,,=,,6.95,1.95,,,Ca2+,0.0,0.0,,71.42857142857143,Ca2+,P41180,0.4965319471663134
173,10.1038/cr.2016.36,casr_human,817,V,A,AC-265347,PubChem CID,52943938,Positive allosteric modulator,pK(b),Functional - Ca2+ accumulation,6.27,,=,,6.36,1.23,,,Ca2+,0.0,0.0,,0.0,,P41180,0.4965319471663134
105,10.1038/cr.2016.36,casr_human,825,Y,A,CInacalcet,PubChem CID,156419,Positive allosteric modulator,pK(b),Functional - Ca2+ accumulation,6.34,,=,,7.04,5.012,,,Ca2+,172.0,0.0,,0.0,,P41180,0.5899423331267694
142,10.1038/cr.2016.36,casr_human,825,Y,A,NPS-2143,PubChem CID,6918446,Negative allosteric modulator - noncompetitive antagonist,pK(b),Functional - Ca2+ accumulation,6.66,,=,,6.49,-1.479,,,Ca2+,0.0,0.0,,132.14285714285714,Ca2+,P41180,0.5899423331267694
176,10.1038/cr.2016.36,casr_human,825,Y,A,AC-265347,PubChem CID,52943938,Positive allosteric modulator,pK(b),Functional - Ca2+ accumulation,6.27,,=,,6.14,-1.35,,,Ca2+,0.0,0.0,,0.0,,P41180,0.5899423331267694
106,10.1038/cr.2016.36,casr_human,831,K,A,CInacalcet,PubChem CID,156419,Positive allosteric modulator,pK(b),Functional - Ca2+ accumulation,6.34,,=,,6.59,1.778,,,Ca2+,108.0,0.0,,0.0,,P41180,0.3599943423948632
143,10.1038/cr.2016.36,casr_human,831,K,A,NPS-2143,PubChem CID,6918446,Negative allosteric modulator - noncompetitive antagonist,pK(b),Functional - Ca2+ accumulation,6.66,,=,,7.04,2.399,,,Ca2+,0.0,0.0,,100.0,Ca2+,P41180,0.3599943423948632
177,10.1038/cr.2016.36,casr_human,831,K,A,AC-265347,PubChem CID,52943938,Positive allosteric modulator,pK(b),Functional - Ca2+ accumulation,6.27,,=,,6.73,2.884,,,Ca2+,0.0,0.0,,0.0,,P41180,0.3599943423948632
107,10.1038/cr.2016.36,casr_human,832,F,A,CInacalcet,PubChem CID,156419,Positive allosteric modulator,pK(b),Functional - Ca2+ accumulation,6.34,,=,,6.36,1.047,,,Ca2+,30.0,0.0,,0.0,,P41180,0.4314906179493752
144,10.1038/cr.2016.36,casr_human,832,F,A,NPS-2143,PubChem CID,6918446,Negative allosteric modulator - noncompetitive antagonist,pK(b),Functional - Ca2+ accumulation,6.66,,=,,7.05,2.455,,,Ca2+,0.0,0.0,,120.23809523809524,Ca2+,P41180,0.4314906179493752
178,10.1038/cr.2016.36,casr_human,832,F,A,AC-265347,PubChem CID,52943938,Positive allosteric modulator,pK(b),Functional - Ca2+ accumulation,6.27,,=,,6.44,1.479,,,Ca2+,0.0,0.0,,0.0,,P41180,0.4314906179493752
108,10.1038/cr.2016.36,casr_human,833,V,A,CInacalcet,PubChem CID,156419,Positive allosteric modulator,pK(b),Functional - Ca2+ accumulation,6.34,,=,,6.94,3.981,,,Ca2+,100.0,0.0,,0.0,,P41180,0.471594309371549
145,10.1038/cr.2016.36,casr_human,833,V,A,NPS-2143,PubChem CID,6918446,Negative allosteric modulator - noncompetitive antagonist,pK(b),Functional - Ca2+ accumulation,6.66,,=,,7.21,3.548,,,Ca2+,0.0,0.0,,100.0,Ca2+,P41180,0.471594309371549
179,10.1038/cr.2016.36,casr_human,833,V,A,AC-265347,PubChem CID,52943938,Positive allosteric modulator,pK(b),Functional - Ca2+ accumulation,6.27,,=,,6.24,-1.072,,,Ca2+,0.0,0.0,,0.0,,P41180,0.471594309371549
109,10.1038/cr.2016.36,casr_human,834,S,A,CInacalcet,PubChem CID,156419,Positive allosteric modulator,pK(b),Functional - Ca2+ accumulation,6.34,,=,,6.01,-2.137,,,Ca2+,78.0,0.0,,0.0,,P41180,0.4541015272467811
146,10.1038/cr.2016.36,casr_human,834,S,A,NPS-2143,PubChem CID,6918446,Negative allosteric modulator - noncompetitive antagonist,pK(b),Functional - Ca2+ accumulation,6.66,,=,,7.14,3.02,,,Ca2+,0.0,0.0,,114.28571428571428,Ca2+,P41180,0.4541015272467811
180,10.1038/cr.2016.36,casr_human,834,S,A,AC-265347,PubChem CID,52943938,Positive allosteric modulator,pK(b),Functional - Ca2+ accumulation,6.27,,=,,6.3,1.072,,,Ca2+,0.0,0.0,,0.0,,P41180,0.4541015272467811
113,10.1038/cr.2016.36,casr_human,838,V,A,CInacalcet,PubChem CID,156419,Positive allosteric modulator,pK(b),Functional - Ca2+ accumulation,6.34,,=,,6.1,-1.739,,,Ca2+,99.0,0.0,,0.0,,P41180,0.526528083655122
150,10.1038/cr.2016.36,casr_human,838,V,A,NPS-2143,PubChem CID,6918446,Negative allosteric modulator - noncompetitive antagonist,pK(b),Functional - Ca2+ accumulation,6.66,,=,,6.17,-3.086,,,Ca2+,0.0,0.0,,107.14285714285714,Ca2+,P41180,0.526528083655122
184,10.1038/cr.2016.36,casr_human,838,V,A,AC-265347,PubChem CID,52943938,Positive allosteric modulator,pK(b),Functional - Ca2+ accumulation,6.27,,=,,5.85,-2.632,,,Ca2+,0.0,0.0,,0.0,,P41180,0.526528083655122
114,10.1038/cr.2016.36,casr_human,840,A,V,CInacalcet,PubChem CID,156419,Positive allosteric modulator,pK(b),Functional - Ca2+ accumulation,6.34,,=,,5.88,-2.882,,,Ca2+,93.0,0.0,,0.0,,P41180,0.5007248614136113
151,10.1038/cr.2016.36,casr_human,840,A,V,NPS-2143,PubChem CID,6918446,Negative allosteric modulator - noncompetitive antagonist,pK(b),Functional - Ca2+ accumulation,6.66,,=,,6.48,-1.513,,,Ca2+,0.0,0.0,,92.85714285714286,Ca2+,P41180,0.5007248614136113
185,10.1038/cr.2016.36,casr_human,840,A,V,AC-265347,PubChem CID,52943938,Positive allosteric modulator,pK(b),Functional - Ca2+ accumulation,6.27,,=,,6.74,2.951,,,Ca2+,0.0,0.0,,0.0,,P41180,0.5007248614136113
116,10.1038/cr.2016.36,casr_human,844,A,V,CInacalcet,PubChem CID,156419,Positive allosteric modulator,pK(b),Functional - Ca2+ accumulation,6.34,,=,,6.65,2.042,,,Ca2+,91.0,0.0,,0.0,,P41180,0.4979250501990803
153,10.1038/cr.2016.36,casr_human,844,A,V,NPS-2143,PubChem CID,6918446,Negative allosteric modulator - noncompetitive antagonist,pK(b),Functional - Ca2+ accumulation,6.66,,=,,7.35,4.898,,,Ca2+,0.0,0.0,,88.09523809523809,Ca2+,P41180,0.4979250501990803
187,10.1038/cr.2016.36,casr_human,844,A,V,AC-265347,PubChem CID,52943938,Positive allosteric modulator,pK(b),Functional - Ca2+ accumulation,6.27,,=,,7.27,10.0,,,Ca2+,0.0,0.0,,0.0,,P41180,0.4979250501990803
194,10.1038/cr.2016.36,casr_human,844,A,V,CInacalcet,PubChem CID,156419,Positive allosteric modulator,pK(b),Functional - ERK activation,6.52,,=,,7.17,4.467,,,Ca2+,0.0,0.0,,0.0,,P41180,0.4979250501990803
201,10.1038/cr.2016.36,casr_human,844,A,V,NPS-2143,PubChem CID,6918446,Negative allosteric modulator - noncompetitive antagonist,pK(b),Functional - ERK activation,6.36,,=,,6.57,1.622,,,Ca2+,0.0,0.0,,0.0,,P41180,0.4979250501990803
208,10.1038/cr.2016.36,casr_human,844,A,V,AC-265347,PubChem CID,52943938,Positive allosteric modulator,pK(b),Functional - ERK activation,6.68,,=,,7.59,8.128,,,Ca2+,0.0,0.0,,0.0,,P41180,0.4979250501990803
117,10.1038/cr.2016.36,casr_human,848,L,A,CInacalcet,PubChem CID,156419,Positive allosteric modulator,pK(b),Functional - Ca2+ accumulation,6.34,,=,,6.22,-1.318,,,Ca2+,109.0,0.0,,0.0,,P41180,0.5482601968171057
154,10.1038/cr.2016.36,casr_human,848,L,A,NPS-2143,PubChem CID,6918446,Negative allosteric modulator - noncompetitive antagonist,pK(b),Functional - Ca2+ accumulation,6.66,,=,,7.06,2.512,,,Ca2+,0.0,0.0,,79.76190476190477,Ca2+,P41180,0.5482601968171057
188,10.1038/cr.2016.36,casr_human,848,L,A,AC-265347,PubChem CID,52943938,Positive allosteric modulator,pK(b),Functional - Ca2+ accumulation,6.27,,=,,6.62,2.239,,,Ca2+,0.0,0.0,,0.0,,P41180,0.5482601968171057
195,10.1038/cr.2016.36,casr_human,848,L,A,CInacalcet,PubChem CID,156419,Positive allosteric modulator,pK(b),Functional - ERK activation,6.52,,=,,6.66,1.38,,,Ca2+,0.0,0.0,,0.0,,P41180,0.5482601968171057
202,10.1038/cr.2016.36,casr_human,848,L,A,NPS-2143,PubChem CID,6918446,Negative allosteric modulator - noncompetitive antagonist,pK(b),Functional - ERK activation,6.36,,=,,6.38,1.047,,,Ca2+,0.0,0.0,,0.0,,P41180,0.5482601968171057
209,10.1038/cr.2016.36,casr_human,848,L,A,AC-265347,PubChem CID,52943938,Positive allosteric modulator,pK(b),Functional - ERK activation,6.68,,=,,7.51,6.761,,,Ca2+,0.0,0.0,,0.0,,P41180,0.5482601968171057
1,10.1016/j.neuropharm.2009.06.017,grm1_human,715,S,C,CFMMC,PubChem CID,73755208,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - Ca2+ accumulation,50.0,nM,=,,33.0,1.515,,,Glutamate,0.0,0.0,,0.0,,Q13255,0.2830017210595072
3,10.1016/j.neuropharm.2009.06.017,grm1_human,719,T,G,CFMMC,PubChem CID,73755208,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - Ca2+ accumulation,50.0,nM,=,,27.0,1.852,,,Glutamate,0.0,0.0,,0.0,,Q13255,0.3182515123305317
4,10.1016/j.neuropharm.2009.06.017,grm1_human,723,T,A,CFMMC,PubChem CID,73755208,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - Ca2+ accumulation,50.0,nM,=,,27.0,1.852,,,Glutamate,0.0,0.0,,0.0,,Q13255,0.2816400326928884
5,10.1016/j.neuropharm.2009.06.017,grm1_human,725,I,F,CFMMC,PubChem CID,73755208,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - Ca2+ accumulation,50.0,nM,=,,510.0,-10.204,,,Glutamate,0.0,0.0,,0.0,,Q13255,0.4312737629649797
14,10.1016/j.neuropharm.2009.06.017,grm1_human,725,I,F,Compound 1,PubChem CID,11695894,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - Ca2+ accumulation,9.3,nM,=,,0.0,-1.538,,,Glutamate,0.0,0.0,,0.0,,Q13255,0.4312737629649797
20,10.1016/j.neuropharm.2009.06.017,grm1_human,725,I,F,FTIDC,PubChem CID,11245287,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - Ca2+ accumulation,11.0,nM,=,,0.0,-2.381,,,Glutamate,0.0,0.0,,0.0,,Q13255,0.4312737629649797
26,10.1016/j.neuropharm.2009.06.017,grm1_human,725,I,F,JNJ16259685,PubChem CID,11313361,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - Ca2+ accumulation,3.6,nM,=,,0.0,-2.041,,,Glutamate,0.0,0.0,,0.0,,Q13255,0.4312737629649797
32,10.1016/j.neuropharm.2009.06.017,grm1_human,725,I,F,LY456066,PubChem CID,9840951,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - Ca2+ accumulation,28.0,nM,=,,0.0,-1.724,,,Glutamate,0.0,0.0,,0.0,,Q13255,0.4312737629649797
38,10.1016/j.neuropharm.2009.06.017,grm1_human,725,I,F,YM-298198,PubChem CID,9819432,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - Ca2+ accumulation,120.0,nM,=,,0.0,-1.471,,,Glutamate,0.0,0.0,,0.0,,Q13255,0.4312737629649797
6,10.1016/j.neuropharm.2009.06.017,grm1_human,755,A,T,CFMMC,PubChem CID,73755208,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - Ca2+ accumulation,50.0,nM,=,,22.0,2.273,,,Glutamate,0.0,0.0,,0.0,,Q13255,0.3720230997807489
9,10.1016/j.neuropharm.2009.06.017,grm1_human,769,Y,F,CFMMC,PubChem CID,73755208,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - Ca2+ accumulation,50.0,nM,=,,27.0,1.852,,,Glutamate,0.0,0.0,,0.0,,Q13255,0.2388789519352889
10,10.1016/j.neuropharm.2009.06.017,grm1_human,798,W,A,CFMMC,PubChem CID,73755208,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - Ca2+ accumulation,50.0,nM,=,,12.0,4.167,,,Glutamate,0.0,0.0,,0.0,,Q13255,0.8297993892663011
16,10.1016/j.neuropharm.2009.06.017,grm1_human,798,W,A,Compound 1,PubChem CID,11695894,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - Ca2+ accumulation,9.3,nM,=,,0.0,-3.704,,,Glutamate,0.0,0.0,,0.0,,Q13255,0.8297993892663011
22,10.1016/j.neuropharm.2009.06.017,grm1_human,798,W,A,FTIDC,PubChem CID,11245287,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - Ca2+ accumulation,11.0,nM,=,,0.0,-1.587,,,Glutamate,0.0,0.0,,0.0,,Q13255,0.8297993892663011
28,10.1016/j.neuropharm.2009.06.017,grm1_human,798,W,A,JNJ16259685,PubChem CID,11313361,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - Ca2+ accumulation,3.6,nM,=,,0.0,-1.266,,,Glutamate,0.0,0.0,,0.0,,Q13255,0.8297993892663011
34,10.1016/j.neuropharm.2009.06.017,grm1_human,798,W,A,LY456066,PubChem CID,9840951,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - Ca2+ accumulation,28.0,nM,=,,0.0,2.6,,,Glutamate,0.0,0.0,,0.0,,Q13255,0.8297993892663011
40,10.1016/j.neuropharm.2009.06.017,grm1_human,798,W,A,YM-298198,PubChem CID,9819432,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - Ca2+ accumulation,120.0,nM,=,,0.0,-1.786,,,Glutamate,0.0,0.0,,0.0,,Q13255,0.8297993892663011
47,10.1124/jpet.106.116574,grm1_human,798,W,A,FTIDC,PubChem CID,11245287,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - Ca2+ accumulation,10.0,nM,=,,8.0,1.25,,,Glutamate,0.0,0.0,,0.0,,Q13255,0.8297993892663011
11,10.1016/j.neuropharm.2009.06.017,grm1_human,801,F,A,CFMMC,PubChem CID,73755208,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - Ca2+ accumulation,50.0,nM,>,,6900.0,-142.857,,,Glutamate,0.0,0.0,,0.0,,Q13255,0.6336202691573807
17,10.1016/j.neuropharm.2009.06.017,grm1_human,801,F,A,Compound 1,PubChem CID,11695894,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - Ca2+ accumulation,9.3,nM,=,,0.0,380.0,,,Glutamate,0.0,0.0,,0.0,,Q13255,0.6336202691573807
23,10.1016/j.neuropharm.2009.06.017,grm1_human,801,F,A,FTIDC,PubChem CID,11245287,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - Ca2+ accumulation,11.0,nM,=,,0.0,67.0,,,Glutamate,0.0,0.0,,0.0,,Q13255,0.6336202691573807
29,10.1016/j.neuropharm.2009.06.017,grm1_human,801,F,A,JNJ16259685,PubChem CID,11313361,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - Ca2+ accumulation,3.6,nM,>,,0.0,2700.0,,,Glutamate,0.0,0.0,,0.0,,Q13255,0.6336202691573807
35,10.1016/j.neuropharm.2009.06.017,grm1_human,801,F,A,LY456066,PubChem CID,9840951,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - Ca2+ accumulation,28.0,nM,=,,0.0,-5.0,,,Glutamate,0.0,0.0,,0.0,,Q13255,0.6336202691573807
48,10.1124/jpet.106.116574,grm1_human,801,F,A,FTIDC,PubChem CID,11245287,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - Ca2+ accumulation,10.0,nM,=,,900.0,-90.909,,,Glutamate,0.0,0.0,,0.0,,Q13255,0.6336202691573807
12,10.1016/j.neuropharm.2009.06.017,grm1_human,805,Y,A,CFMMC,PubChem CID,73755208,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - Ca2+ accumulation,50.0,nM,>,,10000.0,-200.0,,,Glutamate,0.0,0.0,,0.0,,Q13255,0.5709498105523327
18,10.1016/j.neuropharm.2009.06.017,grm1_human,805,Y,A,Compound 1,PubChem CID,11695894,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - Ca2+ accumulation,9.3,nM,=,,0.0,-2.273,,,Glutamate,0.0,0.0,,0.0,,Q13255,0.5709498105523327
24,10.1016/j.neuropharm.2009.06.017,grm1_human,805,Y,A,FTIDC,PubChem CID,11245287,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - Ca2+ accumulation,11.0,nM,=,,0.0,-1.19,,,Glutamate,0.0,0.0,,0.0,,Q13255,0.5709498105523327
30,10.1016/j.neuropharm.2009.06.017,grm1_human,805,Y,A,JNJ16259685,PubChem CID,11313361,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - Ca2+ accumulation,3.6,nM,=,,0.0,13.0,,,Glutamate,0.0,0.0,,0.0,,Q13255,0.5709498105523327
36,10.1016/j.neuropharm.2009.06.017,grm1_human,805,Y,A,LY456066,PubChem CID,9840951,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - Ca2+ accumulation,28.0,nM,=,,0.0,9.1,,,Glutamate,0.0,0.0,,0.0,,Q13255,0.5709498105523327
42,10.1016/j.neuropharm.2009.06.017,grm1_human,805,Y,A,YM-298198,PubChem CID,9819432,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - Ca2+ accumulation,120.0,nM,=,,0.0,12.0,,,Glutamate,0.0,0.0,,0.0,,Q13255,0.5709498105523327
49,10.1124/jpet.106.116574,grm1_human,805,Y,A,FTIDC,PubChem CID,11245287,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - Ca2+ accumulation,10.0,nM,=,,14.0,-1.401,,,Glutamate,0.0,0.0,,0.0,,Q13255,0.5709498105523327
13,10.1016/j.neuropharm.2009.06.017,grm1_human,815,T,M,CFMMC,PubChem CID,73755208,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - Ca2+ accumulation,50.0,nM,>,,10000.0,-200.0,,,Glutamate,0.0,0.0,,0.0,,Q13255,0.5530527771422878
19,10.1016/j.neuropharm.2009.06.017,grm1_human,815,T,M,Compound 1,PubChem CID,11695894,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - Ca2+ accumulation,9.3,nM,=,,0.0,4.2,,,Glutamate,0.0,0.0,,0.0,,Q13255,0.5530527771422878
25,10.1016/j.neuropharm.2009.06.017,grm1_human,815,T,M,FTIDC,PubChem CID,11245287,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - Ca2+ accumulation,11.0,nM,=,,0.0,38.0,,,Glutamate,0.0,0.0,,0.0,,Q13255,0.5530527771422878
31,10.1016/j.neuropharm.2009.06.017,grm1_human,815,T,M,JNJ16259685,PubChem CID,11313361,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - Ca2+ accumulation,3.6,nM,>,,0.0,2700.0,,,Glutamate,0.0,0.0,,0.0,,Q13255,0.5530527771422878
37,10.1016/j.neuropharm.2009.06.017,grm1_human,815,T,M,LY456066,PubChem CID,9840951,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - Ca2+ accumulation,28.0,nM,>,,0.0,350.0,,,Glutamate,0.0,0.0,,0.0,,Q13255,0.5530527771422878
43,10.1016/j.neuropharm.2009.06.017,grm1_human,815,T,M,YM-298198,PubChem CID,9819432,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - Ca2+ accumulation,120.0,nM,>,,0.0,110.0,,,Glutamate,0.0,0.0,,0.0,,Q13255,0.5530527771422878
50,10.1124/jpet.106.116574,grm1_human,815,T,M,FTIDC,PubChem CID,11245287,Negative allosteric modulator - noncompetitive antagonist,IC50,Functional - Ca2+ accumulation,10.0,nM,=,,720.0,-71.429,,,Glutamate,0.0,0.0,,0.0,,Q13255,0.5530527771422878
58,10.1126/science.1249489,grm1_human,815,T,M,FITM,PubChem CID,16660135,Negative allosteric modulator - noncompetitive antagonist,K(b),Functional - Ca2+ accumulation,266.0,nM,=,,1520.0,-5.714,,,Glutamate,0.0,0.0,,0.0,,Q13255,0.5530527771422878
51,10.1126/science.1249489,grm1_human,660,Q,A,FITM,PubChem CID,16660135,Negative allosteric modulator - noncompetitive antagonist,K(b),Functional - Ca2+ accumulation,266.0,nM,=,,265.0,1.004,,,Glutamate,0.0,0.0,,0.0,,Q13255,0.618810608505409
52,10.1126/science.1249489,grm1_human,664,V,I,FITM,PubChem CID,16660135,Negative allosteric modulator - noncompetitive antagonist,K(b),Functional - Ca2+ accumulation,266.0,nM,=,,263.0,1.011,,,Glutamate,0.0,0.0,,0.0,,Q13255,0.3764291080569185
53,10.1126/science.1249489,grm1_human,668,S,P,FITM,PubChem CID,16660135,Negative allosteric modulator - noncompetitive antagonist,K(b),Functional - Ca2+ accumulation,266.0,nM,=,,548.0,-2.062,,,Glutamate,0.0,0.0,,0.0,,Q13255,0.5528803176386409
54,10.1126/science.1249489,grm1_human,748,T,A,FITM,PubChem CID,16660135,Negative allosteric modulator - noncompetitive antagonist,K(b),Functional - Ca2+ accumulation,266.0,nM,=,,505.0,-1.898,,,Glutamate,0.0,0.0,,0.0,,Q13255,0.4769860016623864
55,10.1126/science.1249489,grm1_human,756,P,S,FITM,PubChem CID,16660135,Negative allosteric modulator - noncompetitive antagonist,K(b),Functional - Ca2+ accumulation,266.0,nM,=,,692.0,-2.604,,,Glutamate,0.0,0.0,,0.0,,Q13255,0.4868384672160723
56,10.1126/science.1249489,grm1_human,794,T,A,FITM,PubChem CID,16660135,Negative allosteric modulator - noncompetitive antagonist,K(b),Functional - Ca2+ accumulation,266.0,nM,=,,162.0,1.642,,,Glutamate,0.0,0.0,,0.0,,Q13255,0.5338188023330919
57,10.1126/science.1249489,grm1_human,815,T,A,FITM,PubChem CID,16660135,Negative allosteric modulator - noncompetitive antagonist,K(b),Functional - Ca2+ accumulation,266.0,nM,=,,753.0,-2.833,,,Glutamate,0.0,0.0,,0.0,,Q13255,0.5082746727326902
59,10.1126/science.1249489,grm1_human,818,A,S,FITM,PubChem CID,16660135,Negative allosteric modulator - noncompetitive antagonist,K(b),Functional - Ca2+ accumulation,266.0,nM,=,,174.0,1.529,,,Glutamate,0.0,0.0,,0.0,,Q13255,0.4461559620035721
60,10.1126/science.1249489,grm1_human,822,S,A,FITM,PubChem CID,16660135,Negative allosteric modulator - noncompetitive antagonist,K(b),Functional - Ca2+ accumulation,266.0,nM,=,,214.0,1.243,,,Glutamate,0.0,0.0,,0.0,,Q13255,0.449307684653751
21,15900517,ada1a_human,154,S,A,Phenylephrine,ChEMBL Compound ID,CHEMBL1215,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.69,,=,,4.6,-1.23,,,[125I]HEAT,0.0,0.0,,0.0,,P35348,0.4695962003476118
22,15900517,ada1a_human,154,S,A,Phenylephrine,ChEMBL Compound ID,CHEMBL1215,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.68,,=,,4.72,1.096,,,[125I]HEAT,0.0,0.0,,0.0,,P35348,0.4695962003476118
37,15900517,ada1a_human,154,S,A,Norepinephrine,ChEMBL Compound ID,CHEMBL1437,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.73,,=,,4.73,1.0,,,[125I]HEAT,0.0,0.0,,0.0,,P35348,0.4695962003476118
38,15900517,ada1a_human,154,S,A,Norepinephrine,ChEMBL Compound ID,CHEMBL1437,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.73,,=,,4.78,1.122,,,[125I]HEAT,0.0,0.0,,0.0,,P35348,0.4695962003476118
53,15900517,ada1a_human,154,S,A,Prazosin,ChEMBL Compound ID,CHEMBL2,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.39,,=,,9.34,-1.122,,,[125I]HEAT,0.0,0.0,,0.0,,P35348,0.4695962003476118
54,15900517,ada1a_human,154,S,A,Prazosin,ChEMBL Compound ID,CHEMBL2,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.51,,=,,9.36,-1.412,,,[125I]HEAT,0.0,0.0,,0.0,,P35348,0.4695962003476118
76,15900517,ada1a_human,154,S,A,5-Methylurapidil,ChEMBL Compound ID,CHEMBL420060,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.44,,=,,8.45,1.023,,,[125I]HEAT,0.0,0.0,,0.0,,P35348,0.4695962003476118
77,15900517,ada1a_human,154,S,A,5-Methylurapidil,ChEMBL Compound ID,CHEMBL420060,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.42,,=,,8.38,-1.096,,,[125I]HEAT,0.0,0.0,,0.0,,P35348,0.4695962003476118
91,15900517,ada1a_human,154,S,A,Phentolamine,ChEMBL Compound ID,CHEMBL597,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.7,,=,,7.77,1.175,,,[125I]HEAT,0.0,0.0,,0.0,,P35348,0.4695962003476118
92,15900517,ada1a_human,154,S,A,Phentolamine,ChEMBL Compound ID,CHEMBL597,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.68,,=,,7.64,-1.096,,,[125I]HEAT,0.0,0.0,,0.0,,P35348,0.4695962003476118
105,15900517,ada1a_human,154,S,A,Epinephrine,ChEMBL Compound ID,CHEMBL679,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.01,,=,,4.87,-1.381,,,[125I]HEAT,0.0,0.0,,0.0,,P35348,0.4695962003476118
106,15900517,ada1a_human,154,S,A,Epinephrine,ChEMBL Compound ID,CHEMBL679,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.02,,=,,4.97,-1.122,,,[125I]HEAT,0.0,0.0,,0.0,,P35348,0.4695962003476118
117,15900517,ada1a_human,154,S,A,Oxymetazoline,ChEMBL Compound ID,CHEMBL762,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.67,,=,,7.57,-1.259,,,[125I]HEAT,0.0,0.0,,0.0,,P35348,0.4695962003476118
118,15900517,ada1a_human,154,S,A,Oxymetazoline,ChEMBL Compound ID,CHEMBL762,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.65,,=,,7.78,1.349,,,[125I]HEAT,0.0,0.0,,0.0,,P35348,0.4695962003476118
137,15900517,ada1a_human,154,S,A,[125I]HEAT,PubChem CID,73754995,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,42.1,pM,=,,38.1,1.105,,,,86.4,0.0,,0.0,,P35348,0.4695962003476118
23,15900517,ada1a_human,166,R,K,Phenylephrine,ChEMBL Compound ID,CHEMBL1215,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.69,,=,,4.44,-1.779,,,[125I]HEAT,0.0,0.0,,0.0,,P35348,0.2335373995376241
24,15900517,ada1a_human,166,R,K,Phenylephrine,ChEMBL Compound ID,CHEMBL1215,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.68,,=,,4.37,-2.041,,,[125I]HEAT,0.0,0.0,,0.0,,P35348,0.2335373995376241
39,15900517,ada1a_human,166,R,K,Norepinephrine,ChEMBL Compound ID,CHEMBL1437,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.73,,=,,4.34,-2.457,,,[125I]HEAT,0.0,0.0,,0.0,,P35348,0.2335373995376241
40,15900517,ada1a_human,166,R,K,Norepinephrine,ChEMBL Compound ID,CHEMBL1437,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.73,,=,,4.31,-2.632,,,[125I]HEAT,0.0,0.0,,0.0,,P35348,0.2335373995376241
55,15900517,ada1a_human,166,R,K,Prazosin,ChEMBL Compound ID,CHEMBL2,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.39,,=,,9.19,-1.585,,,[125I]HEAT,0.0,0.0,,0.0,,P35348,0.2335373995376241
56,15900517,ada1a_human,166,R,K,Prazosin,ChEMBL Compound ID,CHEMBL2,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.51,,=,,9.32,-1.548,,,[125I]HEAT,0.0,0.0,,0.0,,P35348,0.2335373995376241
78,15900517,ada1a_human,166,R,K,5-Methylurapidil,ChEMBL Compound ID,CHEMBL420060,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.44,,=,,8.38,-1.148,,,[125I]HEAT,0.0,0.0,,0.0,,P35348,0.2335373995376241
79,15900517,ada1a_human,166,R,K,5-Methylurapidil,ChEMBL Compound ID,CHEMBL420060,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.42,,=,,8.41,-1.024,,,[125I]HEAT,0.0,0.0,,0.0,,P35348,0.2335373995376241
93,15900517,ada1a_human,166,R,K,Phentolamine,ChEMBL Compound ID,CHEMBL597,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.7,,=,,7.77,1.175,,,[125I]HEAT,0.0,0.0,,0.0,,P35348,0.2335373995376241
94,15900517,ada1a_human,166,R,K,Phentolamine,ChEMBL Compound ID,CHEMBL597,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.68,,=,,7.73,1.122,,,[125I]HEAT,0.0,0.0,,0.0,,P35348,0.2335373995376241
107,15900517,ada1a_human,166,R,K,Epinephrine,ChEMBL Compound ID,CHEMBL679,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.01,,=,,4.64,-2.342,,,[125I]HEAT,0.0,0.0,,0.0,,P35348,0.2335373995376241
108,15900517,ada1a_human,166,R,K,Epinephrine,ChEMBL Compound ID,CHEMBL679,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.02,,=,,4.62,-2.513,,,[125I]HEAT,0.0,0.0,,0.0,,P35348,0.2335373995376241
119,15900517,ada1a_human,166,R,K,Oxymetazoline,ChEMBL Compound ID,CHEMBL762,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.67,,=,,7.61,-1.148,,,[125I]HEAT,0.0,0.0,,0.0,,P35348,0.2335373995376241
120,15900517,ada1a_human,166,R,K,Oxymetazoline,ChEMBL Compound ID,CHEMBL762,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.65,,=,,7.63,-1.047,,,[125I]HEAT,0.0,0.0,,0.0,,P35348,0.2335373995376241
139,15900517,ada1a_human,166,R,K,[125I]HEAT,PubChem CID,73754995,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,42.1,pM,=,,35.9,1.173,,,,133.9,0.0,,0.0,,P35348,0.2335373995376241
25,15900517,ada1a_human,200,I,S,Phenylephrine,ChEMBL Compound ID,CHEMBL1215,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.69,,=,,4.82,1.349,,,[125I]HEAT,0.0,0.0,,0.0,,P35348,0.5755033008489397
26,15900517,ada1a_human,200,I,S,Phenylephrine,ChEMBL Compound ID,CHEMBL1215,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.68,,=,,4.75,1.175,,,[125I]HEAT,0.0,0.0,,0.0,,P35348,0.5755033008489397
41,15900517,ada1a_human,200,I,S,Norepinephrine,ChEMBL Compound ID,CHEMBL1437,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.73,,=,,4.9,1.479,,,[125I]HEAT,0.0,0.0,,0.0,,P35348,0.5755033008489397
42,15900517,ada1a_human,200,I,S,Norepinephrine,ChEMBL Compound ID,CHEMBL1437,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.73,,=,,4.82,1.23,,,[125I]HEAT,0.0,0.0,,0.0,,P35348,0.5755033008489397
58,15900517,ada1a_human,200,I,S,Prazosin,ChEMBL Compound ID,CHEMBL2,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.39,,=,,9.69,1.995,,,[125I]HEAT,0.0,0.0,,0.0,,P35348,0.5755033008489397
59,15900517,ada1a_human,200,I,S,Prazosin,ChEMBL Compound ID,CHEMBL2,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.51,,=,,9.54,1.072,,,[125I]HEAT,0.0,0.0,,0.0,,P35348,0.5755033008489397
80,15900517,ada1a_human,200,I,S,5-Methylurapidil,ChEMBL Compound ID,CHEMBL420060,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.44,,=,,8.4,-1.096,,,[125I]HEAT,0.0,0.0,,0.0,,P35348,0.5755033008489397
81,15900517,ada1a_human,200,I,S,5-Methylurapidil,ChEMBL Compound ID,CHEMBL420060,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.42,,=,,8.43,1.023,,,[125I]HEAT,0.0,0.0,,0.0,,P35348,0.5755033008489397
95,15900517,ada1a_human,200,I,S,Phentolamine,ChEMBL Compound ID,CHEMBL597,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.7,,=,,7.2,-3.165,,,[125I]HEAT,0.0,0.0,,0.0,,P35348,0.5755033008489397
96,15900517,ada1a_human,200,I,S,Phentolamine,ChEMBL Compound ID,CHEMBL597,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.68,,=,,7.31,-2.342,,,[125I]HEAT,0.0,0.0,,0.0,,P35348,0.5755033008489397
109,15900517,ada1a_human,200,I,S,Epinephrine,ChEMBL Compound ID,CHEMBL679,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.01,,=,,5.18,1.479,,,[125I]HEAT,0.0,0.0,,0.0,,P35348,0.5755033008489397
110,15900517,ada1a_human,200,I,S,Epinephrine,ChEMBL Compound ID,CHEMBL679,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.02,,=,,5.15,1.349,,,[125I]HEAT,0.0,0.0,,0.0,,P35348,0.5755033008489397
121,15900517,ada1a_human,200,I,S,Oxymetazoline,ChEMBL Compound ID,CHEMBL762,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.67,,=,,7.84,1.479,,,[125I]HEAT,0.0,0.0,,0.0,,P35348,0.5755033008489397
122,15900517,ada1a_human,200,I,S,Oxymetazoline,ChEMBL Compound ID,CHEMBL762,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.65,,=,,7.65,1.0,,,[125I]HEAT,0.0,0.0,,0.0,,P35348,0.5755033008489397
142,15900517,ada1a_human,200,I,S,[125I]HEAT,PubChem CID,73754995,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,42.1,pM,=,,34.5,1.22,,,,86.4,0.0,,0.0,,P35348,0.5755033008489397
29,11015306,ada1a_human,271,A,T,Phenylephrine,ChEMBL Compound ID,CHEMBL1215,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.2,,=,,5.9,5.012,,,[3H]Prazosin,0.0,0.0,,0.0,,P35348,0.5449477658862143
30,11015306,ada1a_human,271,A,T,Phenylephrine,ChEMBL Compound ID,CHEMBL1215,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.0,,=,,5.6,3.981,,,[3H]-KMD-3213,0.0,0.0,,0.0,,P35348,0.5449477658862143
35,11015306,ada1a_human,271,A,T,Noradrenaline,ChEMBL Compound ID,CHEMBL1437,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.7,,=,,6.2,3.162,,,[3H]Prazosin,0.0,0.0,,0.0,,P35348,0.5449477658862143
36,11015306,ada1a_human,271,A,T,Noradrenaline,ChEMBL Compound ID,CHEMBL1437,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.8,,=,,6.2,2.512,,,[3H]-KMD-3213,0.0,0.0,,0.0,,P35348,0.5449477658862143
52,11015306,ada1a_human,271,A,T,[3H]Prazosin,ChEMBL Compound ID,CHEMBL2,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,9.9,,=,,9.8,-1.259,,,,109.1,0.0,,0.0,,P35348,0.5449477658862143
63,11015306,ada1a_human,271,A,T,Prazosin,ChEMBL Compound ID,CHEMBL2,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.8,,=,,9.8,1.0,,,[3H]Prazosin,0.0,0.0,,0.0,,P35348,0.5449477658862143
64,11015306,ada1a_human,271,A,T,Prazosin,ChEMBL Compound ID,CHEMBL2,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.7,,=,,9.8,1.259,,,[3H]-KMD-3213,0.0,0.0,,0.0,,P35348,0.5449477658862143
69,11015306,ada1a_human,271,A,T,[3H]-KMD-3213,ChEMBL Compound ID,CHEMBL24778,Binding - unknown pharmacological activity,pK(d),Binding - Radioligand saturation,10.4,,=,,10.5,1.259,,,,83.3,0.0,,0.0,,P35348,0.5449477658862143
71,11015306,ada1a_human,271,A,T,KMD-3213,ChEMBL Compound ID,CHEMBL24778,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,10.2,,=,,10.3,1.259,,,[3H]Prazosin,0.0,0.0,,0.0,,P35348,0.5449477658862143
72,11015306,ada1a_human,271,A,T,KMD-3213,ChEMBL Compound ID,CHEMBL24778,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,10.4,,=,,10.2,-1.585,,,[3H]-KMD-3213,0.0,0.0,,0.0,,P35348,0.5449477658862143
89,11015306,ada1a_human,271,A,T,Methoxamine,ChEMBL Compound ID,CHEMBL524,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.3,,=,,5.7,2.512,,,[3H]Prazosin,0.0,0.0,,0.0,,P35348,0.5449477658862143
90,11015306,ada1a_human,271,A,T,Methoxamine,ChEMBL Compound ID,CHEMBL524,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.8,,=,,5.6,6.31,,,[3H]-KMD-3213,0.0,0.0,,0.0,,P35348,0.5449477658862143
125,11015306,ada1a_human,271,A,T,Oxymetazoline,ChEMBL Compound ID,CHEMBL762,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.0,,=,,7.7,5.012,,,[3H]Prazosin,0.0,0.0,,0.0,,P35348,0.5449477658862143
126,11015306,ada1a_human,271,A,T,Oxymetazoline,ChEMBL Compound ID,CHEMBL762,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.3,,=,,7.5,1.585,,,[3H]-KMD-3213,0.0,0.0,,0.0,,P35348,0.5449477658862143
31,15900517,ada1a_human,311,V,I,Phenylephrine,ChEMBL Compound ID,CHEMBL1215,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.69,,=,,4.27,-2.632,,,[125I]HEAT,0.0,0.0,,0.0,,P35348,0.3038689474152497
32,15900517,ada1a_human,311,V,I,Phenylephrine,ChEMBL Compound ID,CHEMBL1215,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.68,,=,,4.24,-2.755,,,[125I]HEAT,0.0,0.0,,0.0,,P35348,0.3038689474152497
45,15900517,ada1a_human,311,V,I,Norepinephrine,ChEMBL Compound ID,CHEMBL1437,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.73,,=,,4.34,-2.457,,,[125I]HEAT,0.0,0.0,,0.0,,P35348,0.3038689474152497
46,15900517,ada1a_human,311,V,I,Norepinephrine,ChEMBL Compound ID,CHEMBL1437,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,4.73,,=,,4.32,-2.571,,,[125I]HEAT,0.0,0.0,,0.0,,P35348,0.3038689474152497
65,15900517,ada1a_human,311,V,I,Prazosin,ChEMBL Compound ID,CHEMBL2,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.39,,=,,9.2,-1.548,,,[125I]HEAT,0.0,0.0,,0.0,,P35348,0.3038689474152497
66,15900517,ada1a_human,311,V,I,Prazosin,ChEMBL Compound ID,CHEMBL2,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.51,,=,,9.5,-1.024,,,[125I]HEAT,0.0,0.0,,0.0,,P35348,0.3038689474152497
85,15900517,ada1a_human,311,V,I,5-Methylurapidil,ChEMBL Compound ID,CHEMBL420060,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.44,,=,,8.87,2.692,,,[125I]HEAT,0.0,0.0,,0.0,,P35348,0.3038689474152497
86,15900517,ada1a_human,311,V,I,5-Methylurapidil,ChEMBL Compound ID,CHEMBL420060,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.42,,=,,8.94,3.311,,,[125I]HEAT,0.0,0.0,,0.0,,P35348,0.3038689474152497
100,15900517,ada1a_human,311,V,I,Phentolamine,ChEMBL Compound ID,CHEMBL597,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.7,,=,,7.6,-1.259,,,[125I]HEAT,0.0,0.0,,0.0,,P35348,0.3038689474152497
101,15900517,ada1a_human,311,V,I,Phentolamine,ChEMBL Compound ID,CHEMBL597,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.68,,=,,7.49,-1.548,,,[125I]HEAT,0.0,0.0,,0.0,,P35348,0.3038689474152497
113,15900517,ada1a_human,311,V,I,Epinephrine,ChEMBL Compound ID,CHEMBL679,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.01,,=,,4.57,-2.755,,,[125I]HEAT,0.0,0.0,,0.0,,P35348,0.3038689474152497
114,15900517,ada1a_human,311,V,I,Epinephrine,ChEMBL Compound ID,CHEMBL679,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.02,,=,,4.36,-4.566,,,[125I]HEAT,0.0,0.0,,0.0,,P35348,0.3038689474152497
127,15900517,ada1a_human,311,V,I,Oxymetazoline,ChEMBL Compound ID,CHEMBL762,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.67,,=,,7.82,1.413,,,[125I]HEAT,0.0,0.0,,0.0,,P35348,0.3038689474152497
128,15900517,ada1a_human,311,V,I,Oxymetazoline,ChEMBL Compound ID,CHEMBL762,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,7.65,,=,,7.78,1.349,,,[125I]HEAT,0.0,0.0,,0.0,,P35348,0.3038689474152497
147,15900517,ada1a_human,311,V,I,[125I]HEAT,PubChem CID,73754995,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,42.1,pM,=,,42.7,-1.014,,,,98.9,0.0,,0.0,,P35348,0.3038689474152497
49,18379048,ada1a_human,106,D,A,[3H]Prazosin,ChEMBL Compound ID,CHEMBL2,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,0.13,nM,>,,30.0,-250.0,,,,0.0,0.0,,0.0,,P35348,0.6110859094500566
134,9548959,ada1a_human,85,I,T,[125I]HEAT,PubChem CID,73754995,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,66.0,pM,=,,21.0,3.143,,,,0.0,0.0,,0.0,,P35348,0.3484355528332392
152,8916917,ada1a_human,85,I,T,compound1,SMILES,C1C=C(C(C(=C(N1)C)C(=O)OC)C2=CC=C(C=C2)[N+](=O)[O-])C(=O)NCCCN3CCC(CC3)(C4=CC=CC=C4)C5=CC=CC=C5,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.32,,=,,9.52,1.585,,,[125I]HEAT,0.0,0.0,,0.0,,P35348,0.3484355528332392
155,9548959,ada1a_human,85,I,T,compound 3,SMILES,CCCCOc1ccc(CCN2CCC(CC2)c2nc(OCC(F)(F)F)c(o2)-c2ccccc2)cc1,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.13,,=,,8.08,-1.122,,,[125I]HEAT,0.0,0.0,,0.0,,P35348,0.3484355528332392
160,9548959,ada1a_human,85,I,T,compound 2,SMILES,CCOc1ccc(CCN2CCC(CC2)c2nc(OCC(F)(F)F)c(o2)-c2ccccc2)cc1S(=O)(=O)NCCNCOC,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.83,,=,,8.77,-1.148,,,[125I]HEAT,0.0,0.0,,0.0,,P35348,0.3484355528332392
168,9548959,ada1a_human,85,I,T,compound 5,SMILES,COc1ccc(CCN2CCC(CC2)c2nc(OCC(F)(F)F)c(o2)-c2ccccc2)cc1,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.59,,=,,8.59,1.0,,,[125I]HEAT,0.0,0.0,,0.0,,P35348,0.3484355528332392
172,9548959,ada1a_human,85,I,T,compound 6,SMILES,COc1ccc(CCN2CCC(CC2)c2nc(OCC(F)(F)F)c(o2)-c2ccccc2)cc1S(N)(=O)=O,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.2,,=,,9.1,-1.259,,,[125I]HEAT,0.0,0.0,,0.0,,P35348,0.3484355528332392
183,9548959,ada1a_human,85,I,T,compound 4,SMILES,COCNCCNS(=O)(=O)c1cc(CCN2CCC(CC2)c2nc(OCC(F)(F)F)c(o2)-c2ccccc2)ccc1OC,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.95,,=,,8.69,-1.818,,,[125I]HEAT,0.0,0.0,,0.0,,P35348,0.3484355528332392
186,9548959,ada1a_human,85,I,T,compound 1,SMILES,Oc1ccc(CCN2CCC(CC2)c2nc(OCC(F)(F)F)c(o2)-c2ccccc2)cc1,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.43,,=,,9.56,1.349,,,[125I]HEAT,0.0,0.0,,0.0,,P35348,0.3484355528332392
135,9548959,ada1a_human,86,F,M,[125I]HEAT,PubChem CID,73754995,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,66.0,pM,=,,30.0,2.2,,,,0.0,0.0,,0.0,,P35348,0.354120513507717
150,8916917,ada1a_human,86,F,M,(+)-compound1,SMILES,C1C=C([C@@H](C(=C(N1)C)C(=O)OC)C2=CC=C(C=C2)[N+](=O)[O-])C(=O)NCCCN3CCC(CC3)(C4=CC=CC=C4)C5=CC=CC=C5,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.5,,=,,5.54,-9.091,,,[125I]HEAT,0.0,0.0,,0.0,,P35348,0.354120513507717
151,8916917,ada1a_human,86,F,M,(-)-compound1,SMILES,C1C=C([C@H](C(=C(N1)C)C(=O)OC)C2=CC=C(C=C2)[N+](=O)[O-])C(=O)NCCCN3CCC(CC3)(C4=CC=CC=C4)C5=CC=CC=C5,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.22,,=,,6.45,-500.0,,,[125I]HEAT,0.0,0.0,,0.0,,P35348,0.354120513507717
153,8916917,ada1a_human,86,F,M,compound1,SMILES,C1C=C(C(C(=C(N1)C)C(=O)OC)C2=CC=C(C=C2)[N+](=O)[O-])C(=O)NCCCN3CCC(CC3)(C4=CC=CC=C4)C5=CC=CC=C5,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.32,,=,,6.62,-500.0,,,[125I]HEAT,0.0,0.0,,0.0,,P35348,0.354120513507717
154,8916917,ada1a_human,86,F,M,compound2,SMILES,CC1=C(C(C(C(=O)NCCCN2CCC(CC2)C(C#N)c2ccccc2)=C(C)N1)c1ccc(cc1)N(=O)=O)C(N)=O,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.54,,=,,6.71,-66.667,,,[125I]HEAT,0.0,0.0,,0.0,,P35348,0.354120513507717
156,9548959,ada1a_human,86,F,M,compound 3,SMILES,CCCCOc1ccc(CCN2CCC(CC2)c2nc(OCC(F)(F)F)c(o2)-c2ccccc2)cc1,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.13,,=,,7.37,-5.747,,,[125I]HEAT,0.0,0.0,,0.0,,P35348,0.354120513507717
158,9548959,ada1a_human,86,F,M,compound 11,SMILES,CCCCOCc1nc(oc1-c1ccccc1)C1CCN(CCc2ccc(OC)c(c2)S(N)(=O)=O)CC1,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.15,,=,,8.0,-1.412,,,[125I]HEAT,0.0,0.0,,0.0,,P35348,0.354120513507717
161,9548959,ada1a_human,86,F,M,compound 2,SMILES,CCOc1ccc(CCN2CCC(CC2)c2nc(OCC(F)(F)F)c(o2)-c2ccccc2)cc1S(=O)(=O)NCCNCOC,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.83,,=,,7.4,-27.027,,,[125I]HEAT,0.0,0.0,,0.0,,P35348,0.354120513507717
163,9548959,ada1a_human,86,F,M,compound 8,SMILES,CCOCc1nc(oc1-c1ccccc1)C1CCN(CCc2ccc(OC)c(c2)S(N)(=O)=O)CC1,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.56,,=,,8.42,-1.381,,,[125I]HEAT,0.0,0.0,,0.0,,P35348,0.354120513507717
165,8916917,ada1a_human,86,F,M,compound3,SMILES,COC(=O)C(C1CCN(CCCNC(=O)C2=C(C)NC(C)=C(C2c2ccc(cc2)N(=O)=O)C(N)=O)CC1)c1ccccc1,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.92,,=,,6.35,-333.333,,,[125I]HEAT,0.0,0.0,,0.0,,P35348,0.354120513507717
166,9548959,ada1a_human,86,F,M,compound 10,SMILES,COc1ccc(CCN2CCC(CC2)c2nc(C)c(o2)-c2ccccc2)cc1S(N)(=O)=O,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.86,,=,,9.59,-1.862,,,[125I]HEAT,0.0,0.0,,0.0,,P35348,0.354120513507717
169,9548959,ada1a_human,86,F,M,compound 5,SMILES,COc1ccc(CCN2CCC(CC2)c2nc(OCC(F)(F)F)c(o2)-c2ccccc2)cc1,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.59,,=,,7.79,-6.329,,,[125I]HEAT,0.0,0.0,,0.0,,P35348,0.354120513507717
171,9548959,ada1a_human,86,F,M,compound 12,SMILES,COc1ccc(CCN2CCC(CC2)c2nc(OCC(F)(F)F)c(o2)-c2ccccc2)cc1S(=O)(=O)NCC(N)=O,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.55,,=,,8.0,-3.546,,,[125I]HEAT,0.0,0.0,,0.0,,P35348,0.354120513507717
173,9548959,ada1a_human,86,F,M,compound 6,SMILES,COc1ccc(CCN2CCC(CC2)c2nc(OCC(F)(F)F)c(o2)-c2ccccc2)cc1S(N)(=O)=O,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.2,,=,,8.99,-1.621,,,[125I]HEAT,0.0,0.0,,0.0,,P35348,0.354120513507717
175,9548959,ada1a_human,86,F,M,compound 9,SMILES,COc1ccc(CCN2CCC(CC2)c2ncc(o2)-c2ccccc2)cc1S(N)(=O)=O,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.47,,=,,9.13,-2.188,,,[125I]HEAT,0.0,0.0,,0.0,,P35348,0.354120513507717
181,9548959,ada1a_human,86,F,M,compound 7,SMILES,COCc1nc(oc1-c1ccccc1)C1CCN(CCc2ccc(OC)c(c2)S(N)(=O)=O)CC1,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.31,,=,,8.32,1.023,,,[125I]HEAT,0.0,0.0,,0.0,,P35348,0.354120513507717
184,9548959,ada1a_human,86,F,M,compound 4,SMILES,COCNCCNS(=O)(=O)c1cc(CCN2CCC(CC2)c2nc(OCC(F)(F)F)c(o2)-c2ccccc2)ccc1OC,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.95,,=,,8.22,-5.376,,,[125I]HEAT,0.0,0.0,,0.0,,P35348,0.354120513507717
187,9548959,ada1a_human,86,F,M,compound 1,SMILES,Oc1ccc(CCN2CCC(CC2)c2nc(OCC(F)(F)F)c(o2)-c2ccccc2)cc1,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.43,,=,,9.28,-1.412,,,[125I]HEAT,0.0,0.0,,0.0,,P35348,0.354120513507717
140,9548959,ada1a_human,185,V,A,[125I]HEAT,PubChem CID,73754995,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,66.0,pM,=,,13.0,5.077,,,,0.0,0.0,,0.0,,P35348,0.4823477924011361
157,9548959,ada1a_human,185,V,A,compound 3,SMILES,CCCCOc1ccc(CCN2CCC(CC2)c2nc(OCC(F)(F)F)c(o2)-c2ccccc2)cc1,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.13,,=,,7.28,-7.092,,,[125I]HEAT,0.0,0.0,,0.0,,P35348,0.4823477924011361
159,9548959,ada1a_human,185,V,A,compound 11,SMILES,CCCCOCc1nc(oc1-c1ccccc1)C1CCN(CCc2ccc(OC)c(c2)S(N)(=O)=O)CC1,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.15,,=,,7.99,-1.445,,,[125I]HEAT,0.0,0.0,,0.0,,P35348,0.4823477924011361
162,9548959,ada1a_human,185,V,A,compound 2,SMILES,CCOc1ccc(CCN2CCC(CC2)c2nc(OCC(F)(F)F)c(o2)-c2ccccc2)cc1S(=O)(=O)NCCNCOC,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.83,,=,,7.86,-9.346,,,[125I]HEAT,0.0,0.0,,0.0,,P35348,0.4823477924011361
164,9548959,ada1a_human,185,V,A,compound 8,SMILES,CCOCc1nc(oc1-c1ccccc1)C1CCN(CCc2ccc(OC)c(c2)S(N)(=O)=O)CC1,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.56,,=,,8.17,-2.457,,,[125I]HEAT,0.0,0.0,,0.0,,P35348,0.4823477924011361
167,9548959,ada1a_human,185,V,A,compound 10,SMILES,COc1ccc(CCN2CCC(CC2)c2nc(C)c(o2)-c2ccccc2)cc1S(N)(=O)=O,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.86,,=,,9.46,-2.513,,,[125I]HEAT,0.0,0.0,,0.0,,P35348,0.4823477924011361
170,9548959,ada1a_human,185,V,A,compound 5,SMILES,COc1ccc(CCN2CCC(CC2)c2nc(OCC(F)(F)F)c(o2)-c2ccccc2)cc1,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.59,,=,,7.91,-4.785,,,[125I]HEAT,0.0,0.0,,0.0,,P35348,0.4823477924011361
174,9548959,ada1a_human,185,V,A,compound 6,SMILES,COc1ccc(CCN2CCC(CC2)c2nc(OCC(F)(F)F)c(o2)-c2ccccc2)cc1S(N)(=O)=O,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.2,,=,,8.4,-6.329,,,[125I]HEAT,0.0,0.0,,0.0,,P35348,0.4823477924011361
176,9548959,ada1a_human,185,V,A,compound 9,SMILES,COc1ccc(CCN2CCC(CC2)c2ncc(o2)-c2ccccc2)cc1S(N)(=O)=O,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.47,,=,,9.44,-1.072,,,[125I]HEAT,0.0,0.0,,0.0,,P35348,0.4823477924011361
182,9548959,ada1a_human,185,V,A,compound 7,SMILES,COCc1nc(oc1-c1ccccc1)C1CCN(CCc2ccc(OC)c(c2)S(N)(=O)=O)CC1,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.31,,=,,8.62,2.042,,,[125I]HEAT,0.0,0.0,,0.0,,P35348,0.4823477924011361
185,9548959,ada1a_human,185,V,A,compound 4,SMILES,COCNCCNS(=O)(=O)c1cc(CCN2CCC(CC2)c2nc(OCC(F)(F)F)c(o2)-c2ccccc2)ccc1OC,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.95,,=,,8.22,-5.376,,,[125I]HEAT,0.0,0.0,,0.0,,P35348,0.4823477924011361
188,9548959,ada1a_human,185,V,A,compound 1,SMILES,Oc1ccc(CCN2CCC(CC2)c2nc(OCC(F)(F)F)c(o2)-c2ccccc2)cc1,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,9.43,,=,,8.45,-9.524,,,[125I]HEAT,0.0,0.0,,0.0,,P35348,0.4823477924011361
2,10.1016/j.cell.2018.01.001,5ht2c_human,142,I,F,Mesulergine,PubChem CID,68848,Inverse agonist,K(d),Binding - Radioligand competition/displacement,0.6,nM,=,,2.88,-4.808,,,[3H]-Mesulergine,75.0,0.0,,0.0,,P28335,0.5028924043952697
20,10.1016/j.cell.2018.01.001,5ht2c_human,142,I,F,Ergotamine,PubChem CID,8223,Full agonist,K(i),Binding - Radioligand competition/displacement,1.17,nM,=,,2.99,-2.558,,,[3H]-Mesulergine,0.0,0.0,,0.0,,P28335,0.5028924043952697
38,10.1016/j.cell.2018.01.001,5ht2c_human,142,I,F,Ritanserin,PubChem CID,5074,Inverse agonist,K(i),Binding - Radioligand competition/displacement,0.16,nM,=,,3.2,-20.0,,,[3H]-Mesulergine,0.0,0.0,,0.0,,P28335,0.5028924043952697
56,10.1016/j.cell.2018.01.001,5ht2c_human,142,I,F,5-HT,PubChem CID,5202,Full agonist,K(i),Binding - Radioligand competition/displacement,50.2,nM,=,,490.0,-9.804,,,[3H]-Mesulergine,0.0,0.0,,0.0,,P28335,0.5028924043952697
7,10.1016/j.cell.2018.01.001,5ht2c_human,351,N,L,Mesulergine,PubChem CID,68848,Inverse agonist,K(d),Binding - Radioligand competition/displacement,0.6,nM,=,,0.95,-1.582,,,[3H]-Mesulergine,84.0,0.0,,0.0,,P28335,0.5204921436017963
25,10.1016/j.cell.2018.01.001,5ht2c_human,351,N,L,Ergotamine,PubChem CID,8223,Full agonist,K(i),Binding - Radioligand competition/displacement,1.17,nM,=,,1.25,-1.068,,,[3H]-Mesulergine,0.0,0.0,,0.0,,P28335,0.5204921436017963
43,10.1016/j.cell.2018.01.001,5ht2c_human,351,N,L,Ritanserin,PubChem CID,5074,Inverse agonist,K(i),Binding - Radioligand competition/displacement,0.16,nM,=,,0.77,-4.808,,,[3H]-Mesulergine,0.0,0.0,,0.0,,P28335,0.5204921436017963
61,10.1016/j.cell.2018.01.001,5ht2c_human,351,N,L,5-HT,PubChem CID,5202,Full agonist,K(i),Binding - Radioligand competition/displacement,50.2,nM,=,,135.0,-2.688,,,[3H]-Mesulergine,0.0,0.0,,0.0,,P28335,0.5204921436017963
8,10.1016/j.cell.2018.01.001,5ht2c_human,351,N,F,Mesulergine,PubChem CID,68848,Inverse agonist,K(d),Binding - Radioligand competition/displacement,0.6,nM,=,,0.84,-1.401,,,[3H]-Mesulergine,49.0,0.0,,0.0,,P28335,0.5204921436017963
26,10.1016/j.cell.2018.01.001,5ht2c_human,351,N,F,Ergotamine,PubChem CID,8223,Full agonist,K(i),Binding - Radioligand competition/displacement,1.17,nM,=,,1.36,-1.163,,,[3H]-Mesulergine,0.0,0.0,,0.0,,P28335,0.5204921436017963
44,10.1016/j.cell.2018.01.001,5ht2c_human,351,N,F,Ritanserin,PubChem CID,5074,Inverse agonist,K(i),Binding - Radioligand competition/displacement,0.16,nM,=,,0.76,-4.739,,,[3H]-Mesulergine,0.0,0.0,,0.0,,P28335,0.5204921436017963
62,10.1016/j.cell.2018.01.001,5ht2c_human,351,N,F,5-HT,PubChem CID,5202,Full agonist,K(i),Binding - Radioligand competition/displacement,50.2,nM,=,,55.1,-1.098,,,[3H]-Mesulergine,0.0,0.0,,0.0,,P28335,0.5204921436017963
9,10.1016/j.cell.2018.01.001,5ht2c_human,358,Y,F,Mesulergine,PubChem CID,68848,Inverse agonist,K(d),Binding - Radioligand competition/displacement,0.6,nM,=,,0.41,1.463,,,[3H]-Mesulergine,37.0,0.0,,0.0,,P28335,0.3858452352161034
27,10.1016/j.cell.2018.01.001,5ht2c_human,358,Y,F,Ergotamine,PubChem CID,8223,Full agonist,K(i),Binding - Radioligand competition/displacement,1.17,nM,=,,0.65,1.8,,,[3H]-Mesulergine,0.0,0.0,,0.0,,P28335,0.3858452352161034
45,10.1016/j.cell.2018.01.001,5ht2c_human,358,Y,F,Ritanserin,PubChem CID,5074,Inverse agonist,K(i),Binding - Radioligand competition/displacement,0.16,nM,=,,0.12,1.333,,,[3H]-Mesulergine,0.0,0.0,,0.0,,P28335,0.3858452352161034
63,10.1016/j.cell.2018.01.001,5ht2c_human,358,Y,F,5-HT,PubChem CID,5202,Full agonist,K(i),Binding - Radioligand competition/displacement,50.2,nM,=,,201.0,-4.0,,,[3H]-Mesulergine,0.0,0.0,,0.0,,P28335,0.3858452352161034
108,10.1016/j.cell.2018.01.001,5ht2c_human,358,Y,F,Lorcaserin,PubChem CID,11658860,Full agonist,K(i),Binding - Radioligand competition/displacement,445.0,nM,=,,1166.0,-2.618,,,[3H]-Mesulergine,0.0,0.0,,0.0,,P28335,0.3858452352161034
10,10.1016/j.cell.2018.01.001,5ht2c_human,118,Y,A,Mesulergine,PubChem CID,68848,Inverse agonist,K(d),Binding - Radioligand competition/displacement,0.6,nM,=,,0.82,-1.366,,,[3H]-Mesulergine,45.0,0.0,,0.0,,P28335,0.320764175469677
28,10.1016/j.cell.2018.01.001,5ht2c_human,118,Y,A,Ergotamine,PubChem CID,8223,Full agonist,K(i),Binding - Radioligand competition/displacement,1.17,nM,=,,1.02,1.147,,,[3H]-Mesulergine,0.0,0.0,,0.0,,P28335,0.320764175469677
46,10.1016/j.cell.2018.01.001,5ht2c_human,118,Y,A,Ritanserin,PubChem CID,5074,Inverse agonist,K(i),Binding - Radioligand competition/displacement,0.16,nM,=,,0.29,-1.812,,,[3H]-Mesulergine,0.0,0.0,,0.0,,P28335,0.320764175469677
64,10.1016/j.cell.2018.01.001,5ht2c_human,118,Y,A,5-HT,PubChem CID,5202,Full agonist,K(i),Binding - Radioligand competition/displacement,50.2,nM,=,,116.0,-2.309,,,[3H]-Mesulergine,0.0,0.0,,0.0,,P28335,0.320764175469677
12,10.1016/j.cell.2018.01.001,5ht2c_human,135,V,L,Mesulergine,PubChem CID,68848,Inverse agonist,K(d),Binding - Radioligand competition/displacement,0.6,nM,=,,1.98,-3.3,,,[3H]-Mesulergine,108.0,0.0,,0.0,,P28335,0.503336656574923
30,10.1016/j.cell.2018.01.001,5ht2c_human,135,V,L,Ergotamine,PubChem CID,8223,Full agonist,K(i),Binding - Radioligand competition/displacement,1.17,nM,=,,7.87,-6.711,,,[3H]-Mesulergine,0.0,0.0,,0.0,,P28335,0.503336656574923
48,10.1016/j.cell.2018.01.001,5ht2c_human,135,V,L,Ritanserin,PubChem CID,5074,Inverse agonist,K(i),Binding - Radioligand competition/displacement,0.16,nM,=,,1.45,-9.091,,,[3H]-Mesulergine,0.0,0.0,,0.0,,P28335,0.503336656574923
66,10.1016/j.cell.2018.01.001,5ht2c_human,135,V,L,5-HT,PubChem CID,5202,Full agonist,K(i),Binding - Radioligand competition/displacement,50.2,nM,=,,690.0,-13.699,,,[3H]-Mesulergine,0.0,0.0,,0.0,,P28335,0.503336656574923
96,10.1016/j.cell.2018.01.001,5ht2c_human,135,V,L,Lorcaserin,PubChem CID,11658860,Full agonist,K(i),Binding - Radioligand competition/displacement,445.0,nM,=,,3981.0,-8.929,,,[3H]-Mesulergine,0.0,0.0,,0.0,,P28335,0.503336656574923
13,10.1016/j.cell.2018.01.001,5ht2c_human,135,V,F,Mesulergine,PubChem CID,68848,Inverse agonist,K(d),Binding - Radioligand competition/displacement,0.6,nM,=,,12.7,-21.277,,,[3H]-Mesulergine,79.0,0.0,,0.0,,P28335,0.5922249246481042
31,10.1016/j.cell.2018.01.001,5ht2c_human,135,V,F,Ergotamine,PubChem CID,8223,Full agonist,K(i),Binding - Radioligand competition/displacement,1.17,nM,=,,134.0,-111.111,,,[3H]-Mesulergine,0.0,0.0,,0.0,,P28335,0.5922249246481042
49,10.1016/j.cell.2018.01.001,5ht2c_human,135,V,F,Ritanserin,PubChem CID,5074,Inverse agonist,K(i),Binding - Radioligand competition/displacement,0.16,nM,=,,5.52,-34.483,,,[3H]-Mesulergine,0.0,0.0,,0.0,,P28335,0.5922249246481042
67,10.1016/j.cell.2018.01.001,5ht2c_human,135,V,F,5-HT,PubChem CID,5202,Full agonist,K(i),Binding - Radioligand competition/displacement,50.2,nM,=,,8350.0,-166.667,,,[3H]-Mesulergine,0.0,0.0,,0.0,,P28335,0.5922249246481042
14,10.1016/j.cell.2018.01.001,5ht2c_human,208,V,A,Mesulergine,PubChem CID,68848,Inverse agonist,K(d),Binding - Radioligand competition/displacement,0.6,nM,=,,1.07,-1.783,,,[3H]-Mesulergine,98.0,0.0,,0.0,,P28335,0.3046789396716111
32,10.1016/j.cell.2018.01.001,5ht2c_human,208,V,A,Ergotamine,PubChem CID,8223,Full agonist,K(i),Binding - Radioligand competition/displacement,1.17,nM,=,,2.12,-1.812,,,[3H]-Mesulergine,0.0,0.0,,0.0,,P28335,0.3046789396716111
50,10.1016/j.cell.2018.01.001,5ht2c_human,208,V,A,Ritanserin,PubChem CID,5074,Inverse agonist,K(i),Binding - Radioligand competition/displacement,0.16,nM,=,,0.91,-5.682,,,[3H]-Mesulergine,0.0,0.0,,0.0,,P28335,0.3046789396716111
68,10.1016/j.cell.2018.01.001,5ht2c_human,208,V,A,5-HT,PubChem CID,5202,Full agonist,K(i),Binding - Radioligand competition/displacement,50.2,nM,=,,158.0,-3.145,,,[3H]-Mesulergine,0.0,0.0,,0.0,,P28335,0.3046789396716111
15,10.1016/j.cell.2018.01.001,5ht2c_human,208,V,S,Mesulergine,PubChem CID,68848,Inverse agonist,K(d),Binding - Radioligand competition/displacement,0.6,nM,=,,0.72,-1.2,,,[3H]-Mesulergine,127.0,0.0,,0.0,,P28335,0.385792805397551
33,10.1016/j.cell.2018.01.001,5ht2c_human,208,V,S,Ergotamine,PubChem CID,8223,Full agonist,K(i),Binding - Radioligand competition/displacement,1.17,nM,=,,1.68,-1.437,,,[3H]-Mesulergine,0.0,0.0,,0.0,,P28335,0.385792805397551
51,10.1016/j.cell.2018.01.001,5ht2c_human,208,V,S,Ritanserin,PubChem CID,5074,Inverse agonist,K(i),Binding - Radioligand competition/displacement,0.16,nM,=,,0.62,-3.876,,,[3H]-Mesulergine,0.0,0.0,,0.0,,P28335,0.385792805397551
69,10.1016/j.cell.2018.01.001,5ht2c_human,208,V,S,5-HT,PubChem CID,5202,Full agonist,K(i),Binding - Radioligand competition/displacement,50.2,nM,=,,99.1,-1.972,,,[3H]-Mesulergine,0.0,0.0,,0.0,,P28335,0.385792805397551
17,10.1016/j.cell.2018.01.001,5ht2c_human,218,G,A,Mesulergine,PubChem CID,68848,Inverse agonist,K(d),Binding - Radioligand competition/displacement,0.6,nM,=,,0.56,1.071,,,[3H]-Mesulergine,98.0,0.0,,0.0,,P28335,0.4217664205168027
35,10.1016/j.cell.2018.01.001,5ht2c_human,218,G,A,Ergotamine,PubChem CID,8223,Full agonist,K(i),Binding - Radioligand competition/displacement,1.17,nM,=,,2.28,-1.949,,,[3H]-Mesulergine,0.0,0.0,,0.0,,P28335,0.4217664205168027
53,10.1016/j.cell.2018.01.001,5ht2c_human,218,G,A,Ritanserin,PubChem CID,5074,Inverse agonist,K(i),Binding - Radioligand competition/displacement,0.16,nM,=,,4.04,-25.0,,,[3H]-Mesulergine,0.0,0.0,,0.0,,P28335,0.4217664205168027
71,10.1016/j.cell.2018.01.001,5ht2c_human,218,G,A,5-HT,PubChem CID,5202,Full agonist,K(i),Binding - Radioligand competition/displacement,50.2,nM,=,,586.0,-11.628,,,[3H]-Mesulergine,0.0,0.0,,0.0,,P28335,0.4217664205168027
99,10.1016/j.cell.2018.01.001,5ht2c_human,218,G,A,Lorcaserin,PubChem CID,11658860,Full agonist,K(i),Binding - Radioligand competition/displacement,445.0,nM,=,,616.0,-1.385,,,[3H]-Mesulergine,0.0,0.0,,0.0,,P28335,0.4217664205168027
23,10.1016/j.cell.2018.01.001,5ht2c_human,324,W,L,Mesulergine,PubChem CID,68848,Inverse agonist,K(d),Binding - Radioligand competition/displacement,0.6,nM,=,,4.39,-7.299,,,[3H]-Mesulergine,45.0,0.0,,0.0,,P28335,0.8042687272713127
40,10.1016/j.cell.2018.01.001,5ht2c_human,324,W,L,Ergotamine,PubChem CID,8223,Full agonist,K(i),Binding - Radioligand competition/displacement,1.17,nM,=,,2.58,-2.208,,,[3H]-Mesulergine,0.0,0.0,,0.0,,P28335,0.8042687272713127
59,10.1016/j.cell.2018.01.001,5ht2c_human,324,W,L,5-HT,PubChem CID,5202,Full agonist,K(i),Binding - Radioligand competition/displacement,50.2,nM,=,,22.7,2.211,,,[3H]-Mesulergine,0.0,0.0,,0.0,,P28335,0.8042687272713127
73,10.1016/j.cell.2018.01.001,5ht2c_human,208,V,T,[3H]-Mesulergine,PubChem CID,4081,Inverse agonist,K(d),Binding - Radioligand saturation,0.64,nM,=,,0.7,-1.094,,,,0.0,0.0,,0.0,,P28335,0.3046789396716111
81,10.1016/j.cell.2018.01.001,5ht2c_human,208,V,T,Clozapine,PubChem CID,2818,Inverse agonist,K(i),Binding - Radioligand competition/displacement,9.8,nM,=,,12.0,-1.224,,,[3H]-Mesulergine,0.0,0.0,,0.0,,P28335,0.3046789396716111
89,10.1016/j.cell.2018.01.001,5ht2c_human,208,V,T,Ritanserin,PubChem CID,5074,Inverse agonist,K(i),Binding - Radioligand competition/displacement,0.4,nM,=,,0.91,-2.273,,,[3H]-Mesulergine,0.0,0.0,,0.0,,P28335,0.3046789396716111
98,10.1016/j.cell.2018.01.001,5ht2c_human,208,V,T,Lorcaserin,PubChem CID,11658860,Full agonist,K(i),Binding - Radioligand competition/displacement,445.0,nM,=,,450.0,-1.011,,,[3H]-Mesulergine,0.0,0.0,,0.0,,P28335,0.3046789396716111
74,10.1016/j.cell.2018.01.001,5ht2c_human,218,G,S,[3H]-Mesulergine,PubChem CID,4081,Inverse agonist,K(d),Binding - Radioligand saturation,0.64,nM,=,,3.21,-5.025,,,,0.0,0.0,,0.0,,P28335,0.4217664205168027
82,10.1016/j.cell.2018.01.001,5ht2c_human,218,G,S,Clozapine,PubChem CID,2818,Inverse agonist,K(i),Binding - Radioligand competition/displacement,9.8,nM,=,,24.0,-2.451,,,[3H]-Mesulergine,0.0,0.0,,0.0,,P28335,0.4217664205168027
90,10.1016/j.cell.2018.01.001,5ht2c_human,218,G,S,Ritanserin,PubChem CID,5074,Inverse agonist,K(i),Binding - Radioligand competition/displacement,0.4,nM,=,,24.0,-58.824,,,[3H]-Mesulergine,0.0,0.0,,0.0,,P28335,0.4217664205168027
100,10.1016/j.cell.2018.01.001,5ht2c_human,218,G,S,Lorcaserin,PubChem CID,11658860,Full agonist,K(i),Binding - Radioligand competition/displacement,445.0,nM,=,,6310.0,-14.085,,,[3H]-Mesulergine,0.0,0.0,,0.0,,P28335,0.4217664205168027
75,10.1016/j.cell.2018.01.001,5ht2c_human,219,S,T,[3H]-Mesulergine,PubChem CID,4081,Inverse agonist,K(d),Binding - Radioligand saturation,0.64,nM,=,,0.35,1.829,,,,0.0,0.0,,0.0,,P28335,0.4561771908658631
83,10.1016/j.cell.2018.01.001,5ht2c_human,219,S,T,Clozapine,PubChem CID,2818,Inverse agonist,K(i),Binding - Radioligand competition/displacement,9.8,nM,=,,13.0,-1.326,,,[3H]-Mesulergine,0.0,0.0,,0.0,,P28335,0.4561771908658631
91,10.1016/j.cell.2018.01.001,5ht2c_human,219,S,T,Ritanserin,PubChem CID,5074,Inverse agonist,K(i),Binding - Radioligand competition/displacement,0.4,nM,=,,1.3,-3.247,,,[3H]-Mesulergine,0.0,0.0,,0.0,,P28335,0.4561771908658631
101,10.1016/j.cell.2018.01.001,5ht2c_human,219,S,T,Lorcaserin,PubChem CID,11658860,Full agonist,K(i),Binding - Radioligand competition/displacement,445.0,nM,=,,156.0,2.853,,,[3H]-Mesulergine,0.0,0.0,,0.0,,P28335,0.4561771908658631
77,10.1016/j.cell.2018.01.001,5ht2c_human,350,L,G,[3H]-Mesulergine,PubChem CID,4081,Inverse agonist,K(d),Binding - Radioligand saturation,0.64,nM,=,,1.26,-1.969,,,,0.0,0.0,,0.0,,P28335,0.582122298926196
85,10.1016/j.cell.2018.01.001,5ht2c_human,350,L,G,Clozapine,PubChem CID,2818,Inverse agonist,K(i),Binding - Radioligand competition/displacement,9.8,nM,=,,6.2,1.581,,,[3H]-Mesulergine,0.0,0.0,,0.0,,P28335,0.582122298926196
93,10.1016/j.cell.2018.01.001,5ht2c_human,350,L,G,Ritanserin,PubChem CID,5074,Inverse agonist,K(i),Binding - Radioligand competition/displacement,0.4,nM,=,,1.5,-3.745,,,[3H]-Mesulergine,0.0,0.0,,0.0,,P28335,0.582122298926196
105,10.1016/j.cell.2018.01.001,5ht2c_human,350,L,G,Lorcaserin,PubChem CID,11658860,Full agonist,K(i),Binding - Radioligand competition/displacement,445.0,nM,=,,1186.0,-2.667,,,[3H]-Mesulergine,0.0,0.0,,0.0,,P28335,0.582122298926196
79,10.1016/j.cell.2018.01.001,5ht2c_human,354,V,N,[3H]-Mesulergine,PubChem CID,4081,Inverse agonist,K(d),Binding - Radioligand saturation,0.64,nM,=,,2.37,-3.704,,,,0.0,0.0,,0.0,,P28335,0.6098301141877465
87,10.1016/j.cell.2018.01.001,5ht2c_human,354,V,N,Clozapine,PubChem CID,2818,Inverse agonist,K(i),Binding - Radioligand competition/displacement,9.8,nM,=,,27.0,-2.755,,,[3H]-Mesulergine,0.0,0.0,,0.0,,P28335,0.6098301141877465
95,10.1016/j.cell.2018.01.001,5ht2c_human,354,V,N,Ritanserin,PubChem CID,5074,Inverse agonist,K(i),Binding - Radioligand competition/displacement,0.4,nM,=,,170.0,-500.0,,,[3H]-Mesulergine,0.0,0.0,,0.0,,P28335,0.6098301141877465
107,10.1016/j.cell.2018.01.001,5ht2c_human,354,V,N,Lorcaserin,PubChem CID,11658860,Full agonist,K(i),Binding - Radioligand competition/displacement,445.0,nM,=,,23.0,19.348,,,[3H]-Mesulergine,0.0,0.0,,0.0,,P28335,0.6098301141877465
117,8700116,5ht2c_human,222,A,S,Ergonovine,ChEMBL Compound ID,CHEMBL119443,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,19.0,nM,=,,3.1,6.129,,,[3H]mesulergine,0.0,0.0,,0.0,,P28335,0.4345323240327631
127,8700116,5ht2c_human,222,A,S,Mesulergine,ChEMBL Compound ID,CHEMBL12314,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,0.74,nM,=,,21.0,-28.571,,,,0.0,0.0,,0.0,,P28335,0.4345323240327631
134,8700116,5ht2c_human,222,A,S,Lisuride,ChEMBL Compound ID,CHEMBL157138,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,6.1,nM,=,,1.4,4.357,,,[3H]mesulergine,0.0,0.0,,0.0,,P28335,0.4345323240327631
139,8700116,5ht2c_human,222,A,S,4-HT,ChEMBL Compound ID,CHEMBL18845,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,695.0,nM,=,,330.0,2.106,,,[3H]mesulergine,0.0,0.0,,0.0,,P28335,0.4345323240327631
144,8700116,5ht2c_human,222,A,S,5-HT,ChEMBL Compound ID,CHEMBL39,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,126.0,nM,=,,76.0,1.658,,,[3H]mesulergine,0.0,0.0,,0.0,,P28335,0.4345323240327631
149,8700116,5ht2c_human,222,A,S,Bufotenine,ChEMBL Compound ID,CHEMBL416526,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,234.0,nM,=,,176.0,1.33,,,[3H]mesulergine,0.0,0.0,,0.0,,P28335,0.4345323240327631
150,8700116,5ht2c_human,222,A,S,LSD,ChEMBL Compound ID,CHEMBL463207,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,6.4,nM,=,,1.3,4.923,,,[3H]mesulergine,0.0,0.0,,0.0,,P28335,0.4345323240327631
152,8700116,5ht2c_human,222,A,S,Ketanserin,ChEMBL Compound ID,CHEMBL54,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,28.0,nM,=,,94.0,-3.356,,,[3H]mesulergine,0.0,0.0,,0.0,,P28335,0.4345323240327631
156,8700116,5ht2c_human,222,A,S,Psilocin,ChEMBL Compound ID,CHEMBL65547,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,140.0,nM,=,,73.0,1.918,,,[3H]mesulergine,0.0,0.0,,0.0,,P28335,0.4345323240327631
157,8700116,5ht2c_human,222,A,S,DOI,ChEMBL Compound ID,CHEMBL6616,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,41.0,nM,=,,120.0,-2.924,,,[3H]mesulergine,0.0,0.0,,0.0,,P28335,0.4345323240327631
162,8700116,5ht2c_human,222,A,S,Tryptamine,ChEMBL Compound ID,CHEMBL6640,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,284.0,nM,=,,174.0,1.632,,,[3H]mesulergine,0.0,0.0,,0.0,,P28335,0.4345323240327631
118,22020288,5ht2c_human,138,S,A,[3H]mesulergine,ChEMBL Compound ID,CHEMBL12314,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,1.8,nM,=,,2.0,-1.111,,,,0.0,0.0,,0.0,,P28335,0.4671074701085904
131,22020288,5ht2c_human,138,S,A,trans-PAT,ChEMBL Compound ID,CHEMBL127307,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,78.4,nM,=,,210.0,-2.681,,,[3H]Mesulergine,0.0,0.0,,0.0,,P28335,0.4671074701085904
133,22020288,5ht2c_human,138,S,A,Lisuride,ChEMBL Compound ID,CHEMBL157138,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,11.4,nM,=,,11.3,1.009,,,[3H]Mesulergine,0.0,0.0,,0.0,,P28335,0.4671074701085904
143,22020288,5ht2c_human,138,S,A,5-HT,ChEMBL Compound ID,CHEMBL39,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,9.0,nM,=,,118.2,-13.158,,,[3H]Mesulergine,0.0,0.0,,0.0,,P28335,0.4671074701085904
161,22020288,5ht2c_human,138,S,A,Tryptamine,ChEMBL Compound ID,CHEMBL6640,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,57.1,nM,=,,1513.0,-26.316,,,[3H]Mesulergine,0.0,0.0,,0.0,,P28335,0.4671074701085904
164,10.1080/00268976.2014.952695,5ht2c_human,138,S,A,3'-Br-PAT,SMILES,[H][C@]1(Cc2ccccc2[C@]([H])(C1)c1cccc(Br)c1)N(C)C,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,26.0,nM,=,,103.0,-3.968,,,[3H]Mesulergine,0.0,0.0,,0.0,,P28335,0.4671074701085904
170,10.1080/00268976.2014.952695,5ht2c_human,138,S,A,3'-CF3-PAT,SMILES,[H][C@]1(Cc2ccccc2[C@]([H])(C1)c1cccc(c1)C(F)(F)F)N(C)C,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,52.0,nM,=,,208.0,-4.0,,,[3H]Mesulergine,0.0,0.0,,0.0,,P28335,0.4671074701085904
120,10.1080/00268976.2014.952695,5ht2c_human,139,T,A,[3H]Mesulergine,ChEMBL Compound ID,CHEMBL12314,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,2.0,fmol/mg,=,,3.8,-1.901,,,,0.0,0.0,,0.0,,P28335,0.492634486479073
165,10.1080/00268976.2014.952695,5ht2c_human,139,T,A,3'-Br-PAT,SMILES,[H][C@]1(Cc2ccccc2[C@]([H])(C1)c1cccc(Br)c1)N(C)C,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,26.0,nM,=,,210.0,-8.065,,,[3H]Mesulergine,0.0,0.0,,0.0,,P28335,0.492634486479073
171,10.1080/00268976.2014.952695,5ht2c_human,139,T,A,3'-CF3-PAT,SMILES,[H][C@]1(Cc2ccccc2[C@]([H])(C1)c1cccc(c1)C(F)(F)F)N(C)C,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,52.0,nM,=,,260.0,-5.0,,,[3H]Mesulergine,0.0,0.0,,0.0,,P28335,0.492634486479073
121,10.1080/00268976.2014.952695,5ht2c_human,223,F,A,[3H]Mesulergine,ChEMBL Compound ID,CHEMBL12314,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,2.0,fmol/mg,=,,4.6,-2.299,,,,0.0,0.0,,0.0,,P28335,0.6091211153153626
166,10.1080/00268976.2014.952695,5ht2c_human,223,F,A,3'-Br-PAT,SMILES,[H][C@]1(Cc2ccccc2[C@]([H])(C1)c1cccc(Br)c1)N(C)C,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,26.0,nM,=,,275.0,-10.526,,,[3H]Mesulergine,0.0,0.0,,0.0,,P28335,0.6091211153153626
172,10.1080/00268976.2014.952695,5ht2c_human,223,F,A,3'-CF3-PAT,SMILES,[H][C@]1(Cc2ccccc2[C@]([H])(C1)c1cccc(c1)C(F)(F)F)N(C)C,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,52.0,nM,=,,371.0,-7.143,,,[3H]Mesulergine,0.0,0.0,,0.0,,P28335,0.6091211153153626
123,22020288,5ht2c_human,358,Y,A,[3H]mesulergine,ChEMBL Compound ID,CHEMBL12314,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,1.8,nM,=,,3.0,-1.667,,,,0.0,0.0,,0.0,,P28335,0.6070874368294117
132,22020288,5ht2c_human,358,Y,A,trans-PAT,ChEMBL Compound ID,CHEMBL127307,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,78.4,nM,=,,354.0,-4.525,,,[3H]Mesulergine,0.0,0.0,,0.0,,P28335,0.6070874368294117
135,22020288,5ht2c_human,358,Y,A,Lisuride,ChEMBL Compound ID,CHEMBL157138,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,11.4,nM,=,,7.9,1.443,,,[3H]Mesulergine,0.0,0.0,,0.0,,P28335,0.6070874368294117
145,22020288,5ht2c_human,358,Y,A,5-HT,ChEMBL Compound ID,CHEMBL39,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,9.0,nM,=,,152.0,-16.949,,,[3H]Mesulergine,0.0,0.0,,0.0,,P28335,0.6070874368294117
163,22020288,5ht2c_human,358,Y,A,Tryptamine,ChEMBL Compound ID,CHEMBL6640,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,57.1,nM,=,,298.5,-5.236,,,[3H]Mesulergine,0.0,0.0,,0.0,,P28335,0.6070874368294117
125,16880620,5ht2c_human,361,S,A,[3H]Mesulergine,ChEMBL Compound ID,CHEMBL12314,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,573.0,pM,=,,3557.0,-6.211,,,,0.0,0.0,,0.0,,P28335,0.6191014213594335
151,16880620,5ht2c_human,361,S,A,Sarpogrelate,ChEMBL Compound ID,CHEMBL52939,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.42,,=,,4.87,-35.714,,,[3H]Mesulergine,0.0,0.0,,0.0,,P28335,0.6191014213594335
169,10.1080/00268976.2014.952695,5ht2c_human,361,S,A,3'-Br-PAT,SMILES,[H][C@]1(Cc2ccccc2[C@]([H])(C1)c1cccc(Br)c1)N(C)C,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,26.0,nM,=,,14.0,1.857,,,[3H]Mesulergine,0.0,0.0,,0.0,,P28335,0.6191014213594335
175,10.1080/00268976.2014.952695,5ht2c_human,361,S,A,3'-CF3-PAT,SMILES,[H][C@]1(Cc2ccccc2[C@]([H])(C1)c1cccc(c1)C(F)(F)F)N(C)C,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,52.0,nM,=,,38.0,1.368,,,[3H]Mesulergine,0.0,0.0,,0.0,,P28335,0.6191014213594335
128,11113535,5ht2c_human,368,Y,A,Mesulergine,ChEMBL Compound ID,CHEMBL12314,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,0.78,nM,=,,1.0,-1.282,,,,0.0,0.0,,0.0,,P28335,0.807194949482596
136,11113535,5ht2c_human,368,Y,A,Quipazine,ChEMBL Compound ID,CHEMBL18772,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,489.0,nM,=,,228.0,2.145,,,[3H]Mesulergine,0.0,0.0,,0.0,,P28335,0.807194949482596
140,11113535,5ht2c_human,368,Y,A,SB206553,ChEMBL Compound ID,CHEMBL297784,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,10.0,nM,=,,15.0,-1.499,,,[3H]Mesulergine,0.0,0.0,,0.0,,P28335,0.807194949482596
146,11113535,5ht2c_human,368,Y,A,5-HT,ChEMBL Compound ID,CHEMBL39,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,110.0,nM,=,,29.0,3.793,,,[3H]Mesulergine,0.0,0.0,,0.0,,P28335,0.807194949482596
153,11113535,5ht2c_human,368,Y,A,Mianserin,ChEMBL Compound ID,CHEMBL6437,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,1.29,nM,=,,1.46,-1.131,,,[3H]Mesulergine,0.0,0.0,,0.0,,P28335,0.807194949482596
158,11113535,5ht2c_human,368,Y,A,DOI,ChEMBL Compound ID,CHEMBL6616,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,51.0,nM,=,,15.0,3.4,,,[3H]Mesulergine,0.0,0.0,,0.0,,P28335,0.807194949482596
129,11113535,5ht2c_human,368,Y,C,Mesulergine,ChEMBL Compound ID,CHEMBL12314,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,0.78,nM,=,,1.36,-1.742,,,,0.0,0.0,,0.0,,P28335,0.807194949482596
137,11113535,5ht2c_human,368,Y,C,Quipazine,ChEMBL Compound ID,CHEMBL18772,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,489.0,nM,=,,222.0,2.203,,,[3H]Mesulergine,0.0,0.0,,0.0,,P28335,0.807194949482596
141,11113535,5ht2c_human,368,Y,C,SB206553,ChEMBL Compound ID,CHEMBL297784,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,10.0,nM,=,,14.0,-1.401,,,[3H]Mesulergine,0.0,0.0,,0.0,,P28335,0.807194949482596
147,11113535,5ht2c_human,368,Y,C,5-HT,ChEMBL Compound ID,CHEMBL39,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,110.0,nM,=,,25.0,4.4,,,[3H]Mesulergine,0.0,0.0,,0.0,,P28335,0.807194949482596
154,11113535,5ht2c_human,368,Y,C,Mianserin,ChEMBL Compound ID,CHEMBL6437,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,1.29,nM,=,,1.33,-1.031,,,[3H]Mesulergine,0.0,0.0,,0.0,,P28335,0.807194949482596
159,11113535,5ht2c_human,368,Y,C,DOI,ChEMBL Compound ID,CHEMBL6616,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,51.0,nM,=,,15.0,3.4,,,[3H]Mesulergine,0.0,0.0,,0.0,,P28335,0.807194949482596
130,11113535,5ht2c_human,368,Y,F,Mesulergine,ChEMBL Compound ID,CHEMBL12314,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,0.78,nM,=,,2.64,-3.39,,,,0.0,0.0,,0.0,,P28335,0.6298875346750634
138,11113535,5ht2c_human,368,Y,F,Quipazine,ChEMBL Compound ID,CHEMBL18772,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,489.0,nM,=,,188.0,2.601,,,[3H]Mesulergine,0.0,0.0,,0.0,,P28335,0.6298875346750634
142,11113535,5ht2c_human,368,Y,F,SB206553,ChEMBL Compound ID,CHEMBL297784,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,10.0,nM,=,,14.0,-1.401,,,[3H]Mesulergine,0.0,0.0,,0.0,,P28335,0.6298875346750634
148,11113535,5ht2c_human,368,Y,F,5-HT,ChEMBL Compound ID,CHEMBL39,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,110.0,nM,=,,25.0,4.4,,,[3H]Mesulergine,0.0,0.0,,0.0,,P28335,0.6298875346750634
155,11113535,5ht2c_human,368,Y,F,Mianserin,ChEMBL Compound ID,CHEMBL6437,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,1.29,nM,=,,2.1,-1.629,,,[3H]Mesulergine,0.0,0.0,,0.0,,P28335,0.6298875346750634
160,11113535,5ht2c_human,368,Y,F,DOI,ChEMBL Compound ID,CHEMBL6616,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,51.0,nM,=,,13.0,3.923,,,[3H]Mesulergine,0.0,0.0,,0.0,,P28335,0.6298875346750634
168,10.1080/00268976.2014.952695,5ht2c_human,360,C,A,3'-Br-PAT,SMILES,[H][C@]1(Cc2ccccc2[C@]([H])(C1)c1cccc(Br)c1)N(C)C,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,26.0,nM,=,,22.0,1.182,,,[3H]Mesulergine,0.0,0.0,,0.0,,P28335,0.5335321811981892
174,10.1080/00268976.2014.952695,5ht2c_human,360,C,A,3'-CF3-PAT,SMILES,[H][C@]1(Cc2ccccc2[C@]([H])(C1)c1cccc(c1)C(F)(F)F)N(C)C,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,52.0,nM,=,,38.0,1.368,,,[3H]Mesulergine,0.0,0.0,,0.0,,P28335,0.5335321811981892
1,11498510,vipr2_human,172,R,Q,VIP,PubChem CID,16129679,Full agonist,EC50,Functional - cAMP accumulation,7.0,nM,=,,190.0,-27.027,,,VIP,0.0,0.0,,0.0,,P41587,0.5529632322592619
2,11498510,vipr2_human,172,R,Q,C6-VIP,,,Full agonist,EC50,Functional - cAMP accumulation,0.9,nM,=,,17.0,-18.868,,,VIP,0.0,0.0,,0.0,,P41587,0.5529632322592619
4,11498510,vipr2_human,172,R,Q,C6-VIP,,,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,1.0,nM,=,,13.0,-12.987,,,[125I]-VIP (radioligand),0.0,0.0,,0.0,,P41587,0.5529632322592619
5,11498510,vipr2_human,172,R,Q,Ro 25-1553 ,PubChem CID,16131327,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,5.0,nM,=,,150.0,-30.303,,,[125I]-VIP (radioligand),0.0,0.0,,0.0,,P41587,0.5529632322592619
6,11498510,vipr2_human,172,R,Q,Ro 25-1553 ,PubChem CID,16131327,Full agonist,EC50,Functional - cAMP accumulation,10.0,nM,>,,10000.0,-1000.0,,,VIP,0.0,0.0,,0.0,,P41587,0.5529632322592619
8,11498510,vipr2_human,172,R,Q,VIP,PubChem CID,16129679,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,3.0,nM,=,,150.0,-50.0,,,[125I]-VIP (radioligand),0.0,0.0,,0.0,,P41587,0.5529632322592619
10,11498510,vipr2_human,172,R,Q,VIP-[Asp3Asn] ,FASTA sequence (peptide),HSNAVFTDNYTRLRKQMAVKKYLNSILN,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,300.0,nM,=,,3.0,100.0,,,[125I]-VIP (radioligand),0.0,0.0,,0.0,,P41587,0.5529632322592619
11,11498510,vipr2_human,172,R,Q,VIP-[Asp3Asn] ,FASTA sequence (peptide),HSNAVFTDNYTRLRKQMAVKKYLNSILN,Partial agonist,EC50,Functional - cAMP accumulation,2000.0,nM,=,,2.0,1000.0,,,VIP,0.0,0.0,,0.0,,P41587,0.5529632322592619
13,11498510,vipr2_human,172,R,Q,VIP-[Asp3Gln] ,FASTA sequence (peptide),HSQAVFTDNYTRLRKQMAVKKYLNSILN,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,200.0,nM,=,,3.0,66.667,,,[125I]-VIP (radioligand),0.0,0.0,,0.0,,P41587,0.5529632322592619
14,11498510,vipr2_human,172,R,Q,VIP-[Asp3Gln] ,FASTA sequence (peptide),HSQAVFTDNYTRLRKQMAVKKYLNSILN,Partial agonist,EC50,Functional - cAMP accumulation,200.0,nM,=,,2.0,100.0,,,VIP,0.0,0.0,,0.0,,P41587,0.5529632322592619
16,11498510,vipr2_human,172,R,Q,VIP-[Asp3Glu] ,FASTA sequence (peptide),HSEAVFTDNYTRLRKQMAVKKYLNSILN,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,50.0,nM,=,,900.0,-17.857,,,[125I]-VIP (radioligand),0.0,0.0,,0.0,,P41587,0.5529632322592619
17,11498510,vipr2_human,172,R,Q,VIP-[Asp3Glu] ,FASTA sequence (peptide),HSEAVFTDNYTRLRKQMAVKKYLNSILN,Full agonist,EC50,Functional - cAMP accumulation,70.0,nM,=,,700.0,-10.0,,,VIP,0.0,0.0,,0.0,,P41587,0.5529632322592619
20,11498510,vipr2_human,179,K,Q,C6-VIP,,,Full agonist,EC50,Functional - cAMP accumulation,0.9,nM,=,,900.0,-1000.0,,,VIP,0.0,0.0,,0.0,,P41587,0.4019030302618785
22,11498510,vipr2_human,179,K,Q,Ro 25-1553 ,PubChem CID,16131327,Full agonist,EC50,Functional - cAMP accumulation,10.0,nM,=,,5000.0,-500.0,Abolished effect,,VIP,0.0,0.0,,0.0,,P41587,0.4019030302618785
24,11498510,vipr2_human,179,K,Q,VIP,PubChem CID,16129679,Full agonist,EC50,Functional - cAMP accumulation,7.0,nM,=,,4000.0,-500.0,Abolished effect,,VIP,0.0,0.0,,0.0,,P41587,0.4019030302618785
26,11498510,vipr2_human,179,K,Q,VIP-[Asp3Asn] ,FASTA sequence (peptide),HSNAVFTDNYTRLRKQMAVKKYLNSILN,Partial agonist,EC50,Functional - cAMP accumulation,2000.0,nM,=,,2000.0,1.0,Abolished effect,,VIP,0.0,0.0,,0.0,,P41587,0.4019030302618785
28,11498510,vipr2_human,179,K,Q,VIP-[Asp3Gln] ,FASTA sequence (peptide),HSQAVFTDNYTRLRKQMAVKKYLNSILN,Partial agonist,EC50,Functional - cAMP accumulation,200.0,nM,=,,5000.0,-25.0,Abolished effect,,VIP,0.0,0.0,,0.0,,P41587,0.4019030302618785
30,11498510,vipr2_human,179,K,Q,VIP-[Asp3Glu] ,FASTA sequence (peptide),HSEAVFTDNYTRLRKQMAVKKYLNSILN,Full agonist,EC50,Functional - cAMP accumulation,70.0,nM,=,,2500.0,-35.714,Abolished effect,,VIP,0.0,0.0,,0.0,,P41587,0.4019030302618785
31,12475394,vipr2_human,184,Y,F,VIP,PubChem CID,16129679,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,8.08,M,=,,7.37,-5.128,,,[125I]-VIP,100.0,0.0,,0.0,,P41587,0.1665116723583194
32,12475394,vipr2_human,184,Y,F,VIP,PubChem CID,16129679,Full agonist,pEC50,Functional - cAMP accumulation,8.34,M,=,,8.4,1.148,Abolished effect,,VIP,0.0,0.0,,100.0,VIP,P41587,0.1665116723583194
33,12475394,vipr2_human,184,Y,F,VIP-[Thr11Arg] ,FASTA sequence (peptide),HSDAVFTDNYRRLRKQMAVKKYLNSILN,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.84,M,=,,6.75,8.128,,,[125I]-VIP,100.0,0.0,,0.0,,P41587,0.1665116723583194
34,12475394,vipr2_human,184,Y,F,VIP-[Thr11Arg] ,FASTA sequence (peptide),HSDAVFTDNYRRLRKQMAVKKYLNSILN,Full agonist,pEC50,Functional - cAMP accumulation,5.9,M,=,,6.67,5.888,Abolished effect,,VIP,0.0,0.0,,225.0,VIP,P41587,0.1665116723583194
35,12475394,vipr2_human,184,Y,F,VIP-[Thr11Citrullinel] ,,,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,5.75,M,=,,6.92,14.791,,,[125I]-VIP,100.0,0.0,,0.0,,P41587,0.1665116723583194
36,12475394,vipr2_human,184,Y,F,VIP-[Thr11Citrullinel] ,,,Full agonist,pEC50,Functional - cAMP accumulation,5.95,M,=,,7.13,15.136,Abolished effect,,VIP,0.0,0.0,,192.5,VIP,P41587,0.1665116723583194
37,12475394,vipr2_human,184,Y,F,VIP-[Thr11Val] ,FASTA sequence (peptide),HSDAVFTDNYVRLRKQMAVKKYLNSILN,Binding - unknown pharmacological activity,pK(i),Binding - Radioligand competition/displacement,6.45,M,=,,7.55,12.589,,,[125I]-VIP,100.0,0.0,,0.0,,P41587,0.1665116723583194
38,12475394,vipr2_human,184,Y,F,VIP-[Thr11Val] ,FASTA sequence (peptide),HSDAVFTDNYVRLRKQMAVKKYLNSILN,Full agonist,pEC50,Functional - cAMP accumulation,7.12,M,=,,8.26,13.804,Abolished effect,,VIP,0.0,0.0,,92.3913043478261,VIP,P41587,0.1665116723583194
0,18768385,cxcr4_human,255,Y,A,CXCL12,UniProt Entry Code,P48061,Full agonist,K(d),Binding - Radioligand competition/displacement,35.8,nM,=,,11.8,3.034,,,,96.7,0.0,,0.0,,P61073,0.5730038782163451
1,18768385,cxcr4_human,255,Y,A,CXCL12,UniProt Entry Code,P48061,Full agonist,EC50,Functional - Ca2+ accumulation,34.0,nM,=,,42.0,-1.235,,,,96.7,0.0,,0.0,,P61073,0.5730038782163451
21,25039237,cxcr4_human,255,Y,A,[Aib]FC131,SMILES,O=C(NC(CC1=CC=C(O)C=C1)C(NC(C)(C)C(NC(CCC/N=C(N)\N)C(NC2CC3=CC4=CC=CC=C4C=C3)=O)=O)=O)CNC2=O,Antagonist (neutral/silent),EC50,Functional - IP accumulation,2.9,uM,=,,8.5,-2.933,,,CXCL12,47.0,0.0,,0.0,,P61073,0.5730038782163451
57,25039237,cxcr4_human,255,Y,A,[Cit]FC131,SMILES,O=C(NC(CC1=CC=C(O)C=C1)C(NC(CCCNC(N)=O)C(NC(CCC/N=C(N)\N)C(NC2CC3=CC4=CC=CC=C4C=C3)=O)=O)=O)CNC2=O,Antagonist (neutral/silent),EC50,Functional - IP accumulation,3.0,uM,=,,3.2,-1.066,,,CXCL12,47.0,0.0,,0.0,,P61073,0.5730038782163451
89,18768385,cxcr4_human,255,Y,A,AMD11070,SMILES,NCCCCN(CC1=NC2=CC=CC=C2N1)[C@@H]3C4=NC=CC=C4CCC3,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,11.0,nM,=,,13.0,-1.182,,,radioligand: [125I]-CXCL24,96.7,0.0,,0.0,,P61073,0.5730038782163451
144,14585837,cxcr4_human,255,Y,A,AMD3100,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CN3CCCNCCNCCCNCC3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.89,uM,=,,9.7,-10.87,,,radioligand:12G5(Bolton-Hunter),171.53284671532847,0.0,,0.0,,P61073,0.5730038782163451
162,17599916,cxcr4_human,255,Y,A,AMD3100,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CN3CCCNCCNCCCNCC3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.22,uM,=,,0.66,-3.003,,,CXCL12,0.0,0.0,,67.60967609676096,,P61073,0.5730038782163451
183,17599916,cxcr4_human,255,Y,A,AMD3100,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CN3CCCNCCNCCCNCC3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.89,uM,=,,9.7,-10.87,,,radioligand:[125I] -12G5,171.53284671532847,0.0,,0.0,,P61073,0.5730038782163451
203,18768385,cxcr4_human,255,Y,A,AMD3100,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CN3CCCNCCNCCCNCC3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,842.0,nM,=,,2390.0,-2.841,,,radioligand: [125I]-CXCL12,96.7,0.0,,0.0,,P61073,0.5730038782163451
236,17599916,cxcr4_human,255,Y,A,AMD3389,SMILES,Cc1ccc(CN2CCCNCCNCCCNCC2)cc1,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,20.0,uM,=,,37.0,-1.848,,,CXCL12,0.0,0.0,,67.60967609676096,,P61073,0.5730038782163451
253,17599916,cxcr4_human,255,Y,A,AMD3465,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CNCC3=CC=CC=N3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.01,uM,=,,0.02,-2.0,,,CXCL12,0.0,0.0,,67.60967609676096,,P61073,0.5730038782163451
275,17599916,cxcr4_human,255,Y,A,AMD3465,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CNCC3=CC=CC=N3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.11,uM,=,,0.45,-4.098,,,radioligand:125I-12G5,171.53284671532847,0.0,,0.0,,P61073,0.5730038782163451
294,18768385,cxcr4_human,255,Y,A,AMD3465,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CNCC3=CC=CC=N3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,49.0,nM,=,,225.0,-4.587,,,radioligand: [125I]-CXCL12,96.7,0.0,,0.0,,P61073,0.5730038782163451
308,14585837,cxcr4_human,255,Y,A,AMD3479,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(C[N@@]3([Zn]456)CCCN4CCN6CCCN5CC3)cc2,,K(i),Binding - Radioligand competition/displacement,0.02,uM,=,,0.53,-26.316,,,radioligand:12G5(Bolton-Hunter),171.53284671532847,0.0,,0.0,,P61073,0.5730038782163451
326,17599916,cxcr4_human,255,Y,A,AMD3529,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CNCC3=CC=CC=C3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,1.7,uM,=,,8.8,-5.181,,,CXCL12,0.0,0.0,,22.34522345223452,,P61073,0.5730038782163451
343,17599916,cxcr4_human,255,Y,A,AMD8721,SMILES,N(CCN1CCCN2CC3)([Cu]124)CCC[N@]34Cc5ccc(CNCC6=CC=CC=N6)cc5,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.04,uM,=,,0.11,-2.747,,,CXCL12,0.0,0.0,,22.34522345223452,,P61073,0.5730038782163451
360,17599916,cxcr4_human,255,Y,A,AMD8899,SMILES,N1([Ni]234)CCC[N@@]4(Cc5ccc(CNCC6=CC=CC=N6)cc5)CCN3CCCN2CC1,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.01,uM,=,,0.09,-9.009,,,CXCL12,0.0,0.0,,22.34522345223452,,P61073,0.5730038782163451
419,17599916,cxcr4_human,255,Y,A,CXCL12,UniProt Entry Code,P48061,Full agonist,K(d),Binding - Radioligand competition/displacement,0.81,nM,=,,1.3,-1.605,,,radioligand: [125I]-CXCL12,0.0,0.0,,22.34522345223452,,P61073,0.5730038782163451
471,25039237,cxcr4_human,255,Y,A,CXCL12,UniProt Entry Code,P48061,Full agonist,EC50,Functional - IP accumulation,1.5,nM,=,,1.1,1.364,,,,47.0,0.0,,0.0,,P61073,0.5730038782163451
500,26397724,cxcr4_human,255,Y,A,CXCL12,UniProt Entry Code,P48061,Full agonist,EC50,Functional - IP accumulation,1.5,nM,=,,1.1,1.364,,,CXCL12,47.0,0.0,,0.0,,P61073,0.5730038782163451
522,16188969/16306611,cxcr4_human,255,Y,A,CXCL12,UniProt Entry Code,P48061,Full agonist,IC50,Binding - Radioligand saturation,2.2,nM,=,,7.9,-3.597,,,radioligand: [125I]-CXCL12,64.0,0.0,,0.0,,P61073,0.5730038782163451
592,25039237,cxcr4_human,255,Y,A,FC131,PubChem CID,5275843,Antagonist (neutral/silent),EC50,Functional - IP accumulation,0.4,uM,=,,0.27,1.481,,,CXCL12,47.0,0.0,,0.0,,P61073,0.5730038782163451
626,26397724,cxcr4_human,255,Y,A,KRH1636,SMILES,CC(C1=CC=CC2=CC=CC=C21)NC(=O)C(CCCN=C(N)N)NC(=O)C3=CC=C(C=C3)CNCC4=CC=C,Antagonist (neutral/silent),EC50,Functional - IP accumulation,0.5,uM,=,,1.7,-3.401,,,CXCL12,47.0,0.0,,0.0,,P61073,0.5730038782163451
737,25039237,cxcr4_human,255,Y,A,[D-Arg]FC131,SMILES,N\C(N)=N\CCCC1NC(=O)[C@H](CCC\N=C(\N)N)NC(=O)C(Cc2ccc(O)cc2)NC(=O)CNC(=O)C(Cc2ccc3ccccc3c2)NC1=O,Antagonist (neutral/silent),EC50,Functional - IP accumulation,0.52,uM,=,,0.8,-1.538,,,CXCL12,47.0,0.0,,0.0,,P61073,0.5730038782163451
2,18768385,cxcr4_human,262,D,N,CXCL12,UniProt Entry Code,P48061,Full agonist,K(d),Binding - Radioligand competition/displacement,35.8,nM,=,,80.3,-2.242,,,,32.5,0.0,,0.0,,P61073,0.2834883609373352
24,25039237,cxcr4_human,262,D,N,[Aib]FC131,SMILES,O=C(NC(CC1=CC=C(O)C=C1)C(NC(C)(C)C(NC(CCC/N=C(N)\N)C(NC2CC3=CC4=CC=CC=C4C=C3)=O)=O)=O)CNC2=O,Antagonist (neutral/silent),EC50,Functional - IP accumulation,2.9,uM,=,,4.3,-1.484,,,CXCL12,54.0,0.0,,0.0,,P61073,0.2834883609373352
30,25039237,cxcr4_human,262,D,N,[Aib]FC131,SMILES,O=C(NC(CC1=CC=C(O)C=C1)C(NC(C)(C)C(NC(CCC/N=C(N)\N)C(NC2CC3=CC4=CC=CC=C4C=C3)=O)=O)=O)CNC2=O,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,2.9,uM,=,,100.0,-34.483,,,radioligand:[125I]-12G11,54.0,0.0,,0.0,,P61073,0.2834883609373352
49,18768385,cxcr4_human,262,D,N,CXCL12,UniProt Entry Code,P48061,Full agonist,EC50,Functional - Ca2+ accumulation,34.0,nM,=,,96.5,-2.841,,,,32.5,0.0,,0.0,,P61073,0.2834883609373352
60,25039237,cxcr4_human,262,D,N,[Cit]FC131,SMILES,O=C(NC(CC1=CC=C(O)C=C1)C(NC(CCCNC(N)=O)C(NC(CCC/N=C(N)\N)C(NC2CC3=CC4=CC=CC=C4C=C3)=O)=O)=O)CNC2=O,Antagonist (neutral/silent),EC50,Functional - IP accumulation,3.0,uM,=,,5.5,-1.835,,,CXCL12,54.0,0.0,,0.0,,P61073,0.2834883609373352
65,25039237,cxcr4_human,262,D,N,[Cit]FC131,SMILES,O=C(NC(CC1=CC=C(O)C=C1)C(NC(CCCNC(N)=O)C(NC(CCC/N=C(N)\N)C(NC2CC3=CC4=CC=CC=C4C=C3)=O)=O)=O)CNC2=O,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,4.9,uM,=,,61.0,-12.5,,,radioligand:[125I]-12G11,54.0,0.0,,0.0,,P61073,0.2834883609373352
78,18768385,cxcr4_human,262,D,N,AMD11070,SMILES,NCCCCN(CC1=NC2=CC=CC=C2N1)[C@@H]3C4=NC=CC=C4CCC3,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,11.0,nM,=,,137.0,-12.5,,,radioligand: [125I]-CXCL13,32.5,0.0,,0.0,,P61073,0.2834883609373352
92,11154697,cxcr4_human,262,D,N,AMD2763,SMILES,N1(CCCN2CCNCCCNCCNCCC2)CCCNCCNCCCNCC1,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.18,uM,=,,1.6,-8.929,,,radioligand: [125I]Met-CXCL12,58.82352941176471,0.0,,0.0,,P61073,0.2834883609373352
94,11154697,cxcr4_human,262,D,N,AMD2849,SMILES,N1(CCCCCCN2CCNCCCNCCNCCC2)CCCNCCNCCCNCC1,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,2.3,uM,=,,2.0,1.15,,,radioligand: [125I]Met-CXCL12,58.82352941176471,0.0,,0.0,,P61073,0.2834883609373352
97,11154697,cxcr4_human,262,D,N,AMD2936,SMILES,[H][C@@]1(CCCN2CCNCCCNCCNCCC2)NCCCNCCNCCCNC1,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.65,uM,=,,3.4,-5.236,,,radioligand: [125I]Met-CXCL12,58.82352941176471,0.0,,0.0,,P61073,0.2834883609373352
103,11154697,cxcr4_human,262,D,N,AMD3100,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CN3CCCNCCNCCCNCC3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,550.0,nM,=,,100000.0,-200.0,,,radioligand: [125I]-12G5,197.43589743589743,0.0,,0.0,,P61073,0.2834883609373352
111,11154697,cxcr4_human,262,D,N,AMD3100,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CN3CCCNCCNCCCNCC3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,74.0,nM,=,,1100.0,-14.925,,,radioligand: [125I]Met-CXCL12,58.82352941176471,0.0,,0.0,,P61073,0.2834883609373352
124,12534283,cxcr4_human,262,D,N,AMD3100,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CN3CCCNCCNCCCNCC3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,1.0,uM,=,,17.4,-17.544,,,radioligand: [125I]-12G5,197.43589743589743,0.0,,0.0,,P61073,0.2834883609373352
132,12534283,cxcr4_human,262,D,N,AMD3100,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CN3CCCNCCNCCCNCC3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,74.0,nM,=,,1300.0,-17.544,,,radioligand: [125I]-Met-CXCL12,58.82352941176471,0.0,,0.0,,P61073,0.2834883609373352
148,14585837,cxcr4_human,262,D,N,AMD3100,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CN3CCCNCCNCCCNCC3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.89,uM,=,,46.0,-52.632,,,radioligand:12G5(Bolton-Hunter),118.24817518248176,0.0,,0.0,,P61073,0.2834883609373352
165,17599916,cxcr4_human,262,D,N,AMD3100,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CN3CCCNCCNCCCNCC3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.22,uM,=,,4.7,-21.277,,,CXCL12,0.0,0.0,,96.1049610496105,,P61073,0.2834883609373352
187,17599916,cxcr4_human,262,D,N,AMD3100,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CN3CCCNCCNCCCNCC3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.89,uM,=,,46.0,-52.632,,,radioligand:[125I] -12G5,118.24817518248176,0.0,,0.0,,P61073,0.2834883609373352
204,18768385,cxcr4_human,262,D,N,AMD3100,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CN3CCCNCCNCCCNCC3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,842.0,nM,=,,15030.0,-17.857,,,radioligand: [125I]-CXCL12,32.5,0.0,,0.0,,P61073,0.2834883609373352
212,12534283,cxcr4_human,262,D,N,AMD3100(Zn)2,SMILES,N12CCC[N](Cc3ccc(C[N@@]45[Zn]67N(CCN6CCCN7CC5)CCC4)cc3)([Zn]289)CCN9CCCN8CC1,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.028,nM,=,,13.0,-500.0,,,radioligand: [125I]-12G5,197.43589743589743,0.0,,0.0,,P61073,0.2834883609373352
220,12534283,cxcr4_human,262,D,N,AMD3100(Zn)2,SMILES,N12CCC[N](Cc3ccc(C[N@@]45[Zn]67N(CCN6CCCN7CC5)CCC4)cc3)([Zn]289)CCN9CCCN8CC1,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,12.0,nM,=,,1000.0,-83.333,,,radioligand: [125I]-Met-CXCL12,58.82352941176471,0.0,,0.0,,P61073,0.2834883609373352
224,11154697,cxcr4_human,262,D,N,AMD3106,SMILES,N1(CCCNCCNCCCNCC1)Cc2nc(CN3CCCNCCNCCCNCC3)ccc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.083,uM,=,,1.8,-21.739,,,radioligand: Met-CXCL12,58.82352941176471,0.0,,0.0,,P61073,0.2834883609373352
226,11154697,cxcr4_human,262,D,N,AMD3108,SMILES,N1(CCCNCCNCCCNCC1)Cc2cc(CN3CCCNCCNCCCNCC3)ncc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.85,uM,=,,2.2,-2.591,,,radioligand: Met-CXCL12,58.82352941176471,0.0,,0.0,,P61073,0.2834883609373352
239,17599916,cxcr4_human,262,D,N,AMD3389,SMILES,Cc1ccc(CN2CCCNCCNCCCNCC2)cc1,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,20.0,uM,=,,2.9,6.897,,,CXCL12,0.0,0.0,,96.1049610496105,,P61073,0.2834883609373352
256,17599916,cxcr4_human,262,D,N,AMD3465,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CNCC3=CC=CC=N3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.01,uM,=,,7.8,-1000.0,,,CXCL12,0.0,0.0,,96.1049610496105,,P61073,0.2834883609373352
295,18768385,cxcr4_human,262,D,N,AMD3465,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CNCC3=CC=CC=N3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,49.0,nM,=,,8524.0,-166.667,,,radioligand: [125I]-CXCL12,32.5,0.0,,0.0,,P61073,0.2834883609373352
312,14585837,cxcr4_human,262,D,N,AMD3479,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(C[N@@]3([Zn]456)CCCN4CCN6CCCN5CC3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.02,uM,=,,13.0,-500.0,,,radioligand:12G5(Bolton-Hunter),118.24817518248176,0.0,,0.0,,P61073,0.2834883609373352
329,17599916,cxcr4_human,262,D,N,AMD3529,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CNCC3=CC=CC=C3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,1.7,uM,=,,2.3,-1.353,,,CXCL12,0.0,0.0,,75.97375973759738,,P61073,0.2834883609373352
346,17599916,cxcr4_human,262,D,N,AMD8721,SMILES,N(CCN1CCCN2CC3)([Cu]124)CCC[N@]34Cc5ccc(CNCC6=CC=CC=N6)cc5,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.04,uM,=,,21.0,-500.0,,,CXCL12,0.0,0.0,,75.97375973759738,,P61073,0.2834883609373352
363,17599916,cxcr4_human,262,D,N,AMD8899,SMILES,N1([Ni]234)CCC[N@@]4(Cc5ccc(CNCC6=CC=CC=N6)cc5)CCN3CCCN2CC1,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.01,uM,=,,0.82,-83.333,,,CXCL12,0.0,0.0,,75.97375973759738,,P61073,0.2834883609373352
382,11154697,cxcr4_human,262,D,N,CXCL12,UniProt Entry Code,P48061,Full agonist,K(d),Binding - Radioligand competition/displacement,0.49,nM,=,,1.2,-2.451,,,radioligand: [125I]Met-CXCL12,58.82352941176471,0.0,,0.0,,P61073,0.2834883609373352
422,17599916,cxcr4_human,262,D,N,CXCL12,UniProt Entry Code,P48061,Full agonist,K(d),Binding - Radioligand competition/displacement,0.81,nM,=,,7.5,-9.259,,,radioligand: [125I]-CXCL12,0.0,0.0,,75.97375973759738,,P61073,0.2834883609373352
474,25039237,cxcr4_human,262,D,N,CXCL12,UniProt Entry Code,P48061,Full agonist,EC50,Functional - IP accumulation,1.5,nM,=,,5.8,-3.861,,,,54.0,0.0,,0.0,,P61073,0.2834883609373352
503,26397724,cxcr4_human,262,D,N,CXCL12,UniProt Entry Code,P48061,Full agonist,EC50,Functional - IP accumulation,1.5,nM,=,,5.8,-3.861,,,CXCL12,54.0,0.0,,0.0,,P61073,0.2834883609373352
537,11154697/12534283,cxcr4_human,262,D,N,cyclam,SMILES,C1CNCCNCCCNCCNC1,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,13.0,uM,=,,9.6,1.354,,,radioligand: [125I]-Met-CXCL12,58.82352941176471,0.0,,0.0,,P61073,0.2834883609373352
545,12534283,cxcr4_human,262,D,N,Cyclam (Zn),SMILES,[Zn+2].C1CNCCNCCCNCCNC1,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,3.0,uM,=,,2.3,1.304,,,radioligand: [125I]-Met-CXCL12,58.82352941176471,0.0,,0.0,,P61073,0.2834883609373352
595,25039237,cxcr4_human,262,D,N,FC131,PubChem CID,5275843,Antagonist (neutral/silent),EC50,Functional - IP accumulation,0.4,uM,=,,6.1,-15.152,,,CXCL12,54.0,0.0,,0.0,,P61073,0.2834883609373352
600,25039237,cxcr4_human,262,D,N,FC131,PubChem CID,5275843,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,0.76,uM,=,,73.0,-100.0,,,radioligand:[125I]-12G11,54.0,0.0,,0.0,,P61073,0.2834883609373352
629,26397724,cxcr4_human,262,D,N,KRH1636,SMILES,CC(C1=CC=CC2=CC=CC=C21)NC(=O)C(CCCN=C(N)N)NC(=O)C3=CC=C(C=C3)CNCC4=CC=C,Antagonist (neutral/silent),EC50,Functional - IP accumulation,0.5,uM,=,,13.0,-26.316,,,CXCL12,54.0,0.0,,0.0,,P61073,0.2834883609373352
655,26397724,cxcr4_human,262,D,N,KRH1636-5,SMILES,C[C@H](NC([C@H](CCCNC(N)=N)NC(C1=CC=C(CNCC2=CC=CC=C2)C=C1)=O)=O)C3=CC=CC4=C3C=CC=C4,Antagonist (neutral/silent),EC50,Functional - IP accumulation,8.5,uM,=,,27.0,-3.175,,,CXCL12,54.0,0.0,,0.0,,P61073,0.2834883609373352
680,26397724,cxcr4_human,262,D,N,KRH1636-6,SMILES,C[C@H](NC([C@H](CCCNC(N)=N)NC(C1=CC=C(CN)C=C1)=O)=O)C2=CC=CC3=C2C=CC=C3,Antagonist (neutral/silent),EC50,Functional - IP accumulation,12.0,uM,=,,11.0,1.091,,,CXCL12,54.0,0.0,,0.0,,P61073,0.2834883609373352
690,26397724,cxcr4_human,262,D,N,KRK1636,SMILES,CC(C1=CC=CC2=CC=CC=C21)NC(=O)C(CCCN=C(N)N)NC(=O)C3=CC=C(C=C3)CNCC4=CC=C,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,8.0,uM,=,,100.0,-12.5,,,radioligand:[125I] -12G5,0.0,0.0,,0.0,,P61073,0.2834883609373352
740,25039237,cxcr4_human,262,D,N,[D-Arg]FC131,SMILES,N\C(N)=N\CCCC1NC(=O)[C@H](CCC\N=C(\N)N)NC(=O)C(Cc2ccc(O)cc2)NC(=O)CNC(=O)C(Cc2ccc3ccccc3c2)NC1=O,Antagonist (neutral/silent),EC50,Functional - IP accumulation,0.52,uM,=,,10.0,-19.231,,,CXCL12,54.0,0.0,,0.0,,P61073,0.2834883609373352
750,25039237,cxcr4_human,262,D,N,[D-Arg]FC131,SMILES,N\C(N)=N\CCCC1NC(=O)[C@H](CCC\N=C(\N)N)NC(=O)C(Cc2ccc(O)cc2)NC(=O)CNC(=O)C(Cc2ccc3ccccc3c2)NC1=O,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,0.38,uM,=,,100.0,-250.0,,,radioligand:[125I]-12G5,54.0,0.0,,0.0,,P61073,0.2834883609373352
3,25039237,cxcr4_human,45,Y,A,[Aib]FC131,SMILES,O=C(NC(CC1=CC=C(O)C=C1)C(NC(C)(C)C(NC(CCC/N=C(N)\N)C(NC2CC3=CC4=CC=CC=C4C=C3)=O)=O)=O)CNC2=O,Antagonist (neutral/silent),EC50,Functional - IP accumulation,2.9,uM,=,,46.0,-15.873,,,CXCL12,90.0,0.0,,0.0,,P61073,0.5996777036100179
39,25039237,cxcr4_human,45,Y,A,[Cit]FC131,SMILES,O=C(NC(CC1=CC=C(O)C=C1)C(NC(CCCNC(N)=O)C(NC(CCC/N=C(N)\N)C(NC2CC3=CC4=CC=CC=C4C=C3)=O)=O)=O)CNC2=O,Antagonist (neutral/silent),EC50,Functional - IP accumulation,3.0,uM,=,,17.0,-5.682,,,CXCL12,90.0,0.0,,0.0,,P61073,0.5996777036100179
90,18768385,cxcr4_human,45,Y,A,AMD11070,SMILES,NCCCCN(CC1=NC2=CC=CC=C2N1)[C@@H]3C4=NC=CC=C4CCC3,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,11.0,nM,=,,438.0,-40.0,,,radioligand: [125I]-CXCL25,70.8,0.0,,0.0,,P61073,0.5996777036100179
193,18768385,cxcr4_human,45,Y,A,AMD3100,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CN3CCCNCCNCCCNCC3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,842.0,nM,=,,8465.0,-10.101,,,radioligand: [125I]-CXCL12,70.8,0.0,,0.0,,P61073,0.5996777036100179
284,18768385,cxcr4_human,45,Y,A,AMD3465,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CNCC3=CC=CC=N3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,49.0,nM,=,,1069.0,-21.739,,,radioligand: [125I]-CXCL12,70.8,0.0,,0.0,,P61073,0.5996777036100179
427,18768385,cxcr4_human,45,Y,A,CXCL12,UniProt Entry Code,P48061,Full agonist,K(d),Binding - Radioligand competition/displacement,35.8,nM,=,,22.8,1.57,,,,70.8,0.0,,0.0,,P61073,0.5996777036100179
428,18768385,cxcr4_human,45,Y,A,CXCL12,UniProt Entry Code,P48061,Full agonist,EC50,Functional - Ca2+ accumulation,34.0,nM,=,,33.9,1.003,,,,70.8,0.0,,0.0,,P61073,0.5996777036100179
454,25039237,cxcr4_human,45,Y,A,CXCL12,UniProt Entry Code,P48061,Full agonist,EC50,Functional - IP accumulation,1.5,nM,=,,3.4,-2.268,,,,90.0,0.0,,0.0,,P61073,0.5996777036100179
482,26397724,cxcr4_human,45,Y,A,CXCL12,UniProt Entry Code,P48061,Full agonist,EC50,Functional - IP accumulation,1.5,nM,=,,3.4,-2.268,,,CXCL12,90.0,0.0,,0.0,,P61073,0.5996777036100179
507,16188969/16306611,cxcr4_human,45,Y,A,CXCL12,UniProt Entry Code,P48061,Full agonist,IC50,Binding - Radioligand saturation,2.2,nM,=,,1.0,2.2,,,radioligand: [125I]-CXCL12,139.6,0.0,,0.0,,P61073,0.5996777036100179
574,25039237,cxcr4_human,45,Y,A,FC131,PubChem CID,5275843,Antagonist (neutral/silent),EC50,Functional - IP accumulation,0.4,uM,=,,1.6,-4.0,,,CXCL12,90.0,0.0,,0.0,,P61073,0.5996777036100179
608,26397724,cxcr4_human,45,Y,A,KRH1636,SMILES,CC(C1=CC=CC2=CC=CC=C21)NC(=O)C(CCCN=C(N)N)NC(=O)C3=CC=C(C=C3)CNCC4=CC=C,Antagonist (neutral/silent),EC50,Functional - IP accumulation,0.5,uM,=,,4.0,-8.0,,,CXCL12,90.0,0.0,,0.0,,P61073,0.5996777036100179
633,26397724,cxcr4_human,45,Y,A,KRH1636-5,SMILES,C[C@H](NC([C@H](CCCNC(N)=N)NC(C1=CC=C(CNCC2=CC=CC=C2)C=C1)=O)=O)C3=CC=CC4=C3C=CC=C4,Antagonist (neutral/silent),EC50,Functional - IP accumulation,8.5,uM,=,,56.0,-6.579,,,CXCL12,90.0,0.0,,0.0,,P61073,0.5996777036100179
659,26397724,cxcr4_human,45,Y,A,KRH1636-6,SMILES,C[C@H](NC([C@H](CCCNC(N)=N)NC(C1=CC=C(CN)C=C1)=O)=O)C2=CC=CC3=C2C=CC=C3,Antagonist (neutral/silent),EC50,Functional - IP accumulation,12.0,uM,=,,181.0,-15.152,,,CXCL12,90.0,0.0,,0.0,,P61073,0.5996777036100179
720,25039237,cxcr4_human,45,Y,A,[D-Arg]FC131,SMILES,N\C(N)=N\CCCC1NC(=O)[C@H](CCC\N=C(\N)N)NC(=O)C(Cc2ccc(O)cc2)NC(=O)CNC(=O)C(Cc2ccc3ccccc3c2)NC1=O,Antagonist (neutral/silent),EC50,Functional - IP accumulation,0.52,uM,=,,1.6,-3.077,,,CXCL12,90.0,0.0,,0.0,,P61073,0.5996777036100179
4,25039237,cxcr4_human,94,W,A,[Aib]FC131,SMILES,O=C(NC(CC1=CC=C(O)C=C1)C(NC(C)(C)C(NC(CCC/N=C(N)\N)C(NC2CC3=CC4=CC=CC=C4C=C3)=O)=O)=O)CNC2=O,Antagonist (neutral/silent),EC50,Functional - IP accumulation,2.9,uM,=,,0.02,145.0,,,CXCL12,38.0,0.0,,0.0,,P61073,0.5364446402240167
33,25039237,cxcr4_human,94,W,A,[Aib]FC131,SMILES,O=C(NC(CC1=CC=C(O)C=C1)C(NC(C)(C)C(NC(CCC/N=C(N)\N)C(NC2CC3=CC4=CC=CC=C4C=C3)=O)=O)=O)CNC2=O,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,2.9,uM,=,,0.14,20.714,,,radioligand:[125I]-12G5,38.0,0.0,,0.0,,P61073,0.5364446402240167
40,25039237,cxcr4_human,94,W,A,[Cit]FC131,SMILES,O=C(NC(CC1=CC=C(O)C=C1)C(NC(CCCNC(N)=O)C(NC(CCC/N=C(N)\N)C(NC2CC3=CC4=CC=CC=C4C=C3)=O)=O)=O)CNC2=O,Antagonist (neutral/silent),EC50,Functional - IP accumulation,3.0,uM,=,,0.17,17.647,,,CXCL12,38.0,0.0,,0.0,,P61073,0.5364446402240167
68,25039237,cxcr4_human,94,W,A,[Cit]FC131,SMILES,O=C(NC(CC1=CC=C(O)C=C1)C(NC(CCCNC(N)=O)C(NC(CCC/N=C(N)\N)C(NC2CC3=CC4=CC=CC=C4C=C3)=O)=O)=O)CNC2=O,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,4.9,uM,=,,0.27,18.148,,,radioligand:[125I]-12G5,38.0,0.0,,0.0,,P61073,0.5364446402240167
86,18768385,cxcr4_human,94,W,A,AMD11070,SMILES,NCCCCN(CC1=NC2=CC=CC=C2N1)[C@@H]3C4=NC=CC=C4CCC3,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,11.0,nM,=,,1185.0,-111.111,,,radioligand: [125I]-CXCL21,43.4,0.0,,0.0,,P61073,0.5364446402240167
194,18768385,cxcr4_human,94,W,A,AMD3100,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CN3CCCNCCNCCCNCC3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,842.0,nM,=,,11800.0,-14.085,,,radioligand: [125I]-CXCL12,43.4,0.0,,0.0,,P61073,0.5364446402240167
285,18768385,cxcr4_human,94,W,A,AMD3465,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CNCC3=CC=CC=N3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,49.0,nM,=,,4437.0,-90.909,,,radioligand: [125I]-CXCL12,43.4,0.0,,0.0,,P61073,0.5364446402240167
429,18768385,cxcr4_human,94,W,A,CXCL12,UniProt Entry Code,P48061,Full agonist,K(d),Binding - Radioligand competition/displacement,35.8,nM,=,,54.9,-1.534,,,,43.4,0.0,,0.0,,P61073,0.5364446402240167
430,18768385,cxcr4_human,94,W,A,CXCL12,UniProt Entry Code,P48061,Full agonist,EC50,Functional - Ca2+ accumulation,34.0,nM,=,,45.0,-1.323,,,,43.4,0.0,,0.0,,P61073,0.5364446402240167
455,25039237,cxcr4_human,94,W,A,CXCL12,UniProt Entry Code,P48061,Full agonist,EC50,Functional - IP accumulation,1.5,nM,=,,18.0,-12.048,,,,38.0,0.0,,0.0,,P61073,0.5364446402240167
483,26397724,cxcr4_human,94,W,A,CXCL12,UniProt Entry Code,P48061,Full agonist,EC50,Functional - IP accumulation,1.5,nM,=,,18.0,-12.048,,,CXCL12,38.0,0.0,,0.0,,P61073,0.5364446402240167
575,25039237,cxcr4_human,94,W,A,FC131,PubChem CID,5275843,Antagonist (neutral/silent),EC50,Functional - IP accumulation,0.4,uM,=,,0.01,40.0,,,CXCL12,38.0,0.0,,0.0,,P61073,0.5364446402240167
603,25039237,cxcr4_human,94,W,A,FC131,PubChem CID,5275843,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,0.76,uM,=,,0.03,25.333,,,radioligand:[125I]-12G5,38.0,0.0,,0.0,,P61073,0.5364446402240167
609,26397724,cxcr4_human,94,W,A,KRH1636,SMILES,CC(C1=CC=CC2=CC=CC=C21)NC(=O)C(CCCN=C(N)N)NC(=O)C3=CC=C(C=C3)CNCC4=CC=C,Antagonist (neutral/silent),EC50,Functional - IP accumulation,0.5,uM,=,,0.06,8.333,,,CXCL12,38.0,0.0,,0.0,,P61073,0.5364446402240167
634,26397724,cxcr4_human,94,W,A,KRH1636-5,SMILES,C[C@H](NC([C@H](CCCNC(N)=N)NC(C1=CC=C(CNCC2=CC=CC=C2)C=C1)=O)=O)C3=CC=CC4=C3C=CC=C4,Antagonist (neutral/silent),EC50,Functional - IP accumulation,8.5,uM,=,,0.55,15.455,,,CXCL12,38.0,0.0,,0.0,,P61073,0.5364446402240167
660,26397724,cxcr4_human,94,W,A,KRH1636-6,SMILES,C[C@H](NC([C@H](CCCNC(N)=N)NC(C1=CC=C(CN)C=C1)=O)=O)C2=CC=CC3=C2C=CC=C3,Antagonist (neutral/silent),EC50,Functional - IP accumulation,12.0,uM,=,,0.64,18.75,,,CXCL12,38.0,0.0,,0.0,,P61073,0.5364446402240167
684,26397724,cxcr4_human,94,W,A,KRK1636,SMILES,CC(C1=CC=CC2=CC=CC=C21)NC(=O)C(CCCN=C(N)N)NC(=O)C3=CC=C(C=C3)CNCC4=CC=C,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,8.0,uM,=,,1.7,4.706,,,radioligand:[125I] -12G5,0.0,0.0,,0.0,,P61073,0.5364446402240167
721,25039237,cxcr4_human,94,W,A,[D-Arg]FC131,SMILES,N\C(N)=N\CCCC1NC(=O)[C@H](CCC\N=C(\N)N)NC(=O)C(Cc2ccc(O)cc2)NC(=O)CNC(=O)C(Cc2ccc3ccccc3c2)NC1=O,Antagonist (neutral/silent),EC50,Functional - IP accumulation,0.52,uM,=,,0.05,10.4,,,CXCL12,38.0,0.0,,0.0,,P61073,0.5364446402240167
744,25039237,cxcr4_human,94,W,A,[D-Arg]FC131,SMILES,N\C(N)=N\CCCC1NC(=O)[C@H](CCC\N=C(\N)N)NC(=O)C(Cc2ccc(O)cc2)NC(=O)CNC(=O)C(Cc2ccc3ccccc3c2)NC1=O,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,0.38,uM,=,,0.03,12.667,,,radioligand:[125I]-12G5,38.0,0.0,,0.0,,P61073,0.5364446402240167
5,25039237,cxcr4_human,97,D,A,[Aib]FC131,SMILES,O=C(NC(CC1=CC=C(O)C=C1)C(NC(C)(C)C(NC(CCC/N=C(N)\N)C(NC2CC3=CC4=CC=CC=C4C=C3)=O)=O)=O)CNC2=O,Antagonist (neutral/silent),EC50,Functional - IP accumulation,2.9,uM,=,,0.35,8.286,,,CXCL12,99.0,0.0,,0.0,,P61073,0.4500573986599889
34,25039237,cxcr4_human,97,D,A,[Aib]FC131,SMILES,O=C(NC(CC1=CC=C(O)C=C1)C(NC(C)(C)C(NC(CCC/N=C(N)\N)C(NC2CC3=CC4=CC=CC=C4C=C3)=O)=O)=O)CNC2=O,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,2.9,uM,=,,1.2,2.417,,,radioligand:[125I]-12G6,99.0,0.0,,0.0,,P61073,0.4500573986599889
41,25039237,cxcr4_human,97,D,A,[Cit]FC131,SMILES,O=C(NC(CC1=CC=C(O)C=C1)C(NC(CCCNC(N)=O)C(NC(CCC/N=C(N)\N)C(NC2CC3=CC4=CC=CC=C4C=C3)=O)=O)=O)CNC2=O,Antagonist (neutral/silent),EC50,Functional - IP accumulation,3.0,uM,=,,0.44,6.818,,,CXCL12,99.0,0.0,,0.0,,P61073,0.4500573986599889
69,25039237,cxcr4_human,97,D,A,[Cit]FC131,SMILES,O=C(NC(CC1=CC=C(O)C=C1)C(NC(CCCNC(N)=O)C(NC(CCC/N=C(N)\N)C(NC2CC3=CC4=CC=CC=C4C=C3)=O)=O)=O)CNC2=O,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,4.9,uM,=,,0.87,5.632,,,radioligand:[125I]-12G6,99.0,0.0,,0.0,,P61073,0.4500573986599889
456,25039237,cxcr4_human,97,D,A,CXCL12,UniProt Entry Code,P48061,Full agonist,EC50,Functional - IP accumulation,1.5,nM,=,,20.0,-13.333,,,,99.0,0.0,,0.0,,P61073,0.4500573986599889
484,26397724,cxcr4_human,97,D,A,CXCL12,UniProt Entry Code,P48061,Full agonist,EC50,Functional - IP accumulation,1.5,nM,=,,20.0,-13.333,,,CXCL12,99.0,0.0,,0.0,,P61073,0.4500573986599889
510,16188969/16306611,cxcr4_human,97,D,A,CXCL12,UniProt Entry Code,P48061,Full agonist,IC50,Binding - Radioligand saturation,2.2,nM,=,,2.1,1.048,,,radioligand: [125I]-CXCL12,223.5,0.0,,0.0,,P61073,0.4500573986599889
576,25039237,cxcr4_human,97,D,A,FC131,PubChem CID,5275843,Antagonist (neutral/silent),EC50,Functional - IP accumulation,0.4,uM,=,,0.04,10.0,,,CXCL12,99.0,0.0,,0.0,,P61073,0.4500573986599889
604,25039237,cxcr4_human,97,D,A,FC131,PubChem CID,5275843,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,0.76,uM,=,,0.17,4.471,,,radioligand:[125I]-12G6,99.0,0.0,,0.0,,P61073,0.4500573986599889
610,26397724,cxcr4_human,97,D,A,KRH1636,SMILES,CC(C1=CC=CC2=CC=CC=C21)NC(=O)C(CCCN=C(N)N)NC(=O)C3=CC=C(C=C3)CNCC4=CC=C,Antagonist (neutral/silent),EC50,Functional - IP accumulation,0.5,uM,=,,0.21,2.381,,,CXCL12,99.0,0.0,,0.0,,P61073,0.4500573986599889
635,26397724,cxcr4_human,97,D,A,KRH1636-5,SMILES,C[C@H](NC([C@H](CCCNC(N)=N)NC(C1=CC=C(CNCC2=CC=CC=C2)C=C1)=O)=O)C3=CC=CC4=C3C=CC=C4,Antagonist (neutral/silent),EC50,Functional - IP accumulation,8.5,uM,=,,0.54,15.741,,,CXCL12,99.0,0.0,,0.0,,P61073,0.4500573986599889
661,26397724,cxcr4_human,97,D,A,KRH1636-6,SMILES,C[C@H](NC([C@H](CCCNC(N)=N)NC(C1=CC=C(CN)C=C1)=O)=O)C2=CC=CC3=C2C=CC=C3,Antagonist (neutral/silent),EC50,Functional - IP accumulation,12.0,uM,=,,1.4,8.571,,,CXCL12,99.0,0.0,,0.0,,P61073,0.4500573986599889
685,26397724,cxcr4_human,97,D,A,KRK1636,SMILES,CC(C1=CC=CC2=CC=CC=C21)NC(=O)C(CCCN=C(N)N)NC(=O)C3=CC=C(C=C3)CNCC4=CC=C,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,8.0,uM,=,,8.5,-1.063,,,radioligand:[125I] -12G5,0.0,0.0,,0.0,,P61073,0.4500573986599889
722,25039237,cxcr4_human,97,D,A,[D-Arg]FC131,SMILES,N\C(N)=N\CCCC1NC(=O)[C@H](CCC\N=C(\N)N)NC(=O)C(Cc2ccc(O)cc2)NC(=O)CNC(=O)C(Cc2ccc3ccccc3c2)NC1=O,Antagonist (neutral/silent),EC50,Functional - IP accumulation,0.52,uM,=,,0.06,8.667,,,CXCL12,99.0,0.0,,0.0,,P61073,0.4500573986599889
6,25039237,cxcr4_human,113,H,A,[Aib]FC131,SMILES,O=C(NC(CC1=CC=C(O)C=C1)C(NC(C)(C)C(NC(CCC/N=C(N)\N)C(NC2CC3=CC4=CC=CC=C4C=C3)=O)=O)=O)CNC2=O,Antagonist (neutral/silent),EC50,Functional - IP accumulation,2.9,uM,=,,100.0,-34.483,,,CXCL12,80.0,0.0,,0.0,,P61073,0.533447174074429
38,25039237,cxcr4_human,113,H,A,[Cit]FC131,SMILES,O=C(NC(CC1=CC=C(O)C=C1)C(NC(CCCNC(N)=O)C(NC(CCC/N=C(N)\N)C(NC2CC3=CC4=CC=CC=C4C=C3)=O)=O)=O)CNC2=O,Antagonist (neutral/silent),EC50,Functional - IP accumulation,3.0,uM,=,,100.0,-33.333,,,CXCL12,80.0,0.0,,0.0,,P61073,0.533447174074429
70,25039237,cxcr4_human,113,H,A,[Cit]FC131,SMILES,O=C(NC(CC1=CC=C(O)C=C1)C(NC(CCCNC(N)=O)C(NC(CCC/N=C(N)\N)C(NC2CC3=CC4=CC=CC=C4C=C3)=O)=O)=O)CNC2=O,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,4.9,uM,=,,100.0,-20.408,,,radioligand:[125I]-12G7,80.0,0.0,,0.0,,P61073,0.533447174074429
98,11154697,cxcr4_human,113,H,A,AMD3100,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CN3CCCNCCNCCCNCC3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,550.0,nM,=,,1500.0,-2.725,,,radioligand: [125I]-12G5,64.1025641025641,0.0,,0.0,,P61073,0.533447174074429
106,11154697,cxcr4_human,113,H,A,AMD3100,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CN3CCCNCCNCCCNCC3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,74.0,nM,=,,130.0,-1.757,,,radioligand: [125I]Met-CXCL12,27.058823529411764,0.0,,0.0,,P61073,0.533447174074429
118,12534283,cxcr4_human,113,H,A,AMD3100,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CN3CCCNCCNCCCNCC3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,1.0,uM,=,,1.4,-1.401,,,radioligand: [125I]-12G5,64.1025641025641,0.0,,0.0,,P61073,0.533447174074429
127,12534283,cxcr4_human,113,H,A,AMD3100,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CN3CCCNCCNCCCNCC3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,74.0,nM,=,,130.0,-1.757,,,radioligand: [125I]-Met-CXCL12,27.058823529411764,0.0,,0.0,,P61073,0.533447174074429
135,14585837,cxcr4_human,113,H,A,AMD3100,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CN3CCCNCCNCCCNCC3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.89,uM,=,,1.8,-2.024,,,radioligand:12G5(Bolton-Hunter),35.76642335766424,0.0,,0.0,,P61073,0.533447174074429
153,17599916,cxcr4_human,113,H,A,AMD3100,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CN3CCCNCCNCCCNCC3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.22,uM,=,,0.74,-3.367,,,CXCL12,0.0,0.0,,98.6469864698647,,P61073,0.533447174074429
169,17599916,cxcr4_human,113,H,A,AMD3100,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CN3CCCNCCNCCCNCC3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.89,uM,=,,2.0,-2.247,,,radioligand:[125I] -12G5,40.87591240875913,0.0,,0.0,,P61073,0.533447174074429
207,12534283,cxcr4_human,113,H,A,AMD3100(Zn)2,SMILES,N12CCC[N](Cc3ccc(C[N@@]45[Zn]67N(CCN6CCCN7CC5)CCC4)cc3)([Zn]289)CCN9CCCN8CC1,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.028,nM,=,,0.1,-3.571,,,radioligand: [125I]-12G5,64.1025641025641,0.0,,0.0,,P61073,0.533447174074429
215,12534283,cxcr4_human,113,H,A,AMD3100(Zn)2,SMILES,N12CCC[N](Cc3ccc(C[N@@]45[Zn]67N(CCN6CCCN7CC5)CCC4)cc3)([Zn]289)CCN9CCCN8CC1,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,12.0,nM,=,,23.0,-1.916,,,radioligand: [125I]-Met-CXCL12,27.058823529411764,0.0,,0.0,,P61073,0.533447174074429
227,17599916,cxcr4_human,113,H,A,AMD3389,SMILES,Cc1ccc(CN2CCCNCCNCCCNCC2)cc1,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,20.0,uM,=,,275.0,-13.699,,,CXCL12,0.0,0.0,,98.6469864698647,,P61073,0.533447174074429
244,17599916,cxcr4_human,113,H,A,AMD3465,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CNCC3=CC=CC=N3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.01,uM,=,,0.13,-12.987,,,CXCL12,0.0,0.0,,98.6469864698647,,P61073,0.533447174074429
261,17599916,cxcr4_human,113,H,A,AMD3465,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CNCC3=CC=CC=N3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.11,uM,=,,2.5,-22.727,,,radioligand:125I-12G5,40.87591240875913,0.0,,0.0,,P61073,0.533447174074429
299,14585837,cxcr4_human,113,H,A,AMD3479,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(C[N@@]3([Zn]456)CCCN4CCN6CCCN5CC3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.02,uM,=,,0.1,-5.0,,,radioligand:12G5(Bolton-Hunter),35.76642335766424,0.0,,0.0,,P61073,0.533447174074429
317,17599916,cxcr4_human,113,H,A,AMD3529,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CNCC3=CC=CC=C3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,1.7,uM,=,,18.0,-10.638,,,CXCL12,0.0,0.0,,109.49159491594916,,P61073,0.533447174074429
334,17599916,cxcr4_human,113,H,A,AMD8721,SMILES,N(CCN1CCCN2CC3)([Cu]124)CCC[N@]34Cc5ccc(CNCC6=CC=CC=N6)cc5,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.04,uM,=,,1.2,-30.303,,,CXCL12,0.0,0.0,,109.49159491594916,,P61073,0.533447174074429
351,17599916,cxcr4_human,113,H,A,AMD8899,SMILES,N1([Ni]234)CCC[N@@]4(Cc5ccc(CNCC6=CC=CC=N6)cc5)CCN3CCCN2CC1,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.01,uM,=,,0.17,-16.949,,,CXCL12,0.0,0.0,,109.49159491594916,,P61073,0.533447174074429
377,11154697,cxcr4_human,113,H,A,CXCL12,UniProt Entry Code,P48061,Full agonist,K(d),Binding - Radioligand competition/displacement,0.49,nM,=,,0.28,1.75,,,radioligand: [125I]Met-CXCL12,27.058823529411764,0.0,,0.0,,P61073,0.533447174074429
410,17599916,cxcr4_human,113,H,A,CXCL12,UniProt Entry Code,P48061,Full agonist,K(d),Binding - Radioligand competition/displacement,0.81,nM,=,,0.7,1.157,,,radioligand: [125I]-CXCL12,0.0,0.0,,109.49159491594916,,P61073,0.533447174074429
453,25039237,cxcr4_human,113,H,A,CXCL12,UniProt Entry Code,P48061,Full agonist,EC50,Functional - IP accumulation,1.5,nM,=,,0.84,1.786,,,,80.0,0.0,,0.0,,P61073,0.533447174074429
485,26397724,cxcr4_human,113,H,A,CXCL12,UniProt Entry Code,P48061,Full agonist,EC50,Functional - IP accumulation,1.5,nM,=,,0.84,1.786,,,CXCL12,80.0,0.0,,0.0,,P61073,0.533447174074429
532,11154697/12534283,cxcr4_human,113,H,A,cyclam,SMILES,C1CNCCNCCCNCCNC1,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,13.0,uM,=,,8.5,1.529,,,radioligand: [125I]-Met-CXCL12,27.058823529411764,0.0,,0.0,,P61073,0.533447174074429
540,12534283,cxcr4_human,113,H,A,Cyclam (Zn),SMILES,[Zn+2].C1CNCCNCCCNCCNC1,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,3.0,uM,=,,5.3,-1.767,,,radioligand: [125I]-Met-CXCL12,27.058823529411764,0.0,,0.0,,P61073,0.533447174074429
577,25039237,cxcr4_human,113,H,A,FC131,PubChem CID,5275843,Antagonist (neutral/silent),EC50,Functional - IP accumulation,0.4,uM,=,,48.0,-125.0,,,CXCL12,80.0,0.0,,0.0,,P61073,0.533447174074429
605,25039237,cxcr4_human,113,H,A,FC131,PubChem CID,5275843,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,0.76,uM,=,,48.0,-62.5,,,radioligand:[125I]-12G7,80.0,0.0,,0.0,,P61073,0.533447174074429
611,26397724,cxcr4_human,113,H,A,KRH1636,SMILES,CC(C1=CC=CC2=CC=CC=C21)NC(=O)C(CCCN=C(N)N)NC(=O)C3=CC=C(C=C3)CNCC4=CC=C,Antagonist (neutral/silent),EC50,Functional - IP accumulation,0.5,uM,=,,13.0,-26.316,,,CXCL12,80.0,0.0,,0.0,,P61073,0.533447174074429
636,26397724,cxcr4_human,113,H,A,KRH1636-5,SMILES,C[C@H](NC([C@H](CCCNC(N)=N)NC(C1=CC=C(CNCC2=CC=CC=C2)C=C1)=O)=O)C3=CC=CC4=C3C=CC=C4,Antagonist (neutral/silent),EC50,Functional - IP accumulation,8.5,uM,=,,100.0,-11.765,,,CXCL12,80.0,0.0,,0.0,,P61073,0.533447174074429
662,26397724,cxcr4_human,113,H,A,KRH1636-6,SMILES,C[C@H](NC([C@H](CCCNC(N)=N)NC(C1=CC=C(CN)C=C1)=O)=O)C2=CC=CC3=C2C=CC=C3,Antagonist (neutral/silent),EC50,Functional - IP accumulation,12.0,uM,=,,100.0,-8.333,,,CXCL12,80.0,0.0,,0.0,,P61073,0.533447174074429
686,26397724,cxcr4_human,113,H,A,KRK1636,SMILES,CC(C1=CC=CC2=CC=CC=C21)NC(=O)C(CCCN=C(N)N)NC(=O)C3=CC=C(C=C3)CNCC4=CC=C,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,8.0,uM,=,,100.0,-12.5,,,radioligand:[125I] -12G5,0.0,0.0,,0.0,,P61073,0.533447174074429
719,25039237,cxcr4_human,113,H,A,[D-Arg]FC131,SMILES,N\C(N)=N\CCCC1NC(=O)[C@H](CCC\N=C(\N)N)NC(=O)C(Cc2ccc(O)cc2)NC(=O)CNC(=O)C(Cc2ccc3ccccc3c2)NC1=O,Antagonist (neutral/silent),EC50,Functional - IP accumulation,0.52,uM,=,,100.0,-200.0,,,CXCL12,80.0,0.0,,0.0,,P61073,0.533447174074429
8,25039237,cxcr4_human,117,T,A,[Aib]FC131,SMILES,O=C(NC(CC1=CC=C(O)C=C1)C(NC(C)(C)C(NC(CCC/N=C(N)\N)C(NC2CC3=CC4=CC=CC=C4C=C3)=O)=O)=O)CNC2=O,Antagonist (neutral/silent),EC50,Functional - IP accumulation,2.9,uM,=,,1.0,2.9,,,CXCL12,74.0,0.0,,0.0,,P61073,0.4564349233139418
43,25039237,cxcr4_human,117,T,A,[Cit]FC131,SMILES,O=C(NC(CC1=CC=C(O)C=C1)C(NC(CCCNC(N)=O)C(NC(CCC/N=C(N)\N)C(NC2CC3=CC4=CC=CC=C4C=C3)=O)=O)=O)CNC2=O,Antagonist (neutral/silent),EC50,Functional - IP accumulation,3.0,uM,=,,4.2,-1.401,,,CXCL12,74.0,0.0,,0.0,,P61073,0.4564349233139418
136,14585837,cxcr4_human,117,T,A,AMD3100,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CN3CCCNCCNCCCNCC3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.89,uM,=,,0.46,1.935,,,radioligand:12G5(Bolton-Hunter),44.52554744525548,0.0,,0.0,,P61073,0.4564349233139418
300,14585837,cxcr4_human,117,T,A,AMD3479,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(C[N@@]3([Zn]456)CCCN4CCN6CCCN5CC3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.02,uM,=,,0.01,2.0,,,radioligand:12G5(Bolton-Hunter),44.52554744525548,0.0,,0.0,,P61073,0.4564349233139418
458,25039237,cxcr4_human,117,T,A,CXCL12,UniProt Entry Code,P48061,Full agonist,EC50,Functional - IP accumulation,1.5,nM,=,,1.7,-1.134,,,,74.0,0.0,,0.0,,P61073,0.4564349233139418
487,26397724,cxcr4_human,117,T,A,CXCL12,UniProt Entry Code,P48061,Full agonist,EC50,Functional - IP accumulation,1.5,nM,=,,1.7,-1.134,,,CXCL12,74.0,0.0,,0.0,,P61073,0.4564349233139418
579,25039237,cxcr4_human,117,T,A,FC131,PubChem CID,5275843,Antagonist (neutral/silent),EC50,Functional - IP accumulation,0.4,uM,=,,0.14,2.857,,,CXCL12,74.0,0.0,,0.0,,P61073,0.4564349233139418
613,26397724,cxcr4_human,117,T,A,KRH1636,SMILES,CC(C1=CC=CC2=CC=CC=C21)NC(=O)C(CCCN=C(N)N)NC(=O)C3=CC=C(C=C3)CNCC4=CC=C,Antagonist (neutral/silent),EC50,Functional - IP accumulation,0.5,uM,=,,0.17,2.941,,,CXCL12,74.0,0.0,,0.0,,P61073,0.4564349233139418
638,26397724,cxcr4_human,117,T,A,KRH1636-5,SMILES,C[C@H](NC([C@H](CCCNC(N)=N)NC(C1=CC=C(CNCC2=CC=CC=C2)C=C1)=O)=O)C3=CC=CC4=C3C=CC=C4,Antagonist (neutral/silent),EC50,Functional - IP accumulation,8.5,uM,=,,0.87,9.77,,,CXCL12,74.0,0.0,,0.0,,P61073,0.4564349233139418
664,26397724,cxcr4_human,117,T,A,KRH1636-6,SMILES,C[C@H](NC([C@H](CCCNC(N)=N)NC(C1=CC=C(CN)C=C1)=O)=O)C2=CC=CC3=C2C=CC=C3,Antagonist (neutral/silent),EC50,Functional - IP accumulation,12.0,uM,=,,1.4,8.571,,,CXCL12,74.0,0.0,,0.0,,P61073,0.4564349233139418
724,25039237,cxcr4_human,117,T,A,[D-Arg]FC131,SMILES,N\C(N)=N\CCCC1NC(=O)[C@H](CCC\N=C(\N)N)NC(=O)C(Cc2ccc(O)cc2)NC(=O)CNC(=O)C(Cc2ccc3ccccc3c2)NC1=O,Antagonist (neutral/silent),EC50,Functional - IP accumulation,0.52,uM,=,,0.74,-1.422,,,CXCL12,74.0,0.0,,0.0,,P61073,0.4564349233139418
9,25039237,cxcr4_human,171,D,N,[Aib]FC131,SMILES,O=C(NC(CC1=CC=C(O)C=C1)C(NC(C)(C)C(NC(CCC/N=C(N)\N)C(NC2CC3=CC4=CC=CC=C4C=C3)=O)=O)=O)CNC2=O,Antagonist (neutral/silent),EC50,Functional - IP accumulation,2.9,uM,=,,6.2,-2.137,,,CXCL12,67.0,0.0,,0.0,,P61073,0.3656487425762321
37,25039237,cxcr4_human,171,D,N,[Aib]FC131,SMILES,O=C(NC(CC1=CC=C(O)C=C1)C(NC(C)(C)C(NC(CCC/N=C(N)\N)C(NC2CC3=CC4=CC=CC=C4C=C3)=O)=O)=O)CNC2=O,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,2.9,uM,=,,100.0,-34.483,,,radioligand:[125I]-12G9,67.0,0.0,,0.0,,P61073,0.3656487425762321
44,25039237,cxcr4_human,171,D,N,[Cit]FC131,SMILES,O=C(NC(CC1=CC=C(O)C=C1)C(NC(CCCNC(N)=O)C(NC(CCC/N=C(N)\N)C(NC2CC3=CC4=CC=CC=C4C=C3)=O)=O)=O)CNC2=O,Antagonist (neutral/silent),EC50,Functional - IP accumulation,3.0,uM,=,,25.0,-8.333,,,CXCL12,67.0,0.0,,0.0,,P61073,0.3656487425762321
72,25039237,cxcr4_human,171,D,N,[Cit]FC131,SMILES,O=C(NC(CC1=CC=C(O)C=C1)C(NC(CCCNC(N)=O)C(NC(CCC/N=C(N)\N)C(NC2CC3=CC4=CC=CC=C4C=C3)=O)=O)=O)CNC2=O,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,4.9,uM,=,,47.0,-9.615,,,radioligand:[125I]-12G9,67.0,0.0,,0.0,,P61073,0.3656487425762321
77,18768385,cxcr4_human,171,D,N,AMD11070,SMILES,NCCCCN(CC1=NC2=CC=CC=C2N1)[C@@H]3C4=NC=CC=C4CCC3,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,11.0,nM,=,,13760.0,-1000.0,,,radioligand: [125I]-CXCL12,39.7,0.0,,0.0,,P61073,0.3656487425762321
91,11154697,cxcr4_human,171,D,N,AMD2763,SMILES,N1(CCCN2CCNCCCNCCNCCC2)CCCNCCNCCCNCC1,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.18,uM,=,,45.0,-250.0,,,radioligand: [125I]Met-CXCL12,29.411764705882355,0.0,,0.0,,P61073,0.3656487425762321
93,11154697,cxcr4_human,171,D,N,AMD2849,SMILES,N1(CCCCCCN2CCNCCCNCCNCCC2)CCCNCCNCCCNCC1,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,2.3,uM,=,,23.0,-10.0,,,radioligand: [125I]Met-CXCL12,29.411764705882355,0.0,,0.0,,P61073,0.3656487425762321
95,11154697,cxcr4_human,171,D,N,AMD2936,SMILES,[H][C@@]1(CCCN2CCNCCCNCCNCCC2)NCCCNCCNCCCNC1,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.65,uM,=,,58.0,-90.909,,,radioligand: [125I]Met-CXCL12,29.411764705882355,0.0,,0.0,,P61073,0.3656487425762321
99,11154697,cxcr4_human,171,D,N,AMD3100,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CN3CCCNCCNCCCNCC3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,550.0,nM,=,,100000.0,-200.0,,,radioligand: [125I]-12G5,71.7948717948718,0.0,,0.0,,P61073,0.3656487425762321
107,11154697,cxcr4_human,171,D,N,AMD3100,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CN3CCCNCCNCCCNCC3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,74.0,nM,=,,2800.0,-38.462,,,radioligand: [125I]Met-CXCL12,29.411764705882355,0.0,,0.0,,P61073,0.3656487425762321
119,12534283,cxcr4_human,171,D,N,AMD3100,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CN3CCCNCCNCCCNCC3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,1.0,uM,=,,12.0,-12.048,,,radioligand: [125I]-12G5,71.7948717948718,0.0,,0.0,,P61073,0.3656487425762321
128,12534283,cxcr4_human,171,D,N,AMD3100,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CN3CCCNCCNCCCNCC3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,74.0,nM,=,,6900.0,-90.909,,,radioligand: [125I]-Met-CXCL12,29.411764705882355,0.0,,0.0,,P61073,0.3656487425762321
138,14585837,cxcr4_human,171,D,N,AMD3100,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CN3CCCNCCNCCCNCC3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.89,uM,=,,13.0,-14.706,,,radioligand:12G5(Bolton-Hunter),51.09489051094891,0.0,,0.0,,P61073,0.3656487425762321
155,17599916,cxcr4_human,171,D,N,AMD3100,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CN3CCCNCCNCCCNCC3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.22,uM,=,,1.8,-8.197,,,CXCL12,0.0,0.0,,75.97375973759738,,P61073,0.3656487425762321
170,17599916,cxcr4_human,171,D,N,AMD3100,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CN3CCCNCCNCCCNCC3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.89,uM,=,,13.0,-14.706,,,radioligand:[125I] -12G5,51.09489051094891,0.0,,0.0,,P61073,0.3656487425762321
198,18768385,cxcr4_human,171,D,N,AMD3100,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CN3CCCNCCNCCCNCC3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,842.0,nM,=,,9584.0,-11.364,,,radioligand: [125I]-CXCL12,39.7,0.0,,0.0,,P61073,0.3656487425762321
208,12534283,cxcr4_human,171,D,N,AMD3100(Zn)2,SMILES,N12CCC[N](Cc3ccc(C[N@@]45[Zn]67N(CCN6CCCN7CC5)CCC4)cc3)([Zn]289)CCN9CCCN8CC1,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.028,nM,=,,0.52,-18.519,,,radioligand: [125I]-12G5,71.7948717948718,0.0,,0.0,,P61073,0.3656487425762321
216,12534283,cxcr4_human,171,D,N,AMD3100(Zn)2,SMILES,N12CCC[N](Cc3ccc(C[N@@]45[Zn]67N(CCN6CCCN7CC5)CCC4)cc3)([Zn]289)CCN9CCCN8CC1,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,12.0,nM,=,,1700.0,-142.857,,,radioligand: [125I]-Met-CXCL12,29.411764705882355,0.0,,0.0,,P61073,0.3656487425762321
223,11154697,cxcr4_human,171,D,N,AMD3106,SMILES,N1(CCCNCCNCCCNCC1)Cc2nc(CN3CCCNCCNCCCNCC3)ccc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.083,uM,=,,17.0,-200.0,,,radioligand: Met-CXCL12,29.411764705882355,0.0,,0.0,,P61073,0.3656487425762321
225,11154697,cxcr4_human,171,D,N,AMD3108,SMILES,N1(CCCNCCNCCCNCC1)Cc2cc(CN3CCCNCCNCCCNCC3)ncc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.85,uM,=,,68.0,-83.333,,,radioligand: Met-CXCL12,29.411764705882355,0.0,,0.0,,P61073,0.3656487425762321
229,17599916,cxcr4_human,171,D,N,AMD3389,SMILES,Cc1ccc(CN2CCCNCCNCCCNCC2)cc1,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,20.0,uM,=,,107.0,-5.348,,,CXCL12,0.0,0.0,,75.97375973759738,,P61073,0.3656487425762321
246,17599916,cxcr4_human,171,D,N,AMD3465,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CNCC3=CC=CC=N3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.01,uM,=,,0.18,-17.857,,,CXCL12,0.0,0.0,,75.97375973759738,,P61073,0.3656487425762321
262,17599916,cxcr4_human,171,D,N,AMD3465,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CNCC3=CC=CC=N3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.11,uM,=,,3.2,-29.412,,,radioligand:125I-12G5,51.09489051094891,0.0,,0.0,,P61073,0.3656487425762321
289,18768385,cxcr4_human,171,D,N,AMD3465,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CNCC3=CC=CC=N3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,49.0,nM,=,,1350.0,-27.778,,,radioligand: [125I]-CXCL12,39.7,0.0,,0.0,,P61073,0.3656487425762321
302,14585837,cxcr4_human,171,D,N,AMD3479,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(C[N@@]3([Zn]456)CCCN4CCN6CCCN5CC3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.02,uM,=,,0.28,-14.085,,,radioligand:12G5(Bolton-Hunter),51.09489051094891,0.0,,0.0,,P61073,0.3656487425762321
319,17599916,cxcr4_human,171,D,N,AMD3529,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CNCC3=CC=CC=C3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,1.7,uM,=,,14.0,-8.264,,,CXCL12,0.0,0.0,,52.767527675276746,,P61073,0.3656487425762321
336,17599916,cxcr4_human,171,D,N,AMD8721,SMILES,N(CCN1CCCN2CC3)([Cu]124)CCC[N@]34Cc5ccc(CNCC6=CC=CC=N6)cc5,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.04,uM,=,,0.43,-10.753,,,CXCL12,0.0,0.0,,52.767527675276746,,P61073,0.3656487425762321
353,17599916,cxcr4_human,171,D,N,AMD8899,SMILES,N1([Ni]234)CCC[N@@]4(Cc5ccc(CNCC6=CC=CC=N6)cc5)CCN3CCCN2CC1,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.01,uM,=,,0.13,-12.987,,,CXCL12,0.0,0.0,,52.767527675276746,,P61073,0.3656487425762321
378,11154697,cxcr4_human,171,D,N,CXCL12,UniProt Entry Code,P48061,Full agonist,K(d),Binding - Radioligand competition/displacement,0.49,nM,=,,0.58,-1.183,,,radioligand: [125I]Met-CXCL12,29.411764705882355,0.0,,0.0,,P61073,0.3656487425762321
412,17599916,cxcr4_human,171,D,N,CXCL12,UniProt Entry Code,P48061,Full agonist,K(d),Binding - Radioligand competition/displacement,0.81,nM,=,,4.2,-5.181,,,radioligand: [125I]-CXCL12,0.0,0.0,,52.767527675276746,,P61073,0.3656487425762321
437,18768385,cxcr4_human,171,D,N,CXCL12,UniProt Entry Code,P48061,Full agonist,K(d),Binding - Radioligand competition/displacement,35.8,nM,=,,73.6,-2.058,,,,39.7,0.0,,0.0,,P61073,0.3656487425762321
438,18768385,cxcr4_human,171,D,N,CXCL12,UniProt Entry Code,P48061,Full agonist,EC50,Functional - Ca2+ accumulation,34.0,nM,=,,137.9,-4.049,,,,39.7,0.0,,0.0,,P61073,0.3656487425762321
459,25039237,cxcr4_human,171,D,N,CXCL12,UniProt Entry Code,P48061,Full agonist,EC50,Functional - IP accumulation,1.5,nM,=,,3.2,-2.132,,,,67.0,0.0,,0.0,,P61073,0.3656487425762321
488,26397724,cxcr4_human,171,D,N,CXCL12,UniProt Entry Code,P48061,Full agonist,EC50,Functional - IP accumulation,1.5,nM,=,,3.2,-2.132,,,CXCL12,67.0,0.0,,0.0,,P61073,0.3656487425762321
533,11154697/12534283,cxcr4_human,171,D,N,cyclam,SMILES,C1CNCCNCCCNCCNC1,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,13.0,uM,=,,370.0,-28.571,,,radioligand: [125I]-Met-CXCL12,29.411764705882355,0.0,,0.0,,P61073,0.3656487425762321
541,12534283,cxcr4_human,171,D,N,Cyclam (Zn),SMILES,[Zn+2].C1CNCCNCCCNCCNC1,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,3.0,uM,=,,200.0,-66.667,,,radioligand: [125I]-Met-CXCL12,29.411764705882355,0.0,,0.0,,P61073,0.3656487425762321
580,25039237,cxcr4_human,171,D,N,FC131,PubChem CID,5275843,Antagonist (neutral/silent),EC50,Functional - IP accumulation,0.4,uM,=,,4.6,-11.494,,,CXCL12,67.0,0.0,,0.0,,P61073,0.3656487425762321
607,25039237,cxcr4_human,171,D,N,FC131,PubChem CID,5275843,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,0.76,uM,=,,55.0,-71.429,,,radioligand:[125I]-12G9,67.0,0.0,,0.0,,P61073,0.3656487425762321
614,26397724,cxcr4_human,171,D,N,KRH1636,SMILES,CC(C1=CC=CC2=CC=CC=C21)NC(=O)C(CCCN=C(N)N)NC(=O)C3=CC=C(C=C3)CNCC4=CC=C,Antagonist (neutral/silent),EC50,Functional - IP accumulation,0.5,uM,=,,2.7,-5.405,,,CXCL12,67.0,0.0,,0.0,,P61073,0.3656487425762321
639,26397724,cxcr4_human,171,D,N,KRH1636-5,SMILES,C[C@H](NC([C@H](CCCNC(N)=N)NC(C1=CC=C(CNCC2=CC=CC=C2)C=C1)=O)=O)C3=CC=CC4=C3C=CC=C4,Antagonist (neutral/silent),EC50,Functional - IP accumulation,8.5,uM,=,,68.0,-8.0,,,CXCL12,67.0,0.0,,0.0,,P61073,0.3656487425762321
665,26397724,cxcr4_human,171,D,N,KRH1636-6,SMILES,C[C@H](NC([C@H](CCCNC(N)=N)NC(C1=CC=C(CN)C=C1)=O)=O)C2=CC=CC3=C2C=CC=C3,Antagonist (neutral/silent),EC50,Functional - IP accumulation,12.0,uM,=,,231.0,-19.231,,,CXCL12,67.0,0.0,,0.0,,P61073,0.3656487425762321
688,26397724,cxcr4_human,171,D,N,KRK1636,SMILES,CC(C1=CC=CC2=CC=CC=C21)NC(=O)C(CCCN=C(N)N)NC(=O)C3=CC=C(C=C3)CNCC4=CC=C,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,8.0,uM,=,,67.0,-8.403,,,radioligand:[125I] -12G5,0.0,0.0,,0.0,,P61073,0.3656487425762321
725,25039237,cxcr4_human,171,D,N,[D-Arg]FC131,SMILES,N\C(N)=N\CCCC1NC(=O)[C@H](CCC\N=C(\N)N)NC(=O)C(Cc2ccc(O)cc2)NC(=O)CNC(=O)C(Cc2ccc3ccccc3c2)NC1=O,Antagonist (neutral/silent),EC50,Functional - IP accumulation,0.52,uM,=,,28.0,-52.632,,,CXCL12,67.0,0.0,,0.0,,P61073,0.3656487425762321
748,25039237,cxcr4_human,171,D,N,[D-Arg]FC131,SMILES,N\C(N)=N\CCCC1NC(=O)[C@H](CCC\N=C(\N)N)NC(=O)C(Cc2ccc(O)cc2)NC(=O)CNC(=O)C(Cc2ccc3ccccc3c2)NC1=O,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,0.38,uM,=,,100.0,-250.0,,,radioligand:[125I]-12G5,67.0,0.0,,0.0,,P61073,0.3656487425762321
11,25039237,cxcr4_human,187,D,A,[Aib]FC131,SMILES,O=C(NC(CC1=CC=C(O)C=C1)C(NC(C)(C)C(NC(CCC/N=C(N)\N)C(NC2CC3=CC4=CC=CC=C4C=C3)=O)=O)=O)CNC2=O,Antagonist (neutral/silent),EC50,Functional - IP accumulation,2.9,uM,=,,0.49,5.918,,,CXCL12,49.0,0.0,,0.0,,P61073,0.3006141287246474
29,25039237,cxcr4_human,187,D,A,[Aib]FC131,SMILES,O=C(NC(CC1=CC=C(O)C=C1)C(NC(C)(C)C(NC(CCC/N=C(N)\N)C(NC2CC3=CC4=CC=CC=C4C=C3)=O)=O)=O)CNC2=O,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,2.9,uM,=,,2.6,1.115,,,radioligand:[125I]-12G10,49.0,0.0,,0.0,,P61073,0.3006141287246474
46,25039237,cxcr4_human,187,D,A,[Cit]FC131,SMILES,O=C(NC(CC1=CC=C(O)C=C1)C(NC(CCCNC(N)=O)C(NC(CCC/N=C(N)\N)C(NC2CC3=CC4=CC=CC=C4C=C3)=O)=O)=O)CNC2=O,Antagonist (neutral/silent),EC50,Functional - IP accumulation,3.0,uM,=,,0.76,3.947,,,CXCL12,49.0,0.0,,0.0,,P61073,0.3006141287246474
64,25039237,cxcr4_human,187,D,A,[Cit]FC131,SMILES,O=C(NC(CC1=CC=C(O)C=C1)C(NC(CCCNC(N)=O)C(NC(CCC/N=C(N)\N)C(NC2CC3=CC4=CC=CC=C4C=C3)=O)=O)=O)CNC2=O,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,4.9,uM,=,,4.3,1.14,,,radioligand:[125I]-12G10,49.0,0.0,,0.0,,P61073,0.3006141287246474
176,17599916,cxcr4_human,187,D,A,AMD3100,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CN3CCCNCCNCCCNCC3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.89,uM,=,,14.0,-15.625,,,radioligand:[125I] -12G5,95.62043795620438,0.0,,0.0,,P61073,0.3006141287246474
268,17599916,cxcr4_human,187,D,A,AMD3465,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CNCC3=CC=CC=N3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.11,uM,=,,0.53,-4.808,,,radioligand:125I-12G5,95.62043795620438,0.0,,0.0,,P61073,0.3006141287246474
461,25039237,cxcr4_human,187,D,A,CXCL12,UniProt Entry Code,P48061,Full agonist,EC50,Functional - IP accumulation,1.5,nM,=,,13.0,-8.696,,,,49.0,0.0,,0.0,,P61073,0.3006141287246474
480,25468967,cxcr4_human,187,D,A,CXCL12,UniProt Entry Code,P48061,Full agonist,pEC50,Functional - Ca2+ accumulation,8.8,,=,,7.46,-21.739,,,,100.0,0.0,,0.0,,P61073,0.3006141287246474
490,26397724,cxcr4_human,187,D,A,CXCL12,UniProt Entry Code,P48061,Full agonist,EC50,Functional - IP accumulation,1.5,nM,=,,13.0,-8.696,,,CXCL12,49.0,0.0,,0.0,,P61073,0.3006141287246474
517,16188969/16306611,cxcr4_human,187,D,A,CXCL12,UniProt Entry Code,P48061,Full agonist,IC50,Binding - Radioligand saturation,2.2,nM,=,,4.7,-2.137,,,radioligand: [125I]-CXCL12,111.9,0.0,,0.0,,P61073,0.3006141287246474
582,25039237,cxcr4_human,187,D,A,FC131,PubChem CID,5275843,Antagonist (neutral/silent),EC50,Functional - IP accumulation,0.4,uM,=,,0.14,2.857,,,CXCL12,49.0,0.0,,0.0,,P61073,0.3006141287246474
599,25039237,cxcr4_human,187,D,A,FC131,PubChem CID,5275843,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,0.76,uM,=,,7.7,-10.101,,,radioligand:[125I]-12G10,49.0,0.0,,0.0,,P61073,0.3006141287246474
616,26397724,cxcr4_human,187,D,A,KRH1636,SMILES,CC(C1=CC=CC2=CC=CC=C21)NC(=O)C(CCCN=C(N)N)NC(=O)C3=CC=C(C=C3)CNCC4=CC=C,Antagonist (neutral/silent),EC50,Functional - IP accumulation,0.5,uM,=,,0.35,1.429,,,CXCL12,49.0,0.0,,0.0,,P61073,0.3006141287246474
641,26397724,cxcr4_human,187,D,A,KRH1636-5,SMILES,C[C@H](NC([C@H](CCCNC(N)=N)NC(C1=CC=C(CNCC2=CC=CC=C2)C=C1)=O)=O)C3=CC=CC4=C3C=CC=C4,Antagonist (neutral/silent),EC50,Functional - IP accumulation,8.5,uM,=,,4.1,2.073,,,CXCL12,49.0,0.0,,0.0,,P61073,0.3006141287246474
667,26397724,cxcr4_human,187,D,A,KRH1636-6,SMILES,C[C@H](NC([C@H](CCCNC(N)=N)NC(C1=CC=C(CN)C=C1)=O)=O)C2=CC=CC3=C2C=CC=C3,Antagonist (neutral/silent),EC50,Functional - IP accumulation,12.0,uM,=,,5.4,2.222,,,CXCL12,49.0,0.0,,0.0,,P61073,0.3006141287246474
689,26397724,cxcr4_human,187,D,A,KRK1636,SMILES,CC(C1=CC=CC2=CC=CC=C21)NC(=O)C(CCCN=C(N)N)NC(=O)C3=CC=C(C=C3)CNCC4=CC=C,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,8.0,uM,=,,26.0,-3.247,,,radioligand:[125I] -12G5,0.0,0.0,,0.0,,P61073,0.3006141287246474
727,25039237,cxcr4_human,187,D,A,[D-Arg]FC131,SMILES,N\C(N)=N\CCCC1NC(=O)[C@H](CCC\N=C(\N)N)NC(=O)C(Cc2ccc(O)cc2)NC(=O)CNC(=O)C(Cc2ccc3ccccc3c2)NC1=O,Antagonist (neutral/silent),EC50,Functional - IP accumulation,0.52,uM,=,,0.35,1.486,,,CXCL12,49.0,0.0,,0.0,,P61073,0.3006141287246474
749,25039237,cxcr4_human,187,D,A,[D-Arg]FC131,SMILES,N\C(N)=N\CCCC1NC(=O)[C@H](CCC\N=C(\N)N)NC(=O)C(Cc2ccc(O)cc2)NC(=O)CNC(=O)C(Cc2ccc3ccccc3c2)NC1=O,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,0.38,uM,=,,12.0,-31.25,,,radioligand:[125I]-12G5,49.0,0.0,,0.0,,P61073,0.3006141287246474
12,25039237,cxcr4_human,188,R,A,[Aib]FC131,SMILES,O=C(NC(CC1=CC=C(O)C=C1)C(NC(C)(C)C(NC(CCC/N=C(N)\N)C(NC2CC3=CC4=CC=CC=C4C=C3)=O)=O)=O)CNC2=O,Antagonist (neutral/silent),EC50,Functional - IP accumulation,2.9,uM,=,,10.0,-3.448,,,CXCL12,174.0,0.0,,0.0,,P61073,0.4422323246060745
47,25039237,cxcr4_human,188,R,A,[Cit]FC131,SMILES,O=C(NC(CC1=CC=C(O)C=C1)C(NC(CCCNC(N)=O)C(NC(CCC/N=C(N)\N)C(NC2CC3=CC4=CC=CC=C4C=C3)=O)=O)=O)CNC2=O,Antagonist (neutral/silent),EC50,Functional - IP accumulation,3.0,uM,=,,44.0,-14.706,,,CXCL12,174.0,0.0,,0.0,,P61073,0.4422323246060745
462,25039237,cxcr4_human,188,R,A,CXCL12,UniProt Entry Code,P48061,Full agonist,EC50,Functional - IP accumulation,1.5,nM,=,,0.53,2.83,,,,174.0,0.0,,0.0,,P61073,0.4422323246060745
491,26397724,cxcr4_human,188,R,A,CXCL12,UniProt Entry Code,P48061,Full agonist,EC50,Functional - IP accumulation,1.5,nM,=,,0.53,2.83,,,CXCL12,174.0,0.0,,0.0,,P61073,0.4422323246060745
583,25039237,cxcr4_human,188,R,A,FC131,PubChem CID,5275843,Antagonist (neutral/silent),EC50,Functional - IP accumulation,0.4,uM,=,,0.72,-1.799,,,CXCL12,174.0,0.0,,0.0,,P61073,0.4422323246060745
617,26397724,cxcr4_human,188,R,A,KRH1636,SMILES,CC(C1=CC=CC2=CC=CC=C21)NC(=O)C(CCCN=C(N)N)NC(=O)C3=CC=C(C=C3)CNCC4=CC=C,Antagonist (neutral/silent),EC50,Functional - IP accumulation,0.5,uM,=,,0.86,-1.721,,,CXCL12,174.0,0.0,,0.0,,P61073,0.4422323246060745
642,26397724,cxcr4_human,188,R,A,KRH1636-5,SMILES,C[C@H](NC([C@H](CCCNC(N)=N)NC(C1=CC=C(CNCC2=CC=CC=C2)C=C1)=O)=O)C3=CC=CC4=C3C=CC=C4,Antagonist (neutral/silent),EC50,Functional - IP accumulation,8.5,uM,=,,8.4,1.012,,,CXCL12,174.0,0.0,,0.0,,P61073,0.4422323246060745
668,26397724,cxcr4_human,188,R,A,KRH1636-6,SMILES,C[C@H](NC([C@H](CCCNC(N)=N)NC(C1=CC=C(CN)C=C1)=O)=O)C2=CC=CC3=C2C=CC=C3,Antagonist (neutral/silent),EC50,Functional - IP accumulation,12.0,uM,=,,25.0,-2.083,,,CXCL12,174.0,0.0,,0.0,,P61073,0.4422323246060745
728,25039237,cxcr4_human,188,R,A,[D-Arg]FC131,SMILES,N\C(N)=N\CCCC1NC(=O)[C@H](CCC\N=C(\N)N)NC(=O)C(Cc2ccc(O)cc2)NC(=O)CNC(=O)C(Cc2ccc3ccccc3c2)NC1=O,Antagonist (neutral/silent),EC50,Functional - IP accumulation,0.52,uM,=,,2.2,-4.237,,,CXCL12,174.0,0.0,,0.0,,P61073,0.4422323246060745
13,25039237,cxcr4_human,189,F,A,[Aib]FC131,SMILES,O=C(NC(CC1=CC=C(O)C=C1)C(NC(C)(C)C(NC(CCC/N=C(N)\N)C(NC2CC3=CC4=CC=CC=C4C=C3)=O)=O)=O)CNC2=O,Antagonist (neutral/silent),EC50,Functional - IP accumulation,2.9,uM,=,,0.31,9.355,,,CXCL12,97.0,0.0,,0.0,,P61073,0.3116129814425882
48,25039237,cxcr4_human,189,F,A,[Cit]FC131,SMILES,O=C(NC(CC1=CC=C(O)C=C1)C(NC(CCCNC(N)=O)C(NC(CCC/N=C(N)\N)C(NC2CC3=CC4=CC=CC=C4C=C3)=O)=O)=O)CNC2=O,Antagonist (neutral/silent),EC50,Functional - IP accumulation,3.0,uM,=,,0.79,3.797,,,CXCL12,97.0,0.0,,0.0,,P61073,0.3116129814425882
451,22039044,cxcr4_human,189,F,A,CXCL12,UniProt Entry Code,P48061,Full agonist,Single-point,,100.0,,~,,0.0,130.0,,,,38.70967741935484,0.0,,0.0,,P61073,0.3116129814425882
463,25039237,cxcr4_human,189,F,A,CXCL12,UniProt Entry Code,P48061,Full agonist,EC50,Functional - IP accumulation,1.5,nM,=,,1.8,-1.2,,,,97.0,0.0,,0.0,,P61073,0.3116129814425882
492,26397724,cxcr4_human,189,F,A,CXCL12,UniProt Entry Code,P48061,Full agonist,EC50,Functional - IP accumulation,1.5,nM,=,,1.8,-1.2,,,CXCL12,97.0,0.0,,0.0,,P61073,0.3116129814425882
518,16188969/16306611,cxcr4_human,189,F,A,CXCL12,UniProt Entry Code,P48061,Full agonist,IC50,Binding - Radioligand saturation,2.2,nM,=,,8.0,-3.636,,,radioligand: [125I]-CXCL12,98.5,0.0,,0.0,,P61073,0.3116129814425882
584,25039237,cxcr4_human,189,F,A,FC131,PubChem CID,5275843,Antagonist (neutral/silent),EC50,Functional - IP accumulation,0.4,uM,=,,0.1,4.0,,,CXCL12,97.0,0.0,,0.0,,P61073,0.3116129814425882
618,26397724,cxcr4_human,189,F,A,KRH1636,SMILES,CC(C1=CC=CC2=CC=CC=C21)NC(=O)C(CCCN=C(N)N)NC(=O)C3=CC=C(C=C3)CNCC4=CC=C,Antagonist (neutral/silent),EC50,Functional - IP accumulation,0.5,uM,=,,0.13,3.846,,,CXCL12,97.0,0.0,,0.0,,P61073,0.3116129814425882
643,26397724,cxcr4_human,189,F,A,KRH1636-5,SMILES,C[C@H](NC([C@H](CCCNC(N)=N)NC(C1=CC=C(CNCC2=CC=CC=C2)C=C1)=O)=O)C3=CC=CC4=C3C=CC=C4,Antagonist (neutral/silent),EC50,Functional - IP accumulation,8.5,uM,=,,0.74,11.486,,,CXCL12,97.0,0.0,,0.0,,P61073,0.3116129814425882
669,26397724,cxcr4_human,189,F,A,KRH1636-6,SMILES,C[C@H](NC([C@H](CCCNC(N)=N)NC(C1=CC=C(CN)C=C1)=O)=O)C2=CC=CC3=C2C=CC=C3,Antagonist (neutral/silent),EC50,Functional - IP accumulation,12.0,uM,=,,1.0,12.0,,,CXCL12,97.0,0.0,,0.0,,P61073,0.3116129814425882
698,22039044,cxcr4_human,189,F,A,Ubiquitin,UniProt Entry Code,P0CG48,Agonist,Single-point,,100.0,%,=,,0.0,35.0,,,,38.70967741935484,0.0,,0.0,,P61073,0.3116129814425882
729,25039237,cxcr4_human,189,F,A,[D-Arg]FC131,SMILES,N\C(N)=N\CCCC1NC(=O)[C@H](CCC\N=C(\N)N)NC(=O)C(Cc2ccc(O)cc2)NC(=O)CNC(=O)C(Cc2ccc3ccccc3c2)NC1=O,Antagonist (neutral/silent),EC50,Functional - IP accumulation,0.52,uM,=,,0.15,3.467,,,CXCL12,97.0,0.0,,0.0,,P61073,0.3116129814425882
14,25039237,cxcr4_human,190,Y,A,[Aib]FC131,SMILES,O=C(NC(CC1=CC=C(O)C=C1)C(NC(C)(C)C(NC(CCC/N=C(N)\N)C(NC2CC3=CC4=CC=CC=C4C=C3)=O)=O)=O)CNC2=O,Antagonist (neutral/silent),EC50,Functional - IP accumulation,2.9,uM,=,,4.0,-1.379,,,CXCL12,105.0,0.0,,0.0,,P61073,0.4044844416665799
50,25039237,cxcr4_human,190,Y,A,[Cit]FC131,SMILES,O=C(NC(CC1=CC=C(O)C=C1)C(NC(CCCNC(N)=O)C(NC(CCC/N=C(N)\N)C(NC2CC3=CC4=CC=CC=C4C=C3)=O)=O)=O)CNC2=O,Antagonist (neutral/silent),EC50,Functional - IP accumulation,3.0,uM,=,,2.6,1.154,,,CXCL12,105.0,0.0,,0.0,,P61073,0.4044844416665799
398,11551942,cxcr4_human,190,Y,A,CXCL12,UniProt Entry Code,P48061,Full agonist,Single-point,Binding - Radioligand competition/displacement,100.0,%,~,,0.0,125.0,,,[125I]-SDF-1Î±,140.0,0.0,,0.0,,P61073,0.4044844416665799
399,11551942,cxcr4_human,190,Y,A,CXCL12,UniProt Entry Code,P48061,Full agonist,Single-point,Binding - Radioligand competition/displacement,100.0,%,~,,0.0,75.0,,,12G5,140.0,0.0,,0.0,,P61073,0.4044844416665799
464,25039237,cxcr4_human,190,Y,A,CXCL12,UniProt Entry Code,P48061,Full agonist,EC50,Functional - IP accumulation,1.5,nM,=,,1.2,1.25,,,,105.0,0.0,,0.0,,P61073,0.4044844416665799
493,26397724,cxcr4_human,190,Y,A,CXCL12,UniProt Entry Code,P48061,Full agonist,EC50,Functional - IP accumulation,1.5,nM,=,,1.2,1.25,,,CXCL12,105.0,0.0,,0.0,,P61073,0.4044844416665799
585,25039237,cxcr4_human,190,Y,A,FC131,PubChem CID,5275843,Antagonist (neutral/silent),EC50,Functional - IP accumulation,0.4,uM,=,,0.47,-1.175,,,CXCL12,105.0,0.0,,0.0,,P61073,0.4044844416665799
619,26397724,cxcr4_human,190,Y,A,KRH1636,SMILES,CC(C1=CC=CC2=CC=CC=C21)NC(=O)C(CCCN=C(N)N)NC(=O)C3=CC=C(C=C3)CNCC4=CC=C,Antagonist (neutral/silent),EC50,Functional - IP accumulation,0.5,uM,=,,0.27,1.852,,,CXCL12,105.0,0.0,,0.0,,P61073,0.4044844416665799
644,26397724,cxcr4_human,190,Y,A,KRH1636-5,SMILES,C[C@H](NC([C@H](CCCNC(N)=N)NC(C1=CC=C(CNCC2=CC=CC=C2)C=C1)=O)=O)C3=CC=CC4=C3C=CC=C4,Antagonist (neutral/silent),EC50,Functional - IP accumulation,8.5,uM,=,,12.0,-1.412,,,CXCL12,105.0,0.0,,0.0,,P61073,0.4044844416665799
670,26397724,cxcr4_human,190,Y,A,KRH1636-6,SMILES,C[C@H](NC([C@H](CCCNC(N)=N)NC(C1=CC=C(CN)C=C1)=O)=O)C2=CC=CC3=C2C=CC=C3,Antagonist (neutral/silent),EC50,Functional - IP accumulation,12.0,uM,=,,12.0,1.0,,,CXCL12,105.0,0.0,,0.0,,P61073,0.4044844416665799
713,11551942,cxcr4_human,190,Y,A,vMIP-II,UniProt Entry Code,Q98157,Antagonist (neutral/silent),Single-point,Binding - Radioligand competition/displacement,100.0,%,=,,0.0,120.0,,,[125I]-SDF-1Î±,140.0,0.0,,0.0,,P61073,0.4044844416665799
714,11551942,cxcr4_human,190,Y,A,vMIP-II,UniProt Entry Code,Q98157,Antagonist (neutral/silent),Single-point,Binding - Radioligand competition/displacement,100.0,%,=,,0.0,230.0,,,12G5,140.0,0.0,,0.0,,P61073,0.4044844416665799
730,25039237,cxcr4_human,190,Y,A,[D-Arg]FC131,SMILES,N\C(N)=N\CCCC1NC(=O)[C@H](CCC\N=C(\N)N)NC(=O)C(Cc2ccc(O)cc2)NC(=O)CNC(=O)C(Cc2ccc3ccccc3c2)NC1=O,Antagonist (neutral/silent),EC50,Functional - IP accumulation,0.52,uM,=,,0.66,-1.269,,,CXCL12,105.0,0.0,,0.0,,P61073,0.4044844416665799
15,25039237,cxcr4_human,196,V,A,[Aib]FC131,SMILES,O=C(NC(CC1=CC=C(O)C=C1)C(NC(C)(C)C(NC(CCC/N=C(N)\N)C(NC2CC3=CC4=CC=CC=C4C=C3)=O)=O)=O)CNC2=O,Antagonist (neutral/silent),EC50,Functional - IP accumulation,2.9,uM,=,,4.6,-1.587,,,CXCL12,101.0,0.0,,0.0,,P61073,0.2416552944462486
51,25039237,cxcr4_human,196,V,A,[Cit]FC131,SMILES,O=C(NC(CC1=CC=C(O)C=C1)C(NC(CCCNC(N)=O)C(NC(CCC/N=C(N)\N)C(NC2CC3=CC4=CC=CC=C4C=C3)=O)=O)=O)CNC2=O,Antagonist (neutral/silent),EC50,Functional - IP accumulation,3.0,uM,=,,3.6,-1.2,,,CXCL12,101.0,0.0,,0.0,,P61073,0.2416552944462486
85,18768385,cxcr4_human,196,V,A,AMD11070,SMILES,NCCCCN(CC1=NC2=CC=CC=C2N1)[C@@H]3C4=NC=CC=C4CCC3,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,11.0,nM,=,,28.0,-2.545,,,radioligand: [125I]-CXCL20,89.2,0.0,,0.0,,P61073,0.2416552944462486
141,14585837,cxcr4_human,196,V,A,AMD3100,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CN3CCCNCCNCCCNCC3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.89,uM,=,,4.6,-5.181,,,radioligand:12G5(Bolton-Hunter),19.708029197080293,0.0,,0.0,,P61073,0.2416552944462486
158,17599916,cxcr4_human,196,V,A,AMD3100,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CN3CCCNCCNCCCNCC3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.22,uM,=,,0.14,1.571,,,CXCL12,0.0,0.0,,109.49159491594916,,P61073,0.2416552944462486
177,17599916,cxcr4_human,196,V,A,AMD3100,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CN3CCCNCCNCCCNCC3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.89,uM,=,,4.6,-5.181,,,radioligand:[125I] -12G5,19.708029197080293,0.0,,0.0,,P61073,0.2416552944462486
201,18768385,cxcr4_human,196,V,A,AMD3100,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CN3CCCNCCNCCCNCC3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,842.0,nM,=,,1205.0,-1.431,,,radioligand: [125I]-CXCL12,89.2,0.0,,0.0,,P61073,0.2416552944462486
232,17599916,cxcr4_human,196,V,A,AMD3389,SMILES,Cc1ccc(CN2CCCNCCNCCCNCC2)cc1,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,20.0,uM,=,,28.0,-1.401,,,CXCL12,0.0,0.0,,109.49159491594916,,P61073,0.2416552944462486
249,17599916,cxcr4_human,196,V,A,AMD3465,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CNCC3=CC=CC=N3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.01,uM,=,,0.02,-2.0,,,CXCL12,0.0,0.0,,109.49159491594916,,P61073,0.2416552944462486
269,17599916,cxcr4_human,196,V,A,AMD3465,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CNCC3=CC=CC=N3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.11,uM,=,,1.8,-16.393,,,radioligand:125I-12G5,19.708029197080293,0.0,,0.0,,P61073,0.2416552944462486
292,18768385,cxcr4_human,196,V,A,AMD3465,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CNCC3=CC=CC=N3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,49.0,nM,=,,124.0,-2.532,,,radioligand: [125I]-CXCL12,89.2,0.0,,0.0,,P61073,0.2416552944462486
305,14585837,cxcr4_human,196,V,A,AMD3479,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(C[N@@]3([Zn]456)CCCN4CCN6CCCN5CC3)cc2,,K(i),Binding - Radioligand competition/displacement,0.02,uM,=,,1.7,-83.333,,,radioligand:12G5(Bolton-Hunter),19.708029197080293,0.0,,0.0,,P61073,0.2416552944462486
322,17599916,cxcr4_human,196,V,A,AMD3529,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CNCC3=CC=CC=C3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,1.7,uM,=,,1.3,1.308,,,CXCL12,0.0,0.0,,73.49323493234932,,P61073,0.2416552944462486
339,17599916,cxcr4_human,196,V,A,AMD8721,SMILES,N(CCN1CCCN2CC3)([Cu]124)CCC[N@]34Cc5ccc(CNCC6=CC=CC=N6)cc5,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.04,uM,=,,0.07,-1.751,,,CXCL12,0.0,0.0,,73.49323493234932,,P61073,0.2416552944462486
356,17599916,cxcr4_human,196,V,A,AMD8899,SMILES,N1([Ni]234)CCC[N@@]4(Cc5ccc(CNCC6=CC=CC=N6)cc5)CCN3CCCN2CC1,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.01,uM,=,,0.04,-4.0,,,CXCL12,0.0,0.0,,73.49323493234932,,P61073,0.2416552944462486
415,17599916,cxcr4_human,196,V,A,CXCL12,UniProt Entry Code,P48061,Full agonist,K(d),Binding - Radioligand competition/displacement,0.81,nM,=,,2.1,-2.591,,,radioligand: [125I]-CXCL12,0.0,0.0,,73.49323493234932,,P61073,0.2416552944462486
443,18768385,cxcr4_human,196,V,A,CXCL12,UniProt Entry Code,P48061,Full agonist,K(d),Binding - Radioligand competition/displacement,35.8,nM,=,,22.7,1.577,,,,89.2,0.0,,0.0,,P61073,0.2416552944462486
444,18768385,cxcr4_human,196,V,A,CXCL12,UniProt Entry Code,P48061,Full agonist,EC50,Functional - Ca2+ accumulation,34.0,nM,=,,138.2,-4.065,,,,89.2,0.0,,0.0,,P61073,0.2416552944462486
465,25039237,cxcr4_human,196,V,A,CXCL12,UniProt Entry Code,P48061,Full agonist,EC50,Functional - IP accumulation,1.5,nM,=,,1.4,1.071,,,,101.0,0.0,,0.0,,P61073,0.2416552944462486
494,26397724,cxcr4_human,196,V,A,CXCL12,UniProt Entry Code,P48061,Full agonist,EC50,Functional - IP accumulation,1.5,nM,=,,1.4,1.071,,,CXCL12,101.0,0.0,,0.0,,P61073,0.2416552944462486
586,25039237,cxcr4_human,196,V,A,FC131,PubChem CID,5275843,Antagonist (neutral/silent),EC50,Functional - IP accumulation,0.4,uM,=,,0.47,-1.175,,,CXCL12,101.0,0.0,,0.0,,P61073,0.2416552944462486
620,26397724,cxcr4_human,196,V,A,KRH1636,SMILES,CC(C1=CC=CC2=CC=CC=C21)NC(=O)C(CCCN=C(N)N)NC(=O)C3=CC=C(C=C3)CNCC4=CC=C,Antagonist (neutral/silent),EC50,Functional - IP accumulation,0.5,uM,=,,1.4,-2.801,,,CXCL12,101.0,0.0,,0.0,,P61073,0.2416552944462486
645,26397724,cxcr4_human,196,V,A,KRH1636-5,SMILES,C[C@H](NC([C@H](CCCNC(N)=N)NC(C1=CC=C(CNCC2=CC=CC=C2)C=C1)=O)=O)C3=CC=CC4=C3C=CC=C4,Antagonist (neutral/silent),EC50,Functional - IP accumulation,8.5,uM,=,,4.2,2.024,,,CXCL12,101.0,0.0,,0.0,,P61073,0.2416552944462486
671,26397724,cxcr4_human,196,V,A,KRH1636-6,SMILES,C[C@H](NC([C@H](CCCNC(N)=N)NC(C1=CC=C(CN)C=C1)=O)=O)C2=CC=CC3=C2C=CC=C3,Antagonist (neutral/silent),EC50,Functional - IP accumulation,12.0,uM,=,,13.0,-1.083,,,CXCL12,101.0,0.0,,0.0,,P61073,0.2416552944462486
731,25039237,cxcr4_human,196,V,A,[D-Arg]FC131,SMILES,N\C(N)=N\CCCC1NC(=O)[C@H](CCC\N=C(\N)N)NC(=O)C(Cc2ccc(O)cc2)NC(=O)CNC(=O)C(Cc2ccc3ccccc3c2)NC1=O,Antagonist (neutral/silent),EC50,Functional - IP accumulation,0.52,uM,=,,1.6,-3.077,,,CXCL12,101.0,0.0,,0.0,,P61073,0.2416552944462486
16,25039237,cxcr4_human,199,F,A,[Aib]FC131,SMILES,O=C(NC(CC1=CC=C(O)C=C1)C(NC(C)(C)C(NC(CCC/N=C(N)\N)C(NC2CC3=CC4=CC=CC=C4C=C3)=O)=O)=O)CNC2=O,Antagonist (neutral/silent),EC50,Functional - IP accumulation,2.9,uM,=,,2.9,1.0,,,CXCL12,79.0,0.0,,0.0,,P61073,0.4337043081197642
52,25039237,cxcr4_human,199,F,A,[Cit]FC131,SMILES,O=C(NC(CC1=CC=C(O)C=C1)C(NC(CCCNC(N)=O)C(NC(CCC/N=C(N)\N)C(NC2CC3=CC4=CC=CC=C4C=C3)=O)=O)=O)CNC2=O,Antagonist (neutral/silent),EC50,Functional - IP accumulation,3.0,uM,=,,2.3,1.304,,,CXCL12,79.0,0.0,,0.0,,P61073,0.4337043081197642
466,25039237,cxcr4_human,199,F,A,CXCL12,UniProt Entry Code,P48061,Full agonist,EC50,Functional - IP accumulation,1.5,nM,=,,1.4,1.071,,,,79.0,0.0,,0.0,,P61073,0.4337043081197642
495,26397724,cxcr4_human,199,F,A,CXCL12,UniProt Entry Code,P48061,Full agonist,EC50,Functional - IP accumulation,1.5,nM,=,,1.4,1.071,,,CXCL12,79.0,0.0,,0.0,,P61073,0.4337043081197642
587,25039237,cxcr4_human,199,F,A,FC131,PubChem CID,5275843,Antagonist (neutral/silent),EC50,Functional - IP accumulation,0.4,uM,=,,0.21,1.905,,,CXCL12,79.0,0.0,,0.0,,P61073,0.4337043081197642
621,26397724,cxcr4_human,199,F,A,KRH1636,SMILES,CC(C1=CC=CC2=CC=CC=C21)NC(=O)C(CCCN=C(N)N)NC(=O)C3=CC=C(C=C3)CNCC4=CC=C,Antagonist (neutral/silent),EC50,Functional - IP accumulation,0.5,uM,=,,0.69,-1.379,,,CXCL12,79.0,0.0,,0.0,,P61073,0.4337043081197642
732,25039237,cxcr4_human,199,F,A,[D-Arg]FC131,SMILES,N\C(N)=N\CCCC1NC(=O)[C@H](CCC\N=C(\N)N)NC(=O)C(Cc2ccc(O)cc2)NC(=O)CNC(=O)C(Cc2ccc3ccccc3c2)NC1=O,Antagonist (neutral/silent),EC50,Functional - IP accumulation,0.52,uM,=,,0.31,1.677,,,CXCL12,79.0,0.0,,0.0,,P61073,0.4337043081197642
17,25039237,cxcr4_human,200,Q,A,[Aib]FC131,SMILES,O=C(NC(CC1=CC=C(O)C=C1)C(NC(C)(C)C(NC(CCC/N=C(N)\N)C(NC2CC3=CC4=CC=CC=C4C=C3)=O)=O)=O)CNC2=O,Antagonist (neutral/silent),EC50,Functional - IP accumulation,2.9,uM,=,,6.9,-2.381,,,CXCL12,4.7,0.0,,0.0,,P61073,0.4342365944155879
53,25039237,cxcr4_human,200,Q,A,[Cit]FC131,SMILES,O=C(NC(CC1=CC=C(O)C=C1)C(NC(CCCNC(N)=O)C(NC(CCC/N=C(N)\N)C(NC2CC3=CC4=CC=CC=C4C=C3)=O)=O)=O)CNC2=O,Antagonist (neutral/silent),EC50,Functional - IP accumulation,3.0,uM,=,,0.61,4.918,,,CXCL12,4.7,0.0,,0.0,,P61073,0.4342365944155879
142,14585837,cxcr4_human,200,Q,A,AMD3100,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CN3CCCNCCNCCCNCC3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.89,uM,=,,0.56,1.589,,,radioligand:12G5(Bolton-Hunter),101.45985401459852,0.0,,0.0,,P61073,0.4342365944155879
160,17599916,cxcr4_human,200,Q,A,AMD3100,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CN3CCCNCCNCCCNCC3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.22,uM,=,,0.93,-4.219,,,CXCL12,0.0,0.0,,134.93234932349324,,P61073,0.4342365944155879
178,17599916,cxcr4_human,200,Q,A,AMD3100,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CN3CCCNCCNCCCNCC3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.89,uM,=,,0.56,1.589,,,radioligand:[125I] -12G5,94.8905109489051,0.0,,0.0,,P61073,0.4342365944155879
233,17599916,cxcr4_human,200,Q,A,AMD3389,SMILES,Cc1ccc(CN2CCCNCCNCCCNCC2)cc1,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,20.0,uM,=,,80.0,-4.0,,,CXCL12,0.0,0.0,,134.93234932349324,,P61073,0.4342365944155879
251,17599916,cxcr4_human,200,Q,A,AMD3465,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CNCC3=CC=CC=N3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.01,uM,=,,0.15,-14.925,,,CXCL12,0.0,0.0,,134.93234932349324,,P61073,0.4342365944155879
306,14585837,cxcr4_human,200,Q,A,AMD3479,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(C[N@@]3([Zn]456)CCCN4CCN6CCCN5CC3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.02,uM,=,,0.02,1.0,,,radioligand:12G5(Bolton-Hunter),101.45985401459852,0.0,,0.0,,P61073,0.4342365944155879
323,17599916,cxcr4_human,200,Q,A,AMD3529,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CNCC3=CC=CC=C3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,1.7,uM,=,,12.0,-7.042,,,CXCL12,0.0,0.0,,96.1049610496105,,P61073,0.4342365944155879
340,17599916,cxcr4_human,200,Q,A,AMD8721,SMILES,N(CCN1CCCN2CC3)([Cu]124)CCC[N@]34Cc5ccc(CNCC6=CC=CC=N6)cc5,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.04,uM,=,,0.62,-15.385,,,CXCL12,0.0,0.0,,96.1049610496105,,P61073,0.4342365944155879
357,17599916,cxcr4_human,200,Q,A,AMD8899,SMILES,N1([Ni]234)CCC[N@@]4(Cc5ccc(CNCC6=CC=CC=N6)cc5)CCN3CCCN2CC1,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.01,uM,=,,0.27,-27.027,,,CXCL12,0.0,0.0,,96.1049610496105,,P61073,0.4342365944155879
416,17599916,cxcr4_human,200,Q,A,CXCL12,UniProt Entry Code,P48061,Full agonist,K(d),Binding - Radioligand competition/displacement,0.81,nM,=,,0.67,1.209,,,radioligand: [125I]-CXCL12,0.0,0.0,,96.1049610496105,,P61073,0.4342365944155879
467,25039237,cxcr4_human,200,Q,A,CXCL12,UniProt Entry Code,P48061,Full agonist,EC50,Functional - IP accumulation,1.5,nM,=,,1.4,1.071,,,,4.7,0.0,,0.0,,P61073,0.4342365944155879
496,26397724,cxcr4_human,200,Q,A,CXCL12,UniProt Entry Code,P48061,Full agonist,EC50,Functional - IP accumulation,1.5,nM,=,,1.4,1.071,,,CXCL12,4.7,0.0,,0.0,,P61073,0.4342365944155879
588,25039237,cxcr4_human,200,Q,A,FC131,PubChem CID,5275843,Antagonist (neutral/silent),EC50,Functional - IP accumulation,0.4,uM,=,,0.36,1.111,,,CXCL12,4.7,0.0,,0.0,,P61073,0.4342365944155879
622,26397724,cxcr4_human,200,Q,A,KRH1636,SMILES,CC(C1=CC=CC2=CC=CC=C21)NC(=O)C(CCCN=C(N)N)NC(=O)C3=CC=C(C=C3)CNCC4=CC=C,Antagonist (neutral/silent),EC50,Functional - IP accumulation,0.5,uM,=,,3.7,-7.407,,,CXCL12,4.7,0.0,,0.0,,P61073,0.4342365944155879
647,26397724,cxcr4_human,200,Q,A,KRH1636-5,SMILES,C[C@H](NC([C@H](CCCNC(N)=N)NC(C1=CC=C(CNCC2=CC=CC=C2)C=C1)=O)=O)C3=CC=CC4=C3C=CC=C4,Antagonist (neutral/silent),EC50,Functional - IP accumulation,8.5,uM,=,,17.0,-2.0,,,CXCL12,4.7,0.0,,0.0,,P61073,0.4342365944155879
673,26397724,cxcr4_human,200,Q,A,KRH1636-6,SMILES,C[C@H](NC([C@H](CCCNC(N)=N)NC(C1=CC=C(CN)C=C1)=O)=O)C2=CC=CC3=C2C=CC=C3,Antagonist (neutral/silent),EC50,Functional - IP accumulation,12.0,uM,=,,250.0,-20.833,,,CXCL12,4.7,0.0,,0.0,,P61073,0.4342365944155879
733,25039237,cxcr4_human,200,Q,A,[D-Arg]FC131,SMILES,N\C(N)=N\CCCC1NC(=O)[C@H](CCC\N=C(\N)N)NC(=O)C(Cc2ccc(O)cc2)NC(=O)CNC(=O)C(Cc2ccc3ccccc3c2)NC1=O,Antagonist (neutral/silent),EC50,Functional - IP accumulation,0.52,uM,=,,0.57,-1.096,,,CXCL12,4.7,0.0,,0.0,,P61073,0.4342365944155879
18,25039237,cxcr4_human,200,Q,W,[Aib]FC131,SMILES,O=C(NC(CC1=CC=C(O)C=C1)C(NC(C)(C)C(NC(CCC/N=C(N)\N)C(NC2CC3=CC4=CC=CC=C4C=C3)=O)=O)=O)CNC2=O,Antagonist (neutral/silent),EC50,Functional - IP accumulation,2.9,uM,=,,2.8,1.036,,,CXCL12,75.0,0.0,,0.0,,P61073,0.4788046500213935
54,25039237,cxcr4_human,200,Q,W,[Cit]FC131,SMILES,O=C(NC(CC1=CC=C(O)C=C1)C(NC(CCCNC(N)=O)C(NC(CCC/N=C(N)\N)C(NC2CC3=CC4=CC=CC=C4C=C3)=O)=O)=O)CNC2=O,Antagonist (neutral/silent),EC50,Functional - IP accumulation,3.0,uM,=,,2.7,1.111,,,CXCL12,75.0,0.0,,0.0,,P61073,0.4788046500213935
159,17599916,cxcr4_human,200,Q,W,AMD3100,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CN3CCCNCCNCCCNCC3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.22,uM,=,,0.4,-1.818,,,CXCL12,0.0,0.0,,84.15334153341534,,P61073,0.4788046500213935
179,17599916,cxcr4_human,200,Q,W,AMD3100,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CN3CCCNCCNCCCNCC3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.89,uM,=,,2.7,-3.03,,,radioligand:[125I] -12G5,118.97810218978104,0.0,,0.0,,P61073,0.4788046500213935
234,17599916,cxcr4_human,200,Q,W,AMD3389,SMILES,Cc1ccc(CN2CCCNCCNCCCNCC2)cc1,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,20.0,uM,=,,60.0,-3.003,,,CXCL12,0.0,0.0,,84.15334153341534,,P61073,0.4788046500213935
250,17599916,cxcr4_human,200,Q,W,AMD3465,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CNCC3=CC=CC=N3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.01,uM,=,,0.22,-22.222,,,CXCL12,0.0,0.0,,84.15334153341534,,P61073,0.4788046500213935
270,17599916,cxcr4_human,200,Q,W,AMD3465,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CNCC3=CC=CC=N3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.11,uM,=,,1.2,-10.87,,,radioligand:125I-12G5,94.8905109489051,0.0,,0.0,,P61073,0.4788046500213935
324,17599916,cxcr4_human,200,Q,W,AMD3529,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CNCC3=CC=CC=C3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,1.7,uM,=,,7.2,-4.237,,,CXCL12,0.0,0.0,,63.694136941369415,,P61073,0.4788046500213935
341,17599916,cxcr4_human,200,Q,W,AMD8721,SMILES,N(CCN1CCCN2CC3)([Cu]124)CCC[N@]34Cc5ccc(CNCC6=CC=CC=N6)cc5,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.04,uM,=,,0.81,-20.408,,,CXCL12,0.0,0.0,,63.694136941369415,,P61073,0.4788046500213935
358,17599916,cxcr4_human,200,Q,W,AMD8899,SMILES,N1([Ni]234)CCC[N@@]4(Cc5ccc(CNCC6=CC=CC=N6)cc5)CCN3CCCN2CC1,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.01,uM,=,,0.36,-35.714,,,CXCL12,0.0,0.0,,63.694136941369415,,P61073,0.4788046500213935
417,17599916,cxcr4_human,200,Q,W,CXCL12,UniProt Entry Code,P48061,Full agonist,K(d),Binding - Radioligand competition/displacement,0.81,nM,=,,2.0,-2.469,,,radioligand: [125I]-CXCL12,0.0,0.0,,63.694136941369415,,P61073,0.4788046500213935
468,25039237,cxcr4_human,200,Q,W,CXCL12,UniProt Entry Code,P48061,Full agonist,EC50,Functional - IP accumulation,1.5,nM,=,,1.8,-1.2,,,,75.0,0.0,,0.0,,P61073,0.4788046500213935
497,26397724,cxcr4_human,200,Q,W,CXCL12,UniProt Entry Code,P48061,Full agonist,EC50,Functional - IP accumulation,1.5,nM,=,,1.8,-1.2,,,CXCL12,75.0,0.0,,0.0,,P61073,0.4788046500213935
589,25039237,cxcr4_human,200,Q,W,FC131,PubChem CID,5275843,Antagonist (neutral/silent),EC50,Functional - IP accumulation,0.4,uM,=,,0.33,1.212,,,CXCL12,75.0,0.0,,0.0,,P61073,0.4788046500213935
623,26397724,cxcr4_human,200,Q,W,KRH1636,SMILES,CC(C1=CC=CC2=CC=CC=C21)NC(=O)C(CCCN=C(N)N)NC(=O)C3=CC=C(C=C3)CNCC4=CC=C,Antagonist (neutral/silent),EC50,Functional - IP accumulation,0.5,uM,=,,10.0,-20.0,,,CXCL12,75.0,0.0,,0.0,,P61073,0.4788046500213935
648,26397724,cxcr4_human,200,Q,W,KRH1636-5,SMILES,C[C@H](NC([C@H](CCCNC(N)=N)NC(C1=CC=C(CNCC2=CC=CC=C2)C=C1)=O)=O)C3=CC=CC4=C3C=CC=C4,Antagonist (neutral/silent),EC50,Functional - IP accumulation,8.5,uM,=,,14.0,-1.647,,,CXCL12,75.0,0.0,,0.0,,P61073,0.4788046500213935
674,26397724,cxcr4_human,200,Q,W,KRH1636-6,SMILES,C[C@H](NC([C@H](CCCNC(N)=N)NC(C1=CC=C(CN)C=C1)=O)=O)C2=CC=CC3=C2C=CC=C3,Antagonist (neutral/silent),EC50,Functional - IP accumulation,12.0,uM,=,,85.0,-7.092,,,CXCL12,75.0,0.0,,0.0,,P61073,0.4788046500213935
734,25039237,cxcr4_human,200,Q,W,[D-Arg]FC131,SMILES,N\C(N)=N\CCCC1NC(=O)[C@H](CCC\N=C(\N)N)NC(=O)C(Cc2ccc(O)cc2)NC(=O)CNC(=O)C(Cc2ccc3ccccc3c2)NC1=O,Antagonist (neutral/silent),EC50,Functional - IP accumulation,0.52,uM,=,,0.86,-1.653,,,CXCL12,75.0,0.0,,0.0,,P61073,0.4788046500213935
19,25039237,cxcr4_human,203,H,A,[Aib]FC131,SMILES,O=C(NC(CC1=CC=C(O)C=C1)C(NC(C)(C)C(NC(CCC/N=C(N)\N)C(NC2CC3=CC4=CC=CC=C4C=C3)=O)=O)=O)CNC2=O,Antagonist (neutral/silent),EC50,Functional - IP accumulation,2.9,uM,=,,20.0,-6.897,,,CXCL12,111.0,0.0,,0.0,,P61073,0.4844691302361058
55,25039237,cxcr4_human,203,H,A,[Cit]FC131,SMILES,O=C(NC(CC1=CC=C(O)C=C1)C(NC(CCCNC(N)=O)C(NC(CCC/N=C(N)\N)C(NC2CC3=CC4=CC=CC=C4C=C3)=O)=O)=O)CNC2=O,Antagonist (neutral/silent),EC50,Functional - IP accumulation,3.0,uM,=,,8.0,-2.667,,,CXCL12,111.0,0.0,,0.0,,P61073,0.4844691302361058
81,18768385,cxcr4_human,203,H,A,AMD11070,SMILES,NCCCCN(CC1=NC2=CC=CC=C2N1)[C@@H]3C4=NC=CC=C4CCC3,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,11.0,nM,=,,9.0,1.222,,,radioligand: [125I]-CXCL16,97.9,0.0,,0.0,,P61073,0.4844691302361058
102,11154697,cxcr4_human,203,H,A,AMD3100,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CN3CCCNCCNCCCNCC3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,550.0,nM,=,,2100.0,-3.817,,,radioligand: [125I]-12G5,225.64102564102564,0.0,,0.0,,P61073,0.4844691302361058
110,11154697,cxcr4_human,203,H,A,AMD3100,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CN3CCCNCCNCCCNCC3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,74.0,nM,=,,68.0,1.088,,,radioligand: [125I]Met-CXCL12,22.94117647058824,0.0,,0.0,,P61073,0.4844691302361058
123,12534283,cxcr4_human,203,H,A,AMD3100,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CN3CCCNCCNCCCNCC3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,1.0,uM,=,,2.04,-2.041,,,radioligand: [125I]-12G5,225.64102564102564,0.0,,0.0,,P61073,0.4844691302361058
131,12534283,cxcr4_human,203,H,A,AMD3100,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CN3CCCNCCNCCCNCC3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,74.0,nM,=,,68.0,1.088,,,radioligand: [125I]-Met-CXCL12,22.94117647058824,0.0,,0.0,,P61073,0.4844691302361058
161,17599916,cxcr4_human,203,H,A,AMD3100,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CN3CCCNCCNCCCNCC3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.22,uM,=,,0.29,-1.318,,,CXCL12,0.0,0.0,,68.81918819188192,,P61073,0.4844691302361058
180,17599916,cxcr4_human,203,H,A,AMD3100,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CN3CCCNCCNCCCNCC3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.89,uM,=,,1.8,-2.024,,,radioligand:[125I] -12G5,72.26277372262774,0.0,,0.0,,P61073,0.4844691302361058
202,18768385,cxcr4_human,203,H,A,AMD3100,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CN3CCCNCCNCCCNCC3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,842.0,nM,=,,484.0,1.74,,,radioligand: [125I]-CXCL12,97.9,0.0,,0.0,,P61073,0.4844691302361058
211,12534283,cxcr4_human,203,H,A,AMD3100(Zn)2,SMILES,N12CCC[N](Cc3ccc(C[N@@]45[Zn]67N(CCN6CCCN7CC5)CCC4)cc3)([Zn]289)CCN9CCCN8CC1,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.028,nM,=,,0.052,-1.859,,,radioligand: [125I]-12G5,225.64102564102564,0.0,,0.0,,P61073,0.4844691302361058
219,12534283,cxcr4_human,203,H,A,AMD3100(Zn)2,SMILES,N12CCC[N](Cc3ccc(C[N@@]45[Zn]67N(CCN6CCCN7CC5)CCC4)cc3)([Zn]289)CCN9CCCN8CC1,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,12.0,nM,=,,36.0,-3.003,,,radioligand: [125I]-Met-CXCL12,22.94117647058824,0.0,,0.0,,P61073,0.4844691302361058
235,17599916,cxcr4_human,203,H,A,AMD3389,SMILES,Cc1ccc(CN2CCCNCCNCCCNCC2)cc1,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,20.0,uM,=,,32.0,-1.6,,,CXCL12,0.0,0.0,,68.81918819188192,,P61073,0.4844691302361058
252,17599916,cxcr4_human,203,H,A,AMD3465,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CNCC3=CC=CC=N3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.01,uM,=,,0.04,-4.0,,,CXCL12,0.0,0.0,,68.81918819188192,,P61073,0.4844691302361058
272,17599916,cxcr4_human,203,H,A,AMD3465,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CNCC3=CC=CC=N3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.11,uM,=,,0.44,-4.0,,,radioligand:125I-12G5,72.26277372262774,0.0,,0.0,,P61073,0.4844691302361058
293,18768385,cxcr4_human,203,H,A,AMD3465,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CNCC3=CC=CC=N3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,49.0,nM,=,,31.0,1.581,,,radioligand: [125I]-CXCL12,97.9,0.0,,0.0,,P61073,0.4844691302361058
325,17599916,cxcr4_human,203,H,A,AMD3529,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CNCC3=CC=CC=C3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,1.7,uM,=,,7.2,-4.237,,,CXCL12,0.0,0.0,,84.15334153341534,,P61073,0.4844691302361058
342,17599916,cxcr4_human,203,H,A,AMD8721,SMILES,N(CCN1CCCN2CC3)([Cu]124)CCC[N@]34Cc5ccc(CNCC6=CC=CC=N6)cc5,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.04,uM,=,,0.14,-3.497,,,CXCL12,0.0,0.0,,84.15334153341534,,P61073,0.4844691302361058
359,17599916,cxcr4_human,203,H,A,AMD8899,SMILES,N1([Ni]234)CCC[N@@]4(Cc5ccc(CNCC6=CC=CC=N6)cc5)CCN3CCCN2CC1,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.01,uM,=,,0.02,-2.0,,,CXCL12,0.0,0.0,,84.15334153341534,,P61073,0.4844691302361058
381,11154697,cxcr4_human,203,H,A,CXCL12,UniProt Entry Code,P48061,Full agonist,K(d),Binding - Radioligand competition/displacement,0.49,nM,=,,0.53,-1.081,,,radioligand: [125I]Met-CXCL12,22.94117647058824,0.0,,0.0,,P61073,0.4844691302361058
418,17599916,cxcr4_human,203,H,A,CXCL12,UniProt Entry Code,P48061,Full agonist,K(d),Binding - Radioligand competition/displacement,0.81,nM,=,,0.97,-1.198,,,radioligand: [125I]-CXCL12,0.0,0.0,,84.15334153341534,,P61073,0.4844691302361058
445,18768385,cxcr4_human,203,H,A,CXCL12,UniProt Entry Code,P48061,Full agonist,K(d),Binding - Radioligand competition/displacement,35.8,nM,=,,42.3,-1.182,,,,97.9,0.0,,0.0,,P61073,0.4844691302361058
446,18768385,cxcr4_human,203,H,A,CXCL12,UniProt Entry Code,P48061,Full agonist,EC50,Functional - Ca2+ accumulation,34.0,nM,=,,26.1,1.303,,,,97.9,0.0,,0.0,,P61073,0.4844691302361058
469,25039237,cxcr4_human,203,H,A,CXCL12,UniProt Entry Code,P48061,Full agonist,EC50,Functional - IP accumulation,1.5,nM,=,,1.4,1.071,,,,111.0,0.0,,0.0,,P61073,0.4844691302361058
498,26397724,cxcr4_human,203,H,A,CXCL12,UniProt Entry Code,P48061,Full agonist,EC50,Functional - IP accumulation,1.5,nM,=,,1.4,1.071,,,CXCL12,111.0,0.0,,0.0,,P61073,0.4844691302361058
536,11154697/12534283,cxcr4_human,203,H,A,cyclam,SMILES,C1CNCCNCCCNCCNC1,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,13.0,uM,=,,16.0,-1.232,,,radioligand: [125I]-Met-CXCL12,22.94117647058824,0.0,,0.0,,P61073,0.4844691302361058
544,12534283,cxcr4_human,203,H,A,Cyclam (Zn),SMILES,[Zn+2].C1CNCCNCCCNCCNC1,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,3.0,uM,=,,1.3,2.308,,,radioligand: [125I]-Met-CXCL12,22.94117647058824,0.0,,0.0,,P61073,0.4844691302361058
590,25039237,cxcr4_human,203,H,A,FC131,PubChem CID,5275843,Antagonist (neutral/silent),EC50,Functional - IP accumulation,0.4,uM,=,,0.58,-1.449,,,CXCL12,111.0,0.0,,0.0,,P61073,0.4844691302361058
624,26397724,cxcr4_human,203,H,A,KRH1636,SMILES,CC(C1=CC=CC2=CC=CC=C21)NC(=O)C(CCCN=C(N)N)NC(=O)C3=CC=C(C=C3)CNCC4=CC=C,Antagonist (neutral/silent),EC50,Functional - IP accumulation,0.5,uM,=,,0.71,-1.42,,,CXCL12,111.0,0.0,,0.0,,P61073,0.4844691302361058
735,25039237,cxcr4_human,203,H,A,[D-Arg]FC131,SMILES,N\C(N)=N\CCCC1NC(=O)[C@H](CCC\N=C(\N)N)NC(=O)C(Cc2ccc(O)cc2)NC(=O)CNC(=O)C(Cc2ccc3ccccc3c2)NC1=O,Antagonist (neutral/silent),EC50,Functional - IP accumulation,0.52,uM,=,,0.98,-1.883,,,CXCL12,111.0,0.0,,0.0,,P61073,0.4844691302361058
20,25039237,cxcr4_human,252,W,A,[Aib]FC131,SMILES,O=C(NC(CC1=CC=C(O)C=C1)C(NC(C)(C)C(NC(CCC/N=C(N)\N)C(NC2CC3=CC4=CC=CC=C4C=C3)=O)=O)=O)CNC2=O,Antagonist (neutral/silent),EC50,Functional - IP accumulation,2.9,uM,=,,16.0,-5.525,,,CXCL12,51.0,0.0,,0.0,,P61073,0.7900499992905441
56,25039237,cxcr4_human,252,W,A,[Cit]FC131,SMILES,O=C(NC(CC1=CC=C(O)C=C1)C(NC(CCCNC(N)=O)C(NC(CCC/N=C(N)\N)C(NC2CC3=CC4=CC=CC=C4C=C3)=O)=O)=O)CNC2=O,Antagonist (neutral/silent),EC50,Functional - IP accumulation,3.0,uM,=,,13.0,-4.329,,,CXCL12,51.0,0.0,,0.0,,P61073,0.7900499992905441
470,25039237,cxcr4_human,252,W,A,CXCL12,UniProt Entry Code,P48061,Full agonist,EC50,Functional - IP accumulation,1.5,nM,=,,0.78,1.923,,,,51.0,0.0,,0.0,,P61073,0.7900499992905441
499,26397724,cxcr4_human,252,W,A,CXCL12,UniProt Entry Code,P48061,Full agonist,EC50,Functional - IP accumulation,1.5,nM,=,,0.78,1.923,,,CXCL12,51.0,0.0,,0.0,,P61073,0.7900499992905441
521,16188969/16306611,cxcr4_human,252,W,A,CXCL12,UniProt Entry Code,P48061,Full agonist,IC50,Binding - Radioligand saturation,2.2,nM,=,,4.6,-2.092,,,radioligand: [125I]-CXCL12,84.6,0.0,,0.0,,P61073,0.7900499992905441
591,25039237,cxcr4_human,252,W,A,FC131,PubChem CID,5275843,Antagonist (neutral/silent),EC50,Functional - IP accumulation,0.4,uM,=,,0.71,-1.776,,,CXCL12,51.0,0.0,,0.0,,P61073,0.7900499992905441
625,26397724,cxcr4_human,252,W,A,KRH1636,SMILES,CC(C1=CC=CC2=CC=CC=C21)NC(=O)C(CCCN=C(N)N)NC(=O)C3=CC=C(C=C3)CNCC4=CC=C,Antagonist (neutral/silent),EC50,Functional - IP accumulation,0.5,uM,=,,3.8,-7.576,,,CXCL12,51.0,0.0,,0.0,,P61073,0.7900499992905441
651,26397724,cxcr4_human,252,W,A,KRH1636-5,SMILES,C[C@H](NC([C@H](CCCNC(N)=N)NC(C1=CC=C(CNCC2=CC=CC=C2)C=C1)=O)=O)C3=CC=CC4=C3C=CC=C4,Antagonist (neutral/silent),EC50,Functional - IP accumulation,8.5,uM,=,,27.0,-3.175,,,CXCL12,51.0,0.0,,0.0,,P61073,0.7900499992905441
676,26397724,cxcr4_human,252,W,A,KRH1636-6,SMILES,C[C@H](NC([C@H](CCCNC(N)=N)NC(C1=CC=C(CN)C=C1)=O)=O)C2=CC=CC3=C2C=CC=C3,Antagonist (neutral/silent),EC50,Functional - IP accumulation,12.0,uM,=,,173.0,-14.493,,,CXCL12,51.0,0.0,,0.0,,P61073,0.7900499992905441
736,25039237,cxcr4_human,252,W,A,[D-Arg]FC131,SMILES,N\C(N)=N\CCCC1NC(=O)[C@H](CCC\N=C(\N)N)NC(=O)C(Cc2ccc(O)cc2)NC(=O)CNC(=O)C(Cc2ccc3ccccc3c2)NC1=O,Antagonist (neutral/silent),EC50,Functional - IP accumulation,0.52,uM,=,,3.1,-5.952,,,CXCL12,51.0,0.0,,0.0,,P61073,0.7900499992905441
22,25039237,cxcr4_human,259,I,A,[Aib]FC131,SMILES,O=C(NC(CC1=CC=C(O)C=C1)C(NC(C)(C)C(NC(CCC/N=C(N)\N)C(NC2CC3=CC4=CC=CC=C4C=C3)=O)=O)=O)CNC2=O,Antagonist (neutral/silent),EC50,Functional - IP accumulation,2.9,uM,=,,0.53,5.472,,,CXCL12,3.0,0.0,,0.0,,P61073,0.4501928514307959
58,25039237,cxcr4_human,259,I,A,[Cit]FC131,SMILES,O=C(NC(CC1=CC=C(O)C=C1)C(NC(CCCNC(N)=O)C(NC(CCC/N=C(N)\N)C(NC2CC3=CC4=CC=CC=C4C=C3)=O)=O)=O)CNC2=O,Antagonist (neutral/silent),EC50,Functional - IP accumulation,3.0,uM,=,,0.41,7.317,,,CXCL12,3.0,0.0,,0.0,,P61073,0.4501928514307959
146,14585837,cxcr4_human,259,I,A,AMD3100,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CN3CCCNCCNCCCNCC3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.89,uM,=,,1.5,-1.686,,,radioligand:12G5(Bolton-Hunter),29.1970802919708,0.0,,0.0,,P61073,0.4501928514307959
163,17599916,cxcr4_human,259,I,A,AMD3100,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CN3CCCNCCNCCCNCC3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.22,uM,=,,0.29,-1.318,,,CXCL12,0.0,0.0,,95.55145551455514,,P61073,0.4501928514307959
185,17599916,cxcr4_human,259,I,A,AMD3100,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CN3CCCNCCNCCCNCC3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.89,uM,=,,1.5,-1.686,,,radioligand:[125I] -12G5,51.82481751824818,0.0,,0.0,,P61073,0.4501928514307959
237,17599916,cxcr4_human,259,I,A,AMD3389,SMILES,Cc1ccc(CN2CCCNCCNCCCNCC2)cc1,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,20.0,uM,=,,2.5,8.0,,,CXCL12,0.0,0.0,,95.55145551455514,,P61073,0.4501928514307959
254,17599916,cxcr4_human,259,I,A,AMD3465,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CNCC3=CC=CC=N3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.01,uM,=,,0.03,-3.003,,,CXCL12,0.0,0.0,,95.55145551455514,,P61073,0.4501928514307959
310,14585837,cxcr4_human,259,I,A,AMD3479,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(C[N@@]3([Zn]456)CCCN4CCN6CCCN5CC3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.02,uM,=,,0.03,-1.499,,,radioligand:12G5(Bolton-Hunter),29.1970802919708,0.0,,0.0,,P61073,0.4501928514307959
327,17599916,cxcr4_human,259,I,A,AMD3529,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CNCC3=CC=CC=C3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,1.7,uM,=,,0.91,1.868,,,CXCL12,0.0,0.0,,68.81918819188192,,P61073,0.4501928514307959
344,17599916,cxcr4_human,259,I,A,AMD8721,SMILES,N(CCN1CCCN2CC3)([Cu]124)CCC[N@]34Cc5ccc(CNCC6=CC=CC=N6)cc5,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.04,uM,=,,0.07,-1.751,,,CXCL12,0.0,0.0,,68.81918819188192,,P61073,0.4501928514307959
361,17599916,cxcr4_human,259,I,A,AMD8899,SMILES,N1([Ni]234)CCC[N@@]4(Cc5ccc(CNCC6=CC=CC=N6)cc5)CCN3CCCN2CC1,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.01,uM,=,,0.01,1.0,,,CXCL12,0.0,0.0,,68.81918819188192,,P61073,0.4501928514307959
420,17599916,cxcr4_human,259,I,A,CXCL12,UniProt Entry Code,P48061,Full agonist,K(d),Binding - Radioligand competition/displacement,0.81,nM,=,,6.6,-8.13,,,radioligand: [125I]-CXCL12,0.0,0.0,,68.81918819188192,,P61073,0.4501928514307959
472,25039237,cxcr4_human,259,I,A,CXCL12,UniProt Entry Code,P48061,Full agonist,EC50,Functional - IP accumulation,1.5,nM,=,,2.1,-1.401,,,,3.0,0.0,,0.0,,P61073,0.4501928514307959
501,26397724,cxcr4_human,259,I,A,CXCL12,UniProt Entry Code,P48061,Full agonist,EC50,Functional - IP accumulation,1.5,nM,=,,2.1,-1.401,,,CXCL12,3.0,0.0,,0.0,,P61073,0.4501928514307959
593,25039237,cxcr4_human,259,I,A,FC131,PubChem CID,5275843,Antagonist (neutral/silent),EC50,Functional - IP accumulation,0.4,uM,=,,0.08,5.0,,,CXCL12,3.0,0.0,,0.0,,P61073,0.4501928514307959
627,26397724,cxcr4_human,259,I,A,KRH1636,SMILES,CC(C1=CC=CC2=CC=CC=C21)NC(=O)C(CCCN=C(N)N)NC(=O)C3=CC=C(C=C3)CNCC4=CC=C,Antagonist (neutral/silent),EC50,Functional - IP accumulation,0.5,uM,=,,2.6,-5.208,,,CXCL12,3.0,0.0,,0.0,,P61073,0.4501928514307959
738,25039237,cxcr4_human,259,I,A,[D-Arg]FC131,SMILES,N\C(N)=N\CCCC1NC(=O)[C@H](CCC\N=C(\N)N)NC(=O)C(Cc2ccc(O)cc2)NC(=O)CNC(=O)C(Cc2ccc3ccccc3c2)NC1=O,Antagonist (neutral/silent),EC50,Functional - IP accumulation,0.52,uM,=,,0.4,1.3,,,CXCL12,3.0,0.0,,0.0,,P61073,0.4501928514307959
23,25039237,cxcr4_human,259,I,W,[Aib]FC131,SMILES,O=C(NC(CC1=CC=C(O)C=C1)C(NC(C)(C)C(NC(CCC/N=C(N)\N)C(NC2CC3=CC4=CC=CC=C4C=C3)=O)=O)=O)CNC2=O,Antagonist (neutral/silent),EC50,Functional - IP accumulation,2.9,uM,=,,0.68,4.265,,,CXCL12,34.0,0.0,,0.0,,P61073,0.5398680234372951
59,25039237,cxcr4_human,259,I,W,[Cit]FC131,SMILES,O=C(NC(CC1=CC=C(O)C=C1)C(NC(CCCNC(N)=O)C(NC(CCC/N=C(N)\N)C(NC2CC3=CC4=CC=CC=C4C=C3)=O)=O)=O)CNC2=O,Antagonist (neutral/silent),EC50,Functional - IP accumulation,3.0,uM,=,,2.2,1.364,,,CXCL12,34.0,0.0,,0.0,,P61073,0.5398680234372951
147,14585837,cxcr4_human,259,I,W,AMD3100,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CN3CCCNCCNCCCNCC3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.89,uM,=,,4.6,-5.181,,,radioligand:12G5(Bolton-Hunter),51.82481751824818,0.0,,0.0,,P61073,0.5398680234372951
164,17599916,cxcr4_human,259,I,W,AMD3100,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CN3CCCNCCNCCCNCC3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.22,uM,=,,0.63,-2.865,,,CXCL12,0.0,0.0,,59.61459614596146,,P61073,0.5398680234372951
186,17599916,cxcr4_human,259,I,W,AMD3100,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CN3CCCNCCNCCCNCC3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.89,uM,=,,4.6,-5.181,,,radioligand:[125I] -12G5,29.1970802919708,0.0,,0.0,,P61073,0.5398680234372951
238,17599916,cxcr4_human,259,I,W,AMD3389,SMILES,Cc1ccc(CN2CCCNCCNCCCNCC2)cc1,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,20.0,uM,=,,24.0,-1.2,,,CXCL12,0.0,0.0,,59.61459614596146,,P61073,0.5398680234372951
255,17599916,cxcr4_human,259,I,W,AMD3465,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CNCC3=CC=CC=N3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.01,uM,=,,0.08,-8.0,,,CXCL12,0.0,0.0,,59.61459614596146,,P61073,0.5398680234372951
277,17599916,cxcr4_human,259,I,W,AMD3465,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CNCC3=CC=CC=N3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.11,uM,=,,18.0,-166.667,,,radioligand:125I-12G5,29.1970802919708,0.0,,0.0,,P61073,0.5398680234372951
311,14585837,cxcr4_human,259,I,W,AMD3479,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(C[N@@]3([Zn]456)CCCN4CCN6CCCN5CC3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.02,uM,=,,0.84,-41.667,,,radioligand:12G5(Bolton-Hunter),51.82481751824818,0.0,,0.0,,P61073,0.5398680234372951
328,17599916,cxcr4_human,259,I,W,AMD3529,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CNCC3=CC=CC=C3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,1.7,uM,=,,3.1,-1.825,,,CXCL12,0.0,0.0,,67.60967609676096,,P61073,0.5398680234372951
345,17599916,cxcr4_human,259,I,W,AMD8721,SMILES,N(CCN1CCCN2CC3)([Cu]124)CCC[N@]34Cc5ccc(CNCC6=CC=CC=N6)cc5,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.04,uM,=,,0.18,-4.505,,,CXCL12,0.0,0.0,,67.60967609676096,,P61073,0.5398680234372951
362,17599916,cxcr4_human,259,I,W,AMD8899,SMILES,N1([Ni]234)CCC[N@@]4(Cc5ccc(CNCC6=CC=CC=N6)cc5)CCN3CCCN2CC1,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.01,uM,=,,0.05,-5.0,,,CXCL12,0.0,0.0,,67.60967609676096,,P61073,0.5398680234372951
421,17599916,cxcr4_human,259,I,W,CXCL12,UniProt Entry Code,P48061,Full agonist,K(d),Binding - Radioligand competition/displacement,0.81,nM,=,,2.3,-2.841,,,radioligand: [125I]-CXCL12,0.0,0.0,,67.60967609676096,,P61073,0.5398680234372951
473,25039237,cxcr4_human,259,I,W,CXCL12,UniProt Entry Code,P48061,Full agonist,EC50,Functional - IP accumulation,1.5,nM,=,,1.3,1.154,,,,34.0,0.0,,0.0,,P61073,0.5398680234372951
502,26397724,cxcr4_human,259,I,W,CXCL12,UniProt Entry Code,P48061,Full agonist,EC50,Functional - IP accumulation,1.5,nM,=,,1.3,1.154,,,CXCL12,34.0,0.0,,0.0,,P61073,0.5398680234372951
594,25039237,cxcr4_human,259,I,W,FC131,PubChem CID,5275843,Antagonist (neutral/silent),EC50,Functional - IP accumulation,0.4,uM,=,,0.15,2.667,,,CXCL12,34.0,0.0,,0.0,,P61073,0.5398680234372951
628,26397724,cxcr4_human,259,I,W,KRH1636,SMILES,CC(C1=CC=CC2=CC=CC=C21)NC(=O)C(CCCN=C(N)N)NC(=O)C3=CC=C(C=C3)CNCC4=CC=C,Antagonist (neutral/silent),EC50,Functional - IP accumulation,0.5,uM,=,,1.5,-3.003,,,CXCL12,34.0,0.0,,0.0,,P61073,0.5398680234372951
739,25039237,cxcr4_human,259,I,W,[D-Arg]FC131,SMILES,N\C(N)=N\CCCC1NC(=O)[C@H](CCC\N=C(\N)N)NC(=O)C(Cc2ccc(O)cc2)NC(=O)CNC(=O)C(Cc2ccc3ccccc3c2)NC1=O,Antagonist (neutral/silent),EC50,Functional - IP accumulation,0.52,uM,=,,0.66,-1.269,,,CXCL12,34.0,0.0,,0.0,,P61073,0.5398680234372951
25,25039237,cxcr4_human,281,H,A,[Aib]FC131,SMILES,O=C(NC(CC1=CC=C(O)C=C1)C(NC(C)(C)C(NC(CCC/N=C(N)\N)C(NC2CC3=CC4=CC=CC=C4C=C3)=O)=O)=O)CNC2=O,Antagonist (neutral/silent),EC50,Functional - IP accumulation,2.9,uM,=,,0.36,8.056,,,CXCL12,169.0,0.0,,0.0,,P61073,0.3406440388621614
31,25039237,cxcr4_human,281,H,A,[Aib]FC131,SMILES,O=C(NC(CC1=CC=C(O)C=C1)C(NC(C)(C)C(NC(CCC/N=C(N)\N)C(NC2CC3=CC4=CC=CC=C4C=C3)=O)=O)=O)CNC2=O,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,2.9,uM,=,,91.0,-31.25,,,radioligand:[125I]-12G12,169.0,0.0,,0.0,,P61073,0.3406440388621614
61,25039237,cxcr4_human,281,H,A,[Cit]FC131,SMILES,O=C(NC(CC1=CC=C(O)C=C1)C(NC(CCCNC(N)=O)C(NC(CCC/N=C(N)\N)C(NC2CC3=CC4=CC=CC=C4C=C3)=O)=O)=O)CNC2=O,Antagonist (neutral/silent),EC50,Functional - IP accumulation,3.0,uM,=,,5.2,-1.733,,,CXCL12,169.0,0.0,,0.0,,P61073,0.3406440388621614
66,25039237,cxcr4_human,281,H,A,[Cit]FC131,SMILES,O=C(NC(CC1=CC=C(O)C=C1)C(NC(CCCNC(N)=O)C(NC(CCC/N=C(N)\N)C(NC2CC3=CC4=CC=CC=C4C=C3)=O)=O)=O)CNC2=O,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,4.9,uM,=,,31.0,-6.329,,,radioligand:[125I]-12G12,169.0,0.0,,0.0,,P61073,0.3406440388621614
82,18768385,cxcr4_human,281,H,A,AMD11070,SMILES,NCCCCN(CC1=NC2=CC=CC=C2N1)[C@@H]3C4=NC=CC=C4CCC3,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,11.0,nM,=,,24.0,-2.183,,,radioligand: [125I]-CXCL17,133.2,0.0,,0.0,,P61073,0.3406440388621614
96,18768385,cxcr4_human,281,H,A,CXCL12,UniProt Entry Code,P48061,Full agonist,K(d),Binding - Radioligand competition/displacement,35.8,nM,=,,6.9,5.188,,,,133.2,0.0,,0.0,,P61073,0.3406440388621614
104,11154697,cxcr4_human,281,H,A,AMD3100,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CN3CCCNCCNCCCNCC3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,550.0,nM,=,,26.0,21.154,,,radioligand: [125I]-12G5,14.871794871794872,0.0,,0.0,,P61073,0.3406440388621614
112,11154697,cxcr4_human,281,H,A,AMD3100,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CN3CCCNCCNCCCNCC3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,74.0,nM,=,,24.0,3.083,,,radioligand: [125I]Met-CXCL12,21.176470588235293,0.0,,0.0,,P61073,0.3406440388621614
125,12534283,cxcr4_human,281,H,A,AMD3100,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CN3CCCNCCNCCCNCC3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,1.0,uM,=,,1.1,-1.1,,,radioligand: [125I]-12G5,14.871794871794872,0.0,,0.0,,P61073,0.3406440388621614
133,12534283,cxcr4_human,281,H,A,AMD3100,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CN3CCCNCCNCCCNCC3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,74.0,nM,=,,24.0,3.083,,,radioligand: [125I]-Met-CXCL12,21.176470588235293,0.0,,0.0,,P61073,0.3406440388621614
150,14585837,cxcr4_human,281,H,A,AMD3100,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CN3CCCNCCNCCCNCC3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.89,uM,=,,0.16,5.562,,,radioligand:12G5(Bolton-Hunter),84.67153284671532,0.0,,0.0,,P61073,0.3406440388621614
166,17599916,cxcr4_human,281,H,A,AMD3100,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CN3CCCNCCNCCCNCC3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.22,uM,=,,0.19,1.158,,,CXCL12,0.0,0.0,,63.694136941369415,,P61073,0.3406440388621614
189,17599916,cxcr4_human,281,H,A,AMD3100,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CN3CCCNCCNCCCNCC3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.89,uM,=,,0.16,5.562,,,radioligand:[125I] -12G5,84.67153284671532,0.0,,0.0,,P61073,0.3406440388621614
205,18768385,cxcr4_human,281,H,A,AMD3100,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CN3CCCNCCNCCCNCC3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,842.0,nM,=,,137.0,6.146,,,radioligand: [125I]-CXCL12,133.2,0.0,,0.0,,P61073,0.3406440388621614
213,12534283,cxcr4_human,281,H,A,AMD3100(Zn)2,SMILES,N12CCC[N](Cc3ccc(C[N@@]45[Zn]67N(CCN6CCCN7CC5)CCC4)cc3)([Zn]289)CCN9CCCN8CC1,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.028,nM,=,,0.052,-1.859,,,radioligand: [125I]-12G5,14.871794871794872,0.0,,0.0,,P61073,0.3406440388621614
221,12534283,cxcr4_human,281,H,A,AMD3100(Zn)2,SMILES,N12CCC[N](Cc3ccc(C[N@@]45[Zn]67N(CCN6CCCN7CC5)CCC4)cc3)([Zn]289)CCN9CCCN8CC1,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,12.0,nM,=,,8.7,1.379,,,radioligand: [125I]-Met-CXCL12,21.176470588235293,0.0,,0.0,,P61073,0.3406440388621614
240,17599916,cxcr4_human,281,H,A,AMD3389,SMILES,Cc1ccc(CN2CCCNCCNCCCNCC2)cc1,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,20.0,uM,=,,22.0,-1.1,,,CXCL12,0.0,0.0,,63.694136941369415,,P61073,0.3406440388621614
257,17599916,cxcr4_human,281,H,A,AMD3465,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CNCC3=CC=CC=N3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.01,uM,=,,1.6,-166.667,,,CXCL12,0.0,0.0,,63.694136941369415,,P61073,0.3406440388621614
296,18768385,cxcr4_human,281,H,A,AMD3465,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CNCC3=CC=CC=N3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,49.0,nM,=,,6514.0,-125.0,,,radioligand: [125I]-CXCL12,133.2,0.0,,0.0,,P61073,0.3406440388621614
314,14585837,cxcr4_human,281,H,A,AMD3479,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(C[N@@]3([Zn]456)CCCN4CCN6CCCN5CC3)cc2,,K(i),Binding - Radioligand competition/displacement,0.02,uM,=,,0.03,-1.499,,,radioligand:12G5(Bolton-Hunter),84.67153284671532,0.0,,0.0,,P61073,0.3406440388621614
330,17599916,cxcr4_human,281,H,A,AMD3529,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CNCC3=CC=CC=C3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,1.7,uM,=,,1.8,-1.059,,,CXCL12,0.0,0.0,,134.93234932349324,,P61073,0.3406440388621614
347,17599916,cxcr4_human,281,H,A,AMD8721,SMILES,N(CCN1CCCN2CC3)([Cu]124)CCC[N@]34Cc5ccc(CNCC6=CC=CC=N6)cc5,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.04,uM,=,,2.2,-55.556,,,CXCL12,0.0,0.0,,134.93234932349324,,P61073,0.3406440388621614
364,17599916,cxcr4_human,281,H,A,AMD8899,SMILES,N1([Ni]234)CCC[N@@]4(Cc5ccc(CNCC6=CC=CC=N6)cc5)CCN3CCCN2CC1,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.01,uM,=,,0.2,-20.0,,,CXCL12,0.0,0.0,,134.93234932349324,,P61073,0.3406440388621614
383,11154697,cxcr4_human,281,H,A,CXCL12,UniProt Entry Code,P48061,Full agonist,K(d),Binding - Radioligand competition/displacement,0.49,nM,=,,0.28,1.75,,,radioligand: [125I]Met-CXCL12,21.176470588235293,0.0,,0.0,,P61073,0.3406440388621614
423,17599916,cxcr4_human,281,H,A,CXCL12,UniProt Entry Code,P48061,Full agonist,K(d),Binding - Radioligand competition/displacement,0.81,nM,=,,3.5,-4.329,,,radioligand: [125I]-CXCL12,0.0,0.0,,134.93234932349324,,P61073,0.3406440388621614
447,18768385,cxcr4_human,281,H,A,CXCL12,UniProt Entry Code,P48061,Full agonist,EC50,Functional - Ca2+ accumulation,34.0,nM,=,,136.3,-4.016,,,,133.2,0.0,,0.0,,P61073,0.3406440388621614
475,25039237,cxcr4_human,281,H,A,CXCL12,UniProt Entry Code,P48061,Full agonist,EC50,Functional - IP accumulation,1.5,nM,=,,1.8,-1.2,,,,169.0,0.0,,0.0,,P61073,0.3406440388621614
504,26397724,cxcr4_human,281,H,A,CXCL12,UniProt Entry Code,P48061,Full agonist,EC50,Functional - IP accumulation,1.5,nM,=,,1.8,-1.2,,,CXCL12,169.0,0.0,,0.0,,P61073,0.3406440388621614
538,11154697/12534283,cxcr4_human,281,H,A,cyclam,SMILES,C1CNCCNCCCNCCNC1,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,13.0,uM,=,,33.0,-2.538,,,radioligand: [125I]-Met-CXCL12,21.176470588235293,0.0,,0.0,,P61073,0.3406440388621614
546,12534283,cxcr4_human,281,H,A,Cyclam (Zn),SMILES,[Zn+2].C1CNCCNCCCNCCNC1,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,3.0,uM,=,,5.0,-1.667,,,radioligand: [125I]-Met-CXCL12,21.176470588235293,0.0,,0.0,,P61073,0.3406440388621614
596,25039237,cxcr4_human,281,H,A,FC131,PubChem CID,5275843,Antagonist (neutral/silent),EC50,Functional - IP accumulation,0.4,uM,=,,0.8,-2.0,,,CXCL12,169.0,0.0,,0.0,,P61073,0.3406440388621614
601,25039237,cxcr4_human,281,H,A,FC131,PubChem CID,5275843,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,0.76,uM,=,,13.0,-17.241,,,radioligand:[125I]-12G12,169.0,0.0,,0.0,,P61073,0.3406440388621614
630,26397724,cxcr4_human,281,H,A,KRH1636,SMILES,CC(C1=CC=CC2=CC=CC=C21)NC(=O)C(CCCN=C(N)N)NC(=O)C3=CC=C(C=C3)CNCC4=CC=C,Antagonist (neutral/silent),EC50,Functional - IP accumulation,0.5,uM,=,,31.0,-62.5,,,CXCL12,169.0,0.0,,0.0,,P61073,0.3406440388621614
656,26397724,cxcr4_human,281,H,A,KRH1636-5,SMILES,C[C@H](NC([C@H](CCCNC(N)=N)NC(C1=CC=C(CNCC2=CC=CC=C2)C=C1)=O)=O)C3=CC=CC4=C3C=CC=C4,Antagonist (neutral/silent),EC50,Functional - IP accumulation,8.5,uM,=,,53.0,-6.25,,,CXCL12,169.0,0.0,,0.0,,P61073,0.3406440388621614
681,26397724,cxcr4_human,281,H,A,KRH1636-6,SMILES,C[C@H](NC([C@H](CCCNC(N)=N)NC(C1=CC=C(CN)C=C1)=O)=O)C2=CC=CC3=C2C=CC=C3,Antagonist (neutral/silent),EC50,Functional - IP accumulation,12.0,uM,=,,155.0,-12.987,,,CXCL12,169.0,0.0,,0.0,,P61073,0.3406440388621614
691,26397724,cxcr4_human,281,H,A,KRK1636,SMILES,CC(C1=CC=CC2=CC=CC=C21)NC(=O)C(CCCN=C(N)N)NC(=O)C3=CC=C(C=C3)CNCC4=CC=C,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,8.0,uM,=,,63.0,-7.874,,,radioligand:[125I] -12G5,0.0,0.0,,0.0,,P61073,0.3406440388621614
741,25039237,cxcr4_human,281,H,A,[D-Arg]FC131,SMILES,N\C(N)=N\CCCC1NC(=O)[C@H](CCC\N=C(\N)N)NC(=O)C(Cc2ccc(O)cc2)NC(=O)CNC(=O)C(Cc2ccc3ccccc3c2)NC1=O,Antagonist (neutral/silent),EC50,Functional - IP accumulation,0.52,uM,=,,0.6,-1.153,,,CXCL12,169.0,0.0,,0.0,,P61073,0.3406440388621614
751,25039237,cxcr4_human,281,H,A,[D-Arg]FC131,SMILES,N\C(N)=N\CCCC1NC(=O)[C@H](CCC\N=C(\N)N)NC(=O)C(Cc2ccc(O)cc2)NC(=O)CNC(=O)C(Cc2ccc3ccccc3c2)NC1=O,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,0.38,uM,=,,107.0,-250.0,,,radioligand:[125I]-12G5,169.0,0.0,,0.0,,P61073,0.3406440388621614
26,17599916,cxcr4_human,287,T,A,AMD3100,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CN3CCCNCCNCCCNCC3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.22,uM,=,,0.29,-1.318,,,CXCL12,0.0,0.0,,73.49323493234932,,P61073,0.4339143580673043
191,17599916,cxcr4_human,287,T,A,AMD3100,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CN3CCCNCCNCCCNCC3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.89,uM,=,,3.1,-3.484,,,radioligand:[125I] -12G5,187.5912408759124,0.0,,0.0,,P61073,0.4339143580673043
242,17599916,cxcr4_human,287,T,A,AMD3389,SMILES,Cc1ccc(CN2CCCNCCNCCCNCC2)cc1,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,20.0,uM,=,,3.3,6.061,,,CXCL12,0.0,0.0,,73.49323493234932,,P61073,0.4339143580673043
259,17599916,cxcr4_human,287,T,A,AMD3465,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CNCC3=CC=CC=N3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.01,uM,=,,0.01,1.0,,,CXCL12,0.0,0.0,,73.49323493234932,,P61073,0.4339143580673043
282,17599916,cxcr4_human,287,T,A,AMD3465,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CNCC3=CC=CC=N3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.11,uM,=,,2.0,-18.182,,,radioligand:125I-12G5,187.5912408759124,0.0,,0.0,,P61073,0.4339143580673043
332,17599916,cxcr4_human,287,T,A,AMD3529,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CNCC3=CC=CC=C3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,1.7,uM,=,,0.34,5.0,,,CXCL12,0.0,0.0,,80.29930299302993,,P61073,0.4339143580673043
349,17599916,cxcr4_human,287,T,A,AMD8721,SMILES,N(CCN1CCCN2CC3)([Cu]124)CCC[N@]34Cc5ccc(CNCC6=CC=CC=N6)cc5,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.04,uM,=,,0.01,4.0,,,CXCL12,0.0,0.0,,80.29930299302993,,P61073,0.4339143580673043
366,17599916,cxcr4_human,287,T,A,AMD8899,SMILES,N1([Ni]234)CCC[N@@]4(Cc5ccc(CNCC6=CC=CC=N6)cc5)CCN3CCCN2CC1,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.01,uM,=,,0.02,-2.0,,,CXCL12,0.0,0.0,,80.29930299302993,,P61073,0.4339143580673043
425,17599916,cxcr4_human,287,T,A,CXCL12,UniProt Entry Code,P48061,Full agonist,K(d),Binding - Radioligand competition/displacement,0.81,nM,=,,2.1,-2.591,,,radioligand: [125I]-CXCL12,0.0,0.0,,80.29930299302993,,P61073,0.4339143580673043
27,25039237,cxcr4_human,284,I,A,[Aib]FC131,SMILES,O=C(NC(CC1=CC=C(O)C=C1)C(NC(C)(C)C(NC(CCC/N=C(N)\N)C(NC2CC3=CC4=CC=CC=C4C=C3)=O)=O)=O)CNC2=O,Antagonist (neutral/silent),EC50,Functional - IP accumulation,2.9,uM,=,,3.8,-1.311,,,CXCL12,56.0,0.0,,0.0,,P61073,0.4130184526322255
62,25039237,cxcr4_human,284,I,A,[Cit]FC131,SMILES,O=C(NC(CC1=CC=C(O)C=C1)C(NC(CCCNC(N)=O)C(NC(CCC/N=C(N)\N)C(NC2CC3=CC4=CC=CC=C4C=C3)=O)=O)=O)CNC2=O,Antagonist (neutral/silent),EC50,Functional - IP accumulation,3.0,uM,=,,15.0,-5.0,,,CXCL12,56.0,0.0,,0.0,,P61073,0.4130184526322255
151,14585837,cxcr4_human,284,I,A,AMD3100,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CN3CCCNCCNCCCNCC3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.89,uM,=,,1.1,-1.236,,,radioligand:12G5(Bolton-Hunter),84.67153284671532,0.0,,0.0,,P61073,0.4130184526322255
167,17599916,cxcr4_human,284,I,A,AMD3100,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CN3CCCNCCNCCCNCC3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.22,uM,=,,1.2,-5.464,,,CXCL12,0.0,0.0,,80.29930299302993,,P61073,0.4130184526322255
190,17599916,cxcr4_human,284,I,A,AMD3100,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CN3CCCNCCNCCCNCC3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.89,uM,=,,1.1,-1.236,,,radioligand:[125I] -12G5,84.67153284671532,0.0,,0.0,,P61073,0.4130184526322255
241,17599916,cxcr4_human,284,I,A,AMD3389,SMILES,Cc1ccc(CN2CCCNCCNCCCNCC2)cc1,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,20.0,uM,=,,2.3,8.696,,,CXCL12,0.0,0.0,,80.29930299302993,,P61073,0.4130184526322255
258,17599916,cxcr4_human,284,I,A,AMD3465,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CNCC3=CC=CC=N3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.01,uM,=,,0.03,-3.003,,,CXCL12,0.0,0.0,,80.29930299302993,,P61073,0.4130184526322255
281,17599916,cxcr4_human,284,I,A,AMD3465,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CNCC3=CC=CC=N3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.11,uM,=,,46.0,-500.0,,,radioligand:125I-12G5,84.67153284671532,0.0,,0.0,,P61073,0.4130184526322255
315,14585837,cxcr4_human,284,I,A,AMD3479,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(C[N@@]3([Zn]456)CCCN4CCN6CCCN5CC3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.02,uM,=,,0.23,-11.494,,,radioligand:12G5(Bolton-Hunter),84.67153284671532,0.0,,0.0,,P61073,0.4130184526322255
331,17599916,cxcr4_human,284,I,A,AMD3529,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CNCC3=CC=CC=C3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,1.7,uM,=,,0.42,4.048,,,CXCL12,0.0,0.0,,95.55145551455514,,P61073,0.4130184526322255
348,17599916,cxcr4_human,284,I,A,AMD8721,SMILES,N(CCN1CCCN2CC3)([Cu]124)CCC[N@]34Cc5ccc(CNCC6=CC=CC=N6)cc5,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.04,uM,=,,0.06,-1.499,,,CXCL12,0.0,0.0,,95.55145551455514,,P61073,0.4130184526322255
365,17599916,cxcr4_human,284,I,A,AMD8899,SMILES,N1([Ni]234)CCC[N@@]4(Cc5ccc(CNCC6=CC=CC=N6)cc5)CCN3CCCN2CC1,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.01,uM,=,,0.02,-2.0,,,CXCL12,0.0,0.0,,95.55145551455514,,P61073,0.4130184526322255
424,17599916,cxcr4_human,284,I,A,CXCL12,UniProt Entry Code,P48061,Full agonist,K(d),Binding - Radioligand competition/displacement,0.81,nM,=,,3.6,-4.444,,,radioligand: [125I]-CXCL12,0.0,0.0,,95.55145551455514,,P61073,0.4130184526322255
476,25039237,cxcr4_human,284,I,A,CXCL12,UniProt Entry Code,P48061,Full agonist,EC50,Functional - IP accumulation,1.5,nM,=,,2.3,-1.534,,,,56.0,0.0,,0.0,,P61073,0.4130184526322255
505,26397724,cxcr4_human,284,I,A,CXCL12,UniProt Entry Code,P48061,Full agonist,EC50,Functional - IP accumulation,1.5,nM,=,,2.3,-1.534,,,CXCL12,56.0,0.0,,0.0,,P61073,0.4130184526322255
597,25039237,cxcr4_human,284,I,A,FC131,PubChem CID,5275843,Antagonist (neutral/silent),EC50,Functional - IP accumulation,0.4,uM,=,,0.27,1.481,,,CXCL12,56.0,0.0,,0.0,,P61073,0.4130184526322255
631,26397724,cxcr4_human,284,I,A,KRH1636,SMILES,CC(C1=CC=CC2=CC=CC=C21)NC(=O)C(CCCN=C(N)N)NC(=O)C3=CC=C(C=C3)CNCC4=CC=C,Antagonist (neutral/silent),EC50,Functional - IP accumulation,0.5,uM,=,,3.4,-6.803,,,CXCL12,56.0,0.0,,0.0,,P61073,0.4130184526322255
657,26397724,cxcr4_human,284,I,A,KRH1636-5,SMILES,C[C@H](NC([C@H](CCCNC(N)=N)NC(C1=CC=C(CNCC2=CC=CC=C2)C=C1)=O)=O)C3=CC=CC4=C3C=CC=C4,Antagonist (neutral/silent),EC50,Functional - IP accumulation,8.5,uM,=,,34.0,-4.0,,,CXCL12,56.0,0.0,,0.0,,P61073,0.4130184526322255
682,26397724,cxcr4_human,284,I,A,KRH1636-6,SMILES,C[C@H](NC([C@H](CCCNC(N)=N)NC(C1=CC=C(CN)C=C1)=O)=O)C2=CC=CC3=C2C=CC=C3,Antagonist (neutral/silent),EC50,Functional - IP accumulation,12.0,uM,=,,306.0,-25.641,,,CXCL12,56.0,0.0,,0.0,,P61073,0.4130184526322255
742,25039237,cxcr4_human,284,I,A,[D-Arg]FC131,SMILES,N\C(N)=N\CCCC1NC(=O)[C@H](CCC\N=C(\N)N)NC(=O)C(Cc2ccc(O)cc2)NC(=O)CNC(=O)C(Cc2ccc3ccccc3c2)NC1=O,Antagonist (neutral/silent),EC50,Functional - IP accumulation,0.52,uM,=,,2.6,-5.0,,,CXCL12,56.0,0.0,,0.0,,P61073,0.4130184526322255
32,25039237,cxcr4_human,288,E,A,[Aib]FC131,SMILES,O=C(NC(CC1=CC=C(O)C=C1)C(NC(C)(C)C(NC(CCC/N=C(N)\N)C(NC2CC3=CC4=CC=CC=C4C=C3)=O)=O)=O)CNC2=O,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,2.9,uM,=,,4.2,-1.449,,,radioligand:[125I]-12G13,77.0,0.0,,0.0,,P61073,0.4903707154700722
67,25039237,cxcr4_human,288,E,A,[Cit]FC131,SMILES,O=C(NC(CC1=CC=C(O)C=C1)C(NC(CCCNC(N)=O)C(NC(CCC/N=C(N)\N)C(NC2CC3=CC4=CC=CC=C4C=C3)=O)=O)=O)CNC2=O,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,4.9,uM,=,,2.1,2.333,,,radioligand:[125I]-12G13,77.0,0.0,,0.0,,P61073,0.4903707154700722
80,18768385,cxcr4_human,288,E,A,AMD11070,SMILES,NCCCCN(CC1=NC2=CC=CC=C2N1)[C@@H]3C4=NC=CC=C4CCC3,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,11.0,nM,=,,5073.0,-500.0,,,radioligand: [125I]-CXCL15,53.1,0.0,,0.0,,P61073,0.4903707154700722
152,14585837,cxcr4_human,288,E,A,AMD3100,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CN3CCCNCCNCCCNCC3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.89,uM,=,,63.0,-71.429,,,radioligand:12G5(Bolton-Hunter),102.18978102189782,0.0,,0.0,,P61073,0.4903707154700722
168,17599916,cxcr4_human,288,E,A,AMD3100,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CN3CCCNCCNCCCNCC3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.22,uM,=,,6.4,-29.412,,,CXCL12,0.0,0.0,,22.34522345223452,,P61073,0.4903707154700722
192,17599916,cxcr4_human,288,E,A,AMD3100,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CN3CCCNCCNCCCNCC3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.89,uM,=,,63.0,-71.429,,,radioligand:[125I] -12G5,102.18978102189782,0.0,,0.0,,P61073,0.4903707154700722
206,18768385,cxcr4_human,288,E,A,AMD3100,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CN3CCCNCCNCCCNCC3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,842.0,nM,=,,29445.0,-34.483,,,radioligand: [125I]-CXCL12,53.1,0.0,,0.0,,P61073,0.4903707154700722
243,17599916,cxcr4_human,288,E,A,AMD3389,SMILES,Cc1ccc(CN2CCCNCCNCCCNCC2)cc1,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,20.0,uM,=,,303.0,-15.152,,,CXCL12,0.0,0.0,,22.34522345223452,,P61073,0.4903707154700722
260,17599916,cxcr4_human,288,E,A,AMD3465,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CNCC3=CC=CC=N3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.01,uM,=,,1.9,-200.0,,,CXCL12,0.0,0.0,,22.34522345223452,,P61073,0.4903707154700722
283,17599916,cxcr4_human,288,E,A,AMD3465,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CNCC3=CC=CC=N3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.11,uM,=,,11.0,-100.0,,,radioligand:125I-12G5,102.18978102189782,0.0,,0.0,,P61073,0.4903707154700722
297,18768385,cxcr4_human,288,E,A,AMD3465,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CNCC3=CC=CC=N3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,49.0,nM,=,,3404.0,-71.429,,,radioligand: [125I]-CXCL12,53.1,0.0,,0.0,,P61073,0.4903707154700722
316,14585837,cxcr4_human,288,E,A,AMD3479,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(C[N@@]3([Zn]456)CCCN4CCN6CCCN5CC3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.02,uM,=,,2.3,-111.111,,,radioligand:12G5(Bolton-Hunter),102.18978102189782,0.0,,0.0,,P61073,0.4903707154700722
333,17599916,cxcr4_human,288,E,A,AMD3529,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CNCC3=CC=CC=C3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,1.7,uM,=,,11.0,-6.452,,,CXCL12,0.0,0.0,,105.74005740057402,,P61073,0.4903707154700722
350,17599916,cxcr4_human,288,E,A,AMD8721,SMILES,N(CCN1CCCN2CC3)([Cu]124)CCC[N@]34Cc5ccc(CNCC6=CC=CC=N6)cc5,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.04,uM,=,,0.54,-13.514,,,CXCL12,0.0,0.0,,105.74005740057402,,P61073,0.4903707154700722
367,17599916,cxcr4_human,288,E,A,AMD8899,SMILES,N1([Ni]234)CCC[N@@]4(Cc5ccc(CNCC6=CC=CC=N6)cc5)CCN3CCCN2CC1,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.01,uM,=,,2.7,-250.0,,,CXCL12,0.0,0.0,,105.74005740057402,,P61073,0.4903707154700722
426,17599916,cxcr4_human,288,E,A,CXCL12,UniProt Entry Code,P48061,Full agonist,K(d),Binding - Radioligand competition/displacement,0.81,nM,=,,53.0,-66.667,,,radioligand: [125I]-CXCL12,0.0,0.0,,105.74005740057402,,P61073,0.4903707154700722
448,18768385,cxcr4_human,288,E,A,CXCL12,UniProt Entry Code,P48061,Full agonist,K(d),Binding - Radioligand competition/displacement,35.8,nM,=,,44.1,-1.232,,,,53.1,0.0,,0.0,,P61073,0.4903707154700722
477,25039237,cxcr4_human,288,E,A,CXCL12,UniProt Entry Code,P48061,Full agonist,EC50,Functional - IP accumulation,1.5,nM,=,,100.0,-66.667,,,,77.0,0.0,,0.0,,P61073,0.4903707154700722
527,16188969/16306611,cxcr4_human,288,E,A,CXCL12,UniProt Entry Code,P48061,Full agonist,IC50,Binding - Radioligand saturation,2.2,nM,=,,4.4,-2.0,,,radioligand: [125I]-CXCL12,101.2,0.0,,0.0,,P61073,0.4903707154700722
602,25039237,cxcr4_human,288,E,A,FC131,PubChem CID,5275843,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,0.76,uM,=,,4.1,-5.405,,,radioligand:[125I]-12G13,77.0,0.0,,0.0,,P61073,0.4903707154700722
692,26397724,cxcr4_human,288,E,A,KRK1636,SMILES,CC(C1=CC=CC2=CC=CC=C21)NC(=O)C(CCCN=C(N)N)NC(=O)C3=CC=C(C=C3)CNCC4=CC=C,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,8.0,uM,=,,100.0,-12.5,,,radioligand:[125I] -12G5,0.0,0.0,,0.0,,P61073,0.4903707154700722
752,25039237,cxcr4_human,288,E,A,[D-Arg]FC131,SMILES,N\C(N)=N\CCCC1NC(=O)[C@H](CCC\N=C(\N)N)NC(=O)C(Cc2ccc(O)cc2)NC(=O)CNC(=O)C(Cc2ccc3ccccc3c2)NC1=O,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,0.38,uM,=,,100.0,-250.0,,,radioligand:[125I]-12G5,77.0,0.0,,0.0,,P61073,0.4903707154700722
71,25039237,cxcr4_human,116,Y,A,[Cit]FC131,SMILES,O=C(NC(CC1=CC=C(O)C=C1)C(NC(CCCNC(N)=O)C(NC(CCC/N=C(N)\N)C(NC2CC3=CC4=CC=CC=C4C=C3)=O)=O)=O)CNC2=O,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,4.9,uM,=,,100.0,-20.408,,,radioligand:[125I]-12G8,69.0,0.0,,0.0,,P61073,0.5582996594776034
87,18768385,cxcr4_human,116,Y,A,AMD11070,SMILES,NCCCCN(CC1=NC2=CC=CC=C2N1)[C@@H]3C4=NC=CC=C4CCC3,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,11.0,nM,=,,39.0,-3.546,,,radioligand: [125I]-CXCL22,170.7,0.0,,0.0,,P61073,0.5582996594776034
196,18768385,cxcr4_human,116,Y,A,AMD3100,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CN3CCCNCCNCCCNCC3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,842.0,nM,=,,8099.0,-9.615,,,radioligand: [125I]-CXCL12,170.7,0.0,,0.0,,P61073,0.5582996594776034
287,18768385,cxcr4_human,116,Y,A,AMD3465,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CNCC3=CC=CC=N3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,49.0,nM,=,,777.0,-15.873,,,radioligand: [125I]-CXCL12,170.7,0.0,,0.0,,P61073,0.5582996594776034
433,18768385,cxcr4_human,116,Y,A,CXCL12,UniProt Entry Code,P48061,Full agonist,K(d),Binding - Radioligand competition/displacement,35.8,nM,=,,33.7,1.062,,,,170.7,0.0,,0.0,,P61073,0.5582996594776034
606,25039237,cxcr4_human,116,Y,A,FC131,PubChem CID,5275843,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,0.76,uM,=,,100.0,-125.0,,,radioligand:[125I]-12G8,69.0,0.0,,0.0,,P61073,0.5582996594776034
747,25039237,cxcr4_human,116,Y,A,[D-Arg]FC131,SMILES,N\C(N)=N\CCCC1NC(=O)[C@H](CCC\N=C(\N)N)NC(=O)C(Cc2ccc(O)cc2)NC(=O)CNC(=O)C(Cc2ccc3ccccc3c2)NC1=O,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,0.38,uM,=,,100.0,-250.0,,,radioligand:[125I]-12G5,69.0,0.0,,0.0,,P61073,0.5582996594776034
73,11923301,cxcr4_human,119,N,S,ALX40-4C,PubChem CID,25077385,Partial agonist,IC50,Binding - Radioligand competition/displacement,717.0,nM,=,,4060.0,-5.65,,,radioligand: [125I]-CXCL12,100.0,0.0,,0.0,,P61073,0.5126222411764362
114,11923301,cxcr4_human,119,N,S,AMD3100,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CN3CCCNCCNCCCNCC3)cc2,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,106.0,nM,=,,3440.0,-32.258,,,radioligand: [125I]-CXCL12,100.0,0.0,,0.0,,P61073,0.5126222411764362
406,17197449,cxcr4_human,119,N,S,CXCL12,UniProt Entry Code,P48061,Full agonist,Single-point,Functional - cAMP accumulation,25.0,%,~,,17.0,-1.471,,,,120.0,0.0,,0.0,,P61073,0.5126222411764362
693,11923301,cxcr4_human,119,N,S,T140,PubChem CID,16130395,Inverse agonist,IC50,Binding - Radioligand competition/displacement,16.0,nM,=,,27.6,-1.724,,,radioligand: [125I]-CXCL12,100.0,0.0,,0.0,,P61073,0.5126222411764362
79,18768385,cxcr4_human,97,D,N,AMD11070,SMILES,NCCCCN(CC1=NC2=CC=CC=C2N1)[C@@H]3C4=NC=CC=C4CCC3,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,11.0,nM,=,,3185.0,-333.333,,,radioligand: [125I]-CXCL14,72.6,0.0,,0.0,,P61073,0.3229777674459073
195,18768385,cxcr4_human,97,D,N,AMD3100,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CN3CCCNCCNCCCNCC3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,842.0,nM,=,,2950.0,-3.509,,,radioligand: [125I]-CXCL12,72.6,0.0,,0.0,,P61073,0.3229777674459073
286,18768385,cxcr4_human,97,D,N,AMD3465,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CNCC3=CC=CC=N3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,49.0,nM,=,,176.0,-3.597,,,radioligand: [125I]-CXCL12,72.6,0.0,,0.0,,P61073,0.3229777674459073
431,18768385,cxcr4_human,97,D,N,CXCL12,UniProt Entry Code,P48061,Full agonist,K(d),Binding - Radioligand competition/displacement,35.8,nM,=,,47.6,-1.33,,,,72.6,0.0,,0.0,,P61073,0.3229777674459073
84,18768385,cxcr4_human,183,R,A,AMD11070,SMILES,NCCCCN(CC1=NC2=CC=CC=C2N1)[C@@H]3C4=NC=CC=C4CCC3,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,11.0,nM,=,,15.0,-1.364,,,radioligand: [125I]-CXCL19,79.2,0.0,,0.0,,P61073,0.2871963882755778
200,18768385,cxcr4_human,183,R,A,AMD3100,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CN3CCCNCCNCCCNCC3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,842.0,nM,=,,501.0,1.681,,,radioligand: [125I]-CXCL12,79.2,0.0,,0.0,,P61073,0.2871963882755778
291,18768385,cxcr4_human,183,R,A,AMD3465,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CNCC3=CC=CC=N3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,49.0,nM,=,,52.0,-1.062,,,radioligand: [125I]-CXCL12,79.2,0.0,,0.0,,P61073,0.2871963882755778
394,11551942,cxcr4_human,183,R,A,CXCL12,UniProt Entry Code,P48061,Full agonist,Single-point,Binding - Radioligand competition/displacement,100.0,%,~,,0.0,130.0,,,[125I]-SDF-1Î±,115.0,0.0,,0.0,,P61073,0.2871963882755778
395,11551942,cxcr4_human,183,R,A,CXCL12,UniProt Entry Code,P48061,Full agonist,Single-point,Binding - Radioligand competition/displacement,100.0,%,~,,0.0,80.0,,,12G5,115.0,0.0,,0.0,,P61073,0.2871963882755778
441,18768385,cxcr4_human,183,R,A,CXCL12,UniProt Entry Code,P48061,Full agonist,K(d),Binding - Radioligand competition/displacement,35.8,nM,=,,16.4,2.183,,,,79.2,0.0,,0.0,,P61073,0.2871963882755778
442,18768385,cxcr4_human,183,R,A,CXCL12,UniProt Entry Code,P48061,Full agonist,EC50,Functional - Ca2+ accumulation,34.0,nM,=,,42.9,-1.261,,,,79.2,0.0,,0.0,,P61073,0.2871963882755778
460,25039237,cxcr4_human,183,R,A,CXCL12,UniProt Entry Code,P48061,Full agonist,EC50,Functional - IP accumulation,1.5,nM,=,,0.1,15.0,,,,17.0,0.0,,0.0,,P61073,0.2871963882755778
489,26397724,cxcr4_human,183,R,A,CXCL12,UniProt Entry Code,P48061,Full agonist,EC50,Functional - IP accumulation,1.5,nM,=,,0.1,15.0,,,CXCL12,17.0,0.0,,0.0,,P61073,0.2871963882755778
581,25039237,cxcr4_human,183,R,A,FC131,PubChem CID,5275843,Antagonist (neutral/silent),EC50,Functional - IP accumulation,0.4,uM,=,,0.49,-1.225,,,CXCL12,17.0,0.0,,0.0,,P61073,0.2871963882755778
615,26397724,cxcr4_human,183,R,A,KRH1636,SMILES,CC(C1=CC=CC2=CC=CC=C21)NC(=O)C(CCCN=C(N)N)NC(=O)C3=CC=C(C=C3)CNCC4=CC=C,Antagonist (neutral/silent),EC50,Functional - IP accumulation,0.5,uM,=,,1.0,-2.0,,,CXCL12,17.0,0.0,,0.0,,P61073,0.2871963882755778
709,11551942,cxcr4_human,183,R,A,vMIP-II,UniProt Entry Code,Q98157,Antagonist (neutral/silent),Single-point,Binding - Radioligand competition/displacement,100.0,%,=,,0.0,110.0,,,[125I]-SDF-1Î±,115.0,0.0,,0.0,,P61073,0.2871963882755778
710,11551942,cxcr4_human,183,R,A,vMIP-II,UniProt Entry Code,Q98157,Antagonist (neutral/silent),Single-point,Binding - Radioligand competition/displacement,100.0,%,=,,0.0,100.0,,,12G5,115.0,0.0,,0.0,,P61073,0.2871963882755778
88,18768385,cxcr4_human,121,Y,A,AMD11070,SMILES,NCCCCN(CC1=NC2=CC=CC=C2N1)[C@@H]3C4=NC=CC=C4CCC3,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,11.0,nM,=,,19.0,-1.727,,,radioligand: [125I]-CXCL23,58.4,0.0,,0.0,,P61073,0.585043958500917
197,18768385,cxcr4_human,121,Y,A,AMD3100,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CN3CCCNCCNCCCNCC3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,842.0,nM,=,,401.0,2.1,,,radioligand: [125I]-CXCL12,58.4,0.0,,0.0,,P61073,0.585043958500917
288,18768385,cxcr4_human,121,Y,A,AMD3465,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CNCC3=CC=CC=N3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,49.0,nM,=,,17.0,2.882,,,radioligand: [125I]-CXCL12,58.4,0.0,,0.0,,P61073,0.585043958500917
435,18768385,cxcr4_human,121,Y,A,CXCL12,UniProt Entry Code,P48061,Full agonist,K(d),Binding - Radioligand competition/displacement,35.8,nM,=,,86.2,-2.41,,,,58.4,0.0,,0.0,,P61073,0.585043958500917
436,18768385,cxcr4_human,121,Y,A,CXCL12,UniProt Entry Code,P48061,Full agonist,EC50,Functional - Ca2+ accumulation,34.0,nM,=,,100.0,-2.941,,,,58.4,0.0,,0.0,,P61073,0.585043958500917
512,16188969/16306611,cxcr4_human,121,Y,A,CXCL12,UniProt Entry Code,P48061,Full agonist,IC50,Binding - Radioligand saturation,2.2,nM,=,,2.3,-1.045,,,radioligand: [125I]-CXCL12,87.5,0.0,,0.0,,P61073,0.585043958500917
100,11154697,cxcr4_human,182,D,N,AMD3100,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CN3CCCNCCNCCCNCC3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,550.0,nM,=,,3100.0,-5.65,,,radioligand: [125I]-12G5,202.5641025641025,0.0,,0.0,,P61073,0.2243256637242804
108,11154697,cxcr4_human,182,D,N,AMD3100,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CN3CCCNCCNCCCNCC3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,74.0,nM,=,,130.0,-1.757,,,radioligand: [125I]Met-CXCL12,58.82352941176471,0.0,,0.0,,P61073,0.2243256637242804
121,12534283,cxcr4_human,182,D,N,AMD3100,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CN3CCCNCCNCCCNCC3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,1.0,uM,=,,3.21,-3.205,,,radioligand: [125I]-12G5,202.5641025641025,0.0,,0.0,,P61073,0.2243256637242804
129,12534283,cxcr4_human,182,D,N,AMD3100,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CN3CCCNCCNCCCNCC3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,74.0,nM,=,,130.0,-1.757,,,radioligand: [125I]-Met-CXCL12,58.82352941176471,0.0,,0.0,,P61073,0.2243256637242804
209,12534283,cxcr4_human,182,D,N,AMD3100(Zn)2,SMILES,N12CCC[N](Cc3ccc(C[N@@]45[Zn]67N(CCN6CCCN7CC5)CCC4)cc3)([Zn]289)CCN9CCCN8CC1,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.028,nM,=,,0.072,-2.571,,,radioligand: [125I]-12G5,202.5641025641025,0.0,,0.0,,P61073,0.2243256637242804
217,12534283,cxcr4_human,182,D,N,AMD3100(Zn)2,SMILES,N12CCC[N](Cc3ccc(C[N@@]45[Zn]67N(CCN6CCCN7CC5)CCC4)cc3)([Zn]289)CCN9CCCN8CC1,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,12.0,nM,=,,62.0,-5.155,,,radioligand: [125I]-Met-CXCL12,58.82352941176471,0.0,,0.0,,P61073,0.2243256637242804
379,11154697,cxcr4_human,182,D,N,CXCL12,UniProt Entry Code,P48061,Full agonist,K(d),Binding - Radioligand competition/displacement,0.49,nM,=,,0.43,1.14,,,radioligand: [125I]Met-CXCL12,58.82352941176471,0.0,,0.0,,P61073,0.2243256637242804
534,11154697/12534283,cxcr4_human,182,D,N,cyclam,SMILES,C1CNCCNCCCNCCNC1,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,13.0,uM,=,,12.0,1.083,,,radioligand: [125I]-Met-CXCL12,58.82352941176471,0.0,,0.0,,P61073,0.2243256637242804
542,12534283,cxcr4_human,182,D,N,Cyclam (Zn),SMILES,[Zn+2].C1CNCCNCCCNCCNC1,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,3.0,uM,=,,1.6,1.875,,,radioligand: [125I]-Met-CXCL12,58.82352941176471,0.0,,0.0,,P61073,0.2243256637242804
101,11154697,cxcr4_human,193,D,N,AMD3100,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CN3CCCNCCNCCCNCC3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,550.0,nM,=,,3200.0,-5.814,,,radioligand: [125I]-12G5,233.33333333333331,0.0,,0.0,,P61073,0.2068864889682772
109,11154697,cxcr4_human,193,D,N,AMD3100,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CN3CCCNCCNCCCNCC3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,74.0,nM,=,,81.0,-1.094,,,radioligand: [125I]Met-CXCL12,70.58823529411765,0.0,,0.0,,P61073,0.2068864889682772
122,12534283,cxcr4_human,193,D,N,AMD3100,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CN3CCCNCCNCCCNCC3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,1.0,uM,=,,0.91,1.099,,,radioligand: [125I]-12G5,233.33333333333331,0.0,,0.0,,P61073,0.2068864889682772
130,12534283,cxcr4_human,193,D,N,AMD3100,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CN3CCCNCCNCCCNCC3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,74.0,nM,=,,81.0,-1.094,,,radioligand: [125I]-Met-CXCL12,70.58823529411765,0.0,,0.0,,P61073,0.2068864889682772
210,12534283,cxcr4_human,193,D,N,AMD3100(Zn)2,SMILES,N12CCC[N](Cc3ccc(C[N@@]45[Zn]67N(CCN6CCCN7CC5)CCC4)cc3)([Zn]289)CCN9CCCN8CC1,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.028,nM,=,,0.069,-2.463,,,radioligand: [125I]-12G5,233.33333333333331,0.0,,0.0,,P61073,0.2068864889682772
218,12534283,cxcr4_human,193,D,N,AMD3100(Zn)2,SMILES,N12CCC[N](Cc3ccc(C[N@@]45[Zn]67N(CCN6CCCN7CC5)CCC4)cc3)([Zn]289)CCN9CCCN8CC1,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,12.0,nM,=,,49.0,-4.082,,,radioligand: [125I]-Met-CXCL12,70.58823529411765,0.0,,0.0,,P61073,0.2068864889682772
380,11154697,cxcr4_human,193,D,N,CXCL12,UniProt Entry Code,P48061,Full agonist,K(d),Binding - Radioligand competition/displacement,0.49,nM,=,,0.44,1.114,,,radioligand: [125I]Met-CXCL12,70.58823529411765,0.0,,0.0,,P61073,0.2068864889682772
535,11154697/12534283,cxcr4_human,193,D,N,cyclam,SMILES,C1CNCCNCCCNCCNC1,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,13.0,uM,=,,9.2,1.413,,,radioligand: [125I]-Met-CXCL12,70.58823529411765,0.0,,0.0,,P61073,0.2068864889682772
543,12534283,cxcr4_human,193,D,N,Cyclam (Zn),SMILES,[Zn+2].C1CNCCNCCCNCCNC1,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,3.0,uM,=,,1.6,1.875,,,radioligand: [125I]-Met-CXCL12,70.58823529411765,0.0,,0.0,,P61073,0.2068864889682772
105,11154697,cxcr4_human,294,H,A,AMD3100,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CN3CCCNCCNCCCNCC3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,550.0,nM,=,,930.0,-1.692,,,radioligand: [125I]-12G5,341.025641025641,0.0,,0.0,,P61073,0.6154268834031293
113,11154697,cxcr4_human,294,H,A,AMD3100,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CN3CCCNCCNCCCNCC3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,74.0,nM,=,,140.0,-1.89,,,radioligand: [125I]Met-CXCL12,214.7058823529412,0.0,,0.0,,P61073,0.6154268834031293
126,12534283,cxcr4_human,294,H,A,AMD3100,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CN3CCCNCCNCCCNCC3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,1.0,uM,=,,0.51,1.961,,,radioligand: [125I]-12G5,341.025641025641,0.0,,0.0,,P61073,0.6154268834031293
134,12534283,cxcr4_human,294,H,A,AMD3100,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CN3CCCNCCNCCCNCC3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,74.0,nM,=,,140.0,-1.89,,,radioligand: [125I]-Met-CXCL12,214.7058823529412,0.0,,0.0,,P61073,0.6154268834031293
214,12534283,cxcr4_human,294,H,A,AMD3100(Zn)2,SMILES,N12CCC[N](Cc3ccc(C[N@@]45[Zn]67N(CCN6CCCN7CC5)CCC4)cc3)([Zn]289)CCN9CCCN8CC1,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.028,nM,=,,0.022,1.273,,,radioligand: [125I]-12G5,341.025641025641,0.0,,0.0,,P61073,0.6154268834031293
222,12534283,cxcr4_human,294,H,A,AMD3100(Zn)2,SMILES,N12CCC[N](Cc3ccc(C[N@@]45[Zn]67N(CCN6CCCN7CC5)CCC4)cc3)([Zn]289)CCN9CCCN8CC1,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,12.0,nM,=,,34.0,-2.833,,,radioligand: [125I]-Met-CXCL12,214.7058823529412,0.0,,0.0,,P61073,0.6154268834031293
384,11154697,cxcr4_human,294,H,A,CXCL12,UniProt Entry Code,P48061,Full agonist,K(d),Binding - Radioligand competition/displacement,0.49,nM,=,,0.88,-1.795,,,radioligand: [125I]Met-CXCL12,214.7058823529412,0.0,,0.0,,P61073,0.6154268834031293
529,16188969/16306611,cxcr4_human,294,H,A,CXCL12,UniProt Entry Code,P48061,Full agonist,IC50,Binding - Radioligand saturation,2.2,nM,=,,2.8,-1.272,,,radioligand: [125I]-CXCL12,112.7,0.0,,0.0,,P61073,0.6154268834031293
539,11154697/12534283,cxcr4_human,294,H,A,cyclam,SMILES,C1CNCCNCCCNCCNC1,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,13.0,uM,=,,26.0,-2.0,,,radioligand: [125I]-Met-CXCL12,214.7058823529412,0.0,,0.0,,P61073,0.6154268834031293
547,12534283,cxcr4_human,294,H,A,Cyclam (Zn),SMILES,[Zn+2].C1CNCCNCCCNCCNC1,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,3.0,uM,=,,3.4,-1.134,,,radioligand: [125I]-Met-CXCL12,214.7058823529412,0.0,,0.0,,P61073,0.6154268834031293
116,11923301,cxcr4_human,119,N,D,AMD3100,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CN3CCCNCCNCCCNCC3)cc2,Antagonist (neutral/silent),IC50,Binding - Radioligand competition/displacement,106.0,nM,=,,81.7,1.297,,,radioligand: [125I]-CXCL12,100.0,0.0,,0.0,,P61073,0.5126222411764362
404,17197449,cxcr4_human,119,N,D,CXCL12,UniProt Entry Code,P48061,Full agonist,Single-point,Functional - cAMP accumulation,25.0,%,~,,21.0,-1.19,,,,130.0,0.0,,0.0,,P61073,0.5126222411764362
695,11923301,cxcr4_human,119,N,D,T140,PubChem CID,16130395,Inverse agonist,IC50,Binding - Radioligand competition/displacement,16.0,nM,=,,16.6,-1.037,,,radioligand: [125I]-CXCL12,100.0,0.0,,0.0,,P61073,0.5126222411764362
120,11551942,cxcr4_human,5,S,A,CXCL12,UniProt Entry Code,P48061,Full agonist,Single-point,Binding - Radioligand competition/displacement,100.0,%,~,,0.0,30.0,,,12G5,170.0,0.0,,0.0,,P61073,0.28379168979595
385,11551942,cxcr4_human,5,S,A,CXCL12,UniProt Entry Code,P48061,Full agonist,Single-point,Binding - Radioligand competition/displacement,100.0,%,~,,0.0,95.0,,,[125I]-SDF-1Î±,170.0,0.0,,0.0,,P61073,0.28379168979595
649,11551942,cxcr4_human,5,S,A,vMIP-II,UniProt Entry Code,Q98157,Antagonist (neutral/silent),Single-point,Binding - Radioligand competition/displacement,100.0,%,=,,0.0,100.0,,,12G5,170.0,0.0,,0.0,,P61073,0.28379168979595
700,11551942,cxcr4_human,5,S,A,vMIP-II,UniProt Entry Code,Q98157,Antagonist (neutral/silent),Single-point,Binding - Radioligand competition/displacement,100.0,%,=,,0.0,105.0,,,[125I]-SDF-1Î±,170.0,0.0,,0.0,,P61073,0.28379168979595
137,14585837,cxcr4_human,168,T,A,AMD3100,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CN3CCCNCCNCCCNCC3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.89,uM,=,,0.74,1.203,,,radioligand:12G5(Bolton-Hunter),62.04379562043796,0.0,,0.0,,P61073,0.4824023219325746
301,14585837,cxcr4_human,168,T,A,AMD3479,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(C[N@@]3([Zn]456)CCCN4CCN6CCCN5CC3)cc2,,K(i),Binding - Radioligand competition/displacement,0.02,uM,=,,0.01,2.0,,,radioligand:12G5(Bolton-Hunter),62.04379562043796,0.0,,0.0,,P61073,0.4824023219325746
139,14585837,cxcr4_human,174,F,A,AMD3100,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CN3CCCNCCNCCCNCC3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.89,uM,=,,3.16,-3.546,,,radioligand:12G5(Bolton-Hunter),32.11678832116788,0.0,,0.0,,P61073,0.3528726187306297
172,17599916,cxcr4_human,174,F,A,AMD3100,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CN3CCCNCCNCCCNCC3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.89,uM,=,,3.2,-3.597,,,radioligand:[125I] -12G5,32.11678832116788,0.0,,0.0,,P61073,0.3528726187306297
264,17599916,cxcr4_human,174,F,A,AMD3465,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CNCC3=CC=CC=N3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.11,uM,=,,0.98,-8.929,,,radioligand:125I-12G5,32.11678832116788,0.0,,0.0,,P61073,0.3528726187306297
303,14585837,cxcr4_human,174,F,A,AMD3479,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(C[N@@]3([Zn]456)CCCN4CCN6CCCN5CC3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.02,uM,=,,0.68,-34.483,,,radioligand:12G5(Bolton-Hunter),32.11678832116788,0.0,,0.0,,P61073,0.3528726187306297
140,14585837,cxcr4_human,175,A,F,AMD3100,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CN3CCCNCCNCCCNCC3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.89,uM,=,,36.0,-40.0,,,radioligand:12G5(Bolton-Hunter),30.656934306569344,0.0,,0.0,,P61073,0.4275559944008014
157,17599916,cxcr4_human,175,A,F,AMD3100,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CN3CCCNCCNCCCNCC3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.22,uM,=,,8.5,-38.462,,,CXCL12,0.0,0.0,,68.96268962689626,,P61073,0.4275559944008014
173,17599916,cxcr4_human,175,A,F,AMD3100,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CN3CCCNCCNCCCNCC3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.89,uM,=,,36.0,-40.0,,,radioligand:[125I] -12G5,30.656934306569344,0.0,,0.0,,P61073,0.4275559944008014
231,17599916,cxcr4_human,175,A,F,AMD3389,SMILES,Cc1ccc(CN2CCCNCCNCCCNCC2)cc1,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,20.0,uM,=,,2239.0,-111.111,,,CXCL12,0.0,0.0,,68.96268962689626,,P61073,0.4275559944008014
248,17599916,cxcr4_human,175,A,F,AMD3465,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CNCC3=CC=CC=N3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.01,uM,=,,1.3,-125.0,,,CXCL12,0.0,0.0,,68.96268962689626,,P61073,0.4275559944008014
265,17599916,cxcr4_human,175,A,F,AMD3465,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CNCC3=CC=CC=N3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.11,uM,=,,215.0,-1000.0,,,radioligand:125I-12G5,30.656934306569344,0.0,,0.0,,P61073,0.4275559944008014
304,14585837,cxcr4_human,175,A,F,AMD3479,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(C[N@@]3([Zn]456)CCCN4CCN6CCCN5CC3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.02,uM,=,,8.6,-500.0,,,radioligand:12G5(Bolton-Hunter),30.656934306569344,0.0,,0.0,,P61073,0.4275559944008014
321,17599916,cxcr4_human,175,A,F,AMD3529,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CNCC3=CC=CC=C3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,1.7,uM,=,,128.0,-76.923,,,CXCL12,0.0,0.0,,98.6469864698647,,P61073,0.4275559944008014
338,17599916,cxcr4_human,175,A,F,AMD8721,SMILES,N(CCN1CCCN2CC3)([Cu]124)CCC[N@]34Cc5ccc(CNCC6=CC=CC=N6)cc5,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.04,uM,=,,10.0,-250.0,,,CXCL12,0.0,0.0,,98.6469864698647,,P61073,0.4275559944008014
355,17599916,cxcr4_human,175,A,F,AMD8899,SMILES,N1([Ni]234)CCC[N@@]4(Cc5ccc(CNCC6=CC=CC=N6)cc5)CCN3CCCN2CC1,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.01,uM,=,,0.58,-58.824,,,CXCL12,0.0,0.0,,98.6469864698647,,P61073,0.4275559944008014
414,17599916,cxcr4_human,175,A,F,CXCL12,UniProt Entry Code,P48061,Full agonist,K(d),Binding - Radioligand competition/displacement,0.81,nM,=,,1.8,-2.222,,,radioligand: [125I]-CXCL12,0.0,0.0,,98.6469864698647,,P61073,0.4275559944008014
143,14585837,cxcr4_human,207,G,W,AMD3100,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CN3CCCNCCNCCCNCC3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.89,uM,=,,3.02,-3.39,,,radioligand:12G5(Bolton-Hunter),85.40145985401459,0.0,,0.0,,P61073,0.566994668090002
182,17599916,cxcr4_human,207,G,W,AMD3100,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CN3CCCNCCNCCCNCC3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.89,uM,=,,2.7,-3.03,,,radioligand:[125I] -12G5,118.97810218978104,0.0,,0.0,,P61073,0.566994668090002
274,17599916,cxcr4_human,207,G,W,AMD3465,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CNCC3=CC=CC=N3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.11,uM,=,,0.13,-1.182,,,radioligand:125I-12G5,118.97810218978104,0.0,,0.0,,P61073,0.566994668090002
307,14585837,cxcr4_human,207,G,W,AMD3479,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(C[N@@]3([Zn]456)CCCN4CCN6CCCN5CC3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.02,uM,=,,0.25,-12.5,,,radioligand:12G5(Bolton-Hunter),85.40145985401459,0.0,,0.0,,P61073,0.566994668090002
145,14585837,cxcr4_human,256,Y,A,AMD3100,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CN3CCCNCCNCCCNCC3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.89,uM,=,,4.0,-4.484,,,radioligand:12G5(Bolton-Hunter),125.54744525547446,0.0,,0.0,,P61073,0.59185984851963
184,17599916,cxcr4_human,256,Y,A,AMD3100,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CN3CCCNCCNCCCNCC3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.89,uM,=,,4.0,-4.484,,,radioligand:[125I] -12G5,125.54744525547446,0.0,,0.0,,P61073,0.59185984851963
276,17599916,cxcr4_human,256,Y,A,AMD3465,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CNCC3=CC=CC=N3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.11,uM,=,,0.32,-2.907,,,radioligand:125I-12G5,125.54744525547446,0.0,,0.0,,P61073,0.59185984851963
309,14585837,cxcr4_human,256,Y,A,AMD3479,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(C[N@@]3([Zn]456)CCCN4CCN6CCCN5CC3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.02,uM,=,,0.19,-9.524,,,radioligand:12G5(Bolton-Hunter),125.54744525547446,0.0,,0.0,,P61073,0.59185984851963
523,16188969/16306611,cxcr4_human,256,Y,A,CXCL12,UniProt Entry Code,P48061,Full agonist,IC50,Binding - Radioligand saturation,2.2,nM,=,,3.7,-1.681,,,radioligand: [125I]-CXCL12,174.2,0.0,,0.0,,P61073,0.59185984851963
149,14585837,cxcr4_human,263,S,A,AMD3100,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CN3CCCNCCNCCCNCC3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.89,uM,=,,5.4,-6.061,,,radioligand:12G5(Bolton-Hunter),73.72262773722628,0.0,,0.0,,P61073,0.298983981665148
188,17599916,cxcr4_human,263,S,A,AMD3100,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CN3CCCNCCNCCCNCC3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.89,uM,=,,5.4,-6.061,,,radioligand:[125I] -12G5,73.72262773722628,0.0,,0.0,,P61073,0.298983981665148
279,17599916,cxcr4_human,263,S,A,AMD3465,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CNCC3=CC=CC=N3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.11,uM,=,,0.53,-4.808,,,radioligand:125I-12G5,73.72262773722628,0.0,,0.0,,P61073,0.298983981665148
313,14585837,cxcr4_human,263,S,A,AMD3479,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(C[N@@]3([Zn]456)CCCN4CCN6CCCN5CC3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.02,uM,=,,0.08,-4.0,,,radioligand:12G5(Bolton-Hunter),73.72262773722628,0.0,,0.0,,P61073,0.298983981665148
154,17599916,cxcr4_human,120,L,F,AMD3100,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CN3CCCNCCNCCCNCC3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.22,uM,=,,0.33,-1.499,,,CXCL12,0.0,0.0,,52.767527675276746,,P61073,0.533197218751849
228,17599916,cxcr4_human,120,L,F,AMD3389,SMILES,Cc1ccc(CN2CCCNCCNCCCNCC2)cc1,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,20.0,uM,=,,13.0,1.538,,,CXCL12,0.0,0.0,,52.767527675276746,,P61073,0.533197218751849
245,17599916,cxcr4_human,120,L,F,AMD3465,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CNCC3=CC=CC=N3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.01,uM,=,,0.01,1.0,,,CXCL12,0.0,0.0,,52.767527675276746,,P61073,0.533197218751849
318,17599916,cxcr4_human,120,L,F,AMD3529,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CNCC3=CC=CC=C3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,1.7,uM,=,,0.44,3.864,,,CXCL12,0.0,0.0,,59.61459614596146,,P61073,0.533197218751849
335,17599916,cxcr4_human,120,L,F,AMD8721,SMILES,N(CCN1CCCN2CC3)([Cu]124)CCC[N@]34Cc5ccc(CNCC6=CC=CC=N6)cc5,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.04,uM,=,,0.014,2.857,,,CXCL12,0.0,0.0,,59.61459614596146,,P61073,0.533197218751849
352,17599916,cxcr4_human,120,L,F,AMD8899,SMILES,N1([Ni]234)CCC[N@@]4(Cc5ccc(CNCC6=CC=CC=N6)cc5)CCN3CCCN2CC1,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.01,uM,=,,0.01,1.0,,,CXCL12,0.0,0.0,,59.61459614596146,,P61073,0.533197218751849
411,17599916,cxcr4_human,120,L,F,CXCL12,UniProt Entry Code,P48061,Full agonist,K(d),Binding - Radioligand competition/displacement,0.81,nM,=,,2.8,-3.46,,,radioligand: [125I]-CXCL12,0.0,0.0,,59.61459614596146,,P61073,0.533197218751849
156,17599916,cxcr4_human,172,F,A,AMD3100,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CN3CCCNCCNCCCNCC3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.22,uM,=,,0.17,1.294,,,CXCL12,0.0,0.0,,105.74005740057402,,P61073,0.4331191379845834
171,17599916,cxcr4_human,172,F,A,AMD3100,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CN3CCCNCCNCCCNCC3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.89,uM,=,,4.7,-5.291,,,radioligand:[125I] -12G5,27.73722627737226,0.0,,0.0,,P61073,0.4331191379845834
230,17599916,cxcr4_human,172,F,A,AMD3389,SMILES,Cc1ccc(CN2CCCNCCNCCCNCC2)cc1,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,20.0,uM,=,,15.0,1.333,,,CXCL12,0.0,0.0,,105.74005740057402,,P61073,0.4331191379845834
247,17599916,cxcr4_human,172,F,A,AMD3465,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CNCC3=CC=CC=N3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.01,uM,=,,0.01,1.0,,,CXCL12,0.0,0.0,,105.74005740057402,,P61073,0.4331191379845834
263,17599916,cxcr4_human,172,F,A,AMD3465,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CNCC3=CC=CC=N3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.11,uM,=,,0.56,-5.102,,,radioligand:125I-12G5,27.73722627737226,0.0,,0.0,,P61073,0.4331191379845834
320,17599916,cxcr4_human,172,F,A,AMD3529,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CNCC3=CC=CC=C3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,1.7,uM,=,,1.2,1.417,,,CXCL12,0.0,0.0,,68.96268962689626,,P61073,0.4331191379845834
337,17599916,cxcr4_human,172,F,A,AMD8721,SMILES,N(CCN1CCCN2CC3)([Cu]124)CCC[N@]34Cc5ccc(CNCC6=CC=CC=N6)cc5,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.04,uM,=,,0.04,1.0,,,CXCL12,0.0,0.0,,68.96268962689626,,P61073,0.4331191379845834
354,17599916,cxcr4_human,172,F,A,AMD8899,SMILES,N1([Ni]234)CCC[N@@]4(Cc5ccc(CNCC6=CC=CC=N6)cc5)CCN3CCCN2CC1,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.01,uM,=,,0.05,-5.0,,,CXCL12,0.0,0.0,,68.96268962689626,,P61073,0.4331191379845834
413,17599916,cxcr4_human,172,F,A,CXCL12,UniProt Entry Code,P48061,Full agonist,K(d),Binding - Radioligand competition/displacement,0.81,nM,=,,1.7,-2.101,,,radioligand: [125I]-CXCL12,0.0,0.0,,68.96268962689626,,P61073,0.4331191379845834
175,17599916,cxcr4_human,182,D,A,AMD3100,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CN3CCCNCCNCCCNCC3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.89,uM,=,,3.2,-3.597,,,radioligand:[125I] -12G5,173.72262773722628,0.0,,0.0,,P61073,0.3316710360815474
267,17599916,cxcr4_human,182,D,A,AMD3465,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CNCC3=CC=CC=N3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.11,uM,=,,0.3,-2.725,,,radioligand:125I-12G5,173.72262773722628,0.0,,0.0,,P61073,0.3316710360815474
516,16188969/16306611,cxcr4_human,182,D,A,CXCL12,UniProt Entry Code,P48061,Full agonist,IC50,Binding - Radioligand saturation,2.2,nM,=,,3.4,-1.546,,,radioligand: [125I]-CXCL12,98.2,0.0,,0.0,,P61073,0.3316710360815474
181,17599916,cxcr4_human,207,G,F,AMD3100,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CN3CCCNCCNCCCNCC3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.89,uM,=,,3.0,-3.367,,,radioligand:[125I] -12G5,85.40145985401459,0.0,,0.0,,P61073,0.610532239034817
273,17599916,cxcr4_human,207,G,F,AMD3465,SMILES,N1(CCCNCCNCCCNCC1)Cc2ccc(CNCC3=CC=CC=N3)cc2,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,0.11,uM,=,,0.16,-1.453,,,radioligand:125I-12G5,85.40145985401459,0.0,,0.0,,P61073,0.610532239034817
368,10620340,cxcr4_human,10,D,A,CXCL12,UniProt Entry Code,P48061,Full agonist,K(d),Binding - Radioligand saturation,3.4,nM,=,,7.3,-2.146,,,,150.38910505836577,0.0,,0.0,,P61073,0.3787918642613473
369,10620340,cxcr4_human,28,C,A,CXCL12,UniProt Entry Code,P48061,Full agonist,K(d),Binding - Radioligand saturation,3.4,nM,=,,17.9,-5.263,,,,96.88715953307393,0.0,,0.0,,P61073,0.578619047442864
370,10620340,cxcr4_human,109,C,A,CXCL12,UniProt Entry Code,P48061,Full agonist,K(d),Binding - Radioligand saturation,3.4,nM,=,,31.9,-9.346,,,,136.38132295719845,0.0,,0.0,,P61073,0.7659670902994445
371,10620340,cxcr4_human,186,C,A,CXCL12,UniProt Entry Code,P48061,Full agonist,K(d),Binding - Radioligand saturation,3.4,nM,=,,27.7,-8.13,,,,110.89494163424123,0.0,,0.0,,P61073,0.7500687668496561
372,10620340,cxcr4_human,262,D,A,CXCL12,UniProt Entry Code,P48061,Full agonist,K(d),Binding - Radioligand saturation,3.4,nM,=,,14.9,-4.386,,,,174.31906614785993,0.0,,0.0,,P61073,0.404394525517279
524,16188969/16306611,cxcr4_human,262,D,A,CXCL12,UniProt Entry Code,P48061,Full agonist,IC50,Binding - Radioligand saturation,2.2,nM,=,,4.4,-2.0,,,radioligand: [125I]-CXCL12,137.9,0.0,,0.0,,P61073,0.404394525517279
373,10620340,cxcr4_human,268,E,A,CXCL12,UniProt Entry Code,P48061,Full agonist,K(d),Binding - Radioligand saturation,3.4,nM,=,,3.3,1.03,,,,125.4863813229572,0.0,,0.0,,P61073,0.2734160751517188
400,11551942,cxcr4_human,268,E,A,CXCL12,UniProt Entry Code,P48061,Full agonist,Single-point,Binding - Radioligand competition/displacement,100.0,%,~,,0.0,50.0,,,[125I]-SDF-1Î±,200.0,0.0,,0.0,,P61073,0.2734160751517188
715,11551942,cxcr4_human,268,E,A,vMIP-II,UniProt Entry Code,Q98157,Antagonist (neutral/silent),Single-point,Binding - Radioligand competition/displacement,100.0,%,=,,0.0,50.0,,,[125I]-SDF-1Î±,200.0,0.0,,0.0,,P61073,0.2734160751517188
374,10620340,cxcr4_human,274,C,A,CXCL12,UniProt Entry Code,P48061,Full agonist,K(d),Binding - Radioligand saturation,3.4,nM,=,,18.2,-5.348,,,,173.5408560311284,0.0,,0.0,,P61073,0.4400223794776235
375,10620340,cxcr4_human,275,E,A,CXCL12,UniProt Entry Code,P48061,Full agonist,K(d),Binding - Radioligand saturation,3.4,nM,=,,15.7,-4.608,,,,106.22568093385216,0.0,,0.0,,P61073,0.2713588435886177
376,10620340,cxcr4_human,277,E,A,CXCL12,UniProt Entry Code,P48061,Full agonist,K(d),Binding - Radioligand saturation,3.4,nM,=,,18.4,-5.405,,,,133.07392996108948,0.0,,0.0,,P61073,0.3018370810860834
386,11551942,cxcr4_human,7,Y,A,CXCL12,UniProt Entry Code,P48061,Full agonist,Single-point,Binding - Radioligand competition/displacement,100.0,%,~,,0.0,80.0,,,[125I]-SDF-1Î±,125.0,0.0,,0.0,,P61073,0.3850389466571527
701,11551942,cxcr4_human,7,Y,A,vMIP-II,UniProt Entry Code,Q98157,Antagonist (neutral/silent),Single-point,Binding - Radioligand competition/displacement,100.0,%,=,,0.0,75.0,,,[125I]-SDF-1Î±,125.0,0.0,,0.0,,P61073,0.3850389466571527
702,11551942,cxcr4_human,7,Y,A,vMIP-II,UniProt Entry Code,Q98157,Antagonist (neutral/silent),Single-point,Binding - Radioligand competition/displacement,100.0,%,=,,0.0,75.0,,,12G5,125.0,0.0,,0.0,,P61073,0.3850389466571527
388,11551942,cxcr4_human,20,D,A,CXCL12,UniProt Entry Code,P48061,Full agonist,Single-point,Binding - Radioligand competition/displacement,100.0,%,~,,0.0,40.0,,,[125I]-SDF-1Î±,160.0,0.0,,0.0,,P61073,0.361532325253443
389,11551942,cxcr4_human,20,D,A,CXCL12,UniProt Entry Code,P48061,Full agonist,Single-point,Binding - Radioligand competition/displacement,100.0,%,~,,0.0,20.0,,,12G5,160.0,0.0,,0.0,,P61073,0.361532325253443
703,11551942,cxcr4_human,20,D,A,vMIP-II,UniProt Entry Code,Q98157,Antagonist (neutral/silent),Single-point,Binding - Radioligand competition/displacement,100.0,%,=,,0.0,50.0,,,[125I]-SDF-1Î±,160.0,0.0,,0.0,,P61073,0.361532325253443
704,11551942,cxcr4_human,20,D,A,vMIP-II,UniProt Entry Code,Q98157,Antagonist (neutral/silent),Single-point,Binding - Radioligand competition/displacement,100.0,%,=,,0.0,60.0,,,12G5,160.0,0.0,,0.0,,P61073,0.361532325253443
390,11551942,cxcr4_human,21,Y,A,CXCL12,UniProt Entry Code,P48061,Full agonist,Single-point,Binding - Radioligand competition/displacement,100.0,%,~,,0.0,10.0,,,[125I]-SDF-1Î±,150.0,0.0,,0.0,,P61073,0.3605424381320453
391,11551942,cxcr4_human,21,Y,A,CXCL12,UniProt Entry Code,P48061,Full agonist,Single-point,Binding - Radioligand competition/displacement,100.0,%,~,,0.0,25.0,,,12G5,150.0,0.0,,0.0,,P61073,0.3605424381320453
705,11551942,cxcr4_human,21,Y,A,vMIP-II,UniProt Entry Code,Q98157,Antagonist (neutral/silent),Single-point,Binding - Radioligand competition/displacement,100.0,%,=,,0.0,10.0,,,[125I]-SDF-1Î±,150.0,0.0,,0.0,,P61073,0.3605424381320453
706,11551942,cxcr4_human,21,Y,A,vMIP-II,UniProt Entry Code,Q98157,Antagonist (neutral/silent),Single-point,Binding - Radioligand competition/displacement,100.0,%,=,,0.0,40.0,,,12G5,150.0,0.0,,0.0,,P61073,0.3605424381320453
392,11551942,cxcr4_human,26,E,A,CXCL12,UniProt Entry Code,P48061,Full agonist,Single-point,Binding - Radioligand competition/displacement,100.0,%,~,,0.0,60.0,,,[125I]-SDF-1Î±,165.0,0.0,,0.0,,P61073,0.3000420791419027
393,11551942,cxcr4_human,26,E,A,CXCL12,UniProt Entry Code,P48061,Full agonist,Single-point,Binding - Radioligand competition/displacement,100.0,%,~,,0.0,110.0,,,12G5,165.0,0.0,,0.0,,P61073,0.3000420791419027
707,11551942,cxcr4_human,26,E,A,vMIP-II,UniProt Entry Code,Q98157,Antagonist (neutral/silent),Single-point,Binding - Radioligand competition/displacement,100.0,%,=,,0.0,65.0,,,[125I]-SDF-1Î±,165.0,0.0,,0.0,,P61073,0.3000420791419027
708,11551942,cxcr4_human,26,E,A,vMIP-II,UniProt Entry Code,Q98157,Antagonist (neutral/silent),Single-point,Binding - Radioligand competition/displacement,100.0,%,=,,0.0,100.0,,,12G5,165.0,0.0,,0.0,,P61073,0.3000420791419027
396,11551942,cxcr4_human,184,Y,A,CXCL12,UniProt Entry Code,P48061,Full agonist,Single-point,Binding - Radioligand competition/displacement,100.0,%,~,,0.0,130.0,,,[125I]-SDF-1Î±,100.0,0.0,,0.0,,P61073,0.3254248240325315
397,11551942,cxcr4_human,184,Y,A,CXCL12,UniProt Entry Code,P48061,Full agonist,Single-point,Binding - Radioligand competition/displacement,100.0,%,~,,0.0,120.0,,,12G5,100.0,0.0,,0.0,,P61073,0.3254248240325315
711,11551942,cxcr4_human,184,Y,A,vMIP-II,UniProt Entry Code,Q98157,Antagonist (neutral/silent),Single-point,Binding - Radioligand competition/displacement,100.0,%,=,,0.0,115.0,,,[125I]-SDF-1Î±,100.0,0.0,,0.0,,P61073,0.3254248240325315
712,11551942,cxcr4_human,184,Y,A,vMIP-II,UniProt Entry Code,Q98157,Antagonist (neutral/silent),Single-point,Binding - Radioligand competition/displacement,100.0,%,=,,0.0,125.0,,,12G5,100.0,0.0,,0.0,,P61073,0.3254248240325315
402,11551942,cxcr4_human,272,Q,A,CXCL12,UniProt Entry Code,P48061,Full agonist,Single-point,Binding - Radioligand competition/displacement,100.0,%,~,,0.0,130.0,,,[125I]-SDF-1Î±,145.0,0.0,,0.0,,P61073,0.2682274402644359
403,11551942,cxcr4_human,272,Q,A,CXCL12,UniProt Entry Code,P48061,Full agonist,Single-point,Binding - Radioligand competition/displacement,100.0,%,~,,0.0,50.0,,,12G5,145.0,0.0,,0.0,,P61073,0.2682274402644359
717,11551942,cxcr4_human,272,Q,A,vMIP-II,UniProt Entry Code,Q98157,Antagonist (neutral/silent),Single-point,Binding - Radioligand competition/displacement,100.0,%,=,,0.0,130.0,,,[125I]-SDF-1Î±,145.0,0.0,,0.0,,P61073,0.2682274402644359
718,11551942,cxcr4_human,272,Q,A,vMIP-II,UniProt Entry Code,Q98157,Antagonist (neutral/silent),Single-point,Binding - Radioligand competition/displacement,100.0,%,=,,0.0,80.0,,,12G5,145.0,0.0,,0.0,,P61073,0.2682274402644359
407,17197449,cxcr4_human,133,D,N,CXCL12,UniProt Entry Code,P48061,Full agonist,Single-point,Functional - cAMP accumulation,25.0,%,~,,15.0,-1.667,,,,50.0,0.0,,0.0,,P61073,0.6847851038061165
408,17197449,cxcr4_human,134,R,A,CXCL12,UniProt Entry Code,P48061,Full agonist,Single-point,Functional - cAMP accumulation,25.0,%,~,,10.0,-2.5,,,,60.0,0.0,,0.0,,P61073,0.8459557265062735
409,17197449,cxcr4_human,135,Y,A,CXCL12,UniProt Entry Code,P48061,Full agonist,Single-point,Functional - cAMP accumulation,25.0,%,~,,17.0,-1.471,,,,80.0,0.0,,0.0,,P61073,0.6206357560099713
450,22039044,cxcr4_human,29,F,A,CXCL12,UniProt Entry Code,P48061,Full agonist,Single-point,,100.0,%,~,,0.0,115.0,,,,48.38709677419355,0.0,,0.0,,P61073,0.3231072692245184
697,22039044,cxcr4_human,29,F,A,Ubiquitin,UniProt Entry Code,P0CG48,Agonist,Single-point,,100.0,%,=,,0.0,30.0,,,,48.38709677419355,0.0,,0.0,,P61073,0.3231072692245184
452,22039044,cxcr4_human,271,K,A,CXCL12,UniProt Entry Code,P48061,Full agonist,Single-point,,100.0,%,~,,0.0,130.0,,,,35.483870967741936,0.0,,0.0,,P61073,0.2774284763176701
699,22039044,cxcr4_human,271,K,A,Ubiquitin,UniProt Entry Code,P0CG48,Agonist,Single-point,,100.0,%,=,,0.0,35.0,,,,35.483870967741936,0.0,,0.0,,P61073,0.2774284763176701
479,25468967,cxcr4_human,171,D,A,CXCL12,UniProt Entry Code,P48061,Full agonist,pEC50,Functional - Ca2+ accumulation,8.8,,=,,7.99,-6.452,,,,100.0,0.0,,0.0,,P61073,0.4971846834512022
508,16188969/16306611,cxcr4_human,79,H,A,CXCL12,UniProt Entry Code,P48061,Full agonist,IC50,Binding - Radioligand saturation,2.2,nM,=,,1.6,1.375,,,radioligand: [125I]-CXCL12,121.9,0.0,,0.0,,P61073,0.5870632201831768
513,16188969/16306611,cxcr4_human,161,W,A,CXCL12,UniProt Entry Code,P48061,Full agonist,IC50,Binding - Radioligand saturation,2.2,nM,=,,12.5,-5.682,,,radioligand: [125I]-CXCL12,259.0,0.0,,0.0,,P61073,0.7455750306156231
514,16188969/16306611,cxcr4_human,163,P,A,CXCL12,UniProt Entry Code,P48061,Full agonist,IC50,Binding - Radioligand saturation,2.2,nM,=,,8.6,-3.906,,,radioligand: [125I]-CXCL12,112.4,0.0,,0.0,,P61073,0.3681476516586535
519,16188969/16306611,cxcr4_human,191,P,A,CXCL12,UniProt Entry Code,P48061,Full agonist,IC50,Binding - Radioligand saturation,2.2,nM,=,,2.5,-1.136,,,radioligand: [125I]-CXCL12,114.2,0.0,,0.0,,P61073,0.2779212956574602
520,16188969/16306611,cxcr4_human,219,Y,A,CXCL12,UniProt Entry Code,P48061,Full agonist,IC50,Binding - Radioligand saturation,2.2,nM,=,,4.7,-2.137,,,radioligand: [125I]-CXCL12,87.3,0.0,,0.0,,P61073,0.7909949354639219
531,16188969/16306611,cxcr4_human,302,Y,A,CXCL12,UniProt Entry Code,P48061,Full agonist,IC50,Binding - Radioligand saturation,2.2,nM,=,,11.5,-5.236,,,radioligand: [125I]-CXCL12,141.7,0.0,,0.0,,P61073,0.8148381925378093
550,23219524,cxcr4_human,156,V,C,FC131,PubChem CID,5275843,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,17.0,nM,=,,21.2,-1.247,,,,51.23966942148761,0.0,,0.0,,P61073,0.408727923772395
551,23219524,cxcr4_human,157,Y,C,FC131,PubChem CID,5275843,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,17.0,nM,=,,43.0,-2.532,,,,96.69421487603306,0.0,,0.0,,P61073,0.5662557301216397
552,23219524,cxcr4_human,158,V,C,FC131,PubChem CID,5275843,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,17.0,nM,=,,14.0,1.214,,,,68.59504132231406,0.0,,0.0,,P61073,0.2374816110641039
553,23219524,cxcr4_human,159,G,C,FC131,PubChem CID,5275843,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,17.0,nM,=,,19.5,-1.147,,,,76.03305785123966,0.0,,0.0,,P61073,0.326902304730819
554,23219524,cxcr4_human,160,V,C,FC131,PubChem CID,5275843,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,17.0,nM,=,,35.5,-2.088,,,,93.38842975206612,0.0,,0.0,,P61073,0.5414813872505914
556,23219524,cxcr4_human,162,I,C,FC131,PubChem CID,5275843,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,17.0,nM,=,,13.6,1.25,,,,59.50413223140496,0.0,,0.0,,P61073,0.2762149891841464
557,23219524,cxcr4_human,163,P,C,FC131,PubChem CID,5275843,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,17.0,nM,=,,45.1,-2.653,,,,55.371900826446286,0.0,,0.0,,P61073,0.4550897926058299
558,23219524,cxcr4_human,164,A,C,FC131,PubChem CID,5275843,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,17.0,nM,=,,31.8,-1.869,,,,80.16528925619835,0.0,,0.0,,P61073,0.4864270246500501
559,23219524,cxcr4_human,165,L,C,FC131,PubChem CID,5275843,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,17.0,nM,=,,29.7,-1.748,,,,80.9917355371901,0.0,,0.0,,P61073,0.3369107249481351
562,23219524,cxcr4_human,168,T,C,FC131,PubChem CID,5275843,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,17.0,nM,=,,11.2,1.518,,,,94.21487603305786,0.0,,0.0,,P61073,0.5273693656316099
563,23219524,cxcr4_human,169,I,C,FC131,PubChem CID,5275843,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,17.0,nM,=,,8.7,1.954,,,,25.61983471074381,0.0,,0.0,,P61073,0.3172027111603791
564,23219524,cxcr4_human,170,P,C,FC131,PubChem CID,5275843,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,17.0,nM,=,,23.6,-1.389,,,,24.793388429752067,0.0,,0.0,,P61073,0.5747094223200421
565,23219524,cxcr4_human,171,D,C,FC131,PubChem CID,5275843,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,17.0,nM,=,,39.6,-2.331,,,,22.314049586776864,0.0,,0.0,,P61073,0.5420772977065296
566,23219524,cxcr4_human,172,F,C,FC131,PubChem CID,5275843,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,17.0,nM,=,,22.1,-1.3,,,,93.38842975206612,0.0,,0.0,,P61073,0.4331191379845834
567,23219524,cxcr4_human,173,I,C,FC131,PubChem CID,5275843,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,17.0,nM,=,,23.7,-1.395,,,,65.28925619834712,0.0,,0.0,,P61073,0.2715944655454286
568,23219524,cxcr4_human,174,F,C,FC131,PubChem CID,5275843,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,17.0,nM,=,,8.6,1.977,,,,23.140495867768596,0.0,,0.0,,P61073,0.3528726187306297
571,23219524,cxcr4_human,177,V,C,FC131,PubChem CID,5275843,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,17.0,nM,=,,19.6,-1.153,,,,54.54545454545454,0.0,,0.0,,P61073,0.2725953250552705
572,23219524,cxcr4_human,178,S,C,FC131,PubChem CID,5275843,Antagonist (neutral/silent),K(d),Binding - Radioligand saturation,17.0,nM,=,,21.1,-1.241,,,,55.371900826446286,0.0,,0.0,,P61073,0.2718982386857898
3,1356984,hrh2_human,190,T,A,[3H]-methyltiotidine,ChEMBL Compound ID,CHEMBL269646,Binding - unknown pharmacological activity,K(d),Binding - Radioligand competition/displacement,3.3,nM,=,,79.0,-23.81,,,"[3H]-methyltiotidine
[3H]-methyltiotidine
[3H]-methyltiotidine
[3H]-methyltiotidine (radioligand)",0.0,0.0,,0.0,,P25021,0.4287273330352809
5,1356984,hrh2_human,190,T,A,Cemetidine,ChEMBL Compound ID,CHEMBL30,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,50.0,nM,=,,300.0,-5.988,,,"[3H]-methyltiotidine
[3H]-methyltiotidine
[3H]-methyltiotidine
[3H]-methyltiotidine (radioligand)",0.0,0.0,,0.0,,P25021,0.4287273330352809
4,1356984,hrh2_human,190,T,C,[3H]-methyltiotidine,ChEMBL Compound ID,CHEMBL269646,Binding - unknown pharmacological activity,K(d),Binding - Radioligand competition/displacement,3.3,nM,=,,71.0,-21.739,,,"[3H]-methyltiotidine
[3H]-methyltiotidine
[3H]-methyltiotidine
[3H]-methyltiotidine (radioligand)",0.0,0.0,,0.0,,P25021,0.4732444376883148
6,1356984,hrh2_human,190,T,C,Cemetidine,ChEMBL Compound ID,CHEMBL30,Binding - unknown pharmacological activity,IC50,Binding - Radioligand competition/displacement,50.0,nM,=,,400.0,-8.0,,,"[3H]-methyltiotidine
[3H]-methyltiotidine
[3H]-methyltiotidine
[3H]-methyltiotidine (radioligand)",0.0,0.0,,0.0,,P25021,0.4732444376883148
17,9415408,crfr1_human,257,K,Q,CRF,PubChem CID,16132265,Full agonist,EC50,Functional - cAMP accumulation,0.16,nM,=,,0.15,1.067,,,CRF,0.0,0.0,,0.0,,P34998,0.3583083364445829
24,12029097,crfr1_human,257,K,R,sauvagine,PubChem CID,16132335,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,5.8,nM,=,,5.1,1.137,,,"[125I]sauvagine-[Tyr0,Gln1, Leu17] (radioligand)",90.1,0.0,,0.0,,P34998,0.3180840323530276
25,12029097,crfr1_human,257,K,R,"sauvagine-[Tyr0,Gln1, Leu17]",FASTA sequence (peptide),YSEQPPISLDLTFHLLRLVLEMARAEQLAQQAHSNRKLMEII,Full agonist,EC50,Functional - cAMP accumulation,0.22,nM,=,,2.51,-11.364,,,CRF,0.0,0.0,,31.6,,P34998,0.3180840323530276
87,23863939,crfr1_human,280,L,A,[ 3H]CP-376395,PubChem CID,9862166,Binding - unknown pharmacological activity,Single-point,Binding - Radioligand competition/displacement,0.0,%,=,,0.0,-47.619,,,[ 3H]CP-376395 (radioligand),100.0,0.0,,0.0,,P34998,0.2616792024173182
95,23863939,crfr1_human,323,L,A,[ 3H]CP-376395,PubChem CID,9862166,Binding - unknown pharmacological activity,Single-point,Binding - Radioligand competition/displacement,0.0,,=,,0.0,-3.774,,,[ 3H]CP-376395 (radioligand),100.0,0.0,,0.0,,P34998,0.5989105395288129
23,18727713,tshr_human,27,P,T,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,85.0,-1.176,,,,0.0,0.0,,0.0,,P16473,0.2960048238834418
31,18727713,tshr_human,34,E,K,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,70.0,-1.429,,,,0.0,0.0,,0.0,,P16473,0.2460665340915993
36,17725428,tshr_human,43,D,A,porcine thyrotropin,UniProt Entry Code (peptide),"P01219, P01224",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,70.0,-1.429,,,,0.0,0.0,,0.0,,P16473,0.3749830053747879
37,17725428,tshr_human,43,D,A,porcine thyrotropin,UniProt Entry Code (peptide),"P01219, P01224",Full agonist,Specific-binding,binding,100.0,%,,,100.0,1.0,,,,0.0,0.0,,0.0,,P16473,0.3749830053747879
40,17725428,tshr_human,58,K,A,porcine thyrotropin,UniProt Entry Code (peptide),"P01219, P01224",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,100.0,1.0,,,,0.0,0.0,,0.0,,P16473,0.3737912705235695
41,17725428,tshr_human,58,K,A,porcine thyrotropin,UniProt Entry Code (peptide),"P01219, P01224",Full agonist,Specific-binding,binding,100.0,%,,,100.0,1.0,,,,0.0,0.0,,0.0,,P16473,0.3737912705235695
43,17725428,tshr_human,60,I,A,porcine thyrotropin,UniProt Entry Code (peptide),"P01219, P01224",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,100.0,1.0,,,,0.0,0.0,,0.0,,P16473,0.3461263686725159
44,17725428,tshr_human,60,I,A,porcine thyrotropin,UniProt Entry Code (peptide),"P01219, P01224",Full agonist,Specific-binding,binding,100.0,%,,,100.0,1.0,,,,0.0,0.0,,0.0,,P16473,0.3461263686725159
45,17725428,tshr_human,61,E,A,porcine thyrotropin,UniProt Entry Code (peptide),"P01219, P01224",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,80.0,-1.25,,,,0.0,0.0,,0.0,,P16473,0.3787164225709959
46,17725428,tshr_human,61,E,A,porcine thyrotropin,UniProt Entry Code (peptide),"P01219, P01224",Full agonist,Specific-binding,binding,100.0,%,,,100.0,1.0,,,,0.0,0.0,,0.0,,P16473,0.3787164225709959
49,20736161,tshr_human,80,R,A,human thyrotropin,IUPHAR/BPS Guide to pharmacology,4393,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,70.0,-1.429,,,,0.0,0.0,,0.0,,P16473,0.2977475408646481
50,17725428,tshr_human,80,R,A,porcine thyrotropin,UniProt Entry Code (peptide),"P01219, P01224",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,100.0,1.0,,,,0.0,0.0,,0.0,,P16473,0.2977475408646481
51,17725428,tshr_human,80,R,A,porcine thyrotropin,UniProt Entry Code (peptide),"P01219, P01224",Full agonist,Specific-binding,binding,100.0,%,,,100.0,1.0,,,,0.0,0.0,,0.0,,P16473,0.2977475408646481
54,20736161,tshr_human,80,R,E,human thyrotropin,IUPHAR/BPS Guide to pharmacology,4393,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,104.0,1.04,,,,0.0,0.0,,0.0,,P16473,0.2615180321865943
56,17725428,tshr_human,82,Y,A,porcine thyrotropin,UniProt Entry Code (peptide),"P01219, P01224",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,100.0,1.0,,,,0.0,0.0,,0.0,,P16473,0.3732319958608757
57,17725428,tshr_human,82,Y,A,porcine thyrotropin,UniProt Entry Code (peptide),"P01219, P01224",Full agonist,Specific-binding,binding,100.0,%,,,100.0,1.0,,,,0.0,0.0,,0.0,,P16473,0.3732319958608757
59,20736161,tshr_human,84,S,A,human thyrotropin,IUPHAR/BPS Guide to pharmacology,4393,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,145.0,1.45,,,,0.0,0.0,,0.0,,P16473,0.3348608501378725
61,17725428,tshr_human,107,E,A,porcine thyrotropin,UniProt Entry Code (peptide),"P01219, P01224",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,70.0,-1.429,,,,0.0,0.0,,0.0,,P16473,0.3669131310946507
62,17725428,tshr_human,107,E,A,porcine thyrotropin,UniProt Entry Code (peptide),"P01219, P01224",Full agonist,Specific-binding,binding,100.0,%,,,100.0,1.0,,,,0.0,0.0,,0.0,,P16473,0.3669131310946507
65,17725428,tshr_human,109,R,A,porcine thyrotropin,UniProt Entry Code (peptide),"P01219, P01224",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,100.0,1.0,,,,0.0,0.0,,0.0,,P16473,0.408571264640418
66,17725428,tshr_human,109,R,A,porcine thyrotropin,UniProt Entry Code (peptide),"P01219, P01224",Full agonist,Specific-binding,binding,100.0,%,,,100.0,1.0,,,,0.0,0.0,,0.0,,P16473,0.408571264640418
67,9100579,tshr_human,109,R,Q,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,80.0,-1.25,,,,0.0,0.0,,0.0,,P16473,0.3252162057157823
68,9100579,tshr_human,109,R,Q,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,60.0,-1.667,,,,0.0,0.0,,0.0,,P16473,0.3252162057157823
70,17725428,tshr_human,129,K,A,porcine thyrotropin,UniProt Entry Code (peptide),"P01219, P01224",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,100.0,1.0,,,,0.0,0.0,,0.0,,P16473,0.3502937458355573
71,17725428,tshr_human,129,K,A,porcine thyrotropin,UniProt Entry Code (peptide),"P01219, P01224",Full agonist,Specific-binding,binding,100.0,%,,,100.0,1.0,,,,0.0,0.0,,0.0,,P16473,0.3502937458355573
72,20736161,tshr_human,130,F,A,human thyrotropin,IUPHAR/BPS Guide to pharmacology,4393,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,71.0,-1.408,,,,0.0,0.0,,0.0,,P16473,0.3338289268254281
73,20736161,tshr_human,136,T,A,human thyrotropin,IUPHAR/BPS Guide to pharmacology,4393,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,75.0,-1.333,,,,0.0,0.0,,0.0,,P16473,0.5946894697921183
75,20736161,tshr_human,157,E,A,human thyrotropin,IUPHAR/BPS Guide to pharmacology,4393,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,77.0,-1.299,,,,0.0,0.0,,0.0,,P16473,0.3795662403021407
77,20736161,tshr_human,157,E,Q,human thyrotropin,IUPHAR/BPS Guide to pharmacology,4393,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,82.0,-1.22,,,,0.0,0.0,,0.0,,P16473,0.2628049761803105
78,20736161,tshr_human,160,D,A,human thyrotropin,IUPHAR/BPS Guide to pharmacology,4393,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,68.0,-1.471,,,,0.0,0.0,,0.0,,P16473,0.4126339051546184
84,17456567,tshr_human,162,P,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,104.0,1.04,,,,0.0,0.0,,0.0,,P16473,0.3161733522611203
85,17456567,tshr_human,162,P,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,80.0,-1.25,,,,0.0,0.0,,0.0,,P16473,0.3161733522611203
86,17456567,tshr_human,162,P,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,26.0,-3.846,,,,0.0,0.0,,0.0,,P16473,0.3161733522611203
93,9854118,tshr_human,183,K,R,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,100.0,1.0,,,,0.0,0.0,,0.0,,P16473,0.2348636709931398
97,20736161,tshr_human,232,D,A,human thyrotropin,IUPHAR/BPS Guide to pharmacology,4393,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,52.0,-1.923,,,,0.0,0.0,,0.0,,P16473,0.5657103788434907
98,20736161,tshr_human,234,S,A,human thyrotropin,IUPHAR/BPS Guide to pharmacology,4393,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,90.0,-1.111,,,,0.0,0.0,,0.0,,P16473,0.3955493656221399
101,15531543,tshr_human,252,L,P,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,5.0,-20.0,,,,0.0,0.0,,0.0,,P16473,0.6648334742982958
102,15531543,tshr_human,252,L,P,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,25.0,-4.0,,,,0.0,0.0,,0.0,,P16473,0.6648334742982958
106,21525003,tshr_human,255,R,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,71.0,-1.408,,,,0.0,0.0,,0.0,,P16473,0.377888340913963
107,21525003,tshr_human,255,R,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,62.0,-1.613,,,,0.0,0.0,,0.0,,P16473,0.377888340913963
113,21525003,tshr_human,259,T,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,95.0,-1.053,,,,0.0,0.0,,0.0,,P16473,0.403483886394983
114,21525003,tshr_human,259,T,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,77.0,-1.299,,,,0.0,0.0,,0.0,,P16473,0.403483886394983
118,21525003,tshr_human,260,L,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,56.0,-1.786,,,,0.0,0.0,,0.0,,P16473,0.5823480150187008
119,21525003,tshr_human,260,L,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,17.0,-5.882,,,,0.0,0.0,,0.0,,P16473,0.5823480150187008
123,21525003,tshr_human,260,L,V,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,83.0,-1.205,,,,0.0,0.0,,0.0,,P16473,0.4931186369853814
124,21525003,tshr_human,260,L,V,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,45.0,-2.222,,,,0.0,0.0,,0.0,,P16473,0.4931186369853814
128,21525003,tshr_human,261,K,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,88.0,-1.136,,,,0.0,0.0,,0.0,,P16473,0.3469979998593467
129,21525003,tshr_human,261,K,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,41.0,-2.439,,,,0.0,0.0,,0.0,,P16473,0.3469979998593467
133,21525003,tshr_human,262,K,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,94.0,-1.064,,,,0.0,0.0,,0.0,,P16473,0.3378759053547231
134,21525003,tshr_human,262,K,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,77.0,-1.299,,,,0.0,0.0,,0.0,,P16473,0.3378759053547231
138,21525003,tshr_human,263,L,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,74.0,-1.351,,,,0.0,0.0,,0.0,,P16473,0.5516074609722905
139,21525003,tshr_human,263,L,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,30.0,-3.333,,,,0.0,0.0,,0.0,,P16473,0.5516074609722905
143,21525003,tshr_human,263,L,V,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,101.0,1.01,,,,0.0,0.0,,0.0,,P16473,0.46185439960694
144,21525003,tshr_human,263,L,V,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,86.0,-1.163,,,,0.0,0.0,,0.0,,P16473,0.46185439960694
148,21525003,tshr_human,265,L,V,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,105.0,1.05,,,,0.0,0.0,,0.0,,P16473,0.254345713044836
149,21525003,tshr_human,265,L,V,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,67.0,-1.493,,,,0.0,0.0,,0.0,,P16473,0.254345713044836
153,21525003,tshr_human,266,S,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,92.0,-1.087,,,,0.0,0.0,,0.0,,P16473,0.2973876128548014
154,21525003,tshr_human,266,S,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,123.0,1.23,,,,0.0,0.0,,0.0,,P16473,0.2973876128548014
158,21525003,tshr_human,267,L,V,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,106.0,1.06,,,,0.0,0.0,,0.0,,P16473,0.2696205048606665
159,21525003,tshr_human,267,L,V,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,87.0,-1.149,,,,0.0,0.0,,0.0,,P16473,0.2696205048606665
163,21525003,tshr_human,268,S,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,98.0,-1.02,,,,0.0,0.0,,0.0,,P16473,0.286899108585448
164,21525003,tshr_human,268,S,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,100.0,1.0,,,,0.0,0.0,,0.0,,P16473,0.286899108585448
168,21525003,tshr_human,269,F,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,95.0,-1.053,,,,0.0,0.0,,0.0,,P16473,0.4722033414327485
169,21525003,tshr_human,269,F,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,81.0,-1.235,,,,0.0,0.0,,0.0,,P16473,0.4722033414327485
173,21525003,tshr_human,270,L,V,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,100.0,1.0,,,,0.0,0.0,,0.0,,P16473,0.2470696710387868
174,21525003,tshr_human,270,L,V,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,80.0,-1.25,,,,0.0,0.0,,0.0,,P16473,0.2470696710387868
178,21525003,tshr_human,271,H,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,97.0,-1.031,,,,0.0,0.0,,0.0,,P16473,0.3638787519485694
179,21525003,tshr_human,271,H,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,102.0,1.02,,,,0.0,0.0,,0.0,,P16473,0.3638787519485694
183,21525003,tshr_human,272,L,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,57.0,-1.754,,,,0.0,0.0,,0.0,,P16473,0.5953885449287072
184,21525003,tshr_human,272,L,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,25.0,-4.0,,,,0.0,0.0,,0.0,,P16473,0.5953885449287072
188,21525003,tshr_human,272,L,V,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,91.0,-1.099,,,,0.0,0.0,,0.0,,P16473,0.5065769171675537
189,21525003,tshr_human,272,L,V,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,78.0,-1.282,,,,0.0,0.0,,0.0,,P16473,0.5065769171675537
193,21525003,tshr_human,273,T,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,104.0,1.04,,,,0.0,0.0,,0.0,,P16473,0.2633401866924282
194,21525003,tshr_human,273,T,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,110.0,1.1,,,,0.0,0.0,,0.0,,P16473,0.2633401866924282
198,21525003,tshr_human,274,R,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,87.0,-1.149,,,,0.0,0.0,,0.0,,P16473,0.2804161538256545
199,21525003,tshr_human,274,R,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,89.0,-1.124,,,,0.0,0.0,,0.0,,P16473,0.2804161538256545
204,21525003,tshr_human,275,A,L,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,56.0,-1.786,,,,0.0,0.0,,0.0,,P16473,0.527242557294009
205,21525003,tshr_human,275,A,L,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,36.0,-2.778,,,,0.0,0.0,,0.0,,P16473,0.527242557294009
209,21525003,tshr_human,276,D,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,103.0,1.03,,,,0.0,0.0,,0.0,,P16473,0.4968020339259626
210,21525003,tshr_human,276,D,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,107.0,1.07,,,,0.0,0.0,,0.0,,P16473,0.4968020339259626
213,21525003,tshr_human,277,L,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,35.0,-2.857,,,,0.0,0.0,,0.0,,P16473,0.5927461917118643
214,21525003,tshr_human,277,L,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,14.0,-7.143,,,,0.0,0.0,,0.0,,P16473,0.5927461917118643
218,21525003,tshr_human,277,L,V,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,95.0,-1.053,,,,0.0,0.0,,0.0,,P16473,0.503824308824005
219,21525003,tshr_human,277,L,V,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,42.0,-2.381,,,,0.0,0.0,,0.0,,P16473,0.503824308824005
223,16410307,tshr_human,279,Y,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,31.0,-3.226,,,,0.0,0.0,,0.0,,P16473,0.4503471955228818
224,16410307,tshr_human,279,Y,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,7.0,-14.286,,,,0.0,0.0,,0.0,,P16473,0.4503471955228818
228,16410307,tshr_human,279,Y,N,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,34.0,-2.941,,,,0.0,0.0,,0.0,,P16473,0.4503471955228818
229,16410307,tshr_human,279,Y,N,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,5.0,-20.0,,,,0.0,0.0,,0.0,,P16473,0.4503471955228818
233,16410307,tshr_human,279,Y,W,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,87.0,-1.149,,,,0.0,0.0,,0.0,,P16473,0.2850933343822144
234,16410307,tshr_human,279,Y,W,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,57.0,-1.754,,,,0.0,0.0,,0.0,,P16473,0.2850933343822144
236,21628383,tshr_human,280,P,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,108.0,1.08,,,,0.0,0.0,,0.0,,P16473,0.4770960450595572
242,16410307,tshr_human,281,S,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,94.0,-1.064,,,,0.0,0.0,,0.0,,P16473,0.3777941326179114
243,16410307,tshr_human,281,S,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,96.0,-1.042,,,,0.0,0.0,,0.0,,P16473,0.3777941326179114
247,16410307,tshr_human,281,S,C,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,108.0,1.08,,,,0.0,0.0,,0.0,,P16473,0.4653434858728934
248,16410307,tshr_human,281,S,C,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,78.0,-1.282,,,,0.0,0.0,,0.0,,P16473,0.4653434858728934
255,15817920,tshr_human,281,S,D,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,59.0,-1.695,,,,0.0,0.0,,0.0,,P16473,0.4209465330367468
256,15817920,tshr_human,281,S,D,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,7.0,-14.286,,,,0.0,0.0,,0.0,,P16473,0.4209465330367468
257,15817920,tshr_human,281,S,D,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,13.0,-7.692,,,,0.0,0.0,,0.0,,P16473,0.4209465330367468
258,16410307,tshr_human,281,S,D,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,65.0,-1.538,,,,0.0,0.0,,0.0,,P16473,0.4209465330367468
259,16410307,tshr_human,281,S,D,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,8.0,-12.5,,,,0.0,0.0,,0.0,,P16473,0.4209465330367468
270,16410307,tshr_human,281,S,F,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,75.0,-1.333,,,,0.0,0.0,,0.0,,P16473,0.5102958525398288
271,16410307,tshr_human,281,S,F,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,114.0,1.14,,,,0.0,0.0,,0.0,,P16473,0.5102958525398288
272,18381815,tshr_human,281,S,F,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,114.0,1.14,,,,0.0,0.0,,0.0,,P16473,0.5102958525398288
278,16410307,tshr_human,281,S,G,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,96.0,-1.042,,,,0.0,0.0,,0.0,,P16473,0.4209465330367468
279,16410307,tshr_human,281,S,G,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,59.0,-1.695,,,,0.0,0.0,,0.0,,P16473,0.4209465330367468
283,16410307,tshr_human,281,S,H,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,97.0,-1.031,,,,0.0,0.0,,0.0,,P16473,0.4653434858728934
284,16410307,tshr_human,281,S,H,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,111.0,1.11,,,,0.0,0.0,,0.0,,P16473,0.4653434858728934
290,16410307,tshr_human,281,S,I,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,61.0,-1.639,,,,0.0,0.0,,0.0,,P16473,0.5102958525398288
291,16410307,tshr_human,281,S,I,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,60.0,-1.667,,,,0.0,0.0,,0.0,,P16473,0.5102958525398288
292,9294132,tshr_human,281,S,I,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,90.0,-1.111,,,,0.0,0.0,,0.0,,P16473,0.5102958525398288
293,9294132,tshr_human,281,S,I,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,60.0,-1.667,,,,0.0,0.0,,0.0,,P16473,0.5102958525398288
304,12062436,tshr_human,281,S,L,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,42.0,-2.381,,,,0.0,0.0,,0.0,,P16473,0.5102958525398288
305,16410307,tshr_human,281,S,L,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,63.0,-1.587,,,,0.0,0.0,,0.0,,P16473,0.5102958525398288
306,16410307,tshr_human,281,S,L,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,12.0,-8.333,,,,0.0,0.0,,0.0,,P16473,0.5102958525398288
310,16410307,tshr_human,281,S,M,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,102.0,1.02,,,,0.0,0.0,,0.0,,P16473,0.4653434858728934
311,16410307,tshr_human,281,S,M,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,90.0,-1.111,,,,0.0,0.0,,0.0,,P16473,0.4653434858728934
318,15817920,tshr_human,281,S,N,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,99.0,-1.01,,,,0.0,0.0,,0.0,,P16473,0.3777941326179114
319,15817920,tshr_human,281,S,N,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,56.0,-1.786,,,,0.0,0.0,,0.0,,P16473,0.3777941326179114
320,15817920,tshr_human,281,S,N,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,67.0,-1.493,,,,0.0,0.0,,0.0,,P16473,0.3777941326179114
321,16410307,tshr_human,281,S,N,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,80.0,-1.25,,,,0.0,0.0,,0.0,,P16473,0.3777941326179114
322,16410307,tshr_human,281,S,N,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,72.0,-1.389,,,,0.0,0.0,,0.0,,P16473,0.3777941326179114
323,9224711,tshr_human,281,S,N,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,100.0,1.0,,,,0.0,0.0,,0.0,,P16473,0.3777941326179114
324,9224711,tshr_human,281,S,N,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,100.0,1.0,,,,0.0,0.0,,0.0,,P16473,0.3777941326179114
325,9589634,tshr_human,281,S,N,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,117.0,1.17,,,,0.0,0.0,,0.0,,P16473,0.3777941326179114
326,9589634,tshr_human,281,S,N,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,130.0,1.3,,,,0.0,0.0,,0.0,,P16473,0.3777941326179114
327,9589634,tshr_human,281,S,N,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,35.0,-2.857,,,,0.0,0.0,,0.0,,P16473,0.3777941326179114
331,16410307,tshr_human,281,S,P,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,86.0,-1.163,,,,0.0,0.0,,0.0,,P16473,0.4653434858728934
332,16410307,tshr_human,281,S,P,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,78.0,-1.282,,,,0.0,0.0,,0.0,,P16473,0.4653434858728934
350,16410307,tshr_human,281,S,T,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,90.0,-1.111,,,,0.0,0.0,,0.0,,P16473,0.3777941326179114
351,16410307,tshr_human,281,S,T,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,71.0,-1.408,,,,0.0,0.0,,0.0,,P16473,0.3777941326179114
352,9224711,tshr_human,281,S,T,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,100.0,1.0,,,,0.0,0.0,,0.0,,P16473,0.3777941326179114
353,9224711,tshr_human,281,S,T,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,100.0,1.0,,,,0.0,0.0,,0.0,,P16473,0.3777941326179114
357,16410307,tshr_human,281,S,V,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,71.0,-1.408,,,,0.0,0.0,,0.0,,P16473,0.5102958525398288
358,16410307,tshr_human,281,S,V,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,108.0,1.08,,,,0.0,0.0,,0.0,,P16473,0.5102958525398288
362,16410307,tshr_human,281,S,W,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,98.0,-1.02,,,,0.0,0.0,,0.0,,P16473,0.5550792276087504
363,16410307,tshr_human,281,S,W,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,95.0,-1.053,,,,0.0,0.0,,0.0,,P16473,0.5550792276087504
367,16410307,tshr_human,281,S,Y,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,108.0,1.08,,,,0.0,0.0,,0.0,,P16473,0.5102958525398288
368,16410307,tshr_human,281,S,Y,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,109.0,1.09,,,,0.0,0.0,,0.0,,P16473,0.5102958525398288
371,21525003,tshr_human,282,H,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,68.0,-1.471,,,,0.0,0.0,,0.0,,P16473,0.5275631029287418
374,21525003,tshr_human,282,H,F,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,55.0,-1.818,,,,0.0,0.0,,0.0,,P16473,0.4825890886815477
380,21628383,tshr_human,285,A,V,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,102.0,1.02,,,,0.0,0.0,,0.0,,P16473,0.3549243951244268
383,21628383,tshr_human,286,F,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,96.0,-1.042,,,,0.0,0.0,,0.0,,P16473,0.5014981323437291
384,21628383,tshr_human,286,F,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,66.0,-1.515,,,,0.0,0.0,,0.0,,P16473,0.5014981323437291
386,21628383,tshr_human,286,F,I,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,63.0,-1.587,,,,0.0,0.0,,0.0,,P16473,0.4124021263767585
387,21628383,tshr_human,286,F,I,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,29.0,-3.448,,,,0.0,0.0,,0.0,,P16473,0.4124021263767585
390,21628383,tshr_human,286,F,W,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,88.0,-1.136,,,,0.0,0.0,,0.0,,P16473,0.3695769854335792
391,21628383,tshr_human,286,F,W,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,95.0,-1.053,,,,0.0,0.0,,0.0,,P16473,0.3695769854335792
395,16899458,tshr_human,287,K,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,173.0,1.73,,,,0.0,0.0,,0.0,,P16473,0.3797979101696445
396,16899458,tshr_human,287,K,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,97.0,-1.031,,,,0.0,0.0,,0.0,,P16473,0.3797979101696445
397,23002040,tshr_human,287,K,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,98.0,-1.02,,,,0.0,0.0,,0.0,,P16473,0.3797979101696445
398,23002040,tshr_human,287,K,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,74.0,-1.351,,,,0.0,0.0,,0.0,,P16473,0.3797979101696445
408,21628383,tshr_human,288,N,L,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,70.0,-1.429,,,,0.0,0.0,,0.0,,P16473,0.4757278203762266
409,21628383,tshr_human,288,N,L,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,68.0,-1.471,,,,0.0,0.0,,0.0,,P16473,0.4757278203762266
416,21628383,tshr_human,288,N,S,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,76.0,-1.316,,,,0.0,0.0,,0.0,,P16473,0.3063349504546185
417,21628383,tshr_human,288,N,S,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,100.0,1.0,,,,0.0,0.0,,0.0,,P16473,0.3063349504546185
420,16899458,tshr_human,289,Q,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,61.0,-1.639,,,,0.0,0.0,,0.0,,P16473,0.3863955014052675
421,21525003,tshr_human,289,Q,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,63.0,-1.587,,,,0.0,0.0,,0.0,,P16473,0.3863955014052675
425,16899458,tshr_human,290,K,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,142.0,1.42,,,,0.0,0.0,,0.0,,P16473,0.3232451625379486
426,16899458,tshr_human,290,K,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,84.0,-1.19,,,,0.0,0.0,,0.0,,P16473,0.3232451625379486
427,23002040,tshr_human,290,K,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,32.0,-3.125,,,,0.0,0.0,,0.0,,P16473,0.3232451625379486
428,23002040,tshr_human,290,K,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,44.0,-2.273,,,,0.0,0.0,,0.0,,P16473,0.3232451625379486
432,16899458,tshr_human,291,K,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,142.0,1.42,,,,0.0,0.0,,0.0,,P16473,0.3310691720884247
433,16899458,tshr_human,291,K,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,91.0,-1.099,,,,0.0,0.0,,0.0,,P16473,0.3310691720884247
434,23002040,tshr_human,291,K,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,91.0,-1.099,,,,0.0,0.0,,0.0,,P16473,0.3310691720884247
435,23002040,tshr_human,291,K,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,56.0,-1.786,,,,0.0,0.0,,0.0,,P16473,0.3310691720884247
437,21628383,tshr_human,292,I,V,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,104.0,1.04,,,,0.0,0.0,,0.0,,P16473,0.2701665491563086
442,16899458,tshr_human,293,R,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,106.0,1.06,,,,0.0,0.0,,0.0,,P16473,0.3394846303724695
443,18441013,tshr_human,293,R,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,90.0,-1.111,,,,0.0,0.0,,0.0,,P16473,0.3394846303724695
444,23002040,tshr_human,293,R,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,83.0,-1.205,,,,0.0,0.0,,0.0,,P16473,0.3394846303724695
445,23002040,tshr_human,293,R,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,106.0,1.06,,,,0.0,0.0,,0.0,,P16473,0.3394846303724695
459,21628383,tshr_human,295,I,V,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,99.0,-1.01,,,,0.0,0.0,,0.0,,P16473,0.217263058121702
461,21628383,tshr_human,296,L,V,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,104.0,1.04,,,,0.0,0.0,,0.0,,P16473,0.3050406163726225
465,18441013,tshr_human,297,E,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,95.0,-1.053,,,,0.0,0.0,,0.0,,P16473,0.3858421234345507
466,18441013,tshr_human,297,E,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,40.0,-2.5,,,,0.0,0.0,,0.0,,P16473,0.3858421234345507
467,19386596,tshr_human,297,E,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,84.0,-1.19,,,,0.0,0.0,,0.0,,P16473,0.3858421234345507
468,19386596,tshr_human,297,E,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,40.0,-2.5,,,,0.0,0.0,,0.0,,P16473,0.3858421234345507
479,18441013,tshr_human,297,E,K,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,56.0,-1.786,,,,0.0,0.0,,0.0,,P16473,0.3047282759223244
480,18441013,tshr_human,297,E,K,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,14.0,-7.143,,,,0.0,0.0,,0.0,,P16473,0.3047282759223244
481,19386596,tshr_human,297,E,K,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,46.0,-2.174,,,,0.0,0.0,,0.0,,P16473,0.3047282759223244
482,19386596,tshr_human,297,E,K,human thyrotropin,IUPHAR/BPS Guide to pharmacology,4393,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,59.0,-1.695,,,,0.0,0.0,,0.0,,P16473,0.3047282759223244
487,18441013,tshr_human,297,E,Q,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,89.0,-1.124,,,,0.0,0.0,,0.0,,P16473,0.2679833760473058
488,18441013,tshr_human,297,E,Q,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,45.0,-2.222,,,,0.0,0.0,,0.0,,P16473,0.2679833760473058
489,19386596,tshr_human,297,E,Q,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,46.0,-2.174,,,,0.0,0.0,,0.0,,P16473,0.2679833760473058
490,19386596,tshr_human,297,E,Q,human thyrotropin,IUPHAR/BPS Guide to pharmacology,4393,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,63.0,-1.587,,,,0.0,0.0,,0.0,,P16473,0.2679833760473058
494,21525003,tshr_human,298,S,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,79.0,-1.266,,,,0.0,0.0,,0.0,,P16473,0.3204880801285721
495,21628383,tshr_human,298,S,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,86.0,-1.163,,,,0.0,0.0,,0.0,,P16473,0.3204880801285721
498,21628383,tshr_human,299,L,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,73.0,-1.37,,,,0.0,0.0,,0.0,,P16473,0.3793609052406704
499,21628383,tshr_human,299,L,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,92.0,-1.087,,,,0.0,0.0,,0.0,,P16473,0.3793609052406704
510,21628383,tshr_human,299,L,V,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,75.0,-1.333,,,,0.0,0.0,,0.0,,P16473,0.2989376401984338
511,21628383,tshr_human,299,L,V,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,99.0,-1.01,,,,0.0,0.0,,0.0,,P16473,0.2989376401984338
514,21628383,tshr_human,300,M,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,93.0,-1.075,,,,0.0,0.0,,0.0,,P16473,0.3518190556501162
515,21628383,tshr_human,300,M,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,60.0,-1.667,,,,0.0,0.0,,0.0,,P16473,0.3518190556501162
524,21628383,tshr_human,300,M,V,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,80.0,-1.25,,,,0.0,0.0,,0.0,,P16473,0.2746488781354604
525,21628383,tshr_human,300,M,V,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,86.0,-1.163,,,,0.0,0.0,,0.0,,P16473,0.2746488781354604
531,18441013,tshr_human,303,E,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,75.0,-1.333,,,,0.0,0.0,,0.0,,P16473,0.3214544574625243
532,18441013,tshr_human,303,E,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,60.0,-1.667,,,,0.0,0.0,,0.0,,P16473,0.3214544574625243
533,19386596,tshr_human,303,E,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,87.0,-1.149,,,,0.0,0.0,,0.0,,P16473,0.3214544574625243
534,19386596,tshr_human,303,E,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,60.0,-1.667,,,,0.0,0.0,,0.0,,P16473,0.3214544574625243
539,19386596,tshr_human,303,E,K,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,98.0,-1.02,,,,0.0,0.0,,0.0,,P16473,0.2483842782733294
540,19386596,tshr_human,303,E,K,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,94.0,-1.064,,,,0.0,0.0,,0.0,,P16473,0.2483842782733294
544,18441013,tshr_human,303,E,Q,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,85.0,-1.176,,,,0.0,0.0,,0.0,,P16473,0.2163048339953262
545,18441013,tshr_human,303,E,Q,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,89.0,-1.124,,,,0.0,0.0,,0.0,,P16473,0.2163048339953262
546,19386596,tshr_human,303,E,Q,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,104.0,1.04,,,,0.0,0.0,,0.0,,P16473,0.2163048339953262
547,19386596,tshr_human,303,E,Q,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,89.0,-1.124,,,,0.0,0.0,,0.0,,P16473,0.2163048339953262
551,21525003,tshr_human,304,S,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,98.0,-1.02,,,,0.0,0.0,,0.0,,P16473,0.2726236497424398
552,21628383,tshr_human,304,S,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,86.0,-1.163,,,,0.0,0.0,,0.0,,P16473,0.2726236497424398
554,21525003,tshr_human,305,S,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,79.0,-1.266,,,,0.0,0.0,,0.0,,P16473,0.2542191365335148
555,21628383,tshr_human,305,S,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,94.0,-1.064,,,,0.0,0.0,,0.0,,P16473,0.2542191365335148
557,21628383,tshr_human,306,M,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,105.0,1.05,,,,0.0,0.0,,0.0,,P16473,0.3190727303089999
559,21628383,tshr_human,307,Q,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,102.0,1.02,,,,0.0,0.0,,0.0,,P16473,0.3261507277561161
561,21628383,tshr_human,308,S,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,103.0,1.03,,,,0.0,0.0,,0.0,,P16473,0.2487658923814912
563,21628383,tshr_human,309,L,V,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,99.0,-1.01,,,,0.0,0.0,,0.0,,P16473,0.2476646490969373
566,11095460,tshr_human,310,R,C,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,25.0,-4.0,,,,0.0,0.0,,0.0,,P16473,0.4553092783278445
570,21525003,tshr_human,311,Q,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,145.0,1.45,,,,0.0,0.0,,0.0,,P16473,0.3184233221614042
571,21628383,tshr_human,311,Q,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,91.0,-1.099,,,,0.0,0.0,,0.0,,P16473,0.3184233221614042
575,18441013,tshr_human,312,R,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,93.0,-1.075,,,,0.0,0.0,,0.0,,P16473,0.3374952433184945
576,21525003,tshr_human,312,R,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,136.0,1.36,,,,0.0,0.0,,0.0,,P16473,0.3374952433184945
580,18441013,tshr_human,313,K,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,89.0,-1.124,,,,0.0,0.0,,0.0,,P16473,0.3437687651733752
581,21525003,tshr_human,313,K,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,61.0,-1.639,,,,0.0,0.0,,0.0,,P16473,0.3437687651733752
585,21525003,tshr_human,314,S,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,75.0,-1.333,,,,0.0,0.0,,0.0,,P16473,0.2579908051699838
586,21628383,tshr_human,314,S,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,87.0,-1.149,,,,0.0,0.0,,0.0,,P16473,0.2579908051699838
588,21628383,tshr_human,315,V,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,112.0,1.12,,,,0.0,0.0,,0.0,,P16473,0.2897801758434434
598,21628383,tshr_human,367,G,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,99.0,-1.01,,,,0.0,0.0,,0.0,,P16473,0.3001456183443941
602,21525003,tshr_human,368,Q,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,61.0,-1.639,,,,0.0,0.0,,0.0,,P16473,0.3241350420304586
603,21628383,tshr_human,368,Q,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,94.0,-1.064,,,,0.0,0.0,,0.0,,P16473,0.3241350420304586
607,18441013,tshr_human,369,E,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,80.0,-1.25,,,,0.0,0.0,,0.0,,P16473,0.3351142253113984
608,21525003,tshr_human,369,E,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,64.0,-1.562,,,,0.0,0.0,,0.0,,P16473,0.3351142253113984
610,21628383,tshr_human,370,L,V,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,100.0,1.0,,,,0.0,0.0,,0.0,,P16473,0.2517446555621279
614,18441013,tshr_human,371,K,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,97.0,-1.031,,,,0.0,0.0,,0.0,,P16473,0.312240592483657
615,21525003,tshr_human,371,K,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,65.0,-1.538,,,,0.0,0.0,,0.0,,P16473,0.312240592483657
617,21628383,tshr_human,373,P,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,105.0,1.05,,,,0.0,0.0,,0.0,,P16473,0.3141327091344197
621,21525003,tshr_human,374,Q,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,56.0,-1.786,,,,0.0,0.0,,0.0,,P16473,0.3204934814854361
622,21628383,tshr_human,374,Q,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,75.0,-1.333,,,,0.0,0.0,,0.0,,P16473,0.3204934814854361
626,18441013,tshr_human,375,E,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,72.0,-1.389,,,,0.0,0.0,,0.0,,P16473,0.3166790657146356
627,21525003,tshr_human,375,E,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,47.0,-2.128,,,,0.0,0.0,,0.0,,P16473,0.3166790657146356
631,18441013,tshr_human,376,E,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,83.0,-1.205,,,,0.0,0.0,,0.0,,P16473,0.328630668070261
632,21525003,tshr_human,376,E,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,53.0,-1.887,,,,0.0,0.0,,0.0,,P16473,0.328630668070261
636,21525003,tshr_human,377,T,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,88.0,-1.136,,,,0.0,0.0,,0.0,,P16473,0.2826914322647537
637,21628383,tshr_human,377,T,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,92.0,-1.087,,,,0.0,0.0,,0.0,,P16473,0.2826914322647537
639,21628383,tshr_human,378,L,V,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,100.0,1.0,,,,0.0,0.0,,0.0,,P16473,0.2439425410065742
643,21525003,tshr_human,379,Q,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,54.0,-1.852,,,,0.0,0.0,,0.0,,P16473,0.3156459521057371
644,21628383,tshr_human,379,Q,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,83.0,-1.205,,,,0.0,0.0,,0.0,,P16473,0.3156459521057371
646,21628383,tshr_human,380,A,V,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,84.0,-1.19,,,,0.0,0.0,,0.0,,P16473,0.2811016276784117
649,21628383,tshr_human,381,F,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,61.0,-1.639,,,,0.0,0.0,,0.0,,P16473,0.3658835673446796
650,21628383,tshr_human,381,F,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,61.0,-1.639,,,,0.0,0.0,,0.0,,P16473,0.3658835673446796
653,21628383,tshr_human,381,F,D,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,66.0,-1.515,,,,0.0,0.0,,0.0,,P16473,0.4085586596015016
654,21628383,tshr_human,381,F,D,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,62.0,-1.613,,,,0.0,0.0,,0.0,,P16473,0.4085586596015016
657,21628383,tshr_human,381,F,I,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,86.0,-1.163,,,,0.0,0.0,,0.0,,P16473,0.2870024997642293
658,21628383,tshr_human,381,F,I,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,45.0,-2.222,,,,0.0,0.0,,0.0,,P16473,0.2870024997642293
669,21628383,tshr_human,381,F,V,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,71.0,-1.408,,,,0.0,0.0,,0.0,,P16473,0.3252076420779852
670,21628383,tshr_human,381,F,V,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,38.0,-2.632,,,,0.0,0.0,,0.0,,P16473,0.3252076420779852
673,21628383,tshr_human,381,F,Y,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,102.0,1.02,,,,0.0,0.0,,0.0,,P16473,0.1899777035461693
674,21628383,tshr_human,381,F,Y,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,85.0,-1.176,,,,0.0,0.0,,0.0,,P16473,0.1899777035461693
678,18441013,tshr_human,382,D,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,37.0,-2.703,,,,0.0,0.0,,0.0,,P16473,0.3668789661064099
679,18441013,tshr_human,382,D,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,51.0,-1.961,,,,0.0,0.0,,0.0,,P16473,0.3668789661064099
680,19386596,tshr_human,382,D,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,61.0,-1.639,,,,0.0,0.0,,0.0,,P16473,0.3668789661064099
681,19386596,tshr_human,382,D,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,53.0,-1.887,,,,0.0,0.0,,0.0,,P16473,0.3668789661064099
699,18441013,tshr_human,382,D,N,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,95.0,-1.053,,,,0.0,0.0,,0.0,,P16473,0.2524055352529917
700,18441013,tshr_human,382,D,N,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,57.0,-1.754,,,,0.0,0.0,,0.0,,P16473,0.2524055352529917
701,19386596,tshr_human,382,D,N,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,103.0,1.03,,,,0.0,0.0,,0.0,,P16473,0.2524055352529917
702,19386596,tshr_human,382,D,N,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,57.0,-1.754,,,,0.0,0.0,,0.0,,P16473,0.2524055352529917
706,21525003,tshr_human,383,S,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,84.0,-1.19,,,,0.0,0.0,,0.0,,P16473,0.239757136738746
707,21628383,tshr_human,383,S,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,115.0,1.15,,,,0.0,0.0,,0.0,,P16473,0.239757136738746
709,21628383,tshr_human,384,H,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,93.0,-1.075,,,,0.0,0.0,,0.0,,P16473,0.357380499293592
715,11847099,tshr_human,385,Y,F,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,30.0,-3.333,,,,0.0,0.0,,0.0,,P16473,0.2079256420673432
718,21628383,tshr_human,386,D,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,77.0,-1.299,,,,0.0,0.0,,0.0,,P16473,0.4146743469674688
719,21628383,tshr_human,386,D,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,77.0,-1.299,,,,0.0,0.0,,0.0,,P16473,0.4146743469674688
725,21628383,tshr_human,387,Y,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,90.0,-1.111,,,,0.0,0.0,,0.0,,P16473,0.3871478598732655
731,11847099,tshr_human,387,Y,F,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,100.0,1.0,,,,0.0,0.0,,0.0,,P16473,0.2043248487233659
733,21628383,tshr_human,388,T,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,103.0,1.03,,,,0.0,0.0,,0.0,,P16473,0.3251412203056521
735,21628383,tshr_human,389,I,V,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,90.0,-1.111,,,,0.0,0.0,,0.0,,P16473,0.1977294445881862
739,8954020,tshr_human,390,C,W,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,24.0,-4.167,,,,0.0,0.0,,0.0,,P16473,0.7816009554464731
740,8954020,tshr_human,390,C,W,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,30.0,-3.333,,,,0.0,0.0,,0.0,,P16473,0.7816009554464731
741,9329388,tshr_human,390,C,W,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,79.0,-1.266,,,,0.0,0.0,,0.0,,P16473,0.7816009554464731
742,9329388,tshr_human,390,C,W,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,148.0,1.48,,,,0.0,0.0,,0.0,,P16473,0.7816009554464731
744,21628383,tshr_human,391,G,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,74.0,-1.351,,,,0.0,0.0,,0.0,,P16473,0.3109432257987732
748,21628383,tshr_human,392,D,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,85.0,-1.176,,,,0.0,0.0,,0.0,,P16473,0.3570548200792229
749,21628383,tshr_human,392,D,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,77.0,-1.299,,,,0.0,0.0,,0.0,,P16473,0.3570548200792229
750,23002040,tshr_human,392,D,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,129.0,1.29,,,,0.0,0.0,,0.0,,P16473,0.3570548200792229
751,23002040,tshr_human,392,D,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,81.0,-1.235,,,,0.0,0.0,,0.0,,P16473,0.3570548200792229
761,21628383,tshr_human,393,S,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,87.0,-1.149,,,,0.0,0.0,,0.0,,P16473,0.2323758886253882
767,18441013,tshr_human,394,E,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,71.0,-1.408,,,,0.0,0.0,,0.0,,P16473,0.3154628254186383
768,21525003,tshr_human,394,E,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,48.0,-2.083,,,,0.0,0.0,,0.0,,P16473,0.3154628254186383
769,21628383,tshr_human,394,E,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,59.0,-1.695,,,,0.0,0.0,,0.0,,P16473,0.3154628254186383
770,21628383,tshr_human,394,E,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,71.0,-1.408,,,,0.0,0.0,,0.0,,P16473,0.3154628254186383
777,21628383,tshr_human,394,E,K,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,57.0,-1.754,,,,0.0,0.0,,0.0,,P16473,0.2432733159306141
778,21628383,tshr_human,394,E,K,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,26.0,-3.846,,,,0.0,0.0,,0.0,,P16473,0.2432733159306141
785,18441013,tshr_human,395,D,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,70.0,-1.429,,,,0.0,0.0,,0.0,,P16473,0.380967264282905
786,21525003,tshr_human,395,D,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,42.0,-2.381,,,,0.0,0.0,,0.0,,P16473,0.380967264282905
787,21628383,tshr_human,395,D,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,53.0,-1.887,,,,0.0,0.0,,0.0,,P16473,0.380967264282905
788,21628383,tshr_human,395,D,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,70.0,-1.429,,,,0.0,0.0,,0.0,,P16473,0.380967264282905
789,23002040,tshr_human,395,D,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,102.0,1.02,,,,0.0,0.0,,0.0,,P16473,0.380967264282905
790,23002040,tshr_human,395,D,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,60.0,-1.667,,,,0.0,0.0,,0.0,,P16473,0.380967264282905
800,21628383,tshr_human,396,M,V,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,104.0,1.04,,,,0.0,0.0,,0.0,,P16473,0.2369870449105872
805,16899458,tshr_human,399,T,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,82.0,-1.22,,,,0.0,0.0,,0.0,,P16473,0.3322560468523253
806,16899458,tshr_human,399,T,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,76.0,-1.316,,,,0.0,0.0,,0.0,,P16473,0.3322560468523253
809,16899458,tshr_human,400,P,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,50.0,-2.0,,,,0.0,0.0,,0.0,,P16473,0.5214569735059551
810,16899458,tshr_human,400,P,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,12.0,-8.333,,,,0.0,0.0,,0.0,,P16473,0.5214569735059551
814,16899458,tshr_human,400,P,D,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,3.0,-33.333,,,,0.0,0.0,,0.0,,P16473,0.5214569735059551
821,16899458,tshr_human,400,P,L,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,24.0,-4.167,,,,0.0,0.0,,0.0,,P16473,0.6096654037765779
822,16899458,tshr_human,400,P,L,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,3.0,-33.333,,,,0.0,0.0,,0.0,,P16473,0.6096654037765779
825,16899458,tshr_human,401,K,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,73.0,-1.37,,,,0.0,0.0,,0.0,,P16473,0.353563975196111
826,16899458,tshr_human,401,K,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,82.0,-1.22,,,,0.0,0.0,,0.0,,P16473,0.353563975196111
829,16899458,tshr_human,402,S,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,83.0,-1.205,,,,0.0,0.0,,0.0,,P16473,0.3499501185419521
830,16899458,tshr_human,402,S,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,100.0,1.0,,,,0.0,0.0,,0.0,,P16473,0.3499501185419521
834,15345720,tshr_human,403,D,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,36.0,-2.778,,,,0.0,0.0,,0.0,,P16473,0.5298666289570522
835,15345720,tshr_human,403,D,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,7.0,-14.286,,,,0.0,0.0,,0.0,,P16473,0.5298666289570522
836,15345720,tshr_human,403,D,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,35.0,-2.857,,,,0.0,0.0,,0.0,,P16473,0.5298666289570522
849,16899458,tshr_human,403,D,L,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,69.0,-1.449,,,,0.0,0.0,,0.0,,P16473,0.6176574260913066
850,16899458,tshr_human,403,D,L,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,19.0,-5.263,,,,0.0,0.0,,0.0,,P16473,0.6176574260913066
853,16899458,tshr_human,403,D,N,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,127.0,1.27,,,,0.0,0.0,,0.0,,P16473,0.3963983091829198
854,16899458,tshr_human,403,D,N,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,96.0,-1.042,,,,0.0,0.0,,0.0,,P16473,0.3963983091829198
855,18727713,tshr_human,403,D,N,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,25.0,-4.0,,,,0.0,0.0,,0.0,,P16473,0.3963983091829198
863,15345720,tshr_human,404,E,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,116.0,1.16,,,,0.0,0.0,,0.0,,P16473,0.5264443834782404
864,15345720,tshr_human,404,E,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,121.0,1.21,,,,0.0,0.0,,0.0,,P16473,0.5264443834782404
865,15345720,tshr_human,404,E,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,89.0,-1.124,,,,0.0,0.0,,0.0,,P16473,0.5264443834782404
873,15345720,tshr_human,404,E,K,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,93.0,-1.075,,,,0.0,0.0,,0.0,,P16473,0.4368001971561055
874,15345720,tshr_human,404,E,K,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,27.0,-3.704,,,,0.0,0.0,,0.0,,P16473,0.4368001971561055
875,15345720,tshr_human,404,E,K,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,50.0,-2.0,,,,0.0,0.0,,0.0,,P16473,0.4368001971561055
886,16899458,tshr_human,404,E,S,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,161.0,1.61,,,,0.0,0.0,,0.0,,P16473,0.4814724635463125
887,16899458,tshr_human,404,E,S,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,82.0,-1.22,,,,0.0,0.0,,0.0,,P16473,0.4814724635463125
890,16899458,tshr_human,405,F,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,13.0,-7.692,,,,0.0,0.0,,0.0,,P16473,0.6741134518947296
891,16899458,tshr_human,405,F,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,24.0,-4.167,,,,0.0,0.0,,0.0,,P16473,0.6741134518947296
900,16899458,tshr_human,406,N,D,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,86.0,-1.163,,,,0.0,0.0,,0.0,,P16473,0.4664537941769029
901,16899458,tshr_human,406,N,D,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,63.0,-1.587,,,,0.0,0.0,,0.0,,P16473,0.4664537941769029
908,16899458,tshr_human,406,N,L,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,78.0,-1.282,,,,0.0,0.0,,0.0,,P16473,0.6423698406221467
909,16899458,tshr_human,406,N,L,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,53.0,-1.887,,,,0.0,0.0,,0.0,,P16473,0.6423698406221467
916,16899458,tshr_human,406,N,S,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,121.0,1.21,,,,0.0,0.0,,0.0,,P16473,0.4664537941769029
917,16899458,tshr_human,406,N,S,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,103.0,1.03,,,,0.0,0.0,,0.0,,P16473,0.4664537941769029
920,16899458,tshr_human,407,P,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,30.0,-3.333,,,,0.0,0.0,,0.0,,P16473,0.5369920882071603
921,16899458,tshr_human,407,P,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,69.0,-1.449,,,,0.0,0.0,,0.0,,P16473,0.5369920882071603
928,16899458,tshr_human,407,P,K,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,56.0,-1.786,,,,0.0,0.0,,0.0,,P16473,0.5369920882071603
929,16899458,tshr_human,407,P,K,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,49.0,-2.041,,,,0.0,0.0,,0.0,,P16473,0.5369920882071603
932,16899458,tshr_human,407,P,L,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,39.0,-2.564,,,,0.0,0.0,,0.0,,P16473,0.6243980211519415
933,16899458,tshr_human,407,P,L,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,69.0,-1.449,,,,0.0,0.0,,0.0,,P16473,0.6243980211519415
937,16899458,tshr_human,409,E,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,38.0,-2.632,,,,0.0,0.0,,0.0,,P16473,0.4361712117252889
938,16899458,tshr_human,409,E,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,76.0,-1.316,,,,0.0,0.0,,0.0,,P16473,0.4361712117252889
939,23002040,tshr_human,409,E,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,5.0,-20.0,,,,0.0,0.0,,0.0,,P16473,0.4361712117252889
940,23002040,tshr_human,409,E,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,47.0,-2.128,,,,0.0,0.0,,0.0,,P16473,0.4361712117252889
944,16150909,tshr_human,409,E,K,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,24.0,-4.167,,,,0.0,0.0,,0.0,,P16473,0.35051798059271
945,16150909,tshr_human,409,E,K,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,8.0,-12.5,,,,0.0,0.0,,0.0,,P16473,0.35051798059271
946,16150909,tshr_human,409,E,K,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,90.0,-1.111,,,,0.0,0.0,,0.0,,P16473,0.35051798059271
950,16899458,tshr_human,410,D,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,71.0,-1.408,,,,0.0,0.0,,0.0,,P16473,0.5424623449417203
951,16899458,tshr_human,410,D,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,108.0,1.08,,,,0.0,0.0,,0.0,,P16473,0.5424623449417203
952,23002040,tshr_human,410,D,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,36.0,-2.778,,,,0.0,0.0,,0.0,,P16473,0.5424623449417203
953,23002040,tshr_human,410,D,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,47.0,-2.128,,,,0.0,0.0,,0.0,,P16473,0.5424623449417203
961,8954020,tshr_human,410,D,N,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,28.0,-3.571,,,,0.0,0.0,,0.0,,P16473,0.4085984261945453
962,8954020,tshr_human,410,D,N,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,100.0,1.0,,,,0.0,0.0,,0.0,,P16473,0.4085984261945453
966,17079233,tshr_human,417,L,V,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,80.0,-1.25,,,,0.0,0.0,,0.0,,P16473,0.4620571213030249
967,17079233,tshr_human,417,L,V,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,20.0,-5.0,,,,0.0,0.0,,0.0,,P16473,0.4620571213030249
976,20652618,tshr_human,424,V,I,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,100.0,1.0,,,,0.0,0.0,,0.0,,P16473,0.346260895094212
977,20652618,tshr_human,424,V,I,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,50.0,-2.0,,,,0.0,0.0,,0.0,,P16473,0.346260895094212
980,11434721,tshr_human,425,S,I,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,84.0,-1.19,,,,0.0,0.0,,0.0,,P16473,0.5879869207811894
983,16990652,tshr_human,428,A,V,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,90.0,-1.111,,,,0.0,0.0,,0.0,,P16473,0.6917228029313628
986,11549687,tshr_human,431,G,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,91.0,-1.099,,,,0.0,0.0,,0.0,,P16473,0.6913260975859504
987,11549687,tshr_human,431,G,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,164.0,1.64,,,,0.0,0.0,,0.0,,P16473,0.6913260975859504
988,11549687,tshr_human,431,G,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,101.0,1.01,,,,0.0,0.0,,0.0,,P16473,0.6913260975859504
991,11549687,tshr_human,431,G,C,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,100.0,1.0,,,,0.0,0.0,,0.0,,P16473,0.7935002631647049
992,11549687,tshr_human,431,G,C,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,155.0,1.55,,,,0.0,0.0,,0.0,,P16473,0.7935002631647049
993,11549687,tshr_human,431,G,C,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,82.0,-1.22,,,,0.0,0.0,,0.0,,P16473,0.7935002631647049
999,11549687,tshr_human,431,G,S,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,131.0,1.31,,,,0.0,0.0,,0.0,,P16473,0.6913260975859504
1000,11549687,tshr_human,431,G,S,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,82.0,-1.22,,,,0.0,0.0,,0.0,,P16473,0.6913260975859504
1001,11549687,tshr_human,431,G,S,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,189.0,1.89,,,,0.0,0.0,,0.0,,P16473,0.6913260975859504
1002,18989620,tshr_human,431,G,S,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,98.0,-1.02,,,,0.0,0.0,,0.0,,P16473,0.6913260975859504
1003,18989620,tshr_human,431,G,S,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,110.0,1.1,,,,0.0,0.0,,0.0,,P16473,0.6913260975859504
1011,20305779,tshr_human,438,I,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,56.0,-1.786,,,,0.0,0.0,,0.0,,P16473,0.5619840443802198
1012,20305779,tshr_human,438,I,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,16.0,-6.25,,,,0.0,0.0,,0.0,,P16473,0.5619840443802198
1016,20305779,tshr_human,439,L,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,102.0,1.02,,,,0.0,0.0,,0.0,,P16473,0.580253692930245
1017,20305779,tshr_human,439,L,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,89.0,-1.124,,,,0.0,0.0,,0.0,,P16473,0.580253692930245
1021,20305779,tshr_human,440,L,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,94.0,-1.064,,,,0.0,0.0,,0.0,,P16473,0.4443484989697738
1022,20305779,tshr_human,440,L,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,56.0,-1.786,,,,0.0,0.0,,0.0,,P16473,0.4443484989697738
1026,20305779,tshr_human,441,T,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,85.0,-1.176,,,,0.0,0.0,,0.0,,P16473,0.3978803456599015
1027,20305779,tshr_human,441,T,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,34.0,-2.941,,,,0.0,0.0,,0.0,,P16473,0.3978803456599015
1031,20305779,tshr_human,442,S,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,61.0,-1.639,,,,0.0,0.0,,0.0,,P16473,0.459670974915861
1032,20305779,tshr_human,442,S,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,39.0,-2.564,,,,0.0,0.0,,0.0,,P16473,0.459670974915861
1036,20305779,tshr_human,443,H,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,81.0,-1.235,,,,0.0,0.0,,0.0,,P16473,0.4795122542879944
1037,20305779,tshr_human,443,H,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,47.0,-2.128,,,,0.0,0.0,,0.0,,P16473,0.4795122542879944
1046,20305779,tshr_human,443,H,F,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,77.0,-1.299,,,,0.0,0.0,,0.0,,P16473,0.4348772908638258
1047,20305779,tshr_human,443,H,F,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,13.0,-7.692,,,,0.0,0.0,,0.0,,P16473,0.4348772908638258
1051,20305779,tshr_human,443,H,R,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,80.0,-1.25,,,,0.0,0.0,,0.0,,P16473,0.3912803805153549
1052,20305779,tshr_human,443,H,R,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,96.0,-1.042,,,,0.0,0.0,,0.0,,P16473,0.3912803805153549
1056,20305779,tshr_human,444,Y,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,97.0,-1.031,,,,0.0,0.0,,0.0,,P16473,0.3285721149583159
1057,20305779,tshr_human,444,Y,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,70.0,-1.429,,,,0.0,0.0,,0.0,,P16473,0.3285721149583159
1061,20305779,tshr_human,445,K,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,89.0,-1.124,,,,0.0,0.0,,0.0,,P16473,0.5151584831176956
1062,20305779,tshr_human,445,K,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,79.0,-1.266,,,,0.0,0.0,,0.0,,P16473,0.5151584831176956
1066,20305779,tshr_human,446,L,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,91.0,-1.099,,,,0.0,0.0,,0.0,,P16473,0.5659088293730111
1067,20305779,tshr_human,446,L,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,49.0,-2.041,,,,0.0,0.0,,0.0,,P16473,0.5659088293730111
1076,20305779,tshr_human,448,V,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,89.0,-1.124,,,,0.0,0.0,,0.0,,P16473,0.521428371902122
1077,20305779,tshr_human,448,V,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,67.0,-1.493,,,,0.0,0.0,,0.0,,P16473,0.521428371902122
1081,20305779,tshr_human,449,P,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,112.0,1.12,,,,0.0,0.0,,0.0,,P16473,0.5651241614598325
1082,20305779,tshr_human,449,P,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,107.0,1.07,,,,0.0,0.0,,0.0,,P16473,0.5651241614598325
1085,25978107,tshr_human,449,P,L,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,61.0,-1.639,,,,0.0,0.0,,0.0,,P16473,0.6506105105961111
1086,25978107,tshr_human,449,P,L,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,17.0,-5.882,,,,0.0,0.0,,0.0,,P16473,0.6506105105961111
1090,20305779,tshr_human,450,R,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,70.0,-1.429,,,,0.0,0.0,,0.0,,P16473,0.600820787987052
1091,20305779,tshr_human,450,R,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,16.0,-6.25,,,,0.0,0.0,,0.0,,P16473,0.600820787987052
1099,16756469,tshr_human,450,R,H,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,40.0,-2.5,,,,0.0,0.0,,0.0,,P16473,0.5570059217086102
1101,16756469,tshr_human,450,R,H,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,60.0,-1.667,,,,0.0,0.0,,0.0,,P16473,0.5570059217086102
1110,20305779,tshr_human,450,R,M,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,85.0,-1.176,,,,0.0,0.0,,0.0,,P16473,0.600820787987052
1111,20305779,tshr_human,450,R,M,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,13.0,-7.692,,,,0.0,0.0,,0.0,,P16473,0.600820787987052
1120,20305779,tshr_human,451,F,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,72.0,-1.389,,,,0.0,0.0,,0.0,,P16473,0.6005021803609506
1121,20305779,tshr_human,451,F,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,43.0,-2.326,,,,0.0,0.0,,0.0,,P16473,0.6005021803609506
1125,24608569,tshr_human,453,M,R,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,48.0,-2.083,,,,0.0,0.0,,0.0,,P16473,0.5390785764868291
1126,24608569,tshr_human,453,M,R,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,7.0,-14.286,,,,0.0,0.0,,0.0,,P16473,0.5390785764868291
1134,18989620,tshr_human,453,M,T,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,84.0,-1.19,,,,0.0,0.0,,0.0,,P16473,0.5390785764868291
1135,18989620,tshr_human,453,M,T,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,87.0,-1.149,,,,0.0,0.0,,0.0,,P16473,0.5390785764868291
1136,24608569,tshr_human,453,M,T,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,53.0,-1.887,,,,0.0,0.0,,0.0,,P16473,0.5390785764868291
1137,24608569,tshr_human,453,M,T,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,5.0,-20.0,,,,0.0,0.0,,0.0,,P16473,0.5390785764868291
1138,8964822,tshr_human,453,M,T,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,80.0,-1.25,,,,0.0,0.0,,0.0,,P16473,0.5390785764868291
1139,8964822,tshr_human,453,M,T,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,100.0,1.0,,,,0.0,0.0,,0.0,,P16473,0.5390785764868291
1147,15722344,tshr_human,456,L,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,42.0,-2.381,,,,0.0,0.0,,0.0,,P16473,0.7716443350616851
1153,15722344,tshr_human,456,L,W,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,5.0,-20.0,,,,0.0,0.0,,0.0,,P16473,0.8018040158048165
1156,15722344,tshr_human,460,D,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,19.0,-5.263,,,,0.0,0.0,,0.0,,P16473,0.8519744536676885
1159,15722344,tshr_human,460,D,N,"P01217, P01223",UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,37.0,-2.703,,,,0.0,0.0,,0.0,,P16473,0.7702950048818037
1170,20179143,tshr_human,466,Y,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,50.0,-2.0,,,,0.0,0.0,,0.0,,P16473,0.5461531057483414
1171,20179143,tshr_human,466,Y,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,20.0,-5.0,,,,0.0,0.0,,0.0,,P16473,0.5461531057483414
1178,20652618,tshr_human,467,L,V,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,110.0,1.1,,,,0.0,0.0,,0.0,,P16473,0.4568199309365351
1179,20652618,tshr_human,467,L,V,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,20.0,-5.0,,,,0.0,0.0,,0.0,,P16473,0.4568199309365351
1183,17079233,tshr_human,470,I,V,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,109.0,1.09,,,,0.0,0.0,,0.0,,P16473,0.3180932825058565
1184,17079233,tshr_human,470,I,V,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,77.0,-1.299,,,,0.0,0.0,,0.0,,P16473,0.3180932825058565
1188,16756469,tshr_human,473,V,I,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,80.0,-1.25,,,,0.0,0.0,,0.0,,P16473,0.214118247974736
1189,16756469,tshr_human,473,V,I,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,20.0,-5.0,,,,0.0,0.0,,0.0,,P16473,0.214118247974736
1190,16756469,tshr_human,473,V,I,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,80.0,-1.25,,,,0.0,0.0,,0.0,,P16473,0.214118247974736
1200,16410307,tshr_human,476,Y,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,89.0,-1.124,,,,0.0,0.0,,0.0,,P16473,0.332779642579709
1201,16410307,tshr_human,476,Y,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,107.0,1.07,,,,0.0,0.0,,0.0,,P16473,0.332779642579709
1211,12950268,tshr_human,477,T,I,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,14.0,-7.143,,,,0.0,0.0,,0.0,,P16473,0.4712374541472868
1212,12950268,tshr_human,477,T,I,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,32.0,-3.125,,,,0.0,0.0,,0.0,,P16473,0.4712374541472868
1213,12950268,tshr_human,477,T,I,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,23.0,-4.348,,,,0.0,0.0,,0.0,,P16473,0.4712374541472868
1214,15817920,tshr_human,477,T,I,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,28.0,-3.571,,,,0.0,0.0,,0.0,,P16473,0.4712374541472868
1215,15817920,tshr_human,477,T,I,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,7.0,-14.286,,,,0.0,0.0,,0.0,,P16473,0.4712374541472868
1216,15817920,tshr_human,477,T,I,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,27.0,-3.704,,,,0.0,0.0,,0.0,,P16473,0.4712374541472868
1220,16410307,tshr_human,478,H,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,99.0,-1.01,,,,0.0,0.0,,0.0,,P16473,0.4335690744698731
1221,16410307,tshr_human,478,H,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,109.0,1.09,,,,0.0,0.0,,0.0,,P16473,0.4335690744698731
1224,18381815,tshr_human,479,S,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,99.0,-1.01,,,,0.0,0.0,,0.0,,P16473,0.2792227394281122
1227,18381815,tshr_human,480,E,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,83.0,-1.205,,,,0.0,0.0,,0.0,,P16473,0.3361382435812378
1231,16410307,tshr_human,481,Y,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,10.0,-10.0,,,,0.0,0.0,,0.0,,P16473,0.6884397816413304
1232,16410307,tshr_human,481,Y,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,5.0,-20.0,,,,0.0,0.0,,0.0,,P16473,0.6884397816413304
1236,16410307,tshr_human,481,Y,F,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,70.0,-1.429,,,,0.0,0.0,,0.0,,P16473,0.4732311904129358
1237,16410307,tshr_human,481,Y,F,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,70.0,-1.429,,,,0.0,0.0,,0.0,,P16473,0.4732311904129358
1241,16410307,tshr_human,481,Y,N,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,12.0,-8.333,,,,0.0,0.0,,0.0,,P16473,0.6884397816413304
1242,16410307,tshr_human,481,Y,N,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,5.0,-20.0,,,,0.0,0.0,,0.0,,P16473,0.6884397816413304
1246,16410307,tshr_human,482,Y,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,74.0,-1.351,,,,0.0,0.0,,0.0,,P16473,0.6272464622548249
1247,16410307,tshr_human,482,Y,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,19.0,-5.263,,,,0.0,0.0,,0.0,,P16473,0.6272464622548249
1254,16410307,tshr_human,484,H,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,97.0,-1.031,,,,0.0,0.0,,0.0,,P16473,0.3926273731495025
1255,16410307,tshr_human,484,H,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,39.0,-2.564,,,,0.0,0.0,,0.0,,P16473,0.3926273731495025
1262,18381815,tshr_human,486,I,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,91.0,-1.099,,,,0.0,0.0,,0.0,,P16473,0.3825831398561047
1273,12062436,tshr_human,486,I,F,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,64.0,-1.562,,,,0.0,0.0,,0.0,,P16473,0.3410524864682556
1274,15817920,tshr_human,486,I,F,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,83.0,-1.205,,,,0.0,0.0,,0.0,,P16473,0.3410524864682556
1275,15817920,tshr_human,486,I,F,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,55.0,-1.818,,,,0.0,0.0,,0.0,,P16473,0.3410524864682556
1276,15817920,tshr_human,486,I,F,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,42.0,-2.381,,,,0.0,0.0,,0.0,,P16473,0.3410524864682556
1285,12950268,tshr_human,486,I,M,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,112.0,1.12,,,,0.0,0.0,,0.0,,P16473,0.3018318422538868
1286,12950268,tshr_human,486,I,M,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,175.0,1.75,,,,0.0,0.0,,0.0,,P16473,0.3018318422538868
1287,12950268,tshr_human,486,I,M,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,81.0,-1.235,,,,0.0,0.0,,0.0,,P16473,0.3018318422538868
1288,18850313,tshr_human,486,I,M,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,66.0,-1.515,,,,0.0,0.0,,0.0,,P16473,0.3018318422538868
1294,16990652,tshr_human,486,I,N,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,85.0,-1.176,,,,0.0,0.0,,0.0,,P16473,0.4704008018180894
1295,21835055,tshr_human,486,I,N,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,74.0,-1.351,,,,0.0,0.0,,0.0,,P16473,0.4704008018180894
1296,21835055,tshr_human,486,I,N,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,8.0,-12.5,,,,0.0,0.0,,0.0,,P16473,0.4704008018180894
1299,18381815,tshr_human,487,D,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,96.0,-1.042,,,,0.0,0.0,,0.0,,P16473,0.3828601672064594
1302,18381815,tshr_human,488,W,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,4.0,-25.0,,,,0.0,0.0,,0.0,,P16473,0.7188616974127321
1308,18381815,tshr_human,488,W,L,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,5.0,-20.0,,,,0.0,0.0,,0.0,,P16473,0.6811094982776088
1313,18381815,tshr_human,489,Q,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,34.0,-2.941,,,,0.0,0.0,,0.0,,P16473,0.4711582673031868
1319,18381815,tshr_human,490,T,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,108.0,1.08,,,,0.0,0.0,,0.0,,P16473,0.3974241643205941
1325,20179143,tshr_human,501,T,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,129.0,1.29,,,,0.0,0.0,,0.0,,P16473,0.5090967639605923
1330,20652618,tshr_human,502,V,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,110.0,1.1,,,,0.0,0.0,,0.0,,P16473,0.5110325928717498
1331,20652618,tshr_human,502,V,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,10.0,-10.0,,,,0.0,0.0,,0.0,,P16473,0.5110325928717498
1336,11012571,tshr_human,505,S,N,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,109.0,1.09,,,,0.0,0.0,,0.0,,P16473,0.4580615257175525
1337,11012571,tshr_human,505,S,N,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,100.0,1.0,,,,0.0,0.0,,0.0,,P16473,0.4580615257175525
1338,9360555,tshr_human,505,S,N,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,103.0,1.03,,,,0.0,0.0,,0.0,,P16473,0.4580615257175525
1339,9360555,tshr_human,505,S,N,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,78.0,-1.282,,,,0.0,0.0,,0.0,,P16473,0.4580615257175525
1355,11463854,tshr_human,508,S,G,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,85.0,-1.176,,,,0.0,0.0,,0.0,,P16473,0.7719603620545736
1356,11463854,tshr_human,508,S,G,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,31.0,-3.226,,,,0.0,0.0,,0.0,,P16473,0.7719603620545736
1357,11463854,tshr_human,508,S,G,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,40.0,-2.5,,,,0.0,0.0,,0.0,,P16473,0.7719603620545736
1361,16079263,tshr_human,509,V,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,100.0,1.0,,,,0.0,0.0,,0.0,,P16473,0.5091841834682269
1371,11434721,tshr_human,512,L,Q,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,69.0,-1.449,,,,0.0,0.0,,0.0,,P16473,0.6837673702361553
1372,18850313,tshr_human,512,L,Q,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,79.0,-1.266,,,,0.0,0.0,,0.0,,P16473,0.6837673702361553
1373,18989620,tshr_human,512,L,Q,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,86.0,-1.163,,,,0.0,0.0,,0.0,,P16473,0.6837673702361553
1374,18989620,tshr_human,512,L,Q,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,52.0,-1.923,,,,0.0,0.0,,0.0,,P16473,0.6837673702361553
1378,11022192,tshr_human,512,L,R,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,49.0,-2.041,,,,0.0,0.0,,0.0,,P16473,0.6837673702361553
1379,11022192,tshr_human,512,L,R,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,13.0,-7.692,,,,0.0,0.0,,0.0,,P16473,0.6837673702361553
1380,11022192,tshr_human,512,L,R,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,52.0,-1.923,,,,0.0,0.0,,0.0,,P16473,0.6837673702361553
1386,12062436,tshr_human,518,E,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,33.0,-3.03,,,,0.0,0.0,,0.0,,P16473,0.7875887394914814
1389,12062436,tshr_human,518,E,Q,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,53.0,-1.887,,,,0.0,0.0,,0.0,,P16473,0.6835893893085502
1392,16756469,tshr_human,519,R,C,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,10.0,-10.0,,,,0.0,0.0,,0.0,,P16473,0.8917379067168723
1394,16756469,tshr_human,519,R,C,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,25.0,-4.0,,,,0.0,0.0,,0.0,,P16473,0.8917379067168723
1399,16756469,tshr_human,519,R,G,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,25.0,-4.0,,,,0.0,0.0,,0.0,,P16473,0.8730904653605398
1404,15498884,tshr_human,523,I,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,28.0,-3.571,,,,0.0,0.0,,0.0,,P16473,0.6027519814144535
1405,15498884,tshr_human,523,I,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,8.0,-12.5,,,,0.0,0.0,,0.0,,P16473,0.6027519814144535
1406,15498884,tshr_human,523,I,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,104.0,1.04,,,,0.0,0.0,,0.0,,P16473,0.6027519814144535
1410,15498884,tshr_human,524,T,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,95.0,-1.053,,,,0.0,0.0,,0.0,,P16473,0.4911494381709889
1411,15498884,tshr_human,524,T,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,91.0,-1.099,,,,0.0,0.0,,0.0,,P16473,0.4911494381709889
1412,15498884,tshr_human,524,T,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,45.0,-2.222,,,,0.0,0.0,,0.0,,P16473,0.4911494381709889
1416,15498884,tshr_human,525,F,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,71.0,-1.408,,,,0.0,0.0,,0.0,,P16473,0.4983330457898907
1417,15498884,tshr_human,525,F,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,42.0,-2.381,,,,0.0,0.0,,0.0,,P16473,0.4983330457898907
1418,15498884,tshr_human,525,F,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,100.0,1.0,,,,0.0,0.0,,0.0,,P16473,0.4983330457898907
1431,15498884,tshr_human,527,M,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,45.0,-2.222,,,,0.0,0.0,,0.0,,P16473,0.5470097720837631
1432,15498884,tshr_human,527,M,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,9.0,-11.111,,,,0.0,0.0,,0.0,,P16473,0.5470097720837631
1433,15498884,tshr_human,527,M,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,109.0,1.09,,,,0.0,0.0,,0.0,,P16473,0.5470097720837631
1437,15498884,tshr_human,527,M,K,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,21.0,-4.762,,,,0.0,0.0,,0.0,,P16473,0.5470097720837631
1438,15498884,tshr_human,527,M,K,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,9.0,-11.111,,,,0.0,0.0,,0.0,,P16473,0.5470097720837631
1439,15498884,tshr_human,527,M,K,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,140.0,1.4,,,,0.0,0.0,,0.0,,P16473,0.5470097720837631
1440,18727713,tshr_human,527,M,T,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,30.0,-3.333,,,,0.0,0.0,,0.0,,P16473,0.5470097720837631
1444,15498884,tshr_human,528,R,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,66.0,-1.515,,,,0.0,0.0,,0.0,,P16473,0.4713723531906003
1445,15498884,tshr_human,528,R,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,28.0,-3.571,,,,0.0,0.0,,0.0,,P16473,0.4713723531906003
1446,15498884,tshr_human,528,R,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,58.0,-1.724,,,,0.0,0.0,,0.0,,P16473,0.4713723531906003
1449,9589634,tshr_human,528,R,H,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,59.0,-1.695,,,,0.0,0.0,,0.0,,P16473,0.4268868081210946
1450,9589634,tshr_human,528,R,H,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,112.0,1.12,,,,0.0,0.0,,0.0,,P16473,0.4268868081210946
1451,9589634,tshr_human,528,R,H,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,42.0,-2.381,,,,0.0,0.0,,0.0,,P16473,0.4268868081210946
1455,15498884,tshr_human,529,L,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,92.0,-1.087,,,,0.0,0.0,,0.0,,P16473,0.5466776381588841
1456,15498884,tshr_human,529,L,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,39.0,-2.564,,,,0.0,0.0,,0.0,,P16473,0.5466776381588841
1457,15498884,tshr_human,529,L,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,111.0,1.11,,,,0.0,0.0,,0.0,,P16473,0.5466776381588841
1461,15498884,tshr_human,530,D,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,62.0,-1.613,,,,0.0,0.0,,0.0,,P16473,0.5303878045253294
1462,15498884,tshr_human,530,D,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,19.0,-5.263,,,,0.0,0.0,,0.0,,P16473,0.5303878045253294
1463,15498884,tshr_human,530,D,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,71.0,-1.408,,,,0.0,0.0,,0.0,,P16473,0.5303878045253294
1467,15498884,tshr_human,531,R,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,80.0,-1.25,,,,0.0,0.0,,0.0,,P16473,0.4163985998486727
1468,15498884,tshr_human,531,R,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,51.0,-1.961,,,,0.0,0.0,,0.0,,P16473,0.4163985998486727
1469,15498884,tshr_human,531,R,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,83.0,-1.205,,,,0.0,0.0,,0.0,,P16473,0.4163985998486727
1471,18162522,tshr_human,531,R,Q,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,90.0,-1.111,,,,0.0,0.0,,0.0,,P16473,0.3323445865652676
1475,15498884,tshr_human,532,K,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,69.0,-1.449,,,,0.0,0.0,,0.0,,P16473,0.40830590772307
1476,15498884,tshr_human,532,K,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,72.0,-1.389,,,,0.0,0.0,,0.0,,P16473,0.40830590772307
1477,15498884,tshr_human,532,K,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,67.0,-1.493,,,,0.0,0.0,,0.0,,P16473,0.40830590772307
1481,15498884,tshr_human,533,I,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,82.0,-1.22,,,,0.0,0.0,,0.0,,P16473,0.543775846786198
1482,15498884,tshr_human,533,I,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,79.0,-1.266,,,,0.0,0.0,,0.0,,P16473,0.543775846786198
1483,15498884,tshr_human,533,I,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,103.0,1.03,,,,0.0,0.0,,0.0,,P16473,0.543775846786198
1488,15498884,tshr_human,534,R,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,72.0,-1.389,,,,0.0,0.0,,0.0,,P16473,0.4235073778348359
1489,15498884,tshr_human,534,R,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,79.0,-1.266,,,,0.0,0.0,,0.0,,P16473,0.4235073778348359
1490,15498884,tshr_human,534,R,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,67.0,-1.493,,,,0.0,0.0,,0.0,,P16473,0.4235073778348359
1499,9185526,tshr_human,553,A,T,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,40.0,-2.5,,,,0.0,0.0,,0.0,,P16473,0.5183090920879592
1501,9185526,tshr_human,553,A,T,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,25.0,-4.0,,,,0.0,0.0,,0.0,,P16473,0.5183090920879592
1505,17079233,tshr_human,561,S,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,72.0,-1.389,,,,0.0,0.0,,0.0,,P16473,0.386973892948609
1506,17079233,tshr_human,561,S,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,14.0,-7.143,,,,0.0,0.0,,0.0,,P16473,0.386973892948609
1510,17079233,tshr_human,562,S,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,82.0,-1.22,,,,0.0,0.0,,0.0,,P16473,0.3903879602416312
1511,17079233,tshr_human,562,S,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,15.0,-6.667,,,,0.0,0.0,,0.0,,P16473,0.3903879602416312
1515,17079233,tshr_human,563,Y,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,15.0,-6.667,,,,0.0,0.0,,0.0,,P16473,0.6981727102491782
1516,17079233,tshr_human,563,Y,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,4.0,-25.0,,,,0.0,0.0,,0.0,,P16473,0.6981727102491782
1520,17079233,tshr_human,564,A,F,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,58.0,-1.724,,,,0.0,0.0,,0.0,,P16473,0.5422589856011497
1521,17079233,tshr_human,564,A,F,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,45.0,-2.222,,,,0.0,0.0,,0.0,,P16473,0.5422589856011497
1525,17079233,tshr_human,565,K,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,14.0,-7.143,,,,0.0,0.0,,0.0,,P16473,0.481598483312495
1526,17079233,tshr_human,565,K,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,5.0,-20.0,,,,0.0,0.0,,0.0,,P16473,0.481598483312495
1530,17079233,tshr_human,566,V,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,88.0,-1.136,,,,0.0,0.0,,0.0,,P16473,0.4854520528565262
1531,17079233,tshr_human,566,V,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,78.0,-1.282,,,,0.0,0.0,,0.0,,P16473,0.4854520528565262
1535,17079233,tshr_human,566,V,F,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,37.0,-2.703,,,,0.0,0.0,,0.0,,P16473,0.5304149448641027
1536,17079233,tshr_human,566,V,F,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,7.0,-14.286,,,,0.0,0.0,,0.0,,P16473,0.5304149448641027
1540,17079233,tshr_human,567,S,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,77.0,-1.299,,,,0.0,0.0,,0.0,,P16473,0.5276727218377996
1541,17079233,tshr_human,567,S,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,65.0,-1.538,,,,0.0,0.0,,0.0,,P16473,0.5276727218377996
1545,17079233,tshr_human,568,I,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,55.0,-1.818,,,,0.0,0.0,,0.0,,P16473,0.5946284933794646
1546,17079233,tshr_human,568,I,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,4.0,-25.0,,,,0.0,0.0,,0.0,,P16473,0.5946284933794646
1550,17079233,tshr_human,568,I,F,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,103.0,1.03,,,,0.0,0.0,,0.0,,P16473,0.5506205719390695
1551,17079233,tshr_human,568,I,F,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,128.0,1.28,,,,0.0,0.0,,0.0,,P16473,0.5506205719390695
1554,17079233,tshr_human,568,I,L,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,68.0,-1.471,,,,0.0,0.0,,0.0,,P16473,0.460874633051465
1561,15817920,tshr_human,568,I,T,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,92.0,-1.087,,,,0.0,0.0,,0.0,,P16473,0.5946284933794646
1562,15817920,tshr_human,568,I,T,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,83.0,-1.205,,,,0.0,0.0,,0.0,,P16473,0.5946284933794646
1563,15817920,tshr_human,568,I,T,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,67.0,-1.493,,,,0.0,0.0,,0.0,,P16473,0.5946284933794646
1572,17079233,tshr_human,568,I,V,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,78.0,-1.282,,,,0.0,0.0,,0.0,,P16473,0.4165751915206814
1573,17079233,tshr_human,568,I,V,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,107.0,1.07,,,,0.0,0.0,,0.0,,P16473,0.4165751915206814
1574,18381815,tshr_human,568,I,V,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,104.0,1.04,,,,0.0,0.0,,0.0,,P16473,0.4165751915206814
1578,17079233,tshr_human,570,L,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,62.0,-1.613,,,,0.0,0.0,,0.0,,P16473,0.6074933001333541
1579,17079233,tshr_human,570,L,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,17.0,-5.882,,,,0.0,0.0,,0.0,,P16473,0.6074933001333541
1592,17079233,tshr_human,572,M,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,57.0,-1.754,,,,0.0,0.0,,0.0,,P16473,0.5294882816104093
1593,17079233,tshr_human,572,M,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,14.0,-7.143,,,,0.0,0.0,,0.0,,P16473,0.5294882816104093
1594,18850313,tshr_human,572,M,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,48.0,-2.083,,,,0.0,0.0,,0.0,,P16473,0.5294882816104093
1603,17079233,tshr_human,573,D,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,74.0,-1.351,,,,0.0,0.0,,0.0,,P16473,0.5810926561770374
1604,17079233,tshr_human,573,D,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,68.0,-1.471,,,,0.0,0.0,,0.0,,P16473,0.5810926561770374
1614,17079233,tshr_human,574,T,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,87.0,-1.149,,,,0.0,0.0,,0.0,,P16473,0.4177378950767261
1615,17079233,tshr_human,574,T,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,102.0,1.02,,,,0.0,0.0,,0.0,,P16473,0.4177378950767261
1619,17079233,tshr_human,575,E,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,68.0,-1.471,,,,0.0,0.0,,0.0,,P16473,0.3535359988845564
1620,17079233,tshr_human,575,E,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,88.0,-1.136,,,,0.0,0.0,,0.0,,P16473,0.3535359988845564
1623,21586576,tshr_human,580,L,V,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,102.0,1.02,,,,0.0,0.0,,0.0,,P16473,0.2414069978990846
1627,20652618,tshr_human,582,Y,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,110.0,1.1,,,,0.0,0.0,,0.0,,P16473,0.6109596304086318
1628,20652618,tshr_human,582,Y,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,50.0,-2.0,,,,0.0,0.0,,0.0,,P16473,0.6109596304086318
1632,20652618,tshr_human,582,Y,F,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,110.0,1.1,,,,0.0,0.0,,0.0,,P16473,0.3896737803214727
1633,20652618,tshr_human,582,Y,F,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,110.0,1.1,,,,0.0,0.0,,0.0,,P16473,0.3896737803214727
1636,21586576,tshr_human,583,I,V,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,101.0,1.01,,,,0.0,0.0,,0.0,,P16473,0.3642742523323782
1639,21586576,tshr_human,584,V,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,125.0,1.25,,,,0.0,0.0,,0.0,,P16473,0.259946897561131
1641,16488885,tshr_human,585,F,T,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,92.0,-1.087,,,,0.0,0.0,,0.0,,P16473,0.3903430139752801
1644,20179143,tshr_human,587,L,V,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,97.0,-1.031,,,,0.0,0.0,,0.0,,P16473,0.441177988720499
1647,21586576,tshr_human,591,I,V,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,94.0,-1.064,,,,0.0,0.0,,0.0,,P16473,0.2497821099629303
1650,21586576,tshr_human,593,A,G,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,99.0,-1.01,,,,0.0,0.0,,0.0,,P16473,0.4703815477229306
1653,12589819,tshr_human,593,A,N,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,126.0,1.26,,,,0.0,0.0,,0.0,,P16473,0.5600225392012353
1656,21586576,tshr_human,593,A,P,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,24.0,-4.167,,,,0.0,0.0,,0.0,,P16473,0.5153316185036725
1659,21586576,tshr_human,593,A,V,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,103.0,1.03,,,,0.0,0.0,,0.0,,P16473,0.4703815477229306
1663,21586576,tshr_human,594,F,I,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,92.0,-1.087,,,,0.0,0.0,,0.0,,P16473,0.5241736387676071
1664,21586576,tshr_human,594,F,I,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,41.0,-2.439,,,,0.0,0.0,,0.0,,P16473,0.5241736387676071
1667,11517004,tshr_human,597,V,F,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,100.0,1.0,,,,0.0,0.0,,0.0,,P16473,0.5497133802013169
1672,10560955,tshr_human,597,V,L,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,80.0,-1.25,,,,0.0,0.0,,0.0,,P16473,0.4600232946658326
1673,10560955,tshr_human,597,V,L,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,50.0,-2.0,,,,0.0,0.0,,0.0,,P16473,0.4600232946658326
1674,12062436,tshr_human,597,V,L,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,60.0,-1.667,,,,0.0,0.0,,0.0,,P16473,0.4600232946658326
1690,9806755,tshr_human,601,Y,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,91.0,-1.099,,,,0.0,0.0,,0.0,,P16473,0.8194818639665291
1692,9806755,tshr_human,601,Y,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,96.0,-1.042,,,,0.0,0.0,,0.0,,P16473,0.8194818639665291
1695,9806755,tshr_human,601,Y,D,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,19.0,-5.263,,,,0.0,0.0,,0.0,,P16473,0.844593957602263
1697,9806755,tshr_human,601,Y,D,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,16.0,-6.25,,,,0.0,0.0,,0.0,,P16473,0.844593957602263
1703,10691307,tshr_human,601,Y,F,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,47.0,-2.128,,,,0.0,0.0,,0.0,,P16473,0.6485422395655277
1704,10691307,tshr_human,601,Y,F,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,48.0,-2.083,,,,0.0,0.0,,0.0,,P16473,0.6485422395655277
1705,10691307,tshr_human,601,Y,F,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,104.0,1.04,,,,0.0,0.0,,0.0,,P16473,0.6485422395655277
1706,18850313,tshr_human,601,Y,F,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,26.0,-3.846,,,,0.0,0.0,,0.0,,P16473,0.6485422395655277
1707,9806755,tshr_human,601,Y,F,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,95.0,-1.053,,,,0.0,0.0,,0.0,,P16473,0.6485422395655277
1709,9806755,tshr_human,601,Y,F,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,104.0,1.04,,,,0.0,0.0,,0.0,,P16473,0.6485422395655277
1713,10691307,tshr_human,601,Y,H,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,98.0,-1.02,,,,0.0,0.0,,0.0,,P16473,0.6884102268077162
1715,10691307,tshr_human,601,Y,H,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,114.0,1.14,,,,0.0,0.0,,0.0,,P16473,0.6884102268077162
1724,10691307,tshr_human,601,Y,N,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,120.0,1.2,,,,0.0,0.0,,0.0,,P16473,0.8194818639665291
1725,10691307,tshr_human,601,Y,N,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,105.0,1.05,,,,0.0,0.0,,0.0,,P16473,0.8194818639665291
1726,10691307,tshr_human,601,Y,N,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,62.0,-1.613,,,,0.0,0.0,,0.0,,P16473,0.8194818639665291
1727,12062436,tshr_human,601,Y,N,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,57.0,-1.754,,,,0.0,0.0,,0.0,,P16473,0.8194818639665291
1731,9806755,tshr_human,601,Y,S,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,65.0,-1.538,,,,0.0,0.0,,0.0,,P16473,0.8194818639665291
1733,9806755,tshr_human,601,Y,S,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,107.0,1.07,,,,0.0,0.0,,0.0,,P16473,0.8194818639665291
1736,9806755,tshr_human,601,Y,W,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,50.0,-2.0,,,,0.0,0.0,,0.0,,P16473,0.6884102268077162
1738,9806755,tshr_human,601,Y,W,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,144.0,1.44,,,,0.0,0.0,,0.0,,P16473,0.6884102268077162
1742,16955277,tshr_human,604,I,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,93.0,-1.075,,,,0.0,0.0,,0.0,,P16473,0.6085720732487745
1743,16955277,tshr_human,604,I,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,16.0,-6.25,,,,0.0,0.0,,0.0,,P16473,0.6085720732487745
1744,16955277,tshr_human,604,I,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,38.0,-2.632,,,,0.0,0.0,,0.0,,P16473,0.6085720732487745
1750,16955277,tshr_human,605,Y,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,88.0,-1.136,,,,0.0,0.0,,0.0,,P16473,0.5638463823875893
1752,16955277,tshr_human,605,Y,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,28.0,-3.571,,,,0.0,0.0,,0.0,,P16473,0.5638463823875893
1753,16955277,tshr_human,605,Y,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,90.0,-1.111,,,,0.0,0.0,,0.0,,P16473,0.5638463823875893
1754,9806755,tshr_human,605,Y,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,252.0,2.52,,,,0.0,0.0,,0.0,,P16473,0.5638463823875893
1756,9806755,tshr_human,605,Y,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,56.0,-1.786,,,,0.0,0.0,,0.0,,P16473,0.5638463823875893
1759,9806755,tshr_human,605,Y,H,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,149.0,1.49,,,,0.0,0.0,,0.0,,P16473,0.386212185056689
1761,9806755,tshr_human,605,Y,H,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,67.0,-1.493,,,,0.0,0.0,,0.0,,P16473,0.386212185056689
1765,16955277,tshr_human,606,I,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,135.0,1.35,,,,0.0,0.0,,0.0,,P16473,0.2881163034736625
1766,16955277,tshr_human,606,I,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,86.0,-1.163,,,,0.0,0.0,,0.0,,P16473,0.2881163034736625
1767,16955277,tshr_human,606,I,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,87.0,-1.149,,,,0.0,0.0,,0.0,,P16473,0.2881163034736625
1771,16955277,tshr_human,607,T,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,145.0,1.45,,,,0.0,0.0,,0.0,,P16473,0.4650419717194808
1772,16955277,tshr_human,607,T,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,89.0,-1.124,,,,0.0,0.0,,0.0,,P16473,0.4650419717194808
1773,16955277,tshr_human,607,T,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,86.0,-1.163,,,,0.0,0.0,,0.0,,P16473,0.4650419717194808
1777,15498884,tshr_human,607,T,E,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,85.0,-1.176,,,,0.0,0.0,,0.0,,P16473,0.5099918797262586
1778,15498884,tshr_human,607,T,E,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,102.0,1.02,,,,0.0,0.0,,0.0,,P16473,0.5099918797262586
1779,15498884,tshr_human,607,T,E,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,71.0,-1.408,,,,0.0,0.0,,0.0,,P16473,0.5099918797262586
1783,16955277,tshr_human,608,V,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,103.0,1.03,,,,0.0,0.0,,0.0,,P16473,0.5266511157863822
1785,16955277,tshr_human,608,V,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,51.0,-1.961,,,,0.0,0.0,,0.0,,P16473,0.5266511157863822
1786,16955277,tshr_human,608,V,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,71.0,-1.408,,,,0.0,0.0,,0.0,,P16473,0.5266511157863822
1790,16955277,tshr_human,613,Y,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,95.0,-1.053,,,,0.0,0.0,,0.0,,P16473,0.4079094517728984
1791,16955277,tshr_human,613,Y,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,75.0,-1.333,,,,0.0,0.0,,0.0,,P16473,0.4079094517728984
1792,16955277,tshr_human,613,Y,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,79.0,-1.266,,,,0.0,0.0,,0.0,,P16473,0.4079094517728984
1808,16955277,tshr_human,615,P,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,103.0,1.03,,,,0.0,0.0,,0.0,,P16473,0.3727311640336491
1809,16955277,tshr_human,615,P,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,86.0,-1.163,,,,0.0,0.0,,0.0,,P16473,0.3727311640336491
1810,16955277,tshr_human,615,P,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,103.0,1.03,,,,0.0,0.0,,0.0,,P16473,0.3727311640336491
1814,16955277,tshr_human,616,G,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,155.0,1.55,,,,0.0,0.0,,0.0,,P16473,0.3299432390679228
1815,16955277,tshr_human,616,G,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,105.0,1.05,,,,0.0,0.0,,0.0,,P16473,0.3299432390679228
1816,16955277,tshr_human,616,G,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,94.0,-1.064,,,,0.0,0.0,,0.0,,P16473,0.3299432390679228
1818,16955277,tshr_human,617,D,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,146.0,1.46,,,,0.0,0.0,,0.0,,P16473,0.4139938940927671
1819,16955277,tshr_human,617,D,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,103.0,1.03,,,,0.0,0.0,,0.0,,P16473,0.4139938940927671
1820,16955277,tshr_human,617,D,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,86.0,-1.163,,,,0.0,0.0,,0.0,,P16473,0.4139938940927671
1824,18025759,tshr_human,617,D,Y,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,86.0,-1.163,,,,0.0,0.0,,0.0,,P16473,0.4582389620267081
1825,18025759,tshr_human,617,D,Y,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,78.0,-1.282,,,,0.0,0.0,,0.0,,P16473,0.4582389620267081
1829,16955277,tshr_human,618,K,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,98.0,-1.02,,,,0.0,0.0,,0.0,,P16473,0.5170640062508983
1830,16955277,tshr_human,618,K,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,19.0,-5.263,,,,0.0,0.0,,0.0,,P16473,0.5170640062508983
1831,16955277,tshr_human,618,K,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,63.0,-1.587,,,,0.0,0.0,,0.0,,P16473,0.5170640062508983
1835,16955277,tshr_human,619,D,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,149.0,1.49,,,,0.0,0.0,,0.0,,P16473,0.6688915625194519
1836,16955277,tshr_human,619,D,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,115.0,1.15,,,,0.0,0.0,,0.0,,P16473,0.6688915625194519
1837,16955277,tshr_human,619,D,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,95.0,-1.053,,,,0.0,0.0,,0.0,,P16473,0.6688915625194519
1845,12062436,tshr_human,619,D,G,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,114.0,1.14,,,,0.0,0.0,,0.0,,P16473,0.6279194859706505
1846,18025759,tshr_human,619,D,G,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,92.0,-1.087,,,,0.0,0.0,,0.0,,P16473,0.6279194859706505
1847,18025759,tshr_human,619,D,G,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,85.0,-1.176,,,,0.0,0.0,,0.0,,P16473,0.6279194859706505
1851,16955277,tshr_human,620,T,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,105.0,1.05,,,,0.0,0.0,,0.0,,P16473,0.4078043738633307
1852,16955277,tshr_human,620,T,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,90.0,-1.111,,,,0.0,0.0,,0.0,,P16473,0.4078043738633307
1853,16955277,tshr_human,620,T,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,83.0,-1.205,,,,0.0,0.0,,0.0,,P16473,0.4078043738633307
1855,16756473,tshr_human,620,T,I,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,75.0,-1.333,,,,0.0,0.0,,0.0,,P16473,0.4518824657699106
1859,16955277,tshr_human,621,K,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,87.0,-1.149,,,,0.0,0.0,,0.0,,P16473,0.5233806648756547
1860,16955277,tshr_human,621,K,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,19.0,-5.263,,,,0.0,0.0,,0.0,,P16473,0.5233806648756547
1861,16955277,tshr_human,621,K,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,79.0,-1.266,,,,0.0,0.0,,0.0,,P16473,0.5233806648756547
1865,16955277,tshr_human,622,I,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,93.0,-1.075,,,,0.0,0.0,,0.0,,P16473,0.5559997108268064
1866,16955277,tshr_human,622,I,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,31.0,-3.226,,,,0.0,0.0,,0.0,,P16473,0.5559997108268064
1867,16955277,tshr_human,622,I,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,83.0,-1.205,,,,0.0,0.0,,0.0,,P16473,0.5559997108268064
1871,16955277,tshr_human,622,I,D,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,20.0,-5.0,,,,0.0,0.0,,0.0,,P16473,0.6420886641100667
1872,16955277,tshr_human,622,I,D,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,13.0,-7.692,,,,0.0,0.0,,0.0,,P16473,0.6420886641100667
1873,16955277,tshr_human,622,I,D,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,87.0,-1.149,,,,0.0,0.0,,0.0,,P16473,0.6420886641100667
1876,19499991,tshr_human,623,A,F,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,100.0,1.0,,,,0.0,0.0,,0.0,,P16473,0.7371456621406691
1877,19499991,tshr_human,623,A,F,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,100.0,1.0,,,,0.0,0.0,,0.0,,P16473,0.7371456621406691
1884,18850313,tshr_human,623,A,V,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,112.0,1.12,,,,0.0,0.0,,0.0,,P16473,0.6617987689914175
1885,7989485,tshr_human,623,A,V,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,80.0,-1.25,,,,0.0,0.0,,0.0,,P16473,0.6617987689914175
1886,7989485,tshr_human,623,A,V,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,100.0,1.0,,,,0.0,0.0,,0.0,,P16473,0.6617987689914175
1887,7989485,tshr_human,623,A,V,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,80.0,-1.25,,,,0.0,0.0,,0.0,,P16473,0.6617987689914175
1890,9806755,tshr_human,623,A,Y,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,45.0,-2.222,,,,0.0,0.0,,0.0,,P16473,0.7371456621406691
1891,9806755,tshr_human,623,A,Y,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,42.0,-2.381,,,,0.0,0.0,,0.0,,P16473,0.7371456621406691
1894,15722344,tshr_human,625,R,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,76.0,-1.316,,,,0.0,0.0,,0.0,,P16473,0.6186734694427474
1905,16990652,tshr_human,627,A,V,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,54.0,-1.852,,,,0.0,0.0,,0.0,,P16473,0.4972948411030828
1923,11012571,tshr_human,630,I,L,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,80.0,-1.25,,,,0.0,0.0,,0.0,,P16473,0.4884872961624961
1924,11012571,tshr_human,630,I,L,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,24.0,-4.167,,,,0.0,0.0,,0.0,,P16473,0.4884872961624961
1925,9398745,tshr_human,630,I,L,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,106.0,1.06,,,,0.0,0.0,,0.0,,P16473,0.4884872961624961
1926,9398745,tshr_human,630,I,L,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,42.0,-2.381,,,,0.0,0.0,,0.0,,P16473,0.4884872961624961
1927,9467563,tshr_human,630,I,L,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,62.0,-1.613,,,,0.0,0.0,,0.0,,P16473,0.4884872961624961
1931,15876166,tshr_human,630,I,M,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,87.0,-1.149,,,,0.0,0.0,,0.0,,P16473,0.5334292575154456
1932,15876166,tshr_human,630,I,M,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,32.0,-3.125,,,,0.0,0.0,,0.0,,P16473,0.5334292575154456
1933,15876166,tshr_human,630,I,M,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,46.0,-2.174,,,,0.0,0.0,,0.0,,P16473,0.5334292575154456
1936,7805857,tshr_human,631,F,C,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,100.0,1.0,,,,0.0,0.0,,0.0,,P16473,0.470326208762316
1937,7805857,tshr_human,631,F,C,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,85.0,-1.176,,,,0.0,0.0,,0.0,,P16473,0.470326208762316
1938,7805857,tshr_human,631,F,C,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,45.0,-2.222,,,,0.0,0.0,,0.0,,P16473,0.470326208762316
1947,16756474,tshr_human,631,F,S,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,100.0,1.0,,,,0.0,0.0,,0.0,,P16473,0.470326208762316
1948,16756474,tshr_human,631,F,S,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,35.0,-2.857,,,,0.0,0.0,,0.0,,P16473,0.470326208762316
1952,15876166,tshr_human,631,F,V,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,102.0,1.02,,,,0.0,0.0,,0.0,,P16473,0.4258453409179759
1953,15876166,tshr_human,631,F,V,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,102.0,1.02,,,,0.0,0.0,,0.0,,P16473,0.4258453409179759
1954,15876166,tshr_human,631,F,V,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,86.0,-1.163,,,,0.0,0.0,,0.0,,P16473,0.4258453409179759
1959,12062436,tshr_human,632,T,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,92.0,-1.087,,,,0.0,0.0,,0.0,,P16473,0.4960601158130941
1960,15722344,tshr_human,632,T,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,145.0,1.45,,,,0.0,0.0,,0.0,,P16473,0.4960601158130941
1965,7805857,tshr_human,632,T,I,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,82.0,-1.22,,,,0.0,0.0,,0.0,,P16473,0.5409575447429956
1966,7805857,tshr_human,632,T,I,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,69.0,-1.449,,,,0.0,0.0,,0.0,,P16473,0.5409575447429956
1967,7805857,tshr_human,632,T,I,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,36.0,-2.778,,,,0.0,0.0,,0.0,,P16473,0.5409575447429956
1968,7989485,tshr_human,632,T,I,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,100.0,1.0,,,,0.0,0.0,,0.0,,P16473,0.5409575447429956
1969,7989485,tshr_human,632,T,I,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,100.0,1.0,,,,0.0,0.0,,0.0,,P16473,0.5409575447429956
1970,7989485,tshr_human,632,T,I,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,90.0,-1.111,,,,0.0,0.0,,0.0,,P16473,0.5409575447429956
1975,12062436,tshr_human,633,D,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,91.0,-1.099,,,,0.0,0.0,,0.0,,P16473,0.7650933471704218
1976,15722344,tshr_human,633,D,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,125.0,1.25,,,,0.0,0.0,,0.0,,P16473,0.7650933471704218
1980,11463854,tshr_human,633,D,C,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,70.0,-1.429,,,,0.0,0.0,,0.0,,P16473,0.795876613695792
1981,11463854,tshr_human,633,D,C,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,43.0,-2.326,,,,0.0,0.0,,0.0,,P16473,0.795876613695792
1982,11463854,tshr_human,633,D,C,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,77.0,-1.299,,,,0.0,0.0,,0.0,,P16473,0.795876613695792
2001,11463854,tshr_human,633,D,F,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,94.0,-1.064,,,,0.0,0.0,,0.0,,P16473,0.795876613695792
2002,11463854,tshr_human,633,D,F,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,50.0,-2.0,,,,0.0,0.0,,0.0,,P16473,0.795876613695792
2003,11463854,tshr_human,633,D,F,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,76.0,-1.316,,,,0.0,0.0,,0.0,,P16473,0.795876613695792
2004,15817920,tshr_human,633,D,F,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,77.0,-1.299,,,,0.0,0.0,,0.0,,P16473,0.795876613695792
2005,15817920,tshr_human,633,D,F,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,49.0,-2.041,,,,0.0,0.0,,0.0,,P16473,0.795876613695792
2006,15817920,tshr_human,633,D,F,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,45.0,-2.222,,,,0.0,0.0,,0.0,,P16473,0.795876613695792
2012,11463854,tshr_human,633,D,H,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,67.0,-1.493,,,,0.0,0.0,,0.0,,P16473,0.7312277011364945
2013,11463854,tshr_human,633,D,H,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,100.0,1.0,,,,0.0,0.0,,0.0,,P16473,0.7312277011364945
2014,11463854,tshr_human,633,D,H,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,115.0,1.15,,,,0.0,0.0,,0.0,,P16473,0.7312277011364945
2035,11463854,tshr_human,633,D,N,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,106.0,1.06,,,,0.0,0.0,,0.0,,P16473,0.6549496625799163
2036,11463854,tshr_human,633,D,N,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,46.0,-2.174,,,,0.0,0.0,,0.0,,P16473,0.6549496625799163
2037,11463854,tshr_human,633,D,N,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,93.0,-1.075,,,,0.0,0.0,,0.0,,P16473,0.6549496625799163
2038,15722344,tshr_human,633,D,N,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,167.0,1.67,,,,0.0,0.0,,0.0,,P16473,0.6549496625799163
2042,11463854,tshr_human,633,D,R,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,11.0,-9.091,,,,0.0,0.0,,0.0,,P16473,0.7650933471704218
2043,11463854,tshr_human,633,D,R,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,13.0,-7.692,,,,0.0,0.0,,0.0,,P16473,0.7650933471704218
2044,11463854,tshr_human,633,D,R,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,150.0,1.5,,,,0.0,0.0,,0.0,,P16473,0.7650933471704218
2048,11463854,tshr_human,633,D,W,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,86.0,-1.163,,,,0.0,0.0,,0.0,,P16473,0.8235498246625141
2049,11463854,tshr_human,633,D,W,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,45.0,-2.222,,,,0.0,0.0,,0.0,,P16473,0.8235498246625141
2050,11463854,tshr_human,633,D,W,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,68.0,-1.471,,,,0.0,0.0,,0.0,,P16473,0.8235498246625141
2053,7805857,tshr_human,633,D,Y,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,88.0,-1.136,,,,0.0,0.0,,0.0,,P16473,0.795876613695792
2054,7805857,tshr_human,633,D,Y,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,77.0,-1.299,,,,0.0,0.0,,0.0,,P16473,0.795876613695792
2055,7805857,tshr_human,633,D,Y,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,60.0,-1.667,,,,0.0,0.0,,0.0,,P16473,0.795876613695792
2057,21586576,tshr_human,634,F,I,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,89.0,-1.124,,,,0.0,0.0,,0.0,,P16473,0.5154738265154455
2058,21586576,tshr_human,634,F,I,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,15.0,-6.667,,,,0.0,0.0,,0.0,,P16473,0.5154738265154455
2061,19499991,tshr_human,635,I,V,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,125.0,1.25,,,,0.0,0.0,,0.0,,P16473,0.2944056142374564
2062,19499991,tshr_human,635,I,V,recombinant thyrotropin,ChEMBL Compound ID,,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,100.0,1.0,,,,0.0,0.0,,0.0,,P16473,0.2944056142374564
2066,22112806,tshr_human,636,C,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,92.0,-1.087,,,,0.0,0.0,,0.0,,P16473,0.6368423408575004
2067,22112806,tshr_human,636,C,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,86.0,-1.163,,,,0.0,0.0,,0.0,,P16473,0.6368423408575004
2071,22112806,tshr_human,636,C,F,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,63.0,-1.587,,,,0.0,0.0,,0.0,,P16473,0.7153549193011735
2072,22112806,tshr_human,636,C,F,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,8.0,-12.5,,,,0.0,0.0,,0.0,,P16473,0.7153549193011735
2080,22112806,tshr_human,636,C,R,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,200.0,2.0,,,,0.0,0.0,,0.0,,P16473,0.750521084513136
2081,22112806,tshr_human,636,C,R,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,10.0,-10.0,,,,0.0,0.0,,0.0,,P16473,0.750521084513136
2095,20501679,tshr_human,636,C,W,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,87.0,-1.149,,,,0.0,0.0,,0.0,,P16473,0.7153549193011735
2096,20501679,tshr_human,636,C,W,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,20.0,-5.0,,,,0.0,0.0,,0.0,,P16473,0.7153549193011735
2097,20501679,tshr_human,636,C,W,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,71.0,-1.408,,,,0.0,0.0,,0.0,,P16473,0.7153549193011735
2106,20179143,tshr_human,637,M,W,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,80.0,-1.25,,,,0.0,0.0,,0.0,,P16473,0.742471081474217
2107,20179143,tshr_human,637,M,W,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,100.0,1.0,,,,0.0,0.0,,0.0,,P16473,0.742471081474217
2111,21586576,tshr_human,638,A,V,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,95.0,-1.053,,,,0.0,0.0,,0.0,,P16473,0.4931440291094346
2112,21586576,tshr_human,638,A,V,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,22.0,-4.545,,,,0.0,0.0,,0.0,,P16473,0.4931440291094346
2116,22112806,tshr_human,639,P,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,93.0,-1.075,,,,0.0,0.0,,0.0,,P16473,0.7641363569190747
2117,22112806,tshr_human,639,P,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,61.0,-1.639,,,,0.0,0.0,,0.0,,P16473,0.7641363569190747
2121,22112806,tshr_human,639,P,G,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,107.0,1.07,,,,0.0,0.0,,0.0,,P16473,0.7950228986609046
2122,22112806,tshr_human,639,P,G,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,47.0,-2.128,,,,0.0,0.0,,0.0,,P16473,0.7950228986609046
2126,22112806,tshr_human,639,P,L,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,3.0,-33.333,,,,0.0,0.0,,0.0,,P16473,0.8227976860654872
2127,22112806,tshr_human,639,P,L,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,2.0,-50.0,,,,0.0,0.0,,0.0,,P16473,0.8227976860654872
2135,12950268,tshr_human,639,P,S,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,114.0,1.14,,,,0.0,0.0,,0.0,,P16473,0.7641363569190747
2136,12950268,tshr_human,639,P,S,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,207.0,2.07,,,,0.0,0.0,,0.0,,P16473,0.7641363569190747
2137,12950268,tshr_human,639,P,S,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,69.0,-1.449,,,,0.0,0.0,,0.0,,P16473,0.7641363569190747
2138,22112806,tshr_human,639,P,S,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,83.0,-1.205,,,,0.0,0.0,,0.0,,P16473,0.7641363569190747
2139,22112806,tshr_human,639,P,S,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,63.0,-1.587,,,,0.0,0.0,,0.0,,P16473,0.7641363569190747
2140,9467563,tshr_human,639,P,S,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,54.0,-1.852,,,,0.0,0.0,,0.0,,P16473,0.7641363569190747
2144,17079233,tshr_human,640,I,F,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,55.0,-1.818,,,,0.0,0.0,,0.0,,P16473,0.5187529248365862
2145,17079233,tshr_human,640,I,F,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,18.0,-5.556,,,,0.0,0.0,,0.0,,P16473,0.5187529248365862
2152,17079233,tshr_human,640,I,L,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,50.0,-2.0,,,,0.0,0.0,,0.0,,P16473,0.4292519945726941
2153,17079233,tshr_human,640,I,L,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,30.0,-3.333,,,,0.0,0.0,,0.0,,P16473,0.4292519945726941
2157,17079233,tshr_human,640,I,M,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,60.0,-1.667,,,,0.0,0.0,,0.0,,P16473,0.4737968245011973
2158,17079233,tshr_human,640,I,M,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,44.0,-2.273,,,,0.0,0.0,,0.0,,P16473,0.4737968245011973
2161,17079233,tshr_human,640,I,V,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,68.0,-1.471,,,,0.0,0.0,,0.0,,P16473,0.3858176177690046
2164,20179143,tshr_human,641,S,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,97.0,-1.031,,,,0.0,0.0,,0.0,,P16473,0.4979838081598215
2168,21586576,tshr_human,642,F,I,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,62.0,-1.613,,,,0.0,0.0,,0.0,,P16473,0.3705560396523393
2169,21586576,tshr_human,642,F,I,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,8.0,-12.5,,,,0.0,0.0,,0.0,,P16473,0.3705560396523393
2173,20652618,tshr_human,643,Y,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,90.0,-1.111,,,,0.0,0.0,,0.0,,P16473,0.5660432577320733
2174,20652618,tshr_human,643,Y,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,50.0,-2.0,,,,0.0,0.0,,0.0,,P16473,0.5660432577320733
2179,16488885,tshr_human,643,Y,F,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,85.0,-1.176,,,,0.0,0.0,,0.0,,P16473,0.3465226272580746
2180,20179143,tshr_human,643,Y,F,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,90.0,-1.111,,,,0.0,0.0,,0.0,,P16473,0.3465226272580746
2181,20179143,tshr_human,643,Y,F,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,130.0,1.3,,,,0.0,0.0,,0.0,,P16473,0.3465226272580746
2185,21586576,tshr_human,644,A,V,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,87.0,-1.149,,,,0.0,0.0,,0.0,,P16473,0.5252768992632676
2186,21586576,tshr_human,644,A,V,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,19.0,-5.263,,,,0.0,0.0,,0.0,,P16473,0.5252768992632676
2190,20179143,tshr_human,645,L,V,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,100.0,1.0,,,,0.0,0.0,,0.0,,P16473,0.3723193606960311
2191,20179143,tshr_human,645,L,V,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,70.0,-1.429,,,,0.0,0.0,,0.0,,P16473,0.3723193606960311
2194,21586576,tshr_human,648,I,V,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,93.0,-1.075,,,,0.0,0.0,,0.0,,P16473,0.3283870728560846
2203,8636266,tshr_human,650,N,Y,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,100.0,1.0,,,,0.0,0.0,,0.0,,P16473,0.4848086895246389
2204,8636266,tshr_human,650,N,Y,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,130.0,1.3,,,,0.0,0.0,,0.0,,P16473,0.4848086895246389
2205,8636266,tshr_human,650,N,Y,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,115.0,1.15,,,,0.0,0.0,,0.0,,P16473,0.4848086895246389
2209,16150909,tshr_human,651,K,E,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,128.0,1.28,,,,0.0,0.0,,0.0,,P16473,0.2859983184602446
2210,16150909,tshr_human,651,K,E,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,75.0,-1.333,,,,0.0,0.0,,0.0,,P16473,0.2859983184602446
2211,16150909,tshr_human,651,K,E,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,97.0,-1.031,,,,0.0,0.0,,0.0,,P16473,0.2859983184602446
2215,16150909,tshr_human,652,P,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,66.0,-1.515,,,,0.0,0.0,,0.0,,P16473,0.3267323478252907
2216,16150909,tshr_human,652,P,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,40.0,-2.5,,,,0.0,0.0,,0.0,,P16473,0.3267323478252907
2217,16150909,tshr_human,652,P,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,70.0,-1.429,,,,0.0,0.0,,0.0,,P16473,0.3267323478252907
2221,16150909,tshr_human,653,L,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,62.0,-1.613,,,,0.0,0.0,,0.0,,P16473,0.3183123209314645
2222,16150909,tshr_human,653,L,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,18.0,-5.556,,,,0.0,0.0,,0.0,,P16473,0.3183123209314645
2223,16150909,tshr_human,653,L,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,80.0,-1.25,,,,0.0,0.0,,0.0,,P16473,0.3183123209314645
2227,17456567,tshr_human,653,L,V,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,91.0,-1.099,,,,0.0,0.0,,0.0,,P16473,0.2456990649682942
2228,17456567,tshr_human,653,L,V,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,19.0,-5.263,,,,0.0,0.0,,0.0,,P16473,0.2456990649682942
2229,17456567,tshr_human,653,L,V,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,70.0,-1.429,,,,0.0,0.0,,0.0,,P16473,0.2456990649682942
2233,16150909,tshr_human,654,I,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,50.0,-2.0,,,,0.0,0.0,,0.0,,P16473,0.4213214058167392
2234,16150909,tshr_human,654,I,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,5.0,-20.0,,,,0.0,0.0,,0.0,,P16473,0.4213214058167392
2235,16150909,tshr_human,654,I,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,70.0,-1.429,,,,0.0,0.0,,0.0,,P16473,0.4213214058167392
2239,16150909,tshr_human,655,T,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,50.0,-2.0,,,,0.0,0.0,,0.0,,P16473,0.4132975543993727
2240,16150909,tshr_human,655,T,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,12.0,-8.333,,,,0.0,0.0,,0.0,,P16473,0.4132975543993727
2241,16150909,tshr_human,655,T,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,90.0,-1.111,,,,0.0,0.0,,0.0,,P16473,0.4132975543993727
2245,16150909,tshr_human,656,V,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,38.0,-2.632,,,,0.0,0.0,,0.0,,P16473,0.4152498282742272
2246,16150909,tshr_human,656,V,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,6.0,-16.667,,,,0.0,0.0,,0.0,,P16473,0.4152498282742272
2247,16150909,tshr_human,656,V,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,85.0,-1.176,,,,0.0,0.0,,0.0,,P16473,0.4152498282742272
2260,11012571,tshr_human,656,V,F,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,98.0,-1.02,,,,0.0,0.0,,0.0,,P16473,0.4595194891503806
2261,11012571,tshr_human,656,V,F,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,104.0,1.04,,,,0.0,0.0,,0.0,,P16473,0.4595194891503806
2262,15817920,tshr_human,656,V,F,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,77.0,-1.299,,,,0.0,0.0,,0.0,,P16473,0.4595194891503806
2263,15817920,tshr_human,656,V,F,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,49.0,-2.041,,,,0.0,0.0,,0.0,,P16473,0.4595194891503806
2264,15817920,tshr_human,656,V,F,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,89.0,-1.124,,,,0.0,0.0,,0.0,,P16473,0.4595194891503806
2265,18381815,tshr_human,656,V,F,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,96.0,-1.042,,,,0.0,0.0,,0.0,,P16473,0.4595194891503806
2266,18850313,tshr_human,656,V,F,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,74.0,-1.351,,,,0.0,0.0,,0.0,,P16473,0.4595194891503806
2267,9360556,tshr_human,656,V,F,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,110.0,1.1,,,,0.0,0.0,,0.0,,P16473,0.4595194891503806
2271,16150909,tshr_human,657,S,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,78.0,-1.282,,,,0.0,0.0,,0.0,,P16473,0.3286775429722756
2272,16150909,tshr_human,657,S,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,45.0,-2.222,,,,0.0,0.0,,0.0,,P16473,0.3286775429722756
2273,16150909,tshr_human,657,S,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,92.0,-1.087,,,,0.0,0.0,,0.0,,P16473,0.3286775429722756
2283,16150909,tshr_human,659,S,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,118.0,1.18,,,,0.0,0.0,,0.0,,P16473,0.4382771665932883
2284,16150909,tshr_human,659,S,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,95.0,-1.053,,,,0.0,0.0,,0.0,,P16473,0.4382771665932883
2285,16150909,tshr_human,659,S,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,108.0,1.08,,,,0.0,0.0,,0.0,,P16473,0.4382771665932883
2289,16150909,tshr_human,660,K,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,58.0,-1.724,,,,0.0,0.0,,0.0,,P16473,0.6817963689025349
2290,16150909,tshr_human,660,K,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,6.0,-16.667,,,,0.0,0.0,,0.0,,P16473,0.6817963689025349
2291,16150909,tshr_human,660,K,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,70.0,-1.429,,,,0.0,0.0,,0.0,,P16473,0.6817963689025349
2301,16150909,tshr_human,660,K,E,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,24.0,-4.167,,,,0.0,0.0,,0.0,,P16473,0.5991907922830304
2302,16150909,tshr_human,660,K,E,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,10.0,-10.0,,,,0.0,0.0,,0.0,,P16473,0.5991907922830304
2303,16150909,tshr_human,660,K,E,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,80.0,-1.25,,,,0.0,0.0,,0.0,,P16473,0.5991907922830304
2307,17079233,tshr_human,664,V,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,91.0,-1.099,,,,0.0,0.0,,0.0,,P16473,0.5203566445964874
2308,17079233,tshr_human,664,V,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,37.0,-2.703,,,,0.0,0.0,,0.0,,P16473,0.5203566445964874
2312,20652618,tshr_human,665,L,V,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,100.0,1.0,,,,0.0,0.0,,0.0,,P16473,0.4352605745315444
2313,20652618,tshr_human,665,L,V,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,70.0,-1.429,,,,0.0,0.0,,0.0,,P16473,0.4352605745315444
2316,20179143,tshr_human,667,Y,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,85.0,-1.176,,,,0.0,0.0,,0.0,,P16473,0.621799217220572
2328,11463854,tshr_human,670,N,S,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,45.0,-2.222,,,,0.0,0.0,,0.0,,P16473,0.762962117220174
2329,11463854,tshr_human,670,N,S,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,11.0,-9.091,,,,0.0,0.0,,0.0,,P16473,0.762962117220174
2330,11463854,tshr_human,670,N,S,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,118.0,1.18,,,,0.0,0.0,,0.0,,P16473,0.762962117220174
2331,8636266,tshr_human,670,N,S,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,100.0,1.0,,,,0.0,0.0,,0.0,,P16473,0.762962117220174
2332,8636266,tshr_human,670,N,S,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,100.0,1.0,,,,0.0,0.0,,0.0,,P16473,0.762962117220174
2355,11463854,tshr_human,674,N,D,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,75.0,-1.333,,,,0.0,0.0,,0.0,,P16473,0.7963703697683397
2356,11463854,tshr_human,674,N,D,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,36.0,-2.778,,,,0.0,0.0,,0.0,,P16473,0.7963703697683397
2357,11463854,tshr_human,674,N,D,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,77.0,-1.299,,,,0.0,0.0,,0.0,,P16473,0.7963703697683397
2358,15722344,tshr_human,674,N,D,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,169.0,1.69,,,,0.0,0.0,,0.0,,P16473,0.7963703697683397
2362,11463854,tshr_human,674,N,S,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,64.0,-1.562,,,,0.0,0.0,,0.0,,P16473,0.7963703697683397
2363,11463854,tshr_human,674,N,S,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,18.0,-5.556,,,,0.0,0.0,,0.0,,P16473,0.7963703697683397
2364,11463854,tshr_human,674,N,S,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Specific-binding,binding,100.0,%,,,77.0,-1.299,,,,0.0,0.0,,0.0,,P16473,0.7963703697683397
2369,20305779,tshr_human,687,R,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,80.0,-1.25,,,,0.0,0.0,,0.0,,P16473,0.4163061265315281
2370,20305779,tshr_human,687,R,A,bovine thyrotropin,UniProt Entry Code (peptide),"P01217, P01223",Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,33.0,-3.03,,,,0.0,0.0,,0.0,,P16473,0.4163061265315281
1,12963710,fshr_human,29,V,A,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,102.0,1.02,,,,0.0,0.0,,0.0,,P23945,0.2851040730511835
4,12963710,fshr_human,26,S,A,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,98.0,-1.02,,,,0.0,0.0,,0.0,,P23945,0.2132084104535077
8,12963710,fshr_human,28,R,A,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,96.0,-1.042,,,,0.0,0.0,,0.0,,P23945,0.3392127057035711
9,12963710,fshr_human,30,F,A,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,121.0,1.21,,,,0.0,0.0,,0.0,,P23945,0.5079811427546217
11,12963710,fshr_human,31,L,A,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,83.0,-1.205,,,,0.0,0.0,,0.0,,P23945,0.3440595354907967
16,12963710,fshr_human,33,Q,A,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,97.0,-1.031,,,,0.0,0.0,,0.0,,P23945,0.3851888481291358
18,12963710,fshr_human,34,E,A,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,95.0,-1.053,,,,0.0,0.0,,0.0,,P23945,0.3978715155163214
20,12963710,fshr_human,35,S,A,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,101.0,1.01,,,,0.0,0.0,,0.0,,P23945,0.3064011553459517
22,12963710,fshr_human,36,K,A,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,88.0,-1.136,,,,0.0,0.0,,0.0,,P23945,0.296436423894346
24,12963710,fshr_human,37,V,A,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,101.0,1.01,,,,0.0,0.0,,0.0,,P23945,0.4162109958561348
26,12963710,fshr_human,38,T,A,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,94.0,-1.064,,,,0.0,0.0,,0.0,,P23945,0.255499411530928
28,12963710,fshr_human,39,E,A,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,116.0,1.16,,,,0.0,0.0,,0.0,,P23945,0.2823420369726243
30,12963710,fshr_human,40,I,A,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,36.0,-2.778,,,,0.0,0.0,,0.0,,P23945,0.552834383562502
35,12963710,fshr_human,42,S,A,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,77.0,-1.299,,,,0.0,0.0,,0.0,,P23945,0.2060411033672207
44,12963710,fshr_human,45,P,A,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,108.0,1.08,,,,0.0,0.0,,0.0,,P23945,0.5368380889296478
46,12963710,fshr_human,46,R,A,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,105.0,1.05,,,,0.0,0.0,,0.0,,P23945,0.2719823284775215
50,12963710,fshr_human,48,A,G,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,116.0,1.16,,,,0.0,0.0,,0.0,,P23945,0.4816669426401289
52,12963710,fshr_human,49,I,A,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,102.0,1.02,,,,0.0,0.0,,0.0,,P23945,0.3163312699428845
54,12963710,fshr_human,50,E,A,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,109.0,1.09,,,,0.0,0.0,,0.0,,P23945,0.3687323124107399
60,20736161,fshr_human,74,K,A,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,84.0,-1.19,,,,0.0,0.0,,0.0,,P23945,0.3026939777404303
61,20736161,fshr_human,74,K,A,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Specific-binding,binding,100.0,%,,,87.0,-1.149,,,,0.0,0.0,,0.0,,P23945,0.3026939777404303
62,20736161,fshr_human,74,K,E,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,210.0,2.1,,,,0.0,0.0,,0.0,,P23945,0.2324307935115129
63,20736161,fshr_human,74,K,E,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Specific-binding,binding,100.0,%,,,102.0,1.02,,,,0.0,0.0,,0.0,,P23945,0.2324307935115129
67,10880516,fshr_human,77,I,A,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,6.0,-16.667,,,,0.0,0.0,,0.0,,P23945,0.5411260388319046
68,20736161,fshr_human,78,S,A,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,89.0,-1.124,,,,0.0,0.0,,0.0,,P23945,0.3359567135638577
69,20736161,fshr_human,78,S,A,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Specific-binding,binding,100.0,%,,,66.0,-1.515,,,,0.0,0.0,,0.0,,P23945,0.3359567135638577
78,20736161,fshr_human,124,Y,A,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,72.0,-1.389,,,,0.0,0.0,,0.0,,P23945,0.3166711468556011
79,20736161,fshr_human,124,Y,A,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Specific-binding,binding,100.0,%,,,52.0,-1.923,,,,0.0,0.0,,0.0,,P23945,0.3166711468556011
103,20736161,fshr_human,130,T,A,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,258.0,2.58,,,,0.0,0.0,,0.0,,P23945,0.61819511890824
104,20736161,fshr_human,130,T,A,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Specific-binding,binding,100.0,%,,,310.0,3.1,,,,0.0,0.0,,0.0,,P23945,0.61819511890824
110,20736161,fshr_human,150,D,A,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,115.0,1.15,,,,0.0,0.0,,0.0,,P23945,0.4902656648804929
111,20736161,fshr_human,150,D,A,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Specific-binding,binding,100.0,%,,,60.0,-1.667,,,,0.0,0.0,,0.0,,P23945,0.4902656648804929
115,20736161,fshr_human,150,D,N,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,231.0,2.31,,,,0.0,0.0,,0.0,,P23945,0.3591599467794365
116,20736161,fshr_human,150,D,N,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Specific-binding,binding,100.0,%,,,249.0,2.49,,,,0.0,0.0,,0.0,,P23945,0.3591599467794365
118,10880516,fshr_human,151,I,A,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,33.0,-3.03,,,,0.0,0.0,,0.0,,P23945,0.5024952220472978
119,20736161,fshr_human,153,D,A,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,106.0,1.06,,,,0.0,0.0,,0.0,,P23945,0.4102896014839487
120,20736161,fshr_human,153,D,A,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Specific-binding,binding,100.0,%,,,49.0,-2.041,,,,0.0,0.0,,0.0,,P23945,0.4102896014839487
127,9769327,fshr_human,160,I,T,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Specific-binding,binding,100.0,%,,,10.0,-10.0,,,,0.0,0.0,,0.0,,P23945,0.5513577137696879
131,10880516,fshr_human,177,L,A,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,13.0,-7.692,,,,0.0,0.0,,0.0,,P23945,0.5692622184311398
140,27889471,fshr_human,197,E,S,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,68.0,-1.471,,,,0.0,0.0,,0.0,,P23945,0.3205076049335962
141,27889471,fshr_human,197,E,S,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Specific-binding,binding,100.0,%,,,31.0,-3.226,,,,0.0,0.0,,0.0,,P23945,0.3205076049335962
147,27889471,fshr_human,221,V,G,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,63.0,-1.587,,,,0.0,0.0,,0.0,,P23945,0.4957500591103982
148,27889471,fshr_human,221,V,G,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Specific-binding,binding,100.0,%,,,34.0,-2.941,,,,0.0,0.0,,0.0,,P23945,0.4957500591103982
153,27889471,fshr_human,222,I,T,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,69.0,-1.449,,,,0.0,0.0,,0.0,,P23945,0.2827982396332937
154,27889471,fshr_human,222,I,T,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Specific-binding,binding,100.0,%,,,53.0,-1.887,,,,0.0,0.0,,0.0,,P23945,0.2827982396332937
157,20736161,fshr_human,224,D,A,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,41.0,-2.439,,,,0.0,0.0,,0.0,,P23945,0.5436965341356139
158,20736161,fshr_human,224,D,A,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Specific-binding,binding,100.0,%,,,39.0,-2.564,,,,0.0,0.0,,0.0,,P23945,0.5436965341356139
164,20736161,fshr_human,226,S,A,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Specific-binding,binding,100.0,%,,,5.0,-20.0,,,,0.0,0.0,,0.0,,P23945,0.4065666365408422
166,27889471,fshr_human,243,K,R,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,100.0,1.0,,,,0.0,0.0,,0.0,,P23945,0.2063913804978522
167,27889471,fshr_human,243,K,R,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Specific-binding,binding,100.0,%,,,171.0,1.71,,,,0.0,0.0,,0.0,,P23945,0.2063913804978522
170,16901970,fshr_human,330,Y,F,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,82.0,-1.22,,,,0.0,0.0,,0.0,,P23945,0.1951724537448416
172,16901970,fshr_human,333,F,Y,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,93.0,-1.075,,,,0.0,0.0,,0.0,,P23945,0.1732734809255945
174,16901970,fshr_human,335,Y,F,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,78.0,-1.282,,,,0.0,0.0,,0.0,,P23945,0.1888673212236163
179,26911863,fshr_human,408,D,Y,follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,51.0,-1.961,,,,0.0,0.0,,0.0,,P23945,0.8699069148491528
197,7608154,fshr_human,423,I,A,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,100.0,1.0,,,,0.0,0.0,,0.0,,P23945,0.4657854967673208
199,7608154,fshr_human,424,H,A,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,100.0,1.0,,,,0.0,0.0,,0.0,,P23945,0.330165639044058
201,7608154,fshr_human,425,T,A,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,49.0,-2.041,,,,0.0,0.0,,0.0,,P23945,0.4301790870072647
205,22954680,fshr_human,431,N,I,recombinant follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,147.0,1.47,,,,0.0,0.0,,0.0,,P23945,0.5214940095808848
206,22954680,fshr_human,431,N,I,recombinant follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Specific-binding,binding,100.0,%,,,37.0,-2.703,,,,0.0,0.0,,0.0,,P23945,0.5214940095808848
211,15166252,fshr_human,449,T,A,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,150.0,1.5,,,,0.0,0.0,,0.0,,P23945,0.5094830103564506
214,15166252,fshr_human,449,T,D,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,120.0,1.2,,,,0.0,0.0,,0.0,,P23945,0.5542550103460313
217,15166252,fshr_human,449,T,F,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,139.0,1.39,,,,0.0,0.0,,0.0,,P23945,0.5981522577132374
220,15166252,fshr_human,449,T,G,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,140.0,1.4,,,,0.0,0.0,,0.0,,P23945,0.5981522577132374
225,12930927,fshr_human,449,T,I,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,87.0,-1.149,,,,0.0,0.0,,0.0,,P23945,0.5542550103460313
226,12930927,fshr_human,449,T,I,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Specific-binding,binding,100.0,%,,,70.0,-1.429,,,,0.0,0.0,,0.0,,P23945,0.5542550103460313
227,15166252,fshr_human,449,T,I,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,152.0,1.52,,,,0.0,0.0,,0.0,,P23945,0.5542550103460313
231,15166252,fshr_human,449,T,N,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,95.0,-1.053,,,,0.0,0.0,,0.0,,P23945,0.5094830103564506
232,27889471,fshr_human,449,T,N,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,101.0,1.01,,,,0.0,0.0,,0.0,,P23945,0.5094830103564506
233,27889471,fshr_human,449,T,N,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Specific-binding,binding,100.0,%,,,148.0,1.48,,,,0.0,0.0,,0.0,,P23945,0.5094830103564506
242,15166252,fshr_human,449,T,Y,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,117.0,1.17,,,,0.0,0.0,,0.0,,P23945,0.5981522577132374
244,10935550,fshr_human,460,L,A,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,50.0,-2.0,,,,0.0,0.0,,0.0,,P23945,0.6501993891028035
248,10935550,fshr_human,460,L,K,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,25.0,-4.0,,,,0.0,0.0,,0.0,,P23945,0.6899264796804345
250,10935550,fshr_human,460,L,R,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,25.0,-4.0,,,,0.0,0.0,,0.0,,P23945,0.6899264796804345
252,12039074,fshr_human,467,R,A,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,9.0,-11.111,,,,0.0,0.0,,0.0,,P23945,0.8489595492349166
253,12039074,fshr_human,467,R,A,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Specific-binding,binding,100.0,%,,,99.0,-1.01,,,,0.0,0.0,,0.0,,P23945,0.8489595492349166
258,12039074,fshr_human,467,R,K,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,117.0,1.17,,,,0.0,0.0,,0.0,,P23945,0.7660551474846098
259,12039074,fshr_human,467,R,K,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Specific-binding,binding,100.0,%,,,86.0,-1.163,,,,0.0,0.0,,0.0,,P23945,0.7660551474846098
261,12039074,fshr_human,470,T,A,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,10.0,-10.0,,,,0.0,0.0,,0.0,,P23945,0.4866364632717134
262,12039074,fshr_human,470,T,A,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Specific-binding,binding,100.0,%,,,99.0,-1.01,,,,0.0,0.0,,0.0,,P23945,0.4866364632717134
264,12039074,fshr_human,477,L,A,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,107.0,1.07,,,,0.0,0.0,,0.0,,P23945,0.5198358463850596
265,12039074,fshr_human,477,L,A,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Specific-binding,binding,100.0,%,,,99.0,-1.01,,,,0.0,0.0,,0.0,,P23945,0.5198358463850596
270,12039074,fshr_human,477,L,K,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,16.0,-6.25,,,,0.0,0.0,,0.0,,P23945,0.5644888118071039
271,12039074,fshr_human,477,L,K,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Specific-binding,binding,100.0,%,,,48.0,-2.083,,,,0.0,0.0,,0.0,,P23945,0.5644888118071039
273,12039074,fshr_human,477,L,P,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,34.0,-2.941,,,,0.0,0.0,,0.0,,P23945,0.6081140324203173
274,12039074,fshr_human,477,L,P,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Specific-binding,binding,100.0,%,,,89.0,-1.124,,,,0.0,0.0,,0.0,,P23945,0.6081140324203173
276,12039074,fshr_human,477,L,R,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,48.0,-2.083,,,,0.0,0.0,,0.0,,P23945,0.5644888118071039
277,12039074,fshr_human,477,L,R,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Specific-binding,binding,100.0,%,,,73.0,-1.37,,,,0.0,0.0,,0.0,,P23945,0.5644888118071039
279,25791375,fshr_human,505,I,V,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,79.0,-1.266,,,,0.0,0.0,,0.0,,P23945,0.2854162865621455
280,25791375,fshr_human,505,I,V,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Specific-binding,binding,100.0,%,,,135.0,1.35,,,,0.0,0.0,,0.0,,P23945,0.2854162865621455
282,25581598,fshr_human,514,V,A,follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,86.0,-1.163,,,,0.0,0.0,,0.0,,P23945,0.4784873142174125
283,25581598,fshr_human,514,V,A,follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Specific-binding,binding,100.0,%,,,100.0,1.0,,,,0.0,0.0,,0.0,,P23945,0.4784873142174125
290,16278261,fshr_human,545,I,A,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,80.0,-1.25,,,,0.0,0.0,,0.0,,P23945,0.5864707248178556
293,16278261,fshr_human,545,I,F,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,100.0,1.0,,,,0.0,0.0,,0.0,,P23945,0.5422792564882828
297,16278261,fshr_human,545,I,L,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,40.0,-2.5,,,,0.0,0.0,,0.0,,P23945,0.4525518471535477
300,16278261,fshr_human,545,I,N,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,100.0,1.0,,,,0.0,0.0,,0.0,,P23945,0.6701710818162001
303,16278261,fshr_human,545,I,T,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,100.0,1.0,,,,0.0,0.0,,0.0,,P23945,0.5864707248178556
306,16278261,fshr_human,545,I,V,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,100.0,1.0,,,,0.0,0.0,,0.0,,P23945,0.408453776505026
311,15166252,fshr_human,567,D,A,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,63.0,-1.587,,,,0.0,0.0,,0.0,,P23945,0.6672626039413369
316,15166252,fshr_human,567,D,G,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,69.0,-1.449,,,,0.0,0.0,,0.0,,P23945,0.626195332481761
317,9973249,fshr_human,567,D,G,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,50.0,-2.0,,,,0.0,0.0,,0.0,,P23945,0.626195332481761
318,9973249,fshr_human,567,D,G,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Specific-binding,binding,100.0,%,,,40.0,-2.5,,,,0.0,0.0,,0.0,,P23945,0.626195332481761
321,15166252,fshr_human,567,D,H,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,70.0,-1.429,,,,0.0,0.0,,0.0,,P23945,0.626195332481761
329,15166252,fshr_human,567,D,N,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,110.0,1.1,,,,0.0,0.0,,0.0,,P23945,0.538922281223245
335,15166252,fshr_human,567,D,R,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,50.0,-2.0,,,,0.0,0.0,,0.0,,P23945,0.6672626039413369
338,15166252,fshr_human,567,D,T,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,47.0,-2.128,,,,0.0,0.0,,0.0,,P23945,0.626195332481761
341,15166252,fshr_human,567,D,V,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,25.0,-4.0,,,,0.0,0.0,,0.0,,P23945,0.7059265070343803
347,15166252,fshr_human,567,D,Y,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,30.0,-3.333,,,,0.0,0.0,,0.0,,P23945,0.7059265070343803
349,9769327,fshr_human,573,R,C,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,30.0,-3.333,,,,0.0,0.0,,0.0,,P23945,0.7206533482905685
350,9769327,fshr_human,573,R,C,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Specific-binding,binding,100.0,%,,,82.0,-1.22,,,,0.0,0.0,,0.0,,P23945,0.7206533482905685
354,25581598,fshr_human,575,A,V,follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,31.0,-3.226,,,,0.0,0.0,,0.0,,P23945,0.4964206307785809
355,25581598,fshr_human,575,A,V,follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Specific-binding,binding,100.0,%,,,100.0,1.0,,,,0.0,0.0,,0.0,,P23945,0.4964206307785809
360,12145341,fshr_human,581,D,G,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Specific-binding,binding,100.0,%,,,81.0,-1.235,,,,0.0,0.0,,0.0,,P23945,0.7398685363378092
365,9100567,fshr_human,591,F,S,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Specific-binding,binding,100.0,%,,,35.0,-2.857,,,,0.0,0.0,,0.0,,P23945,0.5500534001414831
367,9786899,fshr_human,598,K,A,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,13.0,-7.692,,,,0.0,0.0,,0.0,,P23945,0.3943092666689411
369,9786899,fshr_human,599,V,A,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,58.0,-1.724,,,,0.0,0.0,,0.0,,P23945,0.309018395545912
372,12374801,fshr_human,600,P,A,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,17.0,-5.882,,,,0.0,0.0,,0.0,,P23945,0.3192775666264695
373,9786899,fshr_human,600,P,A,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,16.0,-6.25,,,,0.0,0.0,,0.0,,P23945,0.3192775666264695
375,12374801,fshr_human,600,P,C,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,12.0,-8.333,,,,0.0,0.0,,0.0,,P23945,0.4020315477761958
377,12374801,fshr_human,600,P,D,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,71.0,-1.408,,,,0.0,0.0,,0.0,,P23945,0.3192775666264695
389,12374801,fshr_human,600,P,S,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,64.0,-1.562,,,,0.0,0.0,,0.0,,P23945,0.3192775666264695
391,12374801,fshr_human,600,P,Y,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,34.0,-2.941,,,,0.0,0.0,,0.0,,P23945,0.4020315477761958
405,12374801,fshr_human,601,L,F,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,75.0,-1.333,,,,0.0,0.0,,0.0,,P23945,0.2863849081756807
415,10551778,fshr_human,601,L,V,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,12.0,-8.333,,,,0.0,0.0,,0.0,,P23945,0.2510396810551577
417,12374801,fshr_human,601,L,Y,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,141.0,1.41,,,,0.0,0.0,,0.0,,P23945,0.3245504249828266
418,12374801,fshr_human,601,L,Y,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Single-point,Functional - IP accumulation,100.0,%,,,27.0,-3.704,,,,0.0,0.0,,0.0,,P23945,0.3245504249828266
440,9786899,fshr_human,603,T,A,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,39.0,-2.564,,,,0.0,0.0,,0.0,,P23945,0.4157073011686124
442,9786899,fshr_human,604,V,A,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,22.0,-4.545,,,,0.0,0.0,,0.0,,P23945,0.432701856916608
444,9786899,fshr_human,605,S,A,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,85.0,-1.176,,,,0.0,0.0,,0.0,,P23945,0.3560363992184454
446,9786899,fshr_human,606,K,A,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,54.0,-1.852,,,,0.0,0.0,,0.0,,P23945,0.4058491562413581
448,9786899,fshr_human,607,A,G,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,37.0,-2.703,,,,0.0,0.0,,0.0,,P23945,0.4703628914417315
475,15166252,fshr_human,615,H,A,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,135.0,1.35,,,,0.0,0.0,,0.0,,P23945,0.5860619557752786
478,15166252,fshr_human,615,H,F,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,117.0,1.17,,,,0.0,0.0,,0.0,,P23945,0.5418602798894784
481,15166252,fshr_human,615,H,Y,human follitropin,IUPHAR/BPS Guide to pharmacology,1157,Full agonist,Single-point,Functional - cAMP accumulation,100.0,%,,,142.0,1.42,,,,0.0,0.0,,0.0,,P23945,0.4080367188988582
4,10821780,5ht4r_human,66,D,N,5-HT,PubChem CID,5202,Full agonist,Single-point,Functional - cAMP accumulation,34.1,%,=,,35.3,1.035,Unchanged,,,0.0,0.0,,0.0,,Q13639,0.7639625541042763
54,10821780,5ht4r_human,66,D,N,ML10375,ChEMBL Compound ID,CHEMBL155917,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.56,nM,=,,14.7,-26.316,,,[3H]GR 113808,0.0,0.0,,0.0,,Q13639,0.7639625541042763
62,10821780,5ht4r_human,66,D,N,ML10302,ChEMBL Compound ID,CHEMBL286136,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,8.5,nM,=,,57.5,-6.757,,,[3H]GR 113808,0.0,0.0,,0.0,,Q13639,0.7639625541042763
70,10821780,5ht4r_human,66,D,N,[3H]GR 113808,ChEMBL Compound ID,CHEMBL33884,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,0.23,nM,=,,0.42,-1.825,,,,0.0,0.0,,0.0,,Q13639,0.7639625541042763
83,10821780,5ht4r_human,66,D,N,5-HT,ChEMBL Compound ID,CHEMBL39,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,772.0,nM,=,,672.0,1.149,,,[3H]GR 113808,0.0,0.0,,0.0,,Q13639,0.7639625541042763
5,10821780,5ht4r_human,100,D,N,5-HT,PubChem CID,5202,Full agonist,Single-point,Functional - cAMP accumulation,34.1,%,=,,1.1,-31.25,Abolished,,,0.0,0.0,,0.0,,Q13639,0.4577492106002547
56,10821780,5ht4r_human,100,D,N,ML10375,ChEMBL Compound ID,CHEMBL155917,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.56,nM,=,,35.2,-62.5,,,[3H]GR 113808,0.0,0.0,,0.0,,Q13639,0.4577492106002547
63,10821780,5ht4r_human,100,D,N,ML10302,ChEMBL Compound ID,CHEMBL286136,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,8.5,nM,=,,29.6,-3.484,,,[3H]GR 113808,0.0,0.0,,0.0,,Q13639,0.4577492106002547
69,10821780,5ht4r_human,100,D,N,[3H]GR 113808,ChEMBL Compound ID,CHEMBL33884,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,0.23,nM,=,,0.32,-1.391,,,,0.0,0.0,,0.0,,Q13639,0.4577492106002547
84,10821780,5ht4r_human,100,D,N,5-HT,ChEMBL Compound ID,CHEMBL39,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,772.0,nM,>,,100000.0,-125.0,,,[3H]GR 113808,0.0,0.0,,0.0,,Q13639,0.4577492106002547
6,10821780,5ht4r_human,149,P,A,5-HT,PubChem CID,5202,Full agonist,Single-point,Functional - cAMP accumulation,34.1,%,=,,56.01,1.643,Unchanged,,,0.0,0.0,,0.0,,Q13639,0.5258480223544246
7,10821780,5ht4r_human,150,T,V,5-HT,PubChem CID,5202,Full agonist,Single-point,Functional - cAMP accumulation,34.1,%,=,,38.8,1.138,Unchanged,,,0.0,0.0,,0.0,,Q13639,0.3359230715906182
57,10821780,5ht4r_human,150,T,V,ML10375,ChEMBL Compound ID,CHEMBL155917,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.56,nM,=,,1.4,-2.5,,,[3H]GR 113808,0.0,0.0,,0.0,,Q13639,0.3359230715906182
64,10821780,5ht4r_human,150,T,V,ML10302,ChEMBL Compound ID,CHEMBL286136,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,8.5,nM,=,,6.1,1.393,,,[3H]GR 113808,0.0,0.0,,0.0,,Q13639,0.3359230715906182
72,10821780,5ht4r_human,150,T,V,[3H]GR 113808,ChEMBL Compound ID,CHEMBL33884,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,0.23,nM,=,,0.5,-2.174,,,,0.0,0.0,,0.0,,Q13639,0.3359230715906182
85,10821780,5ht4r_human,150,T,V,5-HT,ChEMBL Compound ID,CHEMBL39,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,772.0,nM,=,,235.0,3.285,,,[3H]GR 113808,0.0,0.0,,0.0,,Q13639,0.3359230715906182
8,10821780,5ht4r_human,153,S,A,5-HT,PubChem CID,5202,Full agonist,Single-point,Functional - cAMP accumulation,34.1,%,=,,50.5,1.481,Unchanged,,,0.0,0.0,,0.0,,Q13639,0.4606475011858066
58,10821780,5ht4r_human,153,S,A,ML10375,ChEMBL Compound ID,CHEMBL155917,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.56,nM,=,,0.84,-1.499,,,[3H]GR 113808,0.0,0.0,,0.0,,Q13639,0.4606475011858066
65,10821780,5ht4r_human,153,S,A,ML10302,ChEMBL Compound ID,CHEMBL286136,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,8.5,nM,=,,3.1,2.742,,,[3H]GR 113808,0.0,0.0,,0.0,,Q13639,0.4606475011858066
73,10821780,5ht4r_human,153,S,A,[3H]GR 113808,ChEMBL Compound ID,CHEMBL33884,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,0.23,nM,=,,0.34,-1.479,,,,0.0,0.0,,0.0,,Q13639,0.4606475011858066
86,10821780,5ht4r_human,153,S,A,5-HT,ChEMBL Compound ID,CHEMBL39,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,772.0,nM,=,,1043.0,-1.351,,,[3H]GR 113808,0.0,0.0,,0.0,,Q13639,0.4606475011858066
9,10821780,5ht4r_human,196,C,A,5-HT,PubChem CID,5202,Full agonist,Single-point,Functional - cAMP accumulation,34.1,%,=,,36.4,1.067,Unchanged,,,0.0,0.0,,0.0,,Q13639,0.4013970292025207
59,10821780,5ht4r_human,196,C,A,ML10375,ChEMBL Compound ID,CHEMBL155917,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.56,nM,=,,1.6,-2.857,,,[3H]GR 113808,0.0,0.0,,0.0,,Q13639,0.4013970292025207
66,10821780,5ht4r_human,196,C,A,ML10302,ChEMBL Compound ID,CHEMBL286136,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,8.5,nM,=,,1.8,4.722,,,[3H]GR 113808,0.0,0.0,,0.0,,Q13639,0.4013970292025207
74,10821780,5ht4r_human,196,C,A,[3H]GR 113808,ChEMBL Compound ID,CHEMBL33884,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,0.23,nM,=,,0.07,3.286,,,,0.0,0.0,,0.0,,Q13639,0.4013970292025207
87,10821780,5ht4r_human,196,C,A,5-HT,ChEMBL Compound ID,CHEMBL39,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,772.0,nM,=,,378.0,2.042,,,[3H]GR 113808,0.0,0.0,,0.0,,Q13639,0.4013970292025207
10,10821780,5ht4r_human,197,S,A,5-HT,PubChem CID,5202,Full agonist,Single-point,Functional - cAMP accumulation,34.1,%,=,,5.2,-6.579,Abolished,,,0.0,0.0,,0.0,,Q13639,0.4010860354386213
11,10821780,5ht4r_human,275,F,A,5-HT,PubChem CID,5202,Full agonist,Single-point,Functional - cAMP accumulation,34.1,%,=,,45.1,1.323,Unchanged,,,0.0,0.0,,0.0,,Q13639,0.5810454455774672
12,10821780,5ht4r_human,276,F,V,5-HT,PubChem CID,5202,Full agonist,Single-point,Functional - cAMP accumulation,34.1,%,=,,25.6,-1.332,Unchanged,,,0.0,0.0,,0.0,,Q13639,0.5542601271975026
60,10821780,5ht4r_human,276,F,V,ML10375,ChEMBL Compound ID,CHEMBL155917,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.56,nM,=,,1.6,-2.857,,,[3H]GR 113808,0.0,0.0,,0.0,,Q13639,0.5542601271975026
67,10821780,5ht4r_human,276,F,V,ML10302,ChEMBL Compound ID,CHEMBL286136,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,8.5,nM,=,,6.8,1.25,,,[3H]GR 113808,0.0,0.0,,0.0,,Q13639,0.5542601271975026
75,10821780,5ht4r_human,276,F,V,[3H]GR 113808,ChEMBL Compound ID,CHEMBL33884,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,0.23,nM,=,,0.45,-1.957,,,,0.0,0.0,,0.0,,Q13639,0.5542601271975026
88,10821780,5ht4r_human,276,F,V,5-HT,ChEMBL Compound ID,CHEMBL39,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,772.0,nM,=,,695.0,1.111,,,[3H]GR 113808,0.0,0.0,,0.0,,Q13639,0.5542601271975026
13,10821780,5ht4r_human,279,N,L,5-HT,PubChem CID,5202,Full agonist,Single-point,Functional - cAMP accumulation,34.1,%,=,,41.2,1.208,Unchanged,,,0.0,0.0,,0.0,,Q13639,0.5929045554637453
68,10821780,5ht4r_human,279,N,L,ML10302,ChEMBL Compound ID,CHEMBL286136,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,8.5,nM,=,,3.7,2.297,,,[3H]GR 113808,0.0,0.0,,0.0,,Q13639,0.5929045554637453
76,10821780,5ht4r_human,279,N,L,[3H]GR 113808,ChEMBL Compound ID,CHEMBL33884,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,0.23,nM,=,,1.2,-5.208,,,,0.0,0.0,,0.0,,Q13639,0.5929045554637453
89,10821780,5ht4r_human,279,N,L,5-HT,ChEMBL Compound ID,CHEMBL39,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,772.0,nM,>,,100000.0,-125.0,,,[3H]GR 113808,0.0,0.0,,0.0,,Q13639,0.5929045554637453
14,10821780,5ht4r_human,302,Y,A,5-HT,PubChem CID,5202,Full agonist,Single-point,Functional - cAMP accumulation,34.1,%,=,,0.7,-47.619,Abolished,,,0.0,0.0,,0.0,,Q13639,0.5870592174223015
55,15351779,5ht4r_human,96,R,L,ML10375,ChEMBL Compound ID,CHEMBL155917,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.57,nM,=,,0.85,-1.49,,,[3H]GR 113808,0.0,0.0,,0.0,,Q13639,0.4973516233575286
71,15351779,5ht4r_human,96,R,L,[3H]GR 113808,ChEMBL Compound ID,CHEMBL33884,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,0.23,nM,=,,0.55,-2.392,,,,0.0,0.0,,0.0,,Q13639,0.4973516233575286
79,15351779,5ht4r_human,96,R,L,GR 113808,ChEMBL Compound ID,CHEMBL33884,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.23,nM,=,,0.55,-2.392,,,[3H]GR 113808,0.0,0.0,,0.0,,Q13639,0.4973516233575286
90,15351779,5ht4r_human,96,R,L,5-HT,ChEMBL Compound ID,CHEMBL39,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,653.0,nM,=,,402.0,1.624,,,[3H]GR 113808,0.0,0.0,,0.0,,Q13639,0.4973516233575286
92,15351779,5ht4r_human,96,R,L,RS39604,ChEMBL Compound ID,CHEMBL66114,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,2.15,nM,=,,55.8,-25.641,,,[3H]GR 113808,0.0,0.0,,0.0,,Q13639,0.4973516233575286
95,15351779,5ht4r_human,96,R,L,RS100235,ChEMBL Compound ID,CHEMBL69733,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,2.11,nM,=,,3.84,-1.821,,,[3H]GR 113808,0.0,0.0,,0.0,,Q13639,0.4973516233575286
98,15351779,5ht4r_human,96,R,L,ML11411,SMILES,COc1cc(N)c(Cl)cc1C(=O)OCCC1CCC(CCCCNS(=O)(=O)c2cccc3c(cccc23)N(C)C)CC1,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,53.5,nM,=,,1.16,46.121,,,[3H]GR 113808,0.0,0.0,,0.0,,Q13639,0.4973516233575286
78,15351779,5ht4r_human,302,Y,F,[3H]GR 113808,ChEMBL Compound ID,CHEMBL33884,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,0.23,nM,=,,3.06,-13.333,,,,0.0,0.0,,0.0,,Q13639,0.3662719181610827
82,15351779,5ht4r_human,302,Y,F,GR 113808,ChEMBL Compound ID,CHEMBL33884,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,0.23,nM,=,,3.06,-13.333,,,[3H]GR 113808,0.0,0.0,,0.0,,Q13639,0.3662719181610827
94,15351779,5ht4r_human,302,Y,F,RS39604,ChEMBL Compound ID,CHEMBL66114,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,2.15,nM,=,,15.0,-6.993,,,[3H]GR 113808,0.0,0.0,,0.0,,Q13639,0.3662719181610827
97,15351779,5ht4r_human,302,Y,F,RS100235,ChEMBL Compound ID,CHEMBL69733,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,2.11,nM,=,,1.1,1.918,,,[3H]GR 113808,0.0,0.0,,0.0,,Q13639,0.3662719181610827
100,15351779,5ht4r_human,302,Y,F,ML11411,SMILES,COc1cc(N)c(Cl)cc1C(=O)OCCC1CCC(CCCCNS(=O)(=O)c2cccc3c(cccc23)N(C)C)CC1,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,53.5,nM,=,,79.7,-1.49,,,[3H]GR 113808,0.0,0.0,,0.0,,Q13639,0.3662719181610827
75,10.1038/nature19319,ednrb_human,161,K,A,Endothelin-1,PubChem CID,16133807,Full agonist,IC50,Binding - Radioligand competition/displacement,0.3,nM,=,,1.0,-3.333,,,125I-Endothelin-1,0.0,0.0,,0.0,,P24530,0.4373681115249868
91,10.1038/nature19319,ednrb_human,161,K,A,Endothelin-3,pubChem CID,16219334,Full agonist,IC50,Binding - Radioligand competition/displacement,0.3,nM,=,,51.3,-166.667,,,125I-Endothelin-1,0.0,0.0,,0.0,,P24530,0.4373681115249868
76,10.1038/nature19319,ednrb_human,181,Q,A,Endothelin-1,PubChem CID,16133807,Full agonist,IC50,Binding - Radioligand competition/displacement,0.3,nM,=,,0.6,-2.0,,,125I-Endothelin-1,0.0,0.0,,0.0,,P24530,0.5632538253620336
92,10.1038/nature19319,ednrb_human,181,Q,A,Endothelin-3,pubChem CID,16219334,Full agonist,IC50,Binding - Radioligand competition/displacement,0.3,nM,=,,2.7,-9.009,,,125I-Endothelin-1,0.0,0.0,,0.0,,P24530,0.5632538253620336
77,10.1038/nature19319,ednrb_human,182,K,A,Endothelin-1,PubChem CID,16133807,Full agonist,IC50,Binding - Radioligand competition/displacement,0.3,nM,=,,2.1,-6.993,,,125I-Endothelin-1,0.0,0.0,,0.0,,P24530,0.557842168991766
93,10.1038/nature19319,ednrb_human,182,K,A,Endothelin-3,pubChem CID,16219334,Full agonist,IC50,Binding - Radioligand competition/displacement,0.3,nM,=,,114.0,-333.333,,,125I-Endothelin-1,0.0,0.0,,0.0,,P24530,0.557842168991766
78,10.1038/nature19319,ednrb_human,247,Y,A,Endothelin-1,PubChem CID,16133807,Full agonist,IC50,Binding - Radioligand competition/displacement,0.3,nM,=,,1.3,-4.329,,,125I-Endothelin-1,0.0,0.0,,0.0,,P24530,0.329098108228564
94,10.1038/nature19319,ednrb_human,247,Y,A,Endothelin-3,pubChem CID,16219334,Full agonist,IC50,Binding - Radioligand competition/displacement,0.3,nM,=,,3.3,-10.989,,,125I-Endothelin-1,0.0,0.0,,0.0,,P24530,0.329098108228564
79,10.1038/nature19319,ednrb_human,270,K,A,Endothelin-1,PubChem CID,16133807,Full agonist,IC50,Binding - Radioligand competition/displacement,0.3,nM,=,,1.0,-3.333,,,125I-Endothelin-1,0.0,0.0,,0.0,,P24530,0.367442671402682
95,10.1038/nature19319,ednrb_human,270,K,A,Endothelin-3,pubChem CID,16219334,Full agonist,IC50,Binding - Radioligand competition/displacement,0.3,nM,=,,1.1,-3.663,,,125I-Endothelin-1,0.0,0.0,,0.0,,P24530,0.367442671402682
80,10.1038/nature19319,ednrb_human,273,K,A,Endothelin-1,PubChem CID,16133807,Full agonist,IC50,Binding - Radioligand competition/displacement,0.3,nM,=,,1.7,-5.682,,,125I-Endothelin-1,0.0,0.0,,0.0,,P24530,0.4585805608600716
96,10.1038/nature19319,ednrb_human,273,K,A,Endothelin-3,pubChem CID,16219334,Full agonist,IC50,Binding - Radioligand competition/displacement,0.3,nM,=,,54.7,-200.0,,,125I-Endothelin-1,0.0,0.0,,0.0,,P24530,0.4585805608600716
81,10.1038/nature19319,ednrb_human,277,L,A,Endothelin-1,PubChem CID,16133807,Full agonist,IC50,Binding - Radioligand competition/displacement,0.3,nM,=,,2.1,-6.993,,,125I-Endothelin-1,0.0,0.0,,0.0,,P24530,0.4502833352693867
97,10.1038/nature19319,ednrb_human,277,L,A,Endothelin-3,pubChem CID,16219334,Full agonist,IC50,Binding - Radioligand competition/displacement,0.3,nM,=,,4.2,-14.085,,,125I-Endothelin-1,0.0,0.0,,0.0,,P24530,0.4502833352693867
82,10.1038/nature19319,ednrb_human,336,W,A,Endothelin-1,PubChem CID,16133807,Full agonist,IC50,Binding - Radioligand competition/displacement,0.3,nM,=,,1.4,-4.673,,,125I-Endothelin-1,0.0,0.0,,0.0,,P24530,0.7877840854341671
98,10.1038/nature19319,ednrb_human,336,W,A,Endothelin-3,pubChem CID,16219334,Full agonist,IC50,Binding - Radioligand competition/displacement,0.3,nM,=,,1.8,-5.988,,,125I-Endothelin-1,0.0,0.0,,0.0,,P24530,0.7877840854341671
83,10.1038/nature19319,ednrb_human,339,L,A,Endothelin-1,PubChem CID,16133807,Full agonist,IC50,Binding - Radioligand competition/displacement,0.3,nM,=,,2.9,-9.709,,,125I-Endothelin-1,0.0,0.0,,0.0,,P24530,0.5463585466883105
99,10.1038/nature19319,ednrb_human,339,L,A,Endothelin-3,pubChem CID,16219334,Full agonist,IC50,Binding - Radioligand competition/displacement,0.3,nM,=,,7.7,-25.641,,,125I-Endothelin-1,0.0,0.0,,0.0,,P24530,0.5463585466883105
84,10.1038/nature19319,ednrb_human,343,R,A,Endothelin-1,PubChem CID,16133807,Full agonist,IC50,Binding - Radioligand competition/displacement,0.3,nM,=,,0.9,-3.003,,,125I-Endothelin-1,0.0,0.0,,0.0,,P24530,0.516483386295307
100,10.1038/nature19319,ednrb_human,343,R,A,Endothelin-3,pubChem CID,16219334,Full agonist,IC50,Binding - Radioligand competition/displacement,0.3,nM,=,,1.2,-4.0,,,125I-Endothelin-1,0.0,0.0,,0.0,,P24530,0.516483386295307
85,10.1038/nature19319,ednrb_human,350,Y,A,Endothelin-1,PubChem CID,16133807,Full agonist,IC50,Binding - Radioligand competition/displacement,0.3,nM,=,,0.9,-3.003,,,125I-Endothelin-1,0.0,0.0,,0.0,,P24530,0.3594426400496762
101,10.1038/nature19319,ednrb_human,350,Y,A,Endothelin-3,pubChem CID,16219334,Full agonist,IC50,Binding - Radioligand competition/displacement,0.3,nM,=,,11.8,-40.0,,,125I-Endothelin-1,0.0,0.0,,0.0,,P24530,0.3594426400496762
86,10.1038/nature19319,ednrb_human,357,R,A,Endothelin-1,PubChem CID,16133807,Full agonist,IC50,Binding - Radioligand competition/displacement,0.3,nM,=,,1.8,-5.988,,,125I-Endothelin-1,0.0,0.0,,0.0,,P24530,0.3577323950097596
102,10.1038/nature19319,ednrb_human,357,R,A,Endothelin-3,pubChem CID,16219334,Full agonist,IC50,Binding - Radioligand competition/displacement,0.3,nM,=,,66.7,-250.0,,,125I-Endothelin-1,0.0,0.0,,0.0,,P24530,0.3577323950097596
87,10.1038/nature19319,ednrb_human,364,L,A,Endothelin-1,PubChem CID,16133807,Full agonist,IC50,Binding - Radioligand competition/displacement,0.3,nM,=,,0.7,-2.331,,,125I-Endothelin-1,0.0,0.0,,0.0,,P24530,0.417410125290549
103,10.1038/nature19319,ednrb_human,364,L,A,Endothelin-3,pubChem CID,16219334,Full agonist,IC50,Binding - Radioligand competition/displacement,0.3,nM,=,,1.5,-5.0,,,125I-Endothelin-1,0.0,0.0,,0.0,,P24530,0.417410125290549
88,10.1038/nature19319,ednrb_human,365,L,A,Endothelin-1,PubChem CID,16133807,Full agonist,IC50,Binding - Radioligand competition/displacement,0.3,nM,=,,2.1,-6.993,,,125I-Endothelin-1,0.0,0.0,,0.0,,P24530,0.3627402807776521
104,10.1038/nature19319,ednrb_human,365,L,A,Endothelin-3,pubChem CID,16219334,Full agonist,IC50,Binding - Radioligand competition/displacement,0.3,nM,=,,8.4,-27.778,,,125I-Endothelin-1,0.0,0.0,,0.0,,P24530,0.3627402807776521
89,10.1038/nature19319,ednrb_human,368,D,A,Endothelin-1,PubChem CID,16133807,Full agonist,IC50,Binding - Radioligand competition/displacement,0.3,nM,=,,1.6,-5.348,,,125I-Endothelin-1,0.0,0.0,,0.0,,P24530,0.5278584391869854
105,10.1038/nature19319,ednrb_human,368,D,A,Endothelin-3,pubChem CID,16219334,Full agonist,IC50,Binding - Radioligand competition/displacement,0.3,nM,=,,1.6,-5.348,,,125I-Endothelin-1,0.0,0.0,,0.0,,P24530,0.5278584391869854
90,10.1038/nature19319,ednrb_human,369,Y,A,Endothelin-1,PubChem CID,16133807,Full agonist,IC50,Binding - Radioligand competition/displacement,0.3,nM,=,,1.0,-3.333,,,125I-Endothelin-1,0.0,0.0,,0.0,,P24530,0.5027662971907532
106,10.1038/nature19319,ednrb_human,369,Y,A,Endothelin-3,pubChem CID,16219334,Full agonist,IC50,Binding - Radioligand competition/displacement,0.3,nM,=,,4.6,-15.385,,,125I-Endothelin-1,0.0,0.0,,0.0,,P24530,0.5027662971907532
265,10.1016/0014-2999(96)00495-5,aa2ar_human,13,E,Q,CGS21680,PubChem CID,3086599,Full agonist,IC50,Binding - Radioligand competition/displacement,0.85,ÂµM,=,,13.0,-15.385,,,XAC,0.0,0.0,=,0.0,,P29274,0.3786188113046823
266,10.1016/0014-2999(96)00495-5,aa2ar_human,13,E,Q,CGS15943,PubChem CID,2690,Inverse agonist,IC50,Binding - Radioligand competition/displacement,2.2,nM,=,,2.7,-1.227,,,XAC,0.0,0.0,=,0.0,,P29274,0.3786188113046823
267,10.1016/0014-2999(96)00495-5,aa2ar_human,13,E,Q,Amiloride,PubChem CID,16231,Allosteric inverse agonist,IC50,Binding - Radioligand competition/displacement,52.0,ÂµM,=,,46.0,1.13,,,XAC,0.0,0.0,=,0.0,,P29274,0.3786188113046823
268,10.1016/0014-2999(96)00495-5,aa2ar_human,13,E,Q,XAC,PubChem CID,5697,Inverse agonist,IC50,Binding - Radioligand saturation,18.0,nM,=,,42.0,-2.331,,,,0.0,0.0,=,0.0,,P29274,0.3786188113046823
269,10.1016/0014-2999(96)00495-5,aa2ar_human,13,E,Q,CGS21680,PubChem CID,3086599,Full agonist,EC50,Functional - cAMP accumulation,2.1,nM,=,,17.0,-8.065,,,,0.0,0.0,=,0.0,,P29274,0.3786188113046823
270,10.1016/S0006-2952(00)00357-9,aa2ar_human,13,E,Q,ZM241385,PubChem CID,176407,Inverse agonist,K(d),Binding - Radioligand saturation,1.8,nM,=,,3.0,-1.667,,,,0.0,0.0,=,0.0,,P29274,0.3786188113046823
271,10.1016/S0006-2952(00)00357-9,aa2ar_human,13,E,Q,ZM241385,PubChem CID,176407,Inverse agonist,k1,Binding - Radioligand kinetics (association/dissociation),0.15,nM-1 min-1,=,,0.32,-2.132,,,,0.0,0.0,=,0.0,,P29274,0.3786188113046823
272,10.1016/S0006-2952(00)00357-9,aa2ar_human,13,E,Q,ZM241385,PubChem CID,176407,Inverse agonist,k-1,Binding - Radioligand kinetics (association/dissociation),0.29,min-1,=,,0.6,-2.07,,,,0.0,0.0,=,0.0,,P29274,0.3786188113046823
273,10.1016/S0006-2952(00)00357-9,aa2ar_human,13,E,Q,DPMA,PubChem CID,10391971,Full agonist,K(i),Binding - Radioligand competition/displacement,0.31,ÂµM,=,,0.94,-3.03,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.3786188113046823
274,10.1016/S0006-2952(00)00357-9,aa2ar_human,13,E,Q,CGS21680,PubChem CID,3086599,Full agonist,K(i),Binding - Radioligand competition/displacement,0.28,ÂµM,=,,2.5,-8.929,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.3786188113046823
275,10.1016/S0006-2952(00)00357-9,aa2ar_human,13,E,Q,NECA,PubChem CID,448222,Full agonist,K(i),Binding - Radioligand competition/displacement,0.06,ÂµM,=,,0.33,-5.495,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.3786188113046823
276,10.1016/S0006-2952(00)00357-9,aa2ar_human,13,E,Q,CPA,PubChem CID,4402,Full agonist,K(i),Binding - Radioligand competition/displacement,2.7,ÂµM,=,,21.9,-8.13,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.3786188113046823
277,10.1016/S0006-2952(00)00357-9,aa2ar_human,13,E,Q,CGS15943,PubChem CID,2690,Inverse agonist,K(i),Binding - Radioligand competition/displacement,0.002,ÂµM,=,,0.002,1.0,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.3786188113046823
278,10.1016/S0006-2952(00)00357-9,aa2ar_human,13,E,Q,SCH58261,PubChem CID,176408,Inverse agonist,K(i),Binding - Radioligand competition/displacement,0.008,ÂµM,=,,0.003,2.667,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.3786188113046823
279,10.1016/S0006-2952(00)00357-9,aa2ar_human,13,E,Q,Theophylline,PubChem CID,2153,Inverse agonist,K(i),Binding - Radioligand competition/displacement,4.7,ÂµM,=,,9.9,-2.105,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.3786188113046823
280,10.1016/S0006-2952(00)00357-9,aa2ar_human,13,E,Q,XAC,PubChem CID,5697,Inverse agonist,K(i),Binding - Radioligand competition/displacement,0.032,ÂµM,=,,0.031,1.032,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.3786188113046823
281,10.1124/mol.111.075937,aa2ar_human,13,E,A,LUF-5834,PubChem CID,10066330,Full agonist,pEC50,Functional - cAMP accumulation,7.8,,=,,8.4,3.981,,,,0.0,0.0,=,0.0,,P29274,0.511102368501175
282,10.1124/mol.111.075937,aa2ar_human,13,E,A,CGS21680,PubChem CID,3086599,Full agonist,pEC50,Functional - cAMP accumulation,7.7,,=,,6.9,-6.329,,,,0.0,0.0,=,0.0,,P29274,0.511102368501175
283,10.1124/mol.114.095737,aa2ar_human,52,D,A,NECA,PubChem CID,448222,Full agonist,K(d),Binding - Radioligand saturation,81.0,nM,=,,77.0,1.052,,,,0.0,0.0,=,0.0,,P29274,0.8381272743788266
284,10.1124/mol.114.095737,aa2ar_human,52,D,A,ZM241385,PubChem CID,5311506,Inverse agonist,K(d),Binding - Radioligand saturation,4.6,nM,=,,3.5,1.314,,,,0.0,0.0,=,0.0,,P29274,0.8381272743788266
285,10.1124/mol.114.095737,aa2ar_human,52,D,A,Amiloride,PubChem CID,16231,Allosteric inverse agonist,IC50,Binding - Radioligand competition/displacement,16.0,ÂµM,=,,175.0,-10.989,,,NECA,0.0,0.0,=,0.0,,P29274,0.8381272743788266
286,10.1124/mol.114.095737,aa2ar_human,52,D,A,HMA,PubChem CID,1794,Allosteric inverse agonist,IC50,Binding - Radioligand competition/displacement,2.5,ÂµM,=,,35.0,-14.085,,,NECA,0.0,0.0,=,0.0,,P29274,0.8381272743788266
287,10.1124/mol.114.095737,aa2ar_human,52,D,A,Amiloride,PubChem CID,16231,Allosteric inverse agonist,IC50,Binding - Radioligand competition/displacement,63.0,ÂµM,=,,1065.0,-16.949,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.8381272743788266
288,10.1124/mol.114.095737,aa2ar_human,52,D,A,HMA,PubChem CID,1794,Allosteric inverse agonist,IC50,Binding - Radioligand competition/displacement,8.9,ÂµM,=,,164.0,-18.519,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.8381272743788266
297,10.1021/jm2003798,aa2ar_human,66,I,A,Triazine3a,PubChem CID,53354627,Inverse agonist,pK(d),Biing - Surface plasmon resonance,6.7,,=,,5.6,-12.658,,,,0.0,0.0,=,0.0,,P29274,0.4092616313394678
298,10.1021/jm2003798,aa2ar_human,66,I,A,ZM241385,SMILES,Nc1nc(NCCc2ccc(O)cc2)nc3nc(nn13)c4occc4,Inverse agonist,pK(d),Biing - Surface plasmon resonance,9.3,,=,,8.7,-3.984,,,,0.0,0.0,=,0.0,,P29274,0.4092616313394678
299,10.1021/jm2003798,aa2ar_human,66,I,A,SCH420814,PubChem CID,10117987,Inverse agonist,pK(d),Biing - Surface plasmon resonance,9.5,,=,,8.5,-10.0,,,,0.0,0.0,=,0.0,,P29274,0.4092616313394678
300,10.1021/jm2003798,aa2ar_human,66,I,A,KW6002,PubChem CID,5311037,Inverse agonist,pK(d),Biing - Surface plasmon resonance,5.9,,=,,5.7,-1.585,,,,0.0,0.0,=,0.0,,P29274,0.4092616313394678
301,10.1021/jm2003798,aa2ar_human,66,I,A,XAC,PubChem CID,5697,Inverse agonist,pK(d),Biing - Surface plasmon resonance,7.7,,=,,6.8,-7.937,,,,0.0,0.0,=,0.0,,P29274,0.4092616313394678
302,10.1021/jm2003798,aa2ar_human,66,I,A,Caffeine,PubChem CID,2519,Inverse agonist,pK(d),Biing - Surface plasmon resonance,4.6,,=,,3.0,-40.0,,,,0.0,0.0,=,0.0,,P29274,0.4092616313394678
303,10.1021/jm2003798,aa2ar_human,66,I,A,Theophylline,PubChem CID,2153,Antagonist (neutral/silent),pK(d),Biing - Surface plasmon resonance,5.5,,=,,5.4,-1.259,,,,0.0,0.0,=,0.0,,P29274,0.4092616313394678
304,10.1021/jm2003798,aa2ar_human,66,I,A,Chromone1a,,,Inverse agonist,pK(d),Biing - Surface plasmon resonance,7.3,,=,,6.6,-5.0,,,,0.0,0.0,=,0.0,,P29274,0.4092616313394678
305,10.1021/jm2003798,aa2ar_human,66,I,A,Chromone1b,PubChem CID,5413075,Inverse agonist,pK(d),Biing - Surface plasmon resonance,5.9,,=,,5.4,-3.165,,,,0.0,0.0,=,0.0,,P29274,0.4092616313394678
306,10.1021/jm2003798,aa2ar_human,66,I,A,Chromone1c,SMILES,CCc1cc2C(=O)C(=COc2cc1OC(N)=O)c3scc(C)n3,Inverse agonist,pK(d),Biing - Surface plasmon resonance,5.9,,=,,5.2,-5.0,,,,0.0,0.0,=,0.0,,P29274,0.4092616313394678
307,10.1021/jm2003798,aa2ar_human,66,I,A,Chromone1d,PubChem CID,5310837,Inverse agonist,pK(d),Biing - Surface plasmon resonance,6.1,,=,,5.8,-1.996,,,,0.0,0.0,=,0.0,,P29274,0.4092616313394678
308,10.1021/jm2003798,aa2ar_human,66,I,A,Chromone1e,PubChem CID,5425546,Inverse agonist,pK(d),Biing - Surface plasmon resonance,5.8,,=,,5.3,-3.165,,,,0.0,0.0,=,0.0,,P29274,0.4092616313394678
309,10.1021/jm2003798,aa2ar_human,66,I,A,NOTDISCLOSED,,NOT DISCLOSED,Inverse agonist,pK(d),Biing - Surface plasmon resonance,6.0,,=,,5.3,-5.0,,,,0.0,0.0,=,0.0,,P29274,0.4092616313394678
310,10.1021/jm2003798,aa2ar_human,66,I,A,Triazine15,SMILES,CN1CCN(CC1)C(=O)c2cccc(c2)c3nc(N)nc(n3)c4ccccc4O,Inverse agonist,pK(d),Biing - Surface plasmon resonance,7.9,,=,,8.0,1.259,,,,0.0,0.0,=,0.0,,P29274,0.4092616313394678
311,10.1021/jm2003798,aa2ar_human,66,I,A,Triazine3b,PubChem CID,70689850,Inverse agonist,pK(d),Biing - Surface plasmon resonance,8.9,,=,,8.4,-3.165,,,,0.0,0.0,=,0.0,,P29274,0.4092616313394678
312,10.1021/jm2003798,aa2ar_human,66,I,A,Triazine3c,PubChem CID,53353516,Inverse agonist,pK(d),Biing - Surface plasmon resonance,8.5,,=,,8.1,-2.513,,,,0.0,0.0,=,0.0,,P29274,0.4092616313394678
313,10.1021/jm2003798,aa2ar_human,66,I,A,Triazine3d,PubChem CID,56844240,Inverse agonist,pK(d),Biing - Surface plasmon resonance,8.2,,=,,7.9,-1.996,,,,0.0,0.0,=,0.0,,P29274,0.4092616313394678
314,10.1021/jm2003798,aa2ar_human,66,I,A,Triazine3e,PubChem CID,86676119,Inverse agonist,pK(d),Biing - Surface plasmon resonance,8.2,,=,,7.4,-6.329,,,,0.0,0.0,=,0.0,,P29274,0.4092616313394678
315,10.1021/jm2003798,aa2ar_human,66,I,A,Triazine3f,PubChem CID,87370822,Inverse agonist,pK(d),Biing - Surface plasmon resonance,8.5,,=,,7.8,-5.0,,,,0.0,0.0,=,0.0,,P29274,0.4092616313394678
316,10.1021/jm2003798,aa2ar_human,66,I,A,Triazine3g,PubChem CID,86676123,Inverse agonist,pK(d),Biing - Surface plasmon resonance,9.3,,=,,7.8,-31.25,,,,0.0,0.0,=,0.0,,P29274,0.4092616313394678
317,10.1021/jm2003798,aa2ar_human,66,I,A,Triazine3h,PubChem CID,56964225,Inverse agonist,pK(d),Biing - Surface plasmon resonance,9.2,,=,,8.0,-15.873,,,,0.0,0.0,=,0.0,,P29274,0.4092616313394678
318,10.1124/mol.115.102657,aa2ar_human,66,I,A,ZM241385,PubChem CID,5311506,Inverse agonist,pK(i),Binding - Radioligand competition/displacement,7.83,,=,,7.84,1.023,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.4092616313394678
319,10.1124/mol.115.102657,aa2ar_human,66,I,A,ZM241385,PubChem CID,5311506,Inverse agonist,k-1,Binding - Radioligand kinetics (association/dissociation),0.0119,min-1,=,,0.0071,1.676,,,,0.0,0.0,=,0.0,,P29274,0.4092616313394678
321,10.1124/mol.114.097360,aa2ar_human,67,S,A,NECA,PubChem CID,448222,Full agonist,pEC50,Functional - cAMP accumulation,9.05,,=,,8.5,-3.546,,,,0.0,0.0,=,0.0,,P29274,0.3195231208635121
322,10.1124/mol.114.097360,aa2ar_human,67,S,A,CGS21680,PubChem CID,3086599,Full agonist,pEC50,Functional - cAMP accumulation,8.27,,=,,8.4,1.349,,,,0.0,0.0,=,0.0,,P29274,0.3195231208635121
325,10.1124/mol.115.102657,aa2ar_human,67,S,A,ZM241385,PubChem CID,5311506,Inverse agonist,pK(i),Binding - Radioligand competition/displacement,7.83,,=,,7.93,1.259,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.3195231208635121
326,10.1124/mol.115.102657,aa2ar_human,67,S,A,ZM241385,PubChem CID,5311506,Inverse agonist,k-1,Binding - Radioligand kinetics (association/dissociation),0.0119,min-1,=,,0.0077,1.545,,,,0.0,0.0,=,0.0,,P29274,0.3195231208635121
328,10.1124/mol.115.102657,aa2ar_human,68,T,A,ZM241385,PubChem CID,5311506,Inverse agonist,pK(i),Binding - Radioligand competition/displacement,7.83,,=,,7.85,1.047,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.2432420853130728
329,10.1124/mol.115.102657,aa2ar_human,68,T,A,ZM241385,PubChem CID,5311506,Inverse agonist,k-1,Binding - Radioligand kinetics (association/dissociation),0.0119,min-1,=,,0.0113,1.053,,,,0.0,0.0,=,0.0,,P29274,0.2432420853130728
331,8794889,aa2ar_human,88,T,R,XAC,PubChem CID,5697,Inverse agonist,K(d),Binding - Radioligand saturation,8.83,nM,=,,4.21,2.097,,,,0.0,0.0,=,0.0,,P29274,0.5671299078287191
387,8794889,aa2ar_human,88,T,R,CADO,PubChem CID,8974,Full agonist,K(i),Binding - Radioligand competition/displacement,0.118,ÂµM,=,,9.14,-76.923,,,XAC,134.0,0.0,=,0.0,,P29274,0.5671299078287191
390,8794889,aa2ar_human,88,T,R,DPMA,PubChem CID,10391971,Full agonist,K(i),Binding - Radioligand competition/displacement,65.5,nM,=,,4090.0,-62.5,,,XAC,134.0,0.0,=,0.0,,P29274,0.5671299078287191
393,8794889,aa2ar_human,88,T,R,NECA,PubChem CID,448222,Full agonist,K(i),Binding - Radioligand competition/displacement,19.1,nM,=,,2660.0,-142.857,,,XAC,134.0,0.0,=,0.0,,P29274,0.5671299078287191
396,8794889,aa2ar_human,88,T,R,CGS21680,PubChem CID,3086599,Full agonist,K(i),Binding - Radioligand competition/displacement,0.0267,ÂµM,=,,4.62,-166.667,,,XAC,134.0,0.0,=,0.0,,P29274,0.5671299078287191
399,8794889,aa2ar_human,88,T,R,CGS15943,PubChem CID,2690,Inverse agonist,K(i),Binding - Radioligand competition/displacement,1.2,nM,=,,5.0,-4.167,,,XAC,134.0,0.0,=,0.0,,P29274,0.5671299078287191
402,8794889,aa2ar_human,88,T,R,ZM241385,PubChem CID,5311506,Inverse agonist,K(i),Binding - Radioligand competition/displacement,0.758,nM,=,,2.0,-2.639,,,XAC,134.0,0.0,=,0.0,,P29274,0.5671299078287191
333,10.1016/j.bbamem.2014.11.010,aa2ar_human,71,C,A,CGS21680,PubChem CID,3086599,Full agonist,K(d),Binding - Radioligand saturation,94.5,nM,=,,61.5,1.537,,,,0.0,0.0,=,0.0,,P29274,0.2619969580606121
335,10.1016/j.bbamem.2014.11.010,aa2ar_human,74,C,A,CGS21680,PubChem CID,3086599,Full agonist,K(d),Binding - Radioligand saturation,94.5,nM,=,,60.7,1.557,,,,0.0,0.0,=,0.0,,P29274,0.2838025620120655
338,10.1016/j.bbamem.2014.11.010,aa2ar_human,77,C,A,CGS21680,PubChem CID,3086599,Full agonist,K(d),Binding - Radioligand saturation,94.5,nM,=,,70.0,1.35,,,,0.0,0.0,=,0.0,,P29274,0.7769751220074095
339,10.1021/jm970084v,aa2ar_human,84,V,L,CGS21680,PubChem CID,3086599,Full agonist,K(d),Binding - Radioligand saturation,36.4,nM,=,,27.3,1.333,,,,0.0,0.0,=,0.0,,P29274,0.4058142465625233
340,10.1021/jm970084v,aa2ar_human,84,V,L,DPMA,PubChem CID,10391971,Full agonist,K(i),Binding - Radioligand competition/displacement,38.1,nM,=,,18.9,2.016,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.4058142465625233
341,10.1021/jm970084v,aa2ar_human,84,V,L,NECA,PubChem CID,448222,Full agonist,K(i),Binding - Radioligand competition/displacement,21.6,nM,=,,21.5,1.005,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.4058142465625233
342,10.1021/jm970084v,aa2ar_human,84,V,L,IB-MECA,PubChem CID,123683,Full agonist,K(i),Binding - Radioligand competition/displacement,370.0,nM,=,,143.0,2.587,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.4058142465625233
343,10.1021/jm970084v,aa2ar_human,84,V,L,CGS15943,PubChem CID,2690,Inverse agonist,K(i),Binding - Radioligand competition/displacement,0.142,nM,=,,0.842,-5.917,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.4058142465625233
344,10.1021/jm970084v,aa2ar_human,84,V,L,XAC,PubChem CID,5697,Inverse agonist,K(i),Binding - Radioligand competition/displacement,7.89,nM,=,,45.6,-5.78,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.4058142465625233
345,10.1021/jm970084v,aa2ar_human,84,V,L,Galangin,PubChem CID,5281616,Inverse agonist,K(i),Binding - Radioligand competition/displacement,16.7,ÂµM,=,,18.1,-1.083,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.4058142465625233
346,10.1021/jm970084v,aa2ar_human,84,V,L,Nifedipine,PubChem CID,4485,Inverse agonist,K(i),Binding - Radioligand competition/displacement,24.4,ÂµM,=,,22.2,1.099,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.4058142465625233
347,10.1021/jm970084v,aa2ar_human,84,V,L,DPCPX,PubChem CID,1329,Inverse agonist,K(i),Binding - Radioligand competition/displacement,226.0,nM,=,,788.0,-3.484,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.4058142465625233
348,10.1021/jm970084v,aa2ar_human,84,V,L,BTH4,ChEMBL Compound ID,CHEMBL87496,Inverse agonist,K(i),Binding - Radioligand competition/displacement,106.0,ÂµM,=,,72.6,1.46,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.4058142465625233
349,10.1021/jm970084v,aa2ar_human,84,V,L,Amiloride,PubChem CID,16231,Allosteric inverse agonist,K(i),Binding - Radioligand competition/displacement,12.0,ÂµM,=,,11.6,1.034,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.4058142465625233
358,10.1021/jm2003798,aa2ar_human,85,L,A,ZM241385,SMILES,Nc1nc(NCCc2ccc(O)cc2)nc3nc(nn13)c4occc4,Inverse agonist,pK(d),Biing - Surface plasmon resonance,9.3,,=,,7.5,-62.5,,,,0.0,0.0,=,0.0,,P29274,0.5194383347720957
359,10.1021/jm2003798,aa2ar_human,85,L,A,SCH420814,PubChem CID,10117987,Inverse agonist,pK(d),Biing - Surface plasmon resonance,9.5,,=,,7.2,-200.0,,,,0.0,0.0,=,0.0,,P29274,0.5194383347720957
360,10.1021/jm2003798,aa2ar_human,85,L,A,KW6002,PubChem CID,5311037,Inverse agonist,pK(d),Biing - Surface plasmon resonance,5.9,,=,,4.8,-12.658,,,,0.0,0.0,=,0.0,,P29274,0.5194383347720957
361,10.1021/jm2003798,aa2ar_human,85,L,A,XAC,PubChem CID,5697,Inverse agonist,pK(d),Biing - Surface plasmon resonance,7.7,,=,,7.4,-1.996,,,,0.0,0.0,=,0.0,,P29274,0.5194383347720957
362,10.1021/jm2003798,aa2ar_human,85,L,A,Caffeine,PubChem CID,2519,Inverse agonist,pK(d),Biing - Surface plasmon resonance,4.6,,=,,3.0,-40.0,,,,0.0,0.0,=,0.0,,P29274,0.5194383347720957
363,10.1021/jm2003798,aa2ar_human,85,L,A,Theophylline,PubChem CID,2153,Antagonist (neutral/silent),pK(d),Biing - Surface plasmon resonance,5.5,,=,,3.7,-62.5,,,,0.0,0.0,=,0.0,,P29274,0.5194383347720957
364,10.1021/jm2003798,aa2ar_human,85,L,A,Chromone1a,PubChem CID,740769,Inverse agonist,pK(d),Biing - Surface plasmon resonance,7.3,,=,,6.0,-20.0,,,,0.0,0.0,=,0.0,,P29274,0.5194383347720957
365,10.1021/jm2003798,aa2ar_human,85,L,A,Chromone1b,PubChem CID,5413075,Inverse agonist,pK(d),Biing - Surface plasmon resonance,5.9,,=,,3.0,-1000.0,,,,0.0,0.0,=,0.0,,P29274,0.5194383347720957
366,10.1021/jm2003798,aa2ar_human,85,L,A,Chromone1c,SMILES,CCc1cc2C(=O)C(=COc2cc1OC(N)=O)c3scc(C)n3,Inverse agonist,pK(d),Biing - Surface plasmon resonance,5.9,,=,,5.1,-6.329,,,,0.0,0.0,=,0.0,,P29274,0.5194383347720957
367,10.1021/jm2003798,aa2ar_human,85,L,A,Chromone1d,PubChem CID,5310837,Inverse agonist,pK(d),Biing - Surface plasmon resonance,6.1,,=,,5.3,-6.329,,,,0.0,0.0,=,0.0,,P29274,0.5194383347720957
368,10.1021/jm2003798,aa2ar_human,85,L,A,Chromone1e,PubChem CID,5425546,Inverse agonist,pK(d),Biing - Surface plasmon resonance,5.8,,=,,3.0,-500.0,,,,0.0,0.0,=,0.0,,P29274,0.5194383347720957
369,10.1021/jm2003798,aa2ar_human,85,L,A,NOTDISCLOSED,,NOT DISCLOSED,Inverse agonist,pK(d),Biing - Surface plasmon resonance,6.0,,=,,5.2,-6.329,,,,0.0,0.0,=,0.0,,P29274,0.5194383347720957
370,10.1021/jm2003798,aa2ar_human,85,L,A,Triazine15,SMILES,CN1CCN(CC1)C(=O)c2cccc(c2)c3nc(N)nc(n3)c4ccccc4O,Inverse agonist,pK(d),Biing - Surface plasmon resonance,7.9,,=,,7.0,-7.937,,,,0.0,0.0,=,0.0,,P29274,0.5194383347720957
371,10.1021/jm2003798,aa2ar_human,85,L,A,Triazine3a,PubChem CID,53354627,Inverse agonist,pK(d),Biing - Surface plasmon resonance,6.7,,=,,5.6,-12.658,,,,0.0,0.0,=,0.0,,P29274,0.5194383347720957
372,10.1021/jm2003798,aa2ar_human,85,L,A,Triazine3b,PubChem CID,70689850,Inverse agonist,pK(d),Biing - Surface plasmon resonance,8.9,,=,,8.1,-6.329,,,,0.0,0.0,=,0.0,,P29274,0.5194383347720957
373,10.1021/jm2003798,aa2ar_human,85,L,A,Triazine3c,PubChem CID,53353516,Inverse agonist,pK(d),Biing - Surface plasmon resonance,8.5,,=,,7.8,-5.0,,,,0.0,0.0,=,0.0,,P29274,0.5194383347720957
374,10.1021/jm2003798,aa2ar_human,85,L,A,Triazine3d,PubChem CID,56844240,Inverse agonist,pK(d),Biing - Surface plasmon resonance,8.2,,=,,7.4,-6.329,,,,0.0,0.0,=,0.0,,P29274,0.5194383347720957
375,10.1021/jm2003798,aa2ar_human,85,L,A,Triazine3e,PubChem CID,86676119,Inverse agonist,pK(d),Biing - Surface plasmon resonance,8.2,,=,,7.4,-6.329,,,,0.0,0.0,=,0.0,,P29274,0.5194383347720957
376,10.1021/jm2003798,aa2ar_human,85,L,A,Triazine3f,PubChem CID,87370822,Inverse agonist,pK(d),Biing - Surface plasmon resonance,8.5,,=,,7.6,-7.937,,,,0.0,0.0,=,0.0,,P29274,0.5194383347720957
377,10.1021/jm2003798,aa2ar_human,85,L,A,Triazine3g,PubChem CID,86676123,Inverse agonist,pK(d),Biing - Surface plasmon resonance,9.3,,=,,8.2,-12.658,,,,0.0,0.0,=,0.0,,P29274,0.5194383347720957
378,10.1021/jm2003798,aa2ar_human,85,L,A,Triazine3h,PubChem CID,56964225,Inverse agonist,pK(d),Biing - Surface plasmon resonance,9.2,,=,,8.1,-12.658,,,,0.0,0.0,=,0.0,,P29274,0.5194383347720957
381,10.1124/mol.111.075937,aa2ar_human,85,L,A,CGS21680,PubChem CID,3086599,Full agonist,pEC50,Functional - cAMP accumulation,7.7,,=,,5.7,-100.0,,,,0.0,0.0,=,0.0,,P29274,0.5194383347720957
380,10.1124/mol.111.075937,aa2ar_human,85,L,R,LUF-5834,PubChem CID,10066330,Full agonist,pEC50,Functional - cAMP accumulation,7.8,,=,,6.4,-25.0,,,,0.0,0.0,=,0.0,,P29274,0.5640978430191261
382,10.1124/mol.111.075937,aa2ar_human,85,L,R,CGS21680,PubChem CID,3086599,Full agonist,pEC50,Functional - cAMP accumulation,7.7,,=,,4.9,-500.0,,,,0.0,0.0,=,0.0,,P29274,0.5640978430191261
383,8794889,aa2ar_human,88,T,A,XAC,PubChem CID,5697,Inverse agonist,K(d),Binding - Radioligand saturation,8.83,nM,=,,10.8,-1.222,,,,0.0,0.0,=,0.0,,P29274,0.522527180812981
385,8794889,aa2ar_human,88,T,A,CADO,PubChem CID,8974,Full agonist,K(i),Binding - Radioligand competition/displacement,0.118,ÂµM,=,,16.4,-142.857,,,XAC,77.0,0.0,=,0.0,,P29274,0.522527180812981
388,8794889,aa2ar_human,88,T,A,DPMA,PubChem CID,10391971,Full agonist,K(i),Binding - Radioligand competition/displacement,65.5,nM,=,,5710.0,-90.909,,,XAC,77.0,0.0,=,0.0,,P29274,0.522527180812981
391,8794889,aa2ar_human,88,T,A,NECA,PubChem CID,448222,Full agonist,K(i),Binding - Radioligand competition/displacement,19.1,nM,=,,1590.0,-83.333,,,XAC,77.0,0.0,=,0.0,,P29274,0.522527180812981
394,8794889,aa2ar_human,88,T,A,CGS21680,PubChem CID,3086599,Full agonist,K(i),Binding - Radioligand competition/displacement,0.0267,ÂµM,=,,22.1,-1000.0,,,XAC,77.0,0.0,=,0.0,,P29274,0.522527180812981
397,8794889,aa2ar_human,88,T,A,CGS15943,PubChem CID,2690,Inverse agonist,K(i),Binding - Radioligand competition/displacement,1.2,nM,=,,7.98,-6.667,,,XAC,77.0,0.0,=,0.0,,P29274,0.522527180812981
400,8794889,aa2ar_human,88,T,A,ZM241385,PubChem CID,5311506,Inverse agonist,K(i),Binding - Radioligand competition/displacement,0.758,nM,=,,3.47,-4.587,,,XAC,77.0,0.0,=,0.0,,P29274,0.522527180812981
403,8794889,aa2ar_human,88,T,A,CGS21680,PubChem CID,3086599,Full agonist,EC50,Functional - cAMP accumulation,0.915,nM,=,,14.4,-15.625,,,,0.0,0.0,=,0.0,,P29274,0.522527180812981
438,10.1124/mol.111.075937,aa2ar_human,88,T,A,LUF-5834,PubChem CID,10066330,Full agonist,pEC50,Functional - cAMP accumulation,7.8,,=,,7.9,1.259,,,,0.0,0.0,=,0.0,,P29274,0.522527180812981
439,10.1124/mol.111.075937,aa2ar_human,88,T,A,CGS21680,PubChem CID,3086599,Full agonist,pEC50,Functional - cAMP accumulation,7.7,,=,,4.5,-1000.0,,,,0.0,0.0,=,0.0,,P29274,0.522527180812981
440,10.1124/mol.111.075937,aa2ar_human,88,T,A,ZM241385,PubChem CID,5311506,Inverse agonist,K(d),Binding - Radioligand saturation,3.4,nM,=,,3.1,1.097,,,,0.0,0.0,=,0.0,,P29274,0.522527180812981
442,10.1124/mol.111.075937,aa2ar_human,88,T,A,CGS21680,PubChem CID,3086599,Full agonist,pK(i),Binding - Radioligand competition/displacement,7.1,,=,,6.9,-1.585,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.522527180812981
446,10.1111/bph.12165,aa2ar_human,88,T,A,NECA,PubChem CID,448222,Full agonist,K(i),Binding - Radioligand competition/displacement,1.01,ÂµM,=,,187.0,-200.0,,,,0.0,0.0,=,0.0,,P29274,0.522527180812981
447,10.1111/bph.12165,aa2ar_human,88,T,A,Adenosine,PubChem CID,60961,Full agonist,K(i),Binding - Radioligand competition/displacement,0.36,ÂµM,=,,2.71,-7.519,,,,0.0,0.0,=,0.0,,P29274,0.522527180812981
448,10.1111/bph.12165,aa2ar_human,88,T,A,Adenosine,PubChem CID,60961,Full agonist,EC50,Functional - Other,0.37,ÂµM,=,,32.0,-83.333,,,,0.0,0.0,=,0.0,,P29274,0.522527180812981
449,10.1073/pnas.0804396105,aa2ar_human,88,T,A,XAC,PubChem CID,5697,Inverse agonist,K(i),Binding - Radioligand competition/displacement,0.002,mM,=,,0.002,1.0,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.522527180812981
450,10.1073/pnas.0804396105,aa2ar_human,88,T,A,Theophylline,PubChem CID,2153,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,1.52,mM,=,,0.86,1.767,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.522527180812981
452,10.1073/pnas.0804396105,aa2ar_human,88,T,A,R-PIA,PubChem CID,114854,Full agonist,K(i),Binding - Radioligand competition/displacement,0.16,mM,=,,30.0,-200.0,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.522527180812981
384,8794889,aa2ar_human,88,T,S,XAC,PubChem CID,5697,Inverse agonist,K(d),Binding - Radioligand saturation,8.83,nM,=,,5.76,1.533,,,,0.0,0.0,=,0.0,,P29274,0.477557152801851
386,8794889,aa2ar_human,88,T,S,CADO,PubChem CID,8974,Full agonist,K(i),Binding - Radioligand competition/displacement,0.118,ÂµM,=,,0.776,-6.579,,,XAC,90.0,0.0,=,0.0,,P29274,0.477557152801851
389,8794889,aa2ar_human,88,T,S,DPMA,PubChem CID,10391971,Full agonist,K(i),Binding - Radioligand competition/displacement,65.5,nM,=,,655.0,-10.0,,,XAC,90.0,0.0,=,0.0,,P29274,0.477557152801851
392,8794889,aa2ar_human,88,T,S,NECA,PubChem CID,448222,Full agonist,K(i),Binding - Radioligand competition/displacement,19.1,nM,=,,778.0,-40.0,,,XAC,90.0,0.0,=,0.0,,P29274,0.477557152801851
395,8794889,aa2ar_human,88,T,S,CGS21680,PubChem CID,3086599,Full agonist,K(i),Binding - Radioligand competition/displacement,0.0267,ÂµM,=,,0.422,-15.873,,,XAC,90.0,0.0,=,0.0,,P29274,0.477557152801851
398,8794889,aa2ar_human,88,T,S,CGS15943,PubChem CID,2690,Inverse agonist,K(i),Binding - Radioligand competition/displacement,1.2,nM,=,,6.28,-5.236,,,XAC,90.0,0.0,=,0.0,,P29274,0.477557152801851
401,8794889,aa2ar_human,88,T,S,ZM241385,PubChem CID,5311506,Inverse agonist,K(i),Binding - Radioligand competition/displacement,0.758,nM,=,,1.16,-1.531,,,XAC,90.0,0.0,=,0.0,,P29274,0.477557152801851
404,8794889,aa2ar_human,88,T,S,CGS21680,PubChem CID,3086599,Full agonist,EC50,Functional - cAMP accumulation,0.915,nM,=,,48.0,-52.632,,,,0.0,0.0,=,0.0,,P29274,0.477557152801851
407,10.1021/jm0300431,aa2ar_human,88,T,E,CGS15943,PubChem CID,2690,Inverse agonist,K(i),Binding - Radioligand competition/displacement,0.84,nM,=,,0.67,1.254,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.5671299078287191
411,10.1021/jm0300431,aa2ar_human,88,T,E,5'-Deoxy-5'-aminoadenosine,PubChem CID,266234,Full agonist,K(i),Binding - Radioligand competition/displacement,534.0,ÂµM,=,,492.0,1.085,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.5671299078287191
413,10.1021/jm0300431,aa2ar_human,88,T,E,CIDÂ 85129620,PubChem CID,85129620,Full agonist,K(i),Binding - Radioligand competition/displacement,67.0,ÂµM,=,,57.0,1.175,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.5671299078287191
415,10.1021/jm0300431,aa2ar_human,88,T,E,522607-99-4,PubChem CID,85116573,Full agonist,K(i),Binding - Radioligand competition/displacement,79.0,ÂµM,=,,64.0,1.234,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.5671299078287191
417,10.1021/jm0300431,aa2ar_human,88,T,E,Cid13307390,PubChem CID,13307390,Full agonist,K(i),Binding - Radioligand competition/displacement,46.1,ÂµM,=,,57.0,-1.236,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.5671299078287191
456,8794889,aa2ar_human,89,Q,A,ZM241385,PubChem CID,5311506,Inverse agonist,K(i),Binding - Radioligand competition/displacement,0.525,nM,=,,0.197,2.665,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.519646454683869
457,8794889,aa2ar_human,89,Q,A,CGS21680,PubChem CID,3086599,Full agonist,EC50,Functional - cAMP accumulation,0.915,nM,=,,0.223,4.103,,,,0.0,0.0,=,0.0,,P29274,0.519646454683869
458,8794889,aa2ar_human,89,Q,A,SCH58261,PubChem CID,176408,Inverse agonist,K(i),Binding - Radioligand competition/displacement,1.85,nM,=,,0.246,7.52,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.519646454683869
461,8794889,aa2ar_human,89,Q,A,CGS15943,PubChem CID,2690,Inverse agonist,K(i),Binding - Radioligand competition/displacement,1.95,nM,=,,0.455,4.286,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.519646454683869
464,8794889,aa2ar_human,89,Q,A,NECA,PubChem CID,448222,Full agonist,K(i),Binding - Radioligand competition/displacement,27.6,nM,=,,1.9,14.526,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.519646454683869
465,8794889,aa2ar_human,89,Q,A,XAC,PubChem CID,5697,Inverse agonist,K(i),Binding - Radioligand competition/displacement,8.71,nM,=,,2.01,4.333,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.519646454683869
466,8794889,aa2ar_human,89,Q,A,DPMA,PubChem CID,10391971,Full agonist,EC50,Functional - cAMP accumulation,10.8,nM,=,,2.73,3.956,,,,0.0,0.0,=,0.0,,P29274,0.519646454683869
467,8794889,aa2ar_human,89,Q,A,NECA,PubChem CID,448222,Full agonist,EC50,Functional - cAMP accumulation,44.5,nM,=,,2.91,15.292,,,,0.0,0.0,=,0.0,,P29274,0.519646454683869
468,8794889,aa2ar_human,89,Q,A,IB-MECA,PubChem CID,123683,Full agonist,K(i),Binding - Radioligand competition/displacement,435.0,nM,=,,3.21,135.514,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.519646454683869
473,8794889,aa2ar_human,89,Q,A,CGS21680,PubChem CID,3086599,Full agonist,K(d),Binding - Radioligand saturation,31.0,nM,=,,6.7,4.627,,,,0.0,0.0,=,0.0,,P29274,0.519646454683869
474,8794889,aa2ar_human,89,Q,A,CGS21680,PubChem CID,3086599,Full agonist,K(d),Binding - Radioligand competition/displacement,31.0,nM,=,,6.7,4.627,,,,0.0,0.0,=,0.0,,P29274,0.519646454683869
476,8794889,aa2ar_human,89,Q,A,CADO,PubChem CID,8974,Full agonist,K(i),Binding - Radioligand competition/displacement,100.0,nM,=,,19.1,5.236,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.519646454683869
477,8794889,aa2ar_human,89,Q,A,R-PIA,PubChem CID,114854,Full agonist,K(i),Binding - Radioligand competition/displacement,299.0,nM,=,,28.6,10.455,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.519646454683869
479,8794889,aa2ar_human,89,Q,A,ADAC,PubChem CID,23789715,Full agonist,K(i),Binding - Radioligand competition/displacement,1330.0,nM,=,,41.2,32.282,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.519646454683869
486,8794889,aa2ar_human,89,Q,A,BTH4,ChEMBL Compound ID,CHEMBL87496,Inverse agonist,K(i),Binding - Radioligand competition/displacement,859.0,nM,=,,133.0,6.459,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.519646454683869
478,8794889,aa2ar_human,89,Q,L,CGS21680,PubChem CID,3086599,Full agonist,K(d),Binding - Radioligand competition/displacement,31.0,nM,=,,35.6,-1.148,,,,0.0,0.0,=,0.0,,P29274,0.5642972202315735
481,8794889,aa2ar_human,89,Q,R,CGS21680,PubChem CID,3086599,Full agonist,K(d),Binding - Radioligand competition/displacement,31.0,nM,=,,50.8,-1.639,,,,0.0,0.0,=,0.0,,P29274,0.4301439365408345
484,8794889,aa2ar_human,89,Q,S,CGS21680,PubChem CID,3086599,Full agonist,K(d),Binding - Radioligand competition/displacement,31.0,nM,=,,93.3,-3.012,,,,0.0,0.0,=,0.0,,P29274,0.4746870731554964
499,8794889,aa2ar_human,90,S,A,CGS21680,PubChem CID,3086599,Full agonist,K(d),Binding - Radioligand saturation,31.0,nM,=,,16.1,1.925,,,,0.0,0.0,=,0.0,,P29274,0.4091294003503122
500,8794889,aa2ar_human,90,S,A,CADO,PubChem CID,8974,Full agonist,K(i),Binding - Radioligand competition/displacement,100.0,nM,=,,19.4,5.155,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.4091294003503122
501,8794889,aa2ar_human,90,S,A,NECA,PubChem CID,448222,Full agonist,K(i),Binding - Radioligand competition/displacement,27.6,nM,=,,5.9,4.678,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.4091294003503122
502,8794889,aa2ar_human,90,S,A,R-PIA,PubChem CID,114854,Full agonist,K(i),Binding - Radioligand competition/displacement,299.0,nM,=,,76.1,3.929,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.4091294003503122
503,8794889,aa2ar_human,90,S,A,IB-MECA,PubChem CID,123683,Full agonist,K(i),Binding - Radioligand competition/displacement,435.0,nM,=,,78.5,5.541,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.4091294003503122
504,8794889,aa2ar_human,90,S,A,ADAC,PubChem CID,23789715,Full agonist,K(i),Binding - Radioligand competition/displacement,1330.0,nM,=,,675.0,1.97,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.4091294003503122
505,8794889,aa2ar_human,90,S,A,SCH58261,PubChem CID,176408,Inverse agonist,K(i),Binding - Radioligand competition/displacement,1.85,nM,=,,1.5,1.233,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.4091294003503122
506,8794889,aa2ar_human,90,S,A,CGS15943,PubChem CID,2690,Inverse agonist,K(i),Binding - Radioligand competition/displacement,1.95,nM,=,,0.925,2.108,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.4091294003503122
507,8794889,aa2ar_human,90,S,A,XAC,PubChem CID,5697,Inverse agonist,K(i),Binding - Radioligand competition/displacement,8.71,nM,=,,16.6,-1.905,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.4091294003503122
508,8794889,aa2ar_human,90,S,A,BTH4,ChEMBL Compound ID,CHEMBL87496,Inverse agonist,K(i),Binding - Radioligand competition/displacement,859.0,nM,=,,508.0,1.691,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.4091294003503122
509,8794889,aa2ar_human,90,S,A,ZM241385,PubChem CID,5311506,Inverse agonist,K(i),Binding - Radioligand competition/displacement,0.525,nM,=,,0.36,1.458,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.4091294003503122
511,8794889,aa2ar_human,91,S,A,CGS21680,PubChem CID,3086599,Full agonist,K(d),Binding - Radioligand saturation,31.0,nM,=,,59.7,-1.927,,,,0.0,0.0,=,0.0,,P29274,0.5428569902185518
512,8794889,aa2ar_human,91,S,A,CADO,PubChem CID,8974,Full agonist,K(i),Binding - Radioligand competition/displacement,100.0,nM,=,,224.0,-2.242,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.5428569902185518
513,8794889,aa2ar_human,91,S,A,NECA,PubChem CID,448222,Full agonist,K(i),Binding - Radioligand competition/displacement,27.6,nM,=,,35.5,-1.287,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.5428569902185518
514,8794889,aa2ar_human,91,S,A,R-PIA,PubChem CID,114854,Full agonist,K(i),Binding - Radioligand competition/displacement,299.0,nM,=,,314.0,-1.05,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.5428569902185518
515,8794889,aa2ar_human,91,S,A,IB-MECA,PubChem CID,123683,Full agonist,K(i),Binding - Radioligand competition/displacement,435.0,nM,=,,614.0,-1.412,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.5428569902185518
516,8794889,aa2ar_human,91,S,A,ADAC,PubChem CID,23789715,Full agonist,K(i),Binding - Radioligand competition/displacement,1330.0,nM,=,,2530.0,-1.901,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.5428569902185518
517,8794889,aa2ar_human,91,S,A,SCH58261,PubChem CID,176408,Inverse agonist,K(i),Binding - Radioligand competition/displacement,1.85,nM,=,,2.3,-1.244,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.5428569902185518
518,8794889,aa2ar_human,91,S,A,CGS15943,PubChem CID,2690,Inverse agonist,K(i),Binding - Radioligand competition/displacement,1.95,nM,=,,1.95,1.0,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.5428569902185518
519,8794889,aa2ar_human,91,S,A,XAC,PubChem CID,5697,Inverse agonist,K(i),Binding - Radioligand competition/displacement,8.71,nM,=,,18.1,-2.079,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.5428569902185518
520,8794889,aa2ar_human,91,S,A,BTH4,ChEMBL Compound ID,CHEMBL87496,Inverse agonist,K(i),Binding - Radioligand competition/displacement,859.0,nM,=,,1880.0,-2.188,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.5428569902185518
521,8794889,aa2ar_human,91,S,A,ZM241385,PubChem CID,5311506,Inverse agonist,K(i),Binding - Radioligand competition/displacement,0.525,nM,=,,1.09,-2.075,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.5428569902185518
522,10.1124/mol.114.095737,aa2ar_human,91,S,A,NECA,PubChem CID,448222,Full agonist,K(d),Binding - Radioligand saturation,81.0,nM,=,,258.0,-3.185,,,,0.0,0.0,=,0.0,,P29274,0.5428569902185518
523,10.1124/mol.114.095737,aa2ar_human,91,S,A,ZM241385,PubChem CID,5311506,Inverse agonist,K(d),Binding - Radioligand saturation,4.6,nM,=,,7.0,-1.522,,,,0.0,0.0,=,0.0,,P29274,0.5428569902185518
524,10.1124/mol.114.095737,aa2ar_human,91,S,A,Amiloride,PubChem CID,16231,Allosteric inverse agonist,IC50,Binding - Radioligand competition/displacement,16.0,ÂµM,=,,13.0,1.231,,,NECA,0.0,0.0,=,0.0,,P29274,0.5428569902185518
525,10.1124/mol.114.095737,aa2ar_human,91,S,A,HMA,PubChem CID,1794,Allosteric inverse agonist,IC50,Binding - Radioligand competition/displacement,2.5,ÂµM,=,,2.3,1.087,,,NECA,0.0,0.0,=,0.0,,P29274,0.5428569902185518
526,10.1124/mol.114.095737,aa2ar_human,91,S,A,Amiloride,PubChem CID,16231,Allosteric inverse agonist,IC50,Binding - Radioligand competition/displacement,63.0,ÂµM,=,,82.0,-1.302,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.5428569902185518
527,10.1124/mol.114.095737,aa2ar_human,91,S,A,HMA,PubChem CID,1794,Allosteric inverse agonist,IC50,Binding - Radioligand competition/displacement,8.9,ÂµM,=,,8.2,1.085,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.5428569902185518
536,10.1073/pnas.0804396105,aa2ar_human,122,K,A,XAC,PubChem CID,5697,Inverse agonist,K(i),Binding - Radioligand competition/displacement,0.002,mM,=,,0.002,1.0,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.2678775648110701
537,10.1073/pnas.0804396105,aa2ar_human,122,K,A,Theophylline,PubChem CID,2153,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,1.52,mM,=,,0.86,1.767,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.2678775648110701
539,10.1073/pnas.0804396105,aa2ar_human,122,K,A,R-PIA,PubChem CID,114854,Full agonist,K(i),Binding - Radioligand competition/displacement,0.16,mM,=,,30.0,-200.0,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.2678775648110701
542,10.1016/j.bbamem.2014.11.010,aa2ar_human,146,C,A,CGS21680,PubChem CID,3086599,Full agonist,K(d),Binding - Radioligand saturation,94.5,nM,=,,51.7,1.828,,,,0.0,0.0,=,0.0,,P29274,0.2672488041458012
543,10.1124/mol.115.102657,aa2ar_human,148,Q,A,ZM241385,PubChem CID,5311506,Inverse agonist,pK(i),Binding - Radioligand competition/displacement,7.83,,=,,7.78,-1.122,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.2918627427254453
544,10.1124/mol.115.102657,aa2ar_human,148,Q,A,ZM241385,PubChem CID,5311506,Inverse agonist,k-1,Binding - Radioligand kinetics (association/dissociation),0.0119,min-1,=,,0.0148,-1.244,,,,0.0,0.0,=,0.0,,P29274,0.2918627427254453
547,10.1021/ml5002486,aa2ar_human,150,K,A,ZM241385,PubChem CID,5311506,Inverse agonist,K(d),Binding - Radioligand saturation,1.81,nM,=,,1.99,-1.099,,,,0.0,0.0,=,0.0,,P29274,0.3000182266023429
556,10.1021/ml5002486,aa2ar_human,153,K,A,ZM241385,PubChem CID,5311506,Inverse agonist,K(d),Binding - Radioligand saturation,1.81,nM,=,,1.47,1.231,,,,0.0,0.0,=,0.0,,P29274,0.3018045854229417
557,10.1124/mol.115.102657,aa2ar_human,153,K,A,ZM241385,PubChem CID,5311506,Inverse agonist,pK(i),Binding - Radioligand competition/displacement,7.83,,=,,7.91,1.202,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.3018045854229417
558,10.1124/mol.115.102657,aa2ar_human,153,K,A,ZM241385,PubChem CID,5311506,Inverse agonist,k-1,Binding - Radioligand kinetics (association/dissociation),0.0119,min-1,=,,0.0094,1.266,,,,0.0,0.0,=,0.0,,P29274,0.3018045854229417
1148,10.1007/s11302-016-9549-9,aa2ar_human,153,K,A,ZM241385,PubChem CID,176408,Inverse agonist,pK(i),Binding - Radioligand competition/displacement,7.91,,=,,7.83,-1.202,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.3018045854229417
565,10.1124/mol.115.102657,aa2ar_human,156,S,A,ZM241385,PubChem CID,5311506,Inverse agonist,pK(i),Binding - Radioligand competition/displacement,7.83,,=,,7.98,1.413,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.2382839952612386
566,10.1124/mol.115.102657,aa2ar_human,156,S,A,ZM241385,PubChem CID,5311506,Inverse agonist,k-1,Binding - Radioligand kinetics (association/dissociation),0.0119,min-1,=,,0.0128,-1.075,,,,0.0,0.0,=,0.0,,P29274,0.2382839952612386
568,10.1124/mol.115.102657,aa2ar_human,157,Q,A,ZM241385,PubChem CID,5311506,Inverse agonist,pK(i),Binding - Radioligand competition/displacement,7.83,,=,,8.03,1.585,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.3088780516260165
569,10.1124/mol.115.102657,aa2ar_human,157,Q,A,ZM241385,PubChem CID,5311506,Inverse agonist,k-1,Binding - Radioligand kinetics (association/dissociation),0.0119,min-1,=,,0.0112,1.062,,,,0.0,0.0,=,0.0,,P29274,0.3088780516260165
571,10.1016/j.bbamem.2014.11.010,aa2ar_human,159,C,A,CGS21680,PubChem CID,3086599,Full agonist,K(d),Binding - Radioligand saturation,94.5,nM,=,,49.8,1.898,,,,0.0,0.0,=,0.0,,P29274,0.2801577365159871
572,8609897,aa2ar_human,161,E,A,CGS21680,PubChem CID,3086599,Full agonist,K(d),Binding - Radioligand saturation,22.3,nM,=,,41.7,-1.869,,,,0.0,0.0,=,0.0,,P29274,0.3065153615842907
573,8609897,aa2ar_human,161,E,A,CADO,PubChem CID,8974,Full agonist,K(i),Binding - Radioligand competition/displacement,144.0,nM,=,,221.0,-1.534,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.3065153615842907
574,8609897,aa2ar_human,161,E,A,DPMA,PubChem CID,10391971,Full agonist,K(i),Binding - Radioligand competition/displacement,36.3,nM,=,,61.2,-1.686,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.3065153615842907
575,8609897,aa2ar_human,161,E,A,(r)-N6-Phenylisopropyladenosine,PubChem CID,93205,Full agonist,K(i),Binding - Radioligand competition/displacement,158.0,nM,=,,264.0,-1.672,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.3065153615842907
576,8609897,aa2ar_human,161,E,A,IB-MECA,PubChem CID,123683,Full agonist,K(i),Binding - Radioligand competition/displacement,456.0,nM,=,,433.0,1.053,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.3065153615842907
577,8609897,aa2ar_human,161,E,A,NECA,PubChem CID,448222,Full agonist,K(i),Binding - Radioligand competition/displacement,11.4,nM,=,,23.9,-2.096,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.3065153615842907
578,8609897,aa2ar_human,161,E,A,CGS15943,PubChem CID,2690,Inverse agonist,K(i),Binding - Radioligand competition/displacement,1.71,nM,=,,0.287,5.958,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.3065153615842907
579,8609897,aa2ar_human,161,E,A,XAC,PubChem CID,5697,Inverse agonist,K(i),Binding - Radioligand competition/displacement,6.98,nM,=,,7.19,-1.03,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.3065153615842907
581,10.1016/j.bbamem.2014.11.010,aa2ar_human,166,C,A,CGS21680,PubChem CID,3086599,Full agonist,K(d),Binding - Radioligand saturation,94.5,nM,=,,64.4,1.467,,,,0.0,0.0,=,0.0,,P29274,0.7677898311343553
582,10.1021/jm2003798,aa2ar_human,167,L,A,ZM241385,SMILES,Nc1nc(NCCc2ccc(O)cc2)nc3nc(nn13)c4occc4,Inverse agonist,pK(d),Biing - Surface plasmon resonance,9.3,,=,,9.3,1.0,,,,0.0,0.0,=,0.0,,P29274,0.3072248171911685
583,10.1021/jm2003798,aa2ar_human,167,L,A,SCH420814,PubChem CID,10117987,Inverse agonist,pK(d),Biing - Surface plasmon resonance,9.5,,=,,8.5,-10.0,,,,0.0,0.0,=,0.0,,P29274,0.3072248171911685
584,10.1021/jm2003798,aa2ar_human,167,L,A,KW6002,PubChem CID,5311037,Inverse agonist,pK(d),Biing - Surface plasmon resonance,5.9,,=,,5.7,-1.585,,,,0.0,0.0,=,0.0,,P29274,0.3072248171911685
585,10.1021/jm2003798,aa2ar_human,167,L,A,XAC,PubChem CID,5697,Inverse agonist,pK(d),Biing - Surface plasmon resonance,7.7,,=,,7.6,-1.259,,,,0.0,0.0,=,0.0,,P29274,0.3072248171911685
586,10.1021/jm2003798,aa2ar_human,167,L,A,Caffeine,PubChem CID,2519,Inverse agonist,pK(d),Biing - Surface plasmon resonance,4.6,,=,,4.7,1.259,,,,0.0,0.0,=,0.0,,P29274,0.3072248171911685
587,10.1021/jm2003798,aa2ar_human,167,L,A,Theophylline,PubChem CID,2153,Antagonist (neutral/silent),pK(d),Biing - Surface plasmon resonance,5.5,,=,,5.5,1.0,,,,0.0,0.0,=,0.0,,P29274,0.3072248171911685
588,10.1021/jm2003798,aa2ar_human,167,L,A,Chromone1a,PubChem CID,740769,Inverse agonist,pK(d),Biing - Surface plasmon resonance,7.3,,=,,7.2,-1.259,,,,0.0,0.0,=,0.0,,P29274,0.3072248171911685
589,10.1021/jm2003798,aa2ar_human,167,L,A,Chromone1b,PubChem CID,5413075,Inverse agonist,pK(d),Biing - Surface plasmon resonance,5.9,,=,,5.8,-1.259,,,,0.0,0.0,=,0.0,,P29274,0.3072248171911685
590,10.1021/jm2003798,aa2ar_human,167,L,A,Chromone1c,SMILES,CCc1cc2C(=O)C(=COc2cc1OC(N)=O)c3scc(C)n3,Inverse agonist,pK(d),Biing - Surface plasmon resonance,5.9,,=,,6.0,1.259,,,,0.0,0.0,=,0.0,,P29274,0.3072248171911685
591,10.1021/jm2003798,aa2ar_human,167,L,A,Chromone1d,PubChem CID,5310837,Inverse agonist,pK(d),Biing - Surface plasmon resonance,6.1,,=,,5.6,-3.165,,,,0.0,0.0,=,0.0,,P29274,0.3072248171911685
592,10.1021/jm2003798,aa2ar_human,167,L,A,Chromone1e,PubChem CID,5425546,Inverse agonist,pK(d),Biing - Surface plasmon resonance,5.8,,=,,5.7,-1.259,,,,0.0,0.0,=,0.0,,P29274,0.3072248171911685
593,10.1021/jm2003798,aa2ar_human,167,L,A,NOTDISCLOSED,,NOT DISCLOSED,Inverse agonist,pK(d),Biing - Surface plasmon resonance,6.0,,=,,5.6,-2.513,,,,0.0,0.0,=,0.0,,P29274,0.3072248171911685
594,10.1021/jm2003798,aa2ar_human,167,L,A,Triazine15,SMILES,CN1CCN(CC1)C(=O)c2cccc(c2)c3nc(N)nc(n3)c4ccccc4O,Inverse agonist,pK(d),Biing - Surface plasmon resonance,7.9,,=,,7.5,-2.513,,,,0.0,0.0,=,0.0,,P29274,0.3072248171911685
595,10.1021/jm2003798,aa2ar_human,167,L,A,Triazine3a,PubChem CID,53354627,Inverse agonist,pK(d),Biing - Surface plasmon resonance,6.7,,=,,6.6,-1.259,,,,0.0,0.0,=,0.0,,P29274,0.3072248171911685
596,10.1021/jm2003798,aa2ar_human,167,L,A,Triazine3b,PubChem CID,70689850,Inverse agonist,pK(d),Biing - Surface plasmon resonance,8.9,,=,,8.8,-1.259,,,,0.0,0.0,=,0.0,,P29274,0.3072248171911685
597,10.1021/jm2003798,aa2ar_human,167,L,A,Triazine3c,PubChem CID,53353516,Inverse agonist,pK(d),Biing - Surface plasmon resonance,8.5,,=,,8.6,1.259,,,,0.0,0.0,=,0.0,,P29274,0.3072248171911685
598,10.1021/jm2003798,aa2ar_human,167,L,A,Triazine3d,PubChem CID,56844240,Inverse agonist,pK(d),Biing - Surface plasmon resonance,8.2,,=,,8.3,1.259,,,,0.0,0.0,=,0.0,,P29274,0.3072248171911685
599,10.1021/jm2003798,aa2ar_human,167,L,A,Triazine3e,PubChem CID,86676119,Inverse agonist,pK(d),Biing - Surface plasmon resonance,8.2,,=,,8.3,1.259,,,,0.0,0.0,=,0.0,,P29274,0.3072248171911685
600,10.1021/jm2003798,aa2ar_human,167,L,A,Triazine3f,PubChem CID,87370822,Inverse agonist,pK(d),Biing - Surface plasmon resonance,8.5,,=,,8.8,1.995,,,,0.0,0.0,=,0.0,,P29274,0.3072248171911685
601,10.1021/jm2003798,aa2ar_human,167,L,A,Triazine3g,PubChem CID,86676123,Inverse agonist,pK(d),Biing - Surface plasmon resonance,9.3,,=,,7.9,-25.0,,,,0.0,0.0,=,0.0,,P29274,0.3072248171911685
602,10.1021/jm2003798,aa2ar_human,167,L,A,Triazine3h,PubChem CID,56964225,Inverse agonist,pK(d),Biing - Surface plasmon resonance,9.2,,=,,8.5,-5.0,,,,0.0,0.0,=,0.0,,P29274,0.3072248171911685
606,10.1074/jbc.M109.096974,aa2ar_human,168,F,Y,ZM241385,PubChem CID,5311506,Inverse agonist,K(d),Binding - Radioligand saturation,1.6,nM,=,,13.0,-8.13,,,,42.0,0.0,=,0.0,,P29274,0.3521242048521848
609,10.1074/jbc.M109.096974,aa2ar_human,168,F,Y,ZM241385,PubChem CID,5311506,Inverse agonist,K(d),Binding - Other,2.4,nM,=,,5.5,-2.294,,,,23.0,0.0,=,0.0,,P29274,0.3521242048521848
612,10.1074/jbc.M109.096974,aa2ar_human,168,F,Y,NECA,PubChem CID,448222,Full agonist,K(i),Binding - Radioligand competition/displacement,94.0,nM,=,,1190.0,-12.658,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.3521242048521848
614,10.1074/jbc.M109.096974,aa2ar_human,168,F,Y,CGS21680,PubChem CID,3086599,Full agonist,K(i),Binding - Radioligand competition/displacement,357.0,nM,=,,8990.0,-25.0,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.3521242048521848
616,10.1074/jbc.M109.096974,aa2ar_human,168,F,Y,CGS21680,PubChem CID,3086599,Full agonist,EC50,Functional - cAMP accumulation,7.63,nM,=,,7.0,1.09,,,,0.0,0.0,=,0.0,,P29274,0.3521242048521848
607,10.1074/jbc.M109.096974,aa2ar_human,168,F,W,ZM241385,PubChem CID,5311506,Inverse agonist,K(d),Binding - Radioligand saturation,1.6,nM,=,,6.4,-4.0,,,,40.0,0.0,=,0.0,,P29274,0.4378885941143006
610,10.1074/jbc.M109.096974,aa2ar_human,168,F,W,ZM241385,PubChem CID,5311506,Inverse agonist,K(d),Binding - Other,2.4,nM,=,,3.6,-1.499,,,,97.0,0.0,=,0.0,,P29274,0.4378885941143006
613,10.1074/jbc.M109.096974,aa2ar_human,168,F,W,NECA,PubChem CID,448222,Full agonist,K(i),Binding - Radioligand competition/displacement,94.0,nM,=,,39.0,2.41,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.4378885941143006
615,10.1074/jbc.M109.096974,aa2ar_human,168,F,W,CGS21680,PubChem CID,3086599,Full agonist,K(i),Binding - Radioligand competition/displacement,357.0,nM,=,,534.0,-1.495,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.4378885941143006
617,10.1074/jbc.M109.096974,aa2ar_human,168,F,W,CGS21680,PubChem CID,3086599,Full agonist,EC50,Functional - cAMP accumulation,7.63,nM,=,,7.49,1.019,,,,0.0,0.0,=,0.0,,P29274,0.4378885941143006
618,10.1074/jbc.M109.096974,aa2ar_human,168,F,A,CGS21680,PubChem CID,3086599,Full agonist,EC50,Functional - cAMP accumulation,7.63,nM,=,,5.84,1.307,,,,0.0,0.0,=,0.0,,P29274,0.572069199088358
619,10.1124/mol.111.075937,aa2ar_human,168,F,A,LUF-5834,PubChem CID,10066330,Full agonist,pEC50,Functional - cAMP accumulation,7.8,,=,,5.0,-500.0,,,,0.0,0.0,=,0.0,,P29274,0.572069199088358
621,10.1124/mol.111.075937,aa2ar_human,168,F,A,CGS21680,PubChem CID,3086599,Full agonist,pEC50,Functional - cAMP accumulation,7.7,,=,,4.9,-500.0,,,,0.0,0.0,=,0.0,,P29274,0.572069199088358
625,8609897,aa2ar_human,169,E,Q,CGS21680,PubChem CID,3086599,Full agonist,K(d),Binding - Radioligand saturation,22.3,nM,=,,57.0,-2.558,,,,0.0,0.0,=,0.0,,P29274,0.2355985986834375
626,8609897,aa2ar_human,169,E,Q,CADO,PubChem CID,8974,Full agonist,K(i),Binding - Radioligand competition/displacement,144.0,nM,=,,946.0,-6.579,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.2355985986834375
627,8609897,aa2ar_human,169,E,Q,DPMA,PubChem CID,10391971,Full agonist,K(i),Binding - Radioligand competition/displacement,36.3,nM,=,,1.62,22.407,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.2355985986834375
628,8609897,aa2ar_human,169,E,Q,(r)-N6-Phenylisopropyladenosine,PubChem CID,93205,Full agonist,K(i),Binding - Radioligand competition/displacement,158.0,nM,=,,33.9,4.661,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.2355985986834375
629,8609897,aa2ar_human,169,E,Q,IB-MECA,PubChem CID,123683,Full agonist,K(i),Binding - Radioligand competition/displacement,456.0,nM,=,,53.4,8.539,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.2355985986834375
630,8609897,aa2ar_human,169,E,Q,NECA,PubChem CID,448222,Full agonist,K(i),Binding - Radioligand competition/displacement,11.4,nM,=,,253.0,-22.222,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.2355985986834375
631,8609897,aa2ar_human,169,E,Q,CGS15943,PubChem CID,2690,Inverse agonist,K(i),Binding - Radioligand competition/displacement,1.71,nM,=,,2.26,-1.321,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.2355985986834375
632,8609897,aa2ar_human,169,E,Q,XAC,PubChem CID,5697,Inverse agonist,K(i),Binding - Radioligand competition/displacement,6.98,nM,=,,11.5,-1.647,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.2355985986834375
641,10.1124/mol.115.102657,aa2ar_human,169,E,Q,ZM241385,PubChem CID,5311506,Inverse agonist,pK(i),Binding - Radioligand competition/displacement,7.83,,=,,7.46,-2.342,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.2355985986834375
643,10.1124/mol.115.102657,aa2ar_human,169,E,Q,ZM241385,PubChem CID,5311506,Inverse agonist,k-1,Binding - Radioligand kinetics (association/dissociation),0.0119,min-1,=,,0.7329,-62.5,,,,0.0,0.0,=,0.0,,P29274,0.2355985986834375
633,10.1124/mol.111.075937,aa2ar_human,169,E,A,LUF-5834,PubChem CID,10066330,Full agonist,pEC50,Functional - cAMP accumulation,7.8,,=,,8.3,3.162,,,,0.0,0.0,=,0.0,,P29274,0.3459419403744218
634,10.1124/mol.111.075937,aa2ar_human,169,E,A,CGS21680,PubChem CID,3086599,Full agonist,pEC50,Functional - cAMP accumulation,7.7,,=,,7.6,-1.259,,,,0.0,0.0,=,0.0,,P29274,0.3459419403744218
635,10.1124/mol.111.075937,aa2ar_human,169,E,A,ZM241385,PubChem CID,5311506,Inverse agonist,pIC50,Functional - Ca2+ accumulation,8.51,,=,,7.04,-29.412,,,,0.0,0.0,=,0.0,,P29274,0.3459419403744218
636,10.1124/mol.114.097360,aa2ar_human,169,E,A,NECA,PubChem CID,448222,Full agonist,pEC50,Functional - cAMP accumulation,9.05,,=,,7.87,-15.152,,,,0.0,0.0,=,0.0,,P29274,0.3459419403744218
637,10.1124/mol.114.097360,aa2ar_human,169,E,A,CGS21680,PubChem CID,3086599,Full agonist,pEC50,Functional - cAMP accumulation,8.27,,=,,8.07,-1.585,,,,0.0,0.0,=,0.0,,P29274,0.3459419403744218
650,10.1021/jm2003798,aa2ar_human,177,M,A,ZM241385,SMILES,Nc1nc(NCCc2ccc(O)cc2)nc3nc(nn13)c4occc4,Inverse agonist,pK(d),Biing - Surface plasmon resonance,9.3,,=,,9.2,-1.259,,,,0.0,0.0,=,0.0,,P29274,0.4713877414321967
651,10.1021/jm2003798,aa2ar_human,177,M,A,SCH420814,PubChem CID,10117987,Inverse agonist,pK(d),Biing - Surface plasmon resonance,9.5,,=,,8.6,-7.937,,,,0.0,0.0,=,0.0,,P29274,0.4713877414321967
652,10.1021/jm2003798,aa2ar_human,177,M,A,KW6002,PubChem CID,5311037,Inverse agonist,pK(d),Biing - Surface plasmon resonance,5.9,,=,,5.6,-1.996,,,,0.0,0.0,=,0.0,,P29274,0.4713877414321967
653,10.1021/jm2003798,aa2ar_human,177,M,A,XAC,PubChem CID,5697,Inverse agonist,pK(d),Biing - Surface plasmon resonance,7.7,,=,,7.5,-1.585,,,,0.0,0.0,=,0.0,,P29274,0.4713877414321967
656,10.1021/jm2003798,aa2ar_human,177,M,A,Chromone1a,PubChem CID,740769,Inverse agonist,pK(d),Biing - Surface plasmon resonance,7.3,,=,,7.4,1.259,,,,0.0,0.0,=,0.0,,P29274,0.4713877414321967
657,10.1021/jm2003798,aa2ar_human,177,M,A,Chromone1b,PubChem CID,5413075,Inverse agonist,pK(d),Biing - Surface plasmon resonance,5.9,,=,,5.6,-1.996,,,,0.0,0.0,=,0.0,,P29274,0.4713877414321967
658,10.1021/jm2003798,aa2ar_human,177,M,A,Chromone1c,SMILES,CCc1cc2C(=O)C(=COc2cc1OC(N)=O)c3scc(C)n3,Inverse agonist,pK(d),Biing - Surface plasmon resonance,5.9,,=,,5.9,1.0,,,,0.0,0.0,=,0.0,,P29274,0.4713877414321967
660,10.1021/jm2003798,aa2ar_human,177,M,A,Chromone1e,PubChem CID,5425546,Inverse agonist,pK(d),Biing - Surface plasmon resonance,5.8,,=,,5.6,-1.585,,,,0.0,0.0,=,0.0,,P29274,0.4713877414321967
662,10.1021/jm2003798,aa2ar_human,177,M,A,Triazine15,SMILES,CN1CCN(CC1)C(=O)c2cccc(c2)c3nc(N)nc(n3)c4ccccc4O,Inverse agonist,pK(d),Biing - Surface plasmon resonance,7.9,,=,,7.6,-1.996,,,,0.0,0.0,=,0.0,,P29274,0.4713877414321967
663,10.1021/jm2003798,aa2ar_human,177,M,A,Triazine3a,PubChem CID,53354627,Inverse agonist,pK(d),Biing - Surface plasmon resonance,6.7,,=,,6.1,-3.984,,,,0.0,0.0,=,0.0,,P29274,0.4713877414321967
664,10.1021/jm2003798,aa2ar_human,177,M,A,Triazine3b,PubChem CID,70689850,Inverse agonist,pK(d),Biing - Surface plasmon resonance,8.9,,=,,8.9,1.0,,,,0.0,0.0,=,0.0,,P29274,0.4713877414321967
665,10.1021/jm2003798,aa2ar_human,177,M,A,Triazine3c,PubChem CID,53353516,Inverse agonist,pK(d),Biing - Surface plasmon resonance,8.5,,=,,8.5,1.0,,,,0.0,0.0,=,0.0,,P29274,0.4713877414321967
666,10.1021/jm2003798,aa2ar_human,177,M,A,Triazine3d,PubChem CID,56844240,Inverse agonist,pK(d),Biing - Surface plasmon resonance,8.2,,=,,8.3,1.259,,,,0.0,0.0,=,0.0,,P29274,0.4713877414321967
668,10.1021/jm2003798,aa2ar_human,177,M,A,Triazine3f,PubChem CID,87370822,Inverse agonist,pK(d),Biing - Surface plasmon resonance,8.5,,=,,9.0,3.162,,,,0.0,0.0,=,0.0,,P29274,0.4713877414321967
669,10.1021/jm2003798,aa2ar_human,177,M,A,Triazine3g,PubChem CID,86676123,Inverse agonist,pK(d),Biing - Surface plasmon resonance,9.3,,=,,8.5,-6.329,,,,0.0,0.0,=,0.0,,P29274,0.4713877414321967
670,10.1021/jm2003798,aa2ar_human,177,M,A,Triazine3h,PubChem CID,56964225,Inverse agonist,pK(d),Biing - Surface plasmon resonance,9.2,,=,,8.4,-6.329,,,,0.0,0.0,=,0.0,,P29274,0.4713877414321967
672,10.1074/jbc.M109.096974,aa2ar_human,177,M,A,ZM241385,PubChem CID,5311506,Inverse agonist,K(d),Binding - Radioligand saturation,1.6,nM,=,,12.0,-7.519,,,,26.0,0.0,=,0.0,,P29274,0.4713877414321967
673,10.1074/jbc.M109.096974,aa2ar_human,177,M,A,ZM241385,PubChem CID,5311506,Inverse agonist,K(d),Binding - Other,2.4,nM,=,,10.4,-4.329,,,,46.0,0.0,=,0.0,,P29274,0.4713877414321967
674,10.1074/jbc.M109.096974,aa2ar_human,177,M,A,NECA,PubChem CID,448222,Full agonist,K(i),Binding - Radioligand competition/displacement,94.0,nM,=,,66.0,1.424,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.4713877414321967
675,10.1074/jbc.M109.096974,aa2ar_human,177,M,A,CGS21680,PubChem CID,3086599,Full agonist,K(i),Binding - Radioligand competition/displacement,357.0,nM,=,,2440.0,-6.849,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.4713877414321967
676,10.1074/jbc.M109.096974,aa2ar_human,177,M,A,CGS21680,PubChem CID,3086599,Full agonist,EC50,Functional - cAMP accumulation,7.63,nM,=,,6.86,1.112,,,,0.0,0.0,=,0.0,,P29274,0.4713877414321967
677,7775460,aa2ar_human,180,F,A,CGS21680,PubChem CID,3086599,Full agonist,K(d),Binding - Radioligand saturation,21.7,nM,=,,15.1,1.437,,,,0.0,0.0,=,0.0,,P29274,0.3863106645192754
678,7775460,aa2ar_human,180,F,A,DPMA,PubChem CID,10391971,Full agonist,K(i),Binding - Radioligand competition/displacement,244.0,nM,=,,104.0,2.346,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.3863106645192754
679,7775460,aa2ar_human,180,F,A,NECA,PubChem CID,448222,Full agonist,K(i),Binding - Radioligand competition/displacement,19.9,nM,=,,46.0,-2.309,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.3863106645192754
680,7775460,aa2ar_human,180,F,A,R-PIA,PubChem CID,114854,Full agonist,K(i),Binding - Radioligand competition/displacement,318.0,nM,=,,4500.0,-14.085,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.3863106645192754
681,7775460,aa2ar_human,180,F,A,CGS15943,PubChem CID,2690,Inverse agonist,K(i),Binding - Radioligand competition/displacement,10.1,nM,=,,13.7,-1.357,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.3863106645192754
682,7775460,aa2ar_human,180,F,A,XAC,PubChem CID,5697,Inverse agonist,K(i),Binding - Radioligand competition/displacement,63.2,nM,=,,90.3,-1.429,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.3863106645192754
705,7775460,aa2ar_human,181,N,S,CGS21680,PubChem CID,3086599,Full agonist,K(d),Binding - Radioligand saturation,21.7,nM,=,,24.8,-1.143,,,,0.0,0.0,=,0.0,,P29274,0.4184946266275161
706,7775460,aa2ar_human,181,N,S,CADO,PubChem CID,8974,Full agonist,K(i),Binding - Radioligand competition/displacement,152.0,nM,=,,1340.0,-8.85,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.4184946266275161
707,7775460,aa2ar_human,181,N,S,DPMA,PubChem CID,10391971,Full agonist,K(i),Binding - Radioligand competition/displacement,244.0,nM,=,,981.0,-4.016,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.4184946266275161
708,7775460,aa2ar_human,181,N,S,NECA,PubChem CID,448222,Full agonist,K(i),Binding - Radioligand competition/displacement,19.9,nM,=,,16.4,1.213,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.4184946266275161
709,7775460,aa2ar_human,181,N,S,CGS15943,PubChem CID,2690,Inverse agonist,K(i),Binding - Radioligand competition/displacement,10.1,nM,=,,23.7,-2.347,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.4184946266275161
710,7775460,aa2ar_human,181,N,S,XAC,PubChem CID,5697,Inverse agonist,K(i),Binding - Radioligand competition/displacement,63.2,nM,=,,130.0,-2.058,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.4184946266275161
711,10.1016/j.chembiol.2004.12.010,aa2ar_human,181,N,D,ZM241385,PubChem CID,5311506,Inverse agonist,K(d),Binding - Radioligand saturation,2.4,nM,=,,4.1,-1.709,,,,0.0,0.0,=,0.0,,P29274,0.4184946266275161
712,10.1016/j.chembiol.2004.12.010,aa2ar_human,181,N,D,ST092443,PubChem CID,2868392,Full agonist,K(i),Binding - Radioligand competition/displacement,21.4,nM,=,,9.3,2.301,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.4184946266275161
713,10.1016/j.chembiol.2004.12.010,aa2ar_human,181,N,D,CGS15943,PubChem CID,2690,Inverse agonist,K(i),Binding - Radioligand competition/displacement,0.84,nM,=,,0.45,1.867,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.4184946266275161
715,10.1016/j.chembiol.2004.12.010,aa2ar_human,181,N,D,NONAME,SMILES,CCNC(=O)C1OC(C(O)C1O)n2cnc3c(NC(N)=N)ncnc23,Full agonist,K(i),Binding - Radioligand competition/displacement,4510.0,nM,=,,1140.0,3.956,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.4184946266275161
716,10.1016/j.chembiol.2004.12.010,aa2ar_human,181,N,D,CIDÂ 75022550,PubChem CID,75022550,Full agonist,K(i),Binding - Radioligand competition/displacement,11.0,ÂµM,=,,1.18,9.322,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.4184946266275161
717,10.1016/j.chembiol.2004.12.010,aa2ar_human,181,N,D,Cid13307390,PubChem CID,13307390,Full agonist,K(i),Binding - Radioligand competition/displacement,46.1,ÂµM,=,,0.493,93.509,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.4184946266275161
718,10.1016/j.chembiol.2004.12.010,aa2ar_human,181,N,D,Cid76018682,PubChem CID,76018682,Full agonist,K(i),Binding - Radioligand competition/displacement,74.2,ÂµM,=,,4.14,17.923,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.4184946266275161
721,10.1016/j.chembiol.2004.12.010,aa2ar_human,181,N,D,CAS35788-28-4,PubChem CID,53464002,Full agonist,K(i),Binding - Radioligand competition/displacement,2.11,ÂµM,=,,13.3,-6.289,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.4184946266275161
723,10.1016/j.chembiol.2004.12.010,aa2ar_human,181,N,D,Oprea1_724488,PubChem CID,24052235,Full agonist,K(i),Binding - Radioligand competition/displacement,2590.0,nM,=,,3470.0,-1.34,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.4184946266275161
730,10.1016/j.chembiol.2004.12.010,aa2ar_human,181,N,D,NONAME,SMILES,CCNC(=O)C1OC(C(O)C1O)n2cnc3c(NC(N)=N)ncnc23,Full agonist,EC50,Functional - cAMP accumulation,826.0,nM,=,,120.0,6.883,,,,0.0,0.0,=,0.0,,P29274,0.4184946266275161
731,10.1016/j.chembiol.2004.12.010,aa2ar_human,181,N,D,Cid76018686,PubChem CID,76018686,Full agonist,EC50,Functional - cAMP accumulation,5.8,ÂµM,=,,0.052,111.538,,,,0.0,0.0,=,0.0,,P29274,0.4184946266275161
732,7775460,aa2ar_human,182,F,Y,CGS21680,PubChem CID,3086599,Full agonist,K(d),Binding - Radioligand saturation,21.7,nM,=,,57.0,-2.625,,,,0.0,0.0,=,0.0,,P29274,0.3508800743728439
735,7775460,aa2ar_human,182,F,Y,CADO,PubChem CID,8974,Full agonist,K(i),Binding - Radioligand competition/displacement,152.0,nM,=,,1890.0,-12.5,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.3508800743728439
737,7775460,aa2ar_human,182,F,Y,DPMA,PubChem CID,10391971,Full agonist,K(i),Binding - Radioligand competition/displacement,244.0,nM,=,,1720.0,-7.042,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.3508800743728439
739,7775460,aa2ar_human,182,F,Y,NECA,PubChem CID,448222,Full agonist,K(i),Binding - Radioligand competition/displacement,19.9,nM,=,,170.0,-8.547,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.3508800743728439
741,7775460,aa2ar_human,182,F,Y,R-PIA,PubChem CID,114854,Full agonist,K(i),Binding - Radioligand competition/displacement,318.0,nM,=,,2800.0,-8.772,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.3508800743728439
743,7775460,aa2ar_human,182,F,Y,CGS15943,PubChem CID,2690,Inverse agonist,K(i),Binding - Radioligand competition/displacement,10.1,nM,=,,19.2,-1.901,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.3508800743728439
745,7775460,aa2ar_human,182,F,Y,XAC,PubChem CID,5697,Inverse agonist,K(i),Binding - Radioligand competition/displacement,63.2,nM,=,,140.0,-2.217,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.3508800743728439
733,7775460,aa2ar_human,182,F,W,CGS21680,PubChem CID,3086599,Full agonist,K(d),Binding - Radioligand saturation,21.7,nM,=,,66.0,-3.04,,,,0.0,0.0,=,0.0,,P29274,0.4365538536234526
736,7775460,aa2ar_human,182,F,W,CADO,PubChem CID,8974,Full agonist,K(i),Binding - Radioligand competition/displacement,152.0,nM,=,,776.0,-5.102,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.4365538536234526
738,7775460,aa2ar_human,182,F,W,DPMA,PubChem CID,10391971,Full agonist,K(i),Binding - Radioligand competition/displacement,244.0,nM,=,,756.0,-3.096,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.4365538536234526
740,7775460,aa2ar_human,182,F,W,NECA,PubChem CID,448222,Full agonist,K(i),Binding - Radioligand competition/displacement,19.9,nM,=,,144.0,-7.246,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.4365538536234526
742,7775460,aa2ar_human,182,F,W,R-PIA,PubChem CID,114854,Full agonist,K(i),Binding - Radioligand competition/displacement,318.0,nM,=,,1600.0,-5.025,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.4365538536234526
744,7775460,aa2ar_human,182,F,W,CGS15943,PubChem CID,2690,Inverse agonist,K(i),Binding - Radioligand competition/displacement,10.1,nM,=,,10.3,-1.019,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.4365538536234526
746,7775460,aa2ar_human,182,F,W,XAC,PubChem CID,5697,Inverse agonist,K(i),Binding - Radioligand competition/displacement,63.2,nM,=,,66.8,-1.057,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.4365538536234526
767,10.1111/bph.12165,aa2ar_human,239,V,A,NECA,PubChem CID,448222,Full agonist,EC50,,0.033,ÂµM,=,,3.5,-111.111,,,,0.0,0.0,=,0.0,,P29274,0.4899753059134307
768,10.1073/pnas.0804396105,aa2ar_human,239,V,A,XAC,PubChem CID,5697,Inverse agonist,K(i),Binding - Radioligand competition/displacement,0.002,mM,=,,0.002,1.0,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.4899753059134307
769,10.1073/pnas.0804396105,aa2ar_human,239,V,A,Theophylline,PubChem CID,2153,Antagonist (neutral/silent),K(i),Binding - Radioligand competition/displacement,1.52,mM,=,,0.86,1.767,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.4899753059134307
771,10.1073/pnas.0804396105,aa2ar_human,239,V,A,R-PIA,PubChem CID,114854,Full agonist,K(i),Binding - Radioligand competition/displacement,0.16,mM,=,,30.0,-200.0,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.4899753059134307
773,10.1124/mol.111.075937,aa2ar_human,246,W,A,LUF-5834,PubChem CID,10066330,Full agonist,pEC50,Functional - cAMP accumulation,7.8,,=,,8.3,3.162,,,,0.0,0.0,=,0.0,,P29274,0.8025749877730824
775,10.1124/mol.111.075937,aa2ar_human,246,W,A,CGS21680,PubChem CID,3086599,Full agonist,pEC50,Functional - cAMP accumulation,7.7,,=,,6.1,-40.0,,,,0.0,0.0,=,0.0,,P29274,0.8025749877730824
777,10.1124/mol.114.095737,aa2ar_human,246,W,A,NECA,PubChem CID,448222,Full agonist,K(d),Binding - Radioligand saturation,81.0,nM,=,,1942.0,-23.81,,,,0.0,0.0,=,0.0,,P29274,0.8025749877730824
778,10.1124/mol.114.095737,aa2ar_human,246,W,A,ZM241385,PubChem CID,5311506,Inverse agonist,K(d),Binding - Radioligand saturation,4.6,nM,=,,23.2,-5.051,,,,0.0,0.0,=,0.0,,P29274,0.8025749877730824
779,10.1124/mol.114.095737,aa2ar_human,246,W,A,Amiloride,PubChem CID,16231,Allosteric inverse agonist,IC50,Binding - Radioligand competition/displacement,16.0,ÂµM,=,,2.7,5.926,,,NECA,0.0,0.0,=,0.0,,P29274,0.8025749877730824
780,10.1124/mol.114.095737,aa2ar_human,246,W,A,HMA,PubChem CID,1794,Allosteric inverse agonist,IC50,Binding - Radioligand competition/displacement,2.5,ÂµM,=,,0.43,5.814,,,NECA,0.0,0.0,=,0.0,,P29274,0.8025749877730824
781,10.1124/mol.114.095737,aa2ar_human,246,W,A,Amiloride,PubChem CID,16231,Allosteric inverse agonist,IC50,Binding - Radioligand competition/displacement,63.0,ÂµM,=,,2.6,24.231,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.8025749877730824
782,10.1124/mol.114.095737,aa2ar_human,246,W,A,HMA,PubChem CID,1794,Allosteric inverse agonist,IC50,Binding - Radioligand competition/displacement,8.9,ÂµM,=,,0.36,24.722,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.8025749877730824
783,10.1124/mol.114.095737,aa2ar_human,246,W,A,CGS21680,PubChem CID,3086599,Full agonist,pEC50,Functional - cAMP accumulation,7.8,,=,,7.1,-5.0,,,,0.0,0.0,=,46.0,CGS21680,P29274,0.8025749877730824
784,10.1021/acs.jmedchem.6b00142,aa2ar_human,246,W,A,12a,SMILES,NC(N)=NC(=O)c1nc(Cl)c(NC2CC3C=CC=CC3C2)nc1N,Allosteric inverse agonist,%,Binding - Radioligand competition/displacement,68.0,%,=,,6.6,-10.309,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.8025749877730824
785,10.1021/acs.jmedchem.6b00142,aa2ar_human,246,W,A,12b,SMILES,Cc1ccc(CCNc2nc(N)c(nc2Cl)C(=O)N=C(N)N)cc1,Allosteric inverse agonist,%,Binding - Radioligand competition/displacement,50.0,%,=,,2.1,-23.81,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.8025749877730824
786,10.1021/acs.jmedchem.6b00142,aa2ar_human,246,W,A,12c,SMILES,NC(N)=NC(=O)c1nc(Cl)c(NCCc2ccc(Cl)cc2)nc1N,Allosteric inverse agonist,%,Binding - Radioligand competition/displacement,92.0,%,=,,32.0,-2.874,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.8025749877730824
787,10.1021/acs.jmedchem.6b00142,aa2ar_human,246,W,A,12d,SMILES,NC(N)=NC(=O)c1nc(Cl)c(NCCc2ccc(Cl)c(Cl)c2)nc1N,Allosteric inverse agonist,%,Binding - Radioligand competition/displacement,82.0,%,=,,11.0,-7.463,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.8025749877730824
788,10.1021/acs.jmedchem.6b00142,aa2ar_human,246,W,A,12e,SMILES,NC(N)=NC(=O)c1nc(Cl)c(NCCc2ccc(Br)cc2)nc1N,Allosteric inverse agonist,%,Binding - Radioligand competition/displacement,67.0,%,=,,4.8,-13.889,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.8025749877730824
789,10.1021/acs.jmedchem.6b00142,aa2ar_human,246,W,A,12f,SMILES,NC(N)=NC(=O)c1nc(Cl)c(NCCc2ccc(cc2)[N+]([O-])=O)nc1N,Allosteric inverse agonist,%,Binding - Radioligand competition/displacement,68.0,%,=,,5.8,-11.765,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.8025749877730824
790,10.1021/acs.jmedchem.6b00142,aa2ar_human,246,W,A,12g,SMILES,NC(N)=NC(=O)c1nc(Cl)c(NCCc2ccc(O)cc2)nc1N,Allosteric inverse agonist,%,Binding - Radioligand competition/displacement,72.0,%,=,,9.5,-7.576,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.8025749877730824
792,10.1021/acs.jmedchem.6b00142,aa2ar_human,246,W,A,12i,SMILES,COc1cccc(CCNc2nc(N)c(nc2Cl)C(=O)N=C(N)N)c1,Allosteric inverse agonist,%,Binding - Radioligand competition/displacement,41.0,%,=,,5.4,-7.576,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.8025749877730824
793,10.1021/acs.jmedchem.6b00142,aa2ar_human,246,W,A,12j,SMILES,COc1ccc(CCNc2nc(N)c(nc2Cl)C(=O)N=C(N)N)cc1OC,Allosteric inverse agonist,%,Binding - Radioligand competition/displacement,51.0,%,=,,1.8,-28.571,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.8025749877730824
794,10.1021/acs.jmedchem.6b00142,aa2ar_human,246,W,A,12k,SMILES,NC(N)=NC(=O)c1nc(Cl)c(NCCc2ccc3OCOc3c2)nc1N,Allosteric inverse agonist,%,Binding - Radioligand competition/displacement,35.0,%,=,,1.0,-34.483,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.8025749877730824
795,10.1021/acs.jmedchem.6b00142,aa2ar_human,246,W,A,12l,SMILES,CCOc1ccc(CCNc2nc(N)c(nc2Cl)C(=O)N=C(N)N)cc1,Allosteric inverse agonist,%,Binding - Radioligand competition/displacement,27.0,%,=,,3.5,-7.692,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.8025749877730824
796,10.1021/acs.jmedchem.6b00142,aa2ar_human,246,W,A,12m,SMILES,NC(N)=NC(=O)c1nc(Cl)c(NCCc2ccc(OCC=C)cc2)nc1N,Allosteric inverse agonist,%,Binding - Radioligand competition/displacement,43.0,%,=,,2.2,-19.608,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.8025749877730824
797,10.1021/acs.jmedchem.6b00142,aa2ar_human,246,W,A,12n,SMILES,CCCCOc1ccc(CCNc2nc(N)c(nc2Cl)C(=O)N=C(N)N)cc1,Allosteric inverse agonist,%,Binding - Radioligand competition/displacement,66.0,%,=,,3.4,-19.231,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.8025749877730824
798,10.1021/acs.jmedchem.6b00142,aa2ar_human,246,W,A,12o,SMILES,NC(N)=NC(=O)c1nc(Cl)c(NCCc2ccc(OCc3ccccc3)cc2)nc1N,Allosteric inverse agonist,%,Binding - Radioligand competition/displacement,75.0,%,=,,4.0,-18.868,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.8025749877730824
799,10.1021/acs.jmedchem.6b00142,aa2ar_human,246,W,A,12p,SMILES,NC(N)=NC(=O)c1nc(Cl)c(NCCc2ccc(OC(F)(F)F)cc2)nc1N,Allosteric inverse agonist,%,Binding - Radioligand competition/displacement,63.0,%,=,,5.2,-12.048,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.8025749877730824
800,10.1021/acs.jmedchem.6b00142,aa2ar_human,246,W,A,Amiloride,PubChem CID,16231,Allosteric inverse agonist,%,Binding - Radioligand competition/displacement,71.0,%,=,,11.0,-6.452,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.8025749877730824
801,10.1021/acs.jmedchem.6b00142,aa2ar_human,246,W,A,HMA,PubChem CID,1794,Allosteric inverse agonist,%,Binding - Radioligand competition/displacement,30.0,%,=,,1.8,-16.667,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.8025749877730824
802,10.1021/acs.jmedchem.6b00142,aa2ar_human,246,W,A,CID11277660,PubChem CID,11277660,Allosteric inverse agonist,%,Binding - Radioligand competition/displacement,88.0,%,=,,111.0,1.261,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.8025749877730824
803,10.1021/acs.jmedchem.6b00142,aa2ar_human,246,W,A,CID57403241,PubChem CID,57403241,Allosteric inverse agonist,%,Binding - Radioligand competition/displacement,87.0,%,=,,48.0,-1.812,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.8025749877730824
804,10.1021/acs.jmedchem.6b00142,aa2ar_human,246,W,A,CID57396267,PubChem CID,57396267,Allosteric inverse agonist,%,Binding - Radioligand competition/displacement,96.0,%,=,,70.0,-1.372,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.8025749877730824
805,10.1021/acs.jmedchem.6b00142,aa2ar_human,246,W,A,CID57392705,PubChem CID,57392705,Allosteric inverse agonist,%,Binding - Radioligand competition/displacement,65.0,%,=,,17.0,-3.817,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.8025749877730824
806,10.1021/acs.jmedchem.6b00142,aa2ar_human,246,W,A,CID57392707,PubChem CID,57392707,Allosteric inverse agonist,%,Binding - Radioligand competition/displacement,99.0,%,=,,101.0,1.02,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.8025749877730824
807,10.1021/acs.jmedchem.6b00142,aa2ar_human,246,W,A,CID57399649,PubChem CID,57399649,Allosteric inverse agonist,%,Binding - Radioligand competition/displacement,77.0,%,=,,21.0,-3.663,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.8025749877730824
808,10.1021/acs.jmedchem.6b00142,aa2ar_human,246,W,A,CID57403156,PubChem CID,57403156,Allosteric inverse agonist,%,Binding - Radioligand competition/displacement,71.0,%,=,,46.0,-1.543,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.8025749877730824
809,10.1021/acs.jmedchem.6b00142,aa2ar_human,246,W,A,CID57399651,PubChem CID,57399651,Allosteric inverse agonist,%,Binding - Radioligand competition/displacement,87.0,%,=,,73.0,-1.192,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.8025749877730824
810,10.1021/acs.jmedchem.6b00142,aa2ar_human,246,W,A,CID57394421,PubChem CID,57394421,Allosteric inverse agonist,%,Binding - Radioligand competition/displacement,96.0,%,=,,48.0,-2.0,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.8025749877730824
811,10.1021/acs.jmedchem.6b00142,aa2ar_human,246,W,A,CID44574895,PubChem CID,44574895,Allosteric inverse agonist,%,Binding - Radioligand competition/displacement,54.0,%,=,,1.1,-50.0,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.8025749877730824
812,10.1021/acs.jmedchem.6b00142,aa2ar_human,246,W,A,compound_13,SMILES,NC(N)=NC(=O)c1nc(Cl)c(NCCCc2ccccc2)nc1N,Allosteric inverse agonist,%,Binding - Radioligand competition/displacement,60.0,%,=,,9.0,-6.667,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.8025749877730824
813,10.1021/acs.jmedchem.6b00142,aa2ar_human,246,W,A,CID57390905,PubChem CID,57390905,Allosteric inverse agonist,%,Binding - Radioligand competition/displacement,85.0,%,=,,53.0,-1.603,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.8025749877730824
814,10.1021/acs.jmedchem.6b00142,aa2ar_human,246,W,A,CID57397997,PubChem CID,57397997,Allosteric inverse agonist,%,Binding - Radioligand competition/displacement,90.0,%,=,,65.0,-1.385,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.8025749877730824
815,10.1021/acs.jmedchem.6b00142,aa2ar_human,246,W,A,CID57390907,PubChem CID,57390907,Allosteric inverse agonist,%,Binding - Radioligand competition/displacement,84.0,%,=,,35.0,-2.398,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.8025749877730824
816,10.1021/acs.jmedchem.6b00142,aa2ar_human,246,W,A,CID57394423,PubChem CID,57394423,Allosteric inverse agonist,%,Binding - Radioligand competition/displacement,82.0,%,=,,18.0,-4.545,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.8025749877730824
817,10.1021/acs.jmedchem.6b00142,aa2ar_human,246,W,A,CID57401407,PubChem CID,57401407,Allosteric inverse agonist,%,Binding - Radioligand competition/displacement,85.0,%,=,,32.0,-2.66,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.8025749877730824
818,10.1021/acs.jmedchem.6b00142,aa2ar_human,246,W,A,HMA,PubChem CID,1794,Allosteric inverse agonist,IC50,Binding - Radioligand competition/displacement,5.1,ÂµM,=,,0.27,18.889,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.8025749877730824
819,10.1021/acs.jmedchem.6b00142,aa2ar_human,246,W,A,12h,SMILES,COc1ccc(CCNc2nc(N)c(nc2Cl)C(=O)N=C(N)N)cc1,Allosteric inverse agonist,IC50,Binding - Radioligand competition/displacement,4.4,ÂµM,=,,0.12,36.667,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.8025749877730824
820,10.1021/acs.jmedchem.6b00142,aa2ar_human,246,W,A,12i,SMILES,COc1cccc(CCNc2nc(N)c(nc2Cl)C(=O)N=C(N)N)c1,Allosteric inverse agonist,IC50,Binding - Radioligand competition/displacement,8.1,ÂµM,=,,0.25,32.4,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.8025749877730824
821,10.1021/acs.jmedchem.6b00142,aa2ar_human,246,W,A,12k,SMILES,NC(N)=NC(=O)c1nc(Cl)c(NCCc2ccc3OCOc3c2)nc1N,Allosteric inverse agonist,IC50,Binding - Radioligand competition/displacement,5.6,ÂµM,=,,0.07,80.0,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.8025749877730824
822,10.1021/acs.jmedchem.6b00142,aa2ar_human,246,W,A,12l,SMILES,CCOc1ccc(CCNc2nc(N)c(nc2Cl)C(=O)N=C(N)N)cc1,Allosteric inverse agonist,IC50,Binding - Radioligand competition/displacement,3.4,ÂµM,=,,0.05,68.0,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.8025749877730824
823,10.1021/acs.jmedchem.6b00142,aa2ar_human,246,W,A,HMA,PubChem CID,1794,Allosteric inverse agonist,RT,Binding - Radioligand kinetics (association/dissociation),28.0,min,=,,1.4,20.0,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.8025749877730824
824,10.1021/acs.jmedchem.6b00142,aa2ar_human,246,W,A,12h,SMILES,COc1ccc(CCNc2nc(N)c(nc2Cl)C(=O)N=C(N)N)cc1,Allosteric inverse agonist,RT,Binding - Radioligand kinetics (association/dissociation),44.0,min,=,,2.0,22.0,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.8025749877730824
825,10.1021/acs.jmedchem.6b00142,aa2ar_human,246,W,A,12i,SMILES,COc1cccc(CCNc2nc(N)c(nc2Cl)C(=O)N=C(N)N)c1,Allosteric inverse agonist,RT,Binding - Radioligand kinetics (association/dissociation),42.0,min,=,,0.8,52.5,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.8025749877730824
826,10.1021/acs.jmedchem.6b00142,aa2ar_human,246,W,A,12k,SMILES,NC(N)=NC(=O)c1nc(Cl)c(NCCc2ccc3OCOc3c2)nc1N,Allosteric inverse agonist,RT,Binding - Radioligand kinetics (association/dissociation),61.0,min,=,,1.2,50.833,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.8025749877730824
827,10.1021/acs.jmedchem.6b00142,aa2ar_human,246,W,A,12l,SMILES,CCOc1ccc(CCNc2nc(N)c(nc2Cl)C(=O)N=C(N)N)cc1,Allosteric inverse agonist,RT,Binding - Radioligand kinetics (association/dissociation),40.0,min,=,,1.3,30.769,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.8025749877730824
828,10.1021/acs.jmedchem.6b00142,aa2ar_human,246,W,A,ZM241385,PubChem CID,5311506,Inverse agonist,RT,Binding - Radioligand kinetics (association/dissociation),61.0,min,=,,2.8,21.786,,,,0.0,0.0,=,0.0,,P29274,0.8025749877730824
832,10.1074/jbc.M109.096974,aa2ar_human,249,L,A,CGS21680,PubChem CID,3086599,Full agonist,EC50,Functional - cAMP accumulation,7.63,nM,=,,6.51,1.172,,,,0.0,0.0,=,0.0,,P29274,0.5463574851930656
833,7775460,aa2ar_human,250,H,F,CGS21680,PubChem CID,3086599,Full agonist,K(d),Binding - Radioligand saturation,21.7,nM,=,,14.4,1.507,,,,0.0,0.0,=,0.0,,P29274,0.5274836875660316
836,7775460,aa2ar_human,250,H,F,CADO,PubChem CID,8974,Full agonist,K(i),Binding - Radioligand competition/displacement,152.0,nM,=,,2130.0,-14.085,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.5274836875660316
838,7775460,aa2ar_human,250,H,F,DPMA,PubChem CID,10391971,Full agonist,K(i),Binding - Radioligand competition/displacement,244.0,nM,=,,1650.0,-6.757,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.5274836875660316
840,7775460,aa2ar_human,250,H,F,NECA,PubChem CID,448222,Full agonist,K(i),Binding - Radioligand competition/displacement,19.9,nM,=,,41.9,-2.105,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.5274836875660316
842,7775460,aa2ar_human,250,H,F,R-PIA,PubChem CID,114854,Full agonist,K(i),Binding - Radioligand competition/displacement,318.0,nM,=,,7950.0,-25.0,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.5274836875660316
844,7775460,aa2ar_human,250,H,F,CGS15943,PubChem CID,2690,Inverse agonist,K(i),Binding - Radioligand competition/displacement,10.1,nM,=,,25.7,-2.545,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.5274836875660316
846,7775460,aa2ar_human,250,H,F,XAC,PubChem CID,5697,Inverse agonist,K(i),Binding - Radioligand competition/displacement,63.2,nM,=,,60.3,1.048,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.5274836875660316
834,7775460,aa2ar_human,250,H,Y,CGS21680,PubChem CID,3086599,Full agonist,K(d),Binding - Radioligand saturation,21.7,nM,=,,14.9,1.456,,,,0.0,0.0,=,0.0,,P29274,0.3941172674709078
837,7775460,aa2ar_human,250,H,Y,CADO,PubChem CID,8974,Full agonist,K(i),Binding - Radioligand competition/displacement,152.0,nM,=,,8250.0,-55.556,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.3941172674709078
839,7775460,aa2ar_human,250,H,Y,DPMA,PubChem CID,10391971,Full agonist,K(i),Binding - Radioligand competition/displacement,244.0,nM,=,,3000.0,-12.346,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.3941172674709078
841,7775460,aa2ar_human,250,H,Y,NECA,PubChem CID,448222,Full agonist,K(i),Binding - Radioligand competition/displacement,19.9,nM,=,,43.8,-2.203,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.3941172674709078
843,7775460,aa2ar_human,250,H,Y,R-PIA,PubChem CID,114854,Full agonist,K(i),Binding - Radioligand competition/displacement,318.0,nM,=,,9580.0,-30.303,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.3941172674709078
845,7775460,aa2ar_human,250,H,Y,CGS15943,PubChem CID,2690,Inverse agonist,K(i),Binding - Radioligand competition/displacement,10.1,nM,=,,8.4,1.202,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.3941172674709078
847,7775460,aa2ar_human,250,H,Y,XAC,PubChem CID,5697,Inverse agonist,K(i),Binding - Radioligand competition/displacement,63.2,nM,=,,52.7,1.199,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.3941172674709078
850,10.1021/jm970084v,aa2ar_human,250,H,N,CGS21680,PubChem CID,3086599,Full agonist,K(d),Binding - Radioligand saturation,36.4,nM,=,,7.6,4.789,,,,0.0,0.0,=,0.0,,P29274,0.4378210416788077
851,10.1021/jm970084v,aa2ar_human,250,H,N,DPMA,PubChem CID,10391971,Full agonist,K(i),Binding - Radioligand competition/displacement,38.1,nM,=,,35.9,1.061,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.4378210416788077
852,10.1021/jm970084v,aa2ar_human,250,H,N,NECA,PubChem CID,448222,Full agonist,K(i),Binding - Radioligand competition/displacement,21.6,nM,=,,5.24,4.122,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.4378210416788077
853,10.1021/jm970084v,aa2ar_human,250,H,N,IB-MECA,PubChem CID,123683,Full agonist,K(i),Binding - Radioligand competition/displacement,370.0,nM,=,,32.0,11.562,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.4378210416788077
854,10.1021/jm970084v,aa2ar_human,250,H,N,CGS15943,PubChem CID,2690,Inverse agonist,K(i),Binding - Radioligand competition/displacement,0.142,nM,=,,0.457,-3.215,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.4378210416788077
855,10.1021/jm970084v,aa2ar_human,250,H,N,XAC,PubChem CID,5697,Inverse agonist,K(i),Binding - Radioligand competition/displacement,7.89,nM,=,,15.6,-1.976,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.4378210416788077
856,10.1021/jm970084v,aa2ar_human,250,H,N,Galangin,PubChem CID,5281616,Inverse agonist,K(i),Binding - Radioligand competition/displacement,16.7,ÂµM,=,,33.0,-1.976,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.4378210416788077
857,10.1021/jm970084v,aa2ar_human,250,H,N,Nifedipine,PubChem CID,4485,Inverse agonist,K(i),Binding - Radioligand competition/displacement,24.4,ÂµM,=,,22.2,1.099,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.4378210416788077
858,10.1021/jm970084v,aa2ar_human,250,H,N,DPCPX,PubChem CID,1329,Inverse agonist,K(i),Binding - Radioligand competition/displacement,226.0,nM,=,,291.0,-1.287,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.4378210416788077
859,10.1021/jm970084v,aa2ar_human,250,H,N,BTH4,ChEMBL Compound ID,CHEMBL87496,Inverse agonist,K(i),Binding - Radioligand competition/displacement,106.0,ÂµM,=,,54.3,1.952,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.4378210416788077
860,10.1021/jm970084v,aa2ar_human,250,H,N,Amiloride,PubChem CID,16231,Allosteric inverse agonist,K(i),Binding - Radioligand competition/displacement,12.0,ÂµM,=,,3.28,3.659,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.4378210416788077
891,7775460,aa2ar_human,254,C,A,CGS21680,PubChem CID,3086599,Full agonist,K(d),Binding - Radioligand saturation,21.7,nM,=,,23.7,-1.092,,,,0.0,0.0,=,0.0,,P29274,0.358974851242935
892,7775460,aa2ar_human,254,C,A,DPMA,PubChem CID,10391971,Full agonist,K(i),Binding - Radioligand competition/displacement,244.0,nM,=,,99.6,2.45,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.358974851242935
893,7775460,aa2ar_human,254,C,A,NECA,PubChem CID,448222,Full agonist,K(i),Binding - Radioligand competition/displacement,19.9,nM,=,,18.2,1.093,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.358974851242935
894,7775460,aa2ar_human,254,C,A,CGS15943,PubChem CID,2690,Inverse agonist,K(i),Binding - Radioligand competition/displacement,10.1,nM,=,,19.4,-1.919,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.358974851242935
895,7775460,aa2ar_human,254,C,A,XAC,PubChem CID,5697,Inverse agonist,K(i),Binding - Radioligand competition/displacement,63.2,nM,=,,54.1,1.168,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.358974851242935
897,10.1124/mol.115.102657,aa2ar_human,256,T,A,ZM241385,PubChem CID,5311506,Inverse agonist,pK(i),Binding - Radioligand competition/displacement,7.83,,=,,7.43,-2.513,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.3883194613963081
898,10.1124/mol.115.102657,aa2ar_human,256,T,A,ZM241385,PubChem CID,5311506,Inverse agonist,k-1,Binding - Radioligand kinetics (association/dissociation),0.0119,min-1,=,,0.1994,-16.667,,,,0.0,0.0,=,0.0,,P29274,0.3883194613963081
907,10.1124/mol.111.075937,aa2ar_human,264,H,A,LUF-5834,PubChem CID,10066330,Full agonist,pEC50,Functional - cAMP accumulation,7.8,,=,,8.2,2.512,,,,0.0,0.0,=,0.0,,P29274,0.3118051046429985
908,10.1124/mol.111.075937,aa2ar_human,264,H,A,CGS21680,PubChem CID,3086599,Full agonist,pEC50,Functional - cAMP accumulation,7.7,,=,,7.1,-3.984,,,,0.0,0.0,=,0.0,,P29274,0.3118051046429985
909,10.1124/mol.114.097360,aa2ar_human,264,H,A,NECA,PubChem CID,448222,Full agonist,pEC50,Functional - cAMP accumulation,9.05,,=,,8.18,-7.407,,,,0.0,0.0,=,0.0,,P29274,0.3118051046429985
910,10.1124/mol.114.097360,aa2ar_human,264,H,A,CGS21680,PubChem CID,3086599,Full agonist,pEC50,Functional - cAMP accumulation,8.27,,=,,7.52,-5.618,,,,0.0,0.0,=,0.0,,P29274,0.3118051046429985
913,10.1124/mol.115.102657,aa2ar_human,264,H,A,ZM241385,PubChem CID,5311506,Inverse agonist,pK(i),Binding - Radioligand competition/displacement,7.83,,=,,7.69,-1.381,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.3118051046429985
914,10.1124/mol.115.102657,aa2ar_human,264,H,A,ZM241385,PubChem CID,5311506,Inverse agonist,k-1,Binding - Radioligand kinetics (association/dissociation),0.0119,min-1,=,,0.2235,-18.868,,,,0.0,0.0,=,0.0,,P29274,0.3118051046429985
916,10.1021/acs.jmedchem.6b00653,aa2ar_human,264,H,A,CID44394716,PubChem CID,44394716,Inverse agonist,%,Binding - Radioligand saturation,76.0,%,=,,97.0,1.276,,,,0.0,0.0,=,0.0,,P29274,0.3118051046429985
917,10.1021/acs.jmedchem.6b00653,aa2ar_human,264,H,A,CID86302363,PubChem CID,86302363,Inverse agonist,%,Binding - Radioligand saturation,105.0,%,=,,105.0,1.0,,,,0.0,0.0,=,0.0,,P29274,0.3118051046429985
918,10.1021/acs.jmedchem.6b00653,aa2ar_human,264,H,A,ZM241385,PubChem CID,5311506,Inverse agonist,%,Binding - Radioligand saturation,105.0,%,=,,106.0,1.01,,,,0.0,0.0,=,0.0,,P29274,0.3118051046429985
923,10.1124/mol.114.097360,aa2ar_human,267,L,A,NECA,PubChem CID,448222,Full agonist,pEC50,Functional - cAMP accumulation,9.05,,=,,8.81,-1.739,,,,0.0,0.0,=,0.0,,P29274,0.2688774197033378
924,10.1124/mol.114.097360,aa2ar_human,267,L,A,CGS21680,PubChem CID,3086599,Full agonist,pEC50,Functional - cAMP accumulation,8.27,,=,,9.66,24.547,,,,0.0,0.0,=,0.0,,P29274,0.2688774197033378
927,10.1124/mol.115.102657,aa2ar_human,267,L,A,ZM241385,PubChem CID,5311506,Inverse agonist,pK(i),Binding - Radioligand competition/displacement,7.83,,=,,7.78,-1.122,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.2688774197033378
928,10.1124/mol.115.102657,aa2ar_human,267,L,A,ZM241385,PubChem CID,5311506,Inverse agonist,k-1,Binding - Radioligand kinetics (association/dissociation),0.0119,min-1,=,,0.0051,2.333,,,,0.0,0.0,=,0.0,,P29274,0.2688774197033378
929,10.1021/jm2003798,aa2ar_human,271,Y,A,ZM241385,SMILES,Nc1nc(NCCc2ccc(O)cc2)nc3nc(nn13)c4occc4,Inverse agonist,pK(d),Biing - Surface plasmon resonance,9.3,,=,,8.7,-3.984,,,,0.0,0.0,=,0.0,,P29274,0.4255510965629855
930,10.1021/jm2003798,aa2ar_human,271,Y,A,SCH420814,PubChem CID,10117987,Inverse agonist,pK(d),Biing - Surface plasmon resonance,9.5,,=,,8.6,-7.937,,,,0.0,0.0,=,0.0,,P29274,0.4255510965629855
931,10.1021/jm2003798,aa2ar_human,271,Y,A,KW6002,PubChem CID,5311037,Inverse agonist,pK(d),Biing - Surface plasmon resonance,5.9,,=,,5.9,1.0,,,,0.0,0.0,=,0.0,,P29274,0.4255510965629855
932,10.1021/jm2003798,aa2ar_human,271,Y,A,XAC,PubChem CID,5697,Inverse agonist,pK(d),Biing - Surface plasmon resonance,7.7,,=,,7.2,-3.165,,,,0.0,0.0,=,0.0,,P29274,0.4255510965629855
933,10.1021/jm2003798,aa2ar_human,271,Y,A,Caffeine,PubChem CID,2519,Inverse agonist,pK(d),Biing - Surface plasmon resonance,4.6,,=,,4.6,1.0,,,,0.0,0.0,=,0.0,,P29274,0.4255510965629855
934,10.1021/jm2003798,aa2ar_human,271,Y,A,Theophylline,PubChem CID,2153,Antagonist (neutral/silent),pK(d),Biing - Surface plasmon resonance,5.5,,=,,5.6,1.259,,,,0.0,0.0,=,0.0,,P29274,0.4255510965629855
935,10.1021/jm2003798,aa2ar_human,271,Y,A,Chromone1a,PubChem CID,740769,Inverse agonist,pK(d),Biing - Surface plasmon resonance,7.3,,=,,6.6,-5.0,,,,0.0,0.0,=,0.0,,P29274,0.4255510965629855
936,10.1021/jm2003798,aa2ar_human,271,Y,A,Chromone1b,PubChem CID,5413075,Inverse agonist,pK(d),Biing - Surface plasmon resonance,5.9,,=,,6.0,1.259,,,,0.0,0.0,=,0.0,,P29274,0.4255510965629855
937,10.1021/jm2003798,aa2ar_human,271,Y,A,Chromone1c,SMILES,CCc1cc2C(=O)C(=COc2cc1OC(N)=O)c3scc(C)n3,Inverse agonist,pK(d),Biing - Surface plasmon resonance,5.9,,=,,5.9,1.0,,,,0.0,0.0,=,0.0,,P29274,0.4255510965629855
938,10.1021/jm2003798,aa2ar_human,271,Y,A,Chromone1d,PubChem CID,5310837,Inverse agonist,pK(d),Biing - Surface plasmon resonance,6.1,,=,,5.5,-3.984,,,,0.0,0.0,=,0.0,,P29274,0.4255510965629855
939,10.1021/jm2003798,aa2ar_human,271,Y,A,Chromone1e,PubChem CID,5425546,Inverse agonist,pK(d),Biing - Surface plasmon resonance,5.8,,=,,5.5,-1.996,,,,0.0,0.0,=,0.0,,P29274,0.4255510965629855
940,10.1021/jm2003798,aa2ar_human,271,Y,A,NOTDISCLOSED,,NOT DISCLOSED,Inverse agonist,pK(d),Biing - Surface plasmon resonance,6.0,,=,,5.5,-3.165,,,,0.0,0.0,=,0.0,,P29274,0.4255510965629855
941,10.1021/jm2003798,aa2ar_human,271,Y,A,Triazine15,SMILES,CN1CCN(CC1)C(=O)c2cccc(c2)c3nc(N)nc(n3)c4ccccc4O,Inverse agonist,pK(d),Biing - Surface plasmon resonance,7.9,,=,,7.8,-1.259,,,,0.0,0.0,=,0.0,,P29274,0.4255510965629855
942,10.1021/jm2003798,aa2ar_human,271,Y,A,Triazine3a,PubChem CID,53354627,Inverse agonist,pK(d),Biing - Surface plasmon resonance,6.7,,=,,5.9,-6.329,,,,0.0,0.0,=,0.0,,P29274,0.4255510965629855
943,10.1021/jm2003798,aa2ar_human,271,Y,A,Triazine3b,PubChem CID,70689850,Inverse agonist,pK(d),Biing - Surface plasmon resonance,8.9,,=,,8.6,-1.996,,,,0.0,0.0,=,0.0,,P29274,0.4255510965629855
944,10.1021/jm2003798,aa2ar_human,271,Y,A,Triazine3c,PubChem CID,53353516,Inverse agonist,pK(d),Biing - Surface plasmon resonance,8.5,,=,,8.2,-1.996,,,,0.0,0.0,=,0.0,,P29274,0.4255510965629855
945,10.1021/jm2003798,aa2ar_human,271,Y,A,Triazine3d,PubChem CID,56844240,Inverse agonist,pK(d),Biing - Surface plasmon resonance,8.2,,=,,7.9,-1.996,,,,0.0,0.0,=,0.0,,P29274,0.4255510965629855
946,10.1021/jm2003798,aa2ar_human,271,Y,A,Triazine3e,PubChem CID,86676119,Inverse agonist,pK(d),Biing - Surface plasmon resonance,8.2,,=,,8.0,-1.585,,,,0.0,0.0,=,0.0,,P29274,0.4255510965629855
947,10.1021/jm2003798,aa2ar_human,271,Y,A,Triazine3f,PubChem CID,87370822,Inverse agonist,pK(d),Biing - Surface plasmon resonance,8.5,,=,,8.4,-1.259,,,,0.0,0.0,=,0.0,,P29274,0.4255510965629855
948,10.1021/jm2003798,aa2ar_human,271,Y,A,Triazine3g,PubChem CID,86676123,Inverse agonist,pK(d),Biing - Surface plasmon resonance,9.3,,=,,7.9,-25.0,,,,0.0,0.0,=,0.0,,P29274,0.4255510965629855
949,10.1021/jm2003798,aa2ar_human,271,Y,A,Triazine3h,PubChem CID,56964225,Inverse agonist,pK(d),Biing - Surface plasmon resonance,9.2,,=,,8.1,-12.658,,,,0.0,0.0,=,0.0,,P29274,0.4255510965629855
959,7775460,aa2ar_human,274,I,A,CGS21680,PubChem CID,3086599,Full agonist,EC50,Functional - cAMP accumulation,3.0,nM,=,,100.0,-33.333,,,,72.0,0.0,=,0.0,,P29274,0.516782623210858
960,10.1021/jm2003798,aa2ar_human,277,S,A,ZM241385,SMILES,Nc1nc(NCCc2ccc(O)cc2)nc3nc(nn13)c4occc4,Inverse agonist,pK(d),Biing - Surface plasmon resonance,9.3,,=,,8.9,-2.513,,,,0.0,0.0,=,0.0,,P29274,0.4521741654241664
961,10.1021/jm2003798,aa2ar_human,277,S,A,SCH420814,PubChem CID,10117987,Inverse agonist,pK(d),Biing - Surface plasmon resonance,9.5,,=,,8.6,-7.937,,,,0.0,0.0,=,0.0,,P29274,0.4521741654241664
962,10.1021/jm2003798,aa2ar_human,277,S,A,KW6002,PubChem CID,5311037,Inverse agonist,pK(d),Biing - Surface plasmon resonance,5.9,,=,,6.6,5.012,,,,0.0,0.0,=,0.0,,P29274,0.4521741654241664
963,10.1021/jm2003798,aa2ar_human,277,S,A,XAC,PubChem CID,5697,Inverse agonist,pK(d),Biing - Surface plasmon resonance,7.7,,=,,8.0,1.995,,,,0.0,0.0,=,0.0,,P29274,0.4521741654241664
964,10.1021/jm2003798,aa2ar_human,277,S,A,Caffeine,PubChem CID,2519,Inverse agonist,pK(d),Biing - Surface plasmon resonance,4.6,,=,,5.3,5.012,,,,0.0,0.0,=,0.0,,P29274,0.4521741654241664
965,10.1021/jm2003798,aa2ar_human,277,S,A,Theophylline,PubChem CID,2153,Antagonist (neutral/silent),pK(d),Biing - Surface plasmon resonance,5.5,,=,,5.5,1.0,,,,0.0,0.0,=,0.0,,P29274,0.4521741654241664
966,10.1021/jm2003798,aa2ar_human,277,S,A,Chromone1a,PubChem CID,740769,Inverse agonist,pK(d),Biing - Surface plasmon resonance,7.3,,=,,7.6,1.995,,,,0.0,0.0,=,0.0,,P29274,0.4521741654241664
967,10.1021/jm2003798,aa2ar_human,277,S,A,Chromone1b,PubChem CID,5413075,Inverse agonist,pK(d),Biing - Surface plasmon resonance,5.9,,=,,6.2,1.995,,,,0.0,0.0,=,0.0,,P29274,0.4521741654241664
968,10.1021/jm2003798,aa2ar_human,277,S,A,Chromone1c,SMILES,CCc1cc2C(=O)C(=COc2cc1OC(N)=O)c3scc(C)n3,Inverse agonist,pK(d),Biing - Surface plasmon resonance,5.9,,=,,6.1,1.585,,,,0.0,0.0,=,0.0,,P29274,0.4521741654241664
969,10.1021/jm2003798,aa2ar_human,277,S,A,Chromone1d,PubChem CID,5310837,Inverse agonist,pK(d),Biing - Surface plasmon resonance,6.1,,=,,6.2,1.259,,,,0.0,0.0,=,0.0,,P29274,0.4521741654241664
970,10.1021/jm2003798,aa2ar_human,277,S,A,Chromone1e,PubChem CID,5425546,Inverse agonist,pK(d),Biing - Surface plasmon resonance,5.8,,=,,5.8,1.0,,,,0.0,0.0,=,0.0,,P29274,0.4521741654241664
971,10.1021/jm2003798,aa2ar_human,277,S,A,NOTDISCLOSED,,NOT DISCLOSED,Inverse agonist,pK(d),Biing - Surface plasmon resonance,6.0,,=,,5.4,-3.984,,,,0.0,0.0,=,0.0,,P29274,0.4521741654241664
972,10.1021/jm2003798,aa2ar_human,277,S,A,Triazine15,SMILES,CN1CCN(CC1)C(=O)c2cccc(c2)c3nc(N)nc(n3)c4ccccc4O,Inverse agonist,pK(d),Biing - Surface plasmon resonance,7.9,,=,,6.9,-10.0,,,,0.0,0.0,=,0.0,,P29274,0.4521741654241664
973,10.1021/jm2003798,aa2ar_human,277,S,A,Triazine3a,PubChem CID,53354627,Inverse agonist,pK(d),Biing - Surface plasmon resonance,6.7,,=,,7.7,10.0,,,,0.0,0.0,=,0.0,,P29274,0.4521741654241664
974,10.1021/jm2003798,aa2ar_human,277,S,A,Triazine3b,PubChem CID,70689850,Inverse agonist,pK(d),Biing - Surface plasmon resonance,8.9,,=,,9.2,1.995,,,,0.0,0.0,=,0.0,,P29274,0.4521741654241664
975,10.1021/jm2003798,aa2ar_human,277,S,A,Triazine3c,PubChem CID,53353516,Inverse agonist,pK(d),Biing - Surface plasmon resonance,8.5,,=,,9.3,6.31,,,,0.0,0.0,=,0.0,,P29274,0.4521741654241664
976,10.1021/jm2003798,aa2ar_human,277,S,A,Triazine3d,PubChem CID,56844240,Inverse agonist,pK(d),Biing - Surface plasmon resonance,8.2,,=,,9.1,7.943,,,,0.0,0.0,=,0.0,,P29274,0.4521741654241664
977,10.1021/jm2003798,aa2ar_human,277,S,A,Triazine3e,PubChem CID,86676119,Inverse agonist,pK(d),Biing - Surface plasmon resonance,8.2,,=,,9.4,15.849,,,,0.0,0.0,=,0.0,,P29274,0.4521741654241664
978,10.1021/jm2003798,aa2ar_human,277,S,A,Triazine3f,PubChem CID,87370822,Inverse agonist,pK(d),Biing - Surface plasmon resonance,8.5,,=,,9.9,25.119,,,,0.0,0.0,=,0.0,,P29274,0.4521741654241664
979,10.1021/jm2003798,aa2ar_human,277,S,A,Triazine3g,PubChem CID,86676123,Inverse agonist,pK(d),Biing - Surface plasmon resonance,9.3,,=,,10.0,5.012,,,,0.0,0.0,=,0.0,,P29274,0.4521741654241664
980,10.1021/jm2003798,aa2ar_human,277,S,A,Triazine3h,PubChem CID,56964225,Inverse agonist,pK(d),Biing - Surface plasmon resonance,9.2,,=,,10.0,6.31,,,,0.0,0.0,=,0.0,,P29274,0.4521741654241664
996,7775460,aa2ar_human,277,S,A,XAC,PubChem CID,5697,Inverse agonist,K(d),Binding - Radioligand saturation,9.4,nM,=,,6.7,1.403,,,,0.0,0.0,=,0.0,,P29274,0.4521741654241664
997,7775460,aa2ar_human,277,S,A,CGS21680,PubChem CID,3086599,Full agonist,K(i),Binding - Radioligand saturation,0.0407,ÂµM,=,,43.6,-1000.0,,,XAC,25.0,0.0,=,0.0,,P29274,0.4521741654241664
998,7775460,aa2ar_human,277,S,A,CADO,PubChem CID,8974,Full agonist,K(i),Binding - Radioligand saturation,0.208,ÂµM,=,,81.3,-333.333,,,XAC,25.0,0.0,=,0.0,,P29274,0.4521741654241664
999,7775460,aa2ar_human,277,S,A,DPMA,PubChem CID,10391971,Full agonist,K(i),Binding - Radioligand saturation,0.373,ÂµM,=,,40.0,-111.111,,,XAC,25.0,0.0,=,0.0,,P29274,0.4521741654241664
1000,7775460,aa2ar_human,277,S,A,IB-MECA,PubChem CID,123683,Full agonist,K(i),Binding - Radioligand saturation,1.45,ÂµM,=,,96.0,-66.667,,,XAC,25.0,0.0,=,0.0,,P29274,0.4521741654241664
1001,7775460,aa2ar_human,277,S,A,NECA,PubChem CID,448222,Full agonist,K(i),Binding - Radioligand saturation,0.0725,ÂµM,=,,29.1,-500.0,,,XAC,25.0,0.0,=,0.0,,P29274,0.4521741654241664
1002,7775460,aa2ar_human,277,S,A,R-PIA,PubChem CID,114854,Full agonist,K(i),Binding - Radioligand saturation,0.792,ÂµM,=,,33.8,-43.478,,,XAC,25.0,0.0,=,0.0,,P29274,0.4521741654241664
1003,7775460,aa2ar_human,277,S,A,CGS15943,PubChem CID,2690,Inverse agonist,K(i),Binding - Radioligand saturation,20.7,nM,=,,17.5,1.183,,,XAC,25.0,0.0,=,0.0,,P29274,0.4521741654241664
1004,7775460,aa2ar_human,277,S,A,DPCPX,PubChem CID,1329,Inverse agonist,K(i),Binding - Radioligand saturation,663.0,nM,=,,219.0,3.027,,,XAC,25.0,0.0,=,0.0,,P29274,0.4521741654241664
1005,7775460,aa2ar_human,277,S,A,CGS21680,PubChem CID,3086599,Full agonist,EC50,Functional - cAMP accumulation,3.0,nM,=,,210.0,-71.429,,,,25.0,0.0,=,0.0,,P29274,0.4521741654241664
1023,10.1124/mol.111.075937,aa2ar_human,277,S,A,LUF-5834,PubChem CID,10066330,Full agonist,pEC50,Functional - cAMP accumulation,7.8,,=,,8.2,2.512,,,,0.0,0.0,=,0.0,,P29274,0.4521741654241664
1024,10.1124/mol.111.075937,aa2ar_human,277,S,A,CGS21680,PubChem CID,3086599,Full agonist,pEC50,Functional - cAMP accumulation,7.7,,=,,5.6,-125.0,,,,0.0,0.0,=,0.0,,P29274,0.4521741654241664
1025,10.1124/mol.111.075937,aa2ar_human,277,S,A,ZM241385,PubChem CID,5311506,Inverse agonist,K(d),Binding - Radioligand saturation,3.4,nM,=,,2.9,1.172,,,,0.0,0.0,=,0.0,,P29274,0.4521741654241664
1027,10.1124/mol.111.075937,aa2ar_human,277,S,A,CGS21680,PubChem CID,3086599,Full agonist,pK(i),Binding - Radioligand competition/displacement,7.1,,=,,7.8,5.012,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.4521741654241664
982,7775460,aa2ar_human,277,S,N,CGS21680,PubChem CID,3086599,Full agonist,K(d),Binding - Radioligand saturation,21.7,nM,=,,25.0,-1.152,,,,0.0,0.0,=,0.0,,P29274,0.4521741654241664
984,7775460,aa2ar_human,277,S,N,CADO,PubChem CID,8974,Full agonist,K(i),Binding - Radioligand competition/displacement,152.0,nM,=,,221.0,-1.453,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.4521741654241664
986,7775460,aa2ar_human,277,S,N,DPMA,PubChem CID,10391971,Full agonist,K(i),Binding - Radioligand competition/displacement,244.0,nM,=,,311.0,-1.274,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.4521741654241664
988,7775460,aa2ar_human,277,S,N,NECA,PubChem CID,448222,Full agonist,K(i),Binding - Radioligand competition/displacement,19.9,nM,=,,43.0,-2.16,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.4521741654241664
990,7775460,aa2ar_human,277,S,N,R-PIA,PubChem CID,114854,Full agonist,K(i),Binding - Radioligand competition/displacement,318.0,nM,=,,631.0,-1.984,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.4521741654241664
992,7775460,aa2ar_human,277,S,N,CGS15943,PubChem CID,2690,Inverse agonist,K(i),Binding - Radioligand competition/displacement,10.1,nM,=,,12.8,-1.267,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.4521741654241664
994,7775460,aa2ar_human,277,S,N,XAC,PubChem CID,5697,Inverse agonist,K(i),Binding - Radioligand competition/displacement,63.2,nM,=,,60.0,1.053,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.4521741654241664
983,7775460,aa2ar_human,277,S,T,CGS21680,PubChem CID,3086599,Full agonist,K(d),Binding - Radioligand saturation,21.7,nM,=,,23.6,-1.088,,,,0.0,0.0,=,0.0,,P29274,0.4521741654241664
985,7775460,aa2ar_human,277,S,T,CADO,PubChem CID,8974,Full agonist,K(i),Binding - Radioligand competition/displacement,152.0,nM,=,,201.0,-1.323,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.4521741654241664
987,7775460,aa2ar_human,277,S,T,DPMA,PubChem CID,10391971,Full agonist,K(i),Binding - Radioligand competition/displacement,244.0,nM,=,,305.0,-1.25,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.4521741654241664
989,7775460,aa2ar_human,277,S,T,NECA,PubChem CID,448222,Full agonist,K(i),Binding - Radioligand competition/displacement,19.9,nM,=,,39.8,-2.0,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.4521741654241664
991,7775460,aa2ar_human,277,S,T,R-PIA,PubChem CID,114854,Full agonist,K(i),Binding - Radioligand competition/displacement,318.0,nM,=,,534.0,-1.678,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.4521741654241664
993,7775460,aa2ar_human,277,S,T,CGS15943,PubChem CID,2690,Inverse agonist,K(i),Binding - Radioligand competition/displacement,10.1,nM,=,,12.2,-1.208,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.4521741654241664
995,7775460,aa2ar_human,277,S,T,XAC,PubChem CID,5697,Inverse agonist,K(i),Binding - Radioligand competition/displacement,63.2,nM,=,,65.9,-1.043,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.4521741654241664
1006,8794889,aa2ar_human,277,S,C,CGS21680,PubChem CID,3086599,Full agonist,K(d),Binding - Radioligand saturation,31.0,nM,=,,37.2,-1.2,,,,0.0,0.0,=,0.0,,P29274,0.541872972201292
1007,8794889,aa2ar_human,277,S,C,CADO,PubChem CID,8974,Full agonist,K(i),Binding - Radioligand competition/displacement,100.0,nM,=,,384.0,-3.846,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.541872972201292
1008,8794889,aa2ar_human,277,S,C,NECA,PubChem CID,448222,Full agonist,K(i),Binding - Radioligand competition/displacement,27.6,nM,=,,129.0,-4.673,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.541872972201292
1009,8794889,aa2ar_human,277,S,C,R-PIA,PubChem CID,114854,Full agonist,K(i),Binding - Radioligand competition/displacement,299.0,nM,=,,1590.0,-5.319,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.541872972201292
1010,8794889,aa2ar_human,277,S,C,IB-MECA,PubChem CID,123683,Full agonist,K(i),Binding - Radioligand competition/displacement,435.0,nM,=,,1755.0,-4.032,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.541872972201292
1011,8794889,aa2ar_human,277,S,C,ADAC,PubChem CID,23789715,Full agonist,K(i),Binding - Radioligand competition/displacement,1330.0,nM,=,,3580.0,-2.688,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.541872972201292
1012,8794889,aa2ar_human,277,S,C,SCH58261,PubChem CID,176408,Inverse agonist,K(i),Binding - Radioligand competition/displacement,1.85,nM,=,,4.7,-2.538,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.541872972201292
1013,8794889,aa2ar_human,277,S,C,CGS15943,PubChem CID,2690,Inverse agonist,K(i),Binding - Radioligand competition/displacement,1.95,nM,=,,1.53,1.275,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.541872972201292
1014,8794889,aa2ar_human,277,S,C,XAC,PubChem CID,5697,Inverse agonist,K(i),Binding - Radioligand competition/displacement,8.71,nM,=,,10.3,-1.182,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.541872972201292
1015,8794889,aa2ar_human,277,S,C,BTH4,ChEMBL Compound ID,CHEMBL87496,Inverse agonist,K(i),Binding - Radioligand competition/displacement,859.0,nM,=,,279.0,3.079,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.541872972201292
1016,8794889,aa2ar_human,277,S,C,ZM241385,PubChem CID,5311506,Inverse agonist,K(i),Binding - Radioligand competition/displacement,0.525,nM,=,,1.35,-2.571,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.541872972201292
1038,7775460,aa2ar_human,278,H,A,CGS21680,PubChem CID,3086599,Full agonist,EC50,Functional - cAMP accumulation,3.0,nM,=,,920.0,-333.333,,,,72.0,0.0,=,0.0,,P29274,0.6025106322034921
1045,10.1016/S0006-2952(00)00357-9,aa2ar_human,278,H,Y,ZM241385,PubChem CID,176407,Inverse agonist,K(d),Binding - Radioligand saturation,1.8,nM,=,,4.3,-2.387,,,,0.0,0.0,=,0.0,,P29274,0.4245791125075306
1046,10.1016/S0006-2952(00)00357-9,aa2ar_human,278,H,Y,ZM241385,PubChem CID,176407,Inverse agonist,k1,Binding - Radioligand kinetics (association/dissociation),0.15,nM-1 min-1,=,,0.25,-1.667,,,,0.0,0.0,=,0.0,,P29274,0.4245791125075306
1047,10.1016/S0006-2952(00)00357-9,aa2ar_human,278,H,Y,ZM241385,PubChem CID,176407,Inverse agonist,k-1,Binding - Radioligand kinetics (association/dissociation),0.29,min-1,=,,0.51,-1.757,,,,0.0,0.0,=,0.0,,P29274,0.4245791125075306
1048,10.1016/S0006-2952(00)00357-9,aa2ar_human,278,H,Y,DPMA,PubChem CID,10391971,Full agonist,K(i),Binding - Radioligand competition/displacement,0.31,ÂµM,=,,3.0,-9.709,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.4245791125075306
1049,10.1016/S0006-2952(00)00357-9,aa2ar_human,278,H,Y,CGS21680,PubChem CID,3086599,Full agonist,K(i),Binding - Radioligand competition/displacement,0.28,ÂµM,=,,19.6,-71.429,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.4245791125075306
1050,10.1016/S0006-2952(00)00357-9,aa2ar_human,278,H,Y,NECA,PubChem CID,448222,Full agonist,K(i),Binding - Radioligand competition/displacement,0.06,ÂµM,=,,13.8,-250.0,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.4245791125075306
1051,10.1016/S0006-2952(00)00357-9,aa2ar_human,278,H,Y,CPA,PubChem CID,4402,Full agonist,K(i),Binding - Radioligand competition/displacement,2.7,ÂµM,=,,37.6,-13.889,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.4245791125075306
1052,10.1016/S0006-2952(00)00357-9,aa2ar_human,278,H,Y,CGS15943,PubChem CID,2690,Inverse agonist,K(i),Binding - Radioligand competition/displacement,0.002,ÂµM,=,,0.006,-3.003,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.4245791125075306
1053,10.1016/S0006-2952(00)00357-9,aa2ar_human,278,H,Y,SCH58261,PubChem CID,176408,Inverse agonist,K(i),Binding - Radioligand competition/displacement,0.008,ÂµM,=,,0.003,2.667,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.4245791125075306
1054,10.1016/S0006-2952(00)00357-9,aa2ar_human,278,H,Y,Theophylline,PubChem CID,2153,Inverse agonist,K(i),Binding - Radioligand competition/displacement,4.7,ÂµM,=,,98.5,-20.833,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.4245791125075306
1055,10.1016/S0006-2952(00)00357-9,aa2ar_human,278,H,Y,XAC,PubChem CID,5697,Inverse agonist,K(i),Binding - Radioligand competition/displacement,0.032,ÂµM,=,,0.065,-2.033,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.4245791125075306
1056,10.1021/jm0300431,aa2ar_human,278,H,D,CGS15943,PubChem CID,2690,Inverse agonist,K(i),Binding - Radioligand competition/displacement,0.84,nM,=,,0.41,2.049,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.5587272706320813
1058,10.1021/jm0300431,aa2ar_human,278,H,D,NECA,PubChem CID,448222,Full agonist,K(i),Binding - Radioligand competition/displacement,21.4,nM,=,,19.1,1.12,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.5587272706320813
1060,10.1021/jm0300431,aa2ar_human,278,H,D,CIDÂ 85129620,PubChem CID,85129620,Full agonist,K(i),Binding - Radioligand competition/displacement,67.0,ÂµM,=,,87.0,-1.299,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.5587272706320813
1062,10.1021/jm0300431,aa2ar_human,278,H,D,522607-99-4,PubChem CID,85116573,Full agonist,K(i),Binding - Radioligand competition/displacement,79.0,ÂµM,=,,59.0,1.339,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.5587272706320813
1064,10.1021/jm0300431,aa2ar_human,278,H,D,Cid13307390,PubChem CID,13307390,Full agonist,K(i),Binding - Radioligand competition/displacement,46.1,ÂµM,=,,121.0,-2.625,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.5587272706320813
1074,7775460,aa2ar_human,281,S,T,CGS21680,PubChem CID,3086599,Full agonist,K(d),Binding - Radioligand saturation,21.7,nM,=,,17.1,1.269,,,,0.0,0.0,=,0.0,,P29274,0.6091605647310183
1076,7775460,aa2ar_human,281,S,T,CADO,PubChem CID,8974,Full agonist,K(i),Binding - Radioligand competition/displacement,152.0,nM,=,,13.7,11.095,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.6091605647310183
1077,7775460,aa2ar_human,281,S,T,DPMA,PubChem CID,10391971,Full agonist,K(i),Binding - Radioligand competition/displacement,244.0,nM,=,,80.5,3.031,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.6091605647310183
1078,7775460,aa2ar_human,281,S,T,NECA,PubChem CID,448222,Full agonist,K(i),Binding - Radioligand competition/displacement,19.9,nM,=,,6.6,3.015,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.6091605647310183
1079,7775460,aa2ar_human,281,S,T,R-PIA,PubChem CID,114854,Full agonist,K(i),Binding - Radioligand competition/displacement,318.0,nM,=,,30.5,10.426,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.6091605647310183
1080,7775460,aa2ar_human,281,S,T,CGS15943,PubChem CID,2690,Inverse agonist,K(i),Binding - Radioligand competition/displacement,10.1,nM,=,,15.6,-1.546,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.6091605647310183
1081,7775460,aa2ar_human,281,S,T,XAC,PubChem CID,5697,Inverse agonist,K(i),Binding - Radioligand competition/displacement,63.2,nM,=,,17.3,3.653,,,CGS21680,0.0,0.0,=,0.0,,P29274,0.6091605647310183
1106,10.1016/j.str.2017.06.012,aa2ar_human,59,A,V,ZM241385,PubChem CID,5311506,Inverse agonist,K(i),Binding - Radioligand competition/displacement,0.0,,=,,0.0,2.89,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.4842918583687027
1110,10.1016/j.str.2017.06.012,aa2ar_human,59,A,V,SCH58261,PubChem CID,176408,Inverse agonist,K(i),Binding - Radioligand competition/displacement,0.0,,=,,0.0,2.44,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.4842918583687027
1114,10.1016/j.str.2017.06.012,aa2ar_human,59,A,V,SCH442416,PubChem CID,10668061,Inverse agonist,K(i),Binding - Radioligand competition/displacement,0.0,,=,,0.0,3.85,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.4842918583687027
1118,10.1016/j.str.2017.06.012,aa2ar_human,59,A,V,Istradefylline,PubChem CID,5311037,Inverse agonist,K(i),Binding - Radioligand competition/displacement,0.0,,=,,0.0,2.88,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.4842918583687027
1122,10.1016/j.str.2017.06.012,aa2ar_human,59,A,V,PSB36,PubChem CID,11689583,Inverse agonist,K(i),Binding - Radioligand competition/displacement,0.0,,=,,0.0,1.35,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.4842918583687027
1126,10.1016/j.str.2017.06.012,aa2ar_human,59,A,V,DPCPX,PubChem CID,1329,Inverse agonist,K(i),Binding - Radioligand competition/displacement,0.0,,=,,0.0,1.48,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.4842918583687027
1130,10.1016/j.str.2017.06.012,aa2ar_human,59,A,V,KW3902,PubChem CID,64627,Inverse agonist,K(i),Binding - Radioligand competition/displacement,0.0,,=,,0.0,3.11,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.4842918583687027
1134,10.1016/j.str.2017.06.012,aa2ar_human,59,A,V,SLV320,PubChem CID,9953065,Inverse agonist,K(i),Binding - Radioligand competition/displacement,0.0,,=,,0.0,-2.222,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.4842918583687027
1138,10.1016/j.str.2017.06.012,aa2ar_human,59,A,V,XAC,PubChem CID,5697,Inverse agonist,K(i),Binding - Radioligand competition/displacement,0.0,,=,,0.0,3.61,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.4842918583687027
1142,10.1016/j.str.2017.06.012,aa2ar_human,59,A,V,CGS15943,PubChem CID,2690,Inverse agonist,K(i),Binding - Radioligand competition/displacement,0.0,,=,,0.0,2.11,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.4842918583687027
1107,10.1016/j.str.2017.06.012,aa2ar_human,67,S,N,ZM241385,PubChem CID,5311506,Inverse agonist,K(i),Binding - Radioligand competition/displacement,0.0,,=,,0.0,1.58,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.3195231208635121
1111,10.1016/j.str.2017.06.012,aa2ar_human,67,S,N,SCH58261,PubChem CID,176408,Inverse agonist,K(i),Binding - Radioligand competition/displacement,0.0,,=,,0.0,1.67,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.3195231208635121
1115,10.1016/j.str.2017.06.012,aa2ar_human,67,S,N,SCH442416,PubChem CID,10668061,Inverse agonist,K(i),Binding - Radioligand competition/displacement,0.0,,=,,0.0,7.3,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.3195231208635121
1119,10.1016/j.str.2017.06.012,aa2ar_human,67,S,N,Istradefylline,PubChem CID,5311037,Inverse agonist,K(i),Binding - Radioligand competition/displacement,0.0,,=,,0.0,2.79,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.3195231208635121
1123,10.1016/j.str.2017.06.012,aa2ar_human,67,S,N,PSB36,PubChem CID,11689583,Inverse agonist,K(i),Binding - Radioligand competition/displacement,0.0,,=,,0.0,-1.19,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.3195231208635121
1127,10.1016/j.str.2017.06.012,aa2ar_human,67,S,N,DPCPX,PubChem CID,1329,Inverse agonist,K(i),Binding - Radioligand competition/displacement,0.0,,=,,0.0,1.51,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.3195231208635121
1131,10.1016/j.str.2017.06.012,aa2ar_human,67,S,N,KW3902,PubChem CID,64627,Inverse agonist,K(i),Binding - Radioligand competition/displacement,0.0,,=,,0.0,1.87,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.3195231208635121
1135,10.1016/j.str.2017.06.012,aa2ar_human,67,S,N,SLV320,PubChem CID,9953065,Inverse agonist,K(i),Binding - Radioligand competition/displacement,0.0,,=,,0.0,4.78,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.3195231208635121
1139,10.1016/j.str.2017.06.012,aa2ar_human,67,S,N,XAC,PubChem CID,5697,Inverse agonist,K(i),Binding - Radioligand competition/displacement,0.0,,=,,0.0,3.9,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.3195231208635121
1143,10.1016/j.str.2017.06.012,aa2ar_human,67,S,N,CGS15943,PubChem CID,2690,Inverse agonist,K(i),Binding - Radioligand competition/displacement,0.0,,=,,0.0,1.67,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.3195231208635121
1109,10.1016/j.str.2017.06.012,aa2ar_human,270,M,T,ZM241385,PubChem CID,5311506,Inverse agonist,K(i),Binding - Radioligand competition/displacement,0.0,,=,,0.0,4.03,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.4315063004952392
1113,10.1016/j.str.2017.06.012,aa2ar_human,270,M,T,SCH58261,PubChem CID,176408,Inverse agonist,K(i),Binding - Radioligand competition/displacement,0.0,,=,,0.0,3.8,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.4315063004952392
1117,10.1016/j.str.2017.06.012,aa2ar_human,270,M,T,SCH442416,PubChem CID,10668061,Inverse agonist,K(i),Binding - Radioligand competition/displacement,0.0,,=,,0.0,6.68,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.4315063004952392
1121,10.1016/j.str.2017.06.012,aa2ar_human,270,M,T,Istradefylline,PubChem CID,5311037,Inverse agonist,K(i),Binding - Radioligand competition/displacement,0.0,,=,,0.0,1.51,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.4315063004952392
1125,10.1016/j.str.2017.06.012,aa2ar_human,270,M,T,PSB36,PubChem CID,11689583,Inverse agonist,K(i),Binding - Radioligand competition/displacement,0.0,,=,,0.0,-5.0,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.4315063004952392
1129,10.1016/j.str.2017.06.012,aa2ar_human,270,M,T,DPCPX,PubChem CID,1329,Inverse agonist,K(i),Binding - Radioligand competition/displacement,0.0,,=,,0.0,-5.556,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.4315063004952392
1133,10.1016/j.str.2017.06.012,aa2ar_human,270,M,T,KW3902,PubChem CID,64627,Inverse agonist,K(i),Binding - Radioligand competition/displacement,0.0,,=,,0.0,-5.0,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.4315063004952392
1137,10.1016/j.str.2017.06.012,aa2ar_human,270,M,T,SLV320,PubChem CID,9953065,Inverse agonist,K(i),Binding - Radioligand competition/displacement,0.0,,=,,0.0,1.1,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.4315063004952392
1141,10.1016/j.str.2017.06.012,aa2ar_human,270,M,T,XAC,PubChem CID,5697,Inverse agonist,K(i),Binding - Radioligand competition/displacement,0.0,,=,,0.0,1.38,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.4315063004952392
1145,10.1016/j.str.2017.06.012,aa2ar_human,270,M,T,CGS15943,PubChem CID,2690,Inverse agonist,K(i),Binding - Radioligand competition/displacement,0.0,,=,,0.0,1.47,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.4315063004952392
1146,10.1016/j.cell.2017.01.042,aa2ar_human,270,M,T,DPCPX,PubChem CID,1329,Inverse agonist,pK(i),Binding - Radioligand competition/displacement,6.2,,=,,7.0,6.31,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.4315063004952392
1147,10.1016/j.cell.2017.01.042,aa2ar_human,270,M,T,ZM241385,PubChem CID,176408,Inverse agonist,pK(i),Binding - Radioligand competition/displacement,8.7,,=,,7.8,-7.937,,,ZM241385,0.0,0.0,=,0.0,,P29274,0.4315063004952392
2,12821136,ada2b_human,109,D,A,[3H]RX821002,ChEMBL Compound ID,CHEMBL10332,Binding - unknown pharmacological activity,K(d),Binding - Radioligand saturation,5.1,nM,=,,4.5,1.133,,,,116.0,0.0,,0.0,,P18089,0.7959338371656945
3,12821136,ada2b_human,109,D,A,Clonidine,ChEMBL Compound ID,CHEMBL134,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,75.0,nM,=,,28.0,2.679,,,[3H]RX821002 (radioligand),116.0,0.0,,0.0,,P18089,0.7959338371656945
4,12821136,ada2b_human,109,D,A,R-noradrenaline,ChEMBL Compound ID,CHEMBL1437,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,479.0,nM,=,,196.0,2.444,,,[3H]RX821002 (radioligand),116.0,0.0,,0.0,,P18089,0.7959338371656945
5,12821136,ada2b_human,109,D,A,R-adrenaline,ChEMBL Compound ID,CHEMBL679,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,1495.0,nM,=,,603.0,2.479,,,[3H]RX821002 (radioligand),116.0,0.0,,0.0,,P18089,0.7959338371656945
6,12821136,ada2b_human,109,D,A,Oxymetazoline,ChEMBL Compound ID,CHEMBL762,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,1082.0,nM,=,,840.0,1.288,,,[3H]RX821002 (radioligand),116.0,0.0,,0.0,,P18089,0.7959338371656945
7,12821136,ada2b_human,109,D,A,Dexmedetomidine,ChEMBL Compound ID,CHEMBL778,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,5.4,nM,=,,1.4,3.857,,,[3H]RX821002 (radioligand),116.0,0.0,,0.0,,P18089,0.7959338371656945
8,12821136,ada2b_human,109,D,A,UK-14304,ChEMBL Compound ID,CHEMBL844,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,443.0,nM,=,,345.0,1.284,,,[3H]RX821002 (radioligand),116.0,0.0,,0.0,,P18089,0.7959338371656945
9,12821136,ada2b_human,109,D,A,Levomedetomidine,SMILES,C[C@@H](c1c[nH]cn1)c2cccc(C)c2C,Binding - unknown pharmacological activity,K(i),Binding - Radioligand competition/displacement,140.0,nM,=,,57.0,2.456,,,[3H]RX821002 (radioligand),116.0,0.0,,0.0,,P18089,0.7959338371656945
52,10.1124/mol.63.5.1021,aa3r_human,58,D,N,I-AB-MECA,PubChem CID,44208896,Full agonist,K(d),Binding - Radioligand saturation,1.2,nM,=,,2.1,-1.751,,,,0.0,0.0,=,0.0,,P0DMS8,0.7539848458480785
53,10.1124/mol.63.5.1021,aa3r_human,58,D,N,HMA,PubChem CID,1794,Allosteric inverse agonist,IC50,Binding - Radioligand competition/displacement,1.8,ÂµM,=,,1.9,-1.056,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.7539848458480785
54,10.1124/mol.63.5.1021,aa3r_human,58,D,N,DU124183,PubChem CID,10426659,Allosteric inverse agonist,IC50,Binding - Radioligand competition/displacement,1.2,ÂµM,=,,1.3,-1.083,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.7539848458480785
55,10.1124/mol.63.5.1021,aa3r_human,58,D,N,VUF-5455,PubChem CID,10339071,Allosteric inverse agonist,IC50,Binding - Radioligand competition/displacement,2.8,ÂµM,=,,2.9,-1.035,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.7539848458480785
56,10.1124/mol.63.5.1021,aa3r_human,58,D,N,Cl-IB-MECA,PubChem CID,393593,Full agonist,K(i),Binding - Radioligand competition/displacement,2.3,nM,=,,4.6,-2.0,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.7539848458480785
57,10.1124/mol.63.5.1021,aa3r_human,58,D,N,MRS1220,PubChem CID,393595,Inverse agonist,K(i),Binding - Radioligand competition/displacement,1.6,nM,=,,1.2,1.333,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.7539848458480785
58,10.1124/mol.63.5.1021,aa3r_human,58,D,N,PSB-11,PubChem CID,9882625,Inverse agonist,K(i),Binding - Radioligand competition/displacement,2.8,nM,=,,2.5,1.12,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.7539848458480785
59,10.1124/mol.63.5.1021,aa3r_human,58,D,N,HMA,PubChem CID,1794,Allosteric inverse agonist,k-1,Binding - Radioligand kinetics (association/dissociation),0.028,min-1,=,,0.064,-2.283,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.7539848458480785
60,10.1124/mol.63.5.1021,aa3r_human,58,D,N,DU124183,PubChem CID,10426659,Allosteric inverse agonist,k-1,Binding - Radioligand kinetics (association/dissociation),0.029,min-1,=,,0.133,-4.587,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.7539848458480785
61,10.1124/mol.63.5.1021,aa3r_human,58,D,N,VUF-5455,PubChem CID,10339071,Allosteric inverse agonist,k-1,Binding - Radioligand kinetics (association/dissociation),0.025,min-1,=,,0.122,-4.878,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.7539848458480785
62,10.1124/mol.63.5.1021,aa3r_human,58,D,N,I-AB-MECA,PubChem CID,44208896,Full agonist,k-1,Binding - Radioligand kinetics (association/dissociation),0.064,min-1,=,,0.122,-1.905,,,,0.0,0.0,=,0.0,,P0DMS8,0.7539848458480785
63,10.1124/mol.63.5.1021,aa3r_human,58,D,N,PSB-11,PubChem CID,9882625,Inverse agonist,k-1,Binding - Radioligand kinetics (association/dissociation),0.23,min-1,=,,0.27,-1.174,,,,0.0,0.0,=,0.0,,P0DMS8,0.7539848458480785
64,10.1124/mol.63.5.1021,aa3r_human,58,D,N,HMA,PubChem CID,1794,Allosteric inverse agonist,k-1,Binding - Radioligand kinetics (association/dissociation),0.46,min-1,=,,0.52,-1.13,,,PSB-11,0.0,0.0,=,0.0,,P0DMS8,0.7539848458480785
65,10.1124/mol.63.5.1021,aa3r_human,58,D,N,Na+,PubChem CID,923,Allosteric inverse agonist,k-1,Binding - Radioligand kinetics (association/dissociation),0.1,min-1,=,,0.31,-3.096,,,PSB-11,0.0,0.0,=,0.0,,P0DMS8,0.7539848458480785
66,10.1006/bbrc.2001.5027,aa3r_human,88,C,F,Cl-IB-MECA,PubChem CID,393593,Full agonist,EC50,Functional - IP accumulation,0.951,ÂµM,=,,39.3,-41.667,,,,0.0,0.0,=,0.0,,P0DMS8,0.4729573729186905
67,10.1006/bbrc.2001.5027,aa3r_human,88,C,F,I-AB-MECA,PubChem CID,44208896,Full agonist,K(d),Binding - Radioligand saturation,1.2,nM,=,,8.3,-6.897,,,,0.0,0.0,=,0.0,,P0DMS8,0.4729573729186905
68,10.1006/bbrc.2001.5027,aa3r_human,88,C,F,Cl-IB-MECA,PubChem CID,393593,Full agonist,K(i),Binding - Radioligand competition/displacement,3.8,nM,=,,53.6,-14.085,,,,0.0,0.0,=,0.0,,P0DMS8,0.4729573729186905
70,10.1124/mol.63.5.1021,aa3r_human,94,T,A,I-AB-MECA,PubChem CID,44208896,Full agonist,K(d),Binding - Radioligand saturation,1.2,nM,=,,4.3,-3.584,,,,0.0,0.0,=,0.0,,P0DMS8,0.5016631242767476
71,10.1124/mol.63.5.1021,aa3r_human,94,T,A,HMA,PubChem CID,1794,Allosteric inverse agonist,IC50,Binding - Radioligand competition/displacement,1.8,ÂµM,=,,2.2,-1.222,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.5016631242767476
72,10.1124/mol.63.5.1021,aa3r_human,94,T,A,DU124183,PubChem CID,10426659,Allosteric inverse agonist,IC50,Binding - Radioligand competition/displacement,1.2,ÂµM,=,,2.7,-2.252,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.5016631242767476
73,10.1124/mol.63.5.1021,aa3r_human,94,T,A,VUF-5455,PubChem CID,10339071,Allosteric inverse agonist,IC50,Binding - Radioligand competition/displacement,2.8,ÂµM,=,,6.4,-2.288,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.5016631242767476
74,10.1124/mol.63.5.1021,aa3r_human,94,T,A,Cl-IB-MECA,PubChem CID,393593,Full agonist,K(i),Binding - Radioligand competition/displacement,2.3,nM,=,,11.2,-4.878,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.5016631242767476
75,10.1124/mol.63.5.1021,aa3r_human,94,T,A,MRS1220,PubChem CID,393595,Inverse agonist,K(i),Binding - Radioligand competition/displacement,1.6,nM,=,,10.1,-6.329,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.5016631242767476
76,10.1124/mol.63.5.1021,aa3r_human,94,T,A,PSB-11,PubChem CID,9882625,Inverse agonist,K(i),Binding - Radioligand competition/displacement,2.8,nM,=,,33.0,-11.765,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.5016631242767476
77,10.1124/mol.63.5.1021,aa3r_human,94,T,A,HMA,PubChem CID,1794,Allosteric inverse agonist,k-1,Binding - Radioligand kinetics (association/dissociation),0.028,min-1,=,,0.038,-1.357,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.5016631242767476
78,10.1124/mol.63.5.1021,aa3r_human,94,T,A,DU124183,PubChem CID,10426659,Allosteric inverse agonist,k-1,Binding - Radioligand kinetics (association/dissociation),0.029,min-1,=,,0.041,-1.414,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.5016631242767476
79,10.1124/mol.63.5.1021,aa3r_human,94,T,A,VUF-5455,PubChem CID,10339071,Allosteric inverse agonist,k-1,Binding - Radioligand kinetics (association/dissociation),0.025,min-1,=,,0.034,-1.361,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.5016631242767476
80,10.1124/mol.63.5.1021,aa3r_human,94,T,A,I-AB-MECA,PubChem CID,44208896,Full agonist,k-1,Binding - Radioligand kinetics (association/dissociation),0.064,min-1,=,,0.062,1.032,,,,0.0,0.0,=,0.0,,P0DMS8,0.5016631242767476
81,10.1021/jm050968b,aa3r_human,94,T,A,CID75022615,PubChem CID,75022615,Full agonist,K(i),Binding - Radioligand competition/displacement,0.14,ÂµM,=,,0.12,1.167,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.5016631242767476
85,10.1021/jm050968b,aa3r_human,94,T,A,CID85116573,PubChem CID,85116573,Full agonist,K(i),Binding - Radioligand competition/displacement,9.5,ÂµM,=,,10.7,-1.126,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.5016631242767476
87,10.1021/jm050968b,aa3r_human,94,T,A,CID75022525,PubChem CID,75022525,Full agonist,K(i),Binding - Radioligand competition/displacement,13.8,ÂµM,=,,9.8,1.408,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.5016631242767476
92,10.1021/jm050968b,aa3r_human,94,T,A,CHEMBL377071,ChEMBL Compound ID,CHEMBL377071,Full agonist,K(i),Binding - Radioligand competition/displacement,2.26,ÂµM,=,,1.37,1.65,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.5016631242767476
94,10.1074/jbc.M110960200,aa3r_human,95,H,A,I-AB-MECA,PubChem CID,44208896,Full agonist,K(d),Binding - Radioligand saturation,1.7,nM,=,,5.7,-3.356,,,,0.0,0.0,=,0.0,,P0DMS8,0.5059870933606382
95,10.1074/jbc.M110960200,aa3r_human,95,H,A,CADO,PubChem CID,8974,Full agonist,K(i),Binding - Radioligand competition/displacement,0.523,ÂµM,=,,58.2,-111.111,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.5059870933606382
96,10.1074/jbc.M110960200,aa3r_human,95,H,A,NECA,PubChem CID,448222,Full agonist,K(i),Binding - Radioligand competition/displacement,249.0,nM,=,,3430.0,-13.699,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.5059870933606382
97,10.1074/jbc.M110960200,aa3r_human,95,H,A,Cl-IB-MECA,PubChem CID,393593,Full agonist,K(i),Binding - Radioligand competition/displacement,2.3,nM,=,,60.0,-26.316,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.5059870933606382
98,10.1074/jbc.M110960200,aa3r_human,95,H,A,MRS1898,PubChem CID,44354130,Full agonist,K(i),Binding - Radioligand competition/displacement,1.4,nM,=,,143.0,-100.0,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.5059870933606382
99,10.1074/jbc.M110960200,aa3r_human,95,H,A,DBXRM,PubChem CID,11743031,Full agonist,K(i),Binding - Radioligand competition/displacement,2.83,ÂµM,=,,36.3,-12.821,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.5059870933606382
100,10.1074/jbc.M110960200,aa3r_human,95,H,A,CGS15943,PubChem CID,2690,Inverse agonist,K(i),Binding - Radioligand competition/displacement,182.0,nM,=,,5130.0,-28.571,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.5059870933606382
101,10.1074/jbc.M110960200,aa3r_human,95,H,A,MRS1220,PubChem CID,393595,Inverse agonist,K(i),Binding - Radioligand competition/displacement,1.6,nM,=,,976.0,-500.0,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.5059870933606382
102,10.1074/jbc.M110960200,aa3r_human,95,H,A,VUF8504,PubChem CID,10832101,Inverse agonist,K(i),Binding - Radioligand competition/displacement,68.0,nM,=,,4000.0,-58.824,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.5059870933606382
103,10.1074/jbc.M110960200,aa3r_human,95,H,A,XAC,PubChem CID,5697,Inverse agonist,K(i),Binding - Radioligand competition/displacement,0.142,ÂµM,=,,9.44,-66.667,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.5059870933606382
104,10.1074/jbc.M110960200,aa3r_human,95,H,A,Cl-IB-MECA,PubChem CID,393593,Full agonist,EC50,Functional - IP accumulation,260.0,nM,=,,224.0,1.161,,,,0.0,0.0,=,0.0,,P0DMS8,0.5059870933606382
105,10.1074/jbc.M110960200,aa3r_human,95,H,A,IB-MECA,PubChem CID,123683,Full agonist,,Binding - Other,0.0,,=,,0.0,9.8,,,,0.0,0.0,=,0.0,,P0DMS8,0.5059870933606382
106,10.1074/jbc.M110960200,aa3r_human,95,H,A,MRS1939,PubChem CID,44359364,Full agonist,,Binding - Other,0.0,,=,,0.0,92.0,,,,0.0,0.0,=,0.0,,P0DMS8,0.5059870933606382
107,10.1074/jbc.M110960200,aa3r_human,95,H,A,CADO,PubChem CID,8974,Full agonist,,Binding - Other,0.0,,=,,0.0,111.0,,,,0.0,0.0,=,0.0,,P0DMS8,0.5059870933606382
108,10.1074/jbc.M110960200,aa3r_human,95,H,A,Cl-IB-MECA,PubChem CID,393593,Full agonist,,Binding - Other,0.0,,=,,0.0,26.0,,,,0.0,0.0,=,0.0,,P0DMS8,0.5059870933606382
109,10.1074/jbc.M110960200,aa3r_human,95,H,A,MRS1898,PubChem CID,44354130,Full agonist,,Binding - Other,0.0,,=,,0.0,100.0,,,,0.0,0.0,=,0.0,,P0DMS8,0.5059870933606382
110,10.1021/jm020211+,aa3r_human,95,H,A,NU006999,PubChem CID,21989774,Full agonist,K(i),Binding - Radioligand competition/displacement,3.8,nM,=,,85.0,-22.222,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.5059870933606382
111,10.1021/jm020211+,aa3r_human,95,H,A,MRS542,PubChem CID,21989785,Full agonist,K(i),Binding - Radioligand competition/displacement,1.9,nM,=,,132.0,-71.429,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.5059870933606382
112,10.1021/jm020211+,aa3r_human,95,H,A,AC1L1E8Z,PubChem CID,2692,Full agonist,K(i),Binding - Radioligand competition/displacement,142.0,nM,=,,615.0,-4.329,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.5059870933606382
113,10.1021/jm020211+,aa3r_human,95,H,A,CIDÂ 13506456,PubChem CID,13506456,Full agonist,K(i),Binding - Radioligand competition/displacement,114.0,nM,=,,796.0,-6.993,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.5059870933606382
114,10.1021/jm020211+,aa3r_human,95,H,A,CID21989784,PubChem CID,21989784,Full agonist,K(i),Binding - Radioligand competition/displacement,3.9,nM,=,,99.0,-25.641,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.5059870933606382
115,10.1021/jm020211+,aa3r_human,95,H,A,CID18506750,PubChem CID,18506750,Full agonist,K(i),Binding - Radioligand competition/displacement,1.7,nM,=,,460.0,-250.0,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.5059870933606382
116,10.1124/mol.63.5.1021,aa3r_human,95,H,A,I-AB-MECA,PubChem CID,44208896,Full agonist,K(d),Binding - Radioligand saturation,1.2,nM,=,,5.7,-4.739,,,,0.0,0.0,=,0.0,,P0DMS8,0.5059870933606382
117,10.1124/mol.63.5.1021,aa3r_human,95,H,A,HMA,PubChem CID,1794,Allosteric inverse agonist,IC50,Binding - Radioligand competition/displacement,1.8,ÂµM,=,,48.0,-27.027,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.5059870933606382
118,10.1124/mol.63.5.1021,aa3r_human,95,H,A,DU124183,PubChem CID,10426659,Allosteric inverse agonist,IC50,Binding - Radioligand competition/displacement,1.2,ÂµM,=,,36.0,-30.303,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.5059870933606382
119,10.1124/mol.63.5.1021,aa3r_human,95,H,A,VUF-5455,PubChem CID,10339071,Allosteric inverse agonist,IC50,Binding - Radioligand competition/displacement,2.8,ÂµM,=,,28.0,-10.0,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.5059870933606382
120,10.1124/mol.63.5.1021,aa3r_human,95,H,A,Cl-IB-MECA,PubChem CID,393593,Full agonist,K(i),Binding - Radioligand competition/displacement,2.3,nM,=,,60.0,-26.316,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.5059870933606382
121,10.1124/mol.63.5.1021,aa3r_human,95,H,A,MRS1220,PubChem CID,393595,Inverse agonist,K(i),Binding - Radioligand competition/displacement,1.6,nM,=,,976.0,-500.0,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.5059870933606382
122,10.1124/mol.63.5.1021,aa3r_human,95,H,A,PSB-11,PubChem CID,9882625,Inverse agonist,K(i),Binding - Radioligand competition/displacement,2.8,nM,=,,1120.0,-333.333,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.5059870933606382
123,10.1124/mol.63.5.1021,aa3r_human,95,H,A,HMA,PubChem CID,1794,Allosteric inverse agonist,k-1,Binding - Radioligand kinetics (association/dissociation),0.028,min-1,=,,0.07,-2.5,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.5059870933606382
124,10.1124/mol.63.5.1021,aa3r_human,95,H,A,DU124183,PubChem CID,10426659,Allosteric inverse agonist,k-1,Binding - Radioligand kinetics (association/dissociation),0.029,min-1,=,,0.067,-2.309,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.5059870933606382
125,10.1124/mol.63.5.1021,aa3r_human,95,H,A,VUF-5455,PubChem CID,10339071,Allosteric inverse agonist,k-1,Binding - Radioligand kinetics (association/dissociation),0.025,min-1,=,,0.055,-2.198,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.5059870933606382
126,10.1124/mol.63.5.1021,aa3r_human,95,H,A,I-AB-MECA,PubChem CID,44208896,Full agonist,k-1,Binding - Radioligand kinetics (association/dissociation),0.064,min-1,=,,0.112,-1.751,,,,0.0,0.0,=,0.0,,P0DMS8,0.5059870933606382
127,10.1006/bbrc.2001.5027,aa3r_human,107,D,N,Cl-IB-MECA,PubChem CID,393593,Full agonist,EC50,Functional - IP accumulation,0.951,ÂµM,=,,1.69,-1.776,,,,0.0,0.0,=,0.0,,P0DMS8,0.6457873534969181
130,10.1006/bbrc.2001.5027,aa3r_human,107,D,N,I-AB-MECA,PubChem CID,44208896,Full agonist,K(d),Binding - Radioligand saturation,1.2,nM,=,,0.55,2.182,,,,0.0,0.0,=,0.0,,P0DMS8,0.6457873534969181
133,10.1006/bbrc.2001.5027,aa3r_human,107,D,N,Cl-IB-MECA,PubChem CID,393593,Full agonist,K(i),Binding - Radioligand competition/displacement,3.8,nM,=,,1.3,2.923,,,,0.0,0.0,=,0.0,,P0DMS8,0.6457873534969181
139,10.1124/mol.63.5.1021,aa3r_human,107,D,N,I-AB-MECA,PubChem CID,44208896,Full agonist,K(d),Binding - Radioligand saturation,1.2,nM,=,,0.55,2.182,,,,0.0,0.0,=,0.0,,P0DMS8,0.6457873534969181
140,10.1124/mol.63.5.1021,aa3r_human,107,D,N,HMA,PubChem CID,1794,Allosteric inverse agonist,IC50,Binding - Radioligand competition/displacement,1.8,ÂµM,=,,2.0,-1.111,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.6457873534969181
141,10.1124/mol.63.5.1021,aa3r_human,107,D,N,DU124183,PubChem CID,10426659,Allosteric inverse agonist,IC50,Binding - Radioligand competition/displacement,1.2,ÂµM,=,,2.8,-2.331,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.6457873534969181
142,10.1124/mol.63.5.1021,aa3r_human,107,D,N,VUF-5455,PubChem CID,10339071,Allosteric inverse agonist,IC50,Binding - Radioligand competition/displacement,2.8,ÂµM,=,,9.7,-3.46,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.6457873534969181
143,10.1124/mol.63.5.1021,aa3r_human,107,D,N,Cl-IB-MECA,PubChem CID,393593,Full agonist,K(i),Binding - Radioligand competition/displacement,2.3,nM,=,,1.8,1.278,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.6457873534969181
144,10.1124/mol.63.5.1021,aa3r_human,107,D,N,MRS1220,PubChem CID,393595,Inverse agonist,K(i),Binding - Radioligand competition/displacement,1.6,nM,=,,9.2,-5.747,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.6457873534969181
145,10.1124/mol.63.5.1021,aa3r_human,107,D,N,PSB-11,PubChem CID,9882625,Inverse agonist,K(i),Binding - Radioligand competition/displacement,2.8,nM,=,,27.0,-9.615,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.6457873534969181
146,10.1124/mol.63.5.1021,aa3r_human,107,D,N,HMA,PubChem CID,1794,Allosteric inverse agonist,k-1,Binding - Radioligand kinetics (association/dissociation),0.028,min-1,=,,0.014,2.0,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.6457873534969181
147,10.1124/mol.63.5.1021,aa3r_human,107,D,N,DU124183,PubChem CID,10426659,Allosteric inverse agonist,k-1,Binding - Radioligand kinetics (association/dissociation),0.029,min-1,=,,0.03,-1.034,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.6457873534969181
148,10.1124/mol.63.5.1021,aa3r_human,107,D,N,VUF-5455,PubChem CID,10339071,Allosteric inverse agonist,k-1,Binding - Radioligand kinetics (association/dissociation),0.025,min-1,=,,0.013,1.923,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.6457873534969181
149,10.1124/mol.63.5.1021,aa3r_human,107,D,N,I-AB-MECA,PubChem CID,44208896,Full agonist,k-1,Binding - Radioligand kinetics (association/dissociation),0.064,min-1,=,,0.028,2.286,,,,0.0,0.0,=,0.0,,P0DMS8,0.6457873534969181
129,10.1006/bbrc.2001.5027,aa3r_human,107,D,R,Cl-IB-MECA,PubChem CID,393593,Full agonist,EC50,Functional - IP accumulation,0.951,ÂµM,=,,1.42,-1.493,,,,0.0,0.0,=,0.0,,P0DMS8,0.7577695322077941
132,10.1006/bbrc.2001.5027,aa3r_human,107,D,R,I-AB-MECA,PubChem CID,44208896,Full agonist,K(d),Binding - Radioligand saturation,1.2,nM,=,,0.86,1.395,,,,0.0,0.0,=,0.0,,P0DMS8,0.7577695322077941
135,10.1006/bbrc.2001.5027,aa3r_human,107,D,R,Cl-IB-MECA,PubChem CID,393593,Full agonist,K(i),Binding - Radioligand competition/displacement,3.8,nM,=,,1.8,2.111,,,,0.0,0.0,=,0.0,,P0DMS8,0.7577695322077941
150,10.1006/bbrc.2001.5027,aa3r_human,108,R,K,Cl-IB-MECA,PubChem CID,393593,Full agonist,EC50,Functional - IP accumulation,0.951,ÂµM,=,,0.341,2.789,,,,0.0,0.0,=,0.0,,P0DMS8,0.7659493489073637
155,10.1006/bbrc.2001.5027,aa3r_human,108,R,K,I-AB-MECA,PubChem CID,44208896,Full agonist,K(d),Binding - Radioligand saturation,1.2,nM,=,,0.95,1.263,,,,0.0,0.0,=,0.0,,P0DMS8,0.7659493489073637
160,10.1006/bbrc.2001.5027,aa3r_human,108,R,K,Cl-IB-MECA,PubChem CID,393593,Full agonist,K(i),Binding - Radioligand competition/displacement,3.8,nM,=,,4.1,-1.079,,,,0.0,0.0,=,0.0,,P0DMS8,0.7659493489073637
151,10.1006/bbrc.2001.5027,aa3r_human,108,R,A,Cl-IB-MECA,PubChem CID,393593,Full agonist,EC50,Functional - IP accumulation,0.951,ÂµM,=,,0.0375,25.36,,,,0.0,0.0,=,0.0,,P0DMS8,0.8488838692615349
156,10.1006/bbrc.2001.5027,aa3r_human,108,R,A,I-AB-MECA,PubChem CID,44208896,Full agonist,K(d),Binding - Radioligand saturation,1.2,nM,=,,0.7,1.714,,,,0.0,0.0,=,0.0,,P0DMS8,0.8488838692615349
161,10.1006/bbrc.2001.5027,aa3r_human,108,R,A,Cl-IB-MECA,PubChem CID,393593,Full agonist,K(i),Binding - Radioligand competition/displacement,3.8,nM,=,,0.9,4.222,,,,0.0,0.0,=,0.0,,P0DMS8,0.8488838692615349
153,10.1006/bbrc.2001.5027,aa3r_human,108,R,E,Cl-IB-MECA,PubChem CID,393593,Full agonist,EC50,Functional - IP accumulation,0.951,ÂµM,=,,0.279,3.409,,,,0.0,0.0,=,0.0,,P0DMS8,0.8243038795494895
158,10.1006/bbrc.2001.5027,aa3r_human,108,R,E,I-AB-MECA,PubChem CID,44208896,Full agonist,K(d),Binding - Radioligand saturation,1.2,nM,=,,0.86,1.395,,,,0.0,0.0,=,0.0,,P0DMS8,0.8243038795494895
163,10.1006/bbrc.2001.5027,aa3r_human,108,R,E,Cl-IB-MECA,PubChem CID,393593,Full agonist,K(i),Binding - Radioligand competition/displacement,3.8,nM,=,,5.4,-1.42,,,,0.0,0.0,=,0.0,,P0DMS8,0.8243038795494895
170,10.1006/bbrc.2001.5027,aa3r_human,109,Y,F,Cl-IB-MECA,PubChem CID,393593,Full agonist,EC50,Functional - IP accumulation,0.951,ÂµM,=,,11.6,-12.195,,,,0.0,0.0,=,0.0,,P0DMS8,0.3910660204968177
171,10.1006/bbrc.2001.5027,aa3r_human,109,Y,F,I-AB-MECA,PubChem CID,44208896,Full agonist,K(d),Binding - Radioligand saturation,1.2,nM,=,,2.0,-1.667,,,,0.0,0.0,=,0.0,,P0DMS8,0.3910660204968177
172,10.1006/bbrc.2001.5027,aa3r_human,109,Y,F,Cl-IB-MECA,PubChem CID,393593,Full agonist,K(i),Binding - Radioligand competition/displacement,3.8,nM,=,,17.0,-4.464,,,,0.0,0.0,=,0.0,,P0DMS8,0.3910660204968177
174,10.1074/jbc.M110960200,aa3r_human,152,K,A,I-AB-MECA,PubChem CID,44208896,Full agonist,K(d),Binding - Radioligand saturation,1.7,nM,=,,3.7,-2.179,,,,0.0,0.0,=,0.0,,P0DMS8,0.2888248340289015
175,10.1074/jbc.M110960200,aa3r_human,152,K,A,CADO,PubChem CID,8974,Full agonist,K(i),Binding - Radioligand competition/displacement,523.0,nM,=,,323.0,1.619,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.2888248340289015
176,10.1074/jbc.M110960200,aa3r_human,152,K,A,NECA,PubChem CID,448222,Full agonist,K(i),Binding - Radioligand competition/displacement,249.0,nM,=,,278.0,-1.116,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.2888248340289015
177,10.1074/jbc.M110960200,aa3r_human,152,K,A,Cl-IB-MECA,PubChem CID,393593,Full agonist,K(i),Binding - Radioligand competition/displacement,2.3,nM,=,,1.7,1.353,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.2888248340289015
178,10.1074/jbc.M110960200,aa3r_human,152,K,A,MRS1898,PubChem CID,44354130,Full agonist,K(i),Binding - Radioligand competition/displacement,1.4,nM,=,,2.3,-1.642,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.2888248340289015
179,10.1074/jbc.M110960200,aa3r_human,152,K,A,DBXRM,PubChem CID,11743031,Full agonist,K(i),Binding - Radioligand competition/displacement,2.83,ÂµM,=,,6.03,-2.132,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.2888248340289015
180,10.1074/jbc.M110960200,aa3r_human,152,K,A,CGS15943,PubChem CID,2690,Inverse agonist,K(i),Binding - Radioligand competition/displacement,182.0,nM,=,,571.0,-3.135,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.2888248340289015
181,10.1074/jbc.M110960200,aa3r_human,152,K,A,MRS1220,PubChem CID,393595,Inverse agonist,K(i),Binding - Radioligand competition/displacement,1.6,nM,=,,5.4,-3.378,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.2888248340289015
182,10.1074/jbc.M110960200,aa3r_human,152,K,A,VUF8504,PubChem CID,10832101,Inverse agonist,K(i),Binding - Radioligand competition/displacement,68.0,nM,=,,575.0,-8.475,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.2888248340289015
183,10.1074/jbc.M110960200,aa3r_human,152,K,A,XAC,PubChem CID,5697,Inverse agonist,K(i),Binding - Radioligand competition/displacement,0.142,ÂµM,=,,0.726,-5.102,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.2888248340289015
184,10.1124/mol.63.5.1021,aa3r_human,152,K,A,I-AB-MECA,PubChem CID,44208896,Full agonist,K(d),Binding - Radioligand saturation,1.2,nM,=,,3.7,-3.086,,,,0.0,0.0,=,0.0,,P0DMS8,0.2888248340289015
185,10.1124/mol.63.5.1021,aa3r_human,152,K,A,HMA,PubChem CID,1794,Allosteric inverse agonist,IC50,Binding - Radioligand competition/displacement,1.8,ÂµM,=,,1.9,-1.056,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.2888248340289015
186,10.1124/mol.63.5.1021,aa3r_human,152,K,A,DU124183,PubChem CID,10426659,Allosteric inverse agonist,IC50,Binding - Radioligand competition/displacement,1.2,ÂµM,=,,3.2,-2.667,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.2888248340289015
187,10.1124/mol.63.5.1021,aa3r_human,152,K,A,VUF-5455,PubChem CID,10339071,Allosteric inverse agonist,IC50,Binding - Radioligand competition/displacement,2.8,ÂµM,=,,23.0,-8.197,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.2888248340289015
188,10.1124/mol.63.5.1021,aa3r_human,152,K,A,Cl-IB-MECA,PubChem CID,393593,Full agonist,K(i),Binding - Radioligand competition/displacement,2.3,nM,=,,7.0,-3.04,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.2888248340289015
189,10.1124/mol.63.5.1021,aa3r_human,152,K,A,MRS1220,PubChem CID,393595,Inverse agonist,K(i),Binding - Radioligand competition/displacement,1.6,nM,=,,5.4,-3.378,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.2888248340289015
190,10.1124/mol.63.5.1021,aa3r_human,152,K,A,PSB-11,PubChem CID,9882625,Inverse agonist,K(i),Binding - Radioligand competition/displacement,2.8,nM,=,,26.0,-9.259,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.2888248340289015
191,10.1124/mol.63.5.1021,aa3r_human,152,K,A,HMA,PubChem CID,1794,Allosteric inverse agonist,k-1,Binding - Radioligand kinetics (association/dissociation),0.028,min-1,=,,0.028,1.0,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.2888248340289015
192,10.1124/mol.63.5.1021,aa3r_human,152,K,A,DU124183,PubChem CID,10426659,Allosteric inverse agonist,k-1,Binding - Radioligand kinetics (association/dissociation),0.029,min-1,=,,0.029,1.0,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.2888248340289015
193,10.1124/mol.63.5.1021,aa3r_human,152,K,A,VUF-5455,PubChem CID,10339071,Allosteric inverse agonist,k-1,Binding - Radioligand kinetics (association/dissociation),0.025,min-1,=,,0.027,-1.08,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.2888248340289015
194,10.1124/mol.63.5.1021,aa3r_human,152,K,A,I-AB-MECA,PubChem CID,44208896,Full agonist,k-1,Binding - Radioligand kinetics (association/dissociation),0.064,min-1,=,,0.052,1.231,,,,0.0,0.0,=,0.0,,P0DMS8,0.2888248340289015
195,10.1080/15257770500265778,aa3r_human,167,Q,A,CGS15943,PubChem CID,2690,Inverse agonist,K(i),Binding - Radioligand competition/displacement,7.2,nM,=,,94.8,-13.158,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.3690609423302901
198,10.1080/15257770500265778,aa3r_human,167,Q,A,NECA,PubChem CID,448222,Full agonist,K(i),Binding - Radioligand competition/displacement,46.2,nM,=,,893.0,-19.231,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.3690609423302901
201,10.1080/15257770500265778,aa3r_human,167,Q,A,6-methylaminopurinearabinoside,PubChem CID,1869,Full agonist,K(i),Binding - Radioligand competition/displacement,8.2,nM,=,,52.5,-6.41,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.3690609423302901
204,10.1080/15257770500265778,aa3r_human,167,Q,A,Cid44280242,PubChem CID,44280242,Full agonist,K(i),Binding - Radioligand competition/displacement,57.1,nM,=,,551.0,-9.615,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.3690609423302901
207,10.1080/15257770500265778,aa3r_human,167,Q,A,Cid22948626,PubChem CID,22948626,Full agonist,K(i),Binding - Radioligand competition/displacement,775.0,nM,=,,7590.0,-9.804,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.3690609423302901
210,10.1080/15257770500265778,aa3r_human,167,Q,A,NONAME,SMILES,CNc1nc(nc2n(cnc12)C3OC(CO)C(O)C3O)N(C)C=N,Full agonist,K(i),Binding - Radioligand competition/displacement,5.5,ÂµM,=,,16.2,-2.941,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.3690609423302901
213,10.1080/15257770500265778,aa3r_human,167,Q,A,34349-36-5,PubChem CID,13506473,Full agonist,K(i),Binding - Radioligand competition/displacement,2.9,nM,=,,12.6,-4.348,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.3690609423302901
216,10.1080/15257770500265778,aa3r_human,167,Q,A,NONAME,SMILES,COc1ccc(Cl)cc1CNc2nc(nc3n(cnc23)C4OC(CO)C(O)C4O)C(O)=O,Full agonist,K(i),Binding - Radioligand competition/displacement,274.0,nM,=,,794.0,-2.899,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.3690609423302901
219,10.1080/15257770500265778,aa3r_human,167,Q,A,NONAME,SMILES,COC(=O)c1nc(NCc2cc(Cl)ccc2OC)c3ncn(C4OC(CO)C(O)C4O)c3n1,Full agonist,K(i),Binding - Radioligand competition/displacement,21.1,nM,=,,65.8,-3.115,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.3690609423302901
222,10.1080/15257770500265778,aa3r_human,167,Q,A,Cid44289609,PubChem CID,44289609,Full agonist,K(i),Binding - Radioligand competition/displacement,17.0,nM,=,,36.6,-2.155,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.3690609423302901
225,10.1080/15257770500265778,aa3r_human,167,Q,A,NONAME,SMILES,OCC1OC(C(O)C1O)n2cnc3c(NC4CC4c5ccccc5)nc(nc23)C(O)=O,Full agonist,K(i),Binding - Radioligand competition/displacement,1260.0,nM,=,,9350.0,-7.407,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.3690609423302901
228,10.1080/15257770500265778,aa3r_human,167,Q,A,CGS21680,PubChem CID,3086599,Full agonist,K(i),Binding - Radioligand competition/displacement,665.0,nM,=,,8130.0,-12.195,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.3690609423302901
231,10.1080/15257770500265778,aa3r_human,167,Q,A,APEC,PubChem CID,3081741,Full agonist,K(i),Binding - Radioligand competition/displacement,305.0,nM,=,,2550.0,-8.333,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.3690609423302901
234,10.1080/15257770500265778,aa3r_human,167,Q,A,CGS23058,PubChem CID,14775497,Full agonist,K(i),Binding - Radioligand competition/displacement,682.0,nM,=,,1050.0,-1.538,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.3690609423302901
237,10.1080/15257770500265778,aa3r_human,167,Q,A,SPA,PubChem CID,73087488,Full agonist,K(i),Binding - Radioligand competition/displacement,342.0,nM,=,,4090.0,-11.905,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.3690609423302901
240,10.1080/15257770500265778,aa3r_human,167,Q,A,ADAC,PubChem CID,23789715,Full agonist,K(i),Binding - Radioligand competition/displacement,408.0,nM,=,,4000.0,-9.804,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.3690609423302901
196,10.1080/15257770500265778,aa3r_human,167,Q,E,CGS15943,PubChem CID,2690,Inverse agonist,K(i),Binding - Radioligand competition/displacement,7.2,nM,=,,71.8,-10.0,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.254198498004742
199,10.1080/15257770500265778,aa3r_human,167,Q,E,NECA,PubChem CID,448222,Full agonist,K(i),Binding - Radioligand competition/displacement,46.2,nM,=,,918.0,-20.0,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.254198498004742
202,10.1080/15257770500265778,aa3r_human,167,Q,E,6-methylaminopurinearabinoside,PubChem CID,1869,Full agonist,K(i),Binding - Radioligand competition/displacement,8.2,nM,=,,81.5,-9.901,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.254198498004742
205,10.1080/15257770500265778,aa3r_human,167,Q,E,Cid44280242,PubChem CID,44280242,Full agonist,K(i),Binding - Radioligand competition/displacement,57.1,nM,=,,406.0,-7.092,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.254198498004742
208,10.1080/15257770500265778,aa3r_human,167,Q,E,Cid22948626,PubChem CID,22948626,Full agonist,K(i),Binding - Radioligand competition/displacement,775.0,nM,=,,8030.0,-10.309,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.254198498004742
211,10.1080/15257770500265778,aa3r_human,167,Q,E,NONAME,SMILES,CNc1nc(nc2n(cnc12)C3OC(CO)C(O)C3O)N(C)C=N,Full agonist,K(i),Binding - Radioligand competition/displacement,5.5,ÂµM,=,,10.8,-1.965,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.254198498004742
214,10.1080/15257770500265778,aa3r_human,167,Q,E,34349-36-5,PubChem CID,13506473,Full agonist,K(i),Binding - Radioligand competition/displacement,2.9,nM,=,,26.3,-9.091,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.254198498004742
217,10.1080/15257770500265778,aa3r_human,167,Q,E,NONAME,SMILES,COc1ccc(Cl)cc1CNc2nc(nc3n(cnc23)C4OC(CO)C(O)C4O)C(O)=O,Full agonist,K(i),Binding - Radioligand competition/displacement,274.0,nM,=,,1500.0,-5.464,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.254198498004742
220,10.1080/15257770500265778,aa3r_human,167,Q,E,NONAME,SMILES,COC(=O)c1nc(NCc2cc(Cl)ccc2OC)c3ncn(C4OC(CO)C(O)C4O)c3n1,Full agonist,K(i),Binding - Radioligand competition/displacement,21.1,nM,=,,56.2,-2.667,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.254198498004742
223,10.1080/15257770500265778,aa3r_human,167,Q,E,Cid44289609,PubChem CID,44289609,Full agonist,K(i),Binding - Radioligand competition/displacement,17.0,nM,=,,56.6,-3.333,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.254198498004742
226,10.1080/15257770500265778,aa3r_human,167,Q,E,NONAME,SMILES,OCC1OC(C(O)C1O)n2cnc3c(NC4CC4c5ccccc5)nc(nc23)C(O)=O,Full agonist,K(i),Binding - Radioligand competition/displacement,1260.0,nM,=,,5310.0,-4.219,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.254198498004742
229,10.1080/15257770500265778,aa3r_human,167,Q,E,CGS21680,PubChem CID,3086599,Full agonist,K(i),Binding - Radioligand competition/displacement,665.0,nM,=,,5800.0,-8.696,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.254198498004742
232,10.1080/15257770500265778,aa3r_human,167,Q,E,APEC,PubChem CID,3081741,Full agonist,K(i),Binding - Radioligand competition/displacement,305.0,nM,=,,850.0,-2.786,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.254198498004742
235,10.1080/15257770500265778,aa3r_human,167,Q,E,CGS23058,PubChem CID,14775497,Full agonist,K(i),Binding - Radioligand competition/displacement,682.0,nM,=,,1640.0,-2.404,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.254198498004742
238,10.1080/15257770500265778,aa3r_human,167,Q,E,SPA,PubChem CID,73087488,Full agonist,K(i),Binding - Radioligand competition/displacement,342.0,nM,=,,2910.0,-8.475,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.254198498004742
241,10.1080/15257770500265778,aa3r_human,167,Q,E,ADAC,PubChem CID,23789715,Full agonist,K(i),Binding - Radioligand competition/displacement,408.0,nM,=,,1630.0,-4.0,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.254198498004742
243,10.1021/jm050968b,aa3r_human,167,Q,E,CID75022615,PubChem CID,75022615,Full agonist,K(i),Binding - Radioligand competition/displacement,0.14,ÂµM,=,,0.57,-4.065,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.254198498004742
247,10.1021/jm050968b,aa3r_human,167,Q,E,CID75022483,PubChem CID,75022483,Full agonist,K(i),Binding - Radioligand competition/displacement,0.56,ÂµM,=,,7.2,-12.821,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.254198498004742
197,10.1080/15257770500265778,aa3r_human,167,Q,R,CGS15943,PubChem CID,2690,Inverse agonist,K(i),Binding - Radioligand competition/displacement,7.2,nM,=,,87.1,-12.048,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.2898056198978248
200,10.1080/15257770500265778,aa3r_human,167,Q,R,NECA,PubChem CID,448222,Full agonist,K(i),Binding - Radioligand competition/displacement,46.2,nM,=,,1230.0,-26.316,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.2898056198978248
203,10.1080/15257770500265778,aa3r_human,167,Q,R,6-methylaminopurinearabinoside,PubChem CID,1869,Full agonist,K(i),Binding - Radioligand competition/displacement,8.2,nM,=,,52.0,-6.329,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.2898056198978248
206,10.1080/15257770500265778,aa3r_human,167,Q,R,Cid44280242,PubChem CID,44280242,Full agonist,K(i),Binding - Radioligand competition/displacement,57.1,nM,=,,477.0,-8.333,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.2898056198978248
209,10.1080/15257770500265778,aa3r_human,167,Q,R,Cid22948626,PubChem CID,22948626,Full agonist,K(i),Binding - Radioligand competition/displacement,775.0,nM,=,,7040.0,-9.091,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.2898056198978248
215,10.1080/15257770500265778,aa3r_human,167,Q,R,34349-36-5,PubChem CID,13506473,Full agonist,K(i),Binding - Radioligand competition/displacement,2.9,nM,=,,11.8,-4.065,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.2898056198978248
218,10.1080/15257770500265778,aa3r_human,167,Q,R,NONAME,SMILES,COc1ccc(Cl)cc1CNc2nc(nc3n(cnc23)C4OC(CO)C(O)C4O)C(O)=O,Full agonist,K(i),Binding - Radioligand competition/displacement,274.0,nM,=,,397.0,-1.449,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.2898056198978248
221,10.1080/15257770500265778,aa3r_human,167,Q,R,NONAME,SMILES,COC(=O)c1nc(NCc2cc(Cl)ccc2OC)c3ncn(C4OC(CO)C(O)C4O)c3n1,Full agonist,K(i),Binding - Radioligand competition/displacement,21.1,nM,=,,81.8,-3.876,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.2898056198978248
224,10.1080/15257770500265778,aa3r_human,167,Q,R,Cid44289609,PubChem CID,44289609,Full agonist,K(i),Binding - Radioligand competition/displacement,17.0,nM,=,,37.8,-2.222,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.2898056198978248
230,10.1080/15257770500265778,aa3r_human,167,Q,R,CGS21680,PubChem CID,3086599,Full agonist,K(i),Binding - Radioligand competition/displacement,665.0,nM,=,,2380.0,-3.584,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.2898056198978248
233,10.1080/15257770500265778,aa3r_human,167,Q,R,APEC,PubChem CID,3081741,Full agonist,K(i),Binding - Radioligand competition/displacement,305.0,nM,=,,7260.0,-23.81,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.2898056198978248
236,10.1080/15257770500265778,aa3r_human,167,Q,R,CGS23058,PubChem CID,14775497,Full agonist,K(i),Binding - Radioligand competition/displacement,682.0,nM,=,,1300.0,-1.905,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.2898056198978248
239,10.1080/15257770500265778,aa3r_human,167,Q,R,SPA,PubChem CID,73087488,Full agonist,K(i),Binding - Radioligand competition/displacement,342.0,nM,=,,1100.0,-3.215,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.2898056198978248
242,10.1080/15257770500265778,aa3r_human,167,Q,R,ADAC,PubChem CID,23789715,Full agonist,K(i),Binding - Radioligand competition/displacement,408.0,nM,=,,2600.0,-6.369,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.2898056198978248
253,10.1124/mol.63.5.1021,aa3r_human,182,F,A,I-AB-MECA,PubChem CID,44208896,Full agonist,K(d),Binding - Radioligand saturation,1.2,nM,=,,3.5,-2.915,,,,0.0,0.0,=,0.0,,P0DMS8,0.5192418649436006
254,10.1124/mol.63.5.1021,aa3r_human,182,F,A,HMA,PubChem CID,1794,Allosteric inverse agonist,IC50,Binding - Radioligand competition/displacement,1.8,ÂµM,=,,2.4,-1.333,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.5192418649436006
255,10.1124/mol.63.5.1021,aa3r_human,182,F,A,DU124183,PubChem CID,10426659,Allosteric inverse agonist,IC50,Binding - Radioligand competition/displacement,1.2,ÂµM,=,,29.6,-24.39,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.5192418649436006
256,10.1124/mol.63.5.1021,aa3r_human,182,F,A,VUF-5455,PubChem CID,10339071,Allosteric inverse agonist,IC50,Binding - Radioligand competition/displacement,2.8,ÂµM,=,,2.9,-1.035,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.5192418649436006
257,10.1124/mol.63.5.1021,aa3r_human,182,F,A,Cl-IB-MECA,PubChem CID,393593,Full agonist,K(i),Binding - Radioligand competition/displacement,2.3,nM,=,,5.2,-2.262,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.5192418649436006
258,10.1124/mol.63.5.1021,aa3r_human,182,F,A,MRS1220,PubChem CID,393595,Inverse agonist,K(i),Binding - Radioligand competition/displacement,1.6,nM,=,,2.7,-1.686,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.5192418649436006
259,10.1124/mol.63.5.1021,aa3r_human,182,F,A,PSB-11,PubChem CID,9882625,Inverse agonist,K(i),Binding - Radioligand competition/displacement,2.8,nM,=,,9.2,-3.289,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.5192418649436006
260,10.1124/mol.63.5.1021,aa3r_human,182,F,A,HMA,PubChem CID,1794,Allosteric inverse agonist,k-1,Binding - Radioligand kinetics (association/dissociation),0.028,min-1,=,,0.085,-3.04,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.5192418649436006
261,10.1124/mol.63.5.1021,aa3r_human,182,F,A,DU124183,PubChem CID,10426659,Allosteric inverse agonist,k-1,Binding - Radioligand kinetics (association/dissociation),0.029,min-1,=,,0.079,-2.725,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.5192418649436006
262,10.1124/mol.63.5.1021,aa3r_human,182,F,A,VUF-5455,PubChem CID,10339071,Allosteric inverse agonist,k-1,Binding - Radioligand kinetics (association/dissociation),0.025,min-1,=,,0.074,-2.959,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.5192418649436006
263,10.1124/mol.63.5.1021,aa3r_human,182,F,A,I-AB-MECA,PubChem CID,44208896,Full agonist,k-1,Binding - Radioligand kinetics (association/dissociation),0.064,min-1,=,,0.079,-1.235,,,,0.0,0.0,=,0.0,,P0DMS8,0.5192418649436006
268,10.1074/jbc.M110960200,aa3r_human,243,W,A,I-AB-MECA,PubChem CID,44208896,Full agonist,K(d),Binding - Radioligand saturation,1.7,nM,=,,1.1,1.545,,,,0.0,0.0,=,0.0,,P0DMS8,0.786394568917938
270,10.1074/jbc.M110960200,aa3r_human,243,W,A,CADO,PubChem CID,8974,Full agonist,K(i),Binding - Radioligand competition/displacement,523.0,nM,=,,334.0,1.566,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.786394568917938
272,10.1074/jbc.M110960200,aa3r_human,243,W,A,NECA,PubChem CID,448222,Full agonist,K(i),Binding - Radioligand competition/displacement,249.0,nM,=,,166.0,1.5,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.786394568917938
274,10.1074/jbc.M110960200,aa3r_human,243,W,A,Cl-IB-MECA,PubChem CID,393593,Full agonist,K(i),Binding - Radioligand competition/displacement,2.3,nM,=,,2.9,-1.261,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.786394568917938
276,10.1074/jbc.M110960200,aa3r_human,243,W,A,MRS1898,PubChem CID,44354130,Full agonist,K(i),Binding - Radioligand competition/displacement,1.4,nM,=,,2.1,-1.499,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.786394568917938
278,10.1074/jbc.M110960200,aa3r_human,243,W,A,DBXRM,PubChem CID,11743031,Full agonist,K(i),Binding - Radioligand competition/displacement,2.83,ÂµM,=,,4.39,-1.55,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.786394568917938
280,10.1074/jbc.M110960200,aa3r_human,243,W,A,CGS15943,PubChem CID,2690,Inverse agonist,K(i),Binding - Radioligand competition/displacement,182.0,nM,=,,1160.0,-6.369,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.786394568917938
282,10.1074/jbc.M110960200,aa3r_human,243,W,A,MRS1220,PubChem CID,393595,Inverse agonist,K(i),Binding - Radioligand competition/displacement,1.6,nM,=,,45.0,-27.778,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.786394568917938
284,10.1074/jbc.M110960200,aa3r_human,243,W,A,VUF8504,PubChem CID,10832101,Inverse agonist,K(i),Binding - Radioligand competition/displacement,68.0,nM,=,,2570.0,-38.462,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.786394568917938
286,10.1074/jbc.M110960200,aa3r_human,243,W,A,XAC,PubChem CID,5697,Inverse agonist,K(i),Binding - Radioligand competition/displacement,0.142,ÂµM,=,,0.552,-3.891,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.786394568917938
296,10.1021/jm020211+,aa3r_human,243,W,A,NECA,PubChem CID,448222,Full agonist,K(i),Binding - Radioligand competition/displacement,0.8,nM,=,,0.9,-1.125,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.786394568917938
297,10.1021/jm020211+,aa3r_human,243,W,A,NU006999,PubChem CID,21989774,Full agonist,K(i),Binding - Radioligand competition/displacement,3.8,nM,=,,6.0,-1.58,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.786394568917938
298,10.1021/jm020211+,aa3r_human,243,W,A,MRS542,PubChem CID,21989785,Full agonist,K(i),Binding - Radioligand competition/displacement,1.9,nM,=,,2.4,-1.263,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.786394568917938
299,10.1021/jm020211+,aa3r_human,243,W,A,AC1L1E8Z,PubChem CID,2692,Full agonist,K(i),Binding - Radioligand competition/displacement,142.0,nM,=,,137.0,1.036,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.786394568917938
300,10.1021/jm020211+,aa3r_human,243,W,A,CIDÂ 13506456,PubChem CID,13506456,Full agonist,K(i),Binding - Radioligand competition/displacement,114.0,nM,=,,100.0,1.14,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.786394568917938
301,10.1021/jm020211+,aa3r_human,243,W,A,IB-MECA,PubChem CID,3668,Full agonist,K(i),Binding - Radioligand competition/displacement,1.6,nM,=,,0.9,1.778,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.786394568917938
302,10.1021/jm020211+,aa3r_human,243,W,A,CID44359214,PubChem CID,44359214,Full agonist,K(i),Binding - Radioligand competition/displacement,83.0,nM,=,,46.0,1.804,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.786394568917938
303,10.1021/jm020211+,aa3r_human,243,W,A,CID21989784,PubChem CID,21989784,Full agonist,K(i),Binding - Radioligand competition/displacement,3.9,nM,=,,2.7,1.444,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.786394568917938
304,10.1021/jm020211+,aa3r_human,243,W,A,CID18506750,PubChem CID,18506750,Full agonist,K(i),Binding - Radioligand competition/displacement,1.7,nM,=,,1.3,1.308,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.786394568917938
305,10.1021/jm020211+,aa3r_human,243,W,A,MRS1939,PubChem CID,44359364,Full agonist,K(i),Binding - Radioligand competition/displacement,2.1,nM,=,,1.2,1.75,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.786394568917938
306,10.1021/jm020211+,aa3r_human,243,W,A,CID44359257,PubChem CID,44359257,Full agonist,K(i),Binding - Radioligand competition/displacement,584.0,nM,=,,490.0,1.192,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.786394568917938
307,10.1021/jm020211+,aa3r_human,243,W,A,Compound39,SMILES,CCCC1C(=C(CC)N=C(c2ccccc2)C1(CCC)C([O-])=O)C(=O)SCC,Inverse agonist,K(i),Binding - Radioligand competition/displacement,238.0,nM,=,,2150.0,-9.009,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.786394568917938
308,10.1021/jm020211+,aa3r_human,243,W,A,MRS1191,PubChem CID,393594,Inverse agonist,K(i),Binding - Radioligand competition/displacement,78.0,nM,=,,818.0,-10.526,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.786394568917938
309,10.1124/mol.63.5.1021,aa3r_human,243,W,A,I-AB-MECA,PubChem CID,44208896,Full agonist,K(d),Binding - Radioligand saturation,1.2,nM,=,,1.1,1.091,,,,0.0,0.0,=,0.0,,P0DMS8,0.786394568917938
310,10.1124/mol.63.5.1021,aa3r_human,243,W,A,HMA,PubChem CID,1794,Allosteric inverse agonist,IC50,Binding - Radioligand competition/displacement,1.8,ÂµM,=,,0.44,4.091,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.786394568917938
311,10.1124/mol.63.5.1021,aa3r_human,243,W,A,DU124183,PubChem CID,10426659,Allosteric inverse agonist,IC50,Binding - Radioligand competition/displacement,1.2,ÂµM,=,,3.6,-3.003,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.786394568917938
312,10.1124/mol.63.5.1021,aa3r_human,243,W,A,VUF-5455,PubChem CID,10339071,Allosteric inverse agonist,IC50,Binding - Radioligand competition/displacement,2.8,ÂµM,=,,17.0,-6.061,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.786394568917938
313,10.1124/mol.63.5.1021,aa3r_human,243,W,A,Cl-IB-MECA,PubChem CID,393593,Full agonist,K(i),Binding - Radioligand competition/displacement,2.3,nM,=,,2.9,-1.261,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.786394568917938
314,10.1124/mol.63.5.1021,aa3r_human,243,W,A,MRS1220,PubChem CID,393595,Inverse agonist,K(i),Binding - Radioligand competition/displacement,1.6,nM,=,,45.0,-27.778,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.786394568917938
315,10.1124/mol.63.5.1021,aa3r_human,243,W,A,PSB-11,PubChem CID,9882625,Inverse agonist,K(i),Binding - Radioligand competition/displacement,2.8,nM,=,,44.0,-15.625,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.786394568917938
316,10.1124/mol.63.5.1021,aa3r_human,243,W,A,HMA,PubChem CID,1794,Allosteric inverse agonist,k-1,Binding - Radioligand kinetics (association/dissociation),0.028,min-1,=,,0.027,1.037,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.786394568917938
317,10.1124/mol.63.5.1021,aa3r_human,243,W,A,DU124183,PubChem CID,10426659,Allosteric inverse agonist,k-1,Binding - Radioligand kinetics (association/dissociation),0.029,min-1,=,,0.029,1.0,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.786394568917938
318,10.1124/mol.63.5.1021,aa3r_human,243,W,A,VUF-5455,PubChem CID,10339071,Allosteric inverse agonist,k-1,Binding - Radioligand kinetics (association/dissociation),0.025,min-1,=,,0.031,-1.241,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.786394568917938
319,10.1124/mol.63.5.1021,aa3r_human,243,W,A,I-AB-MECA,PubChem CID,44208896,Full agonist,k-1,Binding - Radioligand kinetics (association/dissociation),0.064,min-1,=,,0.051,1.255,,,,0.0,0.0,=,0.0,,P0DMS8,0.786394568917938
320,10.1124/mol.63.5.1021,aa3r_human,243,W,A,Amiloride,PubChem CID,16231,Allosteric inverse agonist,IC50,Binding - Radioligand competition/displacement,74.0,ÂµM,=,,36.0,2.056,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.786394568917938
321,10.1074/jbc.M110960200,aa3r_human,244,L,A,I-AB-MECA,PubChem CID,44208896,Full agonist,K(d),Binding - Radioligand saturation,1.7,nM,=,,0.85,2.0,,,,0.0,0.0,=,0.0,,P0DMS8,0.5176279383322735
323,10.1074/jbc.M110960200,aa3r_human,244,L,A,NECA,PubChem CID,448222,Full agonist,K(i),Binding - Radioligand competition/displacement,249.0,nM,=,,68.0,3.662,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.5176279383322735
324,10.1074/jbc.M110960200,aa3r_human,244,L,A,Cl-IB-MECA,PubChem CID,393593,Full agonist,K(i),Binding - Radioligand competition/displacement,2.3,nM,=,,2.5,-1.087,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.5176279383322735
325,10.1074/jbc.M110960200,aa3r_human,244,L,A,MRS1898,PubChem CID,44354130,Full agonist,K(i),Binding - Radioligand competition/displacement,1.4,nM,=,,0.73,1.918,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.5176279383322735
326,10.1074/jbc.M110960200,aa3r_human,244,L,A,DBXRM,PubChem CID,11743031,Full agonist,K(i),Binding - Radioligand competition/displacement,2.83,ÂµM,=,,7.55,-2.667,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.5176279383322735
327,10.1074/jbc.M110960200,aa3r_human,244,L,A,CGS15943,PubChem CID,2690,Inverse agonist,K(i),Binding - Radioligand competition/displacement,182.0,nM,=,,209.0,-1.148,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.5176279383322735
328,10.1074/jbc.M110960200,aa3r_human,244,L,A,MRS1220,PubChem CID,393595,Inverse agonist,K(i),Binding - Radioligand competition/displacement,1.6,nM,=,,0.63,2.54,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.5176279383322735
329,10.1074/jbc.M110960200,aa3r_human,244,L,A,VUF8504,PubChem CID,10832101,Inverse agonist,K(i),Binding - Radioligand competition/displacement,68.0,nM,=,,42.0,1.619,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.5176279383322735
330,10.1074/jbc.M110960200,aa3r_human,244,L,A,XAC,PubChem CID,5697,Inverse agonist,K(i),Binding - Radioligand competition/displacement,0.142,ÂµM,=,,0.061,2.328,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.5176279383322735
331,10.1074/jbc.M110960200,aa3r_human,244,L,A,Cl-IB-MECA,PubChem CID,393593,Full agonist,EC50,Functional - IP accumulation,260.0,,=,,9430.0,-35.714,,,,0.0,0.0,=,0.0,,P0DMS8,0.5176279383322735
332,10.1124/mol.63.5.1021,aa3r_human,244,L,A,I-AB-MECA,PubChem CID,44208896,Full agonist,K(d),Binding - Radioligand saturation,1.2,nM,=,,0.85,1.412,,,,0.0,0.0,=,0.0,,P0DMS8,0.5176279383322735
333,10.1124/mol.63.5.1021,aa3r_human,244,L,A,HMA,PubChem CID,1794,Allosteric inverse agonist,IC50,Binding - Radioligand competition/displacement,1.8,ÂµM,=,,1.9,-1.056,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.5176279383322735
334,10.1124/mol.63.5.1021,aa3r_human,244,L,A,DU124183,PubChem CID,10426659,Allosteric inverse agonist,IC50,Binding - Radioligand competition/displacement,1.2,ÂµM,=,,2.1,-1.751,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.5176279383322735
335,10.1124/mol.63.5.1021,aa3r_human,244,L,A,VUF-5455,PubChem CID,10339071,Allosteric inverse agonist,IC50,Binding - Radioligand competition/displacement,2.8,ÂµM,=,,4.6,-1.642,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.5176279383322735
336,10.1124/mol.63.5.1021,aa3r_human,244,L,A,Cl-IB-MECA,PubChem CID,393593,Full agonist,K(i),Binding - Radioligand competition/displacement,2.3,nM,=,,2.5,-1.087,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.5176279383322735
337,10.1124/mol.63.5.1021,aa3r_human,244,L,A,MRS1220,PubChem CID,393595,Inverse agonist,K(i),Binding - Radioligand competition/displacement,1.6,nM,=,,0.63,2.54,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.5176279383322735
338,10.1124/mol.63.5.1021,aa3r_human,244,L,A,PSB-11,PubChem CID,9882625,Inverse agonist,K(i),Binding - Radioligand competition/displacement,2.8,nM,=,,2.3,1.217,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.5176279383322735
339,10.1124/mol.63.5.1021,aa3r_human,244,L,A,HMA,PubChem CID,1794,Allosteric inverse agonist,k-1,Binding - Radioligand kinetics (association/dissociation),0.028,min-1,=,,0.068,-2.427,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.5176279383322735
340,10.1124/mol.63.5.1021,aa3r_human,244,L,A,DU124183,PubChem CID,10426659,Allosteric inverse agonist,k-1,Binding - Radioligand kinetics (association/dissociation),0.029,min-1,=,,0.068,-2.347,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.5176279383322735
341,10.1124/mol.63.5.1021,aa3r_human,244,L,A,VUF-5455,PubChem CID,10339071,Allosteric inverse agonist,k-1,Binding - Radioligand kinetics (association/dissociation),0.025,min-1,=,,0.062,-2.481,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.5176279383322735
342,10.1124/mol.63.5.1021,aa3r_human,244,L,A,I-AB-MECA,PubChem CID,44208896,Full agonist,k-1,Binding - Radioligand kinetics (association/dissociation),0.064,min-1,=,,0.12,-1.876,,,,0.0,0.0,=,0.0,,P0DMS8,0.5176279383322735
343,10.1124/mol.63.5.1021,aa3r_human,244,L,A,PSB-11,PubChem CID,9882625,Inverse agonist,k-1,Binding - Radioligand kinetics (association/dissociation),0.23,min-1,=,,0.22,1.045,,,,0.0,0.0,=,0.0,,P0DMS8,0.5176279383322735
344,10.1124/mol.63.5.1021,aa3r_human,244,L,A,HMA,PubChem CID,1794,Allosteric inverse agonist,k-1,Binding - Radioligand kinetics (association/dissociation),0.46,min-1,=,,0.45,1.022,,,PSB-11,0.0,0.0,=,0.0,,P0DMS8,0.5176279383322735
345,10.1124/mol.63.5.1021,aa3r_human,244,L,A,Na+,PubChem CID,923,Allosteric inverse agonist,k-1,Binding - Radioligand kinetics (association/dissociation),0.1,min-1,=,,0.11,-1.1,,,PSB-11,0.0,0.0,=,0.0,,P0DMS8,0.5176279383322735
346,10.1074/jbc.M110960200,aa3r_human,247,S,A,I-AB-MECA,PubChem CID,44208896,Full agonist,K(d),Binding - Radioligand saturation,1.7,nM,=,,1.7,1.0,,,,0.0,0.0,=,0.0,,P0DMS8,0.4446924162851705
347,10.1074/jbc.M110960200,aa3r_human,247,S,A,CADO,PubChem CID,8974,Full agonist,K(i),Binding - Radioligand competition/displacement,523.0,nM,=,,927.0,-1.773,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.4446924162851705
348,10.1074/jbc.M110960200,aa3r_human,247,S,A,NECA,PubChem CID,448222,Full agonist,K(i),Binding - Radioligand competition/displacement,249.0,nM,=,,247.0,1.008,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.4446924162851705
349,10.1074/jbc.M110960200,aa3r_human,247,S,A,Cl-IB-MECA,PubChem CID,393593,Full agonist,K(i),Binding - Radioligand competition/displacement,2.3,nM,=,,2.2,1.045,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.4446924162851705
350,10.1074/jbc.M110960200,aa3r_human,247,S,A,MRS1898,PubChem CID,44354130,Full agonist,K(i),Binding - Radioligand competition/displacement,1.4,nM,=,,1.5,-1.072,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.4446924162851705
351,10.1074/jbc.M110960200,aa3r_human,247,S,A,DBXRM,PubChem CID,11743031,Full agonist,K(i),Binding - Radioligand competition/displacement,2.83,ÂµM,=,,3.04,-1.074,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.4446924162851705
352,10.1074/jbc.M110960200,aa3r_human,247,S,A,CGS15943,PubChem CID,2690,Inverse agonist,K(i),Binding - Radioligand competition/displacement,182.0,nM,=,,333.0,-1.828,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.4446924162851705
353,10.1074/jbc.M110960200,aa3r_human,247,S,A,MRS1220,PubChem CID,393595,Inverse agonist,K(i),Binding - Radioligand competition/displacement,1.6,nM,=,,3.1,-1.938,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.4446924162851705
354,10.1074/jbc.M110960200,aa3r_human,247,S,A,VUF8504,PubChem CID,10832101,Inverse agonist,K(i),Binding - Radioligand competition/displacement,68.0,nM,=,,81.0,-1.19,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.4446924162851705
355,10.1074/jbc.M110960200,aa3r_human,247,S,A,XAC,PubChem CID,5697,Inverse agonist,K(i),Binding - Radioligand competition/displacement,0.142,ÂµM,=,,0.165,-1.161,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.4446924162851705
356,10.1124/mol.63.5.1021,aa3r_human,247,S,A,I-AB-MECA,PubChem CID,44208896,Full agonist,K(d),Binding - Radioligand saturation,1.2,nM,=,,1.7,-1.416,,,,0.0,0.0,=,0.0,,P0DMS8,0.4446924162851705
357,10.1124/mol.63.5.1021,aa3r_human,247,S,A,HMA,PubChem CID,1794,Allosteric inverse agonist,IC50,Binding - Radioligand competition/displacement,1.8,ÂµM,=,,0.9,2.0,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.4446924162851705
358,10.1124/mol.63.5.1021,aa3r_human,247,S,A,DU124183,PubChem CID,10426659,Allosteric inverse agonist,IC50,Binding - Radioligand competition/displacement,1.2,ÂµM,=,,1.0,1.2,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.4446924162851705
359,10.1124/mol.63.5.1021,aa3r_human,247,S,A,VUF-5455,PubChem CID,10339071,Allosteric inverse agonist,IC50,Binding - Radioligand competition/displacement,2.8,ÂµM,=,,3.9,-1.393,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.4446924162851705
360,10.1124/mol.63.5.1021,aa3r_human,247,S,A,Cl-IB-MECA,PubChem CID,393593,Full agonist,K(i),Binding - Radioligand competition/displacement,2.3,nM,=,,2.2,1.045,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.4446924162851705
361,10.1124/mol.63.5.1021,aa3r_human,247,S,A,MRS1220,PubChem CID,393595,Inverse agonist,K(i),Binding - Radioligand competition/displacement,1.6,nM,=,,3.1,-1.938,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.4446924162851705
362,10.1124/mol.63.5.1021,aa3r_human,247,S,A,PSB-11,PubChem CID,9882625,Inverse agonist,K(i),Binding - Radioligand competition/displacement,2.8,nM,=,,2.9,-1.035,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.4446924162851705
363,10.1124/mol.63.5.1021,aa3r_human,247,S,A,HMA,PubChem CID,1794,Allosteric inverse agonist,k-1,Binding - Radioligand kinetics (association/dissociation),0.028,min-1,=,,0.035,-1.25,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.4446924162851705
364,10.1124/mol.63.5.1021,aa3r_human,247,S,A,DU124183,PubChem CID,10426659,Allosteric inverse agonist,k-1,Binding - Radioligand kinetics (association/dissociation),0.029,min-1,=,,0.037,-1.276,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.4446924162851705
365,10.1124/mol.63.5.1021,aa3r_human,247,S,A,VUF-5455,PubChem CID,10339071,Allosteric inverse agonist,k-1,Binding - Radioligand kinetics (association/dissociation),0.025,min-1,=,,0.035,-1.401,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.4446924162851705
366,10.1124/mol.63.5.1021,aa3r_human,247,S,A,I-AB-MECA,PubChem CID,44208896,Full agonist,k-1,Binding - Radioligand kinetics (association/dissociation),0.064,min-1,=,,0.067,-1.047,,,,0.0,0.0,=,0.0,,P0DMS8,0.4446924162851705
367,10.1124/mol.63.5.1021,aa3r_human,247,S,A,PSB-11,PubChem CID,9882625,Inverse agonist,k-1,Binding - Radioligand kinetics (association/dissociation),0.23,min-1,=,,0.24,-1.044,,,,0.0,0.0,=,0.0,,P0DMS8,0.4446924162851705
368,10.1124/mol.63.5.1021,aa3r_human,247,S,A,HMA,PubChem CID,1794,Allosteric inverse agonist,k-1,Binding - Radioligand kinetics (association/dissociation),0.46,min-1,=,,0.47,-1.021,,,PSB-11,0.0,0.0,=,0.0,,P0DMS8,0.4446924162851705
369,10.1124/mol.63.5.1021,aa3r_human,247,S,A,Na+,PubChem CID,923,Allosteric inverse agonist,k-1,Binding - Radioligand kinetics (association/dissociation),0.1,min-1,=,,0.12,-1.2,,,PSB-11,0.0,0.0,=,0.0,,P0DMS8,0.4446924162851705
433,10.1021/jm050968b,aa3r_human,272,H,D,CID75022615,PubChem CID,75022615,Full agonist,K(i),Binding - Radioligand competition/displacement,0.14,ÂµM,=,,0.12,1.167,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.5639166722062356
435,10.1021/jm050968b,aa3r_human,272,H,D,CID85116573,PubChem CID,85116573,Full agonist,K(i),Binding - Radioligand competition/displacement,9.5,ÂµM,=,,0.85,11.176,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.5639166722062356
436,10.1021/jm050968b,aa3r_human,272,H,D,CID75022525,PubChem CID,75022525,Full agonist,K(i),Binding - Radioligand competition/displacement,13.8,ÂµM,=,,2.0,6.9,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.5639166722062356
437,10.1021/jm050968b,aa3r_human,272,H,D,CID75022483,PubChem CID,75022483,Full agonist,K(i),Binding - Radioligand competition/displacement,0.56,ÂµM,=,,0.39,1.436,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.5639166722062356
439,10.1021/jm050968b,aa3r_human,272,H,D,CHEMBL377071,ChEMBL Compound ID,377071,Full agonist,K(i),Binding - Radioligand competition/displacement,2.26,ÂµM,=,,0.14,16.143,,,I-AB-MECA,0.0,0.0,=,0.0,,P0DMS8,0.5639166722062356
457,10.1006/bbrc.2001.5027,aa3r_human,282,Y,F,Cl-IB-MECA,PubChem CID,393593,Full agonist,EC50,Functional - IP accumulation,0.951,ÂµM,=,,27.6,-29.412,,,,0.0,0.0,=,0.0,,P0DMS8,0.6755309769016514
458,10.1006/bbrc.2001.5027,aa3r_human,282,Y,F,I-AB-MECA,PubChem CID,44208896,Full agonist,K(d),Binding - Radioligand saturation,1.2,nM,=,,9.3,-7.752,,,,0.0,0.0,=,0.0,,P0DMS8,0.6755309769016514
459,10.1006/bbrc.2001.5027,aa3r_human,282,Y,F,Cl-IB-MECA,PubChem CID,393593,Full agonist,K(i),Binding - Radioligand competition/displacement,3.8,nM,=,,33.6,-8.85,,,,0.0,0.0,=,0.0,,P0DMS8,0.6755309769016514
